activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	32334	CHEMBL844999	Inhibition of src at 5 mM ATP	B	Nc1ncnc2c1c(-c1cccc(Oc3ccccc3)c1)cn2C1CCCC1		CHEMBL69638	>	IC50	nM	1000.0	CHEMBL267	Homo sapiens	IC50	uM	1.0
	32334	CHEMBL844999	Inhibition of src at 5 mM ATP	B	Nc1ncnc2c1c(-c1cccc(Oc3ccccc3)c1)cn2C1CCCC1		CHEMBL69638	>	IC50	nM	1000.0	CHEMBL267	Homo sapiens	IC50	uM	1.0
	34282	CHEMBL806439	Selectivity for Src protein tyrosine kinase over (KDR) kinase insert domain receptor	B	Cc1ccc(Nc2ncc(-c3ccccc3)s2)nc1		CHEMBL330621	=	Selectivity		570.0	CHEMBL267	Homo sapiens	Selectivity		570.0
	37868	CHEMBL806439	Selectivity for Src protein tyrosine kinase over (KDR) kinase insert domain receptor	B	Cc1ccnc(Nc2ncc(-c3ccccc3)s2)c1		CHEMBL319065	=	Selectivity		190.0	CHEMBL267	Homo sapiens	Selectivity		190.0
	40263	CHEMBL806439	Selectivity for Src protein tyrosine kinase over (KDR) kinase insert domain receptor	B	Cc1cccc(Nc2ncc(-c3ccccc3)s2)n1		CHEMBL98385	=	Selectivity		760.0	CHEMBL267	Homo sapiens	Selectivity		760.0
	40692	CHEMBL844999	Inhibition of src at 5 mM ATP	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1O		CHEMBL419082	=	IC50	nM	40.0	CHEMBL267	Homo sapiens	IC50	uM	0.04
Not Determined	41978	CHEMBL845000	Inhibition of src at 5 mM ATP (not tested)	B	c1ccc(Oc2ccc(Nc3ncnc4ccccc34)cc2)cc1		CHEMBL304760		IC50	nM		CHEMBL267	Homo sapiens	IC50	uM	
	41985	CHEMBL844999	Inhibition of src at 5 mM ATP	B	CC(C)n1cc(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc21		CHEMBL307982	=	IC50	nM	48.0	CHEMBL267	Homo sapiens	IC50	uM	0.048
	42688	CHEMBL806439	Selectivity for Src protein tyrosine kinase over (KDR) kinase insert domain receptor	B	O=C(Nc1ncc(-c2ccccc2)s1)c1ccccc1		CHEMBL98633	>	Selectivity		240.0	CHEMBL267	Homo sapiens	Selectivity		240.0
Not Determined	43151	CHEMBL845000	Inhibition of src at 5 mM ATP (not tested)	B	Nc1ncnc2c1c(-c1ccccc1Oc1ccccc1)cn2C1CCCC1		CHEMBL68774		IC50	nM		CHEMBL267	Homo sapiens	IC50	uM	
	46274	CHEMBL806439	Selectivity for Src protein tyrosine kinase over (KDR) kinase insert domain receptor	B	Cc1cccnc1Nc1ncc(-c2ccccc2)s1		CHEMBL329713	=	Selectivity		1200.0	CHEMBL267	Homo sapiens	Selectivity		1200.0
	48773	CHEMBL806439	Selectivity for Src protein tyrosine kinase over (KDR) kinase insert domain receptor	B	CCCCN(C)c1ccc(/N=N/c2ncc([N+](=O)[O-])s2)c(C)c1		CHEMBL100174	>	Selectivity		130.0	CHEMBL267	Homo sapiens	Selectivity		130.0
	49411	CHEMBL844999	Inhibition of src at 5 mM ATP	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCC(O)C1		CHEMBL69129	=	IC50	nM	88.0	CHEMBL267	Homo sapiens	IC50	uM	0.088
	50208	CHEMBL806439	Selectivity for Src protein tyrosine kinase over (KDR) kinase insert domain receptor	B	c1ccc(-c2cnc(Nc3ccccn3)s2)cc1		CHEMBL98538	=	Selectivity		280.0	CHEMBL267	Homo sapiens	Selectivity		280.0
	51885	CHEMBL844999	Inhibition of src at 5 mM ATP	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CC(O)C(O)C1		CHEMBL69827	=	IC50	nM	84.0	CHEMBL267	Homo sapiens	IC50	uM	0.084
	53295	CHEMBL844999	Inhibition of src at 5 mM ATP	B	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	=	IC50	nM	170.0	CHEMBL267	Homo sapiens	IC50	uM	0.17
	53973	CHEMBL806439	Selectivity for Src protein tyrosine kinase over (KDR) kinase insert domain receptor	B	Brc1cccc(Nc2ncc(-c3ccccc3)s2)n1		CHEMBL101464	=	Selectivity		840.0	CHEMBL267	Homo sapiens	Selectivity		840.0
	55136	CHEMBL806439	Selectivity for Src protein tyrosine kinase over (KDR) kinase insert domain receptor	B	Clc1ccc(Nc2ncc(-c3ccccc3)s2)nc1		CHEMBL319789	>	Selectivity		580.0	CHEMBL267	Homo sapiens	Selectivity		580.0
	60799	CHEMBL844999	Inhibition of src at 5 mM ATP	B	CC(C)(C)n1cc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL306012	=	IC50	nM	150.0	CHEMBL267	Homo sapiens	IC50	uM	0.15
	62145	CHEMBL844999	Inhibition of src at 5 mM ATP	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	IC50	nM	70.0	CHEMBL267	Homo sapiens	IC50	uM	0.07
	66112	CHEMBL844999	Inhibition of src at 5 mM ATP	B	CC(C)(C)n1cc(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc21		CHEMBL302281	=	IC50	nM	610.0	CHEMBL267	Homo sapiens	IC50	uM	0.61
	66862	CHEMBL806439	Selectivity for Src protein tyrosine kinase over (KDR) kinase insert domain receptor	B	N#Cc1cnc(Nc2ccccn2)s1		CHEMBL101544	=	Selectivity		678.0	CHEMBL267	Homo sapiens	Selectivity		678.0
	72283	CHEMBL805362	In vitro inhibition of Src protein tyrosine kinase using the Scintillation proximity kinase assay.	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2-c1ccc(CCOP(=O)(O)CP(=O)(O)O)cc1		CHEMBL104215	=	IC50	nM	60.0	CHEMBL267	Homo sapiens	IC50	uM	0.06
	72284	CHEMBL805362	In vitro inhibition of Src protein tyrosine kinase using the Scintillation proximity kinase assay.	B	COc1cccc(-c2cn(-c3ccc(C(=O)Nc4ccc(P(=O)(O)O)c(P(=O)(O)O)c4)cc3)c3ncnc(N)c23)c1		CHEMBL321569	=	IC50	nM	870.0	CHEMBL267	Homo sapiens	IC50	uM	0.87
	72318	CHEMBL882727	Inhibitory concentration against Src protein tyrosine kinase	B	COc1cc(Nc2c(C#N)cnc3cc(-c4cccc(CCN5CCOCC5)c4)ccc23)c(Cl)cc1Cl		CHEMBL103293	=	IC50	nM	29.0	CHEMBL267	Homo sapiens	IC50	nM	29.0
	73283	CHEMBL805362	In vitro inhibition of Src protein tyrosine kinase using the Scintillation proximity kinase assay.	B	Cc1ccc(-c2cn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL321779	=	IC50	nM	120.0	CHEMBL267	Homo sapiens	IC50	uM	0.12
	73317	CHEMBL882727	Inhibitory concentration against Src protein tyrosine kinase	B	CCN1CCN(CCc2ccc(-c3ccc4c(Nc5cc(OC)c(Cl)cc5Cl)c(C#N)cnc4c3)cc2)CC1		CHEMBL103454	=	IC50	nM	3.7	CHEMBL267	Homo sapiens	IC50	nM	3.7
	73319	CHEMBL882727	Inhibitory concentration against Src protein tyrosine kinase	B	COc1cc(Nc2c(C#N)cnc3cc(-c4cccc(CN5CCN(C)CC5)c4)ccc23)c(Cl)cc1Cl		CHEMBL102595	=	IC50	nM	14.0	CHEMBL267	Homo sapiens	IC50	nM	14.0
	74394	CHEMBL882727	Inhibitory concentration against Src protein tyrosine kinase	B	COc1cc(Nc2c(C#N)cnc3cc(-c4cccc(CCN5CCOCC5)c4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL419171	=	IC50	nM	74.0	CHEMBL267	Homo sapiens	IC50	nM	74.0
	74396	CHEMBL882727	Inhibitory concentration against Src protein tyrosine kinase	B	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(CCN5CCOCC5)cc4)ccc23)c(Cl)cc1Cl		CHEMBL102165	=	IC50	nM	14.0	CHEMBL267	Homo sapiens	IC50	nM	14.0
	76647	CHEMBL805362	In vitro inhibition of Src protein tyrosine kinase using the Scintillation proximity kinase assay.	B	CN(CCO)CCc1ccc(-n2cc(-c3cccc(O)c3)c3c(N)ncnc32)cc1		CHEMBL105056	=	IC50	nM	40.0	CHEMBL267	Homo sapiens	IC50	uM	0.04
	76679	CHEMBL882727	Inhibitory concentration against Src protein tyrosine kinase	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	IC50	nM	1.3	CHEMBL267	Homo sapiens	IC50	nM	1.3
	78011	CHEMBL843061	Evaluated for inhibitory activity towards p60 c-Src tyrosine kinase	B	COc1cccc(-c2ccc3c(c2)NC(=O)/C3=C\c2[nH]c3c(c2CCC(=O)O)CCCC3)c1		CHEMBL432941	=	IC50	nM	100.0	CHEMBL267	Homo sapiens	IC50	uM	0.1
	79180	CHEMBL843061	Evaluated for inhibitory activity towards p60 c-Src tyrosine kinase	B	COc1ccc2c(c1)NC(=O)/C2=C\c1[nH]c2c(c1CCC(=O)O)CCCC2		CHEMBL420609	=	IC50	nM	1390.0	CHEMBL267	Homo sapiens	IC50	uM	1.39
	80322	CHEMBL843061	Evaluated for inhibitory activity towards p60 c-Src tyrosine kinase	B	COc1cccc(-c2ccc3c(c2)NC(=O)/C3=C\c2cc3c([nH]2)CCCC3)c1		CHEMBL419682	>	IC50	nM	20000.0	CHEMBL267	Homo sapiens	IC50	uM	20.0
	81206	CHEMBL882727	Inhibitory concentration against Src protein tyrosine kinase	B	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(CN5CCOCC5)cc4)ccc23)c(Cl)cc1Cl		CHEMBL322395	=	IC50	nM	3.3	CHEMBL267	Homo sapiens	IC50	nM	3.3
	83551	CHEMBL843061	Evaluated for inhibitory activity towards p60 c-Src tyrosine kinase	B	COc1ccccc1-c1ccc2c(c1)NC(=O)/C2=C\c1cc2c([nH]1)CCCC2		CHEMBL88462	>	IC50	nM	20000.0	CHEMBL267	Homo sapiens	IC50	uM	20.0
	84548	CHEMBL843061	Evaluated for inhibitory activity towards p60 c-Src tyrosine kinase	B	O=C(O)CCc1c(/C=C2\C(=O)Nc3ccc(C(=O)O)cc32)[nH]c2c1CCCC2		CHEMBL431996	=	IC50	nM	60.0	CHEMBL267	Homo sapiens	IC50	uM	0.06
	85354	CHEMBL805362	In vitro inhibition of Src protein tyrosine kinase using the Scintillation proximity kinase assay.	B	COc1cccc(-c2cn(-c3cccc(C(=O)Nc4ccc(C(P(=O)(O)O)P(=O)(O)O)cc4)c3)c3ncnc(N)c23)c1		CHEMBL104077	=	IC50	nM	19000.0	CHEMBL267	Homo sapiens	IC50	uM	19.0
	85634	CHEMBL843061	Evaluated for inhibitory activity towards p60 c-Src tyrosine kinase	B	COc1ccc2c(c1)NC(=O)/C2=C\c1cc2c([nH]1)CCCC2		CHEMBL91250	>	IC50	nM	20000.0	CHEMBL267	Homo sapiens	IC50	uM	20.0
	85643	CHEMBL843061	Evaluated for inhibitory activity towards p60 c-Src tyrosine kinase	B	O=C(O)CCc1c(/C=C2\C(=O)Nc3cc(-c4ccccc4)ccc32)[nH]c2c1CCCC2		CHEMBL88771	=	IC50	nM	110.0	CHEMBL267	Homo sapiens	IC50	uM	0.11
	86223	CHEMBL805362	In vitro inhibition of Src protein tyrosine kinase using the Scintillation proximity kinase assay.	B	COc1cccc(-c2cn(-c3ccc(C(=O)NCCCP(=O)(O)CP(=O)(O)O)cc3)c3ncnc(N)c23)c1		CHEMBL104857	=	IC50	nM	250.0	CHEMBL267	Homo sapiens	IC50	uM	0.25
	86274	CHEMBL882727	Inhibitory concentration against Src protein tyrosine kinase	B	COc1cc(Nc2c(C#N)cnc3cc(-c4ccccc4CN4CCOCC4)ccc23)c(Cl)cc1Cl		CHEMBL100076	=	IC50	nM	4000.0	CHEMBL267	Homo sapiens	IC50	nM	4000.0
	87306	CHEMBL805362	In vitro inhibition of Src protein tyrosine kinase using the Scintillation proximity kinase assay.	B	COc1cccc(-c2cn(-c3ccc(CCO)cc3)c3ncnc(N)c23)c1		CHEMBL320417	=	IC50	nM	1150.0	CHEMBL267	Homo sapiens	IC50	uM	1.15
	87307	CHEMBL805362	In vitro inhibition of Src protein tyrosine kinase using the Scintillation proximity kinase assay.	B	Cc1ccc(-c2nn(-c3cccc(C(=O)NCCCP(=O)(O)CP(=O)(O)O)c3)c3ncnc(N)c23)cc1		CHEMBL3706662	=	IC50	nM	400.0	CHEMBL267	Homo sapiens	IC50	uM	0.4
	87622	CHEMBL843061	Evaluated for inhibitory activity towards p60 c-Src tyrosine kinase	B	COc1ccc(-c2ccc3c(c2)NC(=O)/C3=C\c2[nH]c3c(c2CCC(=O)O)CCCC3)cc1		CHEMBL91815	=	IC50	nM	60.0	CHEMBL267	Homo sapiens	IC50	uM	0.06
	88332	CHEMBL805362	In vitro inhibition of Src protein tyrosine kinase using the Scintillation proximity kinase assay.	B	COc1cccc(-c2cn(-c3cccc(C(=O)Nc4ccc(P(=O)(O)O)c(P(=O)(O)O)c4)c3)c3ncnc(N)c23)c1		CHEMBL105516	=	IC50	nM	2500.0	CHEMBL267	Homo sapiens	IC50	uM	2.5
	88633	CHEMBL843061	Evaluated for inhibitory activity towards p60 c-Src tyrosine kinase	B	O=C1Nc2ccccc2/C1=C/c1cc2c([nH]1)CCCC2		CHEMBL328029	=	IC50	nM	4740.0	CHEMBL267	Homo sapiens	IC50	uM	4.74
	88642	CHEMBL843061	Evaluated for inhibitory activity towards p60 c-Src tyrosine kinase	B	O=C(O)CCc1c(/C=C2\C(=O)Nc3ccc(Br)cc32)[nH]c2c1CCCC2		CHEMBL314995	=	IC50	nM	1270.0	CHEMBL267	Homo sapiens	IC50	uM	1.27
	89335	CHEMBL882727	Inhibitory concentration against Src protein tyrosine kinase	B	COc1cc(Nc2c(C#N)cnc3cc(-c4cccc(CN5CCOCC5)c4)ccc23)c(Cl)cc1Cl		CHEMBL103839	=	IC50	nM	28.0	CHEMBL267	Homo sapiens	IC50	nM	28.0
	90223	CHEMBL805362	In vitro inhibition of Src protein tyrosine kinase using the Scintillation proximity kinase assay.	B	COc1cccc(-c2cn(-c3ccc(CCN(C)CCOP(=O)(O)CP(=O)(O)O)cc3)c3ncnc(N)c23)c1		CHEMBL421025	=	IC50	nM	310.0	CHEMBL267	Homo sapiens	IC50	uM	0.31
	91347	CHEMBL882727	Inhibitory concentration against Src protein tyrosine kinase	B	CCN1CCN(Cc2ccc(-c3ccc4c(Nc5cc(OC)c(Cl)cc5Cl)c(C#N)cnc4c3)cc2)CC1		CHEMBL100825	=	IC50	nM	3.0	CHEMBL267	Homo sapiens	IC50	nM	3.0
	91572	CHEMBL843061	Evaluated for inhibitory activity towards p60 c-Src tyrosine kinase	B	NS(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL88483	=	IC50	nM	80.0	CHEMBL267	Homo sapiens	IC50	uM	0.08
	91581	CHEMBL843061	Evaluated for inhibitory activity towards p60 c-Src tyrosine kinase	B	O=C1Nc2cc(-c3ccccc3)ccc2/C1=C/c1cc2c([nH]1)CCCC2		CHEMBL313746	>	IC50	nM	20000.0	CHEMBL267	Homo sapiens	IC50	uM	20.0
	91590	CHEMBL843061	Evaluated for inhibitory activity towards p60 c-Src tyrosine kinase	B	Cc1c[nH]c(/C=C2\C(=O)Nc3ccccc32)c1CCC(=O)O		CHEMBL89363	=	IC50	nM	10600.0	CHEMBL267	Homo sapiens	IC50	uM	10.6
	92272	CHEMBL805362	In vitro inhibition of Src protein tyrosine kinase using the Scintillation proximity kinase assay.	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2-c1ccc(CCO)cc1		CHEMBL102946	=	IC50	nM	40.0	CHEMBL267	Homo sapiens	IC50	uM	0.04
	92602	CHEMBL843061	Evaluated for inhibitory activity towards p60 c-Src tyrosine kinase	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	IC50	nM	16400.0	CHEMBL267	Homo sapiens	IC50	uM	16.4
	93279	CHEMBL805362	In vitro inhibition of Src protein tyrosine kinase using the Scintillation proximity kinase assay.	B	CN(CCOP(=O)(O)CP(=O)(O)O)CCc1ccc(-n2cc(-c3cccc(O)c3)c3c(N)ncnc32)cc1		CHEMBL318996	=	IC50	nM	4.0	CHEMBL267	Homo sapiens	IC50	uM	0.004
	94280	CHEMBL882727	Inhibitory concentration against Src protein tyrosine kinase	B	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(CCN5CCOCC5)cc4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL101081	=	IC50	nM	11.0	CHEMBL267	Homo sapiens	IC50	nM	11.0
	94282	CHEMBL882727	Inhibitory concentration against Src protein tyrosine kinase	B	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(CN5CCN(C)CC5)cc4)ccc23)c(Cl)cc1Cl		CHEMBL317821	=	IC50	nM	3.8	CHEMBL267	Homo sapiens	IC50	nM	3.8
	95252	CHEMBL805362	In vitro inhibition of Src protein tyrosine kinase using the Scintillation proximity kinase assay.	B	COc1cccc(-c2cn(-c3cccc(C(=O)O)c3)c3ncnc(N)c23)c1		CHEMBL105005	=	IC50	nM	4000.0	CHEMBL267	Homo sapiens	IC50	uM	4.0
	95253	CHEMBL805362	In vitro inhibition of Src protein tyrosine kinase using the Scintillation proximity kinase assay.	B	Nc1ncnc2c1c(-c1cccc(O)c1)nn2-c1cccc(P(=O)(O)CC(=O)O)c1		CHEMBL3706663	=	IC50	nM	20.0	CHEMBL267	Homo sapiens	IC50	uM	0.02
	95254	CHEMBL805362	In vitro inhibition of Src protein tyrosine kinase using the Scintillation proximity kinase assay.	B	Cc1ccc(-c2nn(-c3cccc(C(=O)NCc4ccc(P(=O)(O)O)c(P(=O)(O)O)c4)c3)c3ncnc(N)c23)cc1		CHEMBL3706661	=	IC50	nM	320.0	CHEMBL267	Homo sapiens	IC50	uM	0.32
	96281	CHEMBL805362	In vitro inhibition of Src protein tyrosine kinase using the Scintillation proximity kinase assay.	B	COc1cccc(-c2cn(-c3ccc(C(=O)O)cc3)c3ncnc(N)c23)c1		CHEMBL317693	=	IC50	nM	1500.0	CHEMBL267	Homo sapiens	IC50	uM	1.5
	96312	CHEMBL882727	Inhibitory concentration against Src protein tyrosine kinase	B	COc1cc(Nc2c(C#N)cnc3cc(-c4cccc(CN5CCOCC5)c4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL99637	=	IC50	nM	150.0	CHEMBL267	Homo sapiens	IC50	nM	150.0
	96621	CHEMBL843061	Evaluated for inhibitory activity towards p60 c-Src tyrosine kinase	B	COc1ccc(-c2ccc3c(c2)NC(=O)/C3=C\c2cc3c([nH]2)CCCC3)cc1		CHEMBL313500	>	IC50	nM	20000.0	CHEMBL267	Homo sapiens	IC50	uM	20.0
	97344	CHEMBL805362	In vitro inhibition of Src protein tyrosine kinase using the Scintillation proximity kinase assay.	B	COc1cccc(-c2cn(-c3ccc(C(=O)Nc4ccc(C(P(=O)(O)O)P(=O)(O)O)cc4)cc3)c3ncnc(N)c23)c1		CHEMBL101795	=	IC50	nM	40000.0	CHEMBL267	Homo sapiens	IC50	uM	40.0
	98657	CHEMBL843061	Evaluated for inhibitory activity towards p60 c-Src tyrosine kinase	B	O=C1Nc2ccc(C(=O)O)cc2/C1=C/c1cc2c([nH]1)CCCC2		CHEMBL89010	=	IC50	nM	120.0	CHEMBL267	Homo sapiens	IC50	uM	0.12
	98666	CHEMBL843061	Evaluated for inhibitory activity towards p60 c-Src tyrosine kinase	B	NS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCC(=O)O)CCCC3)C(=O)N2		CHEMBL86531	=	IC50	nM	680.0	CHEMBL267	Homo sapiens	IC50	uM	0.68
	99307	CHEMBL882727	Inhibitory concentration against Src protein tyrosine kinase	B	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(CN5CCOCC5)cc4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL318429	=	IC50	nM	15.0	CHEMBL267	Homo sapiens	IC50	nM	15.0
	99529	CHEMBL843061	Evaluated for inhibitory activity towards p60 c-Src tyrosine kinase	B	O=C(O)CCc1c(/C=C2\C(=O)Nc3ccccc32)[nH]c2c1CCCC2		CHEMBL315753	=	IC50	nM	1890.0	CHEMBL267	Homo sapiens	IC50	uM	1.89
	101339	CHEMBL805362	In vitro inhibition of Src protein tyrosine kinase using the Scintillation proximity kinase assay.	B	COc1cccc(-c2cn(-c3ccc(CCN(C)CCO)cc3)c3ncnc(N)c23)c1		CHEMBL105436	=	IC50	nM	160.0	CHEMBL267	Homo sapiens	IC50	uM	0.16
	102362	CHEMBL805362	In vitro inhibition of Src protein tyrosine kinase using the Scintillation proximity kinase assay.	B	COc1cccc(-c2cn(-c3cccc(C(=O)NCCCP(=O)(O)CP(=O)(O)O)c3)c3ncnc(N)c23)c1		CHEMBL321116	=	IC50	nM	360.0	CHEMBL267	Homo sapiens	IC50	uM	0.36
	102363	CHEMBL805362	In vitro inhibition of Src protein tyrosine kinase using the Scintillation proximity kinase assay.	B	Cc1ccc(-c2nn(CCCCOP(=O)(O)CP(=O)(O)O)c3ncnc(N)c23)cc1		CHEMBL421405	=	IC50	nM	680.0	CHEMBL267	Homo sapiens	IC50	uM	0.68
	102391	CHEMBL882727	Inhibitory concentration against Src protein tyrosine kinase	B	CCN1CCN(Cc2ccc(-c3cc4ncc(C#N)c(Nc5cc(OC)c(Cl)cc5Cl)c4cc3OC)cc2)CC1		CHEMBL103627	=	IC50	nM	7.0	CHEMBL267	Homo sapiens	IC50	nM	7.0
	102393	CHEMBL882727	Inhibitory concentration against Src protein tyrosine kinase	B	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(CN5CCN(CCO)CC5)cc4)ccc23)c(Cl)cc1Cl		CHEMBL102727	=	IC50	nM	4.7	CHEMBL267	Homo sapiens	IC50	nM	4.7
	104237	CHEMBL805362	In vitro inhibition of Src protein tyrosine kinase using the Scintillation proximity kinase assay.	B	COc1cccc(-c2cn(-c3ccc(CCOP(=O)(O)CP(=O)(O)O)cc3)c3ncnc(N)c23)c1		CHEMBL102183	=	IC50	nM	700.0	CHEMBL267	Homo sapiens	IC50	uM	0.7
	104238	CHEMBL805362	In vitro inhibition of Src protein tyrosine kinase using the Scintillation proximity kinase assay.	B	COc1cccc(-c2nn(-c3cccc(P(=O)(O)CC(=O)O)c3)c3ncnc(N)c23)c1		CHEMBL3706664	=	IC50	nM	1600.0	CHEMBL267	Homo sapiens	IC50	uM	1.6
	104506	CHEMBL843061	Evaluated for inhibitory activity towards p60 c-Src tyrosine kinase	B	O=C1Nc2ccc(Br)cc2/C1=C/c1cc2c([nH]1)CCCC2		CHEMBL88606	=	IC50	nM	4920.0	CHEMBL267	Homo sapiens	IC50	uM	4.92
	104515	CHEMBL843061	Evaluated for inhibitory activity towards p60 c-Src tyrosine kinase	B	COc1ccccc1-c1ccc2c(c1)NC(=O)/C2=C\c1[nH]c2c(c1CCC(=O)O)CCCC2		CHEMBL313821	=	IC50	nM	840.0	CHEMBL267	Homo sapiens	IC50	uM	0.84
	105576	CHEMBL821534	Inhibitory activity against c-src tyrosine kinase	B	O=C1NC(=O)c2cc(NC3CCCCC3)c(NC3CCCCC3)cc21		CHEMBL266969	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	106904	CHEMBL809573	Inhibitory activity against binding of Src protein tyrosine kinase SH2 domain to biotinylated EPQY*EEIPI Peptide by ELISA.	B	CC(C)[C@H]1NC(=O)[C@H](Cc2ccc(OP(=O)(O)O)cc2)NC(=O)OCCCCCNC(=O)[C@@H]2CCCN2C(=O)[C@@H](C(C)C)NC(=O)[C@H](CC(N)=O)NC1=O		CHEMBL435738	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	106906	CHEMBL809573	Inhibitory activity against binding of Src protein tyrosine kinase SH2 domain to biotinylated EPQY*EEIPI Peptide by ELISA.	B	CC(=O)N[C@H]1CCCCNC(=O)[C@H]2CCCN2C(=O)[C@H](C(C)C)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@H](CC2CCCCC2)NC(=O)[C@@H](Cc2ccc(OP(=O)(O)O)cc2)NC1=O	Outside typical range	CHEMBL451250	>	IC50	nM	150000.0	CHEMBL267	Homo sapiens	IC50	uM	150.0
	107804	CHEMBL843949	Inhibition of tyrosine phosphorylation activity of the pp60v-src tyrosine kinase, protein from v-src baculovirus-infected insect cells	B	Cn1c(SSc2c(C(=O)Nc3ccccc3)c3cccc(Cl)c3n2C)c(C(=O)Nc2ccccc2)c2cccc(Cl)c21		CHEMBL291667	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	110219	CHEMBL843949	Inhibition of tyrosine phosphorylation activity of the pp60v-src tyrosine kinase, protein from v-src baculovirus-infected insect cells	B	COc1cccc2c(C(=O)Nc3ccccc3)c(SSc3c(C(=O)Nc4ccccc4)c4cccc(OC)c4n3C)n(C)c12		CHEMBL292323	=	IC50	nM	3600.0	CHEMBL267	Homo sapiens	IC50	uM	3.6
	110539	CHEMBL809573	Inhibitory activity against binding of Src protein tyrosine kinase SH2 domain to biotinylated EPQY*EEIPI Peptide by ELISA.	B	CC(C)[C@H]1NC(=O)[C@H](Cc2ccc(OP(=O)(O)O)cc2)NC(=O)CCCCCCNC(=O)[C@@H]2CCCN2C(=O)[C@@H](C(C)C)NC(=O)[C@H](CC(N)=O)NC1=O		CHEMBL177372	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	110541	CHEMBL809573	Inhibitory activity against binding of Src protein tyrosine kinase SH2 domain to biotinylated EPQY*EEIPI Peptide by ELISA.	B	C/C(S)=N/[C@H]1CCCCNC(=O)[C@H]2CCCN2C(=O)[C@H](C(C)C)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](Cc2ccc(OP(=O)(O)O)cc2)NC1=O		CHEMBL433805	=	IC50	nM	55000.0	CHEMBL267	Homo sapiens	IC50	uM	55.0
	111702	CHEMBL843949	Inhibition of tyrosine phosphorylation activity of the pp60v-src tyrosine kinase, protein from v-src baculovirus-infected insect cells	B	Cc1ccc2c(C(=O)Nc3ccccc3)c(SSc3c(C(=O)Nc4ccccc4)c4ccc(C)cc4n3C)n(C)c2c1		CHEMBL64459	=	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	111999	CHEMBL809573	Inhibitory activity against binding of Src protein tyrosine kinase SH2 domain to biotinylated EPQY*EEIPI Peptide by ELISA.	B	CC(=O)N[C@@H]1CCCCNC(=O)[C@H]2CCCN2C(=O)[C@H](C(C)C)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](Cc2ccc(OP(=O)(O)O)cc2)NC1=O		CHEMBL359934	=	IC50	nM	73000.0	CHEMBL267	Homo sapiens	IC50	uM	73.0
	112001	CHEMBL809573	Inhibitory activity against binding of Src protein tyrosine kinase SH2 domain to biotinylated EPQY*EEIPI Peptide by ELISA.	B	CC(=O)N[C@H]1CCCCNC(=O)[C@H]2CCCN2C(=O)[C@H](C(C)C)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](Cc2ccc(OP(=O)(O)O)cc2)NC1=O	Outside typical range	CHEMBL435910	>	IC50	nM	150000.0	CHEMBL267	Homo sapiens	IC50	uM	150.0
	113113	CHEMBL843949	Inhibition of tyrosine phosphorylation activity of the pp60v-src tyrosine kinase, protein from v-src baculovirus-infected insect cells	B	Cn1c(SSc2c(C(=O)Nc3ccccc3)c3ccccc3n2C)c(C(=O)Nc2ccccc2)c2ccccc21		CHEMBL304414	=	IC50	nM	3200.0	CHEMBL267	Homo sapiens	IC50	uM	3.2
	115583	CHEMBL821534	Inhibitory activity against c-src tyrosine kinase	B	O=C1NC(=O)c2cc(Nc3ccc(O)cc3)c(Nc3ccc(O)cc3)cc21		CHEMBL267019	=	IC50	nM	8000.0	CHEMBL267	Homo sapiens	IC50	uM	8.0
	116921	CHEMBL843949	Inhibition of tyrosine phosphorylation activity of the pp60v-src tyrosine kinase, protein from v-src baculovirus-infected insect cells	B	Cn1c(SSc2c(C(=O)Nc3ccccc3)c3cc(C#N)ccc3n2C)c(C(=O)Nc2ccccc2)c2cc(C#N)ccc21		CHEMBL291979	=	IC50	nM	4500.0	CHEMBL267	Homo sapiens	IC50	uM	4.5
	116923	CHEMBL843949	Inhibition of tyrosine phosphorylation activity of the pp60v-src tyrosine kinase, protein from v-src baculovirus-infected insect cells	B	Cn1c(SSc2c(C(=O)Nc3ccccc3)c3cccc(O)c3n2C)c(C(=O)Nc2ccccc2)c2cccc(O)c21		CHEMBL62843	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	116925	CHEMBL843949	Inhibition of tyrosine phosphorylation activity of the pp60v-src tyrosine kinase, protein from v-src baculovirus-infected insect cells	B	CN1C(=S)C(C)(C(=O)Nc2ccccc2)c2ccccc21		CHEMBL63009	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	117060	CHEMBL821534	Inhibitory activity against c-src tyrosine kinase	B	CN(c1ccccc1)c1cc2c(cc1N(C)c1ccccc1)C(=O)NC2=O		CHEMBL267941	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	118166	CHEMBL843949	Inhibition of tyrosine phosphorylation activity of the pp60v-src tyrosine kinase, protein from v-src baculovirus-infected insect cells	B	Cc1cccc2c1c(C(=O)Nc1ccccc1)c(SSc1c(C(=O)Nc3ccccc3)c3c(C)cccc3n1C)n2C		CHEMBL292287	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	118169	CHEMBL843949	Inhibition of tyrosine phosphorylation activity of the pp60v-src tyrosine kinase, protein from v-src baculovirus-infected insect cells	B	Cn1c(SSc2c(C(=O)Nc3ccccc3)c3cc([N+](=O)[O-])ccc3n2C)c(C(=O)Nc2ccccc2)c2cc([N+](=O)[O-])ccc21		CHEMBL64430	=	IC50	nM	7200.0	CHEMBL267	Homo sapiens	IC50	uM	7.2
	118171	CHEMBL843949	Inhibition of tyrosine phosphorylation activity of the pp60v-src tyrosine kinase, protein from v-src baculovirus-infected insect cells	B	CC(=O)Oc1ccc2c(C(=O)Nc3ccccc3)c(SSc3c(C(=O)Nc4ccccc4)c4ccc(OC(C)=O)cc4n3C)n(C)c2c1		CHEMBL64068	=	IC50	nM	3500.0	CHEMBL267	Homo sapiens	IC50	uM	3.5
	118173	CHEMBL843949	Inhibition of tyrosine phosphorylation activity of the pp60v-src tyrosine kinase, protein from v-src baculovirus-infected insect cells	B	CN1C(=S)C(C(=O)Nc2ccccc2)c2cc(Cl)ccc21		CHEMBL62067	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	118175	CHEMBL843949	Inhibition of tyrosine phosphorylation activity of the pp60v-src tyrosine kinase, protein from v-src baculovirus-infected insect cells	B	CSc1c(C(=O)Nc2ccccc2)c2ccccc2n1C		CHEMBL64814	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	119382	CHEMBL843949	Inhibition of tyrosine phosphorylation activity of the pp60v-src tyrosine kinase, protein from v-src baculovirus-infected insect cells	B	CN1C(=S)C(C(=O)Nc2ccccc2)c2ccccc21		CHEMBL62176	=	IC50	nM	9700.0	CHEMBL267	Homo sapiens	IC50	uM	9.7
	122147	CHEMBL809573	Inhibitory activity against binding of Src protein tyrosine kinase SH2 domain to biotinylated EPQY*EEIPI Peptide by ELISA.	B	CC(=O)N[C@H]1CSSC[C@@H](C(=O)O)NC(=O)[C@H]2CCCN2C(=O)[C@H](C(C)C)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](Cc2ccc(OP(=O)(O)O)cc2)NC1=O		CHEMBL367440	=	IC50	nM	38000.0	CHEMBL267	Homo sapiens	IC50	uM	38.0
	124276	CHEMBL843949	Inhibition of tyrosine phosphorylation activity of the pp60v-src tyrosine kinase, protein from v-src baculovirus-infected insect cells	B	Cc1cccc2c(C(=O)Nc3ccccc3)c(SSc3c(C(=O)Nc4ccccc4)c4cccc(C)c4n3C)n(C)c12		CHEMBL64165	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	125678	CHEMBL821534	Inhibitory activity against c-src tyrosine kinase	B	O=C1NC(=O)c2cc(Nc3ccccc3)c(Nc3ccccc3)cc21		CHEMBL268868	=	IC50	nM	16000.0	CHEMBL267	Homo sapiens	IC50	uM	16.0
	125802	CHEMBL821534	Inhibitory activity against c-src tyrosine kinase	B	CN(c1ccccc1)c1cc2c(cc1Nc1ccccc1)C(=O)NC2=O		CHEMBL7775	=	IC50	nM	1000.0	CHEMBL267	Homo sapiens	IC50	uM	1.0
	126001	CHEMBL809573	Inhibitory activity against binding of Src protein tyrosine kinase SH2 domain to biotinylated EPQY*EEIPI Peptide by ELISA.	B	C/C(S)=N/[C@@H]1CCCCNC(=O)[C@H]2CCCN2C(=O)[C@H](C(C)C)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](Cc2ccc(OP(=O)(O)O)cc2)NC1=O		CHEMBL366543	=	IC50	nM	88000.0	CHEMBL267	Homo sapiens	IC50	uM	88.0
	126003	CHEMBL809573	Inhibitory activity against binding of Src protein tyrosine kinase SH2 domain to biotinylated EPQY*EEIPI Peptide by ELISA.	B	CC(=O)N[C@H]1CCCCNC(=O)[C@H]2CCCN2C(=O)[C@H](C(C)C)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc2ccc(OP(=O)(O)O)cc2)NC1=O	Outside typical range	CHEMBL177616	>	IC50	nM	150000.0	CHEMBL267	Homo sapiens	IC50	uM	150.0
	127173	CHEMBL843949	Inhibition of tyrosine phosphorylation activity of the pp60v-src tyrosine kinase, protein from v-src baculovirus-infected insect cells	B	Cc1ccc2c(c1)c(C(=O)Nc1ccccc1)c(SSc1c(C(=O)Nc3ccccc3)c3cc(C)ccc3n1C)n2C		CHEMBL60200	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	127176	CHEMBL843949	Inhibition of tyrosine phosphorylation activity of the pp60v-src tyrosine kinase, protein from v-src baculovirus-infected insect cells	B	CC(=O)Oc1ccc2c(c1)c(C(=O)Nc1ccccc1)c(SSc1c(C(=O)Nc3ccccc3)c3cc(OC(C)=O)ccc3n1C)n2C		CHEMBL61119	=	IC50	nM	7700.0	CHEMBL267	Homo sapiens	IC50	uM	7.7
	127319	CHEMBL843949	Inhibition of tyrosine phosphorylation activity of the pp60v-src tyrosine kinase, protein from v-src baculovirus-infected insect cells	B	Cn1c(SSCc2ccccc2)c(C(=O)Nc2ccccc2)c2ccccc21		CHEMBL64231	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	128474	CHEMBL809573	Inhibitory activity against binding of Src protein tyrosine kinase SH2 domain to biotinylated EPQY*EEIPI Peptide by ELISA.	B	CCCCNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(=O)CC)C(C)C)C(C)C		CHEMBL367276	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	129355	CHEMBL805370	Inhibition of Src protein tyrosine kinase	B	O=C1NCc2c(-c3ccc(F)cc3F)cc(C3CCNCC3)cc2N1c1c(Cl)cccc1Cl		CHEMBL319556	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	129505	CHEMBL843949	Inhibition of tyrosine phosphorylation activity of the pp60v-src tyrosine kinase, protein from v-src baculovirus-infected insect cells	B	CN1C(=S)C(C(=O)Nc2ccccc2)c2cccnc21		CHEMBL62699	=	IC50	nM	30700.0	CHEMBL267	Homo sapiens	IC50	uM	30.7
	130897	CHEMBL843949	Inhibition of tyrosine phosphorylation activity of the pp60v-src tyrosine kinase, protein from v-src baculovirus-infected insect cells	B	COc1cccc2c1c(C(=O)Nc1ccccc1)c(SSc1c(C(=O)Nc3ccccc3)c3c(OC)cccc3n1C)n2C		CHEMBL294205	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	130900	CHEMBL843949	Inhibition of tyrosine phosphorylation activity of the pp60v-src tyrosine kinase, protein from v-src baculovirus-infected insect cells	B	Cn1c(SSc2c(C(=O)Nc3ccccc3)c3ccc(O)cc3n2C)c(C(=O)Nc2ccccc2)c2ccc(O)cc21		CHEMBL293913	=	IC50	nM	5100.0	CHEMBL267	Homo sapiens	IC50	uM	5.1
	130932	CHEMBL821534	Inhibitory activity against c-src tyrosine kinase	B	Cc1ccc(Nc2cc3c(cc2Nc2ccc(C)cc2)C(=O)NC3=O)cc1		CHEMBL7914	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	132095	CHEMBL843949	Inhibition of tyrosine phosphorylation activity of the pp60v-src tyrosine kinase, protein from v-src baculovirus-infected insect cells	B	CC(=O)Oc1cccc2c1c(C(=O)Nc1ccccc1)c(SSc1c(C(=O)Nc3ccccc3)c3c(OC(C)=O)cccc3n1C)n2C		CHEMBL59812	=	IC50	nM	650.0	CHEMBL267	Homo sapiens	IC50	uM	0.65
	133313	CHEMBL843949	Inhibition of tyrosine phosphorylation activity of the pp60v-src tyrosine kinase, protein from v-src baculovirus-infected insect cells	B	Cn1c(SSc2c(C(=O)Nc3ccccc3)c3cc(F)ccc3n2C)c(C(=O)Nc2ccccc2)c2cc(F)ccc21		CHEMBL63455	=	IC50	nM	6000.0	CHEMBL267	Homo sapiens	IC50	uM	6.0
	133315	CHEMBL843949	Inhibition of tyrosine phosphorylation activity of the pp60v-src tyrosine kinase, protein from v-src baculovirus-infected insect cells	B	Cn1c(SSc2c(C(=O)Nc3ccccc3)c3cc(O)ccc3n2C)c(C(=O)Nc2ccccc2)c2cc(O)ccc21		CHEMBL293250	=	IC50	nM	3900.0	CHEMBL267	Homo sapiens	IC50	uM	3.9
	133317	CHEMBL843949	Inhibition of tyrosine phosphorylation activity of the pp60v-src tyrosine kinase, protein from v-src baculovirus-infected insect cells	B	Cn1c(SSc2c(C(=O)Nc3ccccc3)c3cccnc3n2C)c(C(=O)Nc2ccccc2)c2cccnc21		CHEMBL62701	=	IC50	nM	5200.0	CHEMBL267	Homo sapiens	IC50	uM	5.2
	133598	CHEMBL809573	Inhibitory activity against binding of Src protein tyrosine kinase SH2 domain to biotinylated EPQY*EEIPI Peptide by ELISA.	B	CC(C)[C@H]1NC(=O)[C@H](Cc2ccc(OP(=O)(O)O)cc2)NC(=O)CNC(=O)[C@H]2CCCN2C(=O)[C@@H](C(C)C)NC(=O)[C@H](CC(N)=O)NC1=O		CHEMBL174819	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	133949	CHEMBL818275	Inhibition of c-Src tyrosine kinase	F	CCN(CC)CCOc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL297523	=	IC50	nM	17.0	CHEMBL267	Homo sapiens	IC50	uM	0.017
	134565	CHEMBL843949	Inhibition of tyrosine phosphorylation activity of the pp60v-src tyrosine kinase, protein from v-src baculovirus-infected insect cells	B	Cn1c(SSc2c(C(=O)Nc3ccccc3)c3ccc(Cl)cc3n2C)c(C(=O)Nc2ccccc2)c2ccc(Cl)cc21		CHEMBL303127	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	135766	CHEMBL843949	Inhibition of tyrosine phosphorylation activity of the pp60v-src tyrosine kinase, protein from v-src baculovirus-infected insect cells	B	Cn1c(SSc2c(C(=O)Nc3ccccc3)c3cc(Cl)ccc3n2C)c(C(=O)Nc2ccccc2)c2cc(Cl)ccc21		CHEMBL293889	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	135768	CHEMBL843949	Inhibition of tyrosine phosphorylation activity of the pp60v-src tyrosine kinase, protein from v-src baculovirus-infected insect cells	B	Cn1c(SSc2c(C(=O)Nc3ccccc3)c3cc(C(F)(F)F)ccc3n2C)c(C(=O)Nc2ccccc2)c2cc(C(F)(F)F)ccc21		CHEMBL61278	=	IC50	nM	5800.0	CHEMBL267	Homo sapiens	IC50	uM	5.8
	138226	CHEMBL843949	Inhibition of tyrosine phosphorylation activity of the pp60v-src tyrosine kinase, protein from v-src baculovirus-infected insect cells	B	Cn1c(SSc2ccccc2)c(C(=O)Nc2ccccc2)c2ccccc21		CHEMBL64781	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	138377	CHEMBL821534	Inhibitory activity against c-src tyrosine kinase	B	O=C1NC(=O)c2cc3c(cc21)N(c1ccccc1)CCN3c1ccccc1		CHEMBL266255	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	138964	CHEMBL818274	Inhibition of c-Src tyrosine kinase	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3ccccc3)nc21		CHEMBL301612	=	IC50	nM	17.0	CHEMBL267	Homo sapiens	IC50	uM	0.017
	139391	CHEMBL843949	Inhibition of tyrosine phosphorylation activity of the pp60v-src tyrosine kinase, protein from v-src baculovirus-infected insect cells	B	Cn1c(SSc2c(C(=O)Nc3ccccc3)c3cc(Br)ccc3n2C)c(C(=O)Nc2ccccc2)c2cc(Br)ccc21		CHEMBL293251	=	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	139393	CHEMBL843949	Inhibition of tyrosine phosphorylation activity of the pp60v-src tyrosine kinase, protein from v-src baculovirus-infected insect cells	B	COc1ccc2c(c1)c(C(=O)Nc1ccccc1)c(SSc1c(C(=O)Nc3ccccc3)c3cc(OC)ccc3n1C)n2C		CHEMBL294341	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	139396	CHEMBL843949	Inhibition of tyrosine phosphorylation activity of the pp60v-src tyrosine kinase, protein from v-src baculovirus-infected insect cells	B	COc1ccc2c(C(=O)Nc3ccccc3)c(SSc3c(C(=O)Nc4ccccc4)c4ccc(OC)cc4n3C)n(C)c2c1		CHEMBL60472	=	IC50	nM	3600.0	CHEMBL267	Homo sapiens	IC50	uM	3.6
	140479	CHEMBL843949	Inhibition of tyrosine phosphorylation activity of the pp60v-src tyrosine kinase, protein from v-src baculovirus-infected insect cells	B	CC(=O)Oc1cccc2c(C(=O)Nc3ccccc3)c(SSc3c(C(=O)Nc4ccccc4)c4cccc(OC(C)=O)c4n3C)n(C)c12		CHEMBL291359	=	IC50	nM	11100.0	CHEMBL267	Homo sapiens	IC50	uM	11.1
	140805	CHEMBL809573	Inhibitory activity against binding of Src protein tyrosine kinase SH2 domain to biotinylated EPQY*EEIPI Peptide by ELISA.	B	CC(=O)N[C@H]1CCCCNC(=O)[C@H]2CCCN2C(=O)[C@H](CC2CCCCC2)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](Cc2ccc(OP(=O)(O)O)cc2)NC1=O	Outside typical range	CHEMBL355759	>	IC50	nM	150000.0	CHEMBL267	Homo sapiens	IC50	uM	150.0
	142996	CHEMBL821534	Inhibitory activity against c-src tyrosine kinase	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	143007	CHEMBL821534	Inhibitory activity against c-src tyrosine kinase	B	COc1ccc(Nc2cc3c(cc2Nc2ccccc2)C(=O)NC3=O)cc1		CHEMBL8095	=	IC50	nM	64000.0	CHEMBL267	Homo sapiens	IC50	uM	64.0
	143284	CHEMBL809573	Inhibitory activity against binding of Src protein tyrosine kinase SH2 domain to biotinylated EPQY*EEIPI Peptide by ELISA.	B	CC(C)[C@H]1NC(=O)[C@H](Cc2ccc(OP(=O)(O)O)cc2)NC(=O)CNC(=O)[C@@H]2CCCN2C(=O)[C@@H](C(C)C)NC(=O)[C@H](CC(N)=O)NC1=O		CHEMBL172299	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	144216	CHEMBL843949	Inhibition of tyrosine phosphorylation activity of the pp60v-src tyrosine kinase, protein from v-src baculovirus-infected insect cells	B	Cn1c(SSc2c(C(=O)Nc3ccccc3)c3c(Cl)cccc3n2C)c(C(=O)Nc2ccccc2)c2c(Cl)cccc21		CHEMBL293986	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	144236	CHEMBL821534	Inhibitory activity against c-src tyrosine kinase	B	CCN(CC)c1ccc(Nc2cc3c(cc2Nc2ccc(N(CC)CC)cc2)C(=O)NC3=O)cc1		CHEMBL8223	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	146140	CHEMBL807493	Radioligand displacement assay for the binding of [125I]Glu-Pro-Gln-pTyr-Glu-Glu-Ile-Pro-Ile-Tyr-Leu to SRC SH2 domain	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N(C)CCCC1CCCCC1		CHEMBL13462	=	IC50	nM	800.0	CHEMBL267	Homo sapiens	IC50	uM	0.8
	146142	CHEMBL762577	Inhibition of [35S]-labeled SH2-GST Src binding to phospho-PDGF receptor intracellular domain	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N(C)CCCC1CCCCC1		CHEMBL13462	=	IC50	nM	9000.0	CHEMBL267	Homo sapiens	IC50	uM	9.0
	146182	CHEMBL806435	Inhibition of Src protein tyrosine kinase	B	COc1cc2c(Nc3ccc(Cl)cc3Cl)c(C#N)cnc2cc1OCCCN1CCN(C)CC1		CHEMBL122744	=	IC50	nM	8.7	CHEMBL267	Homo sapiens	IC50	nM	8.7
	148568	CHEMBL807493	Radioligand displacement assay for the binding of [125I]Glu-Pro-Gln-pTyr-Glu-Glu-Ile-Pro-Ile-Tyr-Leu to SRC SH2 domain	B	CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCC(=O)O)[C@@H](C)CC)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O		CHEMBL414123	=	IC50	nM	800.0	CHEMBL267	Homo sapiens	IC50	uM	0.8
	148570	CHEMBL762577	Inhibition of [35S]-labeled SH2-GST Src binding to phospho-PDGF receptor intracellular domain	B	CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCC(=O)O)[C@@H](C)CC)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O		CHEMBL414123	=	IC50	nM	800.0	CHEMBL267	Homo sapiens	IC50	uM	0.8
	148596	CHEMBL806435	Inhibition of Src protein tyrosine kinase	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	IC50	nM	1.2	CHEMBL267	Homo sapiens	IC50	nM	1.2
	149739	CHEMBL818888	Binding affinity for wild type Src SH2 domain using BIAcore binding assay	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)C(Cc1ccc(C(=O)C(=O)C(=O)OC)cc1)NC(C)=O)C(N)=O		CHEMBL295901	=	IC50	nM	2300.0	CHEMBL267	Homo sapiens	IC50	uM	2.3
	149740	CHEMBL665626	Binding affinity for Cys188Ala Src SH2 domain mutant using BIAcore binding assay	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)C(Cc1ccc(C(=O)C(=O)C(=O)OC)cc1)NC(C)=O)C(N)=O	Outside typical range	CHEMBL295901	>	IC50	nM	1000000.0	CHEMBL267	Homo sapiens	IC50	uM	1000.0
Active	149741	CHEMBL809576	Selectivity for Src SH2 domain compared to Cys188Ala Src SH2 domain mutants	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)C(Cc1ccc(C(=O)C(=O)C(=O)OC)cc1)NC(C)=O)C(N)=O		CHEMBL295901		Selectivity			CHEMBL267	Homo sapiens	Selectivity		
	150921	CHEMBL806435	Inhibition of Src protein tyrosine kinase	B	COCCOc1cc2ncc(C#N)c(Nc3cc(OC)c(OC)c(OC)c3)c2cc1OCCOC		CHEMBL419428	=	IC50	nM	25.0	CHEMBL267	Homo sapiens	IC50	nM	25.0
	152121	CHEMBL807493	Radioligand displacement assay for the binding of [125I]Glu-Pro-Gln-pTyr-Glu-Glu-Ile-Pro-Ile-Tyr-Leu to SRC SH2 domain	B	CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(C(F)(F)P(=O)(O)O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCC(=O)O)[C@@H](C)CC)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O		CHEMBL413629	=	IC50	nM	5500.0	CHEMBL267	Homo sapiens	IC50	uM	5.5
	152123	CHEMBL762577	Inhibition of [35S]-labeled SH2-GST Src binding to phospho-PDGF receptor intracellular domain	B	CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(C(F)(F)P(=O)(O)O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCC(=O)O)[C@@H](C)CC)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O		CHEMBL413629	=	IC50	nM	11700.0	CHEMBL267	Homo sapiens	IC50	uM	11.7
	153396	CHEMBL806435	Inhibition of Src protein tyrosine kinase	B	COCCOc1cc2ncc(C#N)c(Nc3cc(OC)c(Cl)cc3Cl)c2cc1OC		CHEMBL124333	=	IC50	nM	1.5	CHEMBL267	Homo sapiens	IC50	nM	1.5
	154552	CHEMBL807493	Radioligand displacement assay for the binding of [125I]Glu-Pro-Gln-pTyr-Glu-Glu-Ile-Pro-Ile-Tyr-Leu to SRC SH2 domain	B	CC[C@H](NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(C)=O)C(=O)N(C)CCCC1CCCCC1		CHEMBL301845	=	IC50	nM	5500.0	CHEMBL267	Homo sapiens	IC50	uM	5.5
	154554	CHEMBL762577	Inhibition of [35S]-labeled SH2-GST Src binding to phospho-PDGF receptor intracellular domain	B	CC[C@H](NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(C)=O)C(=O)N(C)CCCC1CCCCC1		CHEMBL301845	=	IC50	nM	26000.0	CHEMBL267	Homo sapiens	IC50	uM	26.0
	154573	CHEMBL806346	Inhibition of Src tyrosine kinase	B	Nc1ccc2c(c1)C(=O)/C(=C/c1cc(Cl)c(O)c(Cl)c1)C2=O		CHEMBL84808	=	IC50	nM	3500.0	CHEMBL267	Homo sapiens	IC50	uM	3.5
	154638	CHEMBL818888	Binding affinity for wild type Src SH2 domain using BIAcore binding assay	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CCc1ccc(C(=O)C(O)(O)C(=O)OC)cc1)C(N)=O		CHEMBL288999	=	IC50	nM	20000.0	CHEMBL267	Homo sapiens	IC50	uM	20.0
	154639	CHEMBL665626	Binding affinity for Cys188Ala Src SH2 domain mutant using BIAcore binding assay	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CCc1ccc(C(=O)C(O)(O)C(=O)OC)cc1)C(N)=O	Outside typical range	CHEMBL288999	>	IC50	nM	1000000.0	CHEMBL267	Homo sapiens	IC50	uM	1000.0
Active	154640	CHEMBL809576	Selectivity for Src SH2 domain compared to Cys188Ala Src SH2 domain mutants	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CCc1ccc(C(=O)C(O)(O)C(=O)OC)cc1)C(N)=O		CHEMBL288999		Selectivity			CHEMBL267	Homo sapiens	Selectivity		
	155856	CHEMBL818888	Binding affinity for wild type Src SH2 domain using BIAcore binding assay	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CCc1cccc(C(=O)O)c1)C(N)=O	Outside typical range	CHEMBL297011	=	IC50	nM	250000.0	CHEMBL267	Homo sapiens	IC50	uM	250.0
	155857	CHEMBL665627	Binding affinity for Cys188Ala Src SH2 domain mutant using BIAcore binding assay	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CCc1cccc(C(=O)O)c1)C(N)=O		CHEMBL297011	=	Inhibition	%	15.0	CHEMBL267	Homo sapiens	Inhibition	%	15.0
Not Active	155858	CHEMBL809576	Selectivity for Src SH2 domain compared to Cys188Ala Src SH2 domain mutants	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CCc1cccc(C(=O)O)c1)C(N)=O		CHEMBL297011		Selectivity			CHEMBL267	Homo sapiens	Selectivity		
	157091	CHEMBL806435	Inhibition of Src protein tyrosine kinase	B	COc1cc2c(Nc3cc(OC)c(OC)c(OC)c3)c(C#N)cnc2cc1OCCCN1CCN(C)CC1		CHEMBL436362	=	IC50	nM	5.1	CHEMBL267	Homo sapiens	IC50	nM	5.1
	159482	CHEMBL807493	Radioligand displacement assay for the binding of [125I]Glu-Pro-Gln-pTyr-Glu-Glu-Ile-Pro-Ile-Tyr-Leu to SRC SH2 domain	B	CC(=O)N[C@@H](Cc1ccc(C(F)(F)P(=O)(O)O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N(C)CCCC1CCCCC1		CHEMBL58478	=	IC50	nM	3400.0	CHEMBL267	Homo sapiens	IC50	uM	3.4
	159484	CHEMBL762577	Inhibition of [35S]-labeled SH2-GST Src binding to phospho-PDGF receptor intracellular domain	B	CC(=O)N[C@@H](Cc1ccc(C(F)(F)P(=O)(O)O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N(C)CCCC1CCCCC1		CHEMBL58478	=	IC50	nM	30000.0	CHEMBL267	Homo sapiens	IC50	uM	30.0
	160745	CHEMBL807493	Radioligand displacement assay for the binding of [125I]Glu-Pro-Gln-pTyr-Glu-Glu-Ile-Pro-Ile-Tyr-Leu to SRC SH2 domain	B	CC[C@H](NC(=O)[C@H](Cc1ccc(C(F)(F)P(=O)(O)O)cc1)NC(C)=O)C(=O)N(C)CCCC1CCCCC1		CHEMBL298813	=	IC50	nM	7300.0	CHEMBL267	Homo sapiens	IC50	uM	7.3
	160747	CHEMBL762577	Inhibition of [35S]-labeled SH2-GST Src binding to phospho-PDGF receptor intracellular domain	B	CC[C@H](NC(=O)[C@H](Cc1ccc(C(F)(F)P(=O)(O)O)cc1)NC(C)=O)C(=O)N(C)CCCC1CCCCC1		CHEMBL298813	~	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	161926	CHEMBL806346	Inhibition of Src tyrosine kinase	B	Nc1ccc2c(c1)C(=O)/C(=C/c1cc(Br)c(O)c(Br)c1)C2=O		CHEMBL84807	=	IC50	nM	460.0	CHEMBL267	Homo sapiens	IC50	uM	0.46
	161963	CHEMBL806435	Inhibition of Src protein tyrosine kinase	B	COc1cc(Nc2c(C#N)cnc3cc(OCC4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL42136	=	IC50	nM	2.0	CHEMBL267	Homo sapiens	IC50	nM	2.0
	162001	CHEMBL818888	Binding affinity for wild type Src SH2 domain using BIAcore binding assay	B	COC(=O)C(=O)C(=O)c1ccc(CC(NC(C)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(N)=O)[C@@H](C)O)cc1		CHEMBL295902	=	IC50	nM	8600.0	CHEMBL267	Homo sapiens	IC50	uM	8.6
	162002	CHEMBL665626	Binding affinity for Cys188Ala Src SH2 domain mutant using BIAcore binding assay	B	COC(=O)C(=O)C(=O)c1ccc(CC(NC(C)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(N)=O)[C@@H](C)O)cc1	Outside typical range	CHEMBL295902	>	IC50	nM	1000000.0	CHEMBL267	Homo sapiens	IC50	uM	1000.0
Active	162003	CHEMBL809576	Selectivity for Src SH2 domain compared to Cys188Ala Src SH2 domain mutants	B	COC(=O)C(=O)C(=O)c1ccc(CC(NC(C)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(N)=O)[C@@H](C)O)cc1		CHEMBL295902		Selectivity			CHEMBL267	Homo sapiens	Selectivity		
	163240	CHEMBL807493	Radioligand displacement assay for the binding of [125I]Glu-Pro-Gln-pTyr-Glu-Glu-Ile-Pro-Ile-Tyr-Leu to SRC SH2 domain	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC1CCCCC1)C(N)=O		CHEMBL293803	=	IC50	nM	1800.0	CHEMBL267	Homo sapiens	IC50	uM	1.8
	163242	CHEMBL762577	Inhibition of [35S]-labeled SH2-GST Src binding to phospho-PDGF receptor intracellular domain	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC1CCCCC1)C(N)=O		CHEMBL293803	=	IC50	nM	7700.0	CHEMBL267	Homo sapiens	IC50	uM	7.7
	163244	CHEMBL807493	Radioligand displacement assay for the binding of [125I]Glu-Pro-Gln-pTyr-Glu-Glu-Ile-Pro-Ile-Tyr-Leu to SRC SH2 domain	B	CC(=O)N[C@@H](Cc1ccc(C(F)(F)P(=O)(O)O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC1CCCCC1)C(N)=O		CHEMBL294692	=	IC50	nM	4900.0	CHEMBL267	Homo sapiens	IC50	uM	4.9
	163246	CHEMBL762577	Inhibition of [35S]-labeled SH2-GST Src binding to phospho-PDGF receptor intracellular domain	B	CC(=O)N[C@@H](Cc1ccc(C(F)(F)P(=O)(O)O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC1CCCCC1)C(N)=O		CHEMBL294692	=	IC50	nM	30000.0	CHEMBL267	Homo sapiens	IC50	uM	30.0
	163328	CHEMBL806435	Inhibition of Src protein tyrosine kinase	B	COc1cc2c(Nc3ccc(Cl)cc3Cl)c(C#N)cnc2cc1OCC1CCN(C)CC1		CHEMBL43577	=	IC50	nM	6.6	CHEMBL267	Homo sapiens	IC50	nM	6.6
	165534	CHEMBL807493	Radioligand displacement assay for the binding of [125I]Glu-Pro-Gln-pTyr-Glu-Glu-Ile-Pro-Ile-Tyr-Leu to SRC SH2 domain	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(C(F)(F)P(=O)(O)O)cc1)NC(C)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)O		CHEMBL294420	=	IC50	nM	1100.0	CHEMBL267	Homo sapiens	IC50	uM	1.1
	165536	CHEMBL762577	Inhibition of [35S]-labeled SH2-GST Src binding to phospho-PDGF receptor intracellular domain	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(C(F)(F)P(=O)(O)O)cc1)NC(C)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)O		CHEMBL294420	=	IC50	nM	6000.0	CHEMBL267	Homo sapiens	IC50	uM	6.0
	165595	CHEMBL818888	Binding affinity for wild type Src SH2 domain using BIAcore binding assay	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)Cc1ccc(OP(=O)(O)O)cc1)C(=O)O		CHEMBL46851	=	IC50	nM	1200.0	CHEMBL267	Homo sapiens	IC50	uM	1.2
	165596	CHEMBL665626	Binding affinity for Cys188Ala Src SH2 domain mutant using BIAcore binding assay	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)Cc1ccc(OP(=O)(O)O)cc1)C(=O)O		CHEMBL46851	=	IC50	nM	1330.0	CHEMBL267	Homo sapiens	IC50	uM	1.33
Not Determined	165597	CHEMBL809575	Selectivity for Src SH2 domain compared to Cys188Ala Src SH2 domain mutants; No data	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)Cc1ccc(OP(=O)(O)O)cc1)C(=O)O		CHEMBL46851		Selectivity			CHEMBL267	Homo sapiens	Selectivity		
	166850	CHEMBL807493	Radioligand displacement assay for the binding of [125I]Glu-Pro-Gln-pTyr-Glu-Glu-Ile-Pro-Ile-Tyr-Leu to SRC SH2 domain	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(C)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)O		CHEMBL299477	=	IC50	nM	500.0	CHEMBL267	Homo sapiens	IC50	uM	0.5
	166852	CHEMBL762577	Inhibition of [35S]-labeled SH2-GST Src binding to phospho-PDGF receptor intracellular domain	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(C)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)O		CHEMBL299477	=	IC50	nM	1400.0	CHEMBL267	Homo sapiens	IC50	uM	1.4
	166854	CHEMBL807493	Radioligand displacement assay for the binding of [125I]Glu-Pro-Gln-pTyr-Glu-Glu-Ile-Pro-Ile-Tyr-Leu to SRC SH2 domain	B	CC(=O)N[C@@H](Cc1ccc(P(=O)(O)O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N(C)CCCC1CCCCC1		CHEMBL57393	=	IC50	nM	9300.0	CHEMBL267	Homo sapiens	IC50	uM	9.3
Not Determined	166856	CHEMBL762578	Inhibition of [35S]-labeled SH2-GST Src binding to phospho-PDGF receptor intracellular domain (not determined)	B	CC(=O)N[C@@H](Cc1ccc(P(=O)(O)O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N(C)CCCC1CCCCC1		CHEMBL57393		IC50	nM		CHEMBL267	Homo sapiens	IC50	uM	
	166938	CHEMBL818888	Binding affinity for wild type Src SH2 domain using BIAcore binding assay	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CCc1cccc(C(=O)C(O)(O)C(=O)OC)c1)C(N)=O		CHEMBL39181	=	IC50	nM	18000.0	CHEMBL267	Homo sapiens	IC50	uM	18.0
	166939	CHEMBL665626	Binding affinity for Cys188Ala Src SH2 domain mutant using BIAcore binding assay	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CCc1cccc(C(=O)C(O)(O)C(=O)OC)c1)C(N)=O	Outside typical range	CHEMBL39181	>	IC50	nM	1000000.0	CHEMBL267	Homo sapiens	IC50	uM	1000.0
Active	166940	CHEMBL809576	Selectivity for Src SH2 domain compared to Cys188Ala Src SH2 domain mutants	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CCc1cccc(C(=O)C(O)(O)C(=O)OC)c1)C(N)=O		CHEMBL39181		Selectivity			CHEMBL267	Homo sapiens	Selectivity		
	170586	CHEMBL806435	Inhibition of Src protein tyrosine kinase	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCC4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL290921	=	IC50	nM	1.4	CHEMBL267	Homo sapiens	IC50	nM	1.4
	172992	CHEMBL806435	Inhibition of Src protein tyrosine kinase	B	COc1cc2c(Nc3cc(OC)c(OC)c(OC)c3)c(C#N)cnc2cc1OCC1CCN(C)CC1		CHEMBL440847	=	IC50	nM	8.3	CHEMBL267	Homo sapiens	IC50	nM	8.3
	172994	CHEMBL806435	Inhibition of Src protein tyrosine kinase	B	COc1cc(Nc2c(C#N)cnc3cc(OCCC4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL41465	=	IC50	nM	2.4	CHEMBL267	Homo sapiens	IC50	nM	2.4
	175239	CHEMBL807493	Radioligand displacement assay for the binding of [125I]Glu-Pro-Gln-pTyr-Glu-Glu-Ile-Pro-Ile-Tyr-Leu to SRC SH2 domain	B	CC[C@H](NC(=O)[C@H](Cc1ccc(P(=O)(O)O)cc1)NC(C)=O)C(=O)N(C)CCCC1CCCCC1		CHEMBL58421	=	IC50	nM	6100.0	CHEMBL267	Homo sapiens	IC50	uM	6.1
	175241	CHEMBL762577	Inhibition of [35S]-labeled SH2-GST Src binding to phospho-PDGF receptor intracellular domain	B	CC[C@H](NC(=O)[C@H](Cc1ccc(P(=O)(O)O)cc1)NC(C)=O)C(=O)N(C)CCCC1CCCCC1		CHEMBL58421	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	175281	CHEMBL806435	Inhibition of Src protein tyrosine kinase	B	COCCOc1cc2ncc(C#N)c(Nc3cc(OC)c(OC)c(OC)c3)c2cc1OC		CHEMBL127771	=	IC50	nM	14.0	CHEMBL267	Homo sapiens	IC50	nM	14.0
	175320	CHEMBL818888	Binding affinity for wild type Src SH2 domain using BIAcore binding assay	B	COC(=O)C(O)(O)C(=O)c1ccccc1		CHEMBL45149	=	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	175321	CHEMBL665626	Binding affinity for Cys188Ala Src SH2 domain mutant using BIAcore binding assay	B	COC(=O)C(O)(O)C(=O)c1ccccc1	Outside typical range	CHEMBL45149	>	IC50	nM	1000000.0	CHEMBL267	Homo sapiens	IC50	uM	1000.0
Active	175322	CHEMBL809576	Selectivity for Src SH2 domain compared to Cys188Ala Src SH2 domain mutants	B	COC(=O)C(O)(O)C(=O)c1ccccc1		CHEMBL45149		Selectivity			CHEMBL267	Homo sapiens	Selectivity		
	177502	CHEMBL816698	Inhibition of c-Src tyrosine kinase	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1ncc(C(F)(F)F)cc1Cl		CHEMBL111620	=	Activity	%	93.0	CHEMBL267	Homo sapiens	Activity	%	93.0
	177795	CHEMBL806346	Inhibition of Src tyrosine kinase	B	COc1ccc2c(c1)C(=O)/C(=C/c1cc(Br)c(O)c(Br)c1)C2=O		CHEMBL82560	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	177825	CHEMBL806435	Inhibition of Src protein tyrosine kinase	B	COCCOc1cc2ncc(C#N)c(Nc3ccc(Cl)cc3Cl)c2cc1OC		CHEMBL127633	=	IC50	nM	4.7	CHEMBL267	Homo sapiens	IC50	nM	4.7
	178815	CHEMBL816698	Inhibition of c-Src tyrosine kinase	B	COCCCn1cc(C2=C(c3ccccc3O)C(=O)NC2=O)c2cccnc21		CHEMBL109944	=	Activity	%	99.0	CHEMBL267	Homo sapiens	Activity	%	99.0
	179128	CHEMBL807493	Radioligand displacement assay for the binding of [125I]Glu-Pro-Gln-pTyr-Glu-Glu-Ile-Pro-Ile-Tyr-Leu to SRC SH2 domain	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(P(=O)(O)O)cc1)NC(C)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)O		CHEMBL56697	=	IC50	nM	6700.0	CHEMBL267	Homo sapiens	IC50	uM	6.7
Not Determined	179130	CHEMBL762578	Inhibition of [35S]-labeled SH2-GST Src binding to phospho-PDGF receptor intracellular domain (not determined)	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(P(=O)(O)O)cc1)NC(C)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)O		CHEMBL56697		IC50	nM		CHEMBL267	Homo sapiens	IC50	uM	
	180350	CHEMBL806435	Inhibition of Src protein tyrosine kinase	B	COCCOc1cc2ncc(C#N)c(Nc3ccc(Cl)cc3Cl)c2cc1OCCOC		CHEMBL123733	=	IC50	nM	12.0	CHEMBL267	Homo sapiens	IC50	nM	12.0
	182562	CHEMBL816698	Inhibition of c-Src tyrosine kinase	B	COc1ccccc1C1=C(c2cn(CCCNC(=O)OC(C)(C)C)c3ncccc23)C(=O)NC1=O		CHEMBL109981	=	Activity	%	74.0	CHEMBL267	Homo sapiens	Activity	%	74.0
	183023	CHEMBL806435	Inhibition of Src protein tyrosine kinase	B	COCCOc1cc2ncc(C#N)c(Nc3cc(OC)c(Cl)cc3Cl)c2cc1OCCOC		CHEMBL338413	=	IC50	nM	2.8	CHEMBL267	Homo sapiens	IC50	nM	2.8
	184547	CHEMBL818902	Inhibitory activity against avian c-Src tyrosine kinase was determined.	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(NCCCCN3CCOCC3)cc21		CHEMBL320382	=	IC50	nM	45.0	CHEMBL267	Homo sapiens	IC50	uM	0.045
	184809	CHEMBL823231	Inhibitory concentration against SH2 domain of human p60 Src tyrosine kinase	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)c(C=O)c1)C(=O)N[C@H]1CCCCN(Cc2ccc(-c3ccccc3)cc2)C1=O		CHEMBL78455	=	IC50	nM	0.25	CHEMBL267	Homo sapiens	IC50	nM	0.25
	185459	CHEMBL844770	Binding affinity to p60 src SH2 domain.	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](Cc1ccc(OP(=O)(O)O)cc1)NC(C)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)O		CHEMBL328907	=	IC50	nM	500.0	CHEMBL267	Homo sapiens	IC50	uM	0.5
	185460	CHEMBL764642	Inhibition of src SH2 domain binding to PDGF receptor	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](Cc1ccc(OP(=O)(O)O)cc1)NC(C)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)O		CHEMBL328907	=	IC50	nM	1350.0	CHEMBL267	Homo sapiens	IC50	uM	1.35
	185465	CHEMBL844770	Binding affinity to p60 src SH2 domain.	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)NC(CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O		CHEMBL278824	=	IC50	nM	4000.0	CHEMBL267	Homo sapiens	IC50	uM	4.0
	185694	CHEMBL806425	Inhibition of Src kinase in yeast-based screen	B	COc1cc(Nc2c(C#N)cnc3cc(-c4cscc4CN4CCOCC4)ccc23)c(Cl)cc1Cl		CHEMBL61967	=	IC50	nM	240.0	CHEMBL267	Homo sapiens	IC50	nM	240.0
	185695	CHEMBL806424	Inhibition of Src-dependent cell proliferation	F	COc1cc(Nc2c(C#N)cnc3cc(-c4cscc4CN4CCOCC4)ccc23)c(Cl)cc1Cl		CHEMBL61967	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	186093	CHEMBL818902	Inhibitory activity against avian c-Src tyrosine kinase was determined.	B	CN1CCN(CCCNc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)CC1		CHEMBL299194	=	IC50	nM	150.0	CHEMBL267	Homo sapiens	IC50	uM	0.15
	186294	CHEMBL823231	Inhibitory concentration against SH2 domain of human p60 Src tyrosine kinase	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@H]1CCCCN(CCCc2ccccc2)C1=O		CHEMBL286258	=	IC50	nM	290.0	CHEMBL267	Homo sapiens	IC50	nM	290.0
	187017	CHEMBL806425	Inhibition of Src kinase in yeast-based screen	B	COc1cc(Nc2c(C#N)cnc3cc(-c4cc(CN5CCSCC5)cs4)ccc23)c(Cl)cc1Cl		CHEMBL431136	=	IC50	nM	4.4	CHEMBL267	Homo sapiens	IC50	nM	4.4
	187018	CHEMBL806424	Inhibition of Src-dependent cell proliferation	F	COc1cc(Nc2c(C#N)cnc3cc(-c4cc(CN5CCSCC5)cs4)ccc23)c(Cl)cc1Cl		CHEMBL431136	=	IC50	nM	630.0	CHEMBL267	Homo sapiens	IC50	nM	630.0
	187190	CHEMBL818902	Inhibitory activity against avian c-Src tyrosine kinase was determined.	B	CNc1cc2c(cn1)cc(-c1c(Cl)cccc1Cl)c(=O)n2C		CHEMBL107071	=	IC50	nM	420.0	CHEMBL267	Homo sapiens	IC50	uM	0.42
	188498	CHEMBL818902	Inhibitory activity against avian c-Src tyrosine kinase was determined.	B	CCN(CC)CCCNc1cc2c(cn1)cc(-c1c(Cl)cccc1Cl)c(=O)n2C		CHEMBL420477	=	IC50	nM	300.0	CHEMBL267	Homo sapiens	IC50	uM	0.3
	189684	CHEMBL818902	Inhibitory activity against avian c-Src tyrosine kinase was determined.	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(N)cc21		CHEMBL108004	=	IC50	nM	350.0	CHEMBL267	Homo sapiens	IC50	uM	0.35
	189689	CHEMBL818902	Inhibitory activity against avian c-Src tyrosine kinase was determined.	B	COc1ccc(Nc2ccc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1		CHEMBL323017	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	189835	CHEMBL823231	Inhibitory concentration against SH2 domain of human p60 Src tyrosine kinase	B	CC(=O)N[C@@H](Cc1ccc(C(C(=O)O)C(=O)O)c(C(=O)O)c1)C(=O)N[C@H]1CCCCN(Cc2ccc(-c3ccccc3)cc2)C1=O		CHEMBL421518	=	IC50	nM	3.0	CHEMBL267	Homo sapiens	IC50	nM	3.0
	191000	CHEMBL818902	Inhibitory activity against avian c-Src tyrosine kinase was determined.	B	COc1ccc(Nc2cc3c(cn2)cc(-c2c(Cl)cccc2Cl)c(=O)n3C)cc1		CHEMBL318519	=	IC50	nM	1800.0	CHEMBL267	Homo sapiens	IC50	uM	1.8
	191003	CHEMBL818902	Inhibitory activity against avian c-Src tyrosine kinase was determined.	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2ccc(N)nc21		CHEMBL107372	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	191181	CHEMBL823231	Inhibitory concentration against SH2 domain of human p60 Src tyrosine kinase	B	O=C(N[C@H]1CSCCN(CCCc2ccccc2)C1=O)c1ccc(OP(=O)(O)O)cc1		CHEMBL1160754	=	IC50	nM	2700.0	CHEMBL267	Homo sapiens	IC50	nM	2700.0
	191200	CHEMBL822807	Inhibition of c-Src tyrosine kinase	B	CCn1c2ccccc2c2cc(/C=N\OCCO/N=C/c3ccc(O)c(O)c3)ccc21		CHEMBL119620	=	IC50	nM	64.0	CHEMBL267	Homo sapiens	IC50	uM	0.064
	191798	CHEMBL844770	Binding affinity to p60 src SH2 domain.	B	NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(CCC(=O)O)NC(=O)C(Cc1ccc(OP(=O)(O)O)cc1)c1ccc2ccccc2c1		CHEMBL277697	=	IC50	nM	40000.0	CHEMBL267	Homo sapiens	IC50	uM	40.0
	191974	CHEMBL806425	Inhibition of Src kinase in yeast-based screen	B	COc1cc(Nc2c(C#N)cnc3cc(-c4csc(CN5CCC(O)CC5)c4)ccc23)c(Cl)cc1Cl		CHEMBL418652	=	IC50	nM	1.4	CHEMBL267	Homo sapiens	IC50	nM	1.4
	191975	CHEMBL806424	Inhibition of Src-dependent cell proliferation	F	COc1cc(Nc2c(C#N)cnc3cc(-c4csc(CN5CCC(O)CC5)c4)ccc23)c(Cl)cc1Cl		CHEMBL418652	=	IC50	nM	120.0	CHEMBL267	Homo sapiens	IC50	nM	120.0
	192126	CHEMBL818902	Inhibitory activity against avian c-Src tyrosine kinase was determined.	B	CCN(CC)CCCNc1ccc2cc(-c3c(Cl)cccc3Cl)c(=O)n(C)c2n1		CHEMBL107247	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	193244	CHEMBL818902	Inhibitory activity against avian c-Src tyrosine kinase was determined.	B	CCN(CC)C(=O)c1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1		CHEMBL104357	=	IC50	nM	14.0	CHEMBL267	Homo sapiens	IC50	uM	0.014
	194053	CHEMBL844770	Binding affinity to p60 src SH2 domain.	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)C(Cc1ccc(OP(=O)(O)O)cc1)c1ccc2ccccc2c1)C(=O)N[C@@H](CCC(=O)O)C(=O)O		CHEMBL2092742	=	IC50	nM	4500.0	CHEMBL267	Homo sapiens	IC50	uM	4.5
	194459	CHEMBL818902	Inhibitory activity against avian c-Src tyrosine kinase was determined.	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3ccncc3)cc21		CHEMBL106839	=	IC50	nM	550.0	CHEMBL267	Homo sapiens	IC50	uM	0.55
	194465	CHEMBL818902	Inhibitory activity against avian c-Src tyrosine kinase was determined.	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3ccccc3)nc21		CHEMBL301612	=	IC50	nM	20.0	CHEMBL267	Homo sapiens	IC50	uM	0.02
	195591	CHEMBL818902	Inhibitory activity against avian c-Src tyrosine kinase was determined.	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3ccccc3)cc21		CHEMBL323453	=	IC50	nM	790.0	CHEMBL267	Homo sapiens	IC50	uM	0.79
	195594	CHEMBL818902	Inhibitory activity against avian c-Src tyrosine kinase was determined.	B	CN1CCN(CCOc2ccc(Nc3cc4c(cn3)cc(-c3c(Cl)cccc3Cl)c(=O)n4C)cc2)CC1		CHEMBL110403	=	IC50	nM	16.0	CHEMBL267	Homo sapiens	IC50	uM	0.016
	195710	CHEMBL823231	Inhibitory concentration against SH2 domain of human p60 Src tyrosine kinase	B	CC(=O)N[C@@H](Cc1ccc(CC(=O)O)c(C(=O)O)c1)C(=O)N[C@H]1CCCCN(Cc2ccc(-c3ccccc3)cc2)C1=O		CHEMBL432359	=	IC50	nM	450.0	CHEMBL267	Homo sapiens	IC50	nM	450.0
	195785	CHEMBL823231	Inhibitory concentration against SH2 domain of human p60 Src tyrosine kinase	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@H]1CCCCN(Cc2ccc(-c3ccccc3)cc2)C1=O		CHEMBL25826	=	IC50	nM	9.0	CHEMBL267	Homo sapiens	IC50	nM	9.0
	196765	CHEMBL818902	Inhibitory activity against avian c-Src tyrosine kinase was determined.	B	CN1CCN(CCCCCNc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)CC1		CHEMBL106232	=	IC50	nM	60.0	CHEMBL267	Homo sapiens	IC50	uM	0.06
	197443	CHEMBL844770	Binding affinity to p60 src SH2 domain.	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)C(Cc1ccc(OP(=O)(O)O)cc1)c1cccc2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)O		CHEMBL2092741	=	IC50	nM	7300.0	CHEMBL267	Homo sapiens	IC50	uM	7.3
	197963	CHEMBL822807	Inhibition of c-Src tyrosine kinase	B	CO/N=C/c1ccc(O)c(O)c1		CHEMBL117488	=	IC50	nM	41000.0	CHEMBL267	Homo sapiens	IC50	uM	41.0
	198590	CHEMBL844770	Binding affinity to p60 src SH2 domain.	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)/C(=C/c1ccc(OP(=O)(O)O)cc1)C(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O		CHEMBL3143155	=	IC50	nM	5000.0	CHEMBL267	Homo sapiens	IC50	uM	5.0
	198591	CHEMBL844770	Binding affinity to p60 src SH2 domain.	B	NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(CCC(=O)O)NC(=O)C(Cc1ccc(OP(=O)(O)O)cc1)c1cccc2ccccc12		CHEMBL19562	=	IC50	nM	30000.0	CHEMBL267	Homo sapiens	IC50	uM	30.0
	198996	CHEMBL818902	Inhibitory activity against avian c-Src tyrosine kinase was determined.	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(NCCCN3CCOCC3)nc21		CHEMBL48172	=	IC50	nM	530.0	CHEMBL267	Homo sapiens	IC50	uM	0.53
	199878	CHEMBL844770	Binding affinity to p60 src SH2 domain.	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CCc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)O		CHEMBL3143228	=	IC50	nM	3400.0	CHEMBL267	Homo sapiens	IC50	uM	3.4
	199879	CHEMBL844770	Binding affinity to p60 src SH2 domain.	B	NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(CCC(=O)O)NC(=O)C(Cc1ccc(OP(=O)(O)O)cc1)c1ccccc1		CHEMBL19598	=	IC50	nM	28000.0	CHEMBL267	Homo sapiens	IC50	uM	28.0
	200320	CHEMBL818902	Inhibitory activity against avian c-Src tyrosine kinase was determined.	B	CN1CCN(CCCOc2ccc(Nc3cc4c(cn3)cc(-c3c(Cl)cccc3Cl)c(=O)n4C)cc2)CC1		CHEMBL104071	=	IC50	nM	28.0	CHEMBL267	Homo sapiens	IC50	uM	0.028
	200323	CHEMBL818902	Inhibitory activity against avian c-Src tyrosine kinase was determined.	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3ccc(N4CCOCC4)cc3)cc21		CHEMBL106992	=	IC50	nM	250.0	CHEMBL267	Homo sapiens	IC50	uM	0.25
	200326	CHEMBL818902	Inhibitory activity against avian c-Src tyrosine kinase was determined.	B	CCN(CC)CCCCNc1cc2nc(O)c(-c3c(Cl)cccc3Cl)cc2cn1		CHEMBL104322	=	IC50	nM	42.0	CHEMBL267	Homo sapiens	IC50	uM	0.042
	200329	CHEMBL818902	Inhibitory activity against avian c-Src tyrosine kinase was determined.	B	CCN(CC)CCOc1ccc(Nc2ccc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1		CHEMBL106379	=	IC50	nM	29000.0	CHEMBL267	Homo sapiens	IC50	uM	29.0
	201194	CHEMBL844770	Binding affinity to p60 src SH2 domain.	B	C[C@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)NC(CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O		CHEMBL19754	=	IC50	nM	13400.0	CHEMBL267	Homo sapiens	IC50	uM	13.4
	201683	CHEMBL823231	Inhibitory concentration against SH2 domain of human p60 Src tyrosine kinase	B	CC(=O)N[C@@H](Cc1ccc(P(=O)(O)O)c(P(=O)(O)O)c1)C(=O)N[C@H]1CCCCN(Cc2ccc(-c3ccccc3)cc2)C1=O		CHEMBL319516	=	IC50	nM	2000.0	CHEMBL267	Homo sapiens	IC50	nM	2000.0
	202772	CHEMBL818902	Inhibitory activity against avian c-Src tyrosine kinase was determined.	B	CN1CCN(CCCNc2cc3c(cn2)cc(-c2c(Cl)cccc2Cl)c(=O)n3C)CC1		CHEMBL108013	=	IC50	nM	59.0	CHEMBL267	Homo sapiens	IC50	uM	0.059
	202778	CHEMBL818902	Inhibitory activity against avian c-Src tyrosine kinase was determined.	B	CN1CCN(c2ccc(Nc3ncc4cc(-c5c(Cl)cccc5Cl)c(=O)n(C)c4n3)cc2)CC1		CHEMBL51283	=	IC50	nM	10.0	CHEMBL267	Homo sapiens	IC50	uM	0.01
	202900	CHEMBL823231	Inhibitory concentration against SH2 domain of human p60 Src tyrosine kinase	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@H]1CCCCN(Cc2ccc(-c3cccc4ccccc34)cc2)C1=O		CHEMBL444037	=	IC50	nM	143.0	CHEMBL267	Homo sapiens	IC50	nM	143.0
	202901	CHEMBL823231	Inhibitory concentration against SH2 domain of human p60 Src tyrosine kinase	B	CC(C)(C)c1ccc(CN2CCCC[C@H](NC(=O)c3ccc(OP(=O)(O)O)cc3)C2=O)cc1		CHEMBL1160752	=	IC50	nM	2300.0	CHEMBL267	Homo sapiens	IC50	nM	2300.0
	203950	CHEMBL818902	Inhibitory activity against avian c-Src tyrosine kinase was determined.	B	CCN(CC)CCCCNc1cc2c(cn1)cc(-c1c(Cl)cccc1Cl)c(=O)n2C		CHEMBL107676	=	IC50	nM	44.0	CHEMBL267	Homo sapiens	IC50	uM	0.044
	203953	CHEMBL818902	Inhibitory activity against avian c-Src tyrosine kinase was determined.	B	CN1CCN(CCCNc2ccc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)CC1		CHEMBL104532	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	203956	CHEMBL818902	Inhibitory activity against avian c-Src tyrosine kinase was determined.	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2ccc(Nc3ccccc3)nc21		CHEMBL420473	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	203959	CHEMBL818902	Inhibitory activity against avian c-Src tyrosine kinase was determined.	B	CCN(CC)CCCNc1ncc2cc(-c3c(Cl)cccc3Cl)c(=O)n(C)c2n1		CHEMBL50470	=	IC50	nM	960.0	CHEMBL267	Homo sapiens	IC50	uM	0.96
	205160	CHEMBL818902	Inhibitory activity against avian c-Src tyrosine kinase was determined.	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(NCCCn3ccnc3)cc21		CHEMBL106953	=	IC50	nM	540.0	CHEMBL267	Homo sapiens	IC50	uM	0.54
	205163	CHEMBL818902	Inhibitory activity against avian c-Src tyrosine kinase was determined.	B	CN1CCN(c2ccc(Nc3cc4c(cn3)cc(-c3c(Cl)cccc3Cl)c(=O)n4C)cc2)CC1		CHEMBL104414	=	IC50	nM	23.0	CHEMBL267	Homo sapiens	IC50	uM	0.023
	205169	CHEMBL818902	Inhibitory activity against avian c-Src tyrosine kinase was determined.	B	CCN(CC)CCNc1ncc2cc(-c3c(Cl)cccc3Cl)c(=O)n(C)c2n1		CHEMBL107177	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	205172	CHEMBL818902	Inhibitory activity against avian c-Src tyrosine kinase was determined.	B	CN1CCN(CCCCNc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)CC1		CHEMBL104244	=	IC50	nM	70.0	CHEMBL267	Homo sapiens	IC50	uM	0.07
	206409	CHEMBL818902	Inhibitory activity against avian c-Src tyrosine kinase was determined.	B	CN(C)c1cc2c(cn1)cc(-c1c(Cl)cccc1Cl)c(=O)n2C		CHEMBL108170	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	206412	CHEMBL818902	Inhibitory activity against avian c-Src tyrosine kinase was determined.	B	CNc1ncc2cc(-c3c(Cl)cccc3Cl)c(=O)n(C)c2n1		CHEMBL107472	=	IC50	nM	750.0	CHEMBL267	Homo sapiens	IC50	uM	0.75
	206418	CHEMBL818902	Inhibitory activity against avian c-Src tyrosine kinase was determined.	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3ccncc3)nc21		CHEMBL104779	=	IC50	nM	10.0	CHEMBL267	Homo sapiens	IC50	uM	0.01
	207145	CHEMBL844770	Binding affinity to p60 src SH2 domain.	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)C(Cc1ccc(OP(=O)(O)O)cc1)c1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)O		CHEMBL2092743	=	IC50	nM	9300.0	CHEMBL267	Homo sapiens	IC50	uM	9.3
	207146	CHEMBL844770	Binding affinity to p60 src SH2 domain.	B	NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(CCC(=O)O)NC(=O)CCc1ccc(OP(=O)(O)O)cc1		CHEMBL277236	=	IC50	nM	21300.0	CHEMBL267	Homo sapiens	IC50	uM	21.3
	207390	CHEMBL806425	Inhibition of Src kinase in yeast-based screen	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	IC50	nM	1.2	CHEMBL267	Homo sapiens	IC50	nM	1.2
	207391	CHEMBL806424	Inhibition of Src-dependent cell proliferation	F	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	IC50	nM	100.0	CHEMBL267	Homo sapiens	IC50	nM	100.0
	207587	CHEMBL818902	Inhibitory activity against avian c-Src tyrosine kinase was determined.	B	CN1CCN(CCCCCNc2cc3c(cn2)cc(-c2c(Cl)cccc2Cl)c(=O)n3C)CC1		CHEMBL108332	=	IC50	nM	35.0	CHEMBL267	Homo sapiens	IC50	uM	0.035
	208341	CHEMBL844770	Binding affinity to p60 src SH2 domain.	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)O		CHEMBL3143230	=	IC50	nM	20000.0	CHEMBL267	Homo sapiens	IC50	uM	20.0
	208556	CHEMBL806425	Inhibition of Src kinase in yeast-based screen	B	COc1cc(Nc2c(C#N)cnc3cc(-c4csc(CN5CCOCC5)c4)ccc23)c(Cl)cc1Cl		CHEMBL59786	=	IC50	nM	2.7	CHEMBL267	Homo sapiens	IC50	nM	2.7
	208557	CHEMBL806424	Inhibition of Src-dependent cell proliferation	F	COc1cc(Nc2c(C#N)cnc3cc(-c4csc(CN5CCOCC5)c4)ccc23)c(Cl)cc1Cl		CHEMBL59786	=	IC50	nM	200.0	CHEMBL267	Homo sapiens	IC50	nM	200.0
	208759	CHEMBL818902	Inhibitory activity against avian c-Src tyrosine kinase was determined.	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(N)nc21		CHEMBL49596	=	IC50	nM	260.0	CHEMBL267	Homo sapiens	IC50	uM	0.26
	209465	CHEMBL844770	Binding affinity to p60 src SH2 domain.	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)C(Cc1ccc(OP(=O)(O)O)cc1)c1ccccc1O)C(=O)N[C@@H](CCC(=O)O)C(=O)O		CHEMBL3143231	=	IC50	nM	1400.0	CHEMBL267	Homo sapiens	IC50	uM	1.4
	209933	CHEMBL818902	Inhibitory activity against avian c-Src tyrosine kinase was determined.	B	CN1CCN(CCCCNc2cc3c(cn2)cc(-c2c(Cl)cccc2Cl)c(=O)n3C)CC1		CHEMBL108333	=	IC50	nM	41.0	CHEMBL267	Homo sapiens	IC50	uM	0.041
	209939	CHEMBL818902	Inhibitory activity against avian c-Src tyrosine kinase was determined.	B	CN1CCN(CCCNc2cc3nc(O)c(-c4c(Cl)cccc4Cl)cc3cn2)CC1		CHEMBL104304	=	IC50	nM	110.0	CHEMBL267	Homo sapiens	IC50	uM	0.11
	209942	CHEMBL818902	Inhibitory activity against avian c-Src tyrosine kinase was determined.	B	CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1		CHEMBL49120	=	IC50	nM	9.0	CHEMBL267	Homo sapiens	IC50	uM	0.009
	210624	CHEMBL844770	Binding affinity to p60 src SH2 domain.	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](CC(=O)O)Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)O		CHEMBL3142986	=	IC50	nM	350.0	CHEMBL267	Homo sapiens	IC50	uM	0.35
	211867	CHEMBL844770	Binding affinity to p60 src SH2 domain.	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)C(Cc1ccc(OP(=O)(O)O)cc1)c1ccc2ccccc2c1)C(=O)N[C@@H](CCC(=O)O)C(=O)O		CHEMBL2092742	=	IC50	nM	2800.0	CHEMBL267	Homo sapiens	IC50	uM	2.8
	211868	CHEMBL844770	Binding affinity to p60 src SH2 domain.	B	Cc1cc(OP(=O)(O)O)cc(C)c1CCC(=O)NC(CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O		CHEMBL279003	=	IC50	nM	30000.0	CHEMBL267	Homo sapiens	IC50	uM	30.0
	211869	CHEMBL844770	Binding affinity to p60 src SH2 domain.	B	NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(CCC(=O)O)NC(=O)/C=C/c1ccc(OP(=O)(O)O)cc1		CHEMBL19996	=	IC50	nM	30000.0	CHEMBL267	Homo sapiens	IC50	uM	30.0
	212137	CHEMBL806425	Inhibition of Src kinase in yeast-based screen	B	COc1cc(Nc2c(C#N)cnc3cc(-c4ccsc4CN4CCOCC4)ccc23)c(Cl)cc1Cl		CHEMBL303529	=	IC50	nM	440.0	CHEMBL267	Homo sapiens	IC50	nM	440.0
	212138	CHEMBL806424	Inhibition of Src-dependent cell proliferation	F	COc1cc(Nc2c(C#N)cnc3cc(-c4ccsc4CN4CCOCC4)ccc23)c(Cl)cc1Cl		CHEMBL303529	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	213036	CHEMBL844770	Binding affinity to p60 src SH2 domain.	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)C(Cc1ccc(OP(=O)(O)O)cc1)c1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)O		CHEMBL2092743	=	IC50	nM	1900.0	CHEMBL267	Homo sapiens	IC50	uM	1.9
	213037	CHEMBL764642	Inhibition of src SH2 domain binding to PDGF receptor	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)C(Cc1ccc(OP(=O)(O)O)cc1)c1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)O		CHEMBL2092743	=	IC50	nM	7350.0	CHEMBL267	Homo sapiens	IC50	uM	7.35
	213196	CHEMBL806425	Inhibition of Src kinase in yeast-based screen	B	COc1cc(Nc2c(C#N)cnc3cc(-c4cc(CN5CCCCC5)cs4)ccc23)c(Cl)cc1Cl		CHEMBL304471	=	IC50	nM	4.2	CHEMBL267	Homo sapiens	IC50	nM	4.2
	213197	CHEMBL806424	Inhibition of Src-dependent cell proliferation	F	COc1cc(Nc2c(C#N)cnc3cc(-c4cc(CN5CCCCC5)cs4)ccc23)c(Cl)cc1Cl		CHEMBL304471	=	IC50	nM	190.0	CHEMBL267	Homo sapiens	IC50	nM	190.0
	213397	CHEMBL818902	Inhibitory activity against avian c-Src tyrosine kinase was determined.	B	CCN(CC)C(=O)c1ccc(Nc2cc3c(cn2)cc(-c2c(Cl)cccc2Cl)c(=O)n3C)cc1		CHEMBL322005	=	IC50	nM	1000.0	CHEMBL267	Homo sapiens	IC50	uM	1.0
	214164	CHEMBL844770	Binding affinity to p60 src SH2 domain.	B	CC[C@H](C)[C@H](NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(Cc1ccc(OP(=O)(O)O)cc1)c1cccc(O)c1)C(=O)N[C@@H](CCC(=O)O)C(=O)O		CHEMBL19717	=	IC50	nM	2100.0	CHEMBL267	Homo sapiens	IC50	uM	2.1
	214554	CHEMBL818902	Inhibitory activity against avian c-Src tyrosine kinase was determined.	B	CCN(CC)CCCOc1ccc(Nc2cc3nc(O)c(-c4c(Cl)cccc4Cl)cc3cn2)cc1		CHEMBL419914	=	IC50	nM	11.0	CHEMBL267	Homo sapiens	IC50	uM	0.011
	215326	CHEMBL844770	Binding affinity to p60 src SH2 domain.	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)/C=C/c1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)O		CHEMBL3143156	=	IC50	nM	5500.0	CHEMBL267	Homo sapiens	IC50	uM	5.5
	215539	CHEMBL806425	Inhibition of Src kinase in yeast-based screen	B	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(CN5CCOCC5)s4)ccc23)c(Cl)cc1Cl		CHEMBL59850	=	IC50	nM	2.5	CHEMBL267	Homo sapiens	IC50	nM	2.5
	215540	CHEMBL806424	Inhibition of Src-dependent cell proliferation	F	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(CN5CCOCC5)s4)ccc23)c(Cl)cc1Cl		CHEMBL59850	=	IC50	nM	220.0	CHEMBL267	Homo sapiens	IC50	nM	220.0
	215541	CHEMBL806425	Inhibition of Src kinase in yeast-based screen	B	COc1cc(Nc2c(C#N)cnc3cc(-c4csc(CN5CCN(C)CC5)c4)ccc23)c(Cl)cc1Cl		CHEMBL303786	=	IC50	nM	3.8	CHEMBL267	Homo sapiens	IC50	nM	3.8
	215542	CHEMBL806424	Inhibition of Src-dependent cell proliferation	F	COc1cc(Nc2c(C#N)cnc3cc(-c4csc(CN5CCN(C)CC5)c4)ccc23)c(Cl)cc1Cl		CHEMBL303786	=	IC50	nM	64.0	CHEMBL267	Homo sapiens	IC50	nM	64.0
	215717	CHEMBL818902	Inhibitory activity against avian c-Src tyrosine kinase was determined.	B	CCN(CC)CCOc1ccc(Nc2cc3c(cn2)cc(-c2c(Cl)cccc2Cl)c(=O)n3C)cc1		CHEMBL107277	=	IC50	nM	78.0	CHEMBL267	Homo sapiens	IC50	uM	0.078
	215835	CHEMBL823231	Inhibitory concentration against SH2 domain of human p60 Src tyrosine kinase	B	CC(=O)N[C@@H](Cc1ccc(C(F)(F)P(=O)(O)O)cc1)C(=O)N[C@H]1CCCCN(Cc2ccc(-c3ccccc3)cc2)C1=O		CHEMBL1160756	=	IC50	nM	5.0	CHEMBL267	Homo sapiens	IC50	nM	5.0
	216510	CHEMBL844770	Binding affinity to p60 src SH2 domain.	B	CC[C@H](C)[C@H](NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(Cc1ccc(OP(=O)(O)O)cc1)c1cccc(O)c1)C(=O)N[C@@H](CCC(=O)O)C(=O)O		CHEMBL19717	=	IC50	nM	3300.0	CHEMBL267	Homo sapiens	IC50	uM	3.3
	216746	CHEMBL806425	Inhibition of Src kinase in yeast-based screen	B	COc1cc(Nc2c(C#N)cnc3cc(-c4cc(CN5CCN(C)CC5)cs4)ccc23)c(Cl)cc1Cl		CHEMBL60391	=	IC50	nM	3.8	CHEMBL267	Homo sapiens	IC50	nM	3.8
	216747	CHEMBL806424	Inhibition of Src-dependent cell proliferation	F	COc1cc(Nc2c(C#N)cnc3cc(-c4cc(CN5CCN(C)CC5)cs4)ccc23)c(Cl)cc1Cl		CHEMBL60391	=	IC50	nM	69.0	CHEMBL267	Homo sapiens	IC50	nM	69.0
	217991	CHEMBL806425	Inhibition of Src kinase in yeast-based screen	B	COc1cc(Nc2c(C#N)cnc3cc(-c4cc(CN5CCOCC5)cs4)ccc23)c(Cl)cc1Cl		CHEMBL418693	=	IC50	nM	5.7	CHEMBL267	Homo sapiens	IC50	nM	5.7
	217992	CHEMBL806424	Inhibition of Src-dependent cell proliferation	F	COc1cc(Nc2c(C#N)cnc3cc(-c4cc(CN5CCOCC5)cs4)ccc23)c(Cl)cc1Cl		CHEMBL418693	=	IC50	nM	240.0	CHEMBL267	Homo sapiens	IC50	nM	240.0
	218209	CHEMBL818902	Inhibitory activity against avian c-Src tyrosine kinase was determined.	B	CCN(CC)CCCOc1ccc(Nc2cc3c(cn2)cc(-c2c(Cl)cccc2Cl)c(=O)n3C)cc1		CHEMBL107458	=	IC50	nM	32.0	CHEMBL267	Homo sapiens	IC50	uM	0.032
	218212	CHEMBL818902	Inhibitory activity against avian c-Src tyrosine kinase was determined.	B	COc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1		CHEMBL104153	=	IC50	nM	20.0	CHEMBL267	Homo sapiens	IC50	uM	0.02
	218952	CHEMBL844770	Binding affinity to p60 src SH2 domain.	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(C)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)O		CHEMBL299477	=	IC50	nM	2800.0	CHEMBL267	Homo sapiens	IC50	uM	2.8
	219161	CHEMBL806425	Inhibition of Src kinase in yeast-based screen	B	COc1cc(Nc2c(C#N)cnc3cc(-c4cc(CN5CCC(O)CC5)cs4)ccc23)c(Cl)cc1Cl		CHEMBL294137	=	IC50	nM	2.0	CHEMBL267	Homo sapiens	IC50	nM	2.0
	219162	CHEMBL806424	Inhibition of Src-dependent cell proliferation	F	COc1cc(Nc2c(C#N)cnc3cc(-c4cc(CN5CCC(O)CC5)cs4)ccc23)c(Cl)cc1Cl		CHEMBL294137	=	IC50	nM	120.0	CHEMBL267	Homo sapiens	IC50	nM	120.0
	220584	CHEMBL818902	Inhibitory activity against avian c-Src tyrosine kinase was determined.	B	CCN(CC)CCCCCNc1cc2c(cn1)cc(-c1c(Cl)cccc1Cl)c(=O)n2C		CHEMBL107423	=	IC50	nM	24.0	CHEMBL267	Homo sapiens	IC50	uM	0.024
	220587	CHEMBL818902	Inhibitory activity against avian c-Src tyrosine kinase was determined.	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(NCCCN3CCOCC3)cc21		CHEMBL106295	=	IC50	nM	200.0	CHEMBL267	Homo sapiens	IC50	uM	0.2
	220590	CHEMBL818902	Inhibitory activity against avian c-Src tyrosine kinase was determined.	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3ccc(N4CCOCC4)cc3)nc21		CHEMBL106772	=	IC50	nM	8.0	CHEMBL267	Homo sapiens	IC50	uM	0.008
	220748	CHEMBL823231	Inhibitory concentration against SH2 domain of human p60 Src tyrosine kinase	B	CC(=O)N[C@@H](Cc1ccc(C(F)(F)P(=O)(O)O)cc1)C(=O)N[C@H]1CCCCN(CCCC2CCCCC2)C1=O		CHEMBL1160760	=	IC50	nM	340.0	CHEMBL267	Homo sapiens	IC50	nM	340.0
	220786	CHEMBL822807	Inhibition of c-Src tyrosine kinase	B	CCn1c2ccccc2c2cc(/C=N\OC)ccc21		CHEMBL119388	=	IC50	nM	40000.0	CHEMBL267	Homo sapiens	IC50	uM	40.0
	221362	CHEMBL844770	Binding affinity to p60 src SH2 domain.	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)C(Cc1ccc(OP(=O)(O)O)cc1)c1cccc2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)O		CHEMBL2092741	=	IC50	nM	2600.0	CHEMBL267	Homo sapiens	IC50	uM	2.6
	221363	CHEMBL844770	Binding affinity to p60 src SH2 domain.	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CCc1c(C)cc(OP(=O)(O)O)cc1C)C(=O)N[C@@H](CCC(=O)O)C(=O)O		CHEMBL3143159	=	IC50	nM	4500.0	CHEMBL267	Homo sapiens	IC50	uM	4.5
	221558	CHEMBL806425	Inhibition of Src kinase in yeast-based screen	B	COc1cc(Nc2c(C#N)cnc3ccc(-c4csc(CN5CCOCC5)c4)cc23)c(Cl)cc1Cl		CHEMBL60408	=	IC50	nM	280.0	CHEMBL267	Homo sapiens	IC50	nM	280.0
	221559	CHEMBL806424	Inhibition of Src-dependent cell proliferation	F	COc1cc(Nc2c(C#N)cnc3ccc(-c4csc(CN5CCOCC5)c4)cc23)c(Cl)cc1Cl		CHEMBL60408	=	IC50	nM	3600.0	CHEMBL267	Homo sapiens	IC50	nM	3600.0
	221679	CHEMBL818902	Inhibitory activity against avian c-Src tyrosine kinase was determined.	B	CCN(CC)CCNc1cc2c(cn1)cc(-c1c(Cl)cccc1Cl)c(=O)n2C		CHEMBL107418	=	IC50	nM	13000.0	CHEMBL267	Homo sapiens	IC50	uM	13.0
	222683	CHEMBL806420	Binding affinity against Src-homology 2 (SRC SH2).	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)c1nc(CCC(C)C)no1		CHEMBL76076	=	IC50	nM	33000.0	CHEMBL267	Homo sapiens	IC50	uM	33.0
	224093	CHEMBL806420	Binding affinity against Src-homology 2 (SRC SH2).	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CCC(=O)O)c1nc(CC(C)C)no1	Outside typical range	CHEMBL309687	=	IC50	nM	166000.0	CHEMBL267	Homo sapiens	IC50	uM	166.0
	224094	CHEMBL806420	Binding affinity against Src-homology 2 (SRC SH2).	B	CCCCCCc1noc([C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccc(OP(=O)(O)O)cc2)NC(C)=O)n1		CHEMBL311101	=	IC50	nM	16000.0	CHEMBL267	Homo sapiens	IC50	uM	16.0
	225332	CHEMBL806420	Binding affinity against Src-homology 2 (SRC SH2).	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CCC(N)=O)c1nc(Cc2ccccc2)no1		CHEMBL77067	=	IC50	nM	72000.0	CHEMBL267	Homo sapiens	IC50	uM	72.0
	226612	CHEMBL806420	Binding affinity against Src-homology 2 (SRC SH2).	B	CCCCCCc1noc([C@H](CC)NC(=O)[C@H](Cc2ccc(OP(=O)(O)O)cc2)NC(C)=O)n1		CHEMBL80295	=	IC50	nM	25000.0	CHEMBL267	Homo sapiens	IC50	uM	25.0
	226783	CHEMBL805368	Inhibition of Src protein tyrosine kinase	B	CCN1CCC(n2cc(C3=C(c4cn(C)c5ccccc45)C(=O)NC3=O)c3ccccc32)CC1		CHEMBL54382	=	IC50	nM	11000.0	CHEMBL267	Homo sapiens	IC50	uM	11.0
	227903	CHEMBL806420	Binding affinity against Src-homology 2 (SRC SH2).	B	CCCCCc1noc([C@H](CC)NC(=O)[C@H](Cc2ccc(OP(=O)(O)O)cc2)NC(C)=O)n1		CHEMBL311370	=	IC50	nM	65000.0	CHEMBL267	Homo sapiens	IC50	uM	65.0
	228210	CHEMBL698890	Inhibition of human src kinase.	B	COc1cc(Cc2nn([C@H]3CC[C@H](N4CCN(C)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)[C@@H]1C[C@H]1c1ccccc1		CHEMBL416091	=	IC50	nM	27.0	CHEMBL267	Homo sapiens	IC50	uM	0.027
	229192	CHEMBL806420	Binding affinity against Src-homology 2 (SRC SH2).	B	CCCCCCCc1noc([C@H](CCC(=O)O)NC(=O)[C@H](Cc2ccc(OP(=O)(O)O)cc2)NC(C)=O)n1		CHEMBL432543	=	IC50	nM	7000.0	CHEMBL267	Homo sapiens	IC50	uM	7.0
	230382	CHEMBL806420	Binding affinity against Src-homology 2 (SRC SH2).	B	CCCCCCCc1noc([C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccc(OP(=O)(O)O)cc2)NC(C)=O)n1		CHEMBL422240	=	IC50	nM	35000.0	CHEMBL267	Homo sapiens	IC50	uM	35.0
	230637	CHEMBL806437	Inhibition of Src protein tyrosine kinase	B	CN1CCN([C@H]2CC[C@H](n3nc(-c4ccc(Oc5ccccc5)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL44577	=	IC50	nM	35.0	CHEMBL267	Homo sapiens	IC50	uM	0.035
	230699	CHEMBL698890	Inhibition of human src kinase.	B	COc1cc(-c2nn([C@H]3CC[C@H](N4CCN(C)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)c1ccccc1		CHEMBL297363	=	IC50	nM	189.0	CHEMBL267	Homo sapiens	IC50	uM	0.189
	233212	CHEMBL805368	Inhibition of Src protein tyrosine kinase	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1.CS(=O)(=O)O		CHEMBL432130	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	233266	CHEMBL698890	Inhibition of human src kinase.	B	COc1cc(-c2nn([C@H]3CC[C@H](N4CCN(C)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)C(C)(C)Cc1ccccc1		CHEMBL417006	=	IC50	nM	460.0	CHEMBL267	Homo sapiens	IC50	uM	0.46
	233270	CHEMBL698890	Inhibition of human src kinase.	B	COc1cc(-c2nn([C@H]3CC[C@H](N4CCN(C)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)OCc1ccccc1		CHEMBL47787	=	IC50	nM	12.5	CHEMBL267	Homo sapiens	IC50	uM	0.0125
	234229	CHEMBL806420	Binding affinity against Src-homology 2 (SRC SH2).	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)NCc1nc(CC2CCCCC2)cs1	Outside typical range	CHEMBL76625	=	IC50	nM	483000.0	CHEMBL267	Homo sapiens	IC50	uM	483.0
	234230	CHEMBL806420	Binding affinity against Src-homology 2 (SRC SH2).	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CCC(=O)O)c1nc(CC(C)C)cs1	Outside typical range	CHEMBL77116	=	IC50	nM	218000.0	CHEMBL267	Homo sapiens	IC50	uM	218.0
	234231	CHEMBL806420	Binding affinity against Src-homology 2 (SRC SH2).	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CCC(=O)O)c1nc(CCC(C)C)no1		CHEMBL76813	=	IC50	nM	61000.0	CHEMBL267	Homo sapiens	IC50	uM	61.0
	234232	CHEMBL806420	Binding affinity against Src-homology 2 (SRC SH2).	B	CCCCCCc1noc([C@H](CCC(=O)O)NC(=O)[C@H](Cc2ccc(OP(=O)(O)O)cc2)NC(C)=O)n1		CHEMBL420952	=	IC50	nM	8000.0	CHEMBL267	Homo sapiens	IC50	uM	8.0
	234546	CHEMBL698890	Inhibition of human src kinase.	B	CN1CCN([C@H]2CC[C@H](n3nc(-c4ccc(NCc5cc6ccccc6[nH]5)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL45683	=	IC50	nM	526.0	CHEMBL267	Homo sapiens	IC50	uM	0.526
	235576	CHEMBL806420	Binding affinity against Src-homology 2 (SRC SH2).	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)NCc1nc(CC2CCCCC2)no1	Outside typical range	CHEMBL80769	=	IC50	nM	896000.0	CHEMBL267	Homo sapiens	IC50	uM	896.0
	235577	CHEMBL806420	Binding affinity against Src-homology 2 (SRC SH2).	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CCC(N)=O)c1nc(Cc2cccc3ccccc23)no1	Outside typical range	CHEMBL310313	=	IC50	nM	135000.0	CHEMBL267	Homo sapiens	IC50	uM	135.0
	235578	CHEMBL806420	Binding affinity against Src-homology 2 (SRC SH2).	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)c1nc(Cc2ccccc2)no1		CHEMBL311740	=	IC50	nM	25000.0	CHEMBL267	Homo sapiens	IC50	uM	25.0
	236776	CHEMBL806420	Binding affinity against Src-homology 2 (SRC SH2).	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CCC(=O)O)c1ncc(CC2CCCCC2)s1		CHEMBL77673	=	IC50	nM	16000.0	CHEMBL267	Homo sapiens	IC50	uM	16.0
	238112	CHEMBL806420	Binding affinity against Src-homology 2 (SRC SH2).	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CCC(=O)O)c1nc(CC2CCCCC2)no1		CHEMBL306929	=	IC50	nM	29000.0	CHEMBL267	Homo sapiens	IC50	uM	29.0
	238323	CHEMBL698890	Inhibition of human src kinase.	B	CN1CCN([C@H]2CC[C@H](n3nc(-c4ccc(C(=O)c5ccccc5)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL45693	=	IC50	nM	427.0	CHEMBL267	Homo sapiens	IC50	uM	0.427
	239525	CHEMBL806420	Binding affinity against Src-homology 2 (SRC SH2).	B	CCCCCCCc1noc([C@H](CC)NC(=O)[C@H](Cc2ccc(OP(=O)(O)O)cc2)NC(C)=O)n1		CHEMBL77338	=	IC50	nM	22000.0	CHEMBL267	Homo sapiens	IC50	uM	22.0
	240957	CHEMBL806420	Binding affinity against Src-homology 2 (SRC SH2).	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CCC(N)=O)c1nc(CCC(C)C)no1	Outside typical range	CHEMBL76201	=	IC50	nM	320000.0	CHEMBL267	Homo sapiens	IC50	uM	320.0
	240958	CHEMBL806420	Binding affinity against Src-homology 2 (SRC SH2).	B	CC[C@H](NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(C)=O)c1nc(CCC(C)C)no1	Outside typical range	CHEMBL76812	=	IC50	nM	111000.0	CHEMBL267	Homo sapiens	IC50	uM	111.0
	242448	CHEMBL698890	Inhibition of human src kinase.	B	CN1CCN([C@H]2CC[C@H](n3nc(-c4ccc(Nc5ccccc5)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL46785	=	IC50	nM	65.0	CHEMBL267	Homo sapiens	IC50	uM	0.065
	244915	CHEMBL806420	Binding affinity against Src-homology 2 (SRC SH2).	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CCC(N)=O)c1nc(CC2CCCCC2)no1	Outside typical range	CHEMBL75868	=	IC50	nM	2780000.0	CHEMBL267	Homo sapiens	IC50	uM	2780.0
	246405	CHEMBL806420	Binding affinity against Src-homology 2 (SRC SH2).	B	CCCCCCc1cnc([C@H](CC)NC(=O)[C@H](Cc2ccc(OP(=O)(O)O)cc2)NC(C)=O)s1		CHEMBL80765	=	IC50	nM	12000.0	CHEMBL267	Homo sapiens	IC50	uM	12.0
	246406	CHEMBL806420	Binding affinity against Src-homology 2 (SRC SH2).	B	CCCCCc1noc([C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccc(OP(=O)(O)O)cc2)NC(C)=O)n1		CHEMBL420941	=	IC50	nM	36000.0	CHEMBL267	Homo sapiens	IC50	uM	36.0
	246614	CHEMBL806437	Inhibition of Src protein tyrosine kinase	B	COc1cc(-c2nn([C@H]3CC[C@H](N4CCN(C)CC4)CC3)c3ncnc(N)c23)ccc1NCc1ccccc1		CHEMBL45582	=	IC50	nM	68.0	CHEMBL267	Homo sapiens	IC50	uM	0.068
Not Determined	247744	CHEMBL805369	Inhibition of Src protein tyrosine kinase (Not tested)	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccc5)C4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL291975		IC50	nM		CHEMBL267	Homo sapiens	IC50	uM	
	249026	CHEMBL806420	Binding affinity against Src-homology 2 (SRC SH2).	B	CCCCCc1noc([C@H](CCC(=O)O)NC(=O)[C@H](Cc2ccc(OP(=O)(O)O)cc2)NC(C)=O)n1		CHEMBL76035	=	IC50	nM	21000.0	CHEMBL267	Homo sapiens	IC50	uM	21.0
	249027	CHEMBL806420	Binding affinity against Src-homology 2 (SRC SH2).	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CCC(N)=O)c1nc(CCc2ccccc2)no1	Outside typical range	CHEMBL76963	=	IC50	nM	156000.0	CHEMBL267	Homo sapiens	IC50	uM	156.0
	249028	CHEMBL806420	Binding affinity against Src-homology 2 (SRC SH2).	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)c1nc(CCCC(C)C)no1		CHEMBL405008	=	IC50	nM	89000.0	CHEMBL267	Homo sapiens	IC50	uM	89.0
Not Determined	249201	CHEMBL805369	Inhibition of Src protein tyrosine kinase (Not tested)	B	Cn1cc(C2=C(c3cn(C4CCNCC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL55788		IC50	nM		CHEMBL267	Homo sapiens	IC50	uM	
	249298	CHEMBL698890	Inhibition of human src kinase.	B	COc1cc(-c2nn([C@H]3CC[C@H](N4CCN(C)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)c1cc2ccccc2o1		CHEMBL43773	=	IC50	nM	43.0	CHEMBL267	Homo sapiens	IC50	uM	0.043
Not Determined	250574	CHEMBL805369	Inhibition of Src protein tyrosine kinase (Not tested)	B	CC(C)N1CCC(n2cc(C3=C(c4cn(C)c5ccccc45)C(=O)NC3=O)c3ccccc32)CC1		CHEMBL301860		IC50	nM		CHEMBL267	Homo sapiens	IC50	uM	
	250610	CHEMBL806437	Inhibition of Src protein tyrosine kinase	B	CN1CCN([C@H]2CC[C@H](n3cc(-c4ccc(Oc5ccccc5)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL45177	=	IC50	nM	42.0	CHEMBL267	Homo sapiens	IC50	uM	0.042
	251839	CHEMBL806420	Binding affinity against Src-homology 2 (SRC SH2).	B	CCCCCCc1cnc([C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccc(OP(=O)(O)O)cc2)NC(C)=O)s1		CHEMBL77702	=	IC50	nM	14000.0	CHEMBL267	Homo sapiens	IC50	uM	14.0
	251949	CHEMBL805368	Inhibition of Src protein tyrosine kinase	B	CN1CCC(n2cc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc32)CC1		CHEMBL52654	=	IC50	nM	83000.0	CHEMBL267	Homo sapiens	IC50	uM	83.0
	252041	CHEMBL698890	Inhibition of human src kinase.	B	COc1cc(-c2nn([C@H]3CC[C@H](N4CCN(C)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)CCc1ccccc1		CHEMBL295601	=	IC50	nM	155.0	CHEMBL267	Homo sapiens	IC50	uM	0.155
	253217	CHEMBL806420	Binding affinity against Src-homology 2 (SRC SH2).	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)c1nc(CC2CCCCC2)no1		CHEMBL310193	=	IC50	nM	62000.0	CHEMBL267	Homo sapiens	IC50	uM	62.0
	254640	CHEMBL805368	Inhibition of Src protein tyrosine kinase	B	Cn1cc(C2=C(c3cn(C4CCN(CC5CC5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL55394	=	IC50	nM	68000.0	CHEMBL267	Homo sapiens	IC50	uM	68.0
	255838	CHEMBL806420	Binding affinity against Src-homology 2 (SRC SH2).	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CCC(=O)O)c1nc(Cc2ccccc2)no1		CHEMBL311135	=	IC50	nM	92000.0	CHEMBL267	Homo sapiens	IC50	uM	92.0
	255839	CHEMBL806420	Binding affinity against Src-homology 2 (SRC SH2).	B	CCCCc1noc([C@H](CCC(N)=O)NC(=O)[C@H](Cc2ccc(OP(=O)(O)O)cc2)NC(C)=O)n1	Outside typical range	CHEMBL75974	=	IC50	nM	384000.0	CHEMBL267	Homo sapiens	IC50	uM	384.0
	256033	CHEMBL805368	Inhibition of Src protein tyrosine kinase	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	256154	CHEMBL698890	Inhibition of human src kinase.	B	COc1cc(-c2nn([C@H]3CC[C@H](N4CCN(C)CC4)CC3)c3ncnc(N)c23)ccc1NS(=O)(=O)Nc1ccccc1		CHEMBL46176	=	IC50	nM	463.0	CHEMBL267	Homo sapiens	IC50	uM	0.463
	257382	CHEMBL805368	Inhibition of Src protein tyrosine kinase	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccc5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300549	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	257395	CHEMBL805368	Inhibition of Src protein tyrosine kinase	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	1.0	CHEMBL267	Homo sapiens	IC50	uM	0.001
	257549	CHEMBL698890	Inhibition of human src kinase.	B	COc1cc(-c2nn([C@H]3CC[C@H](N4CCN(C)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)CC(C)(C)c1ccccc1		CHEMBL295528	=	IC50	nM	115.0	CHEMBL267	Homo sapiens	IC50	uM	0.115
	258599	CHEMBL806420	Binding affinity against Src-homology 2 (SRC SH2).	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CCC(=O)O)c1nc(CC2CCCCC2)cs1		CHEMBL73829	=	IC50	nM	26000.0	CHEMBL267	Homo sapiens	IC50	uM	26.0
	258600	CHEMBL806420	Binding affinity against Src-homology 2 (SRC SH2).	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)c1nc(Cc2cccc3ccccc23)no1	Outside typical range	CHEMBL263245	=	IC50	nM	279000.0	CHEMBL267	Homo sapiens	IC50	uM	279.0
	258779	CHEMBL805368	Inhibition of Src protein tyrosine kinase	B	CN1CCC(n2cc(C3=C(c4cn(C)c5ccccc45)C(=O)NC3=O)c3ccccc32)CC1		CHEMBL53596	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	258862	CHEMBL698890	Inhibition of human src kinase.	B	COc1cc(-c2nn([C@H]3CC[C@H](N4CCN(C)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)Nc1ccccc1		CHEMBL45651	=	IC50	nM	310.0	CHEMBL267	Homo sapiens	IC50	uM	0.31
	260180	CHEMBL698890	Inhibition of human src kinase.	B	COc1cc(-c2nn([C@H]3CC[C@H](N4CCN(C)CC4)CC3)c3ncnc(N)c23)ccc1NS(=O)(=O)c1ccccc1		CHEMBL402673	=	IC50	nM	3190.0	CHEMBL267	Homo sapiens	IC50	uM	3.19
	261268	CHEMBL806420	Binding affinity against Src-homology 2 (SRC SH2).	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(C)=O)C(N)=O		CHEMBL311937	=	IC50	nM	6000.0	CHEMBL267	Homo sapiens	IC50	uM	6.0
	262503	CHEMBL806420	Binding affinity against Src-homology 2 (SRC SH2).	B	CCCCCCc1noc([C@H](CCC(N)=O)NC(=O)[C@H](Cc2ccc(OP(=O)(O)O)cc2)NC(C)=O)n1		CHEMBL78037	=	IC50	nM	24000.0	CHEMBL267	Homo sapiens	IC50	uM	24.0
	263894	CHEMBL806420	Binding affinity against Src-homology 2 (SRC SH2).	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CCC(=O)O)c1nc(CCC(C)C)cs1		CHEMBL77068	=	IC50	nM	76000.0	CHEMBL267	Homo sapiens	IC50	uM	76.0
	265170	CHEMBL806345	Inhibition of Src tyrosine kinase	B	CO[C@H]1[C@@H](N(C)C(=O)c2ccccc2)C[C@@H]2O[C@@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL338448	=	IC50	nM	800.0	CHEMBL267	Homo sapiens	IC50	uM	0.8
	271227	CHEMBL822802	Inhibition of C-src tyrosine kinase	B	Cc1cccc(C)c1-c1cc2cnc(N)nc2nc1NC(=O)NC(C)(C)C		CHEMBL57323	=	IC50	nM	110.0	CHEMBL267	Homo sapiens	IC50	uM	0.11
	271232	CHEMBL822802	Inhibition of C-src tyrosine kinase	B	CN1CCN(CCCNc2ncc3cc(-c4c(Cl)cccc4Cl)c(NC(=O)NC(C)(C)C)nc3n2)CC1		CHEMBL57347	=	IC50	nM	31.0	CHEMBL267	Homo sapiens	IC50	uM	0.031
	271239	CHEMBL822802	Inhibition of C-src tyrosine kinase	B	Cc1cc(C)c(C)c(-c2cc3cnc(NCCCN4CCN(C)CC4)nc3nc2NC(=O)NC(C)(C)C)c1C		CHEMBL75188	=	IC50	nM	2200.0	CHEMBL267	Homo sapiens	IC50	uM	2.2
	278589	CHEMBL822802	Inhibition of C-src tyrosine kinase	B	CC(C)(C)NC(=O)Nc1nc2nc(N)ncc2cc1-c1ccccc1		CHEMBL76599	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	278594	CHEMBL822802	Inhibition of C-src tyrosine kinase	B	CCN(CC)CCCNc1ncc2cc(-c3c(Cl)cccc3Cl)c(NC(=O)NC(C)(C)C)nc2n1		CHEMBL299026	=	IC50	nM	73.0	CHEMBL267	Homo sapiens	IC50	uM	0.073
	283235	CHEMBL822802	Inhibition of C-src tyrosine kinase	B	COc1cc(OC)cc(-c2cc3cnc(N)nc3nc2NC(=O)NC(C)(C)C)c1		CHEMBL299763	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	284488	CHEMBL822802	Inhibition of C-src tyrosine kinase	B	CCN(CC)CCCCNc1ncc2cc(-c3c(Cl)cccc3Cl)c(NC(=O)NC(C)(C)C)nc2n1		CHEMBL45827	=	IC50	nM	44.0	CHEMBL267	Homo sapiens	IC50	uM	0.044
	285884	CHEMBL806345	Inhibition of Src tyrosine kinase	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	350.0	CHEMBL267	Homo sapiens	IC50	uM	0.35
	285889	CHEMBL806345	Inhibition of Src tyrosine kinase	B	CCN(C)[C@H]1C[C@@H]2O[C@](C)([C@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL129946	=	IC50	nM	240.0	CHEMBL267	Homo sapiens	IC50	uM	0.24
	285894	CHEMBL806345	Inhibition of Src tyrosine kinase	B	CO[C@H]1[C@@H](N(C)C(=O)CCC(=O)O)C[C@@H]2O[C@@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL337027	=	IC50	nM	200.0	CHEMBL267	Homo sapiens	IC50	uM	0.2
	288015	CHEMBL822802	Inhibition of C-src tyrosine kinase	B	Cc1cc(C)c(C)c(-c2cc3cnc(N)nc3nc2NC(=O)NC(C)(C)C)c1C		CHEMBL56236	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	288448	CHEMBL806345	Inhibition of Src tyrosine kinase	B	CO[C@H]1[C@@H](N(C)C(=O)CNC(=O)OC(C)(C)C)C[C@@H]2O[C@@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL335931	=	IC50	nM	160.0	CHEMBL267	Homo sapiens	IC50	uM	0.16
	288458	CHEMBL806345	Inhibition of Src tyrosine kinase	B	CN[C@H]1C[C@@H]2O[C@](C)([C@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4=O		CHEMBL337026	=	IC50	nM	800.0	CHEMBL267	Homo sapiens	IC50	uM	0.8
	295510	CHEMBL822802	Inhibition of C-src tyrosine kinase	B	CC(C)(C)NC(=O)Nc1nc2nc(N)ncc2cc1-c1c(Cl)cccc1Cl		CHEMBL57366	=	IC50	nM	220.0	CHEMBL267	Homo sapiens	IC50	uM	0.22
	295889	CHEMBL806345	Inhibition of Src tyrosine kinase	B	CN[C@H]1C[C@@H]2O[C@](C)([C@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@@H]4O		CHEMBL338049	=	IC50	nM	600.0	CHEMBL267	Homo sapiens	IC50	uM	0.6
	296903	CHEMBL822802	Inhibition of C-src tyrosine kinase	B	CCNC(=O)Nc1nc2nc(N)ncc2cc1-c1c(Cl)cccc1Cl		CHEMBL432738	=	IC50	nM	77.0	CHEMBL267	Homo sapiens	IC50	uM	0.077
	301083	CHEMBL806345	Inhibition of Src tyrosine kinase	B	CN[C@H]1C[C@@H]2O[C@](C)([C@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)[C@H](O)NC4=O		CHEMBL338155	=	IC50	nM	1800.0	CHEMBL267	Homo sapiens	IC50	uM	1.8
	301872	CHEMBL822802	Inhibition of C-src tyrosine kinase	B	CCNC(=O)Nc1nc2nc(NCCCCN(CC)CC)ncc2cc1-c1c(Cl)cccc1Cl		CHEMBL301483	=	IC50	nM	23.0	CHEMBL267	Homo sapiens	IC50	uM	0.023
	305184	CHEMBL822804	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by avian c-Src tyrosine kinase	B	Oc1cc2ncn(-c3ccccc3)c2cc1O		CHEMBL311449	=	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	305187	CHEMBL822804	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by avian c-Src tyrosine kinase	B	COc1cc2ncn(-c3ccccc3)c2cc1C		CHEMBL77712	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	305200	CHEMBL822804	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by avian c-Src tyrosine kinase	B	CC(C)Oc1ccc2c(c1)ncn2-c1ccccc1		CHEMBL79328	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	305991	CHEMBL843060	Inhibitory activity against p60 c-Src tyrosine kinase	B	N=c1oc2ccccc2cc1C(=O)Nc1ccccc1O		CHEMBL79508	>	IC50	ug.mL-1	20.0	CHEMBL267	Homo sapiens	IC50	ug ml-1	20.0
	306473	CHEMBL822804	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by avian c-Src tyrosine kinase	B	OCCCCOc1ccc2c(c1)ncn2-c1ccccc1		CHEMBL77261	=	IC50	nM	25000.0	CHEMBL267	Homo sapiens	IC50	uM	25.0
	307293	CHEMBL843060	Inhibitory activity against p60 c-Src tyrosine kinase	B	N=c1oc2cc(O)ccc2cc1C(=O)Nc1cccc(O)c1		CHEMBL79253	=	IC50	ug.mL-1	9.0	CHEMBL267	Homo sapiens	IC50	ug ml-1	9.0
	307773	CHEMBL822804	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by avian c-Src tyrosine kinase	B	c1ccc(-n2cnc3cc4c(cc32)OCO4)cc1		CHEMBL80651	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	307776	CHEMBL822804	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by avian c-Src tyrosine kinase	B	CN(C)CCOc1ccc2c(c1)ncn2-c1ccccc1		CHEMBL75969	=	IC50	nM	28000.0	CHEMBL267	Homo sapiens	IC50	uM	28.0
	307794	CHEMBL822804	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by avian c-Src tyrosine kinase	B	COc1ccc2c(c1)ncn2-c1ccccc1		CHEMBL76202	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	307798	CHEMBL822804	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by avian c-Src tyrosine kinase	B	COc1ccc2c(ncn2-c2ccccc2)c1O		CHEMBL77412	=	IC50	nM	40000.0	CHEMBL267	Homo sapiens	IC50	uM	40.0
	309242	CHEMBL822804	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by avian c-Src tyrosine kinase	B	CN(C)CCCOc1ccc2c(c1)ncn2-c1ccccc1		CHEMBL312269	=	IC50	nM	14000.0	CHEMBL267	Homo sapiens	IC50	uM	14.0
	309257	CHEMBL822804	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by avian c-Src tyrosine kinase	B	Oc1ccc2c(c1)ncn2-c1ccccc1		CHEMBL80873	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	309261	CHEMBL822804	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by avian c-Src tyrosine kinase	B	COc1ccc2c(ncn2-c2ccccc2)c1OC		CHEMBL80558	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	309587	CHEMBL821537	Inhibition of c-Src tyrosine kinase at 5 uM	B	COc1cccc(COc2cc(N)[nH]c3nc(-c4ccc(F)cc4)c(-c4ccncc4)c2-3)c1		CHEMBL113851	=	Inhibition	%	58.0	CHEMBL267	Homo sapiens	Inhibition	%	58.0
	310018	CHEMBL843060	Inhibitory activity against p60 c-Src tyrosine kinase	B	COc1cccc2cc(C(=O)Nc3cccc(O)c3)c(=N)oc12		CHEMBL81599	=	IC50	ug.mL-1	1.3	CHEMBL267	Homo sapiens	IC50	ug ml-1	1.3
	310464	CHEMBL822804	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by avian c-Src tyrosine kinase	B	C=CCOc1ccc2c(c1)ncn2-c1ccccc1		CHEMBL311318	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	310467	CHEMBL822804	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by avian c-Src tyrosine kinase	B	COc1cc2ncn(-c3ccccc3)c2cc1CO		CHEMBL306184	=	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	311332	CHEMBL843060	Inhibitory activity against p60 c-Src tyrosine kinase	B	N=c1oc2c(O)cccc2cc1C(=O)Nc1cccc(O)c1		CHEMBL82085	=	IC50	ug.mL-1	0.035	CHEMBL267	Homo sapiens	IC50	ug ml-1	0.035
	311837	CHEMBL822804	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by avian c-Src tyrosine kinase	B	Oc1cccc2c1ncn2-c1ccccc1		CHEMBL75964	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	312217	CHEMBL821537	Inhibition of c-Src tyrosine kinase at 5 uM	B	CCCCOc1cc(N)[nH]c2nc(-c3ccc(F)cc3)c(-c3ccncc3)c1-2		CHEMBL263536	=	Inhibition	%	18.0	CHEMBL267	Homo sapiens	Inhibition	%	18.0
	312681	CHEMBL843060	Inhibitory activity against p60 c-Src tyrosine kinase	B	N=c1oc2c(O)c(O)ccc2cc1C(=O)Nc1cccc(CO)c1		CHEMBL81806	=	IC50	ug.mL-1	5.0	CHEMBL267	Homo sapiens	IC50	ug ml-1	5.0
	313981	CHEMBL843060	Inhibitory activity against p60 c-Src tyrosine kinase	B	N=c1oc2ccccc2cc1C(=O)Nc1ccc(O)cc1		CHEMBL81826	>	IC50	ug.mL-1	20.0	CHEMBL267	Homo sapiens	IC50	ug ml-1	20.0
	318197	CHEMBL822804	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by avian c-Src tyrosine kinase	B	c1ccc(-n2cnc3cc(OCCCCN4CCOCC4)ccc32)cc1		CHEMBL308245	=	IC50	nM	25000.0	CHEMBL267	Homo sapiens	IC50	uM	25.0
	318226	CHEMBL822804	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by avian c-Src tyrosine kinase	B	C=CCOc1ccc2c(ncn2-c2ccccc2)c1Br		CHEMBL310243	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	318229	CHEMBL822804	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by avian c-Src tyrosine kinase	B	Cc1cc2c(cc1O)ncn2-c1ccccc1		CHEMBL311913	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	318888	CHEMBL843060	Inhibitory activity against p60 c-Src tyrosine kinase	B	N=c1oc2c(O)c(O)ccc2cc1C(=O)Nc1ccccc1O		CHEMBL79977	=	IC50	ug.mL-1	12.0	CHEMBL267	Homo sapiens	IC50	ug ml-1	12.0
	318892	CHEMBL843060	Inhibitory activity against p60 c-Src tyrosine kinase	B	N=c1oc2c(O)cccc2cc1C(=O)Nc1cccc(CO)c1		CHEMBL81137	=	IC50	ug.mL-1	2.5	CHEMBL267	Homo sapiens	IC50	ug ml-1	2.5
	319397	CHEMBL822804	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by avian c-Src tyrosine kinase	B	CCCCOc1ccc2c(c1)ncn2-c1ccccc1		CHEMBL80510	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	320120	CHEMBL843060	Inhibitory activity against p60 c-Src tyrosine kinase	B	N=c1oc2cc(O)cc(O)c2cc1C(=O)Nc1ccccc1O		CHEMBL79506	=	IC50	ug.mL-1	2.1	CHEMBL267	Homo sapiens	IC50	ug ml-1	2.1
	320124	CHEMBL843060	Inhibitory activity against p60 c-Src tyrosine kinase	B	COc1ccc2oc(=N)c(C(=O)Nc3ccc(O)cc3)cc2c1		CHEMBL310404	=	IC50	ug.mL-1	12.5	CHEMBL267	Homo sapiens	IC50	ug ml-1	12.5
	320859	CHEMBL821537	Inhibition of c-Src tyrosine kinase at 5 uM	B	Nc1ccc2c(-c3ccncc3)c(-c3ccc(F)cc3)[nH]c2n1		CHEMBL112273	=	Inhibition	%	63.0	CHEMBL267	Homo sapiens	Inhibition	%	63.0
	321348	CHEMBL843060	Inhibitory activity against p60 c-Src tyrosine kinase	B	N=c1oc2ccccc2cc1C(=O)Nc1cccc(O)c1		CHEMBL309785	=	IC50	ug.mL-1	10.0	CHEMBL267	Homo sapiens	IC50	ug ml-1	10.0
	321765	CHEMBL822804	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by avian c-Src tyrosine kinase	B	c1ccc(-n2cnc3cc(OCC4CO4)ccc32)cc1		CHEMBL310726	=	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	321768	CHEMBL822804	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by avian c-Src tyrosine kinase	B	c1ccc(-n2cnc3cc(OCCCN4CCOCC4)ccc32)cc1		CHEMBL80915	=	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	321821	CHEMBL822804	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by avian c-Src tyrosine kinase	B	OCC(O)COc1ccc2c(c1)ncn2-c1ccccc1		CHEMBL310137	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	322116	CHEMBL821537	Inhibition of c-Src tyrosine kinase at 5 uM	B	Nc1cc(OCc2ccccc2)c2c(-c3ccncc3)c(-c3ccc(F)cc3)[nH]c2n1		CHEMBL325211	=	Inhibition	%	19.0	CHEMBL267	Homo sapiens	Inhibition	%	19.0
	322627	CHEMBL843060	Inhibitory activity against p60 c-Src tyrosine kinase	B	N=c1oc2cc(O)ccc2cc1C(=O)Nc1ccc(O)cc1		CHEMBL79252	=	IC50	ug.mL-1	1.2	CHEMBL267	Homo sapiens	IC50	ug ml-1	1.2
	323304	CHEMBL822804	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by avian c-Src tyrosine kinase	B	c1ccc(-n2cnc3cc(SCCCN4CCOCC4)ccc32)cc1		CHEMBL443800	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	324335	CHEMBL822804	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by avian c-Src tyrosine kinase	B	COc1ccc2c(c1)ncn2-c1ccc(N)cc1		CHEMBL309035	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	325064	CHEMBL843060	Inhibitory activity against p60 c-Src tyrosine kinase	B	N=c1oc2ccc(O)cc2cc1C(=O)Nc1cccc(O)c1		CHEMBL79888	=	IC50	ug.mL-1	1.3	CHEMBL267	Homo sapiens	IC50	ug ml-1	1.3
	325068	CHEMBL843060	Inhibitory activity against p60 c-Src tyrosine kinase	B	N=c1oc2c(O)c(O)ccc2cc1C(=O)Nc1ccc(O)cc1		CHEMBL79745	=	IC50	ug.mL-1	3.6	CHEMBL267	Homo sapiens	IC50	ug ml-1	3.6
	325526	CHEMBL822804	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by avian c-Src tyrosine kinase	B	CN(C)CCCCOc1ccc2c(c1)ncn2-c1ccccc1		CHEMBL78698	=	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	328168	CHEMBL822804	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by avian c-Src tyrosine kinase	B	C=CCc1c(O)ccc2c1ncn2-c1ccccc1		CHEMBL307817	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	329532	CHEMBL822804	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by avian c-Src tyrosine kinase	B	CN(C)C(=S)Oc1ccc2c(c1)ncn2-c1ccccc1		CHEMBL309270	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	330723	CHEMBL822804	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by avian c-Src tyrosine kinase	B	Sc1ccc2c(c1)ncn2-c1ccccc1		CHEMBL419653	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	330726	CHEMBL822804	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by avian c-Src tyrosine kinase	B	COc1cc2ncn(-c3ccccc3)c2cc1C=O		CHEMBL76962	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	330763	CHEMBL822804	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by avian c-Src tyrosine kinase	B	CCCOc1ccc2c(c1)ncn2-c1ccccc1		CHEMBL78444	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	330766	CHEMBL822804	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by avian c-Src tyrosine kinase	B	Oc1ccc2c(ncn2-c2ccccc2)c1Br		CHEMBL76839	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	331641	CHEMBL843060	Inhibitory activity against p60 c-Src tyrosine kinase	B	N=c1oc2c(O)c(O)ccc2cc1C(=O)Nc1ccccc1CO		CHEMBL311194	=	IC50	ug.mL-1	0.9	CHEMBL267	Homo sapiens	IC50	ug ml-1	0.9
	332437	CHEMBL821537	Inhibition of c-Src tyrosine kinase at 5 uM	B	COc1cc(N)[nH]c2nc(-c3ccc(F)cc3)c(-c3ccncc3)c1-2		CHEMBL115769	=	Inhibition	%	43.0	CHEMBL267	Homo sapiens	Inhibition	%	43.0
	332974	CHEMBL843060	Inhibitory activity against p60 c-Src tyrosine kinase	B	N=c1oc2c(O)c(O)ccc2cc1C(=O)Nc1cccc(O)c1		CHEMBL81043	=	IC50	ug.mL-1	0.225	CHEMBL267	Homo sapiens	IC50	ug ml-1	0.225
	333552	CHEMBL822804	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by avian c-Src tyrosine kinase	B	c1ccc(-n2cnc3cc(OCCN4CCOCC4)ccc32)cc1		CHEMBL77242	=	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	334389	CHEMBL843060	Inhibitory activity against p60 c-Src tyrosine kinase	B	N=c1oc2c(O)cccc2cc1C(=O)Nc1ccccc1O		CHEMBL81403	>	IC50	ug.mL-1	10.0	CHEMBL267	Homo sapiens	IC50	ug ml-1	10.0
	334840	CHEMBL822804	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by avian c-Src tyrosine kinase	B	c1ccc(-n2cnc3ccccc32)cc1		CHEMBL310080	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	335133	CHEMBL821537	Inhibition of c-Src tyrosine kinase at 5 uM	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Inhibition	%	54.0	CHEMBL267	Homo sapiens	Inhibition	%	54.0
	336027	CHEMBL822804	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by avian c-Src tyrosine kinase	B	CC1Cc2c(ccc3c2ncn3-c2ccccc2)O1		CHEMBL75637	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	336810	CHEMBL843060	Inhibitory activity against p60 c-Src tyrosine kinase	B	N=c1oc2cc(O)cc(O)c2cc1C(=O)Nc1cccc(O)c1		CHEMBL309385	=	IC50	ug.mL-1	1.25	CHEMBL267	Homo sapiens	IC50	ug ml-1	1.25
	336814	CHEMBL843060	Inhibitory activity against p60 c-Src tyrosine kinase	B	N=c1oc2c(O)cccc2cc1C(=O)Nc1ccccc1CO		CHEMBL81807	=	IC50	ug.mL-1	1.8	CHEMBL267	Homo sapiens	IC50	ug ml-1	1.8
	337357	CHEMBL822804	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by avian c-Src tyrosine kinase	B	COc1c(O)ccc2c1ncn2-c1ccccc1		CHEMBL308385	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	338103	CHEMBL843060	Inhibitory activity against p60 c-Src tyrosine kinase	B	N=c1oc2ccc(O)cc2cc1C(=O)Nc1ccc(O)cc1		CHEMBL81561	=	IC50	ug.mL-1	3.2	CHEMBL267	Homo sapiens	IC50	ug ml-1	3.2
	338107	CHEMBL843060	Inhibitory activity against p60 c-Src tyrosine kinase	B	N=c1oc2c(O)c(O)ccc2cc1C(=O)Nc1ccccc1		CHEMBL80091	>	IC50	ug.mL-1	20.0	CHEMBL267	Homo sapiens	IC50	ug ml-1	20.0
	338111	CHEMBL843060	Inhibitory activity against p60 c-Src tyrosine kinase	B	N=c1oc2cc(O)cc(O)c2cc1C(=O)Nc1ccc(O)cc1		CHEMBL79920	=	IC50	ug.mL-1	0.2	CHEMBL267	Homo sapiens	IC50	ug ml-1	0.2
	339478	CHEMBL843060	Inhibitory activity against p60 c-Src tyrosine kinase	B	N=c1oc2cc(O)ccc2cc1C(=O)Nc1ccccc1O		CHEMBL80073	=	IC50	ug.mL-1	0.6	CHEMBL267	Homo sapiens	IC50	ug ml-1	0.6
	340068	CHEMBL822804	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by avian c-Src tyrosine kinase	B	NCCOc1ccc2c(c1)ncn2-c1ccccc1		CHEMBL311777	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	340071	CHEMBL822804	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by avian c-Src tyrosine kinase	B	O=C(O)c1cc2c(cc1O)ncn2-c1ccccc1		CHEMBL77032	=	IC50	nM	33500.0	CHEMBL267	Homo sapiens	IC50	uM	33.5
	341616	CHEMBL821537	Inhibition of c-Src tyrosine kinase at 5 uM	B	Nc1cc(OCCCc2ccccc2)c2c(-c3ccncc3)c(-c3ccc(F)cc3)[nH]c2n1		CHEMBL115778	=	Inhibition	%	3.0	CHEMBL267	Homo sapiens	Inhibition	%	3.0
	342027	CHEMBL843060	Inhibitory activity against p60 c-Src tyrosine kinase	B	CC(=O)c1cccc(NC(=O)c2cc3ccc(O)c(O)c3oc2=N)c1		CHEMBL81700	=	IC50	ug.mL-1	3.0	CHEMBL267	Homo sapiens	IC50	ug ml-1	3.0
	342416	CHEMBL822804	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by avian c-Src tyrosine kinase	B	COc1cc2ncn(-c3ccccc3)c2cc1C(=O)O		CHEMBL80171	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	343580	CHEMBL822804	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by avian c-Src tyrosine kinase	B	CSc1ccc2c(c1)ncn2-c1ccccc1		CHEMBL80810	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	343583	CHEMBL822804	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by avian c-Src tyrosine kinase	B	COc1cc2ncn(-c3ccccc3)c2cc1OC		CHEMBL79177	=	IC50	nM	40000.0	CHEMBL267	Homo sapiens	IC50	uM	40.0
	344490	CHEMBL843060	Inhibitory activity against p60 c-Src tyrosine kinase	B	N=c1oc2c(O)cccc2cc1C(=O)Nc1ccc(O)cc1		CHEMBL79581	=	IC50	ug.mL-1	1.9	CHEMBL267	Homo sapiens	IC50	ug ml-1	1.9
	344494	CHEMBL843060	Inhibitory activity against p60 c-Src tyrosine kinase	B	COc1ccc2cc(C(=O)Nc3ccc(O)cc3)c(=N)oc2c1		CHEMBL433140	>	IC50	ug.mL-1	10.0	CHEMBL267	Homo sapiens	IC50	ug ml-1	10.0
	345024	CHEMBL822804	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by avian c-Src tyrosine kinase	B	Oc1ccc2c(ncn2-c2ccccc2)c1O		CHEMBL77303	=	IC50	nM	460.0	CHEMBL267	Homo sapiens	IC50	uM	0.46
	345062	CHEMBL822804	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by avian c-Src tyrosine kinase	B	COC(=O)c1cc2c(cc1OC)ncn2-c1ccccc1		CHEMBL311574	=	IC50	nM	33300.0	CHEMBL267	Homo sapiens	IC50	uM	33.3
	345841	CHEMBL808037	Inhibition of [125I]-labeled phosphopeptide binding to a Src protein tyrosine kinase SH2 domain.	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)NCCc1cccc2ccccc12		CHEMBL276010	=	IC50	nM	4800.0	CHEMBL267	Homo sapiens	IC50	uM	4.8
	346218	CHEMBL818278	Inhibition against Src kinase	B	CCN1CCN(CCCOc2cc3ncc(C#N)c(Nc4cc(OC)c(Cl)cc4Cl)c3cc2OC)CC1		CHEMBL130529	=	IC50	nM	0.77	CHEMBL267	Homo sapiens	IC50	nM	0.77
	347545	CHEMBL818278	Inhibition against Src kinase	B	COc1cc2ncnc(Nc3ccc(Cl)cc3Cl)c2cc1OC		CHEMBL128356	=	IC50	nM	250.0	CHEMBL267	Homo sapiens	IC50	nM	250.0
	347546	CHEMBL818278	Inhibition against Src kinase	B	CCCN1CCN(CCCOc2cc3ncc(C#N)c(Nc4cc(OC)c(Cl)cc4Cl)c3cc2OC)CC1		CHEMBL129143	=	IC50	nM	1.1	CHEMBL267	Homo sapiens	IC50	nM	1.1
	347577	CHEMBL806418	Binding affinity against Src SH2 domain in competitive fluorescence polarization assay	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@H]1CCCCc2cc(OCC3CCCCC3)c(C(N)=O)cc21		CHEMBL2111833	=	IC50	nM	100.0	CHEMBL267	Homo sapiens	IC50	uM	0.1
	348457	CHEMBL808037	Inhibition of [125I]-labeled phosphopeptide binding to a Src protein tyrosine kinase SH2 domain.	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)NCCCc1ccccc1		CHEMBL13424	=	IC50	nM	3900.0	CHEMBL267	Homo sapiens	IC50	uM	3.9
	348959	CHEMBL818278	Inhibition against Src kinase	B	COc1cc(Nc2c(C#N)cnc3cc(OC)c(OC)cc23)c(Cl)cc1Cl		CHEMBL100651	=	IC50	nM	4.3	CHEMBL267	Homo sapiens	IC50	nM	4.3
	348960	CHEMBL818278	Inhibition against Src kinase	B	COc1cc2ncc(C#N)c(Nc3ccc(Cl)cc3I)c2cc1OC		CHEMBL421440	=	IC50	nM	6.2	CHEMBL267	Homo sapiens	IC50	nM	6.2
	348961	CHEMBL818278	Inhibition against Src kinase	B	COc1cc(Nc2ccnc3cc(OC)c(OC)cc23)c(Cl)cc1Cl		CHEMBL128704	=	IC50	nM	81.0	CHEMBL267	Homo sapiens	IC50	nM	81.0
Not Active	349818	CHEMBL843062	Inhibition of p60 c-Src tyrosine kinase (No inhibition)	B	Oc1cc2cccc[n+]2c2c(Cl)cccc12.[Cl-]		CHEMBL175225		IC50	nM		CHEMBL267	Homo sapiens	IC50	mM	
	349819	CHEMBL808037	Inhibition of [125I]-labeled phosphopeptide binding to a Src protein tyrosine kinase SH2 domain.	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(N)=O		CHEMBL274146	=	IC50	nM	240.0	CHEMBL267	Homo sapiens	IC50	uM	0.24
	350255	CHEMBL818278	Inhibition against Src kinase	B	COc1cc(Nc2c(C#N)cnc3cc(OC)c(OC)cc23)c(C)cc1Cl		CHEMBL127331	=	IC50	nM	4.0	CHEMBL267	Homo sapiens	IC50	nM	4.0
	350256	CHEMBL818278	Inhibition against Src kinase	B	COc1cc(Nc2ncnc3cc(OC)c(OC)cc23)c(Cl)cc1Cl		CHEMBL129123	=	IC50	nM	390.0	CHEMBL267	Homo sapiens	IC50	nM	390.0
	351274	CHEMBL808037	Inhibition of [125I]-labeled phosphopeptide binding to a Src protein tyrosine kinase SH2 domain.	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](C)C(=O)NCCCc1ccccc1		CHEMBL12732	=	IC50	nM	15000.0	CHEMBL267	Homo sapiens	IC50	uM	15.0
	351624	CHEMBL818278	Inhibition against Src kinase	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCn4nccn4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL129776	=	IC50	nM	9.3	CHEMBL267	Homo sapiens	IC50	nM	9.3
	351626	CHEMBL818278	Inhibition against Src kinase	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCn4ccnn4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL129972	=	IC50	nM	1.9	CHEMBL267	Homo sapiens	IC50	nM	1.9
	353093	CHEMBL818278	Inhibition against Src kinase	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCOCC4)c(OC)cc23)c(Cl)cc1C		CHEMBL129209	=	IC50	nM	1.1	CHEMBL267	Homo sapiens	IC50	nM	1.1
	354209	CHEMBL808037	Inhibition of [125I]-labeled phosphopeptide binding to a Src protein tyrosine kinase SH2 domain.	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N(C)CCCc1ccccc1		CHEMBL13313	=	IC50	nM	3500.0	CHEMBL267	Homo sapiens	IC50	uM	3.5
	354644	CHEMBL818278	Inhibition against Src kinase	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(CCO)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL338194	=	IC50	nM	0.76	CHEMBL267	Homo sapiens	IC50	nM	0.76
	354670	CHEMBL806418	Binding affinity against Src SH2 domain in competitive fluorescence polarization assay	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@H]1CCCOc2cc(OCC3CCCCC3)c(C(N)=O)cc21		CHEMBL2111834	=	IC50	nM	200.0	CHEMBL267	Homo sapiens	IC50	uM	0.2
	357062	CHEMBL808037	Inhibition of [125I]-labeled phosphopeptide binding to a Src protein tyrosine kinase SH2 domain.	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](C)C(=O)N(CCCC(=O)O)CCCc1ccccc1		CHEMBL13243	=	IC50	nM	6400.0	CHEMBL267	Homo sapiens	IC50	uM	6.4
	358522	CHEMBL808037	Inhibition of [125I]-labeled phosphopeptide binding to a Src protein tyrosine kinase SH2 domain.	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](CCC1CCCCC1)C(N)=O		CHEMBL273628	=	IC50	nM	2000.0	CHEMBL267	Homo sapiens	IC50	uM	2.0
	358523	CHEMBL808037	Inhibition of [125I]-labeled phosphopeptide binding to a Src protein tyrosine kinase SH2 domain.	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)NCCc1ccccc1		CHEMBL428182	=	IC50	nM	9100.0	CHEMBL267	Homo sapiens	IC50	uM	9.1
	358524	CHEMBL808037	Inhibition of [125I]-labeled phosphopeptide binding to a Src protein tyrosine kinase SH2 domain.	B	CCC[C@H](NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(C)=O)C(=O)NCCCc1ccccc1		CHEMBL13321	=	IC50	nM	12000.0	CHEMBL267	Homo sapiens	IC50	uM	12.0
	358525	CHEMBL808037	Inhibition of [125I]-labeled phosphopeptide binding to a Src protein tyrosine kinase SH2 domain.	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N(CCCC(=O)O)CCCc1ccccc1		CHEMBL13318	=	IC50	nM	2000.0	CHEMBL267	Homo sapiens	IC50	uM	2.0
	358862	CHEMBL818278	Inhibition against Src kinase	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL128326	=	IC50	nM	1.4	CHEMBL267	Homo sapiens	IC50	nM	1.4
	360246	CHEMBL818278	Inhibition against Src kinase	B	CCOc1cc(Nc2c(C#N)cnc3cc(OC)c(OC)cc23)c(Cl)cc1Cl		CHEMBL340177	=	IC50	nM	1200.0	CHEMBL267	Homo sapiens	IC50	nM	1200.0
	360247	CHEMBL818278	Inhibition against Src kinase	B	COc1cc(Nc2c(C#N)cnc3cc(OC)c(OC)cc23)c(Br)cc1Cl		CHEMBL339770	=	IC50	nM	3.0	CHEMBL267	Homo sapiens	IC50	nM	3.0
	360248	CHEMBL818278	Inhibition against Src kinase	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCCCN4CCOCC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL130242	=	IC50	nM	2.5	CHEMBL267	Homo sapiens	IC50	nM	2.5
	360288	CHEMBL806418	Binding affinity against Src SH2 domain in competitive fluorescence polarization assay	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)Cc1ccc(OP(=O)(O)O)cc1)C(=O)O		CHEMBL46851	=	IC50	nM	5600.0	CHEMBL267	Homo sapiens	IC50	uM	5.6
	361487	CHEMBL806418	Binding affinity against Src SH2 domain in competitive fluorescence polarization assay	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H]1CCCCc2cc(OCC3CCCCC3)c(C(N)=O)cc21		CHEMBL2112639	=	IC50	nM	8100.0	CHEMBL267	Homo sapiens	IC50	uM	8.1
	362383	CHEMBL808037	Inhibition of [125I]-labeled phosphopeptide binding to a Src protein tyrosine kinase SH2 domain.	B	CCc1ccccc1CCNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(C)=O		CHEMBL13326	=	IC50	nM	4600.0	CHEMBL267	Homo sapiens	IC50	uM	4.6
	362384	CHEMBL808037	Inhibition of [125I]-labeled phosphopeptide binding to a Src protein tyrosine kinase SH2 domain.	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)NCC(=O)NCCCc1ccccc1		CHEMBL13222	~	IC50	nM	46000.0	CHEMBL267	Homo sapiens	IC50	uM	46.0
	362856	CHEMBL818278	Inhibition against Src kinase	B	COc1ccc(Cl)c(Nc2c(C#N)cnc3cc(OC)c(OC)cc23)c1		CHEMBL128462	=	IC50	nM	10.0	CHEMBL267	Homo sapiens	IC50	nM	10.0
	362857	CHEMBL818278	Inhibition against Src kinase	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCCN4CCOCC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL128612	=	IC50	nM	1.3	CHEMBL267	Homo sapiens	IC50	nM	1.3
	362859	CHEMBL818278	Inhibition against Src kinase	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CC(C)N(C)C(C)C4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL340914	=	IC50	nM	1.4	CHEMBL267	Homo sapiens	IC50	nM	1.4
	364033	CHEMBL808037	Inhibition of [125I]-labeled phosphopeptide binding to a Src protein tyrosine kinase SH2 domain.	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)NCCCc1ccccc1		CHEMBL13085	=	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	364492	CHEMBL818278	Inhibition against Src kinase	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCOCC4)c(OC)cc23)c(C)cc1C		CHEMBL131245	=	IC50	nM	1.7	CHEMBL267	Homo sapiens	IC50	nM	1.7
	365962	CHEMBL818278	Inhibition against Src kinase	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCn4ccnc4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL340944	=	IC50	nM	2.1	CHEMBL267	Homo sapiens	IC50	nM	2.1
	366002	CHEMBL806418	Binding affinity against Src SH2 domain in competitive fluorescence polarization assay	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](C)c1ccc(OCC2CCCCC2)c(C(N)=O)c1		CHEMBL346499	=	IC50	nM	2000.0	CHEMBL267	Homo sapiens	IC50	uM	2.0
	367056	CHEMBL808037	Inhibition of [125I]-labeled phosphopeptide binding to a Src protein tyrosine kinase SH2 domain.	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)NCCC1=CC=CC2CCCCC12		CHEMBL268031	=	IC50	nM	3200.0	CHEMBL267	Homo sapiens	IC50	uM	3.2
	367057	CHEMBL808037	Inhibition of [125I]-labeled phosphopeptide binding to a Src protein tyrosine kinase SH2 domain.	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N(C)CCCC1CCCCC1		CHEMBL13462	=	IC50	nM	1700.0	CHEMBL267	Homo sapiens	IC50	uM	1.7
	367392	CHEMBL818278	Inhibition against Src kinase	B	COc1cc2c(Nc3ccc(Cl)cc3Cl)c(C#N)cnc2cc1OCCCN1CCOCC1		CHEMBL440160	=	IC50	nM	3.8	CHEMBL267	Homo sapiens	IC50	nM	3.8
	367394	CHEMBL818278	Inhibition against Src kinase	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCNCC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL128158	=	IC50	nM	1.1	CHEMBL267	Homo sapiens	IC50	nM	1.1
	367438	CHEMBL806418	Binding affinity against Src SH2 domain in competitive fluorescence polarization assay	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H]1CCCOc2cc(OCC3CCCCC3)c(C(N)=O)cc21		CHEMBL2112641	=	IC50	nM	1600.0	CHEMBL267	Homo sapiens	IC50	uM	1.6
	368792	CHEMBL818278	Inhibition against Src kinase	B	COc1cc(Nc2c(C#N)cnc3cc(OC)c(OC)cc23)c(C)cc1C		CHEMBL129459	=	IC50	nM	4.6	CHEMBL267	Homo sapiens	IC50	nM	4.6
	370206	CHEMBL818278	Inhibition against Src kinase	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCOCC4)c(OC)cc23)c(Br)cc1Cl		CHEMBL128705	=	IC50	nM	0.95	CHEMBL267	Homo sapiens	IC50	nM	0.95
	370208	CHEMBL818278	Inhibition against Src kinase	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCNCCN4CCOCC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL340350	=	IC50	nM	3.0	CHEMBL267	Homo sapiens	IC50	nM	3.0
	370246	CHEMBL806418	Binding affinity against Src SH2 domain in competitive fluorescence polarization assay	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@H](C)c1ccc(OCC2CCCCC2)c(C(N)=O)c1		CHEMBL2112638	=	IC50	nM	32000.0	CHEMBL267	Homo sapiens	IC50	uM	32.0
	371134	CHEMBL808037	Inhibition of [125I]-labeled phosphopeptide binding to a Src protein tyrosine kinase SH2 domain.	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)Cc1cccc2ccccc12		CHEMBL275062	=	IC50	nM	2300.0	CHEMBL267	Homo sapiens	IC50	uM	2.3
	371135	CHEMBL808037	Inhibition of [125I]-labeled phosphopeptide binding to a Src protein tyrosine kinase SH2 domain.	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCCCc1ccccc1		CHEMBL13690	=	IC50	nM	20000.0	CHEMBL267	Homo sapiens	IC50	uM	20.0
	371136	CHEMBL808037	Inhibition of [125I]-labeled phosphopeptide binding to a Src protein tyrosine kinase SH2 domain.	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)NCC(=O)N(CCCC(=O)O)CCCc1ccccc1		CHEMBL267783	=	IC50	nM	14000.0	CHEMBL267	Homo sapiens	IC50	uM	14.0
	373042	CHEMBL818278	Inhibition against Src kinase	B	COc1ccc(Cl)c(Nc2c(C#N)cnc3cc(OCCCN4CCOCC4)c(OC)cc23)c1		CHEMBL128706	=	IC50	nM	1.6	CHEMBL267	Homo sapiens	IC50	nM	1.6
	373044	CHEMBL818278	Inhibition against Src kinase	B	COc1cc(Nc2c(C#N)cnc3cc(OC)c(OCCCN4CCOCC4)cc23)c(Cl)cc1Cl		CHEMBL128241	=	IC50	nM	28.0	CHEMBL267	Homo sapiens	IC50	nM	28.0
	374080	CHEMBL808037	Inhibition of [125I]-labeled phosphopeptide binding to a Src protein tyrosine kinase SH2 domain.	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)NCCCC(=O)NCCCc1ccccc1		CHEMBL439071	=	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	375410	CHEMBL808037	Inhibition of [125I]-labeled phosphopeptide binding to a Src protein tyrosine kinase SH2 domain.	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@H](C(=O)NCCCc1ccccc1)C(C)C		CHEMBL274657	~	IC50	nM	30000.0	CHEMBL267	Homo sapiens	IC50	uM	30.0
	375849	CHEMBL818278	Inhibition against Src kinase	B	COc1cc2nccc(Nc3ccc(Cl)cc3Cl)c2cc1OC		CHEMBL128858	=	IC50	nM	84.0	CHEMBL267	Homo sapiens	IC50	nM	84.0
	378210	CHEMBL808037	Inhibition of [125I]-labeled phosphopeptide binding to a Src protein tyrosine kinase SH2 domain.	B	CCCC(NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(C)=O)C(=O)N(CCCC(=O)O)CCCc1ccccc1		CHEMBL13480	=	IC50	nM	4300.0	CHEMBL267	Homo sapiens	IC50	uM	4.3
	378603	CHEMBL818278	Inhibition against Src kinase	B	COc1cc(Nc2c(C#N)cnc3cc(OC)c(OC)cc23)ccc1Cl		CHEMBL129596	=	IC50	nM	120.0	CHEMBL267	Homo sapiens	IC50	nM	120.0
	378604	CHEMBL818278	Inhibition against Src kinase	B	COc1cc(Nc2c(C#N)cnc3cc(OCCN4CCOCC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL339893	=	IC50	nM	2.3	CHEMBL267	Homo sapiens	IC50	nM	2.3
	378606	CHEMBL818278	Inhibition against Src kinase	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCCCC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL334364	=	IC50	nM	1.2	CHEMBL267	Homo sapiens	IC50	nM	1.2
	380039	CHEMBL818278	Inhibition against Src kinase	B	COc1cc(Nc2c(C#N)cnc3cc(OC)c(OC)cc23)c(F)cc1Cl		CHEMBL132284	=	IC50	nM	66.0	CHEMBL267	Homo sapiens	IC50	nM	66.0
	380040	CHEMBL818278	Inhibition against Src kinase	B	CCOc1cc(Nc2c(C#N)cnc3cc(OC)c(OC)cc23)c(Cl)cc1C		CHEMBL339286	>	IC50	nM	5000.0	CHEMBL267	Homo sapiens	IC50	nM	5000.0
	381357	CHEMBL818278	Inhibition against Src kinase	B	CCCOc1cc(Nc2c(C#N)cnc3cc(OC)c(OC)cc23)c(Cl)cc1Cl		CHEMBL128991	>	IC50	nM	5000.0	CHEMBL267	Homo sapiens	IC50	nM	5000.0
	381358	CHEMBL818278	Inhibition against Src kinase	B	COc1cc(Nc2c(C#N)cnc3cc(OC)c(OC)cc23)c(Cl)cc1C		CHEMBL128938	=	IC50	nM	2.9	CHEMBL267	Homo sapiens	IC50	nM	2.9
	381359	CHEMBL818278	Inhibition against Src kinase	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	IC50	nM	1.2	CHEMBL267	Homo sapiens	IC50	nM	1.2
	384267	CHEMBL818278	Inhibition against Src kinase	B	COc1cc2ncc(C#N)c(Nc3cc(O)c(Cl)cc3Cl)c2cc1OC		CHEMBL339743	=	IC50	nM	190.0	CHEMBL267	Homo sapiens	IC50	nM	190.0
	384268	CHEMBL818278	Inhibition against Src kinase	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCC(O)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL424262	=	IC50	nM	0.64	CHEMBL267	Homo sapiens	IC50	nM	0.64
	385691	CHEMBL818278	Inhibition against Src kinase	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCOCC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL131725	=	IC50	nM	0.8	CHEMBL267	Homo sapiens	IC50	nM	0.8
	387338	CHEMBL818278	Inhibition against Src kinase	B	COc1cc2ncc(C#N)c(Nc3ccc(Cl)cc3Cl)c2cc1OC		CHEMBL101917	=	IC50	nM	30.0	CHEMBL267	Homo sapiens	IC50	nM	30.0
	387339	CHEMBL818278	Inhibition against Src kinase	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN(C)CCN(C)C)c(OC)cc23)c(Cl)cc1Cl		CHEMBL129968	=	IC50	nM	2.3	CHEMBL267	Homo sapiens	IC50	nM	2.3
	388907	CHEMBL818278	Inhibition against Src kinase	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCOCC4)c(OC)cc23)c(C)cc1Cl		CHEMBL423696	=	IC50	nM	1.2	CHEMBL267	Homo sapiens	IC50	nM	1.2
	393854	CHEMBL821539	Inhibition of c-Src tyrosine kinase at 50 uM	B	C[C@H](Nc1ncnc2c1sc1ccccc12)c1ccccc1		CHEMBL3085277	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	Inhibition	%	0.0
	395150	CHEMBL806413	Inhibition of binding to Src SH2 domain	B	CC(=O)N[C@@H](Cc1ccc(CP(=O)(O)O)cc1)C(=O)N[C@@H](C)c1ccc(OCC2CCCCC2)c(C(N)=O)c1		CHEMBL161385	=	IC50	nM	7900.0	CHEMBL267	Homo sapiens	IC50	uM	7.9
	396231	CHEMBL806436	Inhibition of Src protein tyrosine kinase	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3cccc(P(=O)(O)CP(=O)(O)O)c3)nc21		CHEMBL106442	=	IC50	nM	77.0	CHEMBL267	Homo sapiens	IC50	uM	0.077
	400163	CHEMBL821538	Inhibition against c-Src tyrosine kinase at 25 uM	B	COc1ccc2[nH]c3ncnc(Nc4cccc(Br)c4)c3c2c1		CHEMBL153206	=	Inhibition	%	8.0	CHEMBL267	Homo sapiens	Inhibition	%	8.0
	400168	CHEMBL821539	Inhibition of c-Src tyrosine kinase at 50 uM	B	COc1ccc2c(c1)sc1c(Nc3cccc(Br)c3)ncnc12		CHEMBL346846	=	Inhibition	%	22.0	CHEMBL267	Homo sapiens	Inhibition	%	22.0
	401353	CHEMBL806436	Inhibition of Src protein tyrosine kinase	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3ccc(CP(=O)(O)CP(=O)(O)O)cc3)nc21		CHEMBL102217	=	IC50	nM	750.0	CHEMBL267	Homo sapiens	IC50	uM	0.75
	407151	CHEMBL821539	Inhibition of c-Src tyrosine kinase at 50 uM	B	Nc1ccc2sc3c(Nc4cccc(C(F)(F)F)c4)ncnc3c2c1		CHEMBL347282	=	Inhibition	%	13.0	CHEMBL267	Homo sapiens	Inhibition	%	13.0
	415611	CHEMBL806413	Inhibition of binding to Src SH2 domain	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(N)=O		CHEMBL2371237	=	IC50	nM	5000.0	CHEMBL267	Homo sapiens	IC50	uM	5.0
	416440	CHEMBL806436	Inhibition of Src protein tyrosine kinase	B	CN(C)CCCn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3ccc(P(=O)(O)CP(=O)(O)O)cc3)nc21		CHEMBL421024	=	IC50	nM	0.3	CHEMBL267	Homo sapiens	IC50	nM	0.3
	417724	CHEMBL806436	Inhibition of Src protein tyrosine kinase	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3ccc(P(=O)(O)CP(=O)(O)O)cc3)nc21		CHEMBL419360	=	IC50	nM	2.0	CHEMBL267	Homo sapiens	IC50	uM	0.002
	417726	CHEMBL806438	Binding affinity for Src protein tyrosine kinase	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3ccc(P(=O)(O)CP(=O)(O)O)cc3)nc21	Non standard unit for type	CHEMBL419360	=	K		2.4	CHEMBL267	Homo sapiens	K		2.4
	419118	CHEMBL821539	Inhibition of c-Src tyrosine kinase at 50 uM	B	Cc1cccc(Nc2ncnc3c2sc2ccc(N)cc23)c1		CHEMBL155278	=	Inhibition	%	47.0	CHEMBL267	Homo sapiens	Inhibition	%	47.0
	420047	CHEMBL806436	Inhibition of Src protein tyrosine kinase	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3ccccc3)nc21		CHEMBL301612	=	IC50	nM	16.0	CHEMBL267	Homo sapiens	IC50	uM	0.016
	420048	CHEMBL806436	Inhibition of Src protein tyrosine kinase	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3ccc(P(=O)(O)O)c(P(=O)(O)O)c3)nc21		CHEMBL320374	=	IC50	nM	1300.0	CHEMBL267	Homo sapiens	IC50	uM	1.3
	423338	CHEMBL821539	Inhibition of c-Src tyrosine kinase at 50 uM	B	Brc1cccc(Nc2ncnc3c2sc2ccccc23)c1		CHEMBL356850	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	Inhibition	%	0.0
	424457	CHEMBL806413	Inhibition of binding to Src SH2 domain	B	CC(=O)N[C@@H](Cc1ccc(C(P(=O)(O)O)P(=O)(O)O)cc1)C(=O)N[C@@H](C)c1ccc(OCC2CCCCC2)c(C(N)=O)c1		CHEMBL348743	=	IC50	nM	350.0	CHEMBL267	Homo sapiens	IC50	uM	0.35
	424484	CHEMBL821539	Inhibition of c-Src tyrosine kinase at 50 uM	B	c1ccc(CNc2ncnc3c2sc2ccccc23)cc1		CHEMBL153419	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	Inhibition	%	0.0
	427911	CHEMBL806436	Inhibition of Src protein tyrosine kinase	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3ccc(OCC(=O)O)c(P(=O)(O)O)c3)nc21		CHEMBL102801	=	IC50	nM	200.0	CHEMBL267	Homo sapiens	IC50	uM	0.2
	429595	CHEMBL806413	Inhibition of binding to Src SH2 domain	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](C)c1ccc(OCC2CCCCC2)c(C(N)=O)c1		CHEMBL346499	=	IC50	nM	2200.0	CHEMBL267	Homo sapiens	IC50	uM	2.2
	430437	CHEMBL818269	Inhibition of c-SRC	B	COc1ccc(Oc2ccnc3cc(OC)c(OC)cc23)cc1OC		CHEMBL327300	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	431815	CHEMBL822437	Inhibition of p60 c-Src tyrosine kinase enzyme activity in liquid-phase tyrosine phosphorylation assay at 830 ng/mL	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCN(CCO)CC1		CHEMBL169780	=	IC50	nM	1.0	CHEMBL267	Homo sapiens	IC50	uM	0.001
	431821	CHEMBL822437	Inhibition of p60 c-Src tyrosine kinase enzyme activity in liquid-phase tyrosine phosphorylation assay at 830 ng/mL	B	COc1cccc(-c2cn(C3CCN(CC(=O)N(C)C)CC3)c3ncnc(N)c23)c1		CHEMBL355269	=	IC50	nM	67.0	CHEMBL267	Homo sapiens	IC50	uM	0.067
	432174	CHEMBL823240	Inhibitory activity against SH2 domain of human p60 c-Src tyrosine kinase using surface plasmon resonance (SPR) assay.	B	COC(=O)c1cc(C[C@H](NC(C)=O)C(=O)N[C@H]2CCCCN(Cc3ccc(-c4ccccc4)cc3)C2=O)ccc1C(F)(C(=O)O)C(=O)O		CHEMBL357488	=	IC50	nM	10.0	CHEMBL267	Homo sapiens	IC50	nM	10.0
	433253	CHEMBL822437	Inhibition of p60 c-Src tyrosine kinase enzyme activity in liquid-phase tyrosine phosphorylation assay at 830 ng/mL	B	CCOC(=O)C[C@H]1C[C@@H](n2cc(-c3ccccc3)c3c(N)ncnc32)CN1		CHEMBL352829	=	IC50	nM	15.0	CHEMBL267	Homo sapiens	IC50	uM	0.015
	433536	CHEMBL823240	Inhibitory activity against SH2 domain of human p60 c-Src tyrosine kinase using surface plasmon resonance (SPR) assay.	B	CCc1ccc(NC(=O)P(=O)(O)O)cc1		CHEMBL284362	=	IC50	nM	4400000.0	CHEMBL267	Homo sapiens	IC50	mM	4.4
	433537	CHEMBL823240	Inhibitory activity against SH2 domain of human p60 c-Src tyrosine kinase using surface plasmon resonance (SPR) assay.	B	O=Cc1ccccc1OP(=O)(O)OCc1ccccc1		CHEMBL148630	=	IC50	nM	1200000.0	CHEMBL267	Homo sapiens	IC50	mM	1.2
	434417	CHEMBL822437	Inhibition of p60 c-Src tyrosine kinase enzyme activity in liquid-phase tyrosine phosphorylation assay at 830 ng/mL	B	COc1cccc(-c2cn(C3CCN(CCO)CC3)c3ncnc(N)c23)c1		CHEMBL169200	=	IC50	nM	27.0	CHEMBL267	Homo sapiens	IC50	uM	0.027
	434844	CHEMBL806427	Inhibition of recombinant human Src kinase	B	COc1ccc(C)c(Nc2c(C#N)cnc3cc(OCC4CCN(C)CC4)c(OC)cc23)c1		CHEMBL290308	=	IC50	nM	24.0	CHEMBL267	Homo sapiens	IC50	nM	24.0
	435723	CHEMBL822437	Inhibition of p60 c-Src tyrosine kinase enzyme activity in liquid-phase tyrosine phosphorylation assay at 830 ng/mL	B	Nc1ncnc2c1c(-c1ccccc1)cn2C1CCNC1		CHEMBL168829	=	IC50	nM	230.0	CHEMBL267	Homo sapiens	IC50	uM	0.23
	435725	CHEMBL822437	Inhibition of p60 c-Src tyrosine kinase enzyme activity in liquid-phase tyrosine phosphorylation assay at 830 ng/mL	B	CC(C)(C)OC(=O)N1CCC(n2cc(-c3ccc(O)cc3)c3c(N)ncnc32)C1		CHEMBL422565	=	IC50	nM	8.0	CHEMBL267	Homo sapiens	IC50	uM	0.008
	436157	CHEMBL823240	Inhibitory activity against SH2 domain of human p60 c-Src tyrosine kinase using surface plasmon resonance (SPR) assay.	B	O=P(O)(O)Oc1cccc2c1NCCC2		CHEMBL358860	=	IC50	nM	300000.0	CHEMBL267	Homo sapiens	IC50	mM	0.3
	436942	CHEMBL822437	Inhibition of p60 c-Src tyrosine kinase enzyme activity in liquid-phase tyrosine phosphorylation assay at 830 ng/mL	B	Nc1ncnc2c1c(-c1ccc(O)cc1)cn2[C@H]1CN[C@@H](CO)C1		CHEMBL168462	=	IC50	nM	50.0	CHEMBL267	Homo sapiens	IC50	uM	0.05
	436944	CHEMBL822437	Inhibition of p60 c-Src tyrosine kinase enzyme activity in liquid-phase tyrosine phosphorylation assay at 830 ng/mL	B	COC(=O)CN1CCC(n2cc(-c3cccc(O)c3)c3c(N)ncnc32)CC1		CHEMBL262276	<	IC50	nM	1.0	CHEMBL267	Homo sapiens	IC50	uM	0.001
	437269	CHEMBL823240	Inhibitory activity against SH2 domain of human p60 c-Src tyrosine kinase using surface plasmon resonance (SPR) assay.	B	O=Cc1ccccc1OP(=O)(O)O		CHEMBL286678	=	IC50	nM	300000.0	CHEMBL267	Homo sapiens	IC50	mM	0.3
	437270	CHEMBL823240	Inhibitory activity against SH2 domain of human p60 c-Src tyrosine kinase using surface plasmon resonance (SPR) assay.	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@H]1CCCCN(Cc2ccc(-c3ccccc3)cc2)C1=O		CHEMBL25826	=	IC50	nM	9.0	CHEMBL267	Homo sapiens	IC50	nM	9.0
	438298	CHEMBL822437	Inhibition of p60 c-Src tyrosine kinase enzyme activity in liquid-phase tyrosine phosphorylation assay at 830 ng/mL	B	CN(C)C(=O)CN1CCC(n2cc(-c3cccc(O)c3)c3c(N)ncnc32)CC1		CHEMBL169920	=	IC50	nM	3.0	CHEMBL267	Homo sapiens	IC50	uM	0.003
	438693	CHEMBL823240	Inhibitory activity against SH2 domain of human p60 c-Src tyrosine kinase using surface plasmon resonance (SPR) assay.	B	O=C(O)CC(=O)O	Outside typical range	CHEMBL7942	>	IC50	nM	40000000.0	CHEMBL267	Homo sapiens	IC50	mM	40.0
	438694	CHEMBL823240	Inhibitory activity against SH2 domain of human p60 c-Src tyrosine kinase using surface plasmon resonance (SPR) assay.	B	O=P(O)(O)C(O)c1cccc2ccccc12		CHEMBL286758	>	IC50	nM	5000000.0	CHEMBL267	Homo sapiens	IC50	mM	5.0
	438695	CHEMBL823240	Inhibitory activity against SH2 domain of human p60 c-Src tyrosine kinase using surface plasmon resonance (SPR) assay.	B	O=[N+]([O-])c1cc2c(cc1C(O)P(=O)(O)O)OCO2		CHEMBL346901	=	IC50	nM	300000.0	CHEMBL267	Homo sapiens	IC50	mM	0.3
	438782	CHEMBL806427	Inhibition of recombinant human Src kinase	B	COc1cc(Nc2c(C#N)cnc3cc(OCCC4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL41465	=	IC50	nM	7.7	CHEMBL267	Homo sapiens	IC50	nM	7.7
	438785	CHEMBL806428	Inhibition of Src kinase	B	CCOc1cc(Nc2c(C#N)cnc3cc(OCC4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL290398	=	IC50	nM	1400.0	CHEMBL267	Homo sapiens	IC50	nM	1400.0
	439975	CHEMBL823240	Inhibitory activity against SH2 domain of human p60 c-Src tyrosine kinase using surface plasmon resonance (SPR) assay.	B	CC(=O)N[C@@H](Cc1ccc(C(C(=O)O)C(=O)O)c(C(=O)O)c1)C(=O)N[C@H]1CCCCN(Cc2ccc(-c3ccccc3)cc2)C1=O		CHEMBL421518	=	IC50	nM	3.0	CHEMBL267	Homo sapiens	IC50	nM	3.0
	440869	CHEMBL822437	Inhibition of p60 c-Src tyrosine kinase enzyme activity in liquid-phase tyrosine phosphorylation assay at 830 ng/mL	B	NC(=O)CN1CCC(n2cc(-c3cccc(O)c3)c3c(N)ncnc32)C1		CHEMBL408683	=	IC50	nM	4.0	CHEMBL267	Homo sapiens	IC50	uM	0.004
	441235	CHEMBL823240	Inhibitory activity against SH2 domain of human p60 c-Src tyrosine kinase using surface plasmon resonance (SPR) assay.	B	O=P(O)(O)O	Outside typical range	CHEMBL1187	>	IC50	nM	40000000.0	CHEMBL267	Homo sapiens	IC50	mM	40.0
	441236	CHEMBL823240	Inhibitory activity against SH2 domain of human p60 c-Src tyrosine kinase using surface plasmon resonance (SPR) assay.	B	CC(=O)N[C@@H](Cc1ccc(CC(=O)O)c(C(=O)O)c1)C(=O)N[C@H]1CCCCN(Cc2ccc(-c3ccccc3)cc2)C1=O		CHEMBL432359	=	IC50	nM	450.0	CHEMBL267	Homo sapiens	IC50	nM	450.0
	441322	CHEMBL806427	Inhibition of recombinant human Src kinase	B	COc1cc(Nc2c(C#N)cnc3cc(OCC4CCN(C)CC4)c(OC)cc23)c(C)cc1C		CHEMBL41633	=	IC50	nM	13.0	CHEMBL267	Homo sapiens	IC50	nM	13.0
	442376	CHEMBL822437	Inhibition of p60 c-Src tyrosine kinase enzyme activity in liquid-phase tyrosine phosphorylation assay at 830 ng/mL	B	CC(C)(C)OC(=O)N1C[C@@H](n2cc(-c3ccccc3)c3c(N)ncnc32)C[C@@H]1CO		CHEMBL353630	=	IC50	nM	130.0	CHEMBL267	Homo sapiens	IC50	uM	0.13
	442377	CHEMBL822437	Inhibition of p60 c-Src tyrosine kinase enzyme activity in liquid-phase tyrosine phosphorylation assay at 830 ng/mL	B	COC(=O)CN1CCC(n2cc(-c3cccc(OC)c3)c3c(N)ncnc32)C1		CHEMBL355891	=	IC50	nM	50.0	CHEMBL267	Homo sapiens	IC50	uM	0.05
	445002	CHEMBL822437	Inhibition of p60 c-Src tyrosine kinase enzyme activity in liquid-phase tyrosine phosphorylation assay at 830 ng/mL	B	COc1cccc(-c2cn(C3CCN(CCN(C)CCO)CC3)c3ncnc(N)c23)c1		CHEMBL168661	=	IC50	nM	6.0	CHEMBL267	Homo sapiens	IC50	uM	0.006
	445469	CHEMBL806427	Inhibition of recombinant human Src kinase	B	COc1ccc(Cl)c(Nc2c(C#N)cnc3cc(OCC4CCN(C)CC4)c(OC)cc23)c1		CHEMBL290664	=	IC50	nM	12.0	CHEMBL267	Homo sapiens	IC50	nM	12.0
	446793	CHEMBL823240	Inhibitory activity against SH2 domain of human p60 c-Src tyrosine kinase using surface plasmon resonance (SPR) assay.	B	COc1cccc(C=O)c1OP(=O)(O)O		CHEMBL25186	=	IC50	nM	900000.0	CHEMBL267	Homo sapiens	IC50	mM	0.9
	446794	CHEMBL823240	Inhibitory activity against SH2 domain of human p60 c-Src tyrosine kinase using surface plasmon resonance (SPR) assay.	B	CC(=O)N/C(=C\c1ccc(CC(=O)O)c(C=O)c1)C(=O)N[C@H]1CCCCN(Cc2ccc(-c3ccccc3)cc2)C1=O		CHEMBL356002	=	IC50	nM	2200.0	CHEMBL267	Homo sapiens	IC50	nM	2200.0
	448157	CHEMBL806427	Inhibition of recombinant human Src kinase	B	COc1cc(Nc2c(C#N)cnc3cc(OCC4CCCCN4C)c(OC)cc23)c(Cl)cc1Cl		CHEMBL296844	=	IC50	nM	87.0	CHEMBL267	Homo sapiens	IC50	nM	87.0
	448973	CHEMBL822437	Inhibition of p60 c-Src tyrosine kinase enzyme activity in liquid-phase tyrosine phosphorylation assay at 830 ng/mL	B	CCOC(=O)C[C@H]1C[C@@H](n2cc(-c3ccc(O)cc3)c3c(N)ncnc32)CN1C(=O)OC(C)(C)C		CHEMBL353456	=	IC50	nM	300.0	CHEMBL267	Homo sapiens	IC50	uM	0.3
	449351	CHEMBL823240	Inhibitory activity against SH2 domain of human p60 c-Src tyrosine kinase using surface plasmon resonance (SPR) assay.	B	O=P(O)(O)Oc1ccccc1		CHEMBL26128	=	IC50	nM	3500000.0	CHEMBL267	Homo sapiens	IC50	mM	3.5
	449352	CHEMBL823240	Inhibitory activity against SH2 domain of human p60 c-Src tyrosine kinase using surface plasmon resonance (SPR) assay.	B	O=Cc1ccccc1OP(=O)(O)OCC1CCCCC1		CHEMBL24811	=	IC50	nM	2300000.0	CHEMBL267	Homo sapiens	IC50	mM	2.3
	451557	CHEMBL822437	Inhibition of p60 c-Src tyrosine kinase enzyme activity in liquid-phase tyrosine phosphorylation assay at 830 ng/mL	B	COC(=O)CN1CCC(n2cc(-c3cccc(O)c3)c3c(N)ncnc32)C1		CHEMBL355019	=	IC50	nM	3.0	CHEMBL267	Homo sapiens	IC50	uM	0.003
Not Determined	451603	CHEMBL844998	Inhibition of c-src at 1 mM ATP (not tested)	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)c(Br)n2C1CCCC1		CHEMBL66716		IC50	nM		CHEMBL267	Homo sapiens	IC50	uM	
	453201	CHEMBL823240	Inhibitory activity against SH2 domain of human p60 c-Src tyrosine kinase using surface plasmon resonance (SPR) assay.	B	O=C(O)CC(O)(CC(=O)O)C(=O)O	Outside typical range	CHEMBL1261	>	IC50	nM	40000000.0	CHEMBL267	Homo sapiens	IC50	mM	40.0
	453202	CHEMBL823240	Inhibitory activity against SH2 domain of human p60 c-Src tyrosine kinase using surface plasmon resonance (SPR) assay.	B	CC(=O)N[C@@H](Cc1ccc(P(=O)(O)O)c(P(=O)(O)O)c1)C(=O)N[C@H]1CCCCN(Cc2ccc(-c3ccccc3)cc2)C1=O		CHEMBL319516	=	IC50	nM	2000.0	CHEMBL267	Homo sapiens	IC50	nM	2000.0
	454179	CHEMBL822437	Inhibition of p60 c-Src tyrosine kinase enzyme activity in liquid-phase tyrosine phosphorylation assay at 830 ng/mL	B	COCCNCCN1CCC(n2cc(-c3cccc(OC)c3)c3c(N)ncnc32)CC1		CHEMBL172514	=	IC50	nM	15.0	CHEMBL267	Homo sapiens	IC50	uM	0.015
	454185	CHEMBL822437	Inhibition of p60 c-Src tyrosine kinase enzyme activity in liquid-phase tyrosine phosphorylation assay at 830 ng/mL	B	Nc1ncnc2c1c(-c1ccc(O)cc1)cn2C1CCNC1		CHEMBL354033	=	IC50	nM	37.0	CHEMBL267	Homo sapiens	IC50	uM	0.037
	454189	CHEMBL822437	Inhibition of p60 c-Src tyrosine kinase enzyme activity in liquid-phase tyrosine phosphorylation assay at 830 ng/mL	B	COc1cccc(-c2cn(C3CCN(CC(N)=O)C3)c3ncnc(N)c23)c1		CHEMBL355322	=	IC50	nM	38.0	CHEMBL267	Homo sapiens	IC50	uM	0.038
	454570	CHEMBL823240	Inhibitory activity against SH2 domain of human p60 c-Src tyrosine kinase using surface plasmon resonance (SPR) assay.	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)c(C=O)c1)C(=O)N[C@H]1CCCCN(Cc2ccc(-c3ccccc3)cc2)C1=O		CHEMBL78455	=	IC50	nM	0.25	CHEMBL267	Homo sapiens	IC50	nM	0.25
	455579	CHEMBL822437	Inhibition of p60 c-Src tyrosine kinase enzyme activity in liquid-phase tyrosine phosphorylation assay at 830 ng/mL	B	CC(C)(C)OC(=O)N1C[C@@H](n2cc(-c3ccc(O)cc3)c3c(N)ncnc32)C[C@@H]1CO		CHEMBL169043	=	IC50	nM	24.0	CHEMBL267	Homo sapiens	IC50	uM	0.024
	455581	CHEMBL822437	Inhibition of p60 c-Src tyrosine kinase enzyme activity in liquid-phase tyrosine phosphorylation assay at 830 ng/mL	B	COc1cccc(-c2cn(C3CCNC3)c3ncnc(N)c23)c1		CHEMBL169519	=	IC50	nM	53.0	CHEMBL267	Homo sapiens	IC50	uM	0.053
Not Determined	455618	CHEMBL844998	Inhibition of c-src at 1 mM ATP (not tested)	B	COc1ccc(Oc2ccc(-c3cn(C(C)(C)C)c4ncnc(N)c34)cc2)cc1		CHEMBL69649		IC50	nM		CHEMBL267	Homo sapiens	IC50	uM	
	455998	CHEMBL823240	Inhibitory activity against SH2 domain of human p60 c-Src tyrosine kinase using surface plasmon resonance (SPR) assay.	B	CC(=O)N[C@@H](Cc1ccc(C(F)(F)P(=O)(O)O)cc1)C(=O)N[C@H]1CCCCN(Cc2ccc(-c3ccccc3)cc2)C1=O		CHEMBL1160756	=	IC50	nM	4.0	CHEMBL267	Homo sapiens	IC50	nM	4.0
	458333	CHEMBL822437	Inhibition of p60 c-Src tyrosine kinase enzyme activity in liquid-phase tyrosine phosphorylation assay at 830 ng/mL	B	CC(C)(C)OC(=O)N1C[C@H](n2cc(-c3ccccc3)c3c(N)ncnc32)C[C@@H]1CO		CHEMBL167537	=	IC50	nM	2000.0	CHEMBL267	Homo sapiens	IC50	uM	2.0
	458334	CHEMBL822437	Inhibition of p60 c-Src tyrosine kinase enzyme activity in liquid-phase tyrosine phosphorylation assay at 830 ng/mL	B	NC(=O)CN1CCC(n2cc(-c3cccc(O)c3)c3c(N)ncnc32)CC1		CHEMBL263528	=	IC50	nM	1.0	CHEMBL267	Homo sapiens	IC50	uM	0.001
	458704	CHEMBL806427	Inhibition of recombinant human Src kinase	B	COc1cc2c(Nc3ccc(C)cc3C)c(C#N)cnc2cc1OCC1CCN(C)CC1		CHEMBL40912	=	IC50	nM	63.0	CHEMBL267	Homo sapiens	IC50	nM	63.0
	459387	CHEMBL822437	Inhibition of p60 c-Src tyrosine kinase enzyme activity in liquid-phase tyrosine phosphorylation assay at 830 ng/mL	B	Nc1ncnc2c1c(-c1ccccc1)cn2[C@@H]1CN[C@@H](CO)C1		CHEMBL367933	=	IC50	nM	300.0	CHEMBL267	Homo sapiens	IC50	uM	0.3
	459696	CHEMBL823240	Inhibitory activity against SH2 domain of human p60 c-Src tyrosine kinase using surface plasmon resonance (SPR) assay.	B	N#Cc1ccc2cccc(OP(=O)(O)O)c2n1		CHEMBL149603	=	IC50	nM	3600000.0	CHEMBL267	Homo sapiens	IC50	mM	3.6
	459697	CHEMBL823240	Inhibitory activity against SH2 domain of human p60 c-Src tyrosine kinase using surface plasmon resonance (SPR) assay.	B	CC(=O)N[C@@H](Cc1ccc(OCC(=O)O)c(P(=O)(O)O)c1)C(=O)N[C@H]1CCCCN(Cc2ccc(-c3ccccc3)cc2)C1=O		CHEMBL436462	=	IC50	nM	437.0	CHEMBL267	Homo sapiens	IC50	nM	437.0
	459882	CHEMBL806427	Inhibition of recombinant human Src kinase	B	COc1cc2c(Nc3cc(OC)c(OC)c(OC)c3)c(C#N)cnc2cc1OCC1CCN(C)CC1		CHEMBL440847	=	IC50	nM	35.0	CHEMBL267	Homo sapiens	IC50	nM	35.0
	460718	CHEMBL822437	Inhibition of p60 c-Src tyrosine kinase enzyme activity in liquid-phase tyrosine phosphorylation assay at 830 ng/mL	B	COCCN(C)CCN1CCC(n2cc(-c3cccc(OC)c3)c3c(N)ncnc32)CC1		CHEMBL274732	=	IC50	nM	47.0	CHEMBL267	Homo sapiens	IC50	uM	0.047
	460723	CHEMBL822437	Inhibition of p60 c-Src tyrosine kinase enzyme activity in liquid-phase tyrosine phosphorylation assay at 830 ng/mL	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNC1		CHEMBL171545	=	IC50	nM	6.0	CHEMBL267	Homo sapiens	IC50	uM	0.006
Not Determined	460756	CHEMBL844998	Inhibition of c-src at 1 mM ATP (not tested)	B	COCc1c(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc2n1C1CCCC1		CHEMBL69544		IC50	nM		CHEMBL267	Homo sapiens	IC50	uM	
	461174	CHEMBL806427	Inhibition of recombinant human Src kinase	B	COc1cc2c(Nc3ccc(Cl)cc3Cl)c(C#N)cnc2cc1OCC1CCN(C)CC1		CHEMBL43577	=	IC50	nM	21.0	CHEMBL267	Homo sapiens	IC50	nM	21.0
	462005	CHEMBL822437	Inhibition of p60 c-Src tyrosine kinase enzyme activity in liquid-phase tyrosine phosphorylation assay at 830 ng/mL	B	COc1cccc(-c2cn(C3CCN(CC(N)=O)CC3)c3ncnc(N)c23)c1		CHEMBL169064	=	IC50	nM	22.0	CHEMBL267	Homo sapiens	IC50	uM	0.022
	462303	CHEMBL823240	Inhibitory activity against SH2 domain of human p60 c-Src tyrosine kinase using surface plasmon resonance (SPR) assay.	B	O=P(O)(O)C(c1ccccc1)P(=O)(O)O		CHEMBL148732	=	IC50	nM	3900000.0	CHEMBL267	Homo sapiens	IC50	mM	3.9
	462304	CHEMBL823240	Inhibitory activity against SH2 domain of human p60 c-Src tyrosine kinase using surface plasmon resonance (SPR) assay.	B	Cc1cc(C=O)c(OP(=O)(O)O)c(C=O)c1		CHEMBL421138	=	IC50	nM	500000.0	CHEMBL267	Homo sapiens	IC50	mM	0.5
	463204	CHEMBL822437	Inhibition of p60 c-Src tyrosine kinase enzyme activity in liquid-phase tyrosine phosphorylation assay at 830 ng/mL	B	CCOC(=O)C[C@H]1C[C@H](n2cc(-c3ccc(O)cc3)c3c(N)ncnc32)CN1C(=O)OC(C)(C)C		CHEMBL352666	=	IC50	nM	35.0	CHEMBL267	Homo sapiens	IC50	uM	0.035
	463206	CHEMBL822437	Inhibition of p60 c-Src tyrosine kinase enzyme activity in liquid-phase tyrosine phosphorylation assay at 830 ng/mL	B	CCOC(=O)C[C@H]1C[C@@H](n2cc(-c3ccccc3)c3c(N)ncnc32)CN1C(=O)OC(C)(C)C		CHEMBL170004	=	IC50	nM	5000.0	CHEMBL267	Homo sapiens	IC50	uM	5.0
	463207	CHEMBL822437	Inhibition of p60 c-Src tyrosine kinase enzyme activity in liquid-phase tyrosine phosphorylation assay at 830 ng/mL	B	COc1ccc(-c2cn(C3CCN(C(=O)OC(C)(C)C)C3)c3ncnc(N)c23)cc1		CHEMBL352619	=	IC50	nM	400.0	CHEMBL267	Homo sapiens	IC50	uM	0.4
	463209	CHEMBL822437	Inhibition of p60 c-Src tyrosine kinase enzyme activity in liquid-phase tyrosine phosphorylation assay at 830 ng/mL	B	CC(C)(C)OC(=O)N1CCC(n2cc(-c3cccc(O)c3)c3c(N)ncnc32)C1		CHEMBL168921	=	IC50	nM	5.0	CHEMBL267	Homo sapiens	IC50	uM	0.005
Not Determined	463231	CHEMBL844998	Inhibition of c-src at 1 mM ATP (not tested)	B	Cc1c(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc2n1C1CCCC1		CHEMBL69868		IC50	nM		CHEMBL267	Homo sapiens	IC50	uM	
Not Determined	463238	CHEMBL844998	Inhibition of c-src at 1 mM ATP (not tested)	B	CC(O)c1c(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc2n1C1CCCC1		CHEMBL67560		IC50	nM		CHEMBL267	Homo sapiens	IC50	uM	
	463684	CHEMBL806427	Inhibition of recombinant human Src kinase	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	IC50	nM	3.8	CHEMBL267	Homo sapiens	IC50	nM	3.8
Not Determined	464568	CHEMBL844998	Inhibition of c-src at 1 mM ATP (not tested)	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)c(CN1CCOCC1)n2C1CCCC1		CHEMBL68663		IC50	nM		CHEMBL267	Homo sapiens	IC50	uM	
	465871	CHEMBL822437	Inhibition of p60 c-Src tyrosine kinase enzyme activity in liquid-phase tyrosine phosphorylation assay at 830 ng/mL	B	COC(=O)CN1CCC(n2cc(-c3cccc(OC)c3)c3c(N)ncnc32)CC1		CHEMBL169065	=	IC50	nM	84.0	CHEMBL267	Homo sapiens	IC50	uM	0.084
	466216	CHEMBL823240	Inhibitory activity against SH2 domain of human p60 c-Src tyrosine kinase using surface plasmon resonance (SPR) assay.	B	O=C(O)C(c1ccccc1)S(=O)(=O)O		CHEMBL80333	=	IC50	nM	3200000.0	CHEMBL267	Homo sapiens	IC50	mM	3.2
	466342	CHEMBL806427	Inhibition of recombinant human Src kinase	B	COc1cc(Nc2c(C#N)cnc3cc(OCC4CCCN(C)C4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL40557	=	IC50	nM	9.0	CHEMBL267	Homo sapiens	IC50	nM	9.0
	467193	CHEMBL822437	Inhibition of p60 c-Src tyrosine kinase enzyme activity in liquid-phase tyrosine phosphorylation assay at 830 ng/mL	B	CCOC(=O)C[C@H]1C[C@@H](n2cc(-c3ccc(O)cc3)c3c(N)ncnc32)CN1		CHEMBL169939	=	IC50	nM	5.0	CHEMBL267	Homo sapiens	IC50	uM	0.005
	467195	CHEMBL822437	Inhibition of p60 c-Src tyrosine kinase enzyme activity in liquid-phase tyrosine phosphorylation assay at 830 ng/mL	B	CC(C)(C)OC(=O)N1C[C@H](n2cc(-c3ccc(O)cc3)c3c(N)ncnc32)C[C@@H]1CO		CHEMBL434105	=	IC50	nM	350.0	CHEMBL267	Homo sapiens	IC50	uM	0.35
	467196	CHEMBL822437	Inhibition of p60 c-Src tyrosine kinase enzyme activity in liquid-phase tyrosine phosphorylation assay at 830 ng/mL	B	Nc1ncnc2c1c(-c1ccccc1)cn2[C@H]1CN[C@@H](CO)C1		CHEMBL168560	=	IC50	nM	130.0	CHEMBL267	Homo sapiens	IC50	uM	0.13
	467197	CHEMBL822437	Inhibition of p60 c-Src tyrosine kinase enzyme activity in liquid-phase tyrosine phosphorylation assay at 830 ng/mL	B	COc1ccc(-c2cn(C3CCNC3)c3ncnc(N)c23)cc1		CHEMBL352652	=	IC50	nM	300.0	CHEMBL267	Homo sapiens	IC50	uM	0.3
	468554	CHEMBL822437	Inhibition of p60 c-Src tyrosine kinase enzyme activity in liquid-phase tyrosine phosphorylation assay at 830 ng/mL	B	Nc1ncnc2c1c(-c1ccc(O)cc1)cn2[C@@H]1CN[C@@H](CO)C1		CHEMBL172574	=	IC50	nM	95.0	CHEMBL267	Homo sapiens	IC50	uM	0.095
	469018	CHEMBL823240	Inhibitory activity against SH2 domain of human p60 c-Src tyrosine kinase using surface plasmon resonance (SPR) assay.	B	O=C(O)C(=O)O	Outside typical range	CHEMBL146755	>	IC50	nM	40000000.0	CHEMBL267	Homo sapiens	IC50	mM	40.0
	469019	CHEMBL823240	Inhibitory activity against SH2 domain of human p60 c-Src tyrosine kinase using surface plasmon resonance (SPR) assay.	B	O=C(O)C(C(=O)O)c1ccccc1		CHEMBL78794	=	IC50	nM	2500000.0	CHEMBL267	Homo sapiens	IC50	mM	2.5
	469078	CHEMBL806427	Inhibition of recombinant human Src kinase	B	COc1cc(Nc2c(C#N)cnc3cc(OCC4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL42136	=	IC50	nM	7.0	CHEMBL267	Homo sapiens	IC50	nM	7.0
	469083	CHEMBL806427	Inhibition of recombinant human Src kinase	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCC4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL290921	=	IC50	nM	2.7	CHEMBL267	Homo sapiens	IC50	nM	2.7
	469964	CHEMBL822437	Inhibition of p60 c-Src tyrosine kinase enzyme activity in liquid-phase tyrosine phosphorylation assay at 830 ng/mL	B	CCOC(=O)C[C@H]1C[C@H](n2cc(-c3ccccc3)c3c(N)ncnc32)CN1		CHEMBL352510	=	IC50	nM	600.0	CHEMBL267	Homo sapiens	IC50	uM	0.6
	469965	CHEMBL822437	Inhibition of p60 c-Src tyrosine kinase enzyme activity in liquid-phase tyrosine phosphorylation assay at 830 ng/mL	B	CC(C)(C)OC(=O)N1CCC(n2cc(-c3ccccc3)c3c(N)ncnc32)C1		CHEMBL353823	=	IC50	nM	180.0	CHEMBL267	Homo sapiens	IC50	uM	0.18
	469968	CHEMBL822437	Inhibition of p60 c-Src tyrosine kinase enzyme activity in liquid-phase tyrosine phosphorylation assay at 830 ng/mL	B	COc1cccc(-c2cn(C3CCN(C(=O)OC(C)(C)C)C3)c3ncnc(N)c23)c1		CHEMBL168656	=	IC50	nM	270.0	CHEMBL267	Homo sapiens	IC50	uM	0.27
	470495	CHEMBL806427	Inhibition of recombinant human Src kinase	B	COc1cc(Nc2c(C#N)cnc3cc(OC4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL291297	=	IC50	nM	230.0	CHEMBL267	Homo sapiens	IC50	nM	230.0
	471399	CHEMBL822437	Inhibition of p60 c-Src tyrosine kinase enzyme activity in liquid-phase tyrosine phosphorylation assay at 830 ng/mL	B	CCOC(=O)C[C@H]1C[C@H](n2cc(-c3ccccc3)c3c(N)ncnc32)CN1C(=O)OC(C)(C)C		CHEMBL169202	=	IC50	nM	410.0	CHEMBL267	Homo sapiens	IC50	uM	0.41
	472819	CHEMBL822437	Inhibition of p60 c-Src tyrosine kinase enzyme activity in liquid-phase tyrosine phosphorylation assay at 830 ng/mL	B	CCOC(=O)C[C@H]1C[C@H](n2cc(-c3ccc(O)cc3)c3c(N)ncnc32)CN1		CHEMBL170726	=	IC50	nM	100.0	CHEMBL267	Homo sapiens	IC50	uM	0.1
	473151	CHEMBL823240	Inhibitory activity against SH2 domain of human p60 c-Src tyrosine kinase using surface plasmon resonance (SPR) assay.	B	CC(=O)N[C@@H](Cc1ccc(C(=O)O)c(C=O)c1)C(=O)N[C@H]1CCCCN(Cc2ccc(-c3ccccc3)cc2)C1=O		CHEMBL358866	=	IC50	nM	120.0	CHEMBL267	Homo sapiens	IC50	nM	120.0
	474237	CHEMBL818901	Inhibition of the phosphorylation of a random glutamate-tyrosine (4:1) copolymer by isolated avian c-Src protein.	B	CC(C)(C)NC(=O)Nc1nc2cc(N)ncc2cc1-c1c(Cl)cccc1Cl		CHEMBL132358	=	IC50	nM	170.0	CHEMBL267	Homo sapiens	IC50	uM	0.17
	474572	CHEMBL816863	Inhibition of c-Src tyrosine kinase.	B	CC1(C)SSC[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H]1NC(=O)[C@@H](N)Cc1ccc(O)cc1		CHEMBL274532	=	IC50	nM	2800.0	CHEMBL267	Homo sapiens	IC50	uM	2.8
	475054	CHEMBL805373	Inhibitory activity was tested against Src protein tyrosine kinase	B	COc1ccc2c(c1)/C(=C/c1[nH]cc3c1CCOC3=O)C(=O)N2		CHEMBL300767	>	IC50	nM	20000.0	CHEMBL267	Homo sapiens	IC50	uM	20.0
	475733	CHEMBL816863	Inhibition of c-Src tyrosine kinase.	B	CC1(C)SSC[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(N)=O)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@@H]1NC(=O)[C@@H](N)Cc1ccc(O)cc1		CHEMBL408655	=	IC50	nM	3300.0	CHEMBL267	Homo sapiens	IC50	uM	3.3
	475734	CHEMBL816864	Inhibition of c-Src tyrosine kinase against 100 uM cdc2 substrate	B	C[C@@H](c1ccc2ccccc2c1)[C@@H]1NC(=O)[C@H](NC(=O)[C@@H](N)Cc2ccc(O)cc2)C(C)(C)SSC[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(N)=O)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CO)NC(=O)CNC1=O		CHEMBL413670	=	IC50	nM	1800.0	CHEMBL267	Homo sapiens	IC50	uM	1.8
	476895	CHEMBL816864	Inhibition of c-Src tyrosine kinase against 100 uM cdc2 substrate	B	C[C@@H](c1ccc2ccccc2c1)[C@H]1NC(=O)[C@H](NC(=O)[C@@H](N)Cc2ccc(O)cc2)C(C)(C)SSC[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(N)=O)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CO)NC(=O)CNC1=O		CHEMBL412218	=	IC50	nM	1000.0	CHEMBL267	Homo sapiens	IC50	uM	1.0
	477358	CHEMBL805373	Inhibitory activity was tested against Src protein tyrosine kinase	B	NS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]cc3c1CCOC3=O)C(=O)N2		CHEMBL432491	=	IC50	nM	13000.0	CHEMBL267	Homo sapiens	IC50	uM	13.0
	477654	CHEMBL818901	Inhibition of the phosphorylation of a random glutamate-tyrosine (4:1) copolymer by isolated avian c-Src protein.	B	COc1cc(OC)cc(-c2cc3cnc(NC(=O)C(F)(F)F)cc3nc2N)c1		CHEMBL134334	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	478717	CHEMBL805373	Inhibitory activity was tested against Src protein tyrosine kinase	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]cc3c1CCOC3=O)C(=O)N2		CHEMBL60541	>	IC50	nM	20000.0	CHEMBL267	Homo sapiens	IC50	uM	20.0
	479905	CHEMBL806432	Inhibition of Src protein tyrosine kinase activity	B	COc1cc(Nc2c(C#N)cnc3cc4c(cc23)ncn4CCN2CCOCC2)c(Br)cc1Cl		CHEMBL327188	=	IC50	nM	9.0	CHEMBL267	Homo sapiens	IC50	nM	9.0
	480336	CHEMBL818901	Inhibition of the phosphorylation of a random glutamate-tyrosine (4:1) copolymer by isolated avian c-Src protein.	B	COc1cc(OC)cc(-c2cc3cnc(N)cc3nc2NC(=O)Nc2ccccc2)c1		CHEMBL134066	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	480339	CHEMBL818901	Inhibition of the phosphorylation of a random glutamate-tyrosine (4:1) copolymer by isolated avian c-Src protein.	B	CCNC(=O)Nc1nc2cc(N)ncc2cc1-c1c(Cl)cccc1Cl		CHEMBL422797	=	IC50	nM	100.0	CHEMBL267	Homo sapiens	IC50	uM	0.1
	481984	CHEMBL816863	Inhibition of c-Src tyrosine kinase.	B	CC1(C)SSC[C@H](C(=O)N[C@@H](CCCCN)C(N)=O)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H]1NC(=O)[C@@H](N)Cc1ccc(O)cc1		CHEMBL428640	=	IC50	nM	6700.0	CHEMBL267	Homo sapiens	IC50	uM	6.7
	481985	CHEMBL816863	Inhibition of c-Src tyrosine kinase.	B	CC1(C)SSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H]1NC(=O)[C@@H](N)Cc1ccc(O)cc1		CHEMBL408137	=	IC50	nM	2700.0	CHEMBL267	Homo sapiens	IC50	uM	2.7
	482441	CHEMBL805373	Inhibitory activity was tested against Src protein tyrosine kinase	B	O=C1Nc2cc(-c3ccccc3)ccc2/C1=C/c1[nH]cc2c1CCOC2=O		CHEMBL418301	=	IC50	nM	8400.0	CHEMBL267	Homo sapiens	IC50	uM	8.4
	482444	CHEMBL806432	Inhibition of Src protein tyrosine kinase activity	B	COc1cc(Nc2c(C#N)cnc3cc4c(cc23)ncn4CCN2CCOCC2)cc(OC)c1OC		CHEMBL96633	=	IC50	nM	200.0	CHEMBL267	Homo sapiens	IC50	nM	200.0
	482749	CHEMBL818901	Inhibition of the phosphorylation of a random glutamate-tyrosine (4:1) copolymer by isolated avian c-Src protein.	B	COc1cc(OC)cc(-c2cc3cnc(NC(=O)NC(C)(C)C)cc3nc2NC(=O)NC(C)(C)C)c1		CHEMBL135074	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	482756	CHEMBL818901	Inhibition of the phosphorylation of a random glutamate-tyrosine (4:1) copolymer by isolated avian c-Src protein.	B	CC(C)(C)NC(=O)Nc1nc2cc(N)ncc2cc1-c1ccccc1		CHEMBL133436	=	IC50	nM	4400.0	CHEMBL267	Homo sapiens	IC50	uM	4.4
	483166	CHEMBL816863	Inhibition of c-Src tyrosine kinase.	B	CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H]1C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@H](Cc2ccccc2)C(=O)N[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(N)=O)CSSC1(C)C		CHEMBL216616	=	IC50	nM	6500.0	CHEMBL267	Homo sapiens	IC50	uM	6.5
	483674	CHEMBL805373	Inhibitory activity was tested against Src protein tyrosine kinase	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1[nH]cc2c1CCOC2=O		CHEMBL301639	>	IC50	nM	20000.0	CHEMBL267	Homo sapiens	IC50	uM	20.0
	484023	CHEMBL818901	Inhibition of the phosphorylation of a random glutamate-tyrosine (4:1) copolymer by isolated avian c-Src protein.	B	CCNC(=O)Nc1nc2nc(N)ncc2cc1-c1c(Cl)cccc1Cl		CHEMBL432738	=	IC50	nM	80.0	CHEMBL267	Homo sapiens	IC50	uM	0.08
	484401	CHEMBL857848	Inhibition of c-Src tyrosine kinase against 55 uM YIYGSFK-NH2 substrate	B	CC[C@H](C)[C@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(N)=O		CHEMBL67644	=	Km	nM	55000.0	CHEMBL267	Homo sapiens	Km	uM	55.0
	484924	CHEMBL806432	Inhibition of Src protein tyrosine kinase activity	B	COc1cc(Nc2c(C#N)cnc3cc4[nH]c(NCCN5CCOCC5)nc4cc23)cc(OC)c1OC		CHEMBL93262	=	IC50	nM	180.0	CHEMBL267	Homo sapiens	IC50	nM	180.0
	485516	CHEMBL816864	Inhibition of c-Src tyrosine kinase against 100 uM cdc2 substrate	B	CC1(C)SSC[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(N)=O)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](Cc2ccc(O)c(I)c2)NC(=O)[C@@H]1NC(=O)[C@@H](N)Cc1ccc(O)cc1		CHEMBL436961	=	IC50	nM	130.0	CHEMBL267	Homo sapiens	IC50	uM	0.13
	486647	CHEMBL816863	Inhibition of c-Src tyrosine kinase.	B	CC(C)(S)[C@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O		CHEMBL268069	=	IC50	nM	5300.0	CHEMBL267	Homo sapiens	IC50	uM	5.3
	487123	CHEMBL805373	Inhibitory activity was tested against Src protein tyrosine kinase	B	O=C1Nc2cccc(C3CCNCC3)c2/C1=C/c1[nH]cc2c1CCOC2=O		CHEMBL58224	=	IC50	nM	1100.0	CHEMBL267	Homo sapiens	IC50	uM	1.1
	487467	CHEMBL818901	Inhibition of the phosphorylation of a random glutamate-tyrosine (4:1) copolymer by isolated avian c-Src protein.	B	Nc1ncc2cc(-c3c(Cl)cccc3Cl)c(N)nc2n1		CHEMBL58627	=	IC50	nM	210.0	CHEMBL267	Homo sapiens	IC50	uM	0.21
	487470	CHEMBL818901	Inhibition of the phosphorylation of a random glutamate-tyrosine (4:1) copolymer by isolated avian c-Src protein.	B	Nc1cc2nc(N)c(-c3c(Cl)cccc3Cl)cc2cn1		CHEMBL132089	=	IC50	nM	680.0	CHEMBL267	Homo sapiens	IC50	uM	0.68
	487901	CHEMBL816863	Inhibition of c-Src tyrosine kinase.	B	CC1(C)SSC[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(N)=O)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H]1NC(=O)[C@@H](N)Cc1ccc(O)cc1		CHEMBL386921	=	IC50	nM	4500.0	CHEMBL267	Homo sapiens	IC50	uM	4.5
	487902	CHEMBL816864	Inhibition of c-Src tyrosine kinase against 100 uM cdc2 substrate	B	CC1(C)SSC[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(N)=O)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](Cc2cc(I)c(O)c(I)c2)NC(=O)[C@@H]1NC(=O)[C@@H](N)Cc1ccc(O)cc1		CHEMBL216490	=	IC50	nM	540.0	CHEMBL267	Homo sapiens	IC50	uM	0.54
	488407	CHEMBL806432	Inhibition of Src protein tyrosine kinase activity	B	COc1ccc(Cl)c(Nc2c(C#N)cnc3cc4[nH]cnc4cc23)c1		CHEMBL92395	=	IC50	nM	30.0	CHEMBL267	Homo sapiens	IC50	nM	30.0
	488654	CHEMBL818901	Inhibition of the phosphorylation of a random glutamate-tyrosine (4:1) copolymer by isolated avian c-Src protein.	B	COc1cc(OC)cc(-c2cc3cnc(N)nc3nc2NC(=O)NC(C)(C)C)c1		CHEMBL299763	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	489836	CHEMBL818901	Inhibition of the phosphorylation of a random glutamate-tyrosine (4:1) copolymer by isolated avian c-Src protein.	B	COc1cc(OC)cc(-c2cc3cnc(NC(C)=O)cc3nc2NC(=O)NC(C)(C)C)c1		CHEMBL135889	=	IC50	nM	3800.0	CHEMBL267	Homo sapiens	IC50	uM	3.8
	490231	CHEMBL816863	Inhibition of c-Src tyrosine kinase.	B	CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H]1C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@H](Cc2ccccc2)C(=O)N[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O)CSSC1(C)C		CHEMBL413847	=	IC50	nM	26000.0	CHEMBL267	Homo sapiens	IC50	uM	26.0
	490731	CHEMBL806432	Inhibition of Src protein tyrosine kinase activity	B	N#Cc1cnc2cc3[nH]cnc3cc2c1Nc1ccc(Cl)cc1Br		CHEMBL96096	=	IC50	nM	75.0	CHEMBL267	Homo sapiens	IC50	nM	75.0
	491034	CHEMBL818901	Inhibition of the phosphorylation of a random glutamate-tyrosine (4:1) copolymer by isolated avian c-Src protein.	B	CCNC(=O)Nc1nc2cc(N)ncc2cc1-c1cc(OC)cc(OC)c1		CHEMBL422625	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	492205	CHEMBL818901	Inhibition of the phosphorylation of a random glutamate-tyrosine (4:1) copolymer by isolated avian c-Src protein.	B	Nc1cc2nc(N)c(-c3ccccc3)cc2cn1		CHEMBL135061	=	IC50	nM	17000.0	CHEMBL267	Homo sapiens	IC50	uM	17.0
	493115	CHEMBL805373	Inhibitory activity was tested against Src protein tyrosine kinase	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	IC50	nM	11000.0	CHEMBL267	Homo sapiens	IC50	uM	11.0
	494219	CHEMBL805373	Inhibitory activity was tested against Src protein tyrosine kinase	B	Cc1cccc2c1/C(=C/c1[nH]cc3c1CCOC3=O)C(=O)N2		CHEMBL57446	>	IC50	nM	20000.0	CHEMBL267	Homo sapiens	IC50	uM	20.0
	494223	CHEMBL805373	Inhibitory activity was tested against Src protein tyrosine kinase	B	COc1ccc2c(c1)NC(=O)/C2=C\c1[nH]cc2c1CCOC2=O		CHEMBL59073	>	IC50	nM	20000.0	CHEMBL267	Homo sapiens	IC50	uM	20.0
	494266	CHEMBL806432	Inhibition of Src protein tyrosine kinase activity	B	COc1ccc(C)c(Nc2c(C#N)cnc3cc4c(cc23)ncn4CCN2CCOCC2)c1		CHEMBL92729	=	IC50	nM	120.0	CHEMBL267	Homo sapiens	IC50	nM	120.0
	494973	CHEMBL816863	Inhibition of c-Src tyrosine kinase.	B	CC[C@H](C)[C@H](NC(=O)[C@@H](N)CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O		CHEMBL428888	=	IC50	nM	6900.0	CHEMBL267	Homo sapiens	IC50	uM	6.9
	496025	CHEMBL816863	Inhibition of c-Src tyrosine kinase.	B	CC1(C)SSC[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@H]1NC(=O)[C@@H](N)Cc1ccc(O)cc1		CHEMBL267152	=	IC50	nM	2000.0	CHEMBL267	Homo sapiens	IC50	uM	2.0
	496463	CHEMBL805373	Inhibitory activity was tested against Src protein tyrosine kinase	B	O=C1Nc2ccc(C(=O)O)cc2/C1=C/c1[nH]cc2c1CCOC2=O		CHEMBL293068	>	IC50	nM	20000.0	CHEMBL267	Homo sapiens	IC50	uM	20.0
	496467	CHEMBL805373	Inhibitory activity was tested against Src protein tyrosine kinase	B	O=C1Nc2ccc(Br)cc2/C1=C/c1[nH]cc2c1CCOC2=O		CHEMBL292864	>	IC50	nM	20000.0	CHEMBL267	Homo sapiens	IC50	uM	20.0
	497162	CHEMBL816863	Inhibition of c-Src tyrosine kinase.	B	CC(=O)N[C@@H]1C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@H](Cc2ccccc2)C(=O)N[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(N)=O)CSSC1(C)C		CHEMBL385223	=	IC50	nM	11000.0	CHEMBL267	Homo sapiens	IC50	uM	11.0
	497163	CHEMBL816863	Inhibition of c-Src tyrosine kinase.	B	CC1(C)SSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H]1NC(=O)[C@@H](N)Cc1ccc(O)cc1		CHEMBL407087	=	IC50	nM	4300.0	CHEMBL267	Homo sapiens	IC50	uM	4.3
	497580	CHEMBL806432	Inhibition of Src protein tyrosine kinase activity	B	COc1cc(Nc2c(C#N)cnc3cc4[nH]cnc4cc23)c(Br)cc1Cl		CHEMBL96081	=	IC50	nM	16.0	CHEMBL267	Homo sapiens	IC50	nM	16.0
	497870	CHEMBL818901	Inhibition of the phosphorylation of a random glutamate-tyrosine (4:1) copolymer by isolated avian c-Src protein.	B	COc1cc(OC)cc(-c2cc3cnc(N)cc3nc2N)c1		CHEMBL133604	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	498270	CHEMBL816863	Inhibition of c-Src tyrosine kinase.	B	C[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(C)(C)S)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O		CHEMBL275924	=	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	498271	CHEMBL816863	Inhibition of c-Src tyrosine kinase.	B	CC1(C)SSC[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H]1N		CHEMBL306771	=	IC50	nM	14400.0	CHEMBL267	Homo sapiens	IC50	uM	14.4
	498751	CHEMBL806432	Inhibition of Src protein tyrosine kinase activity	B	COc1cc(Nc2c(C#N)cnc3cc4[nH]cnc4cc23)cc(OC)c1OC		CHEMBL94846	=	IC50	nM	330.0	CHEMBL267	Homo sapiens	IC50	nM	330.0
	498756	CHEMBL806432	Inhibition of Src protein tyrosine kinase activity	B	COc1ccc(Cl)c(Nc2c(C#N)cnc3cc4c(cc23)ncn4CCN2CCOCC2)c1		CHEMBL92339	=	IC50	nM	43.0	CHEMBL267	Homo sapiens	IC50	nM	43.0
	498761	CHEMBL806432	Inhibition of Src protein tyrosine kinase activity	B	COc1cc(Nc2c(C#N)cnc3cc4c(cc23)ncn4CCN2CCOCC2)c(C)cc1Cl		CHEMBL330351	=	IC50	nM	29.0	CHEMBL267	Homo sapiens	IC50	nM	29.0
	499100	CHEMBL818901	Inhibition of the phosphorylation of a random glutamate-tyrosine (4:1) copolymer by isolated avian c-Src protein.	B	CNC(=O)Nc1nc2cc(N)ncc2cc1-c1cc(OC)cc(OC)c1		CHEMBL134801	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	499103	CHEMBL818901	Inhibition of the phosphorylation of a random glutamate-tyrosine (4:1) copolymer by isolated avian c-Src protein.	B	COc1cc(OC)cc(-c2cc3cnc(NCCCN4CCOCC4)cc3nc2NC(=O)NC(C)(C)C)c1		CHEMBL339856	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	499110	CHEMBL818901	Inhibition of the phosphorylation of a random glutamate-tyrosine (4:1) copolymer by isolated avian c-Src protein.	B	CC(C)(C)NC(=O)Nc1nc2nc(N)ncc2cc1-c1c(Cl)cccc1Cl		CHEMBL57366	=	IC50	nM	220.0	CHEMBL267	Homo sapiens	IC50	uM	0.22
	499539	CHEMBL816863	Inhibition of c-Src tyrosine kinase.	B	CC[C@H](C)[C@H]1NC(=O)[C@H](N)CSSC[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](Cc2ccc(O)cc2)NC1=O		CHEMBL267322	=	IC50	nM	2700.0	CHEMBL267	Homo sapiens	IC50	uM	2.7
	500782	CHEMBL816863	Inhibition of c-Src tyrosine kinase.	B	C[C@H]1NC(=O)CNC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](NC(=O)[C@@H](N)Cc2ccc(O)cc2)C(C)(C)SSC[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O)NC(=O)[C@@H](Cc2ccccc2)NC1=O		CHEMBL412705	=	IC50	nM	18000.0	CHEMBL267	Homo sapiens	IC50	uM	18.0
	500783	CHEMBL816863	Inhibition of c-Src tyrosine kinase.	B	CC(=O)N[C@@H]1C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@H](Cc2ccccc2)C(=O)N[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O)CSSC1(C)C		CHEMBL420190	=	IC50	nM	20000.0	CHEMBL267	Homo sapiens	IC50	uM	20.0
	501316	CHEMBL805373	Inhibitory activity was tested against Src protein tyrosine kinase	B	CC(C)NS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]cc3c1CCOC3=O)C(=O)N2		CHEMBL299032	>	IC50	nM	20000.0	CHEMBL267	Homo sapiens	IC50	uM	20.0
	502076	CHEMBL816863	Inhibition of c-Src tyrosine kinase.	B	CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc2ccccc2c1)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O)C(C)(C)S		CHEMBL266442	=	IC50	nM	2700.0	CHEMBL267	Homo sapiens	IC50	uM	2.7
	502077	CHEMBL816863	Inhibition of c-Src tyrosine kinase.	B	CC1(C)SSC[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(N)=O)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H]1N		CHEMBL430417	=	IC50	nM	20000.0	CHEMBL267	Homo sapiens	IC50	uM	20.0
	503342	CHEMBL816864	Inhibition of c-Src tyrosine kinase against 100 uM cdc2 substrate	B	C[C@H](c1ccc2ccccc2c1)[C@@H]1NC(=O)[C@H](NC(=O)[C@@H](N)Cc2ccc(O)cc2)C(C)(C)SSC[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(N)=O)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CO)NC(=O)CNC1=O		CHEMBL414159	=	IC50	nM	1500.0	CHEMBL267	Homo sapiens	IC50	uM	1.5
	504970	CHEMBL806432	Inhibition of Src protein tyrosine kinase activity	B	COc1cc(Nc2c(C#N)cnc3cc4[nH]c(CN5CCOCC5)nc4cc23)cc(OC)c1OC		CHEMBL330657	=	IC50	nM	620.0	CHEMBL267	Homo sapiens	IC50	nM	620.0
	505343	CHEMBL818901	Inhibition of the phosphorylation of a random glutamate-tyrosine (4:1) copolymer by isolated avian c-Src protein.	B	COc1cc(OC)cc(-c2cc3cnc(N)cc3nc2NC(=O)NC(C)(C)C)c1		CHEMBL134354	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	505351	CHEMBL818901	Inhibition of the phosphorylation of a random glutamate-tyrosine (4:1) copolymer by isolated avian c-Src protein.	B	COc1cc(OC)cc(-c2cc3cnc(N)nc3nc2N)c1		CHEMBL56942	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	505354	CHEMBL818901	Inhibition of the phosphorylation of a random glutamate-tyrosine (4:1) copolymer by isolated avian c-Src protein.	B	CCNC(=O)Nc1nc2cc(N)ncc2cc1-c1ccccc1		CHEMBL135267	=	IC50	nM	5100.0	CHEMBL267	Homo sapiens	IC50	uM	5.1
	505737	CHEMBL816863	Inhibition of c-Src tyrosine kinase.	B	CC1(C)SSC[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H]1NC(=O)[C@@H](N)Cc1ccc(O)cc1		CHEMBL274532	=	IC50	nM	3000.0	CHEMBL267	Homo sapiens	IC50	uM	3.0
	506108	CHEMBL805373	Inhibitory activity was tested against Src protein tyrosine kinase	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]cc3c1CCOC3=O)C(=O)N2		CHEMBL57256	>	IC50	nM	20000.0	CHEMBL267	Homo sapiens	IC50	uM	20.0
	506169	CHEMBL808762	Inhibition of Src protein tyrosine kinase	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	>	IC50	nM	8000.0	CHEMBL267	Homo sapiens	IC50	uM	8.0
	507373	CHEMBL805373	Inhibitory activity was tested against Src protein tyrosine kinase	B	O=C1Nc2cccc(CCO)c2/C1=C/c1[nH]cc2c1CCOC2=O		CHEMBL58483	>	IC50	nM	20000.0	CHEMBL267	Homo sapiens	IC50	uM	20.0
	509374	CHEMBL816864	Inhibition of c-Src tyrosine kinase against 100 uM cdc2 substrate	B	CC(=O)N[C@H]1C(=O)N[C@@H](Cc2ccc3ccccc3c2)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@H](Cc2ccccc2)C(=O)N[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(N)=O)CSSC1(C)C		CHEMBL405681	=	IC50	nM	1600.0	CHEMBL267	Homo sapiens	IC50	uM	1.6
	509379	CHEMBL816864	Inhibition of c-Src tyrosine kinase against 100 uM cdc2 substrate	B	CC(=O)N[C@H]1C(=O)N[C@H](Cc2ccc3ccccc3c2)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@H](Cc2ccccc2)C(=O)N[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(N)=O)CSSC1(C)C		CHEMBL404595	=	IC50	nM	2100.0	CHEMBL267	Homo sapiens	IC50	uM	2.1
	509384	CHEMBL816864	Inhibition of c-Src tyrosine kinase against 100 uM cdc2 substrate	B	C[C@H](c1ccc2ccccc2c1)[C@H]1NC(=O)[C@H](NC(=O)[C@@H](N)Cc2ccc(O)cc2)C(C)(C)SSC[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(N)=O)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CO)NC(=O)CNC1=O		CHEMBL262212	=	IC50	nM	2900.0	CHEMBL267	Homo sapiens	IC50	uM	2.9
	510258	CHEMBL818901	Inhibition of the phosphorylation of a random glutamate-tyrosine (4:1) copolymer by isolated avian c-Src protein.	B	CC(C)(C)NC(=O)Nc1nc2nc(N)ncc2cc1-c1ccccc1		CHEMBL76599	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	510581	CHEMBL816863	Inhibition of c-Src tyrosine kinase.	B	CC1(C)SSC[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(N)=O)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H]1NC(=O)[C@@H](N)Cc1ccc(O)cc1		CHEMBL384640	=	IC50	nM	1200.0	CHEMBL267	Homo sapiens	IC50	uM	1.2
	511001	CHEMBL805373	Inhibitory activity was tested against Src protein tyrosine kinase	B	O=C1Nc2ccc(F)cc2/C1=C/c1[nH]cc2c1CCOC2=O		CHEMBL59110	>	IC50	nM	20000.0	CHEMBL267	Homo sapiens	IC50	uM	20.0
	511051	CHEMBL806432	Inhibition of Src protein tyrosine kinase activity	B	COc1ccc(C)c(Nc2c(C#N)cnc3cc4[nH]c(NCCN5CCOCC5)nc4cc23)c1		CHEMBL329244	=	IC50	nM	67.0	CHEMBL267	Homo sapiens	IC50	nM	67.0
	512198	CHEMBL806426	Inhibition of Src kinase	B	Cc1cccc(Cl)c1NC(=O)c1cnc(NC(=O)C2CC2)s1		CHEMBL131577	=	IC50	nM	10.0	CHEMBL267	Homo sapiens	IC50	uM	0.01
	517572	CHEMBL843186	Inhibition of human p60 c-src	B	Cn1cc(C2=C(c3c4n(c5ccccc35)CCC(CN)C4)C(=O)NC2=O)c2ccccc21		CHEMBL421565	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	532196	CHEMBL843188	Inhibition of human p60 c-src	B	CN(C)CC1CCn2c(c(C3=C(c4cn(C)c5ccccc45)C(=O)NC3=O)c3ccccc32)C1.Cl		CHEMBL1202927	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	533485	CHEMBL843187	Inhibition of human p60 c-src	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	3000.0	CHEMBL267	Homo sapiens	IC50	uM	3.0
	558567	CHEMBL843190	Inhibition of in vitro protein-tyrosine kinase activity of p60v-src enzyme in presence of 5 uM ATP.	B	Nc1ccc(-c2cc(=O)c3cccc(N)c3o2)cc1		CHEMBL323660	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	558710	CHEMBL808044	Inhibitory activity against Src protein tyrosine kinase SH2 domain	F	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(=O)[C@H](CCC(N)=O)NC(C)=O)C(=O)N1CCC[C@H]1C(N)=O		CHEMBL134928	=	IC50	nM	3200.0	CHEMBL267	Homo sapiens	IC50	uM	3.2
	561984	CHEMBL843190	Inhibition of in vitro protein-tyrosine kinase activity of p60v-src enzyme in presence of 5 uM ATP.	B	Nc1ccc(-c2cc(=O)c3ccc(O)c(N)c3o2)cc1		CHEMBL114568	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	563460	CHEMBL843059	Inhibition of p60 c-Src tyrosine kinase	B	O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12		CHEMBL44	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	564387	CHEMBL843190	Inhibition of in vitro protein-tyrosine kinase activity of p60v-src enzyme in presence of 5 uM ATP.	B	Nc1ccc(-c2cc(=O)c3cc(N)ccc3o2)cc1		CHEMBL112925	=	IC50	nM	28800.0	CHEMBL267	Homo sapiens	IC50	uM	28.8
	564603	CHEMBL843059	Inhibition of p60 c-Src tyrosine kinase	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	IC50	nM	2700.0	CHEMBL267	Homo sapiens	IC50	uM	2.7
Not Determined	565548	CHEMBL843191	Inhibition of protein-tyrosine kinase activity of p60v-src enzyme in presence of 5 uM ATP.	B	O=c1cc(-c2ccc([N+](=O)[O-])cc2)oc2c([N+](=O)[O-])c(O)ccc12		CHEMBL324563		IC50	nM		CHEMBL267	Homo sapiens	IC50	uM	
	565747	CHEMBL843059	Inhibition of p60 c-Src tyrosine kinase	B	O=c1c(-c2cccc(Cl)c2)coc2cc(O)cc(O)c12		CHEMBL7827	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	566765	CHEMBL843190	Inhibition of in vitro protein-tyrosine kinase activity of p60v-src enzyme in presence of 5 uM ATP.	B	Nc1ccc(-c2cc(=O)c3cc(O)cc(N)c3o2)cc1		CHEMBL112421	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	566768	CHEMBL843190	Inhibition of in vitro protein-tyrosine kinase activity of p60v-src enzyme in presence of 5 uM ATP.	B	COc1cc(N)c2oc(-c3cccc(N)c3)cc(=O)c2c1		CHEMBL114550	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	566926	CHEMBL843059	Inhibition of p60 c-Src tyrosine kinase	B	COc1cc(O)c2c(O)c(-c3cccc(Cl)c3)cnc2c1		CHEMBL440453	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
Not Determined	567944	CHEMBL843191	Inhibition of protein-tyrosine kinase activity of p60v-src enzyme in presence of 5 uM ATP.	B	COc1cc([N+](=O)[O-])c2oc(-c3ccc([N+](=O)[O-])cc3)cc(=O)c2c1		CHEMBL115036		IC50	nM		CHEMBL267	Homo sapiens	IC50	uM	
Not Determined	569312	CHEMBL843191	Inhibition of protein-tyrosine kinase activity of p60v-src enzyme in presence of 5 uM ATP.	B	O=c1cc(-c2ccc([N+](=O)[O-])cc2)oc2ccc([N+](=O)[O-])cc12		CHEMBL64704		IC50	nM		CHEMBL267	Homo sapiens	IC50	uM	
Not Determined	569315	CHEMBL843191	Inhibition of protein-tyrosine kinase activity of p60v-src enzyme in presence of 5 uM ATP.	B	O=c1cc(-c2ccc([N+](=O)[O-])cc2)oc2c([N+](=O)[O-])cccc12		CHEMBL330905		IC50	nM		CHEMBL267	Homo sapiens	IC50	uM	
	572082	CHEMBL843059	Inhibition of p60 c-Src tyrosine kinase	B	COC(=O)Cn1cc(-c2cccc(Cl)c2)c(=O)c2c(O)cc(OC)cc21		CHEMBL7866	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	572157	CHEMBL772797	Inhibition of Protein kinase Src at 10 uM	B	O=C(O)Cc1c2ccccc2n2c1[nH]c(=O)c1ccccc12		CHEMBL92361	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	Inhibition	%	0.0
Not Determined	573098	CHEMBL843191	Inhibition of protein-tyrosine kinase activity of p60v-src enzyme in presence of 5 uM ATP.	B	O=c1cc(-c2ccc([N+](=O)[O-])cc2)oc2c([N+](=O)[O-])ccc(O)c12		CHEMBL325385		IC50	nM		CHEMBL267	Homo sapiens	IC50	uM	
	573147	CHEMBL843190	Inhibition of in vitro protein-tyrosine kinase activity of p60v-src enzyme in presence of 5 uM ATP.	B	Nc1ccc(-c2cc(=O)c3cc(N)cc(N)c3o2)cc1		CHEMBL112422	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
Not Determined	574267	CHEMBL843191	Inhibition of protein-tyrosine kinase activity of p60v-src enzyme in presence of 5 uM ATP.	B	O=c1cc(-c2ccc([N+](=O)[O-])cc2)oc2cc(O)c([N+](=O)[O-])cc12		CHEMBL114209		IC50	nM		CHEMBL267	Homo sapiens	IC50	uM	
	575420	CHEMBL843190	Inhibition of in vitro protein-tyrosine kinase activity of p60v-src enzyme in presence of 5 uM ATP.	B	Nc1ccc(-c2cc(=O)c3c(O)c(N)ccc3o2)cc1		CHEMBL116051	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
Not Determined	575476	CHEMBL843191	Inhibition of protein-tyrosine kinase activity of p60v-src enzyme in presence of 5 uM ATP.	B	O=c1cc(-c2ccc([N+](=O)[O-])cc2)oc2ccc([N+](=O)[O-])c(O)c12		CHEMBL116064		IC50	nM		CHEMBL267	Homo sapiens	IC50	uM	
Not Determined	576724	CHEMBL843191	Inhibition of protein-tyrosine kinase activity of p60v-src enzyme in presence of 5 uM ATP.	B	O=c1cc(-c2ccc([N+](=O)[O-])cc2)oc2c([N+](=O)[O-])cc([N+](=O)[O-])cc12		CHEMBL112649		IC50	nM		CHEMBL267	Homo sapiens	IC50	uM	
	576760	CHEMBL843190	Inhibition of in vitro protein-tyrosine kinase activity of p60v-src enzyme in presence of 5 uM ATP.	B	Nc1ccc(-c2cc(=O)c3c(O)ccc(N)c3o2)cc1		CHEMBL114578	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	578010	CHEMBL843190	Inhibition of in vitro protein-tyrosine kinase activity of p60v-src enzyme in presence of 5 uM ATP.	B	Nc1ccc(-c2cc(=O)c3cc(N)c(O)cc3o2)cc1		CHEMBL432416	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	578205	CHEMBL843059	Inhibition of p60 c-Src tyrosine kinase	B	COc1cc(O)c2c(=O)c(-c3cccc(Cl)c3)cn(C)c2c1		CHEMBL7819	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
Not Determined	579128	CHEMBL843191	Inhibition of protein-tyrosine kinase activity of p60v-src enzyme in presence of 5 uM ATP.	B	O=c1cc(-c2ccc([N+](=O)[O-])cc2)oc2cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c12		CHEMBL326778		IC50	nM		CHEMBL267	Homo sapiens	IC50	uM	
	579131	CHEMBL843190	Inhibition of in vitro protein-tyrosine kinase activity of p60v-src enzyme in presence of 5 uM ATP.	B	COc1ccc(N)c2oc(-c3ccc(N)cc3)cc(=O)c12		CHEMBL115397	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
Not Determined	580396	CHEMBL843191	Inhibition of protein-tyrosine kinase activity of p60v-src enzyme in presence of 5 uM ATP.	B	COc1ccc([N+](=O)[O-])c2oc(-c3ccc([N+](=O)[O-])cc3)cc(=O)c12		CHEMBL115784		IC50	nM		CHEMBL267	Homo sapiens	IC50	uM	
Not Determined	580399	CHEMBL843191	Inhibition of protein-tyrosine kinase activity of p60v-src enzyme in presence of 5 uM ATP.	B	O=c1cc(-c2ccc([N+](=O)[O-])cc2)oc2c([N+](=O)[O-])c(O)c([N+](=O)[O-])cc12		CHEMBL115351		IC50	nM		CHEMBL267	Homo sapiens	IC50	uM	
Not Determined	581523	CHEMBL843191	Inhibition of protein-tyrosine kinase activity of p60v-src enzyme in presence of 5 uM ATP.	B	O=c1cc(-c2ccc([N+](=O)[O-])cc2)oc2c([N+](=O)[O-])cc(O)cc12		CHEMBL115148		IC50	nM		CHEMBL267	Homo sapiens	IC50	uM	
	582663	CHEMBL843190	Inhibition of in vitro protein-tyrosine kinase activity of p60v-src enzyme in presence of 5 uM ATP.	B	Nc1ccc(-c2cc(=O)c3c(N)c(O)c(N)cc3o2)cc1		CHEMBL114814	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	582723	CHEMBL843190	Inhibition of in vitro protein-tyrosine kinase activity of p60v-src enzyme in presence of 5 uM ATP.	B	Nc1cccc(-c2cc(=O)c3cc(N)c(O)cc3o2)c1		CHEMBL115102	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	583984	CHEMBL843190	Inhibition of in vitro protein-tyrosine kinase activity of p60v-src enzyme in presence of 5 uM ATP.	B	Nc1cccc(-c2cc(=O)c3c(N)c(O)c(N)cc3o2)c1		CHEMBL325949	=	IC50	nM	38400.0	CHEMBL267	Homo sapiens	IC50	uM	38.4
	584260	CHEMBL843059	Inhibition of p60 c-Src tyrosine kinase	B	COc1cc(O)c2c(=O)c(-c3cccc(Cl)c3)coc2c1		CHEMBL7339	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	585350	CHEMBL843190	Inhibition of in vitro protein-tyrosine kinase activity of p60v-src enzyme in presence of 5 uM ATP.	B	Nc1ccc(-c2cc(=O)c3cc(N)c(O)c(N)c3o2)cc1		CHEMBL115601	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	585353	CHEMBL843190	Inhibition of in vitro protein-tyrosine kinase activity of p60v-src enzyme in presence of 5 uM ATP.	B	Nc1cccc(-c2cc(=O)c3cc(N)ccc3o2)c1		CHEMBL115103	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	586595	CHEMBL808044	Inhibitory activity against Src protein tyrosine kinase SH2 domain	F	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(OC(C(=O)O)C(=O)O)cc1)NC(=O)[C@H](Cc1ccc(OC(C(=O)O)C(=O)O)cc1)NC(=O)[C@H](CCC(N)=O)NC(C)=O)C(=O)N1CCC[C@H]1C(N)=O		CHEMBL437529	=	IC50	nM	22800.0	CHEMBL267	Homo sapiens	IC50	uM	22.8
	587841	CHEMBL808044	Inhibitory activity against Src protein tyrosine kinase SH2 domain	F	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(OC(C(=O)O)C(=O)O)cc1)NC(=O)[C@H](CCC(N)=O)NC(C)=O)C(=O)N1CCC[C@H]1C(N)=O		CHEMBL135042	=	IC50	nM	25000.0	CHEMBL267	Homo sapiens	IC50	uM	25.0
	587978	CHEMBL843059	Inhibition of p60 c-Src tyrosine kinase	B	Oc1cc(O)c2c(O)c(-c3cccc(Cl)c3)cnc2c1		CHEMBL266995	=	IC50	nM	8000.0	CHEMBL267	Homo sapiens	IC50	uM	8.0
	589111	CHEMBL843190	Inhibition of in vitro protein-tyrosine kinase activity of p60v-src enzyme in presence of 5 uM ATP.	B	COc1cc(N)c2oc(-c3ccc(N)cc3)cc(=O)c2c1		CHEMBL116353	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	592664	CHEMBL822438	Inhibition of cellular oncogene pp60 c-src	B	CCc1nc(O)c2c(n1)Nc1ccccc1C2		CHEMBL7350	=	IC50	nM	38000.0	CHEMBL267	Homo sapiens	IC50	uM	38.0
	593025	CHEMBL816861	In vitro inhibition of the c-src tyrosine kinase activity in A431 membranes using angiotensin II as phosphate acceptor as substrate	B	CN(C)CC(CNNC(N)=O)C(=O)c1ccc(OCc2ccccc2)cc1.Cl		CHEMBL541307	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	593302	CHEMBL821541	Concentration of compound required for inhibiting the binding of the fluorescent probe to the c-Src tyrosine kinase SH2 domain by 50%	B	CC[C@@H](C)[C@H](NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc2ccc(OP(=O)(O)O)cc2)NC1=O)C(=O)O		CHEMBL1790810	=	IC50	nM	1500.0	CHEMBL267	Homo sapiens	IC50	uM	1.5
	594152	CHEMBL843948	Inhibition of the tyrosine kinase activity of the product encoded by pp60 v-src.	B	O=C(O)CCc1c(SSc2[nH]c3ccccc3c2CCC(=O)O)[nH]c2ccccc12		CHEMBL79704	=	IC50	nM	51000.0	CHEMBL267	Homo sapiens	IC50	uM	51.0
	594542	CHEMBL821541	Concentration of compound required for inhibiting the binding of the fluorescent probe to the c-Src tyrosine kinase SH2 domain by 50%	B	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)C[C@H](NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(C)=O)C(=O)O)C(=O)O		CHEMBL1790809	=	IC50	nM	75400.0	CHEMBL267	Homo sapiens	IC50	uM	75.4
	594543	CHEMBL821541	Concentration of compound required for inhibiting the binding of the fluorescent probe to the c-Src tyrosine kinase SH2 domain by 50%	B	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)Cc1ccc(OP(=O)(O)O)cc1)C(=O)O)C(=O)O		CHEMBL1790816	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	594544	CHEMBL821541	Concentration of compound required for inhibiting the binding of the fluorescent probe to the c-Src tyrosine kinase SH2 domain by 50%	B	CC(C)[C@H](NC(=O)C[C@@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)Cc1ccc(OP(=O)(O)O)cc1)C(=O)O		CHEMBL431249	=	IC50	nM	76300.0	CHEMBL267	Homo sapiens	IC50	uM	76.3
	595179	CHEMBL822438	Inhibition of cellular oncogene pp60 c-src	B	COc1ccc2c(c1)Cc1c(O)ncnc1N2		CHEMBL6881	=	IC50	nM	3700.0	CHEMBL267	Homo sapiens	IC50	uM	3.7
	595394	CHEMBL816861	In vitro inhibition of the c-src tyrosine kinase activity in A431 membranes using angiotensin II as phosphate acceptor as substrate	B	COC(=O)c1ccccc1SCC(CN(C)C)C(=O)c1ccc(OCc2ccccc2)cc1.Cl		CHEMBL538757	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	596588	CHEMBL805361	Inhibition of Src-mediated dentine resorption in rabbit-osteoclast assay	F	N[C@H]1CC[C@H](Nc2nc(Nc3ccccc3)c3ncn(C4CCCC4)c3n2)CC1		CHEMBL3084839	=	IC50	nM	141.0	CHEMBL267	Homo sapiens	IC50	uM	0.141
	596739	CHEMBL843948	Inhibition of the tyrosine kinase activity of the product encoded by pp60 v-src.	B	O=C(NCc1ccccc1)C(Cc1c(SSc2[nH]c3ccccc3c2CC(NC(=O)C(F)(F)F)C(=O)NCc2ccccc2)[nH]c2ccccc12)NC(=O)C(F)(F)F		CHEMBL350882	=	IC50	nM	700.0	CHEMBL267	Homo sapiens	IC50	uM	0.7
	596824	CHEMBL843948	Inhibition of the tyrosine kinase activity of the product encoded by pp60 v-src.	B	CN(C)C(=O)CCc1c(SSc2[nH]c3ccccc3c2CCC(=O)N(C)C)[nH]c2ccccc12		CHEMBL422531	=	IC50	nM	1200.0	CHEMBL267	Homo sapiens	IC50	uM	1.2
	596830	CHEMBL816861	In vitro inhibition of the c-src tyrosine kinase activity in A431 membranes using angiotensin II as phosphate acceptor as substrate	B	Cc1ccc(SCC(CN(C)C)C(=O)c2ccc(OCc3ccccc3)cc2)cc1C.Cl		CHEMBL538507	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	598023	CHEMBL843948	Inhibition of the tyrosine kinase activity of the product encoded by pp60 v-src.	B	CONC(=O)CCc1c(SSc2[nH]c3ccccc3c2CCC(=O)NOC)[nH]c2ccccc12		CHEMBL154969	=	IC50	nM	2900.0	CHEMBL267	Homo sapiens	IC50	uM	2.9
	598047	CHEMBL816861	In vitro inhibition of the c-src tyrosine kinase activity in A431 membranes using angiotensin II as phosphate acceptor as substrate	B	C=C(CN(C)C)C(=O)c1ccc(OCc2ccccc2)cc1.Cl		CHEMBL552859	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	598293	CHEMBL821541	Concentration of compound required for inhibiting the binding of the fluorescent probe to the c-Src tyrosine kinase SH2 domain by 50%	B	CC[C@@H](C)[C@H](NC(=O)CC[C@@H]1NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc2ccc(OP(=O)(O)O)cc2)NC1=O)C(=O)O		CHEMBL1790802	=	IC50	nM	1100.0	CHEMBL267	Homo sapiens	IC50	uM	1.1
	599028	CHEMBL822438	Inhibition of cellular oncogene pp60 c-src	B	COc1cc2c(cc1OC)Nc1ncn(CCN3CCOCC3)c(=O)c1C2	Outside typical range	CHEMBL267180	=	IC50	nM	105000.0	CHEMBL267	Homo sapiens	IC50	uM	105.0
	599097	CHEMBL805361	Inhibition of Src-mediated dentine resorption in rabbit-osteoclast assay	F	O=P(O)(O)C(O)(CCCNc1nc(Nc2ccccc2)c2ncn(C3CCCC3)c2n1)P(=O)(O)O		CHEMBL105576	=	IC50	nM	48200.0	CHEMBL267	Homo sapiens	IC50	uM	48.2
	600249	CHEMBL822438	Inhibition of cellular oncogene pp60 c-src	B	COc1cc2c(cc1OC)Nc1ncnc(O)c1C2		CHEMBL414013	=	IC50	nM	500.0	CHEMBL267	Homo sapiens	IC50	uM	0.5
	601797	CHEMBL816861	In vitro inhibition of the c-src tyrosine kinase activity in A431 membranes using angiotensin II as phosphate acceptor as substrate	B	C=C(CN1CCCCC1)C(=O)c1ccc(OCc2ccccc2)cc1.Cl		CHEMBL544074	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	602661	CHEMBL822438	Inhibition of cellular oncogene pp60 c-src	B	Oc1ncnc2c1Cc1ccccc1N2		CHEMBL6796	=	IC50	nM	9100.0	CHEMBL267	Homo sapiens	IC50	uM	9.1
	602963	CHEMBL843948	Inhibition of the tyrosine kinase activity of the product encoded by pp60 v-src.	B	O=C(CCc1c(SSc2[nH]c3ccccc3c2CCC(=O)NCCc2ccccc2)[nH]c2ccccc12)NCCc1ccccc1		CHEMBL154260	=	IC50	nM	14000.0	CHEMBL267	Homo sapiens	IC50	uM	14.0
	602965	CHEMBL843948	Inhibition of the tyrosine kinase activity of the product encoded by pp60 v-src.	B	CC(=O)NC(Cc1c(SSc2[nH]c3ccccc3c2CC(NC(C)=O)C(=O)NCc2ccccc2)[nH]c2ccccc12)C(=O)NCc1ccccc1		CHEMBL346716	=	IC50	nM	500.0	CHEMBL267	Homo sapiens	IC50	uM	0.5
	603319	CHEMBL821541	Concentration of compound required for inhibiting the binding of the fluorescent probe to the c-Src tyrosine kinase SH2 domain by 50%	B	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(C)=O)C(=O)O)C(=O)O		CHEMBL1790815	=	IC50	nM	90700.0	CHEMBL267	Homo sapiens	IC50	uM	90.7
	603983	CHEMBL822438	Inhibition of cellular oncogene pp60 c-src	B	COc1cc2cc3c(O)ncnc3nc2cc1OC		CHEMBL7137	=	IC50	nM	32000.0	CHEMBL267	Homo sapiens	IC50	uM	32.0
	604366	CHEMBL816861	In vitro inhibition of the c-src tyrosine kinase activity in A431 membranes using angiotensin II as phosphate acceptor as substrate	B	Cl.O=C(CCN1CCCCC1)c1ccc(OCc2ccccc2)cc1		CHEMBL545006	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	605596	CHEMBL816861	In vitro inhibition of the c-src tyrosine kinase activity in A431 membranes using angiotensin II as phosphate acceptor as substrate	B	CCOC(=O)C1CCN(CCC(=O)c2ccc(OCc3ccccc3)cc2)CC1.Cl		CHEMBL542891	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	605864	CHEMBL821541	Concentration of compound required for inhibiting the binding of the fluorescent probe to the c-Src tyrosine kinase SH2 domain by 50%	B	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)CC[C@H](NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(C)=O)C(=O)O)C(=O)O		CHEMBL1790805	=	IC50	nM	69500.0	CHEMBL267	Homo sapiens	IC50	uM	69.5
	606674	CHEMBL843948	Inhibition of the tyrosine kinase activity of the product encoded by pp60 v-src.	B	NC(Cc1c(SSc2[nH]c3ccccc3c2CC(N)C(=O)NCc2ccccc2)[nH]c2ccccc12)C(=O)NCc1ccccc1		CHEMBL336174	=	IC50	nM	1500.0	CHEMBL267	Homo sapiens	IC50	uM	1.5
	606740	CHEMBL816861	In vitro inhibition of the c-src tyrosine kinase activity in A431 membranes using angiotensin II as phosphate acceptor as substrate	B	C=C(CN1CCNCC1)C(=O)c1ccc(OCc2ccccc2)cc1.Cl		CHEMBL544538	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	607028	CHEMBL821541	Concentration of compound required for inhibiting the binding of the fluorescent probe to the c-Src tyrosine kinase SH2 domain by 50%	B	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCC(=O)N[C@@H](Cc2ccc(OP(=O)(O)O)cc2)C(=O)N1)C(=O)O		CHEMBL1790806	=	IC50	nM	3300.0	CHEMBL267	Homo sapiens	IC50	uM	3.3
	607961	CHEMBL843948	Inhibition of the tyrosine kinase activity of the product encoded by pp60 v-src.	B	N#CCc1c(SSc2[nH]c3ccccc3c2CC#N)[nH]c2ccccc12		CHEMBL348116	=	IC50	nM	2500.0	CHEMBL267	Homo sapiens	IC50	uM	2.5
	607988	CHEMBL816861	In vitro inhibition of the c-src tyrosine kinase activity in A431 membranes using angiotensin II as phosphate acceptor as substrate	B	C=C(CN(C)C)C(=O)c1ccc(OS(=O)(=O)c2ccc(C(=O)O)cc2)cc1		CHEMBL80030	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	609003	CHEMBL805361	Inhibition of Src-mediated dentine resorption in rabbit-osteoclast assay	F	O=P(O)(O)CP(=O)(O)CCCNc1nc(Nc2ccccc2)c2ncn(C3CCCC3)c2n1		CHEMBL102550	=	IC50	nM	5230.0	CHEMBL267	Homo sapiens	IC50	uM	5.23
	609157	CHEMBL843948	Inhibition of the tyrosine kinase activity of the product encoded by pp60 v-src.	B	O=C(CCCc1c(SSc2[nH]c3ccccc3c2CCCC(=O)NCc2ccccc2)[nH]c2ccccc12)NCc1ccccc1		CHEMBL156555	=	IC50	nM	1300.0	CHEMBL267	Homo sapiens	IC50	uM	1.3
	609243	CHEMBL816861	In vitro inhibition of the c-src tyrosine kinase activity in A431 membranes using angiotensin II as phosphate acceptor as substrate	B	O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12		CHEMBL44	=	IC50	nM	75000.0	CHEMBL267	Homo sapiens	IC50	uM	75.0
	609464	CHEMBL821541	Concentration of compound required for inhibiting the binding of the fluorescent probe to the c-Src tyrosine kinase SH2 domain by 50%	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](CC(=O)O)CC(=O)N[C@H](C(=O)O)C(C)C		CHEMBL106840	=	IC50	nM	25700.0	CHEMBL267	Homo sapiens	IC50	uM	25.7
	610678	CHEMBL821541	Concentration of compound required for inhibiting the binding of the fluorescent probe to the c-Src tyrosine kinase SH2 domain by 50%	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(C)=O)C(=O)O		CHEMBL23794	=	IC50	nM	6500.0	CHEMBL267	Homo sapiens	IC50	uM	6.5
	610679	CHEMBL821541	Concentration of compound required for inhibiting the binding of the fluorescent probe to the c-Src tyrosine kinase SH2 domain by 50%	B	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)C[C@@H]1NC(=O)[C@H](Cc2ccc(OP(=O)(O)O)cc2)NC1=O)C(=O)O		CHEMBL1790814	=	IC50	nM	12100.0	CHEMBL267	Homo sapiens	IC50	uM	12.1
	612547	CHEMBL805361	Inhibition of Src-mediated dentine resorption in rabbit-osteoclast assay	F	N[C@H]1CC[C@H](Nc2nc(Nc3ccc(P(=O)(O)O)c(P(=O)(O)O)c3)c3ncn(C4CCCC4)c3n2)CC1		CHEMBL3085229	=	IC50	nM	15700.0	CHEMBL267	Homo sapiens	IC50	uM	15.7
	612773	CHEMBL816861	In vitro inhibition of the c-src tyrosine kinase activity in A431 membranes using angiotensin II as phosphate acceptor as substrate	B	CN(C)CC(CSCCN)C(=O)c1ccc(OCc2ccccc2)cc1.Cl		CHEMBL543361	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	613920	CHEMBL843948	Inhibition of the tyrosine kinase activity of the product encoded by pp60 v-src.	B	NC(=O)CCC1C(S)=Nc2ccccc21		CHEMBL155607	=	IC50	nM	2000.0	CHEMBL267	Homo sapiens	IC50	uM	2.0
	614439	CHEMBL821541	Concentration of compound required for inhibiting the binding of the fluorescent probe to the c-Src tyrosine kinase SH2 domain by 50%	B	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCC(=O)N[C@@H](Cc2ccc(OP(=O)(O)O)cc2)C(=O)N[C@@H](CCC(=O)O)C(=O)N1)C(=O)O		CHEMBL1790807	=	IC50	nM	5900.0	CHEMBL267	Homo sapiens	IC50	uM	5.9
	615188	CHEMBL822438	Inhibition of cellular oncogene pp60 c-src	B	COc1ccc2c(c1)Nc1ncnc(O)c1C2		CHEMBL266404	=	IC50	nM	500.0	CHEMBL267	Homo sapiens	IC50	uM	0.5
	615812	CHEMBL821541	Concentration of compound required for inhibiting the binding of the fluorescent probe to the c-Src tyrosine kinase SH2 domain by 50%	B	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)CC[C@@H]1NC(=O)[C@H](Cc2ccc(OP(=O)(O)O)cc2)NC1=O)C(=O)O		CHEMBL1790811	=	IC50	nM	1200.0	CHEMBL267	Homo sapiens	IC50	uM	1.2
	615813	CHEMBL821541	Concentration of compound required for inhibiting the binding of the fluorescent probe to the c-Src tyrosine kinase SH2 domain by 50%	B	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)C[C@H](NC(=O)[C@@H](N)Cc1ccc(OP(=O)(O)O)cc1)C(=O)O)C(=O)O		CHEMBL1790817	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	616559	CHEMBL818276	Inhibition of c-Src protein tyrosine kinase at 100 nM	B	Cn1ccc2ccc3c4[nH]c5c(CCCN[C@H]6CC[C@H](O)CC6)cccc5c4c4c(c3c21)C(=O)NC4=O		CHEMBL307152	=	Control	%	100.0	CHEMBL267	Homo sapiens	Control	%	100.0
	616598	CHEMBL818277	Inhibition of c-Src protein tyrosine kinase at 500 nM	B	Cn1ccc2ccc3c4[nH]c5c(CCCN[C@H]6CC[C@H](O)CC6)cccc5c4c4c(c3c21)C(=O)NC4=O		CHEMBL307152	=	Control	%	91.0	CHEMBL267	Homo sapiens	Control	%	91.0
	616609	CHEMBL805361	Inhibition of Src-mediated dentine resorption in rabbit-osteoclast assay	F	N[C@H]1CC[C@H](Nc2nc(Nc3ccc(C(P(=O)(O)O)P(=O)(O)O)cc3)c3ncn(C4CCCC4)c3n2)CC1		CHEMBL3085230	=	IC50	nM	22000.0	CHEMBL267	Homo sapiens	IC50	uM	22.0
	617189	CHEMBL821541	Concentration of compound required for inhibiting the binding of the fluorescent probe to the c-Src tyrosine kinase SH2 domain by 50%	B	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)Cc1ccc(OP(=O)(O)O)cc1)C(=O)O)C(=O)O		CHEMBL1790813	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	618172	CHEMBL843948	Inhibition of the tyrosine kinase activity of the product encoded by pp60 v-src.	B	O=C(CC1C(S)=Nc2ccccc21)NCc1ccccc1		CHEMBL155389	=	IC50	nM	3200.0	CHEMBL267	Homo sapiens	IC50	uM	3.2
	618206	CHEMBL843948	Inhibition of the tyrosine kinase activity of the product encoded by pp60 v-src.	B	CNC(=O)CCc1c(SSc2[nH]c3ccccc3c2CCC(=O)NC)[nH]c2ccccc12		CHEMBL345203	=	IC50	nM	750.0	CHEMBL267	Homo sapiens	IC50	uM	0.75
	618240	CHEMBL816861	In vitro inhibition of the c-src tyrosine kinase activity in A431 membranes using angiotensin II as phosphate acceptor as substrate	B	N#CC(Cc1ccc(O)c(O)c1)C(=N)S		CHEMBL78249	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	619216	CHEMBL822438	Inhibition of cellular oncogene pp60 c-src	B	Oc1cc(Nc2ccccc2)ncn1	Outside typical range	CHEMBL7052	=	IC50	nM	1550000.0	CHEMBL267	Homo sapiens	IC50	uM	1550.0
	620372	CHEMBL805361	Inhibition of Src-mediated dentine resorption in rabbit-osteoclast assay	F	CN(C)CCNc1nc(Nc2ccccc2)c2ncn(C3CCCC3)c2n1		CHEMBL102976	=	IC50	nM	9810.0	CHEMBL267	Homo sapiens	IC50	uM	9.81
	620608	CHEMBL816861	In vitro inhibition of the c-src tyrosine kinase activity in A431 membranes using angiotensin II as phosphate acceptor as substrate	B	CN(C)CCC(=O)c1ccc(OCc2ccccc2)cc1.Cl		CHEMBL544770	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	621697	CHEMBL843948	Inhibition of the tyrosine kinase activity of the product encoded by pp60 v-src.	B	O=C(Cc1c(SSc2[nH]c3ccccc3c2CC(=O)NCc2ccccc2)[nH]c2ccccc12)NCc1ccccc1		CHEMBL435831	=	IC50	nM	3800.0	CHEMBL267	Homo sapiens	IC50	uM	3.8
	621732	CHEMBL816861	In vitro inhibition of the c-src tyrosine kinase activity in A431 membranes using angiotensin II as phosphate acceptor as substrate	B	Cl.O=C(CCN1CCOCC1)c1ccc(OCc2ccccc2)cc1		CHEMBL542893	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	621738	CHEMBL816861	In vitro inhibition of the c-src tyrosine kinase activity in A431 membranes using angiotensin II as phosphate acceptor as substrate	B	CN(C)CC(CSc1ccccc1)C(=O)c1ccc(OCc2ccccc2)cc1.Cl		CHEMBL540292	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	622111	CHEMBL821541	Concentration of compound required for inhibiting the binding of the fluorescent probe to the c-Src tyrosine kinase SH2 domain by 50%	B	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)CC[C@H](NC(=O)[C@@H](N)Cc1ccc(OP(=O)(O)O)cc1)C(=O)O)C(=O)O		CHEMBL1790812	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	622112	CHEMBL821541	Concentration of compound required for inhibiting the binding of the fluorescent probe to the c-Src tyrosine kinase SH2 domain by 50%	B	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(C)=O)C(=O)O)C(=O)O		CHEMBL1790804	=	IC50	nM	80700.0	CHEMBL267	Homo sapiens	IC50	uM	80.7
	622993	CHEMBL843948	Inhibition of the tyrosine kinase activity of the product encoded by pp60 v-src.	B	COC(=O)c1ccc(CNC(=O)CCc2c(SSc3[nH]c4ccccc4c3CCC(=O)NCc3ccc(C(=O)OC)cc3)[nH]c3ccccc23)cc1		CHEMBL154080	=	IC50	nM	1800.0	CHEMBL267	Homo sapiens	IC50	uM	1.8
	622995	CHEMBL843948	Inhibition of the tyrosine kinase activity of the product encoded by pp60 v-src.	B	O=C(CCc1c(SSc2[nH]c3ccccc3c2CCC(=O)NCc2ccc(C(=O)O)cc2)[nH]c2ccccc12)NCc1ccc(C(=O)O)cc1		CHEMBL155293	=	IC50	nM	1500.0	CHEMBL267	Homo sapiens	IC50	uM	1.5
	623063	CHEMBL816861	In vitro inhibition of the c-src tyrosine kinase activity in A431 membranes using angiotensin II as phosphate acceptor as substrate	B	C=C(CN1CCOCC1)C(=O)c1ccc(OCc2ccccc2)cc1.Cl		CHEMBL544067	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	624260	CHEMBL843948	Inhibition of the tyrosine kinase activity of the product encoded by pp60 v-src.	B	O=C(CCc1c(SSc2[nH]c3ccccc3c2CCC(=O)NCc2ccccc2)[nH]c2ccccc12)NCc1ccccc1		CHEMBL293261	=	IC50	nM	2900.0	CHEMBL267	Homo sapiens	IC50	uM	2.9
	624337	CHEMBL816861	In vitro inhibition of the c-src tyrosine kinase activity in A431 membranes using angiotensin II as phosphate acceptor as substrate	B	C=C(CN(C)C)C(=O)c1ccccc1.Cl		CHEMBL468975	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	624611	CHEMBL821541	Concentration of compound required for inhibiting the binding of the fluorescent probe to the c-Src tyrosine kinase SH2 domain by 50%	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](C(=O)O)C(=O)N[C@H](CCC(=O)O)CC(=O)N[C@H](C(=O)O)C(C)C		CHEMBL431642	=	IC50	nM	34600.0	CHEMBL267	Homo sapiens	IC50	uM	34.6
	625255	CHEMBL822438	Inhibition of cellular oncogene pp60 c-src	B	CCN1c2ccccc2Cc2c(O)ncnc21	Outside typical range	CHEMBL7404	=	IC50	nM	550000.0	CHEMBL267	Homo sapiens	IC50	uM	550.0
	625512	CHEMBL843948	Inhibition of the tyrosine kinase activity of the product encoded by pp60 v-src.	B	O=C(CCc1c(SSc2[nH]c3ccccc3c2CCC(=O)Nc2ccccc2)[nH]c2ccccc12)Nc1ccccc1		CHEMBL156797	=	IC50	nM	4400.0	CHEMBL267	Homo sapiens	IC50	uM	4.4
	625574	CHEMBL816861	In vitro inhibition of the c-src tyrosine kinase activity in A431 membranes using angiotensin II as phosphate acceptor as substrate	B	C=C(CN(C)C)C(=O)c1ccc(OCc2ccccc2)c(O)c1.Cl		CHEMBL542887	=	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	625580	CHEMBL816861	In vitro inhibition of the c-src tyrosine kinase activity in A431 membranes using angiotensin II as phosphate acceptor as substrate	B	C=C(CN(C)C)C(=O)c1ccc(OS(=O)(=O)c2ccc(C(=O)N(C)C)cc2)cc1.Cl		CHEMBL552634	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	626581	CHEMBL822438	Inhibition of cellular oncogene pp60 c-src	B	Oc1[nH]cnc2nc3ccccc3c1-2	Outside typical range	CHEMBL267004	=	IC50	nM	293000.0	CHEMBL267	Homo sapiens	IC50	uM	293.0
	626715	CHEMBL843948	Inhibition of the tyrosine kinase activity of the product encoded by pp60 v-src.	B	O=C(CCC1C(S)=Nc2ccccc21)NCc1ccccc1		CHEMBL154911	=	IC50	nM	9300.0	CHEMBL267	Homo sapiens	IC50	uM	9.3
	626779	CHEMBL843948	Inhibition of the tyrosine kinase activity of the product encoded by pp60 v-src.	B	NC(=O)CCc1c(SSc2[nH]c3ccccc3c2CCC(N)=O)[nH]c2ccccc12		CHEMBL157021	=	IC50	nM	1500.0	CHEMBL267	Homo sapiens	IC50	uM	1.5
	628129	CHEMBL816861	In vitro inhibition of the c-src tyrosine kinase activity in A431 membranes using angiotensin II as phosphate acceptor as substrate	B	CN(C)CCC(=O)c1ccc(OCc2ccccc2)c(O)c1.Cl		CHEMBL552860	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	629453	CHEMBL843948	Inhibition of the tyrosine kinase activity of the product encoded by pp60 v-src.	B	COC(=O)CCc1c(SSc2[nH]c3ccccc3c2CCC(=O)OC)[nH]c2ccccc12		CHEMBL79808	=	IC50	nM	3500.0	CHEMBL267	Homo sapiens	IC50	uM	3.5
	629482	CHEMBL816861	In vitro inhibition of the c-src tyrosine kinase activity in A431 membranes using angiotensin II as phosphate acceptor as substrate	B	C=C(CN(C)C)C(=O)c1ccc(OS(=O)(=O)c2ccc(C(=O)O)c(O)c2)cc1		CHEMBL310580	=	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	630619	CHEMBL843948	Inhibition of the tyrosine kinase activity of the product encoded by pp60 v-src.	B	COC(=O)c1ccc(CNC(=O)CCc2c(SSc3[nH]c4ccccc4c3CCC(=O)NCc3ccc(C(=O)OC)c(O)c3)[nH]c3ccccc23)cc1O		CHEMBL154822	=	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	631687	CHEMBL822438	Inhibition of cellular oncogene pp60 c-src	B	COc1cc2c(cc1OC)Nc1ncn(C)c(=O)c1C2		CHEMBL6976	=	IC50	nM	1200.0	CHEMBL267	Homo sapiens	IC50	uM	1.2
	631760	CHEMBL805361	Inhibition of Src-mediated dentine resorption in rabbit-osteoclast assay	F	N[C@H]1CC[C@H](Nc2nc(Nc3ccc(P(=O)(O)CP(=O)(O)O)cc3)c3ncn(C4CCCC4)c3n2)CC1		CHEMBL3084838	=	IC50	nM	41.0	CHEMBL267	Homo sapiens	IC50	uM	0.041
	632300	CHEMBL821541	Concentration of compound required for inhibiting the binding of the fluorescent probe to the c-Src tyrosine kinase SH2 domain by 50%	B	CC(C)[C@H](NC(=O)C[C@@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(OP(=O)(O)O)cc1)C(=O)O)C(=O)O		CHEMBL106664	=	IC50	nM	83200.0	CHEMBL267	Homo sapiens	IC50	uM	83.2
	633363	CHEMBL809574	In vitro binding to Src SH2 domain	B	CC(=O)N[C@H](C(N)=O)[C@@H]1CCc2cc(OP(=O)(O)O)ccc21	Non standard unit for type	CHEMBL31278	>	ID50	mM	3.0	CHEMBL267	Homo sapiens	ID50	mM	3.0
	641525	CHEMBL806423	Inhibition of Src kinase	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	642941	CHEMBL809574	In vitro binding to Src SH2 domain	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(N)=O	Non standard unit for type	CHEMBL288311	=	ID50	mM	1.0	CHEMBL267	Homo sapiens	ID50	mM	1.0
	656073	CHEMBL809574	In vitro binding to Src SH2 domain	B	CC(=O)N1CC2CCC(C)(C1)c1ccc(O)cc12	Non standard unit for type	CHEMBL31940	>	ID50	mM	6.0	CHEMBL267	Homo sapiens	ID50	mM	6.0
	656078	CHEMBL809574	In vitro binding to Src SH2 domain	B	CC(=O)N1CC2CCC(C)(C1)c1ccc(OP(=O)(O)O)cc12	Non standard unit for type	CHEMBL288312	=	ID50	mM	0.9	CHEMBL267	Homo sapiens	ID50	mM	0.9
	662055	CHEMBL883642	In vitro binding to Src SH2 domain	B	N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)O	Non standard unit for type	CHEMBL286939	=	ID50	mM	3.5	CHEMBL267	Homo sapiens	ID50	mM	3.5
	668623	CHEMBL809574	In vitro binding to Src SH2 domain	B	CC(=O)N[C@H](C(N)=O)[C@H]1CCc2cc(OP(=O)(O)O)ccc21	Non standard unit for type	CHEMBL29198	>	ID50	mM	3.0	CHEMBL267	Homo sapiens	ID50	mM	3.0
	671982	CHEMBL805363	Affinity for Src protein tyrosine kinase	B	C[C@H](NC(=O)[C@@H](CC(=O)O)Cc1ccc(OP(=O)(O)O)cc1)c1nc(Cc2ccc(Cl)c(Cl)c2)no1		CHEMBL102765	=	IC50	nM	53000.0	CHEMBL267	Homo sapiens	IC50	uM	53.0
	672331	CHEMBL807314	Inhibitory activity against human c-Src Kinase was measured using ELISA assay	B	COc1cc2ncc(C#N)c(Nc3c(Cl)cccc3Cl)c2cc1OC		CHEMBL168862	=	IC50	nM	61.0	CHEMBL267	Homo sapiens	IC50	nM	61.0
	672332	CHEMBL807314	Inhibitory activity against human c-Src Kinase was measured using ELISA assay	B	COc1cc2ncc(C#N)c(Nc3ccc(Br)cc3Cl)c2cc1OC		CHEMBL355353	=	IC50	nM	15.0	CHEMBL267	Homo sapiens	IC50	nM	15.0
	672333	CHEMBL807314	Inhibitory activity against human c-Src Kinase was measured using ELISA assay	B	N#Cc1cnc2cc(OCCCN3CCOCC3)c(OCCCN3CCOCC3)cc2c1Nc1ccc(Cl)cc1Cl		CHEMBL166650	=	IC50	nM	19.0	CHEMBL267	Homo sapiens	IC50	nM	19.0
	672334	CHEMBL783717	Inhibition of Src-transformed rat fibroblast proliferation in anchorage independent assay	F	N#Cc1cnc2cc(OCCCN3CCOCC3)c(OCCCN3CCOCC3)cc2c1Nc1ccc(Cl)cc1Cl		CHEMBL166650	=	IC50	nM	3300.0	CHEMBL267	Homo sapiens	IC50	uM	3.3
	672336	CHEMBL807314	Inhibitory activity against human c-Src Kinase was measured using ELISA assay	B	COc1cc2c(Nc3ccc(Cl)cc3Cl)c(C#N)cnc2cc1OCCCN1CCN(C)CC1		CHEMBL122744	=	IC50	nM	8.7	CHEMBL267	Homo sapiens	IC50	nM	8.7
	672337	CHEMBL783717	Inhibition of Src-transformed rat fibroblast proliferation in anchorage independent assay	F	COc1cc2c(Nc3ccc(Cl)cc3Cl)c(C#N)cnc2cc1OCCCN1CCN(C)CC1		CHEMBL122744	=	IC50	nM	1000.0	CHEMBL267	Homo sapiens	IC50	uM	1.0
	673243	CHEMBL805363	Affinity for Src protein tyrosine kinase	B	C[C@H](NC(=O)c1cc2cc(OP(=O)(O)O)ccc2[nH]1)c1nc(Cc2ccc(Cl)c(Cl)c2)no1		CHEMBL3706656	=	IC50	nM	81000.0	CHEMBL267	Homo sapiens	IC50	uM	81.0
	674643	CHEMBL805363	Affinity for Src protein tyrosine kinase	B	C[C@H](NC(=O)Nc1cccc2cc(OP(=O)(O)O)ccc12)c1nc(Cc2ccc(Cl)c(Cl)c2)no1	Outside typical range	CHEMBL319179	=	IC50	nM	198000.0	CHEMBL267	Homo sapiens	IC50	uM	198.0
	675069	CHEMBL807315	Inhibition of Src Kinase at 1 uM	B	N#Cc1cnc2ccccc2c1Nc1ccc(Cl)cc1Cl		CHEMBL354736	<	Inhibition	%	20.0	CHEMBL267	Homo sapiens	Inhibition	%	20.0
	676488	CHEMBL807314	Inhibitory activity against human c-Src Kinase was measured using ELISA assay	B	COc1cc2ncc(C#N)c(Nc3ccc(Cl)cc3Cl)c2cc1OC		CHEMBL101917	=	IC50	nM	30.0	CHEMBL267	Homo sapiens	IC50	nM	30.0
	676489	CHEMBL807311	Inhibition of Src Kinase at 0.1 mM ATP	B	COc1cc2ncc(C#N)c(Nc3ccc(Cl)cc3Cl)c2cc1OC		CHEMBL101917	=	IC50	nM	23.0	CHEMBL267	Homo sapiens	IC50	nM	23.0
	676490	CHEMBL807312	Inhibition of Src Kinase at 1 mM ATP	B	COc1cc2ncc(C#N)c(Nc3ccc(Cl)cc3Cl)c2cc1OC		CHEMBL101917	=	IC50	nM	130.0	CHEMBL267	Homo sapiens	IC50	nM	130.0
	676491	CHEMBL807313	Inhibition of Src Kinase at 5 mM ATP	B	COc1cc2ncc(C#N)c(Nc3ccc(Cl)cc3Cl)c2cc1OC		CHEMBL101917	=	IC50	nM	270.0	CHEMBL267	Homo sapiens	IC50	nM	270.0
	676492	CHEMBL783717	Inhibition of Src-transformed rat fibroblast proliferation in anchorage independent assay	F	COc1cc2ncc(C#N)c(Nc3ccc(Cl)cc3Cl)c2cc1OC		CHEMBL101917	=	IC50	nM	5200.0	CHEMBL267	Homo sapiens	IC50	uM	5.2
	676494	CHEMBL807315	Inhibition of Src Kinase at 1 uM	B	N#Cc1cnc2cc(O)c(O)cc2c1Nc1ccc(Cl)cc1Cl		CHEMBL352716	<	Inhibition	%	20.0	CHEMBL267	Homo sapiens	Inhibition	%	20.0
	676495	CHEMBL807314	Inhibitory activity against human c-Src Kinase was measured using ELISA assay	B	COc1cc2c(Nc3ccc(Cl)cc3Cl)c(C#N)cnc2cc1OCCCN1CCOCC1		CHEMBL440160	=	IC50	nM	3.8	CHEMBL267	Homo sapiens	IC50	nM	3.8
	676496	CHEMBL783717	Inhibition of Src-transformed rat fibroblast proliferation in anchorage independent assay	F	COc1cc2c(Nc3ccc(Cl)cc3Cl)c(C#N)cnc2cc1OCCCN1CCOCC1		CHEMBL440160	=	IC50	nM	940.0	CHEMBL267	Homo sapiens	IC50	uM	0.94
	677782	CHEMBL807314	Inhibitory activity against human c-Src Kinase was measured using ELISA assay	B	COc1ccc2c(Nc3ccc(Cl)cc3Cl)c(C#N)cnc2c1		CHEMBL167033	=	IC50	nM	200.0	CHEMBL267	Homo sapiens	IC50	nM	200.0
	677783	CHEMBL807314	Inhibitory activity against human c-Src Kinase was measured using ELISA assay	B	COc1cc2ncc(C#N)c(Nc3ccc(Cl)cc3I)c2cc1OC		CHEMBL421440	=	IC50	nM	6.2	CHEMBL267	Homo sapiens	IC50	nM	6.2
	679706	CHEMBL805363	Affinity for Src protein tyrosine kinase	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](C)c1nc(Cc2ccc(Cl)c(Cl)c2)no1	Outside typical range	CHEMBL318300	=	IC50	nM	210000.0	CHEMBL267	Homo sapiens	IC50	uM	210.0
	680067	CHEMBL807314	Inhibitory activity against human c-Src Kinase was measured using ELISA assay	B	COc1cc2ncnc(Nc3ccc(Cl)cc3Cl)c2cc1OC		CHEMBL128356	=	IC50	nM	250.0	CHEMBL267	Homo sapiens	IC50	nM	250.0
	681118	CHEMBL805363	Affinity for Src protein tyrosine kinase	B	C[C@H](NC(=O)CCc1ccc(OP(=O)(O)O)cc1)c1nc(Cc2ccc(Cl)c(Cl)c2)no1	Outside typical range	CHEMBL419353	=	IC50	nM	459000.0	CHEMBL267	Homo sapiens	IC50	uM	459.0
	681501	CHEMBL807314	Inhibitory activity against human c-Src Kinase was measured using ELISA assay	B	COc1cc2ncc(C#N)c(Sc3ccc(Cl)cc3Cl)c2cc1OC		CHEMBL354751	=	IC50	nM	2200.0	CHEMBL267	Homo sapiens	IC50	nM	2200.0
	682702	CHEMBL805363	Affinity for Src protein tyrosine kinase	B	O=C(O)C[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CO)c1nc(Cc2ccc(Cl)c(Cl)c2)no1		CHEMBL102766	=	IC50	nM	54000.0	CHEMBL267	Homo sapiens	IC50	uM	54.0
	683127	CHEMBL807314	Inhibitory activity against human c-Src Kinase was measured using ELISA assay	B	COc1ccc2ncc(C#N)c(Nc3ccc(Cl)cc3Cl)c2c1		CHEMBL166797	=	IC50	nM	320.0	CHEMBL267	Homo sapiens	IC50	nM	320.0
	684551	CHEMBL806337	Inhibition of Src Kinase at 1 uM	B	COc1cc2ncc(C#N)c(NC(=O)c3ccc(Cl)cc3Cl)c2cc1OC		CHEMBL168682	<	Inhibition	%	20.0	CHEMBL267	Homo sapiens	Inhibition	%	20.0
	685843	CHEMBL807315	Inhibition of Src Kinase at 1 uM	B	COc1cc2ncc(C(N)=O)c(Nc3ccc(Cl)cc3Cl)c2cc1OC		CHEMBL355505	<	Inhibition	%	20.0	CHEMBL267	Homo sapiens	Inhibition	%	20.0
	685844	CHEMBL807314	Inhibitory activity against human c-Src Kinase was measured using ELISA assay	B	COc1cc2ncc(C#N)c(Nc3ccc(Cl)cc3Cl)c2cc1OCCCN1CCOCC1		CHEMBL349065	=	IC50	nM	220.0	CHEMBL267	Homo sapiens	IC50	nM	220.0
	685845	CHEMBL783717	Inhibition of Src-transformed rat fibroblast proliferation in anchorage independent assay	F	COc1cc2ncc(C#N)c(Nc3ccc(Cl)cc3Cl)c2cc1OCCCN1CCOCC1		CHEMBL349065	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	688055	CHEMBL805363	Affinity for Src protein tyrosine kinase	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](C)c1nc(Cc2ccc(C(F)(F)F)cc2)no1		CHEMBL103838	=	IC50	nM	72000.0	CHEMBL267	Homo sapiens	IC50	uM	72.0
	689907	CHEMBL807314	Inhibitory activity against human c-Src Kinase was measured using ELISA assay	B	COc1cc2ncc(C#N)c(Nc3cc(Cl)cc(Cl)c3)c2cc1OC		CHEMBL166503	=	IC50	nM	1100.0	CHEMBL267	Homo sapiens	IC50	nM	1100.0
	692363	CHEMBL806337	Inhibition of Src Kinase at 1 uM	B	COc1cc2ncc(C#N)c(Oc3ccc(Cl)cc3Cl)c2cc1OC		CHEMBL170326	=	Inhibition	%	37.0	CHEMBL267	Homo sapiens	Inhibition	%	37.0
	692364	CHEMBL807314	Inhibitory activity against human c-Src Kinase was measured using ELISA assay	B	COc1cc2ncc(C=O)c(Nc3ccc(Cl)cc3Cl)c2cc1OC		CHEMBL166848	=	IC50	nM	250.0	CHEMBL267	Homo sapiens	IC50	nM	250.0
	692365	CHEMBL807314	Inhibitory activity against human c-Src Kinase was measured using ELISA assay	B	Cc1ccc(N2CN(C(C)(C)C)c3[nH]ncc3C2=N)cc1		CHEMBL166390	=	IC50	nM	35.0	CHEMBL267	Homo sapiens	IC50	nM	35.0
	694338	CHEMBL805363	Affinity for Src protein tyrosine kinase	B	C[C@H](NC(=O)[C@@H](CC(=O)O)Cc1ccc(OP(=O)(O)O)cc1)c1nc(Cc2ccc(C(F)(F)F)cc2)no1	Outside typical range	CHEMBL419539	=	IC50	nM	102000.0	CHEMBL267	Homo sapiens	IC50	uM	102.0
	696385	CHEMBL807315	Inhibition of Src Kinase at 1 uM	B	COc1cc2/c(=N/c3ccc(Cl)cc3Cl)c(C#N)cn(C)c2cc1OC		CHEMBL355850	<	Inhibition	%	20.0	CHEMBL267	Homo sapiens	Inhibition	%	20.0
	696386	CHEMBL806412	Inhibition of Src Kinase at 1 uM	B	COc1cc2ncc(CO)c(Nc3ccc(Cl)cc3Cl)c2cc1OC		CHEMBL355347	<	Inhibition	%	20.0	CHEMBL267	Homo sapiens	Inhibition	%	20.0
	696387	CHEMBL807314	Inhibitory activity against human c-Src Kinase was measured using ELISA assay	B	COc1cc2ncc(C#N)c(Nc3ccc(I)cc3Cl)c2cc1OC		CHEMBL165464	=	IC50	nM	95.0	CHEMBL267	Homo sapiens	IC50	nM	95.0
	698927	CHEMBL805363	Affinity for Src protein tyrosine kinase	B	C[C@H](NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)CS(=O)(=O)C(C)(C)C)c1nc(Cc2ccc(C(F)(F)F)cc2)no1	Outside typical range	CHEMBL320372	=	IC50	nM	205000.0	CHEMBL267	Homo sapiens	IC50	uM	205.0
	699457	CHEMBL806337	Inhibition of Src Kinase at 1 uM	B	COc1cc2ncc(C#N)c(CNc3ccc(Cl)cc3Cl)c2cc1OC		CHEMBL353457	=	Inhibition	%	24.0	CHEMBL267	Homo sapiens	Inhibition	%	24.0
	703080	CHEMBL807314	Inhibitory activity against human c-Src Kinase was measured using ELISA assay	B	CCOc1cc2ncc(C#N)c(Nc3ccc(Cl)cc3Cl)c2cc1OCC		CHEMBL168319	=	IC50	nM	11.0	CHEMBL267	Homo sapiens	IC50	nM	11.0
	703081	CHEMBL807314	Inhibitory activity against human c-Src Kinase was measured using ELISA assay	B	COc1cc2ncc(C#N)c(Nc3cc(Cl)ccc3Cl)c2cc1OC		CHEMBL424359	=	IC50	nM	40.0	CHEMBL267	Homo sapiens	IC50	nM	40.0
	704087	CHEMBL805363	Affinity for Src protein tyrosine kinase	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CO)c1nc(Cc2ccc(Cl)c(Cl)c2)no1		CHEMBL316967	=	IC50	nM	75000.0	CHEMBL267	Homo sapiens	IC50	uM	75.0
	704477	CHEMBL807314	Inhibitory activity against human c-Src Kinase was measured using ELISA assay	B	COc1cc2nccc(Nc3ccc(Cl)cc3Cl)c2cc1OC		CHEMBL128858	=	IC50	nM	84.0	CHEMBL267	Homo sapiens	IC50	nM	84.0
	704478	CHEMBL806337	Inhibition of Src Kinase at 1 uM	B	COc1cc2ncc(C#N)c(N(C)c3ccc(Cl)cc3Cl)c2cc1OC		CHEMBL166972	=	Inhibition	%	32.0	CHEMBL267	Homo sapiens	Inhibition	%	32.0
	704479	CHEMBL807314	Inhibitory activity against human c-Src Kinase was measured using ELISA assay	B	COc1cc2ncc(C#N)c(Nc3ccccc3Cl)c2cc1OC		CHEMBL168955	=	IC50	nM	95.0	CHEMBL267	Homo sapiens	IC50	nM	95.0
	705706	CHEMBL807314	Inhibitory activity against human c-Src Kinase was measured using ELISA assay	B	COc1cc2ncc(C#N)c(Nc3ccc(Cl)cc3Br)c2cc1OC		CHEMBL168146	=	IC50	nM	10.0	CHEMBL267	Homo sapiens	IC50	nM	10.0
	707132	CHEMBL806412	Inhibition of Src Kinase at 1 uM	B	CCOC(=O)c1cnc2cc(OC)c(OC)cc2c1Nc1ccc(Cl)cc1Cl		CHEMBL166447	<	Inhibition	%	20.0	CHEMBL267	Homo sapiens	Inhibition	%	20.0
	707133	CHEMBL807314	Inhibitory activity against human c-Src Kinase was measured using ELISA assay	B	COc1cccc2ncc(C#N)c(Nc3ccc(Cl)cc3Cl)c12		CHEMBL355884	=	IC50	nM	1200.0	CHEMBL267	Homo sapiens	IC50	nM	1200.0
	707134	CHEMBL807315	Inhibition of Src Kinase at 1 uM	B	COc1cccc2c(Nc3ccc(Cl)cc3Cl)c(C#N)cnc12		CHEMBL166728	<	Inhibition	%	20.0	CHEMBL267	Homo sapiens	Inhibition	%	20.0
	707135	CHEMBL807314	Inhibitory activity against human c-Src Kinase was measured using ELISA assay	B	COc1cc2ncc(C#N)c(Nc3ccc(Cl)cc3)c2cc1OC		CHEMBL169851	=	IC50	nM	53.0	CHEMBL267	Homo sapiens	IC50	nM	53.0
	708356	CHEMBL807314	Inhibitory activity against human c-Src Kinase was measured using ELISA assay	B	COc1cc2ncc(C#N)c(Nc3ccc(Cl)c(Cl)c3)c2cc1OC		CHEMBL168835	=	IC50	nM	57.0	CHEMBL267	Homo sapiens	IC50	nM	57.0
	709788	CHEMBL807315	Inhibition of Src Kinase at 1 uM	B	COc1cc2ncc(C(=O)O)c(Nc3ccc(Cl)cc3Cl)c2cc1OC		CHEMBL355572	<	Inhibition	%	20.0	CHEMBL267	Homo sapiens	Inhibition	%	20.0
	711014	CHEMBL807315	Inhibition of Src Kinase at 1 uM	B	COc1cc(OC)c2c(Nc3ccc(Cl)cc3Cl)c(C#N)cnc2c1		CHEMBL166457	=	Inhibition	%	52.0	CHEMBL267	Homo sapiens	Inhibition	%	52.0
	711015	CHEMBL807314	Inhibitory activity against human c-Src Kinase was measured using ELISA assay	B	COc1cc2ncc(C#N)c(Nc3cccc(Cl)c3Cl)c2cc1OC		CHEMBL445843	=	IC50	nM	90.0	CHEMBL267	Homo sapiens	IC50	nM	90.0
	711016	CHEMBL807314	Inhibitory activity against human c-Src Kinase was measured using ELISA assay	B	COc1cc2c(Nc3ccc(Cl)cc3Cl)c(C#N)cnc2cc1OCCCN1CCC(O)CC1		CHEMBL354289	=	IC50	nM	3.5	CHEMBL267	Homo sapiens	IC50	nM	3.5
	711017	CHEMBL783717	Inhibition of Src-transformed rat fibroblast proliferation in anchorage independent assay	F	COc1cc2c(Nc3ccc(Cl)cc3Cl)c(C#N)cnc2cc1OCCCN1CCC(O)CC1		CHEMBL354289	=	IC50	nM	1400.0	CHEMBL267	Homo sapiens	IC50	uM	1.4
	713546	CHEMBL807314	Inhibitory activity against human c-Src Kinase was measured using ELISA assay	B	CCCCOc1cc2ncc(C#N)c(Nc3ccc(Cl)cc3Cl)c2cc1OCCCC		CHEMBL166611	=	IC50	nM	160.0	CHEMBL267	Homo sapiens	IC50	nM	160.0
	713547	CHEMBL807314	Inhibitory activity against human c-Src Kinase was measured using ELISA assay	B	COc1cc2ncc(C#N)c(Nc3ccc(Cl)cc3F)c2cc1OC		CHEMBL111664	=	IC50	nM	53.0	CHEMBL267	Homo sapiens	IC50	nM	53.0
	714087	CHEMBL805371	Inhibitory activity against Src protein tyrosine kinase	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCCN1CCN(C)CC1)CCCC3)C(=O)N2		CHEMBL293712	=	IC50	nM	70.0	CHEMBL267	Homo sapiens	IC50	uM	0.07
	714094	CHEMBL805372	Inhibitory activity against cellular Src protein tyrosine kinase using the actin ring assay	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCCN1CCN(C)CC1)CCCC3)C(=O)N2		CHEMBL293712	=	IC50	nM	100.0	CHEMBL267	Homo sapiens	IC50	uM	0.1
	714095	CHEMBL805371	Inhibitory activity against Src protein tyrosine kinase	B	CCOC(=O)CN1CCN(CCCc2c(/C=C3\C(=O)Nc4ccc(S(=O)(=O)NC)cc43)[nH]c3c2CCCC3)CC1		CHEMBL291759	=	IC50	nM	70.0	CHEMBL267	Homo sapiens	IC50	uM	0.07
	714102	CHEMBL805372	Inhibitory activity against cellular Src protein tyrosine kinase using the actin ring assay	B	CCOC(=O)CN1CCN(CCCc2c(/C=C3\C(=O)Nc4ccc(S(=O)(=O)NC)cc43)[nH]c3c2CCCC3)CC1		CHEMBL291759	=	IC50	nM	900.0	CHEMBL267	Homo sapiens	IC50	uM	0.9
	715265	CHEMBL805371	Inhibitory activity against Src protein tyrosine kinase	B	CN(C)CCCc1c(/C=C2\C(=O)Nc3ccc(-c4ccccc4)cc32)[nH]c2c1CCCC2		CHEMBL292929	=	IC50	nM	2300.0	CHEMBL267	Homo sapiens	IC50	uM	2.3
	716437	CHEMBL805371	Inhibitory activity against Src protein tyrosine kinase	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCCN1CCN(CCO)CC1)CCCC3)C(=O)N2		CHEMBL56109	=	IC50	nM	30.0	CHEMBL267	Homo sapiens	IC50	uM	0.03
	716444	CHEMBL805372	Inhibitory activity against cellular Src protein tyrosine kinase using the actin ring assay	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCCN1CCN(CCO)CC1)CCCC3)C(=O)N2		CHEMBL56109	=	IC50	nM	3000.0	CHEMBL267	Homo sapiens	IC50	uM	3.0
	717184	CHEMBL821536	Tested for inhibition of protein tyrosine kinase c-Src phosphorylation in intact cells	B	Nc1ncnc2c1c(-c1ccccc1)cn2-c1cccc(CNCCO)c1		CHEMBL176702	=	IC50	nM	4000.0	CHEMBL267	Homo sapiens	IC50	uM	4.0
	717794	CHEMBL805371	Inhibitory activity against Src protein tyrosine kinase	B	CN(C)CCCc1c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)C)cc32)[nH]c2c1CCCC2		CHEMBL300830	=	IC50	nM	2600.0	CHEMBL267	Homo sapiens	IC50	uM	2.6
	717795	CHEMBL805371	Inhibitory activity against Src protein tyrosine kinase	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCC(N)=O)CCCC3)C(=O)N2		CHEMBL56569	=	IC50	nM	30.0	CHEMBL267	Homo sapiens	IC50	uM	0.03
	717802	CHEMBL805372	Inhibitory activity against cellular Src protein tyrosine kinase using the actin ring assay	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCC(N)=O)CCCC3)C(=O)N2		CHEMBL56569	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	720109	CHEMBL805371	Inhibitory activity against Src protein tyrosine kinase	B	CNOC(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCCN(C)C)CCCC3)C(=O)N2		CHEMBL294619	=	IC50	nM	1100.0	CHEMBL267	Homo sapiens	IC50	uM	1.1
	721124	CHEMBL805371	Inhibitory activity against Src protein tyrosine kinase	B	CN(C)CCCc1c(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)[nH]c2c1CCCC2		CHEMBL56230	=	IC50	nM	600.0	CHEMBL267	Homo sapiens	IC50	uM	0.6
	721125	CHEMBL805371	Inhibitory activity against Src protein tyrosine kinase	B	CN(C)CCCc1c(/C=C2\C(=O)Nc3ccc(S(C)(=O)=O)cc32)[nH]c2c1CCCC2		CHEMBL59487	=	IC50	nM	300.0	CHEMBL267	Homo sapiens	IC50	uM	0.3
	721126	CHEMBL805371	Inhibitory activity against Src protein tyrosine kinase	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3ccccc3c1CCCN(C)C)C(=O)N2		CHEMBL300321	=	IC50	nM	200.0	CHEMBL267	Homo sapiens	IC50	uM	0.2
	721127	CHEMBL805371	Inhibitory activity against Src protein tyrosine kinase	B	CCS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCCN1CCOCC1)CCCC3)C(=O)N2		CHEMBL57863	=	IC50	nM	150.0	CHEMBL267	Homo sapiens	IC50	uM	0.15
	721128	CHEMBL805371	Inhibitory activity against Src protein tyrosine kinase	B	CCS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCCN1CCN(C(C)=O)CC1)CCCC3)C(=O)N2		CHEMBL59538	=	IC50	nM	400.0	CHEMBL267	Homo sapiens	IC50	uM	0.4
	722188	CHEMBL805371	Inhibitory activity against Src protein tyrosine kinase	B	CCS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCCN(C)C)CCCC3)C(=O)N2		CHEMBL59042	=	IC50	nM	60.0	CHEMBL267	Homo sapiens	IC50	uM	0.06
	722195	CHEMBL805372	Inhibitory activity against cellular Src protein tyrosine kinase using the actin ring assay	B	CCS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCCN(C)C)CCCC3)C(=O)N2		CHEMBL59042	=	IC50	nM	500.0	CHEMBL267	Homo sapiens	IC50	uM	0.5
	723377	CHEMBL805371	Inhibitory activity against Src protein tyrosine kinase	B	CN(C)CCCc1c(/C=C2\C(=O)Nc3ccc(C(=O)O)cc32)[nH]c2c1CCCC2		CHEMBL292819	=	IC50	nM	700.0	CHEMBL267	Homo sapiens	IC50	uM	0.7
	723378	CHEMBL805371	Inhibitory activity against Src protein tyrosine kinase	B	CCC(=O)N1CCN(CCCc2c(/C=C3\C(=O)Nc4ccc(S(=O)(=O)CC)cc43)[nH]c3c2CCCC3)CC1		CHEMBL294466	=	IC50	nM	800.0	CHEMBL267	Homo sapiens	IC50	uM	0.8
	724585	CHEMBL805371	Inhibitory activity against Src protein tyrosine kinase	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCCN1CCN(CC(=O)O)CC1)CCCC3)C(=O)N2		CHEMBL292930	=	IC50	nM	20.0	CHEMBL267	Homo sapiens	IC50	uM	0.02
	724592	CHEMBL805372	Inhibitory activity against cellular Src protein tyrosine kinase using the actin ring assay	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCCN1CCN(CC(=O)O)CC1)CCCC3)C(=O)N2		CHEMBL292930	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	725763	CHEMBL805371	Inhibitory activity against Src protein tyrosine kinase	B	CC(C)CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCCN(C)C)CCCC3)C(=O)N2		CHEMBL299724	=	IC50	nM	230.0	CHEMBL267	Homo sapiens	IC50	uM	0.23
	725764	CHEMBL805371	Inhibitory activity against Src protein tyrosine kinase	B	CN(C)CCCc1c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Nc4ccccc4Cl)cc32)[nH]c2c1CCCC2		CHEMBL56504	=	IC50	nM	300.0	CHEMBL267	Homo sapiens	IC50	uM	0.3
	727030	CHEMBL805371	Inhibitory activity against Src protein tyrosine kinase	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCCN1CCC(O)CC1)CCCC3)C(=O)N2		CHEMBL55496	=	IC50	nM	50.0	CHEMBL267	Homo sapiens	IC50	uM	0.05
	727037	CHEMBL805372	Inhibitory activity against cellular Src protein tyrosine kinase using the actin ring assay	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCCN1CCC(O)CC1)CCCC3)C(=O)N2		CHEMBL55496	=	IC50	nM	900.0	CHEMBL267	Homo sapiens	IC50	uM	0.9
	727658	CHEMBL821536	Tested for inhibition of protein tyrosine kinase c-Src phosphorylation in intact cells	B	COc1cccc(-c2cn(-c3ccccc3)c3ncnc(N)c23)c1		CHEMBL172973	=	IC50	nM	3300.0	CHEMBL267	Homo sapiens	IC50	uM	3.3
	727667	CHEMBL821536	Tested for inhibition of protein tyrosine kinase c-Src phosphorylation in intact cells	B	Nc1ncnc2c1c(-c1ccccc1)cn2-c1ccc(CNCCO)cc1		CHEMBL173453	=	IC50	nM	700.0	CHEMBL267	Homo sapiens	IC50	uM	0.7
	728277	CHEMBL805371	Inhibitory activity against Src protein tyrosine kinase	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCCN1CCNCC1)CCCC3)C(=O)N2		CHEMBL55410	=	IC50	nM	200.0	CHEMBL267	Homo sapiens	IC50	uM	0.2
	729440	CHEMBL805371	Inhibitory activity against Src protein tyrosine kinase	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCC(=O)N1CCN(C)CC1)CCCC3)C(=O)N2		CHEMBL291534	=	IC50	nM	300.0	CHEMBL267	Homo sapiens	IC50	uM	0.3
	729942	CHEMBL821536	Tested for inhibition of protein tyrosine kinase c-Src phosphorylation in intact cells	B	COc1cccc(-c2cn(-c3ccc(CCN(C)CCO)cc3)c3ncnc(N)c23)c1		CHEMBL105436	=	IC50	nM	200.0	CHEMBL267	Homo sapiens	IC50	uM	0.2
	731780	CHEMBL805371	Inhibitory activity against Src protein tyrosine kinase	B	COc1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCCN(C)C)CCCC3)C(=O)N2		CHEMBL293595	=	IC50	nM	1000.0	CHEMBL267	Homo sapiens	IC50	uM	1.0
	732853	CHEMBL805371	Inhibitory activity against Src protein tyrosine kinase	B	CCS(=O)(=O)Cc1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCCN(C)C)CCCC3)C(=O)N2		CHEMBL293334	=	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	732854	CHEMBL805371	Inhibitory activity against Src protein tyrosine kinase	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCCN1CCOCC1)CCCC3)C(=O)N2		CHEMBL296185	=	IC50	nM	60.0	CHEMBL267	Homo sapiens	IC50	uM	0.06
	732861	CHEMBL805372	Inhibitory activity against cellular Src protein tyrosine kinase using the actin ring assay	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCCN1CCOCC1)CCCC3)C(=O)N2		CHEMBL296185	=	IC50	nM	100.0	CHEMBL267	Homo sapiens	IC50	uM	0.1
	734134	CHEMBL805371	Inhibitory activity against Src protein tyrosine kinase	B	CN(C)CCCc1c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)NCCO)cc32)[nH]c2c1CCCC2		CHEMBL54574	=	IC50	nM	240.0	CHEMBL267	Homo sapiens	IC50	uM	0.24
	734135	CHEMBL805371	Inhibitory activity against Src protein tyrosine kinase	B	CCS(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL58882	=	IC50	nM	700.0	CHEMBL267	Homo sapiens	IC50	uM	0.7
	735346	CHEMBL805371	Inhibitory activity against Src protein tyrosine kinase	B	CC(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCCN(C)C)CCCC3)C(=O)N2		CHEMBL301676	=	IC50	nM	230.0	CHEMBL267	Homo sapiens	IC50	uM	0.23
	735347	CHEMBL805371	Inhibitory activity against Src protein tyrosine kinase	B	CCS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCCN1CCN(CC(=O)O)CC1)CCCC3)C(=O)N2		CHEMBL300853	=	IC50	nM	70.0	CHEMBL267	Homo sapiens	IC50	uM	0.07
	735354	CHEMBL805372	Inhibitory activity against cellular Src protein tyrosine kinase using the actin ring assay	B	CCS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCCN1CCN(CC(=O)O)CC1)CCCC3)C(=O)N2		CHEMBL300853	=	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	735355	CHEMBL805371	Inhibitory activity against Src protein tyrosine kinase	B	CCS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCCN1CCN(CCO)CC1)CCCC3)C(=O)N2		CHEMBL57143	=	IC50	nM	70.0	CHEMBL267	Homo sapiens	IC50	uM	0.07
	735362	CHEMBL805372	Inhibitory activity against cellular Src protein tyrosine kinase using the actin ring assay	B	CCS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCCN1CCN(CCO)CC1)CCCC3)C(=O)N2		CHEMBL57143	=	IC50	nM	1700.0	CHEMBL267	Homo sapiens	IC50	uM	1.7
	736002	CHEMBL821536	Tested for inhibition of protein tyrosine kinase c-Src phosphorylation in intact cells	B	COc1cccc(-c2cn(-c3ccc(CC(=O)NCCO)cc3)c3ncnc(N)c23)c1		CHEMBL175409	=	IC50	nM	3900.0	CHEMBL267	Homo sapiens	IC50	uM	3.9
	736685	CHEMBL805371	Inhibitory activity against Src protein tyrosine kinase	B	CCS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCCN1CCN(C(=O)CO)CC1)CCCC3)C(=O)N2		CHEMBL56454	=	IC50	nM	220.0	CHEMBL267	Homo sapiens	IC50	uM	0.22
	738127	CHEMBL805371	Inhibitory activity against Src protein tyrosine kinase	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCCN(C)C)CCCC3)C(=O)N2		CHEMBL52513	=	IC50	nM	100.0	CHEMBL267	Homo sapiens	IC50	uM	0.1
	738134	CHEMBL805372	Inhibitory activity against cellular Src protein tyrosine kinase using the actin ring assay	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCCN(C)C)CCCC3)C(=O)N2		CHEMBL52513	=	IC50	nM	100.0	CHEMBL267	Homo sapiens	IC50	uM	0.1
	739279	CHEMBL805371	Inhibitory activity against Src protein tyrosine kinase	B	CCS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCCN1CCN(C)CC1)CCCC3)C(=O)N2		CHEMBL54283	=	IC50	nM	210.0	CHEMBL267	Homo sapiens	IC50	uM	0.21
	739286	CHEMBL805372	Inhibitory activity against cellular Src protein tyrosine kinase using the actin ring assay	B	CCS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCCN1CCN(C)CC1)CCCC3)C(=O)N2		CHEMBL54283	=	IC50	nM	200.0	CHEMBL267	Homo sapiens	IC50	uM	0.2
	739287	CHEMBL805371	Inhibitory activity against Src protein tyrosine kinase	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCCN1CCN(C(=O)CO)CC1)CCCC3)C(=O)N2		CHEMBL291914	=	IC50	nM	400.0	CHEMBL267	Homo sapiens	IC50	uM	0.4
	740506	CHEMBL823439	Inhibition of c-Src tyrosine kinase	F	CCN(CC)CC(O)CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL433520	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	740623	CHEMBL805371	Inhibitory activity against Src protein tyrosine kinase	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL417764	=	IC50	nM	2100.0	CHEMBL267	Homo sapiens	IC50	uM	2.1
	740624	CHEMBL805371	Inhibitory activity against Src protein tyrosine kinase	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCCN1CCN(C(C)=O)CC1)CCCC3)C(=O)N2		CHEMBL293319	=	IC50	nM	300.0	CHEMBL267	Homo sapiens	IC50	uM	0.3
	741244	CHEMBL821536	Tested for inhibition of protein tyrosine kinase c-Src phosphorylation in intact cells	B	COc1cccc(-c2cn(-c3ccc(CNCCO)cc3)c3ncnc(N)c23)c1		CHEMBL424375	=	IC50	nM	500.0	CHEMBL267	Homo sapiens	IC50	uM	0.5
	742612	CHEMBL821536	Tested for inhibition of protein tyrosine kinase c-Src phosphorylation in intact cells	B	Nc1ncnc2c1c(-c1ccccc1)cn2-c1cccc(CO)c1		CHEMBL173478	>	IC50	nM	5000.0	CHEMBL267	Homo sapiens	IC50	uM	5.0
	743310	CHEMBL805371	Inhibitory activity against Src protein tyrosine kinase	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c(C)c(C)c1CCCN(C)C)C(=O)N2		CHEMBL56645	=	IC50	nM	1000.0	CHEMBL267	Homo sapiens	IC50	uM	1.0
	744620	CHEMBL805371	Inhibitory activity against Src protein tyrosine kinase	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CN1CCOCC1)CCCC3)C(=O)N2		CHEMBL301143	=	IC50	nM	10.0	CHEMBL267	Homo sapiens	IC50	uM	0.01
	744627	CHEMBL805372	Inhibitory activity against cellular Src protein tyrosine kinase using the actin ring assay	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CN1CCOCC1)CCCC3)C(=O)N2		CHEMBL301143	=	IC50	nM	1000.0	CHEMBL267	Homo sapiens	IC50	uM	1.0
	744628	CHEMBL805371	Inhibitory activity against Src protein tyrosine kinase	B	CCS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCC(=O)N1CCN(C)CC1)CCCC3)C(=O)N2		CHEMBL294668	=	IC50	nM	500.0	CHEMBL267	Homo sapiens	IC50	uM	0.5
	745967	CHEMBL805371	Inhibitory activity against Src protein tyrosine kinase	B	CN(C)CCCc1c(/C=C2\C(=O)Nc3ccc(F)cc32)[nH]c2c1CCCC2		CHEMBL301663	=	IC50	nM	500.0	CHEMBL267	Homo sapiens	IC50	uM	0.5
	745968	CHEMBL805371	Inhibitory activity against Src protein tyrosine kinase	B	CCS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCCN1CCC(O)CC1)CCCC3)C(=O)N2		CHEMBL298566	=	IC50	nM	70.0	CHEMBL267	Homo sapiens	IC50	uM	0.07
	745975	CHEMBL805372	Inhibitory activity against cellular Src protein tyrosine kinase using the actin ring assay	B	CCS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCCN1CCC(O)CC1)CCCC3)C(=O)N2		CHEMBL298566	=	IC50	nM	800.0	CHEMBL267	Homo sapiens	IC50	uM	0.8
	746481	CHEMBL821536	Tested for inhibition of protein tyrosine kinase c-Src phosphorylation in intact cells	B	Nc1ncnc2c1c(-c1ccccc1)cn2-c1ccccc1		CHEMBL169757	=	IC50	nM	3500.0	CHEMBL267	Homo sapiens	IC50	uM	3.5
	747194	CHEMBL805371	Inhibitory activity against Src protein tyrosine kinase	B	CCS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCC(=O)O)CCCC3)C(=O)N2		CHEMBL294375	=	IC50	nM	400.0	CHEMBL267	Homo sapiens	IC50	uM	0.4
	748511	CHEMBL805371	Inhibitory activity against Src protein tyrosine kinase	B	CCC(=O)N1CCN(CCCc2c(/C=C3\C(=O)Nc4ccc(S(=O)(=O)NC)cc43)[nH]c3c2CCCC3)CC1		CHEMBL57467	=	IC50	nM	300.0	CHEMBL267	Homo sapiens	IC50	uM	0.3
	749664	CHEMBL805371	Inhibitory activity against Src protein tyrosine kinase	B	CCS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CN1CCOCC1)CCCC3)C(=O)N2		CHEMBL55594	=	IC50	nM	70.0	CHEMBL267	Homo sapiens	IC50	uM	0.07
	749671	CHEMBL805372	Inhibitory activity against cellular Src protein tyrosine kinase using the actin ring assay	B	CCS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CN1CCOCC1)CCCC3)C(=O)N2		CHEMBL55594	=	IC50	nM	5000.0	CHEMBL267	Homo sapiens	IC50	uM	5.0
	750878	CHEMBL805371	Inhibitory activity against Src protein tyrosine kinase	B	CN(C)CCCc1c(/C=C2\C(=O)Nc3ccccc32)[nH]c2c1CCCC2		CHEMBL418274	=	IC50	nM	3300.0	CHEMBL267	Homo sapiens	IC50	uM	3.3
	752020	CHEMBL823438	Inhibition of c-Src tyrosine kinase	B	CN(C)CCNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL162034	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	752108	CHEMBL805371	Inhibitory activity against Src protein tyrosine kinase	B	CN(C)CCCc1c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)NCc4ccc(F)cc4)cc32)[nH]c2c1CCCC2		CHEMBL301863	=	IC50	nM	1200.0	CHEMBL267	Homo sapiens	IC50	uM	1.2
	752109	CHEMBL805371	Inhibitory activity against Src protein tyrosine kinase	B	CCS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCC(N)=O)CCCC3)C(=O)N2		CHEMBL301271	=	IC50	nM	40.0	CHEMBL267	Homo sapiens	IC50	uM	0.04
	752115	CHEMBL805372	Inhibitory activity against cellular Src protein tyrosine kinase using the actin ring assay	B	CCS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCC(N)=O)CCCC3)C(=O)N2		CHEMBL301271	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	753177	CHEMBL823438	Inhibition of c-Src tyrosine kinase	B	Brc1cccc(Nc2ncnc3cnc(NCCN4CCOCC4)cc23)c1		CHEMBL162622	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	753761	CHEMBL808041	Binding affinity was determined on Src protein tyrosine kinase SH2 domain using fluorescence polarization assay with 2% DMSO in buffer solution	B	COc1ccc(C2Sc3ccccc3N(CC(=O)NCc3cccc4ccccc34)C(=O)C2NC(=O)CCc2ccc(OP(=O)(O)OCc3ccccc3)cc2)cc1	Outside typical range	CHEMBL304745	=	IC50	nM	339000.0	CHEMBL267	Homo sapiens	IC50	uM	339.0
	754703	CHEMBL808041	Binding affinity was determined on Src protein tyrosine kinase SH2 domain using fluorescence polarization assay with 2% DMSO in buffer solution	B	COc1ccc(C2Sc3ccccc3N(CCCC3CCCCC3)C(=O)C2NC(=O)[C@H](Cc2ccc(OP(=O)(O)OCc3ccccc3)cc2)NC(=O)OC(C)(C)C)cc1		CHEMBL65844	=	IC50	nM	6400.0	CHEMBL267	Homo sapiens	IC50	uM	6.4
	754704	CHEMBL808042	Binding affinity for Src protein tyrosine kinase SH2 domain using fluorescence polarization assay with 20% DMSO in buffer solution	B	COc1ccc(C2Sc3ccccc3N(CCCC3CCCCC3)C(=O)C2NC(=O)[C@H](Cc2ccc(OP(=O)(O)OCc3ccccc3)cc2)NC(=O)OC(C)(C)C)cc1		CHEMBL65844	=	IC50	nM	28000.0	CHEMBL267	Homo sapiens	IC50	uM	28.0
	754705	CHEMBL808039	Binding affinity for Src protein tyrosine kinase SH2 domain	B	COc1ccc(C2Sc3ccccc3N(CCCC3CCCCC3)C(=O)C2NC(=O)[C@H](Cc2ccc(OP(=O)(O)OCc3ccccc3)cc2)NC(=O)OC(C)(C)C)cc1		CHEMBL65844	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	754706	CHEMBL808041	Binding affinity was determined on Src protein tyrosine kinase SH2 domain using fluorescence polarization assay with 2% DMSO in buffer solution	B	CC(C)(C)OC(=O)N[C@@H](Cc1ccc(OP(=O)(O)OCc2ccccc2)cc1)C(=O)NC1CSc2ccccc2N(CCCC2CCCCC2)C1=O		CHEMBL430262	=	IC50	nM	26000.0	CHEMBL267	Homo sapiens	IC50	uM	26.0
	754707	CHEMBL808042	Binding affinity for Src protein tyrosine kinase SH2 domain using fluorescence polarization assay with 20% DMSO in buffer solution	B	CC(C)(C)OC(=O)N[C@@H](Cc1ccc(OP(=O)(O)OCc2ccccc2)cc1)C(=O)NC1CSc2ccccc2N(CCCC2CCCCC2)C1=O		CHEMBL430262	=	IC50	nM	87000.0	CHEMBL267	Homo sapiens	IC50	uM	87.0
	754708	CHEMBL808039	Binding affinity for Src protein tyrosine kinase SH2 domain	B	CC(C)(C)OC(=O)N[C@@H](Cc1ccc(OP(=O)(O)OCc2ccccc2)cc1)C(=O)NC1CSc2ccccc2N(CCCC2CCCCC2)C1=O		CHEMBL430262	=	IC50	nM	13000.0	CHEMBL267	Homo sapiens	IC50	uM	13.0
	755866	CHEMBL808041	Binding affinity was determined on Src protein tyrosine kinase SH2 domain using fluorescence polarization assay with 2% DMSO in buffer solution	B	COc1ccc(C2Sc3ccccc3N(CC(=O)Nc3cccc4ccccc34)C(=O)C2NC(=O)[C@H](Cc2ccc(OP(=O)(O)OCc3ccccc3)cc2)NC(=O)OC(C)(C)C)cc1		CHEMBL302113	=	IC50	nM	26000.0	CHEMBL267	Homo sapiens	IC50	uM	26.0
	756049	CHEMBL844768	Incorporation of 32P into phosphopeptide product (3 mM) in pp60c-src phosphorylation assay	B	CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCCN=C(N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)O		CHEMBL412066	=	CPM x1000		80.3	CHEMBL267	Homo sapiens	CPM x1000		80.3
Not Determined	756050	CHEMBL857270	Michaelis-Menten (Km) constant for peptide phosphorylation by pp60src (Not tested)	F	CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCCN=C(N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)O		CHEMBL412066		Km	nM		CHEMBL267	Homo sapiens	Km	uM	
Not Determined	756051	CHEMBL639173	Maximum enzyme velocity(Vmax) of peptide phosphorylation by pp60src (Not tested)	F	CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCCN=C(N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)O		CHEMBL412066		Vmax			CHEMBL267	Homo sapiens	Vmax	uM min-1mg-1	
	756957	CHEMBL808041	Binding affinity was determined on Src protein tyrosine kinase SH2 domain using fluorescence polarization assay with 2% DMSO in buffer solution	B	COc1ccc(C2Sc3ccccc3N(CC(=O)NCc3cccc4ccccc34)C(=O)C2NC(=O)[C@H](Cc2ccc(OP(=O)(O)OCc3ccccc3)cc2)NC(=O)OC(C)(C)C)cc1	Outside typical range	CHEMBL67271	=	IC50	nM	118000.0	CHEMBL267	Homo sapiens	IC50	uM	118.0
	758361	CHEMBL844768	Incorporation of 32P into phosphopeptide product (3 mM) in pp60c-src phosphorylation assay	B	CC(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(N)=O)[C@@H](C)O		CHEMBL133246	=	CPM x1000		89.5	CHEMBL267	Homo sapiens	CPM x1000		89.5
	758362	CHEMBL844767	Incorporation of 32P into phosphopeptide product (1 mM) in pp60c-src phosphorylation assay	B	CC(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(N)=O)[C@@H](C)O		CHEMBL133246	=	CPM x1000		63.5	CHEMBL267	Homo sapiens	CPM x1000		63.5
Not Determined	758363	CHEMBL857270	Michaelis-Menten (Km) constant for peptide phosphorylation by pp60src (Not tested)	F	CC(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(N)=O)[C@@H](C)O		CHEMBL133246		Km	nM		CHEMBL267	Homo sapiens	Km	uM	
Not Determined	758364	CHEMBL639173	Maximum enzyme velocity(Vmax) of peptide phosphorylation by pp60src (Not tested)	F	CC(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(N)=O)[C@@H](C)O		CHEMBL133246		Vmax			CHEMBL267	Homo sapiens	Vmax	uM min-1mg-1	
	759177	CHEMBL808041	Binding affinity was determined on Src protein tyrosine kinase SH2 domain using fluorescence polarization assay with 2% DMSO in buffer solution	B	CC(C)(C)OC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)NC1CSc2ccccc2N(CCCC2CCCCC2)C1=O		CHEMBL67529	=	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	759178	CHEMBL808042	Binding affinity for Src protein tyrosine kinase SH2 domain using fluorescence polarization assay with 20% DMSO in buffer solution	B	CC(C)(C)OC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)NC1CSc2ccccc2N(CCCC2CCCCC2)C1=O		CHEMBL67529	=	IC50	nM	11000.0	CHEMBL267	Homo sapiens	IC50	uM	11.0
	759179	CHEMBL808039	Binding affinity for Src protein tyrosine kinase SH2 domain	B	CC(C)(C)OC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)NC1CSc2ccccc2N(CCCC2CCCCC2)C1=O		CHEMBL67529	=	IC50	nM	1000.0	CHEMBL267	Homo sapiens	IC50	uM	1.0
	760247	CHEMBL808041	Binding affinity was determined on Src protein tyrosine kinase SH2 domain using fluorescence polarization assay with 2% DMSO in buffer solution	B	CC(C)(C)OC(=O)N[C@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)NC1CSc2ccccc2N(CCCC2CCCCC2)C1=O	Outside typical range	CHEMBL66442	=	IC50	nM	422000.0	CHEMBL267	Homo sapiens	IC50	uM	422.0
Not Determined	760248	CHEMBL808043	Binding affinity for Src protein tyrosine kinase SH2 domain using fluorescence polarization assay with 20% DMSO in buffer solution (Not determined)	B	CC(C)(C)OC(=O)N[C@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)NC1CSc2ccccc2N(CCCC2CCCCC2)C1=O		CHEMBL66442		IC50	nM		CHEMBL267	Homo sapiens	IC50	uM	
	760249	CHEMBL808039	Binding affinity for Src protein tyrosine kinase SH2 domain	B	CC(C)(C)OC(=O)N[C@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)NC1CSc2ccccc2N(CCCC2CCCCC2)C1=O		CHEMBL66442	=	IC50	nM	18000.0	CHEMBL267	Homo sapiens	IC50	uM	18.0
	761382	CHEMBL808041	Binding affinity was determined on Src protein tyrosine kinase SH2 domain using fluorescence polarization assay with 2% DMSO in buffer solution	B	COc1ccc(C2Sc3ccccc3N(CC(=O)NCc3cccc4ccccc34)C(=O)C2NC(=O)[C@H](Cc2ccc(OP(=O)(O)OCc3ccccc3)cc2)NC(=O)OC(C)(C)C)cc1	Outside typical range	CHEMBL67271	=	IC50	nM	128000.0	CHEMBL267	Homo sapiens	IC50	uM	128.0
	761383	CHEMBL808041	Binding affinity was determined on Src protein tyrosine kinase SH2 domain using fluorescence polarization assay with 2% DMSO in buffer solution	B	COc1ccc(C2Sc3ccccc3N(C(C(=O)Nc3cccc4ccccc34)c3ccccc3)C(=O)C2NC(=O)[C@H](Cc2ccc(OP(=O)(O)OCc3ccccc3)cc2)NC(=O)OC(C)(C)C)cc1		CHEMBL409181	=	IC50	nM	23000.0	CHEMBL267	Homo sapiens	IC50	uM	23.0
	761384	CHEMBL808041	Binding affinity was determined on Src protein tyrosine kinase SH2 domain using fluorescence polarization assay with 2% DMSO in buffer solution	B	COC(=O)c1cccc(CN2CCSC[C@H](NC(=O)[C@H](Cc3ccc(OP(=O)(O)O)cc3)NC(C)=O)C2=O)c1		CHEMBL410119	=	IC50	nM	130.0	CHEMBL267	Homo sapiens	IC50	uM	0.13
	764545	CHEMBL808041	Binding affinity was determined on Src protein tyrosine kinase SH2 domain using fluorescence polarization assay with 2% DMSO in buffer solution	B	COc1ccc(C2Sc3ccccc3N(Cc3ccccc3)C(=O)C2NC(=O)[C@H](Cc2ccc(OP(=O)(O)OCc3ccccc3)cc2)NC(=O)OC(C)(C)C)cc1		CHEMBL304746	=	IC50	nM	46000.0	CHEMBL267	Homo sapiens	IC50	uM	46.0
	764546	CHEMBL808041	Binding affinity was determined on Src protein tyrosine kinase SH2 domain using fluorescence polarization assay with 2% DMSO in buffer solution	B	COc1ccc(C2Sc3ccccc3N(CC(=O)Nc3ccc(Oc4ccccc4)cc3)C(=O)C2NC(=O)[C@H](Cc2ccc(OP(=O)(O)OCc3ccccc3)cc2)NC(=O)OC(C)(C)C)cc1		CHEMBL66127	=	IC50	nM	29000.0	CHEMBL267	Homo sapiens	IC50	uM	29.0
	764547	CHEMBL808041	Binding affinity was determined on Src protein tyrosine kinase SH2 domain using fluorescence polarization assay with 2% DMSO in buffer solution	B	COc1ccc(C2Sc3ccccc3N(CC(=O)Nc3cccc4ccccc34)C(=O)C2NC(=O)[C@H](Cc2ccc(OP(=O)(O)OCc3ccccc3)cc2)NC(=O)OC(C)(C)C)cc1	Outside typical range	CHEMBL302113	=	IC50	nM	133000.0	CHEMBL267	Homo sapiens	IC50	uM	133.0
	765703	CHEMBL808041	Binding affinity was determined on Src protein tyrosine kinase SH2 domain using fluorescence polarization assay with 2% DMSO in buffer solution	B	COc1ccc(C2Sc3ccccc3N(CC(=O)Nc3ccccc3OC)C(=O)C2NC(=O)[C@H](Cc2ccc(OP(=O)(O)OCc3ccccc3)cc2)NC(=O)OC(C)(C)C)cc1		CHEMBL306146	=	IC50	nM	95000.0	CHEMBL267	Homo sapiens	IC50	uM	95.0
	766736	CHEMBL808041	Binding affinity was determined on Src protein tyrosine kinase SH2 domain using fluorescence polarization assay with 2% DMSO in buffer solution	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@H]1CSCCN(Cc2ccc3c(c2Cl)OCO3)C1=O		CHEMBL66294	=	IC50	nM	1200.0	CHEMBL267	Homo sapiens	IC50	uM	1.2
	767788	CHEMBL808041	Binding affinity was determined on Src protein tyrosine kinase SH2 domain using fluorescence polarization assay with 2% DMSO in buffer solution	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@H]1CSCCN(CC(=O)c2ccc(N(C)C)cc2)C1=O		CHEMBL63752	=	IC50	nM	9300.0	CHEMBL267	Homo sapiens	IC50	uM	9.3
	767789	CHEMBL808041	Binding affinity was determined on Src protein tyrosine kinase SH2 domain using fluorescence polarization assay with 2% DMSO in buffer solution	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@H]1CSCCN(Cc2cccc(-c3ccccc3C#N)c2)C1=O		CHEMBL304304	=	IC50	nM	300.0	CHEMBL267	Homo sapiens	IC50	uM	0.3
	769060	CHEMBL808041	Binding affinity was determined on Src protein tyrosine kinase SH2 domain using fluorescence polarization assay with 2% DMSO in buffer solution	B	COc1ccc(C2Sc3ccccc3N(CC(=O)NCc3cccc4ccccc34)C(=O)C2NC(=O)c2cc3cc(OP(=O)(O)OCc4ccccc4)ccc3[nH]2)cc1		CHEMBL67608	=	IC50	nM	32000.0	CHEMBL267	Homo sapiens	IC50	uM	32.0
	771361	CHEMBL844768	Incorporation of 32P into phosphopeptide product (3 mM) in pp60c-src phosphorylation assay	B	CC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(N)=O		CHEMBL135629	=	CPM x1000		23.5	CHEMBL267	Homo sapiens	CPM x1000		23.5
Not Determined	771362	CHEMBL857270	Michaelis-Menten (Km) constant for peptide phosphorylation by pp60src (Not tested)	F	CC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(N)=O		CHEMBL135629		Km	nM		CHEMBL267	Homo sapiens	Km	uM	
Not Determined	771363	CHEMBL639173	Maximum enzyme velocity(Vmax) of peptide phosphorylation by pp60src (Not tested)	F	CC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(N)=O		CHEMBL135629		Vmax			CHEMBL267	Homo sapiens	Vmax	uM min-1mg-1	
	772305	CHEMBL808041	Binding affinity was determined on Src protein tyrosine kinase SH2 domain using fluorescence polarization assay with 2% DMSO in buffer solution	B	COc1ccc(C2Sc3ccccc3N(CC(=O)NCc3cccc4ccccc34)C(=O)C2NC(=O)c2ccc3c(Cl)c(OP(=O)(O)OCc4ccccc4)ccc3c2)cc1		CHEMBL279193	=	IC50	nM	27000.0	CHEMBL267	Homo sapiens	IC50	uM	27.0
	772306	CHEMBL808041	Binding affinity was determined on Src protein tyrosine kinase SH2 domain using fluorescence polarization assay with 2% DMSO in buffer solution	B	COc1ccc(C2Sc3ccccc3N(CC(=O)Nc3cccc4ccccc34)C(=O)C2NC(=O)[C@H](Cc2ccc(OP(=O)(O)OCc3ccccc3)cc2)NC(=O)OC(C)(C)C)cc1		CHEMBL302113	=	IC50	nM	23000.0	CHEMBL267	Homo sapiens	IC50	uM	23.0
	772307	CHEMBL808041	Binding affinity was determined on Src protein tyrosine kinase SH2 domain using fluorescence polarization assay with 2% DMSO in buffer solution	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@H]1CSCCN(Cc2ccc(-c3ccccc3)cc2)C1=O		CHEMBL24482	=	IC50	nM	90.0	CHEMBL267	Homo sapiens	IC50	uM	0.09
	773724	CHEMBL844767	Incorporation of 32P into phosphopeptide product (1 mM) in pp60c-src phosphorylation assay	B	CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(C)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O		CHEMBL1790987	=	CPM x1000		402.6	CHEMBL267	Homo sapiens	CPM x1000		402.6
	773725	CHEMBL630683	Michaelis-Menten (Km) constant for peptide phosphorylation by pp60src	B	CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(C)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O		CHEMBL1790987	=	Km	nM	880000.0	CHEMBL267	Homo sapiens	Km	uM	880.0
	773726	CHEMBL639172	Maximum enzyme velocity(Vmax) of peptide phosphorylation by pp60src	B	CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(C)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O		CHEMBL1790987	=	Vmax	uM min-1mg-1	1.86	CHEMBL267	Homo sapiens	Vmax	uM min-1mg-1	1.86
	774720	CHEMBL808041	Binding affinity was determined on Src protein tyrosine kinase SH2 domain using fluorescence polarization assay with 2% DMSO in buffer solution	B	COc1ccc(C2Sc3ccccc3N(CCCC3CCCCC3)C(=O)C2NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)OC(C)(C)C)cc1		CHEMBL304340	=	IC50	nM	20000.0	CHEMBL267	Homo sapiens	IC50	uM	20.0
	774721	CHEMBL808042	Binding affinity for Src protein tyrosine kinase SH2 domain using fluorescence polarization assay with 20% DMSO in buffer solution	B	COc1ccc(C2Sc3ccccc3N(CCCC3CCCCC3)C(=O)C2NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)OC(C)(C)C)cc1	Outside typical range	CHEMBL304340	=	IC50	nM	164000.0	CHEMBL267	Homo sapiens	IC50	uM	164.0
Not Determined	774722	CHEMBL808040	Binding affinity for Src protein tyrosine kinase SH2 domain (Not determined)	B	COc1ccc(C2Sc3ccccc3N(CCCC3CCCCC3)C(=O)C2NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)OC(C)(C)C)cc1		CHEMBL304340		IC50	nM		CHEMBL267	Homo sapiens	IC50	uM	
	775893	CHEMBL808041	Binding affinity was determined on Src protein tyrosine kinase SH2 domain using fluorescence polarization assay with 2% DMSO in buffer solution	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@H]1CSCCN(Cc2cccc(OC(F)(F)F)c2)C1=O		CHEMBL307344	=	IC50	nM	400.0	CHEMBL267	Homo sapiens	IC50	uM	0.4
	775894	CHEMBL808041	Binding affinity was determined on Src protein tyrosine kinase SH2 domain using fluorescence polarization assay with 2% DMSO in buffer solution	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@H]1CSCCN(Cc2cccc(C(=O)c3ccccc3)c2)C1=O		CHEMBL66171	=	IC50	nM	1600.0	CHEMBL267	Homo sapiens	IC50	uM	1.6
	776013	CHEMBL844768	Incorporation of 32P into phosphopeptide product (3 mM) in pp60c-src phosphorylation assay	B	CC(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@H](C(N)=O)C(C)C)[C@@H](C)O		CHEMBL337230	=	CPM x1000		119.6	CHEMBL267	Homo sapiens	CPM x1000		119.6
Not Determined	776014	CHEMBL857270	Michaelis-Menten (Km) constant for peptide phosphorylation by pp60src (Not tested)	F	CC(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@H](C(N)=O)C(C)C)[C@@H](C)O		CHEMBL337230		Km	nM		CHEMBL267	Homo sapiens	Km	uM	
Not Determined	776015	CHEMBL639173	Maximum enzyme velocity(Vmax) of peptide phosphorylation by pp60src (Not tested)	F	CC(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@H](C(N)=O)C(C)C)[C@@H](C)O		CHEMBL337230		Vmax			CHEMBL267	Homo sapiens	Vmax	uM min-1mg-1	
	776016	CHEMBL844767	Incorporation of 32P into phosphopeptide product (1 mM) in pp60c-src phosphorylation assay	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O		CHEMBL263332	=	CPM x1000		701.6	CHEMBL267	Homo sapiens	CPM x1000		701.6
	776017	CHEMBL630683	Michaelis-Menten (Km) constant for peptide phosphorylation by pp60src	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O		CHEMBL263332	=	Km	nM	100000.0	CHEMBL267	Homo sapiens	Km	uM	100.0
	776018	CHEMBL639172	Maximum enzyme velocity(Vmax) of peptide phosphorylation by pp60src	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O		CHEMBL263332	=	Vmax	uM min-1mg-1	3.06	CHEMBL267	Homo sapiens	Vmax	uM min-1mg-1	3.06
	777034	CHEMBL844768	Incorporation of 32P into phosphopeptide product (3 mM) in pp60c-src phosphorylation assay	B	CC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(N)=O		CHEMBL135654	=	CPM x1000		28.5	CHEMBL267	Homo sapiens	CPM x1000		28.5
Not Determined	777035	CHEMBL857270	Michaelis-Menten (Km) constant for peptide phosphorylation by pp60src (Not tested)	F	CC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(N)=O		CHEMBL135654		Km	nM		CHEMBL267	Homo sapiens	Km	uM	
Not Determined	777036	CHEMBL639173	Maximum enzyme velocity(Vmax) of peptide phosphorylation by pp60src (Not tested)	F	CC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(N)=O		CHEMBL135654		Vmax			CHEMBL267	Homo sapiens	Vmax	uM min-1mg-1	
	779061	CHEMBL808041	Binding affinity was determined on Src protein tyrosine kinase SH2 domain using fluorescence polarization assay with 2% DMSO in buffer solution	B	COc1ccc(C2Sc3ccccc3N(Cc3ccc(-c4ccccc4C(=O)OC(C)(C)C)cc3)C(=O)C2NC(=O)[C@H](Cc2ccc(OP(=O)(O)OCc3ccccc3)cc2)NC(=O)OC(C)(C)C)cc1		CHEMBL413955	=	IC50	nM	18000.0	CHEMBL267	Homo sapiens	IC50	uM	18.0
	781465	CHEMBL808041	Binding affinity was determined on Src protein tyrosine kinase SH2 domain using fluorescence polarization assay with 2% DMSO in buffer solution	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@H]1CSCCN(Cc2cccc(C(F)(F)F)c2)C1=O		CHEMBL69373	=	IC50	nM	1600.0	CHEMBL267	Homo sapiens	IC50	uM	1.6
	781566	CHEMBL844767	Incorporation of 32P into phosphopeptide product (1 mM) in pp60c-src phosphorylation assay	B	CNC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(C)=O		CHEMBL2370800	=	CPM x1000		1.6	CHEMBL267	Homo sapiens	CPM x1000		1.6
Not Determined	781567	CHEMBL857270	Michaelis-Menten (Km) constant for peptide phosphorylation by pp60src (Not tested)	F	CNC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(C)=O		CHEMBL2370800		Km	nM		CHEMBL267	Homo sapiens	Km	uM	
Not Determined	781568	CHEMBL639173	Maximum enzyme velocity(Vmax) of peptide phosphorylation by pp60src (Not tested)	F	CNC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(C)=O		CHEMBL2370800		Vmax			CHEMBL267	Homo sapiens	Vmax	uM min-1mg-1	
	782486	CHEMBL808041	Binding affinity was determined on Src protein tyrosine kinase SH2 domain using fluorescence polarization assay with 2% DMSO in buffer solution	B	COc1ccc(C2Sc3ccccc3N(CC(=O)NCc3cccc4ccccc34)C(=O)C2NC(=O)c2ccc(OP(=O)(O)OCc3ccccc3)cc2)cc1		CHEMBL304284	=	IC50	nM	20000.0	CHEMBL267	Homo sapiens	IC50	uM	20.0
	782622	CHEMBL844767	Incorporation of 32P into phosphopeptide product (1 mM) in pp60c-src phosphorylation assay	B	CC[C@H](C)[C@H](NC(C)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O		CHEMBL336741	=	CPM x1000		497.1	CHEMBL267	Homo sapiens	CPM x1000		497.1
	782623	CHEMBL630683	Michaelis-Menten (Km) constant for peptide phosphorylation by pp60src	B	CC[C@H](C)[C@H](NC(C)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O		CHEMBL336741	=	Km	nM	368000.0	CHEMBL267	Homo sapiens	Km	uM	368.0
	782624	CHEMBL639172	Maximum enzyme velocity(Vmax) of peptide phosphorylation by pp60src	B	CC[C@H](C)[C@H](NC(C)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O		CHEMBL336741	=	Vmax	uM min-1mg-1	1.02	CHEMBL267	Homo sapiens	Vmax	uM min-1mg-1	1.02
	783624	CHEMBL808041	Binding affinity was determined on Src protein tyrosine kinase SH2 domain using fluorescence polarization assay with 2% DMSO in buffer solution	B	CC(C)(C)OC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)NC1CSCCN(CCCC2CCCCC2)C1=O	Outside typical range	CHEMBL68300	=	IC50	nM	115000.0	CHEMBL267	Homo sapiens	IC50	uM	115.0
Not Determined	783625	CHEMBL808043	Binding affinity for Src protein tyrosine kinase SH2 domain using fluorescence polarization assay with 20% DMSO in buffer solution (Not determined)	B	CC(C)(C)OC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)NC1CSCCN(CCCC2CCCCC2)C1=O		CHEMBL68300		IC50	nM		CHEMBL267	Homo sapiens	IC50	uM	
	783626	CHEMBL808039	Binding affinity for Src protein tyrosine kinase SH2 domain	B	CC(C)(C)OC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)NC1CSCCN(CCCC2CCCCC2)C1=O		CHEMBL68300	=	IC50	nM	1400.0	CHEMBL267	Homo sapiens	IC50	uM	1.4
	785928	CHEMBL808041	Binding affinity was determined on Src protein tyrosine kinase SH2 domain using fluorescence polarization assay with 2% DMSO in buffer solution	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)Cc1ccc(OP(=O)(O)O)cc1)C(=O)O		CHEMBL46851	=	IC50	nM	6500.0	CHEMBL267	Homo sapiens	IC50	uM	6.5
	785929	CHEMBL808042	Binding affinity for Src protein tyrosine kinase SH2 domain using fluorescence polarization assay with 20% DMSO in buffer solution	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)Cc1ccc(OP(=O)(O)O)cc1)C(=O)O		CHEMBL46851	=	IC50	nM	5000.0	CHEMBL267	Homo sapiens	IC50	uM	5.0
	785930	CHEMBL808039	Binding affinity for Src protein tyrosine kinase SH2 domain	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)Cc1ccc(OP(=O)(O)O)cc1)C(=O)O		CHEMBL46851	=	IC50	nM	150.0	CHEMBL267	Homo sapiens	IC50	uM	0.15
	785931	CHEMBL808041	Binding affinity was determined on Src protein tyrosine kinase SH2 domain using fluorescence polarization assay with 2% DMSO in buffer solution	B	COc1ccc(C2Sc3ccccc3N(CC(=O)Nc3cccc4ccccc34)C(=O)C2NC(=O)[C@H](Cc2ccc(OP(=O)(O)OCc3ccccc3)cc2)NC(=O)OC(C)(C)C)cc1	Outside typical range	CHEMBL302113	=	IC50	nM	189000.0	CHEMBL267	Homo sapiens	IC50	uM	189.0
	785932	CHEMBL808041	Binding affinity was determined on Src protein tyrosine kinase SH2 domain using fluorescence polarization assay with 2% DMSO in buffer solution	B	COc1ccc(C2Sc3ccccc3NC(=O)C2NC(=O)[C@H](Cc2ccc(OP(=O)(O)OCc3ccccc3)cc2)NC(=O)OC(C)(C)C)cc1	Outside typical range	CHEMBL306655	=	IC50	nM	873000.0	CHEMBL267	Homo sapiens	IC50	uM	873.0
	785933	CHEMBL808041	Binding affinity was determined on Src protein tyrosine kinase SH2 domain using fluorescence polarization assay with 2% DMSO in buffer solution	B	COc1ccc(C2Sc3ccccc3N(CC(=O)NCc3cccc4ccccc34)C(=O)C2NC(=O)c2ccc3cc(OP(=O)(O)OCc4ccccc4)ccc3c2)cc1		CHEMBL66278	=	IC50	nM	23000.0	CHEMBL267	Homo sapiens	IC50	uM	23.0
	787083	CHEMBL808041	Binding affinity was determined on Src protein tyrosine kinase SH2 domain using fluorescence polarization assay with 2% DMSO in buffer solution	B	COc1ccc(C2Sc3ccccc3N(CC(=O)Nc3cccc(Oc4ccccc4)c3)C(=O)C2NC(=O)[C@H](Cc2ccc(OP(=O)(O)OCc3ccccc3)cc2)NC(=O)OC(C)(C)C)cc1		CHEMBL304176	=	IC50	nM	14200.0	CHEMBL267	Homo sapiens	IC50	uM	14.2
	788187	CHEMBL808041	Binding affinity was determined on Src protein tyrosine kinase SH2 domain using fluorescence polarization assay with 2% DMSO in buffer solution	B	COc1ccc(C2Sc3ccccc3N(CC(=O)NCc3cccc4ccccc34)C(=O)C2NC(=O)Cc2ccc(OP(=O)(O)OCc3ccccc3)cc2)cc1		CHEMBL303238	=	IC50	nM	5000.0	CHEMBL267	Homo sapiens	IC50	uM	5.0
	788993	CHEMBL823232	Binding affinity towards p60 Src tyrosine kinase using scintillation proximity assay	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@H]1CCCCN(Cc2ccc(C3CCCCC3)cc2)C1=O		CHEMBL444010	=	IC50	nM	2040.0	CHEMBL267	Homo sapiens	IC50	nM	2040.0
	788994	CHEMBL823232	Binding affinity towards p60 Src tyrosine kinase using scintillation proximity assay	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@H]1CCCCN(Cc2ccc(-c3cccc4ccccc34)cc2)C1=O		CHEMBL444037	=	IC50	nM	143.0	CHEMBL267	Homo sapiens	IC50	nM	143.0
	788995	CHEMBL823232	Binding affinity towards p60 Src tyrosine kinase using scintillation proximity assay	B	N#Cc1ccccc1-c1ccc(CN2CCSC[C@H](NC(=O)c3ccc(OP(=O)(O)O)cc3)C2=O)cc1		CHEMBL283465	=	IC50	nM	2460.0	CHEMBL267	Homo sapiens	IC50	nM	2460.0
	789074	CHEMBL816866	Tested for in vitro inhibitory activity against tyrosine protein kinase pp60 c-src	B	O=C(c1ccc(C(F)(F)F)cc1)n1c2cc(O)c(O)cc2c2ccc(O)c(O)c21		CHEMBL422771	=	IC50	nM	700.0	CHEMBL267	Homo sapiens	IC50	uM	0.7
Not Active	789423	CHEMBL808036	Binding affinity for Src SH2 domain in scintillation proximity binding assay (SPA) - inactive	B	O=C(O)CC(CC(=O)O)c1ccccc1		CHEMBL310821		IC50	nM		CHEMBL267	Homo sapiens	IC50	nM	
	790219	CHEMBL823232	Binding affinity towards p60 Src tyrosine kinase using scintillation proximity assay	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@H]1CCCCN(CCCc2ccccc2)C1=O		CHEMBL286258	=	IC50	nM	290.0	CHEMBL267	Homo sapiens	IC50	nM	290.0
	790220	CHEMBL823232	Binding affinity towards p60 Src tyrosine kinase using scintillation proximity assay	B	O=C(N[C@H]1CCCCN(C/C=C/c2ccccc2)C1=O)c1ccc(OP(=O)(O)O)cc1		CHEMBL283636	=	IC50	nM	2300.0	CHEMBL267	Homo sapiens	IC50	nM	2300.0
	791696	CHEMBL823232	Binding affinity towards p60 Src tyrosine kinase using scintillation proximity assay	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@H]1CCCCN(Cc2ccc(-c3ccc(Cl)cc3)cc2)C1=O		CHEMBL413526	=	IC50	nM	1300.0	CHEMBL267	Homo sapiens	IC50	nM	1300.0
	791697	CHEMBL823232	Binding affinity towards p60 Src tyrosine kinase using scintillation proximity assay	B	O=C(N[C@H]1CCCCN(Cc2ccc(C(=O)c3ccccc3)cc2)C1=O)c1ccc(OP(=O)(O)O)cc1		CHEMBL283684	=	IC50	nM	3000.0	CHEMBL267	Homo sapiens	IC50	nM	3000.0
	791698	CHEMBL823232	Binding affinity towards p60 Src tyrosine kinase using scintillation proximity assay	B	O=C(N[C@H]1CCCCN(Cc2cc(C(F)(F)F)cc(C(F)(F)F)c2)C1=O)c1ccc(OP(=O)(O)O)cc1		CHEMBL281316	=	IC50	nM	10400.0	CHEMBL267	Homo sapiens	IC50	nM	10400.0
	791876	CHEMBL816866	Tested for in vitro inhibitory activity against tyrosine protein kinase pp60 c-src	B	O=c1c2cc(O)c(O)cc2c2cc(O)c(O)cc2n1Cc1ccccc1		CHEMBL71210	=	IC50	nM	5400.0	CHEMBL267	Homo sapiens	IC50	uM	5.4
	792274	CHEMBL873263	Binding affinity towards Src protein tyrosine kinase SH2 domain using surface plasmon resonance (SPR) assay	B	O=C(O)C(c1ccccc1)S(=O)(=O)O	Outside typical range	CHEMBL80333	=	IC50	nM	3230000000.0	CHEMBL267	Homo sapiens	IC50	mM	3230.0
	792275	CHEMBL809535	Binding affinity towards Src protein tyrosine kinase SH2 domain using scintillation proximity binding assay (SPA)	B	O=C(O)C(c1ccccc1)S(=O)(=O)O		CHEMBL80333	=	IC50	nM	192000.0	CHEMBL267	Homo sapiens	IC50	uM	192.0
	793987	CHEMBL823232	Binding affinity towards p60 Src tyrosine kinase using scintillation proximity assay	B	CCCc1ccc(CN2CCCC[C@H](NC(=O)[C@H](Cc3ccc(OP(=O)(O)O)cc3)NC(C)=O)C2=O)cc1		CHEMBL24453	=	IC50	nM	150.0	CHEMBL267	Homo sapiens	IC50	nM	150.0
	794066	CHEMBL816866	Tested for in vitro inhibitory activity against tyrosine protein kinase pp60 c-src	B	CCn1c(=O)c2cc(O)c(O)cc2c2cc(O)c(O)cc21		CHEMBL72682	=	IC50	nM	4100.0	CHEMBL267	Homo sapiens	IC50	uM	4.1
	794111	CHEMBL816866	Tested for in vitro inhibitory activity against tyrosine protein kinase pp60 c-src	B	Oc1cc2c3ccc(O)c(O)c3n(Cc3ccc(C(F)(F)F)cc3)c2cc1O		CHEMBL72035	=	IC50	nM	9000.0	CHEMBL267	Homo sapiens	IC50	uM	9.0
	794410	CHEMBL873263	Binding affinity towards Src protein tyrosine kinase SH2 domain using surface plasmon resonance (SPR) assay	B	CC(=O)N[C@@H](Cc1ccc(CC(=O)O)c(C(=O)O)c1)C(=O)N[C@H]1CCCCN(Cc2ccc(-c3ccccc3)cc2)C1=O		CHEMBL432359	=	IC50	nM	450.0	CHEMBL267	Homo sapiens	IC50	nM	450.0
	794957	CHEMBL823232	Binding affinity towards p60 Src tyrosine kinase using scintillation proximity assay	B	O=C(N[C@H]1CSCCN(Cc2ccc(C(=O)c3ccccc3)cc2)C1=O)c1ccc(OP(=O)(O)O)cc1		CHEMBL557332	=	IC50	nM	18500.0	CHEMBL267	Homo sapiens	IC50	nM	18500.0
	795066	CHEMBL816866	Tested for in vitro inhibitory activity against tyrosine protein kinase pp60 c-src	B	Oc1cc2c3ccc(O)c(O)c3n(CCCc3ccccc3)c2cc1O		CHEMBL71144	=	IC50	nM	500.0	CHEMBL267	Homo sapiens	IC50	uM	0.5
	795094	CHEMBL816866	Tested for in vitro inhibitory activity against tyrosine protein kinase pp60 c-src	B	O=S(=O)(c1ccccc1)n1c2cc(O)c(O)cc2c2ccc(O)c(O)c21		CHEMBL305794	=	IC50	nM	15000.0	CHEMBL267	Homo sapiens	IC50	uM	15.0
	795517	CHEMBL873263	Binding affinity towards Src protein tyrosine kinase SH2 domain using surface plasmon resonance (SPR) assay	B	COC(=O)c1cc(C[C@H](NC(C)=O)C(=O)N[C@H]2CCCCN(Cc3ccc(-c4ccccc4)cc3)C2=O)ccc1C(C(=O)O)C(=O)O		CHEMBL305639	=	IC50	nM	556.0	CHEMBL267	Homo sapiens	IC50	nM	556.0
	795526	CHEMBL809531	Binding affinity for Src protein tyrosine kinase SH2 domain using surface plasmon resonance (SPR) assay	B	O=Cc1ccccc1OP(=O)(O)O		CHEMBL286678	=	IC50	nM	300000.0	CHEMBL267	Homo sapiens	IC50	mM	0.3
	795527	CHEMBL808768	Binding affinity for Src SH2 domain in scintillation proximity binding assay (SPA)	B	O=Cc1ccccc1OP(=O)(O)O		CHEMBL286678	=	IC50	nM	80000.0	CHEMBL267	Homo sapiens	IC50	uM	80.0
	796233	CHEMBL823232	Binding affinity towards p60 Src tyrosine kinase using scintillation proximity assay	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@H]1CCCCN(Cc2cc(C(F)(F)F)cc(C(F)(F)F)c2)C1=O		CHEMBL286072	=	IC50	nM	1800.0	CHEMBL267	Homo sapiens	IC50	nM	1800.0
	796234	CHEMBL823232	Binding affinity towards p60 Src tyrosine kinase using scintillation proximity assay	B	O=C(N[C@H]1CCCCN(CCCc2ccccc2)C1=O)c1ccc(OP(=O)(O)O)cc1		CHEMBL25245	=	IC50	nM	4500.0	CHEMBL267	Homo sapiens	IC50	nM	4500.0
	796235	CHEMBL823232	Binding affinity towards p60 Src tyrosine kinase using scintillation proximity assay	B	N#Cc1ccccc1-c1ccc(CN2CCCC[C@H](NC(=O)c3ccc(OP(=O)(O)O)cc3)C2=O)cc1		CHEMBL282328	=	IC50	nM	2110.0	CHEMBL267	Homo sapiens	IC50	nM	2110.0
	796341	CHEMBL816866	Tested for in vitro inhibitory activity against tyrosine protein kinase pp60 c-src	B	Oc1cc2[nH]c3c(O)c(O)ccc3c2cc1O		CHEMBL69240	=	IC50	nM	800.0	CHEMBL267	Homo sapiens	IC50	uM	0.8
	796343	CHEMBL816866	Tested for in vitro inhibitory activity against tyrosine protein kinase pp60 c-src	B	O=C(c1ccc(Br)cc1)n1c2cc(O)c(O)cc2c2ccc(O)c(O)c21		CHEMBL308175	=	IC50	nM	1400.0	CHEMBL267	Homo sapiens	IC50	uM	1.4
	796378	CHEMBL816866	Tested for in vitro inhibitory activity against tyrosine protein kinase pp60 c-src	B	N#Cc1ccc(Cn2c3cc(O)c(O)cc3c3c(Br)cc(O)c(O)c32)cc1		CHEMBL304808	=	IC50	nM	900.0	CHEMBL267	Homo sapiens	IC50	uM	0.9
	796707	CHEMBL808768	Binding affinity for Src SH2 domain in scintillation proximity binding assay (SPA)	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@H]1CCCCN(Cc2ccc(-c3ccccc3)cc2)C1=O	Potential transcription error	CHEMBL25826	=	IC50	nM	9000.0	CHEMBL267	Homo sapiens	IC50	uM	9.0
	796708	CHEMBL809531	Binding affinity for Src protein tyrosine kinase SH2 domain using surface plasmon resonance (SPR) assay	B	Cc1cc(C=O)c(OP(=O)(O)O)c(C=O)c1		CHEMBL421138	=	IC50	nM	500000.0	CHEMBL267	Homo sapiens	IC50	mM	0.5
	796709	CHEMBL808768	Binding affinity for Src SH2 domain in scintillation proximity binding assay (SPA)	B	Cc1cc(C=O)c(OP(=O)(O)O)c(C=O)c1		CHEMBL421138	=	IC50	nM	39000.0	CHEMBL267	Homo sapiens	IC50	uM	39.0
	796710	CHEMBL809531	Binding affinity for Src protein tyrosine kinase SH2 domain using surface plasmon resonance (SPR) assay	B	O=Cc1cccc(OP(=O)(O)O)c1		CHEMBL287306	=	IC50	nM	2100000.0	CHEMBL267	Homo sapiens	IC50	mM	2.1
	796711	CHEMBL808768	Binding affinity for Src SH2 domain in scintillation proximity binding assay (SPA)	B	O=Cc1cccc(OP(=O)(O)O)c1		CHEMBL287306	=	IC50	nM	600000.0	CHEMBL267	Homo sapiens	IC50	uM	600.0
	798439	CHEMBL823232	Binding affinity towards p60 Src tyrosine kinase using scintillation proximity assay	B	COc1cccc(CN2CCCC[C@H](NC(=O)[C@H](Cc3ccc(OP(=O)(O)O)cc3)NC(C)=O)C2=O)c1		CHEMBL25954	=	IC50	nM	1700.0	CHEMBL267	Homo sapiens	IC50	nM	1700.0
	798549	CHEMBL816866	Tested for in vitro inhibitory activity against tyrosine protein kinase pp60 c-src	B	O=S(=O)(c1ccccc1)n1c2cc(O)c(O)cc2c2cc(O)c(O)cc21		CHEMBL70360	=	IC50	nM	24000.0	CHEMBL267	Homo sapiens	IC50	uM	24.0
	798566	CHEMBL816866	Tested for in vitro inhibitory activity against tyrosine protein kinase pp60 c-src	B	O=C(c1ccccc1)n1c2cc(O)c(O)cc2c2cc(O)c(O)cc21		CHEMBL307112	=	IC50	nM	4000.0	CHEMBL267	Homo sapiens	IC50	uM	4.0
	799020	CHEMBL809531	Binding affinity for Src protein tyrosine kinase SH2 domain using surface plasmon resonance (SPR) assay	B	O=P(O)(O)Oc1ccccc1		CHEMBL26128	=	IC50	nM	5000000.0	CHEMBL267	Homo sapiens	IC50	mM	5.0
	799021	CHEMBL809532	Binding affinity for Src protein tyrosine kinase SH2 domain using scintillation proximity binding assay (SPA)	B	O=P(O)(O)Oc1ccccc1		CHEMBL26128	=	IC50	nM	300000.0	CHEMBL267	Homo sapiens	IC50	uM	300.0
	800155	CHEMBL809535	Binding affinity towards Src protein tyrosine kinase SH2 domain using scintillation proximity binding assay (SPA)	B	CC(=O)N[C@@H](Cc1ccc(C(C(=O)O)C(=O)O)c(C(=O)O)c1)C(=O)N[C@H]1CCCCN(Cc2ccc(-c3ccccc3)cc2)C1=O		CHEMBL421518	=	IC50	nM	5.0	CHEMBL267	Homo sapiens	IC50	nM	5.0
	800795	CHEMBL823232	Binding affinity towards p60 Src tyrosine kinase using scintillation proximity assay	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@H]1CCCCN(C/C=C/c2ccccc2)C1=O		CHEMBL24540	=	IC50	nM	280.0	CHEMBL267	Homo sapiens	IC50	nM	280.0
	800796	CHEMBL823232	Binding affinity towards p60 Src tyrosine kinase using scintillation proximity assay	B	COC(=O)c1ccc(CN2CCCC[C@H](NC(=O)[C@H](Cc3ccc(OP(=O)(O)O)cc3)NC(C)=O)C2=O)cc1		CHEMBL281492	=	IC50	nM	58.0	CHEMBL267	Homo sapiens	IC50	nM	58.0
	800797	CHEMBL823232	Binding affinity towards p60 Src tyrosine kinase using scintillation proximity assay	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@H]1CCCCN(Cc2ccc(-c3ccccc3C#N)cc2)C1=O		CHEMBL433046	=	IC50	nM	26.0	CHEMBL267	Homo sapiens	IC50	nM	26.0
	800942	CHEMBL816866	Tested for in vitro inhibitory activity against tyrosine protein kinase pp60 c-src	B	Oc1cc2nc(O)c3c(O)c(O)ccc3c2cc1O		CHEMBL302483	=	IC50	nM	900.0	CHEMBL267	Homo sapiens	IC50	uM	0.9
	800944	CHEMBL816866	Tested for in vitro inhibitory activity against tyrosine protein kinase pp60 c-src	B	Oc1cc2[nH]c3c(O)c(O)cc(Br)c3c2cc1O		CHEMBL70346	=	IC50	nM	600.0	CHEMBL267	Homo sapiens	IC50	uM	0.6
	800946	CHEMBL816866	Tested for in vitro inhibitory activity against tyrosine protein kinase pp60 c-src	B	CC(C)(C)c1ccc(C(=O)n2c3cc(O)c(O)cc3c3ccc(O)c(O)c32)cc1		CHEMBL308112	=	IC50	nM	700.0	CHEMBL267	Homo sapiens	IC50	uM	0.7
	800992	CHEMBL816866	Tested for in vitro inhibitory activity against tyrosine protein kinase pp60 c-src	B	O=c1oc2c(O)c(O)cc3c(=O)oc4c(O)c(O)cc1c4c23		CHEMBL6246	=	IC50	nM	300.0	CHEMBL267	Homo sapiens	IC50	uM	0.3
Not Active	801400	CHEMBL808036	Binding affinity for Src SH2 domain in scintillation proximity binding assay (SPA) - inactive	B	CCC(C(N)=O)(C(=O)O)c1ccccc1		CHEMBL1041		IC50	nM		CHEMBL267	Homo sapiens	IC50	nM	
	802133	CHEMBL823232	Binding affinity towards p60 Src tyrosine kinase using scintillation proximity assay	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@H]1CCCCN(Cc2ccc(C(C)(C)C)cc2)C1=O		CHEMBL281774	=	IC50	nM	2300.0	CHEMBL267	Homo sapiens	IC50	nM	2300.0
	802134	CHEMBL823232	Binding affinity towards p60 Src tyrosine kinase using scintillation proximity assay	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@H]1CCCCN(Cc2ccc(-c3cccs3)cc2)C1=O		CHEMBL281775	=	IC50	nM	3.0	CHEMBL267	Homo sapiens	IC50	nM	3.0
	802135	CHEMBL823232	Binding affinity towards p60 Src tyrosine kinase using scintillation proximity assay	B	Cc1ccc(-c2ccc(CN3CCCC[C@H](NC(=O)c4ccc(OP(=O)(O)O)cc4)C3=O)cc2)cc1		CHEMBL24754	=	IC50	nM	15200.0	CHEMBL267	Homo sapiens	IC50	nM	15200.0
Not Active	802639	CHEMBL808036	Binding affinity for Src SH2 domain in scintillation proximity binding assay (SPA) - inactive	B	O=C(O)CC(CC(=O)O)(c1ccccc1)c1ccccc1		CHEMBL80513		IC50	nM		CHEMBL267	Homo sapiens	IC50	nM	
	803441	CHEMBL816866	Tested for in vitro inhibitory activity against tyrosine protein kinase pp60 c-src	B	O=C(c1ccc(-c2ccccc2)cc1)n1c2cc(O)c(O)cc2c2ccc(O)c(O)c21		CHEMBL304362	=	IC50	nM	600.0	CHEMBL267	Homo sapiens	IC50	uM	0.6
	803443	CHEMBL816866	Tested for in vitro inhibitory activity against tyrosine protein kinase pp60 c-src	B	O=C(c1cccc([N+](=O)[O-])c1)n1c2cc(O)c(O)cc2c2ccc(O)c(O)c21		CHEMBL69174	=	IC50	nM	600.0	CHEMBL267	Homo sapiens	IC50	uM	0.6
	803445	CHEMBL816866	Tested for in vitro inhibitory activity against tyrosine protein kinase pp60 c-src	B	O=C(c1ccc(C(F)(F)F)cc1)n1c2cc(O)c(O)cc2c2c(Br)cc(O)c(O)c21		CHEMBL71002	=	IC50	nM	2000.0	CHEMBL267	Homo sapiens	IC50	uM	2.0
	804562	CHEMBL823232	Binding affinity towards p60 Src tyrosine kinase using scintillation proximity assay	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@H]1CCCCN(Cc2ccc(-c3ccccc3)cc2)C1=O		CHEMBL25826	=	IC50	nM	9.0	CHEMBL267	Homo sapiens	IC50	nM	9.0
	804686	CHEMBL816866	Tested for in vitro inhibitory activity against tyrosine protein kinase pp60 c-src	B	Oc1cc2nc(O)c3cc(O)c(O)cc3c2cc1O		CHEMBL306785	=	IC50	nM	1000.0	CHEMBL267	Homo sapiens	IC50	uM	1.0
	804710	CHEMBL816866	Tested for in vitro inhibitory activity against tyrosine protein kinase pp60 c-src	B	Cc1cccc(Cn2c3cc(O)c(O)cc3c3ccc(O)c(O)c32)c1		CHEMBL73937	=	IC50	nM	1700.0	CHEMBL267	Homo sapiens	IC50	uM	1.7
	804730	CHEMBL816866	Tested for in vitro inhibitory activity against tyrosine protein kinase pp60 c-src	B	O=c1c2cc(O)c(O)cc2c2cc(O)c(O)cc2n1Cc1ccc(S(=O)(=O)c2ccccc2)cc1		CHEMBL302472	=	IC50	nM	2000.0	CHEMBL267	Homo sapiens	IC50	uM	2.0
Not Active	805088	CHEMBL808035	Binding affinity for Src SH2 domain in scintillation proximity binding assay (SPA) - inactive	B	O=S(=O)(O)C(O)c1ccccc1		CHEMBL79148		IC50	nM		CHEMBL267	Homo sapiens	IC50	nM	
	806067	CHEMBL816866	Tested for in vitro inhibitory activity against tyrosine protein kinase pp60 c-src	B	O=c1c2cc(O)c(O)cc2c2cc(O)c(O)cc2n1Cc1ccc(Cl)c(Cl)c1		CHEMBL69237	=	IC50	nM	1300.0	CHEMBL267	Homo sapiens	IC50	uM	1.3
	806095	CHEMBL816866	Tested for in vitro inhibitory activity against tyrosine protein kinase pp60 c-src	B	O=S(=O)(Cc1ccccc1)n1c2cc(O)c(O)cc2c2ccc(O)c(O)c21		CHEMBL421872	=	IC50	nM	14000.0	CHEMBL267	Homo sapiens	IC50	uM	14.0
	807279	CHEMBL823232	Binding affinity towards p60 Src tyrosine kinase using scintillation proximity assay	B	CCCCc1ccc(CN2CCCC[C@H](NC(=O)[C@H](Cc3ccc(OP(=O)(O)O)cc3)NC(C)=O)C2=O)cc1		CHEMBL422397	=	IC50	nM	7800.0	CHEMBL267	Homo sapiens	IC50	nM	7800.0
	807280	CHEMBL823232	Binding affinity towards p60 Src tyrosine kinase using scintillation proximity assay	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@H]1CSCCN(Cc2ccc(-c3ccccc3C#N)cc2)C1=O		CHEMBL285441	=	IC50	nM	315.0	CHEMBL267	Homo sapiens	IC50	nM	315.0
	807424	CHEMBL816866	Tested for in vitro inhibitory activity against tyrosine protein kinase pp60 c-src	B	O=S(=O)(c1cc(Cl)ccc1Cl)n1c2cc(O)c(O)cc2c2ccc(O)c(O)c21		CHEMBL308311	=	IC50	nM	7700.0	CHEMBL267	Homo sapiens	IC50	uM	7.7
	808714	CHEMBL816866	Tested for in vitro inhibitory activity against tyrosine protein kinase pp60 c-src	B	O=c1c2c(O)c(O)ccc2c2cc(O)c(O)cc2n1Cc1ccc(Cl)c(Cl)c1	Outside typical range	CHEMBL71206	=	IC50	nM	197000.0	CHEMBL267	Homo sapiens	IC50	uM	197.0
	808716	CHEMBL816866	Tested for in vitro inhibitory activity against tyrosine protein kinase pp60 c-src	B	O=C(c1ccc2ccccc2c1)n1c2cc(O)c(O)cc2c2ccc(O)c(O)c21		CHEMBL304361	=	IC50	nM	500.0	CHEMBL267	Homo sapiens	IC50	uM	0.5
	809879	CHEMBL823232	Binding affinity towards p60 Src tyrosine kinase using scintillation proximity assay	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@H]1CCCCN(Cc2ccc(-c3ccc(F)cc3F)cc2)C1=O		CHEMBL286993	=	IC50	nM	334.0	CHEMBL267	Homo sapiens	IC50	nM	334.0
	809965	CHEMBL816866	Tested for in vitro inhibitory activity against tyrosine protein kinase pp60 c-src	B	O=c1c2cc(O)c(O)cc2c2cc(O)c(O)cc2n1Cc1ccc([N+](=O)[O-])cc1		CHEMBL305234	=	IC50	nM	900.0	CHEMBL267	Homo sapiens	IC50	uM	0.9
	811260	CHEMBL816866	Tested for in vitro inhibitory activity against tyrosine protein kinase pp60 c-src	B	O=c1c2c(O)c(O)ccc2c2cc(O)c(O)cc2n1Cc1ccccc1		CHEMBL70942	=	IC50	nM	21000.0	CHEMBL267	Homo sapiens	IC50	uM	21.0
	811262	CHEMBL816866	Tested for in vitro inhibitory activity against tyrosine protein kinase pp60 c-src	B	Oc1cc2c3ccc(O)c(O)c3n(Cc3ccccc3)c2cc1O		CHEMBL308438	=	IC50	nM	2000.0	CHEMBL267	Homo sapiens	IC50	uM	2.0
	811264	CHEMBL816866	Tested for in vitro inhibitory activity against tyrosine protein kinase pp60 c-src	B	O=[N+]([O-])c1ccc(S(=O)(=O)n2c3cc(O)c(O)cc3c3ccc(O)c(O)c32)cc1		CHEMBL302325	=	IC50	nM	12000.0	CHEMBL267	Homo sapiens	IC50	uM	12.0
	812350	CHEMBL823232	Binding affinity towards p60 Src tyrosine kinase using scintillation proximity assay	B	O=C(N[C@H]1CSCCN(C/C=C/c2ccccc2)C1=O)c1ccc(OP(=O)(O)O)cc1		CHEMBL24262	=	IC50	nM	2800.0	CHEMBL267	Homo sapiens	IC50	nM	2800.0
	812495	CHEMBL816866	Tested for in vitro inhibitory activity against tyrosine protein kinase pp60 c-src	B	N#Cc1ccc(Cn2c3cc(O)c(O)cc3c3ccc(O)c(O)c32)cc1		CHEMBL306019	=	IC50	nM	400.0	CHEMBL267	Homo sapiens	IC50	uM	0.4
	812516	CHEMBL816866	Tested for in vitro inhibitory activity against tyrosine protein kinase pp60 c-src	B	O=C(CCc1ccccc1)n1c2cc(O)c(O)cc2c2ccc(O)c(O)c21		CHEMBL72338	=	IC50	nM	400.0	CHEMBL267	Homo sapiens	IC50	uM	0.4
	812917	CHEMBL808768	Binding affinity for Src SH2 domain in scintillation proximity binding assay (SPA)	B	Cc1ccc(CC(=O)O)c(C=O)c1		CHEMBL80192	=	IC50	nM	385000.0	CHEMBL267	Homo sapiens	IC50	uM	385.0
	813770	CHEMBL816866	Tested for in vitro inhibitory activity against tyrosine protein kinase pp60 c-src	B	CS(=O)(=O)c1ccc(C(=O)n2c3cc(O)c(O)cc3c3ccc(O)c(O)c32)cc1		CHEMBL305223	=	IC50	nM	400.0	CHEMBL267	Homo sapiens	IC50	uM	0.4
	814096	CHEMBL809531	Binding affinity for Src protein tyrosine kinase SH2 domain using surface plasmon resonance (SPR) assay	B	COc1cccc(C=O)c1OP(=O)(O)O		CHEMBL25186	=	IC50	nM	900000.0	CHEMBL267	Homo sapiens	IC50	mM	0.9
	814097	CHEMBL809532	Binding affinity for Src protein tyrosine kinase SH2 domain using scintillation proximity binding assay (SPA)	B	COc1cccc(C=O)c1OP(=O)(O)O		CHEMBL25186	=	IC50	nM	95000.0	CHEMBL267	Homo sapiens	IC50	uM	95.0
	815312	CHEMBL809531	Binding affinity for Src protein tyrosine kinase SH2 domain using surface plasmon resonance (SPR) assay	B	O=C(O)C(C(=O)O)c1ccccc1	Outside typical range	CHEMBL78794	=	IC50	nM	2530000000.0	CHEMBL267	Homo sapiens	IC50	mM	2530.0
	815313	CHEMBL808768	Binding affinity for Src SH2 domain in scintillation proximity binding assay (SPA)	B	O=C(O)C(C(=O)O)c1ccccc1		CHEMBL78794	=	IC50	nM	200000.0	CHEMBL267	Homo sapiens	IC50	uM	200.0
	815982	CHEMBL823232	Binding affinity towards p60 Src tyrosine kinase using scintillation proximity assay	B	O=C(N[C@H]1CCCCN(Cc2ccc(-c3ccccc3)cc2)C1=O)c1ccc(OP(=O)(O)O)cc1		CHEMBL280763	=	IC50	nM	1500.0	CHEMBL267	Homo sapiens	IC50	nM	1500.0
	816106	CHEMBL816866	Tested for in vitro inhibitory activity against tyrosine protein kinase pp60 c-src	B	O=S(=O)(c1ccccc1)c1ccc(Cn2c3cc(O)c(O)cc3c3ccc(O)c(O)c32)cc1		CHEMBL305621	=	IC50	nM	600.0	CHEMBL267	Homo sapiens	IC50	uM	0.6
	816169	CHEMBL816866	Tested for in vitro inhibitory activity against tyrosine protein kinase pp60 c-src	B	O=c1c2c(O)c(O)ccc2c2cc(O)c(O)cc2n1Cc1ccc(S(=O)(=O)c2ccccc2)cc1		CHEMBL302824	=	IC50	nM	7200.0	CHEMBL267	Homo sapiens	IC50	uM	7.2
Not Active	816456	CHEMBL808036	Binding affinity for Src SH2 domain in scintillation proximity binding assay (SPA) - inactive	B	O=C(O)CC(C(=O)O)c1ccccc1		CHEMBL76085		IC50	nM		CHEMBL267	Homo sapiens	IC50	nM	
	817477	CHEMBL816866	Tested for in vitro inhibitory activity against tyrosine protein kinase pp60 c-src	B	Oc1cc2c3ccc(O)c(O)c3n(Cc3c(Cl)cccc3Cl)c2cc1O		CHEMBL304983	=	IC50	nM	900.0	CHEMBL267	Homo sapiens	IC50	uM	0.9
	817775	CHEMBL873263	Binding affinity towards Src protein tyrosine kinase SH2 domain using surface plasmon resonance (SPR) assay	B	O=C(O)C(c1ccc(O)cc1)S(=O)(=O)O	Outside typical range	CHEMBL451544	=	IC50	nM	2120000000.0	CHEMBL267	Homo sapiens	IC50	mM	2120.0
	817776	CHEMBL809534	Binding affinity towards Src protein tyrosine kinase SH2 domain protein using scintillation proximity binding assay (SPA)	B	O=C(O)C(c1ccc(O)cc1)S(=O)(=O)O		CHEMBL451544	=	IC50	nM	190000.0	CHEMBL267	Homo sapiens	IC50	uM	190.0
	818473	CHEMBL823232	Binding affinity towards p60 Src tyrosine kinase using scintillation proximity assay	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@H]1CCCCN(Cc2ccc(-c3ccc(C)cc3)cc2)C1=O		CHEMBL26131	=	IC50	nM	2160.0	CHEMBL267	Homo sapiens	IC50	nM	2160.0
	818474	CHEMBL823232	Binding affinity towards p60 Src tyrosine kinase using scintillation proximity assay	B	O=C(N[C@H]1CSCCN(Cc2ccc(-c3ccccc3)cc2)C1=O)c1ccc(OP(=O)(O)O)cc1		CHEMBL24382	=	IC50	nM	11900.0	CHEMBL267	Homo sapiens	IC50	nM	11900.0
	818571	CHEMBL816866	Tested for in vitro inhibitory activity against tyrosine protein kinase pp60 c-src	B	Oc1cc2c3cc(O)c(O)cc3n(Cc3cccnc3)c2cc1O		CHEMBL266154	=	IC50	nM	8000.0	CHEMBL267	Homo sapiens	IC50	uM	8.0
	818953	CHEMBL809531	Binding affinity for Src protein tyrosine kinase SH2 domain using surface plasmon resonance (SPR) assay	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(C)=O)C(N)=O		CHEMBL311937	=	IC50	nM	1.0	CHEMBL267	Homo sapiens	IC50	nM	1.0
	818954	CHEMBL808768	Binding affinity for Src SH2 domain in scintillation proximity binding assay (SPA)	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(C)=O)C(N)=O		CHEMBL311937	=	IC50	nM	150.0	CHEMBL267	Homo sapiens	IC50	uM	0.15
	818955	CHEMBL809531	Binding affinity for Src protein tyrosine kinase SH2 domain using surface plasmon resonance (SPR) assay	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(C)=O)C(=O)O		CHEMBL23794	=	IC50	nM	9.0	CHEMBL267	Homo sapiens	IC50	nM	9.0
	819749	CHEMBL816866	Tested for in vitro inhibitory activity against tyrosine protein kinase pp60 c-src	B	CCn1c(=O)c2c(O)c(O)ccc2c2cc(O)c(O)cc21		CHEMBL70413	=	IC50	nM	11000.0	CHEMBL267	Homo sapiens	IC50	uM	11.0
	820801	CHEMBL816866	Tested for in vitro inhibitory activity against tyrosine protein kinase pp60 c-src	B	CC(C)(C)c1ccc(C(=O)n2c3cc(O)c(O)cc3c3c(Br)cc(O)c(O)c32)cc1		CHEMBL73721	=	IC50	nM	12000.0	CHEMBL267	Homo sapiens	IC50	uM	12.0
	820803	CHEMBL816866	Tested for in vitro inhibitory activity against tyrosine protein kinase pp60 c-src	B	CS(=O)(=O)c1ccc(C(=O)n2c3cc(O)c(O)cc3c3c(Br)cc(O)c(O)c32)cc1		CHEMBL302981	=	IC50	nM	9000.0	CHEMBL267	Homo sapiens	IC50	uM	9.0
Not Active	821039	CHEMBL808036	Binding affinity for Src SH2 domain in scintillation proximity binding assay (SPA) - inactive	B	CC(CC(=O)O)(CC(=O)O)c1ccccc1		CHEMBL76143		IC50	nM		CHEMBL267	Homo sapiens	IC50	nM	
	821070	CHEMBL808768	Binding affinity for Src SH2 domain in scintillation proximity binding assay (SPA)	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)c(C=O)c1)C(=O)N[C@H]1CCCCN(Cc2ccc(-c3ccccc3)cc2)C1=O		CHEMBL78455	=	IC50	nM	0.25	CHEMBL267	Homo sapiens	IC50	nM	0.25
	821755	CHEMBL823232	Binding affinity towards p60 Src tyrosine kinase using scintillation proximity assay	B	O=C(N[C@H]1CSCCN(Cc2cc(C(F)(F)F)cc(C(F)(F)F)c2)C1=O)c1ccc(OP(=O)(O)O)cc1		CHEMBL280668	=	IC50	nM	9800.0	CHEMBL267	Homo sapiens	IC50	nM	9800.0
	821873	CHEMBL816866	Tested for in vitro inhibitory activity against tyrosine protein kinase pp60 c-src	B	Oc1cc2c3ccc(O)c(O)c3n(Cc3ccc(Br)cc3)c2cc1O		CHEMBL305966	=	IC50	nM	3400.0	CHEMBL267	Homo sapiens	IC50	uM	3.4
	823418	CHEMBL873263	Binding affinity towards Src protein tyrosine kinase SH2 domain using surface plasmon resonance (SPR) assay	B	COC(=O)c1cc(C[C@@H](NC(C)=O)C(=O)N[C@H]2CCCCN(Cc3ccc(-c4ccccc4)cc3)C2=O)ccc1C(C(=O)O)C(=O)O		CHEMBL305856	=	IC50	nM	7.0	CHEMBL267	Homo sapiens	IC50	nM	7.0
	823423	CHEMBL809533	Binding affinity for Src protein tyrosine kinase SH2 domain using surface plasmon resonance (SPR) assay	B	Cc1cc(C=O)cc(C)c1OP(=O)(O)O		CHEMBL309800	=	IC50	nM	5000000.0	CHEMBL267	Homo sapiens	IC50	mM	5.0
	825565	CHEMBL816866	Tested for in vitro inhibitory activity against tyrosine protein kinase pp60 c-src	B	O=c1c2c(O)c(O)ccc2c2cc(O)c(O)cc2n1Cc1ccc([N+](=O)[O-])cc1		CHEMBL71205	=	IC50	nM	61000.0	CHEMBL267	Homo sapiens	IC50	uM	61.0
	825567	CHEMBL816866	Tested for in vitro inhibitory activity against tyrosine protein kinase pp60 c-src	B	Oc1cc2c3cc(O)c(O)cc3n(Cc3ccccc3)c2cc1O		CHEMBL70750	=	IC50	nM	7000.0	CHEMBL267	Homo sapiens	IC50	uM	7.0
	825582	CHEMBL816866	Tested for in vitro inhibitory activity against tyrosine protein kinase pp60 c-src	B	Oc1cc2[nH]c3cc(O)c(O)cc3c2cc1O		CHEMBL70659	=	IC50	nM	1500.0	CHEMBL267	Homo sapiens	IC50	uM	1.5
	825969	CHEMBL809535	Binding affinity towards Src protein tyrosine kinase SH2 domain using scintillation proximity binding assay (SPA)	B	Cc1ccc(C(C(=O)O)C(=O)O)c(COC=O)c1		CHEMBL77070	=	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	826682	CHEMBL823232	Binding affinity towards p60 Src tyrosine kinase using scintillation proximity assay	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@H]1CSCCN(Cc2ccc(-c3ccccc3)cc2)C1=O		CHEMBL24482	=	IC50	nM	87.0	CHEMBL267	Homo sapiens	IC50	nM	87.0
	826821	CHEMBL816866	Tested for in vitro inhibitory activity against tyrosine protein kinase pp60 c-src	B	O=C(c1ccccc1)n1c2cc(O)c(O)cc2c2ccc(O)c(O)c21		CHEMBL70594	=	IC50	nM	900.0	CHEMBL267	Homo sapiens	IC50	uM	0.9
	828006	CHEMBL823440	Inhibitory activity against cytosolic c-Src	B	CN(C)c1cc(-c2cc3cnc(N)nc3nc2NC(=O)NC(C)(C)C)cc(N(C)C)c1		CHEMBL50371	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	828096	CHEMBL808038	The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domain	B	O=P(O)(O)Oc1ccccc1	Outside typical range	CHEMBL26128	=	IC50	nM	2500000.0	CHEMBL267	Homo sapiens	IC50	mM	2.5
	828097	CHEMBL808038	The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domain	B	O=[N+]([O-])c1ccc(OP(=O)(O)O)cc1	Outside typical range	CHEMBL24231	=	IC50	nM	1000000.0	CHEMBL267	Homo sapiens	IC50	mM	1.0
	829173	CHEMBL823440	Inhibitory activity against cytosolic c-Src	B	Cc1ccc(-c2cc3cnc(N)nc3nc2NC(=O)NC(C)(C)C)cc1		CHEMBL309470	=	IC50	nM	17500.0	CHEMBL267	Homo sapiens	IC50	uM	17.5
	829182	CHEMBL801958	Binding affinity towards SH2 domain of src protein tyrosine kinase(PTK)	B	CC[C@H](NC(=O)[C@H](Cc1ccc(C(F)(F)P(=O)(O)O)cc1)NC(C)=O)C(=O)N(C)CCCC1CCCCC1		CHEMBL298813	=	Activity	uM	20.0	CHEMBL267	Homo sapiens	Activity	uM	20.0
	829215	CHEMBL808038	The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domain	B	Nc1ccc(OP(=O)(O)O)cc1	Outside typical range	CHEMBL287216	=	IC50	nM	600000.0	CHEMBL267	Homo sapiens	IC50	mM	0.6
	829216	CHEMBL808038	The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domain	B	O=Cc1ccccc1OP(=O)(O)O	Outside typical range	CHEMBL286678	=	IC50	nM	200000.0	CHEMBL267	Homo sapiens	IC50	mM	0.2
	830333	CHEMBL808038	The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domain	B	COc1cc(NC(=O)P(=O)(O)O)cc(OC)c1OC	Outside typical range	CHEMBL25950	=	IC50	nM	2100000.0	CHEMBL267	Homo sapiens	IC50	mM	2.1
	831447	CHEMBL823440	Inhibitory activity against cytosolic c-Src	B	COc1ccccc1-c1cc2cnc(N)nc2nc1NC(=O)NC(C)(C)C		CHEMBL79241	=	IC50	nM	10430.0	CHEMBL267	Homo sapiens	IC50	uM	10.43
	831570	CHEMBL808038	The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domain	B	O=C(Nc1ccccc1OC(F)(F)F)P(=O)(O)O	Outside typical range	CHEMBL26166	=	IC50	nM	4000000.0	CHEMBL267	Homo sapiens	IC50	mM	4.0
	832549	CHEMBL823440	Inhibitory activity against cytosolic c-Src	B	Cc1cc(C)cc(-c2cc3cnc(N)nc3nc2NC(=O)NC(C)(C)C)c1		CHEMBL81474	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	832611	CHEMBL808038	The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domain	B	O=P(O)(O)ON1C=CC=C2C=CC=C(O)C21	Outside typical range	CHEMBL285665	>	IC50	nM	10000000.0	CHEMBL267	Homo sapiens	IC50	mM	10.0
	832612	CHEMBL808038	The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domain	B	O=P(O)(O)C(O)c1ccc2ccccc2c1	Outside typical range	CHEMBL26001	=	IC50	nM	4400000.0	CHEMBL267	Homo sapiens	IC50	mM	4.4
	833773	CHEMBL808038	The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domain	B	COP(=O)(O)Oc1ccccc1C=O	Outside typical range	CHEMBL24060	=	IC50	nM	3300000.0	CHEMBL267	Homo sapiens	IC50	mM	3.3
	833774	CHEMBL808038	The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domain	B	O=P(O)(O)C(O)C1CCCCC1	Outside typical range	CHEMBL26124	>	IC50	nM	10000000.0	CHEMBL267	Homo sapiens	IC50	mM	10.0
	834930	CHEMBL801958	Binding affinity towards SH2 domain of src protein tyrosine kinase(PTK)	B	CC[C@H](NC(=O)[C@H](Cc1ccc(C(F)(F)P(=O)(O)O)c(C=O)c1)NC(C)=O)C(=O)N(C)CCCC1CCCCC1		CHEMBL108322	=	Activity	uM	22.0	CHEMBL267	Homo sapiens	Activity	uM	22.0
	834976	CHEMBL808038	The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domain	B	CCc1ccc(NC(=O)P(=O)(O)O)cc1	Outside typical range	CHEMBL284362	=	IC50	nM	4400000.0	CHEMBL267	Homo sapiens	IC50	mM	4.4
	837450	CHEMBL808038	The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domain	B	O=P(O)(O)Oc1ccc2ccccc2c1	Outside typical range	CHEMBL25431	=	IC50	nM	1000000.0	CHEMBL267	Homo sapiens	IC50	mM	1.0
	838572	CHEMBL823440	Inhibitory activity against cytosolic c-Src	B	CCOc1cc(OCC)cc(-c2cc3cnc(N)nc3nc2NC(=O)NC(C)(C)C)c1		CHEMBL48809	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	838573	CHEMBL823440	Inhibitory activity against cytosolic c-Src	B	CC(C)(C)NC(=O)Nc1nc2nc(N)ncc2cc1-c1c(Cl)cccc1Cl		CHEMBL57366	=	IC50	nM	220.0	CHEMBL267	Homo sapiens	IC50	uM	0.22
	838583	CHEMBL823440	Inhibitory activity against cytosolic c-Src	B	Cc1ccccc1-c1cc2cnc(N)nc2nc1NC(=O)NC(C)(C)C		CHEMBL78393	=	IC50	nM	410.0	CHEMBL267	Homo sapiens	IC50	uM	0.41
	838686	CHEMBL808038	The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domain	B	COc1ccccc1C(O)P(=O)(O)O	Outside typical range	CHEMBL24648	>	IC50	nM	10000000.0	CHEMBL267	Homo sapiens	IC50	mM	10.0
	839711	CHEMBL823440	Inhibitory activity against cytosolic c-Src	B	COc1ccc(-c2cc3cnc(N)nc3nc2NC(=O)NC(C)(C)C)cc1		CHEMBL312055	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	839789	CHEMBL808038	The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domain	B	O=Cc1cccc(C=O)c1OP(=O)(O)O	Outside typical range	CHEMBL279466	=	IC50	nM	500000.0	CHEMBL267	Homo sapiens	IC50	mM	0.5
	839790	CHEMBL808038	The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domain	B	CCc1ccc(NC(=O)P(=O)(O)OCc2ccccc2)cc1	Outside typical range	CHEMBL24555	>>	IC50	nM	5000000.0	CHEMBL267	Homo sapiens	IC50	mM	5.0
	839791	CHEMBL808038	The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domain	B	CCOC(=O)c1ccc(NC(=O)P(=O)(O)O)cc1	Outside typical range	CHEMBL26164	=	IC50	nM	3600000.0	CHEMBL267	Homo sapiens	IC50	mM	3.6
	842405	CHEMBL808038	The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domain	B	O=C(NCc1ccccc1)P(=O)(O)O	Outside typical range	CHEMBL287276	=	IC50	nM	4400000.0	CHEMBL267	Homo sapiens	IC50	mM	4.4
	843420	CHEMBL823440	Inhibitory activity against cytosolic c-Src	B	COc1ccc(-c2cc3cnc(N)nc3nc2NC(=O)NC(C)(C)C)cc1OC		CHEMBL78802	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	843423	CHEMBL823440	Inhibitory activity against cytosolic c-Src	B	Cc1cc(C)c(-c2cc3cnc(N)nc3nc2NC(=O)NC(C)(C)C)c(C)c1		CHEMBL81615	=	IC50	nM	360.0	CHEMBL267	Homo sapiens	IC50	uM	0.36
	843532	CHEMBL808038	The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domain	B	O=Cc1cccc(OP(=O)(O)O)c1	Outside typical range	CHEMBL287306	=	IC50	nM	2400000.0	CHEMBL267	Homo sapiens	IC50	mM	2.4
	844714	CHEMBL823440	Inhibitory activity against cytosolic c-Src	B	CC(C)(C)NC(=O)Nc1nc2nc(N)ncc2cc1-c1c(Cl)cccc1Br		CHEMBL312454	=	IC50	nM	210.0	CHEMBL267	Homo sapiens	IC50	uM	0.21
	844717	CHEMBL823440	Inhibitory activity against cytosolic c-Src	B	CCN(CC)CCOc1ccc(C)c(-c2cc3cnc(N)nc3nc2NC(=O)NC(C)(C)C)c1C		CHEMBL312148	=	IC50	nM	1650.0	CHEMBL267	Homo sapiens	IC50	uM	1.65
	844821	CHEMBL808038	The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domain	B	COc1ccc(OP(=O)(O)O)cc1	Outside typical range	CHEMBL24124	=	IC50	nM	4000000.0	CHEMBL267	Homo sapiens	IC50	mM	4.0
	844822	CHEMBL808038	The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domain	B	COc1cccc(C=O)c1OP(=O)(O)O	Outside typical range	CHEMBL25186	=	IC50	nM	900000.0	CHEMBL267	Homo sapiens	IC50	mM	0.9
	844823	CHEMBL808038	The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domain	B	O=P(O)(O)C(O)c1ccccc1	Outside typical range	CHEMBL24720	>	IC50	nM	10000000.0	CHEMBL267	Homo sapiens	IC50	mM	10.0
	845962	CHEMBL823440	Inhibitory activity against cytosolic c-Src	B	CCOc1cccc(-c2cc3cnc(N)nc3nc2NC(=O)NC(C)(C)C)c1		CHEMBL78485	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	847079	CHEMBL823440	Inhibitory activity against cytosolic c-Src	B	Cc1cccc(C)c1-c1cc2cnc(N)nc2nc1NC(=O)NC(C)(C)C		CHEMBL57323	=	IC50	nM	110.0	CHEMBL267	Homo sapiens	IC50	uM	0.11
	847169	CHEMBL808038	The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domain	B	O=P(O)(O)C(O)c1ccc(-c2ccccc2)cc1	Outside typical range	CHEMBL285443	>	IC50	nM	10000000.0	CHEMBL267	Homo sapiens	IC50	mM	10.0
	848302	CHEMBL823440	Inhibitory activity against cytosolic c-Src	B	COc1cccc(-c2cc3cnc(N)nc3nc2NC(=O)NC(C)(C)C)c1		CHEMBL81146	=	IC50	nM	36400.0	CHEMBL267	Homo sapiens	IC50	uM	36.4
	848303	CHEMBL823440	Inhibitory activity against cytosolic c-Src	B	Cc1cc(C)c(C)c(-c2cc3cnc(N)nc3nc2NC(=O)NC(C)(C)C)c1C		CHEMBL56236	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	848376	CHEMBL808038	The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domain	B	Cc1cccc(C)c1OP(=O)(O)O	Outside typical range	CHEMBL26349	>	IC50	nM	10000000.0	CHEMBL267	Homo sapiens	IC50	mM	10.0
	849517	CHEMBL808038	The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domain	B	CCCCOc1ccc(NC(=O)P(=O)(O)O)cc1	Outside typical range	CHEMBL24771	=	IC50	nM	3900000.0	CHEMBL267	Homo sapiens	IC50	mM	3.9
	850617	CHEMBL823440	Inhibitory activity against cytosolic c-Src	B	CC(C)(C)NC(=O)Nc1nc2nc(N)ncc2cc1-c1cc(C(F)(F)F)cc(C(F)(F)F)c1		CHEMBL49658	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	850620	CHEMBL823440	Inhibitory activity against cytosolic c-Src	B	Cc1c(C)c(C)c(-c2cc3cnc(N)nc3nc2NC(=O)NC(C)(C)C)c(C)c1C		CHEMBL78555	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	850700	CHEMBL808038	The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domain	B	Cc1cccc(OP(=O)(O)O)c1	Outside typical range	CHEMBL287555	=	IC50	nM	4000000.0	CHEMBL267	Homo sapiens	IC50	mM	4.0
	850701	CHEMBL808038	The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domain	B	O=P(O)(O)Oc1ccccc1Cl	Outside typical range	CHEMBL26404	=	IC50	nM	3500000.0	CHEMBL267	Homo sapiens	IC50	mM	3.5
	850702	CHEMBL808038	The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domain	B	O=C(O)c1ccccc1OP(=O)(O)O	Outside typical range	CHEMBL287275	=	IC50	nM	2000000.0	CHEMBL267	Homo sapiens	IC50	mM	2.0
	851672	CHEMBL823440	Inhibitory activity against cytosolic c-Src	B	CC(C)(C)NC(=O)Nc1nc2nc(N)ncc2cc1-c1cccc(Cl)c1Cl		CHEMBL79274	=	IC50	nM	4410.0	CHEMBL267	Homo sapiens	IC50	uM	4.41
	855069	CHEMBL808038	The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domain	B	O=P(O)(O)Oc1ccc(SC(F)(F)F)cc1	Outside typical range	CHEMBL24336	=	IC50	nM	1200000.0	CHEMBL267	Homo sapiens	IC50	mM	1.2
	855070	CHEMBL808038	The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domain	B	CC(=O)c1ccc2ccccc2c1OP(=O)(O)O	Outside typical range	CHEMBL285775	=	IC50	nM	3500000.0	CHEMBL267	Homo sapiens	IC50	mM	3.5
	855071	CHEMBL808038	The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domain	B	COC(=O)c1cc2ccccc2cc1OP(=O)(O)O	Outside typical range	CHEMBL24394	=	IC50	nM	3200000.0	CHEMBL267	Homo sapiens	IC50	mM	3.2
	856137	CHEMBL823440	Inhibitory activity against cytosolic c-Src	B	COc1cc(OC)cc(-c2cc3cnc(N)nc3nc2NC(=O)NC(C)(C)C)c1		CHEMBL299763	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	857165	CHEMBL823440	Inhibitory activity against cytosolic c-Src	B	CC(C)(C)NC(=O)Nc1nc2nc(N)ncc2cc1-c1c(Cl)ccc(Cl)c1Cl		CHEMBL312048	=	IC50	nM	1410.0	CHEMBL267	Homo sapiens	IC50	uM	1.41
	857168	CHEMBL823440	Inhibitory activity against cytosolic c-Src	B	CC(C)(C)NC(=O)Nc1nc2nc(N)ncc2cc1-c1c(Br)cccc1Br		CHEMBL300171	=	IC50	nM	210.0	CHEMBL267	Homo sapiens	IC50	uM	0.21
	857261	CHEMBL808038	The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domain	B	O=P(O)(O)ON1CCCc2cccc(O)c21	Outside typical range	CHEMBL26549	=	IC50	nM	300000.0	CHEMBL267	Homo sapiens	IC50	mM	0.3
	858573	CHEMBL808038	The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domain	B	CC(C)(C)c1ccc(OP(=O)(O)O)cc1	Outside typical range	CHEMBL25780	=	IC50	nM	4000000.0	CHEMBL267	Homo sapiens	IC50	mM	4.0
	858574	CHEMBL808038	The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domain	B	CCCOc1ccc(C(O)P(=O)(O)O)cc1	Outside typical range	CHEMBL24730	=	IC50	nM	2400000.0	CHEMBL267	Homo sapiens	IC50	mM	2.4
	858575	CHEMBL808038	The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domain	B	O=C(NCCc1ccccc1)P(=O)(O)O	Outside typical range	CHEMBL24447	>	IC50	nM	5000000.0	CHEMBL267	Homo sapiens	IC50	mM	5.0
	859659	CHEMBL823440	Inhibitory activity against cytosolic c-Src	B	CC(C)(C)NC(=O)Nc1nc2nc(N)ncc2cc1-c1cc(F)cc(F)c1		CHEMBL81975	=	IC50	nM	1350.0	CHEMBL267	Homo sapiens	IC50	uM	1.35
	859662	CHEMBL823440	Inhibitory activity against cytosolic c-Src	B	CCc1ccccc1-c1cc2cnc(N)nc2nc1NC(=O)NC(C)(C)C		CHEMBL421145	=	IC50	nM	10430.0	CHEMBL267	Homo sapiens	IC50	uM	10.43
	859737	CHEMBL808038	The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domain	B	O=Cc1ccccc1OP(=O)(O)OCC1CCCCC1	Outside typical range	CHEMBL24811	=	IC50	nM	2300000.0	CHEMBL267	Homo sapiens	IC50	mM	2.3
	861904	CHEMBL808038	The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domain	B	COC(=O)c1ccc(OP(=O)(O)O)cc1	Outside typical range	CHEMBL284997	=	IC50	nM	4000000.0	CHEMBL267	Homo sapiens	IC50	mM	4.0
	863056	CHEMBL823440	Inhibitory activity against cytosolic c-Src	B	CCc1cc(CC)cc(-c2cc3cnc(N)nc3nc2NC(=O)NC(C)(C)C)c1		CHEMBL445893	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	863059	CHEMBL823440	Inhibitory activity against cytosolic c-Src	B	CC(C)(C)NC(=O)Nc1nc2nc(N)ncc2cc1-c1c(F)cccc1F		CHEMBL77781	=	IC50	nM	800.0	CHEMBL267	Homo sapiens	IC50	uM	0.8
	863062	CHEMBL823440	Inhibitory activity against cytosolic c-Src	B	Cc1cccc(-c2cc3cnc(N)nc3nc2NC(=O)NC(C)(C)C)c1C		CHEMBL82431	=	IC50	nM	4170.0	CHEMBL267	Homo sapiens	IC50	uM	4.17
	863164	CHEMBL808038	The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domain	B	CC(C)OP(=O)(O)Oc1ccccc1C=O	Outside typical range	CHEMBL26438	=	IC50	nM	2100000.0	CHEMBL267	Homo sapiens	IC50	mM	2.1
	863165	CHEMBL808038	The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domain	B	O=P(O)(O)Oc1cccc2ccccc12	Outside typical range	CHEMBL24745	=	IC50	nM	1000000.0	CHEMBL267	Homo sapiens	IC50	mM	1.0
	863166	CHEMBL808038	The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domain	B	CC(C)c1ccc(C(O)P(=O)(O)O)cc1	Outside typical range	CHEMBL24645	>	IC50	nM	10000000.0	CHEMBL267	Homo sapiens	IC50	mM	10.0
	863167	CHEMBL808038	The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domain	B	O=P(O)(O)C(O)c1cccc2ccccc12	Outside typical range	CHEMBL286758	>	IC50	nM	5000000.0	CHEMBL267	Homo sapiens	IC50	mM	5.0
	863168	CHEMBL808038	The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domain	B	O=C(Nc1ccc(OCc2ccccc2)cc1)P(=O)(O)O	Outside typical range	CHEMBL24656	=	IC50	nM	800000.0	CHEMBL267	Homo sapiens	IC50	mM	0.8
	864311	CHEMBL823440	Inhibitory activity against cytosolic c-Src	B	CC(C)(C)NC(=O)Nc1nc2nc(N)ncc2cc1-c1ccccc1		CHEMBL76599	=	IC50	nM	19330.0	CHEMBL267	Homo sapiens	IC50	uM	19.33
	864378	CHEMBL808038	The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domain	B	COC(=O)c1cccc(OP(=O)(O)O)c1	Outside typical range	CHEMBL24101	=	IC50	nM	4000000.0	CHEMBL267	Homo sapiens	IC50	mM	4.0
	864379	CHEMBL808038	The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domain	B	Cc1ccc(OP(=O)(O)O)cc1	Outside typical range	CHEMBL24164	=	IC50	nM	2000000.0	CHEMBL267	Homo sapiens	IC50	mM	2.0
	864380	CHEMBL808038	The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domain	B	N#CC1=CC=C2C=CC=C(O)C2N1OP(=O)(O)O	Outside typical range	CHEMBL286467	>	IC50	nM	10000000.0	CHEMBL267	Homo sapiens	IC50	mM	10.0
	865809	CHEMBL843184	Inhibitory concentration of the against pp60v-src tyrosine kinase obtained from v-src baculovirus-infected insect cells	B	Cn1c(SSc2c(C(=O)Nc3ccccc3)c3cc(Cl)ccc3n2C)c(C(=O)Nc2ccccc2)c2cc(Cl)ccc21		CHEMBL293889	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	865811	CHEMBL843184	Inhibitory concentration of the against pp60v-src tyrosine kinase obtained from v-src baculovirus-infected insect cells	B	Cn1c(SSc2c(C#N)c3ccccc3n2C)c(C#N)c2ccccc21		CHEMBL160566	=	IC50	nM	28000.0	CHEMBL267	Homo sapiens	IC50	uM	28.0
	865813	CHEMBL843183	Inhibition of v-src from baculovirus culture	B	CC1C(=S)N(C)c2ccccc21		CHEMBL346029	>	FC50	uM	100.0	CHEMBL267	Homo sapiens	FC50	uM	100.0
	867146	CHEMBL843183	Inhibition of v-src from baculovirus culture	B	CN(C)CCCn1c(SSc2c(C(=O)Nc3ccccc3)c3ccccc3n2CCCN(C)C)c(C(=O)Nc2ccccc2)c2ccccc21		CHEMBL350699	=	FC50	uM	5.6	CHEMBL267	Homo sapiens	FC50	uM	5.6
	867965	CHEMBL818272	Inhibition of tyrosine kinase(c-Src)	B	Cc1ccc(NC(=O)c2ccc(Cl)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL21162	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	868403	CHEMBL843184	Inhibitory concentration of the against pp60v-src tyrosine kinase obtained from v-src baculovirus-infected insect cells	B	Cc1c(SSc2c(C)c3ccccc3n2C)n(C)c2ccccc12		CHEMBL158879	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	869769	CHEMBL843184	Inhibitory concentration of the against pp60v-src tyrosine kinase obtained from v-src baculovirus-infected insect cells	B	Cn1c(SSc2c(C(N)=O)c3ccccc3n2C)c(C(N)=O)c2ccccc21		CHEMBL157807	=	IC50	nM	800.0	CHEMBL267	Homo sapiens	IC50	uM	0.8
	870937	CHEMBL843184	Inhibitory concentration of the against pp60v-src tyrosine kinase obtained from v-src baculovirus-infected insect cells	B	NC(Cc1c(SSc2[nH]c3ccccc3c2CC(N)C(=O)NCc2ccccc2)[nH]c2ccccc12)C(=O)NCc1ccccc1		CHEMBL336174	=	IC50	nM	600.0	CHEMBL267	Homo sapiens	IC50	uM	0.6
	870939	CHEMBL843184	Inhibitory concentration of the against pp60v-src tyrosine kinase obtained from v-src baculovirus-infected insect cells	B	O=C(Nc1ccccc1)c1c(SSc2[nH]c3ccccc3c2C(=O)Nc2ccccc2)[nH]c2ccccc12		CHEMBL345641	=	IC50	nM	7600.0	CHEMBL267	Homo sapiens	IC50	uM	7.6
	870941	CHEMBL843183	Inhibition of v-src from baculovirus culture	B	CN1C(=S)C(C(=O)c2ccc(C(=O)O)cc2)c2ccccc21		CHEMBL157541	=	FC50	uM	2.1	CHEMBL267	Homo sapiens	FC50	uM	2.1
	871770	CHEMBL818272	Inhibition of tyrosine kinase(c-Src)	B	Cc1ccc([N+](=O)[O-])cc1Nc1nccc(-c2cccnc2)n1		CHEMBL20426	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	872176	CHEMBL843184	Inhibitory concentration of the against pp60v-src tyrosine kinase obtained from v-src baculovirus-infected insect cells	B	Cn1c(SSc2c(C(=O)Nc3cccc(C(=O)O)c3)c3ccccc3n2C)c(C(=O)Nc2cccc(C(=O)O)c2)c2ccccc21		CHEMBL345837	=	IC50	nM	5300.0	CHEMBL267	Homo sapiens	IC50	uM	5.3
	872178	CHEMBL843184	Inhibitory concentration of the against pp60v-src tyrosine kinase obtained from v-src baculovirus-infected insect cells	B	Cn1c(SSc2c(C(=O)c3ccc(C(=O)O)cc3)c3ccccc3n2C)c(C(=O)c2ccc(C(=O)O)cc2)c2ccccc21		CHEMBL346770	=	IC50	nM	4000.0	CHEMBL267	Homo sapiens	IC50	uM	4.0
	872551	CHEMBL808767	Inhibition of Src protein tyrosine kinase	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	=	IC50	nM	30000.0	CHEMBL267	Homo sapiens	IC50	uM	30.0
	873085	CHEMBL818272	Inhibition of tyrosine kinase(c-Src)	B	COc1ccccc1C(=O)Nc1ccc(C)c(Nc2nccc(-c3cccnc3)n2)c1		CHEMBL418010	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
Not Determined	873091	CHEMBL818273	Inhibition of tyrosine kinase(c-Src); Not determined	B	Cc1ccc(NC(=O)c2ccccc2)cc1Nc1nccc(-c2ccc[n+]([O-])c2)n1		CHEMBL21079		IC50	nM		CHEMBL267	Homo sapiens	IC50	uM	
	873215	CHEMBL843063	Binding affinity for p60 c-Src SH2 domain by scintillation proximity assay (SPA)	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(C)=O)C(=O)O		CHEMBL23794	=	IC50	nM	150.0	CHEMBL267	Homo sapiens	IC50	nM	150.0
	873417	CHEMBL843184	Inhibitory concentration of the against pp60v-src tyrosine kinase obtained from v-src baculovirus-infected insect cells	B	Cn1c(SSc2c(C(=O)Nc3ccc(C(=O)O)cc3)c3ccccc3n2C)c(C(=O)Nc2ccc(C(=O)O)cc2)c2ccccc21		CHEMBL347161	=	IC50	nM	4300.0	CHEMBL267	Homo sapiens	IC50	uM	4.3
Not Determined	875260	CHEMBL818273	Inhibition of tyrosine kinase(c-Src); Not determined	B	COc1ccc(NC(=O)c2ccccc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL21086		IC50	nM		CHEMBL267	Homo sapiens	IC50	uM	
	875639	CHEMBL843184	Inhibitory concentration of the against pp60v-src tyrosine kinase obtained from v-src baculovirus-infected insect cells	B	COC(=O)c1ccc(CNC(=O)c2c(SSc3c(C(=O)NCc4ccc(C(=O)OC)cc4)c4ccccc4n3C)n(C)c3ccccc23)cc1		CHEMBL347659	=	IC50	nM	2500.0	CHEMBL267	Homo sapiens	IC50	uM	2.5
	875641	CHEMBL843184	Inhibitory concentration of the against pp60v-src tyrosine kinase obtained from v-src baculovirus-infected insect cells	B	COC(=O)c1cccc(NC(=O)c2c(SSc3c(C(=O)Nc4cccc(C(=O)OC)c4)c4ccccc4n3C)n(C)c3ccccc23)c1		CHEMBL158596	=	IC50	nM	5400.0	CHEMBL267	Homo sapiens	IC50	uM	5.4
	876978	CHEMBL843184	Inhibitory concentration of the against pp60v-src tyrosine kinase obtained from v-src baculovirus-infected insect cells	B	Cn1c(SSc2c(C(=O)NCC(O)CO)c3ccccc3n2C)c(C(=O)NCC(O)CO)c2ccccc21		CHEMBL158797	=	IC50	nM	22500.0	CHEMBL267	Homo sapiens	IC50	uM	22.5
	876980	CHEMBL843184	Inhibitory concentration of the against pp60v-src tyrosine kinase obtained from v-src baculovirus-infected insect cells	B	COC(=O)c1ccc(NC(=O)c2c(SSc3c(C(=O)Nc4ccc(C(=O)OC)cc4)c4ccccc4n3C)n(C)c3ccccc23)cc1		CHEMBL348069	=	IC50	nM	4200.0	CHEMBL267	Homo sapiens	IC50	uM	4.2
	876982	CHEMBL843184	Inhibitory concentration of the against pp60v-src tyrosine kinase obtained from v-src baculovirus-infected insect cells	B	COC(=O)c1ccc(C(=O)c2c(SSc3c(C(=O)c4ccc(C(=O)OC)cc4)c4ccccc4n3C)n(C)c3ccccc23)cc1		CHEMBL346553	=	IC50	nM	7100.0	CHEMBL267	Homo sapiens	IC50	uM	7.1
	878220	CHEMBL843183	Inhibition of v-src from baculovirus culture	B	CN1C(=S)C(C(=O)Nc2ccccc2)c2ccccc21		CHEMBL62176	=	FC50	uM	10.0	CHEMBL267	Homo sapiens	FC50	uM	10.0
	879426	CHEMBL843184	Inhibitory concentration of the against pp60v-src tyrosine kinase obtained from v-src baculovirus-infected insect cells	B	Cn1c(SSc2c(C(=O)Nc3cccnc3)c3ccccc3n2C)c(C(=O)Nc2cccnc2)c2ccccc21		CHEMBL352010	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	879428	CHEMBL843184	Inhibitory concentration of the against pp60v-src tyrosine kinase obtained from v-src baculovirus-infected insect cells	B	CC(=O)c1c(SSc2c(C(C)=O)c3ccccc3n2C)n(C)c2ccccc12		CHEMBL351920	=	IC50	nM	11500.0	CHEMBL267	Homo sapiens	IC50	uM	11.5
	881615	CHEMBL818272	Inhibition of tyrosine kinase(c-Src)	B	Cc1ccc(N)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL278103	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
Not Determined	882800	CHEMBL818273	Inhibition of tyrosine kinase(c-Src); Not determined	B	Cc1ccc(N(C)C(=O)c2ccccc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL278287		IC50	nM		CHEMBL267	Homo sapiens	IC50	uM	
	883184	CHEMBL843184	Inhibitory concentration of the against pp60v-src tyrosine kinase obtained from v-src baculovirus-infected insect cells	B	CNC(=O)c1c(SSc2[nH]c3ccccc3c2C(=O)NC)[nH]c2ccccc12		CHEMBL161226	=	IC50	nM	7900.0	CHEMBL267	Homo sapiens	IC50	uM	7.9
	883186	CHEMBL843183	Inhibition of v-src from baculovirus culture	B	COC(=O)c1ccc(C(=O)C2C(=S)N(C)c3ccccc32)cc1		CHEMBL158796	>	FC50	uM	100.0	CHEMBL267	Homo sapiens	FC50	uM	100.0
Not Determined	883859	CHEMBL818273	Inhibition of tyrosine kinase(c-Src); Not determined	B	Cc1ccc(N(C(=O)c2ccccc2)C(=O)c2ccccc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL277430		IC50	nM		CHEMBL267	Homo sapiens	IC50	uM	
Not Determined	883865	CHEMBL818273	Inhibition of tyrosine kinase(c-Src); Not determined	B	CNc1ccc(C)c(Nc2nccc(-c3cccnc3)n2)c1		CHEMBL21215		IC50	nM		CHEMBL267	Homo sapiens	IC50	uM	
	884335	CHEMBL843184	Inhibitory concentration of the against pp60v-src tyrosine kinase obtained from v-src baculovirus-infected insect cells	B	CN(C(=O)c1c(SSc2c(C(=O)N(C)c3ccccc3)c3ccccc3n2C)n(C)c2ccccc12)c1ccccc1		CHEMBL347256	=	IC50	nM	5500.0	CHEMBL267	Homo sapiens	IC50	uM	5.5
	885616	CHEMBL843184	Inhibitory concentration of the against pp60v-src tyrosine kinase obtained from v-src baculovirus-infected insect cells	B	c1ccc(-c2c(SSc3[nH]c4ccccc4c3-c3ccccc3)[nH]c3ccccc23)cc1		CHEMBL422540	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	886645	CHEMBL818272	Inhibition of tyrosine kinase(c-Src)	B	O=C(Nc1cccc(Nc2nccc(-c3cccnc3)n2)c1)c1ccccc1		CHEMBL277931	=	IC50	nM	15700.0	CHEMBL267	Homo sapiens	IC50	uM	15.7
	887029	CHEMBL843184	Inhibitory concentration of the against pp60v-src tyrosine kinase obtained from v-src baculovirus-infected insect cells	B	Cn1c(SSc2c(C(=O)Nc3ccccn3)c3ccccc3n2C)c(C(=O)Nc2ccccn2)c2ccccc21		CHEMBL435054	=	IC50	nM	47000.0	CHEMBL267	Homo sapiens	IC50	uM	47.0
	888101	CHEMBL843184	Inhibitory concentration of the against pp60v-src tyrosine kinase obtained from v-src baculovirus-infected insect cells	B	Cn1c(SSc2c(C(=O)NCC(=O)O)c3ccccc3n2C)c(C(=O)NCC(=O)O)c2ccccc21		CHEMBL345211	=	IC50	nM	1000.0	CHEMBL267	Homo sapiens	IC50	uM	1.0
	888103	CHEMBL843184	Inhibitory concentration of the against pp60v-src tyrosine kinase obtained from v-src baculovirus-infected insect cells	B	Cn1c(SSc2c(C(=O)Nc3cccs3)c3ccccc3n2C)c(C(=O)Nc2cccs2)c2ccccc21		CHEMBL345622	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	888936	CHEMBL818272	Inhibition of tyrosine kinase(c-Src)	B	Cc1ccc(C(=O)Nc2ccc(C)c(Nc3nccc(-c4cccnc4)n3)c2)cc1		CHEMBL20867	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	889078	CHEMBL843063	Binding affinity for p60 c-Src SH2 domain by scintillation proximity assay (SPA)	B	CC(=O)N[C@@H](Cc1ccc(C(F)(F)P(=O)(O)O)cc1)C(=O)NC(C)c1nc(SCC2CCCCC2)c(C(N)=O)n1C		CHEMBL23531	=	IC50	nM	5300.0	CHEMBL267	Homo sapiens	IC50	uM	5.3
	889315	CHEMBL843184	Inhibitory concentration of the against pp60v-src tyrosine kinase obtained from v-src baculovirus-infected insect cells	B	Cn1c(SSc2c(C(=O)NCc3ccc(C(=O)O)cc3)c3ccccc3n2C)c(C(=O)NCc2ccc(C(=O)O)cc2)c2ccccc21		CHEMBL158805	=	IC50	nM	800.0	CHEMBL267	Homo sapiens	IC50	uM	0.8
	889317	CHEMBL843184	Inhibitory concentration of the against pp60v-src tyrosine kinase obtained from v-src baculovirus-infected insect cells	B	Cn1c(SSc2c(C(=O)Nc3ccccc3)c3ccccc3n2C)c(C(=O)Nc2ccccc2)c2ccccc21		CHEMBL304414	=	IC50	nM	3200.0	CHEMBL267	Homo sapiens	IC50	uM	3.2
	890221	CHEMBL818272	Inhibition of tyrosine kinase(c-Src)	B	Cc1ccc(NC(=O)c2ccc3ccccc3c2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL20252	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	890625	CHEMBL843184	Inhibitory concentration of the against pp60v-src tyrosine kinase obtained from v-src baculovirus-infected insect cells	B	Cn1c(SSc2c(C(=O)Nc3ccccc3C(=O)O)c3ccccc3n2C)c(C(=O)Nc2ccccc2C(=O)O)c2ccccc21		CHEMBL345862	=	IC50	nM	3500.0	CHEMBL267	Homo sapiens	IC50	uM	3.5
	891451	CHEMBL818272	Inhibition of tyrosine kinase(c-Src)	B	Cc1ccc(NC(=O)c2ccccc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL20926	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	891784	CHEMBL843184	Inhibitory concentration of the against pp60v-src tyrosine kinase obtained from v-src baculovirus-infected insect cells	B	Cn1c(SSc2c(C(=O)Nc3ccccc3)c3cc(C(F)(F)F)ccc3n2C)c(C(=O)Nc2ccccc2)c2cc(C(F)(F)F)ccc21		CHEMBL61278	=	IC50	nM	5800.0	CHEMBL267	Homo sapiens	IC50	uM	5.8
	891786	CHEMBL843184	Inhibitory concentration of the against pp60v-src tyrosine kinase obtained from v-src baculovirus-infected insect cells	B	Cn1c(SSc2c(C(=O)Nc3ccncc3)c3ccccc3n2C)c(C(=O)Nc2ccncc2)c2ccccc21		CHEMBL156281	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	892575	CHEMBL818272	Inhibition of tyrosine kinase(c-Src)	B	Cc1ccc(NC(=O)c2ccccc2)cc1Nc1nccc(-c2cccs2)n1		CHEMBL21078	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	892906	CHEMBL843183	Inhibition of v-src from baculovirus culture	B	CC(=O)C1C(=S)N(C)c2ccccc21		CHEMBL158328	>	FC50	uM	50.0	CHEMBL267	Homo sapiens	FC50	uM	50.0
	894015	CHEMBL843184	Inhibitory concentration of the against pp60v-src tyrosine kinase obtained from v-src baculovirus-infected insect cells	B	Cc1ccc(S(=O)(=O)c2c(SSc3[nH]c4ccccc4c3S(=O)(=O)c3ccc(C)cc3)[nH]c3ccccc23)cc1		CHEMBL347854	=	IC50	nM	5500.0	CHEMBL267	Homo sapiens	IC50	uM	5.5
	895112	CHEMBL843184	Inhibitory concentration of the against pp60v-src tyrosine kinase obtained from v-src baculovirus-infected insect cells	B	Cn1c(SSc2c(C(=O)c3ccccc3)c3ccccc3n2C)c(C(=O)c2ccccc2)c2ccccc21		CHEMBL349322	=	IC50	nM	2600.0	CHEMBL267	Homo sapiens	IC50	uM	2.6
	895114	CHEMBL843184	Inhibitory concentration of the against pp60v-src tyrosine kinase obtained from v-src baculovirus-infected insect cells	B	CCn1c(SSc2c(C(=O)Nc3ccccc3)c3ccccc3n2CC)c(C(=O)Nc2ccccc2)c2ccccc21		CHEMBL156020	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	895453	CHEMBL808767	Inhibition of Src protein tyrosine kinase	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCOCC1		CHEMBL125898	>	IC50	nM	30000.0	CHEMBL267	Homo sapiens	IC50	uM	30.0
	896296	CHEMBL843183	Inhibition of v-src from baculovirus culture	B	CN1C(=S)C(C(=O)c2ccccc2)c2ccccc21		CHEMBL158706	=	FC50	uM	69.0	CHEMBL267	Homo sapiens	FC50	uM	69.0
	897195	CHEMBL818272	Inhibition of tyrosine kinase(c-Src)	B	CC(=O)Nc1ccc(C)c(Nc2nccc(-c3cccnc3)n2)c1		CHEMBL423288	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	897526	CHEMBL843184	Inhibitory concentration of the against pp60v-src tyrosine kinase obtained from v-src baculovirus-infected insect cells	B	COC(=O)c1ccccc1NC(=O)c1c(SSc2c(C(=O)Nc3ccccc3C(=O)OC)c3ccccc3n2C)n(C)c2ccccc12		CHEMBL349762	=	IC50	nM	15600.0	CHEMBL267	Homo sapiens	IC50	uM	15.6
	897528	CHEMBL843183	Inhibition of v-src from baculovirus culture	B	CN1C(=S)C(C(=O)c2ccco2)c2ccccc21		CHEMBL346006	=	FC50	uM	10.8	CHEMBL267	Homo sapiens	FC50	uM	10.8
	897803	CHEMBL805366	Inhibition of Src protein tyrosine kinase	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	70.0	CHEMBL267	Homo sapiens	IC50	uM	0.07
	898560	CHEMBL843063	Binding affinity for p60 c-Src SH2 domain by scintillation proximity assay (SPA)	B	CCOC(=O)c1c(SCC2CCCCC2)nc(C(C)NC(=O)[C@H](Cc2ccc(OP(=O)(O)O)cc2)NC(C)=O)n1C		CHEMBL23311	=	IC50	nM	6900.0	CHEMBL267	Homo sapiens	IC50	uM	6.9
	898779	CHEMBL843184	Inhibitory concentration of the against pp60v-src tyrosine kinase obtained from v-src baculovirus-infected insect cells	B	CN(C)C(=O)c1c(SSc2c(C(=O)N(C)C)c3ccccc3n2C)n(C)c2ccccc12		CHEMBL160207	=	IC50	nM	500.0	CHEMBL267	Homo sapiens	IC50	uM	0.5
	898940	CHEMBL822806	Inhibition of c-Src tyrosine kinase	B	CCn1c(=O)ccc2cnc(Nc3ccccc3)nc21		CHEMBL142648	=	IC50	nM	21000.0	CHEMBL267	Homo sapiens	IC50	uM	21.0
Not Determined	899645	CHEMBL818273	Inhibition of tyrosine kinase(c-Src); Not determined	B	O=C(Nc1ccc(Cl)c(Nc2nccc(-c3cccnc3)n2)c1)c1ccccc1		CHEMBL278630		IC50	nM		CHEMBL267	Homo sapiens	IC50	uM	
	900059	CHEMBL843184	Inhibitory concentration of the against pp60v-src tyrosine kinase obtained from v-src baculovirus-infected insect cells	B	CNC(=O)c1c(SSc2c(C(=O)NC)c3ccccc3n2C)n(C)c2ccccc12		CHEMBL342929	=	IC50	nM	6700.0	CHEMBL267	Homo sapiens	IC50	uM	6.7
	900062	CHEMBL843184	Inhibitory concentration of the against pp60v-src tyrosine kinase obtained from v-src baculovirus-infected insect cells	B	CN(C)CCNC(=O)c1c(SSc2c(C(=O)NCCN(C)C)c3ccccc3n2C)n(C)c2ccccc12		CHEMBL348554	=	IC50	nM	15200.0	CHEMBL267	Homo sapiens	IC50	uM	15.2
	901026	CHEMBL843063	Binding affinity for p60 c-Src SH2 domain by scintillation proximity assay (SPA)	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)NC(C)c1nc(SCC2CCCCC2)c(C(N)=O)n1C		CHEMBL22598	=	IC50	nM	8600.0	CHEMBL267	Homo sapiens	IC50	uM	8.6
	901221	CHEMBL843184	Inhibitory concentration of the against pp60v-src tyrosine kinase obtained from v-src baculovirus-infected insect cells	B	Cn1c(SSc2c(C(=O)c3ccco3)c3ccccc3n2C)c(C(=O)c2ccco2)c2ccccc21		CHEMBL160935	=	IC50	nM	8300.0	CHEMBL267	Homo sapiens	IC50	uM	8.3
	902566	CHEMBL843184	Inhibitory concentration of the against pp60v-src tyrosine kinase obtained from v-src baculovirus-infected insect cells	B	O=C(NCc1ccccc1)c1c(SSc2[nH]c3ccccc3c2C(=O)NCc2ccccc2)[nH]c2ccccc12		CHEMBL347160	=	IC50	nM	16300.0	CHEMBL267	Homo sapiens	IC50	uM	16.3
	903741	CHEMBL843184	Inhibitory concentration of the against pp60v-src tyrosine kinase obtained from v-src baculovirus-infected insect cells	B	O=C(O)CCc1c(SSc2[nH]c3ccccc3c2CCC(=O)O)[nH]c2ccccc12		CHEMBL79704	=	IC50	nM	5100.0	CHEMBL267	Homo sapiens	IC50	uM	5.1
	903743	CHEMBL843184	Inhibitory concentration of the against pp60v-src tyrosine kinase obtained from v-src baculovirus-infected insect cells	B	Cn1c(SSc2c(C(=O)NCc3ccccc3)c3ccccc3n2C)c(C(=O)NCc2ccccc2)c2ccccc21		CHEMBL158275	=	IC50	nM	8000.0	CHEMBL267	Homo sapiens	IC50	uM	8.0
	904890	CHEMBL806419	Inhibition of binding to Src SH2 domain	B	CC(=O)NC(Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](C)c1ccc(OCC2CCCCC2)c(C(N)=O)c1		CHEMBL77638	=	IC50	nM	2700.0	CHEMBL267	Homo sapiens	IC50	uM	2.7
	905993	CHEMBL822803	Inhibition of c-Src-tyrosine kinase.	B	O=[N+]([O-])c1cccc(Nc2nccc(-c3ccccn3)n2)c1		CHEMBL60816	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	907476	CHEMBL822803	Inhibition of c-Src-tyrosine kinase.	B	Cc1ccc(C(=O)Nc2ccc(C)c(Nc3nccc(-c4cccnc4)n3)c2)cc1		CHEMBL20867	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	909965	CHEMBL822803	Inhibition of c-Src-tyrosine kinase.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	909974	CHEMBL822803	Inhibition of c-Src-tyrosine kinase.	B	FC(F)C(F)(F)Oc1cccc(Nc2nccc(-c3ccc(Cl)cc3)n2)c1		CHEMBL57581	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	910237	CHEMBL807850	Inhibition of src Protein Tyrosine Kinase	B	CC(CCc1ccc(O)cc1)OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1		CHEMBL148745	=	IC50	nM		CHEMBL267	Homo sapiens	IC50	uM	
	911305	CHEMBL683013	Affinity for GST- Src-SH2 domain in ELISA	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NOC(=O)Cc1cc(=O)oc2cc(O)ccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)O		CHEMBL90976	=	IC50	nM	90.0	CHEMBL267	Homo sapiens	IC50	uM	0.09
	912526	CHEMBL822803	Inhibition of c-Src-tyrosine kinase.	B	Cc1ccc(NC(=O)c2ccc(Cl)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL21162	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	912533	CHEMBL822803	Inhibition of c-Src-tyrosine kinase.	B	Clc1cccc(Nc2nccc(-c3cccnc3)n2)c1		CHEMBL300817	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	913911	CHEMBL822803	Inhibition of c-Src-tyrosine kinase.	B	O=C(Nc1cccc(Nc2nccc(-c3cccnc3)n2)c1)c1ccccc1		CHEMBL277931	=	IC50	nM	15700.0	CHEMBL267	Homo sapiens	IC50	uM	15.7
	913918	CHEMBL822803	Inhibition of c-Src-tyrosine kinase.	B	O=C(O)c1cccc(Nc2nccc(-c3cccnc3)n2)c1	Outside typical range	CHEMBL57556	=	IC50	nM	126000.0	CHEMBL267	Homo sapiens	IC50	uM	126.0
	915413	CHEMBL806419	Inhibition of binding to Src SH2 domain	B	CC(C)(NC(=O)CCc1ccc(O)c(P(=O)(O)O)c1)c1ccc(OCC2CCCCC2)c(C(N)=O)c1	Outside typical range	CHEMBL76937	>	IC50	nM	500000.0	CHEMBL267	Homo sapiens	IC50	uM	500.0
	915746	CHEMBL806343	Inhibition of human Src tyrosine kinase at 10 uM	B	O=C1NC(=O)C2=C1c1cn(c3ncccc13)CCOCCOCCOCCn1cc2c2cccnc21		CHEMBL340776	=	Activity	%	90.0	CHEMBL267	Homo sapiens	Activity	%	90.0
	917717	CHEMBL822803	Inhibition of c-Src-tyrosine kinase.	B	Cc1ccc(NC(=O)c2ccc3ccccc3c2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL20252	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	917724	CHEMBL822803	Inhibition of c-Src-tyrosine kinase.	B	CC(=O)Nc1ccc(C)c(Nc2nccc(-c3cccnc3)n2)c1		CHEMBL423288	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	917903	CHEMBL806419	Inhibition of binding to Src SH2 domain	B	CC(=O)NC(Cc1ccc(OCC(=O)O)c(P(=O)(O)O)c1)C(=O)N[C@@H](C)c1ccc(OCC2CCCCC2)c(C(N)=O)c1		CHEMBL76350	=	IC50	nM	3600.0	CHEMBL267	Homo sapiens	IC50	uM	3.6
	919071	CHEMBL822803	Inhibition of c-Src-tyrosine kinase.	B	O=C(Nc1cccc(Nc2nccc(-c3cccnc3)n2)c1)c1ccc(F)cc1		CHEMBL418279	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	919078	CHEMBL822803	Inhibition of c-Src-tyrosine kinase.	B	O=[N+]([O-])c1cccc(Nc2nccc(-c3ccncc3)n2)c1		CHEMBL55683	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	920263	CHEMBL806419	Inhibition of binding to Src SH2 domain	B	CC(=O)NC(Cc1ccc(OCC(=O)O)cc1)C(=O)N[C@@H](C)c1ccc(OCC2CCCCC2)c(C(N)=O)c1	Outside typical range	CHEMBL75182	=	IC50	nM	370000.0	CHEMBL267	Homo sapiens	IC50	uM	370.0
	921288	CHEMBL822803	Inhibition of c-Src-tyrosine kinase.	B	NCCCNC(=O)c1cccc(Nc2nccc(-c3cccnc3)n2)c1		CHEMBL59099	=	IC50	nM	9800.0	CHEMBL267	Homo sapiens	IC50	uM	9.8
	921424	CHEMBL683013	Affinity for GST- Src-SH2 domain in ELISA	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(C)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)O		CHEMBL299477	=	IC50	nM	2000.0	CHEMBL267	Homo sapiens	IC50	uM	2.0
	922564	CHEMBL822803	Inhibition of c-Src-tyrosine kinase.	B	Nc1cccc(Nc2nccc(-c3ccncc3)n2)c1		CHEMBL57443	=	IC50	nM	16000.0	CHEMBL267	Homo sapiens	IC50	uM	16.0
	922711	CHEMBL806419	Inhibition of binding to Src SH2 domain	B	CC(=O)NC(Cc1ccc(OCC(=O)O)c(P(=O)(O)O)c1)C(=O)Nc1ccc(OCC2CCCCC2)c(C(N)=O)c1	Outside typical range	CHEMBL308164	>	IC50	nM	500000.0	CHEMBL267	Homo sapiens	IC50	uM	500.0
	923898	CHEMBL683013	Affinity for GST- Src-SH2 domain in ELISA	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(C)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Outside typical range	CHEMBL329886	>	IC50	nM	200000.0	CHEMBL267	Homo sapiens	IC50	uM	200.0
	923905	CHEMBL806419	Inhibition of binding to Src SH2 domain	B	CC(=O)NC(Cc1ccc(OCC(=O)O)c(P(=O)(O)O)c1)C(=O)NC(C)(C)c1ccc(OCC2CCCCC2)c(C(N)=O)c1		CHEMBL265777	=	IC50	nM	3200.0	CHEMBL267	Homo sapiens	IC50	uM	3.2
	926654	CHEMBL822803	Inhibition of c-Src-tyrosine kinase.	B	CCCCCC(=O)Nc1cccc(Nc2nccc(-c3cccnc3)n2)c1		CHEMBL56669	=	IC50	nM	3700.0	CHEMBL267	Homo sapiens	IC50	uM	3.7
	926803	CHEMBL683013	Affinity for GST- Src-SH2 domain in ELISA	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)C(Cc1ccc(O)c(O)c1)NOC(=O)CC1=CCC(=O)c2cc(O)ccc21)C(=O)N[C@@H](CCC(=O)O)C(=O)O		CHEMBL430902	=	IC50	nM	65000.0	CHEMBL267	Homo sapiens	IC50	uM	65.0
	928093	CHEMBL822803	Inhibition of c-Src-tyrosine kinase.	B	c1cc(Nc2nccc(-c3cccnc3)n2)cc(OCCn2ccnc2)c1		CHEMBL58436	=	IC50	nM	4900.0	CHEMBL267	Homo sapiens	IC50	uM	4.9
	928100	CHEMBL822803	Inhibition of c-Src-tyrosine kinase.	B	Cc1ccc(C(=O)Nc2cccc(Nc3nccc(-c4cccnc4)n3)c2)cc1		CHEMBL59036	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	928364	CHEMBL807850	Inhibition of src Protein Tyrosine Kinase	B	O=C(OCC(Cc1ccc(O)cc1)NS(=O)(=O)c1ccccc1)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1		CHEMBL358264	>	IC50	nM	12500.0	CHEMBL267	Homo sapiens	IC50	uM	12.5
	929356	CHEMBL822803	Inhibition of c-Src-tyrosine kinase.	B	COc1ccccc1C(=O)Nc1cccc(Nc2nccc(-c3cccnc3)n2)c1		CHEMBL299707	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	929363	CHEMBL822803	Inhibition of c-Src-tyrosine kinase.	B	c1cncc(-c2ccnc(Nc3cccc(-n4ccnc4)c3)n2)c1		CHEMBL291963	=	IC50	nM	1600.0	CHEMBL267	Homo sapiens	IC50	uM	1.6
	929370	CHEMBL822803	Inhibition of c-Src-tyrosine kinase.	B	O=C(Nc1cccc(Nc2nccc(-c3cccnc3)n2)c1)c1ccccn1		CHEMBL292866	=	IC50	nM	90000.0	CHEMBL267	Homo sapiens	IC50	uM	90.0
	929501	CHEMBL683013	Affinity for GST- Src-SH2 domain in ELISA	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(C)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)O		CHEMBL90294	=	IC50	nM	7000.0	CHEMBL267	Homo sapiens	IC50	uM	7.0
	930629	CHEMBL822803	Inhibition of c-Src-tyrosine kinase.	B	COC(=O)c1cccc(Nc2nccc(-c3cccnc3)n2)c1		CHEMBL56671	=	IC50	nM	90000.0	CHEMBL267	Homo sapiens	IC50	uM	90.0
	930773	CHEMBL683013	Affinity for GST- Src-SH2 domain in ELISA	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)N/C=C/c1ccc(O)c(O)c1)C(=O)N[C@@H](CCC(=O)O)C(=O)O		CHEMBL432649	=	IC50	nM	64.0	CHEMBL267	Homo sapiens	IC50	uM	0.064
	930796	CHEMBL806419	Inhibition of binding to Src SH2 domain	B	CCOP(=O)(O)c1cc(CC(NC(C)=O)C(=O)N[C@@H](C)c2ccc(OCC3CCCCC3)c(C(N)=O)c2)ccc1OCC(=O)O		CHEMBL308734	=	IC50	nM	7300.0	CHEMBL267	Homo sapiens	IC50	uM	7.3
	931207	CHEMBL806343	Inhibition of human Src tyrosine kinase at 10 uM	B	O=C1NC(=O)C2=C1c1cn(c3ncccc13)CCOCCOCCOCCOCCn1cc2c2cccnc21		CHEMBL337642	=	Activity	%	89.0	CHEMBL267	Homo sapiens	Activity	%	89.0
	931992	CHEMBL822803	Inhibition of c-Src-tyrosine kinase.	B	FC(F)C(F)(F)Oc1cccc(Nc2nccc(-c3c[nH]c4ccccc34)n2)c1		CHEMBL55379	=	IC50	nM	2200.0	CHEMBL267	Homo sapiens	IC50	uM	2.2
	931999	CHEMBL822803	Inhibition of c-Src-tyrosine kinase.	B	O=C(O)c1ccccc1C(=O)Nc1cccc(Nc2nccc(-c3cccnc3)n2)c1		CHEMBL55742	=	IC50	nM	44000.0	CHEMBL267	Homo sapiens	IC50	uM	44.0
	933463	CHEMBL822803	Inhibition of c-Src-tyrosine kinase.	B	CN1CCN(Cc2ccc(C(=O)Nc3cccc(Nc4nccc(-c5cccnc5)n4)c3)cc2)CC1		CHEMBL56904	=	IC50	nM	7800.0	CHEMBL267	Homo sapiens	IC50	uM	7.8
	933471	CHEMBL822803	Inhibition of c-Src-tyrosine kinase.	B	O=C(Nc1cccc(Nc2nccc(-c3cccnc3)n2)c1)c1cccnc1		CHEMBL418270	=	IC50	nM	9000.0	CHEMBL267	Homo sapiens	IC50	uM	9.0
	933479	CHEMBL822803	Inhibition of c-Src-tyrosine kinase.	B	NCCCn1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)C(F)F)c4)n3)cccc21		CHEMBL293991	=	IC50	nM	500.0	CHEMBL267	Homo sapiens	IC50	uM	0.5
	933486	CHEMBL822803	Inhibition of c-Src-tyrosine kinase.	B	COc1ccccc1C(=O)Nc1ccc(C)c(Nc2nccc(-c3cccnc3)n2)c1		CHEMBL418010	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	936347	CHEMBL822803	Inhibition of c-Src-tyrosine kinase.	B	O=C(Nc1cccc(Nc2nccc(-c3cccnc3)n2)c1)c1cccs1		CHEMBL56359	=	IC50	nM	3000.0	CHEMBL267	Homo sapiens	IC50	uM	3.0
	936519	CHEMBL806419	Inhibition of binding to Src SH2 domain	B	CC(C)(NC(=O)CCc1ccc(OS(=O)(=O)C(F)(F)F)c(P(=O)(O)O)c1)c1ccc(OCC2CCCCC2)c(C(N)=O)c1	Outside typical range	CHEMBL430825	>	IC50	nM	500000.0	CHEMBL267	Homo sapiens	IC50	uM	500.0
	936664	CHEMBL807850	Inhibition of src Protein Tyrosine Kinase	B	O=C(OC1CCCC1Cc1ccc(O)cc1)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1		CHEMBL295806	>	IC50	nM	12500.0	CHEMBL267	Homo sapiens	IC50	uM	12.5
	937851	CHEMBL822803	Inhibition of c-Src-tyrosine kinase.	B	Cc1ccc(NC(=O)c2ccccc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL20926	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	939084	CHEMBL844769	Inhibition of human pp60c-src SH3-SH2 domain binding to autophosphorylated EGFR.	B	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(C)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)O		CHEMBL1790417	<	IC50	nM	500.0	CHEMBL267	Homo sapiens	IC50	uM	0.5
	939137	CHEMBL822803	Inhibition of c-Src-tyrosine kinase.	B	Cc1ccc(N)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL278103	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	939144	CHEMBL822803	Inhibition of c-Src-tyrosine kinase.	B	c1ccc(Nc2nccc(-c3cccnc3)n2)cc1		CHEMBL57690	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	939273	CHEMBL683013	Affinity for GST- Src-SH2 domain in ELISA	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(O)c(O)c1)NC(=O)/C=C/c1ccc(O)c(O)c1)C(=O)N[C@@H](CCC(=O)O)C(=O)O		CHEMBL328034	=	IC50	nM	55000.0	CHEMBL267	Homo sapiens	IC50	uM	55.0
	939429	CHEMBL807850	Inhibition of src Protein Tyrosine Kinase	B	O=C(N[C@@H]1CNCCC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL60254	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	940390	CHEMBL822803	Inhibition of c-Src-tyrosine kinase.	B	FC(F)C(F)(F)Oc1cccc(Nc2nccc(-c3ccncc3)n2)c1		CHEMBL55662	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	941710	CHEMBL822803	Inhibition of c-Src-tyrosine kinase.	B	O=C(Nc1cccc(Nc2nccc(-c3cccnc3)n2)c1)c1ccncc1		CHEMBL55592	=	IC50	nM	78000.0	CHEMBL267	Homo sapiens	IC50	uM	78.0
	941717	CHEMBL822803	Inhibition of c-Src-tyrosine kinase.	B	Nc1cccc(Nc2nccc(-c3cccnc3)n2)c1		CHEMBL57553	=	IC50	nM	14000.0	CHEMBL267	Homo sapiens	IC50	uM	14.0
	941883	CHEMBL683013	Affinity for GST- Src-SH2 domain in ELISA	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)/C=C/c1ccc(O)c(O)c1)C(=O)N[C@@H](CCC(=O)O)C(=O)O		CHEMBL327820	=	IC50	nM	54000.0	CHEMBL267	Homo sapiens	IC50	uM	54.0
	941899	CHEMBL806419	Inhibition of binding to Src SH2 domain	B	CC(=O)NC(Cc1ccc(OCC(=O)O)c(P(=O)(O)O)c1)C(=O)NCc1ccc(OCC2CCCCC2)c(C(N)=O)c1	Outside typical range	CHEMBL263721	=	IC50	nM	378000.0	CHEMBL267	Homo sapiens	IC50	uM	378.0
	942928	CHEMBL822803	Inhibition of c-Src-tyrosine kinase.	B	O=[N+]([O-])c1cccc(Nc2nccc(-c3cccnc3)n2)c1		CHEMBL56081	=	IC50	nM	93000.0	CHEMBL267	Homo sapiens	IC50	uM	93.0
	943110	CHEMBL683013	Affinity for GST- Src-SH2 domain in ELISA	B	CC(=O)N[C@@H](Cc1ccc(O)c(O)c1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Outside typical range	CHEMBL2370170	=	IC50	nM	160000.0	CHEMBL267	Homo sapiens	IC50	uM	160.0
	943135	CHEMBL806419	Inhibition of binding to Src SH2 domain	B	CC(C)(NC(=O)CCc1ccc(OCC(=O)O)c(P(=O)(O)O)c1)c1ccc(OCC2CCCCC2)c(C(N)=O)c1		CHEMBL433507	=	IC50	nM	35400.0	CHEMBL267	Homo sapiens	IC50	uM	35.4
	944416	CHEMBL822803	Inhibition of c-Src-tyrosine kinase.	B	O=C(Nc1cccc(Nc2nccc(-c3cccnc3)n2)c1)C1CCCCC1		CHEMBL58142	=	IC50	nM	46000.0	CHEMBL267	Homo sapiens	IC50	uM	46.0
	945632	CHEMBL822803	Inhibition of c-Src-tyrosine kinase.	B	N#Cc1ccc(C(=O)Nc2cccc(Nc3nccc(-c4cccnc4)n3)c2)cc1		CHEMBL58580	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	945805	CHEMBL806419	Inhibition of binding to Src SH2 domain	B	CC(C)(NC(=O)CCc1ccc(OCn2cnnn2)c(P(=O)(O)O)c1)c1ccc(OCC2CCCCC2)c(C(N)=O)c1	Outside typical range	CHEMBL311114	>	IC50	nM	500000.0	CHEMBL267	Homo sapiens	IC50	uM	500.0
	947203	CHEMBL806414	Binding affinity against Src SH2 domain	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CCC(N)=O)c1nc(Cc2cccc(Cl)c2)no1	Outside typical range	CHEMBL423330	=	IC50	nM	259000.0	CHEMBL267	Homo sapiens	IC50	uM	259.0
	947206	CHEMBL806414	Binding affinity against Src SH2 domain	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CO)c1nc(Cc2ccc(Cl)c(Cl)c2)no1		CHEMBL316967	=	IC50	nM	75000.0	CHEMBL267	Homo sapiens	IC50	uM	75.0
	947210	CHEMBL806414	Binding affinity against Src SH2 domain	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CO)c1nc(Cc2ccc(I)cc2)no1		CHEMBL132006	=	IC50	nM	37000.0	CHEMBL267	Homo sapiens	IC50	uM	37.0
	948211	CHEMBL809579	In vitro inhibition of c-src tyrosine kinase.	B	COc1cc2ncnc(Nc3cc(OC)c(OC(C)(C)C)c(OC)c3)c2cc1OC		CHEMBL444324	=	IC50	nM	2700.0	CHEMBL267	Homo sapiens	IC50	nM	2700.0
	948212	CHEMBL809579	In vitro inhibition of c-src tyrosine kinase.	B	COc1cc2c(Nc3cc(OC)c(OC)c(OC)c3)c(C#N)cnc2cc1OCCCN1CCC(O)CC1		CHEMBL84179	=	IC50	nM	5.3	CHEMBL267	Homo sapiens	IC50	nM	5.3
	948213	CHEMBL785002	Inhibition of c-Src transformed Rat2 fibroblast cell proliferation in anchorage independent assay	F	COc1cc2c(Nc3cc(OC)c(OC)c(OC)c3)c(C#N)cnc2cc1OCCCN1CCC(O)CC1		CHEMBL84179	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	948457	CHEMBL806414	Binding affinity against Src SH2 domain	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CCC(N)=O)c1nc(Cc2ccccc2)no1		CHEMBL77067	=	IC50	nM	72000.0	CHEMBL267	Homo sapiens	IC50	uM	72.0
	948461	CHEMBL806414	Binding affinity against Src SH2 domain	B	CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(N)=O)C(C)C		CHEMBL411163	=	IC50	nM	20000.0	CHEMBL267	Homo sapiens	IC50	uM	20.0
	949380	CHEMBL823857	Inhibition of human purified recombinant pp60c-src tyrosine kinase at 100 uM	B	COc1ccc(CNC(=O)c2cc3cccc(O)c3cc2O)cc1		CHEMBL343869	=	Inhibition	%	14.0	CHEMBL267	Homo sapiens	Inhibition	%	14.0
Not Determined	949381	CHEMBL823239	Inhibition of human purified recombinant pp60c-src tyrosine kinase	B	COc1ccc(CNC(=O)c2cc3cccc(O)c3cc2O)cc1		CHEMBL343869		IC50	nM		CHEMBL267	Homo sapiens	IC50	uM	
	949752	CHEMBL806414	Binding affinity against Src SH2 domain	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CCC(N)=O)c1nc(CC2C=CC(C)=CC2(C)C)no1	Outside typical range	CHEMBL134191	=	IC50	nM	312000.0	CHEMBL267	Homo sapiens	IC50	uM	312.0
	949755	CHEMBL806414	Binding affinity against Src SH2 domain	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](C)c1nc(Cc2cccc(C(F)(F)F)c2)no1	Outside typical range	CHEMBL130106	=	IC50	nM	115000.0	CHEMBL267	Homo sapiens	IC50	uM	115.0
	949758	CHEMBL806414	Binding affinity against Src SH2 domain	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](C)c1nc(Cc2ccc(F)cc2)no1	Outside typical range	CHEMBL133511	=	IC50	nM	200000.0	CHEMBL267	Homo sapiens	IC50	uM	200.0
	950713	CHEMBL823857	Inhibition of human purified recombinant pp60c-src tyrosine kinase at 100 uM	B	O=C(Nc1cccc(O)c1)c1ccc2cc(O)ccc2c1		CHEMBL359432	=	Inhibition	%	45.0	CHEMBL267	Homo sapiens	Inhibition	%	45.0
Not Determined	950714	CHEMBL823239	Inhibition of human purified recombinant pp60c-src tyrosine kinase	B	O=C(Nc1cccc(O)c1)c1ccc2cc(O)ccc2c1		CHEMBL359432		IC50	nM		CHEMBL267	Homo sapiens	IC50	uM	
	951060	CHEMBL806414	Binding affinity against Src SH2 domain	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CCC(N)=O)c1nc(Cc2ccc(Cl)cc2Cl)no1	Outside typical range	CHEMBL341314	>	IC50	nM	500000.0	CHEMBL267	Homo sapiens	IC50	uM	500.0
	951063	CHEMBL806414	Binding affinity against Src SH2 domain	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](C)c1nc(Cc2cccc(Cl)c2)no1		CHEMBL129842	=	IC50	nM	68000.0	CHEMBL267	Homo sapiens	IC50	uM	68.0
	951066	CHEMBL806414	Binding affinity against Src SH2 domain	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(C)=O)C(N)=O		CHEMBL311937	=	IC50	nM	6000.0	CHEMBL267	Homo sapiens	IC50	uM	6.0
	952201	CHEMBL809579	In vitro inhibition of c-src tyrosine kinase.	B	COc1cc2ncnc(Nc3cc(OC)c(OC)c(OC)c3)c2cc1OC		CHEMBL309682	=	IC50	nM	280.0	CHEMBL267	Homo sapiens	IC50	nM	280.0
	952471	CHEMBL806414	Binding affinity against Src SH2 domain	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CO)c1nc(Cc2ccc(F)cc2)no1	Outside typical range	CHEMBL134030	=	IC50	nM	132000.0	CHEMBL267	Homo sapiens	IC50	uM	132.0
	953432	CHEMBL823857	Inhibition of human purified recombinant pp60c-src tyrosine kinase at 100 uM	B	COC(=O)c1cc2ccc(O)cc2cc1O		CHEMBL145142	=	Inhibition	%	47.0	CHEMBL267	Homo sapiens	Inhibition	%	47.0
Not Determined	953433	CHEMBL823239	Inhibition of human purified recombinant pp60c-src tyrosine kinase	B	COC(=O)c1cc2ccc(O)cc2cc1O		CHEMBL145142		IC50	nM		CHEMBL267	Homo sapiens	IC50	uM	
	953434	CHEMBL823857	Inhibition of human purified recombinant pp60c-src tyrosine kinase at 100 uM	B	O=C(Nc1ccc(O)cc1O)c1cc2ccc(O)cc2cc1O		CHEMBL145375	=	Inhibition	%	56.0	CHEMBL267	Homo sapiens	Inhibition	%	56.0
Not Determined	953435	CHEMBL823239	Inhibition of human purified recombinant pp60c-src tyrosine kinase	B	O=C(Nc1ccc(O)cc1O)c1cc2ccc(O)cc2cc1O		CHEMBL145375		IC50	nM		CHEMBL267	Homo sapiens	IC50	uM	
	953436	CHEMBL823857	Inhibition of human purified recombinant pp60c-src tyrosine kinase at 100 uM	B	O=C(NCc1ccc(O)cc1)c1cc2ccc(O)cc2cc1O		CHEMBL144987	=	Inhibition	%	42.0	CHEMBL267	Homo sapiens	Inhibition	%	42.0
Not Determined	953437	CHEMBL823239	Inhibition of human purified recombinant pp60c-src tyrosine kinase	B	O=C(NCc1ccc(O)cc1)c1cc2ccc(O)cc2cc1O		CHEMBL144987		IC50	nM		CHEMBL267	Homo sapiens	IC50	uM	
	953475	CHEMBL809579	In vitro inhibition of c-src tyrosine kinase.	B	CCOc1c(OC)cc(Nc2ncnc3cc(OC)c(OC)cc23)cc1OC		CHEMBL83774	=	IC50	nM	340.0	CHEMBL267	Homo sapiens	IC50	nM	340.0
	953807	CHEMBL806414	Binding affinity against Src SH2 domain	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](C)c1nc(Cc2ccc(C(F)(F)F)cc2)no1	Outside typical range	CHEMBL103838	=	IC50	nM	210000.0	CHEMBL267	Homo sapiens	IC50	uM	210.0
	954728	CHEMBL823857	Inhibition of human purified recombinant pp60c-src tyrosine kinase at 100 uM	B	O=C(Nc1cccc(O)c1)c1cc2ccc(O)cc2cc1O		CHEMBL141704	=	Inhibition	%	89.0	CHEMBL267	Homo sapiens	Inhibition	%	89.0
	954729	CHEMBL823238	Inhibition of human purified recombinant pp60c-src tyrosine kinase	B	O=C(Nc1cccc(O)c1)c1cc2ccc(O)cc2cc1O		CHEMBL141704	=	IC50	nM	16000.0	CHEMBL267	Homo sapiens	IC50	uM	16.0
	956240	CHEMBL823856	Inhibition of human purified recombinant p60 c-Src tyrosine kinase at 100 uM	B	Oc1cc(O)cc(/C=C/c2ccc(O)c(O)c2)c1		CHEMBL69863	=	Inhibition	%	41.0	CHEMBL267	Homo sapiens	Inhibition	%	41.0
	956467	CHEMBL806414	Binding affinity against Src SH2 domain	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C	Outside typical range	CHEMBL336957	=	IC50	nM	261000.0	CHEMBL267	Homo sapiens	IC50	uM	261.0
	957469	CHEMBL809579	In vitro inhibition of c-src tyrosine kinase.	B	COc1cc2ncc(C#N)c(Nc3cc(OC)c(OC)c(OC)c3)c2cc1OC		CHEMBL81073	=	IC50	nM	35.0	CHEMBL267	Homo sapiens	IC50	nM	35.0
	957470	CHEMBL809581	Inhibition of Src kinase at 100 nM ATP	B	COc1cc2ncc(C#N)c(Nc3cc(OC)c(OC)c(OC)c3)c2cc1OC		CHEMBL81073	=	IC50	nM	34.0	CHEMBL267	Homo sapiens	IC50	nM	34.0
	957471	CHEMBL809583	Inhibition of Src kinase at 500 nM ATP	B	COc1cc2ncc(C#N)c(Nc3cc(OC)c(OC)c(OC)c3)c2cc1OC		CHEMBL81073	=	IC50	nM	108.0	CHEMBL267	Homo sapiens	IC50	nM	108.0
	957472	CHEMBL809580	Inhibition of Src kinase at 1000 nM ATP	B	COc1cc2ncc(C#N)c(Nc3cc(OC)c(OC)c(OC)c3)c2cc1OC		CHEMBL81073	=	IC50	nM	190.0	CHEMBL267	Homo sapiens	IC50	nM	190.0
	957473	CHEMBL809582	Inhibition of Src kinase at 5000 nM ATP	B	COc1cc2ncc(C#N)c(Nc3cc(OC)c(OC)c(OC)c3)c2cc1OC		CHEMBL81073	=	IC50	nM	650.0	CHEMBL267	Homo sapiens	IC50	nM	650.0
	957732	CHEMBL806414	Binding affinity against Src SH2 domain	B	C[C@H](NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(=O)Cc1ccccc1)c1nc(Cc2ccc(C(F)(F)F)cc2)no1	Outside typical range	CHEMBL130931	=	IC50	nM	123000.0	CHEMBL267	Homo sapiens	IC50	uM	123.0
	958748	CHEMBL823857	Inhibition of human purified recombinant pp60c-src tyrosine kinase at 100 uM	B	Cc1cc(O)c2c(c1)C(=O)c1cc(O)cc(O)c1C2=O		CHEMBL289277	=	Inhibition	%	22.0	CHEMBL267	Homo sapiens	Inhibition	%	22.0
Not Determined	958749	CHEMBL823239	Inhibition of human purified recombinant pp60c-src tyrosine kinase	B	Cc1cc(O)c2c(c1)C(=O)c1cc(O)cc(O)c1C2=O		CHEMBL289277		IC50	nM		CHEMBL267	Homo sapiens	IC50	uM	
	958780	CHEMBL809579	In vitro inhibition of c-src tyrosine kinase.	B	COc1cc(Nc2c(C#N)cnc3cc(OC)c(OC)cc23)cc(OC)c1		CHEMBL84803	=	IC50	nM	980.0	CHEMBL267	Homo sapiens	IC50	nM	980.0
	959041	CHEMBL806414	Binding affinity against Src SH2 domain	B	C[C@H](NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(=O)Cc1ccc(F)c(F)c1)c1nc(Cc2ccc(C(F)(F)F)cc2)no1	Outside typical range	CHEMBL134004	=	IC50	nM	130000.0	CHEMBL267	Homo sapiens	IC50	uM	130.0
	959044	CHEMBL806414	Binding affinity against Src SH2 domain	B	C[C@H](NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(=O)Cc1c[nH]c2ccccc12)c1nc(Cc2ccc(C(F)(F)F)cc2)no1		CHEMBL131229	=	IC50	nM	62000.0	CHEMBL267	Homo sapiens	IC50	uM	62.0
Not Active	959858	CHEMBL823858	nhibition of human purified recombinant pp60c-src tyrosine kinase at 100 uM (Inactive)	B	COC(=O)c1cc2ccccc2cc1N		CHEMBL145337		Inhibition	%		CHEMBL267	Homo sapiens	Inhibition	%	
Not Determined	959859	CHEMBL823239	Inhibition of human purified recombinant pp60c-src tyrosine kinase	B	COC(=O)c1cc2ccccc2cc1N		CHEMBL145337		IC50	nM		CHEMBL267	Homo sapiens	IC50	uM	
	959910	CHEMBL809579	In vitro inhibition of c-src tyrosine kinase.	B	CCCCOc1c(OC)cc(Nc2ncnc3cc(OC)c(OC)cc23)cc1OC		CHEMBL81261	=	IC50	nM	490.0	CHEMBL267	Homo sapiens	IC50	nM	490.0
	959911	CHEMBL809579	In vitro inhibition of c-src tyrosine kinase.	B	CCCCCCCCCCCCOc1c(OC)cc(Nc2c(C#N)cnc3cc(OC)c(OC)cc23)cc1OC		CHEMBL314568	=	IC50	nM	180.0	CHEMBL267	Homo sapiens	IC50	nM	180.0
	959912	CHEMBL809579	In vitro inhibition of c-src tyrosine kinase.	B	COc1cc2ncc(C#N)c(Oc3cc(OC)c(OC)c(OC)c3)c2cc1OC		CHEMBL81090	=	IC50	nM	290.0	CHEMBL267	Homo sapiens	IC50	nM	290.0
	960234	CHEMBL806414	Binding affinity against Src SH2 domain	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)NCCc1nc(Cc2ccc(C(F)(F)F)cc2)no1	Outside typical range	CHEMBL130751	>	IC50	nM	500000.0	CHEMBL267	Homo sapiens	IC50	uM	500.0
	960237	CHEMBL806414	Binding affinity against Src SH2 domain	B	C[C@H](NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(=O)Cc1ccc2ccccc2c1)c1nc(Cc2ccc(C(F)(F)F)cc2)no1		CHEMBL336864	=	IC50	nM	49000.0	CHEMBL267	Homo sapiens	IC50	uM	49.0
	961070	CHEMBL823857	Inhibition of human purified recombinant pp60c-src tyrosine kinase at 100 uM	B	O=C(Nc1ccccc1O)c1cc2cccc(O)c2cc1O		CHEMBL142548	=	Inhibition	%	12.0	CHEMBL267	Homo sapiens	Inhibition	%	12.0
Not Determined	961071	CHEMBL823239	Inhibition of human purified recombinant pp60c-src tyrosine kinase	B	O=C(Nc1ccccc1O)c1cc2cccc(O)c2cc1O		CHEMBL142548		IC50	nM		CHEMBL267	Homo sapiens	IC50	uM	
	961107	CHEMBL809579	In vitro inhibition of c-src tyrosine kinase.	B	COc1cc2c(Nc3cc(OC)c(OC)c(OC)c3)c(C#N)cnc2cc1OCCCN1CCCCC1		CHEMBL312385	=	IC50	nM	5.5	CHEMBL267	Homo sapiens	IC50	nM	5.5
	961108	CHEMBL785002	Inhibition of c-Src transformed Rat2 fibroblast cell proliferation in anchorage independent assay	F	COc1cc2c(Nc3cc(OC)c(OC)c(OC)c3)c(C#N)cnc2cc1OCCCN1CCCCC1		CHEMBL312385	=	IC50	nM	1300.0	CHEMBL267	Homo sapiens	IC50	uM	1.3
	961382	CHEMBL806414	Binding affinity against Src SH2 domain	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](C)c1nc(Cc2ccc(Cl)c(Cl)c2)no1		CHEMBL318300	=	IC50	nM	72000.0	CHEMBL267	Homo sapiens	IC50	uM	72.0
	961386	CHEMBL806414	Binding affinity against Src SH2 domain	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)NC(C)(C)c1nc(Cc2ccc(C(F)(F)F)cc2)no1	Outside typical range	CHEMBL131768	=	IC50	nM	489000.0	CHEMBL267	Homo sapiens	IC50	uM	489.0
	962305	CHEMBL823857	Inhibition of human purified recombinant pp60c-src tyrosine kinase at 100 uM	B	O=C(Nc1ccc(O)cc1)c1cc2cccc(O)c2cc1O		CHEMBL358786	=	Inhibition	%	60.0	CHEMBL267	Homo sapiens	Inhibition	%	60.0
Not Determined	962306	CHEMBL823239	Inhibition of human purified recombinant pp60c-src tyrosine kinase	B	O=C(Nc1ccc(O)cc1)c1cc2cccc(O)c2cc1O		CHEMBL358786		IC50	nM		CHEMBL267	Homo sapiens	IC50	uM	
	962307	CHEMBL823857	Inhibition of human purified recombinant pp60c-src tyrosine kinase at 100 uM	B	COc1ccc(NC(=O)c2cc3cccc(O)c3cc2O)cc1		CHEMBL145062	=	Inhibition	%	35.0	CHEMBL267	Homo sapiens	Inhibition	%	35.0
Not Determined	962308	CHEMBL823239	Inhibition of human purified recombinant pp60c-src tyrosine kinase	B	COc1ccc(NC(=O)c2cc3cccc(O)c3cc2O)cc1		CHEMBL145062		IC50	nM		CHEMBL267	Homo sapiens	IC50	uM	
	962684	CHEMBL806414	Binding affinity against Src SH2 domain	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CCC(N)=O)c1nc(Cc2cccc3ccccc23)no1	Outside typical range	CHEMBL310313	=	IC50	nM	135000.0	CHEMBL267	Homo sapiens	IC50	uM	135.0
	964003	CHEMBL806414	Binding affinity against Src SH2 domain	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CCC(N)=O)c1nc(Cc2ccc(C(C)C)cc2)no1		CHEMBL130871	=	IC50	nM	96000.0	CHEMBL267	Homo sapiens	IC50	uM	96.0
	964006	CHEMBL806414	Binding affinity against Src SH2 domain	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)NCc1nc(Cc2ccc(C(F)(F)F)cc2)no1	Outside typical range	CHEMBL132014	>	IC50	nM	500000.0	CHEMBL267	Homo sapiens	IC50	uM	500.0
	965096	CHEMBL809579	In vitro inhibition of c-src tyrosine kinase.	B	COc1cc2ncc(C#N)c(Nc3cc(OC)c(OC)c(OC)c3Br)c2cc1OC		CHEMBL83490	=	IC50	nM	170.0	CHEMBL267	Homo sapiens	IC50	nM	170.0
	965422	CHEMBL806414	Binding affinity against Src SH2 domain	B	O=C(Cc1ccccc1)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CO)c1nc(Cc2ccc(Cl)c(Cl)c2)no1		CHEMBL337451	=	IC50	nM	35000.0	CHEMBL267	Homo sapiens	IC50	uM	35.0
	966390	CHEMBL823857	Inhibition of human purified recombinant pp60c-src tyrosine kinase at 100 uM	B	COC(=O)c1cc2cc(O)ccc2cc1O		CHEMBL141878	=	Inhibition	%	19.0	CHEMBL267	Homo sapiens	Inhibition	%	19.0
Not Determined	966391	CHEMBL823239	Inhibition of human purified recombinant pp60c-src tyrosine kinase	B	COC(=O)c1cc2cc(O)ccc2cc1O		CHEMBL141878		IC50	nM		CHEMBL267	Homo sapiens	IC50	uM	
	966392	CHEMBL823857	Inhibition of human purified recombinant pp60c-src tyrosine kinase at 100 uM	B	O=C(Nc1ccc(O)cc1)c1cc2ccc(O)cc2cc1O		CHEMBL142673	=	Inhibition	%	23.0	CHEMBL267	Homo sapiens	Inhibition	%	23.0
Not Determined	966393	CHEMBL823239	Inhibition of human purified recombinant pp60c-src tyrosine kinase	B	O=C(Nc1ccc(O)cc1)c1cc2ccc(O)cc2cc1O		CHEMBL142673		IC50	nM		CHEMBL267	Homo sapiens	IC50	uM	
	966458	CHEMBL809579	In vitro inhibition of c-src tyrosine kinase.	B	CCOC(=O)c1cnc2cc(OC)c(OC)cc2c1Nc1cc(OC)c(OC)c(OC)c1		CHEMBL79876	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	966672	CHEMBL806414	Binding affinity against Src SH2 domain	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CCC(N)=O)c1nc(CCc2ccccc2)no1	Outside typical range	CHEMBL76963	=	IC50	nM	156000.0	CHEMBL267	Homo sapiens	IC50	uM	156.0
	967900	CHEMBL806414	Binding affinity against Src SH2 domain	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CC(N)=O)c1nc(Cc2ccc(C(F)(F)F)cc2)no1	Outside typical range	CHEMBL132963	>	IC50	nM	500000.0	CHEMBL267	Homo sapiens	IC50	uM	500.0
	968779	CHEMBL809579	In vitro inhibition of c-src tyrosine kinase.	B	COc1cc2ncnc(Nc3cc(OC)c(OC(C)C)c(OC)c3)c2cc1OC		CHEMBL79377	=	IC50	nM	830.0	CHEMBL267	Homo sapiens	IC50	nM	830.0
	968780	CHEMBL809579	In vitro inhibition of c-src tyrosine kinase.	B	CCCCCCCCCCCCOc1c(OC)cc(Nc2ncnc3cc(OC)c(OC)cc23)cc1OC		CHEMBL79560	=	IC50	nM	5200.0	CHEMBL267	Homo sapiens	IC50	nM	5200.0
	968781	CHEMBL809579	In vitro inhibition of c-src tyrosine kinase.	B	COc1ccc(Nc2c(C#N)cnc3cc(OC)c(OC)cc23)cc1OC		CHEMBL83228	=	IC50	nM	950.0	CHEMBL267	Homo sapiens	IC50	nM	950.0
	968782	CHEMBL809579	In vitro inhibition of c-src tyrosine kinase.	B	COc1cc2nccc(Nc3cc(OC)c(OC)c(OC)c3)c2cc1OC		CHEMBL311959	=	IC50	nM	200.0	CHEMBL267	Homo sapiens	IC50	nM	200.0
	970320	CHEMBL806414	Binding affinity against Src SH2 domain	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](C)c1nc(Cc2ccc(C)cc2)no1		CHEMBL335284	=	IC50	nM	65000.0	CHEMBL267	Homo sapiens	IC50	uM	65.0
	970323	CHEMBL806414	Binding affinity against Src SH2 domain	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](C)c1nc(Cc2ccc(I)c(Cl)c2)no1		CHEMBL336644	=	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	970326	CHEMBL806414	Binding affinity against Src SH2 domain	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CO)c1nc(Cc2ccc(C(F)(F)F)cc2)no1	Outside typical range	CHEMBL334979	=	IC50	nM	282000.0	CHEMBL267	Homo sapiens	IC50	uM	282.0
	971736	CHEMBL806414	Binding affinity against Src SH2 domain	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CCC(N)=O)c1nc(Cc2ccc(Cl)cc2)no1	Outside typical range	CHEMBL336978	=	IC50	nM	205000.0	CHEMBL267	Homo sapiens	IC50	uM	205.0
	971739	CHEMBL806414	Binding affinity against Src SH2 domain	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](C)c1nc(Cc2ccc3ccccc3c2)no1		CHEMBL335628	=	IC50	nM	64000.0	CHEMBL267	Homo sapiens	IC50	uM	64.0
	971743	CHEMBL806414	Binding affinity against Src SH2 domain	B	CC[C@H](NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(C)=O)c1nc(Cc2ccc(C(F)(F)F)cc2)no1		CHEMBL134042	=	IC50	nM	98000.0	CHEMBL267	Homo sapiens	IC50	uM	98.0
	971746	CHEMBL806414	Binding affinity against Src SH2 domain	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CO)c1nc(Cc2ccc(Cl)cc2)no1	Outside typical range	CHEMBL133185	=	IC50	nM	149000.0	CHEMBL267	Homo sapiens	IC50	uM	149.0
	971749	CHEMBL806414	Binding affinity against Src SH2 domain	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CCc1ccccc1)c1nc(Cc2ccc(C(F)(F)F)cc2)no1		CHEMBL337253	=	IC50	nM	95000.0	CHEMBL267	Homo sapiens	IC50	uM	95.0
	972619	CHEMBL823857	Inhibition of human purified recombinant pp60c-src tyrosine kinase at 100 uM	B	COc1cccc(NC(=O)c2cc3cccc(O)c3cc2O)c1		CHEMBL146605	=	Inhibition	%	33.0	CHEMBL267	Homo sapiens	Inhibition	%	33.0
Not Determined	972620	CHEMBL823239	Inhibition of human purified recombinant pp60c-src tyrosine kinase	B	COc1cccc(NC(=O)c2cc3cccc(O)c3cc2O)c1		CHEMBL146605		IC50	nM		CHEMBL267	Homo sapiens	IC50	uM	
	972621	CHEMBL823857	Inhibition of human purified recombinant pp60c-src tyrosine kinase at 100 uM	B	O=C(NCc1cccc(O)c1)c1cc2ccc(O)cc2cc1O		CHEMBL145582	=	Inhibition	%	55.0	CHEMBL267	Homo sapiens	Inhibition	%	55.0
Not Determined	972622	CHEMBL823239	Inhibition of human purified recombinant pp60c-src tyrosine kinase	B	O=C(NCc1cccc(O)c1)c1cc2ccc(O)cc2cc1O		CHEMBL145582		IC50	nM		CHEMBL267	Homo sapiens	IC50	uM	
	972623	CHEMBL823857	Inhibition of human purified recombinant pp60c-src tyrosine kinase at 100 uM	B	O=C(Nc1cccc(O)c1)c1cc2cc(O)ccc2cc1O		CHEMBL345017	=	Inhibition	%	68.0	CHEMBL267	Homo sapiens	Inhibition	%	68.0
Not Determined	972624	CHEMBL823239	Inhibition of human purified recombinant pp60c-src tyrosine kinase	B	O=C(Nc1cccc(O)c1)c1cc2cc(O)ccc2cc1O		CHEMBL345017		IC50	nM		CHEMBL267	Homo sapiens	IC50	uM	
	972835	CHEMBL806414	Binding affinity against Src SH2 domain	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CCC(N)=O)c1nc(Cc2ccc(C)cc2)no1	Outside typical range	CHEMBL130401	=	IC50	nM	292000.0	CHEMBL267	Homo sapiens	IC50	uM	292.0
	972838	CHEMBL806414	Binding affinity against Src SH2 domain	B	COc1ccc(CC(=O)N[C@@H](Cc2ccc(OP(=O)(O)O)cc2)C(=O)N[C@@H](C)c2nc(Cc3ccc(C(F)(F)F)cc3)no2)cc1		CHEMBL131944	=	IC50	nM	87000.0	CHEMBL267	Homo sapiens	IC50	uM	87.0
	973821	CHEMBL823857	Inhibition of human purified recombinant pp60c-src tyrosine kinase at 100 uM	B	O=C(Nc1ccccc1O)c1cc2ccc(O)cc2cc1O		CHEMBL145382	=	Inhibition	%	39.0	CHEMBL267	Homo sapiens	Inhibition	%	39.0
Not Determined	973822	CHEMBL823239	Inhibition of human purified recombinant pp60c-src tyrosine kinase	B	O=C(Nc1ccccc1O)c1cc2ccc(O)cc2cc1O		CHEMBL145382		IC50	nM		CHEMBL267	Homo sapiens	IC50	uM	
	973823	CHEMBL823857	Inhibition of human purified recombinant pp60c-src tyrosine kinase at 100 uM	B	COc1ccccc1CNC(=O)c1cc2cccc(O)c2cc1O		CHEMBL439985	=	Inhibition	%	13.0	CHEMBL267	Homo sapiens	Inhibition	%	13.0
Not Determined	973824	CHEMBL823239	Inhibition of human purified recombinant pp60c-src tyrosine kinase	B	COc1ccccc1CNC(=O)c1cc2cccc(O)c2cc1O		CHEMBL439985		IC50	nM		CHEMBL267	Homo sapiens	IC50	uM	
	973927	CHEMBL809579	In vitro inhibition of c-src tyrosine kinase.	B	COc1cc2ncc(C#N)c(Nc3cc(OC)c(OC(C)C)c(OC)c3)c2cc1OC		CHEMBL309704	=	IC50	nM	110.0	CHEMBL267	Homo sapiens	IC50	nM	110.0
	973928	CHEMBL809579	In vitro inhibition of c-src tyrosine kinase.	B	COc1cc2ncc(CO)c(Nc3cc(OC)c(OC)c(OC)c3)c2cc1OC		CHEMBL309277	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	974199	CHEMBL806414	Binding affinity against Src SH2 domain	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CCC(N)=O)c1nc(Cc2ccc(Cl)c(Cl)c2)no1	Outside typical range	CHEMBL337459	=	IC50	nM	206000.0	CHEMBL267	Homo sapiens	IC50	uM	206.0
	974203	CHEMBL806414	Binding affinity against Src SH2 domain	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](C)c1nc(Cc2ccc(Br)cc2)no1		CHEMBL339077	=	IC50	nM	31000.0	CHEMBL267	Homo sapiens	IC50	uM	31.0
	974206	CHEMBL806414	Binding affinity against Src SH2 domain	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](C)c1nc(Cc2ccc(Cl)c(Br)c2)no1		CHEMBL131361	=	IC50	nM	45000.0	CHEMBL267	Homo sapiens	IC50	uM	45.0
	974209	CHEMBL806414	Binding affinity against Src SH2 domain	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(N)=O	Outside typical range	CHEMBL430059	=	IC50	nM	237000.0	CHEMBL267	Homo sapiens	IC50	uM	237.0
	975080	CHEMBL823857	Inhibition of human purified recombinant pp60c-src tyrosine kinase at 100 uM	B	COC(=O)c1cc2cccc(O)c2cc1O		CHEMBL145578	=	Inhibition	%	5.0	CHEMBL267	Homo sapiens	Inhibition	%	5.0
Not Determined	975081	CHEMBL823239	Inhibition of human purified recombinant pp60c-src tyrosine kinase	B	COC(=O)c1cc2cccc(O)c2cc1O		CHEMBL145578		IC50	nM		CHEMBL267	Homo sapiens	IC50	uM	
	975082	CHEMBL823857	Inhibition of human purified recombinant pp60c-src tyrosine kinase at 100 uM	B	O=C(Nc1cccc(O)c1)c1cc2cccc(O)c2cc1O		CHEMBL145229	=	Inhibition	%	51.0	CHEMBL267	Homo sapiens	Inhibition	%	51.0
	975083	CHEMBL823238	Inhibition of human purified recombinant pp60c-src tyrosine kinase	B	O=C(Nc1cccc(O)c1)c1cc2cccc(O)c2cc1O	Outside typical range	CHEMBL145229	=	IC50	nM	150000.0	CHEMBL267	Homo sapiens	IC50	uM	150.0
	975084	CHEMBL823857	Inhibition of human purified recombinant pp60c-src tyrosine kinase at 100 uM	B	O=C(NCc1ccccc1O)c1cc2ccc(O)cc2cc1O		CHEMBL359186	=	Inhibition	%	42.0	CHEMBL267	Homo sapiens	Inhibition	%	42.0
Not Determined	975085	CHEMBL823239	Inhibition of human purified recombinant pp60c-src tyrosine kinase	B	O=C(NCc1ccccc1O)c1cc2ccc(O)cc2cc1O		CHEMBL359186		IC50	nM		CHEMBL267	Homo sapiens	IC50	uM	
	976302	CHEMBL823856	Inhibition of human purified recombinant p60 c-Src tyrosine kinase at 100 uM	B	O=C(NCc1ccccc1O)c1cc2cccc(O)c2cc1O		CHEMBL346180	=	Inhibition	%	41.0	CHEMBL267	Homo sapiens	Inhibition	%	41.0
Not Determined	976303	CHEMBL823237	Inhibition of human purified recombinant pp60c-src tyrosine kinase (Not Tested)	B	O=C(NCc1ccccc1O)c1cc2cccc(O)c2cc1O		CHEMBL346180		IC50	nM		CHEMBL267	Homo sapiens	IC50	uM	
	976603	CHEMBL806414	Binding affinity against Src SH2 domain	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](C)c1nc(Cc2ccc(Br)c(Br)c2)no1		CHEMBL424449	=	IC50	nM	39000.0	CHEMBL267	Homo sapiens	IC50	uM	39.0
	976606	CHEMBL806414	Binding affinity against Src SH2 domain	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)c1nc(Cc2ccc(C(F)(F)F)cc2)no1		CHEMBL334539	=	IC50	nM	92000.0	CHEMBL267	Homo sapiens	IC50	uM	92.0
	977764	CHEMBL806414	Binding affinity against Src SH2 domain	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](C)c1nc(Cc2ccc(I)c(Br)c2)no1		CHEMBL340977	=	IC50	nM	40000.0	CHEMBL267	Homo sapiens	IC50	uM	40.0
	977767	CHEMBL806414	Binding affinity against Src SH2 domain	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CO)c1nc(Cc2ccc3ccccc3c2)no1		CHEMBL336314	=	IC50	nM	99000.0	CHEMBL267	Homo sapiens	IC50	uM	99.0
	977771	CHEMBL806414	Binding affinity against Src SH2 domain	B	O=C(Cc1ccccc1)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CO)c1nc(Cc2ccc3ccccc3c2)no1		CHEMBL336958	=	IC50	nM	68000.0	CHEMBL267	Homo sapiens	IC50	uM	68.0
	978665	CHEMBL823856	Inhibition of human purified recombinant p60 c-Src tyrosine kinase at 100 uM	B	O=C(NCc1ccc(O)cc1)c1cc2cccc(O)c2cc1O		CHEMBL348018	=	Inhibition	%	49.0	CHEMBL267	Homo sapiens	Inhibition	%	49.0
Not Determined	978666	CHEMBL823237	Inhibition of human purified recombinant pp60c-src tyrosine kinase (Not Tested)	B	O=C(NCc1ccc(O)cc1)c1cc2cccc(O)c2cc1O		CHEMBL348018		IC50	nM		CHEMBL267	Homo sapiens	IC50	uM	
	978990	CHEMBL806414	Binding affinity against Src SH2 domain	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CCc1ccccc1)c1nc(Cc2ccc3ccccc3c2)no1		CHEMBL407143	=	IC50	nM	78000.0	CHEMBL267	Homo sapiens	IC50	uM	78.0
	980093	CHEMBL823857	Inhibition of human purified recombinant pp60c-src tyrosine kinase at 100 uM	B	O=C(NCc1cccc(O)c1)c1cc2cc(O)ccc2cc1O		CHEMBL358759	=	Inhibition	%	40.0	CHEMBL267	Homo sapiens	Inhibition	%	40.0
Not Determined	980094	CHEMBL823239	Inhibition of human purified recombinant pp60c-src tyrosine kinase	B	O=C(NCc1cccc(O)c1)c1cc2cc(O)ccc2cc1O		CHEMBL358759		IC50	nM		CHEMBL267	Homo sapiens	IC50	uM	
	980146	CHEMBL809579	In vitro inhibition of c-src tyrosine kinase.	B	COc1cc2ncc(C#N)c(NCc3ccc(OC)c(OC)c3OC)c2cc1OC		CHEMBL309439	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	980442	CHEMBL806414	Binding affinity against Src SH2 domain	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CCC(N)=O)c1nc(Cc2ccc3ccccc3c2)no1	Outside typical range	CHEMBL134243	=	IC50	nM	274000.0	CHEMBL267	Homo sapiens	IC50	uM	274.0
Not Active	981254	CHEMBL823858	nhibition of human purified recombinant pp60c-src tyrosine kinase at 100 uM (Inactive)	B	COc1ccccc1CNC(=O)c1cc2ccc(O)cc2cc1O		CHEMBL143034		Inhibition	%		CHEMBL267	Homo sapiens	Inhibition	%	
Not Determined	981255	CHEMBL823239	Inhibition of human purified recombinant pp60c-src tyrosine kinase	B	COc1ccccc1CNC(=O)c1cc2ccc(O)cc2cc1O		CHEMBL143034		IC50	nM		CHEMBL267	Homo sapiens	IC50	uM	
	981297	CHEMBL809579	In vitro inhibition of c-src tyrosine kinase.	B	COc1cc2ncc(C#N)c(Nc3cc(OC)c(OC)c(OC)c3C)c2cc1OC		CHEMBL82832	=	IC50	nM	470.0	CHEMBL267	Homo sapiens	IC50	nM	470.0
	981648	CHEMBL806414	Binding affinity against Src SH2 domain	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](C)c1nc(Cc2ccc(Cl)cc2)no1		CHEMBL334891	=	IC50	nM	66000.0	CHEMBL267	Homo sapiens	IC50	uM	66.0
	984157	CHEMBL806414	Binding affinity against Src SH2 domain	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](C)c1nc(Cc2ccc(I)cc2)no1		CHEMBL133929	=	IC50	nM	18000.0	CHEMBL267	Homo sapiens	IC50	uM	18.0
	985037	CHEMBL809579	In vitro inhibition of c-src tyrosine kinase.	B	CCOc1c(OC)cc(Nc2c(C#N)cnc3cc(OC)c(OC)cc23)cc1OC		CHEMBL79286	=	IC50	nM	63.0	CHEMBL267	Homo sapiens	IC50	nM	63.0
	985356	CHEMBL806414	Binding affinity against Src SH2 domain	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CO)c1nc(Cc2ccc(Br)cc2)no1		CHEMBL132007	=	IC50	nM	32000.0	CHEMBL267	Homo sapiens	IC50	uM	32.0
	986296	CHEMBL823857	Inhibition of human purified recombinant pp60c-src tyrosine kinase at 100 uM	B	O=C(Nc1ccc(O)cc1O)c1cc2cccc(O)c2cc1O		CHEMBL142604	=	Inhibition	%	14.0	CHEMBL267	Homo sapiens	Inhibition	%	14.0
Not Determined	986297	CHEMBL823239	Inhibition of human purified recombinant pp60c-src tyrosine kinase	B	O=C(Nc1ccc(O)cc1O)c1cc2cccc(O)c2cc1O		CHEMBL142604		IC50	nM		CHEMBL267	Homo sapiens	IC50	uM	
	986298	CHEMBL823857	Inhibition of human purified recombinant pp60c-src tyrosine kinase at 100 uM	B	COc1ccc(CNC(=O)c2cc3ccc(O)cc3cc2O)cc1		CHEMBL145607	=	Inhibition	%	4.0	CHEMBL267	Homo sapiens	Inhibition	%	4.0
Not Determined	986299	CHEMBL823239	Inhibition of human purified recombinant pp60c-src tyrosine kinase	B	COc1ccc(CNC(=O)c2cc3ccc(O)cc3cc2O)cc1		CHEMBL145607		IC50	nM		CHEMBL267	Homo sapiens	IC50	uM	
	986639	CHEMBL806414	Binding affinity against Src SH2 domain	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CCc1ccccc1)c1nc(Cc2ccc(Cl)c(Cl)c2)no1		CHEMBL336949	=	IC50	nM	60000.0	CHEMBL267	Homo sapiens	IC50	uM	60.0
	986643	CHEMBL806414	Binding affinity against Src SH2 domain	B	C[C@H](NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(=O)Cc1cccs1)c1nc(Cc2ccc(C(F)(F)F)cc2)no1	Outside typical range	CHEMBL133644	=	IC50	nM	143000.0	CHEMBL267	Homo sapiens	IC50	uM	143.0
	986646	CHEMBL806414	Binding affinity against Src SH2 domain	B	O=C(Cc1ccccc1)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CO)c1nc(Cc2ccc(C(F)(F)F)cc2)no1	Outside typical range	CHEMBL337737	=	IC50	nM	161000.0	CHEMBL267	Homo sapiens	IC50	uM	161.0
	987080	CHEMBL806434	Inhibition of Src protein tyrosine kinase activity with 1 mM ATP and biotinylated lck peptide	B	COc1cc(-c2nn([C@H]3CC[C@H](N4CCN(C)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)CCc1ccccc1		CHEMBL295601	=	IC50	nM	155.0	CHEMBL267	Homo sapiens	IC50	uM	0.155
	994229	CHEMBL806434	Inhibition of Src protein tyrosine kinase activity with 1 mM ATP and biotinylated lck peptide	B	COc1cc(-c2nn([C@H]3CC[C@H](N4CCN(C)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)c1cc2ccccc2o1		CHEMBL43773	=	IC50	nM	57.0	CHEMBL267	Homo sapiens	IC50	uM	0.057
	1006301	CHEMBL809578	Inhibition of Src tyrosine kinase.	B	O=C(Nc1ccccn1)Nc1cccc2c1[C@H]1CCCN1C2=O		CHEMBL141247	>	IC50	nM	5000.0	CHEMBL267	Homo sapiens	IC50	uM	5.0
	1007934	CHEMBL806434	Inhibition of Src protein tyrosine kinase activity with 1 mM ATP and biotinylated lck peptide	B	COc1cc(-c2nn([C@H]3CC[C@H](N4CCN(C)CC4)CC3)c3ncnc(N)c23)ccc1NCc1ccco1		CHEMBL431407	=	IC50	nM	97.0	CHEMBL267	Homo sapiens	IC50	uM	0.097
	1010451	CHEMBL806434	Inhibition of Src protein tyrosine kinase activity with 1 mM ATP and biotinylated lck peptide	B	COc1cc(-c2nn([C@H]3CC[C@H](N4CCN(C)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)OCc1ccccc1		CHEMBL47787	=	IC50	nM	13.0	CHEMBL267	Homo sapiens	IC50	uM	0.013
	1011758	CHEMBL806434	Inhibition of Src protein tyrosine kinase activity with 1 mM ATP and biotinylated lck peptide	B	COc1cc(-c2nn([C@H]3CC[C@H](N4CCN(C)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL314627	=	IC50	nM	70.0	CHEMBL267	Homo sapiens	IC50	uM	0.07
	1013633	CHEMBL806344	Inhibition of Src tyrosine kinase	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2C1=O		CHEMBL1276127	=	IC50	nM	18000.0	CHEMBL267	Homo sapiens	IC50	uM	18.0
	1020847	CHEMBL806434	Inhibition of Src protein tyrosine kinase activity with 1 mM ATP and biotinylated lck peptide	B	COc1cc(-c2nn([C@H]3CC[C@H](N4CCN(C)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)c1ccccc1		CHEMBL297363	=	IC50	nM	189.0	CHEMBL267	Homo sapiens	IC50	uM	0.189
	1022076	CHEMBL806434	Inhibition of Src protein tyrosine kinase activity with 1 mM ATP and biotinylated lck peptide	B	COc1cc(-c2nn([C@H]3CC[C@H](N4CCN(C)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)c1cc2ccccc2[nH]1		CHEMBL431609	=	IC50	nM	56.0	CHEMBL267	Homo sapiens	IC50	uM	0.056
	1022803	CHEMBL806344	Inhibition of Src tyrosine kinase	B	O=C1/C(=C2\Nc3ccccc3C2=O)Nc2ccccc21		CHEMBL599552	=	IC50	nM	28000.0	CHEMBL267	Homo sapiens	IC50	uM	28.0
	1027357	CHEMBL805895	Inhibition of Src protein tyrosine kinase	B	COCCOc1cc2c(cc1OC)Nc1ncnc(Nc3cc(OC)c(Cl)cc3Cl)c1C2		CHEMBL100172	=	IC50	nM	9.8	CHEMBL267	Homo sapiens	IC50	nM	9.8
	1027358	CHEMBL808216	Inhibition of Src protein tyrosine kinase dependent cellular proliferation	F	COCCOc1cc2c(cc1OC)Nc1ncnc(Nc3cc(OC)c(Cl)cc3Cl)c1C2		CHEMBL100172	=	IC50	nM	140.0	CHEMBL267	Homo sapiens	IC50	nM	140.0
	1028644	CHEMBL805895	Inhibition of Src protein tyrosine kinase	B	COc1cc2c(cc1OC)Nc1ncnc(O)c1C2		CHEMBL414013	=	IC50	nM	500.0	CHEMBL267	Homo sapiens	IC50	uM	0.5
	1032354	CHEMBL805896	Inhibition of Src protein tyrosine kinase	B	COCCOc1cc2nc3ncnc(Nc4cc(OC)c(Cl)cc4Cl)c3cc2cc1OC		CHEMBL420839	=	Inhibition	%	35.0	CHEMBL267	Homo sapiens	Inhibition	%	35.0
	1032355	CHEMBL808216	Inhibition of Src protein tyrosine kinase dependent cellular proliferation	F	COCCOc1cc2nc3ncnc(Nc4cc(OC)c(Cl)cc4Cl)c3cc2cc1OC		CHEMBL420839	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	1037291	CHEMBL805895	Inhibition of Src protein tyrosine kinase	B	COc1cc(Nc2c(C#N)cnc3cc(OC)c(OC)cc23)c(Cl)cc1Cl		CHEMBL100651	=	IC50	nM	30.0	CHEMBL267	Homo sapiens	IC50	nM	30.0
	1047054	CHEMBL805895	Inhibition of Src protein tyrosine kinase	B	COCCOc1cc2c(cc1OC)Cc1c(Nc3cc(OC)c(Cl)cc3Cl)ncnc1N2		CHEMBL100551	=	IC50	nM	2.3	CHEMBL267	Homo sapiens	IC50	nM	2.3
	1047055	CHEMBL808216	Inhibition of Src protein tyrosine kinase dependent cellular proliferation	F	COCCOc1cc2c(cc1OC)Cc1c(Nc3cc(OC)c(Cl)cc3Cl)ncnc1N2		CHEMBL100551	=	IC50	nM	28.0	CHEMBL267	Homo sapiens	IC50	nM	28.0
	1047057	CHEMBL805895	Inhibition of Src protein tyrosine kinase	B	COc1cc2ncc(C#N)c(Nc3ccc(Cl)cc3Cl)c2cc1OC		CHEMBL101917	=	IC50	nM	4.3	CHEMBL267	Homo sapiens	IC50	nM	4.3
	1051875	CHEMBL805895	Inhibition of Src protein tyrosine kinase	B	COCCOc1cc2c(cc1OC)Cc1c(Nc3ccc(Cl)cc3Cl)ncnc1N2		CHEMBL322689	=	IC50	nM	16.0	CHEMBL267	Homo sapiens	IC50	nM	16.0
	1051876	CHEMBL808216	Inhibition of Src protein tyrosine kinase dependent cellular proliferation	F	COCCOc1cc2c(cc1OC)Cc1c(Nc3ccc(Cl)cc3Cl)ncnc1N2		CHEMBL322689	=	IC50	nM	120.0	CHEMBL267	Homo sapiens	IC50	nM	120.0
	1053115	CHEMBL805895	Inhibition of Src protein tyrosine kinase	B	COc1cc2cc3c(O)ncnc3nc2cc1OC		CHEMBL7137	=	IC50	nM	32000.0	CHEMBL267	Homo sapiens	IC50	uM	32.0
	1054535	CHEMBL823441	Inhibition of c-src enzyme.	B	Brc1cccc(Nc2ncnc3cc4[nH]cnc4cc23)c1		CHEMBL66031	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	nM	50000.0
	1056885	CHEMBL805895	Inhibition of Src protein tyrosine kinase	B	COc1cc(Nc2ncnc3c2Cc2cc(OC)c(OC)cc2N3)c(Cl)cc1Cl		CHEMBL102000	=	IC50	nM	3.3	CHEMBL267	Homo sapiens	IC50	nM	3.3
	1056886	CHEMBL808216	Inhibition of Src protein tyrosine kinase dependent cellular proliferation	F	COc1cc(Nc2ncnc3c2Cc2cc(OC)c(OC)cc2N3)c(Cl)cc1Cl		CHEMBL102000	=	IC50	nM	190.0	CHEMBL267	Homo sapiens	IC50	nM	190.0
	1056887	CHEMBL805895	Inhibition of Src protein tyrosine kinase	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	IC50	nM	1.2	CHEMBL267	Homo sapiens	IC50	nM	1.2
	1056888	CHEMBL808216	Inhibition of Src protein tyrosine kinase dependent cellular proliferation	F	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	IC50	nM	100.0	CHEMBL267	Homo sapiens	IC50	nM	100.0
	1065686	CHEMBL805895	Inhibition of Src protein tyrosine kinase	B	COc1cc(Nc2ncnc3nc4cc(OC)c(OC)cc4cc23)c(Cl)cc1Cl		CHEMBL450015	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	1065687	CHEMBL808216	Inhibition of Src protein tyrosine kinase dependent cellular proliferation	F	COc1cc(Nc2ncnc3nc4cc(OC)c(OC)cc4cc23)c(Cl)cc1Cl		CHEMBL450015	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	1066868	CHEMBL823859	Percent inhibition determined against human recombinant p60 c-Src tyrosine kinase at 100 uM	B	CCOC(=O)c1cc2cc(O)c(O)cc2[nH]1		CHEMBL342058	=	Inhibition	%	28.0	CHEMBL267	Homo sapiens	Inhibition	%	28.0
Not Determined	1066883	CHEMBL812676	Binding affinity for Human pp60c-src SH2 domain (no data)	B	Cc1cc(CNC(=O)c2ccc(OP(=O)(O)O)cc2)ccc1OCC1CCCCC1		CHEMBL1160321		IC50	nM		CHEMBL267	Homo sapiens	IC50	uM	
	1067947	CHEMBL881135	Inhibitory activity against c-src tyrosine kinase	B	COC(=O)C1=C(c2ccccc2)c2cc(C)ccc2C1=O.COC(=O)C1=C(c2ccccc2)c2ccc(C)cc2C1=O		CHEMBL323564	=	IC50	nM	33000.0	CHEMBL267	Homo sapiens	IC50	uM	33.0
	1068016	CHEMBL818279	Inhibition of c-Src tyrosine kinase	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	IC50	nM	7000.0	CHEMBL267	Homo sapiens	IC50	uM	7.0
	1068075	CHEMBL823859	Percent inhibition determined against human recombinant p60 c-Src tyrosine kinase at 100 uM	B	COc1ccccc1NC(=O)c1cc2cc(O)ccc2[nH]1		CHEMBL144460	=	Inhibition	%	3.0	CHEMBL267	Homo sapiens	Inhibition	%	3.0
	1069339	CHEMBL805365	Inhibition of Src protein tyrosine kinase	B	Cc1cc(Nc2nc3ccc(C(=O)Nc4c(C)cccc4Cl)cc3s2)nc(NCCO)n1		CHEMBL88009	=	IC50	nM	10.0	CHEMBL267	Homo sapiens	IC50	nM	10.0
	1069375	CHEMBL823859	Percent inhibition determined against human recombinant p60 c-Src tyrosine kinase at 100 uM	B	COC(=O)c1ccc(CNC(=O)c2cc3cc(O)ccc3[nH]2)cc1		CHEMBL346182	=	Inhibition	%	11.0	CHEMBL267	Homo sapiens	Inhibition	%	11.0
Not Determined	1069394	CHEMBL812676	Binding affinity for Human pp60c-src SH2 domain (no data)	B	Nc1cc(CNC(=O)c2ccc(OP(=O)(O)O)cc2)ccc1OCC1CCCCC1		CHEMBL1160324		IC50	nM		CHEMBL267	Homo sapiens	IC50	uM	
	1070521	CHEMBL805899	Inhibition of Src protein tyrosine kinase	B	Cc1cc(Nc2nc3ccc(C(=O)Nc4c(C)cccc4Cl)cc3s2)nc(NCC2CCCO2)n1		CHEMBL432189	=	Ki	nM	3.2	CHEMBL267	Homo sapiens	Ki	nM	3.2
	1070531	CHEMBL818279	Inhibition of c-Src tyrosine kinase	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	1071515	CHEMBL822809	Inhibitory activity against c-src tyrosine kinase at 50 uM	B	CCC1=C(C(N)=O)C(=O)c2ccccc21		CHEMBL99077	=	Inhibition	%	53.0	CHEMBL267	Homo sapiens	Inhibition	%	53.0
	1071550	CHEMBL822809	Inhibitory activity against c-src tyrosine kinase at 50 uM	B	NC(=O)C1C(=O)c2ccccc2C1c1ccccc1		CHEMBL99770	=	Inhibition	%	8.0	CHEMBL267	Homo sapiens	Inhibition	%	8.0
	1071601	CHEMBL823859	Percent inhibition determined against human recombinant p60 c-Src tyrosine kinase at 100 uM	B	O=C(Nc1ccc(O)cc1)c1cc2cc(O)ccc2[nH]1		CHEMBL144909	=	Inhibition	%	45.0	CHEMBL267	Homo sapiens	Inhibition	%	45.0
	1071602	CHEMBL823859	Percent inhibition determined against human recombinant p60 c-Src tyrosine kinase at 100 uM	B	O=C(O)Cc1ccc(NC(=O)c2cc3cc(O)ccc3[nH]2)cc1		CHEMBL146112	=	Inhibition	%	7.0	CHEMBL267	Homo sapiens	Inhibition	%	7.0
	1071603	CHEMBL823859	Percent inhibition determined against human recombinant p60 c-Src tyrosine kinase at 100 uM	B	C[C@H](NC(=O)c1cc2cc(O)ccc2[nH]1)c1cccc(O)c1		CHEMBL146113	=	Inhibition	%	13.0	CHEMBL267	Homo sapiens	Inhibition	%	13.0
	1076374	CHEMBL812675	Binding affinity for Human pp60c-src SH2 domain	B	NC(=O)c1cc(CNC(=O)c2ccc(OP(=O)(O)O)cc2)ccc1OCC1CCCCC1		CHEMBL1160313	=	IC50	nM	6500.0	CHEMBL267	Homo sapiens	IC50	uM	6.5
	1077508	CHEMBL822809	Inhibitory activity against c-src tyrosine kinase at 50 uM	B	CN(C)C(=O)C1=C(c2ccccc2)c2ccccc2C1=O		CHEMBL317989	=	Inhibition	%	1.0	CHEMBL267	Homo sapiens	Inhibition	%	1.0
	1077599	CHEMBL823859	Percent inhibition determined against human recombinant p60 c-Src tyrosine kinase at 100 uM	B	O=C(NCc1ccc(O)cc1)c1cc2cc(O)ccc2[nH]1		CHEMBL143503	=	Inhibition	%	54.0	CHEMBL267	Homo sapiens	Inhibition	%	54.0
	1078700	CHEMBL881135	Inhibitory activity against c-src tyrosine kinase	B	NC(=O)C1=C(c2ccc(Cl)cc2)c2ccccc2C1=O		CHEMBL99724	=	IC50	nM	9600.0	CHEMBL267	Homo sapiens	IC50	uM	9.6
	1078703	CHEMBL822809	Inhibitory activity against c-src tyrosine kinase at 50 uM	B	O=C(O)C1=C(c2ccccc2)c2ccccc2C1=O		CHEMBL98396	=	Inhibition	%	7.0	CHEMBL267	Homo sapiens	Inhibition	%	7.0
	1079780	CHEMBL881135	Inhibitory activity against c-src tyrosine kinase	B	COC(=O)C1=C(c2ccccc2)c2c(OC)cccc2C1=O		CHEMBL316567	=	IC50	nM	13000.0	CHEMBL267	Homo sapiens	IC50	uM	13.0
	1079895	CHEMBL823859	Percent inhibition determined against human recombinant p60 c-Src tyrosine kinase at 100 uM	B	COc1cccc(CNC(=O)c2cc3cc(O)ccc3[nH]2)c1		CHEMBL422302	=	Inhibition	%	7.0	CHEMBL267	Homo sapiens	Inhibition	%	7.0
	1079896	CHEMBL823859	Percent inhibition determined against human recombinant p60 c-Src tyrosine kinase at 100 uM	B	O=C(NCc1cccc(O)c1)c1cc2c(O)cccc2[nH]1		CHEMBL143505	=	Inhibition	%	60.0	CHEMBL267	Homo sapiens	Inhibition	%	60.0
	1080949	CHEMBL881135	Inhibitory activity against c-src tyrosine kinase	B	COC(=O)C1=C(c2ccccc2)c2cc([N+](=O)[O-])ccc2C1=O.COC(=O)C1=C(c2ccccc2)c2ccc([N+](=O)[O-])cc2C1=O		CHEMBL85589	=	IC50	nM	8300.0	CHEMBL267	Homo sapiens	IC50	uM	8.3
	1080997	CHEMBL823859	Percent inhibition determined against human recombinant p60 c-Src tyrosine kinase at 100 uM	B	O=C(Nc1cccc(O)c1)c1cc2cc(O)ccc2[nH]1		CHEMBL343442	=	Inhibition	%	30.0	CHEMBL267	Homo sapiens	Inhibition	%	30.0
	1080998	CHEMBL823859	Percent inhibition determined against human recombinant p60 c-Src tyrosine kinase at 100 uM	B	COc1ccc(CNC(=O)c2cc3cc(O)ccc3[nH]2)cc1		CHEMBL144272	=	Inhibition	%	18.0	CHEMBL267	Homo sapiens	Inhibition	%	18.0
	1083254	CHEMBL822809	Inhibitory activity against c-src tyrosine kinase at 50 uM	B	NC(=O)C1=C(c2ccccc2)c2ccccc2C1O		CHEMBL319570	=	Inhibition	%	27.0	CHEMBL267	Homo sapiens	Inhibition	%	27.0
	1083318	CHEMBL823859	Percent inhibition determined against human recombinant p60 c-Src tyrosine kinase at 100 uM	B	COc1ccc(NC(=O)c2cc3cc(O)ccc3[nH]2)cc1		CHEMBL144415	=	Inhibition	%	39.0	CHEMBL267	Homo sapiens	Inhibition	%	39.0
	1083332	CHEMBL812675	Binding affinity for Human pp60c-src SH2 domain	B	CNC(=O)c1cc(CNC(=O)c2ccc(OP(=O)(O)O)cc2)ccc1OCC1CCCCC1		CHEMBL1160318	=	IC50	nM	30000.0	CHEMBL267	Homo sapiens	IC50	uM	30.0
	1084344	CHEMBL881135	Inhibitory activity against c-src tyrosine kinase	B	COC(=O)C1=C(c2ccccc2)c2ccncc2C1=O		CHEMBL98447	=	IC50	nM	7600.0	CHEMBL267	Homo sapiens	IC50	uM	7.6
	1084411	CHEMBL823859	Percent inhibition determined against human recombinant p60 c-Src tyrosine kinase at 100 uM	B	O=C(Nc1cccc(F)c1)c1cc2cc(O)ccc2[nH]1		CHEMBL344325	=	Inhibition	%	21.0	CHEMBL267	Homo sapiens	Inhibition	%	21.0
	1084412	CHEMBL823859	Percent inhibition determined against human recombinant p60 c-Src tyrosine kinase at 100 uM	B	O=C(NCc1cccc(O)c1)c1cc2cc(O)c(O)cc2[nH]1		CHEMBL144774	=	Inhibition	%	26.0	CHEMBL267	Homo sapiens	Inhibition	%	26.0
	1085412	CHEMBL805899	Inhibition of Src protein tyrosine kinase	B	Cc1cccc(Cl)c1NC(=O)c1ccc2nc(Nc3cccc(NCCO)n3)sc2c1		CHEMBL312933	=	Ki	nM	13.0	CHEMBL267	Homo sapiens	Ki	nM	13.0
	1085467	CHEMBL823859	Percent inhibition determined against human recombinant p60 c-Src tyrosine kinase at 100 uM	B	COc1cccc(NC(=O)c2cc3cc(O)ccc3[nH]2)c1		CHEMBL144532	=	Inhibition	%	21.0	CHEMBL267	Homo sapiens	Inhibition	%	21.0
	1085468	CHEMBL823859	Percent inhibition determined against human recombinant p60 c-Src tyrosine kinase at 100 uM	B	COc1ccccc1CNC(=O)c1cc2cc(O)ccc2[nH]1		CHEMBL357397	=	Inhibition	%	21.0	CHEMBL267	Homo sapiens	Inhibition	%	21.0
	1086500	CHEMBL805899	Inhibition of Src protein tyrosine kinase	B	Cc1cccc(Cl)c1NC(=O)c1ccc2nc(NC(=O)NC(C)(C)C)sc2c1		CHEMBL67237	=	Ki	nM	333.0	CHEMBL267	Homo sapiens	Ki	nM	333.0
Not Active	1086541	CHEMBL824016	Percent inhibition of human recombinant p60 c-Src tyrosine kinase at 100 uM (inactive)	B	O=C(O)c1ccc(CNC(=O)c2cc3cc(O)ccc3[nH]2)cc1		CHEMBL144571		Inhibition	%		CHEMBL267	Homo sapiens	Inhibition	%	
	1086542	CHEMBL823859	Percent inhibition determined against human recombinant p60 c-Src tyrosine kinase at 100 uM	B	COC(=O)Cc1ccc(NC(=O)c2cc3cc(O)ccc3[nH]2)cc1		CHEMBL144775	=	Inhibition	%	32.0	CHEMBL267	Homo sapiens	Inhibition	%	32.0
	1088740	CHEMBL823859	Percent inhibition determined against human recombinant p60 c-Src tyrosine kinase at 100 uM	B	O=C(NCc1cccc(O)c1)c1cc2cc(O)ccc2[nH]1		CHEMBL144785	=	Inhibition	%	74.0	CHEMBL267	Homo sapiens	Inhibition	%	74.0
	1088741	CHEMBL823854	Inhibition of human recombinant p60 c-Src tyrosine kinase	B	O=C(NCc1cccc(O)c1)c1cc2cc(O)ccc2[nH]1		CHEMBL144785	=	IC50	nM	38000.0	CHEMBL267	Homo sapiens	IC50	uM	38.0
	1089879	CHEMBL812675	Binding affinity for Human pp60c-src SH2 domain	B	O=C(NCc1ccc(OCC2CCCCC2)cc1)c1ccc(OP(=O)(O)O)cc1		CHEMBL1160323	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	1090893	CHEMBL822809	Inhibitory activity against c-src tyrosine kinase at 50 uM	B	C/C=C1\c2ccccc2C(=O)C1C(N)=O		CHEMBL329972	=	Inhibition	%	3.0	CHEMBL267	Homo sapiens	Inhibition	%	3.0
	1090954	CHEMBL823859	Percent inhibition determined against human recombinant p60 c-Src tyrosine kinase at 100 uM	B	O=C(Nc1ccccc1O)c1cc2cc(O)ccc2[nH]1		CHEMBL356976	=	Inhibition	%	43.0	CHEMBL267	Homo sapiens	Inhibition	%	43.0
	1092014	CHEMBL881135	Inhibitory activity against c-src tyrosine kinase	B	NC(=O)C1=C(c2ccccc2)c2ccccc2C1=O		CHEMBL329706	=	IC50	nM	3600.0	CHEMBL267	Homo sapiens	IC50	uM	3.6
	1092032	CHEMBL822809	Inhibitory activity against c-src tyrosine kinase at 50 uM	B	CNC(=O)C1=C(c2ccccc2)c2ccccc2C1=O		CHEMBL99352	=	Inhibition	%	16.0	CHEMBL267	Homo sapiens	Inhibition	%	16.0
	1093090	CHEMBL881135	Inhibitory activity against c-src tyrosine kinase	B	COC(=O)C1=C(c2ccccc2)c2ccccc2C1=O		CHEMBL317768	=	IC50	nM	25000.0	CHEMBL267	Homo sapiens	IC50	uM	25.0
	1095402	CHEMBL822809	Inhibitory activity against c-src tyrosine kinase at 50 uM	B	NC(=O)C1=C2CCCc3cccc(c32)C1=O		CHEMBL316508	=	Inhibition	%	48.0	CHEMBL267	Homo sapiens	Inhibition	%	48.0
	1095476	CHEMBL823859	Percent inhibition determined against human recombinant p60 c-Src tyrosine kinase at 100 uM	B	O=C(NCc1ccc(O)cc1)c1cc2ccccc2[nH]1		CHEMBL144505	=	Inhibition	%	36.0	CHEMBL267	Homo sapiens	Inhibition	%	36.0
	1095477	CHEMBL823859	Percent inhibition determined against human recombinant p60 c-Src tyrosine kinase at 100 uM	B	C[C@@H](NC(=O)c1cc2cc(O)ccc2[nH]1)c1cccc(O)c1		CHEMBL142973	=	Inhibition	%	15.0	CHEMBL267	Homo sapiens	Inhibition	%	15.0
	1096481	CHEMBL822809	Inhibitory activity against c-src tyrosine kinase at 50 uM	B	COC(=O)C1=C(c2ccccc2)c2cc(Cl)ccc2C1=O.COC(=O)C1=C(c2ccccc2)c2ccc(Cl)cc2C1=O		CHEMBL316556	=	Inhibition	%	10.0	CHEMBL267	Homo sapiens	Inhibition	%	10.0
	1096543	CHEMBL823859	Percent inhibition determined against human recombinant p60 c-Src tyrosine kinase at 100 uM	B	O=C(NCCc1ccc(O)cc1)c1cc2cc(O)ccc2[nH]1		CHEMBL421764	=	Inhibition	%	21.0	CHEMBL267	Homo sapiens	Inhibition	%	21.0
	1096544	CHEMBL823859	Percent inhibition determined against human recombinant p60 c-Src tyrosine kinase at 100 uM	B	O=C(NCc1cccc(F)c1)c1cc2cc(O)ccc2[nH]1		CHEMBL359172	=	Inhibition	%	57.0	CHEMBL267	Homo sapiens	Inhibition	%	57.0
	1098901	CHEMBL822436	Percent inhibition against human recombinant p60 c-Src tyrosine kinase at 500 uM	B	COC(=O)c1cc2cc(O)ccc2[nH]1		CHEMBL144459	=	Inhibition	%	40.0	CHEMBL267	Homo sapiens	Inhibition	%	40.0
	1098902	CHEMBL823859	Percent inhibition determined against human recombinant p60 c-Src tyrosine kinase at 100 uM	B	O=C(NCc1ccccc1O)c1cc2cc(O)ccc2[nH]1		CHEMBL144193	=	Inhibition	%	24.0	CHEMBL267	Homo sapiens	Inhibition	%	24.0
	1098903	CHEMBL823859	Percent inhibition determined against human recombinant p60 c-Src tyrosine kinase at 100 uM	B	O=C(NCc1cccc(O)c1)c1cc2ccc(O)cc2[nH]1		CHEMBL144535	=	Inhibition	%	56.0	CHEMBL267	Homo sapiens	Inhibition	%	56.0
	1099939	CHEMBL822809	Inhibitory activity against c-src tyrosine kinase at 50 uM	B	CCN(CC)CCNC(=O)C1=C(c2ccccc2)c2ccccc2C1=O		CHEMBL99113	=	Inhibition	%	11.0	CHEMBL267	Homo sapiens	Inhibition	%	11.0
	1101001	CHEMBL822809	Inhibitory activity against c-src tyrosine kinase at 50 uM	B	COC(=O)C1=C(c2ccccc2)c2cccc(C)c2C1=O		CHEMBL99049	=	Inhibition	%	38.0	CHEMBL267	Homo sapiens	Inhibition	%	38.0
	1101077	CHEMBL812675	Binding affinity for Human pp60c-src SH2 domain	B	CC(=O)c1cc(CNC(=O)c2ccc(OP(=O)(O)O)cc2)ccc1OCC1CCCCC1		CHEMBL1160317	=	IC50	nM	69000.0	CHEMBL267	Homo sapiens	IC50	uM	69.0
Not Determined	1101078	CHEMBL812676	Binding affinity for Human pp60c-src SH2 domain (no data)	B	O=C(NCc1ccc(OCC2CCCCC2)c(Cl)c1)c1ccc(OP(=O)(O)O)cc1		CHEMBL1160322		IC50	nM		CHEMBL267	Homo sapiens	IC50	uM	
	1102182	CHEMBL881135	Inhibitory activity against c-src tyrosine kinase	B	COc1ccc(C2=C(C(N)=O)C(=O)c3ccccc32)cc1		CHEMBL101457	=	IC50	nM	4000.0	CHEMBL267	Homo sapiens	IC50	uM	4.0
	1102203	CHEMBL805899	Inhibition of Src protein tyrosine kinase	B	CNc1cc(Nc2nc3ccc(C(=O)Nc4c(C)cccc4Cl)cc3s2)ncn1		CHEMBL90002	=	Ki	nM	17.0	CHEMBL267	Homo sapiens	Ki	nM	17.0
	1102245	CHEMBL823859	Percent inhibition determined against human recombinant p60 c-Src tyrosine kinase at 100 uM	B	COc1ccc(CNC(=O)c2cc3ccccc3[nH]2)cc1		CHEMBL359226	=	Inhibition	%	4.0	CHEMBL267	Homo sapiens	Inhibition	%	4.0
	1106342	CHEMBL873261	Inhibition of Src protein tyrosine kinase	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc([N+](=O)[O-])cc4)CC3)c2cc1OC		CHEMBL99743	>	IC50	nM	30000.0	CHEMBL267	Homo sapiens	IC50	uM l-1	30.0
	1108579	CHEMBL873261	Inhibition of Src protein tyrosine kinase	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(C(C)C)cc4)CC3)c2cc1OC		CHEMBL104067	>	IC50	nM	30000.0	CHEMBL267	Homo sapiens	IC50	uM l-1	30.0
	1109331	CHEMBL805897	Inhibition of Src protein tyrosine kinase at 0.01 uM	B	N#Cc1cnc2cc3cc(O)c(O)cc3cc2c1Nc1ccc(Cl)cc1Cl		CHEMBL135839	=	Inhibition	%	10.0	CHEMBL267	Homo sapiens	Inhibition	%	10.0
	1112115	CHEMBL873261	Inhibition of Src protein tyrosine kinase	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	>	IC50	nM	30000.0	CHEMBL267	Homo sapiens	IC50	uM l-1	30.0
	1114177	CHEMBL805898	Inhibition of Src protein tyrosine kinase at 0.1 uM	B	COc1ccc2cc3c(Nc4ccc(Cl)cc4Cl)c(C#N)cnc3cc2c1		CHEMBL337274	=	Inhibition	%	30.0	CHEMBL267	Homo sapiens	Inhibition	%	30.0
	1114588	CHEMBL873261	Inhibition of Src protein tyrosine kinase	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Br)cc4)CC3)c2cc1OC		CHEMBL323336	>	IC50	nM	30000.0	CHEMBL267	Homo sapiens	IC50	uM l-1	30.0
	1115430	CHEMBL805364	Inhibition of Src protein tyrosine kinase	B	COc1cc2ncc(C#N)c(Nc3ccc(Cl)cc3Cl)c2cc1OC		CHEMBL101917	=	IC50	nM	38.0	CHEMBL267	Homo sapiens	IC50	uM	0.038
	1120162	CHEMBL805898	Inhibition of Src protein tyrosine kinase at 0.1 uM	B	COc1ccc2cc3ncc(C#N)c(Nc4ccc(Cl)cc4Cl)c3cc2c1		CHEMBL135281	=	Inhibition	%	30.0	CHEMBL267	Homo sapiens	Inhibition	%	30.0
	1120832	CHEMBL806416	Inhibition of [125I]phosphopeptide binding to Src SH2 domain.	B	CN(CCCC1CCCCC1)C(=O)[C@H](CCC(=O)O)NC(=O)NCc1ccc(OP(=O)(O)O)cc1		CHEMBL331979	=	IC50	nM	12000.0	CHEMBL267	Homo sapiens	IC50	uM	12.0
	1124511	CHEMBL806416	Inhibition of [125I]phosphopeptide binding to Src SH2 domain.	B	CN(CCCC1CCCCC1)C(=O)[C@H](CCC(=O)O)NC(=O)Nc1cccc2cc(OP(=O)(O)O)ccc12		CHEMBL332418	=	IC50	nM	13000.0	CHEMBL267	Homo sapiens	IC50	uM	13.0
	1125744	CHEMBL806416	Inhibition of [125I]phosphopeptide binding to Src SH2 domain.	B	CN(CCCC1CCCCC1)C(=O)[C@H](CCC(=O)O)NC(=O)N(CC(=O)O)Cc1ccc(OP(=O)(O)O)cc1		CHEMBL420910	=	IC50	nM	7000.0	CHEMBL267	Homo sapiens	IC50	uM	7.0
	1128219	CHEMBL806416	Inhibition of [125I]phosphopeptide binding to Src SH2 domain.	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](CC(=O)O)Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)O		CHEMBL3142986	=	IC50	nM	400.0	CHEMBL267	Homo sapiens	IC50	uM	0.4
	1130112	CHEMBL873261	Inhibition of Src protein tyrosine kinase	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(C#N)cc4)CC3)c2cc1OC		CHEMBL106966	>	IC50	nM	30000.0	CHEMBL267	Homo sapiens	IC50	uM l-1	30.0
	1130967	CHEMBL805364	Inhibition of Src protein tyrosine kinase	B	COc1cc(Nc2c(C#N)cnc3cc4cc(OC)c(OC)cc4cc23)c(C)cc1Cl		CHEMBL335025	=	IC50	nM	1.4	CHEMBL267	Homo sapiens	IC50	uM	0.0014
	1130968	CHEMBL677167	Inhibition of Src-transformed fibroblast cell proliferation	F	COc1cc(Nc2c(C#N)cnc3cc4cc(OC)c(OC)cc4cc23)c(C)cc1Cl		CHEMBL335025	=	IC50	nM	210.0	CHEMBL267	Homo sapiens	IC50	uM	0.21
	1130969	CHEMBL805364	Inhibition of Src protein tyrosine kinase	B	COc1cc(Nc2c(C#N)cnc3cc(OC)c(OC)cc23)c(C)cc1Cl		CHEMBL127331	=	IC50	nM	4.0	CHEMBL267	Homo sapiens	IC50	uM	0.004
	1130970	CHEMBL677167	Inhibition of Src-transformed fibroblast cell proliferation	F	COc1cc(Nc2c(C#N)cnc3cc(OC)c(OC)cc23)c(C)cc1Cl		CHEMBL127331	=	IC50	nM	2400.0	CHEMBL267	Homo sapiens	IC50	uM	2.4
	1131618	CHEMBL806416	Inhibition of [125I]phosphopeptide binding to Src SH2 domain.	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(C)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)O		CHEMBL299477	=	IC50	nM	500.0	CHEMBL267	Homo sapiens	IC50	uM	0.5
	1131619	CHEMBL806416	Inhibition of [125I]phosphopeptide binding to Src SH2 domain.	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)NCCCC1CCCCC1		CHEMBL122640	=	IC50	nM	800.0	CHEMBL267	Homo sapiens	IC50	uM	0.8
	1132022	CHEMBL805364	Inhibition of Src protein tyrosine kinase	B	COc1cc2cc3ncc(C#N)c(Nc4ccc(Cl)cc4Cl)c3cc2cc1OC		CHEMBL135282	=	IC50	nM	18.0	CHEMBL267	Homo sapiens	IC50	uM	0.018
	1135574	CHEMBL806416	Inhibition of [125I]phosphopeptide binding to Src SH2 domain.	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](CCC1CCCCC1)C(N)=O		CHEMBL273628	=	IC50	nM	1800.0	CHEMBL267	Homo sapiens	IC50	uM	1.8
	1144042	CHEMBL809577	In vitro inhibitory concentration against src-tyrosine kinase	B	COc1cc2c(Nc3c(Cl)ccc4c3OCO4)ncnc2cc1OCCCN1CCOCC1		CHEMBL369360	<	IC50	nM	4.0	CHEMBL267	Homo sapiens	IC50	uM	0.004
	1144044	CHEMBL806525	Inhibition of c-Src transfected 3T3 cell proliferation	F	COc1cc2c(Nc3c(Cl)ccc4c3OCO4)ncnc2cc1OCCCN1CCOCC1		CHEMBL369360	=	IC50	nM	100.0	CHEMBL267	Homo sapiens	IC50	uM	0.1
	1144370	CHEMBL816862	Inhibitory activity against c-Src tyrosine kinase	B	Nc1ccc(Nc2[nH]nc3ncnc(Nc4cccc(Cl)c4)c23)cc1		CHEMBL332612	=	IC50	nM	2400.0	CHEMBL267	Homo sapiens	IC50	uM	2.4
	1144378	CHEMBL816862	Inhibitory activity against c-Src tyrosine kinase	B	O=[N+]([O-])c1cccc(-c2[nH]nc3ncnc(Nc4cccc(Cl)c4)c23)c1		CHEMBL118904	=	IC50	nM	9800.0	CHEMBL267	Homo sapiens	IC50	uM	9.8
	1145257	CHEMBL809577	In vitro inhibitory concentration against src-tyrosine kinase	B	COc1cc2c(Nc3cccc4occc34)ncnc2cc1OCCCN1CCOCC1		CHEMBL171558	=	IC50	nM	16.0	CHEMBL267	Homo sapiens	IC50	uM	0.016
	1145259	CHEMBL809577	In vitro inhibitory concentration against src-tyrosine kinase	B	COc1cc2c(Nc3c(Cl)ccc4c3OCO4)ncnc2cc1OCc1ccnc(C#N)c1		CHEMBL354145	=	IC50	nM	10.0	CHEMBL267	Homo sapiens	IC50	uM	0.01
	1145261	CHEMBL806525	Inhibition of c-Src transfected 3T3 cell proliferation	F	COc1cc2c(Nc3c(Cl)ccc4c3OCO4)ncnc2cc1OCc1ccnc(C#N)c1		CHEMBL354145	=	IC50	nM	90.0	CHEMBL267	Homo sapiens	IC50	uM	0.09
	1145606	CHEMBL816862	Inhibitory activity against c-Src tyrosine kinase	B	c1ccc(Nc2nc[nH]c3nnc(Nc4ccccc4)c2-3)cc1		CHEMBL332333	=	IC50	nM	75000.0	CHEMBL267	Homo sapiens	IC50	uM	75.0
	1145613	CHEMBL816862	Inhibitory activity against c-Src tyrosine kinase	B	Nc1cccc(-c2[nH]nc3ncnc(Nc4cccc(Cl)c4)c23)c1		CHEMBL332882	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	1145887	CHEMBL806415	Inhibition of binding to Src SH2 domain	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(C)=O)C(N)=O		CHEMBL311937	=	IC50	nM	6000.0	CHEMBL267	Homo sapiens	IC50	uM	6.0
	1146419	CHEMBL808764	Inhibition of src kinase	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCO[C@H](CN1CCCC1)CCn1cc2c2ccccc21		CHEMBL419866	=	IC50	nM	11000.0	CHEMBL267	Homo sapiens	IC50	uM	11.0
	1146667	CHEMBL809577	In vitro inhibitory concentration against src-tyrosine kinase	B	COc1cc2c(Nc3c(Br)ccc4c3OCO4)ncnc2cc1OCCCN1CCOCC1		CHEMBL173799	<	IC50	nM	4.0	CHEMBL267	Homo sapiens	IC50	uM	0.004
	1146669	CHEMBL806525	Inhibition of c-Src transfected 3T3 cell proliferation	F	COc1cc2c(Nc3c(Br)ccc4c3OCO4)ncnc2cc1OCCCN1CCOCC1		CHEMBL173799	=	IC50	nM	60.0	CHEMBL267	Homo sapiens	IC50	uM	0.06
	1148051	CHEMBL809577	In vitro inhibitory concentration against src-tyrosine kinase	B	COc1ccc(Nc2ncnc3cc(OCCCN4CCOCC4)c(OC)cc23)cc1		CHEMBL353901	=	IC50	nM	477.0	CHEMBL267	Homo sapiens	IC50	uM	0.477
	1148291	CHEMBL816862	Inhibitory activity against c-Src tyrosine kinase	B	COc1cccc(Nc2[nH]nc3ncnc(Nc4cccc(Cl)c4)c23)c1		CHEMBL120979	=	IC50	nM	7800.0	CHEMBL267	Homo sapiens	IC50	uM	7.8
	1148928	CHEMBL808764	Inhibition of src kinase	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	1.0	CHEMBL267	Homo sapiens	IC50	uM	0.001
	1149525	CHEMBL816862	Inhibitory activity against c-Src tyrosine kinase	B	COc1ccc(CNc2[nH]nc3ncnc(Nc4cccc(Cl)c4)c23)cc1		CHEMBL122245	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	1150435	CHEMBL809577	In vitro inhibitory concentration against src-tyrosine kinase	B	COc1cccc(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL169473	=	IC50	nM	253.0	CHEMBL267	Homo sapiens	IC50	uM	0.253
	1150436	CHEMBL809577	In vitro inhibitory concentration against src-tyrosine kinase	B	COc1cc2c(Nc3c(Cl)ccc4ccoc34)ncnc2cc1OCCCN1CCOCC1		CHEMBL169643	=	IC50	nM	10.0	CHEMBL267	Homo sapiens	IC50	uM	0.01
	1150438	CHEMBL806525	Inhibition of c-Src transfected 3T3 cell proliferation	F	COc1cc2c(Nc3c(Cl)ccc4ccoc34)ncnc2cc1OCCCN1CCOCC1		CHEMBL169643	=	IC50	nM	340.0	CHEMBL267	Homo sapiens	IC50	uM	0.34
	1150440	CHEMBL809577	In vitro inhibitory concentration against src-tyrosine kinase	B	Clc1ccc2c(c1Nc1ncnc3cc(OCCCN4CCOCC4)ccc13)OCO2		CHEMBL422564	=	IC50	nM	10.0	CHEMBL267	Homo sapiens	IC50	uM	0.01
	1150442	CHEMBL806525	Inhibition of c-Src transfected 3T3 cell proliferation	F	Clc1ccc2c(c1Nc1ncnc3cc(OCCCN4CCOCC4)ccc13)OCO2		CHEMBL422564	=	IC50	nM	450.0	CHEMBL267	Homo sapiens	IC50	uM	0.45
	1151433	CHEMBL808764	Inhibition of src kinase	B	CNC[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL311543	=	IC50	nM		CHEMBL267	Homo sapiens	IC50	uM	
	1151654	CHEMBL809577	In vitro inhibitory concentration against src-tyrosine kinase	B	COc1cc2c(Nc3cccc4c(Cl)coc34)ncnc2cc1OCCCN1CCOCC1		CHEMBL172518	<	IC50	nM	4.0	CHEMBL267	Homo sapiens	IC50	uM	0.004
	1151656	CHEMBL809577	In vitro inhibitory concentration against src-tyrosine kinase	B	COc1cc2c(Nc3cccc4cc[nH]c34)ncnc2cc1OCCCN1CCOCC1		CHEMBL169231	=	IC50	nM	260.0	CHEMBL267	Homo sapiens	IC50	uM	0.26
	1151657	CHEMBL809577	In vitro inhibitory concentration against src-tyrosine kinase	B	COc1cc2c(Nc3cccc4c(Cl)c[nH]c34)ncnc2cc1OCCCN1CCOCC1		CHEMBL353070	=	IC50	nM	20.0	CHEMBL267	Homo sapiens	IC50	uM	0.02
	1151659	CHEMBL806525	Inhibition of c-Src transfected 3T3 cell proliferation	F	COc1cc2c(Nc3cccc4c(Cl)c[nH]c34)ncnc2cc1OCCCN1CCOCC1		CHEMBL353070	=	IC50	nM	380.0	CHEMBL267	Homo sapiens	IC50	uM	0.38
	1151661	CHEMBL809577	In vitro inhibitory concentration against src-tyrosine kinase	B	COc1cc2ncnc(Nc3c(Cl)ccc4c3OCO4)c2cc1OCCCN1CCOCC1		CHEMBL352877	=	IC50	nM	50.0	CHEMBL267	Homo sapiens	IC50	uM	0.05
	1151663	CHEMBL806525	Inhibition of c-Src transfected 3T3 cell proliferation	F	COc1cc2ncnc(Nc3c(Cl)ccc4c3OCO4)c2cc1OCCCN1CCOCC1		CHEMBL352877	=	IC50	nM	1160.0	CHEMBL267	Homo sapiens	IC50	uM	1.16
	1152821	CHEMBL818268	In vitro inhibition of c-SRC kinase expressed in baculovirus	B	O=C(Nc1cccc(C(F)(F)F)c1)c1ccccc1NCc1ccncc1		CHEMBL153843	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	1152860	CHEMBL809577	In vitro inhibitory concentration against src-tyrosine kinase	B	COc1cc2c(Nc3c(Cl)ccc4c3OCO4)ncnc2cc1OCCCN1CCCCC1		CHEMBL169186	<	IC50	nM	4.0	CHEMBL267	Homo sapiens	IC50	uM	0.004
	1152862	CHEMBL806525	Inhibition of c-Src transfected 3T3 cell proliferation	F	COc1cc2c(Nc3c(Cl)ccc4c3OCO4)ncnc2cc1OCCCN1CCCCC1		CHEMBL169186	=	IC50	nM	110.0	CHEMBL267	Homo sapiens	IC50	uM	0.11
	1153156	CHEMBL816862	Inhibitory activity against c-Src tyrosine kinase	B	CN(C)c1ccc(Nc2[nH]nc3ncnc(Nc4cccc(Cl)c4)c23)cc1		CHEMBL332765	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	1153815	CHEMBL808763	Inhibition of src kinase	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	1154175	CHEMBL809577	In vitro inhibitory concentration against src-tyrosine kinase	B	COc1cc2c(Nc3cccc4ccoc34)ncnc2cc1OCCCN1CCOCC1		CHEMBL171745	=	IC50	nM	30.0	CHEMBL267	Homo sapiens	IC50	uM	0.03
	1154750	CHEMBL806415	Inhibition of binding to Src SH2 domain	B	CC[C@H](NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(C)=O)c1cccc(CC2CCCCC2)c1	Outside typical range	CHEMBL76250	=	IC50	nM	306000.0	CHEMBL267	Homo sapiens	IC50	uM	306.0
	1155478	CHEMBL809577	In vitro inhibitory concentration against src-tyrosine kinase	B	CCOc1ccc(Cl)c(Nc2ncnc3cc(OCCCN4CCOCC4)c(OC)cc23)c1		CHEMBL355102	=	IC50	nM	963.0	CHEMBL267	Homo sapiens	IC50	uM	0.963
	1155479	CHEMBL809577	In vitro inhibitory concentration against src-tyrosine kinase	B	COc1cc2c(Nc3c(Cl)ccc4occc34)ncnc2cc1OCCCN1CCOCC1		CHEMBL352977	=	IC50	nM	10.0	CHEMBL267	Homo sapiens	IC50	uM	0.01
	1155481	CHEMBL806525	Inhibition of c-Src transfected 3T3 cell proliferation	F	COc1cc2c(Nc3c(Cl)ccc4occc34)ncnc2cc1OCCCN1CCOCC1		CHEMBL352977	=	IC50	nM	310.0	CHEMBL267	Homo sapiens	IC50	uM	0.31
	1155483	CHEMBL809577	In vitro inhibitory concentration against src-tyrosine kinase	B	COc1cc2c(Nc3cccc4c3OCO4)ncnc2cc1OCCCN1CCOCC1		CHEMBL171125	=	IC50	nM	14.0	CHEMBL267	Homo sapiens	IC50	uM	0.014
	1155485	CHEMBL806525	Inhibition of c-Src transfected 3T3 cell proliferation	F	COc1cc2c(Nc3cccc4c3OCO4)ncnc2cc1OCCCN1CCOCC1		CHEMBL171125	=	IC50	nM	310.0	CHEMBL267	Homo sapiens	IC50	uM	0.31
	1155868	CHEMBL816862	Inhibitory activity against c-Src tyrosine kinase	B	Clc1cccc(Nc2[nH]cnc3nnc(NCc4ccccc4)c2-3)c1		CHEMBL121796	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	1156136	CHEMBL806417	Binding affinity for Src SH2 domain	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)Cc1ccc(OP(=O)(O)O)cc1)C(=O)O		CHEMBL46851	=	Kd	nM	100.0	CHEMBL267	Homo sapiens	Kd	uM	0.1
	1158329	CHEMBL816862	Inhibitory activity against c-Src tyrosine kinase	B	Nc1[nH]cnc2nnc(Nc3cccc(Cl)c3)c1-2		CHEMBL121190	=	IC50	nM	6000.0	CHEMBL267	Homo sapiens	IC50	uM	6.0
	1158336	CHEMBL816862	Inhibitory activity against c-Src tyrosine kinase	B	Oc1cccc(-c2[nH]nc3ncnc(Nc4cccc(Cl)c4)c23)c1		CHEMBL331906	=	IC50	nM	2.0	CHEMBL267	Homo sapiens	IC50	uM	0.002
	1158344	CHEMBL816862	Inhibitory activity against c-Src tyrosine kinase	B	Nc1ccc(-c2[nH]nc3ncnc(Nc4cccc(Cl)c4)c23)cc1		CHEMBL332906	=	IC50	nM	4900.0	CHEMBL267	Homo sapiens	IC50	uM	4.9
	1160766	CHEMBL809577	In vitro inhibitory concentration against src-tyrosine kinase	B	COc1cc2c(Nc3cccc4c3OC(F)(F)O4)ncnc2cc1OCCCN1CCOCC1		CHEMBL168885	=	IC50	nM	270.0	CHEMBL267	Homo sapiens	IC50	uM	0.27
	1162565	CHEMBL816862	Inhibitory activity against c-Src tyrosine kinase	B	Nc1nc(N)c2c(Nc3cccc(Cl)c3)[nH]nc2n1		CHEMBL122068	=	IC50	nM	6000.0	CHEMBL267	Homo sapiens	IC50	uM	6.0
	1162572	CHEMBL816862	Inhibitory activity against c-Src tyrosine kinase	B	Clc1cccc(CNc2[nH]nc3ncnc(Nc4cccc(Cl)c4)c23)c1		CHEMBL333231	=	IC50	nM	2090.0	CHEMBL267	Homo sapiens	IC50	uM	2.09
	1162580	CHEMBL816862	Inhibitory activity against c-Src tyrosine kinase	B	COc1ccc(-c2[nH]nc3ncnc(Nc4cccc(Cl)c4)c23)cc1		CHEMBL332971	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	1163302	CHEMBL808764	Inhibition of src kinase	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCO[C@H](CNCc1ccccc1)CCn1cc2c2ccccc21		CHEMBL328229	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	1164970	CHEMBL809577	In vitro inhibitory concentration against src-tyrosine kinase	B	COc1ccc(Cl)c(Nc2ncnc3cc(OCCCN4CCOCC4)c(OC)cc23)c1		CHEMBL172450	=	IC50	nM	10.0	CHEMBL267	Homo sapiens	IC50	uM	0.01
	1164972	CHEMBL806525	Inhibition of c-Src transfected 3T3 cell proliferation	F	COc1ccc(Cl)c(Nc2ncnc3cc(OCCCN4CCOCC4)c(OC)cc23)c1		CHEMBL172450	=	IC50	nM	310.0	CHEMBL267	Homo sapiens	IC50	uM	0.31
	1166651	CHEMBL816862	Inhibitory activity against c-Src tyrosine kinase	B	CC(C)(C)OC(=O)Nc1ccc(Nc2[nH]nc3ncnc(Nc4cccc(Cl)c4)c23)cc1		CHEMBL120703	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	1166957	CHEMBL806415	Inhibition of binding to Src SH2 domain	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CCC(=O)O)c1nc(CC2CCCCC2)cs1		CHEMBL73829	=	IC50	nM	26000.0	CHEMBL267	Homo sapiens	IC50	uM	26.0
	1167674	CHEMBL809577	In vitro inhibitory concentration against src-tyrosine kinase	B	COc1cc2c(Nc3cccc4c3OCC4)ncnc2cc1OCCCN1CCOCC1		CHEMBL171373	=	IC50	nM	433.0	CHEMBL267	Homo sapiens	IC50	uM	0.433
	1167950	CHEMBL816862	Inhibitory activity against c-Src tyrosine kinase	B	COc1cccc(CNc2[nH]nc3ncnc(Nc4cccc(Cl)c4)c23)c1		CHEMBL123189	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	1168642	CHEMBL808764	Inhibition of src kinase	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCO[C@H](CNS(=O)(=O)c1ccccc1)CCn1cc2c2ccccc21		CHEMBL315389	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	1169280	CHEMBL816862	Inhibitory activity against c-Src tyrosine kinase	B	CC(C)(C)OC(=O)Nc1ccc(-c2[nH]nc3ncnc(Nc4cccc(Cl)c4)c23)cc1		CHEMBL420885	=	IC50	nM	9800.0	CHEMBL267	Homo sapiens	IC50	uM	9.8
	1169288	CHEMBL816862	Inhibitory activity against c-Src tyrosine kinase	B	Clc1cccc(Nc2[nH]nc3ncnc(Oc4cccc(Cl)c4)c23)c1		CHEMBL334026	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	1169954	CHEMBL808764	Inhibition of src kinase	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCO[C@H](CO)CCn1cc2c2ccccc21		CHEMBL292495	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	1170241	CHEMBL873134	Inhibition of human src-tyrosine kinase	B	COc1ccc(Cl)c(Nc2ncnc3cc(OCN4CCN(C)CC4)c(OC)cc23)c1		CHEMBL352992	=	IC50	nM	10.0	CHEMBL267	Homo sapiens	IC50	uM	0.01
	1170243	CHEMBL806525	Inhibition of c-Src transfected 3T3 cell proliferation	F	COc1ccc(Cl)c(Nc2ncnc3cc(OCN4CCN(C)CC4)c(OC)cc23)c1		CHEMBL352992	=	IC50	nM	530.0	CHEMBL267	Homo sapiens	IC50	uM	0.53
	1170745	CHEMBL806415	Inhibition of binding to Src SH2 domain	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)NCc1cccc(CC2CCCCC2)c1	Outside typical range	CHEMBL308344	=	IC50	nM	769000.0	CHEMBL267	Homo sapiens	IC50	uM	769.0
	1171396	CHEMBL809577	In vitro inhibitory concentration against src-tyrosine kinase	B	COc1cc2c(Nc3cccc4c3ccn4C)ncnc2cc1OCCCN1CCOCC1		CHEMBL355282	=	IC50	nM	40.0	CHEMBL267	Homo sapiens	IC50	uM	0.04
	1171617	CHEMBL816862	Inhibitory activity against c-Src tyrosine kinase	B	Clc1cccc(Nc2nc[nH]c3nnc(Nc4cccc(Cl)c4)c2-3)c1		CHEMBL333038	=	IC50	nM	5300.0	CHEMBL267	Homo sapiens	IC50	uM	5.3
	1171628	CHEMBL816862	Inhibitory activity against c-Src tyrosine kinase	B	Clc1cccc(Nc2[nH]nc3ncnc(NCc4ccccc4)c23)c1		CHEMBL119982	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	1173028	CHEMBL816865	Inhibition of c-Src tyrosine kinase	B	Clc1cccc(Nc2[nH]nc3ncnc(Nc4cccc(Br)c4)c23)c1		CHEMBL120319	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	1173942	CHEMBL808766	Inhibition of Src protein tyrosine kinase	B	CCN(CC)C/C=C/c1nc(O)c2c(ccc3nc(Nc4c(Cl)cccc4Cl)n(C)c32)c1C		CHEMBL281957	=	IC50	nM	0.2	CHEMBL267	Homo sapiens	IC50	uM	0.0002
	1174054	CHEMBL809577	In vitro inhibitory concentration against src-tyrosine kinase	B	COc1cccc(Nc2ncnc3cc(OCCCN4CCOCC4)c(OC)cc23)c1		CHEMBL169797	=	IC50	nM	37.0	CHEMBL267	Homo sapiens	IC50	uM	0.037
	1174056	CHEMBL806525	Inhibition of c-Src transfected 3T3 cell proliferation	F	COc1cccc(Nc2ncnc3cc(OCCCN4CCOCC4)c(OC)cc23)c1		CHEMBL169797	=	IC50	nM	690.0	CHEMBL267	Homo sapiens	IC50	uM	0.69
	1174058	CHEMBL809577	In vitro inhibitory concentration against src-tyrosine kinase	B	COc1cc2c(Nc3c(F)ccc4c3OCO4)ncnc2cc1OCCCN1CCOCC1		CHEMBL167890	=	IC50	nM	28.0	CHEMBL267	Homo sapiens	IC50	uM	0.028
	1174060	CHEMBL806525	Inhibition of c-Src transfected 3T3 cell proliferation	F	COc1cc2c(Nc3c(F)ccc4c3OCO4)ncnc2cc1OCCCN1CCOCC1		CHEMBL167890	=	IC50	nM	300.0	CHEMBL267	Homo sapiens	IC50	uM	0.3
	1174286	CHEMBL816862	Inhibitory activity against c-Src tyrosine kinase	B	Clc1cccc(Nc2[nH]nc3ncnc(Nc4ccccc4)c23)c1		CHEMBL121260	=	IC50	nM	2250.0	CHEMBL267	Homo sapiens	IC50	uM	2.25
	1174293	CHEMBL816862	Inhibitory activity against c-Src tyrosine kinase	B	Oc1cccc(Nc2[nH]nc3ncnc(Nc4cccc(Cl)c4)c23)c1		CHEMBL121954	=	IC50	nM	220.0	CHEMBL267	Homo sapiens	IC50	uM	0.22
	1175328	CHEMBL818268	In vitro inhibition of c-SRC kinase expressed in baculovirus	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	IC50	nM	186.0	CHEMBL267	Homo sapiens	IC50	nM	186.0
	1175353	CHEMBL818268	In vitro inhibition of c-SRC kinase expressed in baculovirus	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	1176714	CHEMBL809577	In vitro inhibitory concentration against src-tyrosine kinase	B	COc1cc2c(Nc3c(Cl)ccc4c3OCO4)ncnc2cc1OCC1CCN(C)CC1		CHEMBL170984	=	IC50	nM	5.0	CHEMBL267	Homo sapiens	IC50	uM	0.005
	1176716	CHEMBL806525	Inhibition of c-Src transfected 3T3 cell proliferation	F	COc1cc2c(Nc3c(Cl)ccc4c3OCO4)ncnc2cc1OCC1CCN(C)CC1		CHEMBL170984	=	IC50	nM	120.0	CHEMBL267	Homo sapiens	IC50	uM	0.12
	1177982	CHEMBL809577	In vitro inhibitory concentration against src-tyrosine kinase	B	COc1cc2c(Nc3cccc4c3OCCO4)ncnc2cc1OCCCN1CCOCC1		CHEMBL171423	=	IC50	nM	370.0	CHEMBL267	Homo sapiens	IC50	uM	0.37
	1179476	CHEMBL816862	Inhibitory activity against c-Src tyrosine kinase	B	COc1ccc(Nc2[nH]nc3ncnc(Nc4cccc(Cl)c4)c23)cc1		CHEMBL122411	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	1179484	CHEMBL816862	Inhibitory activity against c-Src tyrosine kinase	B	COc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OC		CHEMBL29197	=	IC50	nM	1400.0	CHEMBL267	Homo sapiens	IC50	uM	1.4
	1180291	CHEMBL808764	Inhibition of src kinase	B	NC[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL316239	=	IC50	nM	89000.0	CHEMBL267	Homo sapiens	IC50	uM	89.0
	1180542	CHEMBL818268	In vitro inhibition of c-SRC kinase expressed in baculovirus	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1.O=C(O)CCC(=O)O		CHEMBL75232	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	1180571	CHEMBL809577	In vitro inhibitory concentration against src-tyrosine kinase	B	COc1cc2c(Nc3ccc4c(c3)OCO4)ncnc2cc1OCCCN1CCOCC1		CHEMBL169725	=	IC50	nM	760.0	CHEMBL267	Homo sapiens	IC50	uM	0.76
	1181210	CHEMBL806415	Inhibition of binding to Src SH2 domain	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)NCc1nc(CC2CCCCC2)cs1	Outside typical range	CHEMBL76625	=	IC50	nM	483000.0	CHEMBL267	Homo sapiens	IC50	uM	483.0
	1181922	CHEMBL809577	In vitro inhibitory concentration against src-tyrosine kinase	B	COc1ccccc1Nc1ncnc2cc(OCCCN3CCOCC3)c(OC)cc12		CHEMBL171368	=	IC50	nM	560.0	CHEMBL267	Homo sapiens	IC50	uM	0.56
	1182244	CHEMBL816862	Inhibitory activity against c-Src tyrosine kinase	B	Oc1ccc(Nc2[nH]nc3ncnc(Nc4cccc(Cl)c4)c23)cc1		CHEMBL122182	=	IC50	nM	400.0	CHEMBL267	Homo sapiens	IC50	uM	0.4
	1183194	CHEMBL818268	In vitro inhibition of c-SRC kinase expressed in baculovirus	B	O=C(Nc1cccc(-c2cncc3ccccc23)c1)c1ccccc1NCc1ccncc1		CHEMBL347537	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	1183278	CHEMBL809577	In vitro inhibitory concentration against src-tyrosine kinase	B	COc1cc2c(Nc3cccc4[nH]ccc34)ncnc2cc1OCCCN1CCOCC1		CHEMBL171003	=	IC50	nM	177.0	CHEMBL267	Homo sapiens	IC50	uM	0.177
	1183557	CHEMBL816865	Inhibition of c-Src tyrosine kinase	B	Cc1cccc(Nc2[nH]cnc3nnc(Nc4cccc(Cl)c4)c2-3)c1		CHEMBL120069	=	IC50	nM	8080.0	CHEMBL267	Homo sapiens	IC50	uM	8.08
	1183568	CHEMBL816865	Inhibition of c-Src tyrosine kinase	B	Clc1cccc(Nc2[nH]cnc3nnc(-c4ccccc4)c2-3)c1		CHEMBL119977	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	1183576	CHEMBL816862	Inhibitory activity against c-Src tyrosine kinase	B	Oc1ccc(-c2[nH]nc3ncnc(Nc4cccc(Cl)c4)c23)cc1		CHEMBL118130	=	IC50	nM	8550.0	CHEMBL267	Homo sapiens	IC50	uM	8.55
	1185349	CHEMBL806433	Inhibition of Src protein tyrosine kinase	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCOC1		CHEMBL48554	=	IC50	nM	320.0	CHEMBL267	Homo sapiens	IC50	uM	0.32
	1185353	CHEMBL806433	Inhibition of Src protein tyrosine kinase	B	CN1CCN([C@H]2CC[C@H](n3cc(-c4ccc(Oc5ccccc5)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL45177	=	IC50	nM	1190.0	CHEMBL267	Homo sapiens	IC50	uM	1.19
	1187510	CHEMBL768942	Affinity for SH2 domain of src in Sf9 insect cells	B	CCCCCN(CCCCC)C(=O)[C@@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(C)=O)C(C)C		CHEMBL137715	=	IC50	nM	1400.0	CHEMBL267	Homo sapiens	IC50	uM	1.4
	1188059	CHEMBL806433	Inhibition of Src protein tyrosine kinase	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2CCO		CHEMBL297359	=	IC50	nM	1470.0	CHEMBL267	Homo sapiens	IC50	uM	1.47
Not Determined	1188983	CHEMBL768943	Affinity for SH2 domain of src in Sf9 insect cells (Not determined)	B	CSCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(C)=O)C(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O		CHEMBL136180		IC50	nM		CHEMBL267	Homo sapiens	IC50	uM	
Not Determined	1190348	CHEMBL768943	Affinity for SH2 domain of src in Sf9 insect cells (Not determined)	B	CSCC[C@H](NC(=O)[C@@H](N)Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)O		CHEMBL136232		IC50	nM		CHEMBL267	Homo sapiens	IC50	uM	
	1190784	CHEMBL806433	Inhibition of Src protein tyrosine kinase	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCNCC1		CHEMBL47202	=	IC50	nM	1780.0	CHEMBL267	Homo sapiens	IC50	uM	1.78
	1191598	CHEMBL768942	Affinity for SH2 domain of src in Sf9 insect cells	B	CCCCN(CCCC)C(=O)[C@@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(C)=O)C(C)C		CHEMBL133031	=	IC50	nM	5700.0	CHEMBL267	Homo sapiens	IC50	uM	5.7
	1191692	CHEMBL803384	Inhibition of human c-Src	B	C[C@H](Nc1cc(-c2sc(C3CCN(C)CC3)nc2-c2ccc(F)cc2)ccn1)c1ccccc1		CHEMBL2111784	=	IC50	nM	8000.0	CHEMBL267	Homo sapiens	IC50	uM	8.0
Not Determined	1192763	CHEMBL768943	Affinity for SH2 domain of src in Sf9 insect cells (Not determined)	B	CSCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(OP(=O)(O)O)cc1)C(C)C)C(N)=O		CHEMBL137060		IC50	nM		CHEMBL267	Homo sapiens	IC50	uM	
	1194100	CHEMBL768942	Affinity for SH2 domain of src in Sf9 insect cells	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)NCCc1ccccc1)C(C)C		CHEMBL343050	=	IC50	nM	17800.0	CHEMBL267	Homo sapiens	IC50	uM	17.8
	1194611	CHEMBL806433	Inhibition of Src protein tyrosine kinase	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2[C@H]1CC[C@H](N2CCCCC2)CC1		CHEMBL431342	=	IC50	nM	5460.0	CHEMBL267	Homo sapiens	IC50	uM	5.46
Not Determined	1195311	CHEMBL768943	Affinity for SH2 domain of src in Sf9 insect cells (Not determined)	B	CCCCCNC(=O)[C@@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(C)=O)C(C)C		CHEMBL2111929		IC50	nM		CHEMBL267	Homo sapiens	IC50	uM	
	1196566	CHEMBL768942	Affinity for SH2 domain of src in Sf9 insect cells	B	CSCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(C)=O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O		CHEMBL134623	=	IC50	nM	5900.0	CHEMBL267	Homo sapiens	IC50	uM	5.9
	1196569	CHEMBL768942	Affinity for SH2 domain of src in Sf9 insect cells	B	CCCCCCCCN(CCCCCCCC)C(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(C)=O)C(C)C		CHEMBL137653	=	IC50	nM	6100.0	CHEMBL267	Homo sapiens	IC50	uM	6.1
	1197967	CHEMBL803385	Inhibition of human c-Src at 10 uM	B	COc1ccc(C#CC(C)(C)N)cc1C(=O)c1ccc(Nc2ccc(F)cc2F)cc1		CHEMBL419409	=	Inhibition	%	-10.0	CHEMBL267	Homo sapiens	Inhibition	%	-10.0
	1199248	CHEMBL803384	Inhibition of human c-Src	B	CN1CCN(c2ccc3c(n2)nc(-c2ccc(F)cc2)n3-c2ccnc(NC3CCCC3)n2)CC1		CHEMBL120185	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	1200650	CHEMBL803384	Inhibition of human c-Src	B	OC1(c2nc(-c3ccc(F)cc3)c(-c3ccnc(NC4CCCCC4)c3)o2)CCNCC1		CHEMBL121405	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	1200671	CHEMBL803385	Inhibition of human c-Src at 10 uM	B	COc1cc2[nH]c(C)nc2cc1C(=O)c1ccc(Nc2ccc(F)cc2F)cc1		CHEMBL120067	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	Inhibition	%	0.0
	1201831	CHEMBL768942	Affinity for SH2 domain of src in Sf9 insect cells	B	CSCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(OP(=O)(O)O)cc1)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O		CHEMBL334689	=	IC50	nM	12700.0	CHEMBL267	Homo sapiens	IC50	uM	12.7
	1201834	CHEMBL768942	Affinity for SH2 domain of src in Sf9 insect cells	B	CCCCN(CCCC)C(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(C)=O)C(C)C		CHEMBL327958	=	IC50	nM	12500.0	CHEMBL267	Homo sapiens	IC50	uM	12.5
Not Determined	1203320	CHEMBL768943	Affinity for SH2 domain of src in Sf9 insect cells (Not determined)	B	CSCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(OP(=O)(O)O)cc1)C(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O		CHEMBL336451		IC50	nM		CHEMBL267	Homo sapiens	IC50	uM	
	1204715	CHEMBL768942	Affinity for SH2 domain of src in Sf9 insect cells	B	CCCCCCN(CCCCCC)C(=O)[C@@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(C)=O)C(C)C		CHEMBL137706	=	IC50	nM	1000.0	CHEMBL267	Homo sapiens	IC50	uM	1.0
	1206032	CHEMBL768942	Affinity for SH2 domain of src in Sf9 insect cells	B	CCCCCN(CCCCC)C(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(C)=O)C(C)C		CHEMBL405059	=	IC50	nM	2700.0	CHEMBL267	Homo sapiens	IC50	uM	2.7
	1206515	CHEMBL806433	Inhibition of Src protein tyrosine kinase	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCOCC1		CHEMBL296103	=	IC50	nM	1120.0	CHEMBL267	Homo sapiens	IC50	uM	1.12
	1207804	CHEMBL806433	Inhibition of Src protein tyrosine kinase	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCNC1		CHEMBL297278	=	IC50	nM	2360.0	CHEMBL267	Homo sapiens	IC50	uM	2.36
	1210404	CHEMBL806433	Inhibition of Src protein tyrosine kinase	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	IC50	nM	560.0	CHEMBL267	Homo sapiens	IC50	uM	0.56
Not Determined	1211162	CHEMBL768943	Affinity for SH2 domain of src in Sf9 insect cells (Not determined)	B	CCCCCNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(C)=O)C(C)C		CHEMBL137257		IC50	nM		CHEMBL267	Homo sapiens	IC50	uM	
	1213061	CHEMBL806433	Inhibition of Src protein tyrosine kinase	B	CN1CCN([C@H]2CC[C@@H](n3cc(-c4ccc(Oc5ccccc5)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL47203	=	IC50	nM	42.0	CHEMBL267	Homo sapiens	IC50	uM	0.042
	1213805	CHEMBL768942	Affinity for SH2 domain of src in Sf9 insect cells	B	CCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(OP(=O)(O)O)cc1)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O		CHEMBL2370829	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	1215196	CHEMBL803384	Inhibition of human c-Src	B	CN1CCC(O)(c2cn(-c3ccnc(NC4CCCC4)n3)c(-c3cccc(C(F)(F)F)c3)n2)CC1		CHEMBL118258	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	1219166	CHEMBL768942	Affinity for SH2 domain of src in Sf9 insect cells	B	CCCCCCN(CCCCCC)C(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(C)=O)C(C)C		CHEMBL421929	=	IC50	nM	3500.0	CHEMBL267	Homo sapiens	IC50	uM	3.5
	1219680	CHEMBL806433	Inhibition of Src protein tyrosine kinase	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CNOC1		CHEMBL296534	=	IC50	nM	390.0	CHEMBL267	Homo sapiens	IC50	uM	0.39
	1219684	CHEMBL806433	Inhibition of Src protein tyrosine kinase	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2[C@H]1CC[C@@H](N2CCCCC2)CC1		CHEMBL44942	=	IC50	nM	298.0	CHEMBL267	Homo sapiens	IC50	uM	0.298
Not Determined	1220429	CHEMBL768943	Affinity for SH2 domain of src in Sf9 insect cells (Not determined)	B	CSCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(OP(=O)(O)O)cc1)C(C)C)C(=O)O		CHEMBL136171		IC50	nM		CHEMBL267	Homo sapiens	IC50	uM	
Not Determined	1220432	CHEMBL768943	Affinity for SH2 domain of src in Sf9 insect cells (Not determined)	B	CCCCN(CC(N)=O)C(=O)[C@@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(C)=O)C(C)C		CHEMBL137056		IC50	nM		CHEMBL267	Homo sapiens	IC50	uM	
	1221694	CHEMBL768942	Affinity for SH2 domain of src in Sf9 insect cells	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@H](C(=O)N[C@H](C)C(=O)NCCC1CCCCC1)C(C)C		CHEMBL136289	=	IC50	nM	5000.0	CHEMBL267	Homo sapiens	IC50	uM	5.0
	1222194	CHEMBL806433	Inhibition of Src protein tyrosine kinase	B	NCCn1cc(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc21		CHEMBL416444	=	IC50	nM	32340.0	CHEMBL267	Homo sapiens	IC50	uM	32.34
Not Determined	1222910	CHEMBL768943	Affinity for SH2 domain of src in Sf9 insect cells (Not determined)	B	CSCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(C)=O)C(C)C)C(N)=O		CHEMBL341913		IC50	nM		CHEMBL267	Homo sapiens	IC50	uM	
	1224378	CHEMBL768942	Affinity for SH2 domain of src in Sf9 insect cells	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@H](C(=O)N[C@H](C)C(=O)NCCc1ccccc1)C(C)C		CHEMBL539942	=	IC50	nM	8600.0	CHEMBL267	Homo sapiens	IC50	uM	8.6
	1224381	CHEMBL768942	Affinity for SH2 domain of src in Sf9 insect cells	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)NCCC1CCCCC1)C(C)C		CHEMBL136380	=	IC50	nM	18400.0	CHEMBL267	Homo sapiens	IC50	uM	18.4
	1227778	CHEMBL818270	Inhibition of c-SRC with 1 uM ATP	B	Cc1nc(O)c2c(ccc3[nH]c(Nc4c(Cl)cccc4Cl)nc32)c1C		CHEMBL27085	=	IC50	nM	12.0	CHEMBL267	Homo sapiens	IC50	uM	0.012
	1228131	CHEMBL806430	Enzyme inhibitory activity against recombinant human Src protein tyrosine kinase	B	N#Cc1cnc2cc(C#Cc3cccnc3)ccc2c1Nc1ccc(Cl)cc1Cl		CHEMBL69470	=	IC50	nM	200.0	CHEMBL267	Homo sapiens	IC50	nM	200.0
	1228133	CHEMBL806430	Enzyme inhibitory activity against recombinant human Src protein tyrosine kinase	B	COc1cc(Nc2c(C#N)cnc3cc(C#Cc4ccncc4)ccc23)c(Cl)cc1Cl		CHEMBL304052	=	IC50	nM	83.0	CHEMBL267	Homo sapiens	IC50	nM	83.0
	1230650	CHEMBL806430	Enzyme inhibitory activity against recombinant human Src protein tyrosine kinase	B	CCOC(=O)c1cnc2cc(/C=C/c3ccncc3)ccc2c1Nc1ccc(Cl)cc1Cl		CHEMBL69650	=	IC50	nM	12000.0	CHEMBL267	Homo sapiens	IC50	nM	12000.0
	1232529	CHEMBL808765	Inhibition of Src protein tyrosine kinase	B	CC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL7572	>	IC50	nM	30000.0	CHEMBL267	Homo sapiens	IC50	uM	30.0
	1232932	CHEMBL806430	Enzyme inhibitory activity against recombinant human Src protein tyrosine kinase	B	COc1cc(Nc2c(C#N)cnc3cc(/C=C/c4ccc5ccccc5c4)ccc23)c(Cl)cc1Cl		CHEMBL67878	=	IC50	nM	320.0	CHEMBL267	Homo sapiens	IC50	nM	320.0
	1233672	CHEMBL808765	Inhibition of Src protein tyrosine kinase	B	CN(C)CC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL7432	>	IC50	nM	30000.0	CHEMBL267	Homo sapiens	IC50	uM	30.0
	1234185	CHEMBL806430	Enzyme inhibitory activity against recombinant human Src protein tyrosine kinase	B	O=C(O)c1cnc2cc(/C=C/c3ccncc3)ccc2c1Nc1ccc(Cl)cc1Cl		CHEMBL69599	=	IC50	nM	1600.0	CHEMBL267	Homo sapiens	IC50	nM	1600.0
Not Determined	1235226	CHEMBL806431	Inhibition of Src protein tyrosine kinase (not tested)	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccsc4)CC3)c2cc1OC.Cl		CHEMBL553824		NT			CHEMBL267	Homo sapiens	NT		
	1235669	CHEMBL806430	Enzyme inhibitory activity against recombinant human Src protein tyrosine kinase	B	C=Cc1ccc2c(Nc3cc(OC)c(Cl)cc3Cl)c(C#N)cnc2c1		CHEMBL69773	=	IC50	nM	97.0	CHEMBL267	Homo sapiens	IC50	nM	97.0
	1236588	CHEMBL806429	Inhibition of Src protein tyrosine kinase	B	COc1cc2ncnc(N3CCN(/C(S)=N\Cc4ccc5c(c4)OCO5)CC3)c2cc1OC		CHEMBL102301	>	IC50	nM	30000.0	CHEMBL267	Homo sapiens	IC50	uM l-1	30.0
	1238314	CHEMBL806430	Enzyme inhibitory activity against recombinant human Src protein tyrosine kinase	B	CCOc1cc(Nc2c(C#N)cnc3cc(/C=C/c4ccncc4)ccc23)c(Cl)cc1Cl		CHEMBL431167	=	IC50	nM	3100.0	CHEMBL267	Homo sapiens	IC50	nM	3100.0
	1238316	CHEMBL806430	Enzyme inhibitory activity against recombinant human Src protein tyrosine kinase	B	COc1cc(Nc2c(C#N)cnc3cc(/C=C/c4cccnc4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL67812	=	IC50	nM	8.4	CHEMBL267	Homo sapiens	IC50	nM	8.4
	1239430	CHEMBL806430	Enzyme inhibitory activity against recombinant human Src protein tyrosine kinase	B	N#Cc1cnc2cc(/C=C/c3ccncc3)ccc2c1NCc1ccc(Cl)cc1Cl		CHEMBL69344	=	IC50	nM	1000.0	CHEMBL267	Homo sapiens	IC50	nM	1000.0
	1242243	CHEMBL806430	Enzyme inhibitory activity against recombinant human Src protein tyrosine kinase	B	COc1cc(Nc2c(C#N)cnc3cc(/C=C/c4ccc(-c5ccccc5)cc4)ccc23)c(Cl)cc1Cl		CHEMBL304290	=	IC50	nM	2300.0	CHEMBL267	Homo sapiens	IC50	nM	2300.0
	1244760	CHEMBL806430	Enzyme inhibitory activity against recombinant human Src protein tyrosine kinase	B	COc1cc(Nc2c(C#N)cnc3cc(C#Cc4ccccn4)ccc23)c(Cl)cc1Cl		CHEMBL65790	=	IC50	nM	530.0	CHEMBL267	Homo sapiens	IC50	nM	530.0
	1245749	CHEMBL806429	Inhibition of Src protein tyrosine kinase	B	COc1cc2ncnc(N3CCN(/C(S)=N\Cc4ccccc4)CC3)c2cc1OC		CHEMBL319894	>	IC50	nM	30000.0	CHEMBL267	Homo sapiens	IC50	uM l-1	30.0
	1246868	CHEMBL808765	Inhibition of Src protein tyrosine kinase	B	O=C(c1cc2ccccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL7735	>	IC50	nM	30000.0	CHEMBL267	Homo sapiens	IC50	uM	30.0
	1247216	CHEMBL806430	Enzyme inhibitory activity against recombinant human Src protein tyrosine kinase	B	N#Cc1cnc2cc(/C=C/c3ccncc3)ccc2c1Oc1ccc(Cl)cc1Cl		CHEMBL68114	=	IC50	nM	380.0	CHEMBL267	Homo sapiens	IC50	nM	380.0
	1248128	CHEMBL808765	Inhibition of Src protein tyrosine kinase	B	COCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL7600	>	IC50	nM	30000.0	CHEMBL267	Homo sapiens	IC50	uM	30.0
	1248572	CHEMBL806430	Enzyme inhibitory activity against recombinant human Src protein tyrosine kinase	B	N#Cc1cnc2cc(/C=C/c3ccncc3)ccc2c1Nc1ccc(Cl)cc1Cl		CHEMBL420549	=	IC50	nM	42.0	CHEMBL267	Homo sapiens	IC50	nM	42.0
	1248574	CHEMBL806430	Enzyme inhibitory activity against recombinant human Src protein tyrosine kinase	B	COc1cc(Nc2c(C#N)cnc3cc(/C=C/c4ccccn4)ccc23)c(Cl)cc1Cl		CHEMBL67770	=	IC50	nM	19.0	CHEMBL267	Homo sapiens	IC50	nM	19.0
	1249949	CHEMBL806430	Enzyme inhibitory activity against recombinant human Src protein tyrosine kinase	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	IC50	nM	3.6	CHEMBL267	Homo sapiens	IC50	nM	3.6
	1249951	CHEMBL806430	Enzyme inhibitory activity against recombinant human Src protein tyrosine kinase	B	COc1cc(Nc2c(C#N)cnc3cc(/C=C/c4ccccc4)ccc23)c(Cl)cc1Cl		CHEMBL67931	=	IC50	nM	180.0	CHEMBL267	Homo sapiens	IC50	nM	180.0
	1249953	CHEMBL806430	Enzyme inhibitory activity against recombinant human Src protein tyrosine kinase	B	COc1cc(Nc2c(C#N)cnc3cc(C#Cc4ccc(-c5ccccc5)cc4)ccc23)c(Cl)cc1Cl		CHEMBL307769	=	IC50	nM	420.0	CHEMBL267	Homo sapiens	IC50	nM	420.0
	1249955	CHEMBL806430	Enzyme inhibitory activity against recombinant human Src protein tyrosine kinase	B	COc1cc(Nc2c(C#N)cnc3cc(CCc4ccncc4)ccc23)c(Cl)cc1Cl		CHEMBL67647	=	IC50	nM	440.0	CHEMBL267	Homo sapiens	IC50	nM	440.0
	1251127	CHEMBL806430	Enzyme inhibitory activity against recombinant human Src protein tyrosine kinase	B	COc1cc(Nc2c(C#N)cnc3cc(C#Cc4ccccc4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL433311	=	IC50	nM	57.0	CHEMBL267	Homo sapiens	IC50	nM	57.0
	1254685	CHEMBL806430	Enzyme inhibitory activity against recombinant human Src protein tyrosine kinase	B	COc1cc(Nc2c(C#N)cnc3cc(C#Cc4cccnc4)ccc23)c(Cl)cc1Cl		CHEMBL67445	=	IC50	nM	47.0	CHEMBL267	Homo sapiens	IC50	nM	47.0
	1259539	CHEMBL805367	Inhibition of Src protein tyrosine kinase	B	CC(=O)NC(Cc1ccc(P(=O)(O)O)c(P(=O)(O)O)c1)C(=O)N[C@H]1CCCCc2cc(OCC3CCCCC3)c(C(N)=O)cc21		CHEMBL42853	=	IC50	nM	300.0	CHEMBL267	Homo sapiens	IC50	uM	0.3
	1259957	CHEMBL806430	Enzyme inhibitory activity against recombinant human Src protein tyrosine kinase	B	COc1cc(Nc2c(C#N)cnc3cc(/C=C/c4ccccc4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL303478	=	IC50	nM	65.0	CHEMBL267	Homo sapiens	IC50	nM	65.0
	1259959	CHEMBL806430	Enzyme inhibitory activity against recombinant human Src protein tyrosine kinase	B	COc1cc(Nc2c(C#N)cnc3cc(C#Cc4cccnc4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL67259	=	IC50	nM	12.0	CHEMBL267	Homo sapiens	IC50	nM	12.0
	1260757	CHEMBL809571	Inhibition of binding to Src SH2 domain	F	CC(=O)NC(Cc1ccc(C(=O)O)c(C=O)c1)C(=O)N[C@H]1CCCCc2cc(OCC3CCCCC3)c(C(N)=O)cc21		CHEMBL41773	=	IC50	nM	5500.0	CHEMBL267	Homo sapiens	IC50	uM	5.5
	1261123	CHEMBL806430	Enzyme inhibitory activity against recombinant human Src protein tyrosine kinase	B	COc1cc(Nc2c(C#N)cnc3cc(/C=C/c4ccncc4)ccc23)c(Cl)cc1Cl		CHEMBL69230	=	IC50	nM	9.9	CHEMBL267	Homo sapiens	IC50	nM	9.9
	1263665	CHEMBL806430	Enzyme inhibitory activity against recombinant human Src protein tyrosine kinase	B	COc1cc(Nc2c(C#N)cnc3cc(/C=C/c4cccnc4)ccc23)c(Cl)cc1Cl		CHEMBL67293	=	IC50	nM	15.0	CHEMBL267	Homo sapiens	IC50	nM	15.0
	1263667	CHEMBL806430	Enzyme inhibitory activity against recombinant human Src protein tyrosine kinase	B	COc1cc(Nc2c(C#N)cnc3cc(/C=C/c4ccncc4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL307087	=	IC50	nM	4.2	CHEMBL267	Homo sapiens	IC50	nM	4.2
	1264820	CHEMBL806430	Enzyme inhibitory activity against recombinant human Src protein tyrosine kinase	B	COc1cc(Nc2c(C#N)cnc3cc(C#Cc4ccccc4)ccc23)c(Cl)cc1Cl		CHEMBL68729	=	IC50	nM	320.0	CHEMBL267	Homo sapiens	IC50	nM	320.0
	1271115	CHEMBL822808	Inhibition of tyrosine kinase c-Src	B	Clc1cccc(Nc2ncnc3[nH]c4ccccc4c23)c1		CHEMBL306315	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	1272221	CHEMBL822805	Inhibition of tyrosine kinase c-Src	B	c1ccc(Nc2ncnc3[nH]c4c(c23)CCCC4)cc1		CHEMBL433305	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	1276124	CHEMBL822805	Inhibition of tyrosine kinase c-Src	B	Cc1cccc(Nc2ncnc3[nH]c4c(c23)CCCC4)c1		CHEMBL307062	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	1277572	CHEMBL822805	Inhibition of tyrosine kinase c-Src	B	Clc1cccc(Nc2ncnc3[nH]c(-c4ccccc4)c(-c4ccccc4)c23)c1		CHEMBL307209	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	1280020	CHEMBL822805	Inhibition of tyrosine kinase c-Src	B	Brc1cccc(Nc2ncnc3[nH]c4c(c23)CCCC4)c1		CHEMBL72393	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	1284933	CHEMBL822805	Inhibition of tyrosine kinase c-Src	B	Cc1[nH]c2ncnc(Nc3cccc(Cl)c3)c2c1-c1ccccc1		CHEMBL308593	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	1288833	CHEMBL822805	Inhibition of tyrosine kinase c-Src	B	Clc1cccc(Nc2ncnc3[nH]c4c(c23)CCCC4)c1		CHEMBL75177	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	1298450	CHEMBL822805	Inhibition of tyrosine kinase c-Src	B	Cc1[nH]c2ncnc(Nc3ccccc3)c2c1C		CHEMBL75049	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	1298457	CHEMBL822805	Inhibition of tyrosine kinase c-Src	B	Cc1[nH]c2ncnc(Nc3cccc(Cl)c3)c2c1C		CHEMBL306081	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	1301111	CHEMBL822805	Inhibition of tyrosine kinase c-Src	B	Cc1[nH]c2ncnc(Nc3cccc(Br)c3)c2c1C		CHEMBL74722	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	1302358	CHEMBL822805	Inhibition of tyrosine kinase c-Src	B	Cc1cccc(Nc2ncnc3[nH]c(C)c(C)c23)c1		CHEMBL307026	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	1305400	CHEMBL822805	Inhibition of tyrosine kinase c-Src	B	Cc1[nH]c2ncnc(Nc3cccc(F)c3)c2c1C		CHEMBL308582	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	1306872	CHEMBL822805	Inhibition of tyrosine kinase c-Src	B	Cc1c(-c2ccccc2)[nH]c2ncnc(Nc3cccc(Cl)c3)c12		CHEMBL311129	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	1428249	CHEMBL832714	Inhibition of human Src kinase	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	IC50	nM	3.6	CHEMBL267	Homo sapiens	IC50	nM	3.6
	1428250	CHEMBL833029	Inhibition of Src-dependent cell proliferation	F	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	IC50	nM	100.0	CHEMBL267	Homo sapiens	IC50	nM	100.0
	1428251	CHEMBL832714	Inhibition of human Src kinase	B	COc1cc(Nc2c(C#N)cnc3cc(/C=C/c4ccncc4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL307087	=	IC50	nM	4.2	CHEMBL267	Homo sapiens	IC50	nM	4.2
	1428252	CHEMBL833029	Inhibition of Src-dependent cell proliferation	F	COc1cc(Nc2c(C#N)cnc3cc(/C=C/c4ccncc4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL307087	=	IC50	nM	80.0	CHEMBL267	Homo sapiens	IC50	nM	80.0
	1428253	CHEMBL832714	Inhibition of human Src kinase	B	COc1cc(Nc2c(C#N)cnc3cc(/C=C/c4ccncc4)ccc23)c(Cl)cc1Cl		CHEMBL69230	=	IC50	nM	9.9	CHEMBL267	Homo sapiens	IC50	nM	9.9
	1428254	CHEMBL832714	Inhibition of human Src kinase	B	N#Cc1cnc2cc(/C=C/c3ccncc3)ccc2c1Nc1ccc(Cl)cc1Cl		CHEMBL420549	=	IC50	nM	42.0	CHEMBL267	Homo sapiens	IC50	nM	42.0
	1428255	CHEMBL832714	Inhibition of human Src kinase	B	COc1cc(Nc2c(C#N)cnc3cc(C#Cc4cccnc4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL67259	=	IC50	nM	12.0	CHEMBL267	Homo sapiens	IC50	nM	12.0
	1428256	CHEMBL832714	Inhibition of human Src kinase	B	COc1cc(Nc2c(C#N)cnc3cc(C#Cc4cccnc4)ccc23)c(Cl)cc1Cl		CHEMBL67445	=	IC50	nM	47.0	CHEMBL267	Homo sapiens	IC50	nM	47.0
	1428257	CHEMBL832714	Inhibition of human Src kinase	B	COc1ccc(Cl)c(Nc2c(C#N)cnc3cc(/C=C/c4ccncc4)ccc23)c1		CHEMBL360937	=	IC50	nM	16.0	CHEMBL267	Homo sapiens	IC50	nM	16.0
	1428258	CHEMBL832714	Inhibition of human Src kinase	B	COc1ccc(C)c(Nc2c(C#N)cnc3cc(/C=C/c4ccncc4)ccc23)c1		CHEMBL181405	=	IC50	nM	21.0	CHEMBL267	Homo sapiens	IC50	nM	21.0
	1428259	CHEMBL832714	Inhibition of human Src kinase	B	Cc1ccc(Nc2c(C#N)cnc3cc(/C=C/c4ccncc4)ccc23)c(C)c1		CHEMBL181639	=	IC50	nM	46.0	CHEMBL267	Homo sapiens	IC50	nM	46.0
	1428368	CHEMBL832714	Inhibition of human Src kinase	B	COc1cc(Nc2c(C#N)cnc3cc(/C=C/c4ccncc4)ccc23)cc(OC)c1OC		CHEMBL426953	=	IC50	nM	19.0	CHEMBL267	Homo sapiens	IC50	nM	19.0
	1428369	CHEMBL832714	Inhibition of human Src kinase	B	COc1cc(Nc2c(C#N)cnc3cc(C#Cc4cccnc4)ccc23)cc(OC)c1OC		CHEMBL179802	=	IC50	nM	89.0	CHEMBL267	Homo sapiens	IC50	nM	89.0
	1428370	CHEMBL832714	Inhibition of human Src kinase	B	COc1ccc(Cl)c(Nc2c(C#N)cnc3cc(/C=C/c4ccncc4)c(OC)cc23)c1		CHEMBL179882	=	IC50	nM	4.7	CHEMBL267	Homo sapiens	IC50	nM	4.7
	1428371	CHEMBL833029	Inhibition of Src-dependent cell proliferation	F	COc1ccc(Cl)c(Nc2c(C#N)cnc3cc(/C=C/c4ccncc4)c(OC)cc23)c1		CHEMBL179882	=	IC50	nM	160.0	CHEMBL267	Homo sapiens	IC50	nM	160.0
	1428372	CHEMBL832714	Inhibition of human Src kinase	B	COc1cc2c(Nc3cc(OC)c(OC)c(OC)c3)c(C#N)cnc2cc1/C=C/c1ccncc1		CHEMBL182201	=	IC50	nM	17.0	CHEMBL267	Homo sapiens	IC50	nM	17.0
	1428373	CHEMBL832714	Inhibition of human Src kinase	B	COc1cc2c(Nc3cc(OC)c(OC)c(OC)c3)c(C#N)cnc2cc1C#Cc1cccnc1		CHEMBL361205	=	IC50	nM	34.0	CHEMBL267	Homo sapiens	IC50	nM	34.0
	1428374	CHEMBL832714	Inhibition of human Src kinase	B	COc1cc(Nc2c(C#N)cnc3ccc(/C=C/c4ccncc4)cc23)c(Cl)cc1Cl		CHEMBL180299	=	IC50	nM	610.0	CHEMBL267	Homo sapiens	IC50	nM	610.0
	1428375	CHEMBL832714	Inhibition of human Src kinase	B	COc1cc(Nc2c(C#N)cnc3ccc(/C=C/c4ccncc4)cc23)cc(OC)c1OC		CHEMBL179755	=	IC50	nM	740.0	CHEMBL267	Homo sapiens	IC50	nM	740.0
	1428376	CHEMBL832714	Inhibition of human Src kinase	B	COc1cc(Cl)c(Cl)c(Nc2c(C#N)cnc3ccc(C#Cc4cccnc4)cc23)c1		CHEMBL425872	=	IC50	nM	440.0	CHEMBL267	Homo sapiens	IC50	nM	440.0
	1428377	CHEMBL832714	Inhibition of human Src kinase	B	COc1cc(Nc2c(C#N)cnc3ccc(C#Cc4cccnc4)cc23)cc(OC)c1OC		CHEMBL179955	=	IC50	nM	910.0	CHEMBL267	Homo sapiens	IC50	nM	910.0
	1428378	CHEMBL832714	Inhibition of human Src kinase	B	COc1cc(Cl)c(Cl)c(Nc2c(C#N)cnc3cc(/C=C/c4cnccn4)ccc23)c1		CHEMBL359464	=	IC50	nM	37.0	CHEMBL267	Homo sapiens	IC50	nM	37.0
	1428380	CHEMBL832714	Inhibition of human Src kinase	B	COc1cc(Cl)c(Cl)c(Nc2c(C#N)cnc3cc(/C=C/c4cnccn4)c(OC)cc23)c1		CHEMBL360499	=	IC50	nM	10.0	CHEMBL267	Homo sapiens	IC50	nM	10.0
	1428381	CHEMBL832714	Inhibition of human Src kinase	B	COc1cc(Cl)c(Cl)c(Nc2c(C#N)cnc3cc(/C=C/c4ncc[nH]4)ccc23)c1		CHEMBL180051	=	IC50	nM	6.6	CHEMBL267	Homo sapiens	IC50	nM	6.6
	1428382	CHEMBL832714	Inhibition of human Src kinase	B	COc1cc(Cl)c(Cl)c(Nc2c(C#N)cnc3cc(/C=C/c4ncc[nH]4)c(OC)cc23)c1		CHEMBL360914	=	IC50	nM	2.0	CHEMBL267	Homo sapiens	IC50	nM	2.0
	1428383	CHEMBL833029	Inhibition of Src-dependent cell proliferation	F	COc1cc(Cl)c(Cl)c(Nc2c(C#N)cnc3cc(/C=C/c4ncc[nH]4)c(OC)cc23)c1		CHEMBL360914	=	IC50	nM	2.0	CHEMBL267	Homo sapiens	IC50	nM	2.0
	1428384	CHEMBL832714	Inhibition of human Src kinase	B	COc1cc(Nc2c(C#N)cnc3cc(/C=C/c4cc[n+]([O-])cc4)ccc23)c(Cl)cc1Cl		CHEMBL181408	=	IC50	nM	4.2	CHEMBL267	Homo sapiens	IC50	nM	4.2
	1428385	CHEMBL833029	Inhibition of Src-dependent cell proliferation	F	COc1cc(Nc2c(C#N)cnc3cc(/C=C/c4cc[n+]([O-])cc4)ccc23)c(Cl)cc1Cl		CHEMBL181408	=	IC50	nM	56.0	CHEMBL267	Homo sapiens	IC50	nM	56.0
	1428816	CHEMBL832714	Inhibition of human Src kinase	B	COc1cc(Nc2c(C#N)cnc3cc(/C=C/c4cc[n+]([O-])cc4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL178787	=	IC50	nM	0.6	CHEMBL267	Homo sapiens	IC50	nM	0.6
	1428817	CHEMBL833029	Inhibition of Src-dependent cell proliferation	F	COc1cc(Nc2c(C#N)cnc3cc(/C=C/c4cc[n+]([O-])cc4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL178787	=	IC50	nM	16.0	CHEMBL267	Homo sapiens	IC50	nM	16.0
	1428818	CHEMBL832714	Inhibition of human Src kinase	B	COc1cc(Nc2c(C#N)cnc3cc(/C=C/c4cc[n+]([O-])cc4)ccc23)cc(OC)c1OC		CHEMBL369339	=	IC50	nM	11.0	CHEMBL267	Homo sapiens	IC50	nM	11.0
	1443966	CHEMBL831481	Inhibition of fluorescent (GpYEEI) binding to Src protein tyrosine kinase SH2 domain	B	COC(=O)c1cc(OCC(=O)N[C@H](C(=O)NCc2ccc3c(c2)OCO3)c2ccccc2)cc(C(=O)OC)n1	Outside typical range	CHEMBL359728	=	IC50	nM	714000.0	CHEMBL267	Homo sapiens	IC50	uM	714.0
Not Active	1443967	CHEMBL828696	Inhibition of fluorescent (GpYEEI) binding to Src protein tyrosine kinase SH2 domain; NA = No significant inhibition	B	COC(=O)c1cc(OCC(=O)N[C@H](C(=O)NCc2cccc(OC)c2)c2ccccc2)cc(C(=O)OC)n1		CHEMBL184351		IC50	nM		CHEMBL267	Homo sapiens	IC50	uM	
	1443968	CHEMBL831481	Inhibition of fluorescent (GpYEEI) binding to Src protein tyrosine kinase SH2 domain	B	COC(=O)c1cc(OCC(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc3c(c2)OCO3)cc(C(=O)OC)n1	Outside typical range	CHEMBL365906	=	IC50	nM	396000.0	CHEMBL267	Homo sapiens	IC50	uM	396.0
	1444082	CHEMBL831481	Inhibition of fluorescent (GpYEEI) binding to Src protein tyrosine kinase SH2 domain	B	COC(=O)c1cc(OCC(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2cccc(OC)c2)cc(C(=O)OC)n1	Outside typical range	CHEMBL183397	=	IC50	nM	663000.0	CHEMBL267	Homo sapiens	IC50	uM	663.0
	1444083	CHEMBL831481	Inhibition of fluorescent (GpYEEI) binding to Src protein tyrosine kinase SH2 domain	B	COC(=O)c1cc(OCC(=O)N[C@H](C(=O)NCc2cccc(OC)c2)C(C)C)cc(C(=O)OC)n1	Outside typical range	CHEMBL185409	=	IC50	nM	713000.0	CHEMBL267	Homo sapiens	IC50	uM	713.0
	1444084	CHEMBL831481	Inhibition of fluorescent (GpYEEI) binding to Src protein tyrosine kinase SH2 domain	B			CHEMBL360940	=	IC50	nM	20000.0	CHEMBL267	Homo sapiens	IC50	uM	20.0
	1444085	CHEMBL831481	Inhibition of fluorescent (GpYEEI) binding to Src protein tyrosine kinase SH2 domain	B			CHEMBL426793	=	IC50	nM	17000.0	CHEMBL267	Homo sapiens	IC50	uM	17.0
	1444086	CHEMBL831481	Inhibition of fluorescent (GpYEEI) binding to Src protein tyrosine kinase SH2 domain	B	COc1ccc(CNC(=O)[C@H](CC(C)C)NC(=O)COc2cc(C(=O)O)cc(C(=O)O)c2)cc1	Outside typical range	CHEMBL435293	=	IC50	nM	864000.0	CHEMBL267	Homo sapiens	IC50	uM	864.0
	1463467	CHEMBL829352	Inhibitory activity against Src tyrosine kinase	B	Cc1cc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)nc(C)n1		CHEMBL364623	<	IC50	nM	1.0	CHEMBL267	Homo sapiens	IC50	uM	0.001
	1466798	CHEMBL832908	Inhibition of Src kinase	B	Cc1cccc(Cl)c1Nc1nc2ccc(N3CCN[C@@H](C)C3)nc2n2cncc12		CHEMBL189338	>	IC50	nM	4.0	CHEMBL267	Homo sapiens	IC50	nM	4.0
	1481520	CHEMBL836163	In vitro percent inhibition of c-Src tyrosine kinase at 10 uM concentration of compound dissolved in 100% DMSO using 5''-[gamma-33P]-triphosphate	B	O=C(O)c1ccc2cc3nc(-c4cccs4)c(-c4cccs4)nc3cc2c1		CHEMBL426445	=	Inhibition	%	83.0	CHEMBL267	Homo sapiens	Inhibition	%	83.0
	1481543	CHEMBL836163	In vitro percent inhibition of c-Src tyrosine kinase at 10 uM concentration of compound dissolved in 100% DMSO using 5''-[gamma-33P]-triphosphate	B	COc1cc2nc(-c3cccs3)c(-c3cccs3)nc2cc1OC		CHEMBL373367	=	Inhibition	%	10.0	CHEMBL267	Homo sapiens	Inhibition	%	10.0
	1481670	CHEMBL836163	In vitro percent inhibition of c-Src tyrosine kinase at 10 uM concentration of compound dissolved in 100% DMSO using 5''-[gamma-33P]-triphosphate	B	Oc1cc2nc(-c3cccs3)c(-c3cccs3)nc2cc1O		CHEMBL190039	=	Inhibition	%	-3.0	CHEMBL267	Homo sapiens	Inhibition	%	-3.0
	1481799	CHEMBL836163	In vitro percent inhibition of c-Src tyrosine kinase at 10 uM concentration of compound dissolved in 100% DMSO using 5''-[gamma-33P]-triphosphate	B	c1csc(-c2nc3cc4c(cc3nc2-c2cccs2)OCO4)c1		CHEMBL189940	=	Inhibition	%	71.0	CHEMBL267	Homo sapiens	Inhibition	%	71.0
	1481941	CHEMBL836163	In vitro percent inhibition of c-Src tyrosine kinase at 10 uM concentration of compound dissolved in 100% DMSO using 5''-[gamma-33P]-triphosphate	B	O=C(O)C1COc2cc3nc(-c4cccs4)c(-c4cccs4)nc3cc2O1		CHEMBL193232	=	Inhibition	%	19.0	CHEMBL267	Homo sapiens	Inhibition	%	19.0
	1482052	CHEMBL836163	In vitro percent inhibition of c-Src tyrosine kinase at 10 uM concentration of compound dissolved in 100% DMSO using 5''-[gamma-33P]-triphosphate	B	c1csc(-c2nc3cc4c(cc3nc2-c2cccs2)OCCO4)c1		CHEMBL192489	=	Inhibition	%	84.0	CHEMBL267	Homo sapiens	Inhibition	%	84.0
	1482073	CHEMBL836163	In vitro percent inhibition of c-Src tyrosine kinase at 10 uM concentration of compound dissolved in 100% DMSO using 5''-[gamma-33P]-triphosphate	B	c1csc(-c2nc3cc4c(cc3nc2-c2cccs2)OCCCO4)c1		CHEMBL191410	=	Inhibition	%	75.0	CHEMBL267	Homo sapiens	Inhibition	%	75.0
	1482719	CHEMBL836163	In vitro percent inhibition of c-Src tyrosine kinase at 10 uM concentration of compound dissolved in 100% DMSO using 5''-[gamma-33P]-triphosphate	B	c1csc(-c2nc3cc4ccccc4cc3nc2-c2cccs2)c1		CHEMBL364499	=	Inhibition	%	20.0	CHEMBL267	Homo sapiens	Inhibition	%	20.0
	1482848	CHEMBL836163	In vitro percent inhibition of c-Src tyrosine kinase at 10 uM concentration of compound dissolved in 100% DMSO using 5''-[gamma-33P]-triphosphate	B	COC(=O)Cc1csc(-c2nc3cc4ccccc4cc3nc2-c2cc(CC(=O)OC)cs2)c1		CHEMBL192974	=	Inhibition	%	8.0	CHEMBL267	Homo sapiens	Inhibition	%	8.0
	1482869	CHEMBL836163	In vitro percent inhibition of c-Src tyrosine kinase at 10 uM concentration of compound dissolved in 100% DMSO using 5''-[gamma-33P]-triphosphate	B	COC(=O)CCc1ccc(-c2nc3cc4ccccc4cc3nc2-c2ccc(CCC(=O)OC)s2)s1		CHEMBL190143	=	Inhibition	%	19.0	CHEMBL267	Homo sapiens	Inhibition	%	19.0
	1483000	CHEMBL836163	In vitro percent inhibition of c-Src tyrosine kinase at 10 uM concentration of compound dissolved in 100% DMSO using 5''-[gamma-33P]-triphosphate	B	COC(=O)CCCc1ccc(-c2nc3cc4ccccc4cc3nc2-c2ccc(CCCC(=O)OC)s2)s1	Outside typical range	CHEMBL189104	=	Inhibition	%	-12.0	CHEMBL267	Homo sapiens	Inhibition	%	-12.0
	1483130	CHEMBL836163	In vitro percent inhibition of c-Src tyrosine kinase at 10 uM concentration of compound dissolved in 100% DMSO using 5''-[gamma-33P]-triphosphate	B	O=C(O)Cc1ccc(-c2nc3cc4ccccc4cc3nc2-c2ccc(CC(=O)O)s2)s1		CHEMBL193162	=	Inhibition	%	14.0	CHEMBL267	Homo sapiens	Inhibition	%	14.0
	1483261	CHEMBL836163	In vitro percent inhibition of c-Src tyrosine kinase at 10 uM concentration of compound dissolved in 100% DMSO using 5''-[gamma-33P]-triphosphate	B	O=C(O)Cc1csc(-c2nc3cc4ccccc4cc3nc2-c2cc(CC(=O)O)cs2)c1		CHEMBL192909	=	Inhibition	%	29.0	CHEMBL267	Homo sapiens	Inhibition	%	29.0
	1483282	CHEMBL836163	In vitro percent inhibition of c-Src tyrosine kinase at 10 uM concentration of compound dissolved in 100% DMSO using 5''-[gamma-33P]-triphosphate	B	O=C(O)CCc1ccc(-c2nc3cc4ccccc4cc3nc2-c2ccc(CCC(=O)O)s2)s1		CHEMBL366201	=	Inhibition	%	70.0	CHEMBL267	Homo sapiens	Inhibition	%	70.0
	1483398	CHEMBL836163	In vitro percent inhibition of c-Src tyrosine kinase at 10 uM concentration of compound dissolved in 100% DMSO using 5''-[gamma-33P]-triphosphate	B	O=C(O)CCCc1ccc(-c2nc3cc4ccccc4cc3nc2-c2ccc(CCCC(=O)O)s2)s1		CHEMBL190057	=	Inhibition	%	35.0	CHEMBL267	Homo sapiens	Inhibition	%	35.0
	1483518	CHEMBL836163	In vitro percent inhibition of c-Src tyrosine kinase at 10 uM concentration of compound dissolved in 100% DMSO using 5''-[gamma-33P]-triphosphate	B	O=C(O)c1ccc(-c2nc3cc4ccccc4cc3nc2-c2ccc(C(=O)O)s2)s1		CHEMBL366185	=	Inhibition	%	20.0	CHEMBL267	Homo sapiens	Inhibition	%	20.0
	1484984	CHEMBL836163	In vitro percent inhibition of c-Src tyrosine kinase at 10 uM concentration of compound dissolved in 100% DMSO using 5''-[gamma-33P]-triphosphate	B	COc1cc2nc3nc(-c4cccs4)c(-c4cccs4)nc3nc2cc1OC		CHEMBL193172	=	Inhibition	%	9.0	CHEMBL267	Homo sapiens	Inhibition	%	9.0
	1489991	CHEMBL827802	Inhibition of c-SRC tyrosine kinase	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F		CHEMBL1788116	=	IC50	nM	1100.0	CHEMBL267	Homo sapiens	IC50	uM	1.1
	1493309	CHEMBL835481	Inhibition of protein tyrosine kinase mediated [gamma-32P]-ATP incorporation at 10 ug/mL in src-transformed NIH3T3	B	O=C1NCc2c1c1c3ccc(O)cc3[nH]c1c1[nH]c3ccccc3c21		CHEMBL190546	>	Inhibition	%	80.0	CHEMBL267	Homo sapiens	Inhibition	%	80.0
	1493311	CHEMBL835475	Inhibition of protein tyrosine kinase mediated [gamma-32P]-ATP incorporation at 1 ug/mL in src-transformed NIH3T3	B	O=C1NCc2c1c1c3ccc(O)cc3[nH]c1c1[nH]c3ccccc3c21		CHEMBL190546	=	Inhibition	%	80.0	CHEMBL267	Homo sapiens	Inhibition	%	80.0
	1493565	CHEMBL834027	Inhibition of protein tyrosine kinase mediated [gamma-32P]-ATP incorporation at 0.1 ug/mL in src-transformed NIH3T3	B	O=C1NCc2c1c1c3ccc(O)cc3[nH]c1c1[nH]c3ccccc3c21		CHEMBL190546	<	Inhibition	%	50.0	CHEMBL267	Homo sapiens	Inhibition	%	50.0
	1511358	CHEMBL832953	Inhibition of Src protein tyrosine kinase in LANCE format enzyme assay	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	IC50	nM	3.8	CHEMBL267	Homo sapiens	IC50	nM	3.8
	1511359	CHEMBL834682	Inhibition of c-Src transformed rat fibroblast proliferation	F	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	IC50	nM	100.0	CHEMBL267	Homo sapiens	IC50	nM	100.0
	1511363	CHEMBL832953	Inhibition of Src protein tyrosine kinase in LANCE format enzyme assay	B	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(N5CCOCC5)cc4)sc23)c(Cl)cc1Cl		CHEMBL426990	=	IC50	nM	34.0	CHEMBL267	Homo sapiens	IC50	nM	34.0
	1511364	CHEMBL834682	Inhibition of c-Src transformed rat fibroblast proliferation	F	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(N5CCOCC5)cc4)sc23)c(Cl)cc1Cl		CHEMBL426990	=	IC50	nM	1200.0	CHEMBL267	Homo sapiens	IC50	nM	1200.0
	1511365	CHEMBL832953	Inhibition of Src protein tyrosine kinase in LANCE format enzyme assay	B	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(CN5CCN(C)CC5)cc4)sc23)c(Cl)cc1Cl		CHEMBL364955	=	IC50	nM	13.0	CHEMBL267	Homo sapiens	IC50	nM	13.0
	1511366	CHEMBL834682	Inhibition of c-Src transformed rat fibroblast proliferation	F	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(CN5CCN(C)CC5)cc4)sc23)c(Cl)cc1Cl		CHEMBL364955	=	IC50	nM	720.0	CHEMBL267	Homo sapiens	IC50	nM	720.0
	1511371	CHEMBL832953	Inhibition of Src protein tyrosine kinase in LANCE format enzyme assay	B	CCN1CCN(Cc2ccc(-c3cc4ncc(C#N)c(Nc5cc(OC)c(Cl)cc5Cl)c4s3)cc2)CC1		CHEMBL195419	=	IC50	nM	8.2	CHEMBL267	Homo sapiens	IC50	nM	8.2
	1511372	CHEMBL834682	Inhibition of c-Src transformed rat fibroblast proliferation	F	CCN1CCN(Cc2ccc(-c3cc4ncc(C#N)c(Nc5cc(OC)c(Cl)cc5Cl)c4s3)cc2)CC1		CHEMBL195419	=	IC50	nM	630.0	CHEMBL267	Homo sapiens	IC50	nM	630.0
	1511373	CHEMBL832953	Inhibition of Src protein tyrosine kinase in LANCE format enzyme assay	B	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(CN5CCNCC5)cc4)sc23)c(Cl)cc1Cl		CHEMBL363575	=	IC50	nM	7.2	CHEMBL267	Homo sapiens	IC50	nM	7.2
	1511374	CHEMBL834682	Inhibition of c-Src transformed rat fibroblast proliferation	F	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(CN5CCNCC5)cc4)sc23)c(Cl)cc1Cl		CHEMBL363575	=	IC50	nM	200.0	CHEMBL267	Homo sapiens	IC50	nM	200.0
	1511378	CHEMBL832953	Inhibition of Src protein tyrosine kinase in LANCE format enzyme assay	B	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(CN5CCN(CCO)CC5)cc4)sc23)c(Cl)cc1Cl		CHEMBL410251	=	IC50	nM	7.4	CHEMBL267	Homo sapiens	IC50	nM	7.4
	1511379	CHEMBL834682	Inhibition of c-Src transformed rat fibroblast proliferation	F	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(CN5CCN(CCO)CC5)cc4)sc23)c(Cl)cc1Cl		CHEMBL410251	=	IC50	nM	420.0	CHEMBL267	Homo sapiens	IC50	nM	420.0
	1511382	CHEMBL832953	Inhibition of Src protein tyrosine kinase in LANCE format enzyme assay	B	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(CN5CCCCC5)cc4)sc23)c(Cl)cc1Cl		CHEMBL425382	=	IC50	nM	17.0	CHEMBL267	Homo sapiens	IC50	nM	17.0
	1511383	CHEMBL834682	Inhibition of c-Src transformed rat fibroblast proliferation	F	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(CN5CCCCC5)cc4)sc23)c(Cl)cc1Cl		CHEMBL425382	=	IC50	nM	850.0	CHEMBL267	Homo sapiens	IC50	nM	850.0
	1511384	CHEMBL832953	Inhibition of Src protein tyrosine kinase in LANCE format enzyme assay	B	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(CN5CCSCC5)cc4)sc23)c(Cl)cc1Cl		CHEMBL373132	=	IC50	nM	52.0	CHEMBL267	Homo sapiens	IC50	nM	52.0
	1511385	CHEMBL834682	Inhibition of c-Src transformed rat fibroblast proliferation	F	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(CN5CCSCC5)cc4)sc23)c(Cl)cc1Cl		CHEMBL373132	=	IC50	nM	3000.0	CHEMBL267	Homo sapiens	IC50	nM	3000.0
	1511386	CHEMBL832953	Inhibition of Src protein tyrosine kinase in LANCE format enzyme assay	B	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(CN(C)C)cc4)sc23)c(Cl)cc1Cl		CHEMBL370473	=	IC50	nM	9.1	CHEMBL267	Homo sapiens	IC50	nM	9.1
	1511387	CHEMBL834682	Inhibition of c-Src transformed rat fibroblast proliferation	F	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(CN(C)C)cc4)sc23)c(Cl)cc1Cl		CHEMBL370473	=	IC50	nM	350.0	CHEMBL267	Homo sapiens	IC50	nM	350.0
	1511390	CHEMBL832953	Inhibition of Src protein tyrosine kinase in LANCE format enzyme assay	B	CCCCNCc1ccc(-c2cc3ncc(C#N)c(Nc4cc(OC)c(Cl)cc4Cl)c3s2)cc1		CHEMBL190981	=	IC50	nM	11.0	CHEMBL267	Homo sapiens	IC50	nM	11.0
	1511391	CHEMBL834682	Inhibition of c-Src transformed rat fibroblast proliferation	F	CCCCNCc1ccc(-c2cc3ncc(C#N)c(Nc4cc(OC)c(Cl)cc4Cl)c3s2)cc1		CHEMBL190981	=	IC50	nM	890.0	CHEMBL267	Homo sapiens	IC50	nM	890.0
	1511392	CHEMBL832953	Inhibition of Src protein tyrosine kinase in LANCE format enzyme assay	B	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(C(=O)N5CCN(C)CC5)cc4)sc23)c(Cl)cc1Cl		CHEMBL195382	=	IC50	nM	13.0	CHEMBL267	Homo sapiens	IC50	nM	13.0
	1511393	CHEMBL834682	Inhibition of c-Src transformed rat fibroblast proliferation	F	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(C(=O)N5CCN(C)CC5)cc4)sc23)c(Cl)cc1Cl		CHEMBL195382	=	IC50	nM	330.0	CHEMBL267	Homo sapiens	IC50	nM	330.0
	1511503	CHEMBL832953	Inhibition of Src protein tyrosine kinase in LANCE format enzyme assay	B	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(C(=O)N(C)C)cc4)sc23)c(Cl)cc1Cl		CHEMBL194992	=	IC50	nM	23.0	CHEMBL267	Homo sapiens	IC50	nM	23.0
	1511504	CHEMBL834682	Inhibition of c-Src transformed rat fibroblast proliferation	F	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(C(=O)N(C)C)cc4)sc23)c(Cl)cc1Cl		CHEMBL194992	=	IC50	nM	1400.0	CHEMBL267	Homo sapiens	IC50	nM	1400.0
	1511505	CHEMBL832953	Inhibition of Src protein tyrosine kinase in LANCE format enzyme assay	B	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(N(C)C)cc4)sc23)c(Cl)cc1Cl		CHEMBL194815	=	IC50	nM	110.0	CHEMBL267	Homo sapiens	IC50	nM	110.0
	1511506	CHEMBL834682	Inhibition of c-Src transformed rat fibroblast proliferation	F	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(N(C)C)cc4)sc23)c(Cl)cc1Cl		CHEMBL194815	=	IC50	nM	1300.0	CHEMBL267	Homo sapiens	IC50	nM	1300.0
	1511507	CHEMBL832953	Inhibition of Src protein tyrosine kinase in LANCE format enzyme assay	B	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(CCN(C)C)cc4)sc23)c(Cl)cc1Cl		CHEMBL194503	=	IC50	nM	8.8	CHEMBL267	Homo sapiens	IC50	nM	8.8
	1511508	CHEMBL834682	Inhibition of c-Src transformed rat fibroblast proliferation	F	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(CCN(C)C)cc4)sc23)c(Cl)cc1Cl		CHEMBL194503	=	IC50	nM	390.0	CHEMBL267	Homo sapiens	IC50	nM	390.0
	1511509	CHEMBL832953	Inhibition of Src protein tyrosine kinase in LANCE format enzyme assay	B	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(CCN5CCN(C)CC5)cc4)sc23)c(Cl)cc1Cl		CHEMBL372219	=	IC50	nM	15.0	CHEMBL267	Homo sapiens	IC50	nM	15.0
	1511510	CHEMBL834682	Inhibition of c-Src transformed rat fibroblast proliferation	F	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(CCN5CCN(C)CC5)cc4)sc23)c(Cl)cc1Cl		CHEMBL372219	=	IC50	nM	630.0	CHEMBL267	Homo sapiens	IC50	nM	630.0
	1511513	CHEMBL832953	Inhibition of Src protein tyrosine kinase in LANCE format enzyme assay	B	CN1CCN(Cc2ccc(-c3cc4ncc(C#N)c(Nc5ccc(Cl)cc5Cl)c4s3)cc2)CC1		CHEMBL425371	=	IC50	nM	50.0	CHEMBL267	Homo sapiens	IC50	nM	50.0
	1511514	CHEMBL834682	Inhibition of c-Src transformed rat fibroblast proliferation	F	CN1CCN(Cc2ccc(-c3cc4ncc(C#N)c(Nc5ccc(Cl)cc5Cl)c4s3)cc2)CC1		CHEMBL425371	=	IC50	nM	4000.0	CHEMBL267	Homo sapiens	IC50	nM	4000.0
	1511515	CHEMBL832953	Inhibition of Src protein tyrosine kinase in LANCE format enzyme assay	B	CCOc1cc(Nc2c(C#N)cnc3cc(-c4ccc(CN5CCN(C)CC5)cc4)sc23)c(Cl)cc1Cl		CHEMBL195046	=	IC50	nM	980.0	CHEMBL267	Homo sapiens	IC50	nM	980.0
	1511516	CHEMBL834682	Inhibition of c-Src transformed rat fibroblast proliferation	F	CCOc1cc(Nc2c(C#N)cnc3cc(-c4ccc(CN5CCN(C)CC5)cc4)sc23)c(Cl)cc1Cl		CHEMBL195046	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	1511517	CHEMBL832953	Inhibition of Src protein tyrosine kinase in LANCE format enzyme assay	B	CN1CCN(Cc2ccc(-c3cc4ncc(C#N)c(Nc5ccc(Oc6ccccc6)cc5)c4s3)cc2)CC1		CHEMBL192679	=	IC50	nM	140.0	CHEMBL267	Homo sapiens	IC50	nM	140.0
	1511518	CHEMBL834682	Inhibition of c-Src transformed rat fibroblast proliferation	F	CN1CCN(Cc2ccc(-c3cc4ncc(C#N)c(Nc5ccc(Oc6ccccc6)cc5)c4s3)cc2)CC1		CHEMBL192679	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	1511519	CHEMBL832953	Inhibition of Src protein tyrosine kinase in LANCE format enzyme assay	B	CN(C)Cc1ccc(-c2cc3ncc(C#N)c(Nc4ccc(Cl)cc4Cl)c3s2)cc1		CHEMBL195157	=	IC50	nM	53.0	CHEMBL267	Homo sapiens	IC50	nM	53.0
	1511520	CHEMBL834682	Inhibition of c-Src transformed rat fibroblast proliferation	F	CN(C)Cc1ccc(-c2cc3ncc(C#N)c(Nc4ccc(Cl)cc4Cl)c3s2)cc1		CHEMBL195157	=	IC50	nM	3300.0	CHEMBL267	Homo sapiens	IC50	nM	3300.0
	1511521	CHEMBL832953	Inhibition of Src protein tyrosine kinase in LANCE format enzyme assay	B	COc1cc(Nc2c(C#N)cnc3cc(-c4csc(CN5CCN(C)CC5)c4)sc23)c(Cl)cc1Cl		CHEMBL194664	=	IC50	nM	7.2	CHEMBL267	Homo sapiens	IC50	nM	7.2
	1511522	CHEMBL834682	Inhibition of c-Src transformed rat fibroblast proliferation	F	COc1cc(Nc2c(C#N)cnc3cc(-c4csc(CN5CCN(C)CC5)c4)sc23)c(Cl)cc1Cl		CHEMBL194664	=	IC50	nM	430.0	CHEMBL267	Homo sapiens	IC50	nM	430.0
	1511525	CHEMBL832953	Inhibition of Src protein tyrosine kinase in LANCE format enzyme assay	B	CN1CCN(Cc2cc(-c3cc4ncc(C#N)c(Nc5ccc(Cl)cc5Cl)c4s3)cs2)CC1		CHEMBL366029	=	IC50	nM	67.0	CHEMBL267	Homo sapiens	IC50	nM	67.0
	1511526	CHEMBL834682	Inhibition of c-Src transformed rat fibroblast proliferation	F	CN1CCN(Cc2cc(-c3cc4ncc(C#N)c(Nc5ccc(Cl)cc5Cl)c4s3)cs2)CC1		CHEMBL366029	=	IC50	nM	1900.0	CHEMBL267	Homo sapiens	IC50	nM	1900.0
	1511527	CHEMBL832953	Inhibition of Src protein tyrosine kinase in LANCE format enzyme assay	B	CCOc1cc(Nc2c(C#N)cnc3cc(-c4csc(CN5CCN(C)CC5)c4)sc23)c(Cl)cc1Cl		CHEMBL365398	=	IC50	nM	1300.0	CHEMBL267	Homo sapiens	IC50	nM	1300.0
	1511528	CHEMBL834682	Inhibition of c-Src transformed rat fibroblast proliferation	F	CCOc1cc(Nc2c(C#N)cnc3cc(-c4csc(CN5CCN(C)CC5)c4)sc23)c(Cl)cc1Cl		CHEMBL365398	=	IC50	nM	6200.0	CHEMBL267	Homo sapiens	IC50	nM	6200.0
	1511529	CHEMBL832953	Inhibition of Src protein tyrosine kinase in LANCE format enzyme assay	B	COc1cc(Nc2c(C#N)cnc3cc(-c4csc(CN(C)C)c4)sc23)c(Cl)cc1Cl		CHEMBL192052	=	IC50	nM	14.0	CHEMBL267	Homo sapiens	IC50	nM	14.0
	1511530	CHEMBL834682	Inhibition of c-Src transformed rat fibroblast proliferation	F	COc1cc(Nc2c(C#N)cnc3cc(-c4csc(CN(C)C)c4)sc23)c(Cl)cc1Cl		CHEMBL192052	=	IC50	nM	690.0	CHEMBL267	Homo sapiens	IC50	nM	690.0
	1511531	CHEMBL832953	Inhibition of Src protein tyrosine kinase in LANCE format enzyme assay	B	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(CN5CCN(C)CC5)s4)sc23)c(Cl)cc1Cl		CHEMBL192652	=	IC50	nM	25.0	CHEMBL267	Homo sapiens	IC50	nM	25.0
	1511532	CHEMBL834682	Inhibition of c-Src transformed rat fibroblast proliferation	F	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(CN5CCN(C)CC5)s4)sc23)c(Cl)cc1Cl		CHEMBL192652	=	IC50	nM	2400.0	CHEMBL267	Homo sapiens	IC50	nM	2400.0
	1511533	CHEMBL832953	Inhibition of Src protein tyrosine kinase in LANCE format enzyme assay	B	COc1cc(Nc2c(C#N)cnc3cc(-c4ccsc4CN4CCN(C)CC4)sc23)c(Cl)cc1Cl		CHEMBL195523	=	IC50	nM	420.0	CHEMBL267	Homo sapiens	IC50	nM	420.0
	1511534	CHEMBL834682	Inhibition of c-Src transformed rat fibroblast proliferation	F	COc1cc(Nc2c(C#N)cnc3cc(-c4ccsc4CN4CCN(C)CC4)sc23)c(Cl)cc1Cl		CHEMBL195523	=	IC50	nM	3100.0	CHEMBL267	Homo sapiens	IC50	nM	3100.0
	1512984	CHEMBL828751	Inhibition v-src sarcoma viral oncogene homolog (Src) at 100 uM ATP	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	IC50	nM	5000.0	CHEMBL267	Homo sapiens	IC50	uM	5.0
	1516925	CHEMBL832158	Selectivity for Src protein tyrosine kinase by homologous time-resolved fluorescence assay	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccn4)c3)o2)c1		CHEMBL194176	=	Selectivity	uM	0.017	CHEMBL267	Homo sapiens	Selectivity	uM	0.017
	1517059	CHEMBL832158	Selectivity for Src protein tyrosine kinase by homologous time-resolved fluorescence assay	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Selectivity	uM	0.26	CHEMBL267	Homo sapiens	Selectivity	uM	0.26
	1517174	CHEMBL832158	Selectivity for Src protein tyrosine kinase by homologous time-resolved fluorescence assay	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4Cl)c3)o2)c1		CHEMBL191993	=	Selectivity	uM	0.29	CHEMBL267	Homo sapiens	Selectivity	uM	0.29
	1519505	CHEMBL834781	Inhibition of protein tyrosine kinase mediated [gamma-32P]-ATP incorporation at 10 ug/mL in src-transformed NIH3T3; range = 50-80%	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(O)c(O)cc3c21		CHEMBL193468	=	Inhibition	%	80.0	CHEMBL267	Homo sapiens	Inhibition	%	80.0
	1519506	CHEMBL835475	Inhibition of protein tyrosine kinase mediated [gamma-32P]-ATP incorporation at 1 ug/mL in src-transformed NIH3T3	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(O)c(O)cc3c21		CHEMBL193468	<	Inhibition	%	50.0	CHEMBL267	Homo sapiens	Inhibition	%	50.0
	1519507	CHEMBL834027	Inhibition of protein tyrosine kinase mediated [gamma-32P]-ATP incorporation at 0.1 ug/mL in src-transformed NIH3T3	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(O)c(O)cc3c21		CHEMBL193468	<	Inhibition	%	50.0	CHEMBL267	Homo sapiens	Inhibition	%	50.0
	1520126	CHEMBL835475	Inhibition of protein tyrosine kinase mediated [gamma-32P]-ATP incorporation at 1 ug/mL in src-transformed NIH3T3	B	COC(=O)c1[nH]c(C(=O)OC)c(-c2c[nH]c3ccc(O)cc23)c1-c1c[nH]c2ccccc12		CHEMBL439675	<	Inhibition	%	50.0	CHEMBL267	Homo sapiens	Inhibition	%	50.0
	1520127	CHEMBL834027	Inhibition of protein tyrosine kinase mediated [gamma-32P]-ATP incorporation at 0.1 ug/mL in src-transformed NIH3T3	B	COC(=O)c1[nH]c(C(=O)OC)c(-c2c[nH]c3ccc(O)cc23)c1-c1c[nH]c2ccccc12		CHEMBL439675	<	Inhibition	%	50.0	CHEMBL267	Homo sapiens	Inhibition	%	50.0
	1520144	CHEMBL835481	Inhibition of protein tyrosine kinase mediated [gamma-32P]-ATP incorporation at 10 ug/mL in src-transformed NIH3T3	B	COC(=O)c1[nH]c(C(=O)OC)c(-c2c[nH]c3ccc(O)cc23)c1-c1c[nH]c2ccccc12		CHEMBL439675	<	Inhibition	%	50.0	CHEMBL267	Homo sapiens	Inhibition	%	50.0
	1523033	CHEMBL835475	Inhibition of protein tyrosine kinase mediated [gamma-32P]-ATP incorporation at 1 ug/mL in src-transformed NIH3T3	B	COC(=O)c1[nH]c(C(=O)OC)c(-c2c[nH]c3ccccc23)c1-c1c[nH]c2ccccc12		CHEMBL371472	<	Inhibition	%	50.0	CHEMBL267	Homo sapiens	Inhibition	%	50.0
	1523034	CHEMBL834027	Inhibition of protein tyrosine kinase mediated [gamma-32P]-ATP incorporation at 0.1 ug/mL in src-transformed NIH3T3	B	COC(=O)c1[nH]c(C(=O)OC)c(-c2c[nH]c3ccccc23)c1-c1c[nH]c2ccccc12		CHEMBL371472	<	Inhibition	%	50.0	CHEMBL267	Homo sapiens	Inhibition	%	50.0
	1523155	CHEMBL835481	Inhibition of protein tyrosine kinase mediated [gamma-32P]-ATP incorporation at 10 ug/mL in src-transformed NIH3T3	B	COC(=O)c1[nH]c(C(=O)OC)c(-c2c[nH]c3ccccc23)c1-c1c[nH]c2ccccc12		CHEMBL371472	<	Inhibition	%	50.0	CHEMBL267	Homo sapiens	Inhibition	%	50.0
	1523812	CHEMBL835475	Inhibition of protein tyrosine kinase mediated [gamma-32P]-ATP incorporation at 1 ug/mL in src-transformed NIH3T3	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	<	Inhibition	%	50.0	CHEMBL267	Homo sapiens	Inhibition	%	50.0
	1523813	CHEMBL834027	Inhibition of protein tyrosine kinase mediated [gamma-32P]-ATP incorporation at 0.1 ug/mL in src-transformed NIH3T3	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	<	Inhibition	%	50.0	CHEMBL267	Homo sapiens	Inhibition	%	50.0
	1523830	CHEMBL835481	Inhibition of protein tyrosine kinase mediated [gamma-32P]-ATP incorporation at 10 ug/mL in src-transformed NIH3T3	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Inhibition	%	80.0	CHEMBL267	Homo sapiens	Inhibition	%	80.0
	1600029	CHEMBL884219	Inhibitory activity against non-receptor tyrosine kinase Src in enzyme assay	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	IC50	nM	3.8	CHEMBL267	Homo sapiens	IC50	nM	3.8
	1600030	CHEMBL885033	Inhibitory activity against non-receptor tyrosine kinase Src in cell assay	F	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	IC50	nM	100.0	CHEMBL267	Homo sapiens	IC50	nM	100.0
	1600032	CHEMBL884219	Inhibitory activity against non-receptor tyrosine kinase Src in enzyme assay	B	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(CN5CCN(C)CC5)cc4)sc23)c(Cl)cc1Cl		CHEMBL364955	=	IC50	nM	13.0	CHEMBL267	Homo sapiens	IC50	nM	13.0
	1600033	CHEMBL885033	Inhibitory activity against non-receptor tyrosine kinase Src in cell assay	F	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(CN5CCN(C)CC5)cc4)sc23)c(Cl)cc1Cl		CHEMBL364955	=	IC50	nM	720.0	CHEMBL267	Homo sapiens	IC50	nM	720.0
	1600035	CHEMBL884219	Inhibitory activity against non-receptor tyrosine kinase Src in enzyme assay	B	COc1cc(Nc2c(C#N)cnc3cc(-c4cccc(CN5CCN(C)CC5)c4)sc23)c(Cl)cc1Cl		CHEMBL193392	=	IC50	nM	21.0	CHEMBL267	Homo sapiens	IC50	nM	21.0
	1600036	CHEMBL885033	Inhibitory activity against non-receptor tyrosine kinase Src in cell assay	F	COc1cc(Nc2c(C#N)cnc3cc(-c4cccc(CN5CCN(C)CC5)c4)sc23)c(Cl)cc1Cl		CHEMBL193392	=	IC50	nM	1200.0	CHEMBL267	Homo sapiens	IC50	nM	1200.0
	1600037	CHEMBL884219	Inhibitory activity against non-receptor tyrosine kinase Src in enzyme assay	B	COc1cc(Nc2c(C#N)cnc3cc(-c4csc(CN5CCN(C)CC5)c4)sc23)c(Cl)cc1Cl		CHEMBL194664	=	IC50	nM	7.2	CHEMBL267	Homo sapiens	IC50	nM	7.2
	1600038	CHEMBL885033	Inhibitory activity against non-receptor tyrosine kinase Src in cell assay	F	COc1cc(Nc2c(C#N)cnc3cc(-c4csc(CN5CCN(C)CC5)c4)sc23)c(Cl)cc1Cl		CHEMBL194664	=	IC50	nM	430.0	CHEMBL267	Homo sapiens	IC50	nM	430.0
	1600039	CHEMBL884219	Inhibitory activity against non-receptor tyrosine kinase Src in enzyme assay	B	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(CN5CCN(C)CC5)s4)sc23)c(Cl)cc1Cl		CHEMBL192652	=	IC50	nM	25.0	CHEMBL267	Homo sapiens	IC50	nM	25.0
	1600040	CHEMBL885033	Inhibitory activity against non-receptor tyrosine kinase Src in cell assay	F	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(CN5CCN(C)CC5)s4)sc23)c(Cl)cc1Cl		CHEMBL192652	=	IC50	nM	2400.0	CHEMBL267	Homo sapiens	IC50	nM	2400.0
	1600043	CHEMBL884219	Inhibitory activity against non-receptor tyrosine kinase Src in enzyme assay	B	COc1cc(Nc2c(C#N)cnc3cc(-c4coc(CN5CCNCC5)c4)sc23)c(Cl)cc1Cl		CHEMBL197094	=	IC50	nM	13.0	CHEMBL267	Homo sapiens	IC50	nM	13.0
	1600044	CHEMBL885033	Inhibitory activity against non-receptor tyrosine kinase Src in cell assay	F	COc1cc(Nc2c(C#N)cnc3cc(-c4coc(CN5CCNCC5)c4)sc23)c(Cl)cc1Cl		CHEMBL197094	=	IC50	nM	260.0	CHEMBL267	Homo sapiens	IC50	nM	260.0
	1600045	CHEMBL884219	Inhibitory activity against non-receptor tyrosine kinase Src in enzyme assay	B	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(CN5CCNCC5)o4)sc23)c(Cl)cc1Cl		CHEMBL370371	=	IC50	nM	52.0	CHEMBL267	Homo sapiens	IC50	nM	52.0
	1600046	CHEMBL885033	Inhibitory activity against non-receptor tyrosine kinase Src in cell assay	F	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(CN5CCNCC5)o4)sc23)c(Cl)cc1Cl		CHEMBL370371	=	IC50	nM	3100.0	CHEMBL267	Homo sapiens	IC50	nM	3100.0
	1600047	CHEMBL884219	Inhibitory activity against non-receptor tyrosine kinase Src in enzyme assay	B	COc1cc(Nc2c(C#N)cnc3cc(-c4csc(CN5CCN(C)CC5)n4)sc23)c(Cl)cc1Cl		CHEMBL372178	=	IC50	nM	56.0	CHEMBL267	Homo sapiens	IC50	nM	56.0
	1600048	CHEMBL885033	Inhibitory activity against non-receptor tyrosine kinase Src in cell assay	F	COc1cc(Nc2c(C#N)cnc3cc(-c4csc(CN5CCN(C)CC5)n4)sc23)c(Cl)cc1Cl		CHEMBL372178	=	IC50	nM	2900.0	CHEMBL267	Homo sapiens	IC50	nM	2900.0
	1600049	CHEMBL884219	Inhibitory activity against non-receptor tyrosine kinase Src in enzyme assay	B	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(CN5CCN(C)CC5)cn4)sc23)c(Cl)cc1Cl		CHEMBL373101	=	IC50	nM	13.0	CHEMBL267	Homo sapiens	IC50	nM	13.0
	1600050	CHEMBL885033	Inhibitory activity against non-receptor tyrosine kinase Src in cell assay	F	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(CN5CCN(C)CC5)cn4)sc23)c(Cl)cc1Cl		CHEMBL373101	=	IC50	nM	420.0	CHEMBL267	Homo sapiens	IC50	nM	420.0
	1600058	CHEMBL884219	Inhibitory activity against non-receptor tyrosine kinase Src in enzyme assay	B	COc1cc(Nc2c(C#N)cnc3cc(-c4cccc(CN5CCN(C)CC5)n4)sc23)c(Cl)cc1Cl		CHEMBL193695	=	IC50	nM	51.0	CHEMBL267	Homo sapiens	IC50	nM	51.0
	1600059	CHEMBL885033	Inhibitory activity against non-receptor tyrosine kinase Src in cell assay	F	COc1cc(Nc2c(C#N)cnc3cc(-c4cccc(CN5CCN(C)CC5)n4)sc23)c(Cl)cc1Cl		CHEMBL193695	=	IC50	nM	1900.0	CHEMBL267	Homo sapiens	IC50	nM	1900.0
	1600060	CHEMBL884219	Inhibitory activity against non-receptor tyrosine kinase Src in enzyme assay	B	COc1cc(Nc2c(C#N)cnc3cc(C#CCN4CCN(C)CC4)sc23)c(Cl)cc1Cl		CHEMBL193751	=	IC50	nM	300.0	CHEMBL267	Homo sapiens	IC50	nM	300.0
	1600061	CHEMBL885033	Inhibitory activity against non-receptor tyrosine kinase Src in cell assay	F	COc1cc(Nc2c(C#N)cnc3cc(C#CCN4CCN(C)CC4)sc23)c(Cl)cc1Cl		CHEMBL193751	>	IC50	nM	5000.0	CHEMBL267	Homo sapiens	IC50	nM	5000.0
	1600062	CHEMBL884219	Inhibitory activity against non-receptor tyrosine kinase Src in enzyme assay	B	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(CN(C)C)cn4)sc23)c(Cl)cc1Cl		CHEMBL193452	=	IC50	nM	13.0	CHEMBL267	Homo sapiens	IC50	nM	13.0
	1600063	CHEMBL885033	Inhibitory activity against non-receptor tyrosine kinase Src in cell assay	F	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(CN(C)C)cn4)sc23)c(Cl)cc1Cl		CHEMBL193452	=	IC50	nM	650.0	CHEMBL267	Homo sapiens	IC50	nM	650.0
	1600064	CHEMBL884219	Inhibitory activity against non-receptor tyrosine kinase Src in enzyme assay	B	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(C(=O)N5CCN(C)CC5)cn4)sc23)c(Cl)cc1Cl		CHEMBL370693	=	IC50	nM	14.0	CHEMBL267	Homo sapiens	IC50	nM	14.0
	1600065	CHEMBL885033	Inhibitory activity against non-receptor tyrosine kinase Src in cell assay	F	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(C(=O)N5CCN(C)CC5)cn4)sc23)c(Cl)cc1Cl		CHEMBL370693	=	IC50	nM	360.0	CHEMBL267	Homo sapiens	IC50	nM	360.0
	1600066	CHEMBL884219	Inhibitory activity against non-receptor tyrosine kinase Src in enzyme assay	B	CN1CCN(Cc2ccc(-c3cc4ncc(C#N)c(Nc5ccc(Cl)cc5Cl)c4s3)nc2)CC1		CHEMBL194674	=	IC50	nM	47.0	CHEMBL267	Homo sapiens	IC50	nM	47.0
	1600067	CHEMBL885033	Inhibitory activity against non-receptor tyrosine kinase Src in cell assay	F	CN1CCN(Cc2ccc(-c3cc4ncc(C#N)c(Nc5ccc(Cl)cc5Cl)c4s3)nc2)CC1		CHEMBL194674	>	IC50	nM	5000.0	CHEMBL267	Homo sapiens	IC50	nM	5000.0
	1607516	CHEMBL881508	Inhibitory concentration against Src kinase	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	IC50	nM	1.2	CHEMBL267	Homo sapiens	IC50	nM	1.2
	1607518	CHEMBL856253	Inhibitory concentration against Src-transformed fibroblast proliferation	F	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	IC50	nM	100.0	CHEMBL267	Homo sapiens	IC50	nM	100.0
	1607519	CHEMBL881508	Inhibitory concentration against Src kinase	B	COc1cc(Nc2c(C#N)cnc3cc4cc(OC)c(OC)cc4cc23)c(C)cc1Cl		CHEMBL335025	=	IC50	nM	1.4	CHEMBL267	Homo sapiens	IC50	nM	1.4
	1607520	CHEMBL856253	Inhibitory concentration against Src-transformed fibroblast proliferation	F	COc1cc(Nc2c(C#N)cnc3cc4cc(OC)c(OC)cc4cc23)c(C)cc1Cl		CHEMBL335025	=	IC50	nM	210.0	CHEMBL267	Homo sapiens	IC50	nM	210.0
	1607521	CHEMBL881508	Inhibitory concentration against Src kinase	B	COc1cc(Nc2c(C#N)cnc3cc4cc(OC)c(OCCN5CCOCC5)cc4cc23)c(C)cc1Cl		CHEMBL198084	=	IC50	nM	2.1	CHEMBL267	Homo sapiens	IC50	nM	2.1
	1607522	CHEMBL856253	Inhibitory concentration against Src-transformed fibroblast proliferation	F	COc1cc(Nc2c(C#N)cnc3cc4cc(OC)c(OCCN5CCOCC5)cc4cc23)c(C)cc1Cl		CHEMBL198084	=	IC50	nM	71.0	CHEMBL267	Homo sapiens	IC50	nM	71.0
	1607523	CHEMBL881508	Inhibitory concentration against Src kinase	B	COc1cc(Nc2c(C#N)cnc3cc4cc(OC)c(OCCN5CCN(C)CC5)cc4cc23)c(C)cc1Cl		CHEMBL196411	=	IC50	nM	1.5	CHEMBL267	Homo sapiens	IC50	nM	1.5
	1607524	CHEMBL856253	Inhibitory concentration against Src-transformed fibroblast proliferation	F	COc1cc(Nc2c(C#N)cnc3cc4cc(OC)c(OCCN5CCN(C)CC5)cc4cc23)c(C)cc1Cl		CHEMBL196411	=	IC50	nM	220.0	CHEMBL267	Homo sapiens	IC50	nM	220.0
	1607525	CHEMBL881508	Inhibitory concentration against Src kinase	B	COc1cc(Nc2c(C#N)cnc3cc4cc(OC)c(OCCN5CCOCC5)cc4cc23)c(Cl)cc1Cl		CHEMBL198211	=	IC50	nM	1.8	CHEMBL267	Homo sapiens	IC50	nM	1.8
	1607526	CHEMBL856253	Inhibitory concentration against Src-transformed fibroblast proliferation	F	COc1cc(Nc2c(C#N)cnc3cc4cc(OC)c(OCCN5CCOCC5)cc4cc23)c(Cl)cc1Cl		CHEMBL198211	=	IC50	nM	230.0	CHEMBL267	Homo sapiens	IC50	nM	230.0
	1607527	CHEMBL881508	Inhibitory concentration against Src kinase	B	COc1cc(Nc2c(C#N)cnc3cc4cc(OC)c(OCCN5CCN(C)CC5)cc4cc23)c(Cl)cc1Cl		CHEMBL194969	=	IC50	nM	1.1	CHEMBL267	Homo sapiens	IC50	nM	1.1
	1607528	CHEMBL856253	Inhibitory concentration against Src-transformed fibroblast proliferation	F	COc1cc(Nc2c(C#N)cnc3cc4cc(OC)c(OCCN5CCN(C)CC5)cc4cc23)c(Cl)cc1Cl		CHEMBL194969	=	IC50	nM	260.0	CHEMBL267	Homo sapiens	IC50	nM	260.0
	1607529	CHEMBL881508	Inhibitory concentration against Src kinase	B	COc1cc(Nc2c(C#N)cnc3cc4cc(OC)c(OCCN5CCC(O)CC5)cc4cc23)c(Cl)cc1Cl		CHEMBL197930	=	IC50	nM	2.1	CHEMBL267	Homo sapiens	IC50	nM	2.1
	1607530	CHEMBL856253	Inhibitory concentration against Src-transformed fibroblast proliferation	F	COc1cc(Nc2c(C#N)cnc3cc4cc(OC)c(OCCN5CCC(O)CC5)cc4cc23)c(Cl)cc1Cl		CHEMBL197930	=	IC50	nM	1600.0	CHEMBL267	Homo sapiens	IC50	nM	1600.0
	1607531	CHEMBL881508	Inhibitory concentration against Src kinase	B	COc1cc(Nc2c(C#N)cnc3cc4cc(OC)c(OCCN5CCOCC5)cc4cc23)c(Cl)cc1C		CHEMBL372552	=	IC50	nM	2.5	CHEMBL267	Homo sapiens	IC50	nM	2.5
	1607532	CHEMBL856253	Inhibitory concentration against Src-transformed fibroblast proliferation	F	COc1cc(Nc2c(C#N)cnc3cc4cc(OC)c(OCCN5CCOCC5)cc4cc23)c(Cl)cc1C		CHEMBL372552	=	IC50	nM	110.0	CHEMBL267	Homo sapiens	IC50	nM	110.0
	1607533	CHEMBL881508	Inhibitory concentration against Src kinase	B	COc1cc2cc3ncc(C#N)c(Nc4cc(OC)c(OC)c(OC)c4)c3cc2cc1OCCN1CCN(C)CC1		CHEMBL197715	=	IC50	nM	2.6	CHEMBL267	Homo sapiens	IC50	nM	2.6
	1607534	CHEMBL856253	Inhibitory concentration against Src-transformed fibroblast proliferation	F	COc1cc2cc3ncc(C#N)c(Nc4cc(OC)c(OC)c(OC)c4)c3cc2cc1OCCN1CCN(C)CC1		CHEMBL197715	=	IC50	nM	2000.0	CHEMBL267	Homo sapiens	IC50	nM	2000.0
	1607535	CHEMBL881508	Inhibitory concentration against Src kinase	B	COc1cc2cc3ncc(C#N)c(Nc4cc(OC)c(OC)c(OC)c4)c3cc2cc1OCCN1CCOCC1		CHEMBL194352	=	IC50	nM	1.2	CHEMBL267	Homo sapiens	IC50	nM	1.2
	1607536	CHEMBL856253	Inhibitory concentration against Src-transformed fibroblast proliferation	F	COc1cc2cc3ncc(C#N)c(Nc4cc(OC)c(OC)c(OC)c4)c3cc2cc1OCCN1CCOCC1		CHEMBL194352	=	IC50	nM	180.0	CHEMBL267	Homo sapiens	IC50	nM	180.0
	1607539	CHEMBL881508	Inhibitory concentration against Src kinase	B	COc1cc2cc3ncc(C#N)c(Nc4ccc(Cl)cc4Cl)c3cc2cc1OCCN1CCOCC1		CHEMBL196474	=	IC50	nM	13.0	CHEMBL267	Homo sapiens	IC50	nM	13.0
	1607540	CHEMBL856253	Inhibitory concentration against Src-transformed fibroblast proliferation	F	COc1cc2cc3ncc(C#N)c(Nc4ccc(Cl)cc4Cl)c3cc2cc1OCCN1CCOCC1		CHEMBL196474	=	IC50	nM	970.0	CHEMBL267	Homo sapiens	IC50	nM	970.0
	1607541	CHEMBL881508	Inhibitory concentration against Src kinase	B	COc1cc(Nc2c(C#N)cnc3cc4cc(OCCN5CCOCC5)c(OC)cc4cc23)c(C)cc1Cl		CHEMBL196797	=	IC50	nM	0.15	CHEMBL267	Homo sapiens	IC50	nM	0.15
	1607542	CHEMBL856253	Inhibitory concentration against Src-transformed fibroblast proliferation	F	COc1cc(Nc2c(C#N)cnc3cc4cc(OCCN5CCOCC5)c(OC)cc4cc23)c(C)cc1Cl		CHEMBL196797	=	IC50	nM	10.0	CHEMBL267	Homo sapiens	IC50	nM	10.0
	1607543	CHEMBL881508	Inhibitory concentration against Src kinase	B	COc1cc(Nc2c(C#N)cnc3cc4cc(OCCN5CCN(C)CC5)c(OC)cc4cc23)c(C)cc1Cl		CHEMBL196889	=	IC50	nM	0.31	CHEMBL267	Homo sapiens	IC50	nM	0.31
	1607544	CHEMBL856253	Inhibitory concentration against Src-transformed fibroblast proliferation	F	COc1cc(Nc2c(C#N)cnc3cc4cc(OCCN5CCN(C)CC5)c(OC)cc4cc23)c(C)cc1Cl		CHEMBL196889	=	IC50	nM	42.0	CHEMBL267	Homo sapiens	IC50	nM	42.0
	1607545	CHEMBL881508	Inhibitory concentration against Src kinase	B	COc1cc(Nc2c(C#N)cnc3cc4cc(OCCN5CCOCC5)c(OC)cc4cc23)c(Cl)cc1Cl		CHEMBL195029	=	IC50	nM	0.46	CHEMBL267	Homo sapiens	IC50	nM	0.46
	1607557	CHEMBL856253	Inhibitory concentration against Src-transformed fibroblast proliferation	F	COc1cc(Nc2c(C#N)cnc3cc4cc(OCCN5CCOCC5)c(OC)cc4cc23)c(Cl)cc1Cl		CHEMBL195029	=	IC50	nM	37.0	CHEMBL267	Homo sapiens	IC50	nM	37.0
	1607560	CHEMBL881508	Inhibitory concentration against Src kinase	B	COc1cc(Nc2c(C#N)cnc3cc4cc(OCCN5CCN(C)CC5)c(OC)cc4cc23)c(Cl)cc1Cl		CHEMBL198650	=	IC50	nM	0.29	CHEMBL267	Homo sapiens	IC50	nM	0.29
	1607561	CHEMBL856253	Inhibitory concentration against Src-transformed fibroblast proliferation	F	COc1cc(Nc2c(C#N)cnc3cc4cc(OCCN5CCN(C)CC5)c(OC)cc4cc23)c(Cl)cc1Cl		CHEMBL198650	=	IC50	nM	61.0	CHEMBL267	Homo sapiens	IC50	nM	61.0
	1607567	CHEMBL881508	Inhibitory concentration against Src kinase	B	COc1cc(Nc2c(C#N)cnc3cc4cc(OCCN5CCC(O)CC5)c(OC)cc4cc23)c(Cl)cc1Cl		CHEMBL197744	=	IC50	nM	0.72	CHEMBL267	Homo sapiens	IC50	nM	0.72
	1607568	CHEMBL856253	Inhibitory concentration against Src-transformed fibroblast proliferation	F	COc1cc(Nc2c(C#N)cnc3cc4cc(OCCN5CCC(O)CC5)c(OC)cc4cc23)c(Cl)cc1Cl		CHEMBL197744	=	IC50	nM	350.0	CHEMBL267	Homo sapiens	IC50	nM	350.0
	1607569	CHEMBL881508	Inhibitory concentration against Src kinase	B	COc1cc(Nc2c(C#N)cnc3cc4cc(OCCN5CCOCC5)c(OC)cc4cc23)c(Cl)cc1C		CHEMBL370633	=	IC50	nM	0.33	CHEMBL267	Homo sapiens	IC50	nM	0.33
	1607570	CHEMBL856253	Inhibitory concentration against Src-transformed fibroblast proliferation	F	COc1cc(Nc2c(C#N)cnc3cc4cc(OCCN5CCOCC5)c(OC)cc4cc23)c(Cl)cc1C		CHEMBL370633	=	IC50	nM	19.0	CHEMBL267	Homo sapiens	IC50	nM	19.0
	1607571	CHEMBL881508	Inhibitory concentration against Src kinase	B	COc1cc(Nc2c(C#N)cnc3cc4cc(OCCN5CCC(O)CC5)c(OC)cc4cc23)c(Cl)cc1C		CHEMBL436486	=	IC50	nM	0.55	CHEMBL267	Homo sapiens	IC50	nM	0.55
	1607572	CHEMBL856253	Inhibitory concentration against Src-transformed fibroblast proliferation	F	COc1cc(Nc2c(C#N)cnc3cc4cc(OCCN5CCC(O)CC5)c(OC)cc4cc23)c(Cl)cc1C		CHEMBL436486	=	IC50	nM	28.0	CHEMBL267	Homo sapiens	IC50	nM	28.0
	1607573	CHEMBL881508	Inhibitory concentration against Src kinase	B	COc1cc(Nc2c(C#N)cnc3cc4cc(OCCN5CCOCC5)c(OC)cc4cc23)c(Cl)cc1F		CHEMBL198868	=	IC50	nM	0.48	CHEMBL267	Homo sapiens	IC50	nM	0.48
	1607574	CHEMBL856253	Inhibitory concentration against Src-transformed fibroblast proliferation	F	COc1cc(Nc2c(C#N)cnc3cc4cc(OCCN5CCOCC5)c(OC)cc4cc23)c(Cl)cc1F		CHEMBL198868	=	IC50	nM	22.0	CHEMBL267	Homo sapiens	IC50	nM	22.0
	1607575	CHEMBL881508	Inhibitory concentration against Src kinase	B	COc1cc2cc3c(Nc4cc(OC)c(OC)c(OC)c4)c(C#N)cnc3cc2cc1OCCN1CCN(C)CC1		CHEMBL197713	=	IC50	nM	0.69	CHEMBL267	Homo sapiens	IC50	nM	0.69
	1607576	CHEMBL856253	Inhibitory concentration against Src-transformed fibroblast proliferation	F	COc1cc2cc3c(Nc4cc(OC)c(OC)c(OC)c4)c(C#N)cnc3cc2cc1OCCN1CCN(C)CC1		CHEMBL197713	=	IC50	nM	270.0	CHEMBL267	Homo sapiens	IC50	nM	270.0
	1607579	CHEMBL881508	Inhibitory concentration against Src kinase	B	COc1cc2cc3c(Nc4cc(OC)c(OC)c(OC)c4)c(C#N)cnc3cc2cc1OCCN1CCOCC1		CHEMBL425389	=	IC50	nM	0.22	CHEMBL267	Homo sapiens	IC50	nM	0.22
	1607580	CHEMBL856253	Inhibitory concentration against Src-transformed fibroblast proliferation	F	COc1cc2cc3c(Nc4cc(OC)c(OC)c(OC)c4)c(C#N)cnc3cc2cc1OCCN1CCOCC1		CHEMBL425389	=	IC50	nM	50.0	CHEMBL267	Homo sapiens	IC50	nM	50.0
	1607581	CHEMBL881508	Inhibitory concentration against Src kinase	B	COc1cc2cc3c(Nc4ccc(Cl)cc4Cl)c(C#N)cnc3cc2cc1OCCN1CCOCC1		CHEMBL427544	=	IC50	nM	2.0	CHEMBL267	Homo sapiens	IC50	nM	2.0
	1607582	CHEMBL856253	Inhibitory concentration against Src-transformed fibroblast proliferation	F	COc1cc2cc3c(Nc4ccc(Cl)cc4Cl)c(C#N)cnc3cc2cc1OCCN1CCOCC1		CHEMBL427544	=	IC50	nM	48.0	CHEMBL267	Homo sapiens	IC50	nM	48.0
	1614498	CHEMBL872195	Inhibitory concentration against Src kinase	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	1614823	CHEMBL872195	Inhibitory concentration against Src kinase	B	O=C(Nc1cccc(Nc2nccc(-c3cccnc3)n2)c1)c1ccccc1		CHEMBL277931	=	IC50	nM	15700.0	CHEMBL267	Homo sapiens	IC50	uM	15.7
	1615158	CHEMBL872195	Inhibitory concentration against Src kinase	B	Cc1ccc(C(=O)Nc2ccc(C)c(Nc3nccc(-c4cccnc4)n3)c2)cc1		CHEMBL20867	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	1615493	CHEMBL872195	Inhibitory concentration against Src kinase	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	IC50	nM	3.8	CHEMBL267	Homo sapiens	IC50	nM	3.8
	1616559	CHEMBL881695	Dissociation constant against Src protein tyrosine kinase SH2 domain	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)Cc1ccc(OP(=O)(O)O)cc1)C(=O)O		CHEMBL46851	=	Kd	nM	100.0	CHEMBL267	Homo sapiens	Kd	nM	100.0
	1616560	CHEMBL881755	Inhibitory concentration against Src protein tyrosine kinase SH2 domain	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)Cc1ccc(OP(=O)(O)O)cc1)C(=O)O		CHEMBL46851	=	IC50	nM	6500.0	CHEMBL267	Homo sapiens	IC50	uM	6.5
	1616561	CHEMBL881755	Inhibitory concentration against Src protein tyrosine kinase SH2 domain	B	CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)O		CHEMBL373179	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	1616562	CHEMBL881755	Inhibitory concentration against Src protein tyrosine kinase SH2 domain	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)O		CHEMBL199202	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	1616563	CHEMBL881755	Inhibitory concentration against Src protein tyrosine kinase SH2 domain	B	CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O		CHEMBL194835	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	1616565	CHEMBL881755	Inhibitory concentration against Src protein tyrosine kinase SH2 domain	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)O		CHEMBL197909	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	1616566	CHEMBL881755	Inhibitory concentration against Src protein tyrosine kinase SH2 domain	B	CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O		CHEMBL199107	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
Not Active	1650864	CHEMBL861049	Average Binding Constant for SRC; NA=Not Active at 10 uM	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554		Kd			CHEMBL267	Homo sapiens	Kd		
	1650865	CHEMBL861049	Average Binding Constant for SRC; NA=Not Active at 10 uM	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	=	Kd	nM	120.0	CHEMBL267	Homo sapiens	Kd	uM	0.12
Not Active	1650866	CHEMBL861049	Average Binding Constant for SRC; NA=Not Active at 10 uM	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253		Kd			CHEMBL267	Homo sapiens	Kd		
	1650867	CHEMBL861049	Average Binding Constant for SRC; NA=Not Active at 10 uM	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	3100.0	CHEMBL267	Homo sapiens	Kd	uM	3.1
Not Active	1650868	CHEMBL861049	Average Binding Constant for SRC; NA=Not Active at 10 uM	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660		Kd			CHEMBL267	Homo sapiens	Kd		
Not Active	1650869	CHEMBL861049	Average Binding Constant for SRC; NA=Not Active at 10 uM	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829		Kd			CHEMBL267	Homo sapiens	Kd		
Not Active	1650870	CHEMBL861049	Average Binding Constant for SRC; NA=Not Active at 10 uM	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336		Kd			CHEMBL267	Homo sapiens	Kd		
Not Active	1650871	CHEMBL861049	Average Binding Constant for SRC; NA=Not Active at 10 uM	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762		Kd			CHEMBL267	Homo sapiens	Kd		
Not Active	1650872	CHEMBL861049	Average Binding Constant for SRC; NA=Not Active at 10 uM	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690		Kd			CHEMBL267	Homo sapiens	Kd		
	1651324	CHEMBL861049	Average Binding Constant for SRC; NA=Not Active at 10 uM	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	100.0	CHEMBL267	Homo sapiens	Kd	uM	0.1
Not Active	1651325	CHEMBL861049	Average Binding Constant for SRC; NA=Not Active at 10 uM	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041		Kd			CHEMBL267	Homo sapiens	Kd		
Not Active	1651326	CHEMBL861049	Average Binding Constant for SRC; NA=Not Active at 10 uM	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10		Kd			CHEMBL267	Homo sapiens	Kd		
	1651327	CHEMBL861049	Average Binding Constant for SRC; NA=Not Active at 10 uM	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	=	Kd	nM	980.0	CHEMBL267	Homo sapiens	Kd	uM	0.98
Not Active	1651328	CHEMBL861049	Average Binding Constant for SRC; NA=Not Active at 10 uM	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667		Kd			CHEMBL267	Homo sapiens	Kd		
Not Active	1651329	CHEMBL861049	Average Binding Constant for SRC; NA=Not Active at 10 uM	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279		Kd			CHEMBL267	Homo sapiens	Kd		
Not Active	1651330	CHEMBL861049	Average Binding Constant for SRC; NA=Not Active at 10 uM	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941		Kd			CHEMBL267	Homo sapiens	Kd		
	1651331	CHEMBL861049	Average Binding Constant for SRC; NA=Not Active at 10 uM	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Kd	nM	5000.0	CHEMBL267	Homo sapiens	Kd	uM	5.0
	1651332	CHEMBL861049	Average Binding Constant for SRC; NA=Not Active at 10 uM	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	1900.0	CHEMBL267	Homo sapiens	Kd	uM	1.9
	1651333	CHEMBL861049	Average Binding Constant for SRC; NA=Not Active at 10 uM	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	170.0	CHEMBL267	Homo sapiens	Kd	uM	0.17
	1651334	CHEMBL861049	Average Binding Constant for SRC; NA=Not Active at 10 uM	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	760.0	CHEMBL267	Homo sapiens	Kd	uM	0.76
	1653643	CHEMBL861592	Inhibitory activity against c-SRC	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	IC50	nM	185.0	CHEMBL267	Homo sapiens	IC50	uM	0.185
	1658904	CHEMBL860331	Inhibitory activity against Src	B	N#Cc1cnc2cnc(NCCN3CCOCC3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL197538	=	IC50	nM	40000.0	CHEMBL267	Homo sapiens	IC50	uM	40.0
	1658905	CHEMBL860331	Inhibitory activity against Src	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1	Outside typical range	CHEMBL200381	>	IC50	nM	400000.0	CHEMBL267	Homo sapiens	IC50	uM	400.0
	1658906	CHEMBL860331	Inhibitory activity against Src	B	N#Cc1cnc2cnc(NCCN3CCOCC3)cc2c1Nc1ccc(Oc2ccccc2)cc1		CHEMBL371095	=	IC50	nM	90000.0	CHEMBL267	Homo sapiens	IC50	uM	90.0
	1658907	CHEMBL860331	Inhibitory activity against Src	B	N#Cc1cnc2cnc(NCCN3CCOCC3)cc2c1Nc1ccc(Sc2ccccc2)cc1		CHEMBL199210	=	IC50	nM	3000.0	CHEMBL267	Homo sapiens	IC50	uM	3.0
	1658908	CHEMBL860331	Inhibitory activity against Src	B	N#Cc1cnc2cnc(NCCN3CCOCC3)cc2c1Nc1ccc(Cc2ccccc2)cc1		CHEMBL371658	=	IC50	nM	4000.0	CHEMBL267	Homo sapiens	IC50	uM	4.0
	1660162	CHEMBL863345	Inhibitory activity against c-Src kinase	B	COc1ccc(Cl)c(Nc2ncnc3cc(OCCCN4CCOCC4)cc(OC4CCOCC4)c23)c1		CHEMBL200217	=	IC50	nM	10.0	CHEMBL267	Homo sapiens	IC50	uM	0.01
	1660164	CHEMBL854323	Inhibition of Src-transfected 3T3 cell proliferation	F	COc1ccc(Cl)c(Nc2ncnc3cc(OCCCN4CCOCC4)cc(OC4CCOCC4)c23)c1		CHEMBL200217	=	IC50	nM	200.0	CHEMBL267	Homo sapiens	IC50	uM	0.2
	1660166	CHEMBL863345	Inhibitory activity against c-Src kinase	B	COc1ncc(Cl)c(Nc2ncnc3cc(OCCN4CCN(C(C)=O)CC4)cc(OC(C)C)c23)n1		CHEMBL199016	=	IC50	nM	15.0	CHEMBL267	Homo sapiens	IC50	uM	0.015
	1660167	CHEMBL863345	Inhibitory activity against c-Src kinase	B	COc1cnc(Cl)c(Nc2ncnc3cc(OCCN4CCN(C(C)=O)CC4)cc(OC(C)C)c23)n1		CHEMBL199110	=	IC50	nM	8.0	CHEMBL267	Homo sapiens	IC50	uM	0.008
	1660168	CHEMBL863345	Inhibitory activity against c-Src kinase	B	COc1ccc(Cl)c(Nc2ncnc3cc(OCCN4CCN(C(C)=O)CC4)cc(OC(C)C)c23)n1		CHEMBL198701	=	IC50	nM	10.0	CHEMBL267	Homo sapiens	IC50	uM	0.01
	1660169	CHEMBL863345	Inhibitory activity against c-Src kinase	B	COc1ccc(Cl)c(Nc2ncnc3cc(OCCN4CCN(C)CC4)cc(OC(C)C)c23)n1		CHEMBL371688	=	IC50	nM	7.0	CHEMBL267	Homo sapiens	IC50	uM	0.007
	1660170	CHEMBL863345	Inhibitory activity against c-Src kinase	B	COc1ccc(Cl)c(Nc2ncnc3cc(OCCN4CCCC4)cc(OC(C)C)c23)n1		CHEMBL198946	=	IC50	nM	15.0	CHEMBL267	Homo sapiens	IC50	uM	0.015
	1660171	CHEMBL863345	Inhibitory activity against c-Src kinase	B	COc1ccc(Cl)c(Nc2ncnc3cc(OCCCN4CCCC4)cc(OC(C)C)c23)n1		CHEMBL424839	=	IC50	nM	6.0	CHEMBL267	Homo sapiens	IC50	uM	0.006
	1660172	CHEMBL863345	Inhibitory activity against c-Src kinase	B	COc1ccc(Cl)c(Nc2ncnc3cc(OCCN4CCOCC4)cc(OC(C)C)c23)n1		CHEMBL425209	=	IC50	nM	20.0	CHEMBL267	Homo sapiens	IC50	uM	0.02
	1660173	CHEMBL863345	Inhibitory activity against c-Src kinase	B	COc1cc(Nc2ncnc3cc(OCCCN4CCOCC4)cc(OC(C)C)c23)c(Cl)cn1		CHEMBL197339	=	IC50	nM	35.0	CHEMBL267	Homo sapiens	IC50	uM	0.035
	1660174	CHEMBL863345	Inhibitory activity against c-Src kinase	B	COc1cc(Nc2ncnc3cc(OCCCN4CCOCC4)cc(OC4CCOCC4)c23)c(Cl)cn1		CHEMBL197186	=	IC50	nM	400.0	CHEMBL267	Homo sapiens	IC50	uM	0.4
	1660175	CHEMBL863345	Inhibitory activity against c-Src kinase	B	COc1cnc(Cl)c(Nc2ncnc3cc(OCCCN4CCOCC4)cc(OC(C)C)c23)c1		CHEMBL197287	=	IC50	nM	5.0	CHEMBL267	Homo sapiens	IC50	uM	0.005
	1660176	CHEMBL863345	Inhibitory activity against c-Src kinase	B	COc1cnc(Cl)c(Nc2ncnc3cc(OCCCN4CCOCC4)cc(OC4CCOCC4)c23)c1		CHEMBL369899	=	IC50	nM	7.0	CHEMBL267	Homo sapiens	IC50	uM	0.007
	1660177	CHEMBL863345	Inhibitory activity against c-Src kinase	B	COc1ccc(Cl)c(Nc2ncnc3cc(OCCCN4CCOCC4)cc(OC4CCOCC4)c23)n1		CHEMBL424664	=	IC50	nM	5.0	CHEMBL267	Homo sapiens	IC50	uM	0.005
	1660178	CHEMBL863345	Inhibitory activity against c-Src kinase	B	COc1ccc(Cl)c(Nc2ncnc3cc(OCCCN4CCOCC4)cc(OC(C)C)c23)c1		CHEMBL381206	=	IC50	nM	40.0	CHEMBL267	Homo sapiens	IC50	uM	0.04
	1660179	CHEMBL854323	Inhibition of Src-transfected 3T3 cell proliferation	F	COc1ncc(Cl)c(Nc2ncnc3cc(OCCN4CCN(C(C)=O)CC4)cc(OC(C)C)c23)n1		CHEMBL199016	=	IC50	nM	280.0	CHEMBL267	Homo sapiens	IC50	uM	0.28
	1660180	CHEMBL854323	Inhibition of Src-transfected 3T3 cell proliferation	F	COc1cnc(Cl)c(Nc2ncnc3cc(OCCN4CCN(C(C)=O)CC4)cc(OC(C)C)c23)n1		CHEMBL199110	=	IC50	nM	70.0	CHEMBL267	Homo sapiens	IC50	uM	0.07
	1660181	CHEMBL854323	Inhibition of Src-transfected 3T3 cell proliferation	F	COc1ccc(Cl)c(Nc2ncnc3cc(OCCN4CCN(C(C)=O)CC4)cc(OC(C)C)c23)n1		CHEMBL198701	=	IC50	nM	60.0	CHEMBL267	Homo sapiens	IC50	uM	0.06
	1660182	CHEMBL854323	Inhibition of Src-transfected 3T3 cell proliferation	F	COc1ccc(Cl)c(Nc2ncnc3cc(OCCCN4CCN(C(C)=O)CC4)cc(OC(C)C)c23)n1		CHEMBL383593	=	IC50	nM	20.0	CHEMBL267	Homo sapiens	IC50	uM	0.02
	1660183	CHEMBL854323	Inhibition of Src-transfected 3T3 cell proliferation	F	COc1ccc(Cl)c(Nc2ncnc3cc(OCCN4CCN(C)CC4)cc(OC(C)C)c23)n1		CHEMBL371688	=	IC50	nM	70.0	CHEMBL267	Homo sapiens	IC50	uM	0.07
	1660184	CHEMBL854323	Inhibition of Src-transfected 3T3 cell proliferation	F	COc1ccc(Cl)c(Nc2ncnc3cc(OCCCN4CCN(C)CC4)cc(OC(C)C)c23)n1		CHEMBL198752	=	IC50	nM	60.0	CHEMBL267	Homo sapiens	IC50	uM	0.06
	1660185	CHEMBL854323	Inhibition of Src-transfected 3T3 cell proliferation	F	COc1ccc(Cl)c(Nc2ncnc3cc(OCCN4CCCC4)cc(OC(C)C)c23)n1		CHEMBL198946	=	IC50	nM	120.0	CHEMBL267	Homo sapiens	IC50	uM	0.12
	1660186	CHEMBL854323	Inhibition of Src-transfected 3T3 cell proliferation	F	COc1ccc(Cl)c(Nc2ncnc3cc(OCCCN4CCCC4)cc(OC(C)C)c23)n1		CHEMBL424839	=	IC50	nM	70.0	CHEMBL267	Homo sapiens	IC50	uM	0.07
	1660187	CHEMBL854323	Inhibition of Src-transfected 3T3 cell proliferation	F	COc1ccc(Cl)c(Nc2ncnc3cc(OCCN4CCOCC4)cc(OC(C)C)c23)n1		CHEMBL425209	=	IC50	nM	120.0	CHEMBL267	Homo sapiens	IC50	uM	0.12
	1660188	CHEMBL854323	Inhibition of Src-transfected 3T3 cell proliferation	F	COc1ccc(Cl)c(Nc2ncnc3cc(OCCCN4CCOCC4)cc(OC(C)C)c23)n1		CHEMBL200231	=	IC50	nM	30.0	CHEMBL267	Homo sapiens	IC50	uM	0.03
	1660189	CHEMBL854323	Inhibition of Src-transfected 3T3 cell proliferation	F	COc1cc(Nc2ncnc3cc(OCCCN4CCOCC4)cc(OC(C)C)c23)c(Cl)cn1		CHEMBL197339	=	IC50	nM	350.0	CHEMBL267	Homo sapiens	IC50	uM	0.35
Not Determined	1660190	CHEMBL854323	Inhibition of Src-transfected 3T3 cell proliferation	F	COc1cc(Nc2ncnc3cc(OCCCN4CCOCC4)cc(OC4CCOCC4)c23)c(Cl)cn1		CHEMBL197186		IC50			CHEMBL267	Homo sapiens	IC50		
	1660191	CHEMBL854323	Inhibition of Src-transfected 3T3 cell proliferation	F	COc1cnc(Cl)c(Nc2ncnc3cc(OCCCN4CCOCC4)cc(OC(C)C)c23)c1		CHEMBL197287	=	IC50	nM	150.0	CHEMBL267	Homo sapiens	IC50	uM	0.15
	1660192	CHEMBL854323	Inhibition of Src-transfected 3T3 cell proliferation	F	COc1cnc(Cl)c(Nc2ncnc3cc(OCCCN4CCOCC4)cc(OC4CCOCC4)c23)c1		CHEMBL369899	=	IC50	nM	140.0	CHEMBL267	Homo sapiens	IC50	uM	0.14
	1660193	CHEMBL854323	Inhibition of Src-transfected 3T3 cell proliferation	F	COc1ccc(Cl)c(Nc2ncnc3cc(OCCCN4CCOCC4)cc(OC4CCOCC4)c23)n1		CHEMBL424664	=	IC50	nM	70.0	CHEMBL267	Homo sapiens	IC50	uM	0.07
	1660194	CHEMBL854323	Inhibition of Src-transfected 3T3 cell proliferation	F	COc1ccc(Cl)c(Nc2ncnc3cc(OCCCN4CCOCC4)cc(OC(C)C)c23)c1		CHEMBL381206	=	IC50	nM	150.0	CHEMBL267	Homo sapiens	IC50	uM	0.15
	1660224	CHEMBL863345	Inhibitory activity against c-Src kinase	B	COc1ccc(Cl)c(Nc2ncnc3cc(OCCCN4CCOCC4)cc(OC(C)C)c23)n1		CHEMBL200231	<	IC50	nM	4.0	CHEMBL267	Homo sapiens	IC50	uM	0.004
	1660225	CHEMBL863345	Inhibitory activity against c-Src kinase	B	COc1ccc(Cl)c(Nc2ncnc3cc(OCCCN4CCN(C(C)=O)CC4)cc(OC(C)C)c23)n1		CHEMBL383593	<	IC50	nM	4.0	CHEMBL267	Homo sapiens	IC50	uM	0.004
	1660226	CHEMBL863345	Inhibitory activity against c-Src kinase	B	COc1ccc(Cl)c(Nc2ncnc3cc(OCCCN4CCN(C)CC4)cc(OC(C)C)c23)n1		CHEMBL198752	<	IC50	nM	4.0	CHEMBL267	Homo sapiens	IC50	uM	0.004
	1663161	CHEMBL863882	Inhibitory activity against src	B	COc1cc(-c2nn(C3CCN(C4CCN(C(C)=O)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL370773	=	IC50	nM	17150.0	CHEMBL267	Homo sapiens	IC50	uM	17.15
	1663199	CHEMBL863882	Inhibitory activity against src	B	COc1cc(-c2nn([C@H]3CC[C@H](N4CCN(C(C)=O)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL197603	=	IC50	nM	9050.0	CHEMBL267	Homo sapiens	IC50	uM	9.05
	1664663	CHEMBL861787	Inhibition of c-Src at 10 uM	B	COc1ccc(C#CC(C)(C)N)cc1-c1[nH]nc2nc(Nc3ccc(F)cc3F)ccc12	Outside typical range	CHEMBL200820	=	Inhibition	%	-17.0	CHEMBL267	Homo sapiens	Inhibition	%	-17.0
	1664711	CHEMBL861787	Inhibition of c-Src at 10 uM	B	COc1ccc(C#CC(C)(C)N)cc1-c1[nH]nc2nc(Nc3ccc(F)cc3F)ncc12	Outside typical range	CHEMBL370808	=	Inhibition	%	-68.0	CHEMBL267	Homo sapiens	Inhibition	%	-68.0
	1664753	CHEMBL861787	Inhibition of c-Src at 10 uM	B	COc1ccc(C#CC(C)(C)O)cc1-c1[nH]nc2nc(Nc3ccc(F)cc3F)cnc12	Outside typical range	CHEMBL370156	=	Inhibition	%	-37.0	CHEMBL267	Homo sapiens	Inhibition	%	-37.0
	1666762	CHEMBL865821	Inhibitory activity against SRC	B	COc1cc(-c2ccc3c(c2)NC(=O)/C3=C\c2ccc[nH]2)ccc1O		CHEMBL202930	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	nM	50000.0
	1666772	CHEMBL865821	Inhibitory activity against SRC	B	COc1cc(-c2ccc3c(c2)NC(=O)/C3=C\c2c[nH]c3ncccc23)ccc1O		CHEMBL383316	=	IC50	nM	2377.0	CHEMBL267	Homo sapiens	IC50	nM	2377.0
	1666785	CHEMBL865821	Inhibitory activity against SRC	B	COc1cc(-c2ccc3c(c2)NC(=O)/C3=C\c2ncc[nH]2)ccc1O		CHEMBL199299	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	nM	50000.0
	1675262	CHEMBL865228	Inhibitory activity against Src	B	CN1CCN(CCc2ccc(NC(=O)c3cc(-c4ccc5c(c4)OCO5)cnc3O)cc2)CC1		CHEMBL199723	>	IC50	nM	20000.0	CHEMBL267	Homo sapiens	IC50	uM	20.0
Not Determined	1675334	CHEMBL865228	Inhibitory activity against Src	B	COc1ccc(-c2cnc(O)c(C(=O)Nc3ccc(CN4CCN(C)CC4)cc3)c2)cn1		CHEMBL203354		IC50			CHEMBL267	Homo sapiens	IC50		
	1675335	CHEMBL865228	Inhibitory activity against Src	B	CN1CCN(CCCc2ccc(NC(=O)c3cc(-c4ccc5c(c4)OCO5)cnc3O)cc2)CC1		CHEMBL381738	>	IC50	nM	20000.0	CHEMBL267	Homo sapiens	IC50	uM	20.0
	1675336	CHEMBL865228	Inhibitory activity against Src	B	CN1CCN(Cc2ccc(NC(=O)c3cc(-c4ccc5c(c4)OCO5)cnc3O)cc2)CC1		CHEMBL370800	>	IC50	nM	20000.0	CHEMBL267	Homo sapiens	IC50	uM	20.0
	1675337	CHEMBL865228	Inhibitory activity against Src	B	CN1CCN(c2ccc(NC(=O)c3cc(-c4ccc5c(c4)OCO5)cnc3O)cc2)CC1		CHEMBL436509	>	IC50	nM	20000.0	CHEMBL267	Homo sapiens	IC50	uM	20.0
Not Determined	1675370	CHEMBL865228	Inhibitory activity against Src	B	CN1CCN(Cc2ccc(NC(=O)c3cc(-c4ccncc4)cnc3O)cc2)CC1		CHEMBL197652		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	1675371	CHEMBL865228	Inhibitory activity against Src	B	COc1cc(-c2cnc(O)c(C(=O)Nc3ccc(CN4CCN(C)CC4)cc3)c2)cc(OC)c1OC		CHEMBL202831		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	1675372	CHEMBL865228	Inhibitory activity against Src	B	CN1CCN(Cc2ccc(NC(=O)c3cc(-c4ccc5nccnc5c4)cnc3O)cc2)CC1		CHEMBL202830		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	1675373	CHEMBL865228	Inhibitory activity against Src	B	Cc1nc2cc(-c3cnc(O)c(C(=O)Nc4ccc(CN5CCN(C)CC5)cc4)c3)ccc2s1		CHEMBL201553		IC50			CHEMBL267	Homo sapiens	IC50		
	1678213	CHEMBL862117	Inhibitory activity against SRC	B	COc1cc2c(Nc3ncc(CC(=O)Nc4cccc(F)c4)s3)ncnc2cc1OCCCN1CCC(CO)CC1		CHEMBL201307	=	IC50	nM	3000.0	CHEMBL267	Homo sapiens	IC50	uM	3.0
	1688623	CHEMBL864338	Inhibitory activity against Src in cell free assay	B	CCCNc1nc(SC)nc2c1cnn2CC(Cl)c1ccccc1		CHEMBL312214	=	Ki	nM	2900.0	CHEMBL267	Homo sapiens	Ki	uM	2.9
	1688734	CHEMBL864338	Inhibitory activity against Src in cell free assay	B	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	=	Ki	nM	500.0	CHEMBL267	Homo sapiens	Ki	uM	0.5
	1688735	CHEMBL864338	Inhibitory activity against Src in cell free assay	B	BrC(Cn1ncc2c(NCc3ccccc3)ncnc21)c1ccccc1		CHEMBL382153	=	Ki	nM	3300.0	CHEMBL267	Homo sapiens	Ki	uM	3.3
Not Determined	1688736	CHEMBL864338	Inhibitory activity against Src in cell free assay	B	BrC(Cn1ncc2c(N3CCCCCC3)ncnc21)c1ccccc1		CHEMBL204964		Ki			CHEMBL267	Homo sapiens	Ki		
Not Determined	1688737	CHEMBL864338	Inhibitory activity against Src in cell free assay	B	BrC(Cn1ncc2c(NC3CCCCC3)ncnc21)c1ccccc1		CHEMBL203636		Ki			CHEMBL267	Homo sapiens	Ki		
Not Determined	1688738	CHEMBL864338	Inhibitory activity against Src in cell free assay	B	BrC(Cn1ncc2c(N3CCOCC3)ncnc21)c1ccccc1		CHEMBL380125		Ki			CHEMBL267	Homo sapiens	Ki		
	1688739	CHEMBL864338	Inhibitory activity against Src in cell free assay	B	BrC(Cn1ncc2c(N3CCCCC3)ncnc21)c1ccccc1		CHEMBL203922	=	Ki	nM	1600.0	CHEMBL267	Homo sapiens	Ki	uM	1.6
	1688740	CHEMBL864338	Inhibitory activity against Src in cell free assay	B	BrC(Cn1ncc2c(N3CCCC3)ncnc21)c1ccccc1		CHEMBL382012	=	Ki	nM	9600.0	CHEMBL267	Homo sapiens	Ki	uM	9.6
	1688741	CHEMBL864338	Inhibitory activity against Src in cell free assay	B	CCOCCNc1ncnc2c1cnn2CC(Br)c1ccccc1		CHEMBL380532	=	Ki	nM	2700.0	CHEMBL267	Homo sapiens	Ki	uM	2.7
	1688742	CHEMBL864338	Inhibitory activity against Src in cell free assay	B	CCCCNc1ncnc2c1cnn2CC(Br)c1ccccc1		CHEMBL204343	=	Ki	nM	2900.0	CHEMBL267	Homo sapiens	Ki	uM	2.9
	1688743	CHEMBL864338	Inhibitory activity against Src in cell free assay	B	CC(C)Nc1ncnc2c1cnn2CC(Br)c1ccccc1		CHEMBL406504	=	Ki	nM	2800.0	CHEMBL267	Homo sapiens	Ki	uM	2.8
	1688745	CHEMBL864338	Inhibitory activity against Src in cell free assay	B	CCCNc1ncnc2c1cnn2CC(Br)c1ccccc1		CHEMBL382586	=	Ki	nM	900.0	CHEMBL267	Homo sapiens	Ki	uM	0.9
Not Active	1688746	CHEMBL864338	Inhibitory activity against Src in cell free assay	B	OC(Cn1ncc2c(NCc3ccc(F)cc3)ncnc21)c1ccccc1		CHEMBL203650		Ki			CHEMBL267	Homo sapiens	Ki		
	1688747	CHEMBL864338	Inhibitory activity against Src in cell free assay	B	OC(Cn1ncc2c(NCCc3ccccc3)ncnc21)c1ccccc1		CHEMBL378603	=	Ki	nM	2400.0	CHEMBL267	Homo sapiens	Ki	uM	2.4
Not Active	1688748	CHEMBL864338	Inhibitory activity against Src in cell free assay	B	OC(Cn1ncc2c(N3CCOCC3)ncnc21)c1ccccc1		CHEMBL41599		Ki			CHEMBL267	Homo sapiens	Ki		
Not Active	1688749	CHEMBL864338	Inhibitory activity against Src in cell free assay	B	CCCCNc1ncnc2c1cnn2CC(O)c1ccccc1		CHEMBL41563		Ki			CHEMBL267	Homo sapiens	Ki		
	1688750	CHEMBL864338	Inhibitory activity against Src in cell free assay	B	OC(Cn1ncc2c(NCc3ccccc3)ncnc21)c1ccccc1		CHEMBL204379	=	Ki	nM	2400.0	CHEMBL267	Homo sapiens	Ki	uM	2.4
Not Active	1688751	CHEMBL864338	Inhibitory activity against Src in cell free assay	B	OC(Cn1ncc2c(N3CCCCC3)ncnc21)c1ccccc1		CHEMBL291288		Ki			CHEMBL267	Homo sapiens	Ki		
Not Active	1688752	CHEMBL864338	Inhibitory activity against Src in cell free assay	B	CCCNc1ncnc2c1cnn2CC(O)c1ccccc1		CHEMBL84945		Ki			CHEMBL267	Homo sapiens	Ki		
Not Active	1688753	CHEMBL864338	Inhibitory activity against Src in cell free assay	B	C(=C\n1ncc2c(NCCc3ccccc3)ncnc21)\c1ccccc1		CHEMBL203493		Ki			CHEMBL267	Homo sapiens	Ki		
	1688754	CHEMBL864338	Inhibitory activity against Src in cell free assay	B	C(=C\n1ncc2c(NCc3ccccc3)ncnc21)\c1ccccc1		CHEMBL203492	=	Ki	nM	2400.0	CHEMBL267	Homo sapiens	Ki	uM	2.4
Not Active	1688755	CHEMBL864338	Inhibitory activity against Src in cell free assay	B	C(=C\n1ncc2c(N3CCCCCC3)ncnc21)\c1ccccc1		CHEMBL203870		Ki			CHEMBL267	Homo sapiens	Ki		
	1688756	CHEMBL864338	Inhibitory activity against Src in cell free assay	B	C(=C\n1ncc2c(NC3CCCCC3)ncnc21)\c1ccccc1		CHEMBL425046	=	Ki	nM	12000.0	CHEMBL267	Homo sapiens	Ki	uM	12.0
Not Active	1688757	CHEMBL864338	Inhibitory activity against Src in cell free assay	B	C(=C\n1ncc2c(N3CCOCC3)ncnc21)\c1ccccc1		CHEMBL41516		Ki			CHEMBL267	Homo sapiens	Ki		
Not Active	1688758	CHEMBL864338	Inhibitory activity against Src in cell free assay	B	C(=C\n1ncc2c(N3CCCCC3)ncnc21)\c1ccccc1		CHEMBL38999		Ki			CHEMBL267	Homo sapiens	Ki		
Not Active	1688759	CHEMBL864338	Inhibitory activity against Src in cell free assay	B	C(=C\n1ncc2c(N3CCCC3)ncnc21)\c1ccccc1		CHEMBL204905		Ki			CHEMBL267	Homo sapiens	Ki		
Not Determined	1688760	CHEMBL864338	Inhibitory activity against Src in cell free assay	B	CCOCCNc1ncnc2c1cnn2/C=C\c1ccccc1		CHEMBL381692		Ki			CHEMBL267	Homo sapiens	Ki		
Not Active	1688761	CHEMBL864338	Inhibitory activity against Src in cell free assay	B	CCCCNc1ncnc2c1cnn2/C=C\c1ccccc1		CHEMBL41397		Ki			CHEMBL267	Homo sapiens	Ki		
	1688762	CHEMBL864338	Inhibitory activity against Src in cell free assay	B	C(=C\n1ncc2c(NC3CC3)ncnc21)\c1ccccc1		CHEMBL381279	=	Ki	nM	9200.0	CHEMBL267	Homo sapiens	Ki	uM	9.2
Not Determined	1688763	CHEMBL864338	Inhibitory activity against Src in cell free assay	B	CCCNc1ncnc2c1cnn2/C=C\c1ccccc1		CHEMBL381278		Ki			CHEMBL267	Homo sapiens	Ki		
	1688764	CHEMBL864338	Inhibitory activity against Src in cell free assay	B	CCSc1nc(N2CC(C)OC(C)C2)c2cnn(/C=C\c3ccccc3)c2n1		CHEMBL203866	=	Ki	nM	23000.0	CHEMBL267	Homo sapiens	Ki	uM	23.0
Not Active	1688765	CHEMBL864338	Inhibitory activity against Src in cell free assay	B	CCSc1nc(N2CCOCC2)c2cnn(/C=C\c3ccccc3)c2n1		CHEMBL204342		Ki			CHEMBL267	Homo sapiens	Ki		
Not Active	1688766	CHEMBL864338	Inhibitory activity against Src in cell free assay	B	CSc1nc(N2CC(C)OC(C)C2)c2cnn(/C=C\c3ccccc3)c2n1		CHEMBL380459		Ki			CHEMBL267	Homo sapiens	Ki		
Not Active	1688767	CHEMBL864338	Inhibitory activity against Src in cell free assay	B	CSc1nc(N2CCOCC2)c2cnn(/C=C\c3ccccc3)c2n1		CHEMBL204763		Ki			CHEMBL267	Homo sapiens	Ki		
Not Active	1688768	CHEMBL864338	Inhibitory activity against Src in cell free assay	B	CSc1nc(N2CCCCC2)c2cnn(/C=C\c3ccccc3)c2n1		CHEMBL380942		Ki			CHEMBL267	Homo sapiens	Ki		
Not Active	1688769	CHEMBL864338	Inhibitory activity against Src in cell free assay	B	CSc1nc(NCCc2ccccc2)c2cnn(/C=C\c3ccccc3)c2n1		CHEMBL204487		Ki			CHEMBL267	Homo sapiens	Ki		
Not Active	1688770	CHEMBL864338	Inhibitory activity against Src in cell free assay	B	CSc1nc(NCc2ccccc2)c2cnn(/C=C\c3ccccc3)c2n1		CHEMBL204436		Ki			CHEMBL267	Homo sapiens	Ki		
Not Active	1688771	CHEMBL864338	Inhibitory activity against Src in cell free assay	B	CCSc1nc(N2CC(C)OC(C)C2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL204916		Ki			CHEMBL267	Homo sapiens	Ki		
	1688772	CHEMBL864338	Inhibitory activity against Src in cell free assay	B	CCSc1nc(NCc2ccccc2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL85452	=	Ki	nM	8200.0	CHEMBL267	Homo sapiens	Ki	uM	8.2
	1688773	CHEMBL864338	Inhibitory activity against Src in cell free assay	B	CCSc1nc(N2CCOCC2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL416439	=	Ki	nM	3600.0	CHEMBL267	Homo sapiens	Ki	uM	3.6
	1688774	CHEMBL864338	Inhibitory activity against Src in cell free assay	B	CCSc1nc(N2CCCCC2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL40913	=	Ki	nM	8600.0	CHEMBL267	Homo sapiens	Ki	uM	8.6
Not Determined	1688775	CHEMBL864338	Inhibitory activity against Src in cell free assay	B	CCSc1nc(N2CCCC2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL83387		Ki			CHEMBL267	Homo sapiens	Ki		
	1688776	CHEMBL864338	Inhibitory activity against Src in cell free assay	B	CCCCNc1nc(SCC)nc2c1cnn2CC(Cl)c1ccccc1		CHEMBL41910	=	Ki	nM	600.0	CHEMBL267	Homo sapiens	Ki	uM	0.6
	1688777	CHEMBL864338	Inhibitory activity against Src in cell free assay	B	CCCNc1nc(SCC)nc2c1cnn2CC(Cl)c1ccccc1		CHEMBL84020	=	Ki	nM	700.0	CHEMBL267	Homo sapiens	Ki	uM	0.7
Not Active	1688778	CHEMBL864338	Inhibitory activity against Src in cell free assay	B	CSc1nc(N2CC(C)OC(C)C2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL382916		Ki			CHEMBL267	Homo sapiens	Ki		
	1688779	CHEMBL864338	Inhibitory activity against Src in cell free assay	B	CSc1nc(NCCc2ccccc2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL289125	=	Ki	nM	700.0	CHEMBL267	Homo sapiens	Ki	uM	0.7
	1688780	CHEMBL864338	Inhibitory activity against Src in cell free assay	B	CSc1nc(NCc2ccccc2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL288280	=	Ki	nM	3700.0	CHEMBL267	Homo sapiens	Ki	uM	3.7
Not Determined	1688781	CHEMBL864338	Inhibitory activity against Src in cell free assay	B	CSc1nc(NC2CCCCC2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL380968		Ki			CHEMBL267	Homo sapiens	Ki		
Not Determined	1688782	CHEMBL864338	Inhibitory activity against Src in cell free assay	B	CSc1nc(N2CCCCCC2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL205019		Ki			CHEMBL267	Homo sapiens	Ki		
	1688783	CHEMBL864338	Inhibitory activity against Src in cell free assay	B	CSc1nc(N2CCOCC2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL38492	=	Ki	nM	6500.0	CHEMBL267	Homo sapiens	Ki	uM	6.5
	1688784	CHEMBL864338	Inhibitory activity against Src in cell free assay	B	CSc1nc(N2CCCCC2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL289298	=	Ki	nM	2400.0	CHEMBL267	Homo sapiens	Ki	uM	2.4
Not Determined	1688785	CHEMBL864338	Inhibitory activity against Src in cell free assay	B	CSc1nc(N2CCCC2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL431614		Ki			CHEMBL267	Homo sapiens	Ki		
Not Active	1688786	CHEMBL864338	Inhibitory activity against Src in cell free assay	B	CCOCCNc1nc(SC)nc2c1cnn2CC(Cl)c1ccccc1		CHEMBL291273		Ki			CHEMBL267	Homo sapiens	Ki		
	1688787	CHEMBL864338	Inhibitory activity against Src in cell free assay	B	CCN(CC)c1nc(SC)nc2c1cnn2CC(Cl)c1ccccc1		CHEMBL83847	=	Ki	nM	500.0	CHEMBL267	Homo sapiens	Ki	uM	0.5
	1688788	CHEMBL864338	Inhibitory activity against Src in cell free assay	B	CCCCNc1nc(SC)nc2c1cnn2CC(Cl)c1ccccc1		CHEMBL40798	=	Ki	nM	1700.0	CHEMBL267	Homo sapiens	Ki	uM	1.7
Not Determined	1688902	CHEMBL864338	Inhibitory activity against Src in cell free assay	B	BrC(Cn1ncc2c(NC3CC3)ncnc21)c1ccccc1		CHEMBL204923		Ki			CHEMBL267	Homo sapiens	Ki		
Active	1688911	CHEMBL864341	Inhibition of Src autophosphorylation of Y419 in A431 cells at 10 uM	B	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845		Activity			CHEMBL267	Homo sapiens	Activity		
Active	1688923	CHEMBL864341	Inhibition of Src autophosphorylation of Y419 in A431 cells at 10 uM	B	CSc1nc(N2CCCCC2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL289298		Activity			CHEMBL267	Homo sapiens	Activity		
Active	1688925	CHEMBL864341	Inhibition of Src autophosphorylation of Y419 in A431 cells at 10 uM	B	CSc1nc(NCCc2ccccc2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL289125		Activity			CHEMBL267	Homo sapiens	Activity		
Active	1688926	CHEMBL864341	Inhibition of Src autophosphorylation of Y419 in A431 cells at 10 uM	B	CSc1nc(NCc2ccccc2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL288280		Activity			CHEMBL267	Homo sapiens	Activity		
Active	1688951	CHEMBL864342	Inhibition of Src autophosphorylation of Y419 in 8701-BC cells at 10 uM	B	CSc1nc(N2CCCCC2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL289298		Activity			CHEMBL267	Homo sapiens	Activity		
Active	1688952	CHEMBL864342	Inhibition of Src autophosphorylation of Y419 in 8701-BC cells at 10 uM	B	CSc1nc(NCCc2ccccc2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL289125		Activity			CHEMBL267	Homo sapiens	Activity		
Active	1688953	CHEMBL864342	Inhibition of Src autophosphorylation of Y419 in 8701-BC cells at 10 uM	B	CSc1nc(NCc2ccccc2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL288280		Activity			CHEMBL267	Homo sapiens	Activity		
Active	1695868	CHEMBL864341	Inhibition of Src autophosphorylation of Y419 in A431 cells at 10 uM	B	C(=C\n1ncc2c(N3CCCCCC3)ncnc21)\c1ccccc1		CHEMBL203870		Activity			CHEMBL267	Homo sapiens	Activity		
Active	1695869	CHEMBL864341	Inhibition of Src autophosphorylation of Y419 in A431 cells at 10 uM	B	CCCNc1ncnc2c1cnn2/C=C\c1ccccc1		CHEMBL381278		Activity			CHEMBL267	Homo sapiens	Activity		
Active	1695870	CHEMBL864341	Inhibition of Src autophosphorylation of Y419 in A431 cells at 10 uM	B	CCCCNc1nc(SCC)nc2c1cnn2CC(Cl)c1ccccc1		CHEMBL41910		Activity			CHEMBL267	Homo sapiens	Activity		
	1697191	CHEMBL869543	Inhibition of SRC kinase using 1.0 mM ATP	B	N[C@H](COc1cncc(/C=C/c2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL383541	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	nM	50000.0
	1697192	CHEMBL869543	Inhibition of SRC kinase using 1.0 mM ATP	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	1920.0	CHEMBL267	Homo sapiens	IC50	nM	1920.0
	1704947	CHEMBL868837	Inhibition of SRC kinase at 1.0 mM ATP	B	N[C@H](COc1cncc(/C=C/c2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL383541	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	nM	50000.0
	1704977	CHEMBL868837	Inhibition of SRC kinase at 1.0 mM ATP	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	1920.0	CHEMBL267	Homo sapiens	IC50	nM	1920.0
	1704978	CHEMBL868837	Inhibition of SRC kinase at 1.0 mM ATP	B	N[C@H](COc1cncc(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL383264	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	nM	50000.0
	1715698	CHEMBL870114	Inhibition of Src	B	COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN1CCCC1		CHEMBL437885	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	1715904	CHEMBL870114	Inhibition of Src	B	COCCN1CC(C(N)=O)(N(C)Cc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)C1		CHEMBL207815	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	1715905	CHEMBL870114	Inhibition of Src	B	COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN(C)C1(C(N)=O)CN(C(C)C)C1		CHEMBL425601	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	1715906	CHEMBL870114	Inhibition of Src	B	COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN(C)C1(C(N)=O)CN(C)C1		CHEMBL207718	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	1715907	CHEMBL870114	Inhibition of Src	B	COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN(C)C1(C(N)=O)CCN(C(C)C)CC1		CHEMBL383246	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	1715908	CHEMBL870114	Inhibition of Src	B	COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN(C)C1(C(N)=O)CCN(C)CC1		CHEMBL207130	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	1715909	CHEMBL870114	Inhibition of Src	B	COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN(C)[C@@H](CN(C)C)C(N)=O		CHEMBL380889	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	1715910	CHEMBL870114	Inhibition of Src	B	COCC[C@@H](C(N)=O)N(C)Cc1cc2c(Nc3cccc(Cl)c3F)ncnc2cc1OC		CHEMBL207445	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	1715911	CHEMBL870114	Inhibition of Src	B	COC[C@@H](C(N)=O)N(C)Cc1cc2c(Nc3cccc(Cl)c3F)ncnc2cc1OC		CHEMBL379905	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	1715912	CHEMBL870114	Inhibition of Src	B	COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN(C)[C@@H](CO)C(N)=O		CHEMBL208286	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	1715913	CHEMBL870114	Inhibition of Src	B	COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN(CCN(C)C)[C@@H](C)C(N)=O		CHEMBL376967	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	1715914	CHEMBL870114	Inhibition of Src	B	COCCN(Cc1cc2c(Nc3cccc(Cl)c3F)ncnc2cc1OC)[C@@H](C)C(N)=O		CHEMBL382823	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	1715915	CHEMBL870114	Inhibition of Src	B	COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN(C(C)C)[C@@H](C)C(N)=O		CHEMBL208048	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	1715916	CHEMBL870114	Inhibition of Src	B	COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN(C)C1CCNC1=O		CHEMBL378370	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	1715917	CHEMBL870114	Inhibition of Src	B	COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN(C)[C@H](C)C(=O)N(C)C		CHEMBL380006	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	1715918	CHEMBL870114	Inhibition of Src	B	CNC(=O)[C@@H](C)N(C)Cc1cc2c(Nc3cccc(Cl)c3F)ncnc2cc1OC		CHEMBL211003	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	1715919	CHEMBL870114	Inhibition of Src	B	COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN(C)[C@@H](C)C(N)=O		CHEMBL207687	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	1715920	CHEMBL870114	Inhibition of Src	B	COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN(C)[C@H](C)C(N)=O		CHEMBL208118	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	1715921	CHEMBL870114	Inhibition of Src	B	COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN(C)CC(N)=O		CHEMBL379601	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	1715922	CHEMBL870114	Inhibition of Src	B	COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN[C@H](C)C(N)=O		CHEMBL380386	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	1715923	CHEMBL870114	Inhibition of Src	B	COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN1CC(C(N)=O)C1		CHEMBL207037	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	1715924	CHEMBL870114	Inhibition of Src	B	COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN1CCC1C(N)=O		CHEMBL207246	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	1715925	CHEMBL870114	Inhibition of Src	B	COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN1CCOCC1C(N)=O		CHEMBL207674	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	1715926	CHEMBL870114	Inhibition of Src	B	COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN1CCCC[C@@H]1C(N)=O		CHEMBL206783	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	1715927	CHEMBL870114	Inhibition of Src	B	COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN1CCN(C)CC1C(N)=O		CHEMBL204420	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	1715928	CHEMBL870114	Inhibition of Src	B	COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN1CCC[C@H]1CC(N)=O		CHEMBL377772	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	1715929	CHEMBL870114	Inhibition of Src	B	COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN1CC[C@H](C(N)=O)C1		CHEMBL380454	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	1715930	CHEMBL870114	Inhibition of Src	B	COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN1CCC[C@@H]1C(=O)N(C)C		CHEMBL382822	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	1715931	CHEMBL870114	Inhibition of Src	B	CNC(=O)[C@H]1CCCN1Cc1cc2c(Nc3cccc(Cl)c3F)ncnc2cc1OC		CHEMBL383760	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	1715932	CHEMBL870114	Inhibition of Src	B	COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN1C[C@H](OC)C[C@@H]1C(N)=O		CHEMBL207235	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	1715933	CHEMBL870114	Inhibition of Src	B	COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN1CCC[C@@H]1C(N)=O		CHEMBL208292	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	1715934	CHEMBL870114	Inhibition of Src	B	COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN1CCC[C@H]1C(N)=O		CHEMBL207584	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	1715935	CHEMBL870114	Inhibition of Src	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1CN1CCC[C@H]1C(N)=O		CHEMBL382638	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	1715936	CHEMBL870114	Inhibition of Src	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1CN1CCC[C@@H]1C(N)=O		CHEMBL206955	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	1719099	CHEMBL859156	Binding affinity to human recombinant Src	B	Nc1[nH]cnc2nnc(-c3ccc(Cl)cc3)c1-2		CHEMBL207471	=	Ki	nM	500.0	CHEMBL267	Homo sapiens	Ki	uM	0.5
	1719100	CHEMBL859156	Binding affinity to human recombinant Src	B	Cc1ccc(N2NC(=O)/C(=C/c3ccc(-c4ccc(C)c(Cl)c4)o3)C2=O)cc1C		CHEMBL206575	=	Ki	nM	1000.0	CHEMBL267	Homo sapiens	Ki	uM	1.0
	1719101	CHEMBL859156	Binding affinity to human recombinant Src	B	O=C1NN(c2ccc(Cl)c(Cl)c2)C(=O)/C1=C\c1cccc(OCc2ccccc2)c1		CHEMBL207360	=	Ki	nM	5400.0	CHEMBL267	Homo sapiens	Ki	uM	5.4
	1719102	CHEMBL859156	Binding affinity to human recombinant Src	B	O=C1NN(c2ccc(I)cc2)C(=O)/C1=C\c1cc2c(cc1Br)OCO2		CHEMBL379308	=	Ki	nM	500.0	CHEMBL267	Homo sapiens	Ki	uM	0.5
	1719103	CHEMBL859156	Binding affinity to human recombinant Src	B	CCN(CC)c1ccc(/C=C2/C(=O)NN(c3ccc(I)cc3)C2=O)c(O)c1		CHEMBL208828	=	Ki	nM	1000.0	CHEMBL267	Homo sapiens	Ki	uM	1.0
	1719104	CHEMBL859156	Binding affinity to human recombinant Src	B	O=C1NN(c2ccc(I)cc2)C(=O)/C1=C\c1ccc(I)cc1		CHEMBL210766	=	Ki	nM	500.0	CHEMBL267	Homo sapiens	Ki	uM	0.5
	1719105	CHEMBL859156	Binding affinity to human recombinant Src	B	O=C1NN(c2ccc(I)cc2)C(=O)/C1=C\c1ccccc1		CHEMBL209617	=	Ki	nM	4300.0	CHEMBL267	Homo sapiens	Ki	uM	4.3
	1719106	CHEMBL859156	Binding affinity to human recombinant Src	B	O=C1NN(c2ccccc2)C(=O)/C1=C\c1ccccc1OCc1ccccc1		CHEMBL380706	=	Ki	nM	900.0	CHEMBL267	Homo sapiens	Ki	uM	0.9
	1719107	CHEMBL859156	Binding affinity to human recombinant Src	B	COc1ccc(C(=O)Nc2nnc(Cc3c[nH]c4ccccc34)s2)cc1		CHEMBL207672	=	Ki	nM	1900.0	CHEMBL267	Homo sapiens	Ki	uM	1.9
	1719108	CHEMBL859156	Binding affinity to human recombinant Src	B	COc1cc(SC)ccc1C(=O)Nc1nnc(CCc2ccccc2)s1		CHEMBL376993	=	Ki	nM	4100.0	CHEMBL267	Homo sapiens	Ki	uM	4.1
	1719109	CHEMBL859156	Binding affinity to human recombinant Src	B	O=C(Nc1nnc(CCc2ccccc2)s1)c1ccc(Cl)cc1Cl		CHEMBL210036	=	Ki	nM	1300.0	CHEMBL267	Homo sapiens	Ki	uM	1.3
	1719110	CHEMBL859156	Binding affinity to human recombinant Src	B	O=C(Nc1nnc(CCc2ccccc2)s1)c1ccccc1I		CHEMBL207986	=	Ki	nM	2000.0	CHEMBL267	Homo sapiens	Ki	uM	2.0
	1719111	CHEMBL859156	Binding affinity to human recombinant Src	B	O=C(Nc1nnc(CCc2ccccc2)s1)c1ccccc1		CHEMBL378903	=	Ki	nM	2900.0	CHEMBL267	Homo sapiens	Ki	uM	2.9
	1719136	CHEMBL859156	Binding affinity to human recombinant Src	B	O=C1NN(c2ccc(I)cc2)C(=O)/C1=C\c1ccc(N2CCOCC2)cc1	Non standard unit for type	CHEMBL378175	>	ID50	mM	2.0	CHEMBL267	Homo sapiens	ID50	mM	2.0
	1719137	CHEMBL859156	Binding affinity to human recombinant Src	B	Cc1ccc(-c2cnc(NC(=O)c3ccc(Br)cc3)s2)cc1	Non standard unit for type	CHEMBL207572	>	ID50	mM	2.0	CHEMBL267	Homo sapiens	ID50	mM	2.0
	1719138	CHEMBL859156	Binding affinity to human recombinant Src	B	O=C(Nc1ccccc1)Nc1nnc(Cc2ccccc2)s1	Non standard unit for type	CHEMBL438610	>	ID50	mM	2.0	CHEMBL267	Homo sapiens	ID50	mM	2.0
	1719139	CHEMBL859156	Binding affinity to human recombinant Src	B	O=C(Nc1nnc(CCc2ccccc2)s1)c1ccc(I)cc1	Non standard unit for type	CHEMBL206046	>	ID50	nM	2.0	CHEMBL267	Homo sapiens	ID50	nM	2.0
	1719723	CHEMBL859180	Inhibition of SRC using polyE4Y as substrate	B	CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(C)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O	Outside typical range	CHEMBL1791370	=	IC50	nM	400000.0	CHEMBL267	Homo sapiens	IC50	uM	400.0
	1719725	CHEMBL859180	Inhibition of SRC using polyE4Y as substrate	B	CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(C)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H]1CCCCNC(=O)CCC(=O)Nc2ccc(cc2)C[C@@H](C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)O)NC1=O	Outside typical range	CHEMBL1791366	>	IC50	nM	400000.0	CHEMBL267	Homo sapiens	IC50	uM	400.0
	1719726	CHEMBL859180	Inhibition of SRC using polyE4Y as substrate	B	CC[C@H](C)[C@H](NC(=O)[C@@H](CS)NC(C)=O)C(=O)N[C@H]1Cc2ccc(cc2)NC(=O)CCCCCCC(=O)NCCCC[C@@H](C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)O)NC1=O		CHEMBL428631	=	IC50	nM	280.0	CHEMBL267	Homo sapiens	IC50	uM	0.28
	1719727	CHEMBL859180	Inhibition of SRC using polyE4Y as substrate	B	CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(C)=O)C(=O)N[C@H]1Cc2ccc(cc2)NC(=O)CCC(=O)NCCCC[C@@H](C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)O)NC1=O		CHEMBL209045	=	IC50	nM	1900.0	CHEMBL267	Homo sapiens	IC50	uM	1.9
	1719728	CHEMBL859180	Inhibition of SRC using polyE4Y as substrate	B	CC[C@H](C)[C@@H]1NC(=O)[C@H](CS)NC(=O)CCC(=O)Nc2ccc(cc2)C[C@@H](C(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O		CHEMBL2371922	=	IC50	nM	16000.0	CHEMBL267	Homo sapiens	IC50	uM	16.0
	1719729	CHEMBL859180	Inhibition of SRC using polyE4Y as substrate	B	CC[C@H](C)[C@@H]1NC(=O)[C@H](CS)NC(=O)CCC(=O)Nc2ccc(cc2)C[C@@H](C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O	Outside typical range	CHEMBL378962	>	IC50	nM	400000.0	CHEMBL267	Homo sapiens	IC50	uM	400.0
	1719730	CHEMBL859180	Inhibition of SRC using polyE4Y as substrate	B	CC[C@H](C)[C@@H]1NC(=O)[C@H](CS)NC(=O)CCC(=O)NCCCC[C@@H](C(=O)N[C@@H](Cc2ccc([N+](=O)[O-])cc2)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O	Outside typical range	CHEMBL1791378	=	IC50	nM	134000.0	CHEMBL267	Homo sapiens	IC50	uM	134.0
	1719731	CHEMBL859180	Inhibition of SRC using polyE4Y as substrate	B	CC[C@H](C)[C@@H]1NC(=O)[C@H](CS)NC(=O)CCC(=O)NCCCC[C@@H](C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O		CHEMBL1791365	=	IC50	nM	75000.0	CHEMBL267	Homo sapiens	IC50	uM	75.0
	1719732	CHEMBL859180	Inhibition of SRC using polyE4Y as substrate	B	CC[C@@H](C)[C@@H]1NC(=O)[C@@H](CS)NC(=O)CCC(=O)Nc2ccc(cc2)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)O)NC1=O		CHEMBL1791369	=	IC50	nM	17000.0	CHEMBL267	Homo sapiens	IC50	uM	17.0
	1719733	CHEMBL859180	Inhibition of SRC using polyE4Y as substrate	B	CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(C)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H]1CCCCNC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O		CHEMBL1791364	=	IC50	nM	54500.0	CHEMBL267	Homo sapiens	IC50	uM	54.5
	1719734	CHEMBL859180	Inhibition of SRC using polyE4Y as substrate	B	CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(C)=O)C(=O)N[C@H]1Cc2ccc(cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCCCN)NC1=O		CHEMBL267213	=	IC50	nM	33600.0	CHEMBL267	Homo sapiens	IC50	uM	33.6
	1719735	CHEMBL859180	Inhibition of SRC using polyE4Y as substrate	B	CC[C@H](C)[C@@H]1NC(=O)[C@H](CS)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O		CHEMBL429525	=	IC50	nM	6400.0	CHEMBL267	Homo sapiens	IC50	uM	6.4
	1719736	CHEMBL859180	Inhibition of SRC using polyE4Y as substrate	B	CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(C)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(NC(=N)N)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O	Outside typical range	CHEMBL1791377	>	IC50	nM	700000.0	CHEMBL267	Homo sapiens	IC50	uM	700.0
	1719737	CHEMBL859180	Inhibition of SRC using polyE4Y as substrate	B	CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(C)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(NS(C)(=O)=O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O	Outside typical range	CHEMBL1791363	>	IC50	nM	700000.0	CHEMBL267	Homo sapiens	IC50	uM	700.0
	1719738	CHEMBL859180	Inhibition of SRC using polyE4Y as substrate	B	CC(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(P(=O)(O)O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O	Outside typical range	CHEMBL378042	>	IC50	nM	700000.0	CHEMBL267	Homo sapiens	IC50	uM	700.0
	1719739	CHEMBL859180	Inhibition of SRC using polyE4Y as substrate	B	CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(C)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(P(=O)(O)O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O	Outside typical range	CHEMBL380085	>	IC50	nM	700000.0	CHEMBL267	Homo sapiens	IC50	uM	700.0
	1719740	CHEMBL859180	Inhibition of SRC using polyE4Y as substrate	B	CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(C)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(N=[N+]=[N-])cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O		CHEMBL1791376	=	IC50	nM	2000.0	CHEMBL267	Homo sapiens	IC50	uM	2.0
	1719741	CHEMBL859180	Inhibition of SRC using polyE4Y as substrate	B	CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(C)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(C#N)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O		CHEMBL1791368	=	IC50	nM	6000.0	CHEMBL267	Homo sapiens	IC50	uM	6.0
	1719742	CHEMBL859180	Inhibition of SRC using polyE4Y as substrate	B	CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(C)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(I)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O		CHEMBL1791362	=	IC50	nM	780.0	CHEMBL267	Homo sapiens	IC50	uM	0.78
	1719744	CHEMBL859180	Inhibition of SRC using polyE4Y as substrate	B	CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(C)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(F)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O		CHEMBL1791360	=	IC50	nM	26000.0	CHEMBL267	Homo sapiens	IC50	uM	26.0
	1719745	CHEMBL859180	Inhibition of SRC using polyE4Y as substrate	B	CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(C)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc([N+](=O)[O-])cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O		CHEMBL1791373	=	IC50	nM	1000.0	CHEMBL267	Homo sapiens	IC50	uM	1.0
	1719746	CHEMBL859180	Inhibition of SRC using polyE4Y as substrate	B	CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(C)=O)C(=O)N[C@@H](Cc1ccc([N+](=O)[O-])cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc([N+](=O)[O-])cc1)C(=O)O		CHEMBL1791372	=	IC50	nM	3400.0	CHEMBL267	Homo sapiens	IC50	uM	3.4
	1719747	CHEMBL859180	Inhibition of SRC using polyE4Y as substrate	B	CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(C)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc([N+](=O)[O-])cc1)C(=O)N[C@@H](Cc1ccc([N+](=O)[O-])cc1)C(=O)O		CHEMBL1791375	=	IC50	nM	5600.0	CHEMBL267	Homo sapiens	IC50	uM	5.6
	1719748	CHEMBL859180	Inhibition of SRC using polyE4Y as substrate	B	CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(C)=O)C(=O)N[C@@H](Cc1ccc([N+](=O)[O-])cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc([N+](=O)[O-])cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O		CHEMBL1791361	=	IC50	nM	1400.0	CHEMBL267	Homo sapiens	IC50	uM	1.4
	1719749	CHEMBL859180	Inhibition of SRC using polyE4Y as substrate	B	CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(C)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(N)cc1)C(=O)O	Outside typical range	CHEMBL1791355	>	IC50	nM	700000.0	CHEMBL267	Homo sapiens	IC50	uM	700.0
	1719750	CHEMBL859180	Inhibition of SRC using polyE4Y as substrate	B	CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(C)=O)C(=O)N[C@@H](Cc1ccc(N)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O	Outside typical range	CHEMBL1791359	=	IC50	nM	760000.0	CHEMBL267	Homo sapiens	IC50	uM	760.0
	1719751	CHEMBL859180	Inhibition of SRC using polyE4Y as substrate	B	CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(C)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc([N+](=O)[O-])cc1)C(=O)O		CHEMBL1791371	=	IC50	nM	10800.0	CHEMBL267	Homo sapiens	IC50	uM	10.8
	1719752	CHEMBL859180	Inhibition of SRC using polyE4Y as substrate	B	CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(C)=O)C(=O)N[C@@H](Cc1ccc([N+](=O)[O-])cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O		CHEMBL1791374	=	IC50	nM	1500.0	CHEMBL267	Homo sapiens	IC50	uM	1.5
	1719753	CHEMBL859180	Inhibition of SRC using polyE4Y as substrate	B	CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(C)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(N)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O		CHEMBL1791367	=	IC50	nM	93000.0	CHEMBL267	Homo sapiens	IC50	uM	93.0
	1719754	CHEMBL859180	Inhibition of SRC using polyE4Y as substrate	B	CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(C)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O	Outside typical range	CHEMBL1791357	>	IC50	nM	700000.0	CHEMBL267	Homo sapiens	IC50	uM	700.0
	1719755	CHEMBL859180	Inhibition of SRC using polyE4Y as substrate	B	CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(C)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc([N+](=O)[O-])cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O		CHEMBL1791358	=	IC50	nM	530.0	CHEMBL267	Homo sapiens	IC50	uM	0.53
	1719756	CHEMBL859179	Inhibition of SRC in presence of ATP	B	CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(C)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc([N+](=O)[O-])cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O		CHEMBL1791358	=	Km	nM	63100.0	CHEMBL267	Homo sapiens	Km	uM	63.1
	1719757	CHEMBL859179	Inhibition of SRC in presence of ATP	B	CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(C)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc([N+](=O)[O-])cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O		CHEMBL1791358	=	Ki	nM	210.0	CHEMBL267	Homo sapiens	Ki	uM	0.21
	1719857	CHEMBL859180	Inhibition of SRC using polyE4Y as substrate	B	CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(C)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(Cl)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O		CHEMBL1791356	=	IC50	nM	7300.0	CHEMBL267	Homo sapiens	IC50	uM	7.3
	1723385	CHEMBL862049	Inhibition of Src	B	CCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL208637	>	Ki	nM	1900.0	CHEMBL267	Homo sapiens	Ki	nM	1900.0
	1723558	CHEMBL862049	Inhibition of Src	B	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1Cl		CHEMBL210928	>	Ki	nM	1900.0	CHEMBL267	Homo sapiens	Ki	nM	1900.0
	1723559	CHEMBL862049	Inhibition of Src	B	CC(=O)Nc1cc(N)c(C#N)c(-c2ccccc2)n1		CHEMBL210032	>	Ki	nM	1900.0	CHEMBL267	Homo sapiens	Ki	nM	1900.0
	1723560	CHEMBL862049	Inhibition of Src	B	COc1cc(S(C)(=O)=O)c(OC)cc1CC(=O)Nc1cc(N)c(C#N)c(OC(C)C)n1		CHEMBL378627	>	Ki	nM	1900.0	CHEMBL267	Homo sapiens	Ki	nM	1900.0
	1723561	CHEMBL862049	Inhibition of Src	B	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1C#N		CHEMBL210963	>	Ki	nM	1900.0	CHEMBL267	Homo sapiens	Ki	nM	1900.0
	1723562	CHEMBL862049	Inhibition of Src	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	>	Ki	nM	1900.0	CHEMBL267	Homo sapiens	Ki	nM	1900.0
	1726478	CHEMBL861330	Inhibition of SRC at 5 uM ATP	B	N[C@H](COc1cncc(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL383264	=	IC50	nM	2000.0	CHEMBL267	Homo sapiens	IC50	nM	2000.0
	1726479	CHEMBL861330	Inhibition of SRC at 5 uM ATP	B	Nc1cc2cc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)ccc2cn1		CHEMBL210390	=	IC50	nM	480.0	CHEMBL267	Homo sapiens	IC50	nM	480.0
	1726480	CHEMBL861330	Inhibition of SRC at 5 uM ATP	B	N[C@H](COc1cncc(-c2ccc3cnc(F)cc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL210246	=	IC50	nM	18000.0	CHEMBL267	Homo sapiens	IC50	nM	18000.0
	1726481	CHEMBL861330	Inhibition of SRC at 5 uM ATP	B	C#Cc1ncc(OC[C@@H](N)Cc2c[nH]c3ccccc23)cc1-c1ccc2cnccc2c1		CHEMBL207544	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	nM	50000.0
	1726482	CHEMBL861330	Inhibition of SRC at 5 uM ATP	B	N[C@H](COc1cnc(Cl)c(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL378963	=	IC50	nM	12100.0	CHEMBL267	Homo sapiens	IC50	nM	12100.0
	1734195	CHEMBL862472	Residual activity at human cSRC at 10 uM in presence of 10 uM ATP relative to control	B	O=C1NC(=O)/C(=C/c2ccc(-c3ccc(F)cc3O)o2)S1		CHEMBL379156	=	Activity	%	66.0	CHEMBL267	Homo sapiens	Activity	%	66.0
	1739104	CHEMBL866214	Inhibition of SRC	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	=	Ki	nM	13000.0	CHEMBL267	Homo sapiens	Ki	nM	13000.0
	1744367	CHEMBL866676	Inhibition of Src	B	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1Cl		CHEMBL377383	>	Ki	nM	1900.0	CHEMBL267	Homo sapiens	Ki	uM	1.9
	1744619	CHEMBL866830	Inhibition of Src	B	O=C(NC1CC1)c1cc(NCc2cnc(Nc3ccccn3)s2)c(F)cc1F		CHEMBL377734	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	1748835	CHEMBL870978	Inhibition of Src	B	COc1ccccc1N(C(=O)Oc1c(C)cccc1C)c1ccnc(Nc2ccc(N3CCN(C)CC3)cc2)n1		CHEMBL211460	=	IC50	nM	4.0	CHEMBL267	Homo sapiens	IC50	uM	0.004
	1748836	CHEMBL870978	Inhibition of Src	B	COc1ccc(N(C(=O)Oc2c(C)cccc2C)c2ccnc(Nc3ccc(N4CCN(C)CC4)cc3)n2)cc1		CHEMBL215847	=	IC50	nM	3.0	CHEMBL267	Homo sapiens	IC50	uM	0.003
	1748837	CHEMBL870978	Inhibition of Src	B	Cc1cccc(C)c1OC(=O)N(c1ccnc(Nc2ccc(N3CCN(C)CC3)cc2)n1)c1ccc(F)cc1OC(C)C		CHEMBL263769	=	IC50	nM	13.0	CHEMBL267	Homo sapiens	IC50	uM	0.013
	1748838	CHEMBL870978	Inhibition of Src	B	COc1ccc(N(C(=O)Oc2c(C)cccc2C)c2ccnc(Nc3ccc(N4CCN(C)CC4)cc3)n2)c(OC)c1		CHEMBL213100	=	IC50	nM	6.0	CHEMBL267	Homo sapiens	IC50	uM	0.006
	1748839	CHEMBL870978	Inhibition of Src	B	COc1ccc(OC)c(N(C(=O)Oc2c(C)cccc2C)c2ccnc(Nc3ccc(N4CCN(C)CC4)cc3)n2)c1		CHEMBL442485	=	IC50	nM	1.0	CHEMBL267	Homo sapiens	IC50	uM	0.001
	1748840	CHEMBL870978	Inhibition of Src	B	Cc1cccc(C)c1OC(=O)N(c1ccc2ccccc2c1)c1ccnc(Nc2ccc(N3CCN(C)CC3)cc2)n1		CHEMBL377481	=	IC50	nM	14.0	CHEMBL267	Homo sapiens	IC50	uM	0.014
	1748841	CHEMBL870978	Inhibition of Src	B	Cc1cccc(C)c1OC(=O)N(c1ccc(-c2ccccc2)cc1)c1ccnc(Nc2ccc(N3CCN(C)CC3)cc2)n1		CHEMBL209908	=	IC50	nM	98.0	CHEMBL267	Homo sapiens	IC50	uM	0.098
	1748842	CHEMBL870978	Inhibition of Src	B	Cc1cccc(C)c1OC(=O)N(c1cccc(-c2ccccc2)c1)c1ccnc(Nc2ccc(N3CCN(C)CC3)cc2)n1		CHEMBL215726	=	IC50	nM	500.0	CHEMBL267	Homo sapiens	IC50	uM	0.5
	1748843	CHEMBL870978	Inhibition of Src	B	COc1ccc(N(C(=O)Oc2c(C)cccc2C)c2ccnc(Nc3ccc(N4CCN(C)CC4)c(OC)c3)n2)c(OC)c1		CHEMBL215730	=	IC50	nM	2.0	CHEMBL267	Homo sapiens	IC50	uM	0.002
	1748844	CHEMBL870978	Inhibition of Src	B	COc1ccc(N(C(=O)Oc2c(C)cccc2C)c2ccnc(Nc3cc(OC)c(N4CCN(C)CC4)c(OC)c3)n2)c(OC)c1		CHEMBL385898	=	IC50	nM	1.0	CHEMBL267	Homo sapiens	IC50	uM	0.001
	1748845	CHEMBL870978	Inhibition of Src	B	COc1ccc(N(C(=O)Oc2c(C)cccc2C)c2ccnc(Nc3ccc(N4CCN(C)CC4)c(F)c3)n2)c(OC)c1		CHEMBL211845	=	IC50	nM	2.0	CHEMBL267	Homo sapiens	IC50	uM	0.002
	1748846	CHEMBL870978	Inhibition of Src	B	COc1ccc(N(C(=O)Oc2c(C)cccc2C)c2ccnc(Nc3ccc(OCCN(C)C)cc3)n2)c(OC)c1		CHEMBL212721	=	IC50	nM	4.0	CHEMBL267	Homo sapiens	IC50	uM	0.004
	1748847	CHEMBL870978	Inhibition of Src	B	COc1ccc(N(C(=O)Oc2c(C)cccc2C)c2ccnc(Nc3ccc(OCCCN(C)C)cc3)n2)c(OC)c1		CHEMBL214775	=	IC50	nM	4.0	CHEMBL267	Homo sapiens	IC50	uM	0.004
	1748848	CHEMBL870978	Inhibition of Src	B	COc1ccc(N(C(=O)Oc2c(C)cccc2C)c2ccnc(Nc3ccc(OCCN4CCN(C)CC4)cc3)n2)c(OC)c1		CHEMBL212668	=	IC50	nM	6.0	CHEMBL267	Homo sapiens	IC50	uM	0.006
	1748849	CHEMBL870978	Inhibition of Src	B	COc1ccc(N(C(=O)Oc2c(C)cccc2C)c2ccnc(Nc3cc(OC)c(OCCN4CCN(C)CC4)c(OC)c3)n2)c(OC)c1		CHEMBL212143	=	IC50	nM	1.0	CHEMBL267	Homo sapiens	IC50	uM	0.001
	1748850	CHEMBL870978	Inhibition of Src	B	COc1ccc(N(C(=O)Oc2c(C)cccc2C)c2ccnc(Nc3cc(OC)c(OCCN4CCOCC4)c(OC)c3)n2)c(OC)c1		CHEMBL264803	=	IC50	nM	2.0	CHEMBL267	Homo sapiens	IC50	uM	0.002
	1748851	CHEMBL870978	Inhibition of Src	B	COc1ccc(N(C(=O)Oc2c(C)cccc2C)c2ccnc(Nc3ccc(OCCN4CCCCC4)cc3)n2)c(OC)c1		CHEMBL379733	=	IC50	nM	7.0	CHEMBL267	Homo sapiens	IC50	uM	0.007
	1748852	CHEMBL870978	Inhibition of Src	B	COc1ccc(N(C(=O)Oc2c(C)cccc2C)c2ccnc(Nc3ccc(OCCCN4CCN(C)CC4)c(OC)c3)n2)c(OC)c1		CHEMBL379080	=	IC50	nM	2.0	CHEMBL267	Homo sapiens	IC50	uM	0.002
	1748853	CHEMBL870978	Inhibition of Src	B	COc1ccc(N(C(=O)Oc2c(C)cccc2C)c2ccnc(Nc3cc(OC)c(OCCCN4CCN(C)CC4)c(OC)c3)n2)c(OC)c1		CHEMBL386760	=	IC50	nM	1.0	CHEMBL267	Homo sapiens	IC50	uM	0.001
	1748854	CHEMBL870978	Inhibition of Src	B	COc1ccc(N(C(=O)Oc2c(C)cccc2C)c2ccnc(Nc3ccc(OCCCN4CCN(C)CC4)c(F)c3)n2)c(OC)c1		CHEMBL215289	=	IC50	nM	5.0	CHEMBL267	Homo sapiens	IC50	uM	0.005
	1748855	CHEMBL870978	Inhibition of Src	B	COc1ccc(N(C(=O)Oc2c(C)cccc2C)c2ccnc(Nc3ccc(OCCCN4CCCCC4)c(F)c3)n2)c(OC)c1		CHEMBL215411	=	IC50	nM	12.0	CHEMBL267	Homo sapiens	IC50	uM	0.012
	1752326	CHEMBL864857	Inhibition of c-Src	B	O=C1NC(=O)c2c1c(-c1ccccc1)cc1[nH]c3ccc(O)cc3c21		CHEMBL214253	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	1755922	CHEMBL869827	Inhibition of human recombinant Src in presence of 10 mM ATP	B	CCN(CC)CCOc1ccc(Nc2ncc3c(n2)N2CCC(=O)N2C(c2c(Cl)cccc2Cl)=C3)cc1		CHEMBL379517	=	IC50	nM	3.0	CHEMBL267	Homo sapiens	IC50	nM	3.0
	1755923	CHEMBL869827	Inhibition of human recombinant Src in presence of 10 mM ATP	B	CN1CCN(c2ccc(Nc3ncc4c(n3)N3CCC(=O)N3C(c3cc(O)ccc3Cl)=C4)cc2)CC1		CHEMBL213356	=	IC50	nM	764.0	CHEMBL267	Homo sapiens	IC50	nM	764.0
	1755924	CHEMBL869827	Inhibition of human recombinant Src in presence of 10 mM ATP	B	CN(C)c1ccc(Nc2ncc3c(n2)N2CCC(=O)N2C(c2cc(O)ccc2Cl)=C3)cc1		CHEMBL211852	=	IC50	nM	273.0	CHEMBL267	Homo sapiens	IC50	nM	273.0
	1755931	CHEMBL869827	Inhibition of human recombinant Src in presence of 10 mM ATP	B	O=C1CCN2c3nc(Nc4ccc(N5CCOCC5)cc4)ncc3C=C(c3c(Cl)cccc3Cl)N12		CHEMBL213745	=	IC50	nM	104.0	CHEMBL267	Homo sapiens	IC50	nM	104.0
	1758171	CHEMBL869798	Inhibition of Src dependent proliferation	F	COc1cc(Nc2c(C#N)cnc3cc(C#Cc4cc(CN(C)C)ccn4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL214035	=	IC50	nM	580.0	CHEMBL267	Homo sapiens	IC50	nM	580.0
	1758172	CHEMBL869798	Inhibition of Src dependent proliferation	F	COc1cc(Nc2c(C#N)cnc3cc(C#Cc4ccc(CN(C)C)cn4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL211417	=	IC50	nM	240.0	CHEMBL267	Homo sapiens	IC50	nM	240.0
	1758173	CHEMBL869798	Inhibition of Src dependent proliferation	F	COc1cc(Nc2c(C#N)cnc3cc(C#Cc4cccc(CN(C)C)n4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL214308	=	IC50	nM	120.0	CHEMBL267	Homo sapiens	IC50	nM	120.0
	1758174	CHEMBL869798	Inhibition of Src dependent proliferation	F	COc1cc(Nc2c(C#N)cnc3cc(C#Cc4ccc(CN5CCN(C)CC5)cn4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL212629	=	IC50	nM	390.0	CHEMBL267	Homo sapiens	IC50	nM	390.0
	1758175	CHEMBL869798	Inhibition of Src dependent proliferation	F	COc1cc(Nc2c(C#N)cnc3cc(C#Cc4cccc(CN5CCN(C)CC5)n4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL211613	=	IC50	nM	120.0	CHEMBL267	Homo sapiens	IC50	nM	120.0
Not Determined	1758176	CHEMBL869798	Inhibition of Src dependent proliferation	F	COc1cc(Nc2c(C#N)cnc3cc(C#Cc4ncccc4CN(C)C)c(OC)cc23)c(Cl)cc1Cl		CHEMBL211399		IC50			CHEMBL267	Homo sapiens	IC50		
	1758177	CHEMBL869798	Inhibition of Src dependent proliferation	F	COc1cc(Nc2c(C#N)cnc3cc(C#Cc4cncc(CN(C)C)c4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL445319	=	IC50	nM	150.0	CHEMBL267	Homo sapiens	IC50	nM	150.0
	1758178	CHEMBL869798	Inhibition of Src dependent proliferation	F	COc1cc(Nc2c(C#N)cnc3cc(C#Cc4cccc(CCN(C)C)n4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL214346	=	IC50	nM	87.0	CHEMBL267	Homo sapiens	IC50	nM	87.0
	1758179	CHEMBL869798	Inhibition of Src dependent proliferation	F	COc1cc(Nc2c(C#N)cnc3cc(C#Cc4cccc(CCN5CCN(C)CC5)n4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL378484	=	IC50	nM	81.0	CHEMBL267	Homo sapiens	IC50	nM	81.0
	1758180	CHEMBL869798	Inhibition of Src dependent proliferation	F	COc1cc(Nc2c(C#N)cnc3cc(C#Cc4ccc(CN(C)C)s4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL213988	=	IC50	nM	390.0	CHEMBL267	Homo sapiens	IC50	nM	390.0
	1758181	CHEMBL869798	Inhibition of Src dependent proliferation	F	COc1cc(Nc2c(C#N)cnc3cc(C#Cc4cccc(CN(C)C)c4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL212818	=	IC50	nM	230.0	CHEMBL267	Homo sapiens	IC50	nM	230.0
	1758182	CHEMBL869798	Inhibition of Src dependent proliferation	F	COc1cc(Nc2c(C#N)cnc3cc(C#Cc4ccc(CN(C)C)cc4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL211079	=	IC50	nM	190.0	CHEMBL267	Homo sapiens	IC50	nM	190.0
	1758183	CHEMBL869798	Inhibition of Src dependent proliferation	F	CCOc1cc2c(Nc3cc(OC)c(Cl)cc3Cl)c(C#N)cnc2cc1C#Cc1cccc(CN(C)C)n1		CHEMBL211647	=	IC50	nM	86.0	CHEMBL267	Homo sapiens	IC50	nM	86.0
	1758184	CHEMBL869798	Inhibition of Src dependent proliferation	F	COc1cc(Nc2c(C#N)cnc3cc(C#Cc4cccc(CN(C)C)n4)ccc23)c(Cl)cc1Cl		CHEMBL379431	=	IC50	nM	470.0	CHEMBL267	Homo sapiens	IC50	nM	470.0
	1758185	CHEMBL869798	Inhibition of Src dependent proliferation	F	COc1cc2c(Nc3cc(OC)c(OC)c(OC)c3)c(C#N)cnc2cc1C#Cc1cccc(CN(C)C)n1		CHEMBL211191	=	IC50	nM	350.0	CHEMBL267	Homo sapiens	IC50	nM	350.0
	1758186	CHEMBL869798	Inhibition of Src dependent proliferation	F	COc1cc(Nc2c(C#N)cnc3cc(C#Cc4cccc(CN(C)C)n4)ccc23)cc(OC)c1OC		CHEMBL208861	=	IC50	nM	2200.0	CHEMBL267	Homo sapiens	IC50	nM	2200.0
	1758188	CHEMBL869797	Inhibition of human recombinant Src	B	COc1cc(Nc2c(C#N)cnc3cc(C#Cc4cc(CN(C)C)ccn4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL214035	=	IC50	nM	18.0	CHEMBL267	Homo sapiens	IC50	nM	18.0
	1758189	CHEMBL869797	Inhibition of human recombinant Src	B	COc1cc(Nc2c(C#N)cnc3cc(C#Cc4ccc(CN(C)C)cn4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL211417	=	IC50	nM	4.9	CHEMBL267	Homo sapiens	IC50	nM	4.9
	1758190	CHEMBL869797	Inhibition of human recombinant Src	B	COc1cc(Nc2c(C#N)cnc3cc(C#Cc4cccc(CN(C)C)n4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL214308	=	IC50	nM	4.5	CHEMBL267	Homo sapiens	IC50	nM	4.5
	1758191	CHEMBL869797	Inhibition of human recombinant Src	B	COc1cc(Nc2c(C#N)cnc3cc(C#Cc4ccc(CN5CCN(C)CC5)cn4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL212629	=	IC50	nM	9.0	CHEMBL267	Homo sapiens	IC50	nM	9.0
	1758192	CHEMBL869797	Inhibition of human recombinant Src	B	COc1cc(Nc2c(C#N)cnc3cc(C#Cc4cccc(CN5CCN(C)CC5)n4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL211613	=	IC50	nM	4.2	CHEMBL267	Homo sapiens	IC50	nM	4.2
	1758193	CHEMBL869797	Inhibition of human recombinant Src	B	COc1cc(Nc2c(C#N)cnc3cc(C#Cc4ncccc4CN(C)C)c(OC)cc23)c(Cl)cc1Cl		CHEMBL211399	=	IC50	nM	2700.0	CHEMBL267	Homo sapiens	IC50	nM	2700.0
	1758194	CHEMBL869797	Inhibition of human recombinant Src	B	COc1cc(Nc2c(C#N)cnc3cc(C#Cc4cncc(CN(C)C)c4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL445319	=	IC50	nM	3.6	CHEMBL267	Homo sapiens	IC50	nM	3.6
	1758195	CHEMBL869797	Inhibition of human recombinant Src	B	COc1cc(Nc2c(C#N)cnc3cc(C#Cc4cccc(CCN(C)C)n4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL214346	=	IC50	nM	5.3	CHEMBL267	Homo sapiens	IC50	nM	5.3
	1758196	CHEMBL869797	Inhibition of human recombinant Src	B	COc1cc(Nc2c(C#N)cnc3cc(C#Cc4cccc(CCN5CCN(C)CC5)n4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL378484	=	IC50	nM	4.3	CHEMBL267	Homo sapiens	IC50	nM	4.3
	1758197	CHEMBL869797	Inhibition of human recombinant Src	B	COc1cc(Nc2c(C#N)cnc3cc(C#Cc4ccc(CN(C)C)s4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL213988	=	IC50	nM	15.0	CHEMBL267	Homo sapiens	IC50	nM	15.0
	1758198	CHEMBL869797	Inhibition of human recombinant Src	B	COc1cc(Nc2c(C#N)cnc3cc(C#Cc4cccc(CN(C)C)c4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL212818	=	IC50	nM	9.9	CHEMBL267	Homo sapiens	IC50	nM	9.9
	1758199	CHEMBL869797	Inhibition of human recombinant Src	B	COc1cc(Nc2c(C#N)cnc3cc(C#Cc4ccc(CN(C)C)cc4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL211079	=	IC50	nM	5.3	CHEMBL267	Homo sapiens	IC50	nM	5.3
	1758200	CHEMBL869797	Inhibition of human recombinant Src	B	CCOc1cc2c(Nc3cc(OC)c(Cl)cc3Cl)c(C#N)cnc2cc1C#Cc1cccc(CN(C)C)n1		CHEMBL211647	=	IC50	nM	3.6	CHEMBL267	Homo sapiens	IC50	nM	3.6
	1758201	CHEMBL869797	Inhibition of human recombinant Src	B	COc1cc(Nc2c(C#N)cnc3cc(C#Cc4cccc(CN(C)C)n4)ccc23)c(Cl)cc1Cl		CHEMBL379431	=	IC50	nM	22.0	CHEMBL267	Homo sapiens	IC50	nM	22.0
	1758202	CHEMBL869797	Inhibition of human recombinant Src	B	COc1cc2c(Nc3cc(OC)c(OC)c(OC)c3)c(C#N)cnc2cc1C#Cc1cccc(CN(C)C)n1		CHEMBL211191	=	IC50	nM	29.0	CHEMBL267	Homo sapiens	IC50	nM	29.0
	1758203	CHEMBL869797	Inhibition of human recombinant Src	B	COc1cc(Nc2c(C#N)cnc3cc(C#Cc4cccc(CN(C)C)n4)ccc23)cc(OC)c1OC		CHEMBL208861	=	IC50	nM	120.0	CHEMBL267	Homo sapiens	IC50	nM	120.0
	1758734	CHEMBL870978	Inhibition of Src	B	Cc1cccc(C)c1OC(=O)N(c1ccccc1)c1ccnc(Nc2ccc(N3CCN(C)CC3)cc2)n1		CHEMBL427047	=	IC50	nM	10.0	CHEMBL267	Homo sapiens	IC50	uM	0.01
	1765456	CHEMBL871537	Inhibition of Src by HTRF kinase assay	B	CNc1ncc2cc(-c3cc(C(=O)Nc4cc(C(F)(F)F)ccc4OC4CCN(C)CC4)ccc3C)ccc2n1		CHEMBL386661	=	IC50	nM	17.0	CHEMBL267	Homo sapiens	IC50	uM	0.017
	1765492	CHEMBL871537	Inhibition of Src by HTRF kinase assay	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2nc(NCCN3CCOCC3)ncc2c1		CHEMBL215943	=	IC50	nM	2.0	CHEMBL267	Homo sapiens	IC50	uM	0.002
	1777545	CHEMBL908847	Inhibition of SRC	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Ki	nM	5000.0	CHEMBL267	Homo sapiens	Ki	uM	5.0
	1777617	CHEMBL855513	Inhibition of human c-Src in NIH3T3 cells	B	COc1ccc(Cl)c(Nc2ncnc3cccc(OC4CCN(C)CC4)c23)c1		CHEMBL386584	=	IC50	nM	300.0	CHEMBL267	Homo sapiens	IC50	uM	0.3
	1778586	CHEMBL910556	Inhibition of Src in presence of ATP	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	IC50	nM	0.5	CHEMBL267	Homo sapiens	IC50	nM	0.5
	1778587	CHEMBL910556	Inhibition of Src in presence of ATP	B	Cc1cc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)nc(C)n1		CHEMBL364623	<	IC50	nM	2.0	CHEMBL267	Homo sapiens	IC50	nM	2.0
	1779144	CHEMBL855513	Inhibition of human c-Src in NIH3T3 cells	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCCO5)ncnc3c2)CC1		CHEMBL214894	=	IC50	nM	65.0	CHEMBL267	Homo sapiens	IC50	uM	0.065
	1779145	CHEMBL855513	Inhibition of human c-Src in NIH3T3 cells	B	Clc1ccc2c(c1Nc1ncnc3cc(OCCN4CCCC4)cc(OC4CCOCC4)c13)OCCO2		CHEMBL215087	=	IC50	nM	110.0	CHEMBL267	Homo sapiens	IC50	uM	0.11
	1779146	CHEMBL855513	Inhibition of human c-Src in NIH3T3 cells	B	COc1ccc(Cl)c(Nc2ncnc3ccc(OCCCN4CCN(C)CC4)c(OC4CCOCC4)c23)c1		CHEMBL426148	=	IC50	nM	600.0	CHEMBL267	Homo sapiens	IC50	uM	0.6
	1779147	CHEMBL855513	Inhibition of human c-Src in NIH3T3 cells	B	COc1ccc(Cl)c(Nc2ncnc3cc(OC)cc(OC)c23)c1		CHEMBL217088	=	IC50	nM	3700.0	CHEMBL267	Homo sapiens	IC50	uM	3.7
	1779148	CHEMBL855513	Inhibition of human c-Src in NIH3T3 cells	B	COc1ccc(Cl)c(Nc2ncnc3ccc(OC)c(OC4CCN(C)CC4)c23)c1		CHEMBL217977	=	IC50	nM	540.0	CHEMBL267	Homo sapiens	IC50	uM	0.54
	1779149	CHEMBL855513	Inhibition of human c-Src in NIH3T3 cells	B	COc1cc2c(Nc3c(Cl)ccc4c3OCO4)ncnc2cc1OCCCN1CCCC1		CHEMBL385723	=	IC50	nM	5.0	CHEMBL267	Homo sapiens	IC50	uM	0.005
	1779150	CHEMBL855513	Inhibition of human c-Src in NIH3T3 cells	B	COc1cc(OCCCN2CCCC2)cc2ncnc(Nc3c(Cl)ccc4c3OCO4)c12		CHEMBL216369	=	IC50	nM	15.0	CHEMBL267	Homo sapiens	IC50	uM	0.015
	1779151	CHEMBL855513	Inhibition of human c-Src in NIH3T3 cells	B	COc1ccc(Cl)c(Nc2ncnc3cc(OCC4CCN(C)CC4)c(OC)cc23)c1		CHEMBL426161	=	IC50	nM	10.0	CHEMBL267	Homo sapiens	IC50	uM	0.01
	1779152	CHEMBL855513	Inhibition of human c-Src in NIH3T3 cells	B	COc1cc2c(Nc3c(Cl)ccc4c3OCO4)ncnc2cc1OCC1CCN(C)CC1		CHEMBL170984	=	IC50	nM	5.0	CHEMBL267	Homo sapiens	IC50	uM	0.005
	1779153	CHEMBL855513	Inhibition of human c-Src in NIH3T3 cells	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	=	IC50	nM	2.7	CHEMBL267	Homo sapiens	IC50	uM	0.0027
	1779154	CHEMBL855513	Inhibition of human c-Src in NIH3T3 cells	B	CC(=O)N1CCN(CCOc2cc(OC(C)C)c3c(Nc4c(F)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL386996	=	IC50	nM	20.0	CHEMBL267	Homo sapiens	IC50	uM	0.02
	1779155	CHEMBL855513	Inhibition of human c-Src in NIH3T3 cells	B	CC(C)Oc1cc(OCCN2CCOCC2)cc2ncnc(Nc3c(Cl)ccc4c3OCO4)c12		CHEMBL436968	=	IC50	nM	5.0	CHEMBL267	Homo sapiens	IC50	uM	0.005
	1779156	CHEMBL855513	Inhibition of human c-Src in NIH3T3 cells	B	CC(C)Oc1cc(OCCCN2CCCC2)cc2ncnc(Nc3c(Cl)ccc4c3OCO4)c12		CHEMBL214376	<	IC50	nM	4.0	CHEMBL267	Homo sapiens	IC50	uM	0.004
	1779157	CHEMBL855513	Inhibition of human c-Src in NIH3T3 cells	B	CC(C)COc1cc(OC2CCN(C)CC2)c2c(Nc3c(Cl)ccc4c3OCO4)ncnc2c1		CHEMBL213762	=	IC50	nM	7.0	CHEMBL267	Homo sapiens	IC50	uM	0.007
	1779158	CHEMBL855513	Inhibition of human c-Src in NIH3T3 cells	B	CN1CCC(Oc2cc(OCCF)cc3ncnc(Nc4c(Cl)ccc5c4OCO5)c23)CC1		CHEMBL217464	=	IC50	nM	4.0	CHEMBL267	Homo sapiens	IC50	uM	0.004
	1779159	CHEMBL855513	Inhibition of human c-Src in NIH3T3 cells	B	CC(C)Oc1cc(OC2CCN(C)CC2)c2c(Nc3c(Cl)ccc4c3OCO4)ncnc2c1		CHEMBL263947	=	IC50	nM	100.0	CHEMBL267	Homo sapiens	IC50	uM	0.1
	1779160	CHEMBL855513	Inhibition of human c-Src in NIH3T3 cells	B	CN1CCC(COc2cccc3ncnc(Nc4c(Cl)ccc5c4OCO5)c23)CC1		CHEMBL439182	=	IC50	nM	500.0	CHEMBL267	Homo sapiens	IC50	uM	0.5
	1779161	CHEMBL855513	Inhibition of human c-Src in NIH3T3 cells	B	CN1CCN(CCCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL216693	<	IC50	nM	4.0	CHEMBL267	Homo sapiens	IC50	uM	0.004
	1779162	CHEMBL855513	Inhibition of human c-Src in NIH3T3 cells	B	COc1cc(Oc2ccncc2)c2c(Nc3c(Cl)ccc4c3OCO4)ncnc2c1		CHEMBL217091	=	IC50	nM	9.5	CHEMBL267	Homo sapiens	IC50	uM	0.0095
	1779163	CHEMBL855513	Inhibition of human c-Src in NIH3T3 cells	B	Clc1ccc2c(c1Nc1ncnc3cccc(Oc4ccncc4)c13)OCO2		CHEMBL215682	=	IC50	nM	55.0	CHEMBL267	Homo sapiens	IC50	uM	0.055
	1779164	CHEMBL855513	Inhibition of human c-Src in NIH3T3 cells	B	COc1ccc(Cl)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL216586	=	IC50	nM	250.0	CHEMBL267	Homo sapiens	IC50	uM	0.25
	1779165	CHEMBL855513	Inhibition of human c-Src in NIH3T3 cells	B	COc1ccc(Cl)c(Nc2ncnc3cc(OCCCN4CCN(C)CC4)cc(OC4CCOCC4)c23)c1		CHEMBL262371	<	IC50	nM	4.0	CHEMBL267	Homo sapiens	IC50	uM	0.004
	1779166	CHEMBL855513	Inhibition of human c-Src in NIH3T3 cells	B	Clc1ccc2c(c1Nc1ncnc3cc(OCCN4CCCC4)cc(N4CCOCC4)c13)OCO2		CHEMBL387093	=	IC50	nM	75.0	CHEMBL267	Homo sapiens	IC50	uM	0.075
	1779167	CHEMBL855513	Inhibition of human c-Src in NIH3T3 cells	B	Clc1ccc2c(c1Nc1ncnc3cc(OCCc4ccncc4)cc(OC4CCOCC4)c13)OCO2		CHEMBL217463	=	IC50	nM	3.0	CHEMBL267	Homo sapiens	IC50	uM	0.003
	1779168	CHEMBL855513	Inhibition of human c-Src in NIH3T3 cells	B	CN1CCC(COc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL216105	=	IC50	nM	6.0	CHEMBL267	Homo sapiens	IC50	uM	0.006
	1779169	CHEMBL855513	Inhibition of human c-Src in NIH3T3 cells	B	c1cc(Nc2ncnc3cc(OCCN4CCCC4)cc(OC4CCOCC4)c23)c2c(c1)OCCO2		CHEMBL266188	=	IC50	nM	85.0	CHEMBL267	Homo sapiens	IC50	uM	0.085
	1779170	CHEMBL855513	Inhibition of human c-Src in NIH3T3 cells	B	Clc1ccc2c(c1Nc1ncnc3cc(OCCN4CCCC4)cc(OC4CCOCC4)c13)OCO2		CHEMBL385563	=	IC50	nM	6.0	CHEMBL267	Homo sapiens	IC50	uM	0.006
	1779171	CHEMBL855513	Inhibition of human c-Src in NIH3T3 cells	B	Clc1ccc2c(c1Nc1ncnc3cc(OCCCN4CCCC4)cc(OC4CCOCC4)c13)OCO2		CHEMBL217090	<	IC50	nM	4.0	CHEMBL267	Homo sapiens	IC50	uM	0.004
	1779172	CHEMBL855513	Inhibition of human c-Src in NIH3T3 cells	B	c1cc(Nc2ncnc3cc(OCCN4CCCC4)cc(OC4CCOCC4)c23)c2c(c1)OCO2		CHEMBL385958	=	IC50	nM	80.0	CHEMBL267	Homo sapiens	IC50	uM	0.08
	1779173	CHEMBL855513	Inhibition of human c-Src in NIH3T3 cells	B	COc1cc(OC2CCN(C)CC2)c2c(Nc3cccc4c3OCCO4)ncnc2c1		CHEMBL262721	=	IC50	nM	570.0	CHEMBL267	Homo sapiens	IC50	uM	0.57
	1779174	CHEMBL855513	Inhibition of human c-Src in NIH3T3 cells	B	COc1cc(OC2CCN(C)CC2)c2c(Nc3cccc4c3OCO4)ncnc2c1		CHEMBL384260	=	IC50	nM	150.0	CHEMBL267	Homo sapiens	IC50	uM	0.15
	1779175	CHEMBL855513	Inhibition of human c-Src in NIH3T3 cells	B	c1cc(Nc2ncnc3cc(OCCCN4CCCC4)cc(OC4CCOCC4)c23)c2c(c1)OCO2		CHEMBL214893	=	IC50	nM	40.0	CHEMBL267	Homo sapiens	IC50	uM	0.04
	1779176	CHEMBL855513	Inhibition of human c-Src in NIH3T3 cells	B	COc1ccc(Cl)c(Nc2ncnc3cc(OCCCN4CCOCC4)cc(OC(C)C)c23)c1		CHEMBL381206	=	IC50	nM	40.0	CHEMBL267	Homo sapiens	IC50	uM	0.04
	1779177	CHEMBL855513	Inhibition of human c-Src in NIH3T3 cells	B	COc1ccc(Cl)c(Nc2ncnc3cc(OCCCN4CCOCC4)cc(OC4CCOC4)c23)c1		CHEMBL216703	<	IC50	nM	4.0	CHEMBL267	Homo sapiens	IC50	uM	0.004
	1779178	CHEMBL855513	Inhibition of human c-Src in NIH3T3 cells	B	COc1ccc(Cl)c(Nc2ncnc3cc(OCCCN4CCOCC4)cc(OC4CCCCC4)c23)c1		CHEMBL217493	=	IC50	nM	20.0	CHEMBL267	Homo sapiens	IC50	uM	0.02
	1779179	CHEMBL855513	Inhibition of human c-Src in NIH3T3 cells	B	COc1ccc(Cl)c(Nc2ncnc3cc(OCCCN4CCOCC4)cc(OC4CCOCC4)c23)c1		CHEMBL200217	=	IC50	nM	20.0	CHEMBL267	Homo sapiens	IC50	uM	0.02
	1779180	CHEMBL855513	Inhibition of human c-Src in NIH3T3 cells	B	COc1cc(OC2CCN(C)CC2)c2c(Nc3c(Cl)ccc4c3OCO4)ncnc2c1		CHEMBL214665	=	IC50	nM	10.0	CHEMBL267	Homo sapiens	IC50	uM	0.01
	1779181	CHEMBL855513	Inhibition of human c-Src in NIH3T3 cells	B	COc1ccc(Cl)c(Nc2ncnc3cc(OC)cc(OC4CCN(C)CC4)c23)c1		CHEMBL385240	=	IC50	nM	30.0	CHEMBL267	Homo sapiens	IC50	uM	0.03
	1779182	CHEMBL855513	Inhibition of human c-Src in NIH3T3 cells	B	COc1ccc(Cl)c(Nc2ncnc3cc(OC)cc(OCCCN4CCOCC4)c23)c1		CHEMBL275513	=	IC50	nM	230.0	CHEMBL267	Homo sapiens	IC50	uM	0.23
	1779183	CHEMBL855513	Inhibition of human c-Src in NIH3T3 cells	B	CN1CCC(Oc2cccc3ncnc(Nc4c(Cl)ccc5c4OCO5)c23)CC1		CHEMBL384031	=	IC50	nM	100.0	CHEMBL267	Homo sapiens	IC50	uM	0.1
	1779184	CHEMBL855513	Inhibition of human c-Src in NIH3T3 cells	B	COc1ccc(Cl)c(Nc2ncnc3cccc(OC4CCOCC4)c23)c1		CHEMBL385533	=	IC50	nM	400.0	CHEMBL267	Homo sapiens	IC50	uM	0.4
Not Determined	1779219	CHEMBL855536	Antiproliferative activity against mouse NIH3T3 cell line transfected with c-SRC	F	COc1ccc(Cl)c(Nc2ncnc3cccc(OC4CCN(C)CC4)c23)c1		CHEMBL386584		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	1779220	CHEMBL855536	Antiproliferative activity against mouse NIH3T3 cell line transfected with c-SRC	F	COc1ccc(Cl)c(Nc2ncnc3cc(OC)cc(OCCCN4CCOCC4)c23)c1		CHEMBL275513		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	1779221	CHEMBL855536	Antiproliferative activity against mouse NIH3T3 cell line transfected with c-SRC	F	COc1ccc(Cl)c(Nc2ncnc3cccc(OC4CCOCC4)c23)c1		CHEMBL385533		IC50			CHEMBL267	Homo sapiens	IC50		
	1779222	CHEMBL855536	Antiproliferative activity against mouse NIH3T3 cell line transfected with c-SRC	F	CN1CCC(Oc2cccc3ncnc(Nc4c(Cl)ccc5c4OCO5)c23)CC1		CHEMBL384031	=	IC50	nM	1000.0	CHEMBL267	Homo sapiens	IC50	uM	1.0
	1779223	CHEMBL855536	Antiproliferative activity against mouse NIH3T3 cell line transfected with c-SRC	F	COc1ccc(Cl)c(Nc2ncnc3ccc(OCCCN4CCN(C)CC4)c(OC4CCOCC4)c23)c1		CHEMBL426148	=	IC50	nM	3900.0	CHEMBL267	Homo sapiens	IC50	uM	3.9
	1779224	CHEMBL855536	Antiproliferative activity against mouse NIH3T3 cell line transfected with c-SRC	F	COc1ccc(Cl)c(Nc2ncnc3ccc(OC)c(OC4CCN(C)CC4)c23)c1		CHEMBL217977	=	IC50	nM	3000.0	CHEMBL267	Homo sapiens	IC50	uM	3.0
	1779225	CHEMBL855536	Antiproliferative activity against mouse NIH3T3 cell line transfected with c-SRC	F	COc1ccc(Cl)c(Nc2ncnc3cc(OCC4CCN(C)CC4)c(OC)cc23)c1		CHEMBL426161	=	IC50	nM	530.0	CHEMBL267	Homo sapiens	IC50	uM	0.53
	1779226	CHEMBL855536	Antiproliferative activity against mouse NIH3T3 cell line transfected with c-SRC	F	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	=	IC50	nM	76.0	CHEMBL267	Homo sapiens	IC50	uM	0.076
	1779227	CHEMBL855536	Antiproliferative activity against mouse NIH3T3 cell line transfected with c-SRC	F	CC(=O)N1CCN(CCOc2cc(OC(C)C)c3c(Nc4c(F)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL386996	=	IC50	nM	200.0	CHEMBL267	Homo sapiens	IC50	uM	0.2
	1779228	CHEMBL855536	Antiproliferative activity against mouse NIH3T3 cell line transfected with c-SRC	F	CC(C)Oc1cc(OCCN2CCOCC2)cc2ncnc(Nc3c(Cl)ccc4c3OCO4)c12		CHEMBL436968	=	IC50	nM	50.0	CHEMBL267	Homo sapiens	IC50	uM	0.05
	1779229	CHEMBL855536	Antiproliferative activity against mouse NIH3T3 cell line transfected with c-SRC	F	CC(C)Oc1cc(OCCCN2CCCC2)cc2ncnc(Nc3c(Cl)ccc4c3OCO4)c12		CHEMBL214376	=	IC50	nM	50.0	CHEMBL267	Homo sapiens	IC50	uM	0.05
	1779230	CHEMBL855536	Antiproliferative activity against mouse NIH3T3 cell line transfected with c-SRC	F	CC(C)COc1cc(OC2CCN(C)CC2)c2c(Nc3c(Cl)ccc4c3OCO4)ncnc2c1		CHEMBL213762	=	IC50	nM	100.0	CHEMBL267	Homo sapiens	IC50	uM	0.1
	1779231	CHEMBL855536	Antiproliferative activity against mouse NIH3T3 cell line transfected with c-SRC	F	CN1CCC(Oc2cc(OCCF)cc3ncnc(Nc4c(Cl)ccc5c4OCO5)c23)CC1		CHEMBL217464	=	IC50	nM	70.0	CHEMBL267	Homo sapiens	IC50	uM	0.07
	1779232	CHEMBL855536	Antiproliferative activity against mouse NIH3T3 cell line transfected with c-SRC	F	CN1CCN(CCCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL216693	=	IC50	nM	50.0	CHEMBL267	Homo sapiens	IC50	uM	0.05
	1779233	CHEMBL855536	Antiproliferative activity against mouse NIH3T3 cell line transfected with c-SRC	F	COc1cc(Oc2ccncc2)c2c(Nc3c(Cl)ccc4c3OCO4)ncnc2c1		CHEMBL217091	=	IC50	nM	150.0	CHEMBL267	Homo sapiens	IC50	uM	0.15
	1779234	CHEMBL855536	Antiproliferative activity against mouse NIH3T3 cell line transfected with c-SRC	F	Clc1ccc2c(c1Nc1ncnc3cccc(Oc4ccncc4)c13)OCO2		CHEMBL215682	=	IC50	nM	600.0	CHEMBL267	Homo sapiens	IC50	uM	0.6
	1779235	CHEMBL855536	Antiproliferative activity against mouse NIH3T3 cell line transfected with c-SRC	F	COc1ccc(Cl)c(Nc2ncnc3cc(OCCCN4CCN(C)CC4)cc(OC4CCOCC4)c23)c1		CHEMBL262371	=	IC50	nM	220.0	CHEMBL267	Homo sapiens	IC50	uM	0.22
	1779236	CHEMBL855536	Antiproliferative activity against mouse NIH3T3 cell line transfected with c-SRC	F	Clc1ccc2c(c1Nc1ncnc3cc(OCCN4CCCC4)cc(N4CCOCC4)c13)OCO2		CHEMBL387093	=	IC50	nM	630.0	CHEMBL267	Homo sapiens	IC50	uM	0.63
	1779237	CHEMBL855536	Antiproliferative activity against mouse NIH3T3 cell line transfected with c-SRC	F	Clc1ccc2c(c1Nc1ncnc3cc(OCCc4ccncc4)cc(OC4CCOCC4)c13)OCO2		CHEMBL217463	=	IC50	nM	40.0	CHEMBL267	Homo sapiens	IC50	uM	0.04
	1779238	CHEMBL855536	Antiproliferative activity against mouse NIH3T3 cell line transfected with c-SRC	F	CN1CCC(COc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL216105	=	IC50	nM	80.0	CHEMBL267	Homo sapiens	IC50	uM	0.08
	1779239	CHEMBL855536	Antiproliferative activity against mouse NIH3T3 cell line transfected with c-SRC	F	c1cc(Nc2ncnc3cc(OCCN4CCCC4)cc(OC4CCOCC4)c23)c2c(c1)OCCO2		CHEMBL266188	=	IC50	nM	1100.0	CHEMBL267	Homo sapiens	IC50	uM	1.1
	1779240	CHEMBL855536	Antiproliferative activity against mouse NIH3T3 cell line transfected with c-SRC	F	Clc1ccc2c(c1Nc1ncnc3cc(OCCN4CCCC4)cc(OC4CCOCC4)c13)OCO2		CHEMBL385563	=	IC50	nM	150.0	CHEMBL267	Homo sapiens	IC50	uM	0.15
	1779241	CHEMBL855536	Antiproliferative activity against mouse NIH3T3 cell line transfected with c-SRC	F	Clc1ccc2c(c1Nc1ncnc3cc(OCCCN4CCCC4)cc(OC4CCOCC4)c13)OCO2		CHEMBL217090	=	IC50	nM	65.0	CHEMBL267	Homo sapiens	IC50	uM	0.065
	1779242	CHEMBL855536	Antiproliferative activity against mouse NIH3T3 cell line transfected with c-SRC	F	c1cc(Nc2ncnc3cc(OCCN4CCCC4)cc(OC4CCOCC4)c23)c2c(c1)OCO2		CHEMBL385958	=	IC50	nM	800.0	CHEMBL267	Homo sapiens	IC50	uM	0.8
	1779243	CHEMBL855536	Antiproliferative activity against mouse NIH3T3 cell line transfected with c-SRC	F	COc1cc(OC2CCN(C)CC2)c2c(Nc3cccc4c3OCCO4)ncnc2c1		CHEMBL262721	=	IC50	nM	6400.0	CHEMBL267	Homo sapiens	IC50	uM	6.4
	1779244	CHEMBL855536	Antiproliferative activity against mouse NIH3T3 cell line transfected with c-SRC	F	COc1cc(OC2CCN(C)CC2)c2c(Nc3cccc4c3OCO4)ncnc2c1		CHEMBL384260	=	IC50	nM	4500.0	CHEMBL267	Homo sapiens	IC50	uM	4.5
	1779245	CHEMBL855536	Antiproliferative activity against mouse NIH3T3 cell line transfected with c-SRC	F	c1cc(Nc2ncnc3cc(OCCCN4CCCC4)cc(OC4CCOCC4)c23)c2c(c1)OCO2		CHEMBL214893	=	IC50	nM	300.0	CHEMBL267	Homo sapiens	IC50	uM	0.3
	1779246	CHEMBL855536	Antiproliferative activity against mouse NIH3T3 cell line transfected with c-SRC	F	COc1ccc(Cl)c(Nc2ncnc3cc(OCCCN4CCOCC4)cc(OC(C)C)c23)c1		CHEMBL381206	=	IC50	nM	180.0	CHEMBL267	Homo sapiens	IC50	uM	0.18
	1779247	CHEMBL855536	Antiproliferative activity against mouse NIH3T3 cell line transfected with c-SRC	F	COc1ccc(Cl)c(Nc2ncnc3cc(OCCCN4CCOCC4)cc(OC4CCOC4)c23)c1		CHEMBL216703	=	IC50	nM	100.0	CHEMBL267	Homo sapiens	IC50	uM	0.1
	1779248	CHEMBL855536	Antiproliferative activity against mouse NIH3T3 cell line transfected with c-SRC	F	COc1ccc(Cl)c(Nc2ncnc3cc(OCCCN4CCOCC4)cc(OC4CCCCC4)c23)c1		CHEMBL217493	=	IC50	nM	750.0	CHEMBL267	Homo sapiens	IC50	uM	0.75
	1779249	CHEMBL855536	Antiproliferative activity against mouse NIH3T3 cell line transfected with c-SRC	F	COc1ccc(Cl)c(Nc2ncnc3cc(OCCCN4CCOCC4)cc(OC4CCOCC4)c23)c1		CHEMBL200217	=	IC50	nM	200.0	CHEMBL267	Homo sapiens	IC50	uM	0.2
	1779250	CHEMBL855536	Antiproliferative activity against mouse NIH3T3 cell line transfected with c-SRC	F	COc1cc(OC2CCN(C)CC2)c2c(Nc3c(Cl)ccc4c3OCO4)ncnc2c1		CHEMBL214665	=	IC50	nM	150.0	CHEMBL267	Homo sapiens	IC50	uM	0.15
	1779251	CHEMBL855536	Antiproliferative activity against mouse NIH3T3 cell line transfected with c-SRC	F	COc1ccc(Cl)c(Nc2ncnc3cc(OC)cc(OC4CCN(C)CC4)c23)c1		CHEMBL385240	=	IC50	nM	500.0	CHEMBL267	Homo sapiens	IC50	uM	0.5
Not Determined	1779252	CHEMBL855536	Antiproliferative activity against mouse NIH3T3 cell line transfected with c-SRC	F	CC(C)Oc1cc(OC2CCN(C)CC2)c2c(Nc3c(Cl)ccc4c3OCO4)ncnc2c1		CHEMBL263947		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	1779253	CHEMBL855536	Antiproliferative activity against mouse NIH3T3 cell line transfected with c-SRC	F	CN1CCC(COc2cccc3ncnc(Nc4c(Cl)ccc5c4OCO5)c23)CC1		CHEMBL439182		IC50			CHEMBL267	Homo sapiens	IC50		
	1790007	CHEMBL853554	Percentage activity of human cSRC in the presence of 10 uM of compound and 10 uM of ATP in comparison with control	B	O=C(NCc1ccc(S(=O)(=O)N2CCC(n3nnc4ccccc43)CC2)s1)c1ccc(Cl)cc1		CHEMBL383955	=	Activity	%	67.0	CHEMBL267	Homo sapiens	Activity	%	67.0
	1790305	CHEMBL873751	Inhibition of c-src	B	CN1CCN(c2ccc(Nc3ncc4ccn(C5CCCCC5)c4n3)cc2)CC1		CHEMBL214329	=	IC50	nM	710.0	CHEMBL267	Homo sapiens	IC50	uM	0.71
	1790326	CHEMBL873766	Percent residual activity, relative to control, of Src at 1 uM concentration of inhibitor in presence of 50 uM ATP	B	N=C(N)NCCC[C@@H](NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)NC(=O)CCCCCNCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL413460	=	Activity	%	88.0	CHEMBL267	Homo sapiens	Activity	%	88.0
	1790380	CHEMBL873766	Percent residual activity, relative to control, of Src at 1 uM concentration of inhibitor in presence of 50 uM ATP	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(N)=O		CHEMBL279185	=	Activity	%	84.0	CHEMBL267	Homo sapiens	Activity	%	84.0
	1790435	CHEMBL912723	Inhibition of human SRC	B	COc1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL201511	=	IC50	nM	20000.0	CHEMBL267	Homo sapiens	IC50	M	0.00002
	1790558	CHEMBL856416	Inhibition of human recombinant SRC	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Ki	nM	10000.0	CHEMBL267	Homo sapiens	Ki	uM	10.0
Active	1794870	CHEMBL856504	Inhibition of SRC kinase at 10 uM	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1		CHEMBL374680		Activity			CHEMBL267	Homo sapiens	Activity		
	1797047	CHEMBL913339	Inhibition of SRC	B	N[C@@H](Cc1ccc(O)cc1)C(=O)NO		CHEMBL217863	=	Ki	nM	18000.0	CHEMBL267	Homo sapiens	Ki	uM	18.0
	1800127	CHEMBL911086	Inhibition of Src	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	IC50	nM	3.8	CHEMBL267	Homo sapiens	IC50	nM	3.8
	1800128	CHEMBL911086	Inhibition of Src	B	COc1cc(Nc2c(C#N)cnc3cc(-c4coc(CN5CCN(c6ccccc6)CC5)c4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL278495	=	IC50	nM	3.6	CHEMBL267	Homo sapiens	IC50	nM	3.6
	1800129	CHEMBL911086	Inhibition of Src	B	COc1cc(Nc2c(C#N)cnc3cc(-c4coc(CN(C)C)c4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL219964	=	IC50	nM	0.75	CHEMBL267	Homo sapiens	IC50	nM	0.75
	1800130	CHEMBL911086	Inhibition of Src	B	COc1cc(Nc2c(C#N)cnc3cc(-c4coc(CN5CCOCC5)c4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL276934	=	IC50	nM	1.5	CHEMBL267	Homo sapiens	IC50	nM	1.5
	1800131	CHEMBL911086	Inhibition of Src	B	COc1cc(Nc2c(C#N)cnc3ccc(-c4coc(CN5CCN(C)CC5)c4)cc23)c(Cl)cc1Cl		CHEMBL220348	=	IC50	nM	84.0	CHEMBL267	Homo sapiens	IC50	nM	84.0
	1800132	CHEMBL911086	Inhibition of Src	B	CN1CCN(Cc2cc(-c3ccc4c(Nc5ccc(Cl)cc5Cl)c(C#N)cnc4c3)co2)CC1		CHEMBL216599	=	IC50	nM	11.0	CHEMBL267	Homo sapiens	IC50	nM	11.0
	1800133	CHEMBL911086	Inhibition of Src	B	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(CN5CCN(C)CC5)o4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL219085	=	IC50	nM	13.0	CHEMBL267	Homo sapiens	IC50	nM	13.0
	1800134	CHEMBL911086	Inhibition of Src	B	COc1cc(Nc2c(C#N)cnc3cc(-c4coc(CN5CCN(C)CC5)c4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL219557	=	IC50	nM	0.78	CHEMBL267	Homo sapiens	IC50	nM	0.78
	1800135	CHEMBL911086	Inhibition of Src	B	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(CN5CCN(C)CC5)o4)ccc23)c(Cl)cc1Cl		CHEMBL415625	=	IC50	nM	7.5	CHEMBL267	Homo sapiens	IC50	nM	7.5
	1800136	CHEMBL911086	Inhibition of Src	B	COc1cc(Nc2c(C#N)cnc3cc(-c4coc(CN5CCN(C)CC5)c4)ccc23)c(Cl)cc1Cl		CHEMBL219260	=	IC50	nM	2.7	CHEMBL267	Homo sapiens	IC50	nM	2.7
	1800137	CHEMBL911086	Inhibition of Src	B	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(CN5CCN(C)CC5)cc4)ccc23)c(Cl)cc1Cl		CHEMBL317821	=	IC50	nM	5.0	CHEMBL267	Homo sapiens	IC50	nM	5.0
	1800138	CHEMBL911086	Inhibition of Src	B	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(CN5CCN(C)CC5)s4)ccc23)c(Cl)cc1Cl		CHEMBL219014	=	IC50	nM	2.3	CHEMBL267	Homo sapiens	IC50	nM	2.3
	1800139	CHEMBL911086	Inhibition of Src	B	COc1cc(Nc2c(C#N)cnc3cc(-c4csc(CN5CCN(C)CC5)c4)ccc23)c(Cl)cc1Cl		CHEMBL303786	=	IC50	nM	3.8	CHEMBL267	Homo sapiens	IC50	nM	3.8
	1800150	CHEMBL910456	Antiproliferative activity against Src-transformed rat2 fibroblast cells	F	COc1cc(Nc2c(C#N)cnc3cc(-c4coc(CN5CCN(C)CC5)c4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL219557	=	IC50	nM	15.0	CHEMBL267	Homo sapiens	IC50	nM	15.0
	1800159	CHEMBL910456	Antiproliferative activity against Src-transformed rat2 fibroblast cells	F	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	IC50	nM	100.0	CHEMBL267	Homo sapiens	IC50	nM	100.0
	1800160	CHEMBL910456	Antiproliferative activity against Src-transformed rat2 fibroblast cells	F	COc1cc(Nc2c(C#N)cnc3cc(-c4coc(CN5CCN(c6ccccc6)CC5)c4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL278495	=	IC50	nM	34.0	CHEMBL267	Homo sapiens	IC50	nM	34.0
	1800161	CHEMBL910456	Antiproliferative activity against Src-transformed rat2 fibroblast cells	F	COc1cc(Nc2c(C#N)cnc3cc(-c4coc(CN(C)C)c4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL219964	=	IC50	nM	21.0	CHEMBL267	Homo sapiens	IC50	nM	21.0
	1800162	CHEMBL910456	Antiproliferative activity against Src-transformed rat2 fibroblast cells	F	COc1cc(Nc2c(C#N)cnc3cc(-c4coc(CN5CCOCC5)c4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL276934	=	IC50	nM	31.0	CHEMBL267	Homo sapiens	IC50	nM	31.0
	1800163	CHEMBL910456	Antiproliferative activity against Src-transformed rat2 fibroblast cells	F	COc1cc(Nc2c(C#N)cnc3ccc(-c4coc(CN5CCN(C)CC5)c4)cc23)c(Cl)cc1Cl		CHEMBL220348	=	IC50	nM	2800.0	CHEMBL267	Homo sapiens	IC50	nM	2800.0
	1800164	CHEMBL910456	Antiproliferative activity against Src-transformed rat2 fibroblast cells	F	CN1CCN(Cc2cc(-c3ccc4c(Nc5ccc(Cl)cc5Cl)c(C#N)cnc4c3)co2)CC1		CHEMBL216599	=	IC50	nM	260.0	CHEMBL267	Homo sapiens	IC50	nM	260.0
	1800165	CHEMBL910456	Antiproliferative activity against Src-transformed rat2 fibroblast cells	F	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(CN5CCN(C)CC5)o4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL219085	=	IC50	nM	550.0	CHEMBL267	Homo sapiens	IC50	nM	550.0
	1800166	CHEMBL910456	Antiproliferative activity against Src-transformed rat2 fibroblast cells	F	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(CN5CCN(C)CC5)o4)ccc23)c(Cl)cc1Cl		CHEMBL415625	=	IC50	nM	120.0	CHEMBL267	Homo sapiens	IC50	nM	120.0
	1800167	CHEMBL910456	Antiproliferative activity against Src-transformed rat2 fibroblast cells	F	COc1cc(Nc2c(C#N)cnc3cc(-c4coc(CN5CCN(C)CC5)c4)ccc23)c(Cl)cc1Cl		CHEMBL219260	=	IC50	nM	46.0	CHEMBL267	Homo sapiens	IC50	nM	46.0
	1800168	CHEMBL910456	Antiproliferative activity against Src-transformed rat2 fibroblast cells	F	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(CN5CCN(C)CC5)cc4)ccc23)c(Cl)cc1Cl		CHEMBL317821	=	IC50	nM	390.0	CHEMBL267	Homo sapiens	IC50	nM	390.0
	1800169	CHEMBL910456	Antiproliferative activity against Src-transformed rat2 fibroblast cells	F	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(CN5CCN(C)CC5)s4)ccc23)c(Cl)cc1Cl		CHEMBL219014	=	IC50	nM	64.0	CHEMBL267	Homo sapiens	IC50	nM	64.0
	1800170	CHEMBL910456	Antiproliferative activity against Src-transformed rat2 fibroblast cells	F	COc1cc(Nc2c(C#N)cnc3cc(-c4csc(CN5CCN(C)CC5)c4)ccc23)c(Cl)cc1Cl		CHEMBL303786	=	IC50	nM	69.0	CHEMBL267	Homo sapiens	IC50	nM	69.0
	1807121	CHEMBL908982	Inhibition of human recombinant Src kinase	B	Cc1cc(-c2c(Cl)cccc2Cl)cc2nnc(N)nc12		CHEMBL218072	=	IC50	nM	3600.0	CHEMBL267	Homo sapiens	IC50	uM	3.6
	1807122	CHEMBL908982	Inhibition of human recombinant Src kinase	B	Nc1nnc2cc(-c3ccccc3)ccc2n1		CHEMBL218411	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	1807123	CHEMBL908982	Inhibition of human recombinant Src kinase	B	CC(=O)Nc1nnc2cc(-c3c(C)cccc3C)cc(C)c2n1		CHEMBL221739	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	1807124	CHEMBL908982	Inhibition of human recombinant Src kinase	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccccn3)nnc2c1		CHEMBL218738	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	1807125	CHEMBL908982	Inhibition of human recombinant Src kinase	B	Cc1ccc(C)c(Nc2nnc3cc(-c4c(C)cccc4C)cc(C)c3n2)c1		CHEMBL374868	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	1807126	CHEMBL908982	Inhibition of human recombinant Src kinase	B	Cc1ccc(Nc2nnc3cc(-c4c(C)cccc4C)cc(C)c3n2)c(C)c1		CHEMBL441545	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	1807127	CHEMBL908982	Inhibition of human recombinant Src kinase	B	Cc1cccc(Nc2nnc3cc(-c4c(C)cccc4C)cc(C)c3n2)c1C		CHEMBL218551	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	1807128	CHEMBL908982	Inhibition of human recombinant Src kinase	B	COc1ccccc1Nc1nnc2cc(-c3c(C)cccc3C)cc(C)c2n1		CHEMBL376860	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	1807129	CHEMBL908982	Inhibition of human recombinant Src kinase	B	CCCCc1ccc(Nc2nnc3cc(-c4c(C)cccc4C)cc(C)c3n2)cc1		CHEMBL218842	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	1807130	CHEMBL908982	Inhibition of human recombinant Src kinase	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3cccc4cccnc34)nnc2c1		CHEMBL218160	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	1807131	CHEMBL908982	Inhibition of human recombinant Src kinase	B	Cc1cc(C)c(-c2cc(C)c3nc(Nc4ccccc4)nnc3c2)c(C)c1		CHEMBL218109	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	1807132	CHEMBL908982	Inhibition of human recombinant Src kinase	B	Cc1cc(-c2ccccc2Cl)cc2nnc(N)nc12		CHEMBL376052	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	1807133	CHEMBL908982	Inhibition of human recombinant Src kinase	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(S(=O)(=O)N4CCNCC4)cc3)nnc2c1		CHEMBL218281	=	IC50	nM	128.0	CHEMBL267	Homo sapiens	IC50	uM	0.128
	1807134	CHEMBL908982	Inhibition of human recombinant Src kinase	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3cccc(S(=O)(=O)N4CCNCC4)c3)nnc2c1		CHEMBL218049	=	IC50	nM	480.0	CHEMBL267	Homo sapiens	IC50	uM	0.48
	1807135	CHEMBL908982	Inhibition of human recombinant Src kinase	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(S(=O)(=O)N4CCN(C)CC4)cc3)nnc2c1		CHEMBL446951	=	IC50	nM	137.0	CHEMBL267	Homo sapiens	IC50	uM	0.137
	1807136	CHEMBL908982	Inhibition of human recombinant Src kinase	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3cccc(S(=O)(=O)N4CCN(C)CC4)c3)nnc2c1		CHEMBL436516	=	IC50	nM	320.0	CHEMBL267	Homo sapiens	IC50	uM	0.32
	1807137	CHEMBL908982	Inhibition of human recombinant Src kinase	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3cccc(NS(=O)(=O)CCN4CCCC4)c3)nnc2c1		CHEMBL220931	=	IC50	nM	26.0	CHEMBL267	Homo sapiens	IC50	uM	0.026
	1807138	CHEMBL908982	Inhibition of human recombinant Src kinase	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(NS(=O)(=O)CCN4CCCC4)cc3)nnc2c1		CHEMBL221742	=	IC50	nM	9.0	CHEMBL267	Homo sapiens	IC50	uM	0.009
	1807139	CHEMBL908982	Inhibition of human recombinant Src kinase	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3cccc(OCCN4CCCC4)c3)nnc2c1		CHEMBL218549	=	IC50	nM	6.0	CHEMBL267	Homo sapiens	IC50	uM	0.006
	1807140	CHEMBL908982	Inhibition of human recombinant Src kinase	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(OCCN4CCCC4)cc3)nnc2c1		CHEMBL436137	=	IC50	nM	7.0	CHEMBL267	Homo sapiens	IC50	uM	0.007
	1807141	CHEMBL908982	Inhibition of human recombinant Src kinase	B	CCOC1CN(C)CCN1c1cccc(Nc2nnc3cc(-c4c(C)cccc4C)cc(C)c3n2)c1		CHEMBL218386	=	IC50	nM	41.0	CHEMBL267	Homo sapiens	IC50	uM	0.041
	1807142	CHEMBL908982	Inhibition of human recombinant Src kinase	B	CCCOC1CN(C)CCN1c1ccc(Nc2nnc3cc(-c4c(C)cccc4C)cc(C)c3n2)cc1		CHEMBL220929	=	IC50	nM	36.0	CHEMBL267	Homo sapiens	IC50	uM	0.036
	1807143	CHEMBL908982	Inhibition of human recombinant Src kinase	B	CCOC1CN(C)CCN1c1ccc(Nc2nnc3cc(-c4c(C)cccc4C)cc(C)c3n2)cc1		CHEMBL221236	=	IC50	nM	21.0	CHEMBL267	Homo sapiens	IC50	uM	0.021
	1807144	CHEMBL908982	Inhibition of human recombinant Src kinase	B	CCOC1CN(c2ccc(Nc3nnc4cc(-c5c(C)cccc5C)cc(C)c4n3)cc2)CCO1		CHEMBL434578	=	IC50	nM	32.0	CHEMBL267	Homo sapiens	IC50	uM	0.032
	1807145	CHEMBL908982	Inhibition of human recombinant Src kinase	B	CCN(CC)CCOc1cccc(Nc2nnc3cc(-c4c(C)cccc4C)cc(C)c3n2)c1		CHEMBL218102	=	IC50	nM	10.0	CHEMBL267	Homo sapiens	IC50	uM	0.01
	1807146	CHEMBL908982	Inhibition of human recombinant Src kinase	B	CCN(CC)CCOc1ccc(Nc2nnc3cc(-c4c(C)cccc4C)cc(C)c3n2)cc1		CHEMBL218656	=	IC50	nM	10.0	CHEMBL267	Homo sapiens	IC50	uM	0.01
	1807147	CHEMBL908982	Inhibition of human recombinant Src kinase	B	Cc1cccc(C)c1-c1cc(C)c2nc(NC(=O)c3ccccc3)nnc2c1		CHEMBL218598	=	IC50	nM	1800.0	CHEMBL267	Homo sapiens	IC50	uM	1.8
	1807148	CHEMBL908982	Inhibition of human recombinant Src kinase	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccncc3)nnc2c1		CHEMBL221582	=	IC50	nM	40.0	CHEMBL267	Homo sapiens	IC50	uM	0.04
	1807149	CHEMBL908982	Inhibition of human recombinant Src kinase	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3cccc(S(N)(=O)=O)c3)nnc2c1		CHEMBL218597	=	IC50	nM	140.0	CHEMBL267	Homo sapiens	IC50	uM	0.14
	1807150	CHEMBL908982	Inhibition of human recombinant Src kinase	B	Cc1ccc(Nc2nnc3cc(-c4c(C)cccc4C)cc(C)c3n2)cc1C		CHEMBL220480	=	IC50	nM	960.0	CHEMBL267	Homo sapiens	IC50	uM	0.96
	1807151	CHEMBL908982	Inhibition of human recombinant Src kinase	B	Cc1cccc(Nc2nnc3cc(-c4c(C)cccc4C)cc(C)c3n2)c1		CHEMBL218742	=	IC50	nM	180.0	CHEMBL267	Homo sapiens	IC50	uM	0.18
	1807152	CHEMBL908982	Inhibition of human recombinant Src kinase	B	CCOc1ccc(Nc2nnc3cc(-c4c(C)cccc4C)cc(C)c3n2)cc1		CHEMBL221431	=	IC50	nM	110.0	CHEMBL267	Homo sapiens	IC50	uM	0.11
	1807153	CHEMBL908982	Inhibition of human recombinant Src kinase	B	COc1ccc(Nc2nnc3cc(-c4c(C)cccc4C)cc(C)c3n2)cc1		CHEMBL220798	=	IC50	nM	140.0	CHEMBL267	Homo sapiens	IC50	uM	0.14
	1807154	CHEMBL908982	Inhibition of human recombinant Src kinase	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(N(C)C)cc3)nnc2c1		CHEMBL220912	=	IC50	nM	240.0	CHEMBL267	Homo sapiens	IC50	uM	0.24
	1807155	CHEMBL908982	Inhibition of human recombinant Src kinase	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3cccc(Cl)c3)nnc2c1		CHEMBL217961	=	IC50	nM	130.0	CHEMBL267	Homo sapiens	IC50	uM	0.13
	1807156	CHEMBL908982	Inhibition of human recombinant Src kinase	B	Cc1cccc(C)c1-c1cc2nnc(Nc3ccccc3)nc2c(C)c1C		CHEMBL221975	=	IC50	nM	130.0	CHEMBL267	Homo sapiens	IC50	uM	0.13
	1807157	CHEMBL908982	Inhibition of human recombinant Src kinase	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccccc3)nnc2c1		CHEMBL374248	=	IC50	nM	410.0	CHEMBL267	Homo sapiens	IC50	uM	0.41
	1807158	CHEMBL908982	Inhibition of human recombinant Src kinase	B	Cc1cccc(C)c1-c1ccc2nc(Nc3ccccc3)nnc2c1		CHEMBL218042	=	IC50	nM	1500.0	CHEMBL267	Homo sapiens	IC50	uM	1.5
	1807159	CHEMBL908982	Inhibition of human recombinant Src kinase	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(N)nc12		CHEMBL218317	=	IC50	nM	1500.0	CHEMBL267	Homo sapiens	IC50	uM	1.5
	1807160	CHEMBL908982	Inhibition of human recombinant Src kinase	B	Cc1cccc(C)c1-c1cc(C)c2nc(N)nnc2c1		CHEMBL218177	=	IC50	nM	7400.0	CHEMBL267	Homo sapiens	IC50	uM	7.4
	1807161	CHEMBL908982	Inhibition of human recombinant Src kinase	B	Cc1cccc(C)c1-c1ccc2nc(N)nnc2c1		CHEMBL374002	=	IC50	nM	2200.0	CHEMBL267	Homo sapiens	IC50	uM	2.2
	1807162	CHEMBL908982	Inhibition of human recombinant Src kinase	B	Nc1nnc2cc(-c3ccc4ccccc4c3)ccc2n1		CHEMBL385112	=	IC50	nM	5200.0	CHEMBL267	Homo sapiens	IC50	uM	5.2
	1807163	CHEMBL908982	Inhibition of human recombinant Src kinase	B	Nc1nnc2cc(-c3ccc4c(c3)OCO4)ccc2n1		CHEMBL384877	=	IC50	nM	12000.0	CHEMBL267	Homo sapiens	IC50	uM	12.0
	1807164	CHEMBL908982	Inhibition of human recombinant Src kinase	B	Nc1nnc2cc(-c3cccc(O)c3)ccc2n1		CHEMBL218003	=	IC50	nM	12000.0	CHEMBL267	Homo sapiens	IC50	uM	12.0
	1807165	CHEMBL908982	Inhibition of human recombinant Src kinase	B	CCCOC1CN(C)CCN1c1cccc(Nc2nnc3cc(-c4c(C)cccc4C)cc(C)c3n2)c1		CHEMBL375433	=	IC50	nM	40.0	CHEMBL267	Homo sapiens	IC50	uM	0.04
Not Active	1810250	CHEMBL855709	Inhibition of Src kinase	B	N#Cc1cnc2ccc(NCc3c[nH]cn3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL220037		Activity			CHEMBL267	Homo sapiens	Activity		
	1812301	CHEMBL908549	Inhibition of human recombinant Src by ProFlour assay	B	CCN(CC)CCNc1cc(Nc2cc(O)ccc2C)nc(-n2cnc3ccccc32)n1		CHEMBL434369	=	IC50	nM	162.0	CHEMBL267	Homo sapiens	IC50	nM	162.0
	1815193	CHEMBL908520	inhibition of Src	B	CNc1ncnc(-c2cccnc2Oc2ccc(F)c(C(=O)Nc3cc(C(F)(F)F)ccc3N(C)CCCN(C)C)c2)n1		CHEMBL373882	=	IC50	nM	5750.0	CHEMBL267	Homo sapiens	IC50	nM	5750.0
	1815232	CHEMBL908520	inhibition of Src	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1Nc1ncccc1-c1ccncn1		CHEMBL385956	<	IC50	nM	25.0	CHEMBL267	Homo sapiens	IC50	nM	25.0
	1820567	CHEMBL917083	Inhibition of SRC kinase	B	O=C(N[C@H](CO)c1ccc(F)c(Cl)c1)c1cc(-c2n[nH]cc2-c2cccc(Cl)c2)c[nH]1		CHEMBL387385	=	Ki	nM	1100.0	CHEMBL267	Homo sapiens	Ki	uM	1.1
	1824594	CHEMBL915369	Inhibition of SRC	B	N#Cc1ncc2nc1OCCCCCOc1cc(CCCO)c(Cl)cc1NC(=O)N2		CHEMBL223367	>	Ki	nM	10000.0	CHEMBL267	Homo sapiens	Ki	uM	10.0
	1824677	CHEMBL915369	Inhibition of SRC	B	CS(=O)(=O)Nc1cc2c(cc1Cl)NC(=O)Nc1cnc(C#N)c(n1)OCCCCCO2		CHEMBL223460	>	Ki	nM	10000.0	CHEMBL267	Homo sapiens	Ki	uM	10.0
	1824761	CHEMBL915369	Inhibition of SRC	B	N#Cc1ncc2nc1OCCCCCOc1cc(OCCCO)c(Cl)cc1NC(=O)N2		CHEMBL373598	>	Ki	nM	10000.0	CHEMBL267	Homo sapiens	Ki	uM	10.0
	1826439	CHEMBL919915	Inhibition of SRC	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	nM	50000.0
	1841810	CHEMBL914495	Inhibition of src kinase	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	IC50	nM	0.5	CHEMBL267	Homo sapiens	IC50	nM	0.5
	1842078	CHEMBL914868	Inhibition of Src kinase	B	COc1cc(Nc2c(C#N)cnc3ccsc23)c(Cl)cc1Cl		CHEMBL222035	=	IC50	nM	2500.0	CHEMBL267	Homo sapiens	IC50	nM	2500.0
	1842079	CHEMBL914868	Inhibition of Src kinase	B	CN1CCN(Cc2ccc(-c3cc4ncc(C#N)c(CNc5ccc(Cl)cc5Cl)c4s3)cc2)CC1		CHEMBL224856	=	IC50	nM	240.0	CHEMBL267	Homo sapiens	IC50	nM	240.0
	1842080	CHEMBL914868	Inhibition of Src kinase	B	CN1CCN(Cc2ccc(-c3cc4ncc(C#N)c(Oc5ccc(Cl)cc5Cl)c4s3)cc2)CC1		CHEMBL413418	=	IC50	nM	580.0	CHEMBL267	Homo sapiens	IC50	nM	580.0
	1842081	CHEMBL914868	Inhibition of Src kinase	B	CN1CCN(Cc2ccc(-c3cc4ncc(C#N)c(Nc5ccc(Cl)cc5Cl)c4s3)cc2)CC1		CHEMBL425371	=	IC50	nM	50.0	CHEMBL267	Homo sapiens	IC50	nM	50.0
	1842082	CHEMBL914868	Inhibition of Src kinase	B	COc1cc(Nc2c(C#N)cnc3sc(-c4ccc(CN5CCOCC5)cc4)cc23)c(Cl)cc1Cl		CHEMBL375012	=	IC50	nM	830.0	CHEMBL267	Homo sapiens	IC50	nM	830.0
	1842083	CHEMBL914868	Inhibition of Src kinase	B	COc1cc(Nc2c(C#N)cnc3c(-c4ccc(CN5CCOCC5)cc4)csc23)c(Cl)cc1Cl		CHEMBL222806	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	1842084	CHEMBL914868	Inhibition of Src kinase	B	COc1cc(Nc2c(C#N)cnc3cc(-c4ccccc4N4CCN(C)CC4)sc23)c(Cl)cc1Cl		CHEMBL390943	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	1842085	CHEMBL914868	Inhibition of Src kinase	B	COc1cc(Nc2c(C#N)cnc3cc(-c4cccc(N5CCN(C)CC5)c4)sc23)c(Cl)cc1Cl		CHEMBL222548	=	IC50	nM	21.0	CHEMBL267	Homo sapiens	IC50	nM	21.0
	1842086	CHEMBL914868	Inhibition of Src kinase	B	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(N5CCN(C)CC5)cc4)sc23)c(Cl)cc1Cl		CHEMBL375844	=	IC50	nM	13.0	CHEMBL267	Homo sapiens	IC50	nM	13.0
	1842087	CHEMBL914868	Inhibition of Src kinase	B	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(N5CCOCC5)cc4)sc23)c(Cl)cc1Cl		CHEMBL426990	=	IC50	nM	34.0	CHEMBL267	Homo sapiens	IC50	nM	34.0
	1842088	CHEMBL914868	Inhibition of Src kinase	B	COc1cc(Nc2c(C#N)cnc3cc(-c4ccccc4)sc23)c(Cl)cc1Cl		CHEMBL373582	=	IC50	nM	250.0	CHEMBL267	Homo sapiens	IC50	nM	250.0
	1842089	CHEMBL914869	Inhibition of Src-mediated proliferation of rat 2 fibroblasts	F	COc1cc(Nc2c(C#N)cnc3cc(-c4ccccc4)sc23)c(Cl)cc1Cl		CHEMBL373582	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	1842090	CHEMBL914869	Inhibition of Src-mediated proliferation of rat 2 fibroblasts	F	CN1CCN(Cc2ccc(-c3cc4ncc(C#N)c(CNc5ccc(Cl)cc5Cl)c4s3)cc2)CC1		CHEMBL224856	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	1842091	CHEMBL914869	Inhibition of Src-mediated proliferation of rat 2 fibroblasts	F	CN1CCN(Cc2ccc(-c3cc4ncc(C#N)c(Oc5ccc(Cl)cc5Cl)c4s3)cc2)CC1		CHEMBL413418	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	1842092	CHEMBL914869	Inhibition of Src-mediated proliferation of rat 2 fibroblasts	F	CN1CCN(Cc2ccc(-c3cc4ncc(C#N)c(Nc5ccc(Cl)cc5Cl)c4s3)cc2)CC1		CHEMBL425371	=	IC50	nM	4000.0	CHEMBL267	Homo sapiens	IC50	nM	4000.0
	1842093	CHEMBL914869	Inhibition of Src-mediated proliferation of rat 2 fibroblasts	F	COc1cc(Nc2c(C#N)cnc3cc(-c4cccc(N5CCN(C)CC5)c4)sc23)c(Cl)cc1Cl		CHEMBL222548	=	IC50	nM	1200.0	CHEMBL267	Homo sapiens	IC50	nM	1200.0
	1842094	CHEMBL914869	Inhibition of Src-mediated proliferation of rat 2 fibroblasts	F	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(N5CCN(C)CC5)cc4)sc23)c(Cl)cc1Cl		CHEMBL375844	=	IC50	nM	720.0	CHEMBL267	Homo sapiens	IC50	nM	720.0
	1842095	CHEMBL914869	Inhibition of Src-mediated proliferation of rat 2 fibroblasts	F	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(N5CCOCC5)cc4)sc23)c(Cl)cc1Cl		CHEMBL426990	=	IC50	nM	1200.0	CHEMBL267	Homo sapiens	IC50	nM	1200.0
	1849897	CHEMBL914202	Inhibition of Src	B	CN1CCN(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCOc5ccccc5)c4)n[nH]c2-3)CC1		CHEMBL390156	=	IC50	nM	30400.0	CHEMBL267	Homo sapiens	IC50	nM	30400.0
	1849909	CHEMBL914202	Inhibition of Src	B	COCCOCC#Cc1cc(-c2n[nH]c3c2Cc2ccc(Cn4cncn4)cc2-3)cs1		CHEMBL223971	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	nM	50000.0
	1855987	CHEMBL918284	Inhibition of cSrc by coupled spectrophotometric enzyme assay	B	COc1ccc(-c2cnc(Nc3ccccc3)c3cncn23)cc1		CHEMBL390957	=	IC50	nM	3700.0	CHEMBL267	Homo sapiens	IC50	uM	3.7
	1856003	CHEMBL918284	Inhibition of cSrc by coupled spectrophotometric enzyme assay	B	Cc1cccc(C)c1Nc1ncc(-c2ccccc2)n2cncc12		CHEMBL223873	=	IC50	nM	13.0	CHEMBL267	Homo sapiens	IC50	uM	0.013
	1856063	CHEMBL918284	Inhibition of cSrc by coupled spectrophotometric enzyme assay	B	COc1ccc(-c2cnc(Nc3ccccc3C)c3cncn23)cc1		CHEMBL227859	=	IC50	nM	260.0	CHEMBL267	Homo sapiens	IC50	uM	0.26
	1856064	CHEMBL918284	Inhibition of cSrc by coupled spectrophotometric enzyme assay	B	COc1ccc(-c2cnc(Nc3c(C)cccc3C)c3cncn23)cc1		CHEMBL389031	=	IC50	nM	15.0	CHEMBL267	Homo sapiens	IC50	uM	0.015
	1856065	CHEMBL918284	Inhibition of cSrc by coupled spectrophotometric enzyme assay	B	CN(c1ccccc1)c1ncc(-c2ccccc2)n2cncc12	Outside typical range	CHEMBL388807	=	IC50	nM	1000000.0	CHEMBL267	Homo sapiens	IC50	uM	1000.0
	1856066	CHEMBL918284	Inhibition of cSrc by coupled spectrophotometric enzyme assay	B	COc1cccc(C)c1Nc1ncc(-c2ccccc2)n2cncc12		CHEMBL390367	=	IC50	nM	693.0	CHEMBL267	Homo sapiens	IC50	uM	0.693
	1856067	CHEMBL918284	Inhibition of cSrc by coupled spectrophotometric enzyme assay	B	Cc1cc(C)c(Nc2ncc(-c3ccccc3)n3cncc23)c(C)c1		CHEMBL388859	=	IC50	nM	38.0	CHEMBL267	Homo sapiens	IC50	uM	0.038
	1856068	CHEMBL918284	Inhibition of cSrc by coupled spectrophotometric enzyme assay	B	Fc1cccc(F)c1Nc1ncc(-c2ccccc2)n2cncc12		CHEMBL388136	=	IC50	nM	490.0	CHEMBL267	Homo sapiens	IC50	uM	0.49
	1856069	CHEMBL918284	Inhibition of cSrc by coupled spectrophotometric enzyme assay	B	Clc1cccc(Cl)c1Nc1ncc(-c2ccccc2)n2cncc12		CHEMBL223912	=	IC50	nM	42.0	CHEMBL267	Homo sapiens	IC50	uM	0.042
	1856070	CHEMBL918284	Inhibition of cSrc by coupled spectrophotometric enzyme assay	B	c1ccc(Nc2ncc(-c3ccccc3)n3cncc23)cc1		CHEMBL426903	=	IC50	nM	5500.0	CHEMBL267	Homo sapiens	IC50	uM	5.5
	1856073	CHEMBL919724	Inhibition of cSrc in COS7 cells at 1 uM by ELISA	B	Cc1cccc(C)c1Nc1ncc(-c2ccccc2)n2cncc12		CHEMBL223873	=	Inhibition	%	10.6	CHEMBL267	Homo sapiens	Inhibition	%	10.6
Not Determined	1856074	CHEMBL919724	Inhibition of cSrc in COS7 cells at 1 uM by ELISA	B	COc1ccc(-c2cnc(Nc3ccccc3)c3cncn23)cc1		CHEMBL390957		Inhibition	%		CHEMBL267	Homo sapiens	Inhibition		
	1856075	CHEMBL919724	Inhibition of cSrc in COS7 cells at 1 uM by ELISA	B	COc1ccc(-c2cnc(Nc3ccccc3C)c3cncn23)cc1		CHEMBL227859	=	Inhibition	%	22.7	CHEMBL267	Homo sapiens	Inhibition	%	22.7
	1856076	CHEMBL919724	Inhibition of cSrc in COS7 cells at 1 uM by ELISA	B	COc1ccc(-c2cnc(Nc3c(C)cccc3C)c3cncn23)cc1		CHEMBL389031	=	Inhibition	%	12.5	CHEMBL267	Homo sapiens	Inhibition	%	12.5
Not Determined	1856077	CHEMBL919724	Inhibition of cSrc in COS7 cells at 1 uM by ELISA	B	CN(c1ccccc1)c1ncc(-c2ccccc2)n2cncc12		CHEMBL388807		Inhibition	%		CHEMBL267	Homo sapiens	Inhibition		
	1856078	CHEMBL919724	Inhibition of cSrc in COS7 cells at 1 uM by ELISA	B	COc1cccc(C)c1Nc1ncc(-c2ccccc2)n2cncc12		CHEMBL390367	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	Inhibition	%	0.0
	1856079	CHEMBL919724	Inhibition of cSrc in COS7 cells at 1 uM by ELISA	B	Cc1cc(C)c(Nc2ncc(-c3ccccc3)n3cncc23)c(C)c1		CHEMBL388859	=	Inhibition	%	0.2	CHEMBL267	Homo sapiens	Inhibition	%	0.2
	1856080	CHEMBL919724	Inhibition of cSrc in COS7 cells at 1 uM by ELISA	B	Fc1cccc(F)c1Nc1ncc(-c2ccccc2)n2cncc12		CHEMBL388136	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	Inhibition	%	0.0
	1856081	CHEMBL919724	Inhibition of cSrc in COS7 cells at 1 uM by ELISA	B	Clc1cccc(Cl)c1Nc1ncc(-c2ccccc2)n2cncc12		CHEMBL223912	=	Inhibition	%	25.6	CHEMBL267	Homo sapiens	Inhibition	%	25.6
	1856082	CHEMBL919724	Inhibition of cSrc in COS7 cells at 1 uM by ELISA	B	c1ccc(Nc2ncc(-c3ccccc3)n3cncc23)cc1		CHEMBL426903	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	Inhibition	%	0.0
	1856085	CHEMBL918284	Inhibition of cSrc by coupled spectrophotometric enzyme assay	B	COc1cccc(-c2cnc(Nc3c(C)cccc3C)c3cncn23)c1		CHEMBL227906	=	IC50	nM	11.0	CHEMBL267	Homo sapiens	IC50	uM	0.011
	1856086	CHEMBL918284	Inhibition of cSrc by coupled spectrophotometric enzyme assay	B	Cc1cccc(Cl)c1Nc1nc2ccc(N3CCN[C@@H](C)C3)nc2n2cncc12		CHEMBL189338	=	IC50	nM	96.0	CHEMBL267	Homo sapiens	IC50	uM	0.096
	1856087	CHEMBL918284	Inhibition of cSrc by coupled spectrophotometric enzyme assay	B	Cc1cccc(C)c1Nc1ncc(-c2cccs2)n2cncc12		CHEMBL387641	=	IC50	nM	12.0	CHEMBL267	Homo sapiens	IC50	uM	0.012
	1856088	CHEMBL918284	Inhibition of cSrc by coupled spectrophotometric enzyme assay	B	Cc1cccc(C)c1Nc1ncc(-c2ccncc2)n2cncc12		CHEMBL376555	=	IC50	nM	108.0	CHEMBL267	Homo sapiens	IC50	uM	0.108
	1856089	CHEMBL918284	Inhibition of cSrc by coupled spectrophotometric enzyme assay	B	Cc1cccc(C)c1Nc1ncc(-c2ccc(C(=O)N(C)C)cc2)n2cncc12		CHEMBL374376	=	IC50	nM	52.0	CHEMBL267	Homo sapiens	IC50	uM	0.052
	1856090	CHEMBL918284	Inhibition of cSrc by coupled spectrophotometric enzyme assay	B	Cc1cccc(C)c1Nc1ncc(-c2ccc(C(=O)O)cc2)n2cncc12		CHEMBL375904	=	IC50	nM	235.0	CHEMBL267	Homo sapiens	IC50	uM	0.235
	1856091	CHEMBL918284	Inhibition of cSrc by coupled spectrophotometric enzyme assay	B	Cc1cccc(C)c1Nc1ncc(-c2ccc(N(C)C)cc2)n2cncc12		CHEMBL226613	=	IC50	nM	19.0	CHEMBL267	Homo sapiens	IC50	uM	0.019
	1856092	CHEMBL918284	Inhibition of cSrc by coupled spectrophotometric enzyme assay	B	Cc1cccc(C)c1Nc1ncc(-c2ccc(C(F)(F)F)cc2)n2cncc12		CHEMBL388820	=	IC50	nM	235.0	CHEMBL267	Homo sapiens	IC50	uM	0.235
	1856093	CHEMBL918284	Inhibition of cSrc by coupled spectrophotometric enzyme assay	B	Cc1cccc(C)c1Nc1ncc(-c2ccc(F)cc2)n2cncc12		CHEMBL228091	=	IC50	nM	42.0	CHEMBL267	Homo sapiens	IC50	uM	0.042
	1856094	CHEMBL918284	Inhibition of cSrc by coupled spectrophotometric enzyme assay	B	COc1ccc(-c2cnc(Nc3c(C)cccc3C)c3cncn23)cc1OC		CHEMBL389451	=	IC50	nM	23.0	CHEMBL267	Homo sapiens	IC50	uM	0.023
	1856095	CHEMBL918284	Inhibition of cSrc by coupled spectrophotometric enzyme assay	B	Cc1cccc(C)c1Nc1ncc(-c2ccc(C#N)cc2)n2cncc12		CHEMBL425492	=	IC50	nM	235.0	CHEMBL267	Homo sapiens	IC50	uM	0.235
	1856096	CHEMBL919724	Inhibition of cSrc in COS7 cells at 1 uM by ELISA	B	COc1cccc(-c2cnc(Nc3c(C)cccc3C)c3cncn23)c1		CHEMBL227906	=	Inhibition	%	18.9	CHEMBL267	Homo sapiens	Inhibition	%	18.9
Not Determined	1856097	CHEMBL919724	Inhibition of cSrc in COS7 cells at 1 uM by ELISA	B	Cc1cccc(Cl)c1Nc1nc2ccc(N3CCN[C@@H](C)C3)nc2n2cncc12		CHEMBL189338		Inhibition	%		CHEMBL267	Homo sapiens	Inhibition		
	1856098	CHEMBL919724	Inhibition of cSrc in COS7 cells at 1 uM by ELISA	B	Cc1cccc(C)c1Nc1ncc(-c2cccs2)n2cncc12		CHEMBL387641	=	Inhibition	%	22.4	CHEMBL267	Homo sapiens	Inhibition	%	22.4
	1856099	CHEMBL919724	Inhibition of cSrc in COS7 cells at 1 uM by ELISA	B	Cc1cccc(C)c1Nc1ncc(-c2ccncc2)n2cncc12		CHEMBL376555	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	Inhibition	%	0.0
	1856100	CHEMBL919724	Inhibition of cSrc in COS7 cells at 1 uM by ELISA	B	Cc1cccc(C)c1Nc1ncc(-c2ccc(C(=O)N(C)C)cc2)n2cncc12		CHEMBL374376	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	Inhibition	%	0.0
	1856101	CHEMBL919724	Inhibition of cSrc in COS7 cells at 1 uM by ELISA	B	Cc1cccc(C)c1Nc1ncc(-c2ccc(C(=O)O)cc2)n2cncc12		CHEMBL375904	=	Inhibition	%	12.0	CHEMBL267	Homo sapiens	Inhibition	%	12.0
	1856102	CHEMBL919724	Inhibition of cSrc in COS7 cells at 1 uM by ELISA	B	Cc1cccc(C)c1Nc1ncc(-c2ccc(N(C)C)cc2)n2cncc12		CHEMBL226613	=	Inhibition	%	25.7	CHEMBL267	Homo sapiens	Inhibition	%	25.7
	1856103	CHEMBL919724	Inhibition of cSrc in COS7 cells at 1 uM by ELISA	B	Cc1cccc(C)c1Nc1ncc(-c2ccc(C(F)(F)F)cc2)n2cncc12		CHEMBL388820	=	Inhibition	%	7.0	CHEMBL267	Homo sapiens	Inhibition	%	7.0
	1856104	CHEMBL919724	Inhibition of cSrc in COS7 cells at 1 uM by ELISA	B	Cc1cccc(C)c1Nc1ncc(-c2ccc(F)cc2)n2cncc12		CHEMBL228091	=	Inhibition	%	0.2	CHEMBL267	Homo sapiens	Inhibition	%	0.2
	1856105	CHEMBL919724	Inhibition of cSrc in COS7 cells at 1 uM by ELISA	B	COc1ccc(-c2cnc(Nc3c(C)cccc3C)c3cncn23)cc1OC		CHEMBL389451	=	Inhibition	%	16.4	CHEMBL267	Homo sapiens	Inhibition	%	16.4
	1856106	CHEMBL919724	Inhibition of cSrc in COS7 cells at 1 uM by ELISA	B	Cc1cccc(C)c1Nc1ncc(-c2ccc(C#N)cc2)n2cncc12		CHEMBL425492	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	Inhibition	%	0.0
	1856107	CHEMBL918284	Inhibition of cSrc by coupled spectrophotometric enzyme assay	B	COc1cccc(-c2cnc(Nc3c(C)cccc3Cl)c3cncn23)c1		CHEMBL226773	=	IC50	nM	59.0	CHEMBL267	Homo sapiens	IC50	uM	0.059
	1856108	CHEMBL918284	Inhibition of cSrc by coupled spectrophotometric enzyme assay	B	Cc1cccc(C)c1Nc1nc(-c2ccc(F)cc2)cn2cncc12		CHEMBL2096880	=	IC50	nM	403.0	CHEMBL267	Homo sapiens	IC50	uM	0.403
	1856109	CHEMBL918284	Inhibition of cSrc by coupled spectrophotometric enzyme assay	B	Cc1cccc(Cl)c1Nc1ncc(-c2ccc(F)cc2)n2cncc12		CHEMBL224691	=	IC50	nM	145.0	CHEMBL267	Homo sapiens	IC50	uM	0.145
	1856110	CHEMBL919724	Inhibition of cSrc in COS7 cells at 1 uM by ELISA	B	COc1cccc(-c2cnc(Nc3c(C)cccc3Cl)c3cncn23)c1		CHEMBL226773	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	Inhibition	%	0.0
	1856111	CHEMBL919724	Inhibition of cSrc in COS7 cells at 1 uM by ELISA	B	Cc1cccc(C)c1Nc1nc(-c2ccc(F)cc2)cn2cncc12		CHEMBL2096880	=	Inhibition	%	7.0	CHEMBL267	Homo sapiens	Inhibition	%	7.0
	1856112	CHEMBL919724	Inhibition of cSrc in COS7 cells at 1 uM by ELISA	B	Cc1cccc(Cl)c1Nc1ncc(-c2ccc(F)cc2)n2cncc12		CHEMBL224691	=	Inhibition	%	5.8	CHEMBL267	Homo sapiens	Inhibition	%	5.8
	1856113	CHEMBL918284	Inhibition of cSrc by coupled spectrophotometric enzyme assay	B	Cc1cccc(C)c1Nc1ncc(-c2ccc(OCCN3CCOCC3)cc2)n2cncc12		CHEMBL227836	=	IC50	nM	37.0	CHEMBL267	Homo sapiens	IC50	uM	0.037
	1856114	CHEMBL918284	Inhibition of cSrc by coupled spectrophotometric enzyme assay	B	Cc1cccc(C)c1Nc1ncc(-c2ccc(CN3CCCC3)s2)n2cncc12.Cl		CHEMBL3392166	=	IC50	nM	52.0	CHEMBL267	Homo sapiens	IC50	uM	0.052
	1856115	CHEMBL918284	Inhibition of cSrc by coupled spectrophotometric enzyme assay	B	Cc1cccc(C)c1Nc1ncc(-c2ccc(CN3CCN(C)CC3)s2)n2cncc12.Cl		CHEMBL3392187	=	IC50	nM	305.0	CHEMBL267	Homo sapiens	IC50	uM	0.305
	1856116	CHEMBL918284	Inhibition of cSrc by coupled spectrophotometric enzyme assay	B	Cc1cccc(C)c1Nc1ncc(-c2cccc(OCCN3CCCC3)c2)n2cncc12.Cl		CHEMBL534947	=	IC50	nM	55.0	CHEMBL267	Homo sapiens	IC50	uM	0.055
	1856117	CHEMBL918284	Inhibition of cSrc by coupled spectrophotometric enzyme assay	B	Cc1cccc(C)c1Nc1ncc(-c2cccc(OCC3CCCN(C)C3)c2)n2cncc12		CHEMBL389422	=	IC50	nM	19.0	CHEMBL267	Homo sapiens	IC50	uM	0.019
	1856118	CHEMBL918284	Inhibition of cSrc by coupled spectrophotometric enzyme assay	B	Cc1cccc(C)c1Nc1ncc(-c2ccc(OCC3CCCN(C)C3)cc2)n2cncc12		CHEMBL227753	=	IC50	nM	20.0	CHEMBL267	Homo sapiens	IC50	uM	0.02
	1856119	CHEMBL918284	Inhibition of cSrc by coupled spectrophotometric enzyme assay	B	Cc1cccc(C)c1Nc1ncc(-c2ccc(OCCN3CCCC3)cc2)n2cncc12		CHEMBL227699	=	IC50	nM	15.0	CHEMBL267	Homo sapiens	IC50	uM	0.015
	1856120	CHEMBL919724	Inhibition of cSrc in COS7 cells at 1 uM by ELISA	B	Cc1cccc(C)c1Nc1ncc(-c2ccc(OCCN3CCOCC3)cc2)n2cncc12		CHEMBL227836	=	Inhibition	%	57.3	CHEMBL267	Homo sapiens	Inhibition	%	57.3
	1856121	CHEMBL919724	Inhibition of cSrc in COS7 cells at 1 uM by ELISA	B	Cc1cccc(C)c1Nc1ncc(-c2ccc(CN3CCCC3)s2)n2cncc12.Cl		CHEMBL3392166	=	Inhibition	%	57.6	CHEMBL267	Homo sapiens	Inhibition	%	57.6
	1856122	CHEMBL919724	Inhibition of cSrc in COS7 cells at 1 uM by ELISA	B	Cc1cccc(C)c1Nc1ncc(-c2ccc(CN3CCN(C)CC3)s2)n2cncc12.Cl		CHEMBL3392187	=	Inhibition	%	28.7	CHEMBL267	Homo sapiens	Inhibition	%	28.7
	1856123	CHEMBL919724	Inhibition of cSrc in COS7 cells at 1 uM by ELISA	B	Cc1cccc(C)c1Nc1ncc(-c2cccc(OCCN3CCCC3)c2)n2cncc12.Cl		CHEMBL534947	=	Inhibition	%	49.1	CHEMBL267	Homo sapiens	Inhibition	%	49.1
	1856124	CHEMBL919724	Inhibition of cSrc in COS7 cells at 1 uM by ELISA	B	Cc1cccc(C)c1Nc1ncc(-c2cccc(OCC3CCCN(C)C3)c2)n2cncc12		CHEMBL389422	=	Inhibition	%	59.9	CHEMBL267	Homo sapiens	Inhibition	%	59.9
	1856125	CHEMBL919724	Inhibition of cSrc in COS7 cells at 1 uM by ELISA	B	Cc1cccc(C)c1Nc1ncc(-c2ccc(OCC3CCCN(C)C3)cc2)n2cncc12		CHEMBL227753	=	Inhibition	%	91.6	CHEMBL267	Homo sapiens	Inhibition	%	91.6
	1856126	CHEMBL919724	Inhibition of cSrc in COS7 cells at 1 uM by ELISA	B	Cc1cccc(C)c1Nc1ncc(-c2ccc(OCCN3CCCC3)cc2)n2cncc12		CHEMBL227699	=	Inhibition	%	51.6	CHEMBL267	Homo sapiens	Inhibition	%	51.6
	1856127	CHEMBL919725	Inhibition of cSrc in COS7 cells by ELISA	B	Cc1cccc(C)c1Nc1ncc(-c2ccc(OCCN3CCOCC3)cc2)n2cncc12		CHEMBL227836	=	IC50	nM	700.0	CHEMBL267	Homo sapiens	IC50	uM	0.7
	1856128	CHEMBL919725	Inhibition of cSrc in COS7 cells by ELISA	B	Cc1cccc(C)c1Nc1ncc(-c2ccc(CN3CCCC3)s2)n2cncc12.Cl		CHEMBL3392166	=	IC50	nM	820.0	CHEMBL267	Homo sapiens	IC50	uM	0.82
	1856129	CHEMBL919725	Inhibition of cSrc in COS7 cells by ELISA	B	Cc1cccc(C)c1Nc1ncc(-c2ccc(CN3CCN(C)CC3)s2)n2cncc12.Cl		CHEMBL3392187	=	IC50	nM	2300.0	CHEMBL267	Homo sapiens	IC50	uM	2.3
	1856130	CHEMBL919725	Inhibition of cSrc in COS7 cells by ELISA	B	Cc1cccc(C)c1Nc1ncc(-c2cccc(OCCN3CCCC3)c2)n2cncc12.Cl		CHEMBL534947	=	IC50	nM	1000.0	CHEMBL267	Homo sapiens	IC50	uM	1.0
	1856131	CHEMBL919725	Inhibition of cSrc in COS7 cells by ELISA	B	Cc1cccc(C)c1Nc1ncc(-c2cccc(OCC3CCCN(C)C3)c2)n2cncc12		CHEMBL389422	=	IC50	nM	740.0	CHEMBL267	Homo sapiens	IC50	uM	0.74
	1856132	CHEMBL919725	Inhibition of cSrc in COS7 cells by ELISA	B	Cc1cccc(C)c1Nc1ncc(-c2ccc(OCC3CCCN(C)C3)cc2)n2cncc12		CHEMBL227753	=	IC50	nM	530.0	CHEMBL267	Homo sapiens	IC50	uM	0.53
	1856133	CHEMBL919725	Inhibition of cSrc in COS7 cells by ELISA	B	Cc1cccc(C)c1Nc1ncc(-c2ccc(OCCN3CCCC3)cc2)n2cncc12		CHEMBL227699	=	IC50	nM	950.0	CHEMBL267	Homo sapiens	IC50	uM	0.95
	1856206	CHEMBL918284	Inhibition of cSrc by coupled spectrophotometric enzyme assay	B	Cc1cccc(C)c1Nc1ncc(-c2ccc(OCC3CCCN(C)C3)cc2)n2cncc12.Cl		CHEMBL534948	=	IC50	nM	20.0	CHEMBL267	Homo sapiens	IC50	uM	0.02
	1856231	CHEMBL918284	Inhibition of cSrc by coupled spectrophotometric enzyme assay	B	Cc1cccc(C)c1Nc1nccn2cncc12		CHEMBL227376	=	IC50	nM	3300.0	CHEMBL267	Homo sapiens	IC50	uM	3.3
Not Determined	1856232	CHEMBL919724	Inhibition of cSrc in COS7 cells at 1 uM by ELISA	B	Cc1cccc(C)c1Nc1nccn2cncc12		CHEMBL227376		Inhibition	%		CHEMBL267	Homo sapiens	Inhibition		
	1891318	CHEMBL905921	Inhibition of Src	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(OCCN4CCCC4)cc3)nnc2c1		CHEMBL436137	=	IC50	nM	7.0	CHEMBL267	Homo sapiens	IC50	uM	0.007
	1891319	CHEMBL905921	Inhibition of Src	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccnc(OCCN4CCCC4)c3)nnc2c1		CHEMBL437004	=	IC50	nM	6.4	CHEMBL267	Homo sapiens	IC50	uM	0.0064
	1891320	CHEMBL905921	Inhibition of Src	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3cccc(N(CCN4CCCC4)C(=O)c4ccccc4)c3)nnc2c1		CHEMBL230820	=	IC50	nM	18.0	CHEMBL267	Homo sapiens	IC50	uM	0.018
	1891321	CHEMBL905921	Inhibition of Src	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(N(CCN4CCCC4)C(=O)c4ccccc4)cc3)nnc2c1		CHEMBL231235	=	IC50	nM	16.0	CHEMBL267	Homo sapiens	IC50	uM	0.016
	1891322	CHEMBL905921	Inhibition of Src	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(C(=O)NN4CCNCC4)cc3)nnc2c1		CHEMBL230720	=	IC50	nM	13.0	CHEMBL267	Homo sapiens	IC50	uM	0.013
	1891323	CHEMBL905921	Inhibition of Src	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(C(=O)NN4CCN(C)CC4)cc3)nnc2c1		CHEMBL230719	=	IC50	nM	15.0	CHEMBL267	Homo sapiens	IC50	uM	0.015
	1891324	CHEMBL905921	Inhibition of Src	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3cccc(OCC(C)N4CCN(C)CC4)c3)nnc2c1		CHEMBL397936	=	IC50	nM	39.0	CHEMBL267	Homo sapiens	IC50	uM	0.039
	1891325	CHEMBL905921	Inhibition of Src	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(OCC(C)N4CCN(C)CC4)cc3)nnc2c1		CHEMBL230718	=	IC50	nM	36.0	CHEMBL267	Homo sapiens	IC50	uM	0.036
	1891326	CHEMBL905921	Inhibition of Src	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3cccc(OCCN4CCN(C)CC4)c3)nnc2c1		CHEMBL230615	=	IC50	nM	40.0	CHEMBL267	Homo sapiens	IC50	uM	0.04
	1891327	CHEMBL905921	Inhibition of Src	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(OCCN4CCN(C)CC4)cc3)nnc2c1		CHEMBL230614	=	IC50	nM	21.0	CHEMBL267	Homo sapiens	IC50	uM	0.021
	1891328	CHEMBL905921	Inhibition of Src	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(OCCN4CCCC4)cc3)nnc2c1		CHEMBL436137	=	IC50	nM	6.4	CHEMBL267	Homo sapiens	IC50	uM	0.0064
	1891329	CHEMBL905921	Inhibition of Src	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(OCCCN4CCCC4)cc3)nnc2c1		CHEMBL397692	=	IC50	nM	13.0	CHEMBL267	Homo sapiens	IC50	uM	0.013
	1891330	CHEMBL905921	Inhibition of Src	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3cccc(OCCN4CCOCC4)c3)nnc2c1		CHEMBL230613	=	IC50	nM	33.0	CHEMBL267	Homo sapiens	IC50	uM	0.033
	1891331	CHEMBL905921	Inhibition of Src	B	CCN(CC)CCOc1ccc(Nc2nnc3cc(-c4c(C)cccc4C)cc(C)c3n2)cc1		CHEMBL218656	=	IC50	nM	10.0	CHEMBL267	Homo sapiens	IC50	uM	0.01
	1891332	CHEMBL905921	Inhibition of Src	B	CCN(CC)CCOc1cccc(Nc2nnc3cc(-c4c(C)cccc4C)cc(C)c3n2)c1		CHEMBL218102	=	IC50	nM	10.0	CHEMBL267	Homo sapiens	IC50	uM	0.01
	1891333	CHEMBL905921	Inhibition of Src	B	Cc1cc2nc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nnc2cc1-c1ccccc1CO		CHEMBL230509	=	IC50	nM	72.0	CHEMBL267	Homo sapiens	IC50	uM	0.072
	1891334	CHEMBL905921	Inhibition of Src	B	Cc1cc2nc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nnc2cc1N		CHEMBL230508	=	IC50	nM	92.0	CHEMBL267	Homo sapiens	IC50	uM	0.092
	1891335	CHEMBL905921	Inhibition of Src	B	Cc1cc(F)ccc1-c1cc2nnc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nc2cc1C		CHEMBL397691	=	IC50	nM	20.0	CHEMBL267	Homo sapiens	IC50	uM	0.02
	1891336	CHEMBL905921	Inhibition of Src	B	Cc1ccc(C#N)cc1-c1cc2nnc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nc2cc1C		CHEMBL395984	=	IC50	nM	12.0	CHEMBL267	Homo sapiens	IC50	uM	0.012
	1891337	CHEMBL905921	Inhibition of Src	B	Cc1cc2nc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nnc2cc1-c1ccccc1C(F)(F)F		CHEMBL231338	=	IC50	nM	67.0	CHEMBL267	Homo sapiens	IC50	uM	0.067
	1891338	CHEMBL905921	Inhibition of Src	B	Cc1ccccc1-c1cc2nnc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nc2cc1C		CHEMBL231237	=	IC50	nM	10.0	CHEMBL267	Homo sapiens	IC50	uM	0.01
	1891339	CHEMBL905921	Inhibition of Src	B	Cc1cc2nc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nnc2cc1Br		CHEMBL397998	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	1891340	CHEMBL905921	Inhibition of Src	B	Cc1ccc2nnc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nc2c1		CHEMBL425997	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	1891341	CHEMBL905921	Inhibition of Src	B	Cc1cc2nc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nnc2cc1-c1ccccc1		CHEMBL230918	=	IC50	nM	315.0	CHEMBL267	Homo sapiens	IC50	uM	0.315
	1891342	CHEMBL905921	Inhibition of Src	B	Cc1cc2nc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nnc2cc1-c1c(C)cccc1C		CHEMBL230816	=	IC50	nM	11.0	CHEMBL267	Homo sapiens	IC50	uM	0.011
	1891343	CHEMBL905921	Inhibition of Src	B	Cc1cc(-c2cccc(NS(C)(=O)=O)c2)cc2nnc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nc12		CHEMBL230815	=	IC50	nM	2900.0	CHEMBL267	Homo sapiens	IC50	uM	2.9
	1891344	CHEMBL905921	Inhibition of Src	B	CNc1cccc(-c2cc(C)c3nc(Nc4ccc(S(=O)(=O)NCCN5CCCC5)cc4)nnc3c2)c1		CHEMBL231627	=	IC50	nM	631.0	CHEMBL267	Homo sapiens	IC50	uM	0.631
	1891345	CHEMBL905921	Inhibition of Src	B	Cc1ccc(CN)cc1-c1cc(C)c2nc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nnc2c1		CHEMBL231626	=	IC50	nM	353.0	CHEMBL267	Homo sapiens	IC50	uM	0.353
	1891346	CHEMBL905921	Inhibition of Src	B	Cc1cc(-c2cccc(N)c2)cc2nnc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nc12		CHEMBL231525	=	IC50	nM	282.0	CHEMBL267	Homo sapiens	IC50	uM	0.282
	1891347	CHEMBL905921	Inhibition of Src	B	Cc1cc(-c2cc(N)ccc2Cl)cc2nnc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nc12		CHEMBL231524	=	IC50	nM	51.0	CHEMBL267	Homo sapiens	IC50	uM	0.051
	1891348	CHEMBL905921	Inhibition of Src	B	Cc1ccc(C#N)cc1-c1cc(C)c2nc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nnc2c1		CHEMBL231316	=	IC50	nM	25.0	CHEMBL267	Homo sapiens	IC50	uM	0.025
	1891349	CHEMBL905921	Inhibition of Src	B	Cc1cc(-c2c(O)cccc2Cl)cc2nnc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nc12		CHEMBL231220	=	IC50	nM	13.0	CHEMBL267	Homo sapiens	IC50	uM	0.013
	1891350	CHEMBL905921	Inhibition of Src	B	Cc1cc(-c2c(Cl)cccc2Cl)cc2nnc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nc12		CHEMBL231219	=	IC50	nM	14.0	CHEMBL267	Homo sapiens	IC50	uM	0.014
	1891351	CHEMBL905921	Inhibition of Src	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nnc2c1		CHEMBL231218	=	IC50	nM	9.0	CHEMBL267	Homo sapiens	IC50	uM	0.009
	1891352	CHEMBL905921	Inhibition of Src	B	Cc1cc2nc(Nc3ccc(OCCN4CCCC4)cc3)nnc2cc1-c1c(C)cccc1C		CHEMBL230272	=	IC50	nM	12.0	CHEMBL267	Homo sapiens	IC50	uM	0.012
	1891353	CHEMBL905921	Inhibition of Src	B	c1ccc2nc(Nc3ccc(OCCN4CCCC4)cc3)nnc2c1		CHEMBL387795	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	1891354	CHEMBL905921	Inhibition of Src	B	Clc1cccc(Cl)c1-c1ccc2nc(Nc3ccc(OCCN4CCCC4)cc3)nnc2c1		CHEMBL230271	=	IC50	nM	30.0	CHEMBL267	Homo sapiens	IC50	uM	0.03
	1891355	CHEMBL905921	Inhibition of Src	B	Cc1cccc(C)c1-c1ccc2nc(Nc3ccc(OCCN4CCCC4)cc3)nnc2c1		CHEMBL230999	=	IC50	nM	15.0	CHEMBL267	Homo sapiens	IC50	uM	0.015
	1891356	CHEMBL905921	Inhibition of Src	B	Cc1cc(-c2ccccn2)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL230899	=	IC50	nM	1800.0	CHEMBL267	Homo sapiens	IC50	uM	1.8
	1891357	CHEMBL905921	Inhibition of Src	B	Cc1cc(-c2ccncn2)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL396205	=	IC50	nM	1500.0	CHEMBL267	Homo sapiens	IC50	uM	1.5
	1891358	CHEMBL905921	Inhibition of Src	B	Cc1noc(C)c1-c1cc(C)c2nc(Nc3ccc(OCCN4CCCC4)cc3)nnc2c1		CHEMBL230898	=	IC50	nM	207.0	CHEMBL267	Homo sapiens	IC50	uM	0.207
	1891359	CHEMBL905921	Inhibition of Src	B	Cc1cnc(F)cc1-c1cc(C)c2nc(Nc3ccc(OCCN4CCCC4)cc3)nnc2c1		CHEMBL230897	=	IC50	nM	204.0	CHEMBL267	Homo sapiens	IC50	uM	0.204
	1891360	CHEMBL905921	Inhibition of Src	B	COc1ccc(Cl)cc1-c1cc(C)c2nc(Nc3ccc(OCCN4CCCC4)cc3)nnc2c1		CHEMBL230793	=	IC50	nM	1200.0	CHEMBL267	Homo sapiens	IC50	uM	1.2
	1891361	CHEMBL905921	Inhibition of Src	B	COc1ccc(Cl)c(-c2cc(C)c3nc(Nc4ccc(OCCN5CCCC5)cc4)nnc3c2)c1		CHEMBL394765	=	IC50	nM	778.0	CHEMBL267	Homo sapiens	IC50	uM	0.778
	1891362	CHEMBL905921	Inhibition of Src	B	COc1cccc(Cl)c1-c1cc(C)c2nc(Nc3ccc(OCCN4CCCC4)cc3)nnc2c1		CHEMBL230792	=	IC50	nM	505.0	CHEMBL267	Homo sapiens	IC50	uM	0.505
	1891363	CHEMBL905921	Inhibition of Src	B	COc1cc2c(cc1O)CCN[C@]21CS[C@H]2c3c(OC(C)=O)c(C)c4c(c3[C@@H](COC1=O)N1[C@@H](O)[C@@H]3Cc5cc(C)c(OC)c(O)c5[C@H]([C@H]21)N3C)OCO4		CHEMBL1224207	=	IC50	nM	208.0	CHEMBL267	Homo sapiens	IC50	uM	0.208
	1891364	CHEMBL905921	Inhibition of Src	B	Cc1cc(-c2ccccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL268825	=	IC50	nM	35.0	CHEMBL267	Homo sapiens	IC50	uM	0.035
	1891365	CHEMBL905921	Inhibition of Src	B	Cc1cc(-c2c(Cl)cccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL230686	=	IC50	nM	11.0	CHEMBL267	Homo sapiens	IC50	uM	0.011
	1891366	CHEMBL905921	Inhibition of Src	B	Cc1cc(-c2ccccc2)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL230685	=	IC50	nM	341.0	CHEMBL267	Homo sapiens	IC50	uM	0.341
	1891367	CHEMBL905921	Inhibition of Src	B	Cc1cccc(C)c1-c1cc(NS(C)(=O)=O)c2nc(Nc3ccc(OCCN4CCCC4)cc3)nnc2c1		CHEMBL390479	=	IC50	nM	21.0	CHEMBL267	Homo sapiens	IC50	uM	0.021
	1891368	CHEMBL905921	Inhibition of Src	B	CC(=O)Nc1cc(-c2c(C)cccc2C)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL231251	=	IC50	nM	14.0	CHEMBL267	Homo sapiens	IC50	uM	0.014
	1891369	CHEMBL905921	Inhibition of Src	B	CNc1cc(-c2c(C)cccc2C)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL230830	=	IC50	nM	10.0	CHEMBL267	Homo sapiens	IC50	uM	0.01
	1891370	CHEMBL905921	Inhibition of Src	B	Cc1cccc(C)c1-c1cc(N)c2nc(Nc3ccc(OCCN4CCCC4)cc3)nnc2c1		CHEMBL230829	=	IC50	nM	10.0	CHEMBL267	Homo sapiens	IC50	uM	0.01
	1891446	CHEMBL905921	Inhibition of Src	B	Cc1cc(-c2c(Cl)cccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL230686	=	Ki	nM	28.1	CHEMBL267	Homo sapiens	Ki	nM	28.1
Dose-dependent effect	1891449	CHEMBL905871	Inhibition of Fak-Y861 phosphorylation in A549 cells xenografted in nu/nu mouse	F	Cc1cc(-c2c(Cl)cccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL230686		Activity			CHEMBL267	Homo sapiens	Activity		
Active	1891450	CHEMBL905872	Inhibition of Fak-Y861 phosphorylation in A549 cells xenografted in (nu/nu) mouse at 40 mg/kg, ip	F	Cc1cc(-c2c(Cl)cccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL230686		Activity			CHEMBL267	Homo sapiens	Activity		
	1898415	CHEMBL887687	Inhibition of cSRC	B	Cc1cc(Nc2ncnc3cnc(N4CCOCC4)cc23)ccc1Oc1ccc(C(=O)NCC(C)(C)C)cc1		CHEMBL375671	>	Activity	uM	10.0	CHEMBL267	Homo sapiens	Activity	uM	10.0
Not Active	1912283	CHEMBL889660	Binding affinity to SRC	B	CCOC(=O)c1cnn(CC(O)c2ccccc2)c1NC(=O)NC(C)C		CHEMBL450013		Activity			CHEMBL267	Homo sapiens	Activity		
Not Active	1912296	CHEMBL889660	Binding affinity to SRC	B	CCOC(=O)c1cnn(CC(O)c2ccccc2)c1NC(=O)Nc1ccccc1		CHEMBL226939		Activity			CHEMBL267	Homo sapiens	Activity		
Not Active	1912297	CHEMBL889660	Binding affinity to SRC	B	CCOC(=O)c1cnn(CC(O)c2ccccc2)c1NC(=O)NCc1ccccc1		CHEMBL226836		Activity			CHEMBL267	Homo sapiens	Activity		
Active	1914359	CHEMBL894848	Inhibition of thrombin-induced pp60src activation at 10 uM after 30 mins	B	Oc1cc(O)c2c(c1)O[C@@]1(c3ccc(O)c(O)c3)Oc3cc(O)c4c(c3[C@@H]2[C@H]1O)O[C@H](c1ccc(O)c(O)c1)[C@H](O)[C@H]4c1c(O)cc(O)c2c1O[C@H](c1ccc(O)c(O)c1)[C@H](O)C2		CHEMBL540956		Activity			CHEMBL267	Homo sapiens	Activity		
Active	1914360	CHEMBL894849	Inhibition of thrombin-induced pp60src activation in presence of catalase	B	Oc1cc(O)c2c(c1)O[C@@]1(c3ccc(O)c(O)c3)Oc3cc(O)c4c(c3[C@@H]2[C@H]1O)O[C@H](c1ccc(O)c(O)c1)[C@H](O)[C@H]4c1c(O)cc(O)c2c1O[C@H](c1ccc(O)c(O)c1)[C@H](O)C2		CHEMBL540956		Activity			CHEMBL267	Homo sapiens	Activity		
	1916316	CHEMBL894114	Inhibition of recombinant SRC by radiometric assay	B	COc1cc(-c2ccc3c(c2)Nc2ccc(CC(=O)Nc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1N		CHEMBL395080	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	1916368	CHEMBL894114	Inhibition of recombinant SRC by radiometric assay	B	COc1cc(-c2ccc3c(c2)Nc2ccc(C(C)(C)C(=O)Nc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1N		CHEMBL389745	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	1917346	CHEMBL895123	Inhibition of Src at 10 uM	B	O=C1NC(=O)c2c1c1[nH]cnc1c1[nH]c3ccccc3c21		CHEMBL240747	=	Inhibition	%	58.0	CHEMBL267	Homo sapiens	Inhibition	%	58.0
	1917386	CHEMBL895117	Inhibition of Src	B	O=C1NC(=O)c2c1c1[nH]cnc1c1[nH]c3ccccc3c21		CHEMBL240747	=	IC50	nM	350.0	CHEMBL267	Homo sapiens	IC50	uM	0.35
	1917387	CHEMBL895117	Inhibition of Src	B	O=C1NC(=O)c2c1c1c(O)ccc(O)c1c1[nH]c3ccc(O)cc3c21		CHEMBL397022	=	IC50	nM	5400.0	CHEMBL267	Homo sapiens	IC50	uM	5.4
	1917391	CHEMBL895123	Inhibition of Src at 10 uM	B	O=C1NC(=O)c2c1c1c(O)ccc(O)c1c1[nH]c3ccc(O)cc3c21		CHEMBL397022	=	Inhibition	%	83.5	CHEMBL267	Homo sapiens	Inhibition	%	83.5
	1917393	CHEMBL895123	Inhibition of Src at 10 uM	B	O=C1NC(=O)c2c1c1c(O)ccc(O)c1c1[nH]c3ccccc3c21		CHEMBL244140	=	Inhibition	%	2.5	CHEMBL267	Homo sapiens	Inhibition	%	2.5
	1917394	CHEMBL895123	Inhibition of Src at 10 uM	B	O=c1ccc(=O)c2c1c1[nH]c3ccc(O)cc3c1c1c(=O)[nH]c(=O)c21		CHEMBL243931	=	Inhibition	%	63.0	CHEMBL267	Homo sapiens	Inhibition	%	63.0
	1917395	CHEMBL895123	Inhibition of Src at 10 uM	B	Cc1ccc2[nH]c3c4c(=O)ccc(=O)c4c4c(=O)[nH]c(=O)c4c3c2c1		CHEMBL388037	=	Inhibition	%	52.5	CHEMBL267	Homo sapiens	Inhibition	%	52.5
	1917397	CHEMBL895123	Inhibition of Src at 10 uM	B	O=C1NC(=O)c2c1c1c(O)cccc1c1[nH]c3ccccc3c21		CHEMBL388434	=	Inhibition	%	35.0	CHEMBL267	Homo sapiens	Inhibition	%	35.0
Not Active	1917398	CHEMBL895123	Inhibition of Src at 10 uM	B	O=C1CCc2c1c1c(c3c2[nH]c2ccccc23)C(=O)NC1=O		CHEMBL395016		Activity			CHEMBL267	Homo sapiens	Activity		
	1917399	CHEMBL895123	Inhibition of Src at 10 uM	B	O=C1NC(=O)c2c1c1c(c3[nH]c4ccccc4c23)C(=O)CCC1		CHEMBL230868	=	Inhibition	%	8.5	CHEMBL267	Homo sapiens	Inhibition	%	8.5
Not Active	1917400	CHEMBL895123	Inhibition of Src at 10 uM	B	O=c1[nH]c(=O)c2c1c1[nH]c3ccccc3c1c1c(=O)[nH]c(=O)c21		CHEMBL388648		Activity			CHEMBL267	Homo sapiens	Activity		
	1922376	CHEMBL895908	Inhibition of Src kinase	B	CNC(=O)c1cc(Oc2ccc3oc(Nc4ccc(Cl)c(OC[C@@H]5CCCN5C)c4)nc3c2)ccn1		CHEMBL231568	=	IC50	nM	720.0	CHEMBL267	Homo sapiens	IC50	uM	0.72
	1923375	CHEMBL896202	Inhibition of Src	B	N#Cc1cnc2c(F)cc(NCc3c[nH]cn3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL245212	=	IC50	nM	20000.0	CHEMBL267	Homo sapiens	IC50	uM	20.0
	1923391	CHEMBL896202	Inhibition of Src	B	Cn1cnc(CNc2cc(Br)c3ncc(C#N)c(Nc4ccc(F)c(Cl)c4)c3c2)c1		CHEMBL230761	>	IC50	nM	40000.0	CHEMBL267	Homo sapiens	IC50	uM	40.0
	1923392	CHEMBL896202	Inhibition of Src	B	CCCc1[nH]cnc1CNc1cc(Cl)c2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2c1		CHEMBL230654	>	IC50	nM	40000.0	CHEMBL267	Homo sapiens	IC50	uM	40.0
	1923393	CHEMBL896202	Inhibition of Src	B	CN(C)CCCn1cc(CNc2cc(Br)c3ncc(C#N)c(Nc4ccc(F)c(Cl)c4)c3c2)nn1		CHEMBL425834	>	IC50	nM	40000.0	CHEMBL267	Homo sapiens	IC50	uM	40.0
	1923394	CHEMBL896202	Inhibition of Src	B	N#Cc1cnc2c(Br)cc(NCc3c[nH]nn3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL230232	=	IC50	nM	40800.0	CHEMBL267	Homo sapiens	IC50	uM	40.8
	1923395	CHEMBL896202	Inhibition of Src	B	N#Cc1cnc2c(Cl)cc(NCc3cccc[n+]3[O-])cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL395573	>	IC50	nM	40000.0	CHEMBL267	Homo sapiens	IC50	uM	40.0
	1923396	CHEMBL896202	Inhibition of Src	B	N#Cc1cnc2c(Cl)cc(NCc3cnc[nH]3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL436817	=	IC50	nM	19900.0	CHEMBL267	Homo sapiens	IC50	uM	19.9
	1944473	CHEMBL891250	Inhibition of SRC by radiometric assay	B	O=C(N[C@H]1CC[C@H](O)CC1)c1ccc2c(c1)Cc1c(-c3ccc(-c4ccc(O)cc4)cc3)n[nH]c1-2		CHEMBL438485	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	nM	50000.0
	1944474	CHEMBL891250	Inhibition of SRC by radiometric assay	B	O=C(NCc1ccncc1)c1ccc2c(c1)Cc1c(-c3ccc(-c4ccc(O)cc4)cc3)n[nH]c1-2		CHEMBL242753	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	nM	50000.0
	1964241	CHEMBL897079	Inhibition of Src	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	<	IC50	nM	10000.0	CHEMBL267	Homo sapiens	pIC50		5.0
	1964251	CHEMBL897079	Inhibition of Src	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	<	IC50	nM	10000.0	CHEMBL267	Homo sapiens	pIC50		5.0
	1964482	CHEMBL897109	Inhibition of Src	B	CCN(CC)C/C=C/c1cnc(N)c2c(-c3ccc(NC(=O)c4cc5ccccc5n4C)c(OC)c3)csc12		CHEMBL232542	=	IC50	nM	9050.0	CHEMBL267	Homo sapiens	IC50	uM	9.05
	1964491	CHEMBL897109	Inhibition of Src	B	COc1cc(-c2csc3c(/C=C/CNC4CCNCC4)cnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL395664	=	IC50	nM	14400.0	CHEMBL267	Homo sapiens	IC50	uM	14.4
	1964496	CHEMBL897109	Inhibition of Src	B	COc1cc(-c2csc3c(/C=C/CN[C@H]4CC[C@H](N)CC4)cnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL395665	=	IC50	nM	19700.0	CHEMBL267	Homo sapiens	IC50	uM	19.7
	1964501	CHEMBL897109	Inhibition of Src	B	COc1cc(-c2csc3c(/C=C/CN[C@H]4CC[C@@H](N)CC4)cnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL395666	=	IC50	nM	27100.0	CHEMBL267	Homo sapiens	IC50	uM	27.1
	1964506	CHEMBL897109	Inhibition of Src	B	COc1cc(-c2csc3c(/C=C/CN4CCC(O)CC4)cnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL233958	=	IC50	nM	33900.0	CHEMBL267	Homo sapiens	IC50	uM	33.9
	1975578	CHEMBL898651	Inhibition of Src tyrosine kinase at 1 uM after 20 mins	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1cccn21		CHEMBL393545	=	Inhibition	%	32.5	CHEMBL267	Homo sapiens	Inhibition	%	32.5
	1975579	CHEMBL898651	Inhibition of Src tyrosine kinase at 1 uM after 20 mins	B	O=C1NC(=O)c2c1c1c3cc(O)ccc3[nH]c1c1cccn21		CHEMBL239698	=	Inhibition	%	1.2	CHEMBL267	Homo sapiens	Inhibition	%	1.2
	1975580	CHEMBL898651	Inhibition of Src tyrosine kinase at 1 uM after 20 mins	B	O=C1NC(=O)c2c1c1c3cc(Br)ccc3[nH]c1c1cccn21		CHEMBL238625	=	Inhibition	%	22.3	CHEMBL267	Homo sapiens	Inhibition	%	22.3
	1975581	CHEMBL898651	Inhibition of Src tyrosine kinase at 1 uM after 20 mins	B	O=C1NC(=O)c2c1c1c3cc(Cl)ccc3[nH]c1c1cccn21		CHEMBL392052	=	Inhibition	%	22.1	CHEMBL267	Homo sapiens	Inhibition	%	22.1
	1980900	CHEMBL898030	Inhibition of Src kinase	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1NC1CCCCCC1		CHEMBL236384	=	IC50	nM	38000.0	CHEMBL267	Homo sapiens	IC50	uM	38.0
Not Active	1980909	CHEMBL898031	Inhibition of Src kinase at 40 uM	B	N#Cc1cnc2ccc(NCc3c[nH]cn3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL220037		Activity			CHEMBL267	Homo sapiens	Activity		
	1981761	CHEMBL899277	Inhibition of Src assessed as residual activity at 0.01 uM	B	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H]1C[C@@H](O)[C@H](n2cnc3c(N)ncnc32)C1)C(N)=O		CHEMBL397521	=	Activity	%	85.0	CHEMBL267	Homo sapiens	Activity	%	85.0
	1981762	CHEMBL899278	Inhibition of Src assessed as residual activity at 1 uM	B	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H]1C[C@@H](O)[C@H](n2cnc3c(N)ncnc32)C1)C(N)=O		CHEMBL397521	=	Activity	%	84.0	CHEMBL267	Homo sapiens	Activity	%	84.0
Active	1989330	CHEMBL899079	Inhibitory of c-SRC	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3csc(C=O)n3)ccc12		CHEMBL237127		Activity			CHEMBL267	Homo sapiens	Activity		
Active	1989331	CHEMBL899079	Inhibitory of c-SRC	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3csc(CN4CCOCC4)n3)c(S(C)(=O)=O)cc12		CHEMBL399208		Activity			CHEMBL267	Homo sapiens	Activity		
Active	1989332	CHEMBL899079	Inhibitory of c-SRC	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347		Activity			CHEMBL267	Homo sapiens	Activity		
	1989377	CHEMBL898059	Inhibition of SRC at 1 uM	B	CC(C)NCc1ccc(Nc2cc(-c3ccc(-c4ccc(O)cc4O)cc3)[nH]n2)cc1		CHEMBL398606	=	Inhibition	%	8.0	CHEMBL267	Homo sapiens	Inhibition	%	8.0
	1996091	CHEMBL899855	Inhibition of human recombinant Src	B	CSc1nc(NCCc2ccccc2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL289125	=	Ki	nM	700.0	CHEMBL267	Homo sapiens	Ki	uM	0.7
	1996143	CHEMBL899855	Inhibition of human recombinant Src	B	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	=	Ki	nM	500.0	CHEMBL267	Homo sapiens	Ki	uM	0.5
	1996144	CHEMBL899855	Inhibition of human recombinant Src	B	CSc1nc(Nc2cccc(Br)c2)c2cnn(CC(Cl)c3ccc(F)cc3)c2n1		CHEMBL399627	=	Ki	nM	4100.0	CHEMBL267	Homo sapiens	Ki	uM	4.1
	1996145	CHEMBL899855	Inhibition of human recombinant Src	B	Clc1cccc(Nc2ncnc3c2cnn3CC(Cl)c2ccccc2)c1		CHEMBL238774	=	Ki	nM	3800.0	CHEMBL267	Homo sapiens	Ki	uM	3.8
	1996146	CHEMBL899855	Inhibition of human recombinant Src	B	CCCSc1nc(Nc2cccc(Cl)c2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL401447	=	Ki	nM	1200.0	CHEMBL267	Homo sapiens	Ki	uM	1.2
	1996147	CHEMBL899855	Inhibition of human recombinant Src	B	CCSc1nc(Nc2cccc(Cl)c2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL428029	=	Ki	nM	500.0	CHEMBL267	Homo sapiens	Ki	uM	0.5
	1996148	CHEMBL899855	Inhibition of human recombinant Src	B	CSc1nc(Nc2ccccc2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL401238	=	Ki	nM	1200.0	CHEMBL267	Homo sapiens	Ki	uM	1.2
	1996149	CHEMBL899855	Inhibition of human recombinant Src	B	CSc1nc(Nc2cccc(Br)c2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL238561	=	Ki	nM	1800.0	CHEMBL267	Homo sapiens	Ki	uM	1.8
	1996150	CHEMBL899855	Inhibition of human recombinant Src	B	CSc1nc(Nc2cccc(F)c2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL238559	=	Ki	nM	1400.0	CHEMBL267	Homo sapiens	Ki	uM	1.4
	1996151	CHEMBL899855	Inhibition of human recombinant Src	B	CSc1nc(Nc2cccc(Cl)c2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL400211	=	Ki	nM	600.0	CHEMBL267	Homo sapiens	Ki	uM	0.6
	1996152	CHEMBL899855	Inhibition of human recombinant Src	B	CSc1nc(NCc2ccccc2)c2cnn(CC(Cl)c3ccc(F)cc3)c2n1		CHEMBL241750	=	Ki	nM	35000.0	CHEMBL267	Homo sapiens	Ki	uM	35.0
	1996153	CHEMBL899855	Inhibition of human recombinant Src	B	CSc1nc(NCc2ccccc2)c2cnn(CC(Cl)c3ccc(Cl)cc3)c2n1		CHEMBL241749	=	Ki	nM	3000.0	CHEMBL267	Homo sapiens	Ki	uM	3.0
	1996154	CHEMBL899855	Inhibition of human recombinant Src	B	CSc1nc(NCc2ccc(F)cc2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL241540	=	Ki	nM	4600.0	CHEMBL267	Homo sapiens	Ki	uM	4.6
	1996155	CHEMBL899855	Inhibition of human recombinant Src	B	CSc1nc(NCc2cccc(F)c2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL241539	=	Ki	nM	5200.0	CHEMBL267	Homo sapiens	Ki	uM	5.2
	1996156	CHEMBL899855	Inhibition of human recombinant Src	B	CSc1nc(NCc2ccccc2F)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL391724	=	Ki	nM	21000.0	CHEMBL267	Homo sapiens	Ki	uM	21.0
	1996157	CHEMBL899855	Inhibition of human recombinant Src	B	CSc1nc(NCc2ccc(Cl)cc2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL239192	=	Ki	nM	24000.0	CHEMBL267	Homo sapiens	Ki	uM	24.0
	1996158	CHEMBL899855	Inhibition of human recombinant Src	B	CSc1nc(NCc2ccccc2Cl)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL236375	=	Ki	nM	3100.0	CHEMBL267	Homo sapiens	Ki	uM	3.1
	1996159	CHEMBL899855	Inhibition of human recombinant Src	B	CSc1nc(NCc2ccccc2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL288280	=	Ki	nM	3700.0	CHEMBL267	Homo sapiens	Ki	uM	3.7
	1996160	CHEMBL899855	Inhibition of human recombinant Src	B	CCSc1nc(NCCc2ccccc2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL392301	=	Ki	nM	7500.0	CHEMBL267	Homo sapiens	Ki	uM	7.5
	1996161	CHEMBL899855	Inhibition of human recombinant Src	B	CSc1nc(NCCc2ccccc2)c2cnn(CC(Cl)c3ccc(Cl)cc3)c2n1		CHEMBL238304	=	Ki	nM	2800.0	CHEMBL267	Homo sapiens	Ki	uM	2.8
	1996162	CHEMBL899855	Inhibition of human recombinant Src	B	COc1ccc(CCNc2nc(SC)nc3c2cnn3CC(Cl)c2ccccc2)cc1		CHEMBL399813	=	Ki	nM	4000.0	CHEMBL267	Homo sapiens	Ki	uM	4.0
	1996163	CHEMBL899855	Inhibition of human recombinant Src	B	CSc1nc(NCCc2ccc(C)cc2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL415264	=	Ki	nM	15000.0	CHEMBL267	Homo sapiens	Ki	uM	15.0
	1996164	CHEMBL899855	Inhibition of human recombinant Src	B	CSc1nc(NCCc2ccc(Cl)cc2)c2ccn(CC(Cl)c3ccccc3)c2n1		CHEMBL401038	=	Ki	nM	25000.0	CHEMBL267	Homo sapiens	Ki	uM	25.0
	1996165	CHEMBL899855	Inhibition of human recombinant Src	B	CSc1nc(NCCc2cccc(Cl)c2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL235758	=	Ki	nM	6000.0	CHEMBL267	Homo sapiens	Ki	uM	6.0
	1996166	CHEMBL899855	Inhibition of human recombinant Src	B	CSc1nc(NCCc2ccccc2Cl)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL235757	=	Ki	nM	4000.0	CHEMBL267	Homo sapiens	Ki	uM	4.0
	1996167	CHEMBL899855	Inhibition of human recombinant Src	B	CSc1nc(NCCc2cccc(F)c2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL235756	=	Ki	nM	13000.0	CHEMBL267	Homo sapiens	Ki	uM	13.0
	1996223	CHEMBL898745	Reduction of Src phosphorylation	B	CSc1nc(Nc2cccc(Cl)c2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL400211	=	Activity	%	62.0	CHEMBL267	Homo sapiens	Activity	%	62.0
	1996224	CHEMBL898745	Reduction of Src phosphorylation	B	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	=	Activity	%	77.0	CHEMBL267	Homo sapiens	Activity	%	77.0
	1998225	CHEMBL900107	Inhibition of Src	B	COc1cc2ncc3c(N)nc4c(C)c(N)ccc4c3c2cc1OC		CHEMBL235157	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	2000757	CHEMBL901543	Inhibition of Src	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	IC50	nM	1.5	CHEMBL267	Homo sapiens	IC50	nM	1.5
	2000762	CHEMBL901543	Inhibition of Src	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCF)CC2)n1		CHEMBL240158	=	IC50	nM	3.5	CHEMBL267	Homo sapiens	IC50	nM	3.5
	2000786	CHEMBL901561	Inhibition of Src at 10 nM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCF)CC2)n1		CHEMBL240158	=	Inhibition	%	97.5	CHEMBL267	Homo sapiens	Inhibition	%	97.5
	2000807	CHEMBL901561	Inhibition of Src at 10 nM	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Inhibition	%	89.8	CHEMBL267	Homo sapiens	Inhibition	%	89.8
	2017675	CHEMBL885859	Inhibition of Src activity	F	COc1cc(Nc2c(C#N)cnc3cc(C#CCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL241040	=	IC50	nM	11.0	CHEMBL267	Homo sapiens	IC50	nM	11.0
	2017676	CHEMBL885859	Inhibition of Src activity	F	COc1cc(Nc2c(C#N)cnc3cc(C#CCCN4CCN(C)CC4)ccc23)cc(OC)c1OC		CHEMBL239996	=	IC50	nM	220.0	CHEMBL267	Homo sapiens	IC50	nM	220.0
	2017677	CHEMBL885859	Inhibition of Src activity	F	COc1cc2c(Nc3cc(OC)c(OC)c(OC)c3)c(C#N)cnc2cc1C#CCCN1CCN(C)CC1		CHEMBL239160	=	IC50	nM	21.0	CHEMBL267	Homo sapiens	IC50	nM	21.0
	2017678	CHEMBL885859	Inhibition of Src activity	F	CCOc1cc2c(Nc3cc(OC)c(Cl)cc3Cl)c(C#N)cnc2cc1C#CCCN1CCN(C)CC1		CHEMBL240830	=	IC50	nM	4.1	CHEMBL267	Homo sapiens	IC50	nM	4.1
	2017679	CHEMBL885859	Inhibition of Src activity	F	COc1cc2c(Nc3ccc(Cl)cc3Cl)c(C#N)cnc2cc1C#CCCN1CCN(C)CC1		CHEMBL240829	=	IC50	nM	8.7	CHEMBL267	Homo sapiens	IC50	nM	8.7
	2017680	CHEMBL885859	Inhibition of Src activity	F	COc1cc(Nc2c(C#N)cnc3ccc(C#CCCN4CCN(C)CC4)cc23)c(Cl)cc1Cl		CHEMBL393150	=	IC50	nM	230.0	CHEMBL267	Homo sapiens	IC50	nM	230.0
	2017681	CHEMBL885859	Inhibition of Src activity	F	COc1cc(Nc2c(C#N)cnc3cc(C#CCCN4CCN(C)CC4)ccc23)c(Cl)cc1Cl		CHEMBL240415	=	IC50	nM	28.0	CHEMBL267	Homo sapiens	IC50	nM	28.0
	2017682	CHEMBL885859	Inhibition of Src activity	F	COc1cc(Nc2c(C#N)cnc3cc(C#CCCN4CCNCC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL240413	=	IC50	nM	5.4	CHEMBL267	Homo sapiens	IC50	nM	5.4
	2017683	CHEMBL885859	Inhibition of Src activity	F	COc1cc(Nc2c(C#N)cnc3cc(C#CCCN4CCOCC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL240207	=	IC50	nM	4.1	CHEMBL267	Homo sapiens	IC50	nM	4.1
	2017684	CHEMBL885859	Inhibition of Src activity	F	COc1cc(Nc2c(C#N)cnc3cc(C#CCCN(C)C)c(OC)cc23)c(Cl)cc1Cl		CHEMBL239140	=	IC50	nM	4.9	CHEMBL267	Homo sapiens	IC50	nM	4.9
	2017685	CHEMBL885859	Inhibition of Src activity	F	COc1cc(Nc2c(C#N)cnc3cc(C#CCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL391738	=	IC50	nM	3.9	CHEMBL267	Homo sapiens	IC50	nM	3.9
	2019930	CHEMBL903333	Inhibition of SRC	B	CCOc1cccc2c1c(/C=C1\C(=O)NN=C1c1snnc1C)cn2C		CHEMBL398610	=	IC50	nM	463.0	CHEMBL267	Homo sapiens	IC50	nM	463.0
	2021692	CHEMBL903568	Inhibition of human SRC	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	IC50	nM	537.03	CHEMBL267	Homo sapiens	Log IC50		-6.27
	2022203	CHEMBL902557	Inhibition of Src	B	c1ccc(-c2c(-c3ccc(OCCN4CCCC4)cc3)oc3ncnc(NCCN4CCNCC4)c23)cc1		CHEMBL247468	=	IC50	nM	45.0	CHEMBL267	Homo sapiens	IC50	uM	0.045
	2022211	CHEMBL902557	Inhibition of Src	B	CC(C)Nc1ncnc2oc(-c3ccc(OCCN4CCCC4)cc3)c(-c3ccccc3)c12		CHEMBL247866	=	IC50	nM	914.0	CHEMBL267	Homo sapiens	IC50	uM	0.914
	2025135	CHEMBL886962	Inhibition of human cSRC at 1 uM relative to control	B	CN(C)c1cc2cc(n1)CCCn1cc(c3ccccc31)C1=C(C(=O)NC1=O)c1cn(c3ccccc13)CCC2		CHEMBL247067	=	Inhibition	%	105.0	CHEMBL267	Homo sapiens	Inhibition	%	105.0
	2025297	CHEMBL886962	Inhibition of human cSRC at 1 uM relative to control	B	CN(C)c1nc2ccc1CCCn1cc(c3ccccc31)C1=C(C(=O)NC1=O)c1cn(c3ccccc13)CC2		CHEMBL1162963	=	Inhibition	%	81.0	CHEMBL267	Homo sapiens	Inhibition	%	81.0
	2025298	CHEMBL886962	Inhibition of human cSRC at 1 uM relative to control	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCCc1ccc(c(N3CCCC3)n1)CCCn1cc2c2ccccc21		CHEMBL396327	=	Inhibition	%	113.0	CHEMBL267	Homo sapiens	Inhibition	%	113.0
	2025299	CHEMBL886962	Inhibition of human cSRC at 1 uM relative to control	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCCc1cc(nc(N3CCCC3)c1)CCCn1cc2c2ccccc21		CHEMBL397771	=	Inhibition	%	97.0	CHEMBL267	Homo sapiens	Inhibition	%	97.0
	2025981	CHEMBL887086	Inhibition of Src by radioactive filtration assay	B	CNc1ncnc(-c2cccnc2Oc2cc(NC(=O)c3cccc(OC(F)(F)C(F)F)c3)ccc2C)n1		CHEMBL246356	=	IC50	nM	2195.0	CHEMBL267	Homo sapiens	IC50	nM	2195.0
	2027331	CHEMBL906399	Inhibition of Src by HTRF assay	B	COCC(=O)Nc1cccc2c1Cc1c-2n[nH]c1-c1csc(C#CCOc2ccccc2)c1		CHEMBL245769	=	IC50	nM	43311.0	CHEMBL267	Homo sapiens	IC50	uM	43.311
	2027360	CHEMBL906399	Inhibition of Src by HTRF assay	B	CN1CCN(CC(=O)Nc2cccc3c2Cc2c-3n[nH]c2-c2csc(C#CCOc3ccccc3)c2)CC1		CHEMBL245377	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	2027361	CHEMBL906399	Inhibition of Src by HTRF assay	B	CCOC(=O)CC(=O)Nc1cccc2c1Cc1c-2n[nH]c1-c1csc(C#CCOc2ccccc2)c1		CHEMBL395427	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	2027362	CHEMBL906399	Inhibition of Src by HTRF assay	B	COC(=O)C(=O)Nc1cccc2c1Cc1c-2n[nH]c1-c1csc(C#CCOc2ccccc2)c1		CHEMBL246166	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	2027363	CHEMBL906399	Inhibition of Src by HTRF assay	B	COCCOCC(=O)Nc1cccc2c1Cc1c-2n[nH]c1-c1csc(C#CCOc2ccccc2)c1		CHEMBL245968	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	2029834	CHEMBL886300	Inhibition of SRC at 10 uM	B	O=C1Cc2cnn(-c3ccccc3)c2-c2ccccc2N1		CHEMBL250583	<=	Inhibition	%	40.0	CHEMBL267	Homo sapiens	Inhibition	%	40.0
	2029908	CHEMBL886300	Inhibition of SRC at 10 uM	B	O=C1Cc2cnn(-c3ccc([N+](=O)[O-])cc3)c2-c2ccccc2N1		CHEMBL400310	<=	Inhibition	%	40.0	CHEMBL267	Homo sapiens	Inhibition	%	40.0
	2029909	CHEMBL886300	Inhibition of SRC at 10 uM	B	O=C1Cc2cnn(-c3ccc(F)cc3F)c2-c2ccccc2N1		CHEMBL248954	<=	Inhibition	%	40.0	CHEMBL267	Homo sapiens	Inhibition	%	40.0
	2029910	CHEMBL886300	Inhibition of SRC at 10 uM	B	O=C1Cc2cnn(-c3ccccc3Br)c2-c2ccccc2N1		CHEMBL400113	<=	Inhibition	%	40.0	CHEMBL267	Homo sapiens	Inhibition	%	40.0
	2029911	CHEMBL886300	Inhibition of SRC at 10 uM	B	O=C1Cc2cnn(-c3ccccc3F)c2-c2ccccc2N1		CHEMBL399076	<=	Inhibition	%	40.0	CHEMBL267	Homo sapiens	Inhibition	%	40.0
	2029912	CHEMBL886300	Inhibition of SRC at 10 uM	B	O=C1Cc2cnn(-c3cccc(Cl)c3)c2-c2ccccc2N1		CHEMBL248760	<=	Inhibition	%	40.0	CHEMBL267	Homo sapiens	Inhibition	%	40.0
	2029913	CHEMBL886300	Inhibition of SRC at 10 uM	B	O=C1Cc2cnn(-c3ccccc3Cl)c2-c2ccccc2N1		CHEMBL248759	<=	Inhibition	%	40.0	CHEMBL267	Homo sapiens	Inhibition	%	40.0
	2029914	CHEMBL886300	Inhibition of SRC at 10 uM	B	CC(C)(C)c1ccc(-n2ncc3c2-c2ccccc2NC(=O)C3)cc1		CHEMBL398877	<=	Inhibition	%	40.0	CHEMBL267	Homo sapiens	Inhibition	%	40.0
	2029915	CHEMBL886300	Inhibition of SRC at 10 uM	B	O=C1Cc2cnn(-c3cc(Cl)cc(Cl)c3)c2-c2ccccc2N1		CHEMBL248758	<=	Inhibition	%	40.0	CHEMBL267	Homo sapiens	Inhibition	%	40.0
	2029916	CHEMBL886300	Inhibition of SRC at 10 uM	B	O=C1Cc2cnn(-c3ccc(C(F)(F)F)cc3)c2-c2ccccc2N1		CHEMBL398876	<=	Inhibition	%	40.0	CHEMBL267	Homo sapiens	Inhibition	%	40.0
	2029917	CHEMBL886300	Inhibition of SRC at 10 uM	B	Cc1ccc(-n2ncc3c2-c2ccccc2NC(=O)C3)cc1		CHEMBL400898	<=	Inhibition	%	40.0	CHEMBL267	Homo sapiens	Inhibition	%	40.0
	2029918	CHEMBL886300	Inhibition of SRC at 10 uM	B	COc1ccc(-n2ncc3c2-c2ccccc2NC(=O)C3)cc1		CHEMBL248558	<=	Inhibition	%	40.0	CHEMBL267	Homo sapiens	Inhibition	%	40.0
	2029919	CHEMBL886300	Inhibition of SRC at 10 uM	B	Cc1ccccc1-n1ncc2c1-c1ccccc1NC(=O)C2		CHEMBL400897	<=	Inhibition	%	40.0	CHEMBL267	Homo sapiens	Inhibition	%	40.0
	2029920	CHEMBL886300	Inhibition of SRC at 10 uM	B	O=C1Cc2cnn(-c3ccc(Cl)cc3)c2-c2ccccc2N1		CHEMBL248557	<=	Inhibition	%	40.0	CHEMBL267	Homo sapiens	Inhibition	%	40.0
	2029921	CHEMBL886300	Inhibition of SRC at 10 uM	B	O=C1Cc2cnn(-c3ccc(Br)cc3)c2-c2ccccc2N1		CHEMBL398288	<=	Inhibition	%	40.0	CHEMBL267	Homo sapiens	Inhibition	%	40.0
	2035446	CHEMBL907532	Inhibition of Src	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-c3ccc(CN4CCOCC4)nc3)c3ccccc23)cc1		CHEMBL381743	=	IC50	nM	1000.0	CHEMBL267	Homo sapiens	IC50	uM	1.0
	2045357	CHEMBL923927	Inhibition of SRC	B	N#Cc1cnc2cc(-c3ccc(CN4CCOCC4)cc3)ccc2c1N[C@@H]1C[C@H]1c1ccccc1		CHEMBL399438	=	Ki	nM	140.0	CHEMBL267	Homo sapiens	Ki	uM	0.14
	2045402	CHEMBL923927	Inhibition of SRC	B	COc1cc2ncc(C#N)c(N[C@@H]3C[C@H]3c3ccccc3)c2cc1OC		CHEMBL248044	=	Ki	nM	150.0	CHEMBL267	Homo sapiens	Ki	uM	0.15
	2045431	CHEMBL923927	Inhibition of SRC	B	COc1cc2c(N[C@@H]3C[C@H]3c3ccccc3)c(C#N)cnc2cc1OC1CCN(C)CC1		CHEMBL245798	>	Ki	nM	10000.0	CHEMBL267	Homo sapiens	Ki	uM	10.0
	2045432	CHEMBL923927	Inhibition of SRC	B	COc1cc2ncc(C#N)c(N[C@@H]3C[C@H]3c3ccccc3)c2cc1OCCCc1cccnc1		CHEMBL248222	>	Ki	nM	10000.0	CHEMBL267	Homo sapiens	Ki	uM	10.0
	2045433	CHEMBL923927	Inhibition of SRC	B	COc1cc2ncc(C#N)c(N[C@@H]3C[C@H]3c3ccccc3)c2cc1OCCCN1CCOCC1		CHEMBL248221	>	Ki	nM	10000.0	CHEMBL267	Homo sapiens	Ki	uM	10.0
	2045434	CHEMBL923927	Inhibition of SRC	B	COc1cc2ncc(C#N)c(N[C@@H]3C[C@H]3c3ccccc3)c2cc1OCCN1CCOCC1		CHEMBL401054	>	Ki	nM	10000.0	CHEMBL267	Homo sapiens	Ki	uM	10.0
	2045467	CHEMBL923927	Inhibition of SRC	B	N#Cc1cnc2ccc(-c3ccc(CN4CCOCC4)cc3)cc2c1N[C@@H]1C[C@H]1c1ccccc1		CHEMBL247024	=	Ki	nM	570.0	CHEMBL267	Homo sapiens	Ki	uM	0.57
	2045468	CHEMBL923927	Inhibition of SRC	B	N#Cc1cnc2ccc(-c3ccc(CN)cc3)cc2c1N[C@@H]1C[C@H]1c1ccccc1		CHEMBL245800	=	Ki	nM	86.0	CHEMBL267	Homo sapiens	Ki	uM	0.086
	2045469	CHEMBL923927	Inhibition of SRC	B	N#Cc1cnc2ccc(-c3cccc(CN4CCOCC4)c3)cc2c1N[C@@H]1C[C@H]1c1ccccc1		CHEMBL245799	=	Ki	nM	280.0	CHEMBL267	Homo sapiens	Ki	uM	0.28
	2045470	CHEMBL923927	Inhibition of SRC	B	COc1cc2c(N[C@@H]3C[C@H]3c3ccccc3)c(C#N)cnc2cc1OCCCN1CCN(C)CC1		CHEMBL248393	=	Ki	nM	27.0	CHEMBL267	Homo sapiens	Ki	uM	0.027
	2045471	CHEMBL923927	Inhibition of SRC	B	COc1cc2c(N[C@@H]3C[C@H]3c3ccccc3)c(C#N)cnc2cc1OCCCN1CCOCC1		CHEMBL248392	=	Ki	nM	45.0	CHEMBL267	Homo sapiens	Ki	uM	0.045
	2045472	CHEMBL923927	Inhibition of SRC	B	COCCOc1cc2ncc(C#N)c(N[C@@H]3C[C@H]3c3ccccc3)c2cc1OC		CHEMBL401251	=	Ki	nM	110.0	CHEMBL267	Homo sapiens	Ki	uM	0.11
	2045473	CHEMBL923927	Inhibition of SRC	B	COc1cc2c(N[C@@H]3C[C@H]3c3ccccc3)c(C#N)cnc2cc1OCCCc1cccnc1		CHEMBL248391	=	Ki	nM	49.0	CHEMBL267	Homo sapiens	Ki	uM	0.049
	2045474	CHEMBL923927	Inhibition of SRC	B	COc1cc2ncc(C#N)c(N[C@@H]3C[C@H]3c3ccccc3)c2cc1OCc1ccccc1		CHEMBL248220	=	Ki	nM	330.0	CHEMBL267	Homo sapiens	Ki	uM	0.33
	2045475	CHEMBL923927	Inhibition of SRC	B	COc1ccc2ncc(C#N)c(N[C@@H]3C[C@H]3c3ccccc3)c2c1		CHEMBL401644	=	Ki	nM	210.0	CHEMBL267	Homo sapiens	Ki	uM	0.21
	2045476	CHEMBL923927	Inhibition of SRC	B	COc1ccc2c(N[C@@H]3C[C@H]3c3ccccc3)c(C#N)cnc2c1		CHEMBL248045	=	Ki	nM	170.0	CHEMBL267	Homo sapiens	Ki	uM	0.17
	2045535	CHEMBL923937	Inhibition of Src	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(OCCN4CCCC4)cc3)nnc2c1		CHEMBL436137	=	Ki	nM	7.0	CHEMBL267	Homo sapiens	Ki	nM	7.0
	2045536	CHEMBL923937	Inhibition of Src	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	=	Ki	nM	1.3	CHEMBL267	Homo sapiens	Ki	nM	1.3
	2045537	CHEMBL923937	Inhibition of Src	B	Cc1cc(-c2ccccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL268825	=	Ki	nM	35.0	CHEMBL267	Homo sapiens	Ki	nM	35.0
	2045538	CHEMBL923937	Inhibition of Src	B	Cc1cc(-c2c(Cl)cccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL230686	=	Ki	nM	11.0	CHEMBL267	Homo sapiens	Ki	nM	11.0
	2047591	CHEMBL924160	Inhibition of Src	B	CN(CCOc1cccc2ncnc(Nc3ccc(OCc4ccccn4)c(Cl)c3)c12)C(=O)CO		CHEMBL249928	>	IC50	nM	1000.0	CHEMBL267	Homo sapiens	IC50	nM	1000.0
	2050183	CHEMBL925578	Inhibition of Src at 1 uM	B	CC1CCN(c2ccc(CO)cc2NC(=O)c2ccc(C#N)o2)CC1		CHEMBL400754	=	Inhibition	%	12.0	CHEMBL267	Homo sapiens	Inhibition	%	12.0
	2051676	CHEMBL941812	Inhibition of SRC	B	N#Cc1ncc2nc1OCCCCOc1cc(NCc3cncs3)c(Cl)cc1NC(=O)N2		CHEMBL248757	>	Ki	nM	1936.0	CHEMBL267	Homo sapiens	Ki	uM	1.936
	2080191	CHEMBL929546	Inhibition of cSrc	B	CCN(CC)CCOc1ccc(Nc2cc(NC(=O)Nc3c(Cl)cccc3Cl)ncn2)cc1		CHEMBL253292	=	IC50	nM	66.0	CHEMBL267	Homo sapiens	IC50	uM	0.066
	2081815	CHEMBL928839	Inhibition of Src at 10 uM	B	CC[C@@H](C)Nc1nc2ccc(-c3c(-c4ccccc4F)n[nH]c3N)cc2s1		CHEMBL404115	<=	Inhibition	%	20.0	CHEMBL267	Homo sapiens	Inhibition	%	20.0
	2081977	CHEMBL929884	Inhibition of c-src	B	CO/N=C(\C)c1ccc2c(c1)c1c3c(c4c(c1n2CC(C)C)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL258015	=	IC50	nM	43.0	CHEMBL267	Homo sapiens	IC50	nM	43.0
	2081978	CHEMBL929884	Inhibition of c-src	B	CCO/N=C(\C)c1ccc2c(c1)c1c3c(c4c(c1n2C(C)C)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL401896	=	IC50	nM	14.0	CHEMBL267	Homo sapiens	IC50	nM	14.0
	2085145	CHEMBL929919	Inhibition of cSrc	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(N)nc21		CHEMBL49596	=	log(10^6/IC50)		3.59	CHEMBL267	Homo sapiens	log(10^6/IC50)		3.59
	2085187	CHEMBL929919	Inhibition of cSrc	B	CC(C)(C)NC(=O)Nc1nc2nc(N)ncc2cc1-c1cc(C(F)(F)F)cc(C(F)(F)F)c1		CHEMBL49658	=	log(10^6/IC50)		1.3	CHEMBL267	Homo sapiens	log(10^6/IC50)		1.3
	2085188	CHEMBL929919	Inhibition of cSrc	B	CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1		CHEMBL49120	=	log(10^6/IC50)		5.05	CHEMBL267	Homo sapiens	log(10^6/IC50)		5.05
	2085189	CHEMBL929919	Inhibition of cSrc	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3ccccc3)nc21		CHEMBL301612	=	log(10^6/IC50)		4.62	CHEMBL267	Homo sapiens	log(10^6/IC50)		4.62
	2085190	CHEMBL929919	Inhibition of cSrc	B	COc1cc(OC)cc(-c2cc3cnc(N)nc3n(C)c2=O)c1		CHEMBL296540	=	log(10^6/IC50)		1.3	CHEMBL267	Homo sapiens	log(10^6/IC50)		1.3
	2085191	CHEMBL929919	Inhibition of cSrc	B	COc1cc(OC)cc(-c2cc3cnc(N)nc3nc2NC(=O)NC(C)(C)C)c1		CHEMBL299763	=	log(10^6/IC50)		1.3	CHEMBL267	Homo sapiens	log(10^6/IC50)		1.3
	2085192	CHEMBL929919	Inhibition of cSrc	B	CCOc1cc(OCC)cc(-c2cc3cnc(N)nc3nc2NC(=O)NC(C)(C)C)c1		CHEMBL48809	=	log(10^6/IC50)		1.3	CHEMBL267	Homo sapiens	log(10^6/IC50)		1.3
	2085193	CHEMBL929919	Inhibition of cSrc	B	CN(C)c1cc(-c2cc3cnc(N)nc3nc2NC(=O)NC(C)(C)C)cc(N(C)C)c1		CHEMBL50371	=	log(10^6/IC50)		1.3	CHEMBL267	Homo sapiens	log(10^6/IC50)		1.3
	2085194	CHEMBL929919	Inhibition of cSrc	B	CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(NC(=O)NC(C)(C)C)nc3n2)cc1		CHEMBL432314	=	log(10^6/IC50)		4.62	CHEMBL267	Homo sapiens	log(10^6/IC50)		4.62
	2085195	CHEMBL929919	Inhibition of cSrc	B	CN1CCN(CCCNc2ncc3cc(-c4c(Cl)cccc4Cl)c(NC(=O)NCc4ccccc4)nc3n2)CC1		CHEMBL51485	=	log(10^6/IC50)		4.52	CHEMBL267	Homo sapiens	log(10^6/IC50)		4.52
	2085196	CHEMBL929919	Inhibition of cSrc	B	COc1ccc(NC(=O)Nc2nc3nc(NCCCN4CCN(C)CC4)ncc3cc2-c2c(Cl)cccc2Cl)cc1		CHEMBL298679	=	log(10^6/IC50)		4.55	CHEMBL267	Homo sapiens	log(10^6/IC50)		4.55
	2085197	CHEMBL929919	Inhibition of cSrc	B	CN1CCN(CCCNc2ncc3cc(-c4c(Cl)cccc4Cl)c(NC(=O)NC4CCCCC4)nc3n2)CC1		CHEMBL51028	=	log(10^6/IC50)		4.51	CHEMBL267	Homo sapiens	log(10^6/IC50)		4.51
	2085198	CHEMBL929919	Inhibition of cSrc	B	CCN(CC)CCCCNc1ncc2cc(-c3c(Cl)cccc3Cl)c(NC(=O)NC(C)(C)C)nc2n1		CHEMBL45827	=	log(10^6/IC50)		4.64	CHEMBL267	Homo sapiens	log(10^6/IC50)		4.64
	2085199	CHEMBL929919	Inhibition of cSrc	B	CN1CCN(c2ccc(Nc3ncc4cc(-c5c(Cl)cccc5Cl)c(=O)n(C)c4n3)cc2)CC1		CHEMBL51283	=	log(10^6/IC50)		5.0	CHEMBL267	Homo sapiens	log(10^6/IC50)		5.0
	2085200	CHEMBL929919	Inhibition of cSrc	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3ccc(CC(=O)O)cc3)nc21		CHEMBL50647	=	log(10^6/IC50)		5.0	CHEMBL267	Homo sapiens	log(10^6/IC50)		5.0
	2085201	CHEMBL929919	Inhibition of cSrc	B	CCN(CC)CCOc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL297523	=	log(10^6/IC50)		5.05	CHEMBL267	Homo sapiens	log(10^6/IC50)		5.05
	2085202	CHEMBL929919	Inhibition of cSrc	B	CCN(CC)CCCNc1ncc2cc(-c3c(Cl)cccc3Cl)c(=O)n(C)c2n1		CHEMBL50470	=	log(10^6/IC50)		3.02	CHEMBL267	Homo sapiens	log(10^6/IC50)		3.02
	2085203	CHEMBL929919	Inhibition of cSrc	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(NCCCN3CCNCC3)nc21		CHEMBL259037	=	log(10^6/IC50)		3.63	CHEMBL267	Homo sapiens	log(10^6/IC50)		3.63
	2085204	CHEMBL929919	Inhibition of cSrc	B	CN(C)c1ncc2cc(-c3c(Cl)cccc3Cl)c(=O)n(C)c2n1		CHEMBL299347	=	log(10^6/IC50)		1.3	CHEMBL267	Homo sapiens	log(10^6/IC50)		1.3
	2085205	CHEMBL929919	Inhibition of cSrc	B	Cc1ncc2cc(-c3c(Cl)cccc3Cl)c(=O)n(C)c2n1		CHEMBL51573	=	log(10^6/IC50)		1.3	CHEMBL267	Homo sapiens	log(10^6/IC50)		1.3
	2085206	CHEMBL929919	Inhibition of cSrc	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cncnc21		CHEMBL50977	=	log(10^6/IC50)		2.0	CHEMBL267	Homo sapiens	log(10^6/IC50)		2.0
	2085208	CHEMBL929919	Inhibition of cSrc	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(NCCCN3CCOCC3)nc21		CHEMBL48172	=	log(10^6/IC50)		3.28	CHEMBL267	Homo sapiens	log(10^6/IC50)		3.28
	2088340	CHEMBL930130	Inhibition of SRC by HTRF assay	B	Cc1cccc(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL404367	>	IC50	nM	12500.0	CHEMBL267	Homo sapiens	IC50	nM	12500.0
	2095567	CHEMBL932075	Inhibition of recombinant human c-Src	B	O=C(Nc1nnc(CCc2ccccc2)s1)c1ccccc1		CHEMBL378903	=	Ki	nM	2900.0	CHEMBL267	Homo sapiens	Ki	uM	2.9
	2095569	CHEMBL932075	Inhibition of recombinant human c-Src	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Ki	nM	31000.0	CHEMBL267	Homo sapiens	Ki	uM	31.0
	2095570	CHEMBL932075	Inhibition of recombinant human c-Src	B	COc1ccc(CSc2nnc(NC(=O)c3ccccc3Cl)s2)cc1		CHEMBL270452	=	Ki	nM	272.0	CHEMBL267	Homo sapiens	Ki	uM	0.272
	2095571	CHEMBL932075	Inhibition of recombinant human c-Src	B	O=C(Nc1nnc(SCc2ccccc2)s1)c1ccccc1Cl		CHEMBL270454	=	Ki	nM	1137.0	CHEMBL267	Homo sapiens	Ki	uM	1.137
	2095572	CHEMBL932075	Inhibition of recombinant human c-Src	B	O=C(Nc1nnc(SCc2cccc(Cl)c2)s1)c1ccccc1Cl		CHEMBL408291	=	Ki	nM	169.0	CHEMBL267	Homo sapiens	Ki	uM	0.169
	2095573	CHEMBL932075	Inhibition of recombinant human c-Src	B	O=C(Nc1nnc(SCc2ccc(F)cc2)s1)c1ccccc1Cl		CHEMBL271010	=	Ki	nM	900.0	CHEMBL267	Homo sapiens	Ki	uM	0.9
	2095574	CHEMBL932075	Inhibition of recombinant human c-Src	B	O=C(Nc1nnc(SCc2ccccc2)s1)c1ccc(Cl)cc1		CHEMBL271009	=	Ki	nM	334.0	CHEMBL267	Homo sapiens	Ki	uM	0.334
	2095575	CHEMBL932075	Inhibition of recombinant human c-Src	B	O=C(Nc1nnc(SCc2cccc(Cl)c2)s1)c1ccc(F)cc1		CHEMBL271008	=	Ki	nM	247.0	CHEMBL267	Homo sapiens	Ki	uM	0.247
	2095576	CHEMBL932075	Inhibition of recombinant human c-Src	B	O=C(Nc1nnc(SCc2cccc(F)c2)s1)c1ccccc1Cl		CHEMBL402288	=	Ki	nM	718.0	CHEMBL267	Homo sapiens	Ki	uM	0.718
	2095577	CHEMBL932075	Inhibition of recombinant human c-Src	B	O=C(Nc1nnc(SCc2ccc(Br)cc2)s1)c1ccccc1Cl		CHEMBL255164	=	Ki	nM	522.0	CHEMBL267	Homo sapiens	Ki	uM	0.522
	2095578	CHEMBL932075	Inhibition of recombinant human c-Src	B	O=C(Nc1nnc(SCc2cccc(F)c2)s1)c1ccc(Cl)cc1		CHEMBL255368	=	Ki	nM	64.0	CHEMBL267	Homo sapiens	Ki	uM	0.064
	2095579	CHEMBL932075	Inhibition of recombinant human c-Src	B	O=C(Nc1nnc(SCc2ccc([N+](=O)[O-])cc2)s1)c1ccc(F)cc1		CHEMBL255165	=	Ki	nM	170.0	CHEMBL267	Homo sapiens	Ki	uM	0.17
	2095580	CHEMBL932075	Inhibition of recombinant human c-Src	B	COc1ccc(CSc2nnc(NC(=O)c3ccc(F)cc3)s2)cc1		CHEMBL402891	=	Ki	nM	263.0	CHEMBL267	Homo sapiens	Ki	uM	0.263
	2095581	CHEMBL932075	Inhibition of recombinant human c-Src	B	COc1ccc(CSc2nnc(NC(=O)c3ccc(Cl)cc3)s2)cc1		CHEMBL272947	=	Ki	nM	199.0	CHEMBL267	Homo sapiens	Ki	uM	0.199
	2095582	CHEMBL932075	Inhibition of recombinant human c-Src	B	O=C(Nc1nnc(SCc2cccc(F)c2)s1)c1ccc(F)cc1		CHEMBL272288	=	Ki	nM	569.0	CHEMBL267	Homo sapiens	Ki	uM	0.569
	2095583	CHEMBL932075	Inhibition of recombinant human c-Src	B	O=C(Nc1nnc(SCc2ccc(F)cc2)s1)c1ccc(Cl)cc1		CHEMBL255225	=	Ki	nM	200.0	CHEMBL267	Homo sapiens	Ki	uM	0.2
	2095584	CHEMBL932075	Inhibition of recombinant human c-Src	B	O=C(Nc1nnc(SCc2ccc([N+](=O)[O-])cc2)s1)c1ccc(Cl)cc1		CHEMBL402568	=	Ki	nM	165.0	CHEMBL267	Homo sapiens	Ki	uM	0.165
	2095585	CHEMBL932075	Inhibition of recombinant human c-Src	B	O=C(Nc1nnc(SCc2ccc(Br)cc2)s1)c1ccc(F)cc1		CHEMBL255324	=	Ki	nM	221.0	CHEMBL267	Homo sapiens	Ki	uM	0.221
	2095586	CHEMBL932075	Inhibition of recombinant human c-Src	B	O=C(Nc1nnc(SCc2ccc([N+](=O)[O-])cc2)s1)c1ccccc1Cl		CHEMBL255522	=	Ki	nM	219.0	CHEMBL267	Homo sapiens	Ki	uM	0.219
	2095587	CHEMBL932075	Inhibition of recombinant human c-Src	B	O=C(Nc1nnc(SCc2cccc(Cl)c2)s1)c1ccc(Cl)cc1		CHEMBL272999	=	Ki	nM	195.0	CHEMBL267	Homo sapiens	Ki	uM	0.195
	2095588	CHEMBL932075	Inhibition of recombinant human c-Src	B	O=C(Nc1nnc(SCc2ccccc2)s1)c1ccc(F)cc1		CHEMBL409082	=	Ki	nM	464.0	CHEMBL267	Homo sapiens	Ki	uM	0.464
	2095589	CHEMBL932075	Inhibition of recombinant human c-Src	B	O=C(Nc1nnc(SCc2ccc(Br)cc2)s1)c1ccc(Cl)cc1		CHEMBL403731	=	Ki	nM	217.0	CHEMBL267	Homo sapiens	Ki	uM	0.217
	2095590	CHEMBL932075	Inhibition of recombinant human c-Src	B	O=C(Nc1nnc(SCc2ccc(F)cc2)s1)c1ccc(F)cc1		CHEMBL255738	=	Ki	nM	354.0	CHEMBL267	Homo sapiens	Ki	uM	0.354
	2095591	CHEMBL932075	Inhibition of recombinant human c-Src	B	O=C(Nc1nnc(CCc2ccccc2)s1)c1ccccc1I		CHEMBL207986	=	Ki	nM	2000.0	CHEMBL267	Homo sapiens	Ki	uM	2.0
Not Active	2095592	CHEMBL932075	Inhibition of recombinant human c-Src	B	O=C(Nc1nnc(CCc2ccccc2)s1)c1ccc(I)cc1		CHEMBL206046		Activity			CHEMBL267	Homo sapiens	Activity		
	2095897	CHEMBL933174	Inhibition of interaction between human Src-SH3 domain and PRP2 at 100 uM by fluorescence polarization technique	B	COc1ccc(NCCNc2cc(C)nc3c2ccc2ccccc23)cc1OC		CHEMBL258127	=	Inhibition	%	22.0	CHEMBL267	Homo sapiens	Inhibition	%	22.0
Active	2095898	CHEMBL933175	Inhibition of interaction between human Src-SH3 domain and PRP2 at 800 uM by fluorescence polarization technique	B	Cc1cc(NCCNc2ccc3c(c2)OCCO3)c2ccc3ccccc3c2n1		CHEMBL269927		Activity			CHEMBL267	Homo sapiens	Activity		
Active	2095899	CHEMBL933175	Inhibition of interaction between human Src-SH3 domain and PRP2 at 800 uM by fluorescence polarization technique	B	COc1ccc(NCCNc2cc(C)nc3c2ccc2ccccc23)cc1OC		CHEMBL258127		Activity			CHEMBL267	Homo sapiens	Activity		
	2109089	CHEMBL947979	Inhibition of SRC by HTRF assay	B	COc1ccc(-c2ccc(NC(=O)Nc3cc(C)ccc3F)cc2)c2c(N)noc12		CHEMBL270084	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	nM	50000.0
	2109105	CHEMBL947979	Inhibition of SRC by HTRF assay	B	COc1ccc(-c2ccc(NC(=O)Nc3cccc(Cl)c3)cc2)c2c(N)noc12		CHEMBL269884	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	nM	50000.0
	2109106	CHEMBL947979	Inhibition of SRC by HTRF assay	B	COc1ccc(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)c2c(N)noc12		CHEMBL430090	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	nM	50000.0
	2111932	CHEMBL934188	Inhibition of Src by HTRF assay	B	COc1cc(Nc2ncc3c(=O)n(-c4c(C)cccc4C)c4nc5ccccc5n4c3n2)cc(OC)c1OC		CHEMBL270777	=	IC50	nM	210.0	CHEMBL267	Homo sapiens	IC50	uM	0.21
	2111955	CHEMBL934188	Inhibition of Src by HTRF assay	B	CCCCOc1ccc(-n2c(=O)c3cnc(Nc4ccc(N5CCN(C)CC5)cc4)nc3n3c4ccccc4nc23)cc1		CHEMBL406685	=	IC50	nM	8300.0	CHEMBL267	Homo sapiens	IC50	uM	8.3
	2111956	CHEMBL934188	Inhibition of Src by HTRF assay	B	COc1ccc(Cl)cc1-n1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n2c3ccccc3nc12		CHEMBL406684	=	IC50	nM	1400.0	CHEMBL267	Homo sapiens	IC50	uM	1.4
	2111957	CHEMBL934188	Inhibition of Src by HTRF assay	B	COc1cccc(-n2c(=O)c3cnc(Nc4ccc(N5CCN(C)CC5)cc4)nc3n3c4ccccc4nc23)c1		CHEMBL260963	=	IC50	nM	1900.0	CHEMBL267	Homo sapiens	IC50	uM	1.9
	2111958	CHEMBL934188	Inhibition of Src by HTRF assay	B	Cc1cccc(-n2c(=O)c3cnc(Nc4ccc(N5CCN(C)CC5)cc4)nc3n3c4ccccc4nc23)c1		CHEMBL409447	=	IC50	nM	1000.0	CHEMBL267	Homo sapiens	IC50	uM	1.0
	2111959	CHEMBL934188	Inhibition of Src by HTRF assay	B	Cc1ccc(-n2c(=O)c3cnc(Nc4ccc(N5CCN(C)CC5)cc4)nc3n3c4ccccc4nc23)cc1		CHEMBL270085	=	IC50	nM	1700.0	CHEMBL267	Homo sapiens	IC50	uM	1.7
	2111960	CHEMBL934188	Inhibition of Src by HTRF assay	B	CN1CCN(c2ccc(Nc3ncc4c(=O)n(-c5c(Cl)cc(Cl)cc5Cl)c5nc6ccccc6n5c4n3)cc2)CC1		CHEMBL254674	=	IC50	nM	35.0	CHEMBL267	Homo sapiens	IC50	uM	0.035
	2111961	CHEMBL934188	Inhibition of Src by HTRF assay	B	CN1CCN(c2ccc(Nc3ncc4c(=O)n(-c5c(Cl)cccc5Cl)c5nc6ccccc6n5c4n3)cc2)CC1		CHEMBL406661	=	IC50	nM	49.0	CHEMBL267	Homo sapiens	IC50	uM	0.049
	2111962	CHEMBL934188	Inhibition of Src by HTRF assay	B	COc1cc(Nc2ncc3c(=O)n(-c4c(C)cccc4C)c4nc5ccccc5n4c3n2)cc(OC)c1OCCCN1CCN(C)CC1		CHEMBL260306	=	IC50	nM	70.0	CHEMBL267	Homo sapiens	IC50	uM	0.07
	2111963	CHEMBL934188	Inhibition of Src by HTRF assay	B	COc1cc(Nc2ncc3c(=O)n(-c4c(C)cccc4C)c4nc5ccccc5n4c3n2)ccc1OCCCN1CCN(C)CC1		CHEMBL405430	=	IC50	nM	180.0	CHEMBL267	Homo sapiens	IC50	uM	0.18
	2111964	CHEMBL934188	Inhibition of Src by HTRF assay	B	Cc1cccc(C)c1-n1c(=O)c2cnc(Nc3ccc(OCCCN4CCCCC4)cc3)nc2n2c3ccccc3nc12		CHEMBL408030	=	IC50	nM	160.0	CHEMBL267	Homo sapiens	IC50	uM	0.16
	2111965	CHEMBL934188	Inhibition of Src by HTRF assay	B	COc1cc(Nc2ncc3c(=O)n(-c4c(C)cccc4C)c4nc5ccccc5n4c3n2)cc(OC)c1OCCN1CCOCC1		CHEMBL406804	=	IC50	nM	44.0	CHEMBL267	Homo sapiens	IC50	uM	0.044
	2111966	CHEMBL934188	Inhibition of Src by HTRF assay	B	Cc1cccc(C)c1-n1c(=O)c2cnc(Nc3ccc(OCCN4CCN(C)CC4)c(F)c3)nc2n2c3ccccc3nc12		CHEMBL407516	=	IC50	nM	160.0	CHEMBL267	Homo sapiens	IC50	uM	0.16
	2111967	CHEMBL934188	Inhibition of Src by HTRF assay	B	COc1cc(Nc2ncc3c(=O)n(-c4c(C)cccc4C)c4nc5ccccc5n4c3n2)cc(OC)c1OCCN1CCN(C)CC1		CHEMBL260956	=	IC50	nM	77.0	CHEMBL267	Homo sapiens	IC50	uM	0.077
	2111968	CHEMBL934188	Inhibition of Src by HTRF assay	B	COc1cc(Nc2ncc3c(=O)n(-c4c(C)cccc4C)c4nc5ccccc5n4c3n2)ccc1OCCN1CCN(C)CC1		CHEMBL407279	=	IC50	nM	240.0	CHEMBL267	Homo sapiens	IC50	uM	0.24
	2111969	CHEMBL934188	Inhibition of Src by HTRF assay	B	Cc1cccc(C)c1-n1c(=O)c2cnc(Nc3ccc(OCCCN(C)C)cc3)nc2n2c3ccccc3nc12		CHEMBL261174	=	IC50	nM	360.0	CHEMBL267	Homo sapiens	IC50	uM	0.36
	2111970	CHEMBL934188	Inhibition of Src by HTRF assay	B	Cc1cccc(C)c1-n1c(=O)c2cnc(Nc3ccc(OCCN(C)C)cc3)nc2n2c3ccccc3nc12		CHEMBL410892	=	IC50	nM	440.0	CHEMBL267	Homo sapiens	IC50	uM	0.44
	2111971	CHEMBL934188	Inhibition of Src by HTRF assay	B	COc1cc(Nc2ncc3c(=O)n(-c4c(C)cccc4C)c4nc5ccccc5n4c3n2)ccc1N1CCN(C)CC1		CHEMBL403522	=	IC50	nM	100.0	CHEMBL267	Homo sapiens	IC50	uM	0.1
	2111972	CHEMBL934188	Inhibition of Src by HTRF assay	B	Cc1cccc(C)c1-n1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n2c3ccccc3nc12		CHEMBL410295	=	IC50	nM	120.0	CHEMBL267	Homo sapiens	IC50	uM	0.12
	2118548	CHEMBL932925	Inhibition of Src	B	Cc1cc(-c2ccccc2)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL230685	=	IC50	nM	340.0	CHEMBL267	Homo sapiens	IC50	nM	340.0
	2118551	CHEMBL932925	Inhibition of Src	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(CCCN4CCCC4)cc3)nc12		CHEMBL250213	=	IC50	nM	1.5	CHEMBL267	Homo sapiens	IC50	nM	1.5
	2118552	CHEMBL932925	Inhibition of Src	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(S(=O)(=O)C4CCNCC4)cc3)nc12		CHEMBL250625	=	IC50	nM	5.2	CHEMBL267	Homo sapiens	IC50	nM	5.2
	2118553	CHEMBL932925	Inhibition of Src	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(C(=O)N4CCNCC4)cc3)nc12		CHEMBL250214	=	IC50	nM	3.6	CHEMBL267	Homo sapiens	IC50	nM	3.6
	2118554	CHEMBL932925	Inhibition of Src	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nc12		CHEMBL249821	=	IC50	nM	3.6	CHEMBL267	Homo sapiens	IC50	nM	3.6
	2118555	CHEMBL932925	Inhibition of Src	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	=	IC50	nM	1.8	CHEMBL267	Homo sapiens	IC50	nM	1.8
	2118556	CHEMBL932925	Inhibition of Src	B	Cc1cc(-c2c(Cl)cccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL230686	=	IC50	nM	14.0	CHEMBL267	Homo sapiens	IC50	nM	14.0
	2118557	CHEMBL932925	Inhibition of Src	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(OCCN4CCCC4)cc3)nnc2c1		CHEMBL436137	=	IC50	nM	7.0	CHEMBL267	Homo sapiens	IC50	nM	7.0
	2118558	CHEMBL932925	Inhibition of Src	B	Cc1cc(-c2ccccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL268825	=	IC50	nM	35.0	CHEMBL267	Homo sapiens	IC50	nM	35.0
	2118638	CHEMBL932925	Inhibition of Src	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>=	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	2120470	CHEMBL951118	Inhibition of Src by HTRF assay	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1C(=O)Nc1cnc(Nc2ccc(N3CCN(C)CC3)cc2)nc1		CHEMBL272888	=	IC50	nM	3.0	CHEMBL267	Homo sapiens	IC50	uM	0.003
	2122205	CHEMBL951159	Inhibition of Src	B	CN1CCN(c2ccc(Nc3ncc4c(=O)c(C(N)=O)cn(-c5ccc6c(c5)CCC6)c4n3)cc2)CC1		CHEMBL414001	=	IC50	nM	1000.0	CHEMBL267	Homo sapiens	IC50	uM	1.0
	2122212	CHEMBL951159	Inhibition of Src	B	CN1CCN(Cc2ccc(Nc3ncc4c(=O)c(C(N)=O)cn(-c5ccc6c(c5)CCC6)c4n3)cc2)CC1		CHEMBL256893	=	IC50	nM	1500.0	CHEMBL267	Homo sapiens	IC50	uM	1.5
	2132667	CHEMBL921291	Inhibition of SRC	B	Nc1nccn2c1c(-c1ccc3ccc(-c4ccccc4)nc3c1)nc2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL410659	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	2133044	CHEMBL938461	Inhibition of human cSrc	B	COc1cc(Nc2nn3c(NC[C@@H](C)O)cc(C)nc3c2C(N)=O)cc(OC)c1		CHEMBL427741	=	IC50	nM	6690.0	CHEMBL267	Homo sapiens	IC50	uM	6.69
Not Determined	2133045	CHEMBL938462	Inhibition of human cSrc in COS7 cells by ELISA	B	COc1cc(Nc2nn3c(NC[C@@H](C)O)cc(C)nc3c2C(N)=O)cc(OC)c1		CHEMBL427741		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	2133046	CHEMBL938463	Inhibition of human cSrc in COS7 cells at 1 uM by ELISA	B	COc1cc(Nc2nn3c(NC[C@@H](C)O)cc(C)nc3c2C(N)=O)cc(OC)c1		CHEMBL427741		Inhibition	%		CHEMBL267	Homo sapiens	Inhibition		
	2133048	CHEMBL938461	Inhibition of human cSrc	B	COc1cc(Nc2nn3c(N[C@H](CO)Cc4cccnc4)cc(C4CC4)nc3c2C(N)=O)cc(OC)c1		CHEMBL261188	=	IC50	nM	5.0	CHEMBL267	Homo sapiens	IC50	uM	0.005
	2133049	CHEMBL938461	Inhibition of human cSrc	B	COc1cc(Nc2nn3c(N[C@H](CO)Cc4c[nH]c5ccccc45)cc(C4CC4)nc3c2C(N)=O)cc(OC)c1		CHEMBL260157	=	IC50	nM	5.0	CHEMBL267	Homo sapiens	IC50	uM	0.005
	2133050	CHEMBL938461	Inhibition of human cSrc	B	COc1cc(Nc2nn3c(N[C@@H](CO)Cc4ccccc4)cc(C4CC4)nc3c2C(N)=O)cc(OC)c1		CHEMBL260860	=	IC50	nM	12.0	CHEMBL267	Homo sapiens	IC50	uM	0.012
	2133051	CHEMBL938461	Inhibition of human cSrc	B	COc1cc(Nc2nn3c(N[C@H](CO)Cc4ccccc4)cc(C4CC4)nc3c2C(N)=O)cc(OC)c1		CHEMBL260861	=	IC50	nM	3.0	CHEMBL267	Homo sapiens	IC50	uM	0.003
	2133052	CHEMBL938461	Inhibition of human cSrc	B	COc1cc(Nc2nn3c(N4CCC[C@H]4CO)cc(C4CC4)nc3c2C(N)=O)cc(OC)c1		CHEMBL261744	=	IC50	nM	25.0	CHEMBL267	Homo sapiens	IC50	uM	0.025
	2133053	CHEMBL938461	Inhibition of human cSrc	B	COc1cc(Nc2nn3c(N4CCC[C@@H]4CO)cc(C4CC4)nc3c2C(N)=O)cc(OC)c1		CHEMBL261743	=	IC50	nM	9.0	CHEMBL267	Homo sapiens	IC50	uM	0.009
	2133054	CHEMBL938461	Inhibition of human cSrc	B	NC(=O)c1c(Nc2ccccc2)nn2c(N)cc(C3CC3)nc12		CHEMBL261450	=	IC50	nM	93.0	CHEMBL267	Homo sapiens	IC50	uM	0.093
	2133055	CHEMBL938461	Inhibition of human cSrc	B	COc1cc(Nc2nn3c(N[C@@H](CO)C(C)C)cc(C4CC4)nc3c2C(N)=O)cc(OC)c1		CHEMBL406418	=	IC50	nM	8.0	CHEMBL267	Homo sapiens	IC50	uM	0.008
	2133056	CHEMBL938461	Inhibition of human cSrc	B	COc1cc(Nc2nn3c(N[C@@H](CO)C(C)C)cc(C(C)C)nc3c2C(N)=O)cc(OC)c1		CHEMBL405893	=	IC50	nM	41.0	CHEMBL267	Homo sapiens	IC50	uM	0.041
	2133057	CHEMBL938461	Inhibition of human cSrc	B	COc1cc(Nc2nn3c(N[C@@H](CO)C(C)C)cc(-c4ccccc4)nc3c2C(N)=O)cc(OC)c1		CHEMBL259200	=	IC50	nM	68.0	CHEMBL267	Homo sapiens	IC50	uM	0.068
	2133058	CHEMBL938461	Inhibition of human cSrc	B	COc1cc(Nc2nn3c(N[C@@H](CO)C(C)C)cc(C)nc3c2C(N)=O)cc(OC)c1		CHEMBL260024	=	IC50	nM	432.0	CHEMBL267	Homo sapiens	IC50	uM	0.432
	2133059	CHEMBL938461	Inhibition of human cSrc	B	COc1cc(Nc2nn3c(N[C@H](CO)C(C)C)cc(C)nc3c2C(N)=O)cc(OC)c1		CHEMBL410296	=	IC50	nM	1210.0	CHEMBL267	Homo sapiens	IC50	uM	1.21
	2133060	CHEMBL938461	Inhibition of human cSrc	B	COc1cc(Nc2nn3c(N[C@@H](C)CO)cc(C)nc3c2C(N)=O)cc(OC)c1		CHEMBL412273	=	IC50	nM	3480.0	CHEMBL267	Homo sapiens	IC50	uM	3.48
	2133061	CHEMBL938461	Inhibition of human cSrc	B	COc1cc(Nc2nn3c(NC[C@H](C)O)cc(C)nc3c2C(N)=O)cc(OC)c1		CHEMBL259627	=	IC50	nM	9200.0	CHEMBL267	Homo sapiens	IC50	uM	9.2
	2133062	CHEMBL938462	Inhibition of human cSrc in COS7 cells by ELISA	B	COc1cc(Nc2nn3c(N[C@H](CO)Cc4cccnc4)cc(C4CC4)nc3c2C(N)=O)cc(OC)c1		CHEMBL261188	=	IC50	nM	100.0	CHEMBL267	Homo sapiens	IC50	uM	0.1
	2133063	CHEMBL938462	Inhibition of human cSrc in COS7 cells by ELISA	B	COc1cc(Nc2nn3c(N[C@H](CO)Cc4c[nH]c5ccccc45)cc(C4CC4)nc3c2C(N)=O)cc(OC)c1		CHEMBL260157	=	IC50	nM	500.0	CHEMBL267	Homo sapiens	IC50	uM	0.5
	2133064	CHEMBL938462	Inhibition of human cSrc in COS7 cells by ELISA	B	COc1cc(Nc2nn3c(N[C@H](CO)Cc4ccccc4)cc(C4CC4)nc3c2C(N)=O)cc(OC)c1		CHEMBL260861	=	IC50	nM	100.0	CHEMBL267	Homo sapiens	IC50	uM	0.1
	2133065	CHEMBL938462	Inhibition of human cSrc in COS7 cells by ELISA	B	COc1cc(Nc2nn3c(N[C@@H](CO)C(C)C)cc(C4CC4)nc3c2C(N)=O)cc(OC)c1		CHEMBL406418	=	IC50	nM	100.0	CHEMBL267	Homo sapiens	IC50	uM	0.1
Not Determined	2133066	CHEMBL938462	Inhibition of human cSrc in COS7 cells by ELISA	B	COc1cc(Nc2nn3c(N[C@@H](CO)Cc4ccccc4)cc(C4CC4)nc3c2C(N)=O)cc(OC)c1		CHEMBL260860		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	2133067	CHEMBL938462	Inhibition of human cSrc in COS7 cells by ELISA	B	COc1cc(Nc2nn3c(N4CCC[C@H]4CO)cc(C4CC4)nc3c2C(N)=O)cc(OC)c1		CHEMBL261744		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	2133068	CHEMBL938462	Inhibition of human cSrc in COS7 cells by ELISA	B	COc1cc(Nc2nn3c(N4CCC[C@@H]4CO)cc(C4CC4)nc3c2C(N)=O)cc(OC)c1		CHEMBL261743		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	2133069	CHEMBL938462	Inhibition of human cSrc in COS7 cells by ELISA	B	NC(=O)c1c(Nc2ccccc2)nn2c(N)cc(C3CC3)nc12		CHEMBL261450		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	2133070	CHEMBL938462	Inhibition of human cSrc in COS7 cells by ELISA	B	COc1cc(Nc2nn3c(N[C@@H](CO)C(C)C)cc(C(C)C)nc3c2C(N)=O)cc(OC)c1		CHEMBL405893		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	2133071	CHEMBL938462	Inhibition of human cSrc in COS7 cells by ELISA	B	COc1cc(Nc2nn3c(N[C@@H](CO)C(C)C)cc(-c4ccccc4)nc3c2C(N)=O)cc(OC)c1		CHEMBL259200		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	2133072	CHEMBL938462	Inhibition of human cSrc in COS7 cells by ELISA	B	COc1cc(Nc2nn3c(N[C@@H](CO)C(C)C)cc(C)nc3c2C(N)=O)cc(OC)c1		CHEMBL260024		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	2133073	CHEMBL938462	Inhibition of human cSrc in COS7 cells by ELISA	B	COc1cc(Nc2nn3c(N[C@H](CO)C(C)C)cc(C)nc3c2C(N)=O)cc(OC)c1		CHEMBL410296		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	2133074	CHEMBL938462	Inhibition of human cSrc in COS7 cells by ELISA	B	COc1cc(Nc2nn3c(N[C@@H](C)CO)cc(C)nc3c2C(N)=O)cc(OC)c1		CHEMBL412273		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	2133075	CHEMBL938462	Inhibition of human cSrc in COS7 cells by ELISA	B	COc1cc(Nc2nn3c(NC[C@H](C)O)cc(C)nc3c2C(N)=O)cc(OC)c1		CHEMBL259627		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	2133076	CHEMBL938463	Inhibition of human cSrc in COS7 cells at 1 uM by ELISA	B	COc1cc(Nc2nn3c(N[C@@H](CO)C(C)C)cc(-c4ccccc4)nc3c2C(N)=O)cc(OC)c1		CHEMBL259200		Inhibition	%		CHEMBL267	Homo sapiens	Inhibition		
Not Determined	2133077	CHEMBL938463	Inhibition of human cSrc in COS7 cells at 1 uM by ELISA	B	COc1cc(Nc2nn3c(N[C@H](CO)C(C)C)cc(C)nc3c2C(N)=O)cc(OC)c1		CHEMBL410296		Inhibition	%		CHEMBL267	Homo sapiens	Inhibition		
Not Determined	2133078	CHEMBL938463	Inhibition of human cSrc in COS7 cells at 1 uM by ELISA	B	COc1cc(Nc2nn3c(N[C@@H](C)CO)cc(C)nc3c2C(N)=O)cc(OC)c1		CHEMBL412273		Inhibition	%		CHEMBL267	Homo sapiens	Inhibition		
Not Determined	2133079	CHEMBL938463	Inhibition of human cSrc in COS7 cells at 1 uM by ELISA	B	COc1cc(Nc2nn3c(NC[C@H](C)O)cc(C)nc3c2C(N)=O)cc(OC)c1		CHEMBL259627		Inhibition	%		CHEMBL267	Homo sapiens	Inhibition		
	2133085	CHEMBL938463	Inhibition of human cSrc in COS7 cells at 1 uM by ELISA	B	COc1cc(Nc2nn3c(N[C@@H](CO)C(C)C)cc(C)nc3c2C(N)=O)cc(OC)c1		CHEMBL260024	=	Inhibition	%	13.3	CHEMBL267	Homo sapiens	Inhibition	%	13.3
	2133086	CHEMBL938463	Inhibition of human cSrc in COS7 cells at 1 uM by ELISA	B	COc1cc(Nc2nn3c(N[C@H](CO)Cc4cccnc4)cc(C4CC4)nc3c2C(N)=O)cc(OC)c1		CHEMBL261188	=	Inhibition	%	100.0	CHEMBL267	Homo sapiens	Inhibition	%	100.0
	2133087	CHEMBL938463	Inhibition of human cSrc in COS7 cells at 1 uM by ELISA	B	COc1cc(Nc2nn3c(N[C@H](CO)Cc4c[nH]c5ccccc45)cc(C4CC4)nc3c2C(N)=O)cc(OC)c1		CHEMBL260157	=	Inhibition	%	71.2	CHEMBL267	Homo sapiens	Inhibition	%	71.2
	2133088	CHEMBL938463	Inhibition of human cSrc in COS7 cells at 1 uM by ELISA	B	COc1cc(Nc2nn3c(N[C@H](CO)Cc4ccccc4)cc(C4CC4)nc3c2C(N)=O)cc(OC)c1		CHEMBL260861	=	Inhibition	%	100.0	CHEMBL267	Homo sapiens	Inhibition	%	100.0
	2133089	CHEMBL938463	Inhibition of human cSrc in COS7 cells at 1 uM by ELISA	B	COc1cc(Nc2nn3c(N4CCC[C@H]4CO)cc(C4CC4)nc3c2C(N)=O)cc(OC)c1		CHEMBL261744	=	Inhibition	%	14.8	CHEMBL267	Homo sapiens	Inhibition	%	14.8
	2133090	CHEMBL938463	Inhibition of human cSrc in COS7 cells at 1 uM by ELISA	B	COc1cc(Nc2nn3c(N4CCC[C@@H]4CO)cc(C4CC4)nc3c2C(N)=O)cc(OC)c1		CHEMBL261743	=	Inhibition	%	41.6	CHEMBL267	Homo sapiens	Inhibition	%	41.6
	2133091	CHEMBL938463	Inhibition of human cSrc in COS7 cells at 1 uM by ELISA	B	NC(=O)c1c(Nc2ccccc2)nn2c(N)cc(C3CC3)nc12		CHEMBL261450	=	Inhibition	%	69.0	CHEMBL267	Homo sapiens	Inhibition	%	69.0
	2133092	CHEMBL938463	Inhibition of human cSrc in COS7 cells at 1 uM by ELISA	B	COc1cc(Nc2nn3c(N[C@@H](CO)C(C)C)cc(C4CC4)nc3c2C(N)=O)cc(OC)c1		CHEMBL406418	=	Inhibition	%	100.0	CHEMBL267	Homo sapiens	Inhibition	%	100.0
	2133093	CHEMBL938463	Inhibition of human cSrc in COS7 cells at 1 uM by ELISA	B	COc1cc(Nc2nn3c(N[C@@H](CO)C(C)C)cc(C(C)C)nc3c2C(N)=O)cc(OC)c1		CHEMBL405893	=	Inhibition	%	60.8	CHEMBL267	Homo sapiens	Inhibition	%	60.8
	2133103	CHEMBL938463	Inhibition of human cSrc in COS7 cells at 1 uM by ELISA	B	COc1cc(Nc2nn3c(N[C@@H](CO)Cc4ccccc4)cc(C4CC4)nc3c2C(N)=O)cc(OC)c1		CHEMBL260860	=	Inhibition	%	36.1	CHEMBL267	Homo sapiens	Inhibition	%	36.1
	2133125	CHEMBL938461	Inhibition of human cSrc	B	COc1cc(Nc2nn3c(NCC(C)(C)N)cc(C)nc3c2C(N)=O)cc(OC)c1		CHEMBL260114	=	IC50	nM	175.0	CHEMBL267	Homo sapiens	IC50	uM	0.175
	2133126	CHEMBL938462	Inhibition of human cSrc in COS7 cells by ELISA	B	COc1cc(Nc2nn3c(NCC(C)(C)N)cc(C)nc3c2C(N)=O)cc(OC)c1		CHEMBL260114	=	IC50	nM	900.0	CHEMBL267	Homo sapiens	IC50	uM	0.9
	2133127	CHEMBL938463	Inhibition of human cSrc in COS7 cells at 1 uM by ELISA	B	COc1cc(Nc2nn3c(NCC(C)(C)N)cc(C)nc3c2C(N)=O)cc(OC)c1		CHEMBL260114	=	Inhibition	%	51.5	CHEMBL267	Homo sapiens	Inhibition	%	51.5
	2133129	CHEMBL938461	Inhibition of human cSrc	B	COc1cc(Nc2nn3c(NC[C@H](C)N)cc(C)nc3c2C(N)=O)cc(OC)c1		CHEMBL412139	=	IC50	nM	2990.0	CHEMBL267	Homo sapiens	IC50	uM	2.99
	2133130	CHEMBL938461	Inhibition of human cSrc	B	COc1cc(Nc2nn3c(NC[C@@H](C)N)cc(C)nc3c2C(N)=O)cc(OC)c1		CHEMBL258677	=	IC50	nM	408.0	CHEMBL267	Homo sapiens	IC50	uM	0.408
Not Determined	2133131	CHEMBL938462	Inhibition of human cSrc in COS7 cells by ELISA	B	COc1cc(Nc2nn3c(NC[C@H](C)N)cc(C)nc3c2C(N)=O)cc(OC)c1		CHEMBL412139		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	2133132	CHEMBL938462	Inhibition of human cSrc in COS7 cells by ELISA	B	COc1cc(Nc2nn3c(NC[C@@H](C)N)cc(C)nc3c2C(N)=O)cc(OC)c1		CHEMBL258677		IC50			CHEMBL267	Homo sapiens	IC50		
	2133133	CHEMBL938463	Inhibition of human cSrc in COS7 cells at 1 uM by ELISA	B	COc1cc(Nc2nn3c(NC[C@H](C)N)cc(C)nc3c2C(N)=O)cc(OC)c1		CHEMBL412139	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	Inhibition	%	0.0
	2133134	CHEMBL938463	Inhibition of human cSrc in COS7 cells at 1 uM by ELISA	B	COc1cc(Nc2nn3c(NC[C@@H](C)N)cc(C)nc3c2C(N)=O)cc(OC)c1		CHEMBL258677	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	Inhibition	%	0.0
	2136888	CHEMBL939372	Inhibition of Src	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	IC50	nM	316.23	CHEMBL267	Homo sapiens	Log IC50		-6.5
	2136980	CHEMBL939372	Inhibition of Src	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	>=	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	2137016	CHEMBL939372	Inhibition of Src	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCC(O)CO		CHEMBL1276317	=	IC50	nM	430.0	CHEMBL267	Homo sapiens	IC50	nM	430.0
	2137020	CHEMBL937643	Inhibition of c-Src	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	IC50	nM	185.0	CHEMBL267	Homo sapiens	IC50	nM	185.0
	2137107	CHEMBL937643	Inhibition of c-Src	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	IC50	nM	15000.0	CHEMBL267	Homo sapiens	IC50	nM	15000.0
	2137160	CHEMBL939372	Inhibition of Src	B	CN(c1cccnc1)c1cc2c(Nc3ccc(F)c(Cl)c3)c(C#N)cnc2cn1	Outside typical range	CHEMBL261238	>	IC50	nM	400000000.0	CHEMBL267	Homo sapiens	IC50	uM	400000.0
	2137186	CHEMBL939372	Inhibition of Src	B	CC(C)(C)c1cc(C=C2C(=O)C=CC2=O)cc(C(C)(C)C)c1O		CHEMBL258726	=	IC50	nM	2200.0	CHEMBL267	Homo sapiens	IC50	nM	2200.0
	2137192	CHEMBL939372	Inhibition of Src	B	Cc1cc(C=C2C(=O)C=CC2=O)cc(C)c1O		CHEMBL437612	=	IC50	nM	4400.0	CHEMBL267	Homo sapiens	IC50	nM	4400.0
	2137380	CHEMBL939372	Inhibition of Src	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	IC50	nM	280.0	CHEMBL267	Homo sapiens	IC50	nM	280.0
	2137384	CHEMBL937643	Inhibition of c-Src	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2	Outside typical range	CHEMBL605003	=	IC50	nM	688000.0	CHEMBL267	Homo sapiens	IC50	nM	688000.0
	2145341	CHEMBL922244	Inhibition of Src at 10 uM after 20 mins	B	CC1(C)C(=O)c2c3c(c4c([nH]c5ccccc54)c2C1=O)C(=O)NC3		CHEMBL264661	=	Inhibition	%	19.0	CHEMBL267	Homo sapiens	Inhibition	%	19.0
	2145342	CHEMBL922244	Inhibition of Src at 10 uM after 20 mins	B	O=C1NC(=O)c2c1c1c(O)ccc3c1c1c2c2ccccc2n1[C@]1(O3)O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O		CHEMBL259432	=	Inhibition	%	9.0	CHEMBL267	Homo sapiens	Inhibition	%	9.0
	2147232	CHEMBL922807	Activity of human cSRC kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	75.0	CHEMBL267	Homo sapiens	Activity	%	75.0
	2147536	CHEMBL934543	Inhibition of Src by luminescence based kinase assay	B	Cc1cc(-c2c(Cl)cccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL230686	=	Ki	nM	28.1	CHEMBL267	Homo sapiens	Ki	nM	28.1
	2147537	CHEMBL934543	Inhibition of Src by luminescence based kinase assay	B	Cc1cc(-c2c(Cl)cccc2Cl)cc2nnc(Nc3ccc(OCC[N+]4([O-])CCCC4)cc3)nc12		CHEMBL256101	=	Ki	nM	7.22	CHEMBL267	Homo sapiens	Ki	nM	7.22
	2151630	CHEMBL931467	Inhibition of Src kinase at 10 uM by ELISA	B	OCc1cc(O)c(Cc2cc(O)ccc2O)c(Cl)c1O		CHEMBL258424	=	Inhibition	%	35.9	CHEMBL267	Homo sapiens	Inhibition	%	35.9
	2151633	CHEMBL931468	Inhibition of Src kinase at 1 uM by ELISA	B	CC(C)(C)N1CN(c2ccc(Cl)cc2)C(N)=C2C=NN=C21		CHEMBL404666	=	Inhibition	%	89.4	CHEMBL267	Homo sapiens	Inhibition	%	89.4
	2153704	CHEMBL928271	Inhibition of cSRC at 20 uM	B	CN(C)CCOc1ccc2c(-c3c(-c4ccccn4)nn4c3CCC4)ccnc2c1		CHEMBL409525	<	Inhibition	%	50.0	CHEMBL267	Homo sapiens	Inhibition	%	50.0
	2153739	CHEMBL928271	Inhibition of cSRC at 20 uM	B	c1ccc(-c2nn3c(c2-c2ccnc4cc(OCCN5CCOCC5)ccc24)CCC3)nc1		CHEMBL260015	<	Inhibition	%	50.0	CHEMBL267	Homo sapiens	Inhibition	%	50.0
	2157677	CHEMBL932643	Inhibition of SRC at 1 uM	B	NCC1(c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL406863	>	Inhibition	%	60.0	CHEMBL267	Homo sapiens	Inhibition	%	60.0
	2167618	CHEMBL932338	Inhibition of Src	B	CS(=O)(=O)c1cccc(Nc2nccc(Nc3c(Cl)ccc4c3OCO4)n2)c1		CHEMBL445162	<	IC50	nM	100.0	CHEMBL267	Homo sapiens	IC50	uM	0.1
	2182419	CHEMBL941318	Inhibition of human cSRC at 1 uM	B	CS(=O)(=O)c1cccc(CNc2nc(Nc3ccc4c(c3)CCC(=O)N4)ncc2C(F)(F)F)c1		CHEMBL514554	=	Inhibition	%	1.0	CHEMBL267	Homo sapiens	INH	%	1.0
	2182834	CHEMBL941460	Inhibition of SRC at 5 uM	B	O=c1cc(N2CCOCC2)nc2c3ccccc3ccn12	Outside typical range	CHEMBL179242	=	Inhibition	%	-14.0	CHEMBL267	Homo sapiens	INH	%	-14.0
	2182937	CHEMBL945560	Inhibition of p60 src	B	CC(C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C	Outside typical range	CHEMBL216830	=	Ki	nM	700000.0	CHEMBL267	Homo sapiens	Ki	mM	0.7
	2186734	CHEMBL966656	Inhibition of human Src by ELISA	B	N#Cc1cnc2c(Cl)cc(NCc3cnc[nH]3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL436817	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	2198012	CHEMBL1006342	Inhibition of Tel-fused SRC kinase-mediated mouse BaF3 cell proliferation	F	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	IC50	nM	1146.0	CHEMBL267	Homo sapiens	IC50	uM	1.146
	2200439	CHEMBL997069	Inhibition of Src kinase	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	=	IC50	nM	1.0	CHEMBL267	Homo sapiens	IC50	nM	1.0
	2202567	CHEMBL942401	Inhibition of p60c-src expressed in chick embryo fibroblast	B	Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]1O		CHEMBL752	=	IC50	nM	100.0	CHEMBL267	Homo sapiens	IC50	10'-1microM	1.0
	2202568	CHEMBL942401	Inhibition of p60c-src expressed in chick embryo fibroblast	B	Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]1O		CHEMBL490984	=	IC50	nM	9000.0	CHEMBL267	Homo sapiens	IC50	uM	9.0
	2202569	CHEMBL942401	Inhibition of p60c-src expressed in chick embryo fibroblast	B	Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@@H](n3cnc4c(N)ncnc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O		CHEMBL339385	=	IC50	nM	46000.0	CHEMBL267	Homo sapiens	IC50	uM	46.0
	2202571	CHEMBL942401	Inhibition of p60c-src expressed in chick embryo fibroblast	B	Nc1nc2c(ncn2[C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4cnc5c(=O)[nH]c(N)nc54)[C@H](O)[C@@H]3O)[C@@H](O)[C@H]2O)c(=O)[nH]1		CHEMBL448348	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	2206776	CHEMBL989735	Inhibition of c-Src	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	=	IC50	nM	6000.0	CHEMBL267	Homo sapiens	IC50	uM	6.0
	2206875	CHEMBL973087	Inhibition of Src	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	=	IC50	nM	3.0	CHEMBL267	Homo sapiens	IC50	nM	3.0
	2206901	CHEMBL974010	Inhibition of Src by cellular assay	F	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1N1Cc2cnc(N)nc2N(C)C1=O		CHEMBL459850	=	EC50	nM	13.0	CHEMBL267	Homo sapiens	EC50	nM	13.0
	2206952	CHEMBL974010	Inhibition of Src by cellular assay	F	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	>	EC50	nM	1000.0	CHEMBL267	Homo sapiens	EC50	uM	1.0
	2206965	CHEMBL973087	Inhibition of Src	B	CCN(CC)CCCCNc1ncc2cc(-c3cc(OC)cc(OC)c3)c(NC(=O)NC(C)(C)C)nc2n1		CHEMBL189584	=	IC50	nM	20000.0	CHEMBL267	Homo sapiens	IC50	uM	20.0
	2206987	CHEMBL989735	Inhibition of c-Src	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	2221909	CHEMBL968473	Inhibition of Src kinase at 10 uM	B	CCOC(=O)c1cc2c(c3c1[nH]c1ccccc13)C(=O)N(CO)C2=O		CHEMBL465738	=	Inhibition	%	11.5	CHEMBL267	Homo sapiens	INH	%	11.5
	2228671	CHEMBL1003141	Inhibition of p60 c-Src	B	O=C(/C=C/c1ccc(O)c(O)c1)c1ccc(O)cc1O		CHEMBL128000	=	IC50	nM	65000.0	CHEMBL267	Homo sapiens	IC50	uM	65.0
Not Determined	2234163	CHEMBL970839	Inhibition of pp60c-src	B	Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1		CHEMBL803		IC50			CHEMBL267	Homo sapiens	IC50		
	2236531	CHEMBL976274	Inhibition of human Src kinase by TR-FRET assay	B	CCCP(=O)(CCC)c1ccc(Nc2nc(C(C)C)nc3c2ncn3/C=C/c2c(C)cccc2C)cc1		CHEMBL528330	=	IC50	nM	1.78	CHEMBL267	Homo sapiens	IC50	nM	1.78
	2236534	CHEMBL976274	Inhibition of human Src kinase by TR-FRET assay	B	Cc1cccc(C)c1/C=C/n1cnc2c(Nc3ccc(P(C)(C)=O)cc3)nc(CCC#N)nc21		CHEMBL517256	<	IC50	nM	0.46	CHEMBL267	Homo sapiens	IC50	nM	0.46
	2236535	CHEMBL976274	Inhibition of human Src kinase by TR-FRET assay	B	Cc1cccc(C)c1/C=C/n1cnc2c(Nc3ccc(P(C)(C)=O)cc3)nc(C3CCCC3)nc21		CHEMBL460074	=	IC50	nM	1.29	CHEMBL267	Homo sapiens	IC50	nM	1.29
	2236536	CHEMBL976274	Inhibition of human Src kinase by TR-FRET assay	B	Cc1cccc(C)c1/C=C/n1cnc2c(Nc3ccc(P(C)(C)=O)cc3)nc(C(C)C)nc21		CHEMBL459877	=	IC50	nM	0.89	CHEMBL267	Homo sapiens	IC50	nM	0.89
	2236537	CHEMBL976274	Inhibition of human Src kinase by TR-FRET assay	B	Cc1cccc(C)c1/C=C/n1cnc2c(Nc3ccc(P(C)(C)=O)cc3)nc(Oc3cccnc3)nc21		CHEMBL518166	<	IC50	nM	0.46	CHEMBL267	Homo sapiens	IC50	nM	0.46
	2236538	CHEMBL976274	Inhibition of human Src kinase by TR-FRET assay	B	Cc1cccc(C)c1/C=C/n1cnc2c(Nc3ccc(P(C)(C)=O)cc3)nc(C3CCN(C)CC3)nc21		CHEMBL461768	<	IC50	nM	0.46	CHEMBL267	Homo sapiens	IC50	nM	0.46
	2236539	CHEMBL976274	Inhibition of human Src kinase by TR-FRET assay	B	COCCOc1nc(Nc2ccc(P(C)(C)=O)cc2)c2ncn(/C=C/c3c(C)cccc3C)c2n1		CHEMBL461767	<	IC50	nM	0.46	CHEMBL267	Homo sapiens	IC50	nM	0.46
	2236540	CHEMBL976274	Inhibition of human Src kinase by TR-FRET assay	B	Cc1cccc(C)c1/C=C/n1cnc2c(Nc3ccc(P(C)(C)=O)cc3)nc(OC(C)C)nc21		CHEMBL516498	<	IC50	nM	0.46	CHEMBL267	Homo sapiens	IC50	nM	0.46
	2236541	CHEMBL976274	Inhibition of human Src kinase by TR-FRET assay	B	COc1nc(Nc2ccc(P(C)(C)=O)cc2)c2ncn(/C=C/c3c(C)cccc3C)c2n1		CHEMBL509002	<	IC50	nM	0.46	CHEMBL267	Homo sapiens	IC50	nM	0.46
	2236542	CHEMBL976274	Inhibition of human Src kinase by TR-FRET assay	B	Cc1cccc(C)c1/C=C/n1cnc2c(Nc3ccc(P(C)(C)=O)cc3)nc(-n3ccnc3)nc21		CHEMBL455384	<	IC50	nM	0.46	CHEMBL267	Homo sapiens	IC50	nM	0.46
	2236543	CHEMBL976274	Inhibition of human Src kinase by TR-FRET assay	B	Cc1cccc(C)c1/C=C/n1cnc2c(Nc3ccc(P(C)(C)=O)cc3)nc(N3CCN(C)CC3)nc21		CHEMBL509941	<	IC50	nM	0.23	CHEMBL267	Homo sapiens	IC50	nM	0.23
	2236544	CHEMBL976274	Inhibition of human Src kinase by TR-FRET assay	B	Cc1cccc(C)c1/C=C/n1cnc2c(Nc3ccc(P(C)(C)=O)cc3)nc(N3CCOCC3)nc21		CHEMBL454358	<	IC50	nM	0.23	CHEMBL267	Homo sapiens	IC50	nM	0.23
	2236545	CHEMBL976274	Inhibition of human Src kinase by TR-FRET assay	B	Cc1cccc(C)c1/C=C/n1cnc2c(Nc3ccc(P(C)(C)=O)cc3)nc(N3CCCC3)nc21		CHEMBL451790	=	IC50	nM	1.43	CHEMBL267	Homo sapiens	IC50	nM	1.43
	2236546	CHEMBL976274	Inhibition of human Src kinase by TR-FRET assay	B	Cc1cccc(C)c1/C=C/n1cnc2c(Nc3ccc(P(C)(C)=O)cc3)nc(N(C)C)nc21		CHEMBL454873	=	IC50	nM	3.74	CHEMBL267	Homo sapiens	IC50	nM	3.74
	2236547	CHEMBL976274	Inhibition of human Src kinase by TR-FRET assay	B	CCCP(=O)(CCC)c1ccc(Nc2ncnc3c2ncn3/C=C/c2c(C)cccc2C)cc1		CHEMBL454872	=	IC50	nM	4.0	CHEMBL267	Homo sapiens	IC50	nM	4.0
	2236548	CHEMBL976274	Inhibition of human Src kinase by TR-FRET assay	B	Cc1ccc2[nH]ncc2c1/C=C/n1cnc2c(Nc3ccc(P(C)(C)=O)cc3)ncnc21		CHEMBL510893	<	IC50	nM	0.46	CHEMBL267	Homo sapiens	IC50	nM	0.46
	2236549	CHEMBL976274	Inhibition of human Src kinase by TR-FRET assay	B	CP(C)(=O)c1ccc(Nc2ncnc3c2ncn3/C=C/c2cccc3[nH]ncc23)cc1		CHEMBL452563	=	IC50	nM	17.0	CHEMBL267	Homo sapiens	IC50	nM	17.0
	2238217	CHEMBL976274	Inhibition of human Src kinase by TR-FRET assay	B	CP(C)(=O)c1ccc(Nc2ncnc3c2ncn3/C=C/c2cccc3[nH]ccc23)cc1		CHEMBL454868	=	IC50	nM	198.0	CHEMBL267	Homo sapiens	IC50	nM	198.0
	2238218	CHEMBL976274	Inhibition of human Src kinase by TR-FRET assay	B	CP(C)(=O)c1ccc(Nc2ncnc3c2ncn3/C=C/c2ccccc2Cl)cc1		CHEMBL510891	=	IC50	nM	126.0	CHEMBL267	Homo sapiens	IC50	nM	126.0
	2238219	CHEMBL976274	Inhibition of human Src kinase by TR-FRET assay	B	Cc1cccc(Cl)c1/C=C/n1cnc2c(Nc3ccc(P(C)(C)=O)cc3)ncnc21		CHEMBL454611	=	IC50	nM	5.56	CHEMBL267	Homo sapiens	IC50	nM	5.56
	2238220	CHEMBL976274	Inhibition of human Src kinase by TR-FRET assay	B	Cc1cccc(C)c1/C=C/n1cnc2c(Nc3ccc(P(C)(C)=O)cc3)ncnc21		CHEMBL488840	=	IC50	nM	8.31	CHEMBL267	Homo sapiens	IC50	nM	8.31
	2238221	CHEMBL976274	Inhibition of human Src kinase by TR-FRET assay	B	CCCP(=O)(CCC)c1ccc(Nc2nc(C(C)C)nc3c2ncn3/C=C\c2ccccc2)cc1		CHEMBL488659	=	IC50	nM	376.0	CHEMBL267	Homo sapiens	IC50	nM	376.0
	2238222	CHEMBL976274	Inhibition of human Src kinase by TR-FRET assay	B	CCCP(=O)(CCC)c1ccc(Nc2nc(C(C)C)nc3c2ncn3/C=C/c2ccccc2)cc1		CHEMBL488658	=	IC50	nM	31.8	CHEMBL267	Homo sapiens	IC50	nM	31.8
	2238223	CHEMBL976274	Inhibition of human Src kinase by TR-FRET assay	B	CCCP(=O)(CCC)c1ccc(Nc2nc(C(C)C)nc3c2ncn3/C=C\c2c(C)cccc2C)cc1		CHEMBL520540	=	IC50	nM	6.58	CHEMBL267	Homo sapiens	IC50	nM	6.58
	2239376	CHEMBL980065	Inhibition of Src assessed as residual enzyme activity at 1 uM	B	Cc1ncc(NC(=O)c2cc(NC(=O)c3cccc(C(F)(F)F)c3)ccc2Cl)s1		CHEMBL462132	=	Activity	%	10.0	CHEMBL267	Homo sapiens	Activity	%	10.0
	2239698	CHEMBL996963	Inhibition of c-Src	B	O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1[nH]c3ccc(O)cc3c21		CHEMBL379975	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	2239699	CHEMBL996963	Inhibition of c-Src	B	O=C(O)CCn1c2ccc(O)cc2c2c3c(c(-c4ccccc4)cc21)C(=O)NC3=O		CHEMBL462170	=	IC50	nM	13000.0	CHEMBL267	Homo sapiens	IC50	uM	13.0
	2239700	CHEMBL996963	Inhibition of c-Src	B	CN1CCN(CCCn2c3ccc(O)cc3c3c4c(c(-c5ccccc5)cc32)C(=O)NC4=O)CC1		CHEMBL453347	=	IC50	nM	17000.0	CHEMBL267	Homo sapiens	IC50	uM	17.0
	2239701	CHEMBL996963	Inhibition of c-Src	B	O=C1NC(=O)c2c1c(-c1ccccc1)cc1c2c2cc(O)ccc2n1CCCN1CCOCC1		CHEMBL510668	=	IC50	nM	46000.0	CHEMBL267	Homo sapiens	IC50	uM	46.0
	2239702	CHEMBL996963	Inhibition of c-Src	B	CN(C)CCCn1c2ccc(O)cc2c2c3c(c(-c4ccccc4)cc21)C(=O)NC3=O		CHEMBL508515	=	IC50	nM	5600.0	CHEMBL267	Homo sapiens	IC50	uM	5.6
	2239703	CHEMBL996963	Inhibition of c-Src	B	O=C1NC(=O)c2c1c(-c1ccccc1)cc1c2c2cc(O)ccc2n1CCn1ccnc1		CHEMBL488899	=	IC50	nM	27000.0	CHEMBL267	Homo sapiens	IC50	uM	27.0
	2239704	CHEMBL996963	Inhibition of c-Src	B	CN(C)CCn1c2ccc(O)cc2c2c3c(c(-c4ccccc4)cc21)C(=O)NC3=O		CHEMBL519891	=	IC50	nM	31000.0	CHEMBL267	Homo sapiens	IC50	uM	31.0
	2239705	CHEMBL996963	Inhibition of c-Src	B	O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1c2c2cc(O)ccc2n1CC(O)CO		CHEMBL520904	=	IC50	nM	2500.0	CHEMBL267	Homo sapiens	IC50	uM	2.5
	2248297	CHEMBL957363	Inhibition of SRC at 5 uM	B	O=C1NC(=O)/C(=C/c2cccc(C(F)(F)F)c2)S1		CHEMBL183906	=	Inhibition	%	4.0	CHEMBL267	Homo sapiens	INH	%	4.0
	2248298	CHEMBL957363	Inhibition of SRC at 5 uM	B	CCCOc1ccc(/C=C2\SC(=O)NC2=O)cc1		CHEMBL84558	=	Inhibition	%	4.0	CHEMBL267	Homo sapiens	INH	%	4.0
	2251080	CHEMBL1022318	Inhibition of SRC at 100 nM relative to control	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H](CCCCN)NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(N)=O		CHEMBL525385	=	Inhibition	%	28.0	CHEMBL267	Homo sapiens	INH	%	28.0
	2251220	CHEMBL1009918	Inhibition of SRC T341M mutant	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	IC50	nM	10.0	CHEMBL267	Homo sapiens	IC50	nM	10.0
	2264721	CHEMBL1011760	Binding affinity to SRC	B	CS(=O)(=O)c1ccc(CNCc2cc(C(=O)O)c(Nc3ccc(I)cc3F)c(F)c2F)cc1		CHEMBL465465	>	IC50	nM	30000.0	CHEMBL267	Homo sapiens	IC50	uM	30.0
	2264722	CHEMBL1011760	Binding affinity to SRC	B	NC(=O)C[C@H](N)C(=O)NCc1cc(C(=O)O)c(Nc2ccc(I)cc2F)c(F)c1F		CHEMBL517647	=	IC50	nM	4000.0	CHEMBL267	Homo sapiens	IC50	uM	4.0
	2264723	CHEMBL1011760	Binding affinity to SRC	B	O=C(N/N=C/c1cc(C(=O)O)c(Nc2ccc(I)cc2F)c(F)c1F)c1ccc(CO)o1		CHEMBL481968	=	IC50	nM	100.0	CHEMBL267	Homo sapiens	IC50	uM	0.1
	2264724	CHEMBL1011760	Binding affinity to SRC	B	O=C(CS(=O)(=O)c1ccc(Cl)cc1)N/N=C/c1cc(C(=O)O)c(Nc2ccc(I)cc2F)c(F)c1F		CHEMBL481969	=	IC50	nM	3000.0	CHEMBL267	Homo sapiens	IC50	uM	3.0
	2268426	CHEMBL960830	Inhibition of Src at 10 uM	B	Clc1cccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)c1		CHEMBL522629	<	Inhibition	%	30.0	CHEMBL267	Homo sapiens	INH	%	30.0
	2268794	CHEMBL960830	Inhibition of Src at 10 uM	B	Clc1cccc(-n2cc(-c3ccccc3NCc3c[nH]cn3)nn2)c1		CHEMBL464619	<	Inhibition	%	30.0	CHEMBL267	Homo sapiens	INH	%	30.0
	2268795	CHEMBL960830	Inhibition of Src at 10 uM	B	FC(F)(F)c1cccc(-n2cc(-c3ccccc3NCc3ccnc4ccccc34)nn2)c1		CHEMBL517021	<	Inhibition	%	30.0	CHEMBL267	Homo sapiens	INH	%	30.0
	2268796	CHEMBL960830	Inhibition of Src at 10 uM	B	Clc1cccc(-n2cc(-c3ccccc3NCc3ccnc4ccccc34)nn2)c1		CHEMBL516635	<	Inhibition	%	30.0	CHEMBL267	Homo sapiens	INH	%	30.0
	2268797	CHEMBL960830	Inhibition of Src at 10 uM	B	FC(F)(F)c1cccc(-n2cc(-c3ccccc3NCc3ccc4c(c3)OCO4)nn2)c1		CHEMBL460959	<	Inhibition	%	30.0	CHEMBL267	Homo sapiens	INH	%	30.0
	2268798	CHEMBL960830	Inhibition of Src at 10 uM	B	Clc1cccc(-n2cc(-c3ccccc3NCc3ccc4c(c3)OCO4)nn2)c1		CHEMBL460958	<	Inhibition	%	30.0	CHEMBL267	Homo sapiens	INH	%	30.0
	2268799	CHEMBL960830	Inhibition of Src at 10 uM	B	Fc1ccc(CNc2ccccc2-c2cn(-c3cccc(Cl)c3)nn2)cc1F		CHEMBL460751	<	Inhibition	%	30.0	CHEMBL267	Homo sapiens	INH	%	30.0
	2268800	CHEMBL960830	Inhibition of Src at 10 uM	B	Cc1cc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)ccc1C(F)(F)F		CHEMBL454403	<	Inhibition	%	30.0	CHEMBL267	Homo sapiens	INH	%	30.0
	2268801	CHEMBL960830	Inhibition of Src at 10 uM	B	Cc1ccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)cc1C(F)(F)F		CHEMBL523320	<	Inhibition	%	30.0	CHEMBL267	Homo sapiens	INH	%	30.0
	2268802	CHEMBL960830	Inhibition of Src at 10 uM	B	Clc1ccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)cc1Cl		CHEMBL491872	<	Inhibition	%	30.0	CHEMBL267	Homo sapiens	INH	%	30.0
	2268803	CHEMBL960830	Inhibition of Src at 10 uM	B	FC(F)(F)c1ccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)cc1Cl		CHEMBL491871	<	Inhibition	%	30.0	CHEMBL267	Homo sapiens	INH	%	30.0
	2268804	CHEMBL960830	Inhibition of Src at 10 uM	B	FC(F)(F)c1cc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)ccc1Cl		CHEMBL522133	<	Inhibition	%	30.0	CHEMBL267	Homo sapiens	INH	%	30.0
	2268805	CHEMBL960830	Inhibition of Src at 10 uM	B	c1ccc(-c2cn(-c3ccc4[nH]ncc4c3)nn2)c(NCc2ccncc2)c1		CHEMBL516645	<	Inhibition	%	30.0	CHEMBL267	Homo sapiens	INH	%	30.0
	2268806	CHEMBL960830	Inhibition of Src at 10 uM	B	c1ccc(-c2cn(-c3ccc4ccccc4n3)nn2)c(NCc2ccncc2)c1		CHEMBL461605	<	Inhibition	%	30.0	CHEMBL267	Homo sapiens	INH	%	30.0
	2268807	CHEMBL960830	Inhibition of Src at 10 uM	B	CC(C)(C)c1ccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)cc1		CHEMBL461392	<	Inhibition	%	30.0	CHEMBL267	Homo sapiens	INH	%	30.0
	2268808	CHEMBL960830	Inhibition of Src at 10 uM	B	CC(C)(C)c1cccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)c1		CHEMBL461391	<	Inhibition	%	30.0	CHEMBL267	Homo sapiens	INH	%	30.0
	2268809	CHEMBL960830	Inhibition of Src at 10 uM	B	CC(C)c1cccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)c1		CHEMBL518652	<	Inhibition	%	30.0	CHEMBL267	Homo sapiens	INH	%	30.0
	2268810	CHEMBL960830	Inhibition of Src at 10 uM	B	FC(F)(F)Oc1ccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)cc1		CHEMBL491681	<	Inhibition	%	30.0	CHEMBL267	Homo sapiens	INH	%	30.0
	2268811	CHEMBL960830	Inhibition of Src at 10 uM	B	FC(F)(F)c1ccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)cc1		CHEMBL522304	<	Inhibition	%	30.0	CHEMBL267	Homo sapiens	INH	%	30.0
	2268812	CHEMBL960830	Inhibition of Src at 10 uM	B	Clc1ccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)cc1		CHEMBL491680	<	Inhibition	%	30.0	CHEMBL267	Homo sapiens	INH	%	30.0
	2268814	CHEMBL960830	Inhibition of Src at 10 uM	B	FC(F)(F)c1cccc(-n2cc(-c3ccccc3NCc3ccccn3)nn2)c1		CHEMBL523133	<	Inhibition	%	30.0	CHEMBL267	Homo sapiens	INH	%	30.0
	2268815	CHEMBL960830	Inhibition of Src at 10 uM	B	FC(F)(F)c1cccc(-n2cc(-c3ccccc3NCc3cccnc3)nn2)c1		CHEMBL490969	<	Inhibition	%	30.0	CHEMBL267	Homo sapiens	INH	%	30.0
	2268816	CHEMBL960830	Inhibition of Src at 10 uM	B	FC(F)(F)c1cccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)c1		CHEMBL490968	<	Inhibition	%	30.0	CHEMBL267	Homo sapiens	INH	%	30.0
	2268817	CHEMBL960830	Inhibition of Src at 10 uM	B	Clc1cccc(-n2cc(-c3ccccc3NCc3ccccn3)nn2)c1		CHEMBL523301	<	Inhibition	%	30.0	CHEMBL267	Homo sapiens	INH	%	30.0
	2268818	CHEMBL960830	Inhibition of Src at 10 uM	B	Clc1cccc(-n2cc(-c3ccccc3NCc3cccnc3)nn2)c1		CHEMBL489329	<	Inhibition	%	30.0	CHEMBL267	Homo sapiens	INH	%	30.0
	2269895	CHEMBL960830	Inhibition of Src at 10 uM	B	FC(F)(F)Oc1cccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)c1		CHEMBL491502	<	Inhibition	%	30.0	CHEMBL267	Homo sapiens	INH	%	30.0
	2270358	CHEMBL960140	Inhibition of Src by virtual HTS assay	B	c1cc(Nc2ncnc3[nH]ccc23)cc(-c2nc3ccccc3s2)c1		CHEMBL490555	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	2270359	CHEMBL960140	Inhibition of Src by virtual HTS assay	B	CNc1nc(Nc2ccc(-c3nc4ccccc4s3)cc2)c2cc(OC)c(OC)cc2n1		CHEMBL514941	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	2270360	CHEMBL960140	Inhibition of Src by virtual HTS assay	B	COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)c(OC)c3)c2cc1OC		CHEMBL473553	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	2270361	CHEMBL960140	Inhibition of Src by virtual HTS assay	B	COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)c(O)c3)c2cc1OC		CHEMBL473351	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	2270362	CHEMBL960140	Inhibition of Src by virtual HTS assay	B	COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)cc3C)c2cc1OC		CHEMBL514942	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	2270363	CHEMBL960140	Inhibition of Src by virtual HTS assay	B	COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)cc3)c2cc1OC		CHEMBL473556	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	2270364	CHEMBL960140	Inhibition of Src by virtual HTS assay	B	COc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1-c1nc2ccccc2s1		CHEMBL474544	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	2270365	CHEMBL960140	Inhibition of Src by virtual HTS assay	B	Fc1cc(-c2nc3ccccc3s2)ccc1Nc1ncnc2ccsc12		CHEMBL474347	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	2270366	CHEMBL960140	Inhibition of Src by virtual HTS assay	B	Clc1cc(Nc2ncnc3ccsc23)ccc1-c1nc2ccccc2s1		CHEMBL474346	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	2270367	CHEMBL960140	Inhibition of Src by virtual HTS assay	B	COc1cc(Nc2ncnc3ccsc23)ccc1-c1nc2ccccc2s1		CHEMBL514929	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	2270368	CHEMBL960140	Inhibition of Src by virtual HTS assay	B	c1ccc2sc(-c3ccc(Nc4ncnc5ccsc45)cc3)nc2c1		CHEMBL472946	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	2270369	CHEMBL960140	Inhibition of Src by virtual HTS assay	B	COc1cc(Nc2ncnc3[nH]cnc23)ccc1-c1nc2ccccc2s1		CHEMBL475352	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	2270370	CHEMBL960140	Inhibition of Src by virtual HTS assay	B	c1ccc2sc(-c3ccc(Nc4ncnc5[nH]cnc45)cc3)nc2c1		CHEMBL515598	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	2270371	CHEMBL960140	Inhibition of Src by virtual HTS assay	B	COc1cc(Nc2ncnc3[nH]ccc23)ccc1-c1nc2ccccc2s1		CHEMBL462162	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	2270457	CHEMBL960140	Inhibition of Src by virtual HTS assay	B	COc1nc(Nc2ccc(-c3nc4ccccc4s3)cc2)c2cc[nH]c2n1		CHEMBL462338	=	IC50	nM	6400.0	CHEMBL267	Homo sapiens	IC50	uM	6.4
	2270484	CHEMBL960140	Inhibition of Src by virtual HTS assay	B	COc1cc2nc(Nc3cc(C)[nH]n3)nc(Nc3ccc(-c4nc5ccccc5s4)cc3)c2cc1OC		CHEMBL473761	=	IC50	nM	3000.0	CHEMBL267	Homo sapiens	IC50	uM	3.0
	2270499	CHEMBL960140	Inhibition of Src by virtual HTS assay	B	COc1nc(Nc2ccc(-c3nc4ccccc4s3)c(OC)c2)c2cc[nH]c2n1		CHEMBL475351	=	IC50	nM	2100.0	CHEMBL267	Homo sapiens	IC50	uM	2.1
	2270514	CHEMBL960140	Inhibition of Src by virtual HTS assay	B	c1ccc2sc(-c3ccc(Nc4ncnc5[nH]ccc45)cc3)nc2c1		CHEMBL518803	=	IC50	nM	1500.0	CHEMBL267	Homo sapiens	IC50	uM	1.5
	2270525	CHEMBL960140	Inhibition of Src by virtual HTS assay	B	c1cc(Nc2ncnc3[nH]cnc23)cc(-c2nc3ccccc3s2)c1		CHEMBL443906	=	IC50	nM	1100.0	CHEMBL267	Homo sapiens	IC50	uM	1.1
	2270533	CHEMBL960140	Inhibition of Src by virtual HTS assay	B	COc1cc2nc(Nc3cc(C)[nH]n3)nc(Nc3cccc(-c4nc5ccccc5s4)c3)c2cc1OC		CHEMBL522785	=	IC50	nM	960.0	CHEMBL267	Homo sapiens	IC50	uM	0.96
	2270553	CHEMBL960140	Inhibition of Src by virtual HTS assay	B	Fc1cc(-c2nc3ccccc3s2)ccc1Nc1ncnc2cc(Cl)ccc12		CHEMBL473557	=	IC50	nM	700.0	CHEMBL267	Homo sapiens	IC50	uM	0.7
	2270557	CHEMBL960140	Inhibition of Src by virtual HTS assay	B	Clc1ccc2c(Nc3ccc(-c4nc5ccccc5s4)cc3)ccnc2c1		CHEMBL474543	=	IC50	nM	630.0	CHEMBL267	Homo sapiens	IC50	uM	0.63
	2270562	CHEMBL960140	Inhibition of Src by virtual HTS assay	B	Clc1ccc2c(Nc3ccc(-c4nc5ccccc5s4)c(Cl)c3)ncnc2c1		CHEMBL514016	=	IC50	nM	500.0	CHEMBL267	Homo sapiens	IC50	uM	0.5
	2270568	CHEMBL960140	Inhibition of Src by virtual HTS assay	B	Cc1cc2c(Nc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1Cl		CHEMBL473354	=	IC50	nM	300.0	CHEMBL267	Homo sapiens	IC50	uM	0.3
	2270572	CHEMBL960140	Inhibition of Src by virtual HTS assay	B	Cc1cc(Nc2ccnc(Nc3cccc(-c4nc5ccccc5s4)c3)n2)n[nH]1		CHEMBL491686	=	IC50	nM	190.0	CHEMBL267	Homo sapiens	IC50	uM	0.19
	2270573	CHEMBL960140	Inhibition of Src by virtual HTS assay	B	O=C(NC(=S)Nc1ccc(O)c(-c2nc3ccccc3s2)c1)c1ccc([N+](=O)[O-])cc1		CHEMBL460746	=	IC50	nM	190.0	CHEMBL267	Homo sapiens	IC50	uM	0.19
	2280939	CHEMBL960935	Inhibition of Src	B	CNc1nc2oc(-c3ccccc3)nc2c2c1ncn2C		CHEMBL493940	<	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	2280940	CHEMBL960935	Inhibition of Src	B	CNc1nc2c(nc(-c3ccccc3)n2C)c2c1ncn2C		CHEMBL522011	<	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	2280941	CHEMBL960935	Inhibition of Src	B	CNc1nc2sc(-c3cccc(CNC(C)=O)c3)nc2c2c1ncn2C		CHEMBL454973	<	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	2298902	CHEMBL1018047	Inhibition of human Src	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	IC50	nM	156.0	CHEMBL267	Homo sapiens	IC50	nM	156.0
Not Active	2301942	CHEMBL949885	Inhibition of SRC	B	COc1ncnc2ncn(CC(=O)c3ccccc3)c12		CHEMBL483271		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	2301966	CHEMBL949885	Inhibition of SRC	B	COc1ncnc2c1ncn2CC(=O)c1ccccc1		CHEMBL519976		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	2301990	CHEMBL949885	Inhibition of SRC	B	Nc1ncnc2c1ncn2CC(=O)c1cccnc1		CHEMBL501256	=	IC50	nM	75000.0	CHEMBL267	Homo sapiens	IC50	uM	75.0
Not Active	2302014	CHEMBL949885	Inhibition of SRC	B	Nc1ncnc2c1ncn2CC(=O)c1ccccn1		CHEMBL504135		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	2302038	CHEMBL949885	Inhibition of SRC	B	Nc1ncnc2ncn(CC(=O)c3ccccc3)c12		CHEMBL485444		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	2302061	CHEMBL949884	Inhibition of SRC up to 100 uM	B	Nc1ncnc2c1ncn2CC(=O)c1ccccc1		CHEMBL520515		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	2302086	CHEMBL949885	Inhibition of SRC	B	Nc1ncnc2ncn(CC(=O)c3c[nH]c4ccccc34)c12		CHEMBL485246	=	IC50	nM	82000.0	CHEMBL267	Homo sapiens	IC50	uM	82.0
Not Active	2302110	CHEMBL949885	Inhibition of SRC	B	Nc1ncnc2c1ncn2CC(=O)c1c[nH]c2ccccc12		CHEMBL521155		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	2302130	CHEMBL949885	Inhibition of SRC	B	CN(C)c1ncnc2c1ncn2CC(=O)c1c[nH]c2ccccc12		CHEMBL519977		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	2304769	CHEMBL938941	Inhibition of Src at 1 uM	B	CO[C@@H]1[C@@H](CN)O[C@@H]2[C@H]([C@H]1O)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4=O.Cl		CHEMBL491263	=	Inhibition	%	35.0	CHEMBL267	Homo sapiens	INH	%	35.0
	2341245	CHEMBL1002715	Inhibition of c-Src	B	COc1cc2nccc(Oc3ccccc3C(=O)c3ccccc3)c2cc1OC		CHEMBL482728	=	IC50	nM	4500.0	CHEMBL267	Homo sapiens	IC50	uM	4.5
	2341247	CHEMBL1002715	Inhibition of c-Src	B	COc1cc2nccc(Oc3ccc(C)cc3C(=O)c3ccccc3)c2cc1OC.Cl		CHEMBL482729	=	IC50	nM	1700.0	CHEMBL267	Homo sapiens	IC50	uM	1.7
	2341249	CHEMBL1002715	Inhibition of c-Src	B	COc1cc2nccc(Oc3ccc(C)cc3C(C)=O)c2cc1OC		CHEMBL484907	=	IC50	nM	8400.0	CHEMBL267	Homo sapiens	IC50	uM	8.4
	2341251	CHEMBL1002715	Inhibition of c-Src	B	COc1cc2nccc(Oc3cc(C)c(C)cc3C(C)=O)c2cc1OC		CHEMBL500149	=	IC50	nM	13000.0	CHEMBL267	Homo sapiens	IC50	uM	13.0
	2341435	CHEMBL953396	Inhibition of Src at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(N3CCN(C(=O)Cc4c[nH]c5ccccc45)CC3)ncn2)c1		CHEMBL524898	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	2341476	CHEMBL953396	Inhibition of Src at 10 uM by HTRF assay relative to control	B	CN(C)CC(C)(C)CNC(=O)c1cccc(Nc2nccc(Nc3ccc4ncsc4c3)n2)c1		CHEMBL501459	=	Inhibition	%	99.0	CHEMBL267	Homo sapiens	INH	%	99.0
	2341517	CHEMBL953396	Inhibition of Src at 10 uM by HTRF assay relative to control	B	Nc1nc(N2CCOCC2)cc(N2CCC(C(=O)NCCc3ccc(O)cc3)CC2)n1		CHEMBL501728	=	Inhibition	%	2.0	CHEMBL267	Homo sapiens	INH	%	2.0
	2341558	CHEMBL953396	Inhibition of Src at 10 uM by HTRF assay relative to control	B	O=C(NCCc1ccc(O)cc1)c1cccc(Nc2nccc(Nc3ccc4ncsc4c3)n2)c1		CHEMBL499617	=	Inhibition	%	71.0	CHEMBL267	Homo sapiens	INH	%	71.0
	2341599	CHEMBL953396	Inhibition of Src at 10 uM by HTRF assay relative to control	B	O=C(c1nc(SCc2ccc(Cl)cc2)n2ccccc12)N1CCN(c2cc(Nc3cccc(Br)c3)ncn2)CC1		CHEMBL501200	=	Inhibition	%	2.0	CHEMBL267	Homo sapiens	INH	%	2.0
	2341640	CHEMBL953396	Inhibition of Src at 10 uM by HTRF assay relative to control	B	Nc1nc(Nc2ccc3ncsc3c2)cc(N2CCC[C@H]2C(=O)N[C@@H](CO)c2ccccc2)n1		CHEMBL525070	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	2341681	CHEMBL953396	Inhibition of Src at 10 uM by HTRF assay relative to control	B	Nc1nc(Nc2ccc3ncsc3c2)cc(N2CCC[C@H]2C(=O)NCCc2cccc(I)c2)n1		CHEMBL501463	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	2341722	CHEMBL953396	Inhibition of Src at 10 uM by HTRF assay relative to control	B	O=C(NC1Cc2ccccc2C1)c1cccc(Nc2ccnc(N3CCN(c4ccccc4)CC3)n2)c1		CHEMBL499624	=	Inhibition	%	9.0	CHEMBL267	Homo sapiens	INH	%	9.0
	2341763	CHEMBL953396	Inhibition of Src at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)NCc4ccc(N(C)C)cc4)c3)ncn2)c1		CHEMBL502826	=	Inhibition	%	4.0	CHEMBL267	Homo sapiens	INH	%	4.0
	2341804	CHEMBL953396	Inhibition of Src at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3ccc(CC(=O)Nc4ccc5ncsc5c4)cc3)ncn2)c1		CHEMBL502827	=	Inhibition	%	6.0	CHEMBL267	Homo sapiens	INH	%	6.0
	2341845	CHEMBL953396	Inhibition of Src at 10 uM by HTRF assay relative to control	B	COc1ccc(NC(=O)Cc2ccc(Nc3cc(N(C)c4cccc(C)c4)ncn3)cc2)cn1		CHEMBL526914	=	Inhibition	%	1.0	CHEMBL267	Homo sapiens	INH	%	1.0
	2341886	CHEMBL953396	Inhibition of Src at 10 uM by HTRF assay relative to control	B	Cc1cccc(Nc2nccc(Nc3cccc(C(=O)NCc4ccc(N(C)C)cc4)c3)n2)c1		CHEMBL501471	=	Inhibition	%	8.0	CHEMBL267	Homo sapiens	INH	%	8.0
	2341927	CHEMBL953396	Inhibition of Src at 10 uM by HTRF assay relative to control	B	O=C(NCc1cccnc1)c1cccc(-c2ccc(Nc3ccc4ncsc4c3)nn2)c1		CHEMBL501182	=	Inhibition	%	11.0	CHEMBL267	Homo sapiens	INH	%	11.0
	2341968	CHEMBL953396	Inhibition of Src at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)N4CCCC5CCCCC54)c3)ncn2)c1		CHEMBL499606	=	Inhibition	%	3.0	CHEMBL267	Homo sapiens	INH	%	3.0
	2342009	CHEMBL953396	Inhibition of Src at 10 uM by HTRF assay relative to control	B	COc1cccc(Nc2cc(Nc3cccc(C(=O)N(C)CCc4ccccn4)c3)nc(N)n2)c1		CHEMBL499865	=	Inhibition	%	6.0	CHEMBL267	Homo sapiens	INH	%	6.0
	2342050	CHEMBL953396	Inhibition of Src at 10 uM by HTRF assay relative to control	B	Cc1cccc(Nc2nccc(Nc3cccc(C(=O)N(C)CCc4ccccn4)c3)n2)c1		CHEMBL499866	=	Inhibition	%	64.0	CHEMBL267	Homo sapiens	INH	%	64.0
	2342091	CHEMBL953396	Inhibition of Src at 10 uM by HTRF assay relative to control	B	O=C(CN1CCN(c2ncnc3c2CN(Cc2ccccc2)CC3)CC1)Nc1cc(F)ccc1F		CHEMBL520451	=	Inhibition	%	1.0	CHEMBL267	Homo sapiens	INH	%	1.0
	2342132	CHEMBL953396	Inhibition of Src at 10 uM by HTRF assay relative to control	B	O=C(NCc1ccncc1)c1cccc(Nc2cc(Nc3cccc(Br)c3)ncn2)c1		CHEMBL482513	=	Inhibition	%	30.0	CHEMBL267	Homo sapiens	INH	%	30.0
	2342173	CHEMBL953396	Inhibition of Src at 10 uM by HTRF assay relative to control	B	Cc1cccc(Nc2cc(Nc3cccc(C(=O)N(CC(C)O)CC(C)O)c3)ncn2)c1		CHEMBL483318	=	Inhibition	%	26.0	CHEMBL267	Homo sapiens	INH	%	26.0
	2342223	CHEMBL953396	Inhibition of Src at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)NCCCn4ccnc4)c3)ncn2)c1		CHEMBL520971	=	Inhibition	%	24.0	CHEMBL267	Homo sapiens	INH	%	24.0
	2342252	CHEMBL953396	Inhibition of Src at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)N(C)CCc4ccccn4)c3)ncn2)c1		CHEMBL521469	=	Inhibition	%	15.0	CHEMBL267	Homo sapiens	INH	%	15.0
	2342296	CHEMBL953396	Inhibition of Src at 10 uM by HTRF assay relative to control	B	CC(=O)N1CCN(C(=O)c2cccc(Nc3cc(N(C)c4cccc(C)c4)ncn3)c2)CC1		CHEMBL521478	=	Inhibition	%	17.0	CHEMBL267	Homo sapiens	INH	%	17.0
	2342337	CHEMBL953396	Inhibition of Src at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)NCc4ccncc4)c3)ncn2)c1		CHEMBL483506	=	Inhibition	%	26.0	CHEMBL267	Homo sapiens	INH	%	26.0
	2342378	CHEMBL953396	Inhibition of Src at 10 uM by HTRF assay relative to control	B	CN(CCc1ccccn1)C(=O)c1cccc(Nc2nccc(Nc3ccc4ncsc4c3)n2)c1		CHEMBL483507	=	Inhibition	%	69.0	CHEMBL267	Homo sapiens	INH	%	69.0
	2342419	CHEMBL953396	Inhibition of Src at 10 uM by HTRF assay relative to control	B	COc1cccc(Nc2cc(Nc3cccc(C(=O)NCCCn4ccnc4)c3)nc(N)n2)c1		CHEMBL520980	=	Inhibition	%	10.0	CHEMBL267	Homo sapiens	INH	%	10.0
	2342460	CHEMBL953396	Inhibition of Src at 10 uM by HTRF assay relative to control	B	COC[C@@H]1CCCN1C(=O)[C@@H]1CCCN1c1cc(Nc2cccc(OC)c2)nc(N)n1		CHEMBL519962	=	Inhibition	%	4.0	CHEMBL267	Homo sapiens	INH	%	4.0
	2342501	CHEMBL953396	Inhibition of Src at 10 uM by HTRF assay relative to control	B	COc1cccc(Nc2cc(N3CCC[C@H]3C(=O)NCCN3CCCCC3)nc(N)n2)c1		CHEMBL526526	=	Inhibition	%	1.0	CHEMBL267	Homo sapiens	INH	%	1.0
	2342542	CHEMBL953396	Inhibition of Src at 10 uM by HTRF assay relative to control	B	O=C(COc1ccccc1)N1CCN(c2nccc(Nc3ccc4ncsc4c3)n2)CC1		CHEMBL482488	=	Inhibition	%	13.0	CHEMBL267	Homo sapiens	INH	%	13.0
	2342753	CHEMBL953396	Inhibition of Src at 10 uM by HTRF assay relative to control	B	Nc1nc(Nc2ccccc2)cc(N2CCC(C(=O)NCCc3ccccn3)CC2)n1		CHEMBL521002	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	2342754	CHEMBL953396	Inhibition of Src at 10 uM by HTRF assay relative to control	B	Clc1ccc2sc(CN3CCN(c4ncnc5c4CN(Cc4ccccc4)CC5)CC3)cc2c1		CHEMBL483710	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	2342755	CHEMBL953396	Inhibition of Src at 10 uM by HTRF assay relative to control	B	CN(CCc1ccccn1)C(=O)[C@@H]1CCCN1c1nccc(Nc2ccccc2)n1		CHEMBL521479	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	2342756	CHEMBL953396	Inhibition of Src at 10 uM by HTRF assay relative to control	B	CN(C)CC(C)(C)CNC(=O)[C@@H]1CCCN1c1nccc(Nc2ccccc2)n1		CHEMBL521000	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	2342757	CHEMBL953396	Inhibition of Src at 10 uM by HTRF assay relative to control	B	COC[C@@H]1CCCN1C(=O)[C@@H]1CCCN1c1nccc(Nc2ccccc2)n1		CHEMBL519349	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	2342758	CHEMBL953396	Inhibition of Src at 10 uM by HTRF assay relative to control	B	Cc1cccc(Nc2ncnc3c2CN(C(=O)c2ccc(N(C)C)c4ccccc24)CC3)c1		CHEMBL484324	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	2342759	CHEMBL953396	Inhibition of Src at 10 uM by HTRF assay relative to control	B	CN(C)c1ccc(C(=O)N2CCN(c3ncnc4c3CN(Cc3ccccc3)CC4)CC2)c2ccccc12		CHEMBL520331	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	2342760	CHEMBL953396	Inhibition of Src at 10 uM by HTRF assay relative to control	B	O=C(c1nc(SCc2ccc(Cl)cc2)n2ccccc12)N1CCN(c2ncnc3c2CN(Cc2ccccc2)CC3)CC1		CHEMBL446637	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	2342761	CHEMBL953396	Inhibition of Src at 10 uM by HTRF assay relative to control	B	Cc1cccc(Oc2ccnc(N3CCC[C@H]3C(=O)NCCCn3ccnc3)n2)c1		CHEMBL482722	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	2342762	CHEMBL953396	Inhibition of Src at 10 uM by HTRF assay relative to control	B	Cc1cccc(Oc2ccnc(N3CCN(C(=O)c4c(C)noc4C)CC3)n2)c1		CHEMBL482721	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	2342763	CHEMBL953396	Inhibition of Src at 10 uM by HTRF assay relative to control	B	COC(=O)C(CO)NC(=O)[C@@H]1CCCN1c1nccc(Oc2cccc(C)c2)n1		CHEMBL519310	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	2342764	CHEMBL953396	Inhibition of Src at 10 uM by HTRF assay relative to control	B	Cc1cccc(Oc2ccnc(N3CCC[C@H]3C(=O)NCc3cccnc3)n2)c1		CHEMBL482717	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	2342765	CHEMBL953396	Inhibition of Src at 10 uM by HTRF assay relative to control	B	Cc1cc(C(=O)N2CCN(c3ncnc4c3CN(Cc3ccccc3)CC4)CC2)c(C)n1C		CHEMBL482710	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	2342766	CHEMBL953396	Inhibition of Src at 10 uM by HTRF assay relative to control	B	Cc1cccc(Nc2nccc3c2CN(C(=O)c2cc(C)n(C)c2C)CC3)c1		CHEMBL519146	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	2342767	CHEMBL953396	Inhibition of Src at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(N3CCN(CC(=O)Nc4nc(-c5ccccc5)cs4)CC3)ncn2)c1		CHEMBL519534	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	2342768	CHEMBL953396	Inhibition of Src at 10 uM by HTRF assay relative to control	B	CC(=O)CCCCC(=O)N1CCN(c2nccc(Oc3cccc(C)c3)n2)CC1		CHEMBL484713	=	Inhibition	%	5.0	CHEMBL267	Homo sapiens	INH	%	5.0
	2342769	CHEMBL953396	Inhibition of Src at 10 uM by HTRF assay relative to control	B	Cc1cccc(Oc2ccnc(N3CCN(CC(=O)Nc4cccc5c4CCCC5)CC3)n2)c1		CHEMBL520512	=	Inhibition	%	5.0	CHEMBL267	Homo sapiens	INH	%	5.0
	2342770	CHEMBL953396	Inhibition of Src at 10 uM by HTRF assay relative to control	B	COc1ccc(-c2noc(CN3CCN(c4cc(Nc5cccc(O)c5)ncn4)CC3)n2)cc1		CHEMBL483715	=	Inhibition	%	3.0	CHEMBL267	Homo sapiens	INH	%	3.0
	2342771	CHEMBL953396	Inhibition of Src at 10 uM by HTRF assay relative to control	B	COC[C@@H]1CCCN1C(=O)C1CCCN1c1cc(Nc2cccc(Br)c2)ncn1		CHEMBL484521	=	Inhibition	%	3.0	CHEMBL267	Homo sapiens	INH	%	3.0
	2342772	CHEMBL953396	Inhibition of Src at 10 uM by HTRF assay relative to control	B	Nc1nc(N2CCOCC2)cc(N2CCC(C(=O)NCc3cccs3)CC2)n1		CHEMBL482910	=	Inhibition	%	3.0	CHEMBL267	Homo sapiens	INH	%	3.0
	2342773	CHEMBL953396	Inhibition of Src at 10 uM by HTRF assay relative to control	B	Nc1nc(Nc2ccc(C(=O)NCCc3ccncc3)cc2)cc(N2CCOCC2)n1		CHEMBL485524	=	Inhibition	%	3.0	CHEMBL267	Homo sapiens	INH	%	3.0
	2342774	CHEMBL953396	Inhibition of Src at 10 uM by HTRF assay relative to control	B	COc1cccc(Nc2cc(N3CCC[C@H]3C(=O)NCCc3ccc(O)cc3)nc(N)n2)c1		CHEMBL483518	=	Inhibition	%	2.0	CHEMBL267	Homo sapiens	INH	%	2.0
	2342775	CHEMBL953396	Inhibition of Src at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)N(CC(C)C)CC(C)C)c3)ncn2)c1		CHEMBL484707	=	Inhibition	%	2.0	CHEMBL267	Homo sapiens	INH	%	2.0
	2342776	CHEMBL953396	Inhibition of Src at 10 uM by HTRF assay relative to control	B	CN(C)CC(C)(C)CNC(=O)C1CCN(c2cc(N3CCOCC3)nc(N)n2)CC1		CHEMBL519311	=	Inhibition	%	10.0	CHEMBL267	Homo sapiens	INH	%	10.0
	2342777	CHEMBL953396	Inhibition of Src at 10 uM by HTRF assay relative to control	B	O=C(C1CCN(c2nccc(Nc3ccccc3)n2)CC1)N1CC[C@@H](O)C1		CHEMBL484706	=	Inhibition	%	4.0	CHEMBL267	Homo sapiens	INH	%	4.0
	2342778	CHEMBL953396	Inhibition of Src at 10 uM by HTRF assay relative to control	B	Cc1ccc(CN2CCN(c3nccc(C(C#N)c4ccccn4)n3)CC2)cc1		CHEMBL521145	=	Inhibition	%	4.0	CHEMBL267	Homo sapiens	INH	%	4.0
	2342779	CHEMBL953396	Inhibition of Src at 10 uM by HTRF assay relative to control	B	CN(CCCn1ccnc1)C(=O)[C@@H]1CCCN1c1nccc(Nc2ccccc2)n1		CHEMBL519658	=	Inhibition	%	8.0	CHEMBL267	Homo sapiens	INH	%	8.0
	2342780	CHEMBL953396	Inhibition of Src at 10 uM by HTRF assay relative to control	B	Cc1cccc(CN2CCN(c3cc(N(C)c4cccc(C)c4)ncn3)CC2)c1		CHEMBL446087	=	Inhibition	%	8.0	CHEMBL267	Homo sapiens	INH	%	8.0
	2342781	CHEMBL953396	Inhibition of Src at 10 uM by HTRF assay relative to control	B	O=C(NC[C@@H]1CCCO1)c1cccc(Nc2nccc(Nc3ccc4ncsc4c3)n2)c1		CHEMBL500661	=	Inhibition	%	97.0	CHEMBL267	Homo sapiens	INH	%	97.0
	2348681	CHEMBL956511	Inhibition of human recombinant cSrc by ELISA	B	Cc1cc2c(Nc3ccccn3)c(C#N)cnc2cc1OCCCN1CCN(C)CC1		CHEMBL520160	=	IC50	nM	75.9	CHEMBL267	Homo sapiens	IC50	nM	75.9
	2348683	CHEMBL956511	Inhibition of human recombinant cSrc by ELISA	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	IC50	nM	1.2	CHEMBL267	Homo sapiens	IC50	nM	1.2
	2348684	CHEMBL956511	Inhibition of human recombinant cSrc by ELISA	B	COc1cc2c(Nc3nc4ccccc4[nH]3)c(C#N)cnc2cc1OCCCN1CCN(C)CC1		CHEMBL526321	=	IC50	nM	133.0	CHEMBL267	Homo sapiens	IC50	nM	133.0
	2348685	CHEMBL956511	Inhibition of human recombinant cSrc by ELISA	B	COc1cc2c(Nc3nc4ccccc4s3)c(C#N)cnc2cc1OCCN1CCN(C)CC1		CHEMBL499623	=	IC50	nM	9.23	CHEMBL267	Homo sapiens	IC50	nM	9.23
	2348686	CHEMBL956511	Inhibition of human recombinant cSrc by ELISA	B	N#Cc1cnc2cc(OCCN3CCOCC3)c(O)cc2c1Nc1nc2ccccc2s1		CHEMBL499346	>	IC50	nM	1000.0	CHEMBL267	Homo sapiens	IC50	nM	1000.0
	2348687	CHEMBL956511	Inhibition of human recombinant cSrc by ELISA	B	COc1cc2c(Nc3nc4ccccc4s3)c(C#N)cnc2cc1OCCN1CCCCC1		CHEMBL501199	=	IC50	nM	371.0	CHEMBL267	Homo sapiens	IC50	nM	371.0
	2348688	CHEMBL956511	Inhibition of human recombinant cSrc by ELISA	B	COc1cc2c(Nc3nc4ccc(OCC(F)(F)F)cc4s3)c(C#N)cnc2cc1OCCCN1CCN(C)CC1		CHEMBL499120	=	IC50	nM	178.0	CHEMBL267	Homo sapiens	IC50	nM	178.0
	2348689	CHEMBL956511	Inhibition of human recombinant cSrc by ELISA	B	COc1cc2c(Nc3nc4ccccc4s3)c(C#N)cnc2cc1OCCCN1CCN(C)CC1		CHEMBL499616	=	IC50	nM	186.0	CHEMBL267	Homo sapiens	IC50	nM	186.0
	2348690	CHEMBL956511	Inhibition of human recombinant cSrc by ELISA	B	Cc1cc2c(Nc3nc4ccccc4[nH]3)c(C#N)cnc2cc1OCCCN1CCN(C)CC1		CHEMBL526135	>	IC50	nM	1000.0	CHEMBL267	Homo sapiens	IC50	nM	1000.0
	2348691	CHEMBL956511	Inhibition of human recombinant cSrc by ELISA	B	Cc1cc2c(Nc3nc4ccc(OCC(F)(F)F)cc4s3)c(C#N)cnc2cc1OCCCN1CCN(C)CC1		CHEMBL501458	=	IC50	nM	111.0	CHEMBL267	Homo sapiens	IC50	nM	111.0
	2348692	CHEMBL956511	Inhibition of human recombinant cSrc by ELISA	B	Cc1ccc2nc(Nc3c(C#N)cnc4cc(OCCCN5CCCCC5)c(C)cc34)sc2c1		CHEMBL526547	=	IC50	nM	15.4	CHEMBL267	Homo sapiens	IC50	nM	15.4
	2348693	CHEMBL956511	Inhibition of human recombinant cSrc by ELISA	B	Cc1ccc2nc(Nc3c(C#N)cnc4cc(OCCCN5CCN(C)CC5)c(C)cc34)sc2c1		CHEMBL482499	=	IC50	nM	646.0	CHEMBL267	Homo sapiens	IC50	nM	646.0
	2348694	CHEMBL956511	Inhibition of human recombinant cSrc by ELISA	B	Cc1cc2c(Nc3nc4ccccc4s3)c(C#N)cnc2cc1OCCCN1CCCCC1		CHEMBL484312	=	IC50	nM	209.0	CHEMBL267	Homo sapiens	IC50	nM	209.0
	2348695	CHEMBL956511	Inhibition of human recombinant cSrc by ELISA	B	Cc1cc2c(Nc3nc4ccccc4s3)c(C#N)cnc2cc1OCCCN1CCOCC1		CHEMBL484311	=	IC50	nM	172.0	CHEMBL267	Homo sapiens	IC50	nM	172.0
	2353885	CHEMBL953219	Inhibition of Src	B	COc1ccc2c(OCc3nnc4ccc(-c5cc(F)c(F)c(F)c5)nn34)ccnc2c1		CHEMBL494979	>	Activity	uM	10.0	CHEMBL267	Homo sapiens	Activity	uM	10.0
	2355806	CHEMBL955811	Inhibition of Src by TR-FRET assay	B	Cc1ccn(-c2ccc3c(c2)NCC3(C)C)c(=O)c1-c1ccc2nc(N)ncc2c1		CHEMBL493986	=	IC50	nM	400.0	CHEMBL267	Homo sapiens	IC50	uM	0.4
	2356813	CHEMBL955811	Inhibition of Src by TR-FRET assay	B	Cc1ccn(CCC2CCCC2)c(=O)c1-c1ccc2nc(N)ncc2c1		CHEMBL494821	=	IC50	nM	800.0	CHEMBL267	Homo sapiens	IC50	uM	0.8
	2356814	CHEMBL955811	Inhibition of Src by TR-FRET assay	B	Cc1ccc(C(=O)NCCC2CCCC2)cc1C(=O)Nc1ccc(N)nc1		CHEMBL487431	=	IC50	nM	5000.0	CHEMBL267	Homo sapiens	IC50	uM	5.0
	2356874	CHEMBL955811	Inhibition of Src by TR-FRET assay	B	Cc1ccn(-c2ccc(-c3ncco3)cc2)c(=O)c1-c1ccc2nc(N)ncc2c1		CHEMBL525893	>	IC50	nM	5000.0	CHEMBL267	Homo sapiens	IC50	uM	5.0
	2356875	CHEMBL955811	Inhibition of Src by TR-FRET assay	B	Cc1ccn(-c2ccc(-n3cccn3)cc2)c(=O)c1-c1ccc2nc(N)ncc2c1		CHEMBL497343	=	IC50	nM	77.0	CHEMBL267	Homo sapiens	IC50	uM	0.077
	2356876	CHEMBL955811	Inhibition of Src by TR-FRET assay	B	Cc1ccn(-c2ccc(N3CCOCC3)cc2)c(=O)c1-c1ccc2nc(N)ncc2c1		CHEMBL525744	=	IC50	nM	1400.0	CHEMBL267	Homo sapiens	IC50	uM	1.4
	2356877	CHEMBL955811	Inhibition of Src by TR-FRET assay	B	CCOC(=O)c1ccc(-n2ccc(C)c(-c3ccc4nc(N)ncc4c3)c2=O)cc1		CHEMBL496713	=	IC50	nM	170.0	CHEMBL267	Homo sapiens	IC50	uM	0.17
	2356878	CHEMBL955811	Inhibition of Src by TR-FRET assay	B	CC(=O)c1ccc(-n2ccc(C)c(-c3ccc4nc(N)ncc4c3)c2=O)cc1		CHEMBL496505	=	IC50	nM	390.0	CHEMBL267	Homo sapiens	IC50	uM	0.39
	2356879	CHEMBL955811	Inhibition of Src by TR-FRET assay	B	Cc1cc(-n2ccc(C)c(-c3ccc4nc(N)ncc4c3)c2=O)ccc1F		CHEMBL497958	=	IC50	nM	43.0	CHEMBL267	Homo sapiens	IC50	uM	0.043
	2356880	CHEMBL955811	Inhibition of Src by TR-FRET assay	B	Cc1ccc(-n2ccc(C)c(-c3ccc4nc(N)ncc4c3)c2=O)cc1F		CHEMBL497957	=	IC50	nM	25000.0	CHEMBL267	Homo sapiens	IC50	uM	25.0
	2356881	CHEMBL955811	Inhibition of Src by TR-FRET assay	B	Cc1ccn(-c2ccc(Cl)c(F)c2)c(=O)c1-c1ccc2nc(N)ncc2c1		CHEMBL497754	=	IC50	nM	390.0	CHEMBL267	Homo sapiens	IC50	uM	0.39
	2356882	CHEMBL955811	Inhibition of Src by TR-FRET assay	B	COc1cccc(-n2ccc(C)c(-c3ccc4nc(N)ncc4c3)c2=O)c1		CHEMBL496916	=	IC50	nM	270.0	CHEMBL267	Homo sapiens	IC50	uM	0.27
	2356883	CHEMBL955811	Inhibition of Src by TR-FRET assay	B	Cc1ccn(-c2cccc(C(F)(F)F)c2)c(=O)c1-c1ccc2nc(N)ncc2c1		CHEMBL504805	=	IC50	nM	860.0	CHEMBL267	Homo sapiens	IC50	uM	0.86
	2356884	CHEMBL955811	Inhibition of Src by TR-FRET assay	B	Cc1ccn(-c2ccc(Cl)cc2)c(=O)c1-c1ccc2nc(N)ncc2c1		CHEMBL522905	=	IC50	nM	260.0	CHEMBL267	Homo sapiens	IC50	uM	0.26
	2356885	CHEMBL955811	Inhibition of Src by TR-FRET assay	B	COc1ccc(-n2ccc(C)c(-c3ccc4nc(N)ncc4c3)c2=O)cc1		CHEMBL506033	=	IC50	nM	150.0	CHEMBL267	Homo sapiens	IC50	uM	0.15
	2356886	CHEMBL955811	Inhibition of Src by TR-FRET assay	B	Cc1ccn(-c2ccc(C(F)(F)F)cc2)c(=O)c1-c1ccc2nc(N)ncc2c1		CHEMBL498557	=	IC50	nM	750.0	CHEMBL267	Homo sapiens	IC50	uM	0.75
	2356887	CHEMBL955811	Inhibition of Src by TR-FRET assay	B	Cc1ccn(-c2ccc(C(C)(C)C)cc2)c(=O)c1-c1ccc2nc(N)ncc2c1		CHEMBL496494	=	IC50	nM	36.0	CHEMBL267	Homo sapiens	IC50	uM	0.036
	2356888	CHEMBL955811	Inhibition of Src by TR-FRET assay	B	Cc1ccn(-c2ccccc2)c(=O)c1-c1ccc2nc(N)ncc2c1		CHEMBL523741	=	IC50	nM	990.0	CHEMBL267	Homo sapiens	IC50	uM	0.99
	2356929	CHEMBL955811	Inhibition of Src by TR-FRET assay	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	IC50	nM	25000.0	CHEMBL267	Homo sapiens	IC50	uM	25.0
	2362690	CHEMBL1034894	Inhibition of Src	B	COc1ccc(-c2cncc(C#N)c2Nc2ccc3[nH]ccc3c2)cc1OC		CHEMBL492251	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	2372055	CHEMBL990804	Inhibition of Src	B	O=C(Nc1cncnc1)c1c(Cl)ccc2c(Nc3cccc(C(F)(F)F)c3)noc12		CHEMBL491429	=	IC50	nM	117.0	CHEMBL267	Homo sapiens	IC50	uM	0.117
	2380539	CHEMBL945297	Inhibition of cSrc	B	Cc1cc2c(Nc3ccc4nc(N)sc4c3)c(C#N)cnc2cc1OCCN1CCCCC1		CHEMBL486370	=	IC50	nM	34.8	CHEMBL267	Homo sapiens	IC50	nM	34.8
	2380541	CHEMBL945297	Inhibition of cSrc	B	COc1cc2c(Nc3ccc4nc(N)sc4c3)c(C#N)cnc2cc1OCCCN1CCNCC1		CHEMBL472038	=	IC50	nM	20.7	CHEMBL267	Homo sapiens	IC50	nM	20.7
	2380542	CHEMBL945297	Inhibition of cSrc	B	Cc1cc2c(Nc3ccc4nc(N)[nH]c4c3)c(C#N)cnc2cc1OCCCN1CCCC1		CHEMBL472037	=	IC50	nM	159.0	CHEMBL267	Homo sapiens	IC50	nM	159.0
	2380543	CHEMBL945297	Inhibition of cSrc	B	Cc1cc2c(Nc3ccc4nc(N)[nH]c4c3)c(C#N)cnc2cc1OCCCN(C)C		CHEMBL472036	=	IC50	nM	143.0	CHEMBL267	Homo sapiens	IC50	nM	143.0
	2380544	CHEMBL945297	Inhibition of cSrc	B	Cc1cc2c(Nc3ccc4nc(N)sc4c3)c(C#N)cnc2cc1OCCCN1CC(C)CC(C)C1		CHEMBL469936	=	IC50	nM	267.0	CHEMBL267	Homo sapiens	IC50	nM	267.0
	2380545	CHEMBL945297	Inhibition of cSrc	B	CCN(CC)CCCOc1cc2ncc(C#N)c(Nc3ccc4nc(N)sc4c3)c2cc1C		CHEMBL512666	=	IC50	nM	42.0	CHEMBL267	Homo sapiens	IC50	nM	42.0
	2380546	CHEMBL945297	Inhibition of cSrc	B	Cc1cc2c(Nc3ccc4nc(N)sc4c3)c(C#N)cnc2cc1OCCCN1CC(C)NC(C)C1		CHEMBL469935	=	IC50	nM	36.6	CHEMBL267	Homo sapiens	IC50	nM	36.6
	2380547	CHEMBL945297	Inhibition of cSrc	B	Cc1cc2c(Nc3ccc4nc(N)sc4c3)c(C#N)cnc2cc1OCCCN1CCC(C)CC1		CHEMBL470991	=	IC50	nM	53.4	CHEMBL267	Homo sapiens	IC50	nM	53.4
	2380548	CHEMBL945297	Inhibition of cSrc	B	Cc1cc2c(Nc3ccc4nc(N)sc4c3)c(C#N)cnc2cc1OCCCN1CCNCC1		CHEMBL487759	=	IC50	nM	129.0	CHEMBL267	Homo sapiens	IC50	nM	129.0
	2380549	CHEMBL945297	Inhibition of cSrc	B	Cc1cc2c(Nc3ccc4nc(N)sc4c3)c(C#N)cnc2cc1OCCCN1CCOCC1		CHEMBL487555	=	IC50	nM	81.1	CHEMBL267	Homo sapiens	IC50	nM	81.1
	2380550	CHEMBL945297	Inhibition of cSrc	B	Cc1cc2c(Nc3ccc4nc(N)sc4c3)c(C#N)cnc2cc1OCCCN1CCN(C)CC1		CHEMBL486371	=	IC50	nM	50.6	CHEMBL267	Homo sapiens	IC50	nM	50.6
	2380551	CHEMBL945297	Inhibition of cSrc	B	Cc1ccc2nc(Nc3c(C#N)cnc4cc(OCCCN5CCCCC5)c(C)cc34)sc2c1		CHEMBL526547	=	IC50	nM	15.4	CHEMBL267	Homo sapiens	IC50	nM	15.4
	2380552	CHEMBL945297	Inhibition of cSrc	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	IC50	nM	1.8	CHEMBL267	Homo sapiens	IC50	nM	1.8
	2380566	CHEMBL945298	Inhibition of cSrc by ELISA	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	IC50	nM	1.2	CHEMBL267	Homo sapiens	IC50	nM	1.2
Not Active	2381827	CHEMBL939555	Inhibition of c-Src phosphorylation in human BT474 cells at 100 uM after 24 hrs by Western blotting	B	Cl.Nc1cc(N)c(N)cc1N		CHEMBL456559		Activity			CHEMBL267	Homo sapiens	Activity		
Not Active	2381859	CHEMBL939568	Inhibition of recombinant c-Src at 1 uM	B	Cl.Nc1cc(N)c(N)cc1N		CHEMBL456559		Activity			CHEMBL267	Homo sapiens	Activity		
	2394488	CHEMBL943612	Inhibition of Src by fluorescence polarization competition immunoassay	B	CONC(=O)c1cn(-c2ccc3c(c2)CCC3)c2nc(Nc3ccc(C4CCN(CC(=O)O)CC4)cc3)ncc2c1=O		CHEMBL452965	=	IC50	nM	930.0	CHEMBL267	Homo sapiens	IC50	uM	0.93
	2394489	CHEMBL943612	Inhibition of Src by fluorescence polarization competition immunoassay	B	CONC(=O)c1cn(-c2ccc3c(c2)CCC3)c2nc(Nc3ccc(C4CCN(C)CC4)cc3)ncc2c1=O		CHEMBL492809	=	IC50	nM	1400.0	CHEMBL267	Homo sapiens	IC50	uM	1.4
	2394490	CHEMBL943612	Inhibition of Src by fluorescence polarization competition immunoassay	B	CONC(=O)c1cn(-c2ccc3c(c2)CCC3)c2nc(Nc3ccc(CCN4CCN(C)CC4)cc3)ncc2c1=O		CHEMBL505830	=	IC50	nM	1500.0	CHEMBL267	Homo sapiens	IC50	uM	1.5
	2394493	CHEMBL943612	Inhibition of Src by fluorescence polarization competition immunoassay	B	CN1CCN(CCc2ccc(Nc3ncc4c(=O)c(C(N)=O)cn(-c5ccc6c(c5)CCC6)c4n3)cc2)CC1		CHEMBL403776	=	IC50	nM	5900.0	CHEMBL267	Homo sapiens	IC50	uM	5.9
	2395475	CHEMBL963603	Inhibition of Src by Ambit binding assay	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	IC50	nM	500.0	CHEMBL267	Homo sapiens	IC50	nM	500.0
	2396085	CHEMBL1006324	Inhibition of SRC at 1 uM relative to control	B	COc1ccc(/C=N/Nc2[nH]nc(C)c2C(=O)Nc2cccc(NC(C)=O)c2)cc1		CHEMBL515560	=	Inhibition	%	33.0	CHEMBL267	Homo sapiens	INH	%	33.0
	2396752	CHEMBL945312	Inhibition of SRC	B	Cc1cc(C)cc(Nc2nccc(-c3nc(C)c(C(=O)N[C@H](C)CO)s3)n2)c1		CHEMBL473229	>	Ki	nM	3330.0	CHEMBL267	Homo sapiens	Ki	uM	3.33
	2396753	CHEMBL945312	Inhibition of SRC	B	Cc1cc(C)cc(Nc2nccc(-c3nc(C)c(C(=O)N[C@@H](C)CO)s3)n2)c1		CHEMBL512172	>	Ki	nM	3330.0	CHEMBL267	Homo sapiens	Ki	uM	3.33
	2396754	CHEMBL945312	Inhibition of SRC	B	OCCCOc1cc(Nc2nccc(-c3nccs3)n2)cc(C(F)(F)F)c1		CHEMBL475254	=	Ki	nM	422.0	CHEMBL267	Homo sapiens	Ki	uM	0.422
	2396755	CHEMBL945312	Inhibition of SRC	B	Oc1cc(Nc2nccc(-c3nccs3)n2)cc(C(F)(F)F)c1		CHEMBL470175	=	Ki	nM	991.0	CHEMBL267	Homo sapiens	Ki	uM	0.991
	2396756	CHEMBL945312	Inhibition of SRC	B	Cc1cc(Nc2nccc(-c3nc(CO)cs3)n2)cc(C(F)(F)F)c1		CHEMBL485731	=	Ki	nM	1800.0	CHEMBL267	Homo sapiens	Ki	uM	1.8
	2396757	CHEMBL945312	Inhibition of SRC	B	COc1cc(Nc2nccc(-c3ncc(C)s3)n2)cc(C(F)(F)F)c1		CHEMBL451450	=	Ki	nM	3700.0	CHEMBL267	Homo sapiens	Ki	uM	3.7
	2396758	CHEMBL945312	Inhibition of SRC	B	OCc1csc(-c2ccnc(Nc3cc(O)cc(C(F)(F)F)c3)n2)n1		CHEMBL485730	=	Ki	nM	4000.0	CHEMBL267	Homo sapiens	Ki	uM	4.0
	2396759	CHEMBL945312	Inhibition of SRC	B	COc1cc(Nc2nccc(-c3nc(CO)cs3)n2)cc(C(F)(F)F)c1		CHEMBL486751	=	Ki	nM	3500.0	CHEMBL267	Homo sapiens	Ki	uM	3.5
	2396760	CHEMBL945312	Inhibition of SRC	B	Cc1cc(Nc2nccc(-c3nc(C)c(CCO)s3)n2)cc(C(F)(F)F)c1		CHEMBL475249	=	Ki	nM	3500.0	CHEMBL267	Homo sapiens	Ki	uM	3.5
	2396761	CHEMBL945312	Inhibition of SRC	B	Cc1cc(C)cc(Nc2nccc(-c3nc(C)c(CCO)s3)n2)c1		CHEMBL471727	=	Ki	nM	3500.0	CHEMBL267	Homo sapiens	Ki	uM	3.5
	2396762	CHEMBL945312	Inhibition of SRC	B	Cc1cc(C)cc(Nc2nccc(-c3nc(CO)cs3)n2)c1		CHEMBL511811	=	Ki	nM	2230.0	CHEMBL267	Homo sapiens	Ki	uM	2.23
	2396763	CHEMBL945312	Inhibition of SRC	B	Cc1cc(C)cc(Nc2nccc(-c3ncc(CO)s3)n2)c1		CHEMBL511670	=	Ki	nM	2000.0	CHEMBL267	Homo sapiens	Ki	uM	2.0
	2396764	CHEMBL945312	Inhibition of SRC	B	Cc1cc(C)cc(Nc2nccc(-c3nc(C)cs3)n2)c1		CHEMBL453217	=	Ki	nM	2030.0	CHEMBL267	Homo sapiens	Ki	uM	2.03
	2396765	CHEMBL945312	Inhibition of SRC	B	Cc1cc(C)cc(Nc2nccc(-c3ncc(C)s3)n2)c1		CHEMBL470780	=	Ki	nM	348.0	CHEMBL267	Homo sapiens	Ki	uM	0.348
	2396766	CHEMBL945312	Inhibition of SRC	B	Cc1ccc(C)c(Nc2nccc(-c3nccs3)n2)c1		CHEMBL475570	=	Ki	nM	153.0	CHEMBL267	Homo sapiens	Ki	uM	0.153
	2396767	CHEMBL945312	Inhibition of SRC	B	Cc1cccc(Nc2nccc(-c3nccs3)n2)c1		CHEMBL471819	=	Ki	nM	2984.0	CHEMBL267	Homo sapiens	Ki	uM	2.984
	2396768	CHEMBL945312	Inhibition of SRC	B	COc1cc(Nc2nccc(-c3nccs3)n2)cc(OC)c1		CHEMBL472478	=	Ki	nM	862.0	CHEMBL267	Homo sapiens	Ki	uM	0.862
	2396769	CHEMBL945312	Inhibition of SRC	B	Cc1cc(Nc2nccc(-c3nccs3)n2)cc(C(F)(F)F)c1		CHEMBL471776	=	Ki	nM	1357.0	CHEMBL267	Homo sapiens	Ki	uM	1.357
	2396770	CHEMBL945312	Inhibition of SRC	B	COc1cc(Nc2nccc(-c3nccs3)n2)cc(C(F)(F)F)c1		CHEMBL512319	=	Ki	nM	1833.0	CHEMBL267	Homo sapiens	Ki	uM	1.833
	2396771	CHEMBL945312	Inhibition of SRC	B	Cc1cc(C)cc(Nc2nccc(-c3nccs3)n2)c1		CHEMBL509161	=	Ki	nM	1062.0	CHEMBL267	Homo sapiens	Ki	uM	1.062
	2401969	CHEMBL1011866	Inhibition of Src	B	O=C1NC(=O)c2ccc(I)cc2/C1=C/NCc1ccc(-c2ccoc2)c(O)c1		CHEMBL504547	>	IC50	nM	30000.0	CHEMBL267	Homo sapiens	IC50	uM	30.0
Active	2418445	CHEMBL1022369	Inhibition of Src kinase at 10 uM	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL484270		Activity			CHEMBL267	Homo sapiens	Activity		
Active	2418446	CHEMBL1022369	Inhibition of Src kinase at 10 uM	B	C=CC(=O)Nc1cc2c(Nc3cc(OC)c(Cl)cc3OC)ncnc2cc1OCC1CCN(C)CC1		CHEMBL483047		Activity			CHEMBL267	Homo sapiens	Activity		
	2419153	CHEMBL1019641	Inhibition of SRC at 1 uM	B	C[C@H]1O[C@@H]2CC(=O)O[C@@H]2C2=C1C(=O)c1c(ccc([C@H]3C[C@@H](N(C)C)[C@H](O)[C@@H](C)O3)c1O)C2=O		CHEMBL2216825	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
Active	2419437	CHEMBL1022369	Inhibition of Src kinase at 10 uM	B	CN(C)CCC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL485303		Activity			CHEMBL267	Homo sapiens	Activity		
Active	2419438	CHEMBL1022369	Inhibition of Src kinase at 10 uM	B	COCCOc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)[C@@H]1CCCN1		CHEMBL485304		Activity			CHEMBL267	Homo sapiens	Activity		
	2419439	CHEMBL1022370	Inhibition of Src kinase	B	COCCOc1cc2ncnc(Nc3c(Cl)ccc4c3OCO4)c2cc1NC(=O)[C@@H]1CCCN1		CHEMBL523122	=	IC50	nM	89.0	CHEMBL267	Homo sapiens	IC50	uM	0.089
	2419440	CHEMBL1022370	Inhibition of Src kinase	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	=	IC50	nM	3.0	CHEMBL267	Homo sapiens	IC50	uM	0.003
	2419441	CHEMBL1022370	Inhibition of Src kinase	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	=	IC50	nM	10.0	CHEMBL267	Homo sapiens	IC50	nM	10.0
	2419442	CHEMBL1022370	Inhibition of Src kinase	B	COCCOc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)[C@@H]1CCCN1		CHEMBL485304	=	IC50	nM	300.0	CHEMBL267	Homo sapiens	IC50	nM	300.0
	2419443	CHEMBL1022370	Inhibition of Src kinase	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	IC50	nM	14.0	CHEMBL267	Homo sapiens	IC50	uM	0.014
	2419444	CHEMBL1022370	Inhibition of Src kinase	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	IC50	nM	0.6	CHEMBL267	Homo sapiens	IC50	nM	0.6
	2419445	CHEMBL1022370	Inhibition of Src kinase	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	IC50	nM	1.2	CHEMBL267	Homo sapiens	IC50	nM	1.2
	2449765	CHEMBL949544	Inhibition of Src	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1C(=O)Nc1cncnc1		CHEMBL259247	=	IC50	nM	240.0	CHEMBL267	Homo sapiens	IC50	uM	0.24
	2449769	CHEMBL949544	Inhibition of Src	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1NC(=O)c1cncnc1		CHEMBL469882	=	IC50	nM	3760.0	CHEMBL267	Homo sapiens	IC50	uM	3.76
	2449817	CHEMBL949544	Inhibition of Src	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1C(=O)Nc1cncnc1		CHEMBL512840	=	IC50	nM	1210.0	CHEMBL267	Homo sapiens	IC50	uM	1.21
	2461795	CHEMBL962871	Inhibition of recombinant SRC	B	Cc1cc(O)cc2oc(=O)c3c(O)cc(O)cc3c12		CHEMBL519982	=	IC50	ug.mL-1	4.4	CHEMBL267	Homo sapiens	IC50	10'-6g/ml	4.4
	2461815	CHEMBL962871	Inhibition of recombinant SRC	B	O=C1C[C@H](O)[C@@H]2c3c(ccc(O)c31)-c1ccc(O)c3c1[C@@]2(O)CCC3=O		CHEMBL521470	=	IC50	ug.mL-1	2.1	CHEMBL267	Homo sapiens	IC50	10'-6g/ml	2.1
	2461816	CHEMBL962871	Inhibition of recombinant SRC	B	COc1cc(O)c(C(=O)O)c(C2=C(C)C[C@@H](O)C2=O)c1		CHEMBL519395	=	IC50	ug.mL-1	4.6	CHEMBL267	Homo sapiens	IC50	10'-6g/ml	4.6
	2461817	CHEMBL962871	Inhibition of recombinant SRC	B	COc1cc(O)c2c(c1)C1(OC2=O)C(C)=CC(=O)C1O		CHEMBL408995	>	IC50	ug.mL-1	10.0	CHEMBL267	Homo sapiens	IC50	10'-5g/ml	1.0
	2461818	CHEMBL962871	Inhibition of recombinant SRC	B	COc1cc(O)c2c(c1)-c1cc(O)c(O)cc1COC2=O		CHEMBL507058	>	IC50	ug.mL-1	10.0	CHEMBL267	Homo sapiens	IC50	10'-5g/ml	1.0
	2461819	CHEMBL962871	Inhibition of recombinant SRC	B	Cc1cc(O)c(O)cc1-c1cc(O)cc(O)c1C(=O)O		CHEMBL483532	=	IC50	ug.mL-1	4.7	CHEMBL267	Homo sapiens	IC50	10'-6g/ml	4.7
	2461820	CHEMBL962871	Inhibition of recombinant SRC	B	COc1cc(O)c(C(=O)O)c(-c2cc(O)c(O)cc2C)c1		CHEMBL483531	=	IC50	ug.mL-1	8.3	CHEMBL267	Homo sapiens	IC50	10'-6g/ml	8.3
	2461821	CHEMBL962871	Inhibition of recombinant SRC	B	COc1cc(O)c2c(=O)oc3c(O)c(O)cc(C)c3c2c1		CHEMBL520144	=	IC50	ug.mL-1	1.4	CHEMBL267	Homo sapiens	IC50	10'-6g/ml	1.4
	2461822	CHEMBL962871	Inhibition of recombinant SRC	B	COc1cc(O)c2c(=O)oc3cc(O)cc(C)c3c2c1		CHEMBL483526	=	IC50	ug.mL-1	1.2	CHEMBL267	Homo sapiens	IC50	10'-6g/ml	1.2
	2461823	CHEMBL962871	Inhibition of recombinant SRC	B	Cc1cc(O)cc2oc(=O)c3c(O)cc(OS(=O)(=O)O)cc3c12		CHEMBL483525	=	IC50	ug.mL-1	5.6	CHEMBL267	Homo sapiens	IC50	10'-6g/ml	5.6
	2465000	CHEMBL957976	Inhibition of human recombinant SRC	B	COc1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL201511	=	IC50	nM	21000.0	CHEMBL267	Homo sapiens	IC50	uM	21.0
	2465061	CHEMBL957976	Inhibition of human recombinant SRC	B	COc1ccc(C2=C(c3cn(C)c4ccccc34)C(=O)NC2)cc1		CHEMBL507056	=	IC50	nM	39000.0	CHEMBL267	Homo sapiens	IC50	uM	39.0
	2465062	CHEMBL957976	Inhibition of human recombinant SRC	B	COc1cc(C2=C(c3cn(COCc4ccccc4)c4ccccc34)CNC2=O)cc(OC)c1OC		CHEMBL453336	=	IC50	nM	9100.0	CHEMBL267	Homo sapiens	IC50	uM	9.1
	2465063	CHEMBL957976	Inhibition of human recombinant SRC	B	COc1cc(C2=C(c3cn(COc4ccccc4)c4ccccc34)CNC2=O)cc(OC)c1OC		CHEMBL488811	=	IC50	nM	49000.0	CHEMBL267	Homo sapiens	IC50	uM	49.0
	2465064	CHEMBL957976	Inhibition of human recombinant SRC	B	COc1cc(C2=C(c3cn(COC(C)(C)C)c4ccccc34)CNC2=O)cc(OC)c1OC		CHEMBL488646	=	IC50	nM	4400.0	CHEMBL267	Homo sapiens	IC50	uM	4.4
	2465065	CHEMBL957976	Inhibition of human recombinant SRC	B	COc1cc(C2=C(c3cn(COC(C)C)c4ccccc34)CNC2=O)cc(OC)c1OC		CHEMBL488645	=	IC50	nM	29000.0	CHEMBL267	Homo sapiens	IC50	uM	29.0
	2465066	CHEMBL957976	Inhibition of human recombinant SRC	B	CCOCn1cc(C2=C(c3cc(OC)c(OC)c(OC)c3)C(=O)NC2)c2ccccc21		CHEMBL529217	=	IC50	nM	40000.0	CHEMBL267	Homo sapiens	IC50	uM	40.0
	2465067	CHEMBL957976	Inhibition of human recombinant SRC	B	COc1cc(C2=C(c3cn(COCC[Si](C)(C)C)c4ccccc34)CNC2=O)cc(OC)c1OC		CHEMBL486437	=	IC50	nM	4500.0	CHEMBL267	Homo sapiens	IC50	uM	4.5
	2465068	CHEMBL957976	Inhibition of human recombinant SRC	B	COc1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2)cc(OC)c1OC		CHEMBL521201	=	IC50	nM	41000.0	CHEMBL267	Homo sapiens	IC50	uM	41.0
	2465069	CHEMBL957976	Inhibition of human recombinant SRC	B	COc1cc(C2=C(c3c[nH]c4ccccc34)CNC2=O)cc(OC)c1OC		CHEMBL529663	=	IC50	nM	14000.0	CHEMBL267	Homo sapiens	IC50	uM	14.0
	2466412	CHEMBL994994	Inhibition of TEL fused Src-mediated proliferation of TEL-Src transformed mouse BA/F3 cells after 48 hrs by bright-glo luciferase assay	F	Cc1cccc(Cl)c1Nc1nc2ccccc2n1-c1cc(Nc2ccc(CCN3CCOCC3)cn2)ncn1		CHEMBL473250	=	IC50	nM	147.0	CHEMBL267	Homo sapiens	IC50	uM	0.147
	2466413	CHEMBL994994	Inhibition of TEL fused Src-mediated proliferation of TEL-Src transformed mouse BA/F3 cells after 48 hrs by bright-glo luciferase assay	F	Cc1nc(Nc2cc(-n3c(Nc4c(C)cccc4Cl)nc4ccccc43)ncn2)cc(N2CCN(CCO)CC2)n1		CHEMBL447107	=	IC50	nM	5.0	CHEMBL267	Homo sapiens	IC50	uM	0.005
	2467250	CHEMBL991655	Inhibition of Src in presence of 100 uM ATP	B	CCN1CCN(CC/C=C/c2ccc3c(Nc4ccc(Sc5nccn5C)c(Cl)c4)c(C#N)cnc3c2)CC1		CHEMBL489058	=	IC50	nM	55.0	CHEMBL267	Homo sapiens	IC50	uM	0.055
Not Active	2467312	CHEMBL991680	Inhibition of Src phosphorylation in human WM266-4 cells up to 10 uM after 2.5 hrs	F	CCN1CCN(CC/C=C/c2ccc3c(Nc4ccc(Sc5nccn5C)c(Cl)c4)c(C#N)cnc3c2)CC1		CHEMBL489058		Activity			CHEMBL267	Homo sapiens	Activity		
	2470394	CHEMBL981776	Inhibition of SRC at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL267	Homo sapiens	INH	%	10.0
Not Active	2470485	CHEMBL995083	Inhibition of c-Src upto 100 uM	B	O=C(CCN1C(=O)/C(=C/c2cccc(Br)c2)SC1=S)Nc1ccccc1O		CHEMBL456198		Activity			CHEMBL267	Homo sapiens	Activity		
	2476611	CHEMBL1035875	Binding affinity to human SRC at 10 uM relative to control	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Activity	%	1.1	CHEMBL267	Homo sapiens	Activity	%	1.1
Not Evaluated	2476814	CHEMBL1035875	Binding affinity to human SRC at 10 uM relative to control	B	NC(=O)c1ccc(-c2cc(C(N)=O)c(N)c(-c3ccc(S(N)(=O)=O)cc3)c2)cc1		CHEMBL514582		Activity			CHEMBL267	Homo sapiens	Activity		
Not Evaluated	2478653	CHEMBL1035875	Binding affinity to human SRC at 10 uM relative to control	B	N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2		CHEMBL233000		Activity			CHEMBL267	Homo sapiens	Activity		
Not Evaluated	2478856	CHEMBL1035875	Binding affinity to human SRC at 10 uM relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755		Activity			CHEMBL267	Homo sapiens	Activity		
Not Evaluated	2479711	CHEMBL1035875	Binding affinity to human SRC at 10 uM relative to control	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312		Activity			CHEMBL267	Homo sapiens	Activity		
Active	2480710	CHEMBL1035875	Binding affinity to human SRC at 10 uM relative to control	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409		Activity			CHEMBL267	Homo sapiens	Activity		
	2486586	CHEMBL994192	Inhibition of Src	B	CCn1c2cc(Cl)c(O)cc2c(=O)c2c(=O)o[nH]c21		CHEMBL523823	>	Ki	nM	1940.0	CHEMBL267	Homo sapiens	Ki	uM	1.94
	2489299	CHEMBL991254	Inhibition of Src	B	COc1ccc(CN(C)C)c(-c2cc3c(Nc4ccc5[nH]ccc5c4C)c(C#N)cnc3s2)c1		CHEMBL479835	>	IC50	nM	5000.0	CHEMBL267	Homo sapiens	IC50	uM	5.0
	2504782	CHEMBL962772	Inhibition of human recombinant c-Src by filter-binding assay	B	CSc1nc(NCCc2ccccc2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL289125	=	Ki	nM	700.0	CHEMBL267	Homo sapiens	Ki	uM	0.7
	2504783	CHEMBL962772	Inhibition of human recombinant c-Src by filter-binding assay	B	CSc1nc(NCc2ccccc2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL288280	=	Ki	nM	3700.0	CHEMBL267	Homo sapiens	Ki	uM	3.7
	2504784	CHEMBL962772	Inhibition of human recombinant c-Src by filter-binding assay	B	CCCNc1nc(SC)nc2c1cnn2CC(Cl)c1ccccc1		CHEMBL312214	=	Ki	nM	2900.0	CHEMBL267	Homo sapiens	Ki	uM	2.9
	2504785	CHEMBL962772	Inhibition of human recombinant c-Src by filter-binding assay	B	CCCCNc1nc(SC)nc2c1cnn2CC(Cl)c1ccccc1		CHEMBL40798	=	Ki	nM	1700.0	CHEMBL267	Homo sapiens	Ki	uM	1.7
	2504786	CHEMBL962772	Inhibition of human recombinant c-Src by filter-binding assay	B	CCOCCNc1nc(SC)nc2c1cnn2CC(Cl)c1ccccc1	Non standard unit for type	CHEMBL291273	>	ID50	mM	2.0	CHEMBL267	Homo sapiens	ID50	mM	2.0
Not Determined	2504787	CHEMBL962772	Inhibition of human recombinant c-Src by filter-binding assay	B	CSc1nc(N2CCCC2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL431614		Ki			CHEMBL267	Homo sapiens	Ki		
	2504788	CHEMBL962772	Inhibition of human recombinant c-Src by filter-binding assay	B	CSc1nc(N2CCCCC2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL289298	=	Ki	nM	2400.0	CHEMBL267	Homo sapiens	Ki	uM	2.4
	2504789	CHEMBL962772	Inhibition of human recombinant c-Src by filter-binding assay	B	CSc1nc(N2CCOCC2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL38492	=	Ki	nM	6500.0	CHEMBL267	Homo sapiens	Ki	uM	6.5
	2504790	CHEMBL962772	Inhibition of human recombinant c-Src by filter-binding assay	B	CCN(CC)c1nc(SC)nc2c1cnn2CC(Cl)c1ccccc1		CHEMBL83847	=	Ki	nM	500.0	CHEMBL267	Homo sapiens	Ki	uM	0.5
	2504791	CHEMBL962772	Inhibition of human recombinant c-Src by filter-binding assay	B	CSc1nc(Nc2ccccc2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL401238	=	Ki	nM	1200.0	CHEMBL267	Homo sapiens	Ki	uM	1.2
	2504792	CHEMBL962772	Inhibition of human recombinant c-Src by filter-binding assay	B	CSc1nc(Nc2cccc(F)c2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL238559	=	Ki	nM	1400.0	CHEMBL267	Homo sapiens	Ki	uM	1.4
	2504793	CHEMBL962772	Inhibition of human recombinant c-Src by filter-binding assay	B	CSc1nc(NCCc2ccccc2F)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL453358	=	Ki	nM	10200.0	CHEMBL267	Homo sapiens	Ki	uM	10.2
	2504794	CHEMBL962772	Inhibition of human recombinant c-Src by filter-binding assay	B	CCCNc1nc(SC)nc2c1cnn2CC(Cl)c1ccc(F)cc1		CHEMBL443929	=	Ki	nM	2610.0	CHEMBL267	Homo sapiens	Ki	uM	2.61
	2504795	CHEMBL962772	Inhibition of human recombinant c-Src by filter-binding assay	B	CCCCNc1nc(SC)nc2c1cnn2CC(Cl)c1ccc(F)cc1		CHEMBL454119	=	Ki	nM	5020.0	CHEMBL267	Homo sapiens	Ki	uM	5.02
	2504796	CHEMBL962772	Inhibition of human recombinant c-Src by filter-binding assay	B	CSc1nc(N2CCOCC2)c2cnn(CC(Cl)c3ccc(F)cc3)c2n1		CHEMBL475739	=	Ki	nM	3320.0	CHEMBL267	Homo sapiens	Ki	uM	3.32
	2504797	CHEMBL962772	Inhibition of human recombinant c-Src by filter-binding assay	B	CSc1nc(NCc2ccc(F)cc2)c2cnn(CC(Cl)c3ccc(F)cc3)c2n1		CHEMBL475740	=	Ki	nM	310.0	CHEMBL267	Homo sapiens	Ki	uM	0.31
	2504798	CHEMBL962772	Inhibition of human recombinant c-Src by filter-binding assay	B	CSc1nc(NCc2ccccc2F)c2cnn(CC(Cl)c3ccc(F)cc3)c2n1		CHEMBL514140	=	Ki	nM	300.0	CHEMBL267	Homo sapiens	Ki	uM	0.3
	2504799	CHEMBL962772	Inhibition of human recombinant c-Src by filter-binding assay	B	CSc1nc(NCCc2ccccc2)c2cnn(CC(Cl)c3ccc(F)cc3)c2n1		CHEMBL473102	=	Ki	nM	3250.0	CHEMBL267	Homo sapiens	Ki	uM	3.25
	2504800	CHEMBL962772	Inhibition of human recombinant c-Src by filter-binding assay	B	CSc1nc(Nc2cccc(F)c2)c2cnn(CC(Cl)c3ccc(F)cc3)c2n1		CHEMBL516070	=	Ki	nM	210.0	CHEMBL267	Homo sapiens	Ki	uM	0.21
	2504801	CHEMBL962772	Inhibition of human recombinant c-Src by filter-binding assay	B	CCCNc1nc(SC)nc2c1cnn2CC(Cl)c1ccc(Cl)cc1		CHEMBL475336	=	Ki	nM	1320.0	CHEMBL267	Homo sapiens	Ki	uM	1.32
	2504802	CHEMBL962772	Inhibition of human recombinant c-Src by filter-binding assay	B	CCCCNc1nc(SC)nc2c1cnn2CC(Cl)c1ccc(Cl)cc1		CHEMBL475337	=	Ki	nM	1530.0	CHEMBL267	Homo sapiens	Ki	uM	1.53
	2504803	CHEMBL962772	Inhibition of human recombinant c-Src by filter-binding assay	B	CCN(CC)c1nc(SC)nc2c1cnn2CC(Cl)c1ccc(Cl)cc1		CHEMBL515135	=	Ki	nM	1620.0	CHEMBL267	Homo sapiens	Ki	uM	1.62
	2504804	CHEMBL962772	Inhibition of human recombinant c-Src by filter-binding assay	B	CSc1nc(N2CCOCC2)c2cnn(CC(Cl)c3ccc(Cl)cc3)c2n1		CHEMBL515885	=	Ki	nM	3210.0	CHEMBL267	Homo sapiens	Ki	uM	3.21
	2504805	CHEMBL962772	Inhibition of human recombinant c-Src by filter-binding assay	B	CCSc1nc(N(CC)CC)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL454120	=	Ki	nM	5280.0	CHEMBL267	Homo sapiens	Ki	uM	5.28
	2504806	CHEMBL962772	Inhibition of human recombinant c-Src by filter-binding assay	B	CCCNc1nc(SCCC)nc2c1cnn2CC(Cl)c1ccccc1		CHEMBL510861	=	Ki	nM	3600.0	CHEMBL267	Homo sapiens	Ki	uM	3.6
	2504807	CHEMBL962772	Inhibition of human recombinant c-Src by filter-binding assay	B	CCCCNc1nc(SCCC)nc2c1cnn2CC(Cl)c1ccccc1		CHEMBL454922	=	Ki	nM	2560.0	CHEMBL267	Homo sapiens	Ki	uM	2.56
	2504808	CHEMBL962772	Inhibition of human recombinant c-Src by filter-binding assay	B	CCCSc1nc(N(CC)CC)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL508986	=	Ki	nM	5370.0	CHEMBL267	Homo sapiens	Ki	uM	5.37
	2504809	CHEMBL962772	Inhibition of human recombinant c-Src by filter-binding assay	B	CCCSc1nc(NCc2ccccc2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL454923	=	Ki	nM	510.0	CHEMBL267	Homo sapiens	Ki	uM	0.51
	2504810	CHEMBL962772	Inhibition of human recombinant c-Src by filter-binding assay	B	CCCNc1nc(SC)nc2c1cnn2CC(Br)c1ccccc1		CHEMBL454144	=	Ki	nM	2550.0	CHEMBL267	Homo sapiens	Ki	uM	2.55
	2504811	CHEMBL962772	Inhibition of human recombinant c-Src by filter-binding assay	B	CCCCNc1nc(SC)nc2c1cnn2CC(Br)c1ccccc1		CHEMBL508027	=	Ki	nM	810.0	CHEMBL267	Homo sapiens	Ki	uM	0.81
	2504812	CHEMBL962772	Inhibition of human recombinant c-Src by filter-binding assay	B	CCOCCNc1nc(SC)nc2c1cnn2CC(Br)c1ccccc1		CHEMBL455163	=	Ki	nM	5660.0	CHEMBL267	Homo sapiens	Ki	uM	5.66
	2504813	CHEMBL962772	Inhibition of human recombinant c-Src by filter-binding assay	B	CSc1nc(N2CCCC2)c2cnn(CC(Br)c3ccccc3)c2n1		CHEMBL507594	=	Ki	nM	1630.0	CHEMBL267	Homo sapiens	Ki	uM	1.63
	2504814	CHEMBL962772	Inhibition of human recombinant c-Src by filter-binding assay	B	CSc1nc(N2CCCCC2)c2cnn(CC(Br)c3ccccc3)c2n1		CHEMBL455164	=	Ki	nM	320.0	CHEMBL267	Homo sapiens	Ki	uM	0.32
	2504815	CHEMBL962772	Inhibition of human recombinant c-Src by filter-binding assay	B	CSc1nc(N2CCOCC2)c2cnn(CC(Br)c3ccccc3)c2n1		CHEMBL473103	=	Ki	nM	2570.0	CHEMBL267	Homo sapiens	Ki	uM	2.57
	2504816	CHEMBL962772	Inhibition of human recombinant c-Src by filter-binding assay	B	CSc1nc(NCc2ccccc2)c2cnn(CC(Br)c3ccccc3)c2n1		CHEMBL473516	=	Ki	nM	220.0	CHEMBL267	Homo sapiens	Ki	uM	0.22
	2504817	CHEMBL962772	Inhibition of human recombinant c-Src by filter-binding assay	B	CSc1nc(NCCc2ccccc2)c2cnn(CC(Br)c3ccccc3)c2n1		CHEMBL473517	=	Ki	nM	2800.0	CHEMBL267	Homo sapiens	Ki	uM	2.8
	2504818	CHEMBL962772	Inhibition of human recombinant c-Src by filter-binding assay	B	CCCNc1nc(N(C)C)nc2c1cnn2CC(Cl)c1ccccc1		CHEMBL473727	=	Ki	nM	4100.0	CHEMBL267	Homo sapiens	Ki	uM	4.1
	2504819	CHEMBL962772	Inhibition of human recombinant c-Src by filter-binding assay	B	CN(C)c1nc(N2CCOCC2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL473923	=	Ki	nM	3630.0	CHEMBL267	Homo sapiens	Ki	uM	3.63
	2504820	CHEMBL962772	Inhibition of human recombinant c-Src by filter-binding assay	B	CN(C)c1nc(NCc2ccccc2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL473726	=	Ki	nM	4220.0	CHEMBL267	Homo sapiens	Ki	uM	4.22
	2504821	CHEMBL962772	Inhibition of human recombinant c-Src by filter-binding assay	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Ki	nM	31000.0	CHEMBL267	Homo sapiens	Ki	uM	31.0
	2504862	CHEMBL962772	Inhibition of human recombinant c-Src by filter-binding assay	B	CC(C)(C)N1CN(c2ccc(Cl)cc2)C(N)=C2C=NN=C21		CHEMBL404666	=	Ki	nM	500.0	CHEMBL267	Homo sapiens	Ki	uM	0.5
	2505613	CHEMBL941572	Inhibition of Src	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	>	IC50	nM	30000.0	CHEMBL267	Homo sapiens	IC50	nM	30000.0
	2506979	CHEMBL942629	Inhibition of Src at 10 uM	B	COc1cc(O)ccc1-c1ccc2c(-c3nc4c(N5CCN(C)CC5)cccc4[nH]3)n[nH]c2c1		CHEMBL474619	<	Inhibition	%	50.0	CHEMBL267	Homo sapiens	INH	%	50.0
	2506980	CHEMBL942629	Inhibition of Src at 10 uM	B	CN1CCN(c2cccc3nc(-c4n[nH]c5cc(-c6ccc(N)cc6)ccc45)[nH]c23)CC1		CHEMBL480391	<	Inhibition	%	50.0	CHEMBL267	Homo sapiens	INH	%	50.0
	2507166	CHEMBL947784	Inhibition of Src	B	Nc1ncc(NC(=O)c2cc(NC(=O)c3cccc(C(F)(F)F)c3)ccc2Cl)cc1Cl		CHEMBL475817	>	IC50	nM	30000.0	CHEMBL267	Homo sapiens	IC50	uM	30.0
	2511572	CHEMBL972531	Inhibition of cSRC	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	1.3	CHEMBL267	Homo sapiens	IC50	uM	0.0013
	2511957	CHEMBL969673	Inhibition of human c-SRC at 1 uM assessed as residual enzyme activity	B	O=C(Nc1ccccc1Cl)c1ccc(Nc2nc(Nc3ccc(O)cc3)ncc2F)cc1		CHEMBL521949	=	Activity	%	66.0	CHEMBL267	Homo sapiens	Activity	%	66.0
	2511968	CHEMBL973501	Inhibition of SRC at 1 uM	B	CC(=O)N1CCN(C(=O)Cc2ccc(Nc3ncc(F)c(Nc4ccc(C(=O)Nc5ccccc5Cl)cc4)n3)cc2)CC1		CHEMBL508307	=	Inhibition	%	30.0	CHEMBL267	Homo sapiens	INH	%	30.0
	2520373	CHEMBL978937	Inhibition of c-Src	B	Nc1ncnc2c1c(-c1ccccc1)cn2-c1ccccc1		CHEMBL169757	=	IC50	nM	100.0	CHEMBL267	Homo sapiens	pIC50		7.0
	2520374	CHEMBL978937	Inhibition of c-Src	B	COc1cccc(-c2cn(-c3ccc(CCO)cc3)c3ncnc(N)c23)c1		CHEMBL320417	=	IC50	nM	100.0	CHEMBL267	Homo sapiens	pIC50		7.0
	2520375	CHEMBL978937	Inhibition of c-Src	B	COc1cccc(-c2cn(-c3ccc(CCN4CCC(O)CC4)cc3)c3ncnc(N)c23)c1		CHEMBL475584	=	IC50	nM	19.95	CHEMBL267	Homo sapiens	pIC50		7.7
	2520376	CHEMBL978937	Inhibition of c-Src	B	COc1cccc(-c2cn(-c3ccccc3)c3ncnc(N)c23)c1		CHEMBL172973	=	IC50	nM	50.12	CHEMBL267	Homo sapiens	pIC50		7.3
	2520377	CHEMBL978937	Inhibition of c-Src	B	Nc1ncnc2c1c(-c1cccc(Cl)c1)cn2-c1ccccc1		CHEMBL176309	=	IC50	nM	199.53	CHEMBL267	Homo sapiens	pIC50		6.7
	2520378	CHEMBL978937	Inhibition of c-Src	B	COc1ccc(-c2cn(-c3ccccc3)c3ncnc(N)c23)cc1		CHEMBL176705	=	IC50	nM	158.49	CHEMBL267	Homo sapiens	pIC50		6.8
	2520379	CHEMBL978937	Inhibition of c-Src	B	COc1ccccc1-c1cn(-c2ccccc2)c2ncnc(N)c12		CHEMBL511495	=	IC50	nM	6309.57	CHEMBL267	Homo sapiens	pIC50		5.2
	2520380	CHEMBL978937	Inhibition of c-Src	B	CCOC(=O)c1ccc(-c2cn(-c3ccccc3)c3ncnc(N)c23)cc1		CHEMBL369014	=	IC50	nM	10000.0	CHEMBL267	Homo sapiens	pIC50		5.0
	2520381	CHEMBL978937	Inhibition of c-Src	B	Nc1ncnc2c1c(-c1ccccc1)cn2-c1ccccc1CO		CHEMBL429057	=	IC50	nM	316.23	CHEMBL267	Homo sapiens	pIC50		6.5
	2520382	CHEMBL978937	Inhibition of c-Src	B	Nc1ncnc2c1c(-c1ccccc1)cn2-c1cccc(CO)c1		CHEMBL173478	=	IC50	nM	63.1	CHEMBL267	Homo sapiens	pIC50		7.2
	2520383	CHEMBL978937	Inhibition of c-Src	B	Nc1ncnc2c1c(-c1ccccc1)cn2-c1ccc(CO)cc1		CHEMBL367442	=	IC50	nM	19.95	CHEMBL267	Homo sapiens	pIC50		7.7
	2520384	CHEMBL978937	Inhibition of c-Src	B	COc1cccc(-c2cn(-c3cccc(CO)c3)c3ncnc(N)c23)c1		CHEMBL176815	=	IC50	nM	63.1	CHEMBL267	Homo sapiens	pIC50		7.2
	2520385	CHEMBL978937	Inhibition of c-Src	B	Nc1ncnc2c1c(-c1ccccc1)cn2-c1ccccc1CNCCO		CHEMBL176470	=	IC50	nM	5011.87	CHEMBL267	Homo sapiens	pIC50		5.3
	2520386	CHEMBL978937	Inhibition of c-Src	B	Nc1ncnc2c1c(-c1ccccc1)cn2-c1cccc(CNCCO)c1		CHEMBL176702	=	IC50	nM	10.0	CHEMBL267	Homo sapiens	pIC50		8.0
	2520387	CHEMBL978937	Inhibition of c-Src	B	Nc1ncnc2c1c(-c1ccccc1)cn2-c1ccc(CNCCO)cc1		CHEMBL173453	=	IC50	nM	31.62	CHEMBL267	Homo sapiens	pIC50		7.5
	2520388	CHEMBL978937	Inhibition of c-Src	B	COc1cccc(-c2cn(-c3ccc(CNCCO)cc3)c3ncnc(N)c23)c1		CHEMBL424375	=	IC50	nM	31.62	CHEMBL267	Homo sapiens	pIC50		7.5
	2520389	CHEMBL978937	Inhibition of c-Src	B	COc1cccc(-c2cn(-c3ccc(CC(=O)NCCO)cc3)c3ncnc(N)c23)c1		CHEMBL175409	=	IC50	nM	19.95	CHEMBL267	Homo sapiens	pIC50		7.7
	2520390	CHEMBL978937	Inhibition of c-Src	B	COc1cccc(-c2cn(-c3ccc(CCN(C)CCO)cc3)c3ncnc(N)c23)c1		CHEMBL105436	=	IC50	nM	31.62	CHEMBL267	Homo sapiens	pIC50		7.5
	2520391	CHEMBL978937	Inhibition of c-Src	B	COc1cccc(-c2cn(-c3ccc(CC(=O)O)cc3)c3ncnc(N)c23)c1		CHEMBL511320	=	IC50	nM	50.12	CHEMBL267	Homo sapiens	pIC50		7.3
	2520392	CHEMBL978937	Inhibition of c-Src	B	COc1cccc(-c2cn(-c3ccc(CCN(C)C)cc3)c3ncnc(N)c23)c1		CHEMBL470746	=	IC50	nM	39.81	CHEMBL267	Homo sapiens	pIC50		7.4
	2520393	CHEMBL978937	Inhibition of c-Src	B	COc1cccc(-c2cn(-c3ccc(CCNCCO)cc3)c3ncnc(N)c23)c1		CHEMBL470925	=	IC50	nM	19.95	CHEMBL267	Homo sapiens	pIC50		7.7
	2520394	CHEMBL978937	Inhibition of c-Src	B	COCCN(C)CCc1ccc(-n2cc(-c3cccc(OC)c3)c3c(N)ncnc32)cc1		CHEMBL515751	=	IC50	nM	10.0	CHEMBL267	Homo sapiens	pIC50		8.0
	2520395	CHEMBL978937	Inhibition of c-Src	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2-c1ccc(OCCNCCO)cc1		CHEMBL474998	=	IC50	nM	0.3162	CHEMBL267	Homo sapiens	pIC50		9.5
	2520396	CHEMBL978937	Inhibition of c-Src	B	Nc1ncnc2c1c(-c1ccc(O)cc1)cn2-c1ccc(OCCNCCO)cc1		CHEMBL473024	=	IC50	nM	3.162	CHEMBL267	Homo sapiens	pIC50		8.5
	2520397	CHEMBL978937	Inhibition of c-Src	B	CN(C)CCc1ccccc1-n1cc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL516062	=	IC50	nM	0.3162	CHEMBL267	Homo sapiens	pIC50		9.5
	2520398	CHEMBL978937	Inhibition of c-Src	B	COc1cccc(-c2cn(-c3ccc(OCCNCCO)cc3)c3ncnc(N)c23)c1		CHEMBL474656	=	IC50	nM	19.95	CHEMBL267	Homo sapiens	pIC50		7.7
	2520399	CHEMBL978937	Inhibition of c-Src	B	Nc1ncnc2c1c(-c1cccc(F)c1)cn2-c1ccc(OCCNCCO)cc1		CHEMBL474657	=	IC50	nM	19.95	CHEMBL267	Homo sapiens	pIC50		7.7
	2520400	CHEMBL978937	Inhibition of c-Src	B	Nc1ncnc2c1c(-c1cccc(Cl)c1)cn2-c1ccc(OCCNCCO)cc1		CHEMBL473155	=	IC50	nM	19.95	CHEMBL267	Homo sapiens	pIC50		7.7
	2520401	CHEMBL978937	Inhibition of c-Src	B	COCCNCCOc1cccc(-n2cc(-c3cccc(O)c3)c3c(N)ncnc32)c1		CHEMBL475156	=	IC50	nM	7.943	CHEMBL267	Homo sapiens	pIC50		8.1
	2520402	CHEMBL978937	Inhibition of c-Src	B	COCCNCCOc1cccc(-n2cc(-c3cccc(OC)c3)c3c(N)ncnc32)c1		CHEMBL475354	=	IC50	nM	158.49	CHEMBL267	Homo sapiens	pIC50		6.8
	2520403	CHEMBL978937	Inhibition of c-Src	B	CNC(=O)CNCCOc1ccc(-n2cc(-c3cccc(OC)c3)c3c(N)ncnc32)cc1		CHEMBL475355	=	IC50	nM	39.81	CHEMBL267	Homo sapiens	pIC50		7.4
	2520404	CHEMBL978937	Inhibition of c-Src	B	COc1cccc(-c2cn(-c3ccc(OCCn4ccnc4)cc3)c3ncnc(N)c23)c1		CHEMBL475413	=	IC50	nM	125.89	CHEMBL267	Homo sapiens	pIC50		6.9
	2520405	CHEMBL978937	Inhibition of c-Src	B	OCCNCCOc1ccc(-n2cc(-c3cccc(O)c3)c3cncnc32)cc1		CHEMBL475414	=	IC50	nM	39.81	CHEMBL267	Homo sapiens	pIC50		7.4
	2520406	CHEMBL978937	Inhibition of c-Src	B	CNc1ncnc2c1c(-c1ccccc1)cn2-c1ccccc1		CHEMBL366831	=	IC50	nM	10000.0	CHEMBL267	Homo sapiens	pIC50		5.0
	2520407	CHEMBL978937	Inhibition of c-Src	B	CCOC(=O)C[C@@H]1C[C@H](n2cc(-c3ccccc3)c3c(N)ncnc32)CN1C(=O)OC(C)(C)C		CHEMBL516072	=	IC50	nM	5011.87	CHEMBL267	Homo sapiens	pIC50		5.3
	2520408	CHEMBL978937	Inhibition of c-Src	B	CCOC(=O)C[C@@H]1C[C@H](n2cc(-c3ccc(O)cc3)c3c(N)ncnc32)CN1C(=O)OC(C)(C)C		CHEMBL475263	=	IC50	nM	316.23	CHEMBL267	Homo sapiens	pIC50		6.5
	2520409	CHEMBL978937	Inhibition of c-Src	B	CCOC(=O)C[C@@H]1C[C@H](n2cc(-c3ccccc3)c3c(N)ncnc32)CN1		CHEMBL475264	=	IC50	nM	15.85	CHEMBL267	Homo sapiens	pIC50		7.8
	2520410	CHEMBL978937	Inhibition of c-Src	B	CCOC(=O)C[C@@H]1C[C@H](n2cc(-c3ccc(O)cc3)c3c(N)ncnc32)CN1		CHEMBL470527	=	IC50	nM	5.012	CHEMBL267	Homo sapiens	pIC50		8.3
	2520411	CHEMBL978937	Inhibition of c-Src	B	CC(C)(C)OC(=O)N1C[C@@H](n2cc(-c3ccccc3)c3c(N)ncnc32)C[C@H]1CO		CHEMBL470708	=	IC50	nM	1995.26	CHEMBL267	Homo sapiens	pIC50		5.7
	2520412	CHEMBL978937	Inhibition of c-Src	B	CC(C)(C)OC(=O)N1C[C@@H](n2cc(-c3ccc(O)cc3)c3c(N)ncnc32)C[C@H]1CO		CHEMBL513043	=	IC50	nM	316.23	CHEMBL267	Homo sapiens	pIC50		6.5
	2520413	CHEMBL978937	Inhibition of c-Src	B	Nc1ncnc2c1c(-c1ccccc1)cn2[C@@H]1CN[C@H](CO)C1		CHEMBL471574	=	IC50	nM	125.89	CHEMBL267	Homo sapiens	pIC50		6.9
	2520414	CHEMBL978937	Inhibition of c-Src	B	Nc1ncnc2c1c(-c1ccc(O)cc1)cn2[C@@H]1CN[C@H](CO)C1		CHEMBL471575	=	IC50	nM	50.12	CHEMBL267	Homo sapiens	pIC50		7.3
	2520415	CHEMBL978937	Inhibition of c-Src	B	CCOC(=O)C[C@@H]1C[C@@H](n2cc(-c3ccccc3)c3c(N)ncnc32)CN1C(=O)OC(C)(C)C		CHEMBL511157	=	IC50	nM	398.11	CHEMBL267	Homo sapiens	pIC50		6.4
	2520416	CHEMBL978937	Inhibition of c-Src	B	CCOC(=O)C[C@@H]1C[C@@H](n2cc(-c3ccc(O)cc3)c3c(N)ncnc32)CN1C(=O)OC(C)(C)C		CHEMBL470731	=	IC50	nM	31.62	CHEMBL267	Homo sapiens	pIC50		7.5
	2520417	CHEMBL978937	Inhibition of c-Src	B	CCOC(=O)C[C@@H]1C[C@@H](n2cc(-c3ccc(O)cc3)c3c(N)ncnc32)CN1		CHEMBL513563	=	IC50	nM	100.0	CHEMBL267	Homo sapiens	pIC50		7.0
	2520418	CHEMBL978937	Inhibition of c-Src	B	CCOC(=O)C[C@@H]1C[C@@H](n2cc(-c3ccccc3)c3c(N)ncnc32)CN1		CHEMBL470732	=	IC50	nM	630.96	CHEMBL267	Homo sapiens	pIC50		6.2
	2520419	CHEMBL978937	Inhibition of c-Src	B	CC(C)(C)OC(=O)N1C[C@H](n2cc(-c3ccccc3)c3c(N)ncnc32)C[C@H]1CO		CHEMBL514652	=	IC50	nM	125.89	CHEMBL267	Homo sapiens	pIC50		6.9
	2520420	CHEMBL978937	Inhibition of c-Src	B	CC(C)(C)OC(=O)N1C[C@H](n2cc(-c3ccc(O)cc3)c3c(N)ncnc32)C[C@H]1CO		CHEMBL474825	=	IC50	nM	25.12	CHEMBL267	Homo sapiens	pIC50		7.6
	2520421	CHEMBL978937	Inhibition of c-Src	B	Nc1ncnc2c1c(-c1ccccc1)cn2[C@H]1CN[C@H](CO)C1		CHEMBL474834	=	IC50	nM	316.23	CHEMBL267	Homo sapiens	pIC50		6.5
	2520422	CHEMBL978937	Inhibition of c-Src	B	Nc1ncnc2c1c(-c1ccc(O)cc1)cn2[C@H]1CN[C@H](CO)C1		CHEMBL475008	=	IC50	nM	100.0	CHEMBL267	Homo sapiens	pIC50		7.0
	2520423	CHEMBL978937	Inhibition of c-Src	B	NC(=O)CN1CCC(n2cc(-c3cccc(O)c3)c3c(N)ncnc32)CC1		CHEMBL263528	=	IC50	nM	1.0	CHEMBL267	Homo sapiens	pIC50		9.0
	2520424	CHEMBL978937	Inhibition of c-Src	B	COc1cccc(-c2cn(C3CCN(CCN(C)CCO)CC3)c3ncnc(N)c23)c1		CHEMBL168661	=	IC50	nM	6.31	CHEMBL267	Homo sapiens	pIC50		8.2
	2520425	CHEMBL978937	Inhibition of c-Src	B	COCCN(C)CCN1CCC(n2cc(-c3cccc(OC)c3)c3c(N)ncnc32)CC1		CHEMBL274732	=	IC50	nM	50.12	CHEMBL267	Homo sapiens	pIC50		7.3
	2520426	CHEMBL978937	Inhibition of c-Src	B	COC(=O)CN1CCC(n2cc(-c3cccc(O)c3)c3c(N)ncnc32)CC1		CHEMBL262276	=	IC50	nM	1.0	CHEMBL267	Homo sapiens	pIC50		9.0
	2520427	CHEMBL978937	Inhibition of c-Src	B	CN(C)C(=O)CN1CCC(n2cc(-c3cccc(O)c3)c3c(N)ncnc32)CC1		CHEMBL169920	=	IC50	nM	3.162	CHEMBL267	Homo sapiens	pIC50		8.5
	2520428	CHEMBL978937	Inhibition of c-Src	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCN(CCO)CC1		CHEMBL169780	=	IC50	nM	1.0	CHEMBL267	Homo sapiens	pIC50		9.0
	2520429	CHEMBL978937	Inhibition of c-Src	B	COC(=O)CN1CCC(n2cc(-c3cccc(OC)c3)c3c(N)ncnc32)CC1		CHEMBL169065	=	IC50	nM	79.43	CHEMBL267	Homo sapiens	pIC50		7.1
	2520430	CHEMBL978937	Inhibition of c-Src	B	COc1cccc(-c2cn(C3CCN(CC(N)=O)CC3)c3ncnc(N)c23)c1		CHEMBL169064	=	IC50	nM	19.95	CHEMBL267	Homo sapiens	pIC50		7.7
	2520431	CHEMBL978937	Inhibition of c-Src	B	COc1cccc(-c2cn(C3CCN(CC(=O)N(C)C)CC3)c3ncnc(N)c23)c1		CHEMBL355269	=	IC50	nM	63.1	CHEMBL267	Homo sapiens	pIC50		7.2
	2520432	CHEMBL978937	Inhibition of c-Src	B	COc1cccc(-c2cn(C3CCN(CCO)CC3)c3ncnc(N)c23)c1		CHEMBL169200	=	IC50	nM	25.12	CHEMBL267	Homo sapiens	pIC50		7.6
	2520433	CHEMBL978937	Inhibition of c-Src	B	Nc1ncnc2c1c(-c1ccccc1)cn2CC(CO)CO		CHEMBL474237	=	IC50	nM	199.53	CHEMBL267	Homo sapiens	pIC50		6.7
	2520434	CHEMBL978937	Inhibition of c-Src	B	Nc1ncnc2c1c(-c1ccc(O)cc1)cn2CC(CO)CO		CHEMBL471914	=	IC50	nM	501.19	CHEMBL267	Homo sapiens	pIC50		6.3
	2520435	CHEMBL978937	Inhibition of c-Src	B	COc1cccc(-c2cn(CC(CO)CO)c3ncnc(N)c23)c1		CHEMBL512352	=	IC50	nM	316.23	CHEMBL267	Homo sapiens	pIC50		6.5
	2520436	CHEMBL978937	Inhibition of c-Src	B	Nc1ncnc2c1c(-c1ccccc1)cn2C1CCCC1		CHEMBL352954	=	IC50	nM	125.89	CHEMBL267	Homo sapiens	pIC50		6.9
	2520437	CHEMBL978937	Inhibition of c-Src	B	COc1ccc(-c2cn(C3CCCC3)c3ncnc(N)c23)cc1		CHEMBL170724	=	IC50	nM	79.43	CHEMBL267	Homo sapiens	pIC50		7.1
	2520438	CHEMBL978937	Inhibition of c-Src	B	Nc1ncnc2c1c(-c1ccc(O)cc1)cn2C1CCCC1		CHEMBL169570	=	IC50	nM	19.95	CHEMBL267	Homo sapiens	pIC50		7.7
	2520439	CHEMBL978937	Inhibition of c-Src	B	COc1cccc(-c2cn(C3CCCC3)c3ncnc(N)c23)c1		CHEMBL168382	=	IC50	nM	1.995	CHEMBL267	Homo sapiens	pIC50		8.7
	2520440	CHEMBL978937	Inhibition of c-Src	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCCC1		CHEMBL169390	=	IC50	nM	1.0	CHEMBL267	Homo sapiens	pIC50		9.0
	2520441	CHEMBL978937	Inhibition of c-Src	B	Nc1ncnc2c1c(-c1ccccc1)cn2C1CCC1		CHEMBL166766	=	IC50	nM	100.0	CHEMBL267	Homo sapiens	pIC50		7.0
	2520442	CHEMBL978937	Inhibition of c-Src	B	COc1ccc(-c2cn(C3CCC3)c3ncnc(N)c23)cc1		CHEMBL169079	=	IC50	nM	199.53	CHEMBL267	Homo sapiens	pIC50		6.7
	2520443	CHEMBL978937	Inhibition of c-Src	B	Nc1ncnc2c1c(-c1ccc(O)cc1)cn2C1CCC1		CHEMBL166765	=	IC50	nM	10.0	CHEMBL267	Homo sapiens	pIC50		8.0
	2520444	CHEMBL978937	Inhibition of c-Src	B	COc1cccc(-c2cn(C3CCC3)c3ncnc(N)c23)c1		CHEMBL355191	=	IC50	nM	39.81	CHEMBL267	Homo sapiens	pIC50		7.4
	2520445	CHEMBL978937	Inhibition of c-Src	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCC1		CHEMBL355330	=	IC50	nM	3.981	CHEMBL267	Homo sapiens	pIC50		8.4
	2520446	CHEMBL978937	Inhibition of c-Src	B	Nc1ncnc2c1c(-c1ccccc1)cn2C1CC1		CHEMBL509767	=	IC50	nM	251.19	CHEMBL267	Homo sapiens	pIC50		6.6
	2520447	CHEMBL978937	Inhibition of c-Src	B	Nc1ncnc2c1c(-c1ccccc1)cn2[C@@H](CO)c1ccccc1		CHEMBL471945	=	IC50	nM	501.19	CHEMBL267	Homo sapiens	pIC50		6.3
	2520448	CHEMBL978937	Inhibition of c-Src	B	Nc1ncnc2c1c(-c1ccccc1)cn2[C@H](CO)c1ccccc1		CHEMBL511124	=	IC50	nM	5011.87	CHEMBL267	Homo sapiens	pIC50		5.3
	2520449	CHEMBL978937	Inhibition of c-Src	B	Clc1ncnc2c1c(-c1ccccc1)cn2-c1ccccc1		CHEMBL426229	=	IC50	nM	7943.28	CHEMBL267	Homo sapiens	pIC50		5.1
	2520450	CHEMBL978937	Inhibition of c-Src	B	Nc1ncnc2c1c(-c1ccccc1)nn2-c1ccccc1		CHEMBL122243	=	IC50	nM	501.19	CHEMBL267	Homo sapiens	pIC50		6.3
	2520451	CHEMBL978937	Inhibition of c-Src	B	O=c1[nH]cnc2c1c(-c1ccccc1)cn2-c1ccccc1		CHEMBL173474	=	IC50	nM	10000.0	CHEMBL267	Homo sapiens	pIC50		5.0
	2520452	CHEMBL978937	Inhibition of c-Src	B	Nc1ncnc2c1c(-c1ccccc1)cn2CCC(CO)CO		CHEMBL475189	=	IC50	nM	2511.89	CHEMBL267	Homo sapiens	pIC50		5.6
	2520453	CHEMBL978937	Inhibition of c-Src	B	ClC(Cn1ncc2c(NC3CC3)ncnc21)c1ccccc1		CHEMBL475190	=	Ki	nM	10000.0	CHEMBL267	Homo sapiens	pKi		5.0
	2520454	CHEMBL978937	Inhibition of c-Src	B	ClC(Cn1ncc2c(NCCc3ccccc3)ncnc21)c1ccccc1		CHEMBL515760	=	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
	2520455	CHEMBL978937	Inhibition of c-Src	B	CCCNc1ncnc2c1cnn2CC(Cl)c1ccccc1		CHEMBL475366	=	Ki	nM	3162.28	CHEMBL267	Homo sapiens	pKi		5.5
	2520456	CHEMBL978937	Inhibition of c-Src	B	CCN(CC)c1ncnc2c1cnn2CC(Cl)c1ccccc1		CHEMBL475367	=	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
	2520457	CHEMBL978937	Inhibition of c-Src	B	CCCCNc1ncnc2c1cnn2CC(Cl)c1ccccc1		CHEMBL472822	=	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
	2520458	CHEMBL978937	Inhibition of c-Src	B	ClC(Cn1ncc2c(NC3CCCCC3)ncnc21)c1ccccc1		CHEMBL514928	=	Ki	nM	2511.89	CHEMBL267	Homo sapiens	pKi		5.6
	2520459	CHEMBL978937	Inhibition of c-Src	B	ClC(Cn1ncc2c(N3CCCCC3)ncnc21)c1ccccc1		CHEMBL472959	=	Ki	nM	6309.57	CHEMBL267	Homo sapiens	pKi		5.2
	2520460	CHEMBL978937	Inhibition of c-Src	B	ClC(Cn1ncc2c(N3CCCCCC3)ncnc21)c1ccccc1		CHEMBL473154	=	Ki	nM	10000.0	CHEMBL267	Homo sapiens	pKi		5.0
	2520461	CHEMBL978937	Inhibition of c-Src	B	ClC(Cn1ncc2c(NCc3ccccc3)ncnc21)c1ccccc1		CHEMBL411043	=	Ki	nM	3162.28	CHEMBL267	Homo sapiens	pKi		5.5
	2520462	CHEMBL978937	Inhibition of c-Src	B	CCCNc1ncnc2c1cnn2CC(Br)c1ccccc1		CHEMBL382586	=	Ki	nM	794.33	CHEMBL267	Homo sapiens	pKi		6.1
	2520463	CHEMBL978937	Inhibition of c-Src	B	CC(C)Nc1ncnc2c1cnn2CC(Br)c1ccccc1		CHEMBL406504	=	Ki	nM	3162.28	CHEMBL267	Homo sapiens	pKi		5.5
	2520464	CHEMBL978937	Inhibition of c-Src	B	CCCCNc1ncnc2c1cnn2CC(Br)c1ccccc1		CHEMBL204343	=	Ki	nM	3162.28	CHEMBL267	Homo sapiens	pKi		5.5
	2520465	CHEMBL978937	Inhibition of c-Src	B	CCOCCNc1ncnc2c1cnn2CC(Br)c1ccccc1		CHEMBL380532	=	Ki	nM	1584.89	CHEMBL267	Homo sapiens	pKi		5.8
	2520466	CHEMBL978937	Inhibition of c-Src	B	BrC(Cn1ncc2c(N3CCCC3)ncnc21)c1ccccc1		CHEMBL382012	=	Ki	nM	10000.0	CHEMBL267	Homo sapiens	pKi		5.0
	2520467	CHEMBL978937	Inhibition of c-Src	B	BrC(Cn1ncc2c(N3CCCCC3)ncnc21)c1ccccc1		CHEMBL203922	=	Ki	nM	1584.89	CHEMBL267	Homo sapiens	pKi		5.8
	2520468	CHEMBL978937	Inhibition of c-Src	B	BrC(Cn1ncc2c(NCc3ccccc3)ncnc21)c1ccccc1		CHEMBL382153	=	Ki	nM	3162.28	CHEMBL267	Homo sapiens	pKi		5.5
	2520469	CHEMBL978937	Inhibition of c-Src	B	CCCNc1ncnc2c1cnn2CC(O)c1ccccc1		CHEMBL84945	=	Ki	nM	10000.0	CHEMBL267	Homo sapiens	pKi		5.0
	2520470	CHEMBL978937	Inhibition of c-Src	B	OC(Cn1ncc2c(NCc3ccccc3)ncnc21)c1ccccc1		CHEMBL204379	=	Ki	nM	2511.89	CHEMBL267	Homo sapiens	pKi		5.6
	2520471	CHEMBL978937	Inhibition of c-Src	B	OC(Cn1ncc2c(NCCc3ccccc3)ncnc21)c1ccccc1		CHEMBL378603	=	Ki	nM	2511.89	CHEMBL267	Homo sapiens	pKi		5.6
	2520472	CHEMBL978937	Inhibition of c-Src	B	OC(Cn1ncc2c(NCc3ccc(F)cc3)ncnc21)c1ccccc1		CHEMBL203650	=	Ki	nM	10000.0	CHEMBL267	Homo sapiens	pKi		5.0
	2520473	CHEMBL978937	Inhibition of c-Src	B	CSc1nc(NC2CC2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL515714	=	Ki	nM	2511.89	CHEMBL267	Homo sapiens	pKi		5.6
	2520474	CHEMBL978937	Inhibition of c-Src	B	CSc1nc(Nc2cccc(Cl)c2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL400211	=	Ki	nM	794.33	CHEMBL267	Homo sapiens	pKi		6.1
	2520475	CHEMBL978937	Inhibition of c-Src	B	CCCNc1nc(SC)nc2c1cnn2CC(Cl)c1ccccc1		CHEMBL312214	=	Ki	nM	794.33	CHEMBL267	Homo sapiens	pKi		6.1
	2520476	CHEMBL978937	Inhibition of c-Src	B	CCCCNc1nc(SC)nc2c1cnn2CC(Cl)c1ccccc1		CHEMBL40798	=	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
	2520477	CHEMBL978937	Inhibition of c-Src	B	CCN(CC)c1nc(SC)nc2c1cnn2CC(Cl)c1ccccc1		CHEMBL83847	=	Ki	nM	501.19	CHEMBL267	Homo sapiens	pKi		6.3
	2520478	CHEMBL978937	Inhibition of c-Src	B	CSc1nc(N2CCCCC2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL289298	=	Ki	nM	2511.89	CHEMBL267	Homo sapiens	pKi		5.6
	2520479	CHEMBL978937	Inhibition of c-Src	B	CSc1nc(N2CCOCC2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL38492	=	Ki	nM	6309.57	CHEMBL267	Homo sapiens	pKi		5.2
	2520480	CHEMBL978937	Inhibition of c-Src	B	CSc1nc(NCc2ccccc2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL288280	=	Ki	nM	3981.07	CHEMBL267	Homo sapiens	pKi		5.4
	2520481	CHEMBL978937	Inhibition of c-Src	B	CCCNc1nc(SCC)nc2c1cnn2CC(Cl)c1ccccc1		CHEMBL84020	=	Ki	nM	630.96	CHEMBL267	Homo sapiens	pKi		6.2
	2520482	CHEMBL978937	Inhibition of c-Src	B	CCCCNc1nc(SCC)nc2c1cnn2CC(Cl)c1ccccc1		CHEMBL41910	=	Ki	nM	630.96	CHEMBL267	Homo sapiens	pKi		6.2
	2520483	CHEMBL978937	Inhibition of c-Src	B	CCSc1nc(N2CCCCC2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL40913	=	Ki	nM	7943.28	CHEMBL267	Homo sapiens	pKi		5.1
	2520484	CHEMBL978937	Inhibition of c-Src	B	CCSc1nc(N2CCOCC2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL416439	=	Ki	nM	3981.07	CHEMBL267	Homo sapiens	pKi		5.4
	2520485	CHEMBL978937	Inhibition of c-Src	B	CCSc1nc(NCc2ccccc2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL85452	=	Ki	nM	7943.28	CHEMBL267	Homo sapiens	pKi		5.1
	2520486	CHEMBL978937	Inhibition of c-Src	B	O=C(O)c1cnc2c(cnn2/C=C/c2ccccc2)c1NCc1ccccc1		CHEMBL471913	=	Ki	nM	3981.07	CHEMBL267	Homo sapiens	pKi		5.4
	2526389	CHEMBL981422	Inhibition of Src	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	=	IC50	nM	20.0	CHEMBL267	Homo sapiens	IC50	nM	20.0
	2526390	CHEMBL981422	Inhibition of Src	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Ki	nM	81.0	CHEMBL267	Homo sapiens	Ki	nM	81.0
	2526391	CHEMBL981422	Inhibition of Src	B	CC(=O)Nc1ccc(Sc2nc(Nc3cc(C)n[nH]3)c3ccccc3n2)cc1		CHEMBL484950	=	Ki	nM	1258.0	CHEMBL267	Homo sapiens	Ki	nM	1258.0
	2547491	CHEMBL970972	Inhibition of c-Src	B	O=C(/C=C/c1ccc(O)c(O)c1)c1ccc(O)cc1O		CHEMBL128000	=	IC50	nM	65000.0	CHEMBL267	Homo sapiens	IC50	uM	65.0
	2551378	CHEMBL974769	Inhibition of His-tagged human src kinase expressed in Sf9 cells by DELFIA assay	B	O=C1C(O)=C(c2cc(O)c(O)c(O)c2)C(=O)C(O)=C1c1ccccc1		CHEMBL470336	=	IC50	nM	3900.0	CHEMBL267	Homo sapiens	IC50	umol/L	3.9
	2551379	CHEMBL974769	Inhibition of His-tagged human src kinase expressed in Sf9 cells by DELFIA assay	B	O=C1C(c2ccccc2)=C(O)C(=O)c2c1oc1cc(O)c(O)cc21		CHEMBL454473	=	IC50	nM	23600.0	CHEMBL267	Homo sapiens	IC50	umol/L	23.6
	2551380	CHEMBL974769	Inhibition of His-tagged human src kinase expressed in Sf9 cells by DELFIA assay	B	O=C1C(O)=C(c2ccc(O)c(O)c2)C(=O)C(O)=C1c1ccccc1		CHEMBL541995	=	IC50	nM	14500.0	CHEMBL267	Homo sapiens	IC50	umol/L	14.5
	2551381	CHEMBL974769	Inhibition of His-tagged human src kinase expressed in Sf9 cells by DELFIA assay	B	O=C1C(O)=C(c2ccccc2)C(=O)C(O)=C1c1ccccc1		CHEMBL480678	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	umol/L	50.0
	2551382	CHEMBL974770	Inhibition of His-tagged human src kinase expressed in Sf9 cells at 35 umol/l by DELFIA assay	B	O=C1C(O)=C(c2ccccc2)C(=O)C(O)=C1c1ccccc1		CHEMBL480678	=	Inhibition	%	17.0	CHEMBL267	Homo sapiens	INH	%	17.0
	2551383	CHEMBL974769	Inhibition of His-tagged human src kinase expressed in Sf9 cells by DELFIA assay	B	O=C1C(O)=C(c2ccc(O)cc2)C(=O)C(O)=C1c1ccccc1		CHEMBL511451	=	IC50	nM	37500.0	CHEMBL267	Homo sapiens	IC50	umol/L	37.5
	2559666	CHEMBL982992	Inhibition of SRC	B	Cc1c(Nc2c(C#N)cnc3sc(/C=C/C(=O)N4CCCC4)cc23)ccc2[nH]ccc12		CHEMBL477817	=	IC50	nM	330.0	CHEMBL267	Homo sapiens	IC50	nM	330.0
	2559950	CHEMBL986511	Inhibition of c-Src at 10 uM by ELISA	B	Oc1ccc(C[C@@]2(O)COc3c(ccc(O)c3O)[C@@H]2O)cc1O		CHEMBL445196	=	Inhibition	%	64.1	CHEMBL267	Homo sapiens	INH	%	64.1
	2559951	CHEMBL986511	Inhibition of c-Src at 10 uM by ELISA	B	Oc1cc2c(cc1O)[C@@H]1c3ccc(O)c(O)c3OC[C@]1(O)C2		CHEMBL477197	=	Inhibition	%	95.4	CHEMBL267	Homo sapiens	INH	%	95.4
	2559952	CHEMBL986511	Inhibition of c-Src at 10 uM by ELISA	B	O=C1COc2c(ccc(O)c2O)-c2cc(O)c(O)cc2C1		CHEMBL475940	=	Inhibition	%	94.4	CHEMBL267	Homo sapiens	INH	%	94.4
	2559953	CHEMBL986511	Inhibition of c-Src at 10 uM by ELISA	B	O=C1COc2cc(O)ccc2-c2cc(O)c(O)cc2C1		CHEMBL447427	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	2559954	CHEMBL986511	Inhibition of c-Src at 10 uM by ELISA	B	CC(C)=CCc1c(O)ccc(C(=O)/C=C/c2ccc(O)cc2)c1O		CHEMBL253467	=	Inhibition	%	50.1	CHEMBL267	Homo sapiens	INH	%	50.1
	2559955	CHEMBL986511	Inhibition of c-Src at 10 uM by ELISA	B	COc1cc(O)ccc1C(=O)/C=C/c1ccc(O)cc1		CHEMBL253777	=	Inhibition	%	1.0	CHEMBL267	Homo sapiens	INH	%	1.0
	2559956	CHEMBL986511	Inhibition of c-Src at 10 uM by ELISA	B	O=C(/C=C/c1ccc(O)cc1)c1ccc(O)cc1O		CHEMBL129795	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	2559957	CHEMBL986511	Inhibition of c-Src at 10 uM by ELISA	B	COc1cc(O)ccc1C(=O)/C=C/c1ccc(O)c(O)c1		CHEMBL476986	=	Inhibition	%	33.3	CHEMBL267	Homo sapiens	INH	%	33.3
	2559958	CHEMBL986511	Inhibition of c-Src at 10 uM by ELISA	B	O=C(/C=C/c1ccc(O)c(O)c1)c1ccc(O)cc1O		CHEMBL128000	=	Inhibition	%	9.1	CHEMBL267	Homo sapiens	INH	%	9.1
	2559959	CHEMBL986511	Inhibition of c-Src at 10 uM by ELISA	B	COc1ccc(/C=C2\COc3cc(O)cc(O)c3C2=O)cc1		CHEMBL476776	=	Inhibition	%	0.7	CHEMBL267	Homo sapiens	INH	%	0.7
	2559960	CHEMBL986511	Inhibition of c-Src at 10 uM by ELISA	B	COc1ccc(/C=C2\COc3cc(O)ccc3C2=O)cc1		CHEMBL450675	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	2559961	CHEMBL986511	Inhibition of c-Src at 10 uM by ELISA	B	O=C1/C(=C/c2ccc(O)c(O)c2)COc2cc(O)ccc21		CHEMBL249002	=	Inhibition	%	7.7	CHEMBL267	Homo sapiens	INH	%	7.7
	2559962	CHEMBL986511	Inhibition of c-Src at 10 uM by ELISA	B	O=C1/C(=C/c2ccc(O)cc2)COc2cc(O)ccc21		CHEMBL250414	=	Inhibition	%	1.6	CHEMBL267	Homo sapiens	INH	%	1.6
	2559963	CHEMBL986511	Inhibition of c-Src at 10 uM by ELISA	B	CO[C@H]1c2ccc(O)cc2OC[C@]1(O)Cc1ccc(O)cc1		CHEMBL518739	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	2559964	CHEMBL986511	Inhibition of c-Src at 10 uM by ELISA	B	CO[C@H]1c2ccc(O)cc2OC[C@]1(O)Cc1ccc(O)c(O)c1		CHEMBL477780	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	2559965	CHEMBL986511	Inhibition of c-Src at 10 uM by ELISA	B	Oc1ccc2c(c1)OC[C@](O)(Cc1ccc(O)c(O)c1)[C@H]2O		CHEMBL477779	=	Inhibition	%	77.4	CHEMBL267	Homo sapiens	INH	%	77.4
	2559966	CHEMBL986511	Inhibition of c-Src at 10 uM by ELISA	B	O=C1c2ccc(O)cc2OC[C@]1(O)Cc1ccc(O)c(O)c1		CHEMBL477778	=	Inhibition	%	82.1	CHEMBL267	Homo sapiens	INH	%	82.1
	2559967	CHEMBL986511	Inhibition of c-Src at 10 uM by ELISA	B	Oc1ccc2c(c1O)OC[C@]1(O)Cc3ccc(O)c(O)c3[C@H]21		CHEMBL447506	=	Inhibition	%	87.1	CHEMBL267	Homo sapiens	INH	%	87.1
	2559968	CHEMBL986511	Inhibition of c-Src at 10 uM by ELISA	B	CO[C@H]1C23C=CC(=O)C(O)=C2OC[C@]1(O)Cc1cc(O)c(O)cc13		CHEMBL477781	=	Inhibition	%	0.3	CHEMBL267	Homo sapiens	INH	%	0.3
	2559969	CHEMBL986511	Inhibition of c-Src at 10 uM by ELISA	B	CO[C@@H]1C23C=CC(=O)C(O)=C2OC[C@]1(O)Cc1cc(O)c(O)cc13		CHEMBL514559	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	2559970	CHEMBL986511	Inhibition of c-Src at 10 uM by ELISA	B	O=C1c2ccc(O)c(O)c2OC[C@]1(O)Cc1ccc(O)c(O)c1		CHEMBL477768	=	Inhibition	%	94.8	CHEMBL267	Homo sapiens	INH	%	94.8
	2559971	CHEMBL986511	Inhibition of c-Src at 10 uM by ELISA	B	Oc1ccc(CC2=Cc3ccc(O)c(O)c3OC2)cc1O		CHEMBL477560	=	Inhibition	%	87.5	CHEMBL267	Homo sapiens	INH	%	87.5
	2559972	CHEMBL986511	Inhibition of c-Src at 10 uM by ELISA	B	Oc1ccc(CC2=Cc3ccc(O)cc3OC2)cc1		CHEMBL477559	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	2559973	CHEMBL986511	Inhibition of c-Src at 10 uM by ELISA	B	CO[C@@H]1c2ccc(O)c(O)c2OC[C@]1(O)Cc1ccc(O)c(O)c1		CHEMBL518432	=	Inhibition	%	74.4	CHEMBL267	Homo sapiens	INH	%	74.4
	2559974	CHEMBL986511	Inhibition of c-Src at 10 uM by ELISA	B	CO[C@H]1c2ccc(O)c(O)c2OC[C@]1(O)Cc1ccc(O)c(O)c1		CHEMBL477769	=	Inhibition	%	25.7	CHEMBL267	Homo sapiens	INH	%	25.7
	2559975	CHEMBL986511	Inhibition of c-Src at 10 uM by ELISA	B	Oc1ccc(C[C@@]2(O)COc3c(ccc(O)c3O)[C@H]2O)cc1O		CHEMBL478611	=	Inhibition	%	91.0	CHEMBL267	Homo sapiens	INH	%	91.0
	2560132	CHEMBL986499	Inhibition of c-Src by ELISA	B	Oc1cc2c(cc1O)[C@@H]1c3ccc(O)c(O)c3OC[C@]1(O)C2		CHEMBL477197	=	IC50	nM	440.0	CHEMBL267	Homo sapiens	IC50	uM	0.44
Dose-dependent effect	2560146	CHEMBL986521	Inhibition of c-Src autophosphorylation in human HT29 cells by Western blot	B	Oc1cc2c(cc1O)[C@@H]1c3ccc(O)c(O)c3OC[C@]1(O)C2		CHEMBL477197		Activity			CHEMBL267	Homo sapiens	Activity		
	2560151	CHEMBL986499	Inhibition of c-Src by ELISA	B	Oc1ccc(C[C@@]2(O)COc3c(ccc(O)c3O)[C@H]2O)cc1O		CHEMBL478611	=	IC50	nM	360.0	CHEMBL267	Homo sapiens	IC50	uM	0.36
	2560152	CHEMBL986499	Inhibition of c-Src by ELISA	B	O=C1c2ccc(O)c(O)c2OC[C@]1(O)Cc1ccc(O)c(O)c1		CHEMBL477768	=	IC50	nM	1800.0	CHEMBL267	Homo sapiens	IC50	uM	1.8
	2560153	CHEMBL986499	Inhibition of c-Src by ELISA	B	Oc1ccc(CC2=Cc3ccc(O)c(O)c3OC2)cc1O		CHEMBL477560	=	IC50	nM	1600.0	CHEMBL267	Homo sapiens	IC50	uM	1.6
	2567204	CHEMBL970790	Inhibition of Src	B	CCN1C(=O)C(C)(C)c2cc3[nH]c4c(c3cc21)CCCc1c(C)n[nH]c1-4		CHEMBL223147	=	IC50	nM	250.0	CHEMBL267	Homo sapiens	IC50	uM	0.25
Not Evaluated	2577332	CHEMBL1035875	Binding affinity to human SRC at 10 uM relative to control	B	CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C		CHEMBL526901		Activity			CHEMBL267	Homo sapiens	Activity		
Not Evaluated	2577535	CHEMBL1035875	Binding affinity to human SRC at 10 uM relative to control	B	NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1		CHEMBL511337		Activity			CHEMBL267	Homo sapiens	Activity		
	2582024	CHEMBL962241	Inhibition of human SRC	B	N=C(N)SCCCn1c(=O)c2c(c1=O)n1c3ccccc3cc1c1cccc3ccn2c31		CHEMBL489083	=	IC50	nM	3800.0	CHEMBL267	Homo sapiens	IC50	uM	3.8
	2592626	CHEMBL1020474	Inhibition of Src	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CO)c1nc(Cc2ccc(C(F)(F)F)cc2)no1	Outside typical range	CHEMBL334979	=	IC50	nM	282000.0	CHEMBL267	Homo sapiens	IC50	uM	282.0
Not Determined	2592627	CHEMBL1020474	Inhibition of Src	B	COc1cc(Nc2nc(SC)n3ccnc3c2C(N)=O)cc(OC)c1		CHEMBL479617		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	2592633	CHEMBL1020474	Inhibition of Src	B	COc1cc(Nc2nc(NCc3ccccc3)n3ccnc3c2C(N)=O)cc(OC)c1		CHEMBL520608		IC50			CHEMBL267	Homo sapiens	IC50		
	2592643	CHEMBL1020474	Inhibition of Src	B	CCOC(=O)/C=C/c1ccc(CNc2nc(Nc3cc(OC)cc(OC)c3)c(C(N)=O)c3nccn23)cc1		CHEMBL480014	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	2592647	CHEMBL1020474	Inhibition of Src	B	COc1cc(Nc2nc(NCc3ccc(/C=C/C(=O)O)cc3)n3ccnc3c2C(N)=O)cc(OC)c1		CHEMBL511829	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	2593537	CHEMBL1035875	Binding affinity to human SRC at 10 uM relative to control	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Activity	%	0.2	CHEMBL267	Homo sapiens	Activity	%	0.2
Active	2593740	CHEMBL1035875	Binding affinity to human SRC at 10 uM relative to control	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097		Activity			CHEMBL267	Homo sapiens	Activity		
Active	2594006	CHEMBL1035875	Binding affinity to human SRC at 10 uM relative to control	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1		CHEMBL450519		Activity			CHEMBL267	Homo sapiens	Activity		
Not Evaluated	2594949	CHEMBL1035875	Binding affinity to human SRC at 10 uM relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649		Activity			CHEMBL267	Homo sapiens	Activity		
Not Evaluated	2595152	CHEMBL1035875	Binding affinity to human SRC at 10 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1964275		Activity			CHEMBL267	Homo sapiens	Activity		
	2595218	CHEMBL1035875	Binding affinity to human SRC at 10 uM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL515466	=	Activity	%	26.9	CHEMBL267	Homo sapiens	Activity	%	26.9
	2596349	CHEMBL1035875	Binding affinity to human SRC at 10 uM relative to control	B	CN(C)c1ccc(-c2cc3ncccc3c(NCCCCN)n2)cc1		CHEMBL282342	=	Activity	%	1.0	CHEMBL267	Homo sapiens	Activity	%	1.0
Not Evaluated	2597618	CHEMBL1035875	Binding affinity to human SRC at 10 uM relative to control	B	O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL408019		Activity			CHEMBL267	Homo sapiens	Activity		
Not Evaluated	2597821	CHEMBL1035875	Binding affinity to human SRC at 10 uM relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454		Activity			CHEMBL267	Homo sapiens	Activity		
	2602485	CHEMBL1034907	Inhibition of Src at 10 uM by HTRF assay	B	O=C(Nc1cccc(C(F)(F)F)c1)c1nscc1NCc1ccncc1		CHEMBL515880	<	Inhibition	%	30.0	CHEMBL267	Homo sapiens	INH	%	30.0
	2602867	CHEMBL1034907	Inhibition of Src at 10 uM by HTRF assay	B	O=C(Nc1cccc(Br)c1)c1nscc1NCc1ccc2ccccc2n1		CHEMBL458532	<	Inhibition	%	30.0	CHEMBL267	Homo sapiens	INH	%	30.0
	2602868	CHEMBL1034907	Inhibition of Src at 10 uM by HTRF assay	B	O=C(Nc1cccc(Br)c1)c1nscc1NCc1cnoc1		CHEMBL512380	<	Inhibition	%	30.0	CHEMBL267	Homo sapiens	INH	%	30.0
	2602869	CHEMBL1034907	Inhibition of Src at 10 uM by HTRF assay	B	O=C(Nc1cccc(C(F)(F)F)c1)c1nscc1NCc1ccnc2ccccc12		CHEMBL458531	<	Inhibition	%	30.0	CHEMBL267	Homo sapiens	INH	%	30.0
	2602870	CHEMBL1034907	Inhibition of Src at 10 uM by HTRF assay	B	O=C(Nc1cccc(Br)c1)c1nscc1NCc1ccnc2ccccc12		CHEMBL517399	<	Inhibition	%	30.0	CHEMBL267	Homo sapiens	INH	%	30.0
	2602871	CHEMBL1034907	Inhibition of Src at 10 uM by HTRF assay	B	O=C(Nc1cccc(Br)c1)c1nscc1NCCc1ccc2c(c1)OCO2		CHEMBL462528	<	Inhibition	%	30.0	CHEMBL267	Homo sapiens	INH	%	30.0
	2602872	CHEMBL1034907	Inhibition of Src at 10 uM by HTRF assay	B	O=C(Nc1cccc(C(F)(F)F)c1)c1nscc1NCCc1ccc2c(c1)OCO2		CHEMBL462527	<	Inhibition	%	30.0	CHEMBL267	Homo sapiens	INH	%	30.0
	2602873	CHEMBL1034907	Inhibition of Src at 10 uM by HTRF assay	B	O=C(Nc1cccc(C(F)(F)F)c1)c1nscc1NCc1ccc(F)c(F)c1		CHEMBL518204	<	Inhibition	%	30.0	CHEMBL267	Homo sapiens	INH	%	30.0
	2602874	CHEMBL1034907	Inhibition of Src at 10 uM by HTRF assay	B	O=C(NCc1ccc2c(c1)OCO2)c1nscc1NCc1ccncc1		CHEMBL462315	<	Inhibition	%	30.0	CHEMBL267	Homo sapiens	INH	%	30.0
	2602875	CHEMBL1034907	Inhibition of Src at 10 uM by HTRF assay	B	Cc1ccc(NC(=O)c2nscc2NCc2ccncc2)c(F)c1		CHEMBL460191	<	Inhibition	%	30.0	CHEMBL267	Homo sapiens	INH	%	30.0
	2602876	CHEMBL1034907	Inhibition of Src at 10 uM by HTRF assay	B	Cc1cc(NC(=O)c2nscc2NCc2ccncc2)ccc1C(F)(F)F		CHEMBL512863	<	Inhibition	%	30.0	CHEMBL267	Homo sapiens	INH	%	30.0
	2602877	CHEMBL1034907	Inhibition of Src at 10 uM by HTRF assay	B	Cc1ccc(NC(=O)c2nscc2NCc2ccncc2)cc1C(F)(F)F		CHEMBL470441	<	Inhibition	%	30.0	CHEMBL267	Homo sapiens	INH	%	30.0
	2602878	CHEMBL1034907	Inhibition of Src at 10 uM by HTRF assay	B	O=C(Nc1ccc(Cl)c(Cl)c1)c1nscc1NCc1ccncc1		CHEMBL470440	<	Inhibition	%	30.0	CHEMBL267	Homo sapiens	INH	%	30.0
	2602879	CHEMBL1034907	Inhibition of Src at 10 uM by HTRF assay	B	O=C(Nc1ccc(C(F)(F)F)c(Cl)c1)c1nscc1NCc1ccncc1		CHEMBL512862	<	Inhibition	%	30.0	CHEMBL267	Homo sapiens	INH	%	30.0
	2602880	CHEMBL1034907	Inhibition of Src at 10 uM by HTRF assay	B	O=C(Nc1ccc(Cl)c(C(F)(F)F)c1)c1nscc1NCc1ccncc1		CHEMBL473268	<	Inhibition	%	30.0	CHEMBL267	Homo sapiens	INH	%	30.0
	2602881	CHEMBL1034907	Inhibition of Src at 10 uM by HTRF assay	B	O=C(NC1=CC2C=NNC2C=C1)c1nscc1NCc1ccncc1		CHEMBL443921	<	Inhibition	%	30.0	CHEMBL267	Homo sapiens	INH	%	30.0
	2602882	CHEMBL1034907	Inhibition of Src at 10 uM by HTRF assay	B	O=C(Nc1ccc2ccccc2n1)c1nscc1NCc1ccncc1		CHEMBL474709	<	Inhibition	%	30.0	CHEMBL267	Homo sapiens	INH	%	30.0
	2602883	CHEMBL1034907	Inhibition of Src at 10 uM by HTRF assay	B	O=C(Nc1ccccc1Br)c1nscc1NCc1ccncc1		CHEMBL509737	<	Inhibition	%	30.0	CHEMBL267	Homo sapiens	INH	%	30.0
	2602884	CHEMBL1034907	Inhibition of Src at 10 uM by HTRF assay	B	O=C(Nc1ccc(Br)cc1)c1nscc1NCc1ccncc1		CHEMBL473288	<	Inhibition	%	30.0	CHEMBL267	Homo sapiens	INH	%	30.0
	2602885	CHEMBL1034907	Inhibition of Src at 10 uM by HTRF assay	B	O=C(Nc1cccc(Br)c1)c1nscc1NCc1ccncc1		CHEMBL473287	<	Inhibition	%	30.0	CHEMBL267	Homo sapiens	INH	%	30.0
	2602886	CHEMBL1034907	Inhibition of Src at 10 uM by HTRF assay	B	O=C(Nc1ccc(Cl)cc1)c1nscc1NCc1ccncc1		CHEMBL475709	<	Inhibition	%	30.0	CHEMBL267	Homo sapiens	INH	%	30.0
	2602887	CHEMBL1034907	Inhibition of Src at 10 uM by HTRF assay	B	CC(C)(C)c1ccc(NC(=O)c2nscc2NCc2ccncc2)cc1		CHEMBL475708	<	Inhibition	%	30.0	CHEMBL267	Homo sapiens	INH	%	30.0
	2602888	CHEMBL1034907	Inhibition of Src at 10 uM by HTRF assay	B	CC(C)(C)c1cccc(NC(=O)c2nscc2NCc2ccncc2)c1		CHEMBL475510	<	Inhibition	%	30.0	CHEMBL267	Homo sapiens	INH	%	30.0
	2602889	CHEMBL1034907	Inhibition of Src at 10 uM by HTRF assay	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1nscc1NCc1ccncc1		CHEMBL516243	<	Inhibition	%	30.0	CHEMBL267	Homo sapiens	INH	%	30.0
	2602890	CHEMBL1034907	Inhibition of Src at 10 uM by HTRF assay	B	O=C(Nc1cccc(OC(F)(F)F)c1)c1nscc1NCc1ccncc1		CHEMBL475509	<	Inhibition	%	30.0	CHEMBL267	Homo sapiens	INH	%	30.0
	2602891	CHEMBL1034907	Inhibition of Src at 10 uM by HTRF assay	B	O=C(Nc1ccc(C(F)(F)F)cc1)c1nscc1NCc1ccccn1		CHEMBL474494	<	Inhibition	%	30.0	CHEMBL267	Homo sapiens	INH	%	30.0
	2602892	CHEMBL1034907	Inhibition of Src at 10 uM by HTRF assay	B	O=C(Nc1ccc(C(F)(F)F)cc1)c1nscc1NCc1cccnc1		CHEMBL474293	<	Inhibition	%	30.0	CHEMBL267	Homo sapiens	INH	%	30.0
	2602893	CHEMBL1034907	Inhibition of Src at 10 uM by HTRF assay	B	O=C(Nc1ccc(C(F)(F)F)cc1)c1nscc1NCc1ccncc1		CHEMBL475704	<	Inhibition	%	30.0	CHEMBL267	Homo sapiens	INH	%	30.0
	2602894	CHEMBL1034907	Inhibition of Src at 10 uM by HTRF assay	B	O=C(Nc1cccc(C(F)(F)F)c1)c1nscc1NCc1ccccn1		CHEMBL475703	<	Inhibition	%	30.0	CHEMBL267	Homo sapiens	INH	%	30.0
	2602895	CHEMBL1034907	Inhibition of Src at 10 uM by HTRF assay	B	O=C(Nc1cccc(C(F)(F)F)c1)c1nscc1NCc1cccnc1		CHEMBL514986	<	Inhibition	%	30.0	CHEMBL267	Homo sapiens	INH	%	30.0
	2603065	CHEMBL1023860	Inhibition of Src	B	Cc1cccc(C(=O)Nc2cccc([C@H](C)Nc3cncc(Cl)n3)c2)c1		CHEMBL504075	=	Kd	nM	1300.0	CHEMBL267	Homo sapiens	Kd	nM	1300.0
	2613477	CHEMBL1031519	Inhibition of SRC	B	COc1ccc(-n2cnc3ccc(-c4nnc(SCc5cccc(C#N)c5)o4)cc32)cc1		CHEMBL516640	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	2618039	CHEMBL1016028	Inhibition of Src	B	Cl.N[C@@H](CCCCN/C=C1\C(=O)Nc2ccccc21)C(=O)O		CHEMBL458440	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	2618057	CHEMBL1016028	Inhibition of Src	B	Cl.N[C@@H](CCCCN/C=C1\C(=O)Nc2ccc(Br)cc21)C(=O)O		CHEMBL458441	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	2618058	CHEMBL1016028	Inhibition of Src	B	Cl.N[C@@H](CCCN/C=C1\C(=O)Nc2ccc(Br)cc21)C(=O)O		CHEMBL503236	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	2618059	CHEMBL1016028	Inhibition of Src	B	Cl.N[C@@H](CCCN/C=C1\C(=O)Nc2ccccc21)C(=O)O		CHEMBL458352	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	2626888	CHEMBL1000627	Binding affinity to human SRC at 5 uM	B	Cc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Nc3ncnc4ccc(N)cc34)cc2)c1		CHEMBL497033	=	Activity	%	11.0	CHEMBL267	Homo sapiens	Activity	%	11.0
	2626915	CHEMBL1000627	Binding affinity to human SRC at 5 uM	B	Cc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc(Nc3ncnc4ccc(N)cc34)c2)c1		CHEMBL497615	=	Activity	%	12.0	CHEMBL267	Homo sapiens	Activity	%	12.0
	2626938	CHEMBL995338	Binding affinity to acrylodan-labeled cSrc assessed as dissociation half life at 100 nM	B	Cc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Nc3ncnc4ccc([N+](=O)[O-])cc34)cc2)c1		CHEMBL526930	=	T1/2	hr	0.009861	CHEMBL267	Homo sapiens	t1/2	s	35.5
	2626939	CHEMBL995338	Binding affinity to acrylodan-labeled cSrc assessed as dissociation half life at 100 nM	B	Cc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Nc3ncnc4ccc(N)cc34)cc2)c1		CHEMBL497033	=	T1/2	hr	0.01675	CHEMBL267	Homo sapiens	t1/2	s	60.3
	2626940	CHEMBL995338	Binding affinity to acrylodan-labeled cSrc assessed as dissociation half life at 100 nM	B	CCC(=O)Nc1ccc2ncnc(Nc3ccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4cccc(C)c4)cc3)c2c1		CHEMBL510516	=	T1/2	hr	0.01833	CHEMBL267	Homo sapiens	t1/2	s	66.0
	2626941	CHEMBL995338	Binding affinity to acrylodan-labeled cSrc assessed as dissociation half life at 100 nM	B	Cc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc(Nc3ncnc4ccc([N+](=O)[O-])cc34)c2)c1		CHEMBL526560	=	T1/2	hr	0.007556	CHEMBL267	Homo sapiens	t1/2	s	27.2
	2626942	CHEMBL995338	Binding affinity to acrylodan-labeled cSrc assessed as dissociation half life at 100 nM	B	Cc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc(Nc3ncnc4ccc(N)cc34)c2)c1		CHEMBL497615	=	T1/2	hr	0.005361	CHEMBL267	Homo sapiens	t1/2	s	19.3
Active	2626943	CHEMBL997166	Inhibition of cSrc in human PC3 cells assessed as reduction of phosphorylated Src Y416 level at 1 to 10 uM after 5 hrs by immunoblot	F	CCC(=O)Nc1ccc2ncnc(Nc3ccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4cccc(C)c4)cc3)c2c1		CHEMBL510516		Activity			CHEMBL267	Homo sapiens	Activity		
Active	2626944	CHEMBL997170	Inhibition of cSrc in human PC3 cells assessed as reduction of phosphorylated FAK Y576/Y577 level at 1 to 10 uM after 5 hrs by immunoblot	F	CCC(=O)Nc1ccc2ncnc(Nc3ccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4cccc(C)c4)cc3)c2c1		CHEMBL510516		Activity			CHEMBL267	Homo sapiens	Activity		
Active	2626947	CHEMBL997165	Inhibition of cSrc in human PC3 cells assessed as reduction of phosphorylated Src Y416 level at 100 nM after 5 hrs by immunoblot	F	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421		Activity			CHEMBL267	Homo sapiens	Activity		
Active	2626948	CHEMBL997169	Inhibition of cSrc in human PC3 cells assessed as reduction of phosphorylated FAK Y576/Y577 level at 100 nM after 5 hrs by immunoblot	F	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421		Activity			CHEMBL267	Homo sapiens	Activity		
Active	2626951	CHEMBL997167	Inhibition of cSrc in human DU145 cells assessed as reduction of phosphorylated Src Y416 level at 100 nM after 5 hrs by immunoblot	F	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421		Activity			CHEMBL267	Homo sapiens	Activity		
Active	2626952	CHEMBL997171	Inhibition of cSrc in human DU145 cells assessed as reduction of phosphorylated FAK Y576/Y577 level at 100 nM after 5 hrs by immunoblot	F	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421		Activity			CHEMBL267	Homo sapiens	Activity		
Not Evaluated	2626955	CHEMBL999797	Inhibition of cSrc in human DU145 cells assessed as effect on total FAK level at 100 nM after 5 hrs by immunoblot	F	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421		Activity			CHEMBL267	Homo sapiens	Activity		
Not Evaluated	2626956	CHEMBL999795	Inhibition of cSrc in human PC3 cells assessed as effect on total FAK level at 100 nM after 5 hrs by immunoblot	F	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421		Activity			CHEMBL267	Homo sapiens	Activity		
Active	2626957	CHEMBL997168	Inhibition of cSrc in human DU145 cells assessed as reduction of phosphorylated Src Y416 level at 1 to 10 uM after 5 hrs by immunoblot	F	CCC(=O)Nc1ccc2ncnc(Nc3ccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4cccc(C)c4)cc3)c2c1		CHEMBL510516		Activity			CHEMBL267	Homo sapiens	Activity		
Active	2626958	CHEMBL997172	Inhibition of cSrc in human DU145 cells assessed as reduction of phosphorylated FAK Y576/Y577 level at 1 to 10 uM after 5 hrs by immunoblot	F	CCC(=O)Nc1ccc2ncnc(Nc3ccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4cccc(C)c4)cc3)c2c1		CHEMBL510516		Activity			CHEMBL267	Homo sapiens	Activity		
Not Evaluated	2626961	CHEMBL999796	Inhibition of cSrc in human PC3 cells assessed as effect on total FAK level at 1 to 10 uM after 5 hrs by immunoblot	F	CCC(=O)Nc1ccc2ncnc(Nc3ccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4cccc(C)c4)cc3)c2c1		CHEMBL510516		Activity			CHEMBL267	Homo sapiens	Activity		
Not Evaluated	2626962	CHEMBL995337	Inhibition of cSrc in human DU145 cells assessed as effect on total FAK level at 1 to 10 uM after 5 hrs by immunoblot	F	CCC(=O)Nc1ccc2ncnc(Nc3ccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4cccc(C)c4)cc3)c2c1		CHEMBL510516		Activity			CHEMBL267	Homo sapiens	Activity		
	2629906	CHEMBL1008387	Inhibition of Src	B	N#Cc1cnc2c(Cl)cc(NCc3cn(C4CCN(C5CCC5)CC4)nn3)cc2c1Nc1ccc(F)c(Cl)c1	Outside typical range	CHEMBL501709	=	IC50	nM	110000.0	CHEMBL267	Homo sapiens	IC50	uM	110.0
	2629909	CHEMBL1008387	Inhibition of Src	B	CCCN1CCC(n2cc(CNc3cc(Cl)c4ncc(C#N)c(Nc5ccc(F)c(Cl)c5)c4c3)nn2)CC1		CHEMBL495617	=	IC50	nM	72000.0	CHEMBL267	Homo sapiens	IC50	uM	72.0
	2629914	CHEMBL1008387	Inhibition of Src	B	CCN1CCC(n2cc(CNc3cc(Cl)c4ncc(C#N)c(Nc5ccc(F)c(Cl)c5)c4c3)nn2)CC1		CHEMBL527026	=	IC50	nM	53000.0	CHEMBL267	Homo sapiens	IC50	uM	53.0
	2629918	CHEMBL1008387	Inhibition of Src	B	N#Cc1cnc2c(Br)cc(NCc3c[nH]nn3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL230232	=	IC50	nM	41000.0	CHEMBL267	Homo sapiens	IC50	uM	41.0
	2629923	CHEMBL1008387	Inhibition of Src	B	CC(C)N1CCC(n2cc(CNc3cc(Cl)c4ncc(C#N)c(Nc5ccc(F)c(Cl)c5)c4c3)nn2)CC1		CHEMBL523059	=	IC50	nM	35000.0	CHEMBL267	Homo sapiens	IC50	uM	35.0
	2635189	CHEMBL1000628	Inhibition of Src at 1 uM relative to control	B	CSc1cc(Oc2ccnc3[nH]c(=O)[nH]c23)ccc1NC(=O)Nc1cccc(C(F)(F)F)c1		CHEMBL496009	<	Residual_activity	%	25.0	CHEMBL267	Homo sapiens	Residual_activity	%	25.0
	2635932	CHEMBL1000628	Inhibition of Src at 1 uM relative to control	B	O=C(Nc1cc(C(F)(F)F)ccc1F)Nc1ccc(Oc2ccnc3[nH]c(=O)[nH]c23)c2ccccc12		CHEMBL498112	<	Residual_activity	%	25.0	CHEMBL267	Homo sapiens	Residual_activity	%	25.0
	2636000	CHEMBL1000628	Inhibition of Src at 1 uM relative to control	B	CC(C)(C)c1cccc(NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)[nH]c34)c3ccccc23)c1		CHEMBL496073	<	Residual_activity	%	25.0	CHEMBL267	Homo sapiens	Residual_activity	%	25.0
	2638349	CHEMBL1011438	Inhibition of SRC	B	C[C@@H](Nc1c(Nc2ccncc2)c(=O)c1=O)c1ccccc1		CHEMBL466496	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	2638350	CHEMBL1011438	Inhibition of SRC	B	NC(=O)C(Nc1c(Nc2ccncc2)c(=O)c1=O)c1ccccc1		CHEMBL467079	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	2638351	CHEMBL1011438	Inhibition of SRC	B	NC(=O)C(Nc1c(Nc2ccncc2)c(=O)c1=O)c1cccc(O)c1		CHEMBL511410	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	2638352	CHEMBL1011438	Inhibition of SRC	B	C[C@@H](Nc1c(Nc2ccnc(-c3ccccc3F)c2)c(=O)c1=O)c1ccccc1		CHEMBL468125	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	2638353	CHEMBL1011438	Inhibition of SRC	B	C[C@@H](Nc1c(Nc2ccnc(-c3ccco3)c2)c(=O)c1=O)c1ccccc1		CHEMBL519113	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	2638354	CHEMBL1011438	Inhibition of SRC	B	C[C@@H](Nc1c(Nc2ccnc(-c3ccsc3)c2)c(=O)c1=O)c1ccccc1		CHEMBL481248	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	2639155	CHEMBL1025482	Inhibition of SRC	B	O[C@H]1CC[C@H](Nc2ccc3nnc(-c4cccc(C(F)(F)F)c4)n3n2)CC1		CHEMBL494221	>	Ki	nM	4000.0	CHEMBL267	Homo sapiens	Ki	nM	4000.0
	2639156	CHEMBL1025482	Inhibition of SRC	B	FC(F)(F)c1cccc(-c2nnc3ccc(NC4CCNCC4)nn23)c1		CHEMBL493169	>	Ki	nM	4000.0	CHEMBL267	Homo sapiens	Ki	nM	4000.0
	2644568	CHEMBL1031297	Inhibition of Src	B	Cc1cc(Nc2nc(-c3ccncc3)nc3ccccc23)n[nH]1		CHEMBL549536	=	Ki	nM	181.0	CHEMBL267	Homo sapiens	Ki	nM	181.0
Not Evaluated	2645020	CHEMBL1036234	Inhibition of SRC phosphorylation	B	CN(C)CCN(Cc1ccc(Cl)cc1)c1ccccn1.Cl		CHEMBL550011		Activity			CHEMBL267	Homo sapiens	Activity		
	2653218	CHEMBL1031881	Inhibition of human Src kinase by TR-FRET assay	B	CNc1ncnc2c1ncn2CCc1cc(NC(=O)c2cccc(C(F)(F)F)c2)ccc1C	Outside typical range	CHEMBL550623	=	IC50	nM	300000.0	CHEMBL267	Homo sapiens	IC50	uM	300.0
	2653219	CHEMBL1031881	Inhibition of human Src kinase by TR-FRET assay	B	CNc1ncnc2c1ncn2/C=C/c1cc(NC(=O)c2cccc(C(F)(F)F)c2)ccc1C		CHEMBL558475	=	IC50	nM	52000.0	CHEMBL267	Homo sapiens	IC50	uM	52.0
	2653220	CHEMBL1031881	Inhibition of human Src kinase by TR-FRET assay	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1/C=C/n1cnc2c(NC3CC3)ncnc21		CHEMBL564575	=	IC50	nM	91000.0	CHEMBL267	Homo sapiens	IC50	uM	91.0
	2653221	CHEMBL1031881	Inhibition of human Src kinase by TR-FRET assay	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1/C=C/n1cnc2c(Nc3ccccn3)ncnc21	Outside typical range	CHEMBL551030	=	IC50	nM	201000.0	CHEMBL267	Homo sapiens	IC50	uM	201.0
	2653222	CHEMBL1031881	Inhibition of human Src kinase by TR-FRET assay	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1/C=C/n1cnc2c(Nc3cccnc3)ncnc21		CHEMBL551031	=	IC50	nM	9300.0	CHEMBL267	Homo sapiens	IC50	uM	9.3
	2653223	CHEMBL1031881	Inhibition of human Src kinase by TR-FRET assay	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1/C=C/n1cnc2c(Nc3ccncc3)ncnc21		CHEMBL551229	=	IC50	nM	4700.0	CHEMBL267	Homo sapiens	IC50	uM	4.7
	2653224	CHEMBL1031881	Inhibition of human Src kinase by TR-FRET assay	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1/C=C/n1cnc2c(Nc3ccncn3)ncnc21		CHEMBL565084	=	IC50	nM	26000.0	CHEMBL267	Homo sapiens	IC50	uM	26.0
	2653225	CHEMBL1031881	Inhibition of human Src kinase by TR-FRET assay	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1/C=C/n1cnc2c(Nc3ccc(P(C)(C)=O)cc3)ncnc21		CHEMBL554084	=	IC50	nM	3800.0	CHEMBL267	Homo sapiens	IC50	uM	3.8
	2653226	CHEMBL1031881	Inhibition of human Src kinase by TR-FRET assay	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1/C=C/n1cnc2c(NCCCN(C)C)ncnc21	Outside typical range	CHEMBL559068	=	IC50	nM	159000.0	CHEMBL267	Homo sapiens	IC50	uM	159.0
	2653227	CHEMBL1031881	Inhibition of human Src kinase by TR-FRET assay	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1/C=C/n1cnc2c(NC3CC3)ncnc21		CHEMBL564726	=	IC50	nM	11000.0	CHEMBL267	Homo sapiens	IC50	uM	11.0
	2653228	CHEMBL1031881	Inhibition of human Src kinase by TR-FRET assay	B	Cc1ccc(NC(=O)Nc2cccc(C(F)(F)F)c2)cc1/C=C/n1cnc2c(NC3CC3)ncnc21	Outside typical range	CHEMBL559069	=	IC50	nM	517000.0	CHEMBL267	Homo sapiens	IC50	uM	517.0
	2653229	CHEMBL1031881	Inhibition of human Src kinase by TR-FRET assay	B	Cc1ccc(C(=O)Nc2cc(C(F)(F)F)ccc2F)cc1/C=C/n1cnc2c(NC3CC3)ncnc21		CHEMBL551838	=	IC50	nM	86000.0	CHEMBL267	Homo sapiens	IC50	uM	86.0
	2653230	CHEMBL1031881	Inhibition of human Src kinase by TR-FRET assay	B	Cc1ccc(C(=O)Nc2ccc(Cl)c(C(F)(F)F)c2)cc1/C=C/n1cnc2c(NC3CC3)ncnc21		CHEMBL564235	=	IC50	nM	45000.0	CHEMBL267	Homo sapiens	IC50	uM	45.0
	2653231	CHEMBL1031881	Inhibition of human Src kinase by TR-FRET assay	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1/C=C/n1cnc2c(NC3CC3)ncnc21		CHEMBL559628	=	IC50	nM	4800.0	CHEMBL267	Homo sapiens	IC50	uM	4.8
	2653232	CHEMBL1031881	Inhibition of human Src kinase by TR-FRET assay	B	Cc1ccc(C(=O)Nc2cccc(C(C)C)c2)cc1/C=C/n1cnc2c(NC3CC3)ncnc21		CHEMBL559702	=	IC50	nM	46000.0	CHEMBL267	Homo sapiens	IC50	uM	46.0
	2653233	CHEMBL1031881	Inhibition of human Src kinase by TR-FRET assay	B	Cc1ccc(C(=O)Nc2ncc(C(C)(C)C)s2)cc1/C=C/n1cnc2c(NC3CC3)ncnc21	Outside typical range	CHEMBL559438	=	IC50	nM	310000.0	CHEMBL267	Homo sapiens	IC50	uM	310.0
	2653234	CHEMBL1031881	Inhibition of human Src kinase by TR-FRET assay	B	Cc1ccc(C(=O)Nc2cc(C(C)(C)C)on2)cc1/C=C/n1cnc2c(NC3CC3)ncnc21		CHEMBL556669	=	IC50	nM	6600.0	CHEMBL267	Homo sapiens	IC50	uM	6.6
	2653235	CHEMBL1031881	Inhibition of human Src kinase by TR-FRET assay	B	Cc1ccc(C(=O)Nc2cc(C(C)(C)C)nn2C)cc1/C=C/n1cnc2c(NC3CC3)ncnc21		CHEMBL556670	=	IC50	nM	46000.0	CHEMBL267	Homo sapiens	IC50	uM	46.0
	2653236	CHEMBL1031881	Inhibition of human Src kinase by TR-FRET assay	B	Cc1ccc(C(=O)Nc2cc(C(F)(F)F)ccn2)cc1/C=C/n1cnc2c(NC3CC3)ncnc21		CHEMBL556874	=	IC50	nM	7000.0	CHEMBL267	Homo sapiens	IC50	uM	7.0
	2653237	CHEMBL1031881	Inhibition of human Src kinase by TR-FRET assay	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(/C=C/n4cnc5c(NC6CC6)ncnc54)c3)cc(C(F)(F)F)c2)cn1		CHEMBL539433	=	IC50	nM	7600.0	CHEMBL267	Homo sapiens	IC50	uM	7.6
	2653238	CHEMBL1031881	Inhibition of human Src kinase by TR-FRET assay	B	Cc1ccc(C(=O)Nc2cc(-n3ccnc3)cc(C(F)(F)F)c2)cc1/C=C/n1cnc2c(NC3CC3)ncnc21		CHEMBL559826	=	IC50	nM	8000.0	CHEMBL267	Homo sapiens	IC50	uM	8.0
	2653239	CHEMBL1031881	Inhibition of human Src kinase by TR-FRET assay	B	Cc1ccc(C(=O)Nc2cc(N3CCOCC3)cc(C(F)(F)F)c2)cc1/C=C/n1cnc2c(NC3CC3)ncnc21		CHEMBL553695	=	IC50	nM	33000.0	CHEMBL267	Homo sapiens	IC50	uM	33.0
	2653240	CHEMBL1031881	Inhibition of human Src kinase by TR-FRET assay	B	Cc1ccc(C(=O)Nc2cc(N3CCN(C)CC3)cc(C(F)(F)F)c2)cc1/C=C/n1cnc2c(NC3CC3)ncnc21		CHEMBL556746	=	IC50	nM	41000.0	CHEMBL267	Homo sapiens	IC50	uM	41.0
	2654022	CHEMBL1031881	Inhibition of human Src kinase by TR-FRET assay	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(/C=C/n4cnc5cncnc54)c3)cc(C(F)(F)F)c2)cn1		CHEMBL559838	=	IC50	nM	84.0	CHEMBL267	Homo sapiens	IC50	nM	84.0
	2654023	CHEMBL1031881	Inhibition of human Src kinase by TR-FRET assay	B	Cc1ccc(C(=O)Nc2cc(C(F)(F)F)ccn2)cc1/C=C/n1cnc2cncnc21		CHEMBL550281	=	IC50	nM	307.0	CHEMBL267	Homo sapiens	IC50	nM	307.0
	2655695	CHEMBL1029457	Inhibition of Src at 10 uM	B	CC(C)C[C@H](NC(=O)OC(C)(C)C)C(=O)Oc1c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c2c1=O		CHEMBL551352	=	Inhibition	%	55.4	CHEMBL267	Homo sapiens	INH	%	55.4
	2655697	CHEMBL1029457	Inhibition of Src at 10 uM	B	C[C@H](NC(=O)OC(C)(C)C)C(=O)Oc1c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c2c1=O		CHEMBL551890	=	Inhibition	%	51.4	CHEMBL267	Homo sapiens	INH	%	51.4
	2655699	CHEMBL1029457	Inhibition of Src at 10 uM	B	CC(C)[C@H](NC(=O)OC(C)(C)C)C(=O)Oc1c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c2c1=O		CHEMBL561091	=	Inhibition	%	52.5	CHEMBL267	Homo sapiens	INH	%	52.5
	2655701	CHEMBL1029457	Inhibition of Src at 10 uM	B	CC(C)C[C@@H](NC(=O)OC(C)(C)C)C(=O)Oc1c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c2c1=O		CHEMBL551547	=	Inhibition	%	44.5	CHEMBL267	Homo sapiens	INH	%	44.5
	2655703	CHEMBL1029457	Inhibition of Src at 10 uM	B	CC(C)[C@@H](NC(=O)OC(C)(C)C)C(=O)Oc1c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c2c1=O		CHEMBL561491	=	Inhibition	%	40.7	CHEMBL267	Homo sapiens	INH	%	40.7
	2655705	CHEMBL1029457	Inhibition of Src at 10 uM	B	CC(=O)N[C@@H](CC(C)C)C(=O)Oc1c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c2c1=O		CHEMBL561492	=	Inhibition	%	39.0	CHEMBL267	Homo sapiens	INH	%	39.0
	2655707	CHEMBL1029457	Inhibition of Src at 10 uM	B	CC(=O)N[C@@H](Cc1ccccc1)C(=O)Oc1c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c2c1=O		CHEMBL549397	=	Inhibition	%	60.5	CHEMBL267	Homo sapiens	INH	%	60.5
	2655709	CHEMBL1029457	Inhibition of Src at 10 uM	B	CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)C(=O)Oc1c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c2c1=O		CHEMBL557882	=	Inhibition	%	40.9	CHEMBL267	Homo sapiens	INH	%	40.9
	2655711	CHEMBL1029457	Inhibition of Src at 10 uM	B	CC(C)(C)OC(=O)NCC(=O)Oc1c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c2c1=O		CHEMBL564008	=	Inhibition	%	76.2	CHEMBL267	Homo sapiens	INH	%	76.2
	2655713	CHEMBL1029457	Inhibition of Src at 10 uM	B	C[C@@H](O)[C@H](NC(=O)OC(C)(C)C)C(=O)Oc1c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c2c1=O		CHEMBL549808	=	Inhibition	%	76.1	CHEMBL267	Homo sapiens	INH	%	76.1
	2655715	CHEMBL1029457	Inhibition of Src at 10 uM	B	C[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C(=O)Oc1c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c2c1=O		CHEMBL563238	=	Inhibition	%	71.0	CHEMBL267	Homo sapiens	INH	%	71.0
	2655717	CHEMBL1029457	Inhibition of Src at 10 uM	B	CC(C)(C)OC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)Oc1c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c2c1=O		CHEMBL553645	=	Inhibition	%	44.4	CHEMBL267	Homo sapiens	INH	%	44.4
	2655719	CHEMBL1029457	Inhibition of Src at 10 uM	B	CC(C)(C)OC(=O)N[C@@H](CC(N)=O)C(=O)Oc1c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c2c1=O		CHEMBL539739	=	Inhibition	%	50.8	CHEMBL267	Homo sapiens	INH	%	50.8
	2655721	CHEMBL1029457	Inhibition of Src at 10 uM	B	CC(C)(C)OC(=O)N1CCC[C@H]1C(=O)Oc1c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c2c1=O		CHEMBL554748	=	Inhibition	%	27.7	CHEMBL267	Homo sapiens	INH	%	27.7
	2655723	CHEMBL1029457	Inhibition of Src at 10 uM	B	CC(=O)N1CCC[C@H]1C(=O)Oc1c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c2c1=O		CHEMBL551952	=	Inhibition	%	24.3	CHEMBL267	Homo sapiens	INH	%	24.3
	2655725	CHEMBL1029457	Inhibition of Src at 10 uM	B	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	=	Inhibition	%	99.0	CHEMBL267	Homo sapiens	INH	%	99.0
	2655726	CHEMBL1029458	Inhibition of Src	B	CC(C)C[C@H](NC(=O)OC(C)(C)C)C(=O)Oc1c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c2c1=O		CHEMBL551352	=	IC50	nM	4200.0	CHEMBL267	Homo sapiens	IC50	uM	4.2
	2655727	CHEMBL1029458	Inhibition of Src	B	C[C@H](NC(=O)OC(C)(C)C)C(=O)Oc1c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c2c1=O		CHEMBL551890	=	IC50	nM	6500.0	CHEMBL267	Homo sapiens	IC50	uM	6.5
	2655728	CHEMBL1029458	Inhibition of Src	B	CC(C)[C@H](NC(=O)OC(C)(C)C)C(=O)Oc1c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c2c1=O		CHEMBL561091	=	IC50	nM	7400.0	CHEMBL267	Homo sapiens	IC50	uM	7.4
	2655729	CHEMBL1029458	Inhibition of Src	B	CC(=O)N[C@@H](Cc1ccccc1)C(=O)Oc1c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c2c1=O		CHEMBL549397	=	IC50	nM	5900.0	CHEMBL267	Homo sapiens	IC50	uM	5.9
	2655730	CHEMBL1029458	Inhibition of Src	B	CC(C)(C)OC(=O)NCC(=O)Oc1c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c2c1=O		CHEMBL564008	=	IC50	nM	3300.0	CHEMBL267	Homo sapiens	IC50	uM	3.3
	2655731	CHEMBL1029458	Inhibition of Src	B	C[C@@H](O)[C@H](NC(=O)OC(C)(C)C)C(=O)Oc1c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c2c1=O		CHEMBL549808	=	IC50	nM	3500.0	CHEMBL267	Homo sapiens	IC50	uM	3.5
	2655732	CHEMBL1029458	Inhibition of Src	B	C[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C(=O)Oc1c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c2c1=O		CHEMBL563238	=	IC50	nM	4900.0	CHEMBL267	Homo sapiens	IC50	uM	4.9
	2655733	CHEMBL1029458	Inhibition of Src	B	CC(C)(C)OC(=O)N[C@@H](CC(N)=O)C(=O)Oc1c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c2c1=O		CHEMBL539739	=	IC50	nM	9900.0	CHEMBL267	Homo sapiens	IC50	uM	9.9
	2655734	CHEMBL1029458	Inhibition of Src	B	O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12		CHEMBL50	=	IC50	nM	15000.0	CHEMBL267	Homo sapiens	IC50	uM	15.0
	2656975	CHEMBL1024395	Inhibition of c-SRC SH2 domain	B	O=C(/C=C/c1ccc(O)c(O)c1)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O		CHEMBL324842	=	IC50	nM	26000.0	CHEMBL267	Homo sapiens	IC50(app)	uM	26.0
	2656976	CHEMBL1024395	Inhibition of c-SRC SH2 domain	B	O=C(/C=C/c1ccc(O)c(O)c1/C=C/c1ccc(O)c(O)c1)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O		CHEMBL457077	=	IC50	nM	36200.0	CHEMBL267	Homo sapiens	IC50(app)	uM	36.2
	2656977	CHEMBL1024395	Inhibition of c-SRC SH2 domain	B	O=C(/C=C/c1cc(O)cc2c1[C@H](C(O)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O)[C@@H](c1ccc(O)c(O)c1)O2)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O		CHEMBL541265	=	IC50	nM	90000.0	CHEMBL267	Homo sapiens	IC50(app)	uM	90.0
	2656978	CHEMBL1024395	Inhibition of c-SRC SH2 domain	B	O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H](C(=O)O)[C@@H](O)C(=O)O		CHEMBL558557	=	IC50	nM	74000.0	CHEMBL267	Homo sapiens	IC50(app)	uM	74.0
	2656980	CHEMBL1024397	Inhibition of SRC SH2 domain at 200 uM	B	O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H](C(=O)O)[C@@H](OC(=O)/C=C/c1ccc(O)c(O)c1)C(=O)O		CHEMBL282731	=	Inhibition	%	12.0	CHEMBL267	Homo sapiens	INH	%	12.0
	2656982	CHEMBL1024397	Inhibition of SRC SH2 domain at 200 uM	B	O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H]1C[C@](O)(C(=O)O)C[C@@H](O)[C@H]1O		CHEMBL284616	=	Inhibition	%	3.0	CHEMBL267	Homo sapiens	INH	%	3.0
	2656984	CHEMBL1024397	Inhibition of SRC SH2 domain at 200 uM	B	O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H]1C[C@@](OC(=O)/C=C/c2ccc(O)c(O)c2)(C(=O)O)C[C@@H](O)[C@@H]1O		CHEMBL487258	=	Inhibition	%	7.0	CHEMBL267	Homo sapiens	INH	%	7.0
	2657007	CHEMBL1024393	Ratio of IC50 for drug to IC50 for rosmarinic acid against SH2 domain of SRC	B	O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H](C(=O)O)[C@@H](O)C(=O)O		CHEMBL558557	=	FC		2.0	CHEMBL267	Homo sapiens	FC		2.0
Not Active	2658011	CHEMBL1031282	Inhibition of recombinant pp60c-Src autophosphorylation at 25 uM by Western blotting	B	CC(CCc1ccccn1)(CCc1ccccn1)C(=O)c1ccccc1		CHEMBL563485		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	2658012	CHEMBL1031282	Inhibition of recombinant pp60c-Src autophosphorylation at 25 uM by Western blotting	B	CC/C(=C(/CC)c1ccc(O)c(CN(CC)CC)c1)c1ccc(O)c(CN(CC)CC)c1		CHEMBL559626		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Active	2658013	CHEMBL1031282	Inhibition of recombinant pp60c-Src autophosphorylation at 25 uM by Western blotting	B	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	2658027	CHEMBL1031279	Inhibition of recombinant pp60c-Src at 25 uM by Western blotting	B	CC/C(=C(/CC)c1ccc(O)c(CN(CC)CC)c1)c1ccc(O)c(CN(CC)CC)c1		CHEMBL559626		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	2658147	CHEMBL1031297	Inhibition of Src	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Ki	nM	81.0	CHEMBL267	Homo sapiens	Ki	nM	81.0
	2658148	CHEMBL1031297	Inhibition of Src	B	Cc1cc(Nc2nc(Nc3ccccc3)nc3ccccc23)n[nH]1		CHEMBL552038	=	Ki	nM	393.0	CHEMBL267	Homo sapiens	Ki	nM	393.0
	2658149	CHEMBL1031297	Inhibition of Src	B	Cc1cc(Nc2nc(N(C)c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL550825	=	Ki	nM	1059.0	CHEMBL267	Homo sapiens	Ki	nM	1059.0
	2658150	CHEMBL1031297	Inhibition of Src	B	Cc1cc(Nc2nc(Oc3ccccc3)nc3ccccc23)n[nH]1		CHEMBL565205	=	Ki	nM	1288.0	CHEMBL267	Homo sapiens	Ki	nM	1288.0
	2658151	CHEMBL1031297	Inhibition of Src	B	Cc1cc(Nc2nc(Sc3ccccc3)nc3ccccc23)n[nH]1		CHEMBL549322	=	Ki	nM	800.0	CHEMBL267	Homo sapiens	Ki	nM	800.0
	2658152	CHEMBL1031297	Inhibition of Src	B	Cc1cc(Nc2nc(Sc3ccc(Cl)cc3)nc3ccccc23)n[nH]1		CHEMBL562157	=	Ki	nM	201.0	CHEMBL267	Homo sapiens	Ki	nM	201.0
	2658153	CHEMBL1031297	Inhibition of Src	B	Cc1cc(Nc2nc(Sc3ccc(Cl)c(Cl)c3)nc3ccccc23)n[nH]1		CHEMBL552385	>	Ki	nM	38.0	CHEMBL267	Homo sapiens	Ki	nM	38.0
	2658154	CHEMBL1031297	Inhibition of Src	B	COc1ccccc1Sc1nc(Nc2cc(C)[nH]n2)c2ccccc2n1		CHEMBL551634	>	Ki	nM	1000.0	CHEMBL267	Homo sapiens	Ki	nM	1000.0
	2658155	CHEMBL1031297	Inhibition of Src	B	COc1ccc(Sc2nc(Nc3cc(C)[nH]n3)c3ccccc3n2)cc1OC		CHEMBL564290	=	Ki	nM	2180.0	CHEMBL267	Homo sapiens	Ki	nM	2180.0
	2658156	CHEMBL1031297	Inhibition of Src	B	Cc1cc(Nc2nc(Sc3ccc4ccccc4c3)nc3ccccc23)n[nH]1		CHEMBL559900	>	Ki	nM	500.0	CHEMBL267	Homo sapiens	Ki	nM	500.0
	2658157	CHEMBL1031297	Inhibition of Src	B	Cc1cc(Nc2nc(Sc3ccc(NS(C)(=O)=O)cc3)nc3ccccc23)n[nH]1		CHEMBL552033	=	Ki	nM	681.0	CHEMBL267	Homo sapiens	Ki	nM	681.0
	2658158	CHEMBL1031297	Inhibition of Src	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)OC(C)(C)C)cc3)nc3ccccc23)n[nH]1		CHEMBL556460	>	Ki	nM	3000.0	CHEMBL267	Homo sapiens	Ki	nM	3000.0
	2658159	CHEMBL1031297	Inhibition of Src	B	CC(=O)Nc1ccc(Sc2nc(Nc3cc(C)n[nH]3)c3ccccc3n2)cc1		CHEMBL484950	=	Ki	nM	1258.0	CHEMBL267	Homo sapiens	Ki	nM	1258.0
	2658160	CHEMBL1031297	Inhibition of Src	B	CC(=O)N(C)c1ccc(Sc2nc(Nc3cc(C)[nH]n3)c3ccccc3n2)cc1		CHEMBL549668	=	Ki	nM	796.0	CHEMBL267	Homo sapiens	Ki	nM	796.0
	2658161	CHEMBL1031297	Inhibition of Src	B	CCC(=O)Nc1ccc(Sc2nc(Nc3cc(C)[nH]n3)c3ccccc3n2)cc1		CHEMBL564941	=	Ki	nM	720.0	CHEMBL267	Homo sapiens	Ki	nM	720.0
	2658162	CHEMBL1031297	Inhibition of Src	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)C4CC4)cc3)nc3ccccc23)n[nH]1		CHEMBL564449	=	Ki	nM	461.0	CHEMBL267	Homo sapiens	Ki	nM	461.0
	2658163	CHEMBL1031297	Inhibition of Src	B	CC(=O)Nc1ccc(Sc2nc(Nc3cc[nH]n3)c3ccccc3n2)cc1		CHEMBL560158	=	Ki	nM	277.0	CHEMBL267	Homo sapiens	Ki	nM	277.0
	2658164	CHEMBL1031297	Inhibition of Src	B	CC(=O)Nc1ccc(Sc2nc(Nc3cc(C4CC4)[nH]n3)c3ccccc3n2)cc1		CHEMBL561421	=	Ki	nM	1735.0	CHEMBL267	Homo sapiens	Ki	nM	1735.0
	2661599	CHEMBL1061350	Inhibition of SRC after 1 hr by mobility shift electrophoresis assay	B	COC(=O)Nc1ccc(-c2nc(N3CCOCC3)c3cnn(C4CCN(C(=O)OC)CC4)c3n2)cc1		CHEMBL561708	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	2671888	CHEMBL1026231	Inhibition of recombinant SRC	B	COc1cc(O)c2c(c1)C(=O)c1cc(C)c(O)cc1C2=O		CHEMBL463054	>	IC50	ug.mL-1	10.0	CHEMBL267	Homo sapiens	IC50	ug ml-1	10.0
	2672289	CHEMBL1026231	Inhibition of recombinant SRC	B	COc1cc(O)c2c(c1)C(=O)C1=C(C2=O)[C@H](O)[C@@H](O)[C@@](C)(O)[C@@H]1O		CHEMBL512054	=	IC50	ug.mL-1	2.4	CHEMBL267	Homo sapiens	IC50	ug ml-1	2.4
	2672295	CHEMBL1026231	Inhibition of recombinant SRC	B	COc1cc(O)c2c(c1)C(=O)c1cc(C)c(O)c(O)c1C2=O		CHEMBL556684	=	IC50	ug.mL-1	1.8	CHEMBL267	Homo sapiens	IC50	ug ml-1	1.8
	2672297	CHEMBL1026231	Inhibition of recombinant SRC	B	COc1cc2c(c(O)c1-c1c(OC)cc(O)c3c1C(=O)C1=C(C3=O)[C@H](O)[C@@H](O)[C@@](C)(O)[C@@H]1O)C(=O)c1cc(O)c(C)cc1C2=O		CHEMBL554993	=	IC50	ug.mL-1	1.7	CHEMBL267	Homo sapiens	IC50	ug ml-1	1.7
	2676438	CHEMBL1035542	Inhibition of SRC	B	CCOC(=O)c1cnn2c(-c3cccc(NC(=O)c4cccc(C(F)(F)F)c4)c3)ccnc12		CHEMBL565061	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	2704626	CHEMBL1054861	Inhibition of c-Src at 10 uM by HotSpot assay relative to control	B	Cc1cc(O)cc(-c2nn(CC#N)cc2-c2cc(NC[C@H](C)O)nc(-c3cccnc3)n2)c1		CHEMBL560733	=	Inhibition	%	16.18	CHEMBL267	Homo sapiens	INH	%	16.18
	2719530	CHEMBL1059980	Inhibition of Tel fused Src expressed in mouse BA/F3 cells	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(NC(=O)c4cncc(-c5cccs5)c4)c3)cc2C(F)(F)F)CC1		CHEMBL556140	<	EC50	nM	500.0	CHEMBL267	Homo sapiens	EC50	nM	500.0
	2721583	CHEMBL1060991	Inhibition of cSRC at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	<	Inhibition	%	50.0	CHEMBL267	Homo sapiens	INH	%	50.0
	2722275	CHEMBL1063592	Inhibition of Src	B	Cc1ccc2c(c1)N(Cc1cc(F)cc3c1OCOC3)C(=O)/C2=N\O		CHEMBL551140	>	Ki	nM	30000.0	CHEMBL267	Homo sapiens	Ki	uM	30.0
	2726472	CHEMBL1056606	Inhibition of human recombinant Src	B	CSc1nc(NCc2ccccc2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL288280	=	Ki	nM	3700.0	CHEMBL267	Homo sapiens	Ki	uM	3.7
	2726474	CHEMBL1056606	Inhibition of human recombinant Src	B	CSc1nc(Nc2ccccc2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL401238	=	Ki	nM	1200.0	CHEMBL267	Homo sapiens	Ki	uM	1.2
	2726475	CHEMBL1056606	Inhibition of human recombinant Src	B	CSc1nc(NCc2cccc(F)c2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL241539	=	Ki	nM	5200.0	CHEMBL267	Homo sapiens	Ki	uM	5.2
	2726476	CHEMBL1056606	Inhibition of human recombinant Src	B	CSc1nc(NCCc2ccccc2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL289125	=	Ki	nM	700.0	CHEMBL267	Homo sapiens	Ki	uM	0.7
	2726477	CHEMBL1056606	Inhibition of human recombinant Src	B	CSc1nc(NCc2ccccc2F)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL391724	=	Ki	nM	21000.0	CHEMBL267	Homo sapiens	Ki	uM	21.0
	2726478	CHEMBL1056606	Inhibition of human recombinant Src	B	CSc1nc(NCc2ccccc2)c2cnn(CC(Cl)c3ccc(F)cc3)c2n1		CHEMBL241750	=	Ki	nM	35000.0	CHEMBL267	Homo sapiens	Ki	uM	35.0
	2726479	CHEMBL1056606	Inhibition of human recombinant Src	B	CSc1nc(NCc2ccc(F)cc2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL241540	=	Ki	nM	4600.0	CHEMBL267	Homo sapiens	Ki	uM	4.6
	2726480	CHEMBL1056606	Inhibition of human recombinant Src	B	COc1ccc(CNc2nc(SC)nc3c2cnn3CC(Cl)c2ccccc2)cc1		CHEMBL551542	=	Ki	nM	4000.0	CHEMBL267	Homo sapiens	Ki	uM	4.0
	2726481	CHEMBL1056606	Inhibition of human recombinant Src	B	CSc1nc(NCc2ccccc2Cl)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL236375	=	Ki	nM	3100.0	CHEMBL267	Homo sapiens	Ki	uM	3.1
	2726482	CHEMBL1056606	Inhibition of human recombinant Src	B	CSc1nc(NCc2ccccc2)c2cnn(CC(Cl)c3ccc(Cl)cc3)c2n1		CHEMBL241749	=	Ki	nM	3000.0	CHEMBL267	Homo sapiens	Ki	uM	3.0
	2726483	CHEMBL1056606	Inhibition of human recombinant Src	B	CCSc1nc(NCCc2ccccc2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL392301	=	Ki	nM	7500.0	CHEMBL267	Homo sapiens	Ki	uM	7.5
	2726484	CHEMBL1056606	Inhibition of human recombinant Src	B	CSc1nc(NCCc2cccc(F)c2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL235756	=	Ki	nM	13000.0	CHEMBL267	Homo sapiens	Ki	uM	13.0
	2726485	CHEMBL1056606	Inhibition of human recombinant Src	B	CSc1nc(NCCc2ccccc2Cl)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL235757	=	Ki	nM	4000.0	CHEMBL267	Homo sapiens	Ki	uM	4.0
	2726486	CHEMBL1056606	Inhibition of human recombinant Src	B	CSc1nc(NCCc2ccccc2)c2cnn(CC(Cl)c3ccc(Cl)cc3)c2n1		CHEMBL238304	=	Ki	nM	2800.0	CHEMBL267	Homo sapiens	Ki	uM	2.8
	2726487	CHEMBL1056606	Inhibition of human recombinant Src	B	CSc1nc(Nc2cccc(Cl)c2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL400211	=	Ki	nM	600.0	CHEMBL267	Homo sapiens	Ki	uM	0.6
	2726488	CHEMBL1056606	Inhibition of human recombinant Src	B	CSc1nc(NCCc2ccc(C)cc2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL415264	=	Ki	nM	15000.0	CHEMBL267	Homo sapiens	Ki	uM	15.0
	2726489	CHEMBL1056606	Inhibition of human recombinant Src	B	CSc1nc(NCCc2ccc(Cl)cc2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL564746	=	Ki	nM	25000.0	CHEMBL267	Homo sapiens	Ki	uM	25.0
	2726490	CHEMBL1056606	Inhibition of human recombinant Src	B	CSc1nc(Nc2cccc(Br)c2)c2cnn(CC(Cl)c3ccc(F)cc3)c2n1		CHEMBL399627	=	Ki	nM	4100.0	CHEMBL267	Homo sapiens	Ki	uM	4.1
	2726491	CHEMBL1056606	Inhibition of human recombinant Src	B	CSc1nc(NCCc2cccc(Cl)c2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL235758	=	Ki	nM	6000.0	CHEMBL267	Homo sapiens	Ki	uM	6.0
	2726492	CHEMBL1056606	Inhibition of human recombinant Src	B	CSc1nc(Nc2cccc(Br)c2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL238561	=	Ki	nM	1800.0	CHEMBL267	Homo sapiens	Ki	uM	1.8
	2726493	CHEMBL1056606	Inhibition of human recombinant Src	B	CCSc1nc(Nc2cccc(Cl)c2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL428029	=	Ki	nM	500.0	CHEMBL267	Homo sapiens	Ki	uM	0.5
	2726494	CHEMBL1056606	Inhibition of human recombinant Src	B	CCCSc1nc(Nc2cccc(Cl)c2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL401447	=	Ki	nM	1200.0	CHEMBL267	Homo sapiens	Ki	uM	1.2
	2896150	CHEMBL1061114	Inhibition of c-Src 	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3cccc(CO)c3)nc21		CHEMBL327127	=	IC50	nM	5.68	CHEMBL267	Homo sapiens	IC50	M	5.68E-9
	2896151	CHEMBL1061114	Inhibition of c-Src 	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3ccc(N4CCOCC4)cc3)nc21		CHEMBL106772	=	IC50	nM	8.35	CHEMBL267	Homo sapiens	IC50	M	8.35E-9
	2896152	CHEMBL1061114	Inhibition of c-Src 	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	=	IC50	nM	24.5	CHEMBL267	Homo sapiens	IC50	M	2.45E-8
	2896153	CHEMBL1061114	Inhibition of c-Src 	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3ccc(F)cc3)nc21		CHEMBL574059	=	IC50	nM	66.3	CHEMBL267	Homo sapiens	IC50	M	6.63E-8
	2896154	CHEMBL1061114	Inhibition of c-Src 	B	CCOc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1		CHEMBL578006	=	IC50	nM	16.3	CHEMBL267	Homo sapiens	IC50	M	1.63E-8
	2896155	CHEMBL1061114	Inhibition of c-Src 	B	CCN(CCOc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1)C(C)=O		CHEMBL573820	=	IC50	nM	9.03	CHEMBL267	Homo sapiens	IC50	M	9.03E-9
	2896156	CHEMBL1061114	Inhibition of c-Src 	B	Cc1cc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)ccc1F		CHEMBL574058	=	IC50	nM	16.8	CHEMBL267	Homo sapiens	IC50	M	1.68E-8
	2897246	CHEMBL1063696	Percent residual c-Src activity in the presence of 10uM inhibitor	B	O=C(O)Cc1c2ccccc2n2c1[nH]c(=O)c1ccccc12		CHEMBL92361	=	Activity	%	80.0	CHEMBL267	Homo sapiens	Activity	%	80.0
	2903985	CHEMBL1061927	Binding constant for SRC kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL267	Homo sapiens	Kd	uM	10.0
	2903986	CHEMBL1061927	Binding constant for SRC kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL267	Homo sapiens	Kd	uM	10.0
	2903987	CHEMBL1061927	Binding constant for SRC kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	340.0	CHEMBL267	Homo sapiens	Kd	nM	340.0
	2903988	CHEMBL1061927	Binding constant for SRC kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL267	Homo sapiens	Kd	uM	10.0
	2903989	CHEMBL1061927	Binding constant for SRC kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL267	Homo sapiens	Kd	uM	10.0
	2903990	CHEMBL1061927	Binding constant for SRC kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL267	Homo sapiens	Kd	uM	10.0
	2903991	CHEMBL1061927	Binding constant for SRC kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	1800.0	CHEMBL267	Homo sapiens	Kd	nM	1800.0
	2903992	CHEMBL1061927	Binding constant for SRC kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	=	Kd	nM	1100.0	CHEMBL267	Homo sapiens	Kd	nM	1100.0
	2903993	CHEMBL1061927	Binding constant for SRC kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	1100.0	CHEMBL267	Homo sapiens	Kd	nM	1100.0
	2903994	CHEMBL1061927	Binding constant for SRC kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL267	Homo sapiens	Kd	uM	10.0
	2903995	CHEMBL1061927	Binding constant for SRC kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL267	Homo sapiens	Kd	uM	10.0
	2903996	CHEMBL1061927	Binding constant for SRC kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	0.21	CHEMBL267	Homo sapiens	Kd	nM	0.21
	2903997	CHEMBL1061927	Binding constant for SRC kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	=	Kd	nM	280.0	CHEMBL267	Homo sapiens	Kd	nM	280.0
	2903998	CHEMBL1061927	Binding constant for SRC kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	700.0	CHEMBL267	Homo sapiens	Kd	nM	700.0
	2903999	CHEMBL1061927	Binding constant for SRC kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL267	Homo sapiens	Kd	uM	10.0
	2904000	CHEMBL1061927	Binding constant for SRC kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Kd	nM	3800.0	CHEMBL267	Homo sapiens	Kd	nM	3800.0
	2904001	CHEMBL1061927	Binding constant for SRC kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL267	Homo sapiens	Kd	uM	10.0
	2904002	CHEMBL1061927	Binding constant for SRC kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	2800.0	CHEMBL267	Homo sapiens	Kd	nM	2800.0
	2904003	CHEMBL1061927	Binding constant for SRC kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL267	Homo sapiens	Kd	uM	10.0
	2904004	CHEMBL1061927	Binding constant for SRC kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	>	Kd	nM	10000.0	CHEMBL267	Homo sapiens	Kd	uM	10.0
	2904005	CHEMBL1061927	Binding constant for SRC kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL267	Homo sapiens	Kd	uM	10.0
	2904006	CHEMBL1061927	Binding constant for SRC kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL267	Homo sapiens	Kd	uM	10.0
	2904007	CHEMBL1061927	Binding constant for SRC kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL267	Homo sapiens	Kd	uM	10.0
	2904008	CHEMBL1061927	Binding constant for SRC kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Kd	nM	800.0	CHEMBL267	Homo sapiens	Kd	nM	800.0
	2904009	CHEMBL1061927	Binding constant for SRC kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL267	Homo sapiens	Kd	uM	10.0
	2904010	CHEMBL1061927	Binding constant for SRC kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	1200.0	CHEMBL267	Homo sapiens	Kd	nM	1200.0
	2904011	CHEMBL1061927	Binding constant for SRC kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL267	Homo sapiens	Kd	uM	10.0
	2904012	CHEMBL1061927	Binding constant for SRC kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL267	Homo sapiens	Kd	uM	10.0
	2904013	CHEMBL1061927	Binding constant for SRC kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL267	Homo sapiens	Kd	uM	10.0
	2904014	CHEMBL1061927	Binding constant for SRC kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Kd	nM	5300.0	CHEMBL267	Homo sapiens	Kd	nM	5300.0
	2904015	CHEMBL1061927	Binding constant for SRC kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL267	Homo sapiens	Kd	uM	10.0
	2904016	CHEMBL1061927	Binding constant for SRC kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL267	Homo sapiens	Kd	uM	10.0
	2904017	CHEMBL1061927	Binding constant for SRC kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	86.0	CHEMBL267	Homo sapiens	Kd	nM	86.0
	2904018	CHEMBL1061927	Binding constant for SRC kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	4900.0	CHEMBL267	Homo sapiens	Kd	nM	4900.0
	2904019	CHEMBL1061927	Binding constant for SRC kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	2100.0	CHEMBL267	Homo sapiens	Kd	nM	2100.0
	2904020	CHEMBL1061927	Binding constant for SRC kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	170.0	CHEMBL267	Homo sapiens	Kd	nM	170.0
	2904021	CHEMBL1061927	Binding constant for SRC kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	=	Kd	nM	5500.0	CHEMBL267	Homo sapiens	Kd	nM	5500.0
	2904022	CHEMBL1061927	Binding constant for SRC kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	70.0	CHEMBL267	Homo sapiens	Kd	nM	70.0
	2922001	CHEMBL1052969	Inhibition of SRC assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	73.0	CHEMBL267	Homo sapiens	Activity	%	73.0
	2924066	CHEMBL1041543	Inhibition of Src by [gamma-33-P]ATP based assay	B	Cc1ccc(-c2ccc3occ(-c4ccc([S@+](C)[O-])cc4)c3c2)o1		CHEMBL574588	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	2924067	CHEMBL1041543	Inhibition of Src by [gamma-33-P]ATP based assay	B	CC[S@+]([O-])c1ccc(-c2coc3ccc(-c4ccc(C)o4)cc23)cc1		CHEMBL574613	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	2926247	CHEMBL1056920	Inhibition of Src assessed as remaining enzyme activity at 3 uM relative to DMSO	B	COc1ccccc1-n1c(-c2ccccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL574236	=	Activity	%	12.0	CHEMBL267	Homo sapiens	Activity	%	12.0
	2926643	CHEMBL1051388	Inhibition of Src assessed as residual enzyme activity at 10 uM relative to untreated control	B	c1ccc2c(c1)[nH]c1c3cc[nH]c3ccc21		CHEMBL567173	=	Activity	%	102.0	CHEMBL267	Homo sapiens	Activity	%	102.0
	2926644	CHEMBL1051388	Inhibition of Src assessed as residual enzyme activity at 10 uM relative to untreated control	B	c1ccc2c(c1)[nH]c1c2ccc2cc[nH]c21		CHEMBL584980	=	Activity	%	98.0	CHEMBL267	Homo sapiens	Activity	%	98.0
	2926645	CHEMBL1051388	Inhibition of Src assessed as residual enzyme activity at 10 uM relative to untreated control	B	O=Cc1c[nH]c2ccc3c4ccccc4[nH]c3c12		CHEMBL575754	=	Activity	%	99.0	CHEMBL267	Homo sapiens	Activity	%	99.0
	2926646	CHEMBL1051388	Inhibition of Src assessed as residual enzyme activity at 10 uM relative to untreated control	B	O=Cc1c[nH]c2c1ccc1c3ccccc3[nH]c12		CHEMBL583972	=	Activity	%	85.0	CHEMBL267	Homo sapiens	Activity	%	85.0
	2928433	CHEMBL1055344	Inhibition of Src assessed as remaining enzyme activity at 1 uM relative to DMSO	B	COc1ccccc1-n1c(-c2cc(O)ccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL566515	=	Activity	%	9.0	CHEMBL267	Homo sapiens	Activity	%	9.0
	2938417	CHEMBL1038674	Inhibition of SRC	B	Cc1cnc(Nc2ccc(F)cc2Cl)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2cccc(Cl)c2)c1		CHEMBL583042	>	Ki	nM	4000.0	CHEMBL267	Homo sapiens	Ki	uM	4.0
Not Active	2938610	CHEMBL1040623	Inhibition of SRC at 10 uM	B	O=C1OC(/C=C/c2ccccc2)=N/C1=C\c1cccnc1		CHEMBL565286		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	2943278	CHEMBL1060320	Inhibition of SRC by HTRF assay	B	O=c1[nH]c(CN2CC[C@H](O)C2)nc2c1sc1ccc(-c3ccc(O)cc3)cc12		CHEMBL583187	>	Ki	nM	1000.0	CHEMBL267	Homo sapiens	Ki	microM	1.0
	2943279	CHEMBL1060320	Inhibition of SRC by HTRF assay	B	O=c1[nH]cnc2c1sc1c(Cl)ccc(Cl)c12		CHEMBL583144	>	Ki	nM	1000.0	CHEMBL267	Homo sapiens	Ki	microM	1.0
	2943673	CHEMBL1044076	Inhibition of Src	B	C=CC(=O)N1CCC[C@H]1C(=O)Nc1cc2c(Nc3cccc(Cl)c3F)ncnc2cc1OCCOC		CHEMBL571040	=	IC50	nM	800.0	CHEMBL267	Homo sapiens	IC50	microM	0.8
	2943689	CHEMBL1044076	Inhibition of Src	B	C=CC(=O)N1CCC[C@H]1C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3F)ncnc2cc1OCCOC		CHEMBL569880	<	IC50	nM	100.0	CHEMBL267	Homo sapiens	IC50	microM	0.1
	2946934	CHEMBL1054420	Inhibition of cSRC at 2 uM	B	c1ccc2c(c1)CC(Nc1nc(Nc3ccncc3)nc(N3CCNCC3)n1)C2		CHEMBL575741	<	Inhibition	%	50.0	CHEMBL267	Homo sapiens	INH	%	50.0
	2947585	CHEMBL1047353	Inhibition of c-SRC at 100 uM	B	COc1cc2nccc(Oc3ccc(NC(=O)N4CCN(c5ccccc5)C4=O)cc3F)c2cc1OC		CHEMBL573761	=	Inhibition	%	7.0	CHEMBL267	Homo sapiens	INH	%	7.0
	2983203	CHEMBL1046248	Inhibition of src kinase	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	IC50	nM	20000.0	CHEMBL267	Homo sapiens	IC50	uM	20.0
	2983207	CHEMBL1046248	Inhibition of src kinase	B	CC1(C)CC(NC(=O)c2cccc(-c3cc4nccc(Nc5cccc(O)c5)n4n3)c2)CC(C)(C)N1[O]		CHEMBL1163016	=	IC50	nM	5.0	CHEMBL267	Homo sapiens	IC50	uM	0.005
Active	2983225	CHEMBL1047038	Inhibition of AMP-PNP binding to ATP binding site of human SRC by saturation transfer difference spectra	B	CC1(C)CC(NC(=O)c2cccc(-c3cc4nccc(Nc5cccc(O)c5)n4n3)c2)CC(C)(C)N1[O]		CHEMBL1163016		Activity			CHEMBL267	Homo sapiens	Activity		
	2983230	CHEMBL1047040	Inhibition of src kinase by cell based functional assay	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	=	IC50	nM	40000.0	CHEMBL267	Homo sapiens	IC50	uM	40.0
Not Active	2983232	CHEMBL1047038	Inhibition of AMP-PNP binding to ATP binding site of human SRC by saturation transfer difference spectra	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546		Activity			CHEMBL267	Homo sapiens	Activity		
Not Active	2983233	CHEMBL1047041	Inhibition of staurosporine binding to ATP binding site of human SRC by saturation transfer difference spectra	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546		Activity			CHEMBL267	Homo sapiens	Activity		
Not Active	2983236	CHEMBL1047041	Inhibition of staurosporine binding to ATP binding site of human SRC by saturation transfer difference spectra	B	O=C(O)c1ccccc1Nc1ccccc1		CHEMBL23832		Activity			CHEMBL267	Homo sapiens	Activity		
Not Active	2985703	CHEMBL1037168	Inhibition of c-Src at 10 uM	B	COc1ccc(/C=C/C(=O)c2cc(OC)c(OC)c(OC)c2)cc1O		CHEMBL9941		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	2988661	CHEMBL1050612	Inhibition of human recombinant Src	B	CN1CCN(C(=O)c2ccc(Nc3ncc4cc(-c5c(Cl)cccc5Cl)c(=O)n(C)c4n3)cc2)CC1		CHEMBL565366	=	IC50	nM	35.0	CHEMBL267	Homo sapiens	IC50	nM	35.0
	2988662	CHEMBL1050612	Inhibition of human recombinant Src	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3ccc(NC(=O)CCNC(=O)OC(C)(C)C)cc3)nc21		CHEMBL565609	=	IC50	nM	213.0	CHEMBL267	Homo sapiens	IC50	nM	213.0
	2988663	CHEMBL1050612	Inhibition of human recombinant Src	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3ccc(NCC(O)CO)cc3)nc21		CHEMBL567068	=	IC50	nM	38.0	CHEMBL267	Homo sapiens	IC50	nM	38.0
	2988664	CHEMBL1050612	Inhibition of human recombinant Src	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3ccc(NC(=O)CCN)cc3)nc21		CHEMBL566635	=	IC50	nM	18.0	CHEMBL267	Homo sapiens	IC50	nM	18.0
	2988665	CHEMBL1050612	Inhibition of human recombinant Src	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3cccc(O)c3)nc21		CHEMBL321193	=	IC50	nM	43.0	CHEMBL267	Homo sapiens	IC50	nM	43.0
	2988666	CHEMBL1050612	Inhibition of human recombinant Src	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3cccc(CO)c3)nc21		CHEMBL327127	=	IC50	nM	43.0	CHEMBL267	Homo sapiens	IC50	nM	43.0
	2988667	CHEMBL1050612	Inhibition of human recombinant Src	B	CCc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL565372	=	IC50	nM	234.0	CHEMBL267	Homo sapiens	IC50	nM	234.0
	2988668	CHEMBL1050612	Inhibition of human recombinant Src	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3cccc(COCC(O)CO)c3)nc21		CHEMBL566834	=	IC50	nM	66.0	CHEMBL267	Homo sapiens	IC50	nM	66.0
	2988669	CHEMBL1050612	Inhibition of human recombinant Src	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3cccc(N)c3)nc21		CHEMBL577269	=	IC50	nM	38.0	CHEMBL267	Homo sapiens	IC50	nM	38.0
	2988670	CHEMBL1050612	Inhibition of human recombinant Src	B	CC(=O)Nc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL565801	=	IC50	nM	150.0	CHEMBL267	Homo sapiens	IC50	nM	150.0
	2988671	CHEMBL1050612	Inhibition of human recombinant Src	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3ccc(O)cc3)nc21		CHEMBL323405	=	IC50	nM	223.0	CHEMBL267	Homo sapiens	IC50	nM	223.0
	2988672	CHEMBL1050612	Inhibition of human recombinant Src	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3ccc(I)cc3)nc21		CHEMBL570175	=	IC50	nM	341.0	CHEMBL267	Homo sapiens	IC50	nM	341.0
	2988673	CHEMBL1050612	Inhibition of human recombinant Src	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3ccc(OC4OC(CO)C(O)C(O)C4O)cc3)nc21		CHEMBL585666	=	IC50	nM	30.0	CHEMBL267	Homo sapiens	IC50	nM	30.0
	2988674	CHEMBL1050612	Inhibition of human recombinant Src	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3ccc(F)cc3)nc21		CHEMBL574059	=	IC50	nM	921.0	CHEMBL267	Homo sapiens	IC50	nM	921.0
	2988675	CHEMBL1050612	Inhibition of human recombinant Src	B	Cc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1		CHEMBL111339	=	IC50	nM	492.0	CHEMBL267	Homo sapiens	IC50	nM	492.0
	2988676	CHEMBL1050612	Inhibition of human recombinant Src	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3ccc(CCO)cc3)nc21		CHEMBL576218	=	IC50	nM	9.2	CHEMBL267	Homo sapiens	IC50	nM	9.2
	2988677	CHEMBL1050612	Inhibition of human recombinant Src	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3ccc(N)cc3)nc21		CHEMBL566636	=	IC50	nM	36.0	CHEMBL267	Homo sapiens	IC50	nM	36.0
	2988678	CHEMBL1050612	Inhibition of human recombinant Src	B	CC(=O)Nc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1		CHEMBL566850	=	IC50	nM	43.0	CHEMBL267	Homo sapiens	IC50	nM	43.0
	2988679	CHEMBL1050612	Inhibition of human recombinant Src	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3ccc(NC(=O)CCl)cc3)nc21		CHEMBL565587	=	IC50	nM	433.0	CHEMBL267	Homo sapiens	IC50	nM	433.0
	2989959	CHEMBL1039186	Inhibition of c-SRC at 100 nM by radiometric protein kinase assay	B	CCn1cnc(-c2cc3nccc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccccc6)CC5)cc4F)c3s2)c1		CHEMBL565807	=	Inhibition	%	93.0	CHEMBL267	Homo sapiens	INH	%	93.0
	2992243	CHEMBL1044546	Inhibition of human SRC at 20 uM by FRET assay	B	C#Cn1c(C#CCCO)nc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL576620	=	Inhibition	%	27.0	CHEMBL267	Homo sapiens	INH	%	27.0
	2999045	CHEMBL1044621	Inhibition of Src assessed as residual activity at 10 uM by Cherenkov counting relative to control in presence of 50 uM ATP	B	CC(C)c1onc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL220227	=	Activity	%	72.0	CHEMBL267	Homo sapiens	Activity	%	72.0
	2999835	CHEMBL1044621	Inhibition of Src assessed as residual activity at 10 uM by Cherenkov counting relative to control in presence of 50 uM ATP	B	CC(C)c1noc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL375428	=	Activity	%	90.0	CHEMBL267	Homo sapiens	Activity	%	90.0
	2999906	CHEMBL1050748	Inhibition of Src assessed as residual activity at 0.1 uM by Cherenkov counting relative to control in presence of 50 uM ATP	B	COc1ccc(/C=C/C(=O)Nc2cc(-c3[nH]c(SC)nc3-c3ccc(F)cc3)ccn2)c(OC)c1		CHEMBL569114	=	Activity	%	49.0	CHEMBL267	Homo sapiens	Activity	%	49.0
	2999982	CHEMBL1050748	Inhibition of Src assessed as residual activity at 0.1 uM by Cherenkov counting relative to control in presence of 50 uM ATP	B	COc1ccc(/C=C/C(=O)Nc2cc(-c3[nH]c([S+](C)[O-])nc3-c3ccc(F)cc3)ccn2)c(OC)c1		CHEMBL572006	=	Activity	%	63.0	CHEMBL267	Homo sapiens	Activity	%	63.0
	3005706	CHEMBL1039166	Inhibition of Src	B	COc1cc(Nc2c(C#N)cnc3cc(-c4ncccc4CN4CCOCC4)ccc23)c(Cl)cc1Cl		CHEMBL569038	=	IC50	nM	950.0	CHEMBL267	Homo sapiens	IC50	nM	950.0
	3005707	CHEMBL1039167	Inhibition of human Src expressed in rat fibroblasts assessed as anchorage independent growth after 3 days	B	COc1cc(Nc2c(C#N)cnc3cc(-c4ncccc4CN4CCOCC4)ccc23)c(Cl)cc1Cl		CHEMBL569038	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	3005708	CHEMBL1039166	Inhibition of Src	B	COc1cc(Nc2c(C#N)cnc3cc(-c4cc(CN5CCOCC5)ccn4)ccc23)c(Cl)cc1Cl		CHEMBL565546	=	IC50	nM	26.0	CHEMBL267	Homo sapiens	IC50	nM	26.0
	3005709	CHEMBL1039167	Inhibition of human Src expressed in rat fibroblasts assessed as anchorage independent growth after 3 days	B	COc1cc(Nc2c(C#N)cnc3cc(-c4cc(CN5CCOCC5)ccn4)ccc23)c(Cl)cc1Cl		CHEMBL565546	=	IC50	nM	310.0	CHEMBL267	Homo sapiens	IC50	nM	310.0
	3005710	CHEMBL1039166	Inhibition of Src	B	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(CN5CCOCC5)cn4)ccc23)c(Cl)cc1Cl		CHEMBL584915	=	IC50	nM	2.9	CHEMBL267	Homo sapiens	IC50	nM	2.9
	3005711	CHEMBL1039167	Inhibition of human Src expressed in rat fibroblasts assessed as anchorage independent growth after 3 days	B	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(CN5CCOCC5)cn4)ccc23)c(Cl)cc1Cl		CHEMBL584915	=	IC50	nM	170.0	CHEMBL267	Homo sapiens	IC50	nM	170.0
	3005712	CHEMBL1039166	Inhibition of Src	B	COc1cc(Nc2c(C#N)cnc3cc(-c4cccc(CN5CCOCC5)n4)ccc23)c(Cl)cc1Cl		CHEMBL569256	=	IC50	nM	24.0	CHEMBL267	Homo sapiens	IC50	nM	24.0
	3005713	CHEMBL1039167	Inhibition of human Src expressed in rat fibroblasts assessed as anchorage independent growth after 3 days	B	COc1cc(Nc2c(C#N)cnc3cc(-c4cccc(CN5CCOCC5)n4)ccc23)c(Cl)cc1Cl		CHEMBL569256	=	IC50	nM	860.0	CHEMBL267	Homo sapiens	IC50	nM	860.0
	3005714	CHEMBL1039166	Inhibition of Src	B	COc1cc(Nc2c(C#N)cnc3cc(-c4cncc(CN5CCOCC5)c4)ccc23)c(Cl)cc1Cl		CHEMBL569064	=	IC50	nM	36.0	CHEMBL267	Homo sapiens	IC50	nM	36.0
	3005715	CHEMBL1039167	Inhibition of human Src expressed in rat fibroblasts assessed as anchorage independent growth after 3 days	B	COc1cc(Nc2c(C#N)cnc3cc(-c4cncc(CN5CCOCC5)c4)ccc23)c(Cl)cc1Cl		CHEMBL569064	=	IC50	nM	2800.0	CHEMBL267	Homo sapiens	IC50	nM	2800.0
	3005716	CHEMBL1039166	Inhibition of Src	B	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(CN5CCOCC5)nc4)ccc23)c(Cl)cc1Cl		CHEMBL569073	=	IC50	nM	7.0	CHEMBL267	Homo sapiens	IC50	nM	7.0
	3005717	CHEMBL1039167	Inhibition of human Src expressed in rat fibroblasts assessed as anchorage independent growth after 3 days	B	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(CN5CCOCC5)nc4)ccc23)c(Cl)cc1Cl		CHEMBL569073	=	IC50	nM	330.0	CHEMBL267	Homo sapiens	IC50	nM	330.0
	3005718	CHEMBL1039166	Inhibition of Src	B	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(CN5CCN(C)CC5)cn4)ccc23)c(Cl)cc1Cl		CHEMBL567875	=	IC50	nM	4.0	CHEMBL267	Homo sapiens	IC50	nM	4.0
	3005719	CHEMBL1039167	Inhibition of human Src expressed in rat fibroblasts assessed as anchorage independent growth after 3 days	B	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(CN5CCN(C)CC5)cn4)ccc23)c(Cl)cc1Cl		CHEMBL567875	=	IC50	nM	61.0	CHEMBL267	Homo sapiens	IC50	nM	61.0
	3005720	CHEMBL1039166	Inhibition of Src	B	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(CN5CCSCC5)cn4)ccc23)c(Cl)cc1Cl		CHEMBL567018	=	IC50	nM	5.1	CHEMBL267	Homo sapiens	IC50	nM	5.1
	3005721	CHEMBL1039167	Inhibition of human Src expressed in rat fibroblasts assessed as anchorage independent growth after 3 days	B	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(CN5CCSCC5)cn4)ccc23)c(Cl)cc1Cl		CHEMBL567018	=	IC50	nM	230.0	CHEMBL267	Homo sapiens	IC50	nM	230.0
	3005722	CHEMBL1039166	Inhibition of Src	B	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(CN5CC[S+]([O-])CC5)cn4)ccc23)c(Cl)cc1Cl		CHEMBL566577	=	IC50	nM	1.9	CHEMBL267	Homo sapiens	IC50	nM	1.9
	3005723	CHEMBL1039167	Inhibition of human Src expressed in rat fibroblasts assessed as anchorage independent growth after 3 days	B	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(CN5CC[S+]([O-])CC5)cn4)ccc23)c(Cl)cc1Cl		CHEMBL566577	=	IC50	nM	96.0	CHEMBL267	Homo sapiens	IC50	nM	96.0
	3005724	CHEMBL1039166	Inhibition of Src	B	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(CN5CCS(=O)(=O)CC5)cn4)ccc23)c(Cl)cc1Cl		CHEMBL585198	=	IC50	nM	1.8	CHEMBL267	Homo sapiens	IC50	nM	1.8
	3005725	CHEMBL1039167	Inhibition of human Src expressed in rat fibroblasts assessed as anchorage independent growth after 3 days	B	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(CN5CCS(=O)(=O)CC5)cn4)ccc23)c(Cl)cc1Cl		CHEMBL585198	=	IC50	nM	130.0	CHEMBL267	Homo sapiens	IC50	nM	130.0
	3005726	CHEMBL1039166	Inhibition of Src	B	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(CN(C)C)cn4)ccc23)c(Cl)cc1Cl		CHEMBL584054	=	IC50	nM	3.9	CHEMBL267	Homo sapiens	IC50	nM	3.9
	3005727	CHEMBL1039167	Inhibition of human Src expressed in rat fibroblasts assessed as anchorage independent growth after 3 days	B	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(CN(C)C)cn4)ccc23)c(Cl)cc1Cl		CHEMBL584054	=	IC50	nM	130.0	CHEMBL267	Homo sapiens	IC50	nM	130.0
	3005728	CHEMBL1039166	Inhibition of Src	B	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(CN5CCN(C)CC5)cn4)ccc23)cc(OC)c1OC		CHEMBL566174	=	IC50	nM	18.0	CHEMBL267	Homo sapiens	IC50	nM	18.0
	3005729	CHEMBL1039167	Inhibition of human Src expressed in rat fibroblasts assessed as anchorage independent growth after 3 days	B	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(CN5CCN(C)CC5)cn4)ccc23)cc(OC)c1OC		CHEMBL566174	=	IC50	nM	360.0	CHEMBL267	Homo sapiens	IC50	nM	360.0
	3005730	CHEMBL1039166	Inhibition of Src	B	CN1CCN(Cc2ccc(-c3ccc4c(Nc5ccc(Cl)cc5Cl)c(C#N)cnc4c3)nc2)CC1		CHEMBL567230	=	IC50	nM	12.0	CHEMBL267	Homo sapiens	IC50	nM	12.0
	3005731	CHEMBL1039167	Inhibition of human Src expressed in rat fibroblasts assessed as anchorage independent growth after 3 days	B	CN1CCN(Cc2ccc(-c3ccc4c(Nc5ccc(Cl)cc5Cl)c(C#N)cnc4c3)nc2)CC1		CHEMBL567230	=	IC50	nM	460.0	CHEMBL267	Homo sapiens	IC50	nM	460.0
	3005732	CHEMBL1039166	Inhibition of Src	B	COc1cc(Nc2c(C#N)cnc3ccc(-c4ccc(CN5CCN(C)CC5)cn4)cc23)c(Cl)cc1Cl		CHEMBL567678	=	IC50	nM	130.0	CHEMBL267	Homo sapiens	IC50	nM	130.0
	3005733	CHEMBL1039167	Inhibition of human Src expressed in rat fibroblasts assessed as anchorage independent growth after 3 days	B	COc1cc(Nc2c(C#N)cnc3ccc(-c4ccc(CN5CCN(C)CC5)cn4)cc23)c(Cl)cc1Cl		CHEMBL567678	=	IC50	nM	2900.0	CHEMBL267	Homo sapiens	IC50	nM	2900.0
	3005734	CHEMBL1039166	Inhibition of Src	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	IC50	nM	3.8	CHEMBL267	Homo sapiens	IC50	nM	3.8
	3005735	CHEMBL1039167	Inhibition of human Src expressed in rat fibroblasts assessed as anchorage independent growth after 3 days	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	IC50	nM	100.0	CHEMBL267	Homo sapiens	IC50	nM	100.0
	3052486	CHEMBL1072524	Residual activity of SRC at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	100.0	CHEMBL267	Homo sapiens	Residual activity	%	100.0
	3052738	CHEMBL1043817	Residual activity of SRC at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	89.0	CHEMBL267	Homo sapiens	Residual activity	%	89.0
	3054047	CHEMBL1071377	Residual activity of SRC at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	45.0	CHEMBL267	Homo sapiens	Residual activity	%	45.0
	3055334	CHEMBL1072524	Residual activity of SRC at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	100.0	CHEMBL267	Homo sapiens	Residual activity	%	100.0
	3055586	CHEMBL1043817	Residual activity of SRC at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	87.0	CHEMBL267	Homo sapiens	Residual activity	%	87.0
	3055719	CHEMBL1048681	Inhibition of Src at 10 uM	B	O=C(CCl)c1cscc1Cl		CHEMBL343821	=	Inhibition	%	24.0	CHEMBL267	Homo sapiens	INH	%	24.0
	3055720	CHEMBL1048681	Inhibition of Src at 10 uM	B	O=C(CCl)c1c(Br)sc(Cl)c1Cl		CHEMBL143273	=	Inhibition	%	26.0	CHEMBL267	Homo sapiens	INH	%	26.0
	3055721	CHEMBL1048681	Inhibition of Src at 10 uM	B	O=C(CCl)c1csc(C(=O)CCl)c1		CHEMBL141190	=	Inhibition	%	94.0	CHEMBL267	Homo sapiens	INH	%	94.0
	3055722	CHEMBL1048681	Inhibition of Src at 10 uM	B	Cc1sc(C(=O)CCl)cc1C(=O)CCl		CHEMBL143743	=	Inhibition	%	54.0	CHEMBL267	Homo sapiens	INH	%	54.0
	3055723	CHEMBL1048681	Inhibition of Src at 10 uM	B	Cc1c(CC(=O)Cl)csc1C(=O)CCl		CHEMBL611357	=	Inhibition	%	61.0	CHEMBL267	Homo sapiens	INH	%	61.0
	3055724	CHEMBL1048681	Inhibition of Src at 10 uM	B	O=C(CCl)c1ccc(Cl)s1		CHEMBL140045	<	Inhibition	%	10.0	CHEMBL267	Homo sapiens	INH	%	10.0
	3055725	CHEMBL1048681	Inhibition of Src at 10 uM	B	O=C(CCl)c1ccc(Br)s1		CHEMBL142764	=	Inhibition	%	19.0	CHEMBL267	Homo sapiens	INH	%	19.0
Not Determined	3055726	CHEMBL1048681	Inhibition of Src at 10 uM	B	O=C(CCl)c1scc(Br)c1Br		CHEMBL357136		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	3055727	CHEMBL1048681	Inhibition of Src at 10 uM	B	O=C(CCl)c1cc(Br)c(Br)s1		CHEMBL142711	=	Inhibition	%	69.0	CHEMBL267	Homo sapiens	INH	%	69.0
	3055728	CHEMBL1048681	Inhibition of Src at 10 uM	B	CC(=O)c1csc(C(=O)CCl)c1		CHEMBL341655	=	Inhibition	%	22.0	CHEMBL267	Homo sapiens	INH	%	22.0
	3055729	CHEMBL1048681	Inhibition of Src at 10 uM	B	O=C(CCl)c1cc(Cl)sc1Cl		CHEMBL356459	=	Inhibition	%	12.0	CHEMBL267	Homo sapiens	INH	%	12.0
	3055730	CHEMBL1048681	Inhibition of Src at 10 uM	B	O=C(CBr)c1scc(Br)c1Br		CHEMBL596352	=	Inhibition	%	66.0	CHEMBL267	Homo sapiens	INH	%	66.0
	3055731	CHEMBL1048681	Inhibition of Src at 10 uM	B	O=C(CBr)c1cc(Br)c(Br)s1		CHEMBL593628	=	Inhibition	%	76.0	CHEMBL267	Homo sapiens	INH	%	76.0
	3056891	CHEMBL1071377	Residual activity of SRC at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	75.0	CHEMBL267	Homo sapiens	Residual activity	%	75.0
	3057143	CHEMBL1072524	Residual activity of SRC at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	100.0	CHEMBL267	Homo sapiens	Residual activity	%	100.0
	3058463	CHEMBL1043817	Residual activity of SRC at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	95.0	CHEMBL267	Homo sapiens	Residual activity	%	95.0
	3059747	CHEMBL1071377	Residual activity of SRC at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	83.0	CHEMBL267	Homo sapiens	Residual activity	%	83.0
	3063559	CHEMBL1050474	Binding affinity to human SRC at 200 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)N[C@H]2CSSC[C@@H](C(=O)NCC(N)=O)NC(=O)CNC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC2=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL595545	=	Activity	%	100.0	CHEMBL267	Homo sapiens	Activity	%	100.0
	3063649	CHEMBL1043378	Binding affinity to human SRC at 500 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(N)=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL595546	=	Activity	%	72.0	CHEMBL267	Homo sapiens	Activity	%	72.0
	3063739	CHEMBL1045145	Binding affinity to human SRC at 50 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)N[C@H]2CNC(=O)C[C@@H](C(N)=O)NC(=O)CNC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC2=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL609010	=	Activity	%	100.0	CHEMBL267	Homo sapiens	Activity	%	100.0
	3066896	CHEMBL1066102	Inhibition of SRC at 10 uM	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Inhibition	%	15.0	CHEMBL267	Homo sapiens	INH	%	15.0
	3066986	CHEMBL1066102	Inhibition of SRC at 10 uM	B	O=C1Nc2ccccc2/C1=C1\C(=O)N(CCCc2ccccc2)c2ccccc21		CHEMBL607196	=	Inhibition	%	15.0	CHEMBL267	Homo sapiens	INH	%	15.0
	3084420	CHEMBL1073283	Inhibition of SRC	B	NCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL590109	=	IC50	nM	6100.0	CHEMBL267	Homo sapiens	IC50	uM	6.1
	3088553	CHEMBL1049478	Inhibition of SRC	B	CN(C)CCOc1ccc2c(c1)CCn1nc(-c3ccc(Oc4ccccc4)cc3)c(C(N)=O)c1N2		CHEMBL591325	=	IC50	nM	0.6	CHEMBL267	Homo sapiens	IC50	nM	0.6
	3088617	CHEMBL1049491	Inhibition of Src	B	NC(=O)c1c(-c2ccc(Oc3ccccc3)cc2)[nH]c(C(=O)c2c(F)cccc2F)c1N		CHEMBL589630	=	IC50	nM	23.0	CHEMBL267	Homo sapiens	IC50	nM	23.0
	3089531	CHEMBL1067368	Inhibition of Src	B	Cc1c(Nc2c(C#N)cncc2/C=C/CCN2CCC[C@@H](N)C2)ccc2[nH]ccc12		CHEMBL606245	=	IC50	nM	600.0	CHEMBL267	Homo sapiens	IC50	nM	600.0
	3094751	CHEMBL1069045	Inhibition of SRC at 1 uM by microfluidic substrate phosphorylation assay	B	NCCNC(=O)c1cc(-c2ccsc2)cnc1N		CHEMBL610226	=	Inhibition	%	-2.0	CHEMBL267	Homo sapiens	INH	%	-2.0
	3094777	CHEMBL1069045	Inhibition of SRC at 1 uM by microfluidic substrate phosphorylation assay	B	NCCNC(=O)c1cc(-c2scc3c2OCCO3)cnc1N		CHEMBL599171	=	Inhibition	%	4.0	CHEMBL267	Homo sapiens	INH	%	4.0
	3094792	CHEMBL1069045	Inhibition of SRC at 1 uM by microfluidic substrate phosphorylation assay	B	NC(=O)c1ccc(-c2cc(-c3scc4c3OCCO4)cnc2N)cc1		CHEMBL602931	=	Inhibition	%	13.0	CHEMBL267	Homo sapiens	INH	%	13.0
	3094799	CHEMBL1069045	Inhibition of SRC at 1 uM by microfluidic substrate phosphorylation assay	B	NC(=O)c1ccc(-c2cc(-c3cccc4c3OCO4)cnc2N)cc1		CHEMBL590335	=	Inhibition	%	18.0	CHEMBL267	Homo sapiens	INH	%	18.0
	3104153	CHEMBL1066395	Inhibition of recombinant Src by TR-FRET assay	B	C[C@@H](Oc1ccc2ncccc2c1)c1c(Cl)ccc(F)c1Cl		CHEMBL600795	=	IC50	nM	22000.0	CHEMBL267	Homo sapiens	IC50	nM	22000.0
	3104204	CHEMBL1066395	Inhibition of recombinant Src by TR-FRET assay	B	CC(Oc1ccc2ncc(/C=C/C(=O)O)cc2c1)c1c(Cl)ccc(F)c1Cl		CHEMBL602470	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	nM	50000.0
	3104208	CHEMBL1066395	Inhibition of recombinant Src by TR-FRET assay	B	CC(Oc1ccc2ncc(/C=C/CN)cc2c1)c1c(Cl)ccc(F)c1Cl		CHEMBL599993	=	IC50	nM	46000.0	CHEMBL267	Homo sapiens	IC50	nM	46000.0
	3104212	CHEMBL1066395	Inhibition of recombinant Src by TR-FRET assay	B	CC(Oc1ccc2ncc(CCC(N)=O)cc2c1)c1c(Cl)ccc(F)c1Cl		CHEMBL591457	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	nM	50000.0
	3104216	CHEMBL1066395	Inhibition of recombinant Src by TR-FRET assay	B	CC(Oc1ccc2ncc(/C=C/C(=O)N(C)C)cc2c1)c1c(Cl)ccc(F)c1Cl		CHEMBL608738	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	nM	50000.0
	3104220	CHEMBL1066395	Inhibition of recombinant Src by TR-FRET assay	B	CNC(=O)/C=C/c1cnc2ccc(OC(C)c3c(Cl)ccc(F)c3Cl)cc2c1		CHEMBL598912	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	nM	50000.0
	3104224	CHEMBL1066395	Inhibition of recombinant Src by TR-FRET assay	B	CC(Oc1ccc2ncc(/C=C/C(N)=O)cc2c1)c1c(Cl)ccc(F)c1Cl		CHEMBL598911	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	nM	50000.0
	3104238	CHEMBL1066395	Inhibition of recombinant Src by TR-FRET assay	B	C[C@H](Oc1ccc2ncccc2c1)c1c(Cl)ccc(F)c1Cl		CHEMBL598523	=	IC50	nM	20000.0	CHEMBL267	Homo sapiens	IC50	nM	20000.0
	3104243	CHEMBL1066395	Inhibition of recombinant Src by TR-FRET assay	B	CC(Oc1ccc2ncccc2c1)c1c(Cl)ccc(F)c1Cl		CHEMBL598727	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	nM	50000.0
	3121094	CHEMBL1065594	Inhibition of Src	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	=	IC50	nM	11000.0	CHEMBL267	Homo sapiens	IC50	nM	11000.0
	3124810	CHEMBL1069631	Inhibition of SRC	B	COc1cc(/C=C2\SC(=N)NC2=O)ccc1OCCCOc1cc(C)cc(C)c1		CHEMBL602890	=	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	3124811	CHEMBL1069631	Inhibition of SRC	B	COc1cc(-c2nc(=O)c3c([nH]2)sc2ccc(C)cc23)ccc1OCC(=O)O		CHEMBL599388	=	IC50	nM	1900.0	CHEMBL267	Homo sapiens	IC50	uM	1.9
	3127306	CHEMBL1074384	Inhibition of SRC at 1 uM	B	NC1(Cc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL263664	=	Inhibition	%	8.0	CHEMBL267	Homo sapiens	INH	%	8.0
	3127325	CHEMBL1074384	Inhibition of SRC at 1 uM	B	CC(C)(C)c1ccc(CC2(N)CCN(c3ncnc4[nH]ccc34)CC2)cc1		CHEMBL597211	=	Inhibition	%	11.0	CHEMBL267	Homo sapiens	INH	%	11.0
	3127344	CHEMBL1074384	Inhibition of SRC at 1 uM	B	NC1(C(=O)NCc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL598194	=	Inhibition	%	2.0	CHEMBL267	Homo sapiens	INH	%	2.0
Active	3128625	CHEMBL1068984	Inhibition of c-Src at 10 uM	B	COc1cc(Br)cc(/C=C2\SC(=O)NC2=O)c1O		CHEMBL599645		Activity			CHEMBL267	Homo sapiens	Activity		
	3130774	CHEMBL1065735	Inhibition of SRC at 3 to 6 uM relative to control	B	COc1ccc(C(=O)NCc2cccc(C(=O)Nc3ccc4c(c3)CNCC4)c2)cc1OC		CHEMBL604087	>	Inhibition	%	50.0	CHEMBL267	Homo sapiens	INH	%	50.0
	3131785	CHEMBL1069440	Inhibition of SRC at 3 uM relative to control	B	NC(=O)c1ccc(NC(=O)NCc2cccc(C(=O)Nc3ccc4c(c3)CNCC4)c2)cc1		CHEMBL600852	>	Inhibition	%	50.0	CHEMBL267	Homo sapiens	INH	%	50.0
	3185713	CHEMBL1105161	Inhibition of Src	B	Cc1c(Nc2c(C#N)cncc2/C=C/c2cccc(CN3CCN(C)CC3)n2)ccc2[nH]ccc12		CHEMBL1084411	=	IC50	nM	130.0	CHEMBL267	Homo sapiens	IC50	nM	130.0
	3186201	CHEMBL1110559	Inhibition of Src	B	Cc1cc2c(Nc3ccc4nc(N)sc4c3)c(C#N)cnc2cc1OCCN1CCCCC1		CHEMBL486370	=	IC50	nM	15.0	CHEMBL267	Homo sapiens	IC50	uM	0.015
	3186205	CHEMBL1110559	Inhibition of Src	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	IC50	nM	0.6	CHEMBL267	Homo sapiens	IC50	nM	0.6
	3186218	CHEMBL1110559	Inhibition of Src	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	IC50	nM	3.8	CHEMBL267	Homo sapiens	IC50	nM	3.8
	3186239	CHEMBL1110559	Inhibition of Src	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	IC50	nM	14.0	CHEMBL267	Homo sapiens	IC50	nM	14.0
	3186435	CHEMBL1113282	Inhibition of human Src at 20 uM	B	CCCC(=O)Nc1n[nH]c2cc(Cl)c(-c3ccccc3)cc12		CHEMBL1095040	=	Inhibition	%	-2.0	CHEMBL267	Homo sapiens	INH	%	-2.0
	3191046	CHEMBL1101913	Inhibition of c-Src at 10 uM	B	C[C@H](O)CNc1nccc(-n2ccnc2-c2cccc(NC(=O)c3ccc(Cl)c(C(F)(F)F)c3)c2)n1		CHEMBL1082876	<=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	3200314	CHEMBL1102114	Inhibition of SRC	B	COc1ccc(C2=NNC(=O)/C2=N\Nc2cccc(OC)c2)cc1		CHEMBL1080902	>	Ki	nM	4000.0	CHEMBL267	Homo sapiens	Ki	nM	4000.0
	3200340	CHEMBL1102114	Inhibition of SRC	B	COc1ccc(C2=NNC(=O)/C2=N\Nc2cccnc2)cc1		CHEMBL1076721	>	Ki	nM	4000.0	CHEMBL267	Homo sapiens	Ki	nM	4000.0
	3200366	CHEMBL1102114	Inhibition of SRC	B	COc1ccncc1C1=NNC(=O)/C1=N\Nc1ccccc1		CHEMBL1086736	>	Ki	nM	4000.0	CHEMBL267	Homo sapiens	Ki	nM	4000.0
	3210385	CHEMBL1109440	Inhibition of Src after 1 hr	B	O=C(Nc1cccc(-c2cn3ccnc3c(NCc3ccncc3)n2)c1)Nc1cccc(C(F)(F)F)c1		CHEMBL1081198	=	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	3213856	CHEMBL1111272	Inhibition of SRC at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	102.0	CHEMBL267	Homo sapiens	INH	%	102.0
	3219712	CHEMBL1116599	Inhibition of SRC at 100 nM relative to control	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H](CCCCN)NC(=O)CCCCCNC(=O)c1ccc(-c2ccnc(N)n2)s1)C(N)=O		CHEMBL1077375	=	Inhibition	%	26.0	CHEMBL267	Homo sapiens	INH	%	26.0
	3219852	CHEMBL1113997	Inhibition of SRC	B	Cc1c(Nc2c(C#N)cncc2/C=C/c2cccc(S(=O)(=O)N3CCN(C)CC3)c2)ccc2[nH]ccc12		CHEMBL1080994	=	IC50	nM	220.0	CHEMBL267	Homo sapiens	IC50	nM	220.0
	3219853	CHEMBL1113997	Inhibition of SRC	B	Cc1ncc(C#N)c(Nc2ccc3[nH]ccc3c2C)c1/C=C/c1cccc(S(=O)(=O)N2CCN(C)CC2)c1		CHEMBL1080995	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	nM	50000.0
	3220017	CHEMBL1115866	Inhibition of SRC	B	CN1C[C@@H]2C[C@H]1CN2c1ccc(-c2ccnc3c(-c4cccc(O)c4)c(-c4ccncc4)nn23)cc1		CHEMBL1087650	=	IC50	nM	675.0	CHEMBL267	Homo sapiens	IC50	uM	0.675
	3224963	CHEMBL1101767	Inhibition of SRC at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL267	Homo sapiens	INH	%	50.0
	3226342	CHEMBL1101767	Inhibition of SRC at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL267	Homo sapiens	INH	%	50.0
	3226949	CHEMBL1113977	Inhibition of SRC	B	Cc1ccc(NC(=O)c2cccc(Cl)c2)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1079422	=	IC50	nM	1650.0	CHEMBL267	Homo sapiens	IC50	nM	1650.0
	3226950	CHEMBL1113977	Inhibition of SRC	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1079945	=	IC50	nM	450.0	CHEMBL267	Homo sapiens	IC50	nM	450.0
	3226951	CHEMBL1113977	Inhibition of SRC	B	Cc1ccc(NC(=O)c2cc(Cl)cc(Cl)c2)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1079946	=	IC50	nM	530.0	CHEMBL267	Homo sapiens	IC50	nM	530.0
	3226952	CHEMBL1113977	Inhibition of SRC	B	Cc1cccc(C(=O)Nc2ccc(C)c(Nc3nc4ccccc4n3-c3cc(N)ncn3)c2)c1		CHEMBL1080299	=	IC50	nM	1539.0	CHEMBL267	Homo sapiens	IC50	nM	1539.0
Not Determined	3226953	CHEMBL1113977	Inhibition of SRC	B	Cc1ccc(NC(=O)c2ccncc2C(C)(C)C)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1080475		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	3226954	CHEMBL1113977	Inhibition of SRC	B	Cc1ccc(NC(=O)c2ccncc2Cl)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1086730		IC50			CHEMBL267	Homo sapiens	IC50		
	3226955	CHEMBL1113977	Inhibition of SRC	B	Cc1ccc(NC(=O)c2cc(OC3CCN(C)CC3)cc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1076432	=	IC50	nM	233.0	CHEMBL267	Homo sapiens	IC50	nM	233.0
	3226956	CHEMBL1113977	Inhibition of SRC	B	Cc1ccc(NC(=O)c2ccc(C(C)(C)C)s2)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1086731	=	IC50	nM	916.0	CHEMBL267	Homo sapiens	IC50	nM	916.0
	3226957	CHEMBL1113977	Inhibition of SRC	B	Cc1ccc(NC(=O)c2cc(C3CC3)n[nH]2)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1086860	=	IC50	nM	7359.0	CHEMBL267	Homo sapiens	IC50	nM	7359.0
	3226958	CHEMBL1113977	Inhibition of SRC	B	Cc1ccc(NC(=O)c2cc(C(C)(C)C)nn2C)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1088153	=	IC50	nM	7188.0	CHEMBL267	Homo sapiens	IC50	nM	7188.0
	3226959	CHEMBL1113977	Inhibition of SRC	B	CCN1CCN(Cc2ccc(C(=O)Nc3ccc(C)c(Nc4nc5ccccc5n4-c4cc(N)ncn4)c3)cc2Cl)CC1		CHEMBL1076433	=	IC50	nM	32.0	CHEMBL267	Homo sapiens	IC50	nM	32.0
	3226960	CHEMBL1113977	Inhibition of SRC	B	Cc1ccc(NC(=O)c2cc(CN3CCN(C)CC3)n(C(C)(C)C)n2)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1075628	=	IC50	nM	177.0	CHEMBL267	Homo sapiens	IC50	nM	177.0
	3226961	CHEMBL1113977	Inhibition of SRC	B	Cc1ccc(NC(=O)c2cc(N3CCN(C)CC3)cc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1076436	=	IC50	nM	130.0	CHEMBL267	Homo sapiens	IC50	nM	130.0
	3226962	CHEMBL1113977	Inhibition of SRC	B	CCN1CCN(c2cc(C(=O)Nc3ccc(C)c(Nc4nc5ccccc5n4-c4cc(N)ncn4)c3)cc(C(F)(F)F)c2)CC1		CHEMBL1076437	=	IC50	nM	71.0	CHEMBL267	Homo sapiens	IC50	nM	71.0
	3226963	CHEMBL1113977	Inhibition of SRC	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(Cl)ncn1		CHEMBL1088429	=	IC50	nM	16507.0	CHEMBL267	Homo sapiens	IC50	nM	16507.0
	3226964	CHEMBL1113977	Inhibition of SRC	B	COc1cc(-n2c(Nc3cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc3C)nc3ccccc32)ncn1		CHEMBL1087513	>	IC50	nM	2500.0	CHEMBL267	Homo sapiens	IC50	nM	2500.0
Not Determined	3226965	CHEMBL1113977	Inhibition of SRC	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(NCCN)ncn1		CHEMBL1087636		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	3226966	CHEMBL1113977	Inhibition of SRC	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(NCCCN)ncn1		CHEMBL1076465		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	3226967	CHEMBL1113977	Inhibition of SRC	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(NCCCCN)ncn1		CHEMBL1076466		IC50			CHEMBL267	Homo sapiens	IC50		
	3226968	CHEMBL1113977	Inhibition of SRC	B	CCN(CC)CCNc1cc(-n2c(Nc3cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc3C)nc3ccccc32)ncn1		CHEMBL1076468	>	IC50	nM	2500.0	CHEMBL267	Homo sapiens	IC50	nM	2500.0
	3226969	CHEMBL1113977	Inhibition of SRC	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(NCCCCN(C)C)ncn1		CHEMBL1076469	=	IC50	nM	139.0	CHEMBL267	Homo sapiens	IC50	nM	139.0
	3226970	CHEMBL1113977	Inhibition of SRC	B	CCN(CC)CCCCNc1cc(-n2c(Nc3cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc3C)nc3ccccc32)ncn1		CHEMBL1076470	=	IC50	nM	97.0	CHEMBL267	Homo sapiens	IC50	nM	97.0
	3226971	CHEMBL1113977	Inhibition of SRC	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(NCCCC2COCCN2)ncn1		CHEMBL1076471	=	IC50	nM	165.0	CHEMBL267	Homo sapiens	IC50	nM	165.0
	3226972	CHEMBL1113977	Inhibition of SRC	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(NCCC2CCCN2)ncn1		CHEMBL1076472	>	IC50	nM	2500.0	CHEMBL267	Homo sapiens	IC50	nM	2500.0
	3226973	CHEMBL1113977	Inhibition of SRC	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(N[C@H]2CC[C@H](N)CC2)ncn1		CHEMBL1076473	=	IC50	nM	1722.0	CHEMBL267	Homo sapiens	IC50	nM	1722.0
	3226974	CHEMBL1113977	Inhibition of SRC	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(NC2CCN(C)CC2)ncn1		CHEMBL1076474	>	IC50	nM	2500.0	CHEMBL267	Homo sapiens	IC50	nM	2500.0
	3226975	CHEMBL1113977	Inhibition of SRC	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(NCCc2ccccn2)ncn1		CHEMBL1076475	=	IC50	nM	2370.0	CHEMBL267	Homo sapiens	IC50	nM	2370.0
	3226976	CHEMBL1113977	Inhibition of SRC	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(N2CCOCC2)ncn1		CHEMBL1076476	>	IC50	nM	2500.0	CHEMBL267	Homo sapiens	IC50	nM	2500.0
	3226977	CHEMBL1113977	Inhibition of SRC	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(NCCN2CCN(C)CC2)ncn1		CHEMBL1076477	=	IC50	nM	305.0	CHEMBL267	Homo sapiens	IC50	nM	305.0
	3226978	CHEMBL1113977	Inhibition of SRC	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(NCCCN2CCN(C)CC2)ncn1		CHEMBL1076478	=	IC50	nM	128.0	CHEMBL267	Homo sapiens	IC50	nM	128.0
	3226979	CHEMBL1113977	Inhibition of SRC	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(NCCO)ncn1		CHEMBL1087638	=	IC50	nM	1920.0	CHEMBL267	Homo sapiens	IC50	nM	1920.0
	3226980	CHEMBL1113977	Inhibition of SRC	B	COCCNc1cc(-n2c(Nc3cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc3C)nc3ccccc32)ncn1		CHEMBL1076480	=	IC50	nM	1688.0	CHEMBL267	Homo sapiens	IC50	nM	1688.0
Not Determined	3226981	CHEMBL1113977	Inhibition of SRC	B	Cc1cccc(NC(=O)c2ccc(C)c(Nc3nc4ccccc4n3-c3cc(N)ncn3)c2)c1		CHEMBL1087002		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	3226982	CHEMBL1113977	Inhibition of SRC	B	Cc1ccc(C(=O)Nc2cccc(C(C)C)c2)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1087127		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	3226983	CHEMBL1113977	Inhibition of SRC	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1087128		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	3226984	CHEMBL1113977	Inhibition of SRC	B	Cc1ccc(C(=O)Nc2cccc(OC(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1088027		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	3226985	CHEMBL1113977	Inhibition of SRC	B	Cc1ccc(C(=O)Nc2cccc(Br)c2)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1088028		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	3226986	CHEMBL1113977	Inhibition of SRC	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1087524		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	3226987	CHEMBL1113977	Inhibition of SRC	B	Cc1ccc(C(=O)Nc2cccc(Cl)c2)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1087649		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	3226988	CHEMBL1113977	Inhibition of SRC	B	COc1cccc(NC(=O)c2ccc(C)c(Nc3nc4ccccc4n3-c3cc(N)ncn3)c2)c1		CHEMBL1081090		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	3226989	CHEMBL1113977	Inhibition of SRC	B	Cc1ccc(C(=O)Nc2ccccc2)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1076533		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	3226990	CHEMBL1113977	Inhibition of SRC	B	Cc1ccc(C(=O)Nc2cccc3cnccc23)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1081436		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	3226991	CHEMBL1113977	Inhibition of SRC	B	Cc1ccc(C(=O)Nc2cccc(C(N)=O)c2)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1080930		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	3226992	CHEMBL1113977	Inhibition of SRC	B	Cc1cc(NC(=O)c2ccc(C)c(Nc3nc4ccccc4n3-c3cc(N)ncn3)c2)ccn1		CHEMBL1079424		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	3226993	CHEMBL1113977	Inhibition of SRC	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nc5ccccc5n4-c4cc(N)ncn4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL1076193		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	3226994	CHEMBL1113977	Inhibition of SRC	B	Cc1cccc(NC(=O)c2ccc(C)c(Nc3nc4ccccc4n3-c3cc(NCCCCN(C)C)ncn3)c2)c1		CHEMBL1076194		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	3226995	CHEMBL1113977	Inhibition of SRC	B	CCN(CC)CCCCNc1cc(-n2c(Nc3cc(C(=O)Nc4cccc(C)c4)ccc3C)nc3ccccc32)ncn1		CHEMBL1076195		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	3226996	CHEMBL1113977	Inhibition of SRC	B	Cc1cccc(NC(=O)c2ccc(C)c(Nc3nc4ccccc4n3-c3cc(NCCN4CCN(C)CC4)ncn3)c2)c1		CHEMBL1076196		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	3226997	CHEMBL1113977	Inhibition of SRC	B	Cc1cccc(NC(=O)c2ccc(C)c(Nc3nc4ccccc4n3-c3cc(NCCCN4CCN(C)CC4)ncn3)c2)c1		CHEMBL1076197		IC50			CHEMBL267	Homo sapiens	IC50		
	3226998	CHEMBL1113977	Inhibition of SRC	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(NCCCCN(C)C)ncn1		CHEMBL1076198	=	IC50	nM	485.0	CHEMBL267	Homo sapiens	IC50	nM	485.0
	3226999	CHEMBL1113977	Inhibition of SRC	B	CCN(CC)CCCCNc1cc(-n2c(Nc3cc(C(=O)Nc4cccc(C(F)(F)F)c4)ccc3C)nc3ccccc32)ncn1		CHEMBL1076199	=	IC50	nM	274.0	CHEMBL267	Homo sapiens	IC50	nM	274.0
	3227000	CHEMBL1113977	Inhibition of SRC	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(NCCN2CCN(C)CC2)ncn1		CHEMBL1076200	=	IC50	nM	458.0	CHEMBL267	Homo sapiens	IC50	nM	458.0
	3227001	CHEMBL1113977	Inhibition of SRC	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(NCCCN2CCN(C)CC2)ncn1		CHEMBL1076201	=	IC50	nM	494.0	CHEMBL267	Homo sapiens	IC50	nM	494.0
Not Determined	3227002	CHEMBL1113977	Inhibition of SRC	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(NCCC#N)ncn1		CHEMBL1076202		IC50			CHEMBL267	Homo sapiens	IC50		
	3227003	CHEMBL1113977	Inhibition of SRC	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1ncnc(N)c1C		CHEMBL1080294	>	IC50	nM	2500.0	CHEMBL267	Homo sapiens	IC50	nM	2500.0
Not Determined	3227004	CHEMBL1113977	Inhibition of SRC	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1ncnc(NCCCN2CCN(C)CC2)n1		CHEMBL1076203		IC50			CHEMBL267	Homo sapiens	IC50		
	3227117	CHEMBL1113980	Inhibition of Tel-fused SRC expressed in mouse BAF3 cells	B	Cc1ccc(NC(=O)c2cccc(Cl)c2)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1079422	=	IC50	nM	650.0	CHEMBL267	Homo sapiens	IC50	nM	650.0
	3227118	CHEMBL1113980	Inhibition of Tel-fused SRC expressed in mouse BAF3 cells	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1079945	=	IC50	nM	78.0	CHEMBL267	Homo sapiens	IC50	nM	78.0
	3227119	CHEMBL1113980	Inhibition of Tel-fused SRC expressed in mouse BAF3 cells	B	Cc1ccc(NC(=O)c2cc(Cl)cc(Cl)c2)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1079946	=	IC50	nM	9693.0	CHEMBL267	Homo sapiens	IC50	nM	9693.0
	3227120	CHEMBL1113980	Inhibition of Tel-fused SRC expressed in mouse BAF3 cells	B	Cc1cccc(C(=O)Nc2ccc(C)c(Nc3nc4ccccc4n3-c3cc(N)ncn3)c2)c1		CHEMBL1080299	=	IC50	nM	490.0	CHEMBL267	Homo sapiens	IC50	nM	490.0
	3227121	CHEMBL1113980	Inhibition of Tel-fused SRC expressed in mouse BAF3 cells	B	Cc1ccc(NC(=O)c2ccncc2C(C)(C)C)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1080475	=	IC50	nM	56.0	CHEMBL267	Homo sapiens	IC50	nM	56.0
	3227122	CHEMBL1113980	Inhibition of Tel-fused SRC expressed in mouse BAF3 cells	B	Cc1ccc(NC(=O)c2ccncc2Cl)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1086730	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	3227123	CHEMBL1113980	Inhibition of Tel-fused SRC expressed in mouse BAF3 cells	B	Cc1ccc(NC(=O)c2cc(OC3CCN(C)CC3)cc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1076432	=	IC50	nM	39.0	CHEMBL267	Homo sapiens	IC50	nM	39.0
	3227124	CHEMBL1113980	Inhibition of Tel-fused SRC expressed in mouse BAF3 cells	B	Cc1ccc(NC(=O)c2ccc(C(C)(C)C)s2)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1086731	=	IC50	nM	4.0	CHEMBL267	Homo sapiens	IC50	nM	4.0
	3227125	CHEMBL1113980	Inhibition of Tel-fused SRC expressed in mouse BAF3 cells	B	Cc1ccc(NC(=O)c2cc(C3CC3)n[nH]2)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1086860	=	IC50	nM	56.0	CHEMBL267	Homo sapiens	IC50	nM	56.0
	3227126	CHEMBL1113980	Inhibition of Tel-fused SRC expressed in mouse BAF3 cells	B	Cc1ccc(NC(=O)c2cc(C(C)(C)C)nn2C)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1088153	=	IC50	nM	959.0	CHEMBL267	Homo sapiens	IC50	nM	959.0
	3227127	CHEMBL1113980	Inhibition of Tel-fused SRC expressed in mouse BAF3 cells	B	CCN1CCN(Cc2ccc(C(=O)Nc3ccc(C)c(Nc4nc5ccccc5n4-c4cc(N)ncn4)c3)cc2Cl)CC1		CHEMBL1076433	=	IC50	nM	47.0	CHEMBL267	Homo sapiens	IC50	nM	47.0
	3227128	CHEMBL1113980	Inhibition of Tel-fused SRC expressed in mouse BAF3 cells	B	Cc1ccc(NC(=O)c2cc(CN3CCN(C)CC3)n(C(C)(C)C)n2)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1075628	=	IC50	nM	249.0	CHEMBL267	Homo sapiens	IC50	nM	249.0
	3227129	CHEMBL1113980	Inhibition of Tel-fused SRC expressed in mouse BAF3 cells	B	Cc1ccc(NC(=O)c2cc(N3CCN(C)CC3)cc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1076436	=	IC50	nM	47.0	CHEMBL267	Homo sapiens	IC50	nM	47.0
	3227130	CHEMBL1113980	Inhibition of Tel-fused SRC expressed in mouse BAF3 cells	B	CCN1CCN(c2cc(C(=O)Nc3ccc(C)c(Nc4nc5ccccc5n4-c4cc(N)ncn4)c3)cc(C(F)(F)F)c2)CC1		CHEMBL1076437	=	IC50	nM	57.0	CHEMBL267	Homo sapiens	IC50	nM	57.0
	3227131	CHEMBL1113980	Inhibition of Tel-fused SRC expressed in mouse BAF3 cells	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(Cl)ncn1		CHEMBL1088429	=	IC50	nM	1220.0	CHEMBL267	Homo sapiens	IC50	nM	1220.0
	3227132	CHEMBL1113980	Inhibition of Tel-fused SRC expressed in mouse BAF3 cells	B	COc1cc(-n2c(Nc3cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc3C)nc3ccccc32)ncn1		CHEMBL1087513	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	3227133	CHEMBL1113980	Inhibition of Tel-fused SRC expressed in mouse BAF3 cells	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(NCCN)ncn1		CHEMBL1087636	=	IC50	nM	1288.0	CHEMBL267	Homo sapiens	IC50	nM	1288.0
	3227134	CHEMBL1113980	Inhibition of Tel-fused SRC expressed in mouse BAF3 cells	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(NCCCN)ncn1		CHEMBL1076465	=	IC50	nM	1322.0	CHEMBL267	Homo sapiens	IC50	nM	1322.0
	3227135	CHEMBL1113980	Inhibition of Tel-fused SRC expressed in mouse BAF3 cells	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(NCCCCN)ncn1		CHEMBL1076466	=	IC50	nM	1661.0	CHEMBL267	Homo sapiens	IC50	nM	1661.0
	3227136	CHEMBL1113980	Inhibition of Tel-fused SRC expressed in mouse BAF3 cells	B	CCN(CC)CCNc1cc(-n2c(Nc3cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc3C)nc3ccccc32)ncn1		CHEMBL1076468	=	IC50	nM	398.0	CHEMBL267	Homo sapiens	IC50	nM	398.0
	3227137	CHEMBL1113980	Inhibition of Tel-fused SRC expressed in mouse BAF3 cells	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(NCCCCN(C)C)ncn1		CHEMBL1076469	=	IC50	nM	1211.0	CHEMBL267	Homo sapiens	IC50	nM	1211.0
	3227138	CHEMBL1113980	Inhibition of Tel-fused SRC expressed in mouse BAF3 cells	B	CCN(CC)CCCCNc1cc(-n2c(Nc3cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc3C)nc3ccccc32)ncn1		CHEMBL1076470	=	IC50	nM	438.0	CHEMBL267	Homo sapiens	IC50	nM	438.0
	3227139	CHEMBL1113980	Inhibition of Tel-fused SRC expressed in mouse BAF3 cells	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(NCCCC2COCCN2)ncn1		CHEMBL1076471	=	IC50	nM	600.0	CHEMBL267	Homo sapiens	IC50	nM	600.0
	3227140	CHEMBL1113980	Inhibition of Tel-fused SRC expressed in mouse BAF3 cells	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(NCCC2CCCN2)ncn1		CHEMBL1076472	=	IC50	nM	903.0	CHEMBL267	Homo sapiens	IC50	nM	903.0
	3227141	CHEMBL1113980	Inhibition of Tel-fused SRC expressed in mouse BAF3 cells	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(N[C@H]2CC[C@H](N)CC2)ncn1		CHEMBL1076473	=	IC50	nM	739.0	CHEMBL267	Homo sapiens	IC50	nM	739.0
	3227142	CHEMBL1113980	Inhibition of Tel-fused SRC expressed in mouse BAF3 cells	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(NC2CCN(C)CC2)ncn1		CHEMBL1076474	=	IC50	nM	1378.0	CHEMBL267	Homo sapiens	IC50	nM	1378.0
	3227143	CHEMBL1113980	Inhibition of Tel-fused SRC expressed in mouse BAF3 cells	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(NCCc2ccccn2)ncn1		CHEMBL1076475	=	IC50	nM	524.0	CHEMBL267	Homo sapiens	IC50	nM	524.0
	3227144	CHEMBL1113980	Inhibition of Tel-fused SRC expressed in mouse BAF3 cells	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(N2CCOCC2)ncn1		CHEMBL1076476	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	3227145	CHEMBL1113980	Inhibition of Tel-fused SRC expressed in mouse BAF3 cells	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(NCCN2CCN(C)CC2)ncn1		CHEMBL1076477	=	IC50	nM	918.0	CHEMBL267	Homo sapiens	IC50	nM	918.0
	3227146	CHEMBL1113980	Inhibition of Tel-fused SRC expressed in mouse BAF3 cells	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(NCCCN2CCN(C)CC2)ncn1		CHEMBL1076478	=	IC50	nM	601.0	CHEMBL267	Homo sapiens	IC50	nM	601.0
	3227147	CHEMBL1113980	Inhibition of Tel-fused SRC expressed in mouse BAF3 cells	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(NCCO)ncn1		CHEMBL1087638	=	IC50	nM	1698.0	CHEMBL267	Homo sapiens	IC50	nM	1698.0
	3227148	CHEMBL1113980	Inhibition of Tel-fused SRC expressed in mouse BAF3 cells	B	COCCNc1cc(-n2c(Nc3cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc3C)nc3ccccc32)ncn1		CHEMBL1076480	=	IC50	nM	606.0	CHEMBL267	Homo sapiens	IC50	nM	606.0
	3227149	CHEMBL1113980	Inhibition of Tel-fused SRC expressed in mouse BAF3 cells	B	Cc1cccc(NC(=O)c2ccc(C)c(Nc3nc4ccccc4n3-c3cc(N)ncn3)c2)c1		CHEMBL1087002	=	IC50	nM	7173.0	CHEMBL267	Homo sapiens	IC50	nM	7173.0
	3227150	CHEMBL1113980	Inhibition of Tel-fused SRC expressed in mouse BAF3 cells	B	Cc1ccc(C(=O)Nc2cccc(C(C)C)c2)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1087127	=	IC50	nM	21.0	CHEMBL267	Homo sapiens	IC50	nM	21.0
	3227151	CHEMBL1113980	Inhibition of Tel-fused SRC expressed in mouse BAF3 cells	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1087128	=	IC50	nM	202.0	CHEMBL267	Homo sapiens	IC50	nM	202.0
	3227152	CHEMBL1113980	Inhibition of Tel-fused SRC expressed in mouse BAF3 cells	B	Cc1ccc(C(=O)Nc2cccc(OC(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1088027	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	3227153	CHEMBL1113980	Inhibition of Tel-fused SRC expressed in mouse BAF3 cells	B	Cc1ccc(C(=O)Nc2cccc(Br)c2)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1088028	=	IC50	nM	5375.0	CHEMBL267	Homo sapiens	IC50	nM	5375.0
	3227154	CHEMBL1113980	Inhibition of Tel-fused SRC expressed in mouse BAF3 cells	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1087524	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	3227155	CHEMBL1113980	Inhibition of Tel-fused SRC expressed in mouse BAF3 cells	B	Cc1ccc(C(=O)Nc2cccc(Cl)c2)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1087649	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	3227156	CHEMBL1113980	Inhibition of Tel-fused SRC expressed in mouse BAF3 cells	B	COc1cccc(NC(=O)c2ccc(C)c(Nc3nc4ccccc4n3-c3cc(N)ncn3)c2)c1		CHEMBL1081090	=	IC50	nM	4389.0	CHEMBL267	Homo sapiens	IC50	nM	4389.0
	3227157	CHEMBL1113980	Inhibition of Tel-fused SRC expressed in mouse BAF3 cells	B	Cc1ccc(C(=O)Nc2ccccc2)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1076533	=	IC50	nM	6168.0	CHEMBL267	Homo sapiens	IC50	nM	6168.0
	3227158	CHEMBL1113980	Inhibition of Tel-fused SRC expressed in mouse BAF3 cells	B	Cc1ccc(C(=O)Nc2cccc3cnccc23)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1081436	=	IC50	nM	7613.0	CHEMBL267	Homo sapiens	IC50	nM	7613.0
	3227159	CHEMBL1113980	Inhibition of Tel-fused SRC expressed in mouse BAF3 cells	B	Cc1ccc(C(=O)Nc2cccc(C(N)=O)c2)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1080930	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	3227160	CHEMBL1113980	Inhibition of Tel-fused SRC expressed in mouse BAF3 cells	B	Cc1cc(NC(=O)c2ccc(C)c(Nc3nc4ccccc4n3-c3cc(N)ncn3)c2)ccn1		CHEMBL1079424	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	3227161	CHEMBL1113980	Inhibition of Tel-fused SRC expressed in mouse BAF3 cells	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nc5ccccc5n4-c4cc(N)ncn4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL1076193	=	IC50	nM	107.0	CHEMBL267	Homo sapiens	IC50	nM	107.0
	3227162	CHEMBL1113980	Inhibition of Tel-fused SRC expressed in mouse BAF3 cells	B	Cc1cccc(NC(=O)c2ccc(C)c(Nc3nc4ccccc4n3-c3cc(NCCCCN(C)C)ncn3)c2)c1		CHEMBL1076194	=	IC50	nM	1268.0	CHEMBL267	Homo sapiens	IC50	nM	1268.0
	3227163	CHEMBL1113980	Inhibition of Tel-fused SRC expressed in mouse BAF3 cells	B	CCN(CC)CCCCNc1cc(-n2c(Nc3cc(C(=O)Nc4cccc(C)c4)ccc3C)nc3ccccc32)ncn1		CHEMBL1076195	=	IC50	nM	1065.0	CHEMBL267	Homo sapiens	IC50	nM	1065.0
	3227164	CHEMBL1113980	Inhibition of Tel-fused SRC expressed in mouse BAF3 cells	B	Cc1cccc(NC(=O)c2ccc(C)c(Nc3nc4ccccc4n3-c3cc(NCCN4CCN(C)CC4)ncn3)c2)c1		CHEMBL1076196	=	IC50	nM	1537.0	CHEMBL267	Homo sapiens	IC50	nM	1537.0
	3227165	CHEMBL1113980	Inhibition of Tel-fused SRC expressed in mouse BAF3 cells	B	Cc1cccc(NC(=O)c2ccc(C)c(Nc3nc4ccccc4n3-c3cc(NCCCN4CCN(C)CC4)ncn3)c2)c1		CHEMBL1076197	=	IC50	nM	1409.0	CHEMBL267	Homo sapiens	IC50	nM	1409.0
	3227166	CHEMBL1113980	Inhibition of Tel-fused SRC expressed in mouse BAF3 cells	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(NCCCCN(C)C)ncn1		CHEMBL1076198	=	IC50	nM	556.0	CHEMBL267	Homo sapiens	IC50	nM	556.0
	3227167	CHEMBL1113980	Inhibition of Tel-fused SRC expressed in mouse BAF3 cells	B	CCN(CC)CCCCNc1cc(-n2c(Nc3cc(C(=O)Nc4cccc(C(F)(F)F)c4)ccc3C)nc3ccccc32)ncn1		CHEMBL1076199	=	IC50	nM	461.0	CHEMBL267	Homo sapiens	IC50	nM	461.0
	3227168	CHEMBL1113980	Inhibition of Tel-fused SRC expressed in mouse BAF3 cells	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(NCCN2CCN(C)CC2)ncn1		CHEMBL1076200	=	IC50	nM	527.0	CHEMBL267	Homo sapiens	IC50	nM	527.0
	3227169	CHEMBL1113980	Inhibition of Tel-fused SRC expressed in mouse BAF3 cells	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(NCCCN2CCN(C)CC2)ncn1		CHEMBL1076201	=	IC50	nM	364.0	CHEMBL267	Homo sapiens	IC50	nM	364.0
	3227170	CHEMBL1113980	Inhibition of Tel-fused SRC expressed in mouse BAF3 cells	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(NCCC#N)ncn1		CHEMBL1076202	=	IC50	nM	1223.0	CHEMBL267	Homo sapiens	IC50	nM	1223.0
	3227171	CHEMBL1113980	Inhibition of Tel-fused SRC expressed in mouse BAF3 cells	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1ncnc(N)c1C		CHEMBL1080294	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	3227172	CHEMBL1113980	Inhibition of Tel-fused SRC expressed in mouse BAF3 cells	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1ncnc(NCCCN2CCN(C)CC2)n1		CHEMBL1076203	=	IC50	nM	117.0	CHEMBL267	Homo sapiens	IC50	nM	117.0
	3228117	CHEMBL1114829	Inhibition of SRC	B	CN(C)Cc1ccc(-c2cnn3c(-c4cccc(NC(=O)c5cccc(C(F)(F)F)c5)c4)ccnc23)cc1		CHEMBL1087397	>	IC50	nM	2000.0	CHEMBL267	Homo sapiens	IC50	uM	2.0
	3240838	CHEMBL1109669	Inhibition of Src	B	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)c1		CHEMBL1090360	=	IC50	nM	310.0	CHEMBL267	Homo sapiens	IC50	uM	0.31
	3242230	CHEMBL1111616	Inhibition of SRC	B	CC(C)N1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(C5CCOCC5)nc(N5C6CCC5COC6)n4)cc3)cc2)CC1		CHEMBL1091356	<	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	3246483	CHEMBL1117094	Inhibition of SRC	B	O=C(Nc1cccc(-c2ncnc3sc(-c4ccncc4)cc23)c1)c1cccc(C(F)(F)F)c1		CHEMBL1090143	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	3251263	CHEMBL1110586	Inhibition of SRC	B	Cn1cc(/C=C2\Oc3cccc(O)c3C2=O)c2c(-c3ccc(C(=O)NCCO)cc3)ccnc21		CHEMBL1092754	=	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	3260515	CHEMBL1110869	Inhibition of Src	B	O=C(Nc1cccc(-c2ccnc3cc(-c4ccncc4)nn23)c1)c1cccc(C(F)(F)F)c1		CHEMBL1089082	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	3261230	CHEMBL1113456	Inhibition of SRC at 10 uM	B	O=C1OC(c2ccccc2)=N/C1=C\c1cccnc1		CHEMBL579387	=	Inhibition	%	13.0	CHEMBL267	Homo sapiens	INH	%	13.0
	3261231	CHEMBL1113456	Inhibition of SRC at 10 uM	B	Cc1cccc(C2=N/C(=C\c3cccnc3)C(=O)O2)c1		CHEMBL1091786	=	Inhibition	%	5.0	CHEMBL267	Homo sapiens	INH	%	5.0
	3261232	CHEMBL1113456	Inhibition of SRC at 10 uM	B	O=C1OC(c2ccc(Cl)cc2)=N/C1=C\c1cccnc1		CHEMBL1091787	=	Inhibition	%	3.0	CHEMBL267	Homo sapiens	INH	%	3.0
	3261233	CHEMBL1113456	Inhibition of SRC at 10 uM	B	O=C1OC(/C=C/c2ccccc2)=N/C1=C\c1cccnc1		CHEMBL565286	=	Inhibition	%	5.0	CHEMBL267	Homo sapiens	INH	%	5.0
	3261234	CHEMBL1113456	Inhibition of SRC at 10 uM	B	O=C1OC(c2ccc(F)c(F)c2)=N/C1=C\c1cccnc1		CHEMBL1091764	=	Inhibition	%	6.0	CHEMBL267	Homo sapiens	INH	%	6.0
	3261235	CHEMBL1113456	Inhibition of SRC at 10 uM	B	Cc1cc(C2=N/C(=C\c3cccnc3)C(=O)O2)ccc1Br		CHEMBL1091766	=	Inhibition	%	2.0	CHEMBL267	Homo sapiens	INH	%	2.0
	3261342	CHEMBL1108061	Inhibition of Src at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control	B	CN(C)CCCC(=O)Nc1ccc2nccc(Nc3cccc(Br)c3)c2c1		CHEMBL1089524	=	Activity	%	13.0	CHEMBL267	Homo sapiens	Activity	%	13.0
	3261366	CHEMBL1108061	Inhibition of Src at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control	B	CN(C)CCCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL1088901	=	Activity	%	44.0	CHEMBL267	Homo sapiens	Activity	%	44.0
	3262018	CHEMBL1114553	Inhibition of SRC	B	CP(C)(=O)c1ccc(Nc2nc(C3CCCC3)nc3c2ncn3CCc2cccc(O)c2)cc1		CHEMBL1089405	=	IC50	nM	0.45	CHEMBL267	Homo sapiens	IC50	nM	0.45
	3262027	CHEMBL1114553	Inhibition of SRC	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	IC50	nM	240.0	CHEMBL267	Homo sapiens	IC50	nM	240.0
	3264383	CHEMBL1104652	Inhibition of SRC	B	CC(C)(C)OC(=O)N1CCC(n2ncc3c(N4CCOCC4)nc(-c4ccc(N)cc4)nc32)CC1		CHEMBL1095627	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	3271273	CHEMBL1104652	Inhibition of SRC	B	COC(=O)N1CCC(n2ncc3c(N4CCOCC4)nc(-c4ccc(N)cc4)nc32)CC1		CHEMBL1095626	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
Not Active	3272560	CHEMBL1108322	Inhibition of SRC	B	COc1cc(OC)c(C=C2C(=O)Nc3ccccc32)c(OC)c1		CHEMBL576349		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	3272561	CHEMBL1108322	Inhibition of SRC	B	COc1ccccc1/C=C1/C(=O)Nc2ccccc21		CHEMBL444673		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	3272562	CHEMBL1108322	Inhibition of SRC	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1ccccc1F		CHEMBL1088391		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	3272563	CHEMBL1108322	Inhibition of SRC	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1ccccc1[N+](=O)[O-]		CHEMBL1088392		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	3272564	CHEMBL1108322	Inhibition of SRC	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1ccccc1S(=O)(=O)O		CHEMBL1088529		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	3272565	CHEMBL1108322	Inhibition of SRC	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1ccc2c(c1)OCO2		CHEMBL1086669		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	3272566	CHEMBL1108322	Inhibition of SRC	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1cc(F)cc(F)c1		CHEMBL1086670		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	3272567	CHEMBL1108322	Inhibition of SRC	B	NC(=O)Cc1ccc(/C=C2/C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL1086795		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	3272568	CHEMBL1108322	Inhibition of SRC	B	COc1ccc(/C=C2/C(=O)Nc3ccc(Cl)cc32)c(OC)c1OC		CHEMBL1086796		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	3272569	CHEMBL1108322	Inhibition of SRC	B	COc1cc(/C=C2/C(=O)Nc3ccc(Cl)cc32)cc(OC)c1OC		CHEMBL383871		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	3272570	CHEMBL1108322	Inhibition of SRC	B	COc1cc(OC)c(/C=C2/C(=O)Nc3ccc(Cl)cc32)c(OC)c1		CHEMBL1086939	<	Inhibition	%	20.0	CHEMBL267	Homo sapiens	INH	%	20.0
Not Active	3272571	CHEMBL1108322	Inhibition of SRC	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	3277978	CHEMBL1105693	Inhibition of human recombinant Src after 70 mins by FRET assay	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	IC50	nM	3.8	CHEMBL267	Homo sapiens	IC50	nM	3.8
	3277979	CHEMBL1105694	Inhibition of Src-mediated cell proliferation in rat Rat-2 fibroblasts after 4 days by MTS assay	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	IC50	nM	100.0	CHEMBL267	Homo sapiens	IC50	nM	100.0
	3277981	CHEMBL1105693	Inhibition of human recombinant Src after 70 mins by FRET assay	B	COc1cc(Nc2c(C#N)cnc3cc(/C=C/c4cc(CN(C)C)ccn4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL1087212	=	IC50	nM	6.8	CHEMBL267	Homo sapiens	IC50	nM	6.8
	3277982	CHEMBL1105694	Inhibition of Src-mediated cell proliferation in rat Rat-2 fibroblasts after 4 days by MTS assay	B	COc1cc(Nc2c(C#N)cnc3cc(/C=C/c4cc(CN(C)C)ccn4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL1087212	=	IC50	nM	280.0	CHEMBL267	Homo sapiens	IC50	nM	280.0
	3277983	CHEMBL1105693	Inhibition of human recombinant Src after 70 mins by FRET assay	B	COc1cc(Nc2c(C#N)cnc3cc(/C=C/c4ccc(CN(C)C)cn4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL1087215	=	IC50	nM	2.2	CHEMBL267	Homo sapiens	IC50	nM	2.2
	3277984	CHEMBL1105694	Inhibition of Src-mediated cell proliferation in rat Rat-2 fibroblasts after 4 days by MTS assay	B	COc1cc(Nc2c(C#N)cnc3cc(/C=C/c4ccc(CN(C)C)cn4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL1087215	=	IC50	nM	58.0	CHEMBL267	Homo sapiens	IC50	nM	58.0
	3277986	CHEMBL1105693	Inhibition of human recombinant Src after 70 mins by FRET assay	B	COc1cc(Nc2c(C#N)cnc3cc(/C=C/c4cccc(CN(C)C)n4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL1087216	=	IC50	nM	2.2	CHEMBL267	Homo sapiens	IC50	nM	2.2
	3277987	CHEMBL1105694	Inhibition of Src-mediated cell proliferation in rat Rat-2 fibroblasts after 4 days by MTS assay	B	COc1cc(Nc2c(C#N)cnc3cc(/C=C/c4cccc(CN(C)C)n4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL1087216	=	IC50	nM	28.0	CHEMBL267	Homo sapiens	IC50	nM	28.0
	3277989	CHEMBL1105693	Inhibition of human recombinant Src after 70 mins by FRET assay	B	COc1cc(Nc2c(C#N)cnc3cc(/C=C/c4ccc(CN(C)C)cc4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL1087340	=	IC50	nM	2.4	CHEMBL267	Homo sapiens	IC50	nM	2.4
	3277990	CHEMBL1105694	Inhibition of Src-mediated cell proliferation in rat Rat-2 fibroblasts after 4 days by MTS assay	B	COc1cc(Nc2c(C#N)cnc3cc(/C=C/c4ccc(CN(C)C)cc4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL1087340	=	IC50	nM	40.0	CHEMBL267	Homo sapiens	IC50	nM	40.0
	3277992	CHEMBL1105693	Inhibition of human recombinant Src after 70 mins by FRET assay	B	COc1cc(Nc2c(C#N)cnc3cc(/C=C/c4cccc(CN(C)C)c4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL1087834	=	IC50	nM	3.0	CHEMBL267	Homo sapiens	IC50	nM	3.0
	3277993	CHEMBL1105694	Inhibition of Src-mediated cell proliferation in rat Rat-2 fibroblasts after 4 days by MTS assay	B	COc1cc(Nc2c(C#N)cnc3cc(/C=C/c4cccc(CN(C)C)c4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL1087834	=	IC50	nM	100.0	CHEMBL267	Homo sapiens	IC50	nM	100.0
	3278012	CHEMBL1105693	Inhibition of human recombinant Src after 70 mins by FRET assay	B	COc1cc(Nc2c(C#N)cnc3cc(/C=C/CN4CCOCC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL1088679	=	IC50	nM	8.7	CHEMBL267	Homo sapiens	IC50	nM	8.7
	3278013	CHEMBL1105694	Inhibition of Src-mediated cell proliferation in rat Rat-2 fibroblasts after 4 days by MTS assay	B	COc1cc(Nc2c(C#N)cnc3cc(/C=C/CN4CCOCC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL1088679	=	IC50	nM	260.0	CHEMBL267	Homo sapiens	IC50	nM	260.0
	3278014	CHEMBL1105693	Inhibition of human recombinant Src after 70 mins by FRET assay	B	COc1cc(Nc2c(C#N)cnc3cc(/C=C/CCN4CCOCC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL1088680	=	IC50	nM	4.8	CHEMBL267	Homo sapiens	IC50	nM	4.8
	3278015	CHEMBL1105694	Inhibition of Src-mediated cell proliferation in rat Rat-2 fibroblasts after 4 days by MTS assay	B	COc1cc(Nc2c(C#N)cnc3cc(/C=C/CCN4CCOCC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL1088680	=	IC50	nM	180.0	CHEMBL267	Homo sapiens	IC50	nM	180.0
	3278016	CHEMBL1105693	Inhibition of human recombinant Src after 70 mins by FRET assay	B	COc1cc(Nc2c(C#N)cnc3cc(/C=C/CCCN4CCOCC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL1088681	=	IC50	nM	5.4	CHEMBL267	Homo sapiens	IC50	nM	5.4
	3278017	CHEMBL1105694	Inhibition of Src-mediated cell proliferation in rat Rat-2 fibroblasts after 4 days by MTS assay	B	COc1cc(Nc2c(C#N)cnc3cc(/C=C/CCCN4CCOCC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL1088681	=	IC50	nM	350.0	CHEMBL267	Homo sapiens	IC50	nM	350.0
	3278018	CHEMBL1105693	Inhibition of human recombinant Src after 70 mins by FRET assay	B	COc1cc(Nc2c(C#N)cnc3cc(/C=C/CCCCN4CCOCC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL1088120	=	IC50	nM	18.0	CHEMBL267	Homo sapiens	IC50	nM	18.0
	3278019	CHEMBL1105694	Inhibition of Src-mediated cell proliferation in rat Rat-2 fibroblasts after 4 days by MTS assay	B	COc1cc(Nc2c(C#N)cnc3cc(/C=C/CCCCN4CCOCC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL1088120	=	IC50	nM	290.0	CHEMBL267	Homo sapiens	IC50	nM	290.0
	3278020	CHEMBL1105693	Inhibition of human recombinant Src after 70 mins by FRET assay	B	COc1cc(Nc2c(C#N)cnc3cc(/C=C/CCCCCCCCCN4CCOCC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL1098363	=	IC50	nM	130.0	CHEMBL267	Homo sapiens	IC50	nM	130.0
	3278021	CHEMBL1105694	Inhibition of Src-mediated cell proliferation in rat Rat-2 fibroblasts after 4 days by MTS assay	B	COc1cc(Nc2c(C#N)cnc3cc(/C=C/CCCCCCCCCN4CCOCC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL1098363	=	IC50	nM	3200.0	CHEMBL267	Homo sapiens	IC50	nM	3200.0
	3278022	CHEMBL1105693	Inhibition of human recombinant Src after 70 mins by FRET assay	B	COc1cc(Nc2c(C#N)cnc3cc(/C=C/CCN4CCOCC4)ccc23)c(Cl)cc1Cl		CHEMBL1088121	=	IC50	nM	15.0	CHEMBL267	Homo sapiens	IC50	nM	15.0
	3278023	CHEMBL1105694	Inhibition of Src-mediated cell proliferation in rat Rat-2 fibroblasts after 4 days by MTS assay	B	COc1cc(Nc2c(C#N)cnc3cc(/C=C/CCN4CCOCC4)ccc23)c(Cl)cc1Cl		CHEMBL1088121	=	IC50	nM	1100.0	CHEMBL267	Homo sapiens	IC50	nM	1100.0
	3278024	CHEMBL1105693	Inhibition of human recombinant Src after 70 mins by FRET assay	B	N#Cc1cnc2cc(/C=C/CCN3CCOCC3)ccc2c1Nc1ccc(Cl)cc1Cl		CHEMBL1088122	=	IC50	nM	41.0	CHEMBL267	Homo sapiens	IC50	nM	41.0
	3278025	CHEMBL1105694	Inhibition of Src-mediated cell proliferation in rat Rat-2 fibroblasts after 4 days by MTS assay	B	N#Cc1cnc2cc(/C=C/CCN3CCOCC3)ccc2c1Nc1ccc(Cl)cc1Cl		CHEMBL1088122	=	IC50	nM	2800.0	CHEMBL267	Homo sapiens	IC50	nM	2800.0
	3278026	CHEMBL1105693	Inhibition of human recombinant Src after 70 mins by FRET assay	B	COc1cc(Nc2c(C#N)cnc3ccc(/C=C/CCN4CCOCC4)cc23)c(Cl)cc1Cl		CHEMBL1086679	=	IC50	nM	340.0	CHEMBL267	Homo sapiens	IC50	nM	340.0
	3278027	CHEMBL1105693	Inhibition of human recombinant Src after 70 mins by FRET assay	B	N#Cc1cnc2ccc(/C=C/CCN3CCOCC3)cc2c1Nc1ccc(Cl)cc1Cl		CHEMBL1086680	=	IC50	nM	1200.0	CHEMBL267	Homo sapiens	IC50	nM	1200.0
	3278028	CHEMBL1105693	Inhibition of human recombinant Src after 70 mins by FRET assay	B	COc1cc(Nc2c(C#N)cnc3cc(/C=C/CCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL1088240	=	IC50	nM	2.1	CHEMBL267	Homo sapiens	IC50	nM	2.1
	3278029	CHEMBL1105694	Inhibition of Src-mediated cell proliferation in rat Rat-2 fibroblasts after 4 days by MTS assay	B	COc1cc(Nc2c(C#N)cnc3cc(/C=C/CCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL1088240	=	IC50	nM	58.0	CHEMBL267	Homo sapiens	IC50	nM	58.0
	3278030	CHEMBL1105693	Inhibition of human recombinant Src after 70 mins by FRET assay	B	COc1cc(Nc2c(C#N)cnc3cc(/C=C/CCN(C)C)c(OC)cc23)c(Cl)cc1Cl		CHEMBL1088241	=	IC50	nM	2.5	CHEMBL267	Homo sapiens	IC50	nM	2.5
	3278031	CHEMBL1105694	Inhibition of Src-mediated cell proliferation in rat Rat-2 fibroblasts after 4 days by MTS assay	B	COc1cc(Nc2c(C#N)cnc3cc(/C=C/CCN(C)C)c(OC)cc23)c(Cl)cc1Cl		CHEMBL1088241	=	IC50	nM	62.0	CHEMBL267	Homo sapiens	IC50	nM	62.0
	3278032	CHEMBL1105693	Inhibition of human recombinant Src after 70 mins by FRET assay	B	COc1cc(Nc2c(C#N)cnc3cc(/C=C/CCN4CCCCC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL1088372	=	IC50	nM	2.6	CHEMBL267	Homo sapiens	IC50	nM	2.6
	3278033	CHEMBL1105694	Inhibition of Src-mediated cell proliferation in rat Rat-2 fibroblasts after 4 days by MTS assay	B	COc1cc(Nc2c(C#N)cnc3cc(/C=C/CCN4CCCCC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL1088372	=	IC50	nM	78.0	CHEMBL267	Homo sapiens	IC50	nM	78.0
	3278034	CHEMBL1105693	Inhibition of human recombinant Src after 70 mins by FRET assay	B	CCN1CCN(CC/C=C/c2cc3ncc(C#N)c(Nc4cc(OC)c(Cl)cc4Cl)c3cc2OC)CC1		CHEMBL1087978	=	IC50	nM	1.7	CHEMBL267	Homo sapiens	IC50	nM	1.7
	3278035	CHEMBL1105694	Inhibition of Src-mediated cell proliferation in rat Rat-2 fibroblasts after 4 days by MTS assay	B	CCN1CCN(CC/C=C/c2cc3ncc(C#N)c(Nc4cc(OC)c(Cl)cc4Cl)c3cc2OC)CC1		CHEMBL1087978	=	IC50	nM	67.0	CHEMBL267	Homo sapiens	IC50	nM	67.0
	3278036	CHEMBL1117432	Inhibition of human recombinant Src at 10 uM after 70 mins by FRET assay	B	COc1cc(Nc2c(C#N)cnc3c(/C=C/CCN4CCOCC4)cccc23)c(Cl)cc1Cl		CHEMBL1088697	=	Inhibition	%	52.0	CHEMBL267	Homo sapiens	INH	%	52.0
Not Active	3293122	CHEMBL1108245	Inhibition of SRC at 10 uM	B	Nc1ccccc1Nc1ccc2c(c1)Cc1ccccc1CC2=O		CHEMBL1096459		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	3293138	CHEMBL1108245	Inhibition of SRC at 10 uM	B	O=C1Cc2ccccc2Cc2cc(Nc3ccc(F)cc3F)ccc21		CHEMBL1096460		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	3293154	CHEMBL1108245	Inhibition of SRC at 10 uM	B	Nc1cc(F)ccc1Nc1ccc2c(c1)Cc1ccccc1CC2=O		CHEMBL1096466		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	3293170	CHEMBL1108245	Inhibition of SRC at 10 uM	B	O=C1Cc2ccccc2Cc2cc(Nc3ccccc3)ccc21		CHEMBL1096672		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	3293186	CHEMBL1108245	Inhibition of SRC at 10 uM	B	Nc1ccc(Nc2ccc3c(c2)Cc2ccccc2CC3=O)cc1		CHEMBL1096769		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	3293202	CHEMBL1108245	Inhibition of SRC at 10 uM	B	Nc1ccccc1Nc1ccc2c(c1)C(=O)Cc1ccccc1C2		CHEMBL1096770		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	3293218	CHEMBL1108245	Inhibition of SRC at 10 uM	B	Nc1ccccc1Nc1ccc2c(c1)Cc1ccccc1C(=O)C2		CHEMBL1096771		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	3293234	CHEMBL1108245	Inhibition of SRC at 10 uM	B	Nc1cc(F)ccc1Nc1ccc2c(c1)Cc1ccccc1C(=O)C2		CHEMBL1097085		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	3293250	CHEMBL1108245	Inhibition of SRC at 10 uM	B	O=C1Cc2ccc(Nc3ccccc3)cc2Cc2ccccc21		CHEMBL1097086		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	3293266	CHEMBL1108245	Inhibition of SRC at 10 uM	B	Nc1ccccc1Nc1ccc2c(c1)CC(=O)c1ccccc1C2		CHEMBL1097087		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	3293282	CHEMBL1108245	Inhibition of SRC at 10 uM	B	Nc1cc(F)ccc1Nc1ccc2c(c1)CC(=O)c1ccccc1C2		CHEMBL1097088		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	3293298	CHEMBL1108245	Inhibition of SRC at 10 uM	B	O=C1Cc2cc(Nc3ccccc3)ccc2Cc2ccccc21		CHEMBL1096988		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	3293314	CHEMBL1108245	Inhibition of SRC at 10 uM	B	Nc1ccccc1Nc1ccc2c(c1)Oc1ccccc1NC2=O		CHEMBL1098461		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	3293330	CHEMBL1108245	Inhibition of SRC at 10 uM	B	Nc1cc(F)ccc1Nc1ccc2c(c1)Oc1ccccc1NC2=O		CHEMBL1098462		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	3293346	CHEMBL1108245	Inhibition of SRC at 10 uM	B	O=C1Cc2ccccc2Cc2cc(-c3ccccc3)ccc21		CHEMBL1096442		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	3293362	CHEMBL1108245	Inhibition of SRC at 10 uM	B	O=C1Cc2ccccc2Cc2cc(NCc3ccccc3)ccc21		CHEMBL1097171		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	3302210	CHEMBL1117888	Inhibition of SRC	B	CCn1cnc2c(Nc3ccc(P(=O)(O)CP(=O)(O)O)cc3)nc([C@H]3CC[C@H](N)CC3)nc21		CHEMBL1084268	=	IC50	nM	68.0	CHEMBL267	Homo sapiens	IC50	nM	68.0
	3302211	CHEMBL1117888	Inhibition of SRC	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	=	IC50	nM	2.7	CHEMBL267	Homo sapiens	IC50	nM	2.7
	3304846	CHEMBL1120009	Inhibition of SRC	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	=	Ki	nM	820.0	CHEMBL267	Homo sapiens	Ki	uM	0.82
	3306952	CHEMBL1118076	Inhibition of SRC at 3 uM	B	O=C(Nc1cc2cc[nH]c(=O)c2cc1Cl)C(NC1CC1)c1ccccc1		CHEMBL1084106	=	Inhibition	%	88.0	CHEMBL267	Homo sapiens	INH	%	88.0
	3307885	CHEMBL1119356	Inhibition of human cSRC	B	Cc1cn(-c2cc(NC(=O)Nc3ccc(-c4nc5[nH]ncc5[nH]4)c(C)c3)cc(C(F)(F)F)c2)cn1		CHEMBL1084036	=	Inhibition	%	20.0	CHEMBL267	Homo sapiens	INH	%	20.0
	3315015	CHEMBL1120228	Inhibition of SRC	B	CN1CCN(c2cccc(-c3cnn4c(N)c(-c5ccc(O)cc5)cnc34)c2)CC1		CHEMBL1083091	=	IC50	nM	442.0	CHEMBL267	Homo sapiens	IC50	nM	442.0
	3315019	CHEMBL1120228	Inhibition of SRC	B	CN1CCN(c2ccc(-c3cnn4c(N)c(-c5ccc(O)cc5)cnc34)cc2)CC1		CHEMBL1083092	=	IC50	nM	396.0	CHEMBL267	Homo sapiens	IC50	nM	396.0
	3315023	CHEMBL1120228	Inhibition of SRC	B	CN1CCN(c2cccc(-c3cnn4c(N)c(-c5ccc(NS(=O)(=O)c6cccc(Cl)c6Cl)cc5)cnc34)c2)CC1		CHEMBL1084974	>	IC50	nM	1000.0	CHEMBL267	Homo sapiens	IC50	nM	1000.0
	3315027	CHEMBL1120228	Inhibition of SRC	B	CN1CCN(c2cccc(-c3cnn4c(N)c(-c5ccc(NC(=O)CCC6CCCC6)cc5)cnc34)c2)CC1		CHEMBL1085316	=	IC50	nM	135.0	CHEMBL267	Homo sapiens	IC50	nM	135.0
	3315031	CHEMBL1120228	Inhibition of SRC	B	CN1CCN(c2cccc(-c3cnn4c(N)c(-c5ccc(NC(=O)c6ccc(C(F)(F)F)cc6)cc5)cnc34)c2)CC1		CHEMBL1085240	>	IC50	nM	1000.0	CHEMBL267	Homo sapiens	IC50	nM	1000.0
	3315035	CHEMBL1120228	Inhibition of SRC	B	CC(C)COC(=O)Nc1ccc(-c2cnc3c(-c4cccc(N5CCN(C)CC5)c4)cnn3c2N)cc1		CHEMBL1085317	=	IC50	nM	1706.0	CHEMBL267	Homo sapiens	IC50	nM	1706.0
	3315039	CHEMBL1120228	Inhibition of SRC	B	CN1CCN(c2cccc(-c3cnn4c(N)c(-c5ccc(NC(=O)Oc6ccccc6)cc5)cnc34)c2)CC1		CHEMBL1085564	=	IC50	nM	688.0	CHEMBL267	Homo sapiens	IC50	nM	688.0
	3315043	CHEMBL1120228	Inhibition of SRC	B	CN1CCN(c2cccc(-c3cnn4c(N)c(-c5ccc(NC(=O)Nc6ccccc6Cl)cc5)cnc34)c2)CC1		CHEMBL1085061	=	IC50	nM	1000.0	CHEMBL267	Homo sapiens	IC50	nM	1000.0
	3315047	CHEMBL1120228	Inhibition of SRC	B	CN1CCN(c2cccc(-c3cnn4c(N)c(-c5ccc(NC(=O)NCC6CCCCC6)cc5)cnc34)c2)CC1		CHEMBL1084028	=	IC50	nM	227.0	CHEMBL267	Homo sapiens	IC50	nM	227.0
	3315051	CHEMBL1120228	Inhibition of SRC	B	CN1CCN(c2cccc(-c3cnn4c(N)c(-c5ccc(NC(=O)N(C)C6CCCCC6)cc5)cnc34)c2)CC1		CHEMBL1084302	=	IC50	nM	554.0	CHEMBL267	Homo sapiens	IC50	nM	554.0
	3315055	CHEMBL1120228	Inhibition of SRC	B	CN1CCN(c2ccc(-c3cnn4c(N)c(-c5ccc(NC(=O)CCC6CCCC6)cc5)cnc34)cc2)CC1		CHEMBL1083001	=	IC50	nM	142.0	CHEMBL267	Homo sapiens	IC50	nM	142.0
	3315059	CHEMBL1120228	Inhibition of SRC	B	CN1CCN(c2ccc(-c3cnn4c(N)c(-c5ccc(NC(=O)c6ccc(C(F)(F)F)cc6)cc5)cnc34)cc2)CC1		CHEMBL1085733	=	IC50	nM	1000.0	CHEMBL267	Homo sapiens	IC50	nM	1000.0
	3315063	CHEMBL1120228	Inhibition of SRC	B	CC(C)COC(=O)Nc1ccc(-c2cnc3c(-c4ccc(N5CCN(C)CC5)cc4)cnn3c2N)cc1		CHEMBL1085511	=	IC50	nM	662.0	CHEMBL267	Homo sapiens	IC50	nM	662.0
	3315067	CHEMBL1120228	Inhibition of SRC	B	CN1CCN(c2ccc(-c3cnn4c(N)c(-c5ccc(NC(=O)Oc6ccccc6)cc5)cnc34)cc2)CC1		CHEMBL1085512	=	IC50	nM	394.0	CHEMBL267	Homo sapiens	IC50	nM	394.0
	3315071	CHEMBL1120228	Inhibition of SRC	B	CN1CCN(c2ccc(-c3cnn4c(N)c(-c5ccc(NC(=O)Nc6ccccc6Cl)cc5)cnc34)cc2)CC1		CHEMBL1084233	>	IC50	nM	1000.0	CHEMBL267	Homo sapiens	IC50	nM	1000.0
	3315075	CHEMBL1120228	Inhibition of SRC	B	CN1CCN(c2ccc(-c3cnn4c(N)c(-c5ccc(NC(=O)NCC6CCCCC6)cc5)cnc34)cc2)CC1		CHEMBL1084234	=	IC50	nM	143.0	CHEMBL267	Homo sapiens	IC50	nM	143.0
	3315079	CHEMBL1120228	Inhibition of SRC	B	CN1CCN(c2ccc(-c3cnn4c(N)c(-c5ccc(NC(=O)N(C)C6CCCCC6)cc5)cnc34)cc2)CC1		CHEMBL1082693	=	IC50	nM	497.0	CHEMBL267	Homo sapiens	IC50	nM	497.0
	3315097	CHEMBL1120228	Inhibition of SRC	B	Cc1nc2c(-c3cccc(N4CCN(C)CC4)c3)cnn2c(N)c1-c1ccc(NC(=O)OCC(C)C)cc1		CHEMBL1085995	>	IC50	nM	1000.0	CHEMBL267	Homo sapiens	IC50	nM	1000.0
	3315101	CHEMBL1120228	Inhibition of SRC	B	Cc1cc(NC(=O)OCC(C)C)ccc1-c1cnc2c(-c3cccc(N4CCN(C)CC4)c3)cnn2c1N		CHEMBL1085996	=	IC50	nM	462.0	CHEMBL267	Homo sapiens	IC50	nM	462.0
	3315105	CHEMBL1120228	Inhibition of SRC	B	COc1cc(-c2cnc3c(-c4cccc(N5CCN(C)CC5)c4)cnn3c2N)ccc1NC(=O)OCC(C)C		CHEMBL1083022	>	IC50	nM	1000.0	CHEMBL267	Homo sapiens	IC50	nM	1000.0
	3315109	CHEMBL1120228	Inhibition of SRC	B	CN1CCN(c2ccc(-c3cnn4c(N)c(-c5cccc(O)c5)cnc34)cc2)CC1		CHEMBL1083023	=	IC50	nM	2.0	CHEMBL267	Homo sapiens	IC50	nM	2.0
	3315113	CHEMBL1120228	Inhibition of SRC	B	Cc1nn2c(N)c(-c3cccc(O)c3)cnc2c1-c1ccc(N2CCN(C)CC2)cc1		CHEMBL1083344	>	IC50	nM	1000.0	CHEMBL267	Homo sapiens	IC50	nM	1000.0
	3315117	CHEMBL1120228	Inhibition of SRC	B	CC(C)COC(=O)Nc1ccc(-c2cnc3c(-c4cccc(N5CCNCC5)c4)cnn3c2N)cc1		CHEMBL1083644	=	IC50	nM	642.0	CHEMBL267	Homo sapiens	IC50	nM	642.0
	3315121	CHEMBL1120228	Inhibition of SRC	B	CC(C)COC(=O)Nc1ccc(-c2cnc3c(-c4cccc(N5CCN(S(C)(=O)=O)CC5)c4)cnn3c2N)cc1		CHEMBL1082403	>	IC50	nM	1000.0	CHEMBL267	Homo sapiens	IC50	nM	1000.0
	3315125	CHEMBL1120228	Inhibition of SRC	B	CC(C)COC(=O)Nc1ccc(-c2cnc3c(-c4cccc(N5CCN(C(=O)CN)CC5)c4)cnn3c2N)cc1		CHEMBL1082404	=	IC50	nM	762.0	CHEMBL267	Homo sapiens	IC50	nM	762.0
	3315129	CHEMBL1120228	Inhibition of SRC	B	COCCN1CCN(c2ccc(-c3cnn4c(N)c(-c5ccc(NC(=O)OCC(C)C)cc5)cnc34)cc2)CC1		CHEMBL1082958	=	IC50	nM	1000.0	CHEMBL267	Homo sapiens	IC50	nM	1000.0
	3315885	CHEMBL1120228	Inhibition of SRC	B	CC(C)COC(=O)Nc1ccc(-c2cnc3c(-c4cccc(N5CCOCC5)c4)cnn3c2N)cc1		CHEMBL1082959	>	IC50	nM	1000.0	CHEMBL267	Homo sapiens	IC50	nM	1000.0
	3316775	CHEMBL1120334	Inhibition of c-SRC at 1 uM	B	O=C(Nc1cccc(-n2ccc3c(NC(=O)c4ccccc4)nccc32)c1)c1ccc(N2CCOCC2)c(C(F)(F)F)c1		CHEMBL1084450	=	Inhibition	%	10.0	CHEMBL267	Homo sapiens	INH	%	10.0
	3327259	CHEMBL1168266	Inhibition of c-SRC at 10 uM by HotSpot assay	B	CC(=O)Nc1cccc(-c2ccc(-c3ccnc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)n3)cn2)c1.Cl		CHEMBL1164847	=	Inhibition	%	60.0	CHEMBL267	Homo sapiens	INH	%	60.0
	3332156	CHEMBL1167704	Inhibition of SRC at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL267	Homo sapiens	INH	%	50.0
	3333571	CHEMBL1167704	Inhibition of SRC at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL267	Homo sapiens	INH	%	50.0
	3334976	CHEMBL1167704	Inhibition of SRC at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL267	Homo sapiens	INH	%	50.0
	3336396	CHEMBL1167704	Inhibition of SRC at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL267	Homo sapiens	INH	%	50.0
	3337654	CHEMBL1167704	Inhibition of SRC at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL267	Homo sapiens	INH	%	50.0
	3338541	CHEMBL1166965	Inhibition of histidine-tagged human recombinant SRC expressed in baculovirus system assessed as [gamma32P]ATP utilization after 10 mins by liquid scintillation counting using ATP as substrate	B	Fc1ccc(C(Cl)Cn2ncc3c(Nc4cccc(F)c4)ncnc32)cc1		CHEMBL1165511	=	Ki	nM	100.0	CHEMBL267	Homo sapiens	Ki	uM	0.1
	3338542	CHEMBL1166965	Inhibition of histidine-tagged human recombinant SRC expressed in baculovirus system assessed as [gamma32P]ATP utilization after 10 mins by liquid scintillation counting using ATP as substrate	B	O=C(Nc1nnc(SCc2ccc(F)cc2)s1)c1ccc(F)cc1		CHEMBL255738	=	Ki	nM	550.0	CHEMBL267	Homo sapiens	Ki	uM	0.55
	3338985	CHEMBL1167704	Inhibition of SRC at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL267	Homo sapiens	INH	%	50.0
	3339240	CHEMBL1167704	Inhibition of SRC at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL267	Homo sapiens	INH	%	50.0
Active	3339666	CHEMBL1166967	Competitive inhibition of histidine-tagged human recombinant SRC expressed in baculovirus system by Lineweaver-Burke plot analysis using ATP as substrate	B	Fc1ccc(C(Cl)Cn2ncc3c(Nc4cccc(F)c4)ncnc32)cc1		CHEMBL1165511		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Active	3339667	CHEMBL1166968	Competitive inhibition of histidine-tagged human recombinant SRC expressed in baculovirus system by Lineweaver-Burke plot analysis using KVEKIGEGTYGVVYK as substrate	B	Fc1ccc(C(Cl)Cn2ncc3c(Nc4cccc(F)c4)ncnc32)cc1		CHEMBL1165511		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Active	3339668	CHEMBL1166967	Competitive inhibition of histidine-tagged human recombinant SRC expressed in baculovirus system by Lineweaver-Burke plot analysis using ATP as substrate	B	O=C(Nc1nnc(SCc2ccc(F)cc2)s1)c1ccc(F)cc1		CHEMBL255738		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Active	3339669	CHEMBL1166968	Competitive inhibition of histidine-tagged human recombinant SRC expressed in baculovirus system by Lineweaver-Burke plot analysis using KVEKIGEGTYGVVYK as substrate	B	O=C(Nc1nnc(SCc2ccc(F)cc2)s1)c1ccc(F)cc1		CHEMBL255738		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	3339679	CHEMBL1166966	Inhibition of histidine-tagged human recombinant SRC expressed in baculovirus system assessed as [gamma32P]ATP utilization after 10 mins by liquid scintillation counting using KVEKIGEGTYGVVYK as substrate	B	Fc1ccc(C(Cl)Cn2ncc3c(Nc4cccc(F)c4)ncnc32)cc1		CHEMBL1165511	=	Ki	nM	100.0	CHEMBL267	Homo sapiens	Ki	uM	0.1
	3339683	CHEMBL1166966	Inhibition of histidine-tagged human recombinant SRC expressed in baculovirus system assessed as [gamma32P]ATP utilization after 10 mins by liquid scintillation counting using KVEKIGEGTYGVVYK as substrate	B	O=C(Nc1nnc(SCc2ccc(F)cc2)s1)c1ccc(F)cc1		CHEMBL255738	=	Ki	nM	550.0	CHEMBL267	Homo sapiens	Ki	uM	0.55
	3340543	CHEMBL1167704	Inhibition of SRC at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	<	Inhibition	%	50.0	CHEMBL267	Homo sapiens	INH	%	50.0
	3341938	CHEMBL1167704	Inhibition of SRC at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL267	Homo sapiens	INH	%	50.0
	3343385	CHEMBL1167704	Inhibition of SRC at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL267	Homo sapiens	INH	%	50.0
	3344709	CHEMBL1167143	Inhibition of SRC assessed as residual activity at 10 uM after 80 mins by microplate scintillation counting	B	CN1CCN(c2ccc(NC(=O)c3ccc4c(c3)/C(=C3/Nc5ccccc5C3=O)C(=O)N4)cc2)CC1		CHEMBL1164526	=	Activity	%	271.0	CHEMBL267	Homo sapiens	Activity	%	271.0
	3344710	CHEMBL1167144	Inhibition of SRC assessed as residual activity at 1 uM after 80 mins by microplate scintillation counting	B	CN1CCN(c2ccc(NC(=O)c3ccc4c(c3)/C(=C3/Nc5ccccc5C3=O)C(=O)N4)cc2)CC1		CHEMBL1164526	=	Activity	%	132.0	CHEMBL267	Homo sapiens	Activity	%	132.0
	3351762	CHEMBL1175342	Inhibition of SRC at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	0.05	CHEMBL267	Homo sapiens	INH	%	0.05
Not Active	3352213	CHEMBL1175397	Inhibition of c-SRC at 10 uM	B	CC(=O)c1cc(C(=O)N2CC(O)C2)c(Nc2ccc(I)cc2F)n1C		CHEMBL1170191		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	3352214	CHEMBL1175397	Inhibition of c-SRC at 10 uM	B	CC(=O)c1cc(C(=O)N2CC(N)C2)c(Nc2ccc(I)cc2F)n1C		CHEMBL1172521		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	3352215	CHEMBL1175397	Inhibition of c-SRC at 10 uM	B	CC(=O)c1cc(C(=O)N2CC[C@@H](O)C2)c(Nc2ccc(I)cc2F)n1C		CHEMBL1169631		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	3354893	CHEMBL1174003	Inhibition of SRC at 10 uM by mobility shift assay	B	c1ccc(-c2cnc3cnc(-c4cc[nH]n4)cn23)cc1		CHEMBL1170750	=	Inhibition	%	43.0	CHEMBL267	Homo sapiens	INH	%	43.0
	3354894	CHEMBL1174003	Inhibition of SRC at 10 uM by mobility shift assay	B	c1ccc(-c2cnc3cnc(-c4cn[nH]c4)cn23)cc1		CHEMBL1172464	=	Inhibition	%	43.0	CHEMBL267	Homo sapiens	INH	%	43.0
	3354895	CHEMBL1174003	Inhibition of SRC at 10 uM by mobility shift assay	B	c1ccc(-c2cnc3cnc(-c4ccncc4)cn23)cc1		CHEMBL1170317	=	Inhibition	%	35.0	CHEMBL267	Homo sapiens	INH	%	35.0
	3354896	CHEMBL1174003	Inhibition of SRC at 10 uM by mobility shift assay	B	c1n[nH]cc1-c1cnc2ncc(-c3cn[nH]c3)n2c1		CHEMBL1171532	=	Inhibition	%	75.0	CHEMBL267	Homo sapiens	INH	%	75.0
	3354897	CHEMBL1174003	Inhibition of SRC at 10 uM by mobility shift assay	B	Cn1cc(-c2cnc3ncc(-c4cn[nH]c4)cn23)cn1		CHEMBL1171533	=	Inhibition	%	46.0	CHEMBL267	Homo sapiens	INH	%	46.0
	3354898	CHEMBL1174003	Inhibition of SRC at 10 uM by mobility shift assay	B	c1cc(-c2cnc3ncc(-c4cn[nH]c4)cn23)n[nH]1		CHEMBL1171534	=	Inhibition	%	85.0	CHEMBL267	Homo sapiens	INH	%	85.0
	3354899	CHEMBL1174003	Inhibition of SRC at 10 uM by mobility shift assay	B	OCc1cccc(-c2cnc3ncc(-c4cn[nH]c4)cn23)c1		CHEMBL1171699	=	Inhibition	%	39.0	CHEMBL267	Homo sapiens	INH	%	39.0
	3354900	CHEMBL1174003	Inhibition of SRC at 10 uM by mobility shift assay	B	c1ccc2c(-c3cnc4cnc(-c5cn[nH]c5)cn34)c[nH]c2c1		CHEMBL1170126	=	Inhibition	%	74.0	CHEMBL267	Homo sapiens	INH	%	74.0
	3354901	CHEMBL1174003	Inhibition of SRC at 10 uM by mobility shift assay	B	NCc1ccc(-c2cn3c(-c4cn[nH]c4)cnc3cn2)cc1		CHEMBL1170747	=	Inhibition	%	97.0	CHEMBL267	Homo sapiens	INH	%	97.0
	3354902	CHEMBL1174003	Inhibition of SRC at 10 uM by mobility shift assay	B	OCc1cccc(-c2cn3c(-c4cn[nH]c4)cnc3cn2)c1		CHEMBL1170748	=	Inhibition	%	97.0	CHEMBL267	Homo sapiens	INH	%	97.0
	3354903	CHEMBL1174003	Inhibition of SRC at 10 uM by mobility shift assay	B	OCc1ccc(-c2cn3c(-c4cn[nH]c4)cnc3cn2)cc1		CHEMBL1170749	=	Inhibition	%	94.0	CHEMBL267	Homo sapiens	INH	%	94.0
	3354933	CHEMBL1174003	Inhibition of SRC at 10 uM by mobility shift assay	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Inhibition	%	21.0	CHEMBL267	Homo sapiens	INH	%	21.0
	3358814	CHEMBL1175342	Inhibition of SRC at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
Dose-dependent effect	3359771	CHEMBL1177633	Inhibition of human SRC-mediated migration of human MDA-MB-231 cells by Western blotting	B	NS(=O)(=O)c1ccc(Nc2nc(N3CCOCC3)nc3[nH]cnc23)cc1		CHEMBL1172957		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Dose-dependent effect	3359772	CHEMBL1177631	Inhibition of SRC phosphorylation in human MDA-MB-231 cells	B	NS(=O)(=O)c1ccc(Nc2nc(N3CCOCC3)nc3[nH]cnc23)cc1		CHEMBL1172957		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Dose-dependent effect	3359791	CHEMBL1177634	Inhibition of human SRC-mediated invasion of human MDA-MB-231 cells	B	NS(=O)(=O)c1ccc(Nc2nc(N3CCOCC3)nc3[nH]cnc23)cc1		CHEMBL1172957		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	3359798	CHEMBL1177351	Inhibition cSRC at 10 uM	B	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	=	Inhibition	%	99.0	CHEMBL267	Homo sapiens	INH	%	99.0
	3359799	CHEMBL1177350	Inhibition cSRC	B	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	=	IC50	nM	50.0	CHEMBL267	Homo sapiens	IC50	uM	0.05
	3359800	CHEMBL1177350	Inhibition cSRC	B	c1ccc(Cn2cnc3c(N4CCOCC4)ncnc32)cc1		CHEMBL1171261	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	3359801	CHEMBL1177350	Inhibition cSRC	B	Brc1ccc(Nc2ncnc3c2ncn3Cc2ccccc2)cc1		CHEMBL1173318	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	3359802	CHEMBL1177350	Inhibition cSRC	B	c1ccc(Cn2cnc3c(Nc4ccccc4)ncnc32)cc1		CHEMBL345677	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	3359803	CHEMBL1177350	Inhibition cSRC	B	c1ccc(Cn2cnc3c(N4CCOCC4)nc(N4CCOCC4)nc32)cc1		CHEMBL1173419	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	3359804	CHEMBL1177350	Inhibition cSRC	B	Brc1ccc(Nc2nc(N3CCOCC3)nc3c2ncn3Cc2ccccc2)cc1		CHEMBL1173420	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	3359805	CHEMBL1177350	Inhibition cSRC	B	c1ccc(Cn2cnc3c(Nc4ccccc4)nc(N4CCOCC4)nc32)cc1		CHEMBL1173421	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	3359806	CHEMBL1177350	Inhibition cSRC	B	c1ccc(Cn2cnc3c(Nc4ccccc4)nc(N4CCNCC4)nc32)cc1		CHEMBL1173422	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	3359807	CHEMBL1177350	Inhibition cSRC	B	COc1ccc(Nc2nc(N3CCOCC3)nc3c2ncn3Cc2ccccc2)cc1		CHEMBL1172968	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	3359808	CHEMBL1177350	Inhibition cSRC	B	COc1ccc(Nc2nc(N3CCNCC3)nc3c2ncn3Cc2ccccc2)cc1		CHEMBL1173031	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	3359809	CHEMBL1177350	Inhibition cSRC	B	Cc1cccc(Nc2nc(N3CCNCC3)nc3[nH]cnc23)c1		CHEMBL1173736	=	IC50	nM	2420.0	CHEMBL267	Homo sapiens	IC50	uM	2.42
	3359810	CHEMBL1177350	Inhibition cSRC	B	COc1ccc(Nc2nc(N3CCNCC3)nc3[nH]cnc23)cc1		CHEMBL1173735	=	IC50	nM	2430.0	CHEMBL267	Homo sapiens	IC50	uM	2.43
	3359811	CHEMBL1177351	Inhibition cSRC at 10 uM	B	c1ccc(Cn2cnc3c(N4CCOCC4)ncnc32)cc1		CHEMBL1171261	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	3359812	CHEMBL1177351	Inhibition cSRC at 10 uM	B	Brc1ccc(Nc2ncnc3c2ncn3Cc2ccccc2)cc1		CHEMBL1173318	=	Inhibition	%	6.9	CHEMBL267	Homo sapiens	INH	%	6.9
	3359813	CHEMBL1177351	Inhibition cSRC at 10 uM	B	c1ccc(Cn2cnc3c(Nc4ccccc4)ncnc32)cc1		CHEMBL345677	=	Inhibition	%	13.9	CHEMBL267	Homo sapiens	INH	%	13.9
	3359814	CHEMBL1177351	Inhibition cSRC at 10 uM	B	c1ccc(Cn2cnc3c(N4CCOCC4)nc(N4CCOCC4)nc32)cc1		CHEMBL1173419	=	Inhibition	%	16.4	CHEMBL267	Homo sapiens	INH	%	16.4
	3359815	CHEMBL1177351	Inhibition cSRC at 10 uM	B	Brc1ccc(Nc2nc(N3CCOCC3)nc3c2ncn3Cc2ccccc2)cc1		CHEMBL1173420	=	Inhibition	%	10.1	CHEMBL267	Homo sapiens	INH	%	10.1
	3359816	CHEMBL1177351	Inhibition cSRC at 10 uM	B	c1ccc(Cn2cnc3c(Nc4ccccc4)nc(N4CCOCC4)nc32)cc1		CHEMBL1173421	=	Inhibition	%	20.2	CHEMBL267	Homo sapiens	INH	%	20.2
	3359817	CHEMBL1177351	Inhibition cSRC at 10 uM	B	c1ccc(Cn2cnc3c(Nc4ccccc4)nc(N4CCNCC4)nc32)cc1		CHEMBL1173422	=	Inhibition	%	35.8	CHEMBL267	Homo sapiens	INH	%	35.8
	3359818	CHEMBL1177351	Inhibition cSRC at 10 uM	B	COc1ccc(Nc2nc(N3CCOCC3)nc3c2ncn3Cc2ccccc2)cc1		CHEMBL1172968	=	Inhibition	%	16.0	CHEMBL267	Homo sapiens	INH	%	16.0
	3359819	CHEMBL1177351	Inhibition cSRC at 10 uM	B	COc1ccc(Nc2nc(N3CCNCC3)nc3c2ncn3Cc2ccccc2)cc1		CHEMBL1173031	=	Inhibition	%	22.5	CHEMBL267	Homo sapiens	INH	%	22.5
	3359820	CHEMBL1177351	Inhibition cSRC at 10 uM	B	Cc1cccc(Nc2nc(N3CCNCC3)nc3[nH]cnc23)c1		CHEMBL1173736	=	Inhibition	%	86.6	CHEMBL267	Homo sapiens	INH	%	86.6
	3359821	CHEMBL1177351	Inhibition cSRC at 10 uM	B	COc1ccc(Nc2nc(N3CCNCC3)nc3[nH]cnc23)cc1		CHEMBL1173735	=	Inhibition	%	90.5	CHEMBL267	Homo sapiens	INH	%	90.5
	3359823	CHEMBL1177350	Inhibition cSRC	B	COc1cccc(Nc2nc(N3CCNCC3)nc3[nH]cnc23)c1		CHEMBL1173805	=	IC50	nM	1210.0	CHEMBL267	Homo sapiens	IC50	uM	1.21
	3359824	CHEMBL1177350	Inhibition cSRC	B	Clc1ccc(Nc2nc(N3CCNCC3)nc3[nH]cnc23)cc1		CHEMBL1173114	=	IC50	nM	1180.0	CHEMBL267	Homo sapiens	IC50	uM	1.18
	3359825	CHEMBL1177350	Inhibition cSRC	B	Brc1ccc(Nc2nc(N3CCNCC3)nc3[nH]cnc23)cc1		CHEMBL1172708	=	IC50	nM	1760.0	CHEMBL267	Homo sapiens	IC50	uM	1.76
	3359826	CHEMBL1177350	Inhibition cSRC	B	O=[N+]([O-])c1ccc(Nc2nc(N3CCNCC3)nc3[nH]cnc23)cc1		CHEMBL1172709	=	IC50	nM	1400.0	CHEMBL267	Homo sapiens	IC50	uM	1.4
	3359827	CHEMBL1177350	Inhibition cSRC	B	O=[N+]([O-])c1cccc(Nc2nc(N3CCNCC3)nc3[nH]cnc23)c1		CHEMBL1172710	=	IC50	nM	950.0	CHEMBL267	Homo sapiens	IC50	uM	0.95
	3359828	CHEMBL1177350	Inhibition cSRC	B	NS(=O)(=O)c1ccc(Nc2nc(N3CCNCC3)nc3[nH]cnc23)cc1		CHEMBL1172711	=	IC50	nM	1820.0	CHEMBL267	Homo sapiens	IC50	uM	1.82
	3359829	CHEMBL1177350	Inhibition cSRC	B	NS(=O)(=O)c1cccc(Nc2nc(N3CCNCC3)nc3[nH]cnc23)c1		CHEMBL1173309	=	IC50	nM	100.0	CHEMBL267	Homo sapiens	IC50	uM	0.1
	3359830	CHEMBL1177350	Inhibition cSRC	B	NC(=O)c1ccc(Nc2nc(N3CCNCC3)nc3[nH]cnc23)cc1		CHEMBL1173310	=	IC50	nM	2200.0	CHEMBL267	Homo sapiens	IC50	uM	2.2
	3359831	CHEMBL1177350	Inhibition cSRC	B	CC(=O)Nc1ccc(Nc2nc(N3CCNCC3)nc3[nH]cnc23)cc1		CHEMBL1173311	=	IC50	nM	1050.0	CHEMBL267	Homo sapiens	IC50	uM	1.05
	3359832	CHEMBL1177350	Inhibition cSRC	B	c1ccc(Nc2nc(N3CCOCC3)nc3[nH]cnc23)cc1		CHEMBL1173388	=	IC50	nM	750.0	CHEMBL267	Homo sapiens	IC50	uM	0.75
	3359833	CHEMBL1177350	Inhibition cSRC	B	COc1ccc(Nc2nc(N3CCOCC3)nc3[nH]cnc23)cc1		CHEMBL1173389	=	IC50	nM	130.0	CHEMBL267	Homo sapiens	IC50	uM	0.13
	3359834	CHEMBL1177350	Inhibition cSRC	B	COc1cccc(Nc2nc(N3CCOCC3)nc3[nH]cnc23)c1		CHEMBL1173484	=	IC50	nM	930.0	CHEMBL267	Homo sapiens	IC50	uM	0.93
	3359835	CHEMBL1177350	Inhibition cSRC	B	Cc1cccc(Nc2nc(N3CCOCC3)nc3[nH]cnc23)c1		CHEMBL1173485	=	IC50	nM	830.0	CHEMBL267	Homo sapiens	IC50	uM	0.83
	3359836	CHEMBL1177350	Inhibition cSRC	B	Clc1ccc(Nc2nc(N3CCOCC3)nc3[nH]cnc23)cc1		CHEMBL1173486	=	IC50	nM	340.0	CHEMBL267	Homo sapiens	IC50	uM	0.34
	3359837	CHEMBL1177350	Inhibition cSRC	B	Brc1ccc(Nc2nc(N3CCOCC3)nc3[nH]cnc23)cc1		CHEMBL1173552	=	IC50	nM	450.0	CHEMBL267	Homo sapiens	IC50	uM	0.45
	3359838	CHEMBL1177350	Inhibition cSRC	B	O=[N+]([O-])c1ccc(Nc2nc(N3CCOCC3)nc3[nH]cnc23)cc1		CHEMBL1173553	=	IC50	nM	390.0	CHEMBL267	Homo sapiens	IC50	uM	0.39
	3359839	CHEMBL1177350	Inhibition cSRC	B	O=[N+]([O-])c1cccc(Nc2nc(N3CCOCC3)nc3[nH]cnc23)c1		CHEMBL1173115	=	IC50	nM	130.0	CHEMBL267	Homo sapiens	IC50	uM	0.13
	3359840	CHEMBL1177350	Inhibition cSRC	B	NS(=O)(=O)c1ccc(Nc2nc(N3CCOCC3)nc3[nH]cnc23)cc1		CHEMBL1172957	=	IC50	nM	20.0	CHEMBL267	Homo sapiens	IC50	uM	0.02
	3359841	CHEMBL1177350	Inhibition cSRC	B	NS(=O)(=O)c1cccc(Nc2nc(N3CCOCC3)nc3[nH]cnc23)c1		CHEMBL1172958	=	IC50	nM	120.0	CHEMBL267	Homo sapiens	IC50	uM	0.12
	3359842	CHEMBL1177350	Inhibition cSRC	B	NC(=O)c1ccc(Nc2nc(N3CCOCC3)nc3[nH]cnc23)cc1		CHEMBL1172959	=	IC50	nM	2010.0	CHEMBL267	Homo sapiens	IC50	uM	2.01
	3359843	CHEMBL1177350	Inhibition cSRC	B	CC(=O)Nc1ccc(Nc2nc(N3CCOCC3)nc3[nH]cnc23)cc1		CHEMBL1173659	=	IC50	nM	650.0	CHEMBL267	Homo sapiens	IC50	uM	0.65
	3359844	CHEMBL1177350	Inhibition cSRC	B	OCCN1CCN(c2nc(Nc3ccccc3)c3nc[nH]c3n2)CC1		CHEMBL1173660	=	IC50	nM	3140.0	CHEMBL267	Homo sapiens	IC50	uM	3.14
	3359845	CHEMBL1177350	Inhibition cSRC	B	COc1ccc(Nc2nc(N3CCN(CCO)CC3)nc3[nH]cnc23)cc1		CHEMBL1173177	=	IC50	nM	1330.0	CHEMBL267	Homo sapiens	IC50	uM	1.33
	3359846	CHEMBL1177350	Inhibition cSRC	B	COc1cccc(Nc2nc(N3CCN(CCO)CC3)nc3[nH]cnc23)c1		CHEMBL1173247	=	IC50	nM	1200.0	CHEMBL267	Homo sapiens	IC50	uM	1.2
	3359847	CHEMBL1177350	Inhibition cSRC	B	Cc1cccc(Nc2nc(N3CCN(CCO)CC3)nc3[nH]cnc23)c1		CHEMBL1172769	=	IC50	nM	2550.0	CHEMBL267	Homo sapiens	IC50	uM	2.55
	3359848	CHEMBL1177350	Inhibition cSRC	B	OCCN1CCN(c2nc(Nc3ccc(Cl)cc3)c3nc[nH]c3n2)CC1		CHEMBL1172770	=	IC50	nM	690.0	CHEMBL267	Homo sapiens	IC50	uM	0.69
	3359849	CHEMBL1177350	Inhibition cSRC	B	O=[N+]([O-])c1ccc(Nc2nc(N3CCN(CCO)CC3)nc3[nH]cnc23)cc1		CHEMBL1172839	=	IC50	nM	780.0	CHEMBL267	Homo sapiens	IC50	uM	0.78
	3359850	CHEMBL1177350	Inhibition cSRC	B	O=[N+]([O-])c1cccc(Nc2nc(N3CCN(CCO)CC3)nc3[nH]cnc23)c1		CHEMBL1173225	=	IC50	nM	340.0	CHEMBL267	Homo sapiens	IC50	uM	0.34
	3359851	CHEMBL1177350	Inhibition cSRC	B	NS(=O)(=O)c1ccc(Nc2nc(N3CCN(CCO)CC3)nc3[nH]cnc23)cc1		CHEMBL1173298	=	IC50	nM	260.0	CHEMBL267	Homo sapiens	IC50	uM	0.26
	3359852	CHEMBL1177350	Inhibition cSRC	B	NS(=O)(=O)c1cccc(Nc2nc(N3CCN(CCO)CC3)nc3[nH]cnc23)c1		CHEMBL1173299	=	IC50	nM	340.0	CHEMBL267	Homo sapiens	IC50	uM	0.34
	3359853	CHEMBL1177350	Inhibition cSRC	B	NC(=O)c1ccc(Nc2nc(N3CCN(CCO)CC3)nc3[nH]cnc23)cc1		CHEMBL1173300	=	IC50	nM	1220.0	CHEMBL267	Homo sapiens	IC50	uM	1.22
	3359854	CHEMBL1177350	Inhibition cSRC	B	CC(=O)Nc1ccc(Nc2nc(N3CCN(CCO)CC3)nc3[nH]cnc23)cc1		CHEMBL1172960	=	IC50	nM	1590.0	CHEMBL267	Homo sapiens	IC50	uM	1.59
	3396633	CHEMBL1220465	Inhibition of wild type cSrc	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2cccc(N)c2)n1		CHEMBL498947	=	IC50	nM	32100.0	CHEMBL267	Homo sapiens	IC50	uM	32.1
	3396634	CHEMBL1220465	Inhibition of wild type cSrc	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	IC50	nM	0.4	CHEMBL267	Homo sapiens	IC50	uM	0.0004
	3396635	CHEMBL1220465	Inhibition of wild type cSrc	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	6.3	CHEMBL267	Homo sapiens	IC50	uM	0.0063
Not Active	3396636	CHEMBL1220465	Inhibition of wild type cSrc	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2c(Cl)cc(C(F)(F)F)cc2Cl)n1		CHEMBL584726		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	3396637	CHEMBL1220465	Inhibition of wild type cSrc	B	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc([N+](=O)[O-])c2)n1		CHEMBL578172		IC50			CHEMBL267	Homo sapiens	IC50		
	3396638	CHEMBL1220465	Inhibition of wild type cSrc	B	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(N)c2)n1		CHEMBL522387	=	IC50	nM	64100.0	CHEMBL267	Homo sapiens	IC50	uM	64.1
	3396639	CHEMBL1220466	Binding affinity to wild type cSrc by fluorescence based binding assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	8.0	CHEMBL267	Homo sapiens	Kd	uM	0.008
Not Determined	3396640	CHEMBL1220465	Inhibition of wild type cSrc	B	CC(C)(C)c1cc(NC(=O)Nc2ccccc2)n(-c2cccc(N)c2)n1		CHEMBL87580		IC50			CHEMBL267	Homo sapiens	IC50		
	3396641	CHEMBL1220467	Binding affinity to wild type cSrc at 50 uM by fluorescence based binding assay relative to imatinib	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2cccc(N)c2)n1		CHEMBL498947	=	Activity	%	35.0	CHEMBL267	Homo sapiens	Activity	%	35.0
Not Active	3396642	CHEMBL1220467	Binding affinity to wild type cSrc at 50 uM by fluorescence based binding assay relative to imatinib	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2c(Cl)cc(C(F)(F)F)cc2Cl)n1		CHEMBL584726		Activity			CHEMBL267	Homo sapiens	Activity		
	3396643	CHEMBL1220467	Binding affinity to wild type cSrc at 50 uM by fluorescence based binding assay relative to imatinib	B	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc([N+](=O)[O-])c2)n1		CHEMBL578172	=	Activity	%	34.0	CHEMBL267	Homo sapiens	Activity	%	34.0
	3396644	CHEMBL1220467	Binding affinity to wild type cSrc at 50 uM by fluorescence based binding assay relative to imatinib	B	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(N)c2)n1		CHEMBL522387	=	Activity	%	26.0	CHEMBL267	Homo sapiens	Activity	%	26.0
	3396645	CHEMBL1220467	Binding affinity to wild type cSrc at 50 uM by fluorescence based binding assay relative to imatinib	B	CC(C)(C)c1cc(NC(=O)Nc2ccccc2)n(-c2cccc(N)c2)n1		CHEMBL87580	=	Activity	%	18.0	CHEMBL267	Homo sapiens	Activity	%	18.0
	3396646	CHEMBL1220466	Binding affinity to wild type cSrc by fluorescence based binding assay	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	11.0	CHEMBL267	Homo sapiens	Kd	uM	0.011
	3396654	CHEMBL1220469	Binding affinity to acrylodan-labelled cSrc assessed as binding half life at 2 uM	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2cccc(N)c2)n1		CHEMBL498947	=	T1/2	hr	0.001486	CHEMBL267	Homo sapiens	t1/2	s	5.35
	3419090	CHEMBL1228767	Inhibition of c-Src at 100 uM	B	NC(=O)c1sc2c([N+](=O)[O-])cc(C(F)(F)F)cc2[n+]1[O-]		CHEMBL476124	<	Inhibition	%	50.0	CHEMBL267	Homo sapiens	INH	%	50.0
	3419470	CHEMBL1226202	Inhibition of c-src S345C mutant by radioactive phosphotransfer assay	B	C=CC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL285063	=	IC50	nM	73.0	CHEMBL267	Homo sapiens	IC50	uM	0.073
	3419473	CHEMBL1226202	Inhibition of c-src S345C mutant by radioactive phosphotransfer assay	B	C=CC(=O)Nc1ccc2ncnc(Nc3ccccc3)c2c1		CHEMBL1221699	=	IC50	nM	126.0	CHEMBL267	Homo sapiens	IC50	uM	0.126
	3419478	CHEMBL1226202	Inhibition of c-src S345C mutant by radioactive phosphotransfer assay	B	C=CC(=O)Nc1ccc2ncnc(Nc3ccc(Br)cc3)c2c1		CHEMBL1221701	=	IC50	nM	294.0	CHEMBL267	Homo sapiens	IC50	uM	0.294
	3419481	CHEMBL1226202	Inhibition of c-src S345C mutant by radioactive phosphotransfer assay	B	C=CC(=O)Nc1ccc2ncnc(Nc3ccc(-c4ccccc4)cc3)c2c1		CHEMBL1221767	=	IC50	nM	387.0	CHEMBL267	Homo sapiens	IC50	uM	0.387
	3419482	CHEMBL1226202	Inhibition of c-src S345C mutant by radioactive phosphotransfer assay	B	C=CC(=O)Nc1ccc2ncnc(NCCc3ccccc3)c2c1		CHEMBL1221822	=	IC50	nM	436.0	CHEMBL267	Homo sapiens	IC50	uM	0.436
	3419483	CHEMBL1226202	Inhibition of c-src S345C mutant by radioactive phosphotransfer assay	B	C=CC(=O)Nc1ccc2ncnc(NCc3cccc4ccccc34)c2c1		CHEMBL1221415	=	IC50	nM	477.0	CHEMBL267	Homo sapiens	IC50	uM	0.477
	3419485	CHEMBL1226202	Inhibition of c-src S345C mutant by radioactive phosphotransfer assay	B	C=CC(=O)Nc1ccc2ncnc(Nc3cccc4ccccc34)c2c1		CHEMBL1221770	=	IC50	nM	820.0	CHEMBL267	Homo sapiens	IC50	uM	0.82
	3419486	CHEMBL1226202	Inhibition of c-src S345C mutant by radioactive phosphotransfer assay	B	C=CC(=O)Nc1ccc2ncnc(Nc3ccc4ccccc4c3)c2c1		CHEMBL1221769	=	IC50	nM	852.0	CHEMBL267	Homo sapiens	IC50	uM	0.852
	3419491	CHEMBL1226202	Inhibition of c-src S345C mutant by radioactive phosphotransfer assay	B	C=CC(=O)Nc1ccc2ncnc(Nc3ccc(C(C)C)cc3)c2c1		CHEMBL1221768	=	IC50	nM	3500.0	CHEMBL267	Homo sapiens	IC50	uM	3.5
	3419492	CHEMBL1226202	Inhibition of c-src S345C mutant by radioactive phosphotransfer assay	B	C=CC(=O)Nc1ccc2ncnc(Nc3ccc(C(C)(C)C)cc3)c2c1		CHEMBL1221700	=	IC50	nM	5290.0	CHEMBL267	Homo sapiens	IC50	uM	5.29
	3419493	CHEMBL1226200	Inhibition of c-src in by radioactive phosphotransfer assay	B	C=CC(=O)Nc1ccc2ncnc(Nc3cccc4ccccc34)c2c1		CHEMBL1221770	=	IC50	nM	16300.0	CHEMBL267	Homo sapiens	IC50	uM	16.3
	3419494	CHEMBL1226200	Inhibition of c-src in by radioactive phosphotransfer assay	B	C=CC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL285063	>	IC50	nM	27000.0	CHEMBL267	Homo sapiens	IC50	uM	27.0
	3419495	CHEMBL1226200	Inhibition of c-src in by radioactive phosphotransfer assay	B	C=CC(=O)Nc1ccc2ncnc(Nc3ccccc3)c2c1		CHEMBL1221699	>	IC50	nM	27000.0	CHEMBL267	Homo sapiens	IC50	uM	27.0
	3419496	CHEMBL1226200	Inhibition of c-src in by radioactive phosphotransfer assay	B	C=CC(=O)Nc1ccc2ncnc(Nc3ccc(C(C)(C)C)cc3)c2c1		CHEMBL1221700	>	IC50	nM	27000.0	CHEMBL267	Homo sapiens	IC50	uM	27.0
	3419497	CHEMBL1226200	Inhibition of c-src in by radioactive phosphotransfer assay	B	C=CC(=O)Nc1ccc2ncnc(Nc3ccc(Br)cc3)c2c1		CHEMBL1221701	>	IC50	nM	27000.0	CHEMBL267	Homo sapiens	IC50	uM	27.0
	3419498	CHEMBL1226200	Inhibition of c-src in by radioactive phosphotransfer assay	B	C=CC(=O)Nc1ccc2ncnc(Nc3ccc(-c4ccccc4)cc3)c2c1		CHEMBL1221767	>	IC50	nM	27000.0	CHEMBL267	Homo sapiens	IC50	uM	27.0
	3419499	CHEMBL1226200	Inhibition of c-src in by radioactive phosphotransfer assay	B	C=CC(=O)Nc1ccc2ncnc(Nc3ccc(C(C)C)cc3)c2c1		CHEMBL1221768	>	IC50	nM	27000.0	CHEMBL267	Homo sapiens	IC50	uM	27.0
	3419500	CHEMBL1226200	Inhibition of c-src in by radioactive phosphotransfer assay	B	C=CC(=O)Nc1ccc2ncnc(Nc3ccc4ccccc4c3)c2c1		CHEMBL1221769	>	IC50	nM	27000.0	CHEMBL267	Homo sapiens	IC50	uM	27.0
	3419501	CHEMBL1226200	Inhibition of c-src in by radioactive phosphotransfer assay	B	C=CC(=O)Nc1ccc2ncnc(NCc3cccc4ccccc34)c2c1		CHEMBL1221415	>	IC50	nM	27000.0	CHEMBL267	Homo sapiens	IC50	uM	27.0
	3419502	CHEMBL1226200	Inhibition of c-src in by radioactive phosphotransfer assay	B	C=CC(=O)Nc1ccc2ncnc(NCCc3ccccc3)c2c1		CHEMBL1221822	>	IC50	nM	27000.0	CHEMBL267	Homo sapiens	IC50	uM	27.0
	3419503	CHEMBL1226200	Inhibition of c-src in by radioactive phosphotransfer assay	B	CCC(=O)Nc1ccc2ncnc(Nc3ccc(C(C)(C)C)cc3)c2c1		CHEMBL1221823	>	IC50	nM	27000.0	CHEMBL267	Homo sapiens	IC50	uM	27.0
	3419504	CHEMBL1226202	Inhibition of c-src S345C mutant by radioactive phosphotransfer assay	B	CCC(=O)Nc1ccc2ncnc(Nc3ccc(C(C)(C)C)cc3)c2c1		CHEMBL1221823	>	IC50	nM	27000.0	CHEMBL267	Homo sapiens	IC50	uM	27.0
	3439115	CHEMBL1247962	Inhibition of Src by HTRF assay	B	CNc1nccc(-c2cccnc2Oc2ccc(NC(=O)c3cccc(C(F)(F)F)c3)cc2C)n1		CHEMBL1242977	=	IC50	nM	5750.0	CHEMBL267	Homo sapiens	IC50	nM	5750.0
	3440707	CHEMBL1243631	Inhibition of human GST-fused Src-mediated Poly Glu4Tyr phosphorylation by ELISA	B	Oc1ccc(CNc2ccc3c(c2)OCO3)cc1O		CHEMBL1240829	=	IC50	nM	1860.0	CHEMBL267	Homo sapiens	IC50	uM	1.86
	3440708	CHEMBL1243631	Inhibition of human GST-fused Src-mediated Poly Glu4Tyr phosphorylation by ELISA	B	Oc1ccc(CN(Cc2ccc(O)c(O)c2)c2ccc3c(c2)OCO3)cc1O		CHEMBL551264	=	IC50	nM	830.0	CHEMBL267	Homo sapiens	IC50	uM	0.83
Not Determined	3440709	CHEMBL1243631	Inhibition of human GST-fused Src-mediated Poly Glu4Tyr phosphorylation by ELISA	B	Oc1ccc(CNc2ccc3cn[nH]c3c2)cc1O		CHEMBL1240676		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	3440710	CHEMBL1243631	Inhibition of human GST-fused Src-mediated Poly Glu4Tyr phosphorylation by ELISA	B	Oc1ccc(CN(Cc2ccc(O)c(O)c2)c2ccc3cn[nH]c3c2)cc1O		CHEMBL1241669		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	3440711	CHEMBL1243631	Inhibition of human GST-fused Src-mediated Poly Glu4Tyr phosphorylation by ELISA	B	Oc1ccc(CNc2ccc3ccccc3c2)cc1O		CHEMBL1240677		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	3440712	CHEMBL1243631	Inhibition of human GST-fused Src-mediated Poly Glu4Tyr phosphorylation by ELISA	B	Oc1ccc(CN(Cc2ccc(O)c(O)c2)c2ccc3ccccc3c2)cc1O		CHEMBL1241670		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	3440713	CHEMBL1243631	Inhibition of human GST-fused Src-mediated Poly Glu4Tyr phosphorylation by ELISA	B	CC(=O)Oc1ccc(CNc2ccc3c(c2)OCO3)cc1OC(C)=O		CHEMBL1241764		IC50			CHEMBL267	Homo sapiens	IC50		
	3440723	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc(O)cc(Br)c2)c2c(N)ncnc21		CHEMBL1242285	=	IC50	nM	31.0	CHEMBL267	Homo sapiens	IC50	uM	0.031
	3440737	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COCOc1cc(-c2nn(C(C)C)c3ncnc(N)c23)ccc1Br		CHEMBL1242286	=	IC50	nM	72.0	CHEMBL267	Homo sapiens	IC50	uM	0.072
	3440751	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241299	=	IC50	nM	61.0	CHEMBL267	Homo sapiens	IC50	uM	0.061
	3440765	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(Br)c(O)c1)nn2C1CCC1		CHEMBL1242287	=	IC50	nM	9.5	CHEMBL267	Homo sapiens	IC50	uM	0.0095
	3440779	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(Br)c(O)c1)nn2C1CCCC1		CHEMBL1242376	=	IC50	nM	11.0	CHEMBL267	Homo sapiens	IC50	uM	0.011
	3440793	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(F)c(O)c2)c2c(N)ncnc21		CHEMBL1242377	=	IC50	nM	6.9	CHEMBL267	Homo sapiens	IC50	uM	0.0069
	3440807	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	C[C@H](CN)n1nc(-c2ccc(F)c(O)c2)c2c(N)ncnc21		CHEMBL1242378	=	IC50	nM	101.0	CHEMBL267	Homo sapiens	IC50	uM	0.101
	3440821	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	C[C@@H](CN)n1nc(-c2ccc(F)c(O)c2)c2c(N)ncnc21		CHEMBL1242468	=	IC50	nM	405.0	CHEMBL267	Homo sapiens	IC50	uM	0.405
	3440835	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	N#CCCCn1nc(-c2ccc(F)c(O)c2)c2c(N)ncnc21		CHEMBL1242469	=	IC50	nM	90.0	CHEMBL267	Homo sapiens	IC50	uM	0.09
	3440849	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	N#CCCCCn1nc(-c2ccc(F)c(O)c2)c2c(N)ncnc21		CHEMBL1242470	=	IC50	nM	18.0	CHEMBL267	Homo sapiens	IC50	uM	0.018
	3440863	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(F)c(O)c1)nn2C1CCC1		CHEMBL1242566	=	IC50	nM	24.0	CHEMBL267	Homo sapiens	IC50	uM	0.024
	3440877	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(F)c(O)c1)nn2C1CNC1		CHEMBL1242567	=	IC50	nM	17.0	CHEMBL267	Homo sapiens	IC50	uM	0.017
	3440891	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(F)c(O)c1)nn2C1CCCC1		CHEMBL1242568	=	IC50	nM	0.55	CHEMBL267	Homo sapiens	IC50	uM	0.00055
	3440905	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC1CCC(n2nc(-c3ccc(F)c(O)c3)c3c(N)ncnc32)C1		CHEMBL1242656	=	IC50	nM	1.0	CHEMBL267	Homo sapiens	IC50	uM	0.001
	3440919	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(F)c(O)c1)nn2[C@H]1CCNC1		CHEMBL1242657	=	IC50	nM	15.0	CHEMBL267	Homo sapiens	IC50	uM	0.015
	3440933	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(F)c(O)c1)nn2[C@@H]1CCNC1		CHEMBL1242658	=	IC50	nM	46.0	CHEMBL267	Homo sapiens	IC50	uM	0.046
	3440947	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(F)c(O)c1)nn2[C@H]1CCOC1		CHEMBL1242748	=	IC50	nM	14.0	CHEMBL267	Homo sapiens	IC50	uM	0.014
	3440961	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(F)c(O)c1)nn2[C@@H]1CCOC1		CHEMBL1242749	=	IC50	nM	31.0	CHEMBL267	Homo sapiens	IC50	uM	0.031
	3440975	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(F)c(O)c1)nn2C1CCCCCC1		CHEMBL1242750	=	IC50	nM	14.0	CHEMBL267	Homo sapiens	IC50	uM	0.014
	3440989	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(F)c(O)c1)nn2CC1CCNCC1		CHEMBL1242844	=	IC50	nM	747.0	CHEMBL267	Homo sapiens	IC50	uM	0.747
	3441003	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1nn(-c2ccccc2)nc1Cn1nc(-c2ccc(F)c(O)c2)c2c(N)ncnc21		CHEMBL1242845	=	IC50	nM	82.0	CHEMBL267	Homo sapiens	IC50	uM	0.082
	3441017	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(F)c(O)c1)nn2Cc1ocnc1-c1ccccc1		CHEMBL1241482	=	IC50	nM	42.0	CHEMBL267	Homo sapiens	IC50	uM	0.042
	3441031	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1cc(-c2nn(C(C)C)c3ncnc(N)c23)ccc1F		CHEMBL1241483	=	IC50	nM	98.0	CHEMBL267	Homo sapiens	IC50	uM	0.098
	3441045	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Cl)c(O)c2)c2c(N)ncnc21		CHEMBL1241484	=	IC50	nM	4.0	CHEMBL267	Homo sapiens	IC50	uM	0.004
	3441059	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	C[C@H](CN)n1nc(-c2ccc(Cl)c(O)c2)c2c(N)ncnc21		CHEMBL1241579	=	IC50	nM	73.0	CHEMBL267	Homo sapiens	IC50	uM	0.073
	3441073	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	C[C@@H](CN)n1nc(-c2ccc(Cl)c(O)c2)c2c(N)ncnc21		CHEMBL1240544	=	IC50	nM	284.0	CHEMBL267	Homo sapiens	IC50	uM	0.284
	3441087	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(Cl)c(O)c1)nn2C1CCC1		CHEMBL1241580	=	IC50	nM	11.0	CHEMBL267	Homo sapiens	IC50	uM	0.011
	3441515	CHEMBL1244098	Inhibition of human Src	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	IC50	nM	156.0	CHEMBL267	Homo sapiens	IC50	nmol/L	156.0
	3441623	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1cc(-c2nn(C(C)C)c3ncnc(N)c23)ccc1NC(=O)OC(C)(C)C		CHEMBL1241481	<	IC50	nM	1.0	CHEMBL267	Homo sapiens	IC50	uM	0.001
	3441637	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	IC50	nM	10.0	CHEMBL267	Homo sapiens	IC50	uM	0.01
	3441651	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	IC50	nM	14.0	CHEMBL267	Homo sapiens	IC50	uM	0.014
	3441665	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	IC50	nM	240.0	CHEMBL267	Homo sapiens	IC50	uM	0.24
	3441679	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	IC50	nM	170.0	CHEMBL267	Homo sapiens	IC50	uM	0.17
	3441693	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	IC50	nM	1400.0	CHEMBL267	Homo sapiens	IC50	uM	1.4
	3441707	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccn3ccnc3c1)nn2C1CCCC1		CHEMBL1241675	=	IC50	nM	11000.0	CHEMBL267	Homo sapiens	IC50	uM	11.0
	3441721	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1ccccc1-n1c(Cn2nc(-c3cccc(O)c3)c3c(N)ncnc32)nc2cccc(C)c2c1=O		CHEMBL1241767	=	IC50	nM	17000.0	CHEMBL267	Homo sapiens	IC50	uM	17.0
	3441864	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1230790	=	IC50	nM	15.0	CHEMBL267	Homo sapiens	IC50	uM	0.015
	3441878	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1234815	=	IC50	nM	1100.0	CHEMBL267	Homo sapiens	IC50	uM	1.1
Not Determined	3441892	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2[nH]nc(-c3ccccc3)c12		CHEMBL1241104		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	3441906	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1ccc(-c2n[nH]c3ncnc(N)c23)cc1		CHEMBL1241142		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	3441920	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1cccc(-c2n[nH]c3ncnc(N)c23)c1		CHEMBL1241143		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	3441934	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1ccccc1-c1n[nH]c2ncnc(N)c12		CHEMBL1241144		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	3441948	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1cccc(-c2n[nH]c3ncnc(N)c23)c1C		CHEMBL1241145		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	3441962	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)(C)c1ccc(-c2n[nH]c3ncnc(N)c23)cc1		CHEMBL1241240		IC50			CHEMBL267	Homo sapiens	IC50		
	3441976	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(O)cc2)c2c(N)ncnc21		CHEMBL1241241	=	IC50	nM	75.0	CHEMBL267	Homo sapiens	IC50	uM	0.075
Not Determined	3441990	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2[nH]nc(-c3cccc(O)c3)c12		CHEMBL1241242		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	3442004	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1cc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1241269		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	3442018	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CNc1ncnc2c1c(-c1cccc(O)c1)nn2C(C)C		CHEMBL1241942		IC50			CHEMBL267	Homo sapiens	IC50		
	3442032	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1cc(O)ccc1-c1nn(C(C)C)c2ncnc(N)c12		CHEMBL1242024	=	IC50	nM	15.0	CHEMBL267	Homo sapiens	IC50	uM	0.015
	3442046	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1ccc(-c2n[nH]c3ncnc(N)c23)cc1OCc1ccccc1		CHEMBL1242025	=	IC50	nM	33000.0	CHEMBL267	Homo sapiens	IC50	uM	33.0
	3442060	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1ccc(-c2n[nH]c3ncnc(N)c23)cc1O		CHEMBL1241270	=	IC50	nM	164.0	CHEMBL267	Homo sapiens	IC50	uM	0.164
	3442074	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1ccc(-c2nn(C)c3ncnc(N)c23)cc1O		CHEMBL1241271	=	IC50	nM	96.0	CHEMBL267	Homo sapiens	IC50	uM	0.096
	3442088	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1ccc(-c2nn(C(C)C)c3ncnc(N)c23)cc1O		CHEMBL1242026	=	IC50	nM	4.3	CHEMBL267	Homo sapiens	IC50	uM	0.0043
	3442102	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CCC(C)n1nc(-c2ccc(C)c(O)c2)c2c(N)ncnc21		CHEMBL1242109	=	IC50	nM	16.0	CHEMBL267	Homo sapiens	IC50	uM	0.016
	3442116	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(O)c2F)c2c(N)ncnc21		CHEMBL1242110	=	IC50	nM	25.0	CHEMBL267	Homo sapiens	IC50	uM	0.025
	3442130	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cccc(O)c1F)nn2C1CCCC1		CHEMBL1242111	=	IC50	nM	10.0	CHEMBL267	Homo sapiens	IC50	uM	0.01
	3442144	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc(O)cc(F)c2)c2c(N)ncnc21		CHEMBL1242198	=	IC50	nM	33.0	CHEMBL267	Homo sapiens	IC50	uM	0.033
	3442158	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cc(O)cc(F)c1)nn2C1CCCC1		CHEMBL1242199	=	IC50	nM	5.0	CHEMBL267	Homo sapiens	IC50	uM	0.005
	3442172	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1cc(Br)cc(-c2nn(C(C)C)c3ncnc(N)c23)c1		CHEMBL1242200	=	IC50	nM	286.0	CHEMBL267	Homo sapiens	IC50	uM	0.286
	3442182	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C[C@H](C)CO)c3ncnc(N)c23)cc1OC		CHEMBL1242380	=	IC50	nM	3900.0	CHEMBL267	Homo sapiens	IC50	uM	3.9
	3442196	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C[C@@H](C)CO)c3ncnc(N)c23)cc1OC		CHEMBL1242381	=	IC50	nM	3200.0	CHEMBL267	Homo sapiens	IC50	uM	3.2
	3442210	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCCC3)c3ncnc(N)c23)cc1OC		CHEMBL1240553	=	IC50	nM	180.0	CHEMBL267	Homo sapiens	IC50	uM	0.18
	3442224	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CCOc1ccc(-c2n[nH]c3ncnc(N)c23)cc1OC		CHEMBL1242471	=	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	3442238	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CCOc1ccc(-c2nn(C(C)C)c3ncnc(N)c23)cc1OC		CHEMBL1242472	=	IC50	nM	361.0	CHEMBL267	Homo sapiens	IC50	uM	0.361
	3442252	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	C=CCn1nc(-c2ccc(OCC)c(OC)c2)c2c(N)ncnc21		CHEMBL1242569	=	IC50	nM	15200.0	CHEMBL267	Homo sapiens	IC50	uM	15.2
	3442266	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CCOc1ccc(-c2nn(C3CCCC3)c3ncnc(N)c23)cc1OC		CHEMBL1240554	=	IC50	nM	142.0	CHEMBL267	Homo sapiens	IC50	uM	0.142
	3442280	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CCOc1ccc(-c2nn(C3CCCCC3)c3ncnc(N)c23)cc1OC		CHEMBL1242659	=	IC50	nM	175.0	CHEMBL267	Homo sapiens	IC50	uM	0.175
	3442294	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1cc(-c2nn(C(C)C)c3ncnc(N)c23)cc(OC)c1OC		CHEMBL1242660	=	IC50	nM	76.0	CHEMBL267	Homo sapiens	IC50	uM	0.076
	3442308	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1cccc(-c2nn(C(C)C)c3ncnc(N)c23)c1OC		CHEMBL1242751	=	IC50	nM	499.0	CHEMBL267	Homo sapiens	IC50	uM	0.499
	3442322	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CCOc1cc(-c2nn(C(C)C)c3ncnc(N)c23)ccc1OC		CHEMBL1242752	=	IC50	nM	2000.0	CHEMBL267	Homo sapiens	IC50	uM	2.0
	3442336	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CCOc1cc(-c2nn(CCO)c3ncnc(N)c23)ccc1OC		CHEMBL1242753	=	IC50	nM	9800.0	CHEMBL267	Homo sapiens	IC50	uM	9.8
	3442350	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1ncc(-c2nn(C(C)C)c3ncnc(N)c23)c(OC)n1		CHEMBL1242846	=	IC50	nM	1430.0	CHEMBL267	Homo sapiens	IC50	uM	1.43
	3442364	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C(C)C)c3ncnc(N)c23)cc1		CHEMBL1242847	=	IC50	nM	380.0	CHEMBL267	Homo sapiens	IC50	uM	0.38
Not Determined	3442378	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2[nH]nc(-c3ccccc3O)c12		CHEMBL1241355		IC50			CHEMBL267	Homo sapiens	IC50		
	3442392	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(N)c(O)c2)c2c(N)ncnc21		CHEMBL1242848	=	IC50	nM	40.0	CHEMBL267	Homo sapiens	IC50	uM	0.04
	3442406	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1cc(-c2nn(C(C)C)c3ncnc(N)c23)ccc1N		CHEMBL1241485	=	IC50	nM	23.0	CHEMBL267	Homo sapiens	IC50	uM	0.023
	3442420	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1cc(-c2nn(C(C)C)c3ncnc(N)c23)ccc1NC(C)CO		CHEMBL1241486	=	IC50	nM	341.0	CHEMBL267	Homo sapiens	IC50	uM	0.341
	3442434	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ccc(-c2nn(C3CCCC3)c3ncnc(N)c23)cc1O		CHEMBL1241487	=	IC50	nM	11.0	CHEMBL267	Homo sapiens	IC50	uM	0.011
	3442448	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1cc(-c2nn(C3CCCC3)c3ncnc(N)c23)ccc1N		CHEMBL1241581	=	IC50	nM	2.2	CHEMBL267	Homo sapiens	IC50	uM	0.0022
Not Determined	3442462	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ccc(-c2n[nH]c3ncnc(N)c23)cc1		CHEMBL1241356		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	3442476	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1cccc(-c2n[nH]c3ncnc(N)c23)c1		CHEMBL1241357		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	3442490	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2[nH]nc(-c3ccc([N+](=O)[O-])cc3)c12		CHEMBL1241358		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	3442504	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2[nH]nc(-c3cccc([N+](=O)[O-])c3)c12		CHEMBL1241389		IC50			CHEMBL267	Homo sapiens	IC50		
	3442518	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(CO)c2)c2c(N)ncnc21		CHEMBL1241582	=	IC50	nM	530.0	CHEMBL267	Homo sapiens	IC50	uM	0.53
	3442532	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(CC#N)c2)c2c(N)ncnc21		CHEMBL1241583	=	IC50	nM	3000.0	CHEMBL267	Homo sapiens	IC50	uM	3.0
	3442546	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(CC#N)cc2)c2c(N)ncnc21		CHEMBL1240545	=	IC50	nM	890.0	CHEMBL267	Homo sapiens	IC50	uM	0.89
	3442559	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(C#N)c2)c2c(N)ncnc21		CHEMBL1241679	=	IC50	nM	5900.0	CHEMBL267	Homo sapiens	IC50	uM	5.9
	3442573	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(F)c(C#N)c2)c2c(N)ncnc21		CHEMBL1241680	=	IC50	nM	1500.0	CHEMBL267	Homo sapiens	IC50	uM	1.5
	3442587	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(C#N)c(F)c2)c2c(N)ncnc21		CHEMBL1241771	=	IC50	nM	4400.0	CHEMBL267	Homo sapiens	IC50	uM	4.4
	3442601	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(C#N)nc2)c2c(N)ncnc21		CHEMBL1241772	=	IC50	nM	12000.0	CHEMBL267	Homo sapiens	IC50	uM	12.0
	3442615	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccnc2)c2c(N)ncnc21		CHEMBL1241390	=	IC50	nM	8700.0	CHEMBL267	Homo sapiens	IC50	uM	8.7
	3442629	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cncnc2)c2c(N)ncnc21		CHEMBL1241391	=	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	3442643	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(=O)c1ccc(-c2nn(C(C)C)c3ncnc(N)c23)cc1		CHEMBL1241773	=	IC50	nM	2100.0	CHEMBL267	Homo sapiens	IC50	uM	2.1
	3442657	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(C=O)c(F)c2)c2c(N)ncnc21		CHEMBL1241860	=	IC50	nM	490.0	CHEMBL267	Homo sapiens	IC50	uM	0.49
	3442671	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc(F)c(C=O)c(F)c2)c2c(N)ncnc21		CHEMBL1241861	=	IC50	nM	764.0	CHEMBL267	Homo sapiens	IC50	uM	0.764
	3442685	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(C(N)=O)c(Cl)c2)c2c(N)ncnc21		CHEMBL1241862	=	IC50	nM	15000.0	CHEMBL267	Homo sapiens	IC50	uM	15.0
	3442699	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(=O)c1cccc(-c2nn(C(C)C)c3ncnc(N)c23)c1		CHEMBL1241946	=	IC50	nM	3400.0	CHEMBL267	Homo sapiens	IC50	uM	3.4
	3442713	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc(C=O)co2)c2c(N)ncnc21		CHEMBL1241439	=	IC50	nM	5200.0	CHEMBL267	Homo sapiens	IC50	uM	5.2
	3442727	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1cc(-c2nn(C(C)C)c3ncnc(N)c23)sc1C=O		CHEMBL1241947	=	IC50	nM	1500.0	CHEMBL267	Homo sapiens	IC50	uM	1.5
	3442740	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(NS(C)(=O)=O)c2)c2c(N)ncnc21		CHEMBL1241948	=	IC50	nM	7200.0	CHEMBL267	Homo sapiens	IC50	uM	7.2
	3442753	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(NS(C)(=O)=O)cc2)c2c(N)ncnc21		CHEMBL1242030	=	IC50	nM	2300.0	CHEMBL267	Homo sapiens	IC50	uM	2.3
	3442767	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(S(N)(=O)=O)c2)c2c(N)ncnc21		CHEMBL1242031	=	IC50	nM	5000.0	CHEMBL267	Homo sapiens	IC50	uM	5.0
	3442781	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(S(N)(=O)=O)cc2)c2c(N)ncnc21		CHEMBL1242032	=	IC50	nM	11000.0	CHEMBL267	Homo sapiens	IC50	uM	11.0
	3442795	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(C(=O)NC3=NCCS3)c2)c2c(N)ncnc21		CHEMBL1242115	=	IC50	nM	3200.0	CHEMBL267	Homo sapiens	IC50	uM	3.2
Not Determined	3442809	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2[nH]nc(-c3ccc(NC(=O)c4ccc(-c5ccccc5)cc4)cc3)c12		CHEMBL1242116		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	3442823	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2[nH]nc(-c3ccc(Oc4ccccc4)cc3)c12		CHEMBL1242204		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	3442837	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2[nH]nc(-c3cccc(Oc4ccccc4)c3)c12		CHEMBL1242205		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	3442851	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc(OCc3ccccc3)cc2)c2c(N)ncnc21		CHEMBL1242206		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	3442865	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2[nH]nc(-c3cccc(OCc4ccccc4)c3)c12		CHEMBL1242291		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	3442879	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2[nH]nc(-c3cccc(OCc4c(Cl)cccc4Cl)c3)c12		CHEMBL1242292		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	3442893	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc3ccccc3c1)nn2CCc1ccccc1		CHEMBL1242382		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	3442907	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	NC(=O)Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1242383		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	3442921	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc3ccccc3c1)nn2CC1CC1		CHEMBL1242473		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	3442935	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)CCn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1242474		IC50			CHEMBL267	Homo sapiens	IC50		
	3442960	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(Cl)c(O)c1)nn2C1CCCC1		CHEMBL1241676	=	IC50	nM	0.12	CHEMBL267	Homo sapiens	IC50	uM	0.00012
	3442974	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(Cl)c(O)c1)nn2[C@@H]1CCNC1		CHEMBL1241677	=	IC50	nM	30.0	CHEMBL267	Homo sapiens	IC50	uM	0.03
	3442988	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(Cl)c(O)c1)nn2[C@H]1CCOC1		CHEMBL1241678	=	IC50	nM	2.0	CHEMBL267	Homo sapiens	IC50	uM	0.002
	3443002	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(Cl)c(O)c1)nn2[C@@H]1CCOC1		CHEMBL1241768	=	IC50	nM	7.0	CHEMBL267	Homo sapiens	IC50	uM	0.007
	3443016	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(Cl)c(O)c1)nn2CC1CCCN1		CHEMBL1241769	=	IC50	nM	96.0	CHEMBL267	Homo sapiens	IC50	uM	0.096
	3443030	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(Cl)c(O)c1)nn2CC1CCNC1		CHEMBL1241770	=	IC50	nM	25.0	CHEMBL267	Homo sapiens	IC50	uM	0.025
	3443044	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(Cl)c(O)c1)nn2CC1CCCNC1		CHEMBL1241858	=	IC50	nM	132.0	CHEMBL267	Homo sapiens	IC50	uM	0.132
	3443058	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(Cl)c(O)c1)nn2CC1CCNCC1		CHEMBL1241859	=	IC50	nM	202.0	CHEMBL267	Homo sapiens	IC50	uM	0.202
	3443072	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(Cl)c(O)c1)nn2CCC1CCCNC1		CHEMBL1241943	=	IC50	nM	144.0	CHEMBL267	Homo sapiens	IC50	uM	0.144
	3443086	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(C#N)c(O)c2)c2c(N)ncnc21		CHEMBL1241944	=	IC50	nM	408.0	CHEMBL267	Homo sapiens	IC50	uM	0.408
	3443100	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(O)c(F)c2)c2c(N)ncnc21		CHEMBL1241945	=	IC50	nM	43.0	CHEMBL267	Homo sapiens	IC50	uM	0.043
	3443114	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1cc(F)c(-c2nn(C(C)C)c3ncnc(N)c23)cc1F		CHEMBL1242027	=	IC50	nM	476.0	CHEMBL267	Homo sapiens	IC50	uM	0.476
	3443128	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc(F)c(O)cc2F)c2c(N)ncnc21		CHEMBL1242028	=	IC50	nM	54.0	CHEMBL267	Homo sapiens	IC50	uM	0.054
	3443142	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1cccc(-c2nn(C(C)C)c3ncnc(N)c23)c1		CHEMBL1242029	=	IC50	nM	160.0	CHEMBL267	Homo sapiens	IC50	uM	0.16
	3443156	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1cc(-c2nn(C(C)C)c3ncnc(N)c23)ccc1O		CHEMBL1242112	=	IC50	nM	120.0	CHEMBL267	Homo sapiens	IC50	uM	0.12
	3443170	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1ccc(-c2n[nH]c3ncnc(N)c23)cc1O		CHEMBL1241300	=	IC50	nM	489.0	CHEMBL267	Homo sapiens	IC50	uM	0.489
	3443184	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C)c3ncnc(N)c23)cc1O		CHEMBL1241301	=	IC50	nM	510.0	CHEMBL267	Homo sapiens	IC50	uM	0.51
	3443198	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CCn1nc(-c2ccc(OC)c(O)c2)c2c(N)ncnc21		CHEMBL1242113	=	IC50	nM	67.0	CHEMBL267	Homo sapiens	IC50	uM	0.067
	3443212	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C(C)C)c3ncnc(N)c23)cc1O		CHEMBL1242114	=	IC50	nM	17.0	CHEMBL267	Homo sapiens	IC50	uM	0.017
	3443226	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCCC3)c3ncnc(N)c23)cc1O		CHEMBL1242201	=	IC50	nM	6.3	CHEMBL267	Homo sapiens	IC50	uM	0.0063
	3443240	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC(C)C3)c3ncnc(N)c23)cc1O		CHEMBL1242202	=	IC50	nM	4.0	CHEMBL267	Homo sapiens	IC50	uM	0.004
	3443254	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CNC3)c3ncnc(N)c23)cc1O		CHEMBL1242203	=	IC50	nM	241.0	CHEMBL267	Homo sapiens	IC50	uM	0.241
	3443268	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1ccc(-c2nn([C@@H]3CCNC3)c3ncnc(N)c23)cc1O		CHEMBL1242288	=	IC50	nM	131.0	CHEMBL267	Homo sapiens	IC50	uM	0.131
	3443282	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CCOc1ccc(-c2nn(C3CCCC3)c3ncnc(N)c23)cc1O		CHEMBL1242289	=	IC50	nM	135.0	CHEMBL267	Homo sapiens	IC50	uM	0.135
	3443296	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C(C)C)c3ncnc(N)c23)cc1OC		CHEMBL1242290	=	IC50	nM	530.0	CHEMBL267	Homo sapiens	IC50	uM	0.53
	3443310	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1OC		CHEMBL1242379	=	IC50	nM	293.0	CHEMBL267	Homo sapiens	IC50	uM	0.293
	3443525	CHEMBL1244291	Inhibition of SRC at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	98.0	CHEMBL267	Homo sapiens	INH	%	98.0
	3443526	CHEMBL1244292	Inhibition of SRC N1 domain at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	100.0	CHEMBL267	Homo sapiens	INH	%	100.0
Not Determined	3443743	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc3ccccc3c1)nn2C/C=C/c1ccccc1		CHEMBL1242570		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	3443757	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	C#CCn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1242571		IC50			CHEMBL267	Homo sapiens	IC50		
	3443771	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CCOc1ccc2cc(-c3nn(C)c4ncnc(N)c34)ccc2c1		CHEMBL1242661	=	IC50	nM	2400.0	CHEMBL267	Homo sapiens	IC50	uM	2.4
	3443785	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3cc(O)ccc3c2)c2c(N)ncnc21		CHEMBL1242662	=	IC50	nM	55.0	CHEMBL267	Homo sapiens	IC50	uM	0.055
	3443799	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3ccccc3nc2Cl)c2c(N)ncnc21		CHEMBL1242663	=	IC50	nM	2100.0	CHEMBL267	Homo sapiens	IC50	uM	2.1
	3443813	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cnc3ccccc3c2)c2c(N)ncnc21		CHEMBL1242754	=	IC50	nM	1530.0	CHEMBL267	Homo sapiens	IC50	uM	1.53
	3443827	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3ccccc3c1)nn2C1CCCC1		CHEMBL1242755	=	IC50	nM	716.0	CHEMBL267	Homo sapiens	IC50	uM	0.716
	3443841	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1242756	=	IC50	nM	12000.0	CHEMBL267	Homo sapiens	IC50	uM	12.0
Not Determined	3443855	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cn1nc(-c2cccc(-c3ccccc3)c2)c2c(N)ncnc21		CHEMBL1242849		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	3443869	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2[nH]nc(-c3ccc(-c4ccccc4)cc3)c12		CHEMBL1242850		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	3443883	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2[nH]nc(C3CCc4ccccc4C3)c12		CHEMBL1241440		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	3443897	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2[nH]nc(-c3ccc4ccccc4c3)c12		CHEMBL1241441		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	3443911	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CCn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1242851		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	3443925	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	C=CCn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1241488		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	3443939	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1241489		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	3443953	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)(C)n1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1231371		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	3443967	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc3ccccc3c1)nn2C1CCCC1		CHEMBL1241584		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	3443981	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc3ccccc3c1)nn2Cc1ccccc1		CHEMBL1241585		IC50			CHEMBL267	Homo sapiens	IC50		
	3443995	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc3ncccc3c1)nn2C1CCCC1		CHEMBL1241681	=	IC50	nM	810.0	CHEMBL267	Homo sapiens	IC50	uM	0.81
	3444009	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1ccc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2n1		CHEMBL1241682	=	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	3444023	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3nc(Cl)ccc3c2)c2c(N)ncnc21		CHEMBL1241683	=	IC50	nM	2700.0	CHEMBL267	Homo sapiens	IC50	uM	2.7
	3444037	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3nccnc3c2)c2c(N)ncnc21		CHEMBL1241774	=	IC50	nM	1000.0	CHEMBL267	Homo sapiens	IC50	uM	1.0
	3444051	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cnc3nccnc3c2)c2c(N)ncnc21		CHEMBL1241775	=	IC50	nM	30000.0	CHEMBL267	Homo sapiens	IC50	uM	30.0
	3444065	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3nc[nH]c(=O)c3c2)c2c(N)ncnc21		CHEMBL1241776	=	IC50	nM	131.0	CHEMBL267	Homo sapiens	IC50	uM	0.131
	3444079	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3[nH]c(=O)ccc3c2)c2c(N)ncnc21		CHEMBL1241863	=	IC50	nM	7200.0	CHEMBL267	Homo sapiens	IC50	uM	7.2
	3444093	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc3[nH]c(=O)ccc3c1)nn2C1CCCC1		CHEMBL1241864	=	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	3444107	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3nc(N)ccc3c2)c2c(N)ncnc21		CHEMBL1241949	=	IC50	nM	7600.0	CHEMBL267	Homo sapiens	IC50	uM	7.6
	3444121	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3nc(NN)ccc3c2)c2c(N)ncnc21		CHEMBL1241950	=	IC50	nM	800.0	CHEMBL267	Homo sapiens	IC50	uM	0.8
	3444135	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3nccc(NC(=O)OC(C)(C)C)c3c2)c2c(N)ncnc21		CHEMBL1242033	=	IC50	nM	12000.0	CHEMBL267	Homo sapiens	IC50	uM	12.0
	3444149	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3nccc(N)c3c2)c2c(N)ncnc21		CHEMBL1242034	=	IC50	nM	2700.0	CHEMBL267	Homo sapiens	IC50	uM	2.7
	3444163	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3occc(=O)c3c2)c2c(N)ncnc21		CHEMBL1242117	=	IC50	nM	15000.0	CHEMBL267	Homo sapiens	IC50	uM	15.0
	3444177	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3occc(=O)c3c2)c2c(N)ncnc21		CHEMBL1242118	=	IC50	nM	1600.0	CHEMBL267	Homo sapiens	IC50	uM	1.6
	3444191	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc3occc(=O)c3c1)nn2C1CCCC1		CHEMBL1242119	=	IC50	nM	525.0	CHEMBL267	Homo sapiens	IC50	uM	0.525
	3444205	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3cnccc3c2)c2c(N)ncnc21		CHEMBL1242207	=	IC50	nM	800.0	CHEMBL267	Homo sapiens	IC50	uM	0.8
	3444219	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ccncc3c2)c2c(N)ncnc21		CHEMBL1242208	=	IC50	nM	11000.0	CHEMBL267	Homo sapiens	IC50	uM	11.0
	3444233	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1ccc2ccc(-c3nn(C(C)C)c4ncnc(N)c34)cc2n1		CHEMBL1242209	=	IC50	nM	550.0	CHEMBL267	Homo sapiens	IC50	uM	0.55
	3444247	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cn1nc(-c2cnc3[nH]ccc3c2)c2c(N)ncnc21		CHEMBL1240565	=	IC50	nM	440.0	CHEMBL267	Homo sapiens	IC50	uM	0.44
	3444261	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cnc3[nH]ccc3c2)c2c(N)ncnc21		CHEMBL1242293	=	IC50	nM	20.0	CHEMBL267	Homo sapiens	IC50	uM	0.02
	3444275	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3[nH]ccc3c2)c2c(N)ncnc21		CHEMBL1242294	=	IC50	nM	39.0	CHEMBL267	Homo sapiens	IC50	uM	0.039
	3444289	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1242295	=	IC50	nM	8.0	CHEMBL267	Homo sapiens	IC50	uM	0.008
	3444303	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3c(ccn3C)c2)c2c(N)ncnc21		CHEMBL1242384	=	IC50	nM	157.0	CHEMBL267	Homo sapiens	IC50	uM	0.157
	3444317	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cn1ccc2cc(-c3nn(C4CCCC4)c4ncnc(N)c34)ccc21		CHEMBL1242385	=	IC50	nM	211.0	CHEMBL267	Homo sapiens	IC50	uM	0.211
	3444331	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3[nH]ncc3c2)c2c(N)ncnc21		CHEMBL1242386	=	IC50	nM	73.0	CHEMBL267	Homo sapiens	IC50	uM	0.073
	3444345	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc3[nH]ncc3c1)nn2C1CCCC1		CHEMBL1242475	=	IC50	nM	49.0	CHEMBL267	Homo sapiens	IC50	uM	0.049
	3444359	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3c(N)n[nH]c3c2)c2c(N)ncnc21		CHEMBL1242476	=	IC50	nM	58.0	CHEMBL267	Homo sapiens	IC50	uM	0.058
	3444373	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3cn[nH]c3c2)c2c(N)ncnc21		CHEMBL1242477	=	IC50	nM	69.0	CHEMBL267	Homo sapiens	IC50	uM	0.069
	3444387	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc3cn[nH]c3c1)nn2C1CCCC1		CHEMBL1242572	=	IC50	nM	42.0	CHEMBL267	Homo sapiens	IC50	uM	0.042
	3444401	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc(F)c3cn[nH]c3c2)c2c(N)ncnc21		CHEMBL1242573	=	IC50	nM	103.0	CHEMBL267	Homo sapiens	IC50	uM	0.103
	3444415	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3cc[nH]c3c2)c2c(N)ncnc21		CHEMBL1240566	=	IC50	nM	250.0	CHEMBL267	Homo sapiens	IC50	uM	0.25
	3444429	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3cc[nH]c3c2)c2c(N)ncnc21		CHEMBL1242574	=	IC50	nM	42.0	CHEMBL267	Homo sapiens	IC50	uM	0.042
	3444443	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc3cc[nH]c3c1)nn2C1CCCC1		CHEMBL1242664	=	IC50	nM	17.0	CHEMBL267	Homo sapiens	IC50	uM	0.017
	3444457	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccn3ccnc3c2)c2c(N)ncnc21		CHEMBL1242665	=	IC50	nM	23000.0	CHEMBL267	Homo sapiens	IC50	uM	23.0
	3444471	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3c(C=O)c[nH]c3c2)c2c(N)ncnc21		CHEMBL1242666	=	IC50	nM	1200.0	CHEMBL267	Homo sapiens	IC50	uM	1.2
	3444485	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc3[nH]ccc23)c2c(N)ncnc21		CHEMBL1242757	=	IC50	nM	37.0	CHEMBL267	Homo sapiens	IC50	uM	0.037
	3444499	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cccc3[nH]ccc13)nn2C1CCCC1		CHEMBL1242758	=	IC50	nM	57.0	CHEMBL267	Homo sapiens	IC50	uM	0.057
	3444513	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3c(ccn3C(=O)OC(C)(C)C)c2)c2c(N)ncnc21		CHEMBL1242852	=	IC50	nM	46.0	CHEMBL267	Homo sapiens	IC50	uM	0.046
	3444527	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)(C)OC(=O)n1ccc2cc(-c3nn(C4CCCC4)c4ncnc(N)c34)ccc21		CHEMBL1242853	=	IC50	nM	194.0	CHEMBL267	Homo sapiens	IC50	uM	0.194
	3444541	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3occc3c2)c2c(N)ncnc21		CHEMBL1241490	=	IC50	nM	238.0	CHEMBL267	Homo sapiens	IC50	uM	0.238
	3444555	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc3occc3c1)nn2C1CCCC1		CHEMBL1241491	=	IC50	nM	140.0	CHEMBL267	Homo sapiens	IC50	uM	0.14
	3444569	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3nonc3c2)c2c(N)ncnc21		CHEMBL1241492	=	IC50	nM	3000.0	CHEMBL267	Homo sapiens	IC50	uM	3.0
	3444583	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3[nH]c(=O)[nH]c3c2)c2c(N)ncnc21		CHEMBL1241586	=	IC50	nM	3500.0	CHEMBL267	Homo sapiens	IC50	uM	3.5
	3444597	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3c(c2)CCO3)c2c(N)ncnc21		CHEMBL1241587	=	IC50	nM	1030.0	CHEMBL267	Homo sapiens	IC50	uM	1.03
Not Determined	3444611	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2[nH]nc(-c3ccc4c(c3)OCO4)c12		CHEMBL1240567		IC50			CHEMBL267	Homo sapiens	IC50		
	3444625	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3c(c2)OCCO3)c2c(N)ncnc21		CHEMBL1241588	=	IC50	nM	930.0	CHEMBL267	Homo sapiens	IC50	uM	0.93
Not Determined	3444639	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cn1nc(-c2cc3ccccc3s2)c2c(N)ncnc21		CHEMBL1240594		IC50			CHEMBL267	Homo sapiens	IC50		
	3444653	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(C=O)ccc3s2)c2c(N)ncnc21		CHEMBL1241684	=	IC50	nM	12000.0	CHEMBL267	Homo sapiens	IC50	uM	12.0
	3444666	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	IC50	nM	1100.0	CHEMBL267	Homo sapiens	IC50	uM	1.1
	3444679	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	<	IC50	nM	1.0	CHEMBL267	Homo sapiens	IC50	uM	0.001
	3444692	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	IC50	nM	400.0	CHEMBL267	Homo sapiens	IC50	uM	0.4
	3444897	CHEMBL1244291	Inhibition of SRC at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	60.0	CHEMBL267	Homo sapiens	INH	%	60.0
	3444898	CHEMBL1244292	Inhibition of SRC N1 domain at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	66.0	CHEMBL267	Homo sapiens	INH	%	66.0
	3445304	CHEMBL1244291	Inhibition of SRC at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	95.0	CHEMBL267	Homo sapiens	INH	%	95.0
	3445305	CHEMBL1244292	Inhibition of SRC N1 domain at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	99.0	CHEMBL267	Homo sapiens	INH	%	99.0
	3445521	CHEMBL1244291	Inhibition of SRC at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	66.0	CHEMBL267	Homo sapiens	INH	%	66.0
	3445522	CHEMBL1244292	Inhibition of SRC N1 domain at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	69.0	CHEMBL267	Homo sapiens	INH	%	69.0
	3445738	CHEMBL1244291	Inhibition of SRC at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	32.0	CHEMBL267	Homo sapiens	INH	%	32.0
	3445739	CHEMBL1244292	Inhibition of SRC N1 domain at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	38.0	CHEMBL267	Homo sapiens	INH	%	38.0
	3445930	CHEMBL1244291	Inhibition of SRC at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1230790	=	Inhibition	%	98.0	CHEMBL267	Homo sapiens	INH	%	98.0
	3445931	CHEMBL1244292	Inhibition of SRC N1 domain at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1230790	=	Inhibition	%	101.0	CHEMBL267	Homo sapiens	INH	%	101.0
	3446120	CHEMBL1244291	Inhibition of SRC at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1234815	=	Inhibition	%	50.0	CHEMBL267	Homo sapiens	INH	%	50.0
	3446121	CHEMBL1244292	Inhibition of SRC N1 domain at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1234815	=	Inhibition	%	68.0	CHEMBL267	Homo sapiens	INH	%	68.0
	3446152	CHEMBL1244313	Inhibition of SRC N2 domain at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1230790	=	Inhibition	%	96.0	CHEMBL267	Homo sapiens	INH	%	96.0
	3446155	CHEMBL1244313	Inhibition of SRC N2 domain at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1234815	=	Inhibition	%	57.0	CHEMBL267	Homo sapiens	INH	%	57.0
	3446171	CHEMBL1243974	Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	IC50	nM	390.0	CHEMBL267	Homo sapiens	IC50	uM	0.39
	3446185	CHEMBL1244325	Inhibition of SRC	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	IC50	nM	1.0	CHEMBL267	Homo sapiens	IC50	nM	1.0
	3447999	CHEMBL1249773	Inhibition of human c-SRC activity at 10 uM by radiometric assay	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Inhibition	%	16.0	CHEMBL267	Homo sapiens	INH	%	16.0
	3448075	CHEMBL1249773	Inhibition of human c-SRC activity at 10 uM by radiometric assay	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Inhibition	%	9.0	CHEMBL267	Homo sapiens	INH	%	9.0
	3448629	CHEMBL1244982	Binding affinity to SRC	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL267	Homo sapiens	Kd	uM	10.0
	3448786	CHEMBL1244982	Binding affinity to SRC	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	640.0	CHEMBL267	Homo sapiens	Kd	nM	640.0
	3449052	CHEMBL1244982	Binding affinity to SRC	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	1200.0	CHEMBL267	Homo sapiens	Kd	nM	1200.0
	3449511	CHEMBL1244982	Binding affinity to SRC	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	=	Kd	nM	1900.0	CHEMBL267	Homo sapiens	Kd	nM	1900.0
	3449512	CHEMBL1244982	Binding affinity to SRC	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	2100.0	CHEMBL267	Homo sapiens	Kd	nM	2100.0
	3449856	CHEMBL1244982	Binding affinity to SRC	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL267	Homo sapiens	Kd	uM	10.0
	3450246	CHEMBL1244982	Binding affinity to SRC	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL267	Homo sapiens	Kd	uM	10.0
	3457247	CHEMBL1246095	Inhibition of GST-tagged recombinant Src after 20 mins by autoradiography	B	O=C(O)c1ccc(C(=O)/C(=C\c2ccc(F)c([N+](=O)[O-])c2)SCc2ccc(Br)cc2)cc1		CHEMBL1242482	=	IC50	nM	13200.0	CHEMBL267	Homo sapiens	IC50	uM	13.2
	3463358	CHEMBL1251691	Inhibition of SRC at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	11.0	CHEMBL267	Homo sapiens	INH	%	11.0
	3463359	CHEMBL1251692	Inhibition of SRC N1 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	5.0	CHEMBL267	Homo sapiens	INH	%	5.0
	3463902	CHEMBL1251691	Inhibition of SRC at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	10.0	CHEMBL267	Homo sapiens	INH	%	10.0
	3463903	CHEMBL1251692	Inhibition of SRC N1 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	15.0	CHEMBL267	Homo sapiens	INH	%	15.0
	3464121	CHEMBL1251691	Inhibition of SRC at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	27.0	CHEMBL267	Homo sapiens	INH	%	27.0
	3464122	CHEMBL1251692	Inhibition of SRC N1 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	30.0	CHEMBL267	Homo sapiens	INH	%	30.0
	3471613	CHEMBL1250654	Inhibition of SRC	B	Cn1ccc2ncnc(Oc3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)c(F)c3)c21		CHEMBL1254007	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
Not Active	3499144	CHEMBL1259888	Inhibition of SRC at 10 uM relative to control	B	CCNC(=O)NCc1ccccc1-c1cc(-c2cnc(NC(C)C)s2)nc(NCCN(C)C)n1		CHEMBL1230171		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	3503191	CHEMBL1261155	Inhibition of Src	B	Cc1[nH]nc2c1N=C(c1ccccc1Cl)c1cc([N+](=O)[O-])ccc1N2		CHEMBL1258821	>	IC50	nM	60000.0	CHEMBL267	Homo sapiens	IC50	uM	60.0
	3503192	CHEMBL1261155	Inhibition of Src	B	N#Cc1ccc2c(c1)C(c1ccccc1F)=Nc1c[nH]nc1N2		CHEMBL1257795	=	IC50	nM	5400.0	CHEMBL267	Homo sapiens	IC50	uM	5.4
	3503193	CHEMBL1261155	Inhibition of Src	B	Nc1ccc2c(c1)C(c1ccccc1Cl)=Nc1c[nH]nc1N2		CHEMBL1257911	=	IC50	nM	1840.0	CHEMBL267	Homo sapiens	IC50	uM	1.84
	3503194	CHEMBL1261155	Inhibition of Src	B	CC(=O)Nc1ccc2c(c1)C(c1ccccc1Cl)=Nc1c[nH]nc1N2		CHEMBL1257912	=	IC50	nM	930.0	CHEMBL267	Homo sapiens	IC50	uM	0.93
	3518579	CHEMBL1274256	Inhibition of SRC at 10 uM	B	CN(c1ccnc(Nc2cc(N3CCOCC3)cc(N3CCOCC3)c2)n1)c1cccc2[nH]ncc12		CHEMBL1269858	=	Inhibition	%	99.0	CHEMBL267	Homo sapiens	INH	%	99.0
	3525175	CHEMBL1274095	Inhibition of Src at 1 uM	B	CCN(C)C(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN2CCCCC2)cc1)c1ccccc1		CHEMBL496862	=	Inhibition	%	86.0	CHEMBL267	Homo sapiens	INH	%	86.0
Not Determined	3525205	CHEMBL1274095	Inhibition of Src at 1 uM	B	O=C1Nc2ccccc2/C1=C(/Nc1ccc(CN2CCCCC2)cc1)c1ccccc1		CHEMBL500435		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Determined	3525235	CHEMBL1274095	Inhibition of Src at 1 uM	B	CN(C)C(=O)c1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL1272078		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Determined	3525265	CHEMBL1274095	Inhibition of Src at 1 uM	B	CCNC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(CCN(C)C)S(C)(=O)=O)cc1)c1ccccc1		CHEMBL1272128		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	3525295	CHEMBL1274095	Inhibition of Src at 1 uM	B	CCNC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL1272289	=	Inhibition	%	86.0	CHEMBL267	Homo sapiens	INH	%	86.0
	3525325	CHEMBL1274095	Inhibition of Src at 1 uM	B	CCNCc1ccc(N/C(=C2\C(=O)Nc3cc(C(=O)N(C)CC)ccc32)c2ccccc2)cc1		CHEMBL1271471	=	Inhibition	%	61.0	CHEMBL267	Homo sapiens	INH	%	61.0
	3526787	CHEMBL1272379	Inhibition of c-SRC by Hot Spot filtration binding assay	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	IC50	nM	2.0	CHEMBL267	Homo sapiens	IC50	uM	0.002
	3526795	CHEMBL1272379	Inhibition of c-SRC by Hot Spot filtration binding assay	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCOCC5)cc4)cnc23)ccn1		CHEMBL324153	=	IC50	nM	50.0	CHEMBL267	Homo sapiens	IC50	uM	0.05
	3526803	CHEMBL1272379	Inhibition of c-SRC by Hot Spot filtration binding assay	B	O=c1ccc(-c2cnn3cc(-c4ccc(OCCN5CCOCC5)cc4)cnc23)c[nH]1		CHEMBL1271480	=	IC50	nM	61.0	CHEMBL267	Homo sapiens	IC50	uM	0.061
	3526811	CHEMBL1272379	Inhibition of c-SRC by Hot Spot filtration binding assay	B	c1cc(-c2cnc3c(-c4cn[nH]c4)cnn3c2)ccc1OCCN1CCOCC1		CHEMBL1271532	=	IC50	nM	3300.0	CHEMBL267	Homo sapiens	IC50	uM	3.3
	3526819	CHEMBL1272379	Inhibition of c-SRC by Hot Spot filtration binding assay	B	Nc1cc(-c2cnn3cc(-c4ccc(OCCN5CCOCC5)cc4)cnc23)ccn1		CHEMBL1271533	=	IC50	nM	21.0	CHEMBL267	Homo sapiens	IC50	uM	0.021
	3526827	CHEMBL1272379	Inhibition of c-SRC by Hot Spot filtration binding assay	B	Oc1ccc(-c2cnn3cc(-c4ccc(OCCN5CCOCC5)cc4)cnc23)cc1O		CHEMBL1271641	=	IC50	nM	96.0	CHEMBL267	Homo sapiens	IC50	uM	0.096
	3526835	CHEMBL1272379	Inhibition of c-SRC by Hot Spot filtration binding assay	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccc(O)c(O)c3)o2)cc1		CHEMBL1271642	=	IC50	nM	3200.0	CHEMBL267	Homo sapiens	IC50	uM	3.2
	3526843	CHEMBL1272379	Inhibition of c-SRC by Hot Spot filtration binding assay	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccc(=O)[nH]c3)o2)cc1		CHEMBL1271692	=	IC50	nM	8200.0	CHEMBL267	Homo sapiens	IC50	uM	8.2
	3556146	CHEMBL1285869	Inhibition of SRC at 1 uM	B	CN1C[C@@H]2C[C@H]1CN2c1cc(F)c(-c2ccnc3c(-c4cccc5[nH]ncc45)c(-c4ccncc4)nn23)c(F)c1		CHEMBL1276179	=	Inhibition	%	77.0	CHEMBL267	Homo sapiens	INH	%	77.0
	3601446	CHEMBL1292420	Inhibition of SRC	B	COc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1		CHEMBL1288582	=	IC50	nM	1310.0	CHEMBL267	Homo sapiens	IC50	uM	1.31
	5105794	CHEMBL1641165	Inhibition of Src at 10 uM after 20 mins	B	Cl.c1ccc(CNc2ncnc3c2nc2n3Cc3ccccc3N2CCN2CCOCC2)cc1		CHEMBL1631593	=	Inhibition	%	9.0	CHEMBL267	Homo sapiens	INH	%	9.0
	5105795	CHEMBL1641165	Inhibition of Src at 10 uM after 20 mins	B	Brc1ccccc1Nc1ncnc2c1nc1n2Cc2ccccc2N1CCN1CCOCC1.Cl		CHEMBL1631592	=	Inhibition	%	30.0	CHEMBL267	Homo sapiens	INH	%	30.0
	5105796	CHEMBL1641165	Inhibition of Src at 10 uM after 20 mins	B	Cl.Clc1ccccc1Nc1ncnc2c1nc1n2Cc2ccccc2N1CCN1CCOCC1		CHEMBL1631591	=	Inhibition	%	20.0	CHEMBL267	Homo sapiens	INH	%	20.0
	5105797	CHEMBL1641165	Inhibition of Src at 10 uM after 20 mins	B	Cl.c1ccc(Nc2ncnc3c2nc2n3Cc3ccccc3N2CCN2CCOCC2)cc1		CHEMBL1631590	=	Inhibition	%	15.0	CHEMBL267	Homo sapiens	INH	%	15.0
	5105798	CHEMBL1641165	Inhibition of Src at 10 uM after 20 mins	B	CCN(CC)CCN1c2ccccc2Cn2c1nc1c(Nc3ccccc3)ncnc12.Cl		CHEMBL1631589	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	5105799	CHEMBL1641165	Inhibition of Src at 10 uM after 20 mins	B	c1ccc(Nc2ncnc3c2nc2n3Cc3ccccc3N2)cc1		CHEMBL1631588	=	Inhibition	%	58.0	CHEMBL267	Homo sapiens	INH	%	58.0
	5105800	CHEMBL1641165	Inhibition of Src at 10 uM after 20 mins	B	Nc1nc(Cl)nc2c1nc1n2Cc2ccccc2N1		CHEMBL1631587	=	Inhibition	%	49.0	CHEMBL267	Homo sapiens	INH	%	49.0
	5105801	CHEMBL1641165	Inhibition of Src at 10 uM after 20 mins	B	Nc1ncnc2c1nc1n2Cc2ccccc2N1		CHEMBL1631586	=	Inhibition	%	72.0	CHEMBL267	Homo sapiens	INH	%	72.0
	5105810	CHEMBL1641166	Inhibition of Src	B	CP(C)(=O)c1ccc(Nc2nc(C3CCCC3)nc3c2ncn3CCc2cccc(O)c2)cc1		CHEMBL1089405	=	IC50	nM	0.45	CHEMBL267	Homo sapiens	IC50	nM	0.45
	5120278	CHEMBL1648382	Inhibition of human c-SRC at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	93.0	CHEMBL267	Homo sapiens	INH	%	93.0
	5120382	CHEMBL1646656	Inhibition of human Src (1 to 530) at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	106.0	CHEMBL267	Homo sapiens	INH	%	106.0
	5120821	CHEMBL1646805	Inhibition of SRC at 10 uM	B	CC(C)(C)c1cc(C(=O)O)c(NC(=O)Nc2ccc3[nH]ncc3c2)s1		CHEMBL1641799	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	5121137	CHEMBL1646657	Inhibition of human Src T341M mutant at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	113.0	CHEMBL267	Homo sapiens	INH	%	113.0
	5126259	CHEMBL1646090	Inhibition of c-Src after 60 mins	B	O=C(Cn1cc(-c2ccccc2)nn1)c1ccccc1		CHEMBL1276040	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	5126260	CHEMBL1646090	Inhibition of c-Src after 60 mins	B	Cc1ccc(-c2cn(CC(=O)c3ccccc3)nn2)cc1		CHEMBL1277990	=	IC50	nM	41600.0	CHEMBL267	Homo sapiens	IC50	uM	41.6
	5126261	CHEMBL1646090	Inhibition of c-Src after 60 mins	B	Cc1cc(-c2cn(CC(=O)c3ccccc3)nn2)ccc1F		CHEMBL1642266	=	IC50	nM	81000.0	CHEMBL267	Homo sapiens	IC50	uM	81.0
	5126262	CHEMBL1646090	Inhibition of c-Src after 60 mins	B	O=C(/C=C/c1ccccc1)Cn1cc(-c2ccccc2)nn1		CHEMBL1642267	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	5126263	CHEMBL1646090	Inhibition of c-Src after 60 mins	B	Cc1ccc(C(=O)Cn2cc(-c3ccc(C)cc3)nn2)cc1		CHEMBL1642269	=	IC50	nM	49800.0	CHEMBL267	Homo sapiens	IC50	uM	49.8
	5126264	CHEMBL1646090	Inhibition of c-Src after 60 mins	B	Cc1ccc(C(=O)Cn2cc(-c3ccc(F)c(C)c3)nn2)cc1		CHEMBL1642270	=	IC50	nM	82300.0	CHEMBL267	Homo sapiens	IC50	uM	82.3
	5126265	CHEMBL1646090	Inhibition of c-Src after 60 mins	B	COc1ccc(C(=O)Cn2cc(-c3ccccc3)nn2)cc1		CHEMBL1277907	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	5126266	CHEMBL1646090	Inhibition of c-Src after 60 mins	B	COc1ccc(C(=O)Cn2cc(-c3cccc(C)c3)nn2)cc1		CHEMBL1642271	=	IC50	nM	72800.0	CHEMBL267	Homo sapiens	IC50	uM	72.8
	5126267	CHEMBL1646090	Inhibition of c-Src after 60 mins	B	O=C(Cn1cc(-c2ccccc2)nn1)c1ccc(Cl)cc1	Outside typical range	CHEMBL1277989	=	IC50	nM	139000.0	CHEMBL267	Homo sapiens	IC50	uM	139.0
	5126268	CHEMBL1646090	Inhibition of c-Src after 60 mins	B	Cc1ccc(-c2cn(CC(=O)c3ccc(Cl)cc3)nn2)cc1	Outside typical range	CHEMBL1642272	=	IC50	nM	108700.0	CHEMBL267	Homo sapiens	IC50	uM	108.7
	5126269	CHEMBL1646090	Inhibition of c-Src after 60 mins	B	O=C(Cn1cc(-c2cccc(-c3ccsc3)c2)nn1)c1ccc(Cl)cc1	Outside typical range	CHEMBL1642275	>	IC50	nM	150000.0	CHEMBL267	Homo sapiens	IC50	uM	150.0
	5126270	CHEMBL1646090	Inhibition of c-Src after 60 mins	B	O=C(Cn1cc(-c2ccc(CCCCCl)cc2)nn1)c1ccc(Br)cc1		CHEMBL1642279	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	5126271	CHEMBL1646090	Inhibition of c-Src after 60 mins	B	O=C(Cn1cc(-c2ccccc2)nn1)c1ccc(-c2cc3ccccc3oc2=O)cc1		CHEMBL1642280	=	IC50	nM	89500.0	CHEMBL267	Homo sapiens	IC50	uM	89.5
	5126272	CHEMBL1646090	Inhibition of c-Src after 60 mins	B	Cc1ccc(-c2cn(CC(=O)c3ccc(-c4cc5ccccc5oc4=O)cc3)nn2)cc1	Outside typical range	CHEMBL1642281	>	IC50	nM	150000.0	CHEMBL267	Homo sapiens	IC50	uM	150.0
	5126273	CHEMBL1646090	Inhibition of c-Src after 60 mins	B	O=C(Cn1cc(-c2ccccc2)nn1)c1ccc(-c2cccs2)cc1		CHEMBL1642282	=	IC50	nM	32500.0	CHEMBL267	Homo sapiens	IC50	uM	32.5
	5126274	CHEMBL1646090	Inhibition of c-Src after 60 mins	B	CC(=O)Cn1cc(-c2ccccc2)nn1	Outside typical range	CHEMBL1642283	>	IC50	nM	150000.0	CHEMBL267	Homo sapiens	IC50	uM	150.0
	5126275	CHEMBL1646090	Inhibition of c-Src after 60 mins	B	CC(=O)Cn1cc(-c2ccc(C)cc2)nn1	Outside typical range	CHEMBL1642284	>	IC50	nM	150000.0	CHEMBL267	Homo sapiens	IC50	uM	150.0
	5126276	CHEMBL1646090	Inhibition of c-Src after 60 mins	B	COC(=O)Cn1cc(-c2ccccc2)nn1		CHEMBL1642285	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	5126277	CHEMBL1646090	Inhibition of c-Src after 60 mins	B	CCNC(=O)Cn1cc(-c2ccccc2)nn1	Outside typical range	CHEMBL1642286	>	IC50	nM	150000.0	CHEMBL267	Homo sapiens	IC50	uM	150.0
	5126278	CHEMBL1646090	Inhibition of c-Src after 60 mins	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	300.0	CHEMBL267	Homo sapiens	IC50	uM	0.3
	5126279	CHEMBL1646090	Inhibition of c-Src after 60 mins	B	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	=	IC50	nM	2800.0	CHEMBL267	Homo sapiens	IC50	uM	2.8
	5126280	CHEMBL1646090	Inhibition of c-Src after 60 mins	B	O=C1CCCC1n1cc(-c2ccccc2)nn1	Outside typical range	CHEMBL1642287	=	IC50	nM	105500.0	CHEMBL267	Homo sapiens	IC50	uM	105.5
	5126281	CHEMBL1646090	Inhibition of c-Src after 60 mins	B	Cc1ccc(-c2cn(C3CCCC3=O)nn2)cc1		CHEMBL1642288	=	IC50	nM	62100.0	CHEMBL267	Homo sapiens	IC50	uM	62.1
	5126282	CHEMBL1646090	Inhibition of c-Src after 60 mins	B	O=C1CCCCC1n1cc(-c2ccccc2)nn1		CHEMBL1642293	=	IC50	nM	43200.0	CHEMBL267	Homo sapiens	IC50	uM	43.2
	5126283	CHEMBL1646090	Inhibition of c-Src after 60 mins	B	Cc1ccc(-c2cn(C3CCCCC3=O)nn2)cc1		CHEMBL1642294	=	IC50	nM	33900.0	CHEMBL267	Homo sapiens	IC50	uM	33.9
	5126284	CHEMBL1646090	Inhibition of c-Src after 60 mins	B	Cc1ccc(-c2cn(C3CCCCCC3=O)nn2)cc1		CHEMBL1642298	=	IC50	nM	66100.0	CHEMBL267	Homo sapiens	IC50	uM	66.1
	5126288	CHEMBL1646094	Inhibition of c-Src at 75 uM after 60 mins	B	O=C(Cn1cc(-c2ccccn2)nn1)c1ccccc1		CHEMBL1276113	<	Inhibition	%	10.0	CHEMBL267	Homo sapiens	INH	%	10.0
	5126289	CHEMBL1646094	Inhibition of c-Src at 75 uM after 60 mins	B	CCCCc1cn(CC(=O)c2ccccc2)nn1		CHEMBL1642268	<	Inhibition	%	10.0	CHEMBL267	Homo sapiens	INH	%	10.0
	5126290	CHEMBL1646094	Inhibition of c-Src at 75 uM after 60 mins	B	O=C(Cn1cc(-c2ccc(F)cc2)nn1)c1ccc(Cl)cc1		CHEMBL1642273	<	Inhibition	%	10.0	CHEMBL267	Homo sapiens	INH	%	10.0
	5126291	CHEMBL1646094	Inhibition of c-Src at 75 uM after 60 mins	B	COc1ccc(-c2cn(CC(=O)c3ccc(Cl)cc3)nn2)cc1		CHEMBL1642274	<	Inhibition	%	10.0	CHEMBL267	Homo sapiens	INH	%	10.0
	5126292	CHEMBL1646094	Inhibition of c-Src at 75 uM after 60 mins	B	Cc1ccc(-c2cn(CC(=O)c3ccc(Br)cc3)nn2)cc1		CHEMBL1642276	<	Inhibition	%	10.0	CHEMBL267	Homo sapiens	INH	%	10.0
	5126293	CHEMBL1646094	Inhibition of c-Src at 75 uM after 60 mins	B	O=C(Cn1cc(-c2ccc(F)cc2)nn1)c1ccc(Br)cc1		CHEMBL1642277	<	Inhibition	%	10.0	CHEMBL267	Homo sapiens	INH	%	10.0
	5126294	CHEMBL1646094	Inhibition of c-Src at 75 uM after 60 mins	B	CCCCc1cn(CC(=O)c2ccc(Br)cc2)nn1		CHEMBL1642278	<	Inhibition	%	10.0	CHEMBL267	Homo sapiens	INH	%	10.0
	5126295	CHEMBL1646094	Inhibition of c-Src at 75 uM after 60 mins	B	O=C1CCCC1n1cc(-c2ccsc2)nn1		CHEMBL1642289	<	Inhibition	%	10.0	CHEMBL267	Homo sapiens	INH	%	10.0
	5126296	CHEMBL1646094	Inhibition of c-Src at 75 uM after 60 mins	B	COc1ccc(-c2cn(C3CCCC3=O)nn2)cc1		CHEMBL1642290	<	Inhibition	%	10.0	CHEMBL267	Homo sapiens	INH	%	10.0
	5126297	CHEMBL1646094	Inhibition of c-Src at 75 uM after 60 mins	B	O=C1CCCC1n1cc(-c2ccc(F)cc2)nn1		CHEMBL1642291	<	Inhibition	%	10.0	CHEMBL267	Homo sapiens	INH	%	10.0
	5126298	CHEMBL1646094	Inhibition of c-Src at 75 uM after 60 mins	B	O=C1CCC(n2cc(-c3ccccc3)nn2)C1		CHEMBL1642292	<	Inhibition	%	10.0	CHEMBL267	Homo sapiens	INH	%	10.0
	5126299	CHEMBL1646094	Inhibition of c-Src at 75 uM after 60 mins	B	O=C1CCCCC1n1cc(-c2ccsc2)nn1		CHEMBL1642295	<	Inhibition	%	10.0	CHEMBL267	Homo sapiens	INH	%	10.0
	5126300	CHEMBL1646094	Inhibition of c-Src at 75 uM after 60 mins	B	O=C1CCCCC1n1cc(-c2ccc(F)cc2)nn1		CHEMBL1641612	<	Inhibition	%	10.0	CHEMBL267	Homo sapiens	INH	%	10.0
	5126301	CHEMBL1646094	Inhibition of c-Src at 75 uM after 60 mins	B	COc1ccc(-c2cn(C3CCCCC3=O)nn2)cc1		CHEMBL1642296	<	Inhibition	%	10.0	CHEMBL267	Homo sapiens	INH	%	10.0
	5126302	CHEMBL1646094	Inhibition of c-Src at 75 uM after 60 mins	B	O=C1CCCC(n2cc(-c3ccccc3)nn2)C1		CHEMBL1642297	<	Inhibition	%	10.0	CHEMBL267	Homo sapiens	INH	%	10.0
	5132497	CHEMBL1648522	Inhibition of Src assessed as residual activity at 10 uM	B	CN1CCN(CCC(=O)Nc2ccc3c(C#N)cnc(Nc4cccc(Br)c4)c3c2)CC1		CHEMBL1641992	=	Activity	%	49.0	CHEMBL267	Homo sapiens	Activity	%	49.0
	5133720	CHEMBL1648522	Inhibition of Src assessed as residual activity at 10 uM	B	CN(C)C/C=C/C(=O)Nc1ccc2c(C#N)cnc(Nc3cccc(Br)c3)c2c1		CHEMBL1641990	=	Activity	%	61.0	CHEMBL267	Homo sapiens	Activity	%	61.0
	5133815	CHEMBL1648522	Inhibition of Src assessed as residual activity at 10 uM	B	CN(C)CCCC(=O)Nc1ccc2c(C#N)cnc(Nc3cccc(Br)c3)c2c1		CHEMBL1641989	=	Activity	%	60.0	CHEMBL267	Homo sapiens	Activity	%	60.0
	5140525	CHEMBL1646069	Inhibition of SRC at 1 uM	B	CC(C)(C)c1cc(C(=O)O)c(NC(=O)Nc2ccc3[nH]ncc3c2)s1		CHEMBL1641799	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	5191447	CHEMBL1664080	Inhibition of Src at 1 uM	B	COc1cc2nc(-c3cc(F)ccc3O)nc(N[C@@H]3CNC[C@H]3C(C)(C)O)c2cc1OC		CHEMBL1236782	=	Inhibition	%	38.0	CHEMBL267	Homo sapiens	INH	%	38.0
	5191448	CHEMBL1664080	Inhibition of Src at 1 uM	B	CC(C)(O)[C@@H]1CNC[C@H]1Nc1nc(-c2cc(-c3cc[nH]n3)ccc2O)nc2ccccc12		CHEMBL1650131	=	Inhibition	%	90.0	CHEMBL267	Homo sapiens	INH	%	90.0
	5235444	CHEMBL1686335	Inhibition of GST-fussed c-SRC after 30 mins	B	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	=	IC50	nM	2800.0	CHEMBL267	Homo sapiens	IC50	uM	2.8
	5235445	CHEMBL1686335	Inhibition of GST-fussed c-SRC after 30 mins	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	300.0	CHEMBL267	Homo sapiens	IC50	uM	0.3
	5235446	CHEMBL1686335	Inhibition of GST-fussed c-SRC after 30 mins	B	CCOC(=O)Cn1cc(Cn2nc(-c3ccccc3)c3c(N)ncnc32)nn1		CHEMBL1683309	=	IC50	nM	12700.0	CHEMBL267	Homo sapiens	IC50	uM	12.7
	5235447	CHEMBL1686335	Inhibition of GST-fussed c-SRC after 30 mins	B	Nc1ncnc2c1c(-c1ccccc1)nn2Cc1cn(CC(=O)CCCO)nn1		CHEMBL1683308	=	IC50	nM	9100.0	CHEMBL267	Homo sapiens	IC50	uM	9.1
	5235448	CHEMBL1686335	Inhibition of GST-fussed c-SRC after 30 mins	B	Nc1ncnc2c1c(-c1ccccc1)nn2Cc1cn(CC(=O)Nc2ccc(Cl)cc2)nn1		CHEMBL1683306	>	IC50	nM	75000.0	CHEMBL267	Homo sapiens	IC50	uM	75.0
	5235449	CHEMBL1686335	Inhibition of GST-fussed c-SRC after 30 mins	B	Nc1ncnc2c1c(-c1ccccc1)nn2Cc1cn(CC(=O)Nc2ccc(F)cc2)nn1		CHEMBL1683305	=	IC50	nM	16400.0	CHEMBL267	Homo sapiens	IC50	uM	16.4
	5235450	CHEMBL1686335	Inhibition of GST-fussed c-SRC after 30 mins	B	Nc1ncnc2c1c(-c1ccccc1)nn2Cc1cn(CC(=O)Nc2ccccc2)nn1		CHEMBL1683304	=	IC50	nM	23100.0	CHEMBL267	Homo sapiens	IC50	uM	23.1
	5235451	CHEMBL1686335	Inhibition of GST-fussed c-SRC after 30 mins	B	Nc1ncnc2c1c(-c1ccccc1)nn2Cc1cn(CC(=O)c2cccs2)nn1		CHEMBL1683303	>	IC50	nM	75000.0	CHEMBL267	Homo sapiens	IC50	uM	75.0
	5235452	CHEMBL1686335	Inhibition of GST-fussed c-SRC after 30 mins	B	Cc1ccc(C(=O)Cn2cc(Cn3nc(-c4ccccc4)c4c(N)ncnc43)nn2)cc1		CHEMBL1683302	>	IC50	nM	75000.0	CHEMBL267	Homo sapiens	IC50	uM	75.0
	5235453	CHEMBL1686335	Inhibition of GST-fussed c-SRC after 30 mins	B	Nc1ncnc2c1c(-c1ccccc1)nn2Cc1cn(CC(=O)c2ccccc2)nn1		CHEMBL1683301	>	IC50	nM	75000.0	CHEMBL267	Homo sapiens	IC50	uM	75.0
	5235454	CHEMBL1686335	Inhibition of GST-fussed c-SRC after 30 mins	B	Nc1ncnc2c1c(-c1ccccc1)nn2Cc1cn(CC(=O)c2ccc(Cl)cc2)nn1		CHEMBL1681804	>	IC50	nM	75000.0	CHEMBL267	Homo sapiens	IC50	uM	75.0
	5235455	CHEMBL1686335	Inhibition of GST-fussed c-SRC after 30 mins	B	CC(=O)c1ccc(-c2cn(CCn3nc(-c4ccccc4)c4c(N)ncnc43)nn2)cc1		CHEMBL1683299	>	IC50	nM	75000.0	CHEMBL267	Homo sapiens	IC50	uM	75.0
	5235456	CHEMBL1686335	Inhibition of GST-fussed c-SRC after 30 mins	B	Nc1ncnc2c1c(-c1ccccc1)nn2CCn1cc(-c2ccc(F)cc2)nn1		CHEMBL1683298	=	IC50	nM	29600.0	CHEMBL267	Homo sapiens	IC50	uM	29.6
	5235457	CHEMBL1686335	Inhibition of GST-fussed c-SRC after 30 mins	B	COc1ccc(-c2cn(CCn3nc(-c4ccccc4)c4c(N)ncnc43)nn2)cc1		CHEMBL1683297	=	IC50	nM	17400.0	CHEMBL267	Homo sapiens	IC50	uM	17.4
	5235458	CHEMBL1686335	Inhibition of GST-fussed c-SRC after 30 mins	B	CCCCCCCCCCc1cn(CCn2nc(-c3ccccc3)c3c(N)ncnc32)nn1		CHEMBL1683295	>	IC50	nM	75000.0	CHEMBL267	Homo sapiens	IC50	uM	75.0
	5235459	CHEMBL1686335	Inhibition of GST-fussed c-SRC after 30 mins	B	CCCCCCCc1cn(CCn2nc(-c3ccccc3)c3c(N)ncnc32)nn1		CHEMBL1683294	>	IC50	nM	75000.0	CHEMBL267	Homo sapiens	IC50	uM	75.0
	5235460	CHEMBL1686335	Inhibition of GST-fussed c-SRC after 30 mins	B	CCCCCCc1cn(CCn2nc(-c3ccccc3)c3c(N)ncnc32)nn1		CHEMBL1683293	=	IC50	nM	5600.0	CHEMBL267	Homo sapiens	IC50	uM	5.6
	5235461	CHEMBL1686335	Inhibition of GST-fussed c-SRC after 30 mins	B	CCCCc1cn(CCn2nc(-c3ccccc3)c3c(N)ncnc32)nn1		CHEMBL1683292	>	IC50	nM	75000.0	CHEMBL267	Homo sapiens	IC50	uM	75.0
	5235462	CHEMBL1686335	Inhibition of GST-fussed c-SRC after 30 mins	B	[N-]=[N+]=NCCn1nc(-c2ccccc2)c2c(N)ncnc21		CHEMBL1683291	=	IC50	nM	6200.0	CHEMBL267	Homo sapiens	IC50	uM	6.2
	5235464	CHEMBL1686336	Inhibition of GST-fussed c-SRC up to 250 uM after 30 mins	B	Nc1ncnc2c1c(-c1ccccc1)nn2CCn1cc(Cc2ccccc2)nn1		CHEMBL1683296	<	Inhibition	%	10.0	CHEMBL267	Homo sapiens	INH	%	10.0
	5235465	CHEMBL1686336	Inhibition of GST-fussed c-SRC up to 250 uM after 30 mins	B	Nc1ncnc2c1c(-c1ccccc1)nn2CCn1cc(CCCCl)nn1		CHEMBL1683300	<	Inhibition	%	10.0	CHEMBL267	Homo sapiens	INH	%	10.0
	5235466	CHEMBL1686336	Inhibition of GST-fussed c-SRC up to 250 uM after 30 mins	B	Nc1ncnc2c1c(-c1ccccc1)nn2Cc1cn(CC(=O)CCc2cccc3ccccc23)nn1		CHEMBL1683307	<	Inhibition	%	10.0	CHEMBL267	Homo sapiens	INH	%	10.0
Not Active	5239584	CHEMBL1686870	Inhibition of c-SRC up to 10 uM	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	5242957	CHEMBL1685651	Inhibition of c-SRC at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	31.0	CHEMBL267	Homo sapiens	INH	%	31.0
	5243796	CHEMBL1685900	Inhibition of c-SRC at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	1.0	CHEMBL267	Homo sapiens	INH	%	1.0
	5243909	CHEMBL1685651	Inhibition of c-SRC at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	16.0	CHEMBL267	Homo sapiens	INH	%	16.0
	5244017	CHEMBL1685900	Inhibition of c-SRC at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	5.0	CHEMBL267	Homo sapiens	INH	%	5.0
	5244890	CHEMBL1685651	Inhibition of c-SRC at 0.1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	64.0	CHEMBL267	Homo sapiens	INH	%	64.0
	5244998	CHEMBL1685900	Inhibition of c-SRC at 1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	10.0	CHEMBL267	Homo sapiens	INH	%	10.0
	5245149	CHEMBL1685651	Inhibition of c-SRC at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	30.0	CHEMBL267	Homo sapiens	INH	%	30.0
	5245979	CHEMBL1685900	Inhibition of c-SRC at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	8.0	CHEMBL267	Homo sapiens	INH	%	8.0
	5249834	CHEMBL1687357	Inhibition of c-Src	B	COc1ccc(Cn2ncc(NC(=O)c3cc(NC(=O)Nc4ccc(Cl)c(C(F)(F)F)c4)ccc3C)c2N)cc1		CHEMBL1684800	=	IC50	nM	4.79	CHEMBL267	Homo sapiens	IC50	nM	4.79
	5249851	CHEMBL1687330	Inhibition of c-Src at 10 uM	B	COc1ccc(Cn2ncc(NC(=O)c3cc(NC(=O)Nc4ccc(Cl)c(C(F)(F)F)c4)ccc3C)c2N)cc1		CHEMBL1684800	=	Inhibition	%	16.0	CHEMBL267	Homo sapiens	INH	%	16.0
	5293854	CHEMBL1696960	Inhibition of Src kinase	B	O=C(Nc1ccc([N+](=O)[O-])cc1Cl)c1cc(Cl)ccc1O		CHEMBL1448	=	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	5293857	CHEMBL1697128	Inhibition of SRC after 60 mins by radiometric assay	B	O=C(Nc1ccc([N+](=O)[O-])cc1Cl)c1cc(Cl)ccc1O		CHEMBL1448	=	IC50	nM	10500.0	CHEMBL267	Homo sapiens	IC50	uM	10.5
Not Active	6150866	CHEMBL1764803	Inhibition of Src	B	C[C@H]1C(=O)N(c2ccc(S(=O)(=O)C(F)(F)F)cc2)C(=O)N1Cc1ccnc2ccccc12		CHEMBL1738841		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	6151043	CHEMBL1764888	Inhibition of SRC at 10 uM	B	Cc1ccc(CO)cc1N(C)c1ccnc(Nc2cc(N3CCOCC3)cc(N3CCOCC3)c2)n1		CHEMBL1762530	=	Inhibition	%	80.0	CHEMBL267	Homo sapiens	INH	%	80.0
	6152360	CHEMBL1763676	Inhibition of SRC	B	Cc1ccc(CO)cc1N(C)c1ccnc(Nc2cc(N3CCOCC3)cc(N3CCOCC3)c2)n1		CHEMBL1762530	<	IC50	nM	1.0	CHEMBL267	Homo sapiens	IC50	uM	0.001
	6154888	CHEMBL1762901	Inhibition of Src	B	CC(=O)NC[C@H]1CC[C@H](c2nc(-c3cc4ccccc4[nH]3)c3c(N)nccn32)CC1		CHEMBL1762110	=	IC50	nM	5300.0	CHEMBL267	Homo sapiens	IC50	uM	5.3
	6154931	CHEMBL1762901	Inhibition of Src	B	CN(C)C(=O)N1CCC(c2nc(-c3cc4ccccc4[nH]3)c3c(N)nccn23)CC1		CHEMBL1762114	=	IC50	nM	770.0	CHEMBL267	Homo sapiens	IC50	uM	0.77
	6166930	CHEMBL1768451	Inhibition of Src after 10 mins by radiometric phosphate incorporation assay	B	CC(C)(C)c1ccc(C(=O)Nc2cc(-c3ccncc3)c[nH]c2=O)cc1		CHEMBL1765770	=	Ki	nM	1320.0	CHEMBL267	Homo sapiens	Ki	uM	1.32
	6166933	CHEMBL1768451	Inhibition of Src after 10 mins by radiometric phosphate incorporation assay	B	CN(C)c1ccc(C(=O)Nc2cc(-c3ccncc3)c[nH]c2=O)cc1		CHEMBL1765772	=	Ki	nM	2800.0	CHEMBL267	Homo sapiens	Ki	uM	2.8
	6166965	CHEMBL1768451	Inhibition of Src after 10 mins by radiometric phosphate incorporation assay	B	O=C(Nc1cc(-c2ccncc2)c[nH]c1=O)c1ccc(N2CCCCC2)cc1		CHEMBL1765097	=	Ki	nM	1800.0	CHEMBL267	Homo sapiens	Ki	uM	1.8
	6166966	CHEMBL1768451	Inhibition of Src after 10 mins by radiometric phosphate incorporation assay	B	CNc1cc(-c2c[nH]c(=O)c(NC(=O)c3ccc(N4CCCCC4)cc3)c2)ccn1		CHEMBL1765774	=	Ki	nM	140.0	CHEMBL267	Homo sapiens	Ki	uM	0.14
	6166967	CHEMBL1768451	Inhibition of Src after 10 mins by radiometric phosphate incorporation assay	B	CNc1nccc(-c2c[nH]c(=O)c(NC(=O)c3ccc(N4CCCCC4)cc3)c2)n1		CHEMBL1738829	=	Ki	nM	40.0	CHEMBL267	Homo sapiens	Ki	uM	0.04
	6166968	CHEMBL1768451	Inhibition of Src after 10 mins by radiometric phosphate incorporation assay	B	CNc1cc(-c2c[nH]c(=O)c(NC(=O)c3ccc(N4CCCCC4)cc3)c2)ncn1		CHEMBL1765775	=	Ki	nM	1200.0	CHEMBL267	Homo sapiens	Ki	uM	1.2
	6166969	CHEMBL1768451	Inhibition of Src after 10 mins by radiometric phosphate incorporation assay	B	CNc1cccc(-c2c[nH]c(=O)c(NC(=O)c3ccc(N4CCCCC4)cc3)c2)c1		CHEMBL1765776	=	Ki	nM	220.0	CHEMBL267	Homo sapiens	Ki	uM	0.22
	6166970	CHEMBL1768451	Inhibition of Src after 10 mins by radiometric phosphate incorporation assay	B	CNc1cccc(-c2c[nH]c(=O)c(NC(=O)c3ccc(N4CCCCC4)cc3)c2)n1		CHEMBL1765777	=	Ki	nM	480.0	CHEMBL267	Homo sapiens	Ki	uM	0.48
	6166971	CHEMBL1768451	Inhibition of Src after 10 mins by radiometric phosphate incorporation assay	B	O=C(Nc1cc(-c2cccc(NC3CC3)n2)c[nH]c1=O)c1ccc(N2CCCCC2)cc1		CHEMBL1765778	>	Ki	nM	4000.0	CHEMBL267	Homo sapiens	Ki	uM	4.0
	6166972	CHEMBL1768451	Inhibition of Src after 10 mins by radiometric phosphate incorporation assay	B	CNc1cncc(-c2c[nH]c(=O)c(NC(=O)c3ccc(N4CCCCC4)cc3)c2)n1		CHEMBL1765779	=	Ki	nM	590.0	CHEMBL267	Homo sapiens	Ki	uM	0.59
	6166973	CHEMBL1768451	Inhibition of Src after 10 mins by radiometric phosphate incorporation assay	B	CNc1cncc(-c2c[nH]c(=O)c(NC(=O)c3ccc(N4CCCCC4)cc3)c2)c1		CHEMBL1765780	=	Ki	nM	590.0	CHEMBL267	Homo sapiens	Ki	uM	0.59
	6166974	CHEMBL1768451	Inhibition of Src after 10 mins by radiometric phosphate incorporation assay	B	CNc1cncc(-c2c[nH]c(=O)c(NC(=O)c3ccc(N4CCC[C@H]4CN4CCCC4)cc3)c2)n1		CHEMBL1765781	=	Ki	nM	120.0	CHEMBL267	Homo sapiens	Ki	uM	0.12
	6166975	CHEMBL1768451	Inhibition of Src after 10 mins by radiometric phosphate incorporation assay	B	CNc1cncc(-c2c[nH]c(=O)c(NC(=O)c3ccc(N4CCC[C@H]4CN4CCCC4)cc3)c2)c1		CHEMBL1765782	=	Ki	nM	280.0	CHEMBL267	Homo sapiens	Ki	uM	0.28
	6166976	CHEMBL1768451	Inhibition of Src after 10 mins by radiometric phosphate incorporation assay	B	CNc1cc(F)cc(-c2c[nH]c(=O)c(NC(=O)c3ccc(N4CCC[C@H]4CN4CCCC4)cc3)c2)c1		CHEMBL1765783	=	Ki	nM	300.0	CHEMBL267	Homo sapiens	Ki	uM	0.3
	6166977	CHEMBL1768451	Inhibition of Src after 10 mins by radiometric phosphate incorporation assay	B	CNc1cc(C#N)cc(-c2c[nH]c(=O)c(NC(=O)c3ccc(N4CCC[C@H]4CN4CCCC4)cc3)c2)c1		CHEMBL1765784	=	Ki	nM	480.0	CHEMBL267	Homo sapiens	Ki	uM	0.48
	6167678	CHEMBL1769219	Inhibition of SRC	B	CNc1cncc(-c2c[nH]c(=O)c(NC(=O)c3ccc(N4CCC[C@H]4CN4CCCC4)cc3)c2)n1		CHEMBL1765781	=	Ki	nM	120.0	CHEMBL267	Homo sapiens	Ki	uM	0.12
	6171345	CHEMBL1768694	Inhibition of c-Src	B	CC(=O)N1CCN(c2cnc3cc(C(F)(F)F)cc(NCc4cccc([N+](=O)[O-])c4)c3c2)CC1		CHEMBL1766529	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	6175408	CHEMBL1768404	Inhibition of c-SRC	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	IC50	nM	1.0	CHEMBL267	Homo sapiens	IC50	nM	1.0
	6175409	CHEMBL1768404	Inhibition of c-SRC	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	IC50	nM	0.6	CHEMBL267	Homo sapiens	IC50	nM	0.6
	6175410	CHEMBL1768404	Inhibition of c-SRC	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	=	IC50	nM	2.7	CHEMBL267	Homo sapiens	IC50	nM	2.7
	6175411	CHEMBL1768404	Inhibition of c-SRC	B	COc1cc(Nc2c(C#N)cnc3cc4cc(OCCN5CCOCC5)c(OC)cc4cc23)c(Cl)cc1Cl		CHEMBL195029	=	IC50	nM	0.46	CHEMBL267	Homo sapiens	IC50	nM	0.46
	6175412	CHEMBL1768404	Inhibition of c-SRC	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	=	IC50	nM	20.0	CHEMBL267	Homo sapiens	IC50	nM	20.0
	6175414	CHEMBL1768532	Inhibition of c-SRC assessed as residual activity using KVEKIGEGYYGVVYK as peptide substrate after 20 mins by scintillation counting	B	Cc1cc(C)c2c(N)c(C(=O)N/N=C/c3cccc4ccccc34)sc2n1		CHEMBL1765547	=	IC50	nM	269.0	CHEMBL267	Homo sapiens	IC50	nM	269.0
	6175415	CHEMBL1768532	Inhibition of c-SRC assessed as residual activity using KVEKIGEGYYGVVYK as peptide substrate after 20 mins by scintillation counting	B	Nc1c(C(=O)N/N=C/c2cccc3ccccc23)sc2ncccc12		CHEMBL1765548	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	6175416	CHEMBL1768532	Inhibition of c-SRC assessed as residual activity using KVEKIGEGYYGVVYK as peptide substrate after 20 mins by scintillation counting	B	Cc1cc(C)c2c(N)c(C(=O)N/N=C/c3cncn3C)sc2n1		CHEMBL1765549	=	IC50	nM	769.0	CHEMBL267	Homo sapiens	IC50	nM	769.0
	6175417	CHEMBL1768532	Inhibition of c-SRC assessed as residual activity using KVEKIGEGYYGVVYK as peptide substrate after 20 mins by scintillation counting	B	Cn1cncc1/C=N/NC(=O)c1sc2ncccc2c1N		CHEMBL1765550	=	IC50	nM	1300.0	CHEMBL267	Homo sapiens	IC50	nM	1300.0
	6175418	CHEMBL1768532	Inhibition of c-SRC assessed as residual activity using KVEKIGEGYYGVVYK as peptide substrate after 20 mins by scintillation counting	B	Cc1cc(C)c2c(N)c(C(=O)N/N=C/c3cccn3CCN(C)C)sc2n1		CHEMBL1765551	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	6175419	CHEMBL1768532	Inhibition of c-SRC assessed as residual activity using KVEKIGEGYYGVVYK as peptide substrate after 20 mins by scintillation counting	B	Cc1cc(C)c2c(N)c(C(=O)N/N=C/c3cccn3C)sc2n1		CHEMBL1765552	=	IC50	nM	840.0	CHEMBL267	Homo sapiens	IC50	nM	840.0
	6175420	CHEMBL1768532	Inhibition of c-SRC assessed as residual activity using KVEKIGEGYYGVVYK as peptide substrate after 20 mins by scintillation counting	B	Cc1cc(C(F)(F)F)nc2sc(C(=O)N/N=C/c3cccc4ccccc34)c(N)c12		CHEMBL1765553	=	IC50	nM	1340.0	CHEMBL267	Homo sapiens	IC50	nM	1340.0
	6175421	CHEMBL1768532	Inhibition of c-SRC assessed as residual activity using KVEKIGEGYYGVVYK as peptide substrate after 20 mins by scintillation counting	B	Cc1cc(C(F)(F)F)nc2sc(C(=O)N/N=C/c3cncn3C)c(N)c12		CHEMBL1765554	=	IC50	nM	330.0	CHEMBL267	Homo sapiens	IC50	nM	330.0
	6175422	CHEMBL1768532	Inhibition of c-SRC assessed as residual activity using KVEKIGEGYYGVVYK as peptide substrate after 20 mins by scintillation counting	B	Cc1cc(NCCN(C)C)nc2sc(C(=O)N/N=C/c3cccc4ccccc34)c(N)c12		CHEMBL1765555	=	IC50	nM	230.0	CHEMBL267	Homo sapiens	IC50	nM	230.0
	6175423	CHEMBL1768532	Inhibition of c-SRC assessed as residual activity using KVEKIGEGYYGVVYK as peptide substrate after 20 mins by scintillation counting	B	Cc1cc(NCCN(C)C)nc2sc(C(=O)N/N=C/c3cccn3C)c(N)c12		CHEMBL1765556	=	IC50	nM	246.0	CHEMBL267	Homo sapiens	IC50	nM	246.0
	6175424	CHEMBL1768532	Inhibition of c-SRC assessed as residual activity using KVEKIGEGYYGVVYK as peptide substrate after 20 mins by scintillation counting	B	CN(C)CCNc1cc(-c2ccccc2)c2c(N)c(C(=O)N/N=C/c3cccc4ccccc34)sc2n1		CHEMBL1765557	=	IC50	nM	107.0	CHEMBL267	Homo sapiens	IC50	nM	107.0
	6175425	CHEMBL1768532	Inhibition of c-SRC assessed as residual activity using KVEKIGEGYYGVVYK as peptide substrate after 20 mins by scintillation counting	B	CN(C)CCNc1cc(-c2ccccc2)c2c(N)c(C(=O)N/N=C/c3cncn3C)sc2n1		CHEMBL1765558	=	IC50	nM	32.0	CHEMBL267	Homo sapiens	IC50	nM	32.0
	6175426	CHEMBL1768532	Inhibition of c-SRC assessed as residual activity using KVEKIGEGYYGVVYK as peptide substrate after 20 mins by scintillation counting	B	CN(C)CCNc1cc(-c2ccccc2)c2c(N)c(C(=O)N/N=C/c3cccn3C)sc2n1		CHEMBL1765559	=	IC50	nM	68.0	CHEMBL267	Homo sapiens	IC50	nM	68.0
	6175427	CHEMBL1768532	Inhibition of c-SRC assessed as residual activity using KVEKIGEGYYGVVYK as peptide substrate after 20 mins by scintillation counting	B	CN(C)CCNc1cc(Cc2ccccc2)c2c(N)c(C(=O)N/N=C/c3cccn3C)sc2n1		CHEMBL1765560	=	IC50	nM	40.0	CHEMBL267	Homo sapiens	IC50	nM	40.0
	6175428	CHEMBL1768532	Inhibition of c-SRC assessed as residual activity using KVEKIGEGYYGVVYK as peptide substrate after 20 mins by scintillation counting	B	CCCc1cc(NCCN(C)C)nc2sc(C(=O)N/N=C/c3cccn3C)c(N)c12		CHEMBL1765561	=	IC50	nM	63.0	CHEMBL267	Homo sapiens	IC50	nM	63.0
	6175429	CHEMBL1768532	Inhibition of c-SRC assessed as residual activity using KVEKIGEGYYGVVYK as peptide substrate after 20 mins by scintillation counting	B	CN(C)CCNc1nc2sc(C(=O)N/N=C/c3cccn3C)c(N)c2cc1Cc1ccccc1		CHEMBL1765563	=	IC50	nM	3870.0	CHEMBL267	Homo sapiens	IC50	nM	3870.0
	6175430	CHEMBL1768532	Inhibition of c-SRC assessed as residual activity using KVEKIGEGYYGVVYK as peptide substrate after 20 mins by scintillation counting	B	CCCc1cc2c(N)c(C(=O)N/N=C/c3cccn3C)sc2nc1NCCN(C)C		CHEMBL1765564	=	IC50	nM	2080.0	CHEMBL267	Homo sapiens	IC50	nM	2080.0
	6175431	CHEMBL1768533	Inhibition of c-SRC in EGF-stimulated human A431 cells assessed as phosphorylated STAT3 level by Western blot assay	B	Cc1cc(C)c2c(N)c(C(=O)N/N=C/c3cccc4ccccc34)sc2n1		CHEMBL1765547	=	Activity	uM	10.0	CHEMBL267	Homo sapiens	Activity	uM	10.0
Not Determined	6175432	CHEMBL1768533	Inhibition of c-SRC in EGF-stimulated human A431 cells assessed as phosphorylated STAT3 level by Western blot assay	B	Nc1c(C(=O)N/N=C/c2cccc3ccccc23)sc2ncccc12		CHEMBL1765548		Activity			CHEMBL267	Homo sapiens	Activity		
	6175433	CHEMBL1768533	Inhibition of c-SRC in EGF-stimulated human A431 cells assessed as phosphorylated STAT3 level by Western blot assay	B	Cc1cc(C)c2c(N)c(C(=O)N/N=C/c3cncn3C)sc2n1		CHEMBL1765549	>	Activity	uM	10.0	CHEMBL267	Homo sapiens	Activity	uM	10.0
Not Determined	6175434	CHEMBL1768533	Inhibition of c-SRC in EGF-stimulated human A431 cells assessed as phosphorylated STAT3 level by Western blot assay	B	Cn1cncc1/C=N/NC(=O)c1sc2ncccc2c1N		CHEMBL1765550		Activity			CHEMBL267	Homo sapiens	Activity		
Not Determined	6175435	CHEMBL1768533	Inhibition of c-SRC in EGF-stimulated human A431 cells assessed as phosphorylated STAT3 level by Western blot assay	B	Cc1cc(C)c2c(N)c(C(=O)N/N=C/c3cccn3CCN(C)C)sc2n1		CHEMBL1765551		Activity			CHEMBL267	Homo sapiens	Activity		
	6175436	CHEMBL1768533	Inhibition of c-SRC in EGF-stimulated human A431 cells assessed as phosphorylated STAT3 level by Western blot assay	B	Cc1cc(C)c2c(N)c(C(=O)N/N=C/c3cccn3C)sc2n1		CHEMBL1765552	=	Activity	uM	10.0	CHEMBL267	Homo sapiens	Activity	uM	10.0
Not Determined	6175437	CHEMBL1768533	Inhibition of c-SRC in EGF-stimulated human A431 cells assessed as phosphorylated STAT3 level by Western blot assay	B	Cc1cc(C(F)(F)F)nc2sc(C(=O)N/N=C/c3cccc4ccccc34)c(N)c12		CHEMBL1765553		Activity			CHEMBL267	Homo sapiens	Activity		
	6175438	CHEMBL1768534	Inhibition of c-SRC in human HCT116 cells assessed as phosphorylated FAK level after 5 hrs by Western blot assay	B	Cc1cc(C(F)(F)F)nc2sc(C(=O)N/N=C/c3cncn3C)c(N)c12		CHEMBL1765554	>	Activity	uM	10.0	CHEMBL267	Homo sapiens	Activity	uM	10.0
	6175439	CHEMBL1768534	Inhibition of c-SRC in human HCT116 cells assessed as phosphorylated FAK level after 5 hrs by Western blot assay	B	Cc1cc(NCCN(C)C)nc2sc(C(=O)N/N=C/c3cccc4ccccc34)c(N)c12		CHEMBL1765555	>	Activity	uM	10.0	CHEMBL267	Homo sapiens	Activity	uM	10.0
	6175440	CHEMBL1768534	Inhibition of c-SRC in human HCT116 cells assessed as phosphorylated FAK level after 5 hrs by Western blot assay	B	Cc1cc(NCCN(C)C)nc2sc(C(=O)N/N=C/c3cccn3C)c(N)c12		CHEMBL1765556	=	Activity	uM	10.0	CHEMBL267	Homo sapiens	Activity	uM	10.0
	6175441	CHEMBL1768534	Inhibition of c-SRC in human HCT116 cells assessed as phosphorylated FAK level after 5 hrs by Western blot assay	B	CN(C)CCNc1cc(-c2ccccc2)c2c(N)c(C(=O)N/N=C/c3cccc4ccccc34)sc2n1		CHEMBL1765557	=	Activity	uM	3.0	CHEMBL267	Homo sapiens	Activity	uM	3.0
	6175442	CHEMBL1768534	Inhibition of c-SRC in human HCT116 cells assessed as phosphorylated FAK level after 5 hrs by Western blot assay	B	CN(C)CCNc1cc(-c2ccccc2)c2c(N)c(C(=O)N/N=C/c3cncn3C)sc2n1		CHEMBL1765558	=	Activity	uM	3.0	CHEMBL267	Homo sapiens	Activity	uM	3.0
	6175443	CHEMBL1768534	Inhibition of c-SRC in human HCT116 cells assessed as phosphorylated FAK level after 5 hrs by Western blot assay	B	CN(C)CCNc1cc(-c2ccccc2)c2c(N)c(C(=O)N/N=C/c3cccn3C)sc2n1		CHEMBL1765559	=	Activity	uM	3.0	CHEMBL267	Homo sapiens	Activity	uM	3.0
	6175444	CHEMBL1768534	Inhibition of c-SRC in human HCT116 cells assessed as phosphorylated FAK level after 5 hrs by Western blot assay	B	CN(C)CCNc1cc(Cc2ccccc2)c2c(N)c(C(=O)N/N=C/c3cccn3C)sc2n1		CHEMBL1765560	=	Activity	uM	3.0	CHEMBL267	Homo sapiens	Activity	uM	3.0
	6175445	CHEMBL1768534	Inhibition of c-SRC in human HCT116 cells assessed as phosphorylated FAK level after 5 hrs by Western blot assay	B	CCCc1cc(NCCN(C)C)nc2sc(C(=O)N/N=C/c3cccn3C)c(N)c12		CHEMBL1765561	=	Activity	uM	10.0	CHEMBL267	Homo sapiens	Activity	uM	10.0
	6175446	CHEMBL1768534	Inhibition of c-SRC in human HCT116 cells assessed as phosphorylated FAK level after 5 hrs by Western blot assay	B	CN(C)CCNc1nc2sc(C(=O)N/N=C/c3cccn3C)c(N)c2cc1-c1ccccc1		CHEMBL1765562	=	Activity	uM	4100.0	CHEMBL267	Homo sapiens	Activity	uM	4100.0
	6189577	CHEMBL1776289	Inhibition of human recombinant c-Src by filter-binding assay	B	Fc1ccc(CNc2ncnc3c2cnn3CC(Cl)c2ccc(Cl)cc2)cc1		CHEMBL406658	=	Ki	nM	800.0	CHEMBL267	Homo sapiens	Ki	uM	0.8
	6189588	CHEMBL1776289	Inhibition of human recombinant c-Src by filter-binding assay	B	Clc1cccc(Nc2nc(N3CCOCC3)nc3c2cnn3CC(Cl)c2ccccc2)c1		CHEMBL1775041	=	Ki	nM	7600.0	CHEMBL267	Homo sapiens	Ki	uM	7.6
	6189599	CHEMBL1776289	Inhibition of human recombinant c-Src by filter-binding assay	B	CSc1nc(NCc2ccccc2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL288280	=	Ki	nM	3700.0	CHEMBL267	Homo sapiens	Ki	uM	3.7
	6189607	CHEMBL1776289	Inhibition of human recombinant c-Src by filter-binding assay	B	CCCNc1nc(SCCN2CCOCC2)nc2c1cnn2CC(Cl)c1ccccc1		CHEMBL1775040	=	Ki	nM	3800.0	CHEMBL267	Homo sapiens	Ki	uM	3.8
	6189609	CHEMBL1776289	Inhibition of human recombinant c-Src by filter-binding assay	B	ClC(Cn1ncc2c(NCc3ccccc3)nc(SCCN3CCOCC3)nc21)c1ccccc1		CHEMBL1775039	=	Ki	nM	2900.0	CHEMBL267	Homo sapiens	Ki	uM	2.9
	6189620	CHEMBL1776289	Inhibition of human recombinant c-Src by filter-binding assay	B	Fc1ccc(CNc2nc(SCCN3CCOCC3)nc3c2cnn3CC(Cl)c2ccccc2)cc1		CHEMBL1775038	=	Ki	nM	1200.0	CHEMBL267	Homo sapiens	Ki	uM	1.2
Not Active	6189622	CHEMBL1776289	Inhibition of human recombinant c-Src by filter-binding assay	B	ClC(Cn1ncc2c(NCCc3ccccc3)nc(SCCN3CCOCC3)nc21)c1ccccc1		CHEMBL1775037		Ki			CHEMBL267	Homo sapiens	Ki		
	6189624	CHEMBL1776289	Inhibition of human recombinant c-Src by filter-binding assay	B	Clc1cccc(Nc2nc(SCCN3CCOCC3)nc3c2cnn3CC(Cl)c2ccccc2)c1		CHEMBL1775036	=	Ki	nM	190.0	CHEMBL267	Homo sapiens	Ki	uM	0.19
	6189635	CHEMBL1776289	Inhibition of human recombinant c-Src by filter-binding assay	B	ClC(Cn1ncc2c(Nc3ccccc3)nc(SCCN3CCOCC3)nc21)c1ccccc1		CHEMBL1775035	=	Ki	nM	210.0	CHEMBL267	Homo sapiens	Ki	uM	0.21
	6189646	CHEMBL1776289	Inhibition of human recombinant c-Src by filter-binding assay	B	Fc1ccc(C(Cl)Cn2ncc3c(NCc4ccncc4)ncnc32)cc1		CHEMBL1775047	=	Ki	nM	3000.0	CHEMBL267	Homo sapiens	Ki	uM	3.0
	6189654	CHEMBL1776289	Inhibition of human recombinant c-Src by filter-binding assay	B	Fc1ccc(C(Cl)Cn2ncc3c(NCc4ccccn4)ncnc32)cc1		CHEMBL1773092	=	Ki	nM	8300.0	CHEMBL267	Homo sapiens	Ki	uM	8.3
	6189662	CHEMBL1776289	Inhibition of human recombinant c-Src by filter-binding assay	B	Clc1ccc(C(Cl)Cn2ncc3c(NCc4ccncc4)ncnc32)cc1		CHEMBL1775046	=	Ki	nM	3900.0	CHEMBL267	Homo sapiens	Ki	uM	3.9
	6189673	CHEMBL1776289	Inhibition of human recombinant c-Src by filter-binding assay	B	Clc1ccc(C(Cl)Cn2ncc3c(NCc4ccccn4)ncnc32)cc1		CHEMBL1775045	=	Ki	nM	4800.0	CHEMBL267	Homo sapiens	Ki	uM	4.8
	6189681	CHEMBL1776289	Inhibition of human recombinant c-Src by filter-binding assay	B	CS(=O)(=O)c1nc(NCc2ccccc2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL1775043	=	Ki	nM	740.0	CHEMBL267	Homo sapiens	Ki	uM	0.74
	6189689	CHEMBL1776289	Inhibition of human recombinant c-Src by filter-binding assay	B	CCCNc1nc(S(C)(=O)=O)nc2c1cnn2/C=C\c1ccccc1		CHEMBL1775044	=	Ki	nM	3000.0	CHEMBL267	Homo sapiens	Ki	uM	3.0
	6189691	CHEMBL1776289	Inhibition of human recombinant c-Src by filter-binding assay	B	OCCNc1nc(NCCc2ccccc2)c2cnn(/C=C\c3ccccc3)c2n1		CHEMBL1775042	=	Ki	nM	2400.0	CHEMBL267	Homo sapiens	Ki	uM	2.4
	6189702	CHEMBL1776289	Inhibition of human recombinant c-Src by filter-binding assay	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Ki	nM	31000.0	CHEMBL267	Homo sapiens	Ki	uM	31.0
Active	6189715	CHEMBL1776302	Inhibition of Src phosphorylation in human K562 cells under normoxic condition after 3 hrs by Western blotting	B	Fc1ccc(CNc2ncnc3c2cnn3CC(Cl)c2ccc(Cl)cc2)cc1		CHEMBL406658		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Active	6189716	CHEMBL1775358	Inhibition of Src phosphorylation in human K562 cells under hypoxic condition after 3 hrs by Western blotting	B	Fc1ccc(CNc2ncnc3c2cnn3CC(Cl)c2ccc(Cl)cc2)cc1		CHEMBL406658		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Active	6189717	CHEMBL1776302	Inhibition of Src phosphorylation in human K562 cells under normoxic condition after 3 hrs by Western blotting	B	Clc1ccc(C(Cl)Cn2ncc3c(NCc4ccncc4)ncnc32)cc1		CHEMBL1775046		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Active	6189719	CHEMBL1775358	Inhibition of Src phosphorylation in human K562 cells under hypoxic condition after 3 hrs by Western blotting	B	Clc1ccc(C(Cl)Cn2ncc3c(NCc4ccncc4)ncnc32)cc1		CHEMBL1775046		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Active	6189726	CHEMBL1776302	Inhibition of Src phosphorylation in human K562 cells under normoxic condition after 3 hrs by Western blotting	B	Clc1cccc(Nc2nc(SCCN3CCOCC3)nc3c2cnn3CC(Cl)c2ccccc2)c1		CHEMBL1775036		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Active	6189727	CHEMBL1775358	Inhibition of Src phosphorylation in human K562 cells under hypoxic condition after 3 hrs by Western blotting	B	Clc1cccc(Nc2nc(SCCN3CCOCC3)nc3c2cnn3CC(Cl)c2ccccc2)c1		CHEMBL1775036		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Active	6189732	CHEMBL1776302	Inhibition of Src phosphorylation in human K562 cells under normoxic condition after 3 hrs by Western blotting	B	ClC(Cn1ncc2c(Nc3ccccc3)nc(SCCN3CCOCC3)nc21)c1ccccc1		CHEMBL1775035		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Active	6189733	CHEMBL1775358	Inhibition of Src phosphorylation in human K562 cells under hypoxic condition after 3 hrs by Western blotting	B	ClC(Cn1ncc2c(Nc3ccccc3)nc(SCCN3CCOCC3)nc21)c1ccccc1		CHEMBL1775035		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Active	6189736	CHEMBL1776302	Inhibition of Src phosphorylation in human K562 cells under normoxic condition after 3 hrs by Western blotting	B	Clc1cccc(Nc2nc(N3CCOCC3)nc3c2cnn3CC(Cl)c2ccccc2)c1		CHEMBL1775041		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Active	6189737	CHEMBL1775358	Inhibition of Src phosphorylation in human K562 cells under hypoxic condition after 3 hrs by Western blotting	B	Clc1cccc(Nc2nc(N3CCOCC3)nc3c2cnn3CC(Cl)c2ccccc2)c1		CHEMBL1775041		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Active	6190664	CHEMBL1775544	Inhibition of Src phosphorylation in human MEG-01 cells under normoxic condition after 3 hrs by Western blotting	B	Fc1ccc(CNc2ncnc3c2cnn3CC(Cl)c2ccc(Cl)cc2)cc1		CHEMBL406658		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Active	6190665	CHEMBL1775544	Inhibition of Src phosphorylation in human MEG-01 cells under normoxic condition after 3 hrs by Western blotting	B	Clc1ccc(C(Cl)Cn2ncc3c(NCc4ccncc4)ncnc32)cc1		CHEMBL1775046		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Active	6190666	CHEMBL1775544	Inhibition of Src phosphorylation in human MEG-01 cells under normoxic condition after 3 hrs by Western blotting	B	Clc1cccc(Nc2nc(N3CCOCC3)nc3c2cnn3CC(Cl)c2ccccc2)c1		CHEMBL1775041		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Active	6190667	CHEMBL1775544	Inhibition of Src phosphorylation in human MEG-01 cells under normoxic condition after 3 hrs by Western blotting	B	ClC(Cn1ncc2c(NCc3ccccc3)nc(SCCN3CCOCC3)nc21)c1ccccc1		CHEMBL1775039		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Active	6190668	CHEMBL1775544	Inhibition of Src phosphorylation in human MEG-01 cells under normoxic condition after 3 hrs by Western blotting	B	Clc1cccc(Nc2nc(SCCN3CCOCC3)nc3c2cnn3CC(Cl)c2ccccc2)c1		CHEMBL1775036		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Active	6190669	CHEMBL1775544	Inhibition of Src phosphorylation in human MEG-01 cells under normoxic condition after 3 hrs by Western blotting	B	ClC(Cn1ncc2c(Nc3ccccc3)nc(SCCN3CCOCC3)nc21)c1ccccc1		CHEMBL1775035		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Active	6190670	CHEMBL1775545	Inhibition of Src phosphorylation in human MEG-01 cells under hypoxic condition after 3 hrs by Western blotting	B	Fc1ccc(CNc2ncnc3c2cnn3CC(Cl)c2ccc(Cl)cc2)cc1		CHEMBL406658		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Active	6190671	CHEMBL1775545	Inhibition of Src phosphorylation in human MEG-01 cells under hypoxic condition after 3 hrs by Western blotting	B	Clc1ccc(C(Cl)Cn2ncc3c(NCc4ccncc4)ncnc32)cc1		CHEMBL1775046		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Active	6190672	CHEMBL1775545	Inhibition of Src phosphorylation in human MEG-01 cells under hypoxic condition after 3 hrs by Western blotting	B	Clc1cccc(Nc2nc(N3CCOCC3)nc3c2cnn3CC(Cl)c2ccccc2)c1		CHEMBL1775041		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Active	6190673	CHEMBL1775545	Inhibition of Src phosphorylation in human MEG-01 cells under hypoxic condition after 3 hrs by Western blotting	B	ClC(Cn1ncc2c(NCc3ccccc3)nc(SCCN3CCOCC3)nc21)c1ccccc1		CHEMBL1775039		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Active	6190674	CHEMBL1775545	Inhibition of Src phosphorylation in human MEG-01 cells under hypoxic condition after 3 hrs by Western blotting	B	Clc1cccc(Nc2nc(SCCN3CCOCC3)nc3c2cnn3CC(Cl)c2ccccc2)c1		CHEMBL1775036		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Active	6190675	CHEMBL1775545	Inhibition of Src phosphorylation in human MEG-01 cells under hypoxic condition after 3 hrs by Western blotting	B	ClC(Cn1ncc2c(Nc3ccccc3)nc(SCCN3CCOCC3)nc21)c1ccccc1		CHEMBL1775035		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Active	6190700	CHEMBL1775688	Inhibition of Src phosphorylation in human KU812 cells under normoxic condition after 3 hrs by Western blotting	B	Fc1ccc(CNc2ncnc3c2cnn3CC(Cl)c2ccc(Cl)cc2)cc1		CHEMBL406658		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Active	6190701	CHEMBL1775688	Inhibition of Src phosphorylation in human KU812 cells under normoxic condition after 3 hrs by Western blotting	B	Clc1ccc(C(Cl)Cn2ncc3c(NCc4ccncc4)ncnc32)cc1		CHEMBL1775046		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Active	6190702	CHEMBL1775688	Inhibition of Src phosphorylation in human KU812 cells under normoxic condition after 3 hrs by Western blotting	B	Clc1cccc(Nc2nc(N3CCOCC3)nc3c2cnn3CC(Cl)c2ccccc2)c1		CHEMBL1775041		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Active	6190703	CHEMBL1775688	Inhibition of Src phosphorylation in human KU812 cells under normoxic condition after 3 hrs by Western blotting	B	ClC(Cn1ncc2c(NCc3ccccc3)nc(SCCN3CCOCC3)nc21)c1ccccc1		CHEMBL1775039		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Active	6190704	CHEMBL1775688	Inhibition of Src phosphorylation in human KU812 cells under normoxic condition after 3 hrs by Western blotting	B	Clc1cccc(Nc2nc(SCCN3CCOCC3)nc3c2cnn3CC(Cl)c2ccccc2)c1		CHEMBL1775036		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Active	6190705	CHEMBL1775688	Inhibition of Src phosphorylation in human KU812 cells under normoxic condition after 3 hrs by Western blotting	B	ClC(Cn1ncc2c(Nc3ccccc3)nc(SCCN3CCOCC3)nc21)c1ccccc1		CHEMBL1775035		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Active	6190706	CHEMBL1775689	Inhibition of Src phosphorylation in human KU812 cells under hypoxic condition after 3 hrs by Western blotting	B	Fc1ccc(CNc2ncnc3c2cnn3CC(Cl)c2ccc(Cl)cc2)cc1		CHEMBL406658		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Active	6190707	CHEMBL1775689	Inhibition of Src phosphorylation in human KU812 cells under hypoxic condition after 3 hrs by Western blotting	B	Clc1ccc(C(Cl)Cn2ncc3c(NCc4ccncc4)ncnc32)cc1		CHEMBL1775046		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Active	6190708	CHEMBL1775689	Inhibition of Src phosphorylation in human KU812 cells under hypoxic condition after 3 hrs by Western blotting	B	Clc1cccc(Nc2nc(N3CCOCC3)nc3c2cnn3CC(Cl)c2ccccc2)c1		CHEMBL1775041		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Active	6190709	CHEMBL1775689	Inhibition of Src phosphorylation in human KU812 cells under hypoxic condition after 3 hrs by Western blotting	B	ClC(Cn1ncc2c(NCc3ccccc3)nc(SCCN3CCOCC3)nc21)c1ccccc1		CHEMBL1775039		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Active	6190710	CHEMBL1775689	Inhibition of Src phosphorylation in human KU812 cells under hypoxic condition after 3 hrs by Western blotting	B	Clc1cccc(Nc2nc(SCCN3CCOCC3)nc3c2cnn3CC(Cl)c2ccccc2)c1		CHEMBL1775036		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Active	6190711	CHEMBL1775689	Inhibition of Src phosphorylation in human KU812 cells under hypoxic condition after 3 hrs by Western blotting	B	ClC(Cn1ncc2c(Nc3ccccc3)nc(SCCN3CCOCC3)nc21)c1ccccc1		CHEMBL1775035		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	6193894	CHEMBL1777653	Inhibition of c-Src at 10 uM by ELISA based method	B	Cc1c(N)ccc2[nH]c(-c3ccc(N)cc3)nc12		CHEMBL529177	=	Inhibition	%	8.2	CHEMBL267	Homo sapiens	INH	%	8.2
	6193905	CHEMBL1777653	Inhibition of c-Src at 10 uM by ELISA based method	B	Oc1ccc(NCn2nnc3ccccc32)cc1		CHEMBL1775067	=	Inhibition	%	14.2	CHEMBL267	Homo sapiens	INH	%	14.2
	6193916	CHEMBL1777653	Inhibition of c-Src at 10 uM by ELISA based method	B	Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL6291	=	Inhibition	%	37.4	CHEMBL267	Homo sapiens	INH	%	37.4
	6201870	CHEMBL1781373	Inhibition of Src assessed as biotin-EGPWLEEEEEAYGWMDF peptide phosphorylation by TR-FRET assay	B	CC1(C)c2cc(C3CCN(C4COC4)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL1779202	=	IC50	nM	250.0	CHEMBL267	Homo sapiens	IC50	uM	0.25
	6204405	CHEMBL1781316	Inhibition of c-SRC	B	Cc1cc(Nc2cc(C)c(C#N)c(NC(C)CCCC(C)(C)O)n2)n[nH]1.Cl		CHEMBL1778662	=	Ki	nM	26.0	CHEMBL267	Homo sapiens	Ki	nM	26.0
	6210052	CHEMBL1781224	Inhibition of SRC at 4 uM by mobility shift assay	B	Cc1cc(-c2cccc(N)c2)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL1778718	=	Inhibition	%	39.0	CHEMBL267	Homo sapiens	INH	%	39.0
	6210978	CHEMBL1780628	Inhibition of SRC-related membrane-associated tyrosine kinase	B	Cc1c2c(n3c1CCCN1CCC[C@@H]1CNc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O		CHEMBL1738705	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	6211221	CHEMBL1781662	Inhibition of c-Src using AEEEIYGEFEAKKKK substrate by fluorescence intensity assay	B	CN(c1ccccc1)C(c1ccc(Cl)cc1)c1c[nH]c2ccccc12	Outside typical range	CHEMBL1779735	>	IC50	nM	150000.0	CHEMBL267	Homo sapiens	IC50	uM	150.0
	6211222	CHEMBL1781662	Inhibition of c-Src using AEEEIYGEFEAKKKK substrate by fluorescence intensity assay	B	Cc1ccc(C(c2c[nH]c3ccccc23)N(C)c2ccccc2)cc1	Outside typical range	CHEMBL1779736	>	IC50	nM	150000.0	CHEMBL267	Homo sapiens	IC50	uM	150.0
	6211223	CHEMBL1781662	Inhibition of c-Src using AEEEIYGEFEAKKKK substrate by fluorescence intensity assay	B	COc1ccc(C(c2c[nH]c3ccccc23)N(C)c2ccccc2)cc1	Outside typical range	CHEMBL1779737	>	IC50	nM	150000.0	CHEMBL267	Homo sapiens	IC50	uM	150.0
	6211224	CHEMBL1781662	Inhibition of c-Src using AEEEIYGEFEAKKKK substrate by fluorescence intensity assay	B	CN(c1ccccc1)C(c1ccccc1)c1c[nH]c2ccccc12		CHEMBL1779738	=	IC50	nM	50600.0	CHEMBL267	Homo sapiens	IC50	uM	50.6
	6211225	CHEMBL1781662	Inhibition of c-Src using AEEEIYGEFEAKKKK substrate by fluorescence intensity assay	B	CN(c1ccccc1)C(c1ccc(O)cc1)c1c[nH]c2ccccc12	Outside typical range	CHEMBL1779739	>	IC50	nM	150000.0	CHEMBL267	Homo sapiens	IC50	uM	150.0
	6211226	CHEMBL1781662	Inhibition of c-Src using AEEEIYGEFEAKKKK substrate by fluorescence intensity assay	B	CN(c1ccccc1)C(c1ccc(O)c(Br)c1)c1c[nH]c2ccccc12	Outside typical range	CHEMBL1779740	>	IC50	nM	150000.0	CHEMBL267	Homo sapiens	IC50	uM	150.0
	6211227	CHEMBL1781662	Inhibition of c-Src using AEEEIYGEFEAKKKK substrate by fluorescence intensity assay	B	COc1cccc(C(c2c[nH]c3ccccc23)N(C)c2ccccc2)c1	Outside typical range	CHEMBL1779741	>	IC50	nM	150000.0	CHEMBL267	Homo sapiens	IC50	uM	150.0
	6211228	CHEMBL1781662	Inhibition of c-Src using AEEEIYGEFEAKKKK substrate by fluorescence intensity assay	B	COc1ccc(C(c2c[nH]c3ccccc23)N(C)c2ccccc2)c(OC)c1	Outside typical range	CHEMBL1779742	>	IC50	nM	150000.0	CHEMBL267	Homo sapiens	IC50	uM	150.0
	6211229	CHEMBL1781662	Inhibition of c-Src using AEEEIYGEFEAKKKK substrate by fluorescence intensity assay	B	CN(c1ccccc1)C(c1ccccc1)c1cn(C)c2ccccc12	Outside typical range	CHEMBL1779743	>	IC50	nM	150000.0	CHEMBL267	Homo sapiens	IC50	uM	150.0
	6211230	CHEMBL1781662	Inhibition of c-Src using AEEEIYGEFEAKKKK substrate by fluorescence intensity assay	B	CN(c1ccccc1)C(c1ccc(Cl)cc1)c1cn(C)c2ccccc12		CHEMBL1779744	=	IC50	nM	98300.0	CHEMBL267	Homo sapiens	IC50	uM	98.3
	6211231	CHEMBL1781662	Inhibition of c-Src using AEEEIYGEFEAKKKK substrate by fluorescence intensity assay	B	Cc1ccc(C(c2cn(C)c3ccccc23)N(C)c2ccccc2)cc1		CHEMBL1779745	=	IC50	nM	60500.0	CHEMBL267	Homo sapiens	IC50	uM	60.5
	6211232	CHEMBL1781662	Inhibition of c-Src using AEEEIYGEFEAKKKK substrate by fluorescence intensity assay	B	CN(c1ccccc1)C(c1cccc([N+](=O)[O-])c1)c1c[nH]c2ccccc12		CHEMBL1779746	=	IC50	nM	58300.0	CHEMBL267	Homo sapiens	IC50	uM	58.3
	6211233	CHEMBL1781662	Inhibition of c-Src using AEEEIYGEFEAKKKK substrate by fluorescence intensity assay	B	CN(c1ccccc1)C(c1ccccc1)c1c[nH]c2ccc(Br)cc12		CHEMBL1779747	=	IC50	nM	71600.0	CHEMBL267	Homo sapiens	IC50	uM	71.6
	6211234	CHEMBL1781662	Inhibition of c-Src using AEEEIYGEFEAKKKK substrate by fluorescence intensity assay	B	COc1ccc(C(c2c[nH]c3ccc(OC)cc23)N(C)c2ccccc2)cc1		CHEMBL1779748	=	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	6211235	CHEMBL1781662	Inhibition of c-Src using AEEEIYGEFEAKKKK substrate by fluorescence intensity assay	B	COc1ccc2[nH]cc(C(c3ccc(C)cc3)N(C)c3ccccc3)c2c1	Outside typical range	CHEMBL1779749	>	IC50	nM	150000.0	CHEMBL267	Homo sapiens	IC50	uM	150.0
	6211236	CHEMBL1781662	Inhibition of c-Src using AEEEIYGEFEAKKKK substrate by fluorescence intensity assay	B	Cc1ccc(C(c2c[nH]c3ccc(Br)cc23)N(C)c2ccccc2)cc1	Outside typical range	CHEMBL1779750	>	IC50	nM	150000.0	CHEMBL267	Homo sapiens	IC50	uM	150.0
	6211237	CHEMBL1781662	Inhibition of c-Src using AEEEIYGEFEAKKKK substrate by fluorescence intensity assay	B	COc1ccc(C(c2c[nH]c3ccc(Br)cc23)N(C)c2ccccc2)cc1	Outside typical range	CHEMBL1779751	=	IC50	nM	106000.0	CHEMBL267	Homo sapiens	IC50	uM	106.0
	6211238	CHEMBL1781662	Inhibition of c-Src using AEEEIYGEFEAKKKK substrate by fluorescence intensity assay	B	COc1ccc2[nH]cc(C(c3ccc(Cl)cc3)N(C)c3ccccc3)c2c1		CHEMBL1779752	=	IC50	nM	87000.0	CHEMBL267	Homo sapiens	IC50	uM	87.0
	6212369	CHEMBL1786253	Inhibition of c-Src expressed in Bac-to-Bac Baculovirus expression system using poly(Glu-Tyr)4:1 as substrate after 60 mins by ELISA	B	CCOC(=O)C1=C2C(=NC1=O)c1cccc3cccc2c13		CHEMBL1784725	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	6215977	CHEMBL1785470	Inhibition of SRC catalytic domain assessed as inhibition of [gamma-33P]ATP incorporation into Ac-EIYGEFKKK-OH substrate after 30 mins by phosphor imaging analysis	B	CC(C)(C)n1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1231371	>	IC50	nM	1000.0	CHEMBL267	Homo sapiens	IC50	uM	1.0
Not Active	6215979	CHEMBL1785470	Inhibition of SRC catalytic domain assessed as inhibition of [gamma-33P]ATP incorporation into Ac-EIYGEFKKK-OH substrate after 30 mins by phosphor imaging analysis	B	CC(C)n1nc(-c2ccc(Cl)c(Cl)c2)c2c(N)ncnc21		CHEMBL1785012		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	6215981	CHEMBL1785470	Inhibition of SRC catalytic domain assessed as inhibition of [gamma-33P]ATP incorporation into Ac-EIYGEFKKK-OH substrate after 30 mins by phosphor imaging analysis	B	CCOc1ccc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2c1		CHEMBL1785021		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	6215982	CHEMBL1785470	Inhibition of SRC catalytic domain assessed as inhibition of [gamma-33P]ATP incorporation into Ac-EIYGEFKKK-OH substrate after 30 mins by phosphor imaging analysis	B	COc1ccc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2c1		CHEMBL1785020		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	6215983	CHEMBL1785470	Inhibition of SRC catalytic domain assessed as inhibition of [gamma-33P]ATP incorporation into Ac-EIYGEFKKK-OH substrate after 30 mins by phosphor imaging analysis	B	CC(C)c1cccc(-c2nn(C(C)C)c3ncnc(N)c23)c1		CHEMBL1785014		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Active	6215987	CHEMBL1785470	Inhibition of SRC catalytic domain assessed as inhibition of [gamma-33P]ATP incorporation into Ac-EIYGEFKKK-OH substrate after 30 mins by phosphor imaging analysis	B	CCN1CCC(n2nc(Cc3cccc4ccccc34)c3c(N)ncnc32)CC1		CHEMBL1784969		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Active	6216052	CHEMBL1785470	Inhibition of SRC catalytic domain assessed as inhibition of [gamma-33P]ATP incorporation into Ac-EIYGEFKKK-OH substrate after 30 mins by phosphor imaging analysis	B	CS(=O)(=O)N1CCC(n2nc(Cc3cccc4ccccc34)c3c(N)ncnc32)CC1		CHEMBL1784972		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	6219910	CHEMBL1785338	Inhibition of human Src using poly[Glu:Tyr] by Hotspot assay	B	CNC(=O)c1ncc(C#Cc2cc(C(=O)Nc3ccc(CN4CCN(CCO)CC4)c(C(F)(F)F)c3)ccc2C)n1C		CHEMBL1784637	=	IC50	nM	4.0	CHEMBL267	Homo sapiens	IC50	nM	4.0
Not Active	6230345	CHEMBL1785292	Inhibition of human SRC	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Determined	6264619	CHEMBL1798374	Inhibition of SRC assessed as incorporation of p33 using [gammaP33]-ATP by microplate scintillation counting	B	O=C(NNC(=O)c1ccc([N+](=O)[O-])cc1)C(=O)c1c[nH]c2ccccc12		CHEMBL1796172		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	6264620	CHEMBL1798374	Inhibition of SRC assessed as incorporation of p33 using [gammaP33]-ATP by microplate scintillation counting	B	O=C(NNc1ccccc1)C(=O)c1c[nH]c2ccccc12		CHEMBL72505		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	6264621	CHEMBL1798374	Inhibition of SRC assessed as incorporation of p33 using [gammaP33]-ATP by microplate scintillation counting	B	O=C(NNc1ccc(Cl)cc1)C(=O)c1c[nH]c2ccccc12		CHEMBL124871		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	6264622	CHEMBL1798374	Inhibition of SRC assessed as incorporation of p33 using [gammaP33]-ATP by microplate scintillation counting	B	O=C(NNc1ccc(Br)cc1)C(=O)c1c[nH]c2ccccc12		CHEMBL1796173		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	6265240	CHEMBL1798374	Inhibition of SRC assessed as incorporation of p33 using [gammaP33]-ATP by microplate scintillation counting	B	O=C(NNc1ccc(I)cc1)C(=O)c1c[nH]c2ccccc12		CHEMBL1796174		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	6265241	CHEMBL1798374	Inhibition of SRC assessed as incorporation of p33 using [gammaP33]-ATP by microplate scintillation counting	B	O=C(NCc1ccccc1)C(=O)c1c[nH]c2ccccc12		CHEMBL75289		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	6265242	CHEMBL1798374	Inhibition of SRC assessed as incorporation of p33 using [gammaP33]-ATP by microplate scintillation counting	B	Cc1ccc(CNC(=O)C(=O)c2c[nH]c3ccccc23)cc1		CHEMBL220737		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	6265243	CHEMBL1798374	Inhibition of SRC assessed as incorporation of p33 using [gammaP33]-ATP by microplate scintillation counting	B	O=C(NCc1ccc(Cl)cc1)C(=O)c1c[nH]c2ccccc12		CHEMBL73288		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	6265244	CHEMBL1798374	Inhibition of SRC assessed as incorporation of p33 using [gammaP33]-ATP by microplate scintillation counting	B	O=C(NCc1cccc(Cl)c1)C(=O)c1c[nH]c2ccccc12		CHEMBL358147		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	6265245	CHEMBL1798374	Inhibition of SRC assessed as incorporation of p33 using [gammaP33]-ATP by microplate scintillation counting	B	Cc1ccc(CCNC(=O)C(=O)c2c[nH]c3ccccc23)cc1		CHEMBL1796175		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	6265246	CHEMBL1798374	Inhibition of SRC assessed as incorporation of p33 using [gammaP33]-ATP by microplate scintillation counting	B	COc1ccc(CCNC(=O)C(=O)c2c[nH]c3ccccc23)cc1OC		CHEMBL71999		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	6265247	CHEMBL1798374	Inhibition of SRC assessed as incorporation of p33 using [gammaP33]-ATP by microplate scintillation counting	B	O=C(NCCc1ccc(Cl)cc1)C(=O)c1c[nH]c2ccccc12		CHEMBL71184		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	6265248	CHEMBL1798374	Inhibition of SRC assessed as incorporation of p33 using [gammaP33]-ATP by microplate scintillation counting	B	O=C(NCCc1cccc(Cl)c1)C(=O)c1c[nH]c2ccccc12		CHEMBL1796176		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	6265249	CHEMBL1798374	Inhibition of SRC assessed as incorporation of p33 using [gammaP33]-ATP by microplate scintillation counting	B	O=C(NNC(=O)c1ccccc1)C(=O)c1c[nH]c2ccccc12		CHEMBL1796177		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	6265250	CHEMBL1798374	Inhibition of SRC assessed as incorporation of p33 using [gammaP33]-ATP by microplate scintillation counting	B	Cc1ccc(C(=O)NNC(=O)C(=O)c2c[nH]c3ccccc23)cc1		CHEMBL1796178		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	6265251	CHEMBL1798374	Inhibition of SRC assessed as incorporation of p33 using [gammaP33]-ATP by microplate scintillation counting	B	COc1ccc(C(=O)NNC(=O)C(=O)c2c[nH]c3ccccc23)cc1		CHEMBL1796179		IC50			CHEMBL267	Homo sapiens	IC50		
	6265252	CHEMBL1798374	Inhibition of SRC assessed as incorporation of p33 using [gammaP33]-ATP by microplate scintillation counting	B	CC(C)(C)c1ccc(C(=O)NNC(=O)C(=O)c2c[nH]c3ccccc23)cc1		CHEMBL1796180	=	IC50	nM	5900.0	CHEMBL267	Homo sapiens	IC50	uM	5.9
	6265253	CHEMBL1798374	Inhibition of SRC assessed as incorporation of p33 using [gammaP33]-ATP by microplate scintillation counting	B	O=C(NNC(=O)c1ccc(C(F)(F)F)cc1)C(=O)c1c[nH]c2ccccc12		CHEMBL1796181	=	IC50	nM	1300.0	CHEMBL267	Homo sapiens	IC50	uM	1.3
Not Determined	6265254	CHEMBL1798374	Inhibition of SRC assessed as incorporation of p33 using [gammaP33]-ATP by microplate scintillation counting	B	O=C(NNC(=O)c1ccc(Cl)cc1)C(=O)c1c[nH]c2ccccc12		CHEMBL1796182		IC50			CHEMBL267	Homo sapiens	IC50		
	6265255	CHEMBL1798374	Inhibition of SRC assessed as incorporation of p33 using [gammaP33]-ATP by microplate scintillation counting	B	O=C(NNC(=O)c1ccc(I)cc1)C(=O)c1c[nH]c2ccccc12		CHEMBL1796183	=	IC50	nM	4500.0	CHEMBL267	Homo sapiens	IC50	uM	4.5
	6265256	CHEMBL1798374	Inhibition of SRC assessed as incorporation of p33 using [gammaP33]-ATP by microplate scintillation counting	B	O=C(NNC(=O)c1ccccc1F)C(=O)c1c[nH]c2ccccc12		CHEMBL1796184	=	IC50	nM	96000.0	CHEMBL267	Homo sapiens	IC50	uM	96.0
	6265257	CHEMBL1798374	Inhibition of SRC assessed as incorporation of p33 using [gammaP33]-ATP by microplate scintillation counting	B	Cc1ccc(C)n1-c1ccc(C(=O)NNC(=O)C(=O)c2c[nH]c3ccccc23)cc1		CHEMBL1796185	=	IC50	nM	3600.0	CHEMBL267	Homo sapiens	IC50	uM	3.6
	6265258	CHEMBL1798374	Inhibition of SRC assessed as incorporation of p33 using [gammaP33]-ATP by microplate scintillation counting	B	Cc1nc(-c2ccc(C(=O)NNC(=O)C(=O)c3c[nH]c4ccccc34)cc2)no1		CHEMBL1796186	=	IC50	nM	22000.0	CHEMBL267	Homo sapiens	IC50	uM	22.0
	6265259	CHEMBL1798374	Inhibition of SRC assessed as incorporation of p33 using [gammaP33]-ATP by microplate scintillation counting	B	Cc1cncc(Oc2ccc(C(=O)NNC(=O)C(=O)c3c[nH]c4ccccc34)cc2)n1		CHEMBL1796187	=	IC50	nM	40000.0	CHEMBL267	Homo sapiens	IC50	uM	40.0
	6265260	CHEMBL1798374	Inhibition of SRC assessed as incorporation of p33 using [gammaP33]-ATP by microplate scintillation counting	B	O=C(NNC(=O)c1ccc(-c2ccccc2OCc2ccc(F)cc2)cc1)C(=O)c1c[nH]c2ccccc12		CHEMBL1796188	=	IC50	nM	1900.0	CHEMBL267	Homo sapiens	IC50	uM	1.9
	6265261	CHEMBL1798374	Inhibition of SRC assessed as incorporation of p33 using [gammaP33]-ATP by microplate scintillation counting	B	O=C(NNC(=O)c1ccc(-c2ccccc2COc2cccc(C(F)(F)F)c2)cc1)C(=O)c1c[nH]c2ccccc12		CHEMBL1796189	=	IC50	nM	620.0	CHEMBL267	Homo sapiens	IC50	uM	0.62
	6265262	CHEMBL1798374	Inhibition of SRC assessed as incorporation of p33 using [gammaP33]-ATP by microplate scintillation counting	B	O=C(NNC(=O)c1ccc(-c2cccc(COc3cccc(C(F)(F)F)c3)c2)cc1)C(=O)c1c[nH]c2ccccc12		CHEMBL1796190	=	IC50	nM	720.0	CHEMBL267	Homo sapiens	IC50	uM	0.72
	6265263	CHEMBL1798374	Inhibition of SRC assessed as incorporation of p33 using [gammaP33]-ATP by microplate scintillation counting	B	Cc1cc(C(C)(C)C)ccc1OCc1cccc(-c2ccc(C(=O)NNC(=O)C(=O)c3c[nH]c4ccccc34)cc2)c1		CHEMBL1796191	=	IC50	nM	520.0	CHEMBL267	Homo sapiens	IC50	uM	0.52
	6265264	CHEMBL1798374	Inhibition of SRC assessed as incorporation of p33 using [gammaP33]-ATP by microplate scintillation counting	B	COCCc1ccc(OCc2cccc(-c3ccc(C(=O)NNC(=O)C(=O)c4c[nH]c5ccccc45)cc3)c2)cc1		CHEMBL1796192	=	IC50	nM	380.0	CHEMBL267	Homo sapiens	IC50	uM	0.38
	6265265	CHEMBL1798374	Inhibition of SRC assessed as incorporation of p33 using [gammaP33]-ATP by microplate scintillation counting	B	CS(=O)(=O)NCc1cccc(-c2ccc(C(=O)NNC(=O)C(=O)c3c[nH]c4ccccc34)cc2)c1		CHEMBL1796193	=	IC50	nM	2800.0	CHEMBL267	Homo sapiens	IC50	uM	2.8
	6265577	CHEMBL1798286	Inhibition of SRC at 1 uM	B	COCCN1CCc2cc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4NS(C)(=O)=O)n3)c(OC)cc2CC1		CHEMBL1796254	<	Inhibition	%	65.0	CHEMBL267	Homo sapiens	INH	%	65.0
	6265681	CHEMBL1798286	Inhibition of SRC at 1 uM	B	COCCN1CCc2cc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4N(C)S(C)(=O)=O)n3)c(OC)cc2CC1		CHEMBL1796257	<	Inhibition	%	65.0	CHEMBL267	Homo sapiens	INH	%	65.0
	6268422	CHEMBL1803833	Inhibition of Src kinase at 10 uM	B	O=C(CCl)c1ccc(Cl)cc1		CHEMBL143090	=	Inhibition	%	19.0	CHEMBL267	Homo sapiens	INH	%	19.0
	6268423	CHEMBL1803833	Inhibition of Src kinase at 10 uM	B	O=C(CBr)c1ccc(Br)cc1		CHEMBL142826	=	Inhibition	%	38.0	CHEMBL267	Homo sapiens	INH	%	38.0
	6268424	CHEMBL1803833	Inhibition of Src kinase at 10 uM	B	Cc1ccc(C(=O)CBr)cc1		CHEMBL142824	=	Inhibition	%	69.0	CHEMBL267	Homo sapiens	INH	%	69.0
	6274414	CHEMBL1806262	Inhibition of Src assessed as residual enzyme activity at 10 uM	B	CC(C)c1cnn2c(NCc3ccccc3)cc(N[C@@H](CO)[C@H](O)CO)nc12		CHEMBL1234833	=	Activity	%	95.0	CHEMBL267	Homo sapiens	Activity	%	95.0
	6286551	CHEMBL1810170	Inhibition of SRC at 0.1 uM	B	Cc1nc(Nc2cc(-c3cccc(NS(=O)(=O)c4ccccc4)c3)n[nH]2)cc(N2CCN(C)CC2)n1		CHEMBL1807483	=	Inhibition	%	44.0	CHEMBL267	Homo sapiens	INH	%	44.0
	6304890	CHEMBL1816281	Inhibition of c-SRC	B	O=C(Nc1ccc(Oc2ncnc3scc(-c4ccccc4)c23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL1813632	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
Not Active	6307655	CHEMBL1816876	Inhibition of recombinant SRC assessed as 33Pi incorporation after 60 mins by scintillation counting	B	C=C[C@]1(C)C=C2[C@@H](O)[C@@H]3OC(=O)[C@@]4(C)CC[C@H]5C[C@]5([C@@H]34)[C@@]2(O)C(=O)C1		CHEMBL1812030		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	6307656	CHEMBL1816876	Inhibition of recombinant SRC assessed as 33Pi incorporation after 60 mins by scintillation counting	B	C=C[C@@]1(C)C=C2C(=O)C(O)=C3[C@](C)(C(=O)O)CC[C@@H]4C[C@]34[C@]2(O)C(=O)C1		CHEMBL516554		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	6307657	CHEMBL1816876	Inhibition of recombinant SRC assessed as 33Pi incorporation after 60 mins by scintillation counting	B	Cc1cc(O)cc2oc3cc(O)cc(O)c3c(=O)c12		CHEMBL466154	=	IC50	nM	35000.0	CHEMBL267	Homo sapiens	IC50	uM	35.0
	6307658	CHEMBL1816876	Inhibition of recombinant SRC assessed as 33Pi incorporation after 60 mins by scintillation counting	B	Cc1c(O)c(O)cc2oc3cc(O)cc(O)c3c(=O)c12		CHEMBL454440	=	IC50	nM	12900.0	CHEMBL267	Homo sapiens	IC50	uM	12.9
	6310987	CHEMBL1816340	Inhibition of SRC at 50 uM after 1 hr	B	COc1ccc2nc3cc(Cl)ccc3c(Nc3ccc(C(=O)O)c(O)c3)c2c1		CHEMBL1271378	=	Inhibition	%	2.8	CHEMBL267	Homo sapiens	INH	%	2.8
	6311000	CHEMBL1816340	Inhibition of SRC at 50 uM after 1 hr	B	COc1ccc2nc3cc(Cl)ccc3c(Nc3cccc(N)n3)c2c1		CHEMBL1811987	=	Inhibition	%	6.12	CHEMBL267	Homo sapiens	INH	%	6.12
	6311006	CHEMBL1816340	Inhibition of SRC at 50 uM after 1 hr	B	COc1ccc2nc3cc(Cl)ccc3c(NCc3ccccc3OC)c2c1		CHEMBL1811988	=	Inhibition	%	8.02	CHEMBL267	Homo sapiens	INH	%	8.02
	6311040	CHEMBL1816340	Inhibition of SRC at 50 uM after 1 hr	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Inhibition	%	99.36	CHEMBL267	Homo sapiens	INH	%	99.36
tde	6311063	CHEMBL1816344	Inhibition of SRC in human K562 cells assessed as reduction in activated ERK1/2 levels at 10 uM by Western blot analysis	B	COc1ccc2nc3cc(Cl)ccc3c(NCc3ccccc3OC)c2c1		CHEMBL1811988		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	6316535	CHEMBL1815732	Inhibition of SRC at 30 uM by microfluidic mobility shift assay	B	Cc1cc2[nH]nc(N)c2c(=O)[nH]1		CHEMBL1813604	=	Inhibition	%	14.0	CHEMBL267	Homo sapiens	INH	%	14.0
	6316536	CHEMBL1815732	Inhibition of SRC at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2cc(-c3cccnc3)[nH]c(=O)c12		CHEMBL1813606	=	Inhibition	%	46.0	CHEMBL267	Homo sapiens	INH	%	46.0
	6316537	CHEMBL1815732	Inhibition of SRC at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2cc(-c3ccccn3)[nH]c(=O)c12		CHEMBL1813607	=	Inhibition	%	63.0	CHEMBL267	Homo sapiens	INH	%	63.0
	6316538	CHEMBL1815732	Inhibition of SRC at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2cc(-c3ccncc3)[nH]c(=O)c12		CHEMBL1813608	=	Inhibition	%	46.0	CHEMBL267	Homo sapiens	INH	%	46.0
	6316539	CHEMBL1815732	Inhibition of SRC at 30 uM by microfluidic mobility shift assay	B	COc1cccc(-c2cc3[nH]nc(N)c3c(=O)[nH]2)c1		CHEMBL1813609	=	Inhibition	%	62.0	CHEMBL267	Homo sapiens	INH	%	62.0
	6316540	CHEMBL1815732	Inhibition of SRC at 30 uM by microfluidic mobility shift assay	B	COc1ccc(-c2cc3[nH]nc(N)c3c(=O)[nH]2)cc1		CHEMBL1813610	=	Inhibition	%	59.0	CHEMBL267	Homo sapiens	INH	%	59.0
	6316541	CHEMBL1815732	Inhibition of SRC at 30 uM by microfluidic mobility shift assay	B	CN1CCN(c2ccc(-c3cc4[nH]nc(N)c4c(=O)[nH]3)cc2)CC1		CHEMBL1813611	=	Inhibition	%	85.0	CHEMBL267	Homo sapiens	INH	%	85.0
	6316542	CHEMBL1815732	Inhibition of SRC at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2cc(-c3cccs3)[nH]c(=O)c12		CHEMBL1813612	=	Inhibition	%	74.0	CHEMBL267	Homo sapiens	INH	%	74.0
	6316543	CHEMBL1815732	Inhibition of SRC at 30 uM by microfluidic mobility shift assay	B	CC(C)(C)c1cc2[nH]nc(N)c2c(=O)[nH]1		CHEMBL1813613	=	Inhibition	%	58.0	CHEMBL267	Homo sapiens	INH	%	58.0
	6316544	CHEMBL1815732	Inhibition of SRC at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2cc(-c3ccc(N4CCOCC4)cc3)[nH]c(=O)c12		CHEMBL1813614	=	Inhibition	%	74.0	CHEMBL267	Homo sapiens	INH	%	74.0
	6316545	CHEMBL1815732	Inhibition of SRC at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2cc(CC3CCNCC3)[nH]c(=O)c12		CHEMBL1813615	=	Inhibition	%	4.0	CHEMBL267	Homo sapiens	INH	%	4.0
	6316546	CHEMBL1815732	Inhibition of SRC at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2c3c([nH]c(=O)c12)CCCC3		CHEMBL1813617	=	Inhibition	%	6.0	CHEMBL267	Homo sapiens	INH	%	6.0
	6316547	CHEMBL1815732	Inhibition of SRC at 30 uM by microfluidic mobility shift assay	B	Cc1cc2[nH]nc(N)c2c(N2CCCCC2)n1		CHEMBL1813618	=	Inhibition	%	33.0	CHEMBL267	Homo sapiens	INH	%	33.0
	6316548	CHEMBL1815732	Inhibition of SRC at 30 uM by microfluidic mobility shift assay	B	Cc1cc2[nH]nc(N)c2c(N2CCOCC2)n1		CHEMBL1813619	=	Inhibition	%	45.0	CHEMBL267	Homo sapiens	INH	%	45.0
	6316549	CHEMBL1815732	Inhibition of SRC at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(c(N)nn2C)c(=O)[nH]1		CHEMBL1813620	=	Inhibition	%	9.0	CHEMBL267	Homo sapiens	INH	%	9.0
	6316550	CHEMBL1815732	Inhibition of SRC at 30 uM by microfluidic mobility shift assay	B	Cn1nc(N)c2c(=O)[nH]c(-c3ccccc3)cc21		CHEMBL1813621	=	Inhibition	%	32.0	CHEMBL267	Homo sapiens	INH	%	32.0
	6316551	CHEMBL1815732	Inhibition of SRC at 30 uM by microfluidic mobility shift assay	B	Cn1nc(N)c2c(=O)[nH]c(-c3ccccn3)cc21		CHEMBL1813622	=	Inhibition	%	18.0	CHEMBL267	Homo sapiens	INH	%	18.0
	6316552	CHEMBL1815732	Inhibition of SRC at 30 uM by microfluidic mobility shift assay	B	COc1ccc(-c2cc3c(c(N)nn3C)c(=O)[nH]2)cc1		CHEMBL1813623	=	Inhibition	%	62.0	CHEMBL267	Homo sapiens	INH	%	62.0
	6316553	CHEMBL1815732	Inhibition of SRC at 30 uM by microfluidic mobility shift assay	B	COc1cccc(-c2cc3c(c(N)nn3C)c(=O)[nH]2)c1		CHEMBL1813624	=	Inhibition	%	30.0	CHEMBL267	Homo sapiens	INH	%	30.0
	6316554	CHEMBL1815732	Inhibition of SRC at 30 uM by microfluidic mobility shift assay	B	CN1CCN(c2ccc(-c3cc4c(c(N)nn4C)c(=O)[nH]3)cc2)CC1		CHEMBL1813625	=	Inhibition	%	80.0	CHEMBL267	Homo sapiens	INH	%	80.0
	6316555	CHEMBL1815732	Inhibition of SRC at 30 uM by microfluidic mobility shift assay	B	COC(=O)CCc1c(C)[nH]c(=O)c2c(N)nn(C)c12		CHEMBL1813627	=	Inhibition	%	13.0	CHEMBL267	Homo sapiens	INH	%	13.0
	6316556	CHEMBL1815732	Inhibition of SRC at 30 uM by microfluidic mobility shift assay	B	COc1ccc(-c2c(C)[nH]c(=O)c3c(N)nn(C)c23)cc1		CHEMBL1813628	=	Inhibition	%	15.0	CHEMBL267	Homo sapiens	INH	%	15.0
	6316557	CHEMBL1815732	Inhibition of SRC at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(c(NC(=O)Nc3ccccc3)nn2C)c(=O)[nH]1		CHEMBL1813630	=	Inhibition	%	17.0	CHEMBL267	Homo sapiens	INH	%	17.0
	6316558	CHEMBL1815732	Inhibition of SRC at 30 uM by microfluidic mobility shift assay	B	CC(=O)Nc1nn(C)c2cc(-c3ccccc3)[nH]c(=O)c12		CHEMBL1813777	=	Inhibition	%	12.0	CHEMBL267	Homo sapiens	INH	%	12.0
	6316559	CHEMBL1815732	Inhibition of SRC at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(c(NS(C)(=O)=O)nn2C)c(=O)[nH]1		CHEMBL1813778	=	Inhibition	%	-2.0	CHEMBL267	Homo sapiens	INH	%	-2.0
	6316560	CHEMBL1815732	Inhibition of SRC at 30 uM by microfluidic mobility shift assay	B	COc1ccc(S(=O)(=O)Nc2nn(C)c3cc(C)[nH]c(=O)c23)c(OC)c1		CHEMBL1813779	=	Inhibition	%	2.0	CHEMBL267	Homo sapiens	INH	%	2.0
	6316561	CHEMBL1815732	Inhibition of SRC at 30 uM by microfluidic mobility shift assay	B	CC(=O)Nc1nn(C)c2cc(-c3ccc(N4CCN(C)CC4)cc3)[nH]c(=O)c12		CHEMBL1813780	=	Inhibition	%	20.0	CHEMBL267	Homo sapiens	INH	%	20.0
	6316562	CHEMBL1815732	Inhibition of SRC at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(c(N)nn2C)c(N2CCCCC2)n1		CHEMBL1813781	=	Inhibition	%	4.0	CHEMBL267	Homo sapiens	INH	%	4.0
	6316563	CHEMBL1815732	Inhibition of SRC at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(c(N)nn2C)c(N2CCOCC2)n1		CHEMBL1813782	=	Inhibition	%	7.0	CHEMBL267	Homo sapiens	INH	%	7.0
	6316564	CHEMBL1815732	Inhibition of SRC at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(c(N)nn2C)c(N2CC[C@H](O)C2)n1		CHEMBL1813784	=	Inhibition	%	3.0	CHEMBL267	Homo sapiens	INH	%	3.0
	6316565	CHEMBL1815732	Inhibition of SRC at 30 uM by microfluidic mobility shift assay	B	COCCNc1nc(C)cc2c1c(N)nn2C		CHEMBL1813785	=	Inhibition	%	2.0	CHEMBL267	Homo sapiens	INH	%	2.0
	6316566	CHEMBL1815732	Inhibition of SRC at 30 uM by microfluidic mobility shift assay	B	COCCNc1nc(-c2ccccc2)cc2c1c(N)nn2C		CHEMBL1813786	=	Inhibition	%	3.0	CHEMBL267	Homo sapiens	INH	%	3.0
	6316567	CHEMBL1815732	Inhibition of SRC at 30 uM by microfluidic mobility shift assay	B	COCCNc1nc(C)cc2nn(-c3ccccc3)c(N)c12		CHEMBL1813787	=	Inhibition	%	2.0	CHEMBL267	Homo sapiens	INH	%	2.0
	6316568	CHEMBL1815732	Inhibition of SRC at 30 uM by microfluidic mobility shift assay	B	Cc1cc2nn(-c3ccccc3)c(N)c2c(=O)[nH]1		CHEMBL1813788	=	Inhibition	%	26.0	CHEMBL267	Homo sapiens	INH	%	26.0
	6316569	CHEMBL1815732	Inhibition of SRC at 30 uM by microfluidic mobility shift assay	B	CC(C)(C)c1cc2nn(-c3ccccc3)c(N)c2c(=O)[nH]1		CHEMBL1813789	=	Inhibition	%	7.0	CHEMBL267	Homo sapiens	INH	%	7.0
	6316570	CHEMBL1815732	Inhibition of SRC at 30 uM by microfluidic mobility shift assay	B	Nc1c2c(=O)[nH]c(-c3ccccc3)cc2nn1-c1ccccc1		CHEMBL1813790	=	Inhibition	%	98.0	CHEMBL267	Homo sapiens	INH	%	98.0
	6316571	CHEMBL1815732	Inhibition of SRC at 30 uM by microfluidic mobility shift assay	B	Nc1c2c(=O)[nH]c(-c3ccccn3)cc2nn1-c1ccccc1		CHEMBL1813791	=	Inhibition	%	98.0	CHEMBL267	Homo sapiens	INH	%	98.0
	6316572	CHEMBL1815732	Inhibition of SRC at 30 uM by microfluidic mobility shift assay	B	COc1ccccc1-c1cc2nn(-c3ccccc3)c(N)c2c(=O)[nH]1		CHEMBL1813792	=	Inhibition	%	87.0	CHEMBL267	Homo sapiens	INH	%	87.0
	6316573	CHEMBL1815732	Inhibition of SRC at 30 uM by microfluidic mobility shift assay	B	COc1ccc(-c2cc3nn(-c4ccccc4)c(N)c3c(=O)[nH]2)cc1		CHEMBL1813793	=	Inhibition	%	89.0	CHEMBL267	Homo sapiens	INH	%	89.0
	6316574	CHEMBL1815732	Inhibition of SRC at 30 uM by microfluidic mobility shift assay	B	CN1CCN(c2ccc(-c3cc4nn(-c5ccccc5)c(N)c4c(=O)[nH]3)cc2)CC1		CHEMBL1813795	=	Inhibition	%	99.0	CHEMBL267	Homo sapiens	INH	%	99.0
	6316575	CHEMBL1815732	Inhibition of SRC at 30 uM by microfluidic mobility shift assay	B	Nc1c2c(=O)[nH]c(-c3ccccc3)cc2nn1-c1ccccn1		CHEMBL1813796	=	Inhibition	%	37.0	CHEMBL267	Homo sapiens	INH	%	37.0
	6316576	CHEMBL1815732	Inhibition of SRC at 30 uM by microfluidic mobility shift assay	B	Cc1cc2nn(-c3ccccc3)c(N)c2c(N2CCCCC2)n1		CHEMBL1813797	=	Inhibition	%	7.0	CHEMBL267	Homo sapiens	INH	%	7.0
	6316577	CHEMBL1815732	Inhibition of SRC at 30 uM by microfluidic mobility shift assay	B	Cc1[nH]c(=O)c2c(N)n(-c3ccccc3)nc2c1-c1ccccc1		CHEMBL1813798	=	Inhibition	%	71.0	CHEMBL267	Homo sapiens	INH	%	71.0
	6316578	CHEMBL1815732	Inhibition of SRC at 30 uM by microfluidic mobility shift assay	B	Cn1nc2c3c(nc(-c4ccccc4)cc31)NCC(=O)N2		CHEMBL1813799	=	Inhibition	%	22.0	CHEMBL267	Homo sapiens	INH	%	22.0
	6316579	CHEMBL1815732	Inhibition of SRC at 30 uM by microfluidic mobility shift assay	B	Cn1nc(N)c2cnc(-c3ccccc3)cc21		CHEMBL1813800	=	Inhibition	%	7.0	CHEMBL267	Homo sapiens	INH	%	7.0
	6316580	CHEMBL1815732	Inhibition of SRC at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(cn1)c(N)nn2C		CHEMBL1813801	=	Inhibition	%	3.0	CHEMBL267	Homo sapiens	INH	%	3.0
	6316581	CHEMBL1815732	Inhibition of SRC at 30 uM by microfluidic mobility shift assay	B	Nc1c2cnc(-c3ccccc3)cc2nn1-c1ccccc1		CHEMBL1813802	=	Inhibition	%	9.0	CHEMBL267	Homo sapiens	INH	%	9.0
	6316582	CHEMBL1815732	Inhibition of SRC at 30 uM by microfluidic mobility shift assay	B	Cc1cc2[nH]nc(N)c2cn1		CHEMBL1813803	=	Inhibition	%	6.0	CHEMBL267	Homo sapiens	INH	%	6.0
	6316583	CHEMBL1815732	Inhibition of SRC at 30 uM by microfluidic mobility shift assay	B	Cc1cc2[nH]ncc2c(=O)[nH]1		CHEMBL1813804	=	Inhibition	%	5.0	CHEMBL267	Homo sapiens	INH	%	5.0
	6316584	CHEMBL1815732	Inhibition of SRC at 30 uM by microfluidic mobility shift assay	B	Cc1cc2nc(N)nc(N)c2c(=O)[nH]1		CHEMBL1813805	=	Inhibition	%	12.0	CHEMBL267	Homo sapiens	INH	%	12.0
	6316585	CHEMBL1815732	Inhibition of SRC at 30 uM by microfluidic mobility shift assay	B	Cc1cc2nc(-c3ccccc3)nc(N)c2c(=O)[nH]1		CHEMBL1813806	=	Inhibition	%	40.0	CHEMBL267	Homo sapiens	INH	%	40.0
	6316586	CHEMBL1815732	Inhibition of SRC at 30 uM by microfluidic mobility shift assay	B	Cc1nc(N)c2c(=O)[nH]c(C)cc2n1		CHEMBL1813807	=	Inhibition	%	9.0	CHEMBL267	Homo sapiens	INH	%	9.0
	6316587	CHEMBL1815732	Inhibition of SRC at 30 uM by microfluidic mobility shift assay	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Inhibition	%	18.0	CHEMBL267	Homo sapiens	INH	%	18.0
	6318065	CHEMBL1816259	Inhibition of Src kinase at 1 uM	B	CC(=O)Nc1cccc(Nc2ncnc(N3CCC(OCc4ccccc4)CC3)n2)c1C		CHEMBL1813033	>	Inhibition	%	10.0	CHEMBL267	Homo sapiens	INH	%	10.0
	6318066	CHEMBL1816259	Inhibition of Src kinase at 1 uM	B	CC(=O)Nc1cccc(Nc2ncnc(N3CCC(OCc4ccccc4)CC3)n2)c1		CHEMBL1813032	=	Inhibition	%	81.0	CHEMBL267	Homo sapiens	INH	%	81.0
	6318856	CHEMBL1815750	Inhibition of SRC by microfluidic mobility shift assay	B	CN1CCN(c2ccc(-c3cc4c(c(N)nn4C)c(=O)[nH]3)cc2)CC1		CHEMBL1813625	=	IC50	nM	7700.0	CHEMBL267	Homo sapiens	IC50	uM	7.7
	6318857	CHEMBL1815750	Inhibition of SRC by microfluidic mobility shift assay	B	Nc1c2c(=O)[nH]c(-c3ccccc3)cc2nn1-c1ccccc1		CHEMBL1813790	=	IC50	nM	870.0	CHEMBL267	Homo sapiens	IC50	uM	0.87
	6339251	CHEMBL1828293	Inhibition of SRC activity by TR-FRET assay	B	CCc1cc2c(cc1N1CCN(C3COC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1823221	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	6339252	CHEMBL1828293	Inhibition of SRC activity by TR-FRET assay	B	CC1(C)c2cc(C3CCN(C4COC4)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL1779202	=	IC50	nM	250.0	CHEMBL267	Homo sapiens	IC50	uM	0.25
	6341131	CHEMBL1826703	Activity of SRC kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	100.0	CHEMBL267	Homo sapiens	Activity	%	100.0
	6341247	CHEMBL1827047	Inhibition of SRC at 1 uM	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)Nc2cnc3[nH]nc(OC)c3c2)c1F		CHEMBL1822067	=	Inhibition	%	22.0	CHEMBL267	Homo sapiens	INH	%	22.0
	6341248	CHEMBL1827047	Inhibition of SRC at 1 uM	B	COc1n[nH]c2ncc(NC(=O)c3c(F)ccc(NS(=O)(=O)N4CCCC4)c3F)cc12		CHEMBL1822099	=	Inhibition	%	52.0	CHEMBL267	Homo sapiens	INH	%	52.0
	6341249	CHEMBL1827047	Inhibition of SRC at 1 uM	B	COc1n[nH]c2ncc(NC(=O)c3c(F)ccc(NS(=O)(=O)c4cccc(F)c4)c3F)cc12		CHEMBL1822258	=	Inhibition	%	77.0	CHEMBL267	Homo sapiens	INH	%	77.0
	6343521	CHEMBL1828285	Inhibition of SRC at 28 uM by luciferase fragment complementation assay	B	CCOc1ccc(OCC(O)CN(C)Cc2c(C)nn(Cc3ccccc3Cl)c2C)cc1		CHEMBL1223751	>	Inhibition	%	27.0	CHEMBL267	Homo sapiens	INH	%	27.0
	6343522	CHEMBL1828286	Inhibition of SRC at 16 uM by luciferase fragment complementation assay	B	Cc1nn(Cc2ccccc2Cl)c(C)c1CN(C)CC(O)COc1ccc(Cl)cc1		CHEMBL1824695	>	Inhibition	%	27.0	CHEMBL267	Homo sapiens	INH	%	27.0
	6352279	CHEMBL1826256	Inhibition of Src assessed as residual activity at 10 uM by radioactivity assay in presence of 50 uM ATP	B	Nc1n[nH]c(N)c1/N=N/c1ccc(O)cc1		CHEMBL215205	=	Activity	%	62.0	CHEMBL267	Homo sapiens	Activity	%	62.0
	6360084	CHEMBL1832342	Inhibition of cSRC at 5 uM assessed as remaining activity	B	CNC(=O)CCc1cc(-c2ccc(-c3ccc(C(F)(F)F)cc3)cc2)n(-c2ccc(N3CCNCC3)cc2)n1		CHEMBL1830587	=	Activity	%	91.0	CHEMBL267	Homo sapiens	Activity	%	91.0
	6372663	CHEMBL1837741	Inhibition human recombinant cSRC using KVEKIGEGTYGVVYK peptide substrate in presence of [gamma-32P]-ATP	B	CSc1nc(NCc2ccccc2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL288280	=	Ki	nM	3700.0	CHEMBL267	Homo sapiens	Ki	uM	3.7
	6372664	CHEMBL1837741	Inhibition human recombinant cSRC using KVEKIGEGTYGVVYK peptide substrate in presence of [gamma-32P]-ATP	B	CSc1nc(NCCc2ccccc2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL289125	=	Ki	nM	700.0	CHEMBL267	Homo sapiens	Ki	uM	0.7
	6372665	CHEMBL1837741	Inhibition human recombinant cSRC using KVEKIGEGTYGVVYK peptide substrate in presence of [gamma-32P]-ATP	B	CSc1nc(Nc2cccc(Cl)c2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL400211	=	Ki	nM	700.0	CHEMBL267	Homo sapiens	Ki	uM	0.7
	6372666	CHEMBL1837741	Inhibition human recombinant cSRC using KVEKIGEGTYGVVYK peptide substrate in presence of [gamma-32P]-ATP	B	CSc1nc(Nc2cccc(Cl)c2)c2cnn(CCc3ccccc3)c2n1		CHEMBL1836673	=	Ki	nM	90.0	CHEMBL267	Homo sapiens	Ki	uM	0.09
	6372667	CHEMBL1837741	Inhibition human recombinant cSRC using KVEKIGEGTYGVVYK peptide substrate in presence of [gamma-32P]-ATP	B	CSc1nc(NCc2ccccc2F)c2cnn(CC(C)c3ccccc3)c2n1		CHEMBL1836675	=	Ki	nM	2160.0	CHEMBL267	Homo sapiens	Ki	uM	2.16
	6372668	CHEMBL1837741	Inhibition human recombinant cSRC using KVEKIGEGTYGVVYK peptide substrate in presence of [gamma-32P]-ATP	B	CSc1nc(NCc2ccc(F)cc2)c2cnn(CC(C)c3ccccc3)c2n1		CHEMBL1836676	=	Ki	nM	2810.0	CHEMBL267	Homo sapiens	Ki	uM	2.81
	6372669	CHEMBL1837741	Inhibition human recombinant cSRC using KVEKIGEGTYGVVYK peptide substrate in presence of [gamma-32P]-ATP	B	CSc1nc(NCc2ccccc2Cl)c2cnn(CC(C)c3ccccc3)c2n1		CHEMBL1836677	=	Ki	nM	2000.0	CHEMBL267	Homo sapiens	Ki	uM	2.0
	6372670	CHEMBL1837741	Inhibition human recombinant cSRC using KVEKIGEGTYGVVYK peptide substrate in presence of [gamma-32P]-ATP	B	CSc1nc(Nc2ccccc2)c2cnn(CC(C)c3ccccc3)c2n1		CHEMBL1836678	=	Ki	nM	25.0	CHEMBL267	Homo sapiens	Ki	uM	0.025
	6372671	CHEMBL1837741	Inhibition human recombinant cSRC using KVEKIGEGTYGVVYK peptide substrate in presence of [gamma-32P]-ATP	B	CSc1nc(Nc2cccc(Cl)c2)c2cnn(CC(C)c3ccccc3)c2n1		CHEMBL1836679	=	Ki	nM	25.0	CHEMBL267	Homo sapiens	Ki	uM	0.025
	6372672	CHEMBL1837741	Inhibition human recombinant cSRC using KVEKIGEGTYGVVYK peptide substrate in presence of [gamma-32P]-ATP	B	CSc1nc(Nc2cccc(Br)c2)c2cnn(CC(C)c3ccccc3)c2n1		CHEMBL1836680	=	Ki	nM	18.0	CHEMBL267	Homo sapiens	Ki	uM	0.018
	6372673	CHEMBL1837741	Inhibition human recombinant cSRC using KVEKIGEGTYGVVYK peptide substrate in presence of [gamma-32P]-ATP	B	Fc1cccc(CNc2ncnc3c2cnn3CCc2ccccc2)c1		CHEMBL1836681	=	Ki	nM	510.0	CHEMBL267	Homo sapiens	Ki	uM	0.51
	6372674	CHEMBL1837741	Inhibition human recombinant cSRC using KVEKIGEGTYGVVYK peptide substrate in presence of [gamma-32P]-ATP	B	Clc1cccc(Nc2ncnc3c2cnn3CCc2ccccc2)c1		CHEMBL1836682	=	Ki	nM	480.0	CHEMBL267	Homo sapiens	Ki	uM	0.48
	6372675	CHEMBL1837741	Inhibition human recombinant cSRC using KVEKIGEGTYGVVYK peptide substrate in presence of [gamma-32P]-ATP	B	CC(Cn1ncc2c(Nc3cccc(Cl)c3)ncnc21)c1ccccc1		CHEMBL1775034	=	Ki	nM	7140.0	CHEMBL267	Homo sapiens	Ki	uM	7.14
	6372676	CHEMBL1837741	Inhibition human recombinant cSRC using KVEKIGEGTYGVVYK peptide substrate in presence of [gamma-32P]-ATP	B	CSc1nc(NCc2ccccc2F)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL391724	=	Ki	nM	21200.0	CHEMBL267	Homo sapiens	Ki	uM	21.2
	6372677	CHEMBL1837741	Inhibition human recombinant cSRC using KVEKIGEGTYGVVYK peptide substrate in presence of [gamma-32P]-ATP	B	CSc1nc(NCc2ccc(F)cc2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL241540	=	Ki	nM	4600.0	CHEMBL267	Homo sapiens	Ki	uM	4.6
	6372678	CHEMBL1837741	Inhibition human recombinant cSRC using KVEKIGEGTYGVVYK peptide substrate in presence of [gamma-32P]-ATP	B	CSc1nc(Nc2ccccc2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL401238	=	Ki	nM	1600.0	CHEMBL267	Homo sapiens	Ki	uM	1.6
	6372679	CHEMBL1837741	Inhibition human recombinant cSRC using KVEKIGEGTYGVVYK peptide substrate in presence of [gamma-32P]-ATP	B	CSc1nc(NCc2cccc(Br)c2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL1629808	=	Ki	nM	1760.0	CHEMBL267	Homo sapiens	Ki	uM	1.76
	6372680	CHEMBL1837741	Inhibition human recombinant cSRC using KVEKIGEGTYGVVYK peptide substrate in presence of [gamma-32P]-ATP	B	Fc1cccc(CNc2ncnc3c2cnn3CC(Cl)c2ccccc2)c1		CHEMBL412298	=	Ki	nM	81.0	CHEMBL267	Homo sapiens	Ki	uM	0.081
	6372681	CHEMBL1837741	Inhibition human recombinant cSRC using KVEKIGEGTYGVVYK peptide substrate in presence of [gamma-32P]-ATP	B	Clc1cccc(Nc2ncnc3c2cnn3CC(Cl)c2ccccc2)c1		CHEMBL238774	=	Ki	nM	1710.0	CHEMBL267	Homo sapiens	Ki	uM	1.71
	6372682	CHEMBL1837741	Inhibition human recombinant cSRC using KVEKIGEGTYGVVYK peptide substrate in presence of [gamma-32P]-ATP	B	ClC(Cn1ncc2c(NCc3ccccc3)ncnc21)c1ccccc1		CHEMBL411043	=	Ki	nM	3000.0	CHEMBL267	Homo sapiens	Ki	uM	3.0
	6372683	CHEMBL1837741	Inhibition human recombinant cSRC using KVEKIGEGTYGVVYK peptide substrate in presence of [gamma-32P]-ATP	B	Fc1ccccc1CNc1ncnc2c1cnn2CC(Cl)c1ccccc1		CHEMBL270958	=	Ki	nM	151.0	CHEMBL267	Homo sapiens	Ki	uM	0.151
	6372684	CHEMBL1837741	Inhibition human recombinant cSRC using KVEKIGEGTYGVVYK peptide substrate in presence of [gamma-32P]-ATP	B	Fc1ccc(CNc2ncnc3c2cnn3CC(Cl)c2ccccc2)cc1		CHEMBL272169	=	Ki	nM	500.0	CHEMBL267	Homo sapiens	Ki	uM	0.5
Not Active	6372685	CHEMBL1837742	Inhibition human recombinant cSRC using KVEKIGEGTYGVVYK peptide substrate at 100 uM in presence of [gamma-32P]-ATP	B	CSc1nc(NCc2ccccc2)c2cnn(CC(C)c3ccccc3)c2n1		CHEMBL1836674		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	6372686	CHEMBL1837742	Inhibition human recombinant cSRC using KVEKIGEGTYGVVYK peptide substrate at 100 uM in presence of [gamma-32P]-ATP	B	CC(Cn1ncc2c(NCc3ccccc3)ncnc21)c1ccccc1		CHEMBL1836683		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	6372687	CHEMBL1837742	Inhibition human recombinant cSRC using KVEKIGEGTYGVVYK peptide substrate at 100 uM in presence of [gamma-32P]-ATP	B	CC(Cn1ncc2c(NCc3ccccc3F)ncnc21)c1ccccc1		CHEMBL1836684		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	6372688	CHEMBL1837742	Inhibition human recombinant cSRC using KVEKIGEGTYGVVYK peptide substrate at 100 uM in presence of [gamma-32P]-ATP	B	CC(Cn1ncc2c(NCc3cccc(F)c3)ncnc21)c1ccccc1		CHEMBL1836685		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	6372689	CHEMBL1837742	Inhibition human recombinant cSRC using KVEKIGEGTYGVVYK peptide substrate at 100 uM in presence of [gamma-32P]-ATP	B	CC(Cn1ncc2c(NCc3ccc(F)cc3)ncnc21)c1ccccc1		CHEMBL1836686		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	6372756	CHEMBL1837742	Inhibition human recombinant cSRC using KVEKIGEGTYGVVYK peptide substrate at 100 uM in presence of [gamma-32P]-ATP	B	CSc1nc(NCc2ccccc2Cl)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL236375		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	6375136	CHEMBL1838155	Inhibition of SRC at 1 uM	B	CC(=O)Nc1ccc(-c2cc3ncnc(SCC(=O)O)c3s2)cc1		CHEMBL1836724	=	Inhibition	%	17.0	CHEMBL267	Homo sapiens	INH	%	17.0
	6375146	CHEMBL1838155	Inhibition of SRC at 1 uM	B	O=C(O)COc1ncnc2cc(-c3ccc4[nH]ncc4c3)sc12		CHEMBL1836641	=	Inhibition	%	29.0	CHEMBL267	Homo sapiens	INH	%	29.0
	6387475	CHEMBL1839925	Inhibition of recombinant SRC	B	CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1.O=P(O)(O)O		CHEMBL1834657	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	6387487	CHEMBL1839937	Inhibition of SRC-mediated proliferation of mouse BAF3 cells transformed with TEL-Kinase construct	B	CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1.O=P(O)(O)O		CHEMBL1834657	=	IC50	nM	2969.0	CHEMBL267	Homo sapiens	IC50	nM	2969.0
	7567414	CHEMBL1908713	Binding constant for SRC kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	=	Kd	nM	81.0	CHEMBL267	Homo sapiens	Kd	nM	81.0
	7567902	CHEMBL1908713	Binding constant for SRC kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	=	Kd	nM	4100.0	CHEMBL267	Homo sapiens	Kd	nM	4100.0
	7568370	CHEMBL1908713	Binding constant for SRC kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	=	Kd	nM	0.71	CHEMBL267	Homo sapiens	Kd	nM	0.71
	7568802	CHEMBL1908713	Binding constant for SRC kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	4900.0	CHEMBL267	Homo sapiens	Kd	nM	4900.0
	7569387	CHEMBL1908713	Binding constant for SRC kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL267	Homo sapiens	Kd	nM	10000.0
	7569405	CHEMBL1908713	Binding constant for SRC kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL267	Homo sapiens	Kd	nM	10000.0
	7569877	CHEMBL1908713	Binding constant for SRC kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL267	Homo sapiens	Kd	nM	10000.0
	7570340	CHEMBL1908713	Binding constant for SRC kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	Kd	nM	10000.0	CHEMBL267	Homo sapiens	Kd	nM	10000.0
	7570767	CHEMBL1908713	Binding constant for SRC kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	2100.0	CHEMBL267	Homo sapiens	Kd	nM	2100.0
	7571378	CHEMBL1908713	Binding constant for SRC kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	Kd	nM	560.0	CHEMBL267	Homo sapiens	Kd	nM	560.0
	7571854	CHEMBL1908713	Binding constant for SRC kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL267	Homo sapiens	Kd	nM	10000.0
	7572317	CHEMBL1908713	Binding constant for SRC kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL267	Homo sapiens	Kd	nM	10000.0
	7572733	CHEMBL1908713	Binding constant for SRC kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	280.0	CHEMBL267	Homo sapiens	Kd	nM	280.0
	7572902	CHEMBL1908713	Binding constant for SRC kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL267	Homo sapiens	Kd	nM	10000.0
	7573359	CHEMBL1908713	Binding constant for SRC kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	0.21	CHEMBL267	Homo sapiens	Kd	nM	0.21
	7573835	CHEMBL1908713	Binding constant for SRC kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	=	Kd	nM	2400.0	CHEMBL267	Homo sapiens	Kd	nM	2400.0
	7574304	CHEMBL1908713	Binding constant for SRC kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	1200.0	CHEMBL267	Homo sapiens	Kd	nM	1200.0
	7574712	CHEMBL1908713	Binding constant for SRC kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL267	Homo sapiens	Kd	nM	10000.0
	7574880	CHEMBL1908713	Binding constant for SRC kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	580.0	CHEMBL267	Homo sapiens	Kd	nM	580.0
	7575341	CHEMBL1908713	Binding constant for SRC kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	700.0	CHEMBL267	Homo sapiens	Kd	nM	700.0
	7575812	CHEMBL1908713	Binding constant for SRC kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	=	Kd	nM	2300.0	CHEMBL267	Homo sapiens	Kd	nM	2300.0
	7576277	CHEMBL1908713	Binding constant for SRC kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	=	Kd	nM	4700.0	CHEMBL267	Homo sapiens	Kd	nM	4700.0
	7576854	CHEMBL1908713	Binding constant for SRC kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	=	Kd	nM	2800.0	CHEMBL267	Homo sapiens	Kd	nM	2800.0
	7577313	CHEMBL1908713	Binding constant for SRC kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	20.0	CHEMBL267	Homo sapiens	Kd	nM	20.0
	7577791	CHEMBL1908713	Binding constant for SRC kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	2800.0	CHEMBL267	Homo sapiens	Kd	nM	2800.0
	7578224	CHEMBL1908713	Binding constant for SRC kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	75.0	CHEMBL267	Homo sapiens	Kd	nM	75.0
	7578862	CHEMBL1908713	Binding constant for SRC kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL267	Homo sapiens	Kd	nM	10000.0
	7579236	CHEMBL1908713	Binding constant for SRC kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL267	Homo sapiens	Kd	nM	10000.0
	7579686	CHEMBL1908713	Binding constant for SRC kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL267	Homo sapiens	Kd	nM	10000.0
	7580187	CHEMBL1908713	Binding constant for SRC kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Kd	nM	220.0	CHEMBL267	Homo sapiens	Kd	nM	220.0
	7580590	CHEMBL1908713	Binding constant for SRC kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	70.0	CHEMBL267	Homo sapiens	Kd	nM	70.0
	7581220	CHEMBL1908713	Binding constant for SRC kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	=	Kd	nM	900.0	CHEMBL267	Homo sapiens	Kd	nM	900.0
	7581605	CHEMBL1908713	Binding constant for SRC kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL267	Homo sapiens	Kd	nM	10000.0
	7582050	CHEMBL1908713	Binding constant for SRC kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL267	Homo sapiens	Kd	nM	10000.0
	7582079	CHEMBL1908713	Binding constant for SRC kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL267	Homo sapiens	Kd	nM	10000.0
	7582543	CHEMBL1908713	Binding constant for SRC kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL267	Homo sapiens	Kd	nM	10000.0
	7582943	CHEMBL1908713	Binding constant for SRC kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	170.0	CHEMBL267	Homo sapiens	Kd	nM	170.0
	7583566	CHEMBL1908713	Binding constant for SRC kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL267	Homo sapiens	Kd	nM	10000.0
	7583963	CHEMBL1908713	Binding constant for SRC kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL267	Homo sapiens	Kd	nM	10000.0
	7584437	CHEMBL1908713	Binding constant for SRC kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL267	Homo sapiens	Kd	nM	10000.0
	7584899	CHEMBL1908713	Binding constant for SRC kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	8.4	CHEMBL267	Homo sapiens	Kd	nM	8.4
	7585303	CHEMBL1908713	Binding constant for SRC kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	=	Kd	nM	5500.0	CHEMBL267	Homo sapiens	Kd	nM	5500.0
	7586308	CHEMBL1908713	Binding constant for SRC kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL267	Homo sapiens	Kd	nM	10000.0
	7586779	CHEMBL1908713	Binding constant for SRC kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL267	Homo sapiens	Kd	nM	10000.0
	7587233	CHEMBL1908713	Binding constant for SRC kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL267	Homo sapiens	Kd	nM	10000.0
	7587415	CHEMBL1908713	Binding constant for SRC kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL267	Homo sapiens	Kd	nM	10000.0
	7587834	CHEMBL1908713	Binding constant for SRC kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	=	Kd	nM	1600.0	CHEMBL267	Homo sapiens	Kd	nM	1600.0
	7588287	CHEMBL1908713	Binding constant for SRC kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Kd	nM	3800.0	CHEMBL267	Homo sapiens	Kd	nM	3800.0
	7588758	CHEMBL1908713	Binding constant for SRC kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL267	Homo sapiens	Kd	nM	10000.0
	7589209	CHEMBL1908713	Binding constant for SRC kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Kd	nM	5300.0	CHEMBL267	Homo sapiens	Kd	nM	5300.0
	7589380	CHEMBL1908713	Binding constant for SRC kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL267	Homo sapiens	Kd	nM	10000.0
	7589804	CHEMBL1908713	Binding constant for SRC kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	640.0	CHEMBL267	Homo sapiens	Kd	nM	640.0
	7590271	CHEMBL1908713	Binding constant for SRC kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL267	Homo sapiens	Kd	nM	10000.0
	7590745	CHEMBL1908713	Binding constant for SRC kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	=	Kd	nM	9600.0	CHEMBL267	Homo sapiens	Kd	nM	9600.0
	7591196	CHEMBL1908713	Binding constant for SRC kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL267	Homo sapiens	Kd	nM	10000.0
	7591353	CHEMBL1908713	Binding constant for SRC kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL267	Homo sapiens	Kd	nM	10000.0
	7591775	CHEMBL1908713	Binding constant for SRC kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	1800.0	CHEMBL267	Homo sapiens	Kd	nM	1800.0
	7592247	CHEMBL1908713	Binding constant for SRC kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL267	Homo sapiens	Kd	nM	10000.0
	7592720	CHEMBL1908713	Binding constant for SRC kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Kd	nM	800.0	CHEMBL267	Homo sapiens	Kd	nM	800.0
	7593320	CHEMBL1908713	Binding constant for SRC kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	340.0	CHEMBL267	Homo sapiens	Kd	nM	340.0
	7593755	CHEMBL1908713	Binding constant for SRC kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	=	Kd	nM	1100.0	CHEMBL267	Homo sapiens	Kd	nM	1100.0
	7594227	CHEMBL1908713	Binding constant for SRC kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL267	Homo sapiens	Kd	nM	10000.0
	7594710	CHEMBL1908713	Binding constant for SRC kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	1.0	CHEMBL267	Homo sapiens	Kd	nM	1.0
	7595288	CHEMBL1908713	Binding constant for SRC kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL267	Homo sapiens	Kd	nM	10000.0
	7595732	CHEMBL1908713	Binding constant for SRC kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	1100.0	CHEMBL267	Homo sapiens	Kd	nM	1100.0
	7596206	CHEMBL1908713	Binding constant for SRC kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL267	Homo sapiens	Kd	nM	10000.0
	7596235	CHEMBL1908713	Binding constant for SRC kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	=	Kd	nM	1900.0	CHEMBL267	Homo sapiens	Kd	nM	1900.0
	7596682	CHEMBL1908713	Binding constant for SRC kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL267	Homo sapiens	Kd	nM	10000.0
	7597260	CHEMBL1908713	Binding constant for SRC kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL267	Homo sapiens	Kd	nM	10000.0
	7597713	CHEMBL1908713	Binding constant for SRC kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL267	Homo sapiens	Kd	nM	10000.0
	7598214	CHEMBL1908713	Binding constant for SRC kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	2800.0	CHEMBL267	Homo sapiens	Kd	nM	2800.0
	7598656	CHEMBL1908713	Binding constant for SRC kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	86.0	CHEMBL267	Homo sapiens	Kd	nM	86.0
	7841911	CHEMBL1913896	Inhibition of c-Src using biotinylated substrate preincubated for 15 mins before substrate addition measured after 30 mins by fluorescence microplate analysis	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	IC50	nM	152.8	CHEMBL267	Homo sapiens	IC50	nM	152.8
	7841916	CHEMBL1913896	Inhibition of c-Src using biotinylated substrate preincubated for 15 mins before substrate addition measured after 30 mins by fluorescence microplate analysis	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	<	IC50	nM	1.0	CHEMBL267	Homo sapiens	IC50	nM	1.0
	7841925	CHEMBL1913896	Inhibition of c-Src using biotinylated substrate preincubated for 15 mins before substrate addition measured after 30 mins by fluorescence microplate analysis	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	0.83	CHEMBL267	Homo sapiens	IC50	nM	0.83
	7843038	CHEMBL1913275	Inhibition of human recombinant Src at 10 uM after 4 hrs by Kinase-Glo luminescent assay	B	O=C(c1c[nH]c2ccccc12)c1nccc2c1[nH]c1ccc(O)cc12		CHEMBL1910715	=	Inhibition	%	8.0	CHEMBL267	Homo sapiens	INH	%	8.0
	7922689	CHEMBL1918457	Inhibition of human recombinant SRC at 0.5 uM by radiometric filter-binding assay	B	Clc1ccccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12		CHEMBL1915438	=	Inhibition	%	36.0	CHEMBL267	Homo sapiens	INH	%	36.0
	7930429	CHEMBL1919045	Inhibition cSRC expressed in Sf9 cells after 60 mins by TR-FRET Assay	B	Cc1ccccc1Nc1nc2cc(F)c(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12		CHEMBL1916891	=	IC50	nM	298.0	CHEMBL267	Homo sapiens	IC50	nM	298.0
	7930430	CHEMBL1919045	Inhibition cSRC expressed in Sf9 cells after 60 mins by TR-FRET Assay	B	Cc1ccc(F)cc1Nc1nc2cc(Cl)c(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12		CHEMBL1916897	=	IC50	nM	1620.0	CHEMBL267	Homo sapiens	IC50	nM	1620.0
	7930437	CHEMBL1919049	Inhibition cSRC expressed in Sf9 cells preincubated for 60 mins measured after 60 mins by TR-FRET Assay	B	Cc1ccccc1Nc1nc2cc(F)c(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12		CHEMBL1916891	=	IC50	nM	84.0	CHEMBL267	Homo sapiens	IC50	nM	84.0
	7930438	CHEMBL1919049	Inhibition cSRC expressed in Sf9 cells preincubated for 60 mins measured after 60 mins by TR-FRET Assay	B	Cc1ccc(F)cc1Nc1nc2cc(Cl)c(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12		CHEMBL1916897	=	IC50	nM	410.0	CHEMBL267	Homo sapiens	IC50	nM	410.0
	7931134	CHEMBL1919471	Inhibition of SRC relative to control	B	Cc1ccccc1Nc1nc2cc(F)c(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12		CHEMBL1916891	=	Inhibition	%	43.0	CHEMBL267	Homo sapiens	INH	%	43.0
Not Active	7933255	CHEMBL1920113	Inhibition of human SRC phosphorylation in MDA-MB-231 cells at 100 uM after 30 mins by Western blot analysis	B	c1ccc(C[C@H](CCNCc2ccc3c(c2)OCO3)c2ccc3c(c2)OCO3)cc1		CHEMBL1916396		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	7939633	CHEMBL1919593	Inhibition of human cSRC	B	[O-][n+]1ccc2c(-c3ccc(F)cc3Cl)ccnc2c1-c1c(Cl)cccc1Cl		CHEMBL1916359	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	7943729	CHEMBL1921572	Inhibition cSRC	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	3.78	CHEMBL267	Homo sapiens	IC50	nM	3.78
	7943769	CHEMBL1921426	Inhibition cSRC at 10 uM	B	O=C1CC(c2cccc(NC(=O)c3ccc(Cl)c(C(F)(F)F)c3)c2)=Nc2cnn(Cc3ccccc3)c2N1		CHEMBL1917776	=	Inhibition	%	4.3	CHEMBL267	Homo sapiens	INH	%	4.3
	7951430	CHEMBL1926233	Inhibition of recombinant human SRC using poly(Glu,Tyr)4:1 as substrate	B	Cc1ccc(O)cc1CC[C@@H]1[C@@H](O)CC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)/C=C/CC(C)C		CHEMBL1922224	=	IC50	nM	2400.0	CHEMBL267	Homo sapiens	IC50	uM	2.4
	7951431	CHEMBL1926233	Inhibition of recombinant human SRC using poly(Glu,Tyr)4:1 as substrate	B	Cc1ccc(O)cc1CC[C@@H]1C(=O)CC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)/C=C/CC(C)C		CHEMBL518060	=	IC50	nM	2240.0	CHEMBL267	Homo sapiens	IC50	uM	2.24
	7951432	CHEMBL1926233	Inhibition of recombinant human SRC using poly(Glu,Tyr)4:1 as substrate	B	C=C(CC[C@@H](C)[C@H]1CC[C@H]2[C@H](CCc3cc(O)ccc3C)C(=O)CC[C@@]21C)C(C)C		CHEMBL1922225	=	IC50	nM	1480.0	CHEMBL267	Homo sapiens	IC50	uM	1.48
	7951433	CHEMBL1926233	Inhibition of recombinant human SRC using poly(Glu,Tyr)4:1 as substrate	B	Cc1ccc(O)cc1CC[C@@H]1C(=O)CC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)CCCC(C)C		CHEMBL456936	=	IC50	nM	2170.0	CHEMBL267	Homo sapiens	IC50	uM	2.17
	7951434	CHEMBL1926233	Inhibition of recombinant human SRC using poly(Glu,Tyr)4:1 as substrate	B	Cc1ccc(O)cc1CC[C@H]1[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC[C@H]1O		CHEMBL517956	=	IC50	nM	1910.0	CHEMBL267	Homo sapiens	IC50	uM	1.91
	7951435	CHEMBL1926233	Inhibition of recombinant human SRC using poly(Glu,Tyr)4:1 as substrate	B	Cc1ccc(O)cc1CC[C@@H]1C(=O)CC[C@@]2(C)[C@H]1C[C@H](O)[C@@H]2[C@H](C)CCCC(C)C		CHEMBL456294	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	7951436	CHEMBL1926233	Inhibition of recombinant human SRC using poly(Glu,Tyr)4:1 as substrate	B	C=C(CC[C@@H](C)[C@H]1CC[C@H]2[C@H](CCc3cc(O)ccc3C)[C@H](O)CC[C@@]21C)C(C)C		CHEMBL515982	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	7951437	CHEMBL1926233	Inhibition of recombinant human SRC using poly(Glu,Tyr)4:1 as substrate	B	Cc1ccc(O)cc1CC[C@H]1[C@@H]2C[C@H](O)[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC[C@H]1O		CHEMBL464351	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	7956228	CHEMBL1924891	Inhibition of N-terminus flag-tagged Src expressed in baculovirus infected insect cells using ATP as substrate after 10 mins	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	7959725	CHEMBL1932837	Inhibition of c-SRC	B	CN(C)CCN1CCN(C(=O)c2cc(C(C)(C)C)sc2NC(=O)Nc2cccc(Cl)c2Cl)CCC1=O		CHEMBL1929238	>	IC50	nM	30000.0	CHEMBL267	Homo sapiens	IC50	uM	30.0
	7959726	CHEMBL1932837	Inhibition of c-SRC	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	IC50	nM	35000.0	CHEMBL267	Homo sapiens	IC50	uM	35.0
	7969797	CHEMBL1930369	Inhibition of Src assessed as residual activity at 10 uM using [33P-ATP] by radiometric filter binding assay	B	Cc1ccc(F)cc1-c1nc2[nH]nc(N)c2c2c1CCCC2		CHEMBL1927262	=	Activity	%	25.0	CHEMBL267	Homo sapiens	Activity	%	25.0
	7971383	CHEMBL1929899	Inhibition of SRC at 10 uM	B	NCCN1C(=O)S/C(=C\CCC2CCCCC2)C1=O		CHEMBL1929247	=	Inhibition	%	2.0	CHEMBL267	Homo sapiens	INH	%	2.0
	7987129	CHEMBL1936082	Inhibition of Src	B	O=C(c1cc2cc(F)ccc2[nH]1)N1C[C@]2(CCN(C3CCCNC3)C2)c2ccccc21		CHEMBL1933538	>	IC50	nM	30000.0	CHEMBL267	Homo sapiens	IC50	uM	30.0
	7987151	CHEMBL1936082	Inhibition of Src	B	O=C(c1cc2ccc(F)cc2[nH]1)N1C[C@]2(CCN(C3CCNC3)C2)c2ccccc21		CHEMBL1933550	>	IC50	nM	30000.0	CHEMBL267	Homo sapiens	IC50	uM	30.0
	7987173	CHEMBL1936082	Inhibition of Src	B	C[C@@H]1CCC(N2CC[C@]3(CN(C(=O)c4cc5ccccc5[nH]4)c4ccccc43)C2)CN1		CHEMBL1933551	>	IC50	nM	30000.0	CHEMBL267	Homo sapiens	IC50	uM	30.0
	7987205	CHEMBL1936082	Inhibition of Src	B	C[C@@H]1CCC(N2CC[C@]3(CN(C(=O)c4cc5ccc(F)cc5[nH]4)c4ccccc43)C2)CN1		CHEMBL1933552	>	IC50	nM	30000.0	CHEMBL267	Homo sapiens	IC50	uM	30.0
	7988304	CHEMBL1936377	Inhibition of His6-tagged c-Src kinase domain using AEEEIYGEFEAKKKK as substrate pre-incubated for 10 mins before substrate addition measured after 30 mins by Transcreener ADP2 FI Assay	B	CC1(C)CC(=O)c2c(nn(-c3ccc(Cl)cc3)c2-c2ccc(Cl)c(Cl)c2)C1		CHEMBL1933729	=	IC50	nM	86000.0	CHEMBL267	Homo sapiens	IC50	uM	86.0
	7988305	CHEMBL1936377	Inhibition of His6-tagged c-Src kinase domain using AEEEIYGEFEAKKKK as substrate pre-incubated for 10 mins before substrate addition measured after 30 mins by Transcreener ADP2 FI Assay	B	CC1(C)CC(=O)c2c(nn(-c3ccc([N+](=O)[O-])cc3)c2-c2ccc(Cl)c(Cl)c2)C1	Outside typical range	CHEMBL1933730	>	IC50	nM	150000.0	CHEMBL267	Homo sapiens	IC50	uM	150.0
	7988306	CHEMBL1936377	Inhibition of His6-tagged c-Src kinase domain using AEEEIYGEFEAKKKK as substrate pre-incubated for 10 mins before substrate addition measured after 30 mins by Transcreener ADP2 FI Assay	B	CC1(C)CC(=O)c2c(nn(-c3cccs3)c2-c2ccc(Cl)c(Cl)c2)C1	Outside typical range	CHEMBL1933731	>	IC50	nM	150000.0	CHEMBL267	Homo sapiens	IC50	uM	150.0
	7988307	CHEMBL1936377	Inhibition of His6-tagged c-Src kinase domain using AEEEIYGEFEAKKKK as substrate pre-incubated for 10 mins before substrate addition measured after 30 mins by Transcreener ADP2 FI Assay	B	Cc1ccc(-n2nc3c(c2-c2ccc(Cl)c(Cl)c2)C(=O)CC(C)(C)C3)cc1	Outside typical range	CHEMBL1933732	>	IC50	nM	150000.0	CHEMBL267	Homo sapiens	IC50	uM	150.0
	7988308	CHEMBL1936377	Inhibition of His6-tagged c-Src kinase domain using AEEEIYGEFEAKKKK as substrate pre-incubated for 10 mins before substrate addition measured after 30 mins by Transcreener ADP2 FI Assay	B	COc1ccc(-n2nc3c(c2-c2ccc(Cl)c(Cl)c2)C(=O)CC(C)(C)C3)cc1O	Outside typical range	CHEMBL1933733	>	IC50	nM	150000.0	CHEMBL267	Homo sapiens	IC50	uM	150.0
	7988309	CHEMBL1936377	Inhibition of His6-tagged c-Src kinase domain using AEEEIYGEFEAKKKK as substrate pre-incubated for 10 mins before substrate addition measured after 30 mins by Transcreener ADP2 FI Assay	B	CC1(C)CC(=O)c2c(nn(-c3ccc(O)cc3)c2-c2ccc(Cl)c(Cl)c2)C1		CHEMBL1933734	=	IC50	nM	66600.0	CHEMBL267	Homo sapiens	IC50	uM	66.6
	7988310	CHEMBL1936377	Inhibition of His6-tagged c-Src kinase domain using AEEEIYGEFEAKKKK as substrate pre-incubated for 10 mins before substrate addition measured after 30 mins by Transcreener ADP2 FI Assay	B	CC1(C)CC(=O)c2c(nn(-c3ccc[nH]3)c2-c2ccc(Cl)c(Cl)c2)C1	Outside typical range	CHEMBL1933735	>	IC50	nM	150000.0	CHEMBL267	Homo sapiens	IC50	uM	150.0
	7988311	CHEMBL1936377	Inhibition of His6-tagged c-Src kinase domain using AEEEIYGEFEAKKKK as substrate pre-incubated for 10 mins before substrate addition measured after 30 mins by Transcreener ADP2 FI Assay	B	COc1ccc(-n2nc3c(c2-c2ccc(Cl)c(Cl)c2)C(=O)CC(C)(C)C3)cc1		CHEMBL1933736	=	IC50	nM	94100.0	CHEMBL267	Homo sapiens	IC50	uM	94.1
	7988312	CHEMBL1936377	Inhibition of His6-tagged c-Src kinase domain using AEEEIYGEFEAKKKK as substrate pre-incubated for 10 mins before substrate addition measured after 30 mins by Transcreener ADP2 FI Assay	B	CC1(C)CC(=O)c2c(nn(-c3ccccc3)c2-c2ccc(Cl)c(Cl)c2)C1		CHEMBL1933737	=	IC50	nM	62100.0	CHEMBL267	Homo sapiens	IC50	uM	62.1
	7988313	CHEMBL1936377	Inhibition of His6-tagged c-Src kinase domain using AEEEIYGEFEAKKKK as substrate pre-incubated for 10 mins before substrate addition measured after 30 mins by Transcreener ADP2 FI Assay	B	CC1(C)CC(=O)c2c(nn(-c3cccc(Cl)c3)c2-c2ccc(Cl)c(Cl)c2)C1		CHEMBL1933738	=	IC50	nM	50700.0	CHEMBL267	Homo sapiens	IC50	uM	50.7
	7988314	CHEMBL1936377	Inhibition of His6-tagged c-Src kinase domain using AEEEIYGEFEAKKKK as substrate pre-incubated for 10 mins before substrate addition measured after 30 mins by Transcreener ADP2 FI Assay	B	O=C1CCCc2nn(-c3ccc(Cl)cc3)c(-c3ccc(Cl)c(Cl)c3)c21		CHEMBL1933074	=	IC50	nM	81000.0	CHEMBL267	Homo sapiens	IC50	uM	81.0
	7988315	CHEMBL1936377	Inhibition of His6-tagged c-Src kinase domain using AEEEIYGEFEAKKKK as substrate pre-incubated for 10 mins before substrate addition measured after 30 mins by Transcreener ADP2 FI Assay	B	O=C1CCCc2nn(-c3cccs3)c(-c3ccc(Cl)c(Cl)c3)c21	Outside typical range	CHEMBL1933739	>	IC50	nM	150000.0	CHEMBL267	Homo sapiens	IC50	uM	150.0
	7988316	CHEMBL1936377	Inhibition of His6-tagged c-Src kinase domain using AEEEIYGEFEAKKKK as substrate pre-incubated for 10 mins before substrate addition measured after 30 mins by Transcreener ADP2 FI Assay	B	Cc1ccc(-n2nc3c(c2-c2ccc(Cl)c(Cl)c2)C(=O)CCC3)cc1	Outside typical range	CHEMBL1933740	>	IC50	nM	150000.0	CHEMBL267	Homo sapiens	IC50	uM	150.0
	7988317	CHEMBL1936377	Inhibition of His6-tagged c-Src kinase domain using AEEEIYGEFEAKKKK as substrate pre-incubated for 10 mins before substrate addition measured after 30 mins by Transcreener ADP2 FI Assay	B	O=C1CCCc2nn(-c3ccccc3F)c(-c3ccc(Cl)c(Cl)c3)c21	Outside typical range	CHEMBL1933741	>	IC50	nM	150000.0	CHEMBL267	Homo sapiens	IC50	uM	150.0
	7988318	CHEMBL1936377	Inhibition of His6-tagged c-Src kinase domain using AEEEIYGEFEAKKKK as substrate pre-incubated for 10 mins before substrate addition measured after 30 mins by Transcreener ADP2 FI Assay	B	COc1ccc(-n2nc3c(c2-c2ccc(Cl)c(Cl)c2)C(=O)CCC3)cc1	Outside typical range	CHEMBL1933742	>	IC50	nM	150000.0	CHEMBL267	Homo sapiens	IC50	uM	150.0
	7988319	CHEMBL1936377	Inhibition of His6-tagged c-Src kinase domain using AEEEIYGEFEAKKKK as substrate pre-incubated for 10 mins before substrate addition measured after 30 mins by Transcreener ADP2 FI Assay	B	O=C1CCCc2nn(-c3ccccc3)c(-c3ccc(Cl)c(Cl)c3)c21		CHEMBL1933743	=	IC50	nM	65800.0	CHEMBL267	Homo sapiens	IC50	uM	65.8
	7988320	CHEMBL1936377	Inhibition of His6-tagged c-Src kinase domain using AEEEIYGEFEAKKKK as substrate pre-incubated for 10 mins before substrate addition measured after 30 mins by Transcreener ADP2 FI Assay	B	O=C1CCCc2nn(-c3ccc(O)cc3)c(-c3ccc(Cl)c(Cl)c3)c21	Outside typical range	CHEMBL1933744	>	IC50	nM	150000.0	CHEMBL267	Homo sapiens	IC50	uM	150.0
	7988321	CHEMBL1936377	Inhibition of His6-tagged c-Src kinase domain using AEEEIYGEFEAKKKK as substrate pre-incubated for 10 mins before substrate addition measured after 30 mins by Transcreener ADP2 FI Assay	B	COc1ccc(-n2nc3c(c2-c2ccc(Cl)c(Cl)c2)C(=O)CCC3)cc1O	Outside typical range	CHEMBL1933745	>	IC50	nM	150000.0	CHEMBL267	Homo sapiens	IC50	uM	150.0
	7988322	CHEMBL1936377	Inhibition of His6-tagged c-Src kinase domain using AEEEIYGEFEAKKKK as substrate pre-incubated for 10 mins before substrate addition measured after 30 mins by Transcreener ADP2 FI Assay	B	O=C1CCCc2nn(-c3ccc([N+](=O)[O-])cc3)c(-c3ccc(Cl)c(Cl)c3)c21	Outside typical range	CHEMBL1933746	>	IC50	nM	150000.0	CHEMBL267	Homo sapiens	IC50	uM	150.0
	7988323	CHEMBL1936377	Inhibition of His6-tagged c-Src kinase domain using AEEEIYGEFEAKKKK as substrate pre-incubated for 10 mins before substrate addition measured after 30 mins by Transcreener ADP2 FI Assay	B	COc1cccc(-n2nc3c(c2-c2ccc(C)c(Cl)c2)C(=O)CCC3)c1		CHEMBL1933747	=	IC50	nM	82700.0	CHEMBL267	Homo sapiens	IC50	uM	82.7
	7988324	CHEMBL1936377	Inhibition of His6-tagged c-Src kinase domain using AEEEIYGEFEAKKKK as substrate pre-incubated for 10 mins before substrate addition measured after 30 mins by Transcreener ADP2 FI Assay	B	Cc1ccc(-c2c3c(nn2-c2ccc(Cl)cc2)CC(C)(C)CC3=O)cc1Cl	Outside typical range	CHEMBL1933748	=	IC50	nM	131800.0	CHEMBL267	Homo sapiens	IC50	uM	131.8
	7988325	CHEMBL1936377	Inhibition of His6-tagged c-Src kinase domain using AEEEIYGEFEAKKKK as substrate pre-incubated for 10 mins before substrate addition measured after 30 mins by Transcreener ADP2 FI Assay	B	Cc1ccc(-c2c3c(nn2-c2ccncc2)CC(C)(C)CC3=O)cc1Cl		CHEMBL1933749	=	IC50	nM	74300.0	CHEMBL267	Homo sapiens	IC50	uM	74.3
	7988326	CHEMBL1936377	Inhibition of His6-tagged c-Src kinase domain using AEEEIYGEFEAKKKK as substrate pre-incubated for 10 mins before substrate addition measured after 30 mins by Transcreener ADP2 FI Assay	B	Cc1ccc(-c2c3c(nn2-c2ccc[nH]2)CC(C)(C)CC3=O)cc1Cl	Outside typical range	CHEMBL1933750	>	IC50	nM	150000.0	CHEMBL267	Homo sapiens	IC50	uM	150.0
	7988327	CHEMBL1936377	Inhibition of His6-tagged c-Src kinase domain using AEEEIYGEFEAKKKK as substrate pre-incubated for 10 mins before substrate addition measured after 30 mins by Transcreener ADP2 FI Assay	B	CC1(C)CC(=O)c2c(nn(-c3cccs3)c2C2CCCCC2)C1		CHEMBL1933751	=	IC50	nM	77300.0	CHEMBL267	Homo sapiens	IC50	uM	77.3
	7988328	CHEMBL1936377	Inhibition of His6-tagged c-Src kinase domain using AEEEIYGEFEAKKKK as substrate pre-incubated for 10 mins before substrate addition measured after 30 mins by Transcreener ADP2 FI Assay	B	CC1(C)CC(=O)c2c(nn(-c3ccc([N+](=O)[O-])cc3)c2C2CCCCC2)C1	Outside typical range	CHEMBL1933752	>	IC50	nM	150000.0	CHEMBL267	Homo sapiens	IC50	uM	150.0
	7988329	CHEMBL1936377	Inhibition of His6-tagged c-Src kinase domain using AEEEIYGEFEAKKKK as substrate pre-incubated for 10 mins before substrate addition measured after 30 mins by Transcreener ADP2 FI Assay	B	CC1(C)OC(=O)c2c(nn(-c3ccc(Cl)cc3)c2C2CCCCC2)O1	Outside typical range	CHEMBL1933753	>	IC50	nM	150000.0	CHEMBL267	Homo sapiens	IC50	uM	150.0
	7988330	CHEMBL1936377	Inhibition of His6-tagged c-Src kinase domain using AEEEIYGEFEAKKKK as substrate pre-incubated for 10 mins before substrate addition measured after 30 mins by Transcreener ADP2 FI Assay	B	O=C1CCCc2nn(-c3cccc(Cl)c3)c(C3CCCCC3)c21		CHEMBL1933754	=	IC50	nM	58400.0	CHEMBL267	Homo sapiens	IC50	uM	58.4
	7988331	CHEMBL1936377	Inhibition of His6-tagged c-Src kinase domain using AEEEIYGEFEAKKKK as substrate pre-incubated for 10 mins before substrate addition measured after 30 mins by Transcreener ADP2 FI Assay	B	Cc1ccc(-n2nc3c(c2C2CCCCC2)C(=O)CCC3)cc1		CHEMBL1933755	=	IC50	nM	57700.0	CHEMBL267	Homo sapiens	IC50	uM	57.7
	7988332	CHEMBL1936377	Inhibition of His6-tagged c-Src kinase domain using AEEEIYGEFEAKKKK as substrate pre-incubated for 10 mins before substrate addition measured after 30 mins by Transcreener ADP2 FI Assay	B	COc1ccc(-n2nc3c(c2-c2ccc(C(C)(C)C)cc2)C(=O)CC(C)(C)C3)cc1		CHEMBL1933756	=	IC50	nM	35100.0	CHEMBL267	Homo sapiens	IC50	uM	35.1
	7988333	CHEMBL1936377	Inhibition of His6-tagged c-Src kinase domain using AEEEIYGEFEAKKKK as substrate pre-incubated for 10 mins before substrate addition measured after 30 mins by Transcreener ADP2 FI Assay	B	COc1ccc(-n2nc3c(c2-c2ccc(C(C)(C)C)cc2)C(=O)CC(C)(C)C3)cc1OC	Outside typical range	CHEMBL1933757	>	IC50	nM	150000.0	CHEMBL267	Homo sapiens	IC50	uM	150.0
	7988334	CHEMBL1936377	Inhibition of His6-tagged c-Src kinase domain using AEEEIYGEFEAKKKK as substrate pre-incubated for 10 mins before substrate addition measured after 30 mins by Transcreener ADP2 FI Assay	B	CC1(C)CC(=O)c2c(nn(-c3ccc(Cl)cc3)c2-c2ccc(C(C)(C)C)cc2)C1	Outside typical range	CHEMBL1933758	>	IC50	nM	150000.0	CHEMBL267	Homo sapiens	IC50	uM	150.0
	7988335	CHEMBL1936377	Inhibition of His6-tagged c-Src kinase domain using AEEEIYGEFEAKKKK as substrate pre-incubated for 10 mins before substrate addition measured after 30 mins by Transcreener ADP2 FI Assay	B	CC1(C)OC(=O)c2c(nn(-c3ccc(Cl)cc3)c2-c2ccc(C(C)(C)C)cc2)O1	Outside typical range	CHEMBL1933759	>	IC50	nM	150000.0	CHEMBL267	Homo sapiens	IC50	uM	150.0
	7988336	CHEMBL1936377	Inhibition of His6-tagged c-Src kinase domain using AEEEIYGEFEAKKKK as substrate pre-incubated for 10 mins before substrate addition measured after 30 mins by Transcreener ADP2 FI Assay	B	Cc1ccc(-n2nc3c(c2-c2ccc(C(C)(C)C)cc2)C(=O)CC(C)(C)C3)cc1	Outside typical range	CHEMBL1933760	>	IC50	nM	150000.0	CHEMBL267	Homo sapiens	IC50	uM	150.0
	7988337	CHEMBL1936377	Inhibition of His6-tagged c-Src kinase domain using AEEEIYGEFEAKKKK as substrate pre-incubated for 10 mins before substrate addition measured after 30 mins by Transcreener ADP2 FI Assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	600.0	CHEMBL267	Homo sapiens	IC50	uM	0.6
	7988338	CHEMBL1936377	Inhibition of His6-tagged c-Src kinase domain using AEEEIYGEFEAKKKK as substrate pre-incubated for 10 mins before substrate addition measured after 30 mins by Transcreener ADP2 FI Assay	B	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21	Potential transcription error	CHEMBL406845	=	IC50	nM	500.0	CHEMBL267	Homo sapiens	IC50	uM	0.5
	7991914	CHEMBL1937681	Inhibition of c-Src at 10 uM	B	Oc1cccc(-c2nc(N3CCOCC3)c3cc4ncccc4n3n2)c1		CHEMBL1934300	=	Inhibition	%	65.3	CHEMBL267	Homo sapiens	INH	%	65.3
	7991915	CHEMBL1937681	Inhibition of c-Src at 10 uM	B	CC(=O)Oc1cccc(-c2nc(N3CCOCC3)c3cc4ncccc4n3n2)c1		CHEMBL1934301	=	Inhibition	%	40.0	CHEMBL267	Homo sapiens	INH	%	40.0
	7991916	CHEMBL1937681	Inhibition of c-Src at 10 uM	B	CCC(=O)Oc1cccc(-c2nc(N3CCOCC3)c3cc4ncccc4n3n2)c1		CHEMBL1934302	=	Inhibition	%	52.8	CHEMBL267	Homo sapiens	INH	%	52.8
	7991917	CHEMBL1937681	Inhibition of c-Src at 10 uM	B	CCCC(=O)Oc1cccc(-c2nc(N3CCOCC3)c3cc4ncccc4n3n2)c1		CHEMBL1934303	=	Inhibition	%	48.2	CHEMBL267	Homo sapiens	INH	%	48.2
	7991918	CHEMBL1937681	Inhibition of c-Src at 10 uM	B	CCCC(CCC)C(=O)Oc1cccc(-c2nc(N3CCOCC3)c3cc4ncccc4n3n2)c1		CHEMBL1934304	=	Inhibition	%	49.8	CHEMBL267	Homo sapiens	INH	%	49.8
	7991919	CHEMBL1937681	Inhibition of c-Src at 10 uM	B	C=CC(=O)Oc1cccc(-c2nc(N3CCOCC3)c3cc4ncccc4n3n2)c1		CHEMBL1934305	=	Inhibition	%	56.2	CHEMBL267	Homo sapiens	INH	%	56.2
	7991920	CHEMBL1937681	Inhibition of c-Src at 10 uM	B	O=C(Oc1cccc(-c2nc(N3CCOCC3)c3cc4ncccc4n3n2)c1)c1ccco1		CHEMBL1934306	=	Inhibition	%	47.9	CHEMBL267	Homo sapiens	INH	%	47.9
	7991921	CHEMBL1937681	Inhibition of c-Src at 10 uM	B	O=C(Oc1cccc(-c2nc(N3CCOCC3)c3cc4ncccc4n3n2)c1)c1ccncc1		CHEMBL1934307	=	Inhibition	%	67.2	CHEMBL267	Homo sapiens	INH	%	67.2
Not Determined	7991922	CHEMBL1937681	Inhibition of c-Src at 10 uM	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Determined	7991923	CHEMBL1937681	Inhibition of c-Src at 10 uM	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	7991924	CHEMBL1937681	Inhibition of c-Src at 10 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Inhibition	%	93.6	CHEMBL267	Homo sapiens	INH	%	93.6
Not Determined	7991925	CHEMBL1937681	Inhibition of c-Src at 10 uM	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)c(C)c1C(=O)N1CCN(C)CC1		CHEMBL261641		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Determined	7991926	CHEMBL1937681	Inhibition of c-Src at 10 uM	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)c1ccc(O)c(O)c1		CHEMBL56393		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Determined	7991927	CHEMBL1937681	Inhibition of c-Src at 10 uM	B	Cc1c[nH]c(/C=C2\C(=O)Nc3ccccc32)c1CCC(=O)O		CHEMBL89363		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	7992220	CHEMBL1936092	Inhibition of SRC at 1 uM	B	CN(c1ccccc1-c1cc(Cl)c2cnc(Nc3ccc(C4CCN(CC(N)=O)CC4)cc3)nn12)S(C)(=O)=O		CHEMBL1934353	=	Inhibition	%	100.0	CHEMBL267	Homo sapiens	INH	%	100.0
	7996725	CHEMBL1944377	Inhibition of SRC at 1 uM	B	CNC(=O)c1cccc(F)c1Nc1nc(Nc2ccc3c(c2)NC(=O)[C@H](NC(=O)N2CCCC2)CC3(C)C)ncc1Cl		CHEMBL1939491	=	Inhibition	%	100.0	CHEMBL267	Homo sapiens	INH	%	100.0
	8002107	CHEMBL1942185	Inhibition of SRC at 1 uM	B	CC(C)n1cc(C(=O)c2cncc(N[C@@H]3CCN(C=O)[C@@H]3c3ccc(F)cc3)n2)c2c(N)ncnc21		CHEMBL1940251	=	Inhibition	%	29.0	CHEMBL267	Homo sapiens	INH	%	29.0
	8002108	CHEMBL1942185	Inhibition of SRC at 1 uM	B	CC(=O)N1CC[C@@H](Nc2cncc(C(=O)c3cn(C(C)C)c4ncnc(N)c34)n2)[C@H]1c1ccc(F)cc1		CHEMBL1940252	=	Inhibition	%	21.0	CHEMBL267	Homo sapiens	INH	%	21.0
	8002109	CHEMBL1942185	Inhibition of SRC at 1 uM	B	CC(=O)N1CC[C@@H](Nc2cncc(C(=O)c3cn(C(C)C)c4ncnc(N)c34)n2)[C@H]1c1ccccc1		CHEMBL1940253	=	Inhibition	%	14.0	CHEMBL267	Homo sapiens	INH	%	14.0
	8004507	CHEMBL1943939	Inhibition of SRC at 1 uM	B	O=c1c2ccccc2[se]n1-c1ccccc1		CHEMBL51085	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	8004551	CHEMBL1943939	Inhibition of SRC at 1 uM	B	CC(=O)OC[C@H]1O[C@@H](O[C@H]2[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@H](n3[se]c4ccccc4c3=O)O[C@@H]2COC(C)=O)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@H]1OC(C)=O		CHEMBL1940993	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	8005215	CHEMBL1943939	Inhibition of SRC at 1 uM	B	CC(=O)OC[C@H]1O[C@@H](NC(=O)CCCn2[se]c3ccccc3c2=O)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O		CHEMBL1940997	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	8005258	CHEMBL1943939	Inhibition of SRC at 1 uM	B	O=C(CCCn1[se]c2ccccc2c1=O)N[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O		CHEMBL1940999	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
Not Active	8012275	CHEMBL1941706	Inhibition of SRC at 10 uM by colorimetric analysis	B	Clc1ccc(-n2cc(-c3ccncc3)nn2)cc1		CHEMBL1938953		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	8012276	CHEMBL1941706	Inhibition of SRC at 10 uM by colorimetric analysis	B	Clc1cccc(-n2cc(-c3ccncc3)nn2)c1		CHEMBL1938954		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	8012277	CHEMBL1941706	Inhibition of SRC at 10 uM by colorimetric analysis	B	Clc1ccc(-n2nncc2-c2ccncc2)cc1		CHEMBL62965		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	8012278	CHEMBL1941706	Inhibition of SRC at 10 uM by colorimetric analysis	B	Clc1cccc(-n2nncc2-c2ccncc2)c1		CHEMBL303351		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	8013061	CHEMBL1947848	Inhibition of cSRC using ATP as substrate	B	Cn1c2c(c3ccc(Cl)c(Cl)c31)C(C#N)C1(CCNCC1)NC2=O		CHEMBL1945559	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	8017866	CHEMBL1948822	Inhibition of cSRC assessed as activity remaining at 10 uM	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CC1CCOCC1		CHEMBL1945953	=	Activity	%	92.0	CHEMBL267	Homo sapiens	Activity	%	92.0
	8017867	CHEMBL1948822	Inhibition of cSRC assessed as activity remaining at 10 uM	B	CC(C)(O)c1ccc(-c2cnc3[nH]c(=O)n(CC4CCCCC4)c3n2)cc1		CHEMBL1945950	=	Activity	%	73.0	CHEMBL267	Homo sapiens	Activity	%	73.0
	8017868	CHEMBL1948822	Inhibition of cSRC assessed as activity remaining at 10 uM	B	O=c1[nH]c2ncc(-c3ccc4[nH]cnc4c3)nc2n1CC1CCCCC1		CHEMBL1946262	=	Activity	%	63.0	CHEMBL267	Homo sapiens	Activity	%	63.0
	8039292	CHEMBL1953275	Inhibition of Src	B	COc1ccc(C(=O)NC[C@@H](O)CO)cc1/C=C/c1ccc(Cl)cc1		CHEMBL1949788	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	8039293	CHEMBL1953275	Inhibition of Src	B	COc1ccc(C(=O)NC[C@H](O)CO)cc1/C=C/c1ccc(Cl)cc1		CHEMBL1949789	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	8045848	CHEMBL1959327	Inhibition of human GST-tagged c-SRC autophosphorylation using biotin-(6-amino caproic acid)-AAAQQIYGQ-NH2 as substrate after 40 mins by homogenous time-resolved fluorescence method	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	IC50	nM	16000.0	CHEMBL267	Homo sapiens	IC50	uM	16.0
	8046097	CHEMBL1959421	Inhibition of Src using fluorescent substrate by IMAP assay	B	CN1CCN(c2ccc(Nc3nc(N)c(C(=O)c4ccc5c(c4)OCCO5)s3)cc2)CC1	Outside typical range	CHEMBL1956070	=	IC50	nM	3210000.0	CHEMBL267	Homo sapiens	IC50	uM	3210.0
	8046098	CHEMBL1959421	Inhibition of Src using fluorescent substrate by IMAP assay	B	COc1cccc(C(=O)c2sc(Nc3ccc(N4CCN(C(C)C)CC4)cc3)nc2N)c1	Outside typical range	CHEMBL1956069	=	IC50	nM	3480000.0	CHEMBL267	Homo sapiens	IC50	uM	3480.0
	8047171	CHEMBL1959397	Inhibition of SRC at 1 uM	B	CN1CCN(c2ccc(Nc3nc(N)c(C(=O)c4ccc5c(c4)OCCO5)s3)cc2)CC1		CHEMBL1956070	<	Inhibition	%	50.0	CHEMBL267	Homo sapiens	INH	%	50.0
	8059495	CHEMBL1958989	Inhibition of Src	B	Nc1nc(Nc2ccc([C@H]3CC[C@H](N4CCOCC4)CC3)cc2)nn1-c1ccccn1		CHEMBL1835870	=	Ki	nM	770.0	CHEMBL267	Homo sapiens	Ki	uM	0.77
	8060121	CHEMBL1960851	Inhibition of human recombinant SRC expressed in Sf9 cells using poly(E,Y)4:1 as substrate after 80 mins by scintillation counting	B	CC(C)n1c2c(c3c1-c1ccccc1C3=O)C(=O)CCC2		CHEMBL1957190	>	IC50	nM	35000.0	CHEMBL267	Homo sapiens	IC50	uM	35.0
	8060122	CHEMBL1960851	Inhibition of human recombinant SRC expressed in Sf9 cells using poly(E,Y)4:1 as substrate after 80 mins by scintillation counting	B	O=c1oc2c(O)c(O)cc3c(=O)oc4c(O)c(O)cc1c4c23		CHEMBL6246	=	IC50	nM	800.0	CHEMBL267	Homo sapiens	IC50	uM	0.8
	8061598	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	76.45	CHEMBL267	Homo sapiens	Inhibition	%	76.45
	8061705	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	9.92	CHEMBL267	Homo sapiens	Inhibition	%	9.92
	8062120	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	12.75	CHEMBL267	Homo sapiens	Inhibition	%	12.75
	8062236	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	13.06	CHEMBL267	Homo sapiens	Inhibition	%	13.06
	8062460	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	-0.58	CHEMBL267	Homo sapiens	Inhibition	%	-0.58
	8062622	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	9.87	CHEMBL267	Homo sapiens	Inhibition	%	9.87
	8062944	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	4.59	CHEMBL267	Homo sapiens	Inhibition	%	4.59
	8063076	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	19.77	CHEMBL267	Homo sapiens	Inhibition	%	19.77
	8063467	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	1.05	CHEMBL267	Homo sapiens	Inhibition	%	1.05
	8063575	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	11.84	CHEMBL267	Homo sapiens	Inhibition	%	11.84
	8063799	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	3.87	CHEMBL267	Homo sapiens	Inhibition	%	3.87
	8063981	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	42.2	CHEMBL267	Homo sapiens	Inhibition	%	42.2
	8064320	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	6.9	CHEMBL267	Homo sapiens	Inhibition	%	6.9
	8064530	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	3.94	CHEMBL267	Homo sapiens	Inhibition	%	3.94
	8064668	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	63.28	CHEMBL267	Homo sapiens	Inhibition	%	63.28
	8064892	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	12.15	CHEMBL267	Homo sapiens	Inhibition	%	12.15
	8065058	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	9.68	CHEMBL267	Homo sapiens	Inhibition	%	9.68
	8065398	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	4.86	CHEMBL267	Homo sapiens	Inhibition	%	4.86
	8065573	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	12.81	CHEMBL267	Homo sapiens	Inhibition	%	12.81
	8065912	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	3.64	CHEMBL267	Homo sapiens	Inhibition	%	3.64
	8066122	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	3.62	CHEMBL267	Homo sapiens	Inhibition	%	3.62
	8066482	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	54.04	CHEMBL267	Homo sapiens	Inhibition	%	54.04
	8066648	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	7.63	CHEMBL267	Homo sapiens	Inhibition	%	7.63
	8066996	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	3.27	CHEMBL267	Homo sapiens	Inhibition	%	3.27
	8067171	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	47.86	CHEMBL267	Homo sapiens	Inhibition	%	47.86
	8067395	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	7.41	CHEMBL267	Homo sapiens	Inhibition	%	7.41
	8067516	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	1.89	CHEMBL267	Homo sapiens	Inhibition	%	1.89
	8067726	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	-0.62	CHEMBL267	Homo sapiens	Inhibition	%	-0.62
	8067950	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	10.07	CHEMBL267	Homo sapiens	Inhibition	%	10.07
	8068085	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	17.11	CHEMBL267	Homo sapiens	Inhibition	%	17.11
	8068249	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	4.36	CHEMBL267	Homo sapiens	Inhibition	%	4.36
	8068473	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	6.64	CHEMBL267	Homo sapiens	Inhibition	%	6.64
	8068598	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	6.9	CHEMBL267	Homo sapiens	Inhibition	%	6.9
	8068996	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	6.38	CHEMBL267	Homo sapiens	Inhibition	%	6.38
	8069121	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	-0.8	CHEMBL267	Homo sapiens	Inhibition	%	-0.8
	8069416	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	63.92	CHEMBL267	Homo sapiens	Inhibition	%	63.92
	8069801	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	19.94	CHEMBL267	Homo sapiens	Inhibition	%	19.94
	8069927	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	4.79	CHEMBL267	Homo sapiens	Inhibition	%	4.79
	8070151	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	1.56	CHEMBL267	Homo sapiens	Inhibition	%	1.56
	8070323	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	4.77	CHEMBL267	Homo sapiens	Inhibition	%	4.77
	8070448	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	5.0	CHEMBL267	Homo sapiens	Inhibition	%	5.0
	8070672	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	1.53	CHEMBL267	Homo sapiens	Inhibition	%	1.53
	8070746	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	12.54	CHEMBL267	Homo sapiens	Inhibition	%	12.54
	8070970	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	62.62	CHEMBL267	Homo sapiens	Inhibition	%	62.62
	8071127	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	5.04	CHEMBL267	Homo sapiens	Inhibition	%	5.04
	8071477	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	2.63	CHEMBL267	Homo sapiens	Inhibition	%	2.63
	8071650	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	8.58	CHEMBL267	Homo sapiens	Inhibition	%	8.58
	8071999	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	0.23	CHEMBL267	Homo sapiens	Inhibition	%	0.23
	8072313	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	9.23	CHEMBL267	Homo sapiens	Inhibition	%	9.23
	8072470	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	5.85	CHEMBL267	Homo sapiens	Inhibition	%	5.85
	8072819	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	3.67	CHEMBL267	Homo sapiens	Inhibition	%	3.67
	8072986	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	12.53	CHEMBL267	Homo sapiens	Inhibition	%	12.53
	8073210	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	14.25	CHEMBL267	Homo sapiens	Inhibition	%	14.25
	8073335	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	0.46	CHEMBL267	Homo sapiens	Inhibition	%	0.46
	8073678	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	0.59	CHEMBL267	Homo sapiens	Inhibition	%	0.59
	8073911	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	5.13	CHEMBL267	Homo sapiens	Inhibition	%	5.13
	8074063	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	5.93	CHEMBL267	Homo sapiens	Inhibition	%	5.93
	8074287	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	7.76	CHEMBL267	Homo sapiens	Inhibition	%	7.76
	8074417	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	0.91	CHEMBL267	Homo sapiens	Inhibition	%	0.91
	8074798	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	1.88	CHEMBL267	Homo sapiens	Inhibition	%	1.88
	8074925	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	26.9	CHEMBL267	Homo sapiens	Inhibition	%	26.9
	8075260	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	6.44	CHEMBL267	Homo sapiens	Inhibition	%	6.44
	8075497	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	0.78	CHEMBL267	Homo sapiens	Inhibition	%	0.78
	8075862	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	8.46	CHEMBL267	Homo sapiens	Inhibition	%	8.46
	8076004	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	3.6	CHEMBL267	Homo sapiens	Inhibition	%	3.6
	8076376	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	5.52	CHEMBL267	Homo sapiens	Inhibition	%	5.52
	8076510	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	2.0	CHEMBL267	Homo sapiens	Inhibition	%	2.0
	8076734	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	0.42	CHEMBL267	Homo sapiens	Inhibition	%	0.42
	8076836	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	3.31	CHEMBL267	Homo sapiens	Inhibition	%	3.31
	8077083	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	0.68	CHEMBL267	Homo sapiens	Inhibition	%	0.68
	8077435	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	8.07	CHEMBL267	Homo sapiens	Inhibition	%	8.07
	8077586	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	-2.12	CHEMBL267	Homo sapiens	Inhibition	%	-2.12
	8077810	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	-0.06	CHEMBL267	Homo sapiens	Inhibition	%	-0.06
	8077953	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	1.6	CHEMBL267	Homo sapiens	Inhibition	%	1.6
	8078316	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	-0.44	CHEMBL267	Homo sapiens	Inhibition	%	-0.44
	8078418	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	1.01	CHEMBL267	Homo sapiens	Inhibition	%	1.01
	8078642	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	2.03	CHEMBL267	Homo sapiens	Inhibition	%	2.03
	8078668	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	2.84	CHEMBL267	Homo sapiens	Inhibition	%	2.84
	8078892	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	20.9	CHEMBL267	Homo sapiens	Inhibition	%	20.9
	8079008	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	3.95	CHEMBL267	Homo sapiens	Inhibition	%	3.95
	8079390	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	3.67	CHEMBL267	Homo sapiens	Inhibition	%	3.67
	8079532	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	12.89	CHEMBL267	Homo sapiens	Inhibition	%	12.89
	8079895	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	8.59	CHEMBL267	Homo sapiens	Inhibition	%	8.59
	8080224	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	0.66	CHEMBL267	Homo sapiens	Inhibition	%	0.66
	8080476	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	2.28	CHEMBL267	Homo sapiens	Inhibition	%	2.28
	8080591	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	6.82	CHEMBL267	Homo sapiens	Inhibition	%	6.82
	8080815	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	2.84	CHEMBL267	Homo sapiens	Inhibition	%	2.84
	8080979	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	5.14	CHEMBL267	Homo sapiens	Inhibition	%	5.14
	8081114	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	5.28	CHEMBL267	Homo sapiens	Inhibition	%	5.28
	8081338	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	8.51	CHEMBL267	Homo sapiens	Inhibition	%	8.51
	8081482	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	-0.59	CHEMBL267	Homo sapiens	Inhibition	%	-0.59
	8081809	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	3.33	CHEMBL267	Homo sapiens	Inhibition	%	3.33
	8082061	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	39.47	CHEMBL267	Homo sapiens	Inhibition	%	39.47
	8082398	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	8.82	CHEMBL267	Homo sapiens	Inhibition	%	8.82
	8082571	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-4.6	CHEMBL267	Homo sapiens	Inhibition	%	-4.6
	8082918	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	1.78	CHEMBL267	Homo sapiens	Inhibition	%	1.78
	8083074	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	15.3	CHEMBL267	Homo sapiens	Inhibition	%	15.3
	8083397	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	5.62	CHEMBL267	Homo sapiens	Inhibition	%	5.62
	8083651	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	1.24	CHEMBL267	Homo sapiens	Inhibition	%	1.24
	8083985	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	1.96	CHEMBL267	Homo sapiens	Inhibition	%	1.96
	8084170	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	0.47	CHEMBL267	Homo sapiens	Inhibition	%	0.47
	8084512	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	4.45	CHEMBL267	Homo sapiens	Inhibition	%	4.45
	8084673	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	9.31	CHEMBL267	Homo sapiens	Inhibition	%	9.31
	8084897	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	27.08	CHEMBL267	Homo sapiens	Inhibition	%	27.08
	8084995	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	1.2	CHEMBL267	Homo sapiens	Inhibition	%	1.2
	8085251	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	-1.17	CHEMBL267	Homo sapiens	Inhibition	%	-1.17
	8085475	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	31.17	CHEMBL267	Homo sapiens	Inhibition	%	31.17
	8085583	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	10.62	CHEMBL267	Homo sapiens	Inhibition	%	10.62
	8085772	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	19.28	CHEMBL267	Homo sapiens	Inhibition	%	19.28
	8085996	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	71.06	CHEMBL267	Homo sapiens	Inhibition	%	71.06
	8086111	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	3.91	CHEMBL267	Homo sapiens	Inhibition	%	3.91
	8086497	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	6.76	CHEMBL267	Homo sapiens	Inhibition	%	6.76
	8086596	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	4.09	CHEMBL267	Homo sapiens	Inhibition	%	4.09
	8086820	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	8.34	CHEMBL267	Homo sapiens	Inhibition	%	8.34
	8087031	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	14.35	CHEMBL267	Homo sapiens	Inhibition	%	14.35
	8087189	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	14.29	CHEMBL267	Homo sapiens	Inhibition	%	14.29
	8087527	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	81.16	CHEMBL267	Homo sapiens	Inhibition	%	81.16
	8087889	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	13.41	CHEMBL267	Homo sapiens	Inhibition	%	13.41
	8088031	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	14.07	CHEMBL267	Homo sapiens	Inhibition	%	14.07
	8088403	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	2.73	CHEMBL267	Homo sapiens	Inhibition	%	2.73
	8088531	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	6.62	CHEMBL267	Homo sapiens	Inhibition	%	6.62
	8088755	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	10.35	CHEMBL267	Homo sapiens	Inhibition	%	10.35
	8088848	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	11.41	CHEMBL267	Homo sapiens	Inhibition	%	11.41
	8089200	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	-3.73	CHEMBL267	Homo sapiens	Inhibition	%	-3.73
	8089348	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	5.22	CHEMBL267	Homo sapiens	Inhibition	%	5.22
	8089572	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	10.79	CHEMBL267	Homo sapiens	Inhibition	%	10.79
	8089692	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	1.84	CHEMBL267	Homo sapiens	Inhibition	%	1.84
	8089872	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	1.35	CHEMBL267	Homo sapiens	Inhibition	%	1.35
	8090096	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	1.39	CHEMBL267	Homo sapiens	Inhibition	%	1.39
	8090261	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	4.53	CHEMBL267	Homo sapiens	Inhibition	%	4.53
	8090428	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	7.08	CHEMBL267	Homo sapiens	Inhibition	%	7.08
	8090652	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	6.46	CHEMBL267	Homo sapiens	Inhibition	%	6.46
	8090791	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	3.76	CHEMBL267	Homo sapiens	Inhibition	%	3.76
	8090996	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	10.0	CHEMBL267	Homo sapiens	Inhibition	%	10.0
	8091220	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	9.13	CHEMBL267	Homo sapiens	Inhibition	%	9.13
	8091357	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	47.22	CHEMBL267	Homo sapiens	Inhibition	%	47.22
	8091512	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	6.28	CHEMBL267	Homo sapiens	Inhibition	%	6.28
	8091736	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	6.57	CHEMBL267	Homo sapiens	Inhibition	%	6.57
	8091852	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	8.59	CHEMBL267	Homo sapiens	Inhibition	%	8.59
	8092213	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	1.52	CHEMBL267	Homo sapiens	Inhibition	%	1.52
	8092364	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	16.42	CHEMBL267	Homo sapiens	Inhibition	%	16.42
	8092588	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	10.7	CHEMBL267	Homo sapiens	Inhibition	%	10.7
	8092736	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	4.51	CHEMBL267	Homo sapiens	Inhibition	%	4.51
	8093089	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	30.09	CHEMBL267	Homo sapiens	Inhibition	%	30.09
	8093177	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	6.84	CHEMBL267	Homo sapiens	Inhibition	%	6.84
	8093401	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	5.06	CHEMBL267	Homo sapiens	Inhibition	%	5.06
	8093541	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	6.62	CHEMBL267	Homo sapiens	Inhibition	%	6.62
	8093904	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	46.38	CHEMBL267	Homo sapiens	Inhibition	%	46.38
	8094024	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	4.44	CHEMBL267	Homo sapiens	Inhibition	%	4.44
	8094428	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	2.38	CHEMBL267	Homo sapiens	Inhibition	%	2.38
	8094603	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	11.77	CHEMBL267	Homo sapiens	Inhibition	%	11.77
	8094983	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	6.81	CHEMBL267	Homo sapiens	Inhibition	%	6.81
	8095123	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	41.93	CHEMBL267	Homo sapiens	Inhibition	%	41.93
	8095550	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	12.49	CHEMBL267	Homo sapiens	Inhibition	%	12.49
	8095691	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	8.87	CHEMBL267	Homo sapiens	Inhibition	%	8.87
	8096063	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	10.12	CHEMBL267	Homo sapiens	Inhibition	%	10.12
	8096180	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	11.23	CHEMBL267	Homo sapiens	Inhibition	%	11.23
	8096404	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	9.16	CHEMBL267	Homo sapiens	Inhibition	%	9.16
	8096543	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	2.45	CHEMBL267	Homo sapiens	Inhibition	%	2.45
	8096923	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	14.71	CHEMBL267	Homo sapiens	Inhibition	%	14.71
	8097070	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	2.2	CHEMBL267	Homo sapiens	Inhibition	%	2.2
	8097381	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	5.73	CHEMBL267	Homo sapiens	Inhibition	%	5.73
	8097601	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	8.49	CHEMBL267	Homo sapiens	Inhibition	%	8.49
	8097751	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	2.45	CHEMBL267	Homo sapiens	Inhibition	%	2.45
	8098108	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	1.83	CHEMBL267	Homo sapiens	Inhibition	%	1.83
	8098228	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	23.35	CHEMBL267	Homo sapiens	Inhibition	%	23.35
	8098452	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	-0.77	CHEMBL267	Homo sapiens	Inhibition	%	-0.77
	8098632	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	2.91	CHEMBL267	Homo sapiens	Inhibition	%	2.91
	8098817	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	6.34	CHEMBL267	Homo sapiens	Inhibition	%	6.34
	8099041	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	10.45	CHEMBL267	Homo sapiens	Inhibition	%	10.45
	8099185	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	8.85	CHEMBL267	Homo sapiens	Inhibition	%	8.85
	8099327	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	86.55	CHEMBL267	Homo sapiens	Inhibition	%	86.55
	8099551	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	6.86	CHEMBL267	Homo sapiens	Inhibition	%	6.86
	8099745	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	2.91	CHEMBL267	Homo sapiens	Inhibition	%	2.91
	8099892	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	17.45	CHEMBL267	Homo sapiens	Inhibition	%	17.45
	8100116	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	14.19	CHEMBL267	Homo sapiens	Inhibition	%	14.19
	8100262	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	41.79	CHEMBL267	Homo sapiens	Inhibition	%	41.79
	8100602	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	7.46	CHEMBL267	Homo sapiens	Inhibition	%	7.46
	8100742	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	1.76	CHEMBL267	Homo sapiens	Inhibition	%	1.76
	8100966	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	6.34	CHEMBL267	Homo sapiens	Inhibition	%	6.34
	8101126	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	11.32	CHEMBL267	Homo sapiens	Inhibition	%	11.32
	8101268	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	2.77	CHEMBL267	Homo sapiens	Inhibition	%	2.77
	8101492	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	19.7	CHEMBL267	Homo sapiens	Inhibition	%	19.7
	8101677	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	6.13	CHEMBL267	Homo sapiens	Inhibition	%	6.13
	8101930	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	29.76	CHEMBL267	Homo sapiens	Inhibition	%	29.76
	8102085	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	0.1	CHEMBL267	Homo sapiens	Inhibition	%	0.1
	8102309	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	86.31	CHEMBL267	Homo sapiens	Inhibition	%	86.31
	8102440	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	7.71	CHEMBL267	Homo sapiens	Inhibition	%	7.71
	8102784	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	-2.52	CHEMBL267	Homo sapiens	Inhibition	%	-2.52
	8102962	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	0.54	CHEMBL267	Homo sapiens	Inhibition	%	0.54
	8103382	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	8.29	CHEMBL267	Homo sapiens	Inhibition	%	8.29
	8103520	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	10.94	CHEMBL267	Homo sapiens	Inhibition	%	10.94
	8103894	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	6.06	CHEMBL267	Homo sapiens	Inhibition	%	6.06
	8104079	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	3.58	CHEMBL267	Homo sapiens	Inhibition	%	3.58
	8104451	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	32.88	CHEMBL267	Homo sapiens	Inhibition	%	32.88
	8104597	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	3.76	CHEMBL267	Homo sapiens	Inhibition	%	3.76
	8104935	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	7.01	CHEMBL267	Homo sapiens	Inhibition	%	7.01
	8105299	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	1.09	CHEMBL267	Homo sapiens	Inhibition	%	1.09
	8105465	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	12.37	CHEMBL267	Homo sapiens	Inhibition	%	12.37
	8105827	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	72.42	CHEMBL267	Homo sapiens	Inhibition	%	72.42
	8106107	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	10.85	CHEMBL267	Homo sapiens	Inhibition	%	10.85
	8106272	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	77.26	CHEMBL267	Homo sapiens	Inhibition	%	77.26
	8106652	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	94.9	CHEMBL267	Homo sapiens	Inhibition	%	94.9
	8106781	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	9.87	CHEMBL267	Homo sapiens	Inhibition	%	9.87
	8107126	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	1.17	CHEMBL267	Homo sapiens	Inhibition	%	1.17
	8107298	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	1.64	CHEMBL267	Homo sapiens	Inhibition	%	1.64
	8107522	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	3.37	CHEMBL267	Homo sapiens	Inhibition	%	3.37
	8107723	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	13.71	CHEMBL267	Homo sapiens	Inhibition	%	13.71
	8107858	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	16.66	CHEMBL267	Homo sapiens	Inhibition	%	16.66
	8108082	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	64.77	CHEMBL267	Homo sapiens	Inhibition	%	64.77
	8108240	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	6.71	CHEMBL267	Homo sapiens	Inhibition	%	6.71
	8108415	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	4.21	CHEMBL267	Homo sapiens	Inhibition	%	4.21
	8108786	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	11.94	CHEMBL267	Homo sapiens	Inhibition	%	11.94
	8108928	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	20.5	CHEMBL267	Homo sapiens	Inhibition	%	20.5
	8109152	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	0.66	CHEMBL267	Homo sapiens	Inhibition	%	0.66
	8109266	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	6.12	CHEMBL267	Homo sapiens	Inhibition	%	6.12
	8109620	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	2.18	CHEMBL267	Homo sapiens	Inhibition	%	2.18
	8109791	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	10.31	CHEMBL267	Homo sapiens	Inhibition	%	10.31
	8110147	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	14.91	CHEMBL267	Homo sapiens	Inhibition	%	14.91
	8110426	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	6.18	CHEMBL267	Homo sapiens	Inhibition	%	6.18
	8110592	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	16.62	CHEMBL267	Homo sapiens	Inhibition	%	16.62
	8110816	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	9.03	CHEMBL267	Homo sapiens	Inhibition	%	9.03
	8110974	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	-2.04	CHEMBL267	Homo sapiens	Inhibition	%	-2.04
	8111097	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	56.36	CHEMBL267	Homo sapiens	Inhibition	%	56.36
	8111321	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	0.79	CHEMBL267	Homo sapiens	Inhibition	%	0.79
	8111448	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	6.43	CHEMBL267	Homo sapiens	Inhibition	%	6.43
	8111838	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	2.02	CHEMBL267	Homo sapiens	Inhibition	%	2.02
	8112043	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	8.62	CHEMBL267	Homo sapiens	Inhibition	%	8.62
	8112404	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	2.45	CHEMBL267	Homo sapiens	Inhibition	%	2.45
	8112572	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	8.35	CHEMBL267	Homo sapiens	Inhibition	%	8.35
	8112744	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	1.43	CHEMBL267	Homo sapiens	Inhibition	%	1.43
	8112968	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	3.56	CHEMBL267	Homo sapiens	Inhibition	%	3.56
	8113120	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	33.17	CHEMBL267	Homo sapiens	Inhibition	%	33.17
	8113480	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	0.4	CHEMBL267	Homo sapiens	Inhibition	%	0.4
	8113604	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	6.18	CHEMBL267	Homo sapiens	Inhibition	%	6.18
	8113944	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-1.91	CHEMBL267	Homo sapiens	Inhibition	%	-1.91
	8114120	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	18.68	CHEMBL267	Homo sapiens	Inhibition	%	18.68
	8114344	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	9.03	CHEMBL267	Homo sapiens	Inhibition	%	9.03
	8114476	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	49.71	CHEMBL267	Homo sapiens	Inhibition	%	49.71
	8114752	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	0.23	CHEMBL267	Homo sapiens	Inhibition	%	0.23
	8115142	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	10.07	CHEMBL267	Homo sapiens	Inhibition	%	10.07
	8115307	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	-4.29	CHEMBL267	Homo sapiens	Inhibition	%	-4.29
	8115651	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	5.84	CHEMBL267	Homo sapiens	Inhibition	%	5.84
	8115784	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	-0.2	CHEMBL267	Homo sapiens	Inhibition	%	-0.2
	8116008	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	-2.58	CHEMBL267	Homo sapiens	Inhibition	%	-2.58
	8116167	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	5.77	CHEMBL267	Homo sapiens	Inhibition	%	5.77
	8116370	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	19.32	CHEMBL267	Homo sapiens	Inhibition	%	19.32
	8116728	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	3.26	CHEMBL267	Homo sapiens	Inhibition	%	3.26
	8116900	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	19.6	CHEMBL267	Homo sapiens	Inhibition	%	19.6
	8117295	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	4.6	CHEMBL267	Homo sapiens	Inhibition	%	4.6
	8117453	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	8.38	CHEMBL267	Homo sapiens	Inhibition	%	8.38
	8117807	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	0.6	CHEMBL267	Homo sapiens	Inhibition	%	0.6
	8117945	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	6.58	CHEMBL267	Homo sapiens	Inhibition	%	6.58
	8118169	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	5.82	CHEMBL267	Homo sapiens	Inhibition	%	5.82
	8118285	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-3.03	CHEMBL267	Homo sapiens	Inhibition	%	-3.03
	8118681	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	15.81	CHEMBL267	Homo sapiens	Inhibition	%	15.81
	8118817	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	7.3	CHEMBL267	Homo sapiens	Inhibition	%	7.3
	8119088	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	4.58	CHEMBL267	Homo sapiens	Inhibition	%	4.58
	8119471	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	48.34	CHEMBL267	Homo sapiens	Inhibition	%	48.34
	8119638	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	2.96	CHEMBL267	Homo sapiens	Inhibition	%	2.96
	8119981	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	8.61	CHEMBL267	Homo sapiens	Inhibition	%	8.61
	8120344	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	1.69	CHEMBL267	Homo sapiens	Inhibition	%	1.69
	8120504	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	34.16	CHEMBL267	Homo sapiens	Inhibition	%	34.16
	8120705	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	7.32	CHEMBL267	Homo sapiens	Inhibition	%	7.32
	8120929	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	11.44	CHEMBL267	Homo sapiens	Inhibition	%	11.44
	8121057	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	3.8	CHEMBL267	Homo sapiens	Inhibition	%	3.8
	8121229	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	57.07	CHEMBL267	Homo sapiens	Inhibition	%	57.07
	8121453	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	3.84	CHEMBL267	Homo sapiens	Inhibition	%	3.84
	8121620	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	3.83	CHEMBL267	Homo sapiens	Inhibition	%	3.83
	8121783	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	11.86	CHEMBL267	Homo sapiens	Inhibition	%	11.86
	8122007	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	7.25	CHEMBL267	Homo sapiens	Inhibition	%	7.25
	8122128	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	3.9	CHEMBL267	Homo sapiens	Inhibition	%	3.9
	8122490	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	7.25	CHEMBL267	Homo sapiens	Inhibition	%	7.25
	8122610	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	10.88	CHEMBL267	Homo sapiens	Inhibition	%	10.88
	8122834	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	14.63	CHEMBL267	Homo sapiens	Inhibition	%	14.63
	8123001	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	9.91	CHEMBL267	Homo sapiens	Inhibition	%	9.91
	8123143	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	6.58	CHEMBL267	Homo sapiens	Inhibition	%	6.58
	8123367	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	8.15	CHEMBL267	Homo sapiens	Inhibition	%	8.15
	8123421	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	11.07	CHEMBL267	Homo sapiens	Inhibition	%	11.07
	8123645	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	6.65	CHEMBL267	Homo sapiens	Inhibition	%	6.65
	8123795	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	28.64	CHEMBL267	Homo sapiens	Inhibition	%	28.64
	8123962	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	0.48	CHEMBL267	Homo sapiens	Inhibition	%	0.48
	8124186	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	12.48	CHEMBL267	Homo sapiens	Inhibition	%	12.48
	8124305	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	9.31	CHEMBL267	Homo sapiens	Inhibition	%	9.31
	8124668	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	5.52	CHEMBL267	Homo sapiens	Inhibition	%	5.52
	8124833	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	0.01	CHEMBL267	Homo sapiens	Inhibition	%	0.01
	8125258	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	10.16	CHEMBL267	Homo sapiens	Inhibition	%	10.16
	8125388	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	13.97	CHEMBL267	Homo sapiens	Inhibition	%	13.97
	8125780	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	7.75	CHEMBL267	Homo sapiens	Inhibition	%	7.75
	8125944	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	9.5	CHEMBL267	Homo sapiens	Inhibition	%	9.5
	8126332	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	12.87	CHEMBL267	Homo sapiens	Inhibition	%	12.87
	8126447	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	1.77	CHEMBL267	Homo sapiens	Inhibition	%	1.77
	8126671	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	31.86	CHEMBL267	Homo sapiens	Inhibition	%	31.86
	8126807	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	12.19	CHEMBL267	Homo sapiens	Inhibition	%	12.19
	8127153	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	10.86	CHEMBL267	Homo sapiens	Inhibition	%	10.86
	8127320	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	17.81	CHEMBL267	Homo sapiens	Inhibition	%	17.81
	8127686	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	21.16	CHEMBL267	Homo sapiens	Inhibition	%	21.16
	8127974	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	-4.09	CHEMBL267	Homo sapiens	Inhibition	%	-4.09
	8128126	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	78.98	CHEMBL267	Homo sapiens	Inhibition	%	78.98
	8128517	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	50.4	CHEMBL267	Homo sapiens	Inhibition	%	50.4
	8128636	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	7.33	CHEMBL267	Homo sapiens	Inhibition	%	7.33
	8128860	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	41.61	CHEMBL267	Homo sapiens	Inhibition	%	41.61
	8128997	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	1.09	CHEMBL267	Homo sapiens	Inhibition	%	1.09
	8129168	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	-0.98	CHEMBL267	Homo sapiens	Inhibition	%	-0.98
	8129392	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	1.1	CHEMBL267	Homo sapiens	Inhibition	%	1.1
	8129581	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	10.04	CHEMBL267	Homo sapiens	Inhibition	%	10.04
	8129720	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	0.98	CHEMBL267	Homo sapiens	Inhibition	%	0.98
	8129944	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	2.5	CHEMBL267	Homo sapiens	Inhibition	%	2.5
	8130105	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	3.96	CHEMBL267	Homo sapiens	Inhibition	%	3.96
	8130277	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	-1.14	CHEMBL267	Homo sapiens	Inhibition	%	-1.14
	8130501	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	-2.38	CHEMBL267	Homo sapiens	Inhibition	%	-2.38
	8130661	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	10.28	CHEMBL267	Homo sapiens	Inhibition	%	10.28
	8131001	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	6.81	CHEMBL267	Homo sapiens	Inhibition	%	6.81
	8131140	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	42.86	CHEMBL267	Homo sapiens	Inhibition	%	42.86
	8131484	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	15.29	CHEMBL267	Homo sapiens	Inhibition	%	15.29
	8131651	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	49.36	CHEMBL267	Homo sapiens	Inhibition	%	49.36
	8131875	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	89.28	CHEMBL267	Homo sapiens	Inhibition	%	89.28
	8132016	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	14.37	CHEMBL267	Homo sapiens	Inhibition	%	14.37
	8132302	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	21.66	CHEMBL267	Homo sapiens	Inhibition	%	21.66
	8132449	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	1.66	CHEMBL267	Homo sapiens	Inhibition	%	1.66
	8132673	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	7.43	CHEMBL267	Homo sapiens	Inhibition	%	7.43
	8132841	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	10.12	CHEMBL267	Homo sapiens	Inhibition	%	10.12
	8133186	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	0.82	CHEMBL267	Homo sapiens	Inhibition	%	0.82
	8133324	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	-0.12	CHEMBL267	Homo sapiens	Inhibition	%	-0.12
	8133720	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	2.61	CHEMBL267	Homo sapiens	Inhibition	%	2.61
	8133900	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	10.66	CHEMBL267	Homo sapiens	Inhibition	%	10.66
	8134272	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-1.14	CHEMBL267	Homo sapiens	Inhibition	%	-1.14
	8134432	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	3.98	CHEMBL267	Homo sapiens	Inhibition	%	3.98
	8134840	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	-2.8	CHEMBL267	Homo sapiens	Inhibition	%	-2.8
	8135000	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	38.22	CHEMBL267	Homo sapiens	Inhibition	%	38.22
	8135339	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	1.59	CHEMBL267	Homo sapiens	Inhibition	%	1.59
	8135480	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	8.0	CHEMBL267	Homo sapiens	Inhibition	%	8.0
	8135704	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	7.72	CHEMBL267	Homo sapiens	Inhibition	%	7.72
	8135825	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	9.5	CHEMBL267	Homo sapiens	Inhibition	%	9.5
	8136217	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	7.02	CHEMBL267	Homo sapiens	Inhibition	%	7.02
	8136361	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	52.8	CHEMBL267	Homo sapiens	Inhibition	%	52.8
	8136651	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	3.62	CHEMBL267	Homo sapiens	Inhibition	%	3.62
	8137010	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	17.43	CHEMBL267	Homo sapiens	Inhibition	%	17.43
	8137173	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	7.14	CHEMBL267	Homo sapiens	Inhibition	%	7.14
	8137517	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	6.25	CHEMBL267	Homo sapiens	Inhibition	%	6.25
	8137665	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	5.1	CHEMBL267	Homo sapiens	Inhibition	%	5.1
	8137889	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	0.53	CHEMBL267	Homo sapiens	Inhibition	%	0.53
	8138055	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-4.11	CHEMBL267	Homo sapiens	Inhibition	%	-4.11
	8138234	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	42.23	CHEMBL267	Homo sapiens	Inhibition	%	42.23
	8138458	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	6.29	CHEMBL267	Homo sapiens	Inhibition	%	6.29
	8138606	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	7.59	CHEMBL267	Homo sapiens	Inhibition	%	7.59
	8138764	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	5.81	CHEMBL267	Homo sapiens	Inhibition	%	5.81
	8138988	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	4.32	CHEMBL267	Homo sapiens	Inhibition	%	4.32
	8139173	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	8.01	CHEMBL267	Homo sapiens	Inhibition	%	8.01
	8139332	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	7.7	CHEMBL267	Homo sapiens	Inhibition	%	7.7
	8139556	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	15.39	CHEMBL267	Homo sapiens	Inhibition	%	15.39
	8139670	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	6.38	CHEMBL267	Homo sapiens	Inhibition	%	6.38
	8140035	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	8.56	CHEMBL267	Homo sapiens	Inhibition	%	8.56
	8140158	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	15.68	CHEMBL267	Homo sapiens	Inhibition	%	15.68
	8140382	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	9.4	CHEMBL267	Homo sapiens	Inhibition	%	9.4
	8140541	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	17.51	CHEMBL267	Homo sapiens	Inhibition	%	17.51
	8140684	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	7.77	CHEMBL267	Homo sapiens	Inhibition	%	7.77
	8140908	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	8.43	CHEMBL267	Homo sapiens	Inhibition	%	8.43
	8140986	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	5.62	CHEMBL267	Homo sapiens	Inhibition	%	5.62
	8141340	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	24.89	CHEMBL267	Homo sapiens	Inhibition	%	24.89
	8141500	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	19.49	CHEMBL267	Homo sapiens	Inhibition	%	19.49
	8141724	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	81.78	CHEMBL267	Homo sapiens	Inhibition	%	81.78
	8141843	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	17.52	CHEMBL267	Homo sapiens	Inhibition	%	17.52
	8142228	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	7.57	CHEMBL267	Homo sapiens	Inhibition	%	7.57
	8142396	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-4.48	CHEMBL267	Homo sapiens	Inhibition	%	-4.48
	8142796	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	7.64	CHEMBL267	Homo sapiens	Inhibition	%	7.64
	8142945	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-4.72	CHEMBL267	Homo sapiens	Inhibition	%	-4.72
	8143324	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	5.95	CHEMBL267	Homo sapiens	Inhibition	%	5.95
	8143511	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	8.18	CHEMBL267	Homo sapiens	Inhibition	%	8.18
	8143894	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	25.32	CHEMBL267	Homo sapiens	Inhibition	%	25.32
	8144008	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	7.74	CHEMBL267	Homo sapiens	Inhibition	%	7.74
	8144371	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	10.17	CHEMBL267	Homo sapiens	Inhibition	%	10.17
	8144725	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	12.18	CHEMBL267	Homo sapiens	Inhibition	%	12.18
	8144878	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	5.46	CHEMBL267	Homo sapiens	Inhibition	%	5.46
	8145239	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	9.13	CHEMBL267	Homo sapiens	Inhibition	%	9.13
	8145328	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	1.56	CHEMBL267	Homo sapiens	Inhibition	%	1.56
	8145552	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	8.12	CHEMBL267	Homo sapiens	Inhibition	%	8.12
	8145676	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	-4.02	CHEMBL267	Homo sapiens	Inhibition	%	-4.02
	8146061	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	40.67	CHEMBL267	Homo sapiens	Inhibition	%	40.67
	8146181	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	59.01	CHEMBL267	Homo sapiens	Inhibition	%	59.01
	8146405	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	17.41	CHEMBL267	Homo sapiens	Inhibition	%	17.41
	8146565	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	51.66	CHEMBL267	Homo sapiens	Inhibition	%	51.66
	8146732	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	-1.27	CHEMBL267	Homo sapiens	Inhibition	%	-1.27
	8146956	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	21.31	CHEMBL267	Homo sapiens	Inhibition	%	21.31
	8147125	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	6.26	CHEMBL267	Homo sapiens	Inhibition	%	6.26
	8147267	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-6.71	CHEMBL267	Homo sapiens	Inhibition	%	-6.71
	8147491	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	5.04	CHEMBL267	Homo sapiens	Inhibition	%	5.04
	8147644	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	3.71	CHEMBL267	Homo sapiens	Inhibition	%	3.71
	8147831	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	14.23	CHEMBL267	Homo sapiens	Inhibition	%	14.23
	8148213	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	72.87	CHEMBL267	Homo sapiens	Inhibition	%	72.87
	8148327	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	6.71	CHEMBL267	Homo sapiens	Inhibition	%	6.71
	8148551	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	6.55	CHEMBL267	Homo sapiens	Inhibition	%	6.55
	8148690	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	4.96	CHEMBL267	Homo sapiens	Inhibition	%	4.96
	8149052	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	12.98	CHEMBL267	Homo sapiens	Inhibition	%	12.98
	8149211	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	6.17	CHEMBL267	Homo sapiens	Inhibition	%	6.17
	8149569	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	8.52	CHEMBL267	Homo sapiens	Inhibition	%	8.52
	8149891	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	5.94	CHEMBL267	Homo sapiens	Inhibition	%	5.94
	8150016	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	4.81	CHEMBL267	Homo sapiens	Inhibition	%	4.81
	8150240	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	7.67	CHEMBL267	Homo sapiens	Inhibition	%	7.67
	8150400	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	65.38	CHEMBL267	Homo sapiens	Inhibition	%	65.38
	8150744	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	12.5	CHEMBL267	Homo sapiens	Inhibition	%	12.5
	8150909	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	8.11	CHEMBL267	Homo sapiens	Inhibition	%	8.11
	8151296	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-6.61	CHEMBL267	Homo sapiens	Inhibition	%	-6.61
	8151473	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	8.29	CHEMBL267	Homo sapiens	Inhibition	%	8.29
	8151835	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	8.31	CHEMBL267	Homo sapiens	Inhibition	%	8.31
	8151989	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	6.2	CHEMBL267	Homo sapiens	Inhibition	%	6.2
	8152177	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	8.74	CHEMBL267	Homo sapiens	Inhibition	%	8.74
	8152401	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	19.56	CHEMBL267	Homo sapiens	Inhibition	%	19.56
	8152559	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	9.27	CHEMBL267	Homo sapiens	Inhibition	%	9.27
	8152897	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	42.53	CHEMBL267	Homo sapiens	Inhibition	%	42.53
	8153036	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	3.88	CHEMBL267	Homo sapiens	Inhibition	%	3.88
	8153260	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	4.74	CHEMBL267	Homo sapiens	Inhibition	%	4.74
	8153397	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	13.58	CHEMBL267	Homo sapiens	Inhibition	%	13.58
	8153554	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	3.38	CHEMBL267	Homo sapiens	Inhibition	%	3.38
	8153778	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	4.01	CHEMBL267	Homo sapiens	Inhibition	%	4.01
	8153911	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	8.77	CHEMBL267	Homo sapiens	Inhibition	%	8.77
	8154232	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	49.24	CHEMBL267	Homo sapiens	Inhibition	%	49.24
	8154582	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	36.99	CHEMBL267	Homo sapiens	Inhibition	%	36.99
	8154741	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	-0.84	CHEMBL267	Homo sapiens	Inhibition	%	-0.84
	8155085	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	-8.85	CHEMBL267	Homo sapiens	Inhibition	%	-8.85
	8155261	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	6.64	CHEMBL267	Homo sapiens	Inhibition	%	6.64
	8155646	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-7.08	CHEMBL267	Homo sapiens	Inhibition	%	-7.08
	8155824	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	6.38	CHEMBL267	Homo sapiens	Inhibition	%	6.38
	8156186	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	4.83	CHEMBL267	Homo sapiens	Inhibition	%	4.83
	8156398	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	7.62	CHEMBL267	Homo sapiens	Inhibition	%	7.62
	8156772	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	70.66	CHEMBL267	Homo sapiens	Inhibition	%	70.66
	8156915	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	1.97	CHEMBL267	Homo sapiens	Inhibition	%	1.97
	8157259	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	1.6	CHEMBL267	Homo sapiens	Inhibition	%	1.6
	8157400	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	91.09	CHEMBL267	Homo sapiens	Inhibition	%	91.09
	8157624	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	22.56	CHEMBL267	Homo sapiens	Inhibition	%	22.56
	8157754	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	11.2	CHEMBL267	Homo sapiens	Inhibition	%	11.2
	8158139	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	1.97	CHEMBL267	Homo sapiens	Inhibition	%	1.97
	8158389	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	11.2	CHEMBL267	Homo sapiens	Inhibition	%	11.2
	8158547	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	4.44	CHEMBL267	Homo sapiens	Inhibition	%	4.44
	8158771	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	9.16	CHEMBL267	Homo sapiens	Inhibition	%	9.16
	8158940	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	-1.08	CHEMBL267	Homo sapiens	Inhibition	%	-1.08
	8159075	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	8.09	CHEMBL267	Homo sapiens	Inhibition	%	8.09
	8159299	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	-0.25	CHEMBL267	Homo sapiens	Inhibition	%	-0.25
	8159419	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	30.79	CHEMBL267	Homo sapiens	Inhibition	%	30.79
	8159774	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	11.87	CHEMBL267	Homo sapiens	Inhibition	%	11.87
	8159915	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	-7.85	CHEMBL267	Homo sapiens	Inhibition	%	-7.85
	8160139	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	2.73	CHEMBL267	Homo sapiens	Inhibition	%	2.73
	8160276	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	-1.56	CHEMBL267	Homo sapiens	Inhibition	%	-1.56
	8160426	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	5.61	CHEMBL267	Homo sapiens	Inhibition	%	5.61
	8160650	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	0.34	CHEMBL267	Homo sapiens	Inhibition	%	0.34
	8160720	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	1.85	CHEMBL267	Homo sapiens	Inhibition	%	1.85
	8160944	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	24.39	CHEMBL267	Homo sapiens	Inhibition	%	24.39
	8161094	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	4.5	CHEMBL267	Homo sapiens	Inhibition	%	4.5
	8161237	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	18.33	CHEMBL267	Homo sapiens	Inhibition	%	18.33
	8161461	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	-0.83	CHEMBL267	Homo sapiens	Inhibition	%	-0.83
	8161586	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	22.72	CHEMBL267	Homo sapiens	Inhibition	%	22.72
	8161948	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	74.39	CHEMBL267	Homo sapiens	Inhibition	%	74.39
	8162078	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	5.48	CHEMBL267	Homo sapiens	Inhibition	%	5.48
	8162302	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	27.36	CHEMBL267	Homo sapiens	Inhibition	%	27.36
	8162462	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	4.89	CHEMBL267	Homo sapiens	Inhibition	%	4.89
	8162715	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	-1.35	CHEMBL267	Homo sapiens	Inhibition	%	-1.35
	8163087	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	14.18	CHEMBL267	Homo sapiens	Inhibition	%	14.18
	8163256	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	8.62	CHEMBL267	Homo sapiens	Inhibition	%	8.62
	8163614	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	11.35	CHEMBL267	Homo sapiens	Inhibition	%	11.35
	8163737	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	-3.16	CHEMBL267	Homo sapiens	Inhibition	%	-3.16
	8163961	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	9.68	CHEMBL267	Homo sapiens	Inhibition	%	9.68
	8164095	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	-0.17	CHEMBL267	Homo sapiens	Inhibition	%	-0.17
	8164459	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	-1.43	CHEMBL267	Homo sapiens	Inhibition	%	-1.43
	8164614	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	7.9	CHEMBL267	Homo sapiens	Inhibition	%	7.9
	8164982	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	18.34	CHEMBL267	Homo sapiens	Inhibition	%	18.34
	8165276	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	0.68	CHEMBL267	Homo sapiens	Inhibition	%	0.68
	8165417	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	18.43	CHEMBL267	Homo sapiens	Inhibition	%	18.43
	8165784	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	32.33	CHEMBL267	Homo sapiens	Inhibition	%	32.33
	8165910	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	3.41	CHEMBL267	Homo sapiens	Inhibition	%	3.41
	8166134	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	7.83	CHEMBL267	Homo sapiens	Inhibition	%	7.83
	8166272	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	3.21	CHEMBL267	Homo sapiens	Inhibition	%	3.21
	8166626	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	18.67	CHEMBL267	Homo sapiens	Inhibition	%	18.67
	8166727	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	68.38	CHEMBL267	Homo sapiens	Inhibition	%	68.38
	8166951	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	92.08	CHEMBL267	Homo sapiens	Inhibition	%	92.08
	8167039	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	7.23	CHEMBL267	Homo sapiens	Inhibition	%	7.23
	8167404	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	61.85	CHEMBL267	Homo sapiens	Inhibition	%	61.85
	8167568	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	12.3	CHEMBL267	Homo sapiens	Inhibition	%	12.3
	8167925	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	4.3	CHEMBL267	Homo sapiens	Inhibition	%	4.3
	8168273	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	-8.18	CHEMBL267	Homo sapiens	Inhibition	%	-8.18
	8168414	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	14.55	CHEMBL267	Homo sapiens	Inhibition	%	14.55
	8168774	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	5.26	CHEMBL267	Homo sapiens	Inhibition	%	5.26
	8168938	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	14.27	CHEMBL267	Homo sapiens	Inhibition	%	14.27
	8169304	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	-4.32	CHEMBL267	Homo sapiens	Inhibition	%	-4.32
	8169608	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	8.9	CHEMBL267	Homo sapiens	Inhibition	%	8.9
	8169742	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	0.44	CHEMBL267	Homo sapiens	Inhibition	%	0.44
	8169966	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	8.47	CHEMBL267	Homo sapiens	Inhibition	%	8.47
	8170111	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	-4.73	CHEMBL267	Homo sapiens	Inhibition	%	-4.73
	8170460	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	4.47	CHEMBL267	Homo sapiens	Inhibition	%	4.47
	8170600	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	10.41	CHEMBL267	Homo sapiens	Inhibition	%	10.41
	8170959	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	63.23	CHEMBL267	Homo sapiens	Inhibition	%	63.23
	8171156	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	3.58	CHEMBL267	Homo sapiens	Inhibition	%	3.58
	8171373	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	3.92	CHEMBL267	Homo sapiens	Inhibition	%	3.92
	8171597	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	7.72	CHEMBL267	Homo sapiens	Inhibition	%	7.72
	8171738	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	0.33	CHEMBL267	Homo sapiens	Inhibition	%	0.33
	8171891	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	7.06	CHEMBL267	Homo sapiens	Inhibition	%	7.06
	8172115	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	0.4	CHEMBL267	Homo sapiens	Inhibition	%	0.4
	8172247	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	9.9	CHEMBL267	Homo sapiens	Inhibition	%	9.9
	8172599	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	4.28	CHEMBL267	Homo sapiens	Inhibition	%	4.28
	8172741	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	0.24	CHEMBL267	Homo sapiens	Inhibition	%	0.24
	8172965	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	12.89	CHEMBL267	Homo sapiens	Inhibition	%	12.89
	8173101	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-4.15	CHEMBL267	Homo sapiens	Inhibition	%	-4.15
	8173266	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	65.96	CHEMBL267	Homo sapiens	Inhibition	%	65.96
	8173490	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	49.11	CHEMBL267	Homo sapiens	Inhibition	%	49.11
	8173631	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	8.03	CHEMBL267	Homo sapiens	Inhibition	%	8.03
	8173942	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	-1.33	CHEMBL267	Homo sapiens	Inhibition	%	-1.33
	8174298	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	11.77	CHEMBL267	Homo sapiens	Inhibition	%	11.77
	8174446	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	24.37	CHEMBL267	Homo sapiens	Inhibition	%	24.37
	8174792	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	6.45	CHEMBL267	Homo sapiens	Inhibition	%	6.45
	8174935	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	-0.03	CHEMBL267	Homo sapiens	Inhibition	%	-0.03
	8175159	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	8.65	CHEMBL267	Homo sapiens	Inhibition	%	8.65
	8175295	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	1.55	CHEMBL267	Homo sapiens	Inhibition	%	1.55
	8175551	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	9.95	CHEMBL267	Homo sapiens	Inhibition	%	9.95
	8175938	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	11.12	CHEMBL267	Homo sapiens	Inhibition	%	11.12
	8176091	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	11.72	CHEMBL267	Homo sapiens	Inhibition	%	11.72
	8176464	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	57.2	CHEMBL267	Homo sapiens	Inhibition	%	57.2
	8176596	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	5.5	CHEMBL267	Homo sapiens	Inhibition	%	5.5
	8176820	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	30.99	CHEMBL267	Homo sapiens	Inhibition	%	30.99
	8176950	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	-2.63	CHEMBL267	Homo sapiens	Inhibition	%	-2.63
	8177316	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	11.4	CHEMBL267	Homo sapiens	Inhibition	%	11.4
	8177454	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-1.21	CHEMBL267	Homo sapiens	Inhibition	%	-1.21
	8177842	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	87.26	CHEMBL267	Homo sapiens	Inhibition	%	87.26
	8177982	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	2.96	CHEMBL267	Homo sapiens	Inhibition	%	2.96
	8178206	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	12.11	CHEMBL267	Homo sapiens	Inhibition	%	12.11
	8178294	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	33.0	CHEMBL267	Homo sapiens	Inhibition	%	33.0
	8178645	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	38.21	CHEMBL267	Homo sapiens	Inhibition	%	38.21
	8178794	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	2.23	CHEMBL267	Homo sapiens	Inhibition	%	2.23
	8179018	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	7.22	CHEMBL267	Homo sapiens	Inhibition	%	7.22
	8179141	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	0.25	CHEMBL267	Homo sapiens	Inhibition	%	0.25
	8179509	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	2.77	CHEMBL267	Homo sapiens	Inhibition	%	2.77
	8179646	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	13.39	CHEMBL267	Homo sapiens	Inhibition	%	13.39
	8179903	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	19.2	CHEMBL267	Homo sapiens	Inhibition	%	19.2
	8180127	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	9.17	CHEMBL267	Homo sapiens	Inhibition	%	9.17
	8180281	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	49.47	CHEMBL267	Homo sapiens	Inhibition	%	49.47
	8180437	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	9.83	CHEMBL267	Homo sapiens	Inhibition	%	9.83
	8180661	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	9.77	CHEMBL267	Homo sapiens	Inhibition	%	9.77
	8180809	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	-4.52	CHEMBL267	Homo sapiens	Inhibition	%	-4.52
	8181166	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	92.22	CHEMBL267	Homo sapiens	Inhibition	%	92.22
	8181297	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	8.69	CHEMBL267	Homo sapiens	Inhibition	%	8.69
	8181661	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	69.41	CHEMBL267	Homo sapiens	Inhibition	%	69.41
	8181800	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	-1.01	CHEMBL267	Homo sapiens	Inhibition	%	-1.01
	8182024	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	20.35	CHEMBL267	Homo sapiens	Inhibition	%	20.35
	8182187	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	-1.89	CHEMBL267	Homo sapiens	Inhibition	%	-1.89
	8182551	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	-0.44	CHEMBL267	Homo sapiens	Inhibition	%	-0.44
	8182643	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	3.86	CHEMBL267	Homo sapiens	Inhibition	%	3.86
	8182867	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	6.56	CHEMBL267	Homo sapiens	Inhibition	%	6.56
	8182989	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	14.55	CHEMBL267	Homo sapiens	Inhibition	%	14.55
	8183362	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	30.69	CHEMBL267	Homo sapiens	Inhibition	%	30.69
	8183491	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	6.91	CHEMBL267	Homo sapiens	Inhibition	%	6.91
	8183857	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	29.18	CHEMBL267	Homo sapiens	Inhibition	%	29.18
	8183993	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	3.8	CHEMBL267	Homo sapiens	Inhibition	%	3.8
	8184217	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	6.22	CHEMBL267	Homo sapiens	Inhibition	%	6.22
	8184483	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	8.13	CHEMBL267	Homo sapiens	Inhibition	%	8.13
	8184630	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	3.22	CHEMBL267	Homo sapiens	Inhibition	%	3.22
	8185011	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	40.19	CHEMBL267	Homo sapiens	Inhibition	%	40.19
	8185160	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	27.38	CHEMBL267	Homo sapiens	Inhibition	%	27.38
	8185515	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	95.11	CHEMBL267	Homo sapiens	Inhibition	%	95.11
	8185646	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	-2.31	CHEMBL267	Homo sapiens	Inhibition	%	-2.31
	8185870	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	0.81	CHEMBL267	Homo sapiens	Inhibition	%	0.81
	8186009	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	0.33	CHEMBL267	Homo sapiens	Inhibition	%	0.33
	8186374	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	3.58	CHEMBL267	Homo sapiens	Inhibition	%	3.58
	8186538	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	14.2	CHEMBL267	Homo sapiens	Inhibition	%	14.2
	8186901	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	6.45	CHEMBL267	Homo sapiens	Inhibition	%	6.45
	8187223	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	5.55	CHEMBL267	Homo sapiens	Inhibition	%	5.55
	8187347	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	49.24	CHEMBL267	Homo sapiens	Inhibition	%	49.24
	8187719	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	79.36	CHEMBL267	Homo sapiens	Inhibition	%	79.36
	8187848	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	0.84	CHEMBL267	Homo sapiens	Inhibition	%	0.84
	8188072	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	15.78	CHEMBL267	Homo sapiens	Inhibition	%	15.78
	8188215	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	-2.96	CHEMBL267	Homo sapiens	Inhibition	%	-2.96
	8188574	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	56.53	CHEMBL267	Homo sapiens	Inhibition	%	56.53
	8188848	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1	Outside typical range	CHEMBL475761	=	Inhibition	%	-28.25	CHEMBL267	Homo sapiens	Inhibition	%	-28.25
	8188996	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	6.79	CHEMBL267	Homo sapiens	Inhibition	%	6.79
	8189220	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	20.83	CHEMBL267	Homo sapiens	Inhibition	%	20.83
	8189376	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	83.86	CHEMBL267	Homo sapiens	Inhibition	%	83.86
	8189525	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	0.53	CHEMBL267	Homo sapiens	Inhibition	%	0.53
	8189749	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	2.01	CHEMBL267	Homo sapiens	Inhibition	%	2.01
	8189881	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	1.2	CHEMBL267	Homo sapiens	Inhibition	%	1.2
	8190237	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	4.87	CHEMBL267	Homo sapiens	Inhibition	%	4.87
	8190377	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	10.72	CHEMBL267	Homo sapiens	Inhibition	%	10.72
	8190601	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	10.39	CHEMBL267	Homo sapiens	Inhibition	%	10.39
	8190738	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	19.39	CHEMBL267	Homo sapiens	Inhibition	%	19.39
	8190902	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	-1.55	CHEMBL267	Homo sapiens	Inhibition	%	-1.55
	8191126	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	10.76	CHEMBL267	Homo sapiens	Inhibition	%	10.76
	8191264	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	4.55	CHEMBL267	Homo sapiens	Inhibition	%	4.55
	8191584	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	54.25	CHEMBL267	Homo sapiens	Inhibition	%	54.25
	8191706	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	5.55	CHEMBL267	Homo sapiens	Inhibition	%	5.55
	8191930	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	23.56	CHEMBL267	Homo sapiens	Inhibition	%	23.56
	8192079	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	2.97	CHEMBL267	Homo sapiens	Inhibition	%	2.97
	8192432	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	1.18	CHEMBL267	Homo sapiens	Inhibition	%	1.18
	8192576	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	14.06	CHEMBL267	Homo sapiens	Inhibition	%	14.06
	8192800	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	8.47	CHEMBL267	Homo sapiens	Inhibition	%	8.47
	8192936	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	77.37	CHEMBL267	Homo sapiens	Inhibition	%	77.37
	8193208	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	18.34	CHEMBL267	Homo sapiens	Inhibition	%	18.34
	8193577	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	72.67	CHEMBL267	Homo sapiens	Inhibition	%	72.67
	8193734	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	1.93	CHEMBL267	Homo sapiens	Inhibition	%	1.93
	8194107	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-2.23	CHEMBL267	Homo sapiens	Inhibition	%	-2.23
	8194238	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	17.85	CHEMBL267	Homo sapiens	Inhibition	%	17.85
	8194593	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	17.09	CHEMBL267	Homo sapiens	Inhibition	%	17.09
	8194960	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	59.78	CHEMBL267	Homo sapiens	Inhibition	%	59.78
	8195093	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	2.31	CHEMBL267	Homo sapiens	Inhibition	%	2.31
	8195481	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	3.8	CHEMBL267	Homo sapiens	Inhibition	%	3.8
	8195620	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	14.39	CHEMBL267	Homo sapiens	Inhibition	%	14.39
	8195942	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	-1.49	CHEMBL267	Homo sapiens	Inhibition	%	-1.49
	8196283	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	0.79	CHEMBL267	Homo sapiens	Inhibition	%	0.79
	8196433	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	10.25	CHEMBL267	Homo sapiens	Inhibition	%	10.25
	8196657	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	15.35	CHEMBL267	Homo sapiens	Inhibition	%	15.35
	8196785	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	2.9	CHEMBL267	Homo sapiens	Inhibition	%	2.9
	8197150	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	13.65	CHEMBL267	Homo sapiens	Inhibition	%	13.65
	8197287	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	-3.54	CHEMBL267	Homo sapiens	Inhibition	%	-3.54
	8197562	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	-1.61	CHEMBL267	Homo sapiens	Inhibition	%	-1.61
	8197926	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	20.5	CHEMBL267	Homo sapiens	Inhibition	%	20.5
	8198083	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	12.91	CHEMBL267	Homo sapiens	Inhibition	%	12.91
	8198445	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-2.52	CHEMBL267	Homo sapiens	Inhibition	%	-2.52
	8198575	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	22.88	CHEMBL267	Homo sapiens	Inhibition	%	22.88
	8198799	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	70.55	CHEMBL267	Homo sapiens	Inhibition	%	70.55
	8198930	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	5.94	CHEMBL267	Homo sapiens	Inhibition	%	5.94
	8199302	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	-0.18	CHEMBL267	Homo sapiens	Inhibition	%	-0.18
	8199436	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	7.94	CHEMBL267	Homo sapiens	Inhibition	%	7.94
	8199660	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	4.7	CHEMBL267	Homo sapiens	Inhibition	%	4.7
	8199823	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	15.47	CHEMBL267	Homo sapiens	Inhibition	%	15.47
	8199961	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	-0.99	CHEMBL267	Homo sapiens	Inhibition	%	-0.99
	8200185	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	10.57	CHEMBL267	Homo sapiens	Inhibition	%	10.57
	8200289	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	9.03	CHEMBL267	Homo sapiens	Inhibition	%	9.03
	8200628	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	12.8	CHEMBL267	Homo sapiens	Inhibition	%	12.8
	8201002	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	63.25	CHEMBL267	Homo sapiens	Inhibition	%	63.25
	8201132	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	3.31	CHEMBL267	Homo sapiens	Inhibition	%	3.31
	8201491	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	-0.21	CHEMBL267	Homo sapiens	Inhibition	%	-0.21
	8201624	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	16.3	CHEMBL267	Homo sapiens	Inhibition	%	16.3
	8201848	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	2.64	CHEMBL267	Homo sapiens	Inhibition	%	2.64
	8201903	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	10.91	CHEMBL267	Homo sapiens	Inhibition	%	10.91
	8202127	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	-1.31	CHEMBL267	Homo sapiens	Inhibition	%	-1.31
	8202267	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	20.88	CHEMBL267	Homo sapiens	Inhibition	%	20.88
	8202434	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	3.03	CHEMBL267	Homo sapiens	Inhibition	%	3.03
	8202658	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	8.62	CHEMBL267	Homo sapiens	Inhibition	%	8.62
	8202783	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	0.27	CHEMBL267	Homo sapiens	Inhibition	%	0.27
	8203137	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	-1.81	CHEMBL267	Homo sapiens	Inhibition	%	-1.81
	8203268	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	15.49	CHEMBL267	Homo sapiens	Inhibition	%	15.49
	8203492	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	40.49	CHEMBL267	Homo sapiens	Inhibition	%	40.49
	8203638	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	20.1	CHEMBL267	Homo sapiens	Inhibition	%	20.1
	8203996	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	9.06	CHEMBL267	Homo sapiens	Inhibition	%	9.06
	8204162	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	14.06	CHEMBL267	Homo sapiens	Inhibition	%	14.06
	8204523	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	60.98	CHEMBL267	Homo sapiens	Inhibition	%	60.98
	8204628	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	6.5	CHEMBL267	Homo sapiens	Inhibition	%	6.5
	8204852	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	39.27	CHEMBL267	Homo sapiens	Inhibition	%	39.27
	8204967	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	27.86	CHEMBL267	Homo sapiens	Inhibition	%	27.86
	8205340	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	10.1	CHEMBL267	Homo sapiens	Inhibition	%	10.1
	8205476	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	17.56	CHEMBL267	Homo sapiens	Inhibition	%	17.56
	8205700	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC	Outside typical range	CHEMBL188240	=	Inhibition	%	-13.19	CHEMBL267	Homo sapiens	Inhibition	%	-13.19
	8205839	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	6.83	CHEMBL267	Homo sapiens	Inhibition	%	6.83
	8206195	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	3.54	CHEMBL267	Homo sapiens	Inhibition	%	3.54
	8206471	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	8.28	CHEMBL267	Homo sapiens	Inhibition	%	8.28
	8206614	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	0.53	CHEMBL267	Homo sapiens	Inhibition	%	0.53
	8207018	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	2.96	CHEMBL267	Homo sapiens	Inhibition	%	2.96
	8207144	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	9.0	CHEMBL267	Homo sapiens	Inhibition	%	9.0
	8207368	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	4.18	CHEMBL267	Homo sapiens	Inhibition	%	4.18
	8207498	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	13.12	CHEMBL267	Homo sapiens	Inhibition	%	13.12
	8207854	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	82.85	CHEMBL267	Homo sapiens	Inhibition	%	82.85
	8207999	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	2.26	CHEMBL267	Homo sapiens	Inhibition	%	2.26
	8208355	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	0.76	CHEMBL267	Homo sapiens	Inhibition	%	0.76
	8208521	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	58.57	CHEMBL267	Homo sapiens	Inhibition	%	58.57
	8208745	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	12.96	CHEMBL267	Homo sapiens	Inhibition	%	12.96
	8208878	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	90.39	CHEMBL267	Homo sapiens	Inhibition	%	90.39
	8209207	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	12.6	CHEMBL267	Homo sapiens	Inhibition	%	12.6
	8209323	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	83.24	CHEMBL267	Homo sapiens	Inhibition	%	83.24
	8209547	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	0.7	CHEMBL267	Homo sapiens	Inhibition	%	0.7
	8209697	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	8.4	CHEMBL267	Homo sapiens	Inhibition	%	8.4
	8210057	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	5.71	CHEMBL267	Homo sapiens	Inhibition	%	5.71
	8210198	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	4.43	CHEMBL267	Homo sapiens	Inhibition	%	4.43
	8210558	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	15.38	CHEMBL267	Homo sapiens	Inhibition	%	15.38
	8210817	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	-1.25	CHEMBL267	Homo sapiens	Inhibition	%	-1.25
	8210961	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-0.25	CHEMBL267	Homo sapiens	Inhibition	%	-0.25
	8211185	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	1.51	CHEMBL267	Homo sapiens	Inhibition	%	1.51
	8211355	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	6.8	CHEMBL267	Homo sapiens	Inhibition	%	6.8
	8211702	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	13.55	CHEMBL267	Homo sapiens	Inhibition	%	13.55
	8211831	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	-2.92	CHEMBL267	Homo sapiens	Inhibition	%	-2.92
	8212187	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	5.87	CHEMBL267	Homo sapiens	Inhibition	%	5.87
	8212328	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	5.93	CHEMBL267	Homo sapiens	Inhibition	%	5.93
	8212552	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	0.9	CHEMBL267	Homo sapiens	Inhibition	%	0.9
	8212685	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	11.1	CHEMBL267	Homo sapiens	Inhibition	%	11.1
	8213079	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	64.87	CHEMBL267	Homo sapiens	Inhibition	%	64.87
	8213208	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	3.78	CHEMBL267	Homo sapiens	Inhibition	%	3.78
	8213536	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	74.51	CHEMBL267	Homo sapiens	Inhibition	%	74.51
	8213873	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	7.78	CHEMBL267	Homo sapiens	Inhibition	%	7.78
	8214020	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	1.32	CHEMBL267	Homo sapiens	Inhibition	%	1.32
	8214381	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	7.81	CHEMBL267	Homo sapiens	Inhibition	%	7.81
	8214515	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	8.28	CHEMBL267	Homo sapiens	Inhibition	%	8.28
	8214739	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	78.27	CHEMBL267	Homo sapiens	Inhibition	%	78.27
	8214891	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-4.33	CHEMBL267	Homo sapiens	Inhibition	%	-4.33
	8215142	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	7.15	CHEMBL267	Homo sapiens	Inhibition	%	7.15
	8215519	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	24.74	CHEMBL267	Homo sapiens	Inhibition	%	24.74
	8215683	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	0.52	CHEMBL267	Homo sapiens	Inhibition	%	0.52
	8216026	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	3.75	CHEMBL267	Homo sapiens	Inhibition	%	3.75
	8216145	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	20.27	CHEMBL267	Homo sapiens	Inhibition	%	20.27
	8216369	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	1.66	CHEMBL267	Homo sapiens	Inhibition	%	1.66
	8216505	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	11.18	CHEMBL267	Homo sapiens	Inhibition	%	11.18
	8216867	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	6.35	CHEMBL267	Homo sapiens	Inhibition	%	6.35
	8217001	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	12.47	CHEMBL267	Homo sapiens	Inhibition	%	12.47
	8217225	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	10.22	CHEMBL267	Homo sapiens	Inhibition	%	10.22
	8217399	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	-4.51	CHEMBL267	Homo sapiens	Inhibition	%	-4.51
	8217530	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	8.03	CHEMBL267	Homo sapiens	Inhibition	%	8.03
	8217754	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	3.54	CHEMBL267	Homo sapiens	Inhibition	%	3.54
	8217855	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	0.48	CHEMBL267	Homo sapiens	Inhibition	%	0.48
	8218194	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	0.25	CHEMBL267	Homo sapiens	Inhibition	%	0.25
	8218321	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	4.59	CHEMBL267	Homo sapiens	Inhibition	%	4.59
	8218545	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	64.99	CHEMBL267	Homo sapiens	Inhibition	%	64.99
	8218688	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	40.71	CHEMBL267	Homo sapiens	Inhibition	%	40.71
	8219043	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	90.66	CHEMBL267	Homo sapiens	Inhibition	%	90.66
	8219203	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	1.88	CHEMBL267	Homo sapiens	Inhibition	%	1.88
	8219453	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	-0.33	CHEMBL267	Homo sapiens	Inhibition	%	-0.33
	8219677	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	8.77	CHEMBL267	Homo sapiens	Inhibition	%	8.77
	8219838	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	5.47	CHEMBL267	Homo sapiens	Inhibition	%	5.47
	8220007	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	8.86	CHEMBL267	Homo sapiens	Inhibition	%	8.86
	8220231	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	-1.98	CHEMBL267	Homo sapiens	Inhibition	%	-1.98
	8220360	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	9.14	CHEMBL267	Homo sapiens	Inhibition	%	9.14
	8220698	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	10.05	CHEMBL267	Homo sapiens	Inhibition	%	10.05
	8220836	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	-0.52	CHEMBL267	Homo sapiens	Inhibition	%	-0.52
	8221196	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	-1.17	CHEMBL267	Homo sapiens	Inhibition	%	-1.17
	8221553	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	-3.89	CHEMBL267	Homo sapiens	Inhibition	%	-3.89
	8221718	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	3.93	CHEMBL267	Homo sapiens	Inhibition	%	3.93
	8222073	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	50.12	CHEMBL267	Homo sapiens	Inhibition	%	50.12
	8222171	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-1.52	CHEMBL267	Homo sapiens	Inhibition	%	-1.52
	8222395	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	16.34	CHEMBL267	Homo sapiens	Inhibition	%	16.34
	8222529	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	11.94	CHEMBL267	Homo sapiens	Inhibition	%	11.94
	8222871	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	89.72	CHEMBL267	Homo sapiens	Inhibition	%	89.72
	8223015	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	43.13	CHEMBL267	Homo sapiens	Inhibition	%	43.13
	8223368	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	4.33	CHEMBL267	Homo sapiens	Inhibition	%	4.33
	8223529	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	4.39	CHEMBL267	Homo sapiens	Inhibition	%	4.39
	8223753	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	3.77	CHEMBL267	Homo sapiens	Inhibition	%	3.77
	8224003	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	3.38	CHEMBL267	Homo sapiens	Inhibition	%	3.38
	8224165	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	8.84	CHEMBL267	Homo sapiens	Inhibition	%	8.84
	8224559	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	9.66	CHEMBL267	Homo sapiens	Inhibition	%	9.66
	8224694	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	2.1	CHEMBL267	Homo sapiens	Inhibition	%	2.1
	8225032	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	1.84	CHEMBL267	Homo sapiens	Inhibition	%	1.84
	8225166	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	15.25	CHEMBL267	Homo sapiens	Inhibition	%	15.25
	8225390	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	3.91	CHEMBL267	Homo sapiens	Inhibition	%	3.91
	8225528	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	5.68	CHEMBL267	Homo sapiens	Inhibition	%	5.68
	8225887	CHEMBL1962171	GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	8.5	CHEMBL267	Homo sapiens	Inhibition	%	8.5
	8226045	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-5.2	CHEMBL267	Homo sapiens	Inhibition	%	-5.2
	8226394	CHEMBL1962170	GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	0.36	CHEMBL267	Homo sapiens	Inhibition	%	0.36
inactive	9572453	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CC(=NNC(=N)N)c1cc(NC(=O)c2cccc(C(=O)Nc3cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c3)c2)cc(C(C)=NNC(=N)N)c1		CHEMBL2000685	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
inactive	9572454	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572455	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cc(CO)ccc4F)cc3)c12		CHEMBL1985311	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
inactive	9572456	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9572457	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C1NN=Cc2c[nH]c3cc(NC(=O)C4CC4c4ccccc4)cc1c23		CHEMBL1969502	=	Ki	nM	31.62	CHEMBL267	Homo sapiens	pKi		7.5
inactive	9572458	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2C1CCC(N2CCCC2)CC1		CHEMBL1965910	<	Ki	nM	3162.28	CHEMBL267	Homo sapiens	pKi		5.5
inactive	9572459	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CC(C)Nc1c(-c2ccc3[nH]ncc3c2)nc2ncccn12		CHEMBL1682553	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572460	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1cccc(-c2c(-c3ccncc3)nc(NCC(N)Cc3ccccc3)n(C)c2=O)c1		CHEMBL1971430	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572461	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1ccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)cc1		CHEMBL1997764	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9572462	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1cccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)c1		CHEMBL1983963	=	Ki	nM	630.96	CHEMBL267	Homo sapiens	pKi		6.2
active	9572463	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1n[nH]c2ccc(-c3cncc(OCC(CN)Cc4ccccc4)c3)cc12		CHEMBL2000271	=	Ki	nM	19.95	CHEMBL267	Homo sapiens	pKi		7.7
inactive	9572464	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Oc1ccc(-c2n[nH]c(Nc3cccc(Cl)c3)c2-c2ccc(O)cc2)cc1		CHEMBL1985092	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572465	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2cccs2)c1-c1ccccc1		CHEMBL2004692	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
inactive	9572466	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CNc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc1)CCN2		CHEMBL1981410	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572467	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CC1(O)CC(c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn23)C1		CHEMBL1996234	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572468	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1ccc(C=C2C(=O)ON=C2c2ccc(Br)cc2)cc1OC		CHEMBL1991434	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
inactive	9572469	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CN(C)c1cccc2c(S(=O)(=O)N(CCN)c3cncc(-c4ccc5cnccc5c4)c3)cccc12		CHEMBL1967544	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572470	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	N#Cc1ncc2nc1OCCCCCOc1cc(CCCO)c(Cl)cc1NC(=O)N2		CHEMBL223367	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
active	9572471	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	=	Ki	nM	31.62	CHEMBL267	Homo sapiens	pKi		7.5
inactive	9572472	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	NC(=O)c1cn(-c2ccc(O)cc2Cl)c2cc(-c3ccncc3)ccc2c1=O		CHEMBL340384	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572473	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CC(C)(CO)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1996587	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572474	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CS(=O)(=O)NCCOc1cncc(-c2ccc3cnccc3c2)c1		CHEMBL1964804	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572475	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1ccc(-c2cnc3c(Br)cnn3c2)cc1		CHEMBL443962	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
inactive	9572476	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1ccc(C=C2SC(=Nc3ccccc3)NC2=O)cc1O		CHEMBL2000354	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572477	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1cccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1965507	<	Ki	nM	1584.89	CHEMBL267	Homo sapiens	pKi		5.8
inactive	9572478	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
inactive	9572479	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CCCC(=O)Nc1n[nH]c2nc3ccccc3cc12		CHEMBL1967564	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572480	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	NCCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL592030	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572481	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	OCCCNc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL2000071	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572482	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1ccc2c(NC(=O)Nc3cc(C(F)(F)F)ccn3)ccnc2c1		CHEMBL1979176	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572483	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4c3c(N)nn4C)cc2)c1		CHEMBL1985491	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9572484	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1970317	=	Ki	nM	31.62	CHEMBL267	Homo sapiens	pKi		7.5
inactive	9572485	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1cn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc2c(C)n1		CHEMBL2000408	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572486	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	N#Cc1ncc2nc1OCCCCOc1cc(NCc3cncs3)c(Cl)cc1NC(=O)N2		CHEMBL248757	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572487	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CN1CCC(C(=O)n2nc(N)c3cc(-c4cn(Cc5ccccc5)nn4)ccc32)CC1		CHEMBL1978014	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572488	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C(Nc1cnccn1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1994538	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572489	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	NCCCOc1cc2c(c(-c3ccc(Nc4nc5ccccc5o4)cc3)c1)CNC2=O		CHEMBL1975490	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572490	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL1964444	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572491	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CC(=O)Nc1cc(N)c(C#N)c(-c2ccsc2)n1		CHEMBL2006567	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
inactive	9572492	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Clc1csc2ncnc(Nc3ccccc3)c12		CHEMBL1986139	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572493	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	NC(Cc1cccc2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1985580	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572494	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(Cl)cccc12		CHEMBL1980540	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9572495	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN(C)C)cnc(N)c34)cc2)c1		CHEMBL1979883	=	Ki	nM	398.11	CHEMBL267	Homo sapiens	pKi		6.4
active	9572496	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COCCOC1CCC(n2nc(-c3ccc(Nc4nc5cc(C)cc(C)c5o4)cc3)c3c(N)ncnc32)CC1		CHEMBL1984162	=	Ki	nM	39.81	CHEMBL267	Homo sapiens	pKi		7.4
active	9572497	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Fc1cnc(Nc2ccccc2)nc1Nc1ccccc1		CHEMBL491758	=	Ki	nM	1584.89	CHEMBL267	Homo sapiens	pKi		5.8
inactive	9572498	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)C(C)(C)C		CHEMBL1986186	<	Ki	nM	3981.07	CHEMBL267	Homo sapiens	pKi		5.4
inactive	9572499	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1n[nH]c2c1C(c1ccccc1Cl)C(C#N)=C(N)O2		CHEMBL1970189	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9572500	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Nc1ncnc2c1c(I)nn2C1CCC(O)CC1		CHEMBL1996791	=	Ki	nM	1000.0	CHEMBL267	Homo sapiens	pKi		6.0
active	9572501	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3c(C)sc4ncnc(N)c34)cc2)c1		CHEMBL371206	=	Ki	nM	1000.0	CHEMBL267	Homo sapiens	pKi		6.0
active	9572502	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1ccc(C=NNc2ncnc3c2[nH]c2ccccc23)cc1OC		CHEMBL1974664	=	Ki	nM	50.12	CHEMBL267	Homo sapiens	pKi		7.3
active	9572503	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	=	Ki	nM	158.49	CHEMBL267	Homo sapiens	pKi		6.8
inactive	9572504	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C(NC(CO)c1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1974288	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9572505	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)c1		CHEMBL196363	=	Ki	nM	316.23	CHEMBL267	Homo sapiens	pKi		6.5
inactive	9572506	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1ccc(-c2cc3nccn3c(Nc3ncccc3C(N)=O)n2)cc1OC		CHEMBL1190711	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9572507	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Nc1n[nH]c2cccc(-c3ccc(Br)cc3)c12		CHEMBL1990346	=	Ki	nM	3162.28	CHEMBL267	Homo sapiens	pKi		5.5
inactive	9572508	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CCCC(=O)Nc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3cc(OCCN4CCCC4)ccc3n2)c1		CHEMBL1968705	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572509	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1cccc(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL404367	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572510	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CC(C)Cc1cc(-c2ccc3[nH]nc(N)c3c2)on1		CHEMBL1966343	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572511	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1n[nH]c2ccc(-c3cncc(OCCN)c3)cc12		CHEMBL1967887	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572512	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CC(=O)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL2000568	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572513	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)cc1C		CHEMBL2000335	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9572514	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	=	Ki	nM	501.19	CHEMBL267	Homo sapiens	pKi		6.3
active	9572515	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cn1cc(-c2cnn3c(N)c(-c4ccc(NC(=O)Nc5cccc(C(F)(F)F)c5)cc4)cnc23)cn1		CHEMBL1988717	=	Ki	nM	25.12	CHEMBL267	Homo sapiens	pKi		7.6
active	9572516	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1cccc(Nc2nc(NC3CCCCC3N)cnc2C(N)=O)c1		CHEMBL1974328	=	Ki	nM	158.49	CHEMBL267	Homo sapiens	pKi		6.8
active	9572517	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Ki	nM	25.12	CHEMBL267	Homo sapiens	pKi		7.6
inactive	9572518	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C(Nc1ccc2[nH]ncc2c1)c1ccc(Cl)cc1		CHEMBL1973808	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572519	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CC(C)Oc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2000429	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572520	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1ccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)cc1		CHEMBL1972576	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572521	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572522	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1992342	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572523	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1cc(Cl)ccc1NC(=S)NNC(=O)C(O)(c1ccccc1)c1ccccc1		CHEMBL1988173	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9572524	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	=	Ki	nM	630.96	CHEMBL267	Homo sapiens	pKi		6.2
inactive	9572525	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	N#CC1=C(N)n2c(sc(=Cc3ccco3)c2=O)=C(C(N)=O)C1c1ccco1		CHEMBL1989805	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572526	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CC(C)Cn1c(N)nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL1965423	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9572527	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CCC(N)(C#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12)CC		CHEMBL1983025	=	Ki	nM	1258.93	CHEMBL267	Homo sapiens	pKi		5.9
inactive	9572528	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	NC(Cc1c[nH]c2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1983945	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572529	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C(NCc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1977135	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572530	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C1NC(=S)SC1=C1C(=O)Nc2ccc(Br)cc21		CHEMBL2001920	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572531	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	NC(=O)c1cc2c(-c3cc(C(F)(F)F)cc(C(F)(F)F)c3)cncc2s1		CHEMBL2002322	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
active	9572532	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)c(F)c3)c12		CHEMBL1980904	=	Ki	nM	158.49	CHEMBL267	Homo sapiens	pKi		6.8
active	9572533	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1cc(Nc2ncc([N+](=O)[O-])c(Nc3ccccc3C(N)=O)n2)cc(OC)c1OC		CHEMBL1241473	=	Ki	nM	31.62	CHEMBL267	Homo sapiens	pKi		7.5
active	9572534	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1ccc(F)c(-c2ccc3nnc(N)n3c2)c1		CHEMBL2002323	=	Ki	nM	15.85	CHEMBL267	Homo sapiens	pKi		7.8
active	9572535	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CS(=O)(=O)N(Cc1ccc2[nH]c(=O)c3cccn3c2c1)C1CC1		CHEMBL1978448	=	Ki	nM	1258.93	CHEMBL267	Homo sapiens	pKi		5.9
inactive	9572536	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CCN(CC)CC#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2001257	<	Ki	nM	1258.93	CHEMBL267	Homo sapiens	pKi		5.9
inactive	9572537	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CC(C)(C)OC(=O)n1ncc2cc(Nc3c(NCc4ccc(Cl)cc4Cl)c(=O)c3=O)ccc21		CHEMBL2005548	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9572538	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cncc4[nH]nc(N)c34)cc2)c1		CHEMBL271441	=	Ki	nM	398.11	CHEMBL267	Homo sapiens	pKi		6.4
inactive	9572539	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1ccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)cc1		CHEMBL1992536	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572540	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CCN1CCN(CCCC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1		CHEMBL1992740	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572541	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	OCCCn1cnc(-c2ccccc2)c1-c1ccncc1		CHEMBL2002373	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572542	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1cccc(Cl)c1		CHEMBL1973348	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572543	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2NCCCN)c1		CHEMBL2006188	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572544	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1967531	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572545	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CCCC(=O)Nc1nn(C(=O)CC)c2nc3ccccc3cc12		CHEMBL1970913	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
inactive	9572546	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(C)=O)c3c2)cc1		CHEMBL1973893	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572547	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1cccc(C(C)NC(=O)c2cc(C)c(-c3ccc4[nH]nc(C)c4c3)s2)c1		CHEMBL1997534	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572548	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1996500	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572549	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	NC(=O)Cn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL1985095	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9572550	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1cc(NC(=O)Nc2ccc(-c3ccnc4[nH]nc(N)c34)cc2)ccc1F		CHEMBL273187	=	Ki	nM	251.19	CHEMBL267	Homo sapiens	pKi		6.6
inactive	9572551	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COCc1nnn(-c2nonc2N)c1C(=O)NN=C(C)c1ccc(O)cc1O		CHEMBL1991180	<	Ki	nM	2511.89	CHEMBL267	Homo sapiens	pKi		5.6
active	9572552	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	=	Ki	nM	39.81	CHEMBL267	Homo sapiens	pKi		7.4
inactive	9572553	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)cn2c1		CHEMBL1682540	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9572554	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1cc(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)c(F)c2)ccc1F		CHEMBL1986979	=	Ki	nM	1000.0	CHEMBL267	Homo sapiens	pKi		6.0
active	9572555	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CCc1c(-c2ccc(C(C)(C)O)cc2)[nH]c2nccnc12		CHEMBL1976420	=	Ki	nM	251.19	CHEMBL267	Homo sapiens	pKi		6.6
inactive	9572556	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1		CHEMBL1994864	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572557	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	N#Cc1ncc2nc1OCCCCCOc1cc(OCCO)c(Cl)cc1NC(=O)N2		CHEMBL413779	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
inactive	9572558	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CN1CCN(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCOCC5CC5)c4)n[nH]c2-3)CC1		CHEMBL2002446	<	Ki	nM	1258.93	CHEMBL267	Homo sapiens	pKi		5.9
inactive	9572559	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=c1nc(-c2cc3c(Oc4ccc(I)cc4)cncc3s2)[nH]o1		CHEMBL497151	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572560	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1cc(N2CCN(C)CC2)ccc1C(=O)Nc1n[nH]c2ccc(Cc3cc(F)cc(F)c3)cc12		CHEMBL1973961	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572561	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	NCC1CCC(CNc2nc(NCc3ccccc3Cl)ncc2[N+](=O)[O-])CC1		CHEMBL246970	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572562	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1cc(O)ccc1-n1cc(C(N)=O)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL340921	<	Ki	nM	3162.28	CHEMBL267	Homo sapiens	pKi		5.5
inactive	9572563	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	N#Cc1ncc2nc1OCCCCCOc1cc(OCCCO)c(Cl)cc1NC(=O)N2		CHEMBL373598	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
inactive	9572564	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	N#Cc1ccc(NC(=O)Nc2ccnc3cc(C(F)(F)F)ccc23)nc1		CHEMBL1999718	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9572565	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C1Nc2ccc3ncsc3c2C1=CNc1ccc(S(=O)(=O)Nc2ccccn2)cc1		CHEMBL1973540	=	Ki	nM	158.49	CHEMBL267	Homo sapiens	pKi		6.8
inactive	9572566	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C1Nc2ccccc2Nc2nnc(I)cc21		CHEMBL1977346	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572567	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3ccc4nccnc4c3N)cc2)c1		CHEMBL1971649	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572568	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CC(C)S(=O)(=O)n1c(N)nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL2003657	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9572569	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Ki	nM	158.49	CHEMBL267	Homo sapiens	pKi		6.8
inactive	9572570	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Clc1cc(-c2c[nH]c3ncccc23)nc(NC2CCCCC2)n1		CHEMBL2006439	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572571	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CC(C)N(C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1)C(C)C		CHEMBL2006156	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
active	9572572	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1ccc(-c2ccc(NC(=O)Nc3cc(F)cc(F)c3)cc2)c2c(N)noc12		CHEMBL1969190	=	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572573	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)n[nH]c12		CHEMBL1973937	<	Ki	nM	1584.89	CHEMBL267	Homo sapiens	pKi		5.8
active	9572574	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Ki	nM	6.31	CHEMBL267	Homo sapiens	pKi		8.2
inactive	9572575	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	OC1CCC(Nc2cc(Cl)nc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1991674	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572576	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	NC(=O)c1ccc(-c2c[nH]c3nccc(Cl)c23)cc1		CHEMBL1982711	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572577	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CC(C)COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL1984842	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9572578	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cn[nH]c5)cnc(N)c34)cc2)c1		CHEMBL1969102	=	Ki	nM	12.59	CHEMBL267	Homo sapiens	pKi		7.9
inactive	9572579	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1682346	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572580	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CCN(CC)CC#Cc1ccc2c(c1)-c1[nH]nc(-c3ccc(C#N)nc3)c1C2		CHEMBL2007044	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
inactive	9572581	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CNC(=O)N1CCN(CCCOc2ccc3c(c2)-c2[nH]nc(-c4ccc(C#N)nc4)c2C3)CC1		CHEMBL2001998	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572582	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1cc(C=C(C#N)c2nc3ccccc3[nH]2)c(Br)cc1O		CHEMBL1994241	<	Ki	nM	1584.89	CHEMBL267	Homo sapiens	pKi		5.8
inactive	9572583	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CS(=O)(=O)Nc1cc2c(cc1Cl)NC(=O)Nc1cnc(C#N)c(n1)OCCCCCO2		CHEMBL223460	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
inactive	9572584	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1ccc(Cl)cc1		CHEMBL1998829	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9572585	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Ki	nM	398.11	CHEMBL267	Homo sapiens	pKi		6.4
active	9572586	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1cnc(Nc2cccc(S(N)(=O)=O)c2)nc1Nc1ccc(OCC(N)=O)cc1		CHEMBL1988838	=	Ki	nM	251.19	CHEMBL267	Homo sapiens	pKi		6.6
active	9572587	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CCN1CCN(c2ccc(Nc3nccc(-c4c(-c5cccc(C(=O)Nc6ccccc6F)c5)nc5ccccn45)n3)cc2)CC1		CHEMBL1981725	=	Ki	nM	7.943	CHEMBL267	Homo sapiens	pKi		8.1
inactive	9572588	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]ncc34)cc2)c1		CHEMBL375284	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
inactive	9572589	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COCCn1cc(-c2ccncn2)c(-c2ccc(Cl)cc2)n1		CHEMBL1982866	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572590	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL2005792	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572591	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Nc1c(-c2ccccc2)c2cc(Cl)ccc2[nH]c1=O		CHEMBL462120	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
inactive	9572592	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CCOc1nc(C(=O)NCc2ccncc2)cc(N)c1C#N		CHEMBL1984206	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
inactive	9572593	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)C1CCCCC1		CHEMBL1991577	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9572594	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Nc1ncc(-c2ccoc2)c2scc(-c3ccc(NC(=O)Nc4ccccc4F)cc3)c12		CHEMBL1965570	=	Ki	nM	398.11	CHEMBL267	Homo sapiens	pKi		6.4
inactive	9572595	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccccc4)nn12)CCCC3		CHEMBL2007592	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572596	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1C#N		CHEMBL210963	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572597	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1cncc2cccc(S(=O)(=O)N3CCCNCC3C)c12		CHEMBL1082440	<	Ki	nM	3981.07	CHEMBL267	Homo sapiens	pKi		5.4
inactive	9572598	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C(CO)N1CCC(c2[nH]nc(-c3ccc(Cl)cc3F)c2-c2ccncn2)CC1		CHEMBL1614705	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572599	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CS(=O)(=O)c1ccc(-c2cncc3sc(C(N)=O)cc23)cc1		CHEMBL1972362	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572600	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1cccc(C(C)NC(=O)c2cnc(-c3ccncc3)s2)c1		CHEMBL1984633	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572601	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572602	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1cccc(C(C)NC(=O)N2CC=C(c3c[nH]c4ncccc34)CC2)c1		CHEMBL1965845	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9572603	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C(Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCCC4=O)c3)n2)c1)c1c(F)cccc1F		CHEMBL2006715	=	Ki	nM	12.59	CHEMBL267	Homo sapiens	pKi		7.9
inactive	9572604	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	NC(=O)c1cccc2[nH]c(-c3ccc(NC(=O)c4cccc(S(=O)(=O)N5CCOCC5)c4)cc3)nc12		CHEMBL1986597	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572605	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	NC(=O)c1cc2c(-c3cccc(F)c3)cncc2s1		CHEMBL1971017	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
inactive	9572606	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	NC(=O)c1cccc2[nH]c(-c3ccncc3)nc12		CHEMBL1990482	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572607	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Fc1ccc(-c2nc3cnccn3c2-c2ccnc(NCC3CC3)n2)cc1		CHEMBL1990904	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572608	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C(NCC1CCCCC1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL2005475	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572609	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CCS(=O)(=O)c1ccc(-c2cncc3sc(C(N)=O)cc23)cc1		CHEMBL2000104	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572610	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2C)c1		CHEMBL183844	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572611	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL220057	<	Ki	nM	1258.93	CHEMBL267	Homo sapiens	pKi		5.9
inactive	9572612	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	c1ccc(Nc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682545	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572613	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	NC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1974935	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572614	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1cc(OC2CCCC2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL2001224	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572615	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572616	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CC(C)(O)Cc1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1976732	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572617	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CC(C)(C)OC(=O)n1ncc2cc(Nc3c(NCc4ccc(S(N)(=O)=O)cc4)c(=O)c3=O)ccc21		CHEMBL1969506	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572618	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C(NC(CO)c1ccccc1)N1CC=C(c2c[nH]c3ncccc23)CC1		CHEMBL1964937	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572619	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	c1ccc(COc2ccc(Nc3ncnc4ccccc34)cc2)cc1		CHEMBL1980163	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572620	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	NCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL590109	<	Ki	nM	3162.28	CHEMBL267	Homo sapiens	pKi		5.5
active	9572621	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1cc(-c2nn(C3CCC(N4CCN(C(C)=O)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL1970879	=	Ki	nM	3.162	CHEMBL267	Homo sapiens	pKi		8.5
active	9572622	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1c(C=O)c(O)n2c(nc3ccccc32)c1C#N		CHEMBL1989856	=	Ki	nM	1584.89	CHEMBL267	Homo sapiens	pKi		5.8
inactive	9572623	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CC(=O)N(c1ccncc1)c1c(NC(C)C(C)(C)C)c(=O)c1=O		CHEMBL2005899	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572624	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)c(NC3CCCCC3)n2c1		CHEMBL1682552	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572625	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
inactive	9572626	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(Cl)c4)c3)cc12		CHEMBL1974870	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572627	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CCCc1cc(-c2ccc3[nH]ncc3c2)on1		CHEMBL1682359	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9572628	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1cc(C)c(C=C2C(=O)Nc3ccccc32)[nH]1		CHEMBL2002702	=	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572629	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL1970903	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572630	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	NC(COc1cncc(C=Cc2ccncc2)c1)Cc1ccccc1		CHEMBL1991846	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9572631	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1cccc(Nc2nccc(Nc3c(NC(C)C(C)(C)C)c(=O)c3=O)n2)c1		CHEMBL1969523	=	Ki	nM	3981.07	CHEMBL267	Homo sapiens	pKi		5.4
inactive	9572632	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1cc(C=O)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL207995	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572633	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C1Nc2cc(CCOc3ccc(N4CCOCC4)cc3)ccc2Nc2cc(-c3cn(Cc4cc(F)c(F)c(F)c4)c4cnccc34)ccc21		CHEMBL2001923	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572634	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CC(=O)N1CCC(Nc2nccc(-c3c(-c4ccc(F)cc4)nc4occn34)n2)CC1		CHEMBL1986781	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572635	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=c1nc(-c2ccc3[nH]ncc3c2)cc(-c2ccccc2)[nH]1		CHEMBL526133	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9572636	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cn1nc(N)c2c(-c3ccc(NC(=O)Nc4ccc(F)c(C(F)(F)F)c4)cc3)ccnc21		CHEMBL1966836	=	Ki	nM	1258.93	CHEMBL267	Homo sapiens	pKi		5.9
inactive	9572637	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc21		CHEMBL1230122	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572638	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3[nH]2)cc1		CHEMBL1979057	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572639	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1cc(-c2ccc3c(c2)Nc2ccc(CCOc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1OCC(O)CO		CHEMBL1981045	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
inactive	9572640	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COCCOCC#Cc1cc(-c2n[nH]c3c2C(=O)c2cc(CN4CCN(C)CC4)ccc2-3)cs1		CHEMBL387971	<	Ki	nM	1584.89	CHEMBL267	Homo sapiens	pKi		5.8
inactive	9572641	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	c1ccc(Cn2nnc(-c3ccc4[nH]ncc4c3)c2C2CC2)cc1		CHEMBL1975418	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572642	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=c1[nH]c2ccc(Cl)cc2c(-c2ccccc2)c1C1=NNC(c2ccccc2)C1		CHEMBL1992796	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
inactive	9572643	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1999428	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572644	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	N#Cc1ncc2nc1OCCCCCOc1cc(OCC(O)CO)c(Cl)cc1NC(=O)N2		CHEMBL223257	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
inactive	9572645	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CCN1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1967560	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9572646	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Ki	nM	501.19	CHEMBL267	Homo sapiens	pKi		6.3
inactive	9572647	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1cccc(NC(=O)Nc2ccc(-c3noc4ncnc(N)c34)cc2)c1		CHEMBL211378	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
active	9572648	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCOCC5)cnc(N)c34)cc2)c1		CHEMBL1982465	=	Ki	nM	630.96	CHEMBL267	Homo sapiens	pKi		6.2
active	9572649	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	NC(COc1cncc(-c2ccc3c(c2)C(=Cc2ccco2)C(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL2001751	=	Ki	nM	398.11	CHEMBL267	Homo sapiens	pKi		6.4
inactive	9572650	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C(NCCCCCCNC(=O)NCc1cccnc1)NCc1cccnc1		CHEMBL2003420	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572651	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1ccccc1NC(=O)Nc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL1984586	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9572652	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1cccc(NC(=O)Nc2ccc(-c3cncc4[nH]nc(N)c34)cc2)c1		CHEMBL272938	=	Ki	nM	251.19	CHEMBL267	Homo sapiens	pKi		6.6
inactive	9572653	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1c(O)ccc2c1CCCC2=NNC(=O)Cc1cccc2ccccc12		CHEMBL1972659	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
inactive	9572654	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	OC1CCN(c2ncnc3[nH]cc(-c4ccccc4)c23)CC1		CHEMBL1973395	<	Ki	nM	3981.07	CHEMBL267	Homo sapiens	pKi		5.4
inactive	9572655	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1ccc(NC(=O)Nc2ccc(-c3cccc4onc(N)c34)cc2)cc1Cl		CHEMBL272453	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572656	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3C)cc2)c1		CHEMBL1970217	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572657	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C1Nc2ccccc2Nc2nnccc21		CHEMBL1971801	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
inactive	9572658	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C1Nc2ccccc2Nc2nnc(Cl)cc21		CHEMBL1968850	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
inactive	9572659	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CCOC(=O)c1ccc2[nH]c3c(c2c1)CCNC3=O		CHEMBL2005528	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572660	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)c1		CHEMBL185569	<	Ki	nM	3981.07	CHEMBL267	Homo sapiens	pKi		5.4
inactive	9572661	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	c1cc2[nH]ncc2cc1-c1cn(CC2CCOCC2)nn1		CHEMBL1969843	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572662	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1cc(-c2ccc3[nH]nc(C(=O)Nc4ccccc4)c3c2)ccc1O		CHEMBL2007002	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572663	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572664	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CN1CCC(NC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)CC1		CHEMBL1987007	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9572665	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Clc1cc(-c2c[nH]c3ncccc23)cc(NCc2ccccc2)n1		CHEMBL1969588	=	Ki	nM	79.43	CHEMBL267	Homo sapiens	pKi		7.1
active	9572666	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1cc(Nc2ncc(F)c(NC3C4C=CC(C4)C3C(N)=O)n2)ccc1N1CCN(C)CC1		CHEMBL1967878	=	Ki	nM	10.0	CHEMBL267	Homo sapiens	pKi		8.0
active	9572667	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1cc(Nc2nccc(Nc3cc(C4CCCCC4)no3)n2)cc(OC)c1OC		CHEMBL1984711	=	Ki	nM	50.12	CHEMBL267	Homo sapiens	pKi		7.3
inactive	9572668	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572669	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CCCCn1c(NC(=O)c2ccc(C#N)cc2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL484390	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572670	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=c1c(NCc2cccc(C(F)(F)F)c2)c(Nc2ccncc2)c1=O		CHEMBL1979252	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572671	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	c1ccc(Cc2cn(-c3ccc4[nH]ncc4c3)nn2)cc1		CHEMBL1682341	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9572672	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)(C)O)c5)cnc(N)c34)cc2)cc1		CHEMBL2004290	=	Ki	nM	63.1	CHEMBL267	Homo sapiens	pKi		7.2
inactive	9572673	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccc(F)cc3)cc12		CHEMBL1986499	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572674	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1cccc(C=C2SC(=Nc3ccccc3)NC2=O)c1		CHEMBL1972937	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572675	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	C#Cc1cc2c(cc1OC)-c1[nH]nc(-c3ccc(C#N)nc3)c1C2		CHEMBL1972250	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
active	9572676	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=c1[nH]c2cnc(-n3cnc4ccc(F)cc43)nc2n1C1CCOc2c(F)cccc21		CHEMBL2000393	=	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9572677	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Nc1n[nH]c2nccc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL403402	=	Ki	nM	316.23	CHEMBL267	Homo sapiens	pKi		6.5
inactive	9572678	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C)c2)c1		CHEMBL2004311	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572679	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Brc1cnc2[nH]cc(-c3ccccc3)c2c1		CHEMBL1992634	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572680	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1242373	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572681	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1ccc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1988075	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572682	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Fc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL316264	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572683	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1991678	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572684	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Nc1ncnc(Nc2cc(CNC(=O)C(F)(F)F)c(O)c(-c3ccc(Cl)cc3)c2)n1		CHEMBL2001239	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
inactive	9572685	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Nc1ncnc2scc(C(=O)Nc3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1988594	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9572686	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Nc1ncnc2c1c(I)nn2C1OC(CO)C(O)C1O		CHEMBL2001288	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9576273	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Nc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc1)CCN2		CHEMBL260092	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
active	9576274	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	=	Ki	nM	125.89	CHEMBL267	Homo sapiens	pKi		6.9
inactive	9576275	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C(NN=Cc1ccc(O)cc1O)Nc1cccc2nsnc12		CHEMBL1999811	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9576276	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1n[nH]c2ncc(C#N)c(-c3ccccc3)c12		CHEMBL1965495	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
inactive	9576277	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CSc1ccc2nc3c(c(Cl)c2c1)CCNC3=O		CHEMBL1985074	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9576278	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Nc1nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc2n1CC1CC1		CHEMBL1982874	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9576279	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	NCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1		CHEMBL2000481	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9576280	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CN(C)CC(=O)NC(COc1cncc(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1991725	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9576281	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4sncc34)cc2)c1		CHEMBL1992242	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
inactive	9576282	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CCCOc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL2007296	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9576283	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc3[nH]ncc3c2)n1		CHEMBL396523	=	Ki	nM	1258.93	CHEMBL267	Homo sapiens	pKi		5.9
inactive	9576284	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL208637	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
inactive	9576285	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1cc(C)cc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1970203	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9576286	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C(c1cc(Cc2n[nH]c(=O)c3c2CCCC3)ccc1F)N1CCN(c2ncccn2)CC1		CHEMBL1986530	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9576287	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=c1c(NCCc2ccc(Oc3ccccc3)cc2)c(Nc2ccncc2)c1=O		CHEMBL1999321	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9576288	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4sc(C)nc4c3)csc12		CHEMBL1968590	=	Ki	nM	630.96	CHEMBL267	Homo sapiens	pKi		6.2
active	9576289	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1cc(Nc2ncnc3ccc(-c4ccc(CN5CC6C(CO)C6C5)cc4)cc23)ccc1Oc1ccccc1		CHEMBL1999749	=	Ki	nM	398.11	CHEMBL267	Homo sapiens	pKi		6.4
inactive	9576290	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCCCC4)cc3OC)nc2N1C1CCCC1		CHEMBL2005375	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9576291	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Clc1ccc(-c2n[nH]cc2-c2ccncn2)cc1Cl		CHEMBL1984191	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9576292	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1cc(C(=O)O)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL1983006	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9576293	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(N3CCN(C(C)=O)CC3)ccc2OC)ncc1Br		CHEMBL1971029	=	Ki	nM	79.43	CHEMBL267	Homo sapiens	pKi		7.1
inactive	9576294	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12		CHEMBL394790	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9576295	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C1NCCc2[nH]c(-c3ccnc(-c4ccccc4F)c3)cc21		CHEMBL226471	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
inactive	9576296	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1nc2c(sc3c(Br)ccc(Cl)c32)c(=O)o1		CHEMBL1974702	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9576297	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1996111	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9576298	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1nccn2c(-c3ccnc(NCC4(O)CC4)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1965589	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9576299	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C(NCCCCCCNC(=O)Nc1cccnc1)Nc1cccnc1		CHEMBL1998193	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9576300	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)O)s3)c2cc1OC		CHEMBL474432	=	Ki	nM	1584.89	CHEMBL267	Homo sapiens	pKi		5.8
inactive	9576301	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1nnc(-c2cc3c(Oc4ccc(C(F)(F)F)cc4)cncc3s2)o1		CHEMBL1988153	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9576302	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	=	Ki	nM	199.53	CHEMBL267	Homo sapiens	pKi		6.7
inactive	9576303	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	N#Cc1ccc2[nH]c(O)c(-c3ccc(CN4CCOCC4)cn3)c2c1		CHEMBL1969664	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9576304	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	NC(=O)c1cc2c(-c3ccccc3)cncc2s1		CHEMBL1999556	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
inactive	9576305	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CNC(=O)c1ccccc1Sc1ccc2c(C=Cc3ccccn3)n[nH]c2c1		CHEMBL1988437	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9576306	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	NC(COc1cc(C=Cc2ccncc2)cnc1Cl)Cc1c[nH]c2ccccc12		CHEMBL1968245	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9576307	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	NCCC(C(=O)Nc1ccc2[nH]ncc2c1)c1ccc(Cl)c(Cl)c1		CHEMBL1998121	=	Ki	nM	398.11	CHEMBL267	Homo sapiens	pKi		6.4
active	9576308	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CC(C)(C)N)cnc(N)c34)cc2)c1		CHEMBL1979577	=	Ki	nM	398.11	CHEMBL267	Homo sapiens	pKi		6.4
inactive	9576309	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(CC4CC4)nccn23)n1		CHEMBL1991800	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9576310	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CCC(CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL52387	<	Ki	nM	3981.07	CHEMBL267	Homo sapiens	pKi		5.4
inactive	9576311	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1nn(-c2ccccc2)c2c1c(=O)c1cc(Cl)ccc1n2O		CHEMBL379835	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
inactive	9576312	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cn1cc(C(CN)c2cncc(C=Cc3ccncc3)c2)c2ccccc21		CHEMBL1979357	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9576313	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	N#Cc1ncc2nc1OCC(O)C(O)COc1ccc(Cl)cc1NC(=O)N2		CHEMBL1980802	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
inactive	9576314	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=c1c(NCc2ccc(Cl)cc2Cl)c(Nc2ccc3[nH]ncc3c2)c1=O		CHEMBL1979554	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9576315	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CCCCOc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1996817	<	Ki	nM	1000.0	CHEMBL267	Homo sapiens	pKi		6.0
active	9576316	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4onc(N)c34)cc2)c1		CHEMBL409349	=	Ki	nM	398.11	CHEMBL267	Homo sapiens	pKi		6.4
inactive	9576317	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CCOc1nc(C(=O)NCc2ccc(S(N)(=O)=O)cc2)cc(N)c1C#N		CHEMBL2004355	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
active	9576318	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	=	Ki	nM	316.23	CHEMBL267	Homo sapiens	pKi		6.5
inactive	9576319	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CCn1c2cc(Cl)c(F)cc2c(=O)c2c(=O)o[nH]c21		CHEMBL468280	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9576320	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1cc(C)c2oc(Nc3ccc(-c4cccc(C(N)=O)c4N)cc3F)nc2c1		CHEMBL1990884	=	Ki	nM	158.49	CHEMBL267	Homo sapiens	pKi		6.8
active	9576321	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2C(=O)Nc3ccc(F)cc32)c1C		CHEMBL1990885	=	Ki	nM	630.96	CHEMBL267	Homo sapiens	pKi		6.2
inactive	9576322	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL256835	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9576323	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1980142	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9576324	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CN(C)CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12		CHEMBL41783	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9576325	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Nc1c(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccc2nccnc12		CHEMBL2004438	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
inactive	9576326	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1cccc2c1Nc1cc(Nc3ccncc3)ccc1C(=O)N2		CHEMBL2006276	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9576327	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)noc12		CHEMBL271381	<	Ki	nM	1584.89	CHEMBL267	Homo sapiens	pKi		5.8
inactive	9576328	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1ccc(C(=O)Nc2c(C#N)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL2006785	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9576329	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1		CHEMBL1982466	=	Ki	nM	25.12	CHEMBL267	Homo sapiens	pKi		7.6
active	9576330	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)c(F)c2)c1		CHEMBL1994638	=	Ki	nM	1000.0	CHEMBL267	Homo sapiens	pKi		6.0
inactive	9576331	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1cc(-c2ccc3c(c2)Nc2ccc([N+](=O)[O-])cc2NC3=O)ccc1O		CHEMBL1995740	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9576332	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cn1nc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)ccnc21		CHEMBL1985888	=	Ki	nM	794.33	CHEMBL267	Homo sapiens	pKi		6.1
inactive	9576333	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C(O)c1cc2c(-c3ccccc3)cncc2s1		CHEMBL1996390	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
inactive	9576334	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9576335	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CC1CCN(C(=O)CC#N)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL234085	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9576336	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1995832	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9576337	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Oc1ccc(Nc2[nH]nc(-c3ccc(O)cc3)c2-c2ccc(O)cc2)cc1		CHEMBL1969042	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9576338	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1cc(C=C(C#N)c2nc3cc(C)ccc3[nH]2)c(Br)cc1O		CHEMBL2000345	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9576339	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1ccccc1		CHEMBL1999931	=	Ki	nM	630.96	CHEMBL267	Homo sapiens	pKi		6.2
inactive	9576340	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=c1[nH]sc2c1c(=O)c1cc(F)c(NCc3ccccc3)c(F)c1n2C1CC1		CHEMBL1991640	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9576341	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1ccc(CNc2ccc3nnc(-c4ccccc4)n3n2)cc1		CHEMBL1375418	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9576342	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
inactive	9576343	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1[nH]c(C=C2C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL2007064	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
active	9576344	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COC(C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL1981047	=	Ki	nM	5.012	CHEMBL267	Homo sapiens	pKi		8.3
inactive	9576345	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccc(Cl)c(Cl)c4)c3)cc12		CHEMBL1991063	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9576346	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1cccc(C(CN)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1976240	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9576347	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1ccc(-c2ccc(NC(=O)Nc3ccc(F)c(C)c3)cc2)c2c(N)noc12		CHEMBL1979093	=	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9576348	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=c1[nH]c2sccc2c2nc(-c3ccncc3)nn12		CHEMBL1968151	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9576349	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Clc1ccc(CNc2ccc3nnc(-c4ccccc4)n3n2)cc1		CHEMBL1381197	=	Ki	nM	398.11	CHEMBL267	Homo sapiens	pKi		6.4
inactive	9576350	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1cccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)c1		CHEMBL1987009	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9576351	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccccc4)c3)cc12		CHEMBL2002726	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9576352	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C(Nc1cnccn1)Nc1ccnc2cc(C(F)(F)F)ccc12		CHEMBL2003817	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
inactive	9576353	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ncccc2N1		CHEMBL336961	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9576354	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Nc1nnc(-c2cc3c(Oc4ccc(Cl)cc4)cncc3s2)o1		CHEMBL1994830	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9576355	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COCCOC1CCC(n2nc(-c3ccc(Nc4nc5cc(C)cc(Cl)c5o4)cc3)c3c(N)ncnc32)CC1		CHEMBL1987054	=	Ki	nM	63.1	CHEMBL267	Homo sapiens	pKi		7.2
active	9576356	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Nc1ncc(-c2ccncc2)c2scc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL1970083	=	Ki	nM	63.1	CHEMBL267	Homo sapiens	pKi		7.2
inactive	9576357	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C1NCCc2[nH]c(-c3ccnc(-c4cnc5ccccc5c4)c3)cc21		CHEMBL226403	<	Ki	nM	3981.07	CHEMBL267	Homo sapiens	pKi		5.4
active	9576358	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cc(C)ccc4F)cc3)csc12		CHEMBL2005631	=	Ki	nM	25.12	CHEMBL267	Homo sapiens	pKi		7.6
active	9576359	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Nc1ncc(C=CC(=O)NCCCn2ccnc2)c2scc(-c3ccc(Br)cc3)c12		CHEMBL1994938	=	Ki	nM	0.7943	CHEMBL267	Homo sapiens	pKi		9.1
inactive	9576360	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9576361	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CCCC(=O)Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1977223	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9576362	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CC(C)(C)C(=O)Oc1ccc2c(c1)nc(NC(=O)c1cccc([N+](=O)[O-])c1)n2CCCO		CHEMBL1236126	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
inactive	9576363	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	NCCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1		CHEMBL1966279	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9576364	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Clc1cc(NC2CCCCC2)nc(-c2c[nH]c3ncccc23)n1		CHEMBL1997846	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9576365	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CC(C)Cn1c(N)nc2c(F)cc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL2004419	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9576366	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CC(=NNC(=N)N)c1cc(NC(=O)NCCCCCCNC(=O)Nc2cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c2)cc(C(C)=NNC(=N)N)c1		CHEMBL1991728	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
inactive	9576367	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	NC(=O)c1cc2c(-c3ccc(F)cc3F)cncc2s1		CHEMBL1975787	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
inactive	9576368	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1cc(C=C(C#N)c2n[nH]c(N)c2C#N)ccc1O		CHEMBL2002407	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
inactive	9576369	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C(Nc1ccc2cn[nH]c2c1)c1ccc(Cl)cc1		CHEMBL1972489	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9576370	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Brc1ccc2[nH]nc(-c3ccccc3)c2c1		CHEMBL1994074	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9576371	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1ccc(Nc2nc3ccc([N+](=O)[O-])cc3[nH]2)nc1		CHEMBL1992937	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
inactive	9576372	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1cc(-c2ccc3c(c2)Nc2ccc(CCOc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1CC#N		CHEMBL1985566	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
inactive	9576373	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C(Nc1cccc(N2CCOCC2)n1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1972119	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9576374	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CN(C)C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1		CHEMBL1986328	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9576375	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL95692	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9576376	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)c1		CHEMBL1090356	<	Ki	nM	1584.89	CHEMBL267	Homo sapiens	pKi		5.8
inactive	9576377	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C(Nc1cnccn1)Nc1ccnc2ccc(C(F)(F)F)cc12		CHEMBL1976455	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9576378	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(C=Cc3ccccc3)n2)n[nH]1		CHEMBL1983923	=	Ki	nM	15.85	CHEMBL267	Homo sapiens	pKi		7.8
inactive	9576379	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	c1ccc(CNc2nc3ccc(-c4ccncc4)cc3s2)cc1		CHEMBL1983534	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9576380	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=c1c(NCc2ccccc2F)c(Nc2ccncc2)c1=O		CHEMBL1982361	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9576381	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CCOC(=O)C1=c2sc(=Cc3ccco3)c(=O)n2C(N)=C(C#N)C1c1ccco1		CHEMBL1999112	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9576382	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	OCCC(Nc1nc2ccc(-c3ccncc3)cc2s1)c1ccccc1		CHEMBL1982122	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9576383	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C(Nc1ccc(-c2cccc3sncc23)cc1)Nc1ccc(F)c(C(F)(F)F)c1		CHEMBL2000801	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9576384	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	c1ccc(CNc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682546	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9576385	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1991395	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9576386	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CN1CCN(c2cccc(Nc3nccc(-c4c(C(N)=O)nc5ccccn45)n3)c2)CC1		CHEMBL1971245	=	Ki	nM	1584.89	CHEMBL267	Homo sapiens	pKi		5.8
inactive	9576387	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL1987648	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9576388	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CCOC(=O)c1cn(-c2ccc(O)cc2C)c2cc(-c3ccncc3)ccc2c1=O		CHEMBL1996780	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
inactive	9576389	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C(NCc1ccccc1)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL1972142	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9576390	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Nc1ncc(-c2ccoc2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1966514	=	Ki	nM	501.19	CHEMBL267	Homo sapiens	pKi		6.3
inactive	9576391	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CCCCCCCCCCCCOc1ccc(NC(=N)N)cc1NC(=N)N		CHEMBL1980715	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
active	9576392	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1cccc(F)c1		CHEMBL2003638	=	Ki	nM	794.33	CHEMBL267	Homo sapiens	pKi		6.1
active	9576393	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Ki	nM	1000.0	CHEMBL267	Homo sapiens	pKi		6.0
inactive	9576394	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	N#Cc1ccc2nc(N)n(-c3nc(-c4ccccc4)cs3)c2c1		CHEMBL1996066	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9576395	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	NC(COc1cncc(-c2cc3ccncc3s2)c1)Cc1c[nH]c2ccccc12		CHEMBL1966524	<	Ki	nM	2511.89	CHEMBL267	Homo sapiens	pKi		5.6
inactive	9576396	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cc(C(=O)O)ccc4F)cc3)c12		CHEMBL1993722	<	Ki	nM	6309.57	CHEMBL267	Homo sapiens	pKi		5.2
inactive	9576397	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=c1[nH]c2sc3c(c2c2nc(-c4cccnc4)nn12)CCCC3		CHEMBL1970806	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9576398	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1nc(COc2ccccc2Cl)sc1-c1ccnc(N)n1		CHEMBL1375640	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9576399	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12		CHEMBL1979970	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9576400	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCN4CCOCC4)cc2-3)cn1		CHEMBL249282	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
inactive	9576401	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CC(C)(C)NC(=O)c1ccc2nc3[nH]c4ccccc4c3nc2c1		CHEMBL1969264	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
inactive	9576402	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	N#Cc1c(O)[nH]c(=O)c2c(=N)oc3ccc(Cl)cc3c12		CHEMBL1973711	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
active	9576403	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CN1CCN(CCCNc2cccc(-c3nc4c(C(N)=O)cccc4[nH]3)n2)CC1		CHEMBL2006237	=	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9576404	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CC(C)(C(N)=O)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1967720	=	Ki	nM	100.0	CHEMBL267	Homo sapiens	pKi		7.0
inactive	9576405	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	NC1C2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)CC12		CHEMBL1624529	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9576406	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Nc1nccn2c(C3CC(CN4CCCC4)C3)nc(-c3cccc(OCc4ccccc4)c3)c12		CHEMBL1991138	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9576407	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1F		CHEMBL1969755	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9576408	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)csc12		CHEMBL1979516	=	Ki	nM	100.0	CHEMBL267	Homo sapiens	pKi		7.0
inactive	9576409	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CC(N)C1CCC(C(=O)Nc2ccncc2)CC1		CHEMBL1994526	<	Ki	nM	7943.28	CHEMBL267	Homo sapiens	pKi		5.1
inactive	9576410	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CC(C)OC1=NNC(=O)C1=Cc1c[nH]c2ccccc12		CHEMBL1989029	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9576411	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CSc1ccccc1CNc1ncc([N+](=O)[O-])c(NCC2CCC(CN)CC2)n1		CHEMBL392642	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9576412	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)c(F)c3)c12		CHEMBL2000652	=	Ki	nM	501.19	CHEMBL267	Homo sapiens	pKi		6.3
active	9576413	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
inactive	9576414	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CN(C)CC(=O)Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1965631	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9576415	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1ccccc1NC(=O)Nc1ccc(NC(=O)c2csc3ncnc(N)c23)cc1		CHEMBL1980144	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9576416	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3F)cc2OC)c1		CHEMBL1991188	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9576417	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CC(C)(CO)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1972849	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9576418	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CCOc1nc(C(=O)NCc2ccccc2S(N)(=O)=O)cc(N)c1C#N		CHEMBL377408	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9576419	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9576420	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL231209	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9576421	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Br)c4)cc3)c12		CHEMBL1976220	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9576422	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1ccc(C(=O)Nc2ccon2)cc1Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL259922	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9576423	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(CCN)nccn23)n1		CHEMBL1982383	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9576424	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CCCCn1c(NC(=O)c2cccc(C#N)c2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL1969301	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9576425	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CSc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17370	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9576426	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4ccccc4C(F)(F)F)cc3)c12		CHEMBL1987910	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9576427	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1cc(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)ccc1F		CHEMBL374044	=	Ki	nM	316.23	CHEMBL267	Homo sapiens	pKi		6.5
inactive	9576428	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1ccc2c(NC(=O)Nc3cccc(Br)n3)ccnc2c1		CHEMBL1983932	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9576429	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cn1nc(N)c2c(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cncc21		CHEMBL404366	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9576430	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1980297	=	Ki	nM	31.62	CHEMBL267	Homo sapiens	pKi		7.5
inactive	9576431	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	c1ccc2c(c1)nnn2Cc1cn(-c2ccc3[nH]ncc3c2)nn1		CHEMBL1966069	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9576432	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	<	Ki	nM	630.96	CHEMBL267	Homo sapiens	pKi		6.2
inactive	9576433	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1cc2cc(-c3csc4c(-c5cccc(S(C)(=O)=O)c5)cnc(N)c34)ccc2[nH]1		CHEMBL1997822	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9576434	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1cc(OCC2CCC(C(=O)O)C2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL1991285	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9576435	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C(O)c1ccccc1Nc1ccnc(Nc2cccc(O)c2)n1		CHEMBL243088	=	Ki	nM	630.96	CHEMBL267	Homo sapiens	pKi		6.2
inactive	9576436	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1cc(-c2ccc3c(c2)NC(=O)c2ccc(-c4ccccc4NS(C)(=O)=O)cc2N3)cc(OC)c1OC		CHEMBL1984038	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9576437	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1cccc(F)c1F		CHEMBL1974416	=	Ki	nM	316.23	CHEMBL267	Homo sapiens	pKi		6.5
active	9576438	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1cc2c(cc1F)C(c1ccccc1Cl)=Nc1c(n[nH]c1C)N2		CHEMBL1980391	=	Ki	nM	125.89	CHEMBL267	Homo sapiens	pKi		6.9
inactive	9576439	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C(c1cccc(-c2cnc3[nH]ccc3c2)c1)N1CCOCC1		CHEMBL1997872	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9625647	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1cccc(-c2[nH]c(-c3ccnc(N)n3)cc2C(N)=O)c1C		CHEMBL1964290	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9625648	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Nc1ncnc2onc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL213505	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9625649	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9625650	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	N#CCOc1ccc(Nc2nc(Nc3cccc(S(N)(=O)=O)c3)ncc2Br)cc1		CHEMBL1987034	=	Ki	nM	158.49	CHEMBL267	Homo sapiens	pKi		6.8
active	9625651	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CCCn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1993941	=	Ki	nM	31.62	CHEMBL267	Homo sapiens	pKi		7.5
inactive	9625652	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1Cl		CHEMBL377383	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9625653	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1cc(N2CCOCC2)cc2[nH]c(-c3c(NCC(O)c4cccc(Cl)c4)cc[nH]c3=O)nc12		CHEMBL2005886	=	Ki	nM	7.943	CHEMBL267	Homo sapiens	pKi		8.1
inactive	9625654	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL481491	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9625655	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	c1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)cc1		CHEMBL1682345	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
inactive	9625656	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CC(=O)Nc1c(C(N)=O)sc2ccc(Cl)c(Cl)c12		CHEMBL1973142	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9625657	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4nc(N)nc(N)c34)cc2)c1		CHEMBL1973145	<	Ki	nM	3981.07	CHEMBL267	Homo sapiens	pKi		5.4
inactive	9625658	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1cccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982924	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9625659	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CCCC(=O)Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL2005936	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9625660	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	NC1CCC(Nc2nccc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1966628	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9625661	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc(C(N)=O)c3)cc2)c1		CHEMBL1971141	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9625662	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	NC1CCCCC1Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL1995813	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9625663	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1c(C)n(Cc2ccccc2)c2ccc(C(=O)Nc3nc[nH]n3)cc12		CHEMBL1979718	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
inactive	9625664	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CCn1c2cc(Cl)c(O)cc2c(=O)c2c(=O)o[nH]c21		CHEMBL523823	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9625665	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1ccc(-c2ccc(NC(=O)Nc3ccc(OC(F)(F)F)cc3)cc2)c2c(N)noc12		CHEMBL1973178	=	Ki	nM	125.89	CHEMBL267	Homo sapiens	pKi		6.9
active	9625666	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc3cn[nH]c3c2)n1		CHEMBL244378	=	Ki	nM	794.33	CHEMBL267	Homo sapiens	pKi		6.1
active	9625667	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)c(F)c2)c1		CHEMBL1988778	=	Ki	nM	501.19	CHEMBL267	Homo sapiens	pKi		6.3
inactive	9625668	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(OCC(F)(F)F)nccn23)n1		CHEMBL2001957	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9625669	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COCCNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1969372	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9625670	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Nc1ncnn2ccc(C(=O)Nc3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1990583	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9625671	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9625672	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1nc2ccc(NS(=O)(=O)c3ccc(N)cc3)cc2nc1C		CHEMBL2006263	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9625673	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	OC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1993584	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9625674	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CCn1c(C)c(-c2ccnc(Nc3cccc(OC)c3)n2)sc1=O		CHEMBL1986263	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9625675	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CSc1c[nH]c2ncnc(NCCCO)c12		CHEMBL2000114	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9625676	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
inactive	9625677	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C(Nc1cnccn1)Nc1ccnc2c(F)cccc12		CHEMBL1975647	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9625678	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1968380	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9625679	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C(NCc1ccccc1)Nc1ncc([N+](=O)[O-])s1		CHEMBL1964644	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9625680	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C(NCc1ccc(Cl)c(Cl)c1)Nc1ccc2[nH]ncc2c1		CHEMBL1981782	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9625681	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CNC(=O)c1cc2c(-c3ccccc3F)n[nH]c2s1		CHEMBL1977681	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9625682	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CNC(=O)C(C)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(C)cc5)cc4)csc23)cn1		CHEMBL1970142	=	Ki	nM	15.85	CHEMBL267	Homo sapiens	pKi		7.8
inactive	9625683	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
inactive	9625684	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	OCCNc1cc2cc(-c3cccnc3)ccc2cn1		CHEMBL1990912	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9625685	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
active	9629243	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	NS(=O)(=O)c1cccc(Nc2ncc3ccn(-c4ccccc4)c3n2)c1		CHEMBL1988163	=	Ki	nM	125.89	CHEMBL267	Homo sapiens	pKi		6.9
inactive	9629244	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1cc(O)ccc1-n1c2cc(Cl)ccc2c(=O)c2c(N)nc(N)nc21		CHEMBL1995592	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
inactive	9629245	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C1CCCc2oc3cc(C(F)(F)F)ccc3c(=O)c21		CHEMBL2006493	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629246	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Clc1cc2nn[nH]c2cc1Cl		CHEMBL1996923	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
inactive	9629247	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1C		CHEMBL1983449	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629248	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=c1[nH]cnc2c1oc1ccc(Cl)cc12		CHEMBL1992323	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629249	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(Cl)nccn23)n1		CHEMBL1969735	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629250	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CCc1nc2c(c3cc(OC)c(OC)cc13)C(=O)NC2=O		CHEMBL2003524	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
inactive	9629251	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1ccc2c(c1)C(=Cc1c[nH]cn1)C(=O)N2		CHEMBL2002649	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629252	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CCCn1c(C2CCNCC2)nc(-c2ccc(Cl)c(Cl)c2)c1-c1ccnc(NC2CCCCC2)n1		CHEMBL437747	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629253	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1cccc(NC(=O)Nc2ccc(-c3ccc4nccnc4c3N)cc2)c1		CHEMBL507936	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
inactive	9629254	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=S(=O)(NCCNCC=Cc1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL1987756	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
active	9629255	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCNS(C)(=O)=O)cnc(N)c34)cc2)c1		CHEMBL1994321	=	Ki	nM	398.11	CHEMBL267	Homo sapiens	pKi		6.4
inactive	9629256	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C1NCCc2[nH]c(-c3ccnc(C=Cc4ccccc4)c3)cc21		CHEMBL1997129	<	Ki	nM	3162.28	CHEMBL267	Homo sapiens	pKi		5.5
inactive	9629257	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	FC(F)(F)c1ccc(-c2nnc3ccc(NC4CC4)nn23)cc1		CHEMBL451964	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629258	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1cccc(NC(=O)Cc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL1964307	<	Ki	nM	3162.28	CHEMBL267	Homo sapiens	pKi		5.5
inactive	9629259	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Fc1ccc(-c2nc3sccn3c2-c2ccncc2)cc1		CHEMBL2000508	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629260	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CCCCNc1n[s+]([O-])nc1Nc1ccc(F)cc1		CHEMBL1971694	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629261	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CCc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2001547	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629262	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1Cl		CHEMBL210928	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629263	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1ccccc1F		CHEMBL1994361	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629264	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1cc(NC(=O)CCNC(=O)Nc2nc(C)c(-c3ccc(-n4cccn4)cc3)s2)no1		CHEMBL1986603	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629265	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	<	Ki	nM	1258.93	CHEMBL267	Homo sapiens	pKi		5.9
inactive	9629266	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	NC(COc1cncc(-c2cc3cnccc3s2)c1)Cc1c[nH]c2ccccc12		CHEMBL1972840	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
active	9629267	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CCO)c5)cnc(N)c34)cc2)cc1		CHEMBL1977148	=	Ki	nM	7.943	CHEMBL267	Homo sapiens	pKi		8.1
inactive	9629268	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1cc(C=C2SC(=O)NC2=O)ccc1O		CHEMBL2003286	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9629269	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccn1		CHEMBL1992306	=	Ki	nM	1000.0	CHEMBL267	Homo sapiens	pKi		6.0
active	9629270	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CC(O)Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL2002165	=	Ki	nM	50.12	CHEMBL267	Homo sapiens	pKi		7.3
inactive	9629271	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	NCCOc1cncc(C=Cc2ccncc2)c1		CHEMBL1989518	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629272	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL1998585	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629273	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cn1cncc1C(OCc1c(-c2ccc(OC(F)(F)F)cc2)cc(C#N)c(=O)n1C)c1ccc(C#N)cc1		CHEMBL127898	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629274	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2C		CHEMBL519697	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629275	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(F)c2)c1		CHEMBL2004934	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629276	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3I)cc12		CHEMBL1975128	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9629277	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1ccc(-c2cc3c(NCCN)ccc(C(N)=O)c3[nH]2)cc1		CHEMBL1996048	=	Ki	nM	1000.0	CHEMBL267	Homo sapiens	pKi		6.0
inactive	9629278	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL461876	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9629279	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C(C)C(=O)N(C)C)c5)cnc(N)c34)cc2)cc1		CHEMBL2001485	=	Ki	nM	199.53	CHEMBL267	Homo sapiens	pKi		6.7
active	9629280	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	=	Ki	nM	50.12	CHEMBL267	Homo sapiens	pKi		7.3
inactive	9629281	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1cc(C)c2c(n1)sc1c(N)ncnc12		CHEMBL504950	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629282	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1cc(NC(=O)Cc2ccc(-c3cccc4[nH]nc(N)c34)cc2)ccc1F		CHEMBL1984363	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9629283	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CNC(=O)COc1ccc(Nc2nc(Nc3ccc(C)c(S(N)(=O)=O)c3)ncc2F)cc1		CHEMBL1978099	=	Ki	nM	630.96	CHEMBL267	Homo sapiens	pKi		6.2
active	9629284	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COC(=O)c1c(-c2ccc(NC(=O)Nc3ccccc3)cc2)c2c(N)ncnn2c1C		CHEMBL1977041	=	Ki	nM	794.33	CHEMBL267	Homo sapiens	pKi		6.1
inactive	9629285	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	NC(=O)c1cccc2c1Nc1nnc(Cl)cc1C(=O)N2		CHEMBL1968070	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
inactive	9629286	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CC(=O)Nc1cccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)c1		CHEMBL1988608	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629287	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1ccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)cc1C		CHEMBL184847	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629288	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CN(C)c1ccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)cc1		CHEMBL1984367	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629289	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1n[nH]c2cnc(-c3cncc(OCC(N)Cc4cccc(C(F)(F)F)c4)c3)cc12		CHEMBL1998159	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629290	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COCC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(C)nccn23)n1		CHEMBL1982563	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9629291	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C1CCCN1Cc1ccc2c(c1)[nH]c(=O)c1cccn12		CHEMBL539474	=	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629292	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	NC(COc1cncc(-c2ccc3[nH]c(=O)oc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1987679	<	Ki	nM	3981.07	CHEMBL267	Homo sapiens	pKi		5.4
active	9629293	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(OC(F)F)cc5)cc4)csc23)cn1		CHEMBL1988387	=	Ki	nM	19.95	CHEMBL267	Homo sapiens	pKi		7.7
inactive	9629294	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9629295	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	=	Ki	nM	25.12	CHEMBL267	Homo sapiens	pKi		7.6
inactive	9629296	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=c1[nH]c2cc(Cl)cc(Cl)c2c(-c2cc(Cl)ccc2O)c1O		CHEMBL1974803	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
inactive	9629297	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL1970074	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
active	9629298	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	=	Ki	nM	316.23	CHEMBL267	Homo sapiens	pKi		6.5
inactive	9629299	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COCCN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1986970	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629300	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=c1cc(-c2ccncc2)nc(NC2CCCCC2)[nH]1		CHEMBL1958401	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629301	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	NC(COCc1ccccc1)COc1cncc(C=Cc2ccncc2)c1		CHEMBL1993781	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629302	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=c1[nH]c2cc(-c3ccccc3)cnc2[nH]1		CHEMBL2003456	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629303	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(F)cccc12		CHEMBL1966816	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629304	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CC(N)C1CCC(C(=O)Nc2ccnc3[nH]ccc23)CC1		CHEMBL2002992	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629305	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	N#Cc1cnc(NC(=O)Nc2ccc3cc(C(=O)O)ccc3c2)cn1		CHEMBL560813	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629306	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1c(-c2cccc(OCc3ccccc3)c2)c2c(N)ncnc2n1C1CC(CN2CCCC2)C1		CHEMBL1968791	<	Ki	nM	3162.28	CHEMBL267	Homo sapiens	pKi		5.5
inactive	9629307	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C1CC(c2ccc(Cl)cc2Cl)Cc2nc3cc(Cl)ccc3c(O)c21		CHEMBL326282	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629308	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CCOc1ccccc1C=NNC(=O)c1nnn(-c2nonc2N)c1N1CCCC1		CHEMBL1992732	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
inactive	9629309	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Fc1ccc(-c2nc3occn3c2-c2ccnc(NC3CCNCC3)n2)cc1		CHEMBL1971186	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629310	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C(Cc1ccc(Cl)cc1)Nc1[nH]nc2c1CCC2		CHEMBL2003482	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9629311	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCCC5)cnc(N)c34)cc2)c1		CHEMBL1973211	=	Ki	nM	398.11	CHEMBL267	Homo sapiens	pKi		6.4
inactive	9629312	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CC(C)Oc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1984700	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629313	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
active	9629314	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1c(-c2cccc(OCc3ccccc3)c2)c2c(N)ncnc2n1C1CCC(N2CCCC2)CC1		CHEMBL2007151	=	Ki	nM	2511.89	CHEMBL267	Homo sapiens	pKi		5.6
inactive	9629315	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1ccccc1		CHEMBL1972125	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629316	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	<	Ki	nM	3981.07	CHEMBL267	Homo sapiens	pKi		5.4
active	9629317	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	c1cc2cc(-c3ccc4cn[nH]c4c3)cnc2[nH]1		CHEMBL1976134	=	Ki	nM	1000.0	CHEMBL267	Homo sapiens	pKi		6.0
inactive	9629318	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1ccc(C(=O)Nc2c(C(N)=O)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL1965131	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629319	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL1972158	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629320	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C(O)c1cc2c(-c3cccc(F)c3)cncc2s1		CHEMBL1974457	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
inactive	9629321	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629322	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CCOc1nc(C(=O)NCc2ccccc2S(N)(=O)=O)cc(N)c1Cl		CHEMBL2006581	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629323	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCC#N)c2)n1		CHEMBL1979855	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9629324	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Nc1noc2cccc(-c3cccc(O)c3)c12		CHEMBL1970340	=	Ki	nM	1258.93	CHEMBL267	Homo sapiens	pKi		5.9
inactive	9629325	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CC(C)NC(=O)COc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3ccccc3n2)c1		CHEMBL2005186	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629326	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	NCC(O)C(O)Cn1cc(I)c2c(N)ncnc21		CHEMBL1975534	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9629327	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	NS(=O)(=O)c1cccc(Nc2ncc3ccn(Cc4ccccc4)c3n2)c1		CHEMBL1993424	=	Ki	nM	63.1	CHEMBL267	Homo sapiens	pKi		7.2
inactive	9629328	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1n[nH]c2c1C(c1ccccc1F)C1=C(CC(C)(C)CC1=O)N2		CHEMBL1966703	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629329	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CC(C)N(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1969561	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629330	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1975121	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629331	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CN(C)c1cc2sncc2cc1NC(=O)C(=O)O		CHEMBL1997023	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
inactive	9629332	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1cc(C)cc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1964687	<	Ki	nM	3981.07	CHEMBL267	Homo sapiens	pKi		5.4
inactive	9629333	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629334	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	NC(=O)c1cc2c(-c3ccc(Br)c(F)c3F)cncc2s1		CHEMBL1999918	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
active	9629335	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CCOc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1		CHEMBL1974254	=	Ki	nM	15.85	CHEMBL267	Homo sapiens	pKi		7.8
inactive	9629336	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1ccc(C(=O)N2c3ccccc3Sc3c(Cl)cncc32)cc1		CHEMBL1988537	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629337	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(C)c2)c1		CHEMBL1969049	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629338	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1ccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)cc1		CHEMBL2005828	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629339	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CCc1nc(-c2cccc(C)c2)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1		CHEMBL363648	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629340	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629341	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	NC(=O)c1sc2c(Br)ccc(Cl)c2c1N		CHEMBL1998611	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9629342	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2CCC(N)=O		CHEMBL485556	=	Ki	nM	794.33	CHEMBL267	Homo sapiens	pKi		6.1
inactive	9629343	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=c1c(NCc2ccc(Cl)c(Cl)c2)c(Nc2ccncc2)c1=O		CHEMBL1975900	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629344	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1cc(C=C2SC(=S)NC2=O)ccc1O		CHEMBL1973098	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629345	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(=O)CC)c3c2)cc1		CHEMBL1972221	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9629346	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CNC(=O)C=Cc1cnc(N)c2c(-c3cc(F)c4[nH]c(C)cc4c3)csc12		CHEMBL2006778	=	Ki	nM	50.12	CHEMBL267	Homo sapiens	pKi		7.3
inactive	9629347	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1cc(S(C)(=O)=O)c(OC)cc1CC(=O)Nc1cc(N)c(C#N)c(OC(C)C)n1		CHEMBL378627	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9629348	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1c(F)cccc1F		CHEMBL1996979	=	Ki	nM	15.85	CHEMBL267	Homo sapiens	pKi		7.8
inactive	9629349	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CCc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1968406	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9629350	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)csc12		CHEMBL1982476	=	Ki	nM	1.995	CHEMBL267	Homo sapiens	pKi		8.7
inactive	9629351	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C1C(=NNc2cccc3c(=O)[nH][nH]c(=O)c23)C(c2ccccc2)=NN1c1ccccc1		CHEMBL1984274	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
inactive	9629352	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1998545	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629353	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1csc(NC(=O)c2sc3nc(-c4ccncc4)ccc3c2N)n1		CHEMBL1986869	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629354	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Fc1ccc(-c2ncn(CCN3CCOCC3)c2-c2ccc3[nH]ncc3c2)cc1		CHEMBL1682558	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629355	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cn1c(NCC(N)Cc2ccccc2)nc(-c2ccncc2)c(-c2ccc3ccccc3c2)c1=O		CHEMBL1990496	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629356	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Nc1n[nH]c2cc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)ccc12		CHEMBL1997623	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
inactive	9629357	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	NCCCOc1cc2c(c(-c3ccc(Nc4nc5ccc(Cl)cc5o4)cc3)c1)CNC2=O		CHEMBL2002479	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629358	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CC(=NNC(=N)N)c1cc(NC(=O)NCCCN(C)CCCNC(=O)Nc2cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c2)cc(C(C)=NNC(=N)N)c1		CHEMBL1993166	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
inactive	9629359	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C(NCc1ccc(Cl)cc1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL1967094	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629360	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C(NC(CO)c1cc(Cl)cc(Cl)c1)c1ccc(-c2ccncc2)cc1		CHEMBL2003341	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629361	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C(NS(=O)(=O)c1ccc(NCCSc2ccc(O)cc2)c([N+](=O)[O-])c1)c1ccc(-c2ccc(F)cc2)cc1		CHEMBL1992645	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629362	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Oc1cccc(Nc2ncnc3scc(Cl)c23)c1		CHEMBL1982992	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9629363	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1cc(-c2ccccc2)n(-c2cc(NN=Cc3ccco3)ncn2)n1		CHEMBL1999590	=	Ki	nM	501.19	CHEMBL267	Homo sapiens	pKi		6.3
inactive	9629364	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1F		CHEMBL1981079	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629365	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=c1c(NCc2ccc(Cl)cc2)c(Nc2ccncc2)c1=O		CHEMBL1980489	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629366	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCc4cccc(F)c4)cc2NC3=O)ccc1O		CHEMBL2000832	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9629367	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)c1		CHEMBL1967116	=	Ki	nM	25.12	CHEMBL267	Homo sapiens	pKi		7.6
inactive	9629368	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1nn(C)c2c1c(=O)c1cc(Cl)ccc1n2OCC(C)C		CHEMBL1977814	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
inactive	9629369	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C(NCc1ccc(Br)cc1)Nc1ccc2[nH]ncc2c1		CHEMBL1970709	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629370	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9629371	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1ccc(-c2cc3nccn3c(Nc3ccccc3C(N)=O)n2)cc1OC		CHEMBL1998112	=	Ki	nM	158.49	CHEMBL267	Homo sapiens	pKi		6.8
active	9629372	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1cc(NC(=O)Nc2ccc(-c3c(F)ccc4[nH]nc(N)c34)cc2)ccc1F		CHEMBL1993996	=	Ki	nM	794.33	CHEMBL267	Homo sapiens	pKi		6.1
inactive	9629373	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CC(C)n1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)cc21		CHEMBL1969126	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9629374	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Nc1ncnc2sc(Br)c(-c3ccc(NC(=O)Cc4cccc(Cl)c4)cc3)c12		CHEMBL1980896	=	Ki	nM	1258.93	CHEMBL267	Homo sapiens	pKi		5.9
active	9629375	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	=	Ki	nM	158.49	CHEMBL267	Homo sapiens	pKi		6.8
active	9629376	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCCC4=O)c3)n2)c1		CHEMBL1991429	=	Ki	nM	251.19	CHEMBL267	Homo sapiens	pKi		6.6
inactive	9629377	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)C(=O)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1971149	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629378	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1ccc2c(c1)NC(=O)c1ccccc1N2		CHEMBL1999714	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629379	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C(Cc1ccccc1Cl)Nc1ccc2cn[nH]c2c1		CHEMBL1987533	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
inactive	9629380	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CC(C)(O)CNc1nccc(-c2c(-c3ccc(F)cc3F)nc3c(CC4CC4)nccn23)n1		CHEMBL1994040	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9629381	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CNC1CC2OC(C)(C1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL1980995	=	Ki	nM	19.95	CHEMBL267	Homo sapiens	pKi		7.7
inactive	9629382	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	NC(COc1cncc(-c2ccc3c(c2)CC(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL1967302	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
inactive	9629383	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCCCN4CCOCC4)cc2-3)cn1		CHEMBL398951	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629384	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1cc2cnc3c(c2cc1OC)C(=O)NC3=O		CHEMBL1982506	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
active	9629385	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CCN(CC)CCNC(=O)C=Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2004716	=	Ki	nM	19.95	CHEMBL267	Homo sapiens	pKi		7.7
inactive	9629386	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1		CHEMBL1968127	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629387	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1cc(C)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL1975233	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629388	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CCCC(=O)Nc1n[nH]c2ccc(-c3cccc(F)c3F)cc12		CHEMBL1985406	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629389	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cn1nc(C(F)(F)F)c2c(=O)c3cc(Cl)ccc3n(O)c21		CHEMBL207400	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
inactive	9629390	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1cc(O)ccc1-n1cc(C(=O)NN)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL2000894	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629391	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1ccccc1NC(=O)Nc1ccc2c(c1)CCc1sc3ncnc(N)c3c1-2		CHEMBL1982135	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629392	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Nc1ncnc2c1sc1ncnc(N)c12		CHEMBL1976090	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9629393	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4c(c3)OCO4)csc12		CHEMBL1993243	=	Ki	nM	7.943	CHEMBL267	Homo sapiens	pKi		8.1
inactive	9629394	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	OCC(CO)Nc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1992922	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
inactive	9629395	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3o2)cc1		CHEMBL2004771	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9629396	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2C1CC(CN2CCCC2)C1		CHEMBL1988370	=	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629397	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1997597	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629398	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	S=c1[nH]nc2c3c4c(sc3n3c(=S)[nH]nc3n12)CCC4		CHEMBL1969537	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629399	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
inactive	9629400	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1976093	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629401	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2cccs2)c1-c1cccs1		CHEMBL1975256	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9629402	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1cccc(NC(=O)Nc2ccc(-c3cnc4c(-c5cnn(C)c5)cnn4c3N)cc2)c1		CHEMBL508928	=	Ki	nM	19.95	CHEMBL267	Homo sapiens	pKi		7.7
inactive	9629403	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1cccc(-c2cc3c(=O)[nH]c4ccccc4n3c2)c1		CHEMBL1991356	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629404	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL2004892	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629405	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	NC(=O)c1cc2c(Oc3ccc(Br)cc3)cncc2s1		CHEMBL116070	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629406	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1cc(C)c(C)c(OCCCc2c(C(=O)O)[nH]c3c(-c4ccccc4C)cccc23)c1		CHEMBL1990821	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629407	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	NC(=O)c1cc(-c2cccc(N)c2)cc2cccnc12		CHEMBL1970314	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629408	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	OCCCn1cnc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL2004871	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629409	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncn3)cc2)c1		CHEMBL2004872	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629410	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C1Nc2ccccc2Nc2ccccc21		CHEMBL1727312	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
inactive	9629411	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CC1CCN(C(=O)CO)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL1969879	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629412	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C(Nc1cnccn1)Nc1ccnc2ccccc12		CHEMBL1981720	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629413	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CC(N)COc1cnc(Cl)c(C=Cc2ccncc2)c1		CHEMBL1993548	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629414	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3nsc4ncnc(N)c34)cc2)c1		CHEMBL262433	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9629415	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL373798	=	Ki	nM	630.96	CHEMBL267	Homo sapiens	pKi		6.2
active	9629416	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	=	Ki	nM	39.81	CHEMBL267	Homo sapiens	pKi		7.4
inactive	9629417	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C(NNC(=S)Nc1ccc(Cl)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1966722	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629418	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCCNC(C)=O)cc2NC3=O)ccc1O		CHEMBL1975500	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629419	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4snc(N)c34)cc2)c1		CHEMBL1976328	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629420	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ccnc(N)c34)cc2)c1		CHEMBL394619	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629421	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1ccc(Nc2nccc(Nc3c(NC(C)C(C)(C)C)c(=O)c3=O)n2)cc1OC		CHEMBL1964399	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
inactive	9629422	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C(O)c1c2c(nc3ccccc13)C(=C1CCCC1)CC2		CHEMBL1996831	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629423	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Nc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc1)CCN2		CHEMBL411903	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9629424	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN)cnc(N)c34)cc2)c1		CHEMBL1965988	=	Ki	nM	398.11	CHEMBL267	Homo sapiens	pKi		6.4
inactive	9629425	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CN1CCC(c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)C(O)C1		CHEMBL422897	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629426	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1c(-c2ccc3[nH]nc(N)c3c2)nnn1Cc1ccccc1		CHEMBL1989646	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629427	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	c1ccc(Cc2cc(-c3ccc4[nH]ncc4c3)on2)cc1		CHEMBL1682357	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629428	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C1NCCc2[nH]c(-c3ccncc3)cc21		CHEMBL225519	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629429	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CCOc1nc(C(=O)NCc2cccnc2)cc(N)c1C#N		CHEMBL209534	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
inactive	9629430	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1nccn2c(-c3ccnc(NCCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1978200	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9629431	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Ki	nM	63.1	CHEMBL267	Homo sapiens	pKi		7.2
inactive	9629432	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1cc(C=C2SC(=Nc3ccccc3)NC2=O)ccc1O		CHEMBL1970522	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629433	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL402846	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9629434	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cn1nc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)cncc21		CHEMBL1964692	=	Ki	nM	794.33	CHEMBL267	Homo sapiens	pKi		6.1
inactive	9629435	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C(NC(CO)Cc1ccc(Cl)cc1)c1ccc(-c2ccncc2)cc1		CHEMBL1996931	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629436	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	FC(F)(F)c1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c(C(F)(F)F)c1		CHEMBL1964413	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629437	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(C(F)(F)F)ccc12		CHEMBL1973483	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629438	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c(C)c1		CHEMBL1984432	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9629439	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL219722	=	Ki	nM	1584.89	CHEMBL267	Homo sapiens	pKi		5.8
inactive	9629440	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C(c1cc(-c2ccc3[nH]ncc3c2)on1)N1CCCC(O)C1		CHEMBL1997340	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629441	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1cccc(Nc2ncnc3ccccc23)c1		CHEMBL117697	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9629442	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	=	Ki	nM	316.23	CHEMBL267	Homo sapiens	pKi		6.5
inactive	9629443	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cn1cc(-c2ccncn2)c(-c2ccc(F)cc2)n1		CHEMBL1989474	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9629444	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)c1		CHEMBL1090360	=	Ki	nM	63.1	CHEMBL267	Homo sapiens	pKi		7.2
inactive	9629445	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C(Nc1nc2ccccc2n1CCCO)c1cccc([N+](=O)[O-])c1		CHEMBL210887	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629446	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)ncc1Cl		CHEMBL458997	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629447	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C(F)(F)F)c2)c1		CHEMBL1971021	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629448	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(OC(F)(F)F)c4)c3)cc12		CHEMBL1965836	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629449	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=c1[nH]cnc2c1sc1c(Cl)ccc(Cl)c12		CHEMBL583144	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629450	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	NC(=O)c1cc2c(-c3ccc(F)cc3)cncc2s1		CHEMBL1974310	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629451	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1		CHEMBL1982660	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629452	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Nc1ncnc2sc3c(c12)-c1ccc(NC(=O)Nc2ccccc2)cc1CC3		CHEMBL1994693	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629453	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	NC(=O)c1cccc(-c2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982957	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629454	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629455	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C(NNC(=S)Nc1ccc(F)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1975138	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629456	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1C#N		CHEMBL424872	<	Ki	nM	6309.57	CHEMBL267	Homo sapiens	pKi		5.2
inactive	9629457	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CC1=NN(c2ccc(C(=O)O)cc2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL2006836	<	Ki	nM	3981.07	CHEMBL267	Homo sapiens	pKi		5.4
active	9629458	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#Cc5cccnc5)cnc(N)c34)cc2)c1		CHEMBL1971947	=	Ki	nM	158.49	CHEMBL267	Homo sapiens	pKi		6.8
inactive	9629459	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
inactive	9629460	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629461	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1cc2nnc(SCc3cn4ccccc4n3)n2c2ccccc12		CHEMBL1980704	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629462	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	NC(=O)c1sc2ccc(Cl)c(Cl)c2c1NC(=O)c1ccc(Cl)cc1		CHEMBL2003271	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629463	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccncc4)nn12)CCCC3		CHEMBL1966808	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9629464	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3c(F)ccc4[nH]nc(N)c34)cc2)c1		CHEMBL1996255	=	Ki	nM	501.19	CHEMBL267	Homo sapiens	pKi		6.3
inactive	9629465	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CC(C)(C)c1n[nH]c2c1C(c1ccccc1F)C(C#N)=C(N)O2		CHEMBL2004447	<	Ki	nM	3981.07	CHEMBL267	Homo sapiens	pKi		5.4
active	9629466	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	=	Ki	nM	63.1	CHEMBL267	Homo sapiens	pKi		7.2
inactive	9629467	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	OCCNc1cc2cc(-c3ccsc3)ccc2cn1		CHEMBL1973860	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629468	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Nc1n[nH]c2nnc(-c3ccccc3)c(-c3ccccc3)c12		CHEMBL260135	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
inactive	9629469	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21		CHEMBL220241	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
active	9629470	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=c1[nH]cc(I)c2nc(-c3cccc(Cl)c3)cn12		CHEMBL1982610	=	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629471	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Cc1cccc(C2(c3cccc(C)c3)CC2C(=O)Nc2ccncc2)c1		CHEMBL1999496	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
inactive	9629472	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CSc1cnc2c(ccc3cnccc32)c1O		CHEMBL2006933	<	Ki	nM	5011.87	CHEMBL267	Homo sapiens	pKi		5.3
active	9629473	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	Nc1ccc(-c2csc3c(C=Cc4nc5ccccc5[nH]4)cnc(N)c23)cc1		CHEMBL1988300	=	Ki	nM	630.96	CHEMBL267	Homo sapiens	pKi		6.2
active	9629474	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	COc1ccc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)cc1OC		CHEMBL1991078	=	Ki	nM	316.23	CHEMBL267	Homo sapiens	pKi		6.5
active	9629475	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Ki	nM	1584.89	CHEMBL267	Homo sapiens	pKi		5.8
inactive	9629476	CHEMBL1963768	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRC	F	CCCCNc1ccc2c3c(cccc13)C(=O)N(CCNCCO)C2=O		CHEMBL1987359	<	Ki	nM	1995.26	CHEMBL267	Homo sapiens	pKi		5.7
	10838629	CHEMBL2014507	Inhibition of SRC at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	17.0	CHEMBL267	Homo sapiens	INH	%	17.0
	10840365	CHEMBL2014661	Inhibition of Src assessed as residual activity at 1 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	44.0	CHEMBL267	Homo sapiens	Activity	%	44.0
	10840406	CHEMBL2015811	Inhibition of Src assessed as residual activity at 10 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	20.0	CHEMBL267	Homo sapiens	Activity	%	20.0
Not Active	10842768	CHEMBL2016346	Inhibition of cSRC at 10 uM	B	Cc1c(Nc2ccc(I)cc2F)c(C(=O)NOCCO)c2n(c1=O)CCC2		CHEMBL2012908		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	10842769	CHEMBL2016346	Inhibition of cSRC at 10 uM	B	O=C(NOC[C@@H](O)CO)c1c(Nc2ccc(I)cc2F)c(F)c(=O)n2c1CCC2		CHEMBL2012904		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	10842770	CHEMBL2016346	Inhibition of cSRC at 10 uM	B	O=C(NOCCO)c1c(Nc2ccc(I)cc2F)c(F)c(=O)n2c1CCC2		CHEMBL2012902		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	10842771	CHEMBL2016346	Inhibition of cSRC at 10 uM	B	C#Cc1ccc(Nc2c(C(=O)NOCCO)c3c(n2C)C(=O)CC3)c(F)c1		CHEMBL2012901		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	10842772	CHEMBL2016346	Inhibition of cSRC at 10 uM	B	C#Cc1ccc(Nc2c(C(=O)NOCCO)c3c(n2C)C(=O)CCC3)c(F)c1		CHEMBL2012899		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	10842773	CHEMBL2016346	Inhibition of cSRC at 10 uM	B	Cn1c(Nc2ccc(I)cc2F)c(C(=O)NOC[C@H](O)CO)c2c1C(=O)CCC2		CHEMBL2012892		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	10843859	CHEMBL2016109	Inhibition of human cSrc using ATP as substrate	B	CC(C)Cn1c2ccc(Nc3ncccn3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL2010872	=	IC50	nM	37.0	CHEMBL267	Homo sapiens	IC50	nM	37.0
	10844825	CHEMBL2015057	Inhibition of SRC using poly(Glu,Tyr) as substrate assessed as [33P-gamma]-ATP incorporation after 60 mins by microplate scintillation counting	B	Fc1ccc(-c2cn(-c3ccc(C(F)(F)F)cc3)nc2-c2ccncc2)cc1		CHEMBL2011305	=	IC50	nM	12000.0	CHEMBL267	Homo sapiens	IC50	uM	12.0
	10844826	CHEMBL2015057	Inhibition of SRC using poly(Glu,Tyr) as substrate assessed as [33P-gamma]-ATP incorporation after 60 mins by microplate scintillation counting	B	Fc1ccc(-c2cn(-c3c(Cl)cc(Cl)cc3Cl)nc2-c2ccncc2)cc1		CHEMBL2011304	=	IC50	nM	2000.0	CHEMBL267	Homo sapiens	IC50	uM	2.0
	10844827	CHEMBL2015057	Inhibition of SRC using poly(Glu,Tyr) as substrate assessed as [33P-gamma]-ATP incorporation after 60 mins by microplate scintillation counting	B	Nc1cc(-c2ccncc2)nn1-c1c(Cl)cc(Cl)cc1Cl		CHEMBL2011303	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	10844828	CHEMBL2015057	Inhibition of SRC using poly(Glu,Tyr) as substrate assessed as [33P-gamma]-ATP incorporation after 60 mins by microplate scintillation counting	B	Nc1c(C(=O)O)c(-c2ccncc2)nn1-c1c(Cl)cc(Cl)cc1Cl		CHEMBL2011302	=	IC50	nM	55000.0	CHEMBL267	Homo sapiens	IC50	uM	55.0
	10844829	CHEMBL2015057	Inhibition of SRC using poly(Glu,Tyr) as substrate assessed as [33P-gamma]-ATP incorporation after 60 mins by microplate scintillation counting	B	NC(=O)c1c(-c2ccncc2)nn(-c2ccccc2)c1N		CHEMBL2011301	=	IC50	nM	19000.0	CHEMBL267	Homo sapiens	IC50	uM	19.0
	10844830	CHEMBL2015057	Inhibition of SRC using poly(Glu,Tyr) as substrate assessed as [33P-gamma]-ATP incorporation after 60 mins by microplate scintillation counting	B	CCOC(=O)c1c(-c2ccncc2)nn(-c2c(Cl)cc(Cl)cc2Cl)c1N		CHEMBL2011300	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	10844831	CHEMBL2015057	Inhibition of SRC using poly(Glu,Tyr) as substrate assessed as [33P-gamma]-ATP incorporation after 60 mins by microplate scintillation counting	B	NC(=O)c1c(-c2ccncc2)nn(-c2c(Cl)cc(Cl)cc2Cl)c1N		CHEMBL2011299	=	IC50	nM	6400.0	CHEMBL267	Homo sapiens	IC50	uM	6.4
	10844832	CHEMBL2015057	Inhibition of SRC using poly(Glu,Tyr) as substrate assessed as [33P-gamma]-ATP incorporation after 60 mins by microplate scintillation counting	B	Nc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(C(F)(F)F)cc1		CHEMBL2011298	=	IC50	nM	6700.0	CHEMBL267	Homo sapiens	IC50	uM	6.7
	10844833	CHEMBL2015057	Inhibition of SRC using poly(Glu,Tyr) as substrate assessed as [33P-gamma]-ATP incorporation after 60 mins by microplate scintillation counting	B	N#Cc1ccc(-n2nc(-c3ccncc3)c(-c3ccc(F)cc3)c2N)cc1		CHEMBL2011297	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	10844834	CHEMBL2015057	Inhibition of SRC using poly(Glu,Tyr) as substrate assessed as [33P-gamma]-ATP incorporation after 60 mins by microplate scintillation counting	B	Cc1ccc(-n2nc(-c3ccncc3)c(-c3ccc(F)cc3)c2N)cc1		CHEMBL2011296	=	IC50	nM	53000.0	CHEMBL267	Homo sapiens	IC50	uM	53.0
	10844835	CHEMBL2015057	Inhibition of SRC using poly(Glu,Tyr) as substrate assessed as [33P-gamma]-ATP incorporation after 60 mins by microplate scintillation counting	B	Nc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc([N+](=O)[O-])cc1		CHEMBL2011295	=	IC50	nM	82000.0	CHEMBL267	Homo sapiens	IC50	uM	82.0
	10844836	CHEMBL2015057	Inhibition of SRC using poly(Glu,Tyr) as substrate assessed as [33P-gamma]-ATP incorporation after 60 mins by microplate scintillation counting	B	COc1ccc(-n2nc(-c3ccncc3)c(-c3ccc(F)cc3)c2N)cc1		CHEMBL2011294	=	IC50	nM	23000.0	CHEMBL267	Homo sapiens	IC50	uM	23.0
	10844837	CHEMBL2015057	Inhibition of SRC using poly(Glu,Tyr) as substrate assessed as [33P-gamma]-ATP incorporation after 60 mins by microplate scintillation counting	B	Nc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL2011293	=	IC50	nM	23000.0	CHEMBL267	Homo sapiens	IC50	uM	23.0
	10844838	CHEMBL2015057	Inhibition of SRC using poly(Glu,Tyr) as substrate assessed as [33P-gamma]-ATP incorporation after 60 mins by microplate scintillation counting	B	Nc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccccc1		CHEMBL2011292	=	IC50	nM	52000.0	CHEMBL267	Homo sapiens	IC50	uM	52.0
	10844839	CHEMBL2015057	Inhibition of SRC using poly(Glu,Tyr) as substrate assessed as [33P-gamma]-ATP incorporation after 60 mins by microplate scintillation counting	B	Nc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1c(Cl)cc(Cl)cc1Cl		CHEMBL2011291	=	IC50	nM	399.0	CHEMBL267	Homo sapiens	IC50	uM	0.399
	10845894	CHEMBL2013606	Inhibition of SRC by DEL method	B	NC(=O)[C@@H]1CCCNC(=O)[C@H](Cc2ccc([N+](=O)[O-])cc2)NC(=O)[C@H](Cc2ccco2)NC(=O)[C@H](CC2CC2)NC(=O)/C=C/C(=O)N1		CHEMBL2011503	=	IC50	nM	680.0	CHEMBL267	Homo sapiens	IC50	nM	680.0
	10849729	CHEMBL2019688	Inhibition of SRC	B	CSc1ccccc1Nc1nc(N2CCNCC2)nc2c(NCC3CC3)ncnc12		CHEMBL2017214	>	IC50	nM	40000.0	CHEMBL267	Homo sapiens	IC50	uM	40.0
	10850674	CHEMBL2019794	Inhibition of human cSrc at 1 uM	B	Cn1cc(-c2cccc(-c3cnc(N)c(C(=O)N[C@H]4C5CC6CC4C[C@@](O)(C6)C5)n3)c2)cn1		CHEMBL2018022	>	Inhibition	%	50.0	CHEMBL267	Homo sapiens	INH	%	50.0
	10867127	CHEMBL2026021	Inhibition of SRC at 1 uM	B	CCCS(=O)(=O)Nc1ccc(F)c(-c2cc3cnc(Nc4ccccc4)nc3n(C)c2=O)c1F		CHEMBL2023500	>	Inhibition	%	90.0	CHEMBL267	Homo sapiens	INH	%	90.0
	10867132	CHEMBL2026021	Inhibition of SRC at 1 uM	B	CCCS(=O)(=O)Nc1ccc(F)c(-c2cc3cnc(Nc4cnn(C)c4)nc3n(C)c2=O)c1F		CHEMBL2023502	>	Inhibition	%	90.0	CHEMBL267	Homo sapiens	INH	%	90.0
	10867133	CHEMBL2026021	Inhibition of SRC at 1 uM	B	CCCS(=O)(=O)Nc1ccc(F)c(-c2cc3cnc(Nc4cccnc4)nc3n(C)c2=O)c1F		CHEMBL2023501	>	Inhibition	%	90.0	CHEMBL267	Homo sapiens	INH	%	90.0
	10867561	CHEMBL2026616	Inhibition of SRC by filter binding assay	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	IC50	nM	5000.0	CHEMBL267	Homo sapiens	IC50	uM	5.0
	10884699	CHEMBL2033710	Inhibition of human SRC by radiometric assay	B	CC(C)n1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1241489	=	Ki	nM	65.0	CHEMBL267	Homo sapiens	Ki	uM	0.065
	10884703	CHEMBL2033710	Inhibition of human SRC by radiometric assay	B	Nc1ncnc2c1c(-c1ccc3ccccc3c1)nn2CC1CCNCC1		CHEMBL2030552	>	Ki	nM	10000.0	CHEMBL267	Homo sapiens	Ki	uM	10.0
	10884707	CHEMBL2033710	Inhibition of human SRC by radiometric assay	B	COc1ccc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2c1		CHEMBL1785020	=	Ki	nM	770.0	CHEMBL267	Homo sapiens	Ki	uM	0.77
	10884711	CHEMBL2033710	Inhibition of human SRC by radiometric assay	B	COc1ccc2cc(-c3nn(CC4CCNCC4)c4ncnc(N)c34)ccc2c1		CHEMBL2030553	>	Ki	nM	20000.0	CHEMBL267	Homo sapiens	Ki	uM	20.0
	10884715	CHEMBL2033710	Inhibition of human SRC by radiometric assay	B	CCOc1ccc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2c1		CHEMBL1785021	=	Ki	nM	200.0	CHEMBL267	Homo sapiens	Ki	uM	0.2
	10884719	CHEMBL2033710	Inhibition of human SRC by radiometric assay	B	CCOc1ccc2cc(-c3nn(CC4CCNCC4)c4ncnc(N)c34)ccc2c1		CHEMBL2030554	>	Ki	nM	20000.0	CHEMBL267	Homo sapiens	Ki	uM	20.0
	10884723	CHEMBL2033710	Inhibition of human SRC by radiometric assay	B	CC(C)n1nc(-c2cnc3ccccc3c2)c2c(N)ncnc21		CHEMBL1242754	=	Ki	nM	200.0	CHEMBL267	Homo sapiens	Ki	uM	0.2
	10884727	CHEMBL2033710	Inhibition of human SRC by radiometric assay	B	Nc1ncnc2c1c(-c1cnc3ccccc3c1)nn2CC1CCNCC1		CHEMBL2030555	>	Ki	nM	20000.0	CHEMBL267	Homo sapiens	Ki	uM	20.0
	10884731	CHEMBL2033710	Inhibition of human SRC by radiometric assay	B	CC(C)n1nc(-c2cc3c(Cl)cccc3[nH]2)c2c(N)ncnc21		CHEMBL2030556	=	Ki	nM	1240.0	CHEMBL267	Homo sapiens	Ki	uM	1.24
	10884735	CHEMBL2033710	Inhibition of human SRC by radiometric assay	B	Nc1ncnc2c1c(-c1cc3c(Cl)cccc3[nH]1)nn2CC1CCNCC1		CHEMBL2030557	>	Ki	nM	10000.0	CHEMBL267	Homo sapiens	Ki	uM	10.0
	10884739	CHEMBL2033710	Inhibition of human SRC by radiometric assay	B	COc1ccc(-c2nn(C(C)C)c3ncnc(N)c23)cc1C		CHEMBL1785018	=	Ki	nM	650.0	CHEMBL267	Homo sapiens	Ki	uM	0.65
	10884743	CHEMBL2033710	Inhibition of human SRC by radiometric assay	B	COc1ccc(-c2nn(CC3CCNCC3)c3ncnc(N)c23)cc1C		CHEMBL2030558	>	Ki	nM	10000.0	CHEMBL267	Homo sapiens	Ki	uM	10.0
	10884747	CHEMBL2033710	Inhibition of human SRC by radiometric assay	B	Nc1ncnc2c1cnn2CC1CCNCC1		CHEMBL2030559	>	Ki	nM	10000.0	CHEMBL267	Homo sapiens	Ki	uM	10.0
	10884751	CHEMBL2033710	Inhibition of human SRC by radiometric assay	B	COC(=O)Nc1nc2ccc(C(=O)c3ccccc3)cc2[nH]1		CHEMBL685	>	Ki	nM	10000.0	CHEMBL267	Homo sapiens	Ki	uM	10.0
	10884755	CHEMBL2033710	Inhibition of human SRC by radiometric assay	B	Nc1nc2ccc(C(=O)c3ccccc3)cc2[nH]1		CHEMBL2030560	>	Ki	nM	10000.0	CHEMBL267	Homo sapiens	Ki	uM	10.0
	10884759	CHEMBL2033710	Inhibition of human SRC by radiometric assay	B	Nc1nc2ccc(C(=O)c3ccccc3)cc2n1CC1CCNCC1		CHEMBL2030561	>	Ki	nM	10000.0	CHEMBL267	Homo sapiens	Ki	uM	10.0
	10889053	CHEMBL2032462	Inhibition of Src	B	COc1ccc2c(Oc3ccc(NC(=O)c4c(C)n(CC(C)(C)O)n(-c5ccccc5)c4=O)nc3)ccnc2c1		CHEMBL460472	=	IC50	nM	1000.0	CHEMBL267	Homo sapiens	IC50	uM	1.0
	10889080	CHEMBL2032462	Inhibition of Src	B	COc1cc2nccc(Oc3ccc(NC(=O)c4c(C)n(C)n(-c5ccccc5)c4=O)cc3F)c2cc1OC		CHEMBL2031893	=	IC50	nM	10.0	CHEMBL267	Homo sapiens	IC50	uM	0.01
	10901186	CHEMBL2039537	Inhibition of SRC	B	CP(C)(=O)c1ccc(Nc2nc(C3CCCC3)nc3c2ncn3CCc2cccc(O)c2)cc1		CHEMBL1089405	=	IC50	nM	0.9	CHEMBL267	Homo sapiens	IC50	nM	0.9
	10901187	CHEMBL2039537	Inhibition of SRC	B	CCCP(=O)(CCC)c1ccc(Nc2nc(C(C)C)nc3c2ncn3CC)cc1		CHEMBL2036005	=	IC50	nM	3.9	CHEMBL267	Homo sapiens	IC50	nM	3.9
	10901188	CHEMBL2039537	Inhibition of SRC	B	CCCCP(=O)(CCCC)c1ccc(Nc2nc(C(C)C)nc3c2ncn3CC)cc1		CHEMBL2036006	=	IC50	nM	8.8	CHEMBL267	Homo sapiens	IC50	nM	8.8
	10901189	CHEMBL2039537	Inhibition of SRC	B	CCn1cnc2c(Nc3ccc(P(C)(C)=O)cc3)nc(C(C)C)nc21		CHEMBL2036007	=	IC50	nM	25.1	CHEMBL267	Homo sapiens	IC50	nM	25.1
	10901190	CHEMBL2039537	Inhibition of SRC	B	CCn1cnc2c(Nc3ccc(P(C)(C)=O)cc3)nc(NC3CCOCC3)nc21		CHEMBL2036008	=	IC50	nM	41.2	CHEMBL267	Homo sapiens	IC50	nM	41.2
	10901191	CHEMBL2039537	Inhibition of SRC	B	Cc1cccc(C)c1/C=C/n1cnc2c(Nc3ccc(P(C)(C)=O)cc3)nc(-c3ccccn3)nc21		CHEMBL2036009	=	IC50	nM	43.1	CHEMBL267	Homo sapiens	IC50	nM	43.1
	10901192	CHEMBL2039537	Inhibition of SRC	B	C=Cn1cnc2c(Nc3ccc(P(C)(C)=O)cc3)nc(N3CCC(CO)CC3)nc21		CHEMBL2036010	=	IC50	nM	155.0	CHEMBL267	Homo sapiens	IC50	nM	155.0
	10901193	CHEMBL2039537	Inhibition of SRC	B	C=Cn1cnc2c(Nc3ccc(P(C)(C)=O)cc3)nc(OC3CCOC3)nc21		CHEMBL2036011	=	IC50	nM	188.0	CHEMBL267	Homo sapiens	IC50	nM	188.0
	10901194	CHEMBL2039537	Inhibition of SRC	B	CP(C)(=O)c1ccc(Nc2ncnc3c2ncn3/C=C/c2cccc3[nH]ccc23)cc1		CHEMBL454868	=	IC50	nM	198.0	CHEMBL267	Homo sapiens	IC50	nM	198.0
	10901195	CHEMBL2039537	Inhibition of SRC	B	CCn1cnc2c(Nc3ccc(C(C)C)cc3)nc(C(C)C)nc21		CHEMBL2036012	=	IC50	nM	385.0	CHEMBL267	Homo sapiens	IC50	nM	385.0
	10901196	CHEMBL2039537	Inhibition of SRC	B	C=Cn1cnc2c(Nc3ccc(P(C)(C)=O)cc3)ncnc21		CHEMBL2036013	=	IC50	nM	1000.0	CHEMBL267	Homo sapiens	IC50	nM	1000.0
Not Active	10912564	CHEMBL2038047	Inhibition of recombinant SRC at <10 uM by radiometric kinase assay	B	Cn1c(=O)c2ccc(-c3nc4ccccc4n3C)nc2n(C)c1=O		CHEMBL2036871		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	10913474	CHEMBL2038047	Inhibition of recombinant SRC at <10 uM by radiometric kinase assay	B	Cn1c(-c2ccnc(Nc3ccccc3)n2)nc2ccccc21		CHEMBL2036725		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	10913490	CHEMBL2038047	Inhibition of recombinant SRC at <10 uM by radiometric kinase assay	B	Cc1ccc(Nc2nccc(-c3nc4ccccc4n3C)n2)cc1		CHEMBL2036726		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	10913506	CHEMBL2038047	Inhibition of recombinant SRC at <10 uM by radiometric kinase assay	B	Cn1c(-c2ccnc(Nc3ccc(Cl)cc3)n2)nc2ccccc21		CHEMBL2036727		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	10913522	CHEMBL2038047	Inhibition of recombinant SRC at <10 uM by radiometric kinase assay	B	Cn1c(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)nc2ccccc21		CHEMBL2036728		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	10913538	CHEMBL2038047	Inhibition of recombinant SRC at <10 uM by radiometric kinase assay	B	CCOc1ccc(Nc2nccc(-c3nc4ccccc4n3C)n2)cc1		CHEMBL2036867		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	10913554	CHEMBL2038047	Inhibition of recombinant SRC at <10 uM by radiometric kinase assay	B	COc1ccc(Nc2nccc(-c3nc4ccccc4n3C)n2)cc1		CHEMBL2036868		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	10923955	CHEMBL2044298	Inhibition of SRC incubated for 30 mins prior to substrate addition study done at apparent ATP Km for enzyme	B	C[C@H](/C=C\C(F)(F)F)Oc1cc(-c2cc(-c3cc(CN(C)C)cs3)cnc2N)ccc1C(N)=O		CHEMBL2042135	=	IC50	nM	840.0	CHEMBL267	Homo sapiens	IC50	uM	0.84
	10923976	CHEMBL2044297	Inhibition of SRC at 1 uM incubated for 30 mins prior to substrate addition study done at apparent ATP Km for enzyme	B	C[C@H](/C=C\C(F)(F)F)Oc1cc(-c2cc(-c3cc(CN(C)C)cs3)cnc2N)ccc1C(N)=O		CHEMBL2042135	=	Inhibition	%	51.0	CHEMBL267	Homo sapiens	INH	%	51.0
	10949778	CHEMBL2050664	Inhibition of Src using ATP preincubated with compound for 5 mins measured after 10 mins	B	CC(C)(N)C(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc5sncc45)c(Cl)c3)c21		CHEMBL2048912	=	IC50	nM	8400.0	CHEMBL267	Homo sapiens	IC50	nM	8400.0
	10956808	CHEMBL2061830	Inhibition of human SRC	B	COC(=O)Nc1nc2ccc(C(=O)c3ccccc3)cc2[nH]1		CHEMBL685	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	10956809	CHEMBL2061830	Inhibition of human SRC	B	Nc1nc2ccc(C(=O)c3ccccc3)cc2[nH]1		CHEMBL2030560	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	10956810	CHEMBL2061830	Inhibition of human SRC	B	NCCC(=O)Nc1nc2ccc(C(=O)c3ccccc3)cc2[nH]1		CHEMBL2059166	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	10956811	CHEMBL2061830	Inhibition of human SRC	B	Nc1nc2ccc(C(=O)c3ccccc3)cc2n1CC1CCNCC1		CHEMBL2030561	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	10956812	CHEMBL2061830	Inhibition of human SRC	B	Nc1nc2ccc(C(=O)c3ccccc3)cc2n1CCC1CCNCC1		CHEMBL2059176	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	10956813	CHEMBL2061830	Inhibition of human SRC	B	CN1CCC(CCn2c(N)nc3ccc(C(=O)c4ccccc4)cc32)CC1		CHEMBL2059177	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	10956814	CHEMBL2061830	Inhibition of human SRC	B	Nc1nc2ccc(C(=O)c3ccccc3)cc2n1CC[C@@H]1CCCN1		CHEMBL2059353	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	10956815	CHEMBL2061830	Inhibition of human SRC	B	CN1CCN(CCn2c(N)nc3ccc(C(=O)c4ccccc4)cc32)CC1		CHEMBL2059361	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	10956816	CHEMBL2061830	Inhibition of human SRC	B	NCCC(=O)Nc1nc2ccc(C(=O)c3ccccc3)cc2n1CC1CCNCC1		CHEMBL2059365	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	10967447	CHEMBL2066002	Inhibition of SRC	B	CCOC(=O)c1ccc(Nc2ncnc3cc4oc(=O)n(CCCN5CCOCC5)c4cc23)cc1		CHEMBL2064374	=	IC50	nM	3100.0	CHEMBL267	Homo sapiens	IC50	uM	3.1
	10967448	CHEMBL2066002	Inhibition of SRC	B	O=c1oc2cc3ncnc(Nc4ccc(O)cc4)c3cc2n1CCCN1CCOCC1		CHEMBL2064381	=	IC50	nM	66000.0	CHEMBL267	Homo sapiens	IC50	uM	66.0
	10967449	CHEMBL2066002	Inhibition of SRC	B	Cc1ccc(Nc2ncnc3cc4oc(=O)n(CCCN5CCOCC5)c4cc23)cc1		CHEMBL2064383	=	IC50	nM	7500.0	CHEMBL267	Homo sapiens	IC50	uM	7.5
	10967450	CHEMBL2066002	Inhibition of SRC	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	IC50	nM	73.0	CHEMBL267	Homo sapiens	IC50	uM	0.073
Not Active	10967451	CHEMBL2066003	Inhibition of SRC at >100 uM	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	10975657	CHEMBL2064944	Inhibition of Src in presence of 10 uM ATP	B	Nc1ncnn2ccc(C(=O)Nc3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1990583	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	10978440	CHEMBL2066789	Inhibition of human recombinant Src expressed in insect cells using ulight-Poly GAT[EAY(1:1:1)]n as substrate assessed as residual activity at 1 uM after 10 mins by Cerep assay	B	N#Cc1ccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCO5)o3)cc2)cc1		CHEMBL2064515	>	Activity	%	80.0	CHEMBL267	Homo sapiens	Activity	%	80.0
	10980288	CHEMBL2065133	Inhibition of SRC at 10 uM by FRET assay	B	CSc1ccccc1Nc1nc(N2CC3(CNC3)C2)nc2c(NCC3CC3)ncnc12		CHEMBL2017253	=	Inhibition	%	25.0	CHEMBL267	Homo sapiens	INH	%	25.0
	10980289	CHEMBL2065133	Inhibition of SRC at 10 uM by FRET assay	B	CSc1ccccc1Nc1nc(N2CCN(C3CCNCC3)CC2)nc2c(NCC3CC3)ncnc12		CHEMBL2063926	<	Inhibition	%	15.0	CHEMBL267	Homo sapiens	INH	%	15.0
	10980319	CHEMBL2065163	Inhibition of SRC by FRET assay	B	CSc1ccccc1Nc1nc(N2CCN(C3CCNCC3)CC2)nc2c(NCC3CC3)ncnc12		CHEMBL2063926	<	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
Active	10983889	CHEMBL2071983	Inhibition of SRC using biotinylated HNRNPK as substrate at 0.2 to 6 uM by blotting method	B	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	10983890	CHEMBL2071984	Inhibition of SRC using biotinylated HNRNPK as substrate up to 6 uM by blotting method	B	CN(C)c1ccc(/C=C/c2ccc3ncnc(NCc4ccccc4)c3c2)cc1		CHEMBL2071602		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	10984764	CHEMBL2072060	Inhibition of human cSRC at 1 uM	B	Nc1cc(Nc2cnccn2)nc(-c2ccnc(N3CCNCC3)c2)c1		CHEMBL2069349	>	Inhibition	%	50.0	CHEMBL267	Homo sapiens	INH	%	50.0
	10990440	CHEMBL2072943	Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphor imaging method	B	CC(C)(C)n1ncc2c(N)ncnc21.Cl		CHEMBL2069936	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	10990441	CHEMBL2072943	Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphor imaging method	B	Cl.Nc1ncnc2c1cnn2CC1CCNCC1		CHEMBL2069937	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	10990442	CHEMBL2072943	Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphor imaging method	B	CC(C)(C)n1nc(-c2ccccc2)c2c(N)ncnc21.Cl		CHEMBL2069938	=	IC50	nM	130.0	CHEMBL267	Homo sapiens	IC50	uM	0.13
	10990443	CHEMBL2072943	Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphor imaging method	B	Cl.Nc1ncnc2c1c(-c1ccccc1)nn2CC1CCNCC1		CHEMBL2069939	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	10990444	CHEMBL2072943	Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphor imaging method	B	Cc1cccc(-c2nn(C(C)C)c3ncnc(N)c23)c1.Cl		CHEMBL2069940	=	IC50	nM	1300.0	CHEMBL267	Homo sapiens	IC50	uM	1.3
	10990445	CHEMBL2072943	Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphor imaging method	B	Cc1cccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)c1.Cl		CHEMBL2069941	=	IC50	nM	580.0	CHEMBL267	Homo sapiens	IC50	uM	0.58
	10990446	CHEMBL2072943	Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphor imaging method	B	COc1ccc(-c2nn(C(C)C)c3ncnc(N)c23)cc1.Cl		CHEMBL2069942	=	IC50	nM	5100.0	CHEMBL267	Homo sapiens	IC50	uM	5.1
	10990447	CHEMBL2072943	Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphor imaging method	B	COc1ccc(-c2nn(C(C)C)c3ncnc(N)c23)cc1C.Cl		CHEMBL2069943	=	IC50	nM	650.0	CHEMBL267	Homo sapiens	IC50	uM	0.65
	10990448	CHEMBL2072943	Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphor imaging method	B	COc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1C.Cl		CHEMBL2069944	=	IC50	nM	180.0	CHEMBL267	Homo sapiens	IC50	uM	0.18
	10990449	CHEMBL2072943	Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphor imaging method	B	COc1ccc(-c2nn(CC3CCNCC3)c3ncnc(N)c23)cc1C.Cl		CHEMBL2069945	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	10990450	CHEMBL2072943	Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphor imaging method	B	CC(C)n1nc(-c2cc3ccccc3[nH]2)c2c(N)ncnc21.Cl		CHEMBL2069946	=	IC50	nM	1500.0	CHEMBL267	Homo sapiens	IC50	uM	1.5
	10990451	CHEMBL2072943	Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphor imaging method	B	Cl.Nc1ncnc2c1c(-c1cc3ccccc3[nH]1)nn2CC1CCNCC1		CHEMBL2069947	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	10990452	CHEMBL2072943	Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphor imaging method	B	CC(C)n1nc(-c2cc3c(Cl)cccc3[nH]2)c2c(N)ncnc21.Cl		CHEMBL2069948	=	IC50	nM	1200.0	CHEMBL267	Homo sapiens	IC50	uM	1.2
	10990453	CHEMBL2072943	Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphor imaging method	B	Cl.Nc1ncnc2c1c(-c1cc3c(Cl)cccc3[nH]1)nn2CC1CCNCC1		CHEMBL2069949	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	10990454	CHEMBL2072943	Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphor imaging method	B	CC(C)n1nc(-c2ccc3c(ccn3C)c2)c2c(N)ncnc21.Cl		CHEMBL2069950	=	IC50	nM	290.0	CHEMBL267	Homo sapiens	IC50	uM	0.29
	10990455	CHEMBL2072943	Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphor imaging method	B	Cl.Cn1ccc2cc(-c3nn(C(C)(C)C)c4ncnc(N)c34)ccc21		CHEMBL2069951	=	IC50	nM	520.0	CHEMBL267	Homo sapiens	IC50	uM	0.52
	10990456	CHEMBL2072943	Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphor imaging method	B	Cl.Cn1ncc2cc(-c3nn(C(C)(C)C)c4ncnc(N)c34)ccc21		CHEMBL2069952	=	IC50	nM	2100.0	CHEMBL267	Homo sapiens	IC50	uM	2.1
	10990457	CHEMBL2072943	Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphor imaging method	B	Cl.Cn1ncc2cc(-c3nn(CC4CCNCC4)c4ncnc(N)c34)ccc21		CHEMBL2069953	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	10990458	CHEMBL2072943	Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphor imaging method	B	CC(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21.Cl		CHEMBL2069954	=	IC50	nM	8800.0	CHEMBL267	Homo sapiens	IC50	uM	8.8
	10990459	CHEMBL2072943	Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphor imaging method	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21.Cl		CHEMBL2069955	=	IC50	nM	2200.0	CHEMBL267	Homo sapiens	IC50	uM	2.2
	10990460	CHEMBL2072943	Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphor imaging method	B	Cl.Nc1ncnc2c1c(Cc1cccc3ccccc13)nn2CC1CCNCC1		CHEMBL2069314	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	10990461	CHEMBL2072943	Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphor imaging method	B	CC(C)n1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21.Cl		CHEMBL2069956	=	IC50	nM	65.0	CHEMBL267	Homo sapiens	IC50	uM	0.065
	10990462	CHEMBL2072943	Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphor imaging method	B	CC(C)(C)n1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21.Cl		CHEMBL2069957	=	IC50	nM	120.0	CHEMBL267	Homo sapiens	IC50	uM	0.12
	10990463	CHEMBL2072943	Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphor imaging method	B	Cl.Nc1ncnc2c1c(-c1ccc3ccccc3c1)nn2CC1CCNCC1		CHEMBL2069958	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	10990464	CHEMBL2072943	Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphor imaging method	B	CC(C)n1nc(-c2cnc3ccccc3c2)c2c(N)ncnc21.Cl		CHEMBL2069959	=	IC50	nM	200.0	CHEMBL267	Homo sapiens	IC50	uM	0.2
	10990465	CHEMBL2072943	Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphor imaging method	B	Cl.Nc1ncnc2c1c(-c1cnc3ccccc3c1)nn2CC1CCNCC1		CHEMBL2069960	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	10990466	CHEMBL2072943	Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphor imaging method	B	CC(C)(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21.Cl		CHEMBL2069961	=	IC50	nM	4100.0	CHEMBL267	Homo sapiens	IC50	uM	4.1
	10991066	CHEMBL2072943	Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphor imaging method	B	Cl.Nc1ncnc2c1c(-c1ccc3ncccc3c1)nn2CC1CCNCC1		CHEMBL2070044	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	10991067	CHEMBL2072943	Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphor imaging method	B	COc1ccc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2c1.Cl		CHEMBL2070045	=	IC50	nM	670.0	CHEMBL267	Homo sapiens	IC50	uM	0.67
	10991068	CHEMBL2072943	Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphor imaging method	B	COc1ccc2cc(-c3nn(C(C)(C)C)c4ncnc(N)c34)ccc2c1.Cl		CHEMBL2070046	=	IC50	nM	2000.0	CHEMBL267	Homo sapiens	IC50	uM	2.0
	10991069	CHEMBL2072943	Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphor imaging method	B	COc1ccc2cc(-c3nn(CC4CCNCC4)c4ncnc(N)c34)ccc2c1.Cl		CHEMBL2070047	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	10991070	CHEMBL2072943	Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphor imaging method	B	CCOc1ccc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2c1.Cl		CHEMBL2070048	=	IC50	nM	380.0	CHEMBL267	Homo sapiens	IC50	uM	0.38
	10991071	CHEMBL2072943	Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphor imaging method	B	CCOc1ccc2cc(-c3nn(C(C)(C)C)c4ncnc(N)c34)ccc2c1.Cl		CHEMBL2070049	=	IC50	nM	2200.0	CHEMBL267	Homo sapiens	IC50	uM	2.2
	10991072	CHEMBL2072943	Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphor imaging method	B	CCOc1ccc2cc(-c3nn(CC4CCNCC4)c4ncnc(N)c34)ccc2c1.Cl		CHEMBL2070050	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	10991073	CHEMBL2072943	Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphor imaging method	B	CCOc1ccc2cc(-c3nn(CC4CCNCC4)c4ncnc(N)c34)ccc2n1.Cl		CHEMBL2070051	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	10991074	CHEMBL2072943	Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphor imaging method	B	CC(C)Oc1ccc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2c1.Cl		CHEMBL2070052	=	IC50	nM	550.0	CHEMBL267	Homo sapiens	IC50	uM	0.55
	10991075	CHEMBL2072943	Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphor imaging method	B	CC(C)Oc1ccc2cc(-c3nn(CC4CCNCC4)c4ncnc(N)c34)ccc2c1.Cl		CHEMBL2070053	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	10991076	CHEMBL2072943	Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphor imaging method	B	C=CCOc1ccc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2c1.Cl		CHEMBL2070054	=	IC50	nM	200.0	CHEMBL267	Homo sapiens	IC50	uM	0.2
	10991077	CHEMBL2072943	Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphor imaging method	B	C=CCOc1ccc2cc(-c3nn(CC4CCNCC4)c4ncnc(N)c34)ccc2c1.Cl		CHEMBL2069315	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	10991078	CHEMBL2072943	Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphor imaging method	B	CCCOc1ccc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2c1.Cl		CHEMBL2070055	=	IC50	nM	300.0	CHEMBL267	Homo sapiens	IC50	uM	0.3
	10991079	CHEMBL2072943	Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphor imaging method	B	CCCOc1ccc2cc(-c3nn(CC4CCNCC4)c4ncnc(N)c34)ccc2c1.Cl		CHEMBL2070056	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	10991080	CHEMBL2072943	Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphor imaging method	B	CC(C)COc1ccc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2c1.Cl		CHEMBL2070057	=	IC50	nM	260.0	CHEMBL267	Homo sapiens	IC50	uM	0.26
	10991081	CHEMBL2072943	Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphor imaging method	B	CC(C)COc1ccc2cc(-c3nn(C(C)(C)C)c4ncnc(N)c34)ccc2c1.Cl		CHEMBL2070058	=	IC50	nM	1100.0	CHEMBL267	Homo sapiens	IC50	uM	1.1
	10991082	CHEMBL2072943	Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphor imaging method	B	CC(C)COc1ccc2cc(-c3nn(CC4CCNCC4)c4ncnc(N)c34)ccc2c1.Cl		CHEMBL2070059	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	10991083	CHEMBL2072943	Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphor imaging method	B	CCCCOc1ccc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2c1.Cl		CHEMBL2070060	=	IC50	nM	780.0	CHEMBL267	Homo sapiens	IC50	uM	0.78
	10991084	CHEMBL2072943	Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphor imaging method	B	CCCCOc1ccc2cc(-c3nn(CC4CCNCC4)c4ncnc(N)c34)ccc2c1.Cl		CHEMBL2070061	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	10991085	CHEMBL2072943	Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphor imaging method	B	CC(C)n1nc(-c2ccc3cc(OCc4ccccc4)ccc3c2)c2c(N)ncnc21.Cl		CHEMBL2070062	=	IC50	nM	41.0	CHEMBL267	Homo sapiens	IC50	uM	0.041
	10991086	CHEMBL2072943	Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphor imaging method	B	Cl.Nc1ncnc2c1c(-c1ccc3cc(OCc4ccccc4)ccc3c1)nn2CC1CCNCC1		CHEMBL2070063	=	IC50	nM	3100.0	CHEMBL267	Homo sapiens	IC50	uM	3.1
	10991087	CHEMBL2072943	Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphor imaging method	B	CC(C)n1nc(-c2ccc3cc(OCc4ccccc4Cl)ccc3c2)c2c(N)ncnc21.Cl		CHEMBL2070064	=	IC50	nM	280.0	CHEMBL267	Homo sapiens	IC50	uM	0.28
	10991088	CHEMBL2072943	Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphor imaging method	B	Cl.Nc1ncnc2c1c(-c1ccc3cc(OCc4ccccc4Cl)ccc3c1)nn2CC1CCNCC1		CHEMBL2070065	=	IC50	nM	1800.0	CHEMBL267	Homo sapiens	IC50	uM	1.8
	10991089	CHEMBL2072943	Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphor imaging method	B	CC(C)n1nc(-c2ccc3cc(OCc4cccc(Cl)c4)ccc3c2)c2c(N)ncnc21.Cl		CHEMBL2070066	=	IC50	nM	280.0	CHEMBL267	Homo sapiens	IC50	uM	0.28
	10991090	CHEMBL2072943	Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphor imaging method	B	Cl.Nc1ncnc2c1c(-c1ccc3cc(OCc4cccc(Cl)c4)ccc3c1)nn2CC1CCNCC1		CHEMBL2070067	=	IC50	nM	380.0	CHEMBL267	Homo sapiens	IC50	uM	0.38
	10991091	CHEMBL2072943	Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphor imaging method	B	CC(C)n1nc(-c2ccc3cc(OCc4ccc(Cl)cc4)ccc3c2)c2c(N)ncnc21.Cl		CHEMBL2070068	=	IC50	nM	270.0	CHEMBL267	Homo sapiens	IC50	uM	0.27
	10991092	CHEMBL2072943	Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphor imaging method	B	Cl.Nc1ncnc2c1c(-c1ccc3cc(OCc4ccc(Cl)cc4)ccc3c1)nn2CC1CCNCC1		CHEMBL2070069	=	IC50	nM	1600.0	CHEMBL267	Homo sapiens	IC50	uM	1.6
	10991093	CHEMBL2072943	Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphor imaging method	B	CCOc1ccc2cc(-c3nn(C[C@@H](N)C(C)C)c4ncnc(N)c34)ccc2c1.Cl		CHEMBL2070070	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	10991094	CHEMBL2072943	Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphor imaging method	B	CCOc1ccc2cc(-c3nn(C[C@H](C(C)C)N(C)C)c4ncnc(N)c34)ccc2c1.Cl		CHEMBL2070071	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	10991095	CHEMBL2072943	Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphor imaging method	B	CCOc1ccc2cc(-c3nn(C[C@H]4CCCN4)c4ncnc(N)c34)ccc2c1.Cl		CHEMBL2070072	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	10991096	CHEMBL2072943	Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphor imaging method	B	CCOc1ccc2cc(-c3nn(C[C@H]4CCCN4C)c4ncnc(N)c34)ccc2c1.Cl		CHEMBL2070073	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	10991097	CHEMBL2072943	Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphor imaging method	B	CCOc1ccc2cc(-c3nn(C4CCNCC4)c4ncnc(N)c34)ccc2c1.Cl		CHEMBL2070074	=	IC50	nM	5000.0	CHEMBL267	Homo sapiens	IC50	uM	5.0
	10991098	CHEMBL2072943	Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphor imaging method	B	CCOc1ccc2cc(-c3nn(C4CCN(C)CC4)c4ncnc(N)c34)ccc2c1.Cl		CHEMBL2070075	=	IC50	nM	5600.0	CHEMBL267	Homo sapiens	IC50	uM	5.6
	10991099	CHEMBL2072943	Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphor imaging method	B	CCOc1ccc2cc(-c3nn(C4CCN(CC)CC4)c4ncnc(N)c34)ccc2c1.Cl		CHEMBL2070076	=	IC50	nM	8700.0	CHEMBL267	Homo sapiens	IC50	uM	8.7
	10991100	CHEMBL2072943	Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphor imaging method	B	CCCN1CCC(n2nc(-c3ccc4cc(OCC)ccc4c3)c3c(N)ncnc32)CC1.Cl		CHEMBL2070077	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	10991101	CHEMBL2072943	Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphor imaging method	B	CCOc1ccc2cc(-c3nn(C4CCN(CCCN)CC4)c4ncnc(N)c34)ccc2c1.Cl		CHEMBL2070078	=	IC50	nM	730.0	CHEMBL267	Homo sapiens	IC50	uM	0.73
	10991102	CHEMBL2072943	Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphor imaging method	B	CCOc1ccc2cc(-c3nn(C4CCN(C(C)=O)CC4)c4ncnc(N)c34)ccc2c1.Cl		CHEMBL2070079	=	IC50	nM	1600.0	CHEMBL267	Homo sapiens	IC50	uM	1.6
	10991103	CHEMBL2072943	Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphor imaging method	B	CCOc1ccc2cc(-c3nn(C4CCN(S(C)(=O)=O)CC4)c4ncnc(N)c34)ccc2c1.Cl		CHEMBL2070080	=	IC50	nM	810.0	CHEMBL267	Homo sapiens	IC50	uM	0.81
	10991104	CHEMBL2072943	Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphor imaging method	B	CCOc1ccc2cc(-c3nn(CC4CCN(C)CC4)c4ncnc(N)c34)ccc2c1.Cl		CHEMBL2070081	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	10991105	CHEMBL2072943	Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphor imaging method	B	CCOc1ccc2cc(-c3nn(CC4CCN(CC)CC4)c4ncnc(N)c34)ccc2c1.Cl		CHEMBL2070082	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	10991106	CHEMBL2072943	Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphor imaging method	B	CCOc1ccc2cc(-c3nn(CC4CCN(C(C)=O)CC4)c4ncnc(N)c34)ccc2c1.Cl		CHEMBL2070083	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	10991107	CHEMBL2072943	Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphor imaging method	B	CCOc1ccc2cc(-c3nn(CC4CCN(S(C)(=O)=O)CC4)c4ncnc(N)c34)ccc2c1.Cl		CHEMBL2070084	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	10991108	CHEMBL2072943	Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphor imaging method	B	CCOc1ccc2cc(-c3nn(CCC4CCNCC4)c4ncnc(N)c34)ccc2c1.Cl		CHEMBL2070085	=	IC50	nM	3300.0	CHEMBL267	Homo sapiens	IC50	uM	3.3
	10991109	CHEMBL2072943	Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphor imaging method	B	CCOc1ccc2cc(-c3nn(CCC4CCN(C)CC4)c4ncnc(N)c34)ccc2c1.Cl		CHEMBL2070086	=	IC50	nM	5200.0	CHEMBL267	Homo sapiens	IC50	uM	5.2
	10991110	CHEMBL2072943	Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphor imaging method	B	CCOc1ccc2cc(-c3nn(CCC4CCN(CC)CC4)c4ncnc(N)c34)ccc2c1.Cl		CHEMBL2070087	=	IC50	nM	6300.0	CHEMBL267	Homo sapiens	IC50	uM	6.3
	10991111	CHEMBL2072943	Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphor imaging method	B	CCCN1CCC(CCn2nc(-c3ccc4cc(OCC)ccc4c3)c3c(N)ncnc32)CC1.Cl		CHEMBL2070088	=	IC50	nM	6700.0	CHEMBL267	Homo sapiens	IC50	uM	6.7
	10991112	CHEMBL2072943	Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphor imaging method	B	CCOc1ccc2cc(-c3nn(CCC4CCN(CCCN)CC4)c4ncnc(N)c34)ccc2c1.Cl		CHEMBL2070089	=	IC50	nM	8200.0	CHEMBL267	Homo sapiens	IC50	uM	8.2
	10993445	CHEMBL2073049	Inhibition of c-Src	B	ClC(Cn1ncc2c(NCc3ccccc3)ncnc21)c1ccccc1		CHEMBL411043	=	Ki	nM	3000.0	CHEMBL267	Homo sapiens	Ki	uM	3.0
	10993446	CHEMBL2073049	Inhibition of c-Src	B	Clc1cccc(Nc2nc(SCCN3CCOCC3)nc3c2cnn3CC(Cl)c2ccccc2)c1		CHEMBL1775036	=	Ki	nM	190.0	CHEMBL267	Homo sapiens	Ki	uM	0.19
	10993447	CHEMBL2073049	Inhibition of c-Src	B	ClC(Cn1ncc2c(Nc3ccccc3)nc(SCCN3CCOCC3)nc21)c1ccccc1		CHEMBL1775035	=	Ki	nM	210.0	CHEMBL267	Homo sapiens	Ki	uM	0.21
	10993448	CHEMBL2073049	Inhibition of c-Src	B	ClC(Cn1ncc2c(NCc3ccccc3)nc(SCCN3CCOCC3)nc21)c1ccccc1		CHEMBL1775039	=	Ki	nM	2900.0	CHEMBL267	Homo sapiens	Ki	uM	2.9
	10993449	CHEMBL2073049	Inhibition of c-Src	B	CCCNc1nc(SCCN2CCOCC2)nc2c1cnn2CC(Cl)c1ccccc1		CHEMBL1775040	=	Ki	nM	3800.0	CHEMBL267	Homo sapiens	Ki	uM	3.8
	10993450	CHEMBL2073049	Inhibition of c-Src	B	Fc1ccc(CNc2nc(SCCN3CCOCC3)nc3c2cnn3CC(Cl)c2ccccc2)cc1		CHEMBL1775038	=	Ki	nM	1200.0	CHEMBL267	Homo sapiens	Ki	uM	1.2
	10993451	CHEMBL2073049	Inhibition of c-Src	B	OC(Cn1ncc2c(NCCc3ccccc3)ncnc21)c1ccccc1		CHEMBL378603	=	Ki	nM	2400.0	CHEMBL267	Homo sapiens	Ki	uM	2.4
	10993452	CHEMBL2073049	Inhibition of c-Src	B	OCCNc1nc(NCCc2ccccc2)c2cnn(/C=C\c3ccccc3)c2n1		CHEMBL1775042	=	Ki	nM	2400.0	CHEMBL267	Homo sapiens	Ki	uM	2.4
Not Active	10993463	CHEMBL2073051	Inhibition of c-Src at 100 uM	B	ClC(Cn1ncc2c(NCCc3ccccc3)nc(SCCN3CCOCC3)nc21)c1ccccc1		CHEMBL1775037		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	10993464	CHEMBL2073051	Inhibition of c-Src at 100 uM	B	C(=C\n1ncc2c(NCCc3ccccc3)ncnc21)\c1ccccc1		CHEMBL203493		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	10993504	CHEMBL2073080	Inhibition of Src at 10 uM	B	ClC(Cn1ncc2c(NCc3ccccc3)ncnc21)c1ccccc1		CHEMBL411043	=	Inhibition	%	89.0	CHEMBL267	Homo sapiens	INH	%	89.0
	11020084	CHEMBL2091832	Inhibition of SRC	B	CCN1CCC(Nc2ccc3c(c2)C(=C(c2ccc(Cl)cc2)c2ncc[nH]2)C(=O)N3)CC1		CHEMBL2086760	=	IC50	nM	33.0	CHEMBL267	Homo sapiens	IC50	nM	33.0
Not Active	11022089	CHEMBL2090281	Inhibition of c-Src at >1000 nM	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	12036446	CHEMBL2150417	Inhibition of Src after 5 mins	B	CC(C)(C(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(Cl)c4)c(Cl)c3)c21)S(C)(=O)=O.Cc1ccc(S(=O)(=O)O)cc1		CHEMBL2148053	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	12047353	CHEMBL2157706	Inhibition of Src at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	Inhibition	%	4.7	CHEMBL267	Homo sapiens	INH	%	4.7
Not Active	12047546	CHEMBL2155540	Inhibition of SRC at 10 uM	B	COc1ccc2c(c1)C(=O)c1ccc(Nc3ccccc3Cl)cc1CC2		CHEMBL2152781		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	12048337	CHEMBL2155540	Inhibition of SRC at 10 uM	B	COc1ccc2c(c1)C(=O)c1ccc(Nc3ccccc3C(F)(F)F)cc1CC2		CHEMBL2152782		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	12048352	CHEMBL2155540	Inhibition of SRC at 10 uM	B	COc1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3Cl)cc1CC2		CHEMBL2152785		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	12048367	CHEMBL2155540	Inhibition of SRC at 10 uM	B	COc1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3C)cc1CC2		CHEMBL2152786		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	12048382	CHEMBL2155540	Inhibition of SRC at 10 uM	B	COc1ccc2c(c1)C(=O)c1ccc(Nc3ccc(C(F)(F)F)cc3N)cc1CC2		CHEMBL2152787		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	12048397	CHEMBL2155540	Inhibition of SRC at 10 uM	B	COc1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(C)c3)cc1CC2		CHEMBL2152788		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	12048412	CHEMBL2155540	Inhibition of SRC at 10 uM	B	COc1ccc2c(c1)C(=O)c1ccc(Nc3cc(F)cc(F)c3F)cc1CC2		CHEMBL2152789		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	12048427	CHEMBL2155540	Inhibition of SRC at 10 uM	B	COc1ccc2c(c1)C(=O)c1ccc(-c3ccccc3)cc1CC2		CHEMBL2152791		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	12048442	CHEMBL2155540	Inhibition of SRC at 10 uM	B	COc1ccc2ccc3cc(Nc4ccc(F)cc4F)ccc3c(=O)c2c1		CHEMBL2152792		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	12048457	CHEMBL2155540	Inhibition of SRC at 10 uM	B	CC1(C)OC[C@H](COc2ccc3c(c2)C(=O)c2ccc(Nc4ccccc4N)cc2CC3)O1		CHEMBL2152798		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	12048472	CHEMBL2155540	Inhibition of SRC at 10 uM	B	Nc1ccccc1Nc1ccc2c(c1)CCc1ccc(OC[C@H](O)CO)cc1C2=O		CHEMBL2152936		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	12048487	CHEMBL2155540	Inhibition of SRC at 10 uM	B	Nc1ccccc1Nc1ccc2c(=O)c3cc(OCCN4CCOCC4)ccc3ccc2c1		CHEMBL2152939		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	12048502	CHEMBL2155540	Inhibition of SRC at 10 uM	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OCCO)cc21		CHEMBL2152940		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	12048517	CHEMBL2155540	Inhibition of SRC at 10 uM	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OCCCO)cc21		CHEMBL2152941		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	12048532	CHEMBL2155540	Inhibition of SRC at 10 uM	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC3CCOCC3)cc21		CHEMBL2152942		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	12048547	CHEMBL2155540	Inhibition of SRC at 10 uM	B	CC1(C)OC[C@H](COc2ccc3c(c2)C(=O)c2ccc(Nc4ccc(F)cc4F)cc2CC3)O1		CHEMBL2152943		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	12048562	CHEMBL2155540	Inhibition of SRC at 10 uM	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@@H](O)CO)cc21		CHEMBL2152946		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	12048577	CHEMBL2155540	Inhibition of SRC at 10 uM	B	CC1(C)OC[C@@H](CCOc2ccc3c(c2)C(=O)c2ccc(Nc4ccc(F)cc4F)cc2CC3)O1		CHEMBL2152947		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	12048592	CHEMBL2155540	Inhibition of SRC at 10 uM	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OCCCN3CCOCC3)cc21		CHEMBL2152950		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	12048607	CHEMBL2155540	Inhibition of SRC at 10 uM	B	CC1(C)OC[C@H](COc2ccc3c(c2)CCc2cc(Nc4ccc(F)cc4F)ccc2C3=O)O1		CHEMBL2152957		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	12048622	CHEMBL2155540	Inhibition of SRC at 10 uM	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2cc(OC[C@H](O)CO)ccc21		CHEMBL2152958		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	12048637	CHEMBL2155540	Inhibition of SRC at 10 uM	B	CC1(C)OC[C@@H](COc2ccc3c(c2)CCc2cc(Nc4ccc(F)cc4F)ccc2C3=O)O1		CHEMBL2152959		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	12048652	CHEMBL2155540	Inhibition of SRC at 10 uM	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2cc(OC[C@@H](O)CO)ccc21		CHEMBL2152960		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	12048667	CHEMBL2155540	Inhibition of SRC at 10 uM	B	COc1cccc2c1CCc1cc(Nc3ccc(F)cc3F)ccc1C2=O		CHEMBL2152965		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	12049611	CHEMBL2155540	Inhibition of SRC at 10 uM	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2c(O)cccc21		CHEMBL2152966		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	12049626	CHEMBL2155540	Inhibition of SRC at 10 uM	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2c1cccc2C1CCOCC1		CHEMBL2152967		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	12049641	CHEMBL2155540	Inhibition of SRC at 10 uM	B	CC1(C)OC[C@H](COc2cccc3c2CCc2cc(Nc4ccc(F)cc4F)ccc2C3=O)O1		CHEMBL2152968		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	12049656	CHEMBL2155540	Inhibition of SRC at 10 uM	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2c(OC[C@H](O)CO)cccc21		CHEMBL2152969		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	12049671	CHEMBL2155540	Inhibition of SRC at 10 uM	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2c(OCCN3CCOCC3)cccc21		CHEMBL2152970		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	12049686	CHEMBL2155540	Inhibition of SRC at 10 uM	B	COc1cccc2c1CCc1cc(Nc3ccccc3N)ccc1C2=O		CHEMBL2152971		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	12049701	CHEMBL2155540	Inhibition of SRC at 10 uM	B	CC1(C)OC[C@H](COc2cccc3c2CCc2cc(Nc4ccccc4N)ccc2C3=O)O1		CHEMBL2152972		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	12049716	CHEMBL2155540	Inhibition of SRC at 10 uM	B	Nc1ccccc1Nc1ccc2c(c1)CCc1c(OC[C@H](O)CO)cccc1C2=O		CHEMBL2152973		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	12051571	CHEMBL2154711	Inhibition of cSrc	B	CC(C)Oc1cc(-n2cnc3ccc(N[C@@H](C)c4ccc(F)cn4)nc32)n[nH]1		CHEMBL2151321	=	IC50	nM	18.2	CHEMBL267	Homo sapiens	IC50	nM	18.2
	12051593	CHEMBL2154972	Inhibition of cSrc at 10 uM	B	CC(C)Oc1cc(-n2cnc3ccc(N[C@@H](C)c4ccc(F)cn4)nc32)n[nH]1		CHEMBL2151321	>	Inhibition	%	30.0	CHEMBL267	Homo sapiens	INH	%	30.0
	12057077	CHEMBL2154040	Inhibition of recombinant Src catalytic domain in presence of 1 uM radiolabeled ATP	B	Cc1ccc(O)cc1-n1c(=O)c2c(c3c(N)ncnc31)CCCC2		CHEMBL2152704	=	IC50	nM	338.0	CHEMBL267	Homo sapiens	IC50	uM	0.338
	12060792	CHEMBL2156909	Inhibition of SRC	B	CNC(=O)c1nc(-c2ccc(Cl)c(S(=O)(=O)Nc3cccc(F)c3F)c2)cnc1N		CHEMBL2152252	>	IC50	nM	3600.0	CHEMBL267	Homo sapiens	IC50	nM	3600.0
	12060793	CHEMBL2156909	Inhibition of SRC	B	CNC(=O)c1nc(-c2ccc(Cl)c(S(=O)(=O)Nc3cccc(F)c3C)c2)cnc1N		CHEMBL2152253	>	IC50	nM	3600.0	CHEMBL267	Homo sapiens	IC50	nM	3600.0
	12074661	CHEMBL2161223	Inhibition of Src at 1 uM	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1		CHEMBL1908842	<	Inhibition	%	50.0	CHEMBL267	Homo sapiens	INH	%	50.0
	12136292	CHEMBL2185481	Inhibition of SRC at 10 uM incubated for 60 mins using poly(Glu,Tyr)4:1 substrate and 10 uM ATP by ELISA	B	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	=	Inhibition	%	94.0	CHEMBL267	Homo sapiens	INH	%	94.0
	12136293	CHEMBL2185481	Inhibition of SRC at 10 uM incubated for 60 mins using poly(Glu,Tyr)4:1 substrate and 10 uM ATP by ELISA	B	N[C@H]1CC[C@H](NC(=O)c2nc(Br)c3cccnc3c2NCc2ccc(F)cc2)CC1		CHEMBL2180249	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
Not Determined	12136294	CHEMBL2185481	Inhibition of SRC at 10 uM incubated for 60 mins using poly(Glu,Tyr)4:1 substrate and 10 uM ATP by ELISA	B	N[C@H]1CC[C@H](Nc2c(C(=O)Nc3ccccc3)nc(Br)c3cccnc23)CC1		CHEMBL2180246		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Determined	12136295	CHEMBL2185481	Inhibition of SRC at 10 uM incubated for 60 mins using poly(Glu,Tyr)4:1 substrate and 10 uM ATP by ELISA	B	N[C@H]1CC[C@H](Nc2c(C(=O)NCCc3ccccc3)nc(Br)c3cccnc23)CC1		CHEMBL2180245		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	12136296	CHEMBL2185481	Inhibition of SRC at 10 uM incubated for 60 mins using poly(Glu,Tyr)4:1 substrate and 10 uM ATP by ELISA	B	N[C@H]1CC[C@H](Nc2c(C(=O)NCc3ccc(Cl)cc3Cl)nc(Br)c3cccnc23)CC1		CHEMBL2180568	=	Inhibition	%	90.0	CHEMBL267	Homo sapiens	INH	%	90.0
	12136297	CHEMBL2185481	Inhibition of SRC at 10 uM incubated for 60 mins using poly(Glu,Tyr)4:1 substrate and 10 uM ATP by ELISA	B	N[C@H]1CC[C@H](Nc2c(C(=O)NCc3ccc(Cl)cc3)nc(Br)c3cccnc23)CC1		CHEMBL2180567	=	Inhibition	%	70.0	CHEMBL267	Homo sapiens	INH	%	70.0
Not Determined	12136298	CHEMBL2185481	Inhibition of SRC at 10 uM incubated for 60 mins using poly(Glu,Tyr)4:1 substrate and 10 uM ATP by ELISA	B	COc1cccc(CNC(=O)c2nc(Br)c3cccnc3c2N[C@H]2CC[C@H](N)CC2)c1		CHEMBL2180565		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Determined	12136299	CHEMBL2185481	Inhibition of SRC at 10 uM incubated for 60 mins using poly(Glu,Tyr)4:1 substrate and 10 uM ATP by ELISA	B	N[C@H]1CC[C@H](Nc2c(C(=O)NCc3ccc4c(c3)OCO4)nc(Br)c3cccnc23)CC1		CHEMBL2180562		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	12136300	CHEMBL2185481	Inhibition of SRC at 10 uM incubated for 60 mins using poly(Glu,Tyr)4:1 substrate and 10 uM ATP by ELISA	B	COc1ccc(CNC(=O)c2nc(Br)c3cccnc3c2N[C@H]2CC[C@H](N)CC2)cc1		CHEMBL2180561	=	Inhibition	%	76.0	CHEMBL267	Homo sapiens	INH	%	76.0
Not Determined	12136301	CHEMBL2185481	Inhibition of SRC at 10 uM incubated for 60 mins using poly(Glu,Tyr)4:1 substrate and 10 uM ATP by ELISA	B	N[C@H]1CC[C@H](Nc2c(C(=O)NCc3ccccc3)nc(Br)c3cccnc23)CC1		CHEMBL2180560		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	12136302	CHEMBL2185481	Inhibition of SRC at 10 uM incubated for 60 mins using poly(Glu,Tyr)4:1 substrate and 10 uM ATP by ELISA	B	N[C@H]1CC[C@H](Nc2c(C(=O)NCc3ccc(F)cc3)nc(Br)c3cccnc23)CC1		CHEMBL2180584	=	Inhibition	%	13.0	CHEMBL267	Homo sapiens	INH	%	13.0
	12136303	CHEMBL2185481	Inhibition of SRC at 10 uM incubated for 60 mins using poly(Glu,Tyr)4:1 substrate and 10 uM ATP by ELISA	B	O=C(NCc1ccc(F)cc1)c1nc(Br)c2cccnc2c1N1CCNCC1		CHEMBL2177139	=	Inhibition	%	29.0	CHEMBL267	Homo sapiens	INH	%	29.0
	12136304	CHEMBL2185481	Inhibition of SRC at 10 uM incubated for 60 mins using poly(Glu,Tyr)4:1 substrate and 10 uM ATP by ELISA	B	O=C(NCc1ccc(F)cc1)c1nc(Br)c2cccnc2c1NC1CCNCC1		CHEMBL2180582	=	Inhibition	%	9.0	CHEMBL267	Homo sapiens	INH	%	9.0
	12136305	CHEMBL2185481	Inhibition of SRC at 10 uM incubated for 60 mins using poly(Glu,Tyr)4:1 substrate and 10 uM ATP by ELISA	B	Nc1ccc(Nc2c(C(=O)NCc3ccc(F)cc3)nc(Br)c3cccnc23)cc1		CHEMBL2180579	=	Inhibition	%	7.0	CHEMBL267	Homo sapiens	INH	%	7.0
	12136306	CHEMBL2185481	Inhibition of SRC at 10 uM incubated for 60 mins using poly(Glu,Tyr)4:1 substrate and 10 uM ATP by ELISA	B	NCCCCCCNc1c(C(=O)NCc2ccc(F)cc2)nc(Br)c2cccnc12		CHEMBL2180578	=	Inhibition	%	18.0	CHEMBL267	Homo sapiens	INH	%	18.0
	12136307	CHEMBL2185481	Inhibition of SRC at 10 uM incubated for 60 mins using poly(Glu,Tyr)4:1 substrate and 10 uM ATP by ELISA	B	CN(C)CCCNc1c(C(=O)NCc2ccc(F)cc2)nc(Br)c2cccnc12		CHEMBL2180576	=	Inhibition	%	17.0	CHEMBL267	Homo sapiens	INH	%	17.0
	12136308	CHEMBL2185481	Inhibition of SRC at 10 uM incubated for 60 mins using poly(Glu,Tyr)4:1 substrate and 10 uM ATP by ELISA	B	NCCCNc1c(C(=O)NCc2ccc(F)cc2)ncc2cccnc12		CHEMBL2180573	=	Inhibition	%	15.0	CHEMBL267	Homo sapiens	INH	%	15.0
	12136309	CHEMBL2185481	Inhibition of SRC at 10 uM incubated for 60 mins using poly(Glu,Tyr)4:1 substrate and 10 uM ATP by ELISA	B	O=CNCCCCCCNc1nc(C(=O)NCc2ccc(F)cc2)c(O)c2ncccc12		CHEMBL2180587	=	Inhibition	%	23.0	CHEMBL267	Homo sapiens	INH	%	23.0
	12136310	CHEMBL2185481	Inhibition of SRC at 10 uM incubated for 60 mins using poly(Glu,Tyr)4:1 substrate and 10 uM ATP by ELISA	B	O=C(NCc1ccc(F)cc1)c1nc(N2CCCCS2(=O)=O)c2cccnc2c1O		CHEMBL414850	=	Inhibition	%	13.0	CHEMBL267	Homo sapiens	INH	%	13.0
	12150598	CHEMBL2188533	Inhibition of human recombinant SRC by radiometric kinase assay	B	CN1CCN(c2ccc(Nc3ncc4nc(Nc5ccccc5)n(C5CCCC5)c4n3)cc2)CC1		CHEMBL2178352	=	IC50	nM	290.0	CHEMBL267	Homo sapiens	IC50	uM	0.29
	12155959	CHEMBL2185155	Inhibition of SRC assessed as residual activity at 1000 nM	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccnc4[nH]c(-c5ccccc5)cc34)[nH]2)cc1		CHEMBL2179119	=	Activity	%	28.0	CHEMBL267	Homo sapiens	Activity	%	28.0
	12170732	CHEMBL2214640	Inhibition of Src assessed as residual activity at 1 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	93.0	CHEMBL267	Homo sapiens	Activity	%	93.0
	12170863	CHEMBL2212730	Inhibition of Src assessed as residual activity at 10 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	86.0	CHEMBL267	Homo sapiens	Activity	%	86.0
	12172201	CHEMBL2209694	Inhibition of SRC assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	100.0	CHEMBL267	Homo sapiens	Activity	%	100.0
	12175192	CHEMBL2210718	Inhibition of Src	B	CN(c1ccc(F)c(NC(=O)c2cccc(OC(C)(C)C#N)c2Cl)c1)c1ccc2nc(NC(=O)C3CC3)sc2n1		CHEMBL2204532	=	IC50	nM	130.0	CHEMBL267	Homo sapiens	IC50	nM	130.0
	12183813	CHEMBL2214448	Inhibition of SRC	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1		CHEMBL2205766	<	IC50	nM	10000.0	CHEMBL267	Homo sapiens	pIC50		5.0
	12188406	CHEMBL2211128	Binding affinity to SRC at 1 uM	B	Cc1nc(N)nc(-c2cc(Cl)cnc2Nc2cnc(Cl)c(NS(=O)(=O)N(C)C)c2)n1		CHEMBL2206921	<	Activity	%	50.0	CHEMBL267	Homo sapiens	Activity	%	50.0
	12195493	CHEMBL2209626	Inhibition of recombinant SRC after 1 hr by scintillation counter analysis in presence of gamma-[33P]ATP	B	CC(C)(C)Nc1c(Nc2ccnc(Nc3ccc(-c4ccncc4)cc3)n2)c(=O)c1=O		CHEMBL2205426	>	Ki	nM	1900.0	CHEMBL267	Homo sapiens	Ki	nM	1900.0
	12195584	CHEMBL2212363	Inhibition of human recombinant SRC expressed in insect cells using Ulight-Poly GAT[EAY(1:1:1)]n as substrate assessed as residual activity at 1 uM after 10 mins relative to staurosporine	B	CCN(CC)CCOc1ccc(/C=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL2206008	=	Activity	%	100.8	CHEMBL267	Homo sapiens	Activity	%	100.8
Not Active	12202300	CHEMBL2210029	Inhibition of GST-tagged c-Src up to 100 uM preincubated for 30 mins measured after 60 mins	B	OC[C@H]1O[C@H](Oc2ccc(O)cc2)[C@H](O)[C@@H]1O		CHEMBL2205379		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	12202301	CHEMBL2210029	Inhibition of GST-tagged c-Src up to 100 uM preincubated for 30 mins measured after 60 mins	B	COc1ccc(O[C@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1		CHEMBL2205393		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	12202302	CHEMBL2210029	Inhibition of GST-tagged c-Src up to 100 uM preincubated for 30 mins measured after 60 mins	B	COc1cccc(O[C@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c1		CHEMBL2205391		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	12202303	CHEMBL2210029	Inhibition of GST-tagged c-Src up to 100 uM preincubated for 30 mins measured after 60 mins	B	OC[C@H]1O[C@H](Oc2ccc(-c3ccccc3)cc2)[C@H](O)[C@@H]1O		CHEMBL2205385		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	12202304	CHEMBL2210030	Inhibition of GST-tagged c-Src preincubated for 30 mins measured after 60 mins	B	OC[C@H]1O[C@@H](Oc2ccc(O)cc2)[C@H](O)[C@@H]1O	Outside typical range	CHEMBL2205394	=	IC50	nM	272100.0	CHEMBL267	Homo sapiens	IC50	uM	272.1
	12202305	CHEMBL2210030	Inhibition of GST-tagged c-Src preincubated for 30 mins measured after 60 mins	B	COc1ccc(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1	Outside typical range	CHEMBL2205392	=	IC50	nM	483900.0	CHEMBL267	Homo sapiens	IC50	uM	483.9
	12202306	CHEMBL2210030	Inhibition of GST-tagged c-Src preincubated for 30 mins measured after 60 mins	B	COc1cccc(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c1		CHEMBL2205390	=	IC50	nM	95000.0	CHEMBL267	Homo sapiens	IC50	uM	95.0
Not Determined	12202307	CHEMBL2210030	Inhibition of GST-tagged c-Src preincubated for 30 mins measured after 60 mins	B	Cc1ccc(O[C@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1		CHEMBL2205389		IC50			CHEMBL267	Homo sapiens	IC50		
	12202308	CHEMBL2210030	Inhibition of GST-tagged c-Src preincubated for 30 mins measured after 60 mins	B	Cc1ccc(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1	Outside typical range	CHEMBL2205388	=	IC50	nM	143400.0	CHEMBL267	Homo sapiens	IC50	uM	143.4
	12202309	CHEMBL2210030	Inhibition of GST-tagged c-Src preincubated for 30 mins measured after 60 mins	B	Cc1cccc(O[C@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c1	Outside typical range	CHEMBL2205387	=	IC50	nM	451000.0	CHEMBL267	Homo sapiens	IC50	uM	451.0
Not Determined	12202310	CHEMBL2210030	Inhibition of GST-tagged c-Src preincubated for 30 mins measured after 60 mins	B	Cc1cccc(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c1		CHEMBL2205386		IC50			CHEMBL267	Homo sapiens	IC50		
	12202311	CHEMBL2210030	Inhibition of GST-tagged c-Src preincubated for 30 mins measured after 60 mins	B	OC[C@H]1O[C@@H](Oc2ccc(-c3ccccc3)cc2)[C@H](O)[C@@H]1O	Outside typical range	CHEMBL2205384	=	IC50	nM	125000.0	CHEMBL267	Homo sapiens	IC50	uM	125.0
	12202312	CHEMBL2210030	Inhibition of GST-tagged c-Src preincubated for 30 mins measured after 60 mins	B	OC[C@H]1O[C@H](Oc2ccc3ccccc3c2)[C@H](O)[C@@H]1O	Outside typical range	CHEMBL2205383	=	IC50	nM	297300.0	CHEMBL267	Homo sapiens	IC50	uM	297.3
	12202313	CHEMBL2210030	Inhibition of GST-tagged c-Src preincubated for 30 mins measured after 60 mins	B	OC[C@H]1O[C@@H](Oc2ccc3ccccc3c2)[C@H](O)[C@@H]1O	Outside typical range	CHEMBL2205382	=	IC50	nM	224800.0	CHEMBL267	Homo sapiens	IC50	uM	224.8
	12202314	CHEMBL2210030	Inhibition of GST-tagged c-Src preincubated for 30 mins measured after 60 mins	B	OC[C@H]1O[C@H](Oc2cccc3ccccc23)[C@H](O)[C@@H]1O	Outside typical range	CHEMBL2205381	=	IC50	nM	184700.0	CHEMBL267	Homo sapiens	IC50	uM	184.7
	12202315	CHEMBL2210030	Inhibition of GST-tagged c-Src preincubated for 30 mins measured after 60 mins	B	OC[C@H]1O[C@@H](Oc2cccc3ccccc23)[C@H](O)[C@@H]1O	Outside typical range	CHEMBL2205380	=	IC50	nM	1370700.0	CHEMBL267	Homo sapiens	IC50	uM	1370.7
	12202316	CHEMBL2210030	Inhibition of GST-tagged c-Src preincubated for 30 mins measured after 60 mins	B	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	=	IC50	nM	2800.0	CHEMBL267	Homo sapiens	IC50	uM	2.8
	12202317	CHEMBL2210030	Inhibition of GST-tagged c-Src preincubated for 30 mins measured after 60 mins	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	300.0	CHEMBL267	Homo sapiens	IC50	uM	0.3
	12267596	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	91.0	CHEMBL267	Homo sapiens	Residual Activity	%	91.0
	12267597	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	98.0	CHEMBL267	Homo sapiens	Residual Activity	%	98.0
	12267598	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	110.0	CHEMBL267	Homo sapiens	Residual Activity	%	110.0
	12267599	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	93.0	CHEMBL267	Homo sapiens	Residual Activity	%	93.0
	12267600	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	86.0	CHEMBL267	Homo sapiens	Residual Activity	%	86.0
	12267601	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	79.0	CHEMBL267	Homo sapiens	Residual Activity	%	79.0
	12267602	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	49.0	CHEMBL267	Homo sapiens	Residual Activity	%	49.0
	12267603	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	58.0	CHEMBL267	Homo sapiens	Residual Activity	%	58.0
	12267604	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	78.0	CHEMBL267	Homo sapiens	Residual Activity	%	78.0
	12267605	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	64.0	CHEMBL267	Homo sapiens	Residual Activity	%	64.0
	12267606	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	89.0	CHEMBL267	Homo sapiens	Residual Activity	%	89.0
	12267607	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	84.0	CHEMBL267	Homo sapiens	Residual Activity	%	84.0
	12267608	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	88.0	CHEMBL267	Homo sapiens	Residual Activity	%	88.0
	12267609	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	63.0	CHEMBL267	Homo sapiens	Residual Activity	%	63.0
	12267610	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	70.0	CHEMBL267	Homo sapiens	Residual Activity	%	70.0
	12267611	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	86.0	CHEMBL267	Homo sapiens	Residual Activity	%	86.0
	12267612	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	85.0	CHEMBL267	Homo sapiens	Residual Activity	%	85.0
	12267613	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	74.0	CHEMBL267	Homo sapiens	Residual Activity	%	74.0
	12267614	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	76.0	CHEMBL267	Homo sapiens	Residual Activity	%	76.0
	12267615	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	72.0	CHEMBL267	Homo sapiens	Residual Activity	%	72.0
	12267616	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	81.0	CHEMBL267	Homo sapiens	Residual Activity	%	81.0
	12267617	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	74.0	CHEMBL267	Homo sapiens	Residual Activity	%	74.0
	12267618	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	89.0	CHEMBL267	Homo sapiens	Residual Activity	%	89.0
	12267619	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	78.0	CHEMBL267	Homo sapiens	Residual Activity	%	78.0
	12267620	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	82.0	CHEMBL267	Homo sapiens	Residual Activity	%	82.0
	12267621	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	53.0	CHEMBL267	Homo sapiens	Residual Activity	%	53.0
	12267622	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	28.0	CHEMBL267	Homo sapiens	Residual Activity	%	28.0
	12267623	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	54.0	CHEMBL267	Homo sapiens	Residual Activity	%	54.0
	12267624	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	95.0	CHEMBL267	Homo sapiens	Residual Activity	%	95.0
	12267625	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	88.0	CHEMBL267	Homo sapiens	Residual Activity	%	88.0
	12267626	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	86.0	CHEMBL267	Homo sapiens	Residual Activity	%	86.0
	12267627	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	26.0	CHEMBL267	Homo sapiens	Residual Activity	%	26.0
	12267628	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	93.0	CHEMBL267	Homo sapiens	Residual Activity	%	93.0
	12267629	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	92.0	CHEMBL267	Homo sapiens	Residual Activity	%	92.0
	12267630	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	84.0	CHEMBL267	Homo sapiens	Residual Activity	%	84.0
	12267631	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	79.0	CHEMBL267	Homo sapiens	Residual Activity	%	79.0
	12267632	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	44.0	CHEMBL267	Homo sapiens	Residual Activity	%	44.0
	12267633	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	89.0	CHEMBL267	Homo sapiens	Residual Activity	%	89.0
	12267634	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	91.0	CHEMBL267	Homo sapiens	Residual Activity	%	91.0
	12267635	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	73.0	CHEMBL267	Homo sapiens	Residual Activity	%	73.0
	12267636	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	81.0	CHEMBL267	Homo sapiens	Residual Activity	%	81.0
	12267637	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	86.0	CHEMBL267	Homo sapiens	Residual Activity	%	86.0
	12267638	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	69.0	CHEMBL267	Homo sapiens	Residual Activity	%	69.0
	12267639	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	68.0	CHEMBL267	Homo sapiens	Residual Activity	%	68.0
	12267640	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	32.0	CHEMBL267	Homo sapiens	Residual Activity	%	32.0
	12267641	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	80.0	CHEMBL267	Homo sapiens	Residual Activity	%	80.0
	12267642	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	89.0	CHEMBL267	Homo sapiens	Residual Activity	%	89.0
	12267643	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	78.0	CHEMBL267	Homo sapiens	Residual Activity	%	78.0
	12267644	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	85.0	CHEMBL267	Homo sapiens	Residual Activity	%	85.0
	12267645	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	91.0	CHEMBL267	Homo sapiens	Residual Activity	%	91.0
	12267646	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	82.0	CHEMBL267	Homo sapiens	Residual Activity	%	82.0
	12267647	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	5.0	CHEMBL267	Homo sapiens	Residual Activity	%	5.0
	12267648	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	70.0	CHEMBL267	Homo sapiens	Residual Activity	%	70.0
	12267649	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	86.0	CHEMBL267	Homo sapiens	Residual Activity	%	86.0
	12267650	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	87.0	CHEMBL267	Homo sapiens	Residual Activity	%	87.0
	12267651	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	77.0	CHEMBL267	Homo sapiens	Residual Activity	%	77.0
	12267652	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	83.0	CHEMBL267	Homo sapiens	Residual Activity	%	83.0
	12267653	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	85.0	CHEMBL267	Homo sapiens	Residual Activity	%	85.0
	12267654	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	86.0	CHEMBL267	Homo sapiens	Residual Activity	%	86.0
	12267655	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	93.0	CHEMBL267	Homo sapiens	Residual Activity	%	93.0
	12267656	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	84.0	CHEMBL267	Homo sapiens	Residual Activity	%	84.0
	12267657	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	40.0	CHEMBL267	Homo sapiens	Residual Activity	%	40.0
	12267658	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	83.0	CHEMBL267	Homo sapiens	Residual Activity	%	83.0
	12267659	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	87.0	CHEMBL267	Homo sapiens	Residual Activity	%	87.0
	12267660	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	87.0	CHEMBL267	Homo sapiens	Residual Activity	%	87.0
	12267661	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	87.0	CHEMBL267	Homo sapiens	Residual Activity	%	87.0
	12267662	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	101.0	CHEMBL267	Homo sapiens	Residual Activity	%	101.0
	12267663	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	94.0	CHEMBL267	Homo sapiens	Residual Activity	%	94.0
	12267664	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	86.0	CHEMBL267	Homo sapiens	Residual Activity	%	86.0
	12267665	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	36.0	CHEMBL267	Homo sapiens	Residual Activity	%	36.0
	12267666	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	83.0	CHEMBL267	Homo sapiens	Residual Activity	%	83.0
	12267667	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	56.0	CHEMBL267	Homo sapiens	Residual Activity	%	56.0
	12267668	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	82.0	CHEMBL267	Homo sapiens	Residual Activity	%	82.0
	12267669	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	81.0	CHEMBL267	Homo sapiens	Residual Activity	%	81.0
	12267670	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	70.0	CHEMBL267	Homo sapiens	Residual Activity	%	70.0
	12267671	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	77.0	CHEMBL267	Homo sapiens	Residual Activity	%	77.0
	12267672	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	91.0	CHEMBL267	Homo sapiens	Residual Activity	%	91.0
	12267673	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	48.0	CHEMBL267	Homo sapiens	Residual Activity	%	48.0
	12267674	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	88.0	CHEMBL267	Homo sapiens	Residual Activity	%	88.0
	12267675	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	8.0	CHEMBL267	Homo sapiens	Residual Activity	%	8.0
	12267676	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	100.0	CHEMBL267	Homo sapiens	Residual Activity	%	100.0
	12267677	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	88.0	CHEMBL267	Homo sapiens	Residual Activity	%	88.0
	12267678	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	117.0	CHEMBL267	Homo sapiens	Residual Activity	%	117.0
	12267679	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	100.0	CHEMBL267	Homo sapiens	Residual Activity	%	100.0
	12267680	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	31.0	CHEMBL267	Homo sapiens	Residual Activity	%	31.0
	12267681	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	113.0	CHEMBL267	Homo sapiens	Residual Activity	%	113.0
	12267682	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	129.0	CHEMBL267	Homo sapiens	Residual Activity	%	129.0
	12267683	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	112.0	CHEMBL267	Homo sapiens	Residual Activity	%	112.0
	12267684	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	89.0	CHEMBL267	Homo sapiens	Residual Activity	%	89.0
	12267685	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	35.0	CHEMBL267	Homo sapiens	Residual Activity	%	35.0
	12267686	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	118.0	CHEMBL267	Homo sapiens	Residual Activity	%	118.0
	12267687	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	103.0	CHEMBL267	Homo sapiens	Residual Activity	%	103.0
	12267688	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	14.0	CHEMBL267	Homo sapiens	Residual Activity	%	14.0
	12267689	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	112.0	CHEMBL267	Homo sapiens	Residual Activity	%	112.0
	12267690	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	113.0	CHEMBL267	Homo sapiens	Residual Activity	%	113.0
	12267691	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	114.0	CHEMBL267	Homo sapiens	Residual Activity	%	114.0
	12267692	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	98.0	CHEMBL267	Homo sapiens	Residual Activity	%	98.0
	12267693	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	114.0	CHEMBL267	Homo sapiens	Residual Activity	%	114.0
	12267694	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	106.0	CHEMBL267	Homo sapiens	Residual Activity	%	106.0
	12267695	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	95.0	CHEMBL267	Homo sapiens	Residual Activity	%	95.0
	12267696	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	100.0	CHEMBL267	Homo sapiens	Residual Activity	%	100.0
	12267697	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	35.0	CHEMBL267	Homo sapiens	Residual Activity	%	35.0
	12267698	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	113.0	CHEMBL267	Homo sapiens	Residual Activity	%	113.0
	12267699	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	103.0	CHEMBL267	Homo sapiens	Residual Activity	%	103.0
	12267700	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	53.0	CHEMBL267	Homo sapiens	Residual Activity	%	53.0
	12267701	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	100.0	CHEMBL267	Homo sapiens	Residual Activity	%	100.0
	12267702	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	101.0	CHEMBL267	Homo sapiens	Residual Activity	%	101.0
	12267703	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	111.0	CHEMBL267	Homo sapiens	Residual Activity	%	111.0
	12267704	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	110.0	CHEMBL267	Homo sapiens	Residual Activity	%	110.0
	12267705	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	73.0	CHEMBL267	Homo sapiens	Residual Activity	%	73.0
	12267706	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	113.0	CHEMBL267	Homo sapiens	Residual Activity	%	113.0
	12267707	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	113.0	CHEMBL267	Homo sapiens	Residual Activity	%	113.0
	12267708	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	46.0	CHEMBL267	Homo sapiens	Residual Activity	%	46.0
	12267709	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	115.0	CHEMBL267	Homo sapiens	Residual Activity	%	115.0
	12267710	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	108.0	CHEMBL267	Homo sapiens	Residual Activity	%	108.0
	12267711	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	116.0	CHEMBL267	Homo sapiens	Residual Activity	%	116.0
	12267712	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	54.0	CHEMBL267	Homo sapiens	Residual Activity	%	54.0
	12267713	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	116.0	CHEMBL267	Homo sapiens	Residual Activity	%	116.0
	12267714	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	117.0	CHEMBL267	Homo sapiens	Residual Activity	%	117.0
	12267715	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	107.0	CHEMBL267	Homo sapiens	Residual Activity	%	107.0
	12267716	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	61.0	CHEMBL267	Homo sapiens	Residual Activity	%	61.0
	12267717	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	22.0	CHEMBL267	Homo sapiens	Residual Activity	%	22.0
	12267718	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	54.0	CHEMBL267	Homo sapiens	Residual Activity	%	54.0
	12267719	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	113.0	CHEMBL267	Homo sapiens	Residual Activity	%	113.0
	12267720	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	20.0	CHEMBL267	Homo sapiens	Residual Activity	%	20.0
	12267721	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	112.0	CHEMBL267	Homo sapiens	Residual Activity	%	112.0
	12267722	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	23.0	CHEMBL267	Homo sapiens	Residual Activity	%	23.0
	12267723	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	116.0	CHEMBL267	Homo sapiens	Residual Activity	%	116.0
	12267724	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	61.0	CHEMBL267	Homo sapiens	Residual Activity	%	61.0
	12267725	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	23.0	CHEMBL267	Homo sapiens	Residual Activity	%	23.0
	12267726	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	104.0	CHEMBL267	Homo sapiens	Residual Activity	%	104.0
	12267727	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	60.0	CHEMBL267	Homo sapiens	Residual Activity	%	60.0
	12267728	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	89.0	CHEMBL267	Homo sapiens	Residual Activity	%	89.0
	12267729	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	124.0	CHEMBL267	Homo sapiens	Residual Activity	%	124.0
	12267730	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	6.0	CHEMBL267	Homo sapiens	Residual Activity	%	6.0
	12267731	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	28.0	CHEMBL267	Homo sapiens	Residual Activity	%	28.0
	12267732	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	105.0	CHEMBL267	Homo sapiens	Residual Activity	%	105.0
	12267733	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	62.0	CHEMBL267	Homo sapiens	Residual Activity	%	62.0
	12267734	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	2.0	CHEMBL267	Homo sapiens	Residual Activity	%	2.0
	12267735	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	114.0	CHEMBL267	Homo sapiens	Residual Activity	%	114.0
	12267736	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	125.0	CHEMBL267	Homo sapiens	Residual Activity	%	125.0
	12267737	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	124.0	CHEMBL267	Homo sapiens	Residual Activity	%	124.0
	12267738	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	120.0	CHEMBL267	Homo sapiens	Residual Activity	%	120.0
	12267739	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	75.0	CHEMBL267	Homo sapiens	Residual Activity	%	75.0
	12267740	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	96.0	CHEMBL267	Homo sapiens	Residual Activity	%	96.0
	12267741	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	110.0	CHEMBL267	Homo sapiens	Residual Activity	%	110.0
	12267742	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	22.0	CHEMBL267	Homo sapiens	Residual Activity	%	22.0
	12267743	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	99.0	CHEMBL267	Homo sapiens	Residual Activity	%	99.0
	12267744	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	100.0	CHEMBL267	Homo sapiens	Residual Activity	%	100.0
	12267745	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	111.0	CHEMBL267	Homo sapiens	Residual Activity	%	111.0
	12267746	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	119.0	CHEMBL267	Homo sapiens	Residual Activity	%	119.0
	12267747	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	120.0	CHEMBL267	Homo sapiens	Residual Activity	%	120.0
	12267748	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	103.0	CHEMBL267	Homo sapiens	Residual Activity	%	103.0
	12267749	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	102.0	CHEMBL267	Homo sapiens	Residual Activity	%	102.0
	12267750	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	116.0	CHEMBL267	Homo sapiens	Residual Activity	%	116.0
	12267751	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	110.0	CHEMBL267	Homo sapiens	Residual Activity	%	110.0
	12267752	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	108.0	CHEMBL267	Homo sapiens	Residual Activity	%	108.0
	12267753	CHEMBL2219341	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	56.0	CHEMBL267	Homo sapiens	Residual Activity	%	56.0
	12267754	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	75.0	CHEMBL267	Homo sapiens	Residual Activity	%	75.0
	12267755	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	76.0	CHEMBL267	Homo sapiens	Residual Activity	%	76.0
	12267756	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	64.0	CHEMBL267	Homo sapiens	Residual Activity	%	64.0
	12267757	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	113.0	CHEMBL267	Homo sapiens	Residual Activity	%	113.0
	12267758	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	78.0	CHEMBL267	Homo sapiens	Residual Activity	%	78.0
	12267759	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	98.0	CHEMBL267	Homo sapiens	Residual Activity	%	98.0
	12267760	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	25.0	CHEMBL267	Homo sapiens	Residual Activity	%	25.0
	12267761	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	29.0	CHEMBL267	Homo sapiens	Residual Activity	%	29.0
	12267762	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	86.0	CHEMBL267	Homo sapiens	Residual Activity	%	86.0
	12267763	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	32.0	CHEMBL267	Homo sapiens	Residual Activity	%	32.0
	12267764	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	92.0	CHEMBL267	Homo sapiens	Residual Activity	%	92.0
	12267765	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	99.0	CHEMBL267	Homo sapiens	Residual Activity	%	99.0
	12267766	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	89.0	CHEMBL267	Homo sapiens	Residual Activity	%	89.0
	12267767	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	24.0	CHEMBL267	Homo sapiens	Residual Activity	%	24.0
	12267768	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	43.0	CHEMBL267	Homo sapiens	Residual Activity	%	43.0
	12267769	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	104.0	CHEMBL267	Homo sapiens	Residual Activity	%	104.0
	12267770	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	128.0	CHEMBL267	Homo sapiens	Residual Activity	%	128.0
	12267771	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	69.0	CHEMBL267	Homo sapiens	Residual Activity	%	69.0
	12267772	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	104.0	CHEMBL267	Homo sapiens	Residual Activity	%	104.0
	12267773	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	91.0	CHEMBL267	Homo sapiens	Residual Activity	%	91.0
	12267774	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	94.0	CHEMBL267	Homo sapiens	Residual Activity	%	94.0
	12267775	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	51.0	CHEMBL267	Homo sapiens	Residual Activity	%	51.0
	12267776	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	106.0	CHEMBL267	Homo sapiens	Residual Activity	%	106.0
	12267777	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	88.0	CHEMBL267	Homo sapiens	Residual Activity	%	88.0
	12267778	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	96.0	CHEMBL267	Homo sapiens	Residual Activity	%	96.0
	12267779	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	14.0	CHEMBL267	Homo sapiens	Residual Activity	%	14.0
	12267780	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	3.0	CHEMBL267	Homo sapiens	Residual Activity	%	3.0
	12267781	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	18.0	CHEMBL267	Homo sapiens	Residual Activity	%	18.0
	12267782	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	97.0	CHEMBL267	Homo sapiens	Residual Activity	%	97.0
	12267783	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	88.0	CHEMBL267	Homo sapiens	Residual Activity	%	88.0
	12267784	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	90.0	CHEMBL267	Homo sapiens	Residual Activity	%	90.0
	12267785	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	-1.0	CHEMBL267	Homo sapiens	Residual Activity	%	-1.0
	12267786	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	96.0	CHEMBL267	Homo sapiens	Residual Activity	%	96.0
	12267787	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	90.0	CHEMBL267	Homo sapiens	Residual Activity	%	90.0
	12267788	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	90.0	CHEMBL267	Homo sapiens	Residual Activity	%	90.0
	12267789	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	86.0	CHEMBL267	Homo sapiens	Residual Activity	%	86.0
	12267790	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	7.0	CHEMBL267	Homo sapiens	Residual Activity	%	7.0
	12267791	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	95.0	CHEMBL267	Homo sapiens	Residual Activity	%	95.0
	12267792	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	102.0	CHEMBL267	Homo sapiens	Residual Activity	%	102.0
	12267793	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	99.0	CHEMBL267	Homo sapiens	Residual Activity	%	99.0
	12267794	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	109.0	CHEMBL267	Homo sapiens	Residual Activity	%	109.0
	12267795	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	93.0	CHEMBL267	Homo sapiens	Residual Activity	%	93.0
	12267796	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	79.0	CHEMBL267	Homo sapiens	Residual Activity	%	79.0
	12267797	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	32.0	CHEMBL267	Homo sapiens	Residual Activity	%	32.0
	12267798	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	7.0	CHEMBL267	Homo sapiens	Residual Activity	%	7.0
	12267799	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	101.0	CHEMBL267	Homo sapiens	Residual Activity	%	101.0
	12267800	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	100.0	CHEMBL267	Homo sapiens	Residual Activity	%	100.0
	12267801	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	70.0	CHEMBL267	Homo sapiens	Residual Activity	%	70.0
	12267802	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	112.0	CHEMBL267	Homo sapiens	Residual Activity	%	112.0
	12267803	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	94.0	CHEMBL267	Homo sapiens	Residual Activity	%	94.0
	12267804	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	86.0	CHEMBL267	Homo sapiens	Residual Activity	%	86.0
	12267805	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	-1.0	CHEMBL267	Homo sapiens	Residual Activity	%	-1.0
	12267806	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	40.0	CHEMBL267	Homo sapiens	Residual Activity	%	40.0
	12267807	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	96.0	CHEMBL267	Homo sapiens	Residual Activity	%	96.0
	12267808	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	104.0	CHEMBL267	Homo sapiens	Residual Activity	%	104.0
	12267809	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	102.0	CHEMBL267	Homo sapiens	Residual Activity	%	102.0
	12267810	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	95.0	CHEMBL267	Homo sapiens	Residual Activity	%	95.0
	12267811	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	97.0	CHEMBL267	Homo sapiens	Residual Activity	%	97.0
	12267812	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	90.0	CHEMBL267	Homo sapiens	Residual Activity	%	90.0
	12267813	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	86.0	CHEMBL267	Homo sapiens	Residual Activity	%	86.0
	12267814	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	65.0	CHEMBL267	Homo sapiens	Residual Activity	%	65.0
	12267815	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	24.0	CHEMBL267	Homo sapiens	Residual Activity	%	24.0
	12267816	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	101.0	CHEMBL267	Homo sapiens	Residual Activity	%	101.0
	12267817	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	93.0	CHEMBL267	Homo sapiens	Residual Activity	%	93.0
	12267818	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	98.0	CHEMBL267	Homo sapiens	Residual Activity	%	98.0
	12267819	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	85.0	CHEMBL267	Homo sapiens	Residual Activity	%	85.0
	12267820	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	92.0	CHEMBL267	Homo sapiens	Residual Activity	%	92.0
	12267821	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	99.0	CHEMBL267	Homo sapiens	Residual Activity	%	99.0
	12267822	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	103.0	CHEMBL267	Homo sapiens	Residual Activity	%	103.0
	12267823	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	24.0	CHEMBL267	Homo sapiens	Residual Activity	%	24.0
	12267824	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	99.0	CHEMBL267	Homo sapiens	Residual Activity	%	99.0
	12267825	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	12.0	CHEMBL267	Homo sapiens	Residual Activity	%	12.0
	12269464	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	95.0	CHEMBL267	Homo sapiens	Residual Activity	%	95.0
	12269465	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	77.0	CHEMBL267	Homo sapiens	Residual Activity	%	77.0
	12269466	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	29.0	CHEMBL267	Homo sapiens	Residual Activity	%	29.0
	12269467	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	40.0	CHEMBL267	Homo sapiens	Residual Activity	%	40.0
	12269468	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	106.0	CHEMBL267	Homo sapiens	Residual Activity	%	106.0
	12269469	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	13.0	CHEMBL267	Homo sapiens	Residual Activity	%	13.0
	12269470	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	95.0	CHEMBL267	Homo sapiens	Residual Activity	%	95.0
	12269471	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	-2.0	CHEMBL267	Homo sapiens	Residual Activity	%	-2.0
	12269472	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	71.0	CHEMBL267	Homo sapiens	Residual Activity	%	71.0
	12269473	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	34.0	CHEMBL267	Homo sapiens	Residual Activity	%	34.0
	12269474	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	93.0	CHEMBL267	Homo sapiens	Residual Activity	%	93.0
	12269475	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	103.0	CHEMBL267	Homo sapiens	Residual Activity	%	103.0
	12269476	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	35.0	CHEMBL267	Homo sapiens	Residual Activity	%	35.0
	12269477	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	100.0	CHEMBL267	Homo sapiens	Residual Activity	%	100.0
	12269478	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	100.0	CHEMBL267	Homo sapiens	Residual Activity	%	100.0
	12269479	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	65.0	CHEMBL267	Homo sapiens	Residual Activity	%	65.0
	12269480	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	92.0	CHEMBL267	Homo sapiens	Residual Activity	%	92.0
	12269481	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	5.0	CHEMBL267	Homo sapiens	Residual Activity	%	5.0
	12269482	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	93.0	CHEMBL267	Homo sapiens	Residual Activity	%	93.0
	12269483	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	77.0	CHEMBL267	Homo sapiens	Residual Activity	%	77.0
	12269484	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	-2.0	CHEMBL267	Homo sapiens	Residual Activity	%	-2.0
	12269485	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	88.0	CHEMBL267	Homo sapiens	Residual Activity	%	88.0
	12269486	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	79.0	CHEMBL267	Homo sapiens	Residual Activity	%	79.0
	12269487	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	106.0	CHEMBL267	Homo sapiens	Residual Activity	%	106.0
	12269488	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	83.0	CHEMBL267	Homo sapiens	Residual Activity	%	83.0
	12269489	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	76.0	CHEMBL267	Homo sapiens	Residual Activity	%	76.0
	12269490	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	87.0	CHEMBL267	Homo sapiens	Residual Activity	%	87.0
	12269491	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	87.0	CHEMBL267	Homo sapiens	Residual Activity	%	87.0
	12269492	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	64.0	CHEMBL267	Homo sapiens	Residual Activity	%	64.0
	12269493	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	5.0	CHEMBL267	Homo sapiens	Residual Activity	%	5.0
	12269494	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	87.0	CHEMBL267	Homo sapiens	Residual Activity	%	87.0
	12269495	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	87.0	CHEMBL267	Homo sapiens	Residual Activity	%	87.0
	12269496	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	29.0	CHEMBL267	Homo sapiens	Residual Activity	%	29.0
	12269497	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	86.0	CHEMBL267	Homo sapiens	Residual Activity	%	86.0
	12269498	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	84.0	CHEMBL267	Homo sapiens	Residual Activity	%	84.0
	12269499	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	91.0	CHEMBL267	Homo sapiens	Residual Activity	%	91.0
	12269500	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	86.0	CHEMBL267	Homo sapiens	Residual Activity	%	86.0
	12269501	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	30.0	CHEMBL267	Homo sapiens	Residual Activity	%	30.0
	12269502	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	90.0	CHEMBL267	Homo sapiens	Residual Activity	%	90.0
	12269503	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	81.0	CHEMBL267	Homo sapiens	Residual Activity	%	81.0
	12269504	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	13.0	CHEMBL267	Homo sapiens	Residual Activity	%	13.0
	12269505	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	80.0	CHEMBL267	Homo sapiens	Residual Activity	%	80.0
	12269506	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	92.0	CHEMBL267	Homo sapiens	Residual Activity	%	92.0
	12269507	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	92.0	CHEMBL267	Homo sapiens	Residual Activity	%	92.0
	12269508	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	10.0	CHEMBL267	Homo sapiens	Residual Activity	%	10.0
	12269509	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	90.0	CHEMBL267	Homo sapiens	Residual Activity	%	90.0
	12269510	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	66.0	CHEMBL267	Homo sapiens	Residual Activity	%	66.0
	12269511	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	97.0	CHEMBL267	Homo sapiens	Residual Activity	%	97.0
	12269512	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	22.0	CHEMBL267	Homo sapiens	Residual Activity	%	22.0
	12269513	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	-1.0	CHEMBL267	Homo sapiens	Residual Activity	%	-1.0
	12269514	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	7.0	CHEMBL267	Homo sapiens	Residual Activity	%	7.0
	12269515	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	83.0	CHEMBL267	Homo sapiens	Residual Activity	%	83.0
	12269516	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	-2.0	CHEMBL267	Homo sapiens	Residual Activity	%	-2.0
	12269517	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	88.0	CHEMBL267	Homo sapiens	Residual Activity	%	88.0
	12269518	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	-2.0	CHEMBL267	Homo sapiens	Residual Activity	%	-2.0
	12269519	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	93.0	CHEMBL267	Homo sapiens	Residual Activity	%	93.0
	12269520	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	41.0	CHEMBL267	Homo sapiens	Residual Activity	%	41.0
	12269521	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	1.0	CHEMBL267	Homo sapiens	Residual Activity	%	1.0
	12269522	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	82.0	CHEMBL267	Homo sapiens	Residual Activity	%	82.0
	12269523	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	38.0	CHEMBL267	Homo sapiens	Residual Activity	%	38.0
	12269524	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	64.0	CHEMBL267	Homo sapiens	Residual Activity	%	64.0
	12269525	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	89.0	CHEMBL267	Homo sapiens	Residual Activity	%	89.0
	12269526	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	-3.0	CHEMBL267	Homo sapiens	Residual Activity	%	-3.0
	12269527	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	2.0	CHEMBL267	Homo sapiens	Residual Activity	%	2.0
	12269528	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	83.0	CHEMBL267	Homo sapiens	Residual Activity	%	83.0
	12269529	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	12.0	CHEMBL267	Homo sapiens	Residual Activity	%	12.0
	12269530	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	3.0	CHEMBL267	Homo sapiens	Residual Activity	%	3.0
	12269531	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	93.0	CHEMBL267	Homo sapiens	Residual Activity	%	93.0
	12269532	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	91.0	CHEMBL267	Homo sapiens	Residual Activity	%	91.0
	12269533	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	90.0	CHEMBL267	Homo sapiens	Residual Activity	%	90.0
	12269534	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	95.0	CHEMBL267	Homo sapiens	Residual Activity	%	95.0
	12269535	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	9.0	CHEMBL267	Homo sapiens	Residual Activity	%	9.0
	12269536	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	94.0	CHEMBL267	Homo sapiens	Residual Activity	%	94.0
	12269537	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	87.0	CHEMBL267	Homo sapiens	Residual Activity	%	87.0
	12269538	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	8.0	CHEMBL267	Homo sapiens	Residual Activity	%	8.0
	12269539	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	86.0	CHEMBL267	Homo sapiens	Residual Activity	%	86.0
	12269540	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	54.0	CHEMBL267	Homo sapiens	Residual Activity	%	54.0
	12269541	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	97.0	CHEMBL267	Homo sapiens	Residual Activity	%	97.0
	12269542	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	55.0	CHEMBL267	Homo sapiens	Residual Activity	%	55.0
	12269543	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	82.0	CHEMBL267	Homo sapiens	Residual Activity	%	82.0
	12269544	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	99.0	CHEMBL267	Homo sapiens	Residual Activity	%	99.0
	12269545	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	93.0	CHEMBL267	Homo sapiens	Residual Activity	%	93.0
	12269546	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	102.0	CHEMBL267	Homo sapiens	Residual Activity	%	102.0
	12269547	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	95.0	CHEMBL267	Homo sapiens	Residual Activity	%	95.0
	12269548	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	45.0	CHEMBL267	Homo sapiens	Residual Activity	%	45.0
	12269549	CHEMBL2219342	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	39.0	CHEMBL267	Homo sapiens	Residual Activity	%	39.0
	12582815	CHEMBL3075220	Inhibition of SRC (unknown origin)	B	Cc1cccn2cc(CN(Cc3nc4ccccc4c(=O)[nH]3)C(C)C)nc12		CHEMBL2297163	<	Ki	nM	100.0	CHEMBL267	Homo sapiens	Ki	nM	100.0
	12582816	CHEMBL3075220	Inhibition of SRC (unknown origin)	B	Cc1nc[nH]c1[C@H]1c2nc[nH]c2CCN1Cc1nc2ccccc2[nH]1		CHEMBL2297162	<	Ki	nM	100.0	CHEMBL267	Homo sapiens	Ki	nM	100.0
	12582817	CHEMBL3075220	Inhibition of SRC (unknown origin)	B	Cc1nc[nH]c1[C@@H]1c2nc[nH]c2CCN1Cc1nc2ccccc2[nH]1		CHEMBL2297161	<	Ki	nM	100.0	CHEMBL267	Homo sapiens	Ki	nM	100.0
	12591014	CHEMBL3069803	Inhibition of c-Src kinase (unknown origin)	B	COc1cccc(-c2cn(-c3ccc(OCCn4ccnc4)cc3)c3ncnc(N)c23)c1		CHEMBL475413	=	IC50	nM	125.89	CHEMBL267	Homo sapiens	pIC50		6.9
	12591015	CHEMBL3069803	Inhibition of c-Src kinase (unknown origin)	B	CNC(=O)CNCCOc1ccc(-n2cc(-c3cccc(OC)c3)c3c(N)ncnc32)cc1		CHEMBL475355	=	IC50	nM	39.81	CHEMBL267	Homo sapiens	pIC50		7.4
	12591016	CHEMBL3069803	Inhibition of c-Src kinase (unknown origin)	B	COCCNCCOc1cccc(-n2cc(-c3cccc(OC)c3)c3c(N)ncnc32)c1		CHEMBL475354	=	IC50	nM	158.49	CHEMBL267	Homo sapiens	pIC50		6.8
	12591017	CHEMBL3069803	Inhibition of c-Src kinase (unknown origin)	B	COCCNCCOc1cccc(-n2cc(-c3cccc(O)c3)c3c(N)ncnc32)c1		CHEMBL475156	=	IC50	nM	7.943	CHEMBL267	Homo sapiens	pIC50		8.1
	12591018	CHEMBL3069803	Inhibition of c-Src kinase (unknown origin)	B	Nc1ncnc2c1c(-c1cccc(Cl)c1)cn2-c1ccc(OCCNCCO)cc1		CHEMBL473155	=	IC50	nM	19.95	CHEMBL267	Homo sapiens	pIC50		7.7
	12591019	CHEMBL3069803	Inhibition of c-Src kinase (unknown origin)	B	Nc1ncnc2c1c(-c1cccc(F)c1)cn2-c1ccc(OCCNCCO)cc1		CHEMBL474657	=	IC50	nM	19.95	CHEMBL267	Homo sapiens	pIC50		7.7
	12591020	CHEMBL3069803	Inhibition of c-Src kinase (unknown origin)	B	COc1cccc(-c2cn(-c3ccc(OCCNCCO)cc3)c3ncnc(N)c23)c1		CHEMBL474656	=	IC50	nM	19.95	CHEMBL267	Homo sapiens	pIC50		7.7
	12591021	CHEMBL3069803	Inhibition of c-Src kinase (unknown origin)	B	CN(C)CCc1ccccc1-n1cc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL516062	=	IC50	nM	0.3162	CHEMBL267	Homo sapiens	pIC50		9.5
	12591022	CHEMBL3069803	Inhibition of c-Src kinase (unknown origin)	B	Nc1ncnc2c1c(-c1ccc(O)cc1)cn2-c1ccc(OCCNCCO)cc1		CHEMBL473024	=	IC50	nM	3.162	CHEMBL267	Homo sapiens	pIC50		8.5
	12591023	CHEMBL3069803	Inhibition of c-Src kinase (unknown origin)	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2-c1ccc(OCCNCCO)cc1		CHEMBL474998	=	IC50	nM	0.3162	CHEMBL267	Homo sapiens	pIC50		9.5
	12591024	CHEMBL3069803	Inhibition of c-Src kinase (unknown origin)	B	COCCN(C)CCc1ccc(-n2cc(-c3cccc(OC)c3)c3c(N)ncnc32)cc1		CHEMBL515751	=	IC50	nM	10.0	CHEMBL267	Homo sapiens	pIC50		8.0
	12591025	CHEMBL3069803	Inhibition of c-Src kinase (unknown origin)	B	COc1cccc(-c2cn(-c3ccc(CCNCCO)cc3)c3ncnc(N)c23)c1		CHEMBL470925	=	IC50	nM	19.95	CHEMBL267	Homo sapiens	pIC50		7.7
	12591026	CHEMBL3069803	Inhibition of c-Src kinase (unknown origin)	B	COc1cccc(-c2cn(-c3ccc(CCN(C)C)cc3)c3ncnc(N)c23)c1		CHEMBL470746	=	IC50	nM	39.81	CHEMBL267	Homo sapiens	pIC50		7.4
	12591027	CHEMBL3069803	Inhibition of c-Src kinase (unknown origin)	B	COc1cccc(-c2cn(-c3ccc(CC(=O)O)cc3)c3ncnc(N)c23)c1		CHEMBL511320	=	IC50	nM	50.12	CHEMBL267	Homo sapiens	pIC50		7.3
	12591028	CHEMBL3069803	Inhibition of c-Src kinase (unknown origin)	B	COc1cccc(-c2cn(-c3ccc(CCN(C)CCO)cc3)c3ncnc(N)c23)c1		CHEMBL105436	=	IC50	nM	31.62	CHEMBL267	Homo sapiens	pIC50		7.5
	12591029	CHEMBL3069803	Inhibition of c-Src kinase (unknown origin)	B	COc1cccc(-c2cn(-c3ccc(CC(=O)NCCO)cc3)c3ncnc(N)c23)c1		CHEMBL175409	=	IC50	nM	19.95	CHEMBL267	Homo sapiens	pIC50		7.7
	12591030	CHEMBL3069803	Inhibition of c-Src kinase (unknown origin)	B	COc1cccc(-c2cn(-c3ccc(CNCCO)cc3)c3ncnc(N)c23)c1		CHEMBL424375	=	IC50	nM	31.62	CHEMBL267	Homo sapiens	pIC50		7.5
	12591031	CHEMBL3069803	Inhibition of c-Src kinase (unknown origin)	B	Nc1ncnc2c1c(-c1ccccc1)cn2-c1ccc(CNCCO)cc1		CHEMBL173453	=	IC50	nM	31.62	CHEMBL267	Homo sapiens	pIC50		7.5
	12591032	CHEMBL3069803	Inhibition of c-Src kinase (unknown origin)	B	Nc1ncnc2c1c(-c1ccccc1)cn2-c1cccc(CNCCO)c1		CHEMBL176702	=	IC50	nM	10.0	CHEMBL267	Homo sapiens	pIC50		8.0
	12591033	CHEMBL3069803	Inhibition of c-Src kinase (unknown origin)	B	Nc1ncnc2c1c(-c1ccccc1)cn2-c1ccccc1CNCCO		CHEMBL176470	=	IC50	nM	5011.87	CHEMBL267	Homo sapiens	pIC50		5.3
	12591034	CHEMBL3069803	Inhibition of c-Src kinase (unknown origin)	B	COc1cccc(-c2cn(-c3cccc(CO)c3)c3ncnc(N)c23)c1		CHEMBL176815	=	IC50	nM	63.1	CHEMBL267	Homo sapiens	pIC50		7.2
	12591035	CHEMBL3069803	Inhibition of c-Src kinase (unknown origin)	B	Nc1ncnc2c1c(-c1ccccc1)cn2-c1ccc(CO)cc1		CHEMBL367442	=	IC50	nM	19.95	CHEMBL267	Homo sapiens	pIC50		7.7
	12591036	CHEMBL3069803	Inhibition of c-Src kinase (unknown origin)	B	Nc1ncnc2c1c(-c1ccccc1)cn2-c1cccc(CO)c1		CHEMBL173478	=	IC50	nM	63.1	CHEMBL267	Homo sapiens	pIC50		7.2
	12591037	CHEMBL3069803	Inhibition of c-Src kinase (unknown origin)	B	Nc1ncnc2c1c(-c1ccccc1)cn2-c1ccccc1CO		CHEMBL429057	=	IC50	nM	316.23	CHEMBL267	Homo sapiens	pIC50		6.5
	12591038	CHEMBL3069803	Inhibition of c-Src kinase (unknown origin)	B	CCOC(=O)c1ccc(-c2cn(-c3ccccc3)c3ncnc(N)c23)cc1		CHEMBL369014	=	IC50	nM	10000.0	CHEMBL267	Homo sapiens	pIC50		5.0
	12591039	CHEMBL3069803	Inhibition of c-Src kinase (unknown origin)	B	Cc1ccccc1-c1cn(-c2ccccc2)c2ncnc(N)c12		CHEMBL174634	=	IC50	nM	6309.57	CHEMBL267	Homo sapiens	pIC50		5.2
	12591040	CHEMBL3069803	Inhibition of c-Src kinase (unknown origin)	B	COc1ccc(-c2cn(-c3ccccc3)c3ncnc(N)c23)cc1		CHEMBL176705	=	IC50	nM	158.49	CHEMBL267	Homo sapiens	pIC50		6.8
	12591041	CHEMBL3069803	Inhibition of c-Src kinase (unknown origin)	B	Nc1ncnc2c1c(-c1cccc(Cl)c1)cn2-c1ccccc1		CHEMBL176309	=	IC50	nM	199.53	CHEMBL267	Homo sapiens	pIC50		6.7
	12591042	CHEMBL3069803	Inhibition of c-Src kinase (unknown origin)	B	COc1cccc(-c2cn(-c3ccccc3)c3ncnc(N)c23)c1		CHEMBL172973	=	IC50	nM	50.12	CHEMBL267	Homo sapiens	pIC50		7.3
	12591043	CHEMBL3069803	Inhibition of c-Src kinase (unknown origin)	B	COc1cccc(-c2cn(-c3ccc(CCN4CCC(O)CC4)cc3)c3ncnc(N)c23)c1		CHEMBL475584	=	IC50	nM	19.95	CHEMBL267	Homo sapiens	pIC50		7.7
	12591044	CHEMBL3069803	Inhibition of c-Src kinase (unknown origin)	B	Nc1ncnc2c1c(-c1ccccc1)cn2-c1ccccc1		CHEMBL169757	=	IC50	nM	100.0	CHEMBL267	Homo sapiens	pIC50		7.0
	12591045	CHEMBL3069803	Inhibition of c-Src kinase (unknown origin)	B	COc1cccc(-c2cn(-c3ccc(CCO)cc3)c3ncnc(N)c23)c1		CHEMBL320417	=	IC50	nM	100.0	CHEMBL267	Homo sapiens	pIC50		7.0
Not Active	12623296	CHEMBL2318776	Binding affinity to SRC (unknown origin) at 10 nM after 2 hrs by FRET assay	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2[nH]ncc2c1		CHEMBL2316582		Activity			CHEMBL267	Homo sapiens	Activity		
	12626701	CHEMBL2316979	Inhibition of c-SRC (unknown origin) at 1 uM	B	COc1cc(Nc2ncc(Cl)c(-c3cccc(CC#N)c3)n2)ccc1N1CCN(C)CC1		CHEMBL2312140	>=	Inhibition	%	80.0	CHEMBL267	Homo sapiens	INH	%	80.0
	12627694	CHEMBL2317041	Inhibition of SRC (unknown origin)	B	O=C(NCCCN1CCOC1=O)c1cnc(NCc2cc(Cl)ccc2Cl)nc1NC1CCCC1		CHEMBL2312304	>	IC50	nM	30000.0	CHEMBL267	Homo sapiens	IC50	uM	30.0
	12629474	CHEMBL2317041	Inhibition of SRC (unknown origin)	B	O=C(NCCCN1CCCC1=O)c1cnc(NCc2cc(Cl)ccc2Cl)nc1NC1CCCC1		CHEMBL2312303	>	IC50	nM	30000.0	CHEMBL267	Homo sapiens	IC50	uM	30.0
	12629475	CHEMBL2317041	Inhibition of SRC (unknown origin)	B	COc1ccccc1CNc1ncc(C(=O)NCCCN2CCCC2=O)c(NC2CCCC2)n1		CHEMBL2312301	>	IC50	nM	30000.0	CHEMBL267	Homo sapiens	IC50	uM	30.0
	12629476	CHEMBL2317041	Inhibition of SRC (unknown origin)	B	COc1ccc(CCNc2ncc(C(=O)NCCCN3CCCC3=O)c(NC3CCCC3)n2)cc1OC		CHEMBL2312290	=	IC50	nM	3690.0	CHEMBL267	Homo sapiens	IC50	uM	3.69
	12647851	CHEMBL2329056	Inhibition of SRC (unknown origin) at 1 uM	B	CC(C)(C)[C@@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(=O)N1CC(C#N)C1		CHEMBL2325895	=	Inhibition	%	57.0	CHEMBL267	Homo sapiens	INH	%	57.0
	12647852	CHEMBL2329056	Inhibition of SRC (unknown origin) at 1 uM	B	C[C@@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(=O)N1CC(C#N)C1		CHEMBL2325894	=	Inhibition	%	23.0	CHEMBL267	Homo sapiens	INH	%	23.0
	12647853	CHEMBL2329056	Inhibition of SRC (unknown origin) at 1 uM	B	C[C@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(C)(C)C#N		CHEMBL2325906	=	Inhibition	%	1.0	CHEMBL267	Homo sapiens	INH	%	1.0
	12647854	CHEMBL2329056	Inhibition of SRC (unknown origin) at 1 uM	B	C[C@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(C)(C)C		CHEMBL2325903	=	Inhibition	%	37.0	CHEMBL267	Homo sapiens	INH	%	37.0
	12649549	CHEMBL2329517	Inhibition of SRC (unknown origin) at 10 uM	B	C[C@@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(=O)N1CC(C#N)C1		CHEMBL2325894	=	Inhibition	%	85.0	CHEMBL267	Homo sapiens	INH	%	85.0
	12649550	CHEMBL2329517	Inhibition of SRC (unknown origin) at 10 uM	B	C[C@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(C)(C)O		CHEMBL2325904	=	Inhibition	%	74.0	CHEMBL267	Homo sapiens	INH	%	74.0
	12649551	CHEMBL2329517	Inhibition of SRC (unknown origin) at 10 uM	B	CC(C)NC(=O)c1c[nH]c2ncc(C3CC3)nc12		CHEMBL2325901	=	Inhibition	%	59.0	CHEMBL267	Homo sapiens	INH	%	59.0
	12660156	CHEMBL2329208	Inhibition of SRC (unknown origin) at 1 uM	B	COc1cc(Oc2ccccc2)ccc1-c1nc([C@H]2C[C@@](C)(O)C2)n2ccnc(N)c12		CHEMBL2325940	>	Inhibition	%	80.0	CHEMBL267	Homo sapiens	INH	%	80.0
	12670882	CHEMBL2338946	Inhibition of Src kinase (unknown origin) using [33P]-ATP at 10 uM after 20 to 40 mins by scintillation counting analysis	B	O=C(Nc1ccc(Cl)cc1)Nc1ccc2c(c1)C(Nc1ccc(Cl)cc1Cl)=NS2(=O)=O		CHEMBL2334805	=	Inhibition	%	58.0	CHEMBL267	Homo sapiens	INH	%	58.0
	12672893	CHEMBL2341148	Inhibition of recombinant SRC (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336379	=	Activity	%	6.0	CHEMBL267	Homo sapiens	Activity	%	6.0
	12672894	CHEMBL2341148	Inhibition of recombinant SRC (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336377	=	Activity	%	22.0	CHEMBL267	Homo sapiens	Activity	%	22.0
	12674099	CHEMBL2345555	Inhibition of SRC (unknown origin)	B	O=C(NCCc1ccc(O)c(Br)c1)/C(Cc1cc(Br)c(O)c(Oc2ccc(CCNC(=O)/C(Cc3cc(Br)c(O)c(-c4cc(C/C(=N\O)C(=O)NCCc5ccc(O)c(Br)c5)cc(Br)c4O)c3)=N/O)cc2Br)c1)=N/O		CHEMBL2333163	=	IC50	nM	700.0	CHEMBL267	Homo sapiens	IC50	uM	0.7
	12674100	CHEMBL2345555	Inhibition of SRC (unknown origin)	B	O=C(NCCc1ccc(O)c(Br)c1)/C(Cc1cc(Br)c(O)c(-c2cc(C/C(=N/O)C(=O)NCCc3ccc(O)c(Br)c3)cc(Br)c2O)c1)=N\O		CHEMBL505637	=	IC50	nM	1900.0	CHEMBL267	Homo sapiens	IC50	uM	1.9
	12674101	CHEMBL2345555	Inhibition of SRC (unknown origin)	B	O=C1N/C=C/c2ccc(c(Br)c2)Oc2cc(cc(Br)c2O)CCNC(=O)/C(=N/O)Cc2ccc(c(Br)c2)Oc2cc(cc(Br)c2O)C/C1=N\O		CHEMBL360190	=	IC50	nM	2000.0	CHEMBL267	Homo sapiens	IC50	uM	2.0
	12674228	CHEMBL2344631	Inhibition of human Src using [gamma-33P]ATP assessed as residual activity at 3 uM after 30 mins by radiometric assay	B	CCCCn1c(-c2ccccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL2333603	=	Activity	%	2.0	CHEMBL267	Homo sapiens	Activity	%	2.0
	12674239	CHEMBL2344637	Inhibition of Src (unknown origin) using [gamma-33P]ATP after 30 mins by radiometric assay	B	CCCCn1c(-c2cc(-c3cccc4[nH]ncc34)ccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL2333602	=	IC50	nM	46.0	CHEMBL267	Homo sapiens	IC50	nM	46.0
	12674240	CHEMBL2344637	Inhibition of Src (unknown origin) using [gamma-33P]ATP after 30 mins by radiometric assay	B	CCCCn1c(-c2ccc(F)cc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL2333595	=	IC50	nM	110.0	CHEMBL267	Homo sapiens	IC50	nM	110.0
	12674241	CHEMBL2344637	Inhibition of Src (unknown origin) using [gamma-33P]ATP after 30 mins by radiometric assay	B	CCCCn1c(-c2ccccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL2333603	=	IC50	nM	71.0	CHEMBL267	Homo sapiens	IC50	nM	71.0
	12674242	CHEMBL2344637	Inhibition of Src (unknown origin) using [gamma-33P]ATP after 30 mins by radiometric assay	B	COc1ccccc1-n1c(-c2cc(O)ccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL566515	=	IC50	nM	1.14	CHEMBL267	Homo sapiens	IC50	nM	1.14
	12679748	CHEMBL2346288	Inhibition of SRC (unknown origin) at 1 uM	B	Cc1ccc(-c2ccc3ncc4c(c3n2)n(C2CCN(C(=O)[C@H](C)O)CC2)c(=O)n4C)cn1		CHEMBL2331664	=	Inhibition	%	8.25	CHEMBL267	Homo sapiens	INH	%	8.25
	12693277	CHEMBL2343954	Inhibition of SRC (unknown origin)	B	Cc1c(C(=O)N2CCOc3ccc(-c4ccc(N)nc4)cc3C2)ccc(S(C)(=O)=O)c1F		CHEMBL2333365	>	IC50	nM	3500.0	CHEMBL267	Homo sapiens	IC50	nM	3500.0
	12705267	CHEMBL2345798	Inhibition of Src (unknown origin)	B	CN1c2ccc(NCc3ccc(C(C)(C)C)cc3)cc2-c2c(cnn2C)S1(=O)=O		CHEMBL2333444	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	12705268	CHEMBL2345798	Inhibition of Src (unknown origin)	B	CCc1ccc(-c2ccc3c(c2)-c2c(cnn2C)S(=O)(=O)N3C)cc1		CHEMBL2333435	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	12705269	CHEMBL2345798	Inhibition of Src (unknown origin)	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	12716042	CHEMBL2350814	Inhibition of cSRC (unknown origin)	B	CNc1nc(C)c(-c2nc(Nc3cccc(N4CCCNCC4)c3)ncc2C#N)s1		CHEMBL2312185	>	IC50	nM	5000.0	CHEMBL267	Homo sapiens	IC50	nM	5000.0
	12718784	CHEMBL2350669	Inhibition of SRC (unknown origin) after 10 mins by mobility shift assay	B	O=C1Nc2ccccc2/C1=C/c1c[nH]nc1-c1ccccc1[N+](=O)[O-]		CHEMBL2347053	=	IC50	nM	7.9	CHEMBL267	Homo sapiens	IC50	nM	7.9
	12718808	CHEMBL2350692	Inhibition of SRC (unknown origin) at 3 uM after 10 mins by mobility shift assay relative to control	B	O=C1Nc2ccccc2/C1=C/c1c[nH]nc1-c1ccccc1[N+](=O)[O-]		CHEMBL2347053	=	Inhibition	%	30.0	CHEMBL267	Homo sapiens	INH	%	30.0
	12718831	CHEMBL2350984	Inhibition of SRC (unknown origin) at 10 uM after 10 mins by mobility shift assay relative to control	B	O=C1Nc2ccccc2/C1=C/c1c[nH]nc1-c1ccccc1[N+](=O)[O-]		CHEMBL2347053	=	Inhibition	%	55.0	CHEMBL267	Homo sapiens	INH	%	55.0
Not Active	12719949	CHEMBL2353051	Effect on SRC in human HepG2 cells pretreated at 50 uM for 6 to 48 hrs prior to IL-6 stimulation by Western blot analysis	B	NS(=O)(=O)c1ccc(NCc2cc(Cl)ccc2OCc2ccccc2)cc1		CHEMBL2347241		Activity			CHEMBL267	Homo sapiens	Activity		
Not Active	12719950	CHEMBL2353051	Effect on SRC in human HepG2 cells pretreated at 50 uM for 6 to 48 hrs prior to IL-6 stimulation by Western blot analysis	B	Oc1ccc(NCc2cc(Cl)ccc2OCc2ccc(Cl)cc2)cc1		CHEMBL2347240		Activity			CHEMBL267	Homo sapiens	Activity		
	12721795	CHEMBL2351851	Inhibition of SRC (unknown origin) at 1 uM relative to control	B	CCNC(=O)Nc1nc2ccc(-c3ccccc3OC)cc2s1		CHEMBL2347710	=	Inhibition	%	72.0	CHEMBL267	Homo sapiens	INH	%	72.0
	12727629	CHEMBL2350836	Inhibition of cSRC (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	86.0	CHEMBL267	Homo sapiens	Activity	%	86.0
	12728914	CHEMBL2352813	Inhibition of cSRC (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	92.0	CHEMBL267	Homo sapiens	Activity	%	92.0
	12729782	CHEMBL2350027	Inhibition of c-Src T341M mutant (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	77.0	CHEMBL267	Homo sapiens	Activity	%	77.0
	12730057	CHEMBL2350836	Inhibition of cSRC (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	100.0	CHEMBL267	Homo sapiens	Activity	%	100.0
	12730882	CHEMBL2352483	Inhibition of c-Src (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	58.0	CHEMBL267	Homo sapiens	Activity	%	58.0
	13281257	CHEMBL2378200	Inhibition of SRC (unknown origin) at 10 uM relative to control	B	C[C@@H](NC(=O)c1c[nH]c2ncc(-c3ncn4cc(F)cc(F)c34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376158	=	Inhibition	%	35.0	CHEMBL267	Homo sapiens	INH	%	35.0
	13281258	CHEMBL2378200	Inhibition of SRC (unknown origin) at 10 uM relative to control	B	Cn1nc(-c2cnc3[nH]cc(C(=O)N[C@@H](C(=O)N4CC(C#N)C4)C4CC4)c3n2)c2ccc(Cl)cc21		CHEMBL2376154	=	Inhibition	%	70.0	CHEMBL267	Homo sapiens	INH	%	70.0
	13281259	CHEMBL2378200	Inhibition of SRC (unknown origin) at 10 uM relative to control	B	CC[C@@H](NC(=O)c1c[nH]c2ncc(-c3nn(C)c4cc(Cl)ccc34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376153	=	Inhibition	%	72.0	CHEMBL267	Homo sapiens	INH	%	72.0
	13281260	CHEMBL2378200	Inhibition of SRC (unknown origin) at 10 uM relative to control	B	C[C@@H](NC(=O)c1c[nH]c2ncc(-c3nn(C)c4cc(Cl)cc(F)c34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376152	=	Inhibition	%	12.0	CHEMBL267	Homo sapiens	INH	%	12.0
	13281261	CHEMBL2378200	Inhibition of SRC (unknown origin) at 10 uM relative to control	B	C[C@@H](NC(=O)c1c[nH]c2ncc(-c3nn(C)c4cc(Cl)ccc34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376144	=	Inhibition	%	-3.0	CHEMBL267	Homo sapiens	INH	%	-3.0
	13281262	CHEMBL2378200	Inhibition of SRC (unknown origin) at 10 uM relative to control	B	C[C@@H](NC(=O)c1c[nH]c2ncc(-c3cn(C)c4cc(Cl)ccc34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376143	=	Inhibition	%	91.0	CHEMBL267	Homo sapiens	INH	%	91.0
Not Determined	13292708	CHEMBL2379104	Inhibition of human recombinant SRC at 10 uM relative to control	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Determined	13292709	CHEMBL2379104	Inhibition of human recombinant SRC at 10 uM relative to control	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	13292710	CHEMBL2379104	Inhibition of human recombinant SRC at 10 uM relative to control	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Inhibition	%	98.1	CHEMBL267	Homo sapiens	INH	%	98.1
	13292711	CHEMBL2379104	Inhibition of human recombinant SRC at 10 uM relative to control	B	COc1cc2c(Nc3nc4ccc(C(=O)Nc5c(C)cc(C)cc5C)cc4s3)ncnc2cc1OCCCN1CCCCC1C		CHEMBL2377290	=	Inhibition	%	89.2	CHEMBL267	Homo sapiens	INH	%	89.2
	13292712	CHEMBL2379104	Inhibition of human recombinant SRC at 10 uM relative to control	B	COc1cc2c(Nc3nc4ccc(C(=O)Nc5c(C)cc(C)cc5C)cc4s3)ncnc2cc1OCCCN1CCOCC1		CHEMBL2377291	=	Inhibition	%	80.6	CHEMBL267	Homo sapiens	INH	%	80.6
	13292713	CHEMBL2379104	Inhibition of human recombinant SRC at 10 uM relative to control	B	COc1cc2c(Nc3nc4ccc(C(=O)Nc5c(C)cc(C)cc5C)cc4s3)ncnc2cc1OCCCN1CCCC1		CHEMBL2377292	=	Inhibition	%	91.8	CHEMBL267	Homo sapiens	INH	%	91.8
	13292714	CHEMBL2379104	Inhibition of human recombinant SRC at 10 uM relative to control	B	CCN(CC)CCCOc1cc2ncnc(Nc3nc4ccc(C(=O)Nc5c(C)cc(C)cc5C)cc4s3)c2cc1OC		CHEMBL2377293	=	Inhibition	%	65.3	CHEMBL267	Homo sapiens	INH	%	65.3
	13292715	CHEMBL2379104	Inhibition of human recombinant SRC at 10 uM relative to control	B	COc1cc2c(Nc3nc4ccc(C(=O)Nc5c(C)cc(C)cc5C)cc4s3)ncnc2cc1OCCCN1CCCCC1		CHEMBL2377276	=	Inhibition	%	69.7	CHEMBL267	Homo sapiens	INH	%	69.7
	13292716	CHEMBL2379104	Inhibition of human recombinant SRC at 10 uM relative to control	B	COc1cc2c(Nc3nc4ccc(C(=O)Nc5c(C)cc(C)cc5C)cc4s3)ncnc2cc1OCCCN1CCC(C)CC1		CHEMBL2377277	=	Inhibition	%	78.6	CHEMBL267	Homo sapiens	INH	%	78.6
	13292717	CHEMBL2379104	Inhibition of human recombinant SRC at 10 uM relative to control	B	COc1cc2c(Nc3nc4ccc(C(=O)Nc5c(C)cccc5C)cc4s3)ncnc2cc1OCCCN1CCCCC1C		CHEMBL2377278	=	Inhibition	%	49.0	CHEMBL267	Homo sapiens	INH	%	49.0
	13292718	CHEMBL2379104	Inhibition of human recombinant SRC at 10 uM relative to control	B	COc1cc2c(Nc3nc4ccc(C(=O)Nc5c(C)cccc5C)cc4s3)ncnc2cc1OCCCN1CCOCC1		CHEMBL2377279	=	Inhibition	%	28.7	CHEMBL267	Homo sapiens	INH	%	28.7
	13292719	CHEMBL2379104	Inhibition of human recombinant SRC at 10 uM relative to control	B	COc1cc2c(Nc3nc4ccc(C(=O)Nc5c(C)cccc5C)cc4s3)ncnc2cc1OCCCN1CCCC1		CHEMBL2377280	=	Inhibition	%	39.9	CHEMBL267	Homo sapiens	INH	%	39.9
	13292720	CHEMBL2379104	Inhibition of human recombinant SRC at 10 uM relative to control	B	CCN(CC)CCCOc1cc2ncnc(Nc3nc4ccc(C(=O)Nc5c(C)cccc5C)cc4s3)c2cc1OC		CHEMBL2377281	=	Inhibition	%	53.6	CHEMBL267	Homo sapiens	INH	%	53.6
	13292721	CHEMBL2379104	Inhibition of human recombinant SRC at 10 uM relative to control	B	COc1cc2c(Nc3nc4ccc(C(=O)Nc5c(C)cccc5C)cc4s3)ncnc2cc1OCCCN1CCCCC1		CHEMBL2377282	=	Inhibition	%	43.4	CHEMBL267	Homo sapiens	INH	%	43.4
	13292722	CHEMBL2379104	Inhibition of human recombinant SRC at 10 uM relative to control	B	COc1cc2c(Nc3nc4ccc(C(=O)Nc5c(C)cccc5C)cc4s3)ncnc2cc1OCCCN1CCC(C)CC1		CHEMBL2377283	=	Inhibition	%	56.5	CHEMBL267	Homo sapiens	INH	%	56.5
	13292723	CHEMBL2379104	Inhibition of human recombinant SRC at 10 uM relative to control	B	COc1cc2c(Nc3nc4ccc(C(=O)Nc5c(C)cccc5Cl)cc4s3)ncnc2cc1OCCCN1CCCCC1C		CHEMBL2377284	=	Inhibition	%	78.9	CHEMBL267	Homo sapiens	INH	%	78.9
	13292724	CHEMBL2379104	Inhibition of human recombinant SRC at 10 uM relative to control	B	COc1cc2c(Nc3nc4ccc(C(=O)Nc5c(C)cccc5Cl)cc4s3)ncnc2cc1OCCCN1CCOCC1		CHEMBL2377289	=	Inhibition	%	34.3	CHEMBL267	Homo sapiens	INH	%	34.3
	13293632	CHEMBL2379104	Inhibition of human recombinant SRC at 10 uM relative to control	B	COc1cc2c(Nc3nc4ccc(C(=O)Nc5c(C)cccc5Cl)cc4s3)ncnc2cc1OCCCN1CCCC1		CHEMBL2377288	=	Inhibition	%	55.7	CHEMBL267	Homo sapiens	INH	%	55.7
	13293633	CHEMBL2379104	Inhibition of human recombinant SRC at 10 uM relative to control	B	CCN(CC)CCCOc1cc2ncnc(Nc3nc4ccc(C(=O)Nc5c(C)cccc5Cl)cc4s3)c2cc1OC		CHEMBL2377287	=	Inhibition	%	68.2	CHEMBL267	Homo sapiens	INH	%	68.2
	13293634	CHEMBL2379104	Inhibition of human recombinant SRC at 10 uM relative to control	B	COc1cc2c(Nc3nc4ccc(C(=O)Nc5c(C)cccc5Cl)cc4s3)ncnc2cc1OCCCN1CCCCC1		CHEMBL2377286	=	Inhibition	%	83.3	CHEMBL267	Homo sapiens	INH	%	83.3
	13293635	CHEMBL2379104	Inhibition of human recombinant SRC at 10 uM relative to control	B	COc1cc2c(Nc3nc4ccc(C(=O)Nc5c(C)cccc5Cl)cc4s3)ncnc2cc1OCCCN1CCC(C)CC1		CHEMBL2377285	=	Inhibition	%	67.4	CHEMBL267	Homo sapiens	INH	%	67.4
Active	13300195	CHEMBL2384444	Inhibition of human SRC at 1 uM	B	CC(C)CCNc1ccc(-c2cnc3ccc(NC4CCN(C)CC4)nn23)cn1		CHEMBL2380687		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	13302657	CHEMBL2382641	Ratio of Kcat to Km for 6xHis-tagged Src catalytic domain (unknown origin) expressed in Escherichia coli at 1 uM (Rvb = 1.91 no unit)	B	N=C(N)NCCC[C@@H]1NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC1=O		CHEMBL2382016	=	Kcat/Km	/min/microM	1.34	CHEMBL267	Homo sapiens	Kcat/Km	/min/microM	1.34
	13302659	CHEMBL2382766	Ratio of Kcat to Km for 6xHis-tagged Src catalytic domain (unknown origin) expressed in Escherichia coli at 0.5 uM (Rvb = 1.91 no unit)	B	N=C(N)NCCC[C@@H]1NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC1=O		CHEMBL2382016	=	Kcat/Km	/min/microM	1.44	CHEMBL267	Homo sapiens	Kcat/Km	/min/microM	1.44
	13302662	CHEMBL2382769	Inhibition of 6xHis-tagged Src catalytic domain (unknown origin) expressed in Escherichia coli using polyE4Y as substrate after 20 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	N=C(N)NCCC[C@@H]1NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC1=O		CHEMBL2382016	=	IC50	nM	800.0	CHEMBL267	Homo sapiens	IC50	uM	0.8
	13302665	CHEMBL2382772	Inhibition of 6xHis-tagged Src catalytic domain (unknown origin) expressed in Escherichia coli using AEEEIYGEFEAKKKK as substrate incubated for 10 mins prior to substrate addition measured after 30 mins by fluorescence intensity assay	B	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21	Potential transcription error	CHEMBL406845	=	IC50	nM	500.0	CHEMBL267	Homo sapiens	IC50	uM	0.5
	13302666	CHEMBL2382772	Inhibition of 6xHis-tagged Src catalytic domain (unknown origin) expressed in Escherichia coli using AEEEIYGEFEAKKKK as substrate incubated for 10 mins prior to substrate addition measured after 30 mins by fluorescence intensity assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	600.0	CHEMBL267	Homo sapiens	IC50	uM	0.6
	13302667	CHEMBL2382772	Inhibition of 6xHis-tagged Src catalytic domain (unknown origin) expressed in Escherichia coli using AEEEIYGEFEAKKKK as substrate incubated for 10 mins prior to substrate addition measured after 30 mins by fluorescence intensity assay	B	NCCCC[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O		CHEMBL2382019	=	IC50	nM	69100.0	CHEMBL267	Homo sapiens	IC50	uM	69.1
	13302668	CHEMBL2382772	Inhibition of 6xHis-tagged Src catalytic domain (unknown origin) expressed in Escherichia coli using AEEEIYGEFEAKKKK as substrate incubated for 10 mins prior to substrate addition measured after 30 mins by fluorescence intensity assay	B	N=C(N)NCCC[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O		CHEMBL2382018	=	IC50	nM	7100.0	CHEMBL267	Homo sapiens	IC50	uM	7.1
	13302669	CHEMBL2382772	Inhibition of 6xHis-tagged Src catalytic domain (unknown origin) expressed in Escherichia coli using AEEEIYGEFEAKKKK as substrate incubated for 10 mins prior to substrate addition measured after 30 mins by fluorescence intensity assay	B	NCCCC[C@@H]1NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC1=O		CHEMBL2382017	=	IC50	nM	46900.0	CHEMBL267	Homo sapiens	IC50	uM	46.9
	13302670	CHEMBL2382772	Inhibition of 6xHis-tagged Src catalytic domain (unknown origin) expressed in Escherichia coli using AEEEIYGEFEAKKKK as substrate incubated for 10 mins prior to substrate addition measured after 30 mins by fluorescence intensity assay	B	N=C(N)NCCC[C@@H]1NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC1=O		CHEMBL2382016	=	IC50	nM	2800.0	CHEMBL267	Homo sapiens	IC50	uM	2.8
	13302671	CHEMBL2382772	Inhibition of 6xHis-tagged Src catalytic domain (unknown origin) expressed in Escherichia coli using AEEEIYGEFEAKKKK as substrate incubated for 10 mins prior to substrate addition measured after 30 mins by fluorescence intensity assay	B	N=C(N)NCCC[C@@H]1NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC1=O		CHEMBL2382015	=	IC50	nM	25000.0	CHEMBL267	Homo sapiens	IC50	uM	25.0
	13302672	CHEMBL2382772	Inhibition of 6xHis-tagged Src catalytic domain (unknown origin) expressed in Escherichia coli using AEEEIYGEFEAKKKK as substrate incubated for 10 mins prior to substrate addition measured after 30 mins by fluorescence intensity assay	B	N=C(N)NCCC[C@@H]1NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC1=O		CHEMBL2382014	=	IC50	nM	21500.0	CHEMBL267	Homo sapiens	IC50	uM	21.5
	13302673	CHEMBL2382772	Inhibition of 6xHis-tagged Src catalytic domain (unknown origin) expressed in Escherichia coli using AEEEIYGEFEAKKKK as substrate incubated for 10 mins prior to substrate addition measured after 30 mins by fluorescence intensity assay	B	N=C(N)NCCC[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccccc2)NC1=O		CHEMBL2382013	=	IC50	nM	31300.0	CHEMBL267	Homo sapiens	IC50	uM	31.3
	13302674	CHEMBL2382772	Inhibition of 6xHis-tagged Src catalytic domain (unknown origin) expressed in Escherichia coli using AEEEIYGEFEAKKKK as substrate incubated for 10 mins prior to substrate addition measured after 30 mins by fluorescence intensity assay	B	N=C(N)NCCC[C@@H]1NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL2382012	=	IC50	nM	52600.0	CHEMBL267	Homo sapiens	IC50	uM	52.6
	13302675	CHEMBL2382772	Inhibition of 6xHis-tagged Src catalytic domain (unknown origin) expressed in Escherichia coli using AEEEIYGEFEAKKKK as substrate incubated for 10 mins prior to substrate addition measured after 30 mins by fluorescence intensity assay	B	NCCCC[C@@H]1NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC1=O	Outside typical range	CHEMBL2382011	>=	IC50	nM	300000.0	CHEMBL267	Homo sapiens	IC50	uM	300.0
	13302676	CHEMBL2382772	Inhibition of 6xHis-tagged Src catalytic domain (unknown origin) expressed in Escherichia coli using AEEEIYGEFEAKKKK as substrate incubated for 10 mins prior to substrate addition measured after 30 mins by fluorescence intensity assay	B	N=C(N)NCCC[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc2ccccc2)NC1=O	Outside typical range	CHEMBL2382022	>=	IC50	nM	300000.0	CHEMBL267	Homo sapiens	IC50	uM	300.0
	13302677	CHEMBL2382772	Inhibition of 6xHis-tagged Src catalytic domain (unknown origin) expressed in Escherichia coli using AEEEIYGEFEAKKKK as substrate incubated for 10 mins prior to substrate addition measured after 30 mins by fluorescence intensity assay	B	C[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC1=O	Outside typical range	CHEMBL2382021	>=	IC50	nM	300000.0	CHEMBL267	Homo sapiens	IC50	uM	300.0
	13302678	CHEMBL2382772	Inhibition of 6xHis-tagged Src catalytic domain (unknown origin) expressed in Escherichia coli using AEEEIYGEFEAKKKK as substrate incubated for 10 mins prior to substrate addition measured after 30 mins by fluorescence intensity assay	B	NCCCC[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2ccccc2)NC1=O	Outside typical range	CHEMBL2382020	=	IC50	nM	1567600.0	CHEMBL267	Homo sapiens	IC50	uM	1567.6
	13327634	CHEMBL2389809	Inhibition of SRC (unknown origin) at 1 uM	B	CC(C)(C)c1cc(NC(=O)NCc2ccc(-c3cc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)[nH]n3)cc2)no1		CHEMBL2386802	=	Inhibition	%	35.0	CHEMBL267	Homo sapiens	INH	%	35.0
	13327635	CHEMBL2389809	Inhibition of SRC (unknown origin) at 1 uM	B	Cc1cc(-c2cc(NC(=O)c3ccc(CN4CCN(C)CC4)cc3)[nH]n2)ccc1NC(=O)Nc1cc(C(C)(C)C)on1		CHEMBL2386796	=	Inhibition	%	77.0	CHEMBL267	Homo sapiens	INH	%	77.0
Not Active	13328749	CHEMBL2387911	Inhibition of SRC (unknown origin)	B	Cc1cccc2nc(Cn3cnc4ccccc43)cc(=O)n12		CHEMBL2386917		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	13330033	CHEMBL2389546	Inhibition of SRC (unknown origin)	B	COc1cc(-c2cn([C@H]3CC[C@H](N4CCN(C)CC4)CC3)c3ncnc(N)c23)ccc1NS(=O)(=O)c1ccccc1		CHEMBL2387003	>	IC50	nM	3000.0	CHEMBL267	Homo sapiens	IC50	nM	3000.0
Not Active	13335955	CHEMBL2393920	Inhibition of SRC (unknown origin) transfected in mouse Ba/F3 cells up to 1 uM	B	Fc1ccc(-c2n[nH]cc2-c2ccncc2)cc1Cl		CHEMBL2390985		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	13335968	CHEMBL2393929	Inhibition of SRC (unknown origin) transfected in mouse Ba/F3 cells at 5 uM after 24 hrs	B	Cc1ccc(-n2cnc3cc(Nc4nnc(C)c5ccccc45)ccc32)cc1		CHEMBL2390986		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Active	13335969	CHEMBL2393929	Inhibition of SRC (unknown origin) transfected in mouse Ba/F3 cells at 5 uM after 24 hrs	B	Fc1ccc(-c2n[nH]cc2-c2ccncc2)cc1Cl		CHEMBL2390985		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	13336020	CHEMBL2394058	Inhibition of SRC (unknown origin) transfected in mouse Ba/F3 cells at 1 uM after 24 hrs	B	Cc1cccc(C(=O)Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL2390984		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	13336021	CHEMBL2394058	Inhibition of SRC (unknown origin) transfected in mouse Ba/F3 cells at 1 uM after 24 hrs	B	Cc1ccc(-c2cc(NC(=O)c3ccc(F)cc3)[nH]n2)cc1		CHEMBL2390983		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	13336022	CHEMBL2394058	Inhibition of SRC (unknown origin) transfected in mouse Ba/F3 cells at 1 uM after 24 hrs	B	COc1ccc(C(=O)Nc2cc(-c3ccccc3)[nH]n2)cc1		CHEMBL167454		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Determined	13363410	CHEMBL2399911	Binding affinity to recombinant human c-Src using KVEKIGEGTYGVVYK as substrate	B	ClC(Cn1ncc2c(Nc3ccccc3)ncnc21)c1ccc(I)cc1		CHEMBL2397818		Ki			CHEMBL267	Homo sapiens	Ki		
Not Determined	13363411	CHEMBL2399911	Binding affinity to recombinant human c-Src using KVEKIGEGTYGVVYK as substrate	B	Cc1ccc(C(Cl)Cn2ncc3c(Nc4ccccc4)ncnc32)cc1		CHEMBL2397817		Ki			CHEMBL267	Homo sapiens	Ki		
	13363412	CHEMBL2399911	Binding affinity to recombinant human c-Src using KVEKIGEGTYGVVYK as substrate	B	FC(F)(F)c1cc(CNc2ncnc3c2cnn3CC(Cl)c2ccc(Br)cc2)cc(C(F)(F)F)c1		CHEMBL2397816	=	Ki	nM	637.0	CHEMBL267	Homo sapiens	Ki	uM	0.637
	13363413	CHEMBL2399911	Binding affinity to recombinant human c-Src using KVEKIGEGTYGVVYK as substrate	B	COc1cccc(CNc2ncnc3c2cnn3CC(Cl)c2ccc(Br)cc2)c1		CHEMBL2397815	=	Ki	nM	150.0	CHEMBL267	Homo sapiens	Ki	uM	0.15
	13363414	CHEMBL2399911	Binding affinity to recombinant human c-Src using KVEKIGEGTYGVVYK as substrate	B	ClC(Cn1ncc2c(NCc3cccc(Br)c3)ncnc21)c1ccc(Br)cc1		CHEMBL2397814	=	Ki	nM	770.0	CHEMBL267	Homo sapiens	Ki	uM	0.77
	13363415	CHEMBL2399911	Binding affinity to recombinant human c-Src using KVEKIGEGTYGVVYK as substrate	B	ClC(Cn1ncc2c(NCc3ccccc3Br)ncnc21)c1ccc(Br)cc1		CHEMBL2397813	=	Ki	nM	723.0	CHEMBL267	Homo sapiens	Ki	uM	0.723
	13363416	CHEMBL2399911	Binding affinity to recombinant human c-Src using KVEKIGEGTYGVVYK as substrate	B	ClC(Cn1ncc2c(NCc3ccc(Br)cc3)ncnc21)c1ccc(Br)cc1		CHEMBL2397812	=	Ki	nM	1097.0	CHEMBL267	Homo sapiens	Ki	uM	1.097
	13363417	CHEMBL2399911	Binding affinity to recombinant human c-Src using KVEKIGEGTYGVVYK as substrate	B	Fc1ccc(CNc2ncnc3c2cnn3CC(Cl)c2ccc(Br)cc2)cc1F		CHEMBL2397811	=	Ki	nM	1700.0	CHEMBL267	Homo sapiens	Ki	uM	1.7
	13363418	CHEMBL2399911	Binding affinity to recombinant human c-Src using KVEKIGEGTYGVVYK as substrate	B	Fc1ccc(F)c(CNc2ncnc3c2cnn3CC(Cl)c2ccc(Br)cc2)c1		CHEMBL2397810	=	Ki	nM	165.0	CHEMBL267	Homo sapiens	Ki	uM	0.165
	13363419	CHEMBL2399911	Binding affinity to recombinant human c-Src using KVEKIGEGTYGVVYK as substrate	B	Fc1ccc(CNc2ncnc3c2cnn3CC(Cl)c2ccc(Br)cc2)cc1		CHEMBL2397809	=	Ki	nM	1080.0	CHEMBL267	Homo sapiens	Ki	uM	1.08
	13363420	CHEMBL2399911	Binding affinity to recombinant human c-Src using KVEKIGEGTYGVVYK as substrate	B	Clc1ccc(CNc2ncnc3c2cnn3CC(Cl)c2ccc(Br)cc2)cc1Cl		CHEMBL2397808	=	Ki	nM	500.0	CHEMBL267	Homo sapiens	Ki	uM	0.5
	13363421	CHEMBL2399911	Binding affinity to recombinant human c-Src using KVEKIGEGTYGVVYK as substrate	B	Clc1ccc(Cl)c(CNc2ncnc3c2cnn3CC(Cl)c2ccc(Br)cc2)c1		CHEMBL2397807	=	Ki	nM	610.0	CHEMBL267	Homo sapiens	Ki	uM	0.61
	13363422	CHEMBL2399911	Binding affinity to recombinant human c-Src using KVEKIGEGTYGVVYK as substrate	B	Clc1ccc(CNc2ncnc3c2cnn3CC(Cl)c2ccc(Br)cc2)cc1		CHEMBL2397806	=	Ki	nM	6.0	CHEMBL267	Homo sapiens	Ki	uM	0.006
	13363423	CHEMBL2399911	Binding affinity to recombinant human c-Src using KVEKIGEGTYGVVYK as substrate	B	Clc1ccccc1CNc1ncnc2c1cnn2CC(Cl)c1ccc(Br)cc1		CHEMBL2397805	=	Ki	nM	620.0	CHEMBL267	Homo sapiens	Ki	uM	0.62
	13363424	CHEMBL2399911	Binding affinity to recombinant human c-Src using KVEKIGEGTYGVVYK as substrate	B	Clc1cccc(CNc2ncnc3c2cnn3CC(Cl)c2ccc(Br)cc2)c1		CHEMBL2397804	=	Ki	nM	70.0	CHEMBL267	Homo sapiens	Ki	uM	0.07
	13363425	CHEMBL2399911	Binding affinity to recombinant human c-Src using KVEKIGEGTYGVVYK as substrate	B	ClC(Cn1ncc2c(NCc3ccccc3)ncnc21)c1ccc(Br)cc1		CHEMBL2397803	=	Ki	nM	618.0	CHEMBL267	Homo sapiens	Ki	uM	0.618
	13363426	CHEMBL2399911	Binding affinity to recombinant human c-Src using KVEKIGEGTYGVVYK as substrate	B	ClC(Cn1ncc2c(Nc3ccccc3)ncnc21)c1ccc(Br)cc1		CHEMBL2397802	=	Ki	nM	64.0	CHEMBL267	Homo sapiens	Ki	uM	0.064
	13363427	CHEMBL2399911	Binding affinity to recombinant human c-Src using KVEKIGEGTYGVVYK as substrate	B	ClC(Cn1ncc2c(Nc3ccccc3)ncnc21)c1ccccc1		CHEMBL2397801	=	Ki	nM	110.0	CHEMBL267	Homo sapiens	Ki	uM	0.11
	13363428	CHEMBL2399911	Binding affinity to recombinant human c-Src using KVEKIGEGTYGVVYK as substrate	B	Fc1cccc(Nc2ncnc3c2cnn3CC(Cl)c2ccccc2)c1		CHEMBL2397800	=	Ki	nM	2350.0	CHEMBL267	Homo sapiens	Ki	uM	2.35
	13363429	CHEMBL2399911	Binding affinity to recombinant human c-Src using KVEKIGEGTYGVVYK as substrate	B	ClC(Cn1ncc2c(Nc3cccc(Br)c3)ncnc21)c1ccccc1		CHEMBL2397799	=	Ki	nM	395.0	CHEMBL267	Homo sapiens	Ki	uM	0.395
	13363430	CHEMBL2399911	Binding affinity to recombinant human c-Src using KVEKIGEGTYGVVYK as substrate	B	Fc1ccc(C(Cl)Cn2ncc3c(Nc4cccc(Br)c4)ncnc32)cc1		CHEMBL2397798	=	Ki	nM	340.0	CHEMBL267	Homo sapiens	Ki	uM	0.34
	13363431	CHEMBL2399911	Binding affinity to recombinant human c-Src using KVEKIGEGTYGVVYK as substrate	B	Fc1ccc(C(Cl)Cn2ncc3c(Nc4cccc(Cl)c4)ncnc32)cc1		CHEMBL2397797	=	Ki	nM	1400.0	CHEMBL267	Homo sapiens	Ki	uM	1.4
	13363432	CHEMBL2399911	Binding affinity to recombinant human c-Src using KVEKIGEGTYGVVYK as substrate	B	Fc1cccc(CNc2ncnc3c2cnn3CC(Cl)c2ccccc2)c1		CHEMBL412298	=	Ki	nM	80.0	CHEMBL267	Homo sapiens	Ki	uM	0.08
	13363433	CHEMBL2399911	Binding affinity to recombinant human c-Src using KVEKIGEGTYGVVYK as substrate	B	Fc1ccc(C(Cl)Cn2ncc3c(NCc4cccc(F)c4)ncnc32)cc1		CHEMBL261827	=	Ki	nM	1500.0	CHEMBL267	Homo sapiens	Ki	uM	1.5
	13363434	CHEMBL2399911	Binding affinity to recombinant human c-Src using KVEKIGEGTYGVVYK as substrate	B	Fc1cccc(CNc2ncnc3c2cnn3CC(Cl)c2ccc(Br)cc2)c1		CHEMBL2397796	=	Ki	nM	45.0	CHEMBL267	Homo sapiens	Ki	uM	0.045
	13363435	CHEMBL2399911	Binding affinity to recombinant human c-Src using KVEKIGEGTYGVVYK as substrate	B	Fc1ccc(C(Cl)Cn2ncc3c(Nc4cccc(F)c4)ncnc32)cc1		CHEMBL1165511	=	Ki	nM	160.0	CHEMBL267	Homo sapiens	Ki	uM	0.16
	13363436	CHEMBL2399911	Binding affinity to recombinant human c-Src using KVEKIGEGTYGVVYK as substrate	B	Fc1ccc(CNc2ncnc3c2cnn3CC(Cl)c2ccc(Cl)cc2)cc1		CHEMBL406658	=	Ki	nM	800.0	CHEMBL267	Homo sapiens	Ki	uM	0.8
	13365841	CHEMBL2405535	Inhibition of TEL-fused SRC (unknown origin) by cell-based assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	1694.0	CHEMBL267	Homo sapiens	IC50	nM	1694.0
	13374343	CHEMBL2405672	Inhibition of SRC (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	12.0	CHEMBL267	Homo sapiens	INH	%	12.0
Not Active	13387488	CHEMBL2411064	Inhibition of recombinant c-SRC (unknown origin) at 100 uM after 5 mins by scintillation counting analysis in presence of [gamma32P]ATP	B	CSc1nc(N(C(=O)OCCN2CCN(C)CC2)c2cccc(Br)c2)c2cnn(CC(C)c3ccccc3)c2n1		CHEMBL2407628		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	13387489	CHEMBL2411064	Inhibition of recombinant c-SRC (unknown origin) at 100 uM after 5 mins by scintillation counting analysis in presence of [gamma32P]ATP	B	CCCCN(C(=O)OCCN1CCN(C)CC1)c1nc(SCC)nc2c1cnn2CC(Cl)c1ccccc1		CHEMBL2407627		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	13388390	CHEMBL2411065	Inhibition of recombinant c-SRC (unknown origin) after 5 mins by scintillation counting analysis in presence of [gamma32P]ATP	B	CCCCNc1nc(SCC)nc2c1cnn2CC(Cl)c1ccccc1		CHEMBL41910	=	Ki	nM	600.0	CHEMBL267	Homo sapiens	Ki	uM	0.6
	13388393	CHEMBL2411065	Inhibition of recombinant c-SRC (unknown origin) after 5 mins by scintillation counting analysis in presence of [gamma32P]ATP	B	CSc1nc(Nc2cccc(Br)c2)c2cnn(CC(C)c3ccccc3)c2n1		CHEMBL1836680	=	Ki	nM	20.0	CHEMBL267	Homo sapiens	Ki	uM	0.02
	13389914	CHEMBL2410715	Inhibition of Src (unknown origin) using biotinylated poly-GluTyr as substrate by AlphaScreen assay	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)nn4c3)ccc2F)n(C)n1		CHEMBL2409778	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	13395524	CHEMBL2410770	Inhibition of c-Src (unknown origin) by fluorescence assay	B	Nc1ncnc2c1c(-c1ccc(Cl)cc1)nn2-c1ccccc1		CHEMBL2408783	=	Ki	nM	605.0	CHEMBL267	Homo sapiens	Ki	nM	605.0
	13395525	CHEMBL2410770	Inhibition of c-Src (unknown origin) by fluorescence assay	B	O=C(CCCCCn1nncc1-c1ccccc1)NO	Outside typical range	CHEMBL2407108	>	Ki	nM	12500000.0	CHEMBL267	Homo sapiens	Ki	uM	12500.0
	13395530	CHEMBL2410767	Inhibition of c-Src (unknown origin) after 10 mins by fluorimetric assay	B	Nc1ncnc2c1c(-c1ccc(Cl)cc1)nn2-c1cccc(-c2cnnn2CCCCCC(=O)NO)c1		CHEMBL2408778	=	Ki	nM	138.0	CHEMBL267	Homo sapiens	Ki	nM	138.0
	13395531	CHEMBL2410767	Inhibition of c-Src (unknown origin) after 10 mins by fluorimetric assay	B	Nc1ncnc2c1c(-c1ccc(Cl)cc1)nn2-c1cccc(-c2cnnn2CCCCCCC(=O)NO)c1		CHEMBL2408779	=	Ki	nM	190.0	CHEMBL267	Homo sapiens	Ki	nM	190.0
	13395532	CHEMBL2410767	Inhibition of c-Src (unknown origin) after 10 mins by fluorimetric assay	B	Nc1ncnc2c1c(-c1ccc(Cl)cc1)nn2-c1cccc(-c2cnnn2CCCCCCCC(=O)NO)c1		CHEMBL2408780	=	Ki	nM	407.0	CHEMBL267	Homo sapiens	Ki	nM	407.0
	13395533	CHEMBL2410767	Inhibition of c-Src (unknown origin) after 10 mins by fluorimetric assay	B	Nc1ncnc2c1c(-c1ccc(Cl)cc1)nn2-c1cccc(-c2cnnn2Cc2ccc(/C=C/C(=O)NO)cc2)c1		CHEMBL2408781	=	Ki	nM	4300.0	CHEMBL267	Homo sapiens	Ki	nM	4300.0
	13395534	CHEMBL2410767	Inhibition of c-Src (unknown origin) after 10 mins by fluorimetric assay	B	Nc1ncnc2c1c(-c1ccc(Cl)cc1)nn2-c1cccc(-c2cnnn2Cc2cccc(/C=C/C(=O)NO)c2)c1		CHEMBL2408782	=	Ki	nM	2140.0	CHEMBL267	Homo sapiens	Ki	nM	2140.0
	13395553	CHEMBL2410770	Inhibition of c-Src (unknown origin) by fluorescence assay	B	Nc1ncnc2c1c(-c1ccc(Cl)cc1)nn2-c1cccc(-c2cn(CCCCCC(=O)NO)nn2)c1		CHEMBL2408777	=	Ki	nM	371.0	CHEMBL267	Homo sapiens	Ki	nM	371.0
	13395554	CHEMBL2410770	Inhibition of c-Src (unknown origin) by fluorescence assay	B	Nc1ncnc2c1c(-c1ccc(Cl)cc1)nn2-c1cccc(-c2cnnn2CCCCCC(=O)NO)c1		CHEMBL2408778	=	Ki	nM	138.0	CHEMBL267	Homo sapiens	Ki	nM	138.0
	13414485	CHEMBL2422322	Inhibition of Src (unknown origin)	B	Cl.c1ccc(-c2cccc(Nc3ncnc4cc5c(cc34)OCCCO5)c2)cc1		CHEMBL2419762	=	IC50	nM	645.0	CHEMBL267	Homo sapiens	IC50	uM	0.645
	13414486	CHEMBL2422322	Inhibition of Src (unknown origin)	B	Cl.c1ccc(-c2cccc(Nc3ncnc4cc5c(cc34)OCCO5)c2)cc1		CHEMBL2419761	=	IC50	nM	642.0	CHEMBL267	Homo sapiens	IC50	uM	0.642
	13414487	CHEMBL2422322	Inhibition of Src (unknown origin)	B	Cl.c1ccc(-c2cccc(Nc3ncnc4cc5c(cc34)OCO5)c2)cc1		CHEMBL2419760	=	IC50	nM	32.0	CHEMBL267	Homo sapiens	IC50	uM	0.032
	13419780	CHEMBL2424113	Inhibition of SRC (unknown origin) by microfluidic mobility shift assay	B	c1nc(N2CCC3(CCCNC3)CC2)c2nc[nH]c2n1		CHEMBL2420911	=	IC50	nM	18000.0	CHEMBL267	Homo sapiens	IC50	uM	18.0
	13419781	CHEMBL2424113	Inhibition of SRC (unknown origin) by microfluidic mobility shift assay	B	c1nc(N2CCC3(CCCCN3)CC2)c2nc[nH]c2n1	Outside typical range	CHEMBL2420909	=	IC50	nM	150000.0	CHEMBL267	Homo sapiens	IC50	uM	150.0
	13421081	CHEMBL2424134	Inhibition of SRC (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Inhibition	%	4.0	CHEMBL267	Homo sapiens	INH	%	4.0
	13421082	CHEMBL2424134	Inhibition of SRC (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=C(C1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1)N1CCOCC1		CHEMBL2420907	=	Inhibition	%	15.0	CHEMBL267	Homo sapiens	INH	%	15.0
	13421083	CHEMBL2424134	Inhibition of SRC (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	CN(C)C(=O)C1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1		CHEMBL2420906	=	Inhibition	%	16.0	CHEMBL267	Homo sapiens	INH	%	16.0
	13421084	CHEMBL2424134	Inhibition of SRC (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	CNC(=O)C1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1		CHEMBL2420905	=	Inhibition	%	24.0	CHEMBL267	Homo sapiens	INH	%	24.0
	13421085	CHEMBL2424134	Inhibition of SRC (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	OCC1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1		CHEMBL2417586	=	Inhibition	%	34.0	CHEMBL267	Homo sapiens	INH	%	34.0
	13421086	CHEMBL2424134	Inhibition of SRC (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=C(O)C1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1		CHEMBL2420904	=	Inhibition	%	20.0	CHEMBL267	Homo sapiens	INH	%	20.0
	13421087	CHEMBL2424134	Inhibition of SRC (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	COC(=O)C1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1		CHEMBL2420903	=	Inhibition	%	26.0	CHEMBL267	Homo sapiens	INH	%	26.0
	13421088	CHEMBL2424134	Inhibition of SRC (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(C2CCC3(CCN(c4ncnc5[nH]cnc45)CC3)NC2)cc1		CHEMBL2420902	=	Inhibition	%	33.0	CHEMBL267	Homo sapiens	INH	%	33.0
	13421089	CHEMBL2424134	Inhibition of SRC (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(CC2CCC3(CCN(c4ncnc5[nH]cnc45)CC3)NC2)cc1		CHEMBL2420901	=	Inhibition	%	33.0	CHEMBL267	Homo sapiens	INH	%	33.0
	13421090	CHEMBL2424134	Inhibition of SRC (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(CC2CCNC3(CCN(c4ncnc5[nH]cnc45)CC3)C2)cc1		CHEMBL2420900	=	Inhibition	%	64.0	CHEMBL267	Homo sapiens	INH	%	64.0
	13421091	CHEMBL2424134	Inhibition of SRC (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(C2CCNC3(CCN(c4ncnc5[nH]cnc45)CC3)C2)cc1		CHEMBL2420899	=	Inhibition	%	76.0	CHEMBL267	Homo sapiens	INH	%	76.0
	13421092	CHEMBL2424134	Inhibition of SRC (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCC2(CC1)CC(O)CCN2		CHEMBL2420898	=	Inhibition	%	18.0	CHEMBL267	Homo sapiens	INH	%	18.0
	13421093	CHEMBL2424134	Inhibition of SRC (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	OC1CCNC2(CCN(c3ncnc4[nH]cnc34)CC2)C1		CHEMBL2420897	=	Inhibition	%	22.0	CHEMBL267	Homo sapiens	INH	%	22.0
	13421094	CHEMBL2424134	Inhibition of SRC (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCC2(CCC(O)CN2)CC1		CHEMBL2420928	=	Inhibition	%	29.0	CHEMBL267	Homo sapiens	INH	%	29.0
	13421095	CHEMBL2424134	Inhibition of SRC (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	OC1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1		CHEMBL2420927	=	Inhibition	%	38.0	CHEMBL267	Homo sapiens	INH	%	38.0
	13421096	CHEMBL2424134	Inhibition of SRC (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCCOC3)CC2)c2nc[nH]c2n1		CHEMBL2420926	=	Inhibition	%	41.0	CHEMBL267	Homo sapiens	INH	%	41.0
	13421097	CHEMBL2424134	Inhibition of SRC (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCCCO3)CC2)c2nc[nH]c2n1		CHEMBL2420925	=	Inhibition	%	49.0	CHEMBL267	Homo sapiens	INH	%	49.0
	13421098	CHEMBL2424134	Inhibition of SRC (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCCCC3)CC2)c2nc[nH]c2n1		CHEMBL2420924	=	Inhibition	%	32.0	CHEMBL267	Homo sapiens	INH	%	32.0
	13421099	CHEMBL2424134	Inhibition of SRC (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCCC12CCNCC2		CHEMBL2420923	=	Inhibition	%	5.0	CHEMBL267	Homo sapiens	INH	%	5.0
	13421100	CHEMBL2424134	Inhibition of SRC (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCCC2(CCCNC2)C1		CHEMBL2420922	=	Inhibition	%	21.0	CHEMBL267	Homo sapiens	INH	%	21.0
	13421101	CHEMBL2424134	Inhibition of SRC (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCCC2(CCNCC2)C1		CHEMBL2420921	=	Inhibition	%	5.0	CHEMBL267	Homo sapiens	INH	%	5.0
	13421102	CHEMBL2424134	Inhibition of SRC (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCC2(CCNC2)CC1		CHEMBL2420920	=	Inhibition	%	10.0	CHEMBL267	Homo sapiens	INH	%	10.0
	13421103	CHEMBL2424134	Inhibition of SRC (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCC2(CCCNC2)CC1		CHEMBL2420919	=	Inhibition	%	35.0	CHEMBL267	Homo sapiens	INH	%	35.0
	13421104	CHEMBL2424134	Inhibition of SRC (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCC2(CCCN2)CC1		CHEMBL2420918	=	Inhibition	%	10.0	CHEMBL267	Homo sapiens	INH	%	10.0
	13421105	CHEMBL2424134	Inhibition of SRC (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCC2(CCCCN2)CC1		CHEMBL2420917	=	Inhibition	%	12.0	CHEMBL267	Homo sapiens	INH	%	12.0
	13421106	CHEMBL2424134	Inhibition of SRC (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	NC1(Cc2ccccc2)CCN(S(=O)(=O)c2cccc3cnccc23)CC1		CHEMBL2420916	=	Inhibition	%	6.0	CHEMBL267	Homo sapiens	INH	%	6.0
	13421107	CHEMBL2424134	Inhibition of SRC (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCCC23CCNCC3)c2nc[nH]c2n1		CHEMBL2420915	=	Inhibition	%	6.0	CHEMBL267	Homo sapiens	INH	%	6.0
	13421108	CHEMBL2424134	Inhibition of SRC (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCCC3(CCCNC3)C2)c2nc[nH]c2n1		CHEMBL2420914	=	Inhibition	%	5.0	CHEMBL267	Homo sapiens	INH	%	5.0
	13421109	CHEMBL2424134	Inhibition of SRC (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCCC3(CCNCC3)C2)c2nc[nH]c2n1		CHEMBL2420913	=	Inhibition	%	19.0	CHEMBL267	Homo sapiens	INH	%	19.0
	13421110	CHEMBL2424134	Inhibition of SRC (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCNC3)CC2)c2nc[nH]c2n1		CHEMBL2420912	=	Inhibition	%	61.0	CHEMBL267	Homo sapiens	INH	%	61.0
	13421111	CHEMBL2424134	Inhibition of SRC (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCCNC3)CC2)c2nc[nH]c2n1		CHEMBL2420911	=	Inhibition	%	70.0	CHEMBL267	Homo sapiens	INH	%	70.0
	13421112	CHEMBL2424134	Inhibition of SRC (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCCN3)CC2)c2nc[nH]c2n1		CHEMBL2420910	=	Inhibition	%	24.0	CHEMBL267	Homo sapiens	INH	%	24.0
	13421113	CHEMBL2424134	Inhibition of SRC (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCCCN3)CC2)c2nc[nH]c2n1		CHEMBL2420909	=	Inhibition	%	25.0	CHEMBL267	Homo sapiens	INH	%	25.0
	13421114	CHEMBL2424134	Inhibition of SRC (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	NC1(Cc2ccccc2)CCN(c2ncnc3[nH]cnc23)CC1		CHEMBL2420908	=	Inhibition	%	63.0	CHEMBL267	Homo sapiens	INH	%	63.0
	13436482	CHEMBL2422431	Inhibition of SRC in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(Cc2ccc(F)cc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420551	<	Inhibition	%	35.0	CHEMBL267	Homo sapiens	INH	%	35.0
	13436483	CHEMBL2422431	Inhibition of SRC in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccc(F)cc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420555	<	Inhibition	%	35.0	CHEMBL267	Homo sapiens	INH	%	35.0
	13436484	CHEMBL2422431	Inhibition of SRC in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccccc2)CCC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420573	<	Inhibition	%	35.0	CHEMBL267	Homo sapiens	INH	%	35.0
	13436485	CHEMBL2422431	Inhibition of SRC in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccccc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420572	<	Inhibition	%	35.0	CHEMBL267	Homo sapiens	INH	%	35.0
	13436486	CHEMBL2422431	Inhibition of SRC in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CC(C)(NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420570	<	Inhibition	%	35.0	CHEMBL267	Homo sapiens	INH	%	35.0
	13436487	CHEMBL2422431	Inhibition of SRC in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CCC[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420565	<	Inhibition	%	35.0	CHEMBL267	Homo sapiens	INH	%	35.0
	13436488	CHEMBL2422431	Inhibition of SRC in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(N[C@H](CO)c1ccccc1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420564	<	Inhibition	%	35.0	CHEMBL267	Homo sapiens	INH	%	35.0
	13436489	CHEMBL2422431	Inhibition of SRC in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CC[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420562	<	Inhibition	%	35.0	CHEMBL267	Homo sapiens	INH	%	35.0
	13436490	CHEMBL2422431	Inhibition of SRC in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	C[C@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420560	<	Inhibition	%	35.0	CHEMBL267	Homo sapiens	INH	%	35.0
	13436491	CHEMBL2422431	Inhibition of SRC in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	C[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420556	<	Inhibition	%	35.0	CHEMBL267	Homo sapiens	INH	%	35.0
	13436492	CHEMBL2422431	Inhibition of SRC in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420587	<	Inhibition	%	35.0	CHEMBL267	Homo sapiens	INH	%	35.0
	13436493	CHEMBL2422431	Inhibition of SRC in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420585	<	Inhibition	%	35.0	CHEMBL267	Homo sapiens	INH	%	35.0
	13439925	CHEMBL2429468	Competitive binding affinity to SRC (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL267	Homo sapiens	INH	%	50.0
	13445435	CHEMBL2429468	Competitive binding affinity to SRC (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-c3n[nH]c4ccccc34)n2)CC1		CHEMBL2425644	=	Inhibition	%	78.0	CHEMBL267	Homo sapiens	INH	%	78.0
	13448490	CHEMBL2429468	Competitive binding affinity to SRC (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	<	Inhibition	%	50.0	CHEMBL267	Homo sapiens	INH	%	50.0
	13448626	CHEMBL2429468	Competitive binding affinity to SRC (unknown origin) at 10 uM in presence of ATP relative to control	B	O=C([C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1)N1CCOCC1		CHEMBL2425649	<	Inhibition	%	50.0	CHEMBL267	Homo sapiens	INH	%	50.0
	13451421	CHEMBL2429468	Competitive binding affinity to SRC (unknown origin) at 10 uM in presence of ATP relative to control	B	N[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425652	<	Inhibition	%	50.0	CHEMBL267	Homo sapiens	INH	%	50.0
	13454606	CHEMBL2429468	Competitive binding affinity to SRC (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	<	Inhibition	%	50.0	CHEMBL267	Homo sapiens	INH	%	50.0
	13465457	CHEMBL2434208	Inhibition of human SRC assessed as residual activity at 1 uM relative to control	B	CCCC(=O)Nc1n[nH]c2ncc(-c3cccnc3)cc12		CHEMBL407002	=	Activity	%	75.0	CHEMBL267	Homo sapiens	Activity	%	75.0
	13465483	CHEMBL2434376	Inhibition of human SRC assessed as residual activity at 10 uM relative to control	B	CCCC(=O)Nc1n[nH]c2ncc(-c3cccnc3)cc12		CHEMBL407002	=	Activity	%	72.0	CHEMBL267	Homo sapiens	Activity	%	72.0
	13465508	CHEMBL2434032	Inhibition of human SRC assessed as residual activity at 25 uM relative to control	B	COc1cc(OC)c(C=C2C(=O)Nc3ccccc32)c(OC)c1		CHEMBL576349	=	Activity	%	70.0	CHEMBL267	Homo sapiens	Activity	%	70.0
	13465531	CHEMBL2434376	Inhibition of human SRC assessed as residual activity at 10 uM relative to control	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Activity	%	82.0	CHEMBL267	Homo sapiens	Activity	%	82.0
	13466458	CHEMBL2434208	Inhibition of human SRC assessed as residual activity at 1 uM relative to control	B	CC(=O)Nc1nccc(-c2c(-c3ccccc3)noc2C)n1		CHEMBL2430324	=	Activity	%	98.27	CHEMBL267	Homo sapiens	Activity	%	98.27
	13466485	CHEMBL2434376	Inhibition of human SRC assessed as residual activity at 10 uM relative to control	B	CC(=O)Nc1nccc(-c2c(-c3ccccc3)noc2C)n1		CHEMBL2430324	=	Activity	%	91.94	CHEMBL267	Homo sapiens	Activity	%	91.94
	13466512	CHEMBL2434208	Inhibition of human SRC assessed as residual activity at 1 uM relative to control	B	CC(=O)Nc1cccc(-c2cnc3[nH]nc(C)c3c2)c1		CHEMBL2430323	=	Activity	%	65.01	CHEMBL267	Homo sapiens	Activity	%	65.01
	13466539	CHEMBL2434376	Inhibition of human SRC assessed as residual activity at 10 uM relative to control	B	CC(=O)Nc1cccc(-c2cnc3[nH]nc(C)c3c2)c1		CHEMBL2430323	=	Activity	%	23.75	CHEMBL267	Homo sapiens	Activity	%	23.75
	13475326	CHEMBL2439152	Inhibition of wild type human SRC by high throughput ATP-[33P] radiolabeled assay	B	CN1CCN(Cc2ccc(-c3cnc4[nH]cc(-c5ccc6[nH]ccc6c5)c4c3)cc2)CC1		CHEMBL2436978	=	IC50	nM	4330.0	CHEMBL267	Homo sapiens	IC50	nM	4330.0
	13481616	CHEMBL2439450	Inhibition of c-Src (unknown origin) using [33P]-ATP as substrate at 10 uM after 30 mins by scintillation counting analysis relative to control	B	O=C1N(c2ccccc2)c2nc[nH]c(=O)c2C2CCCCCN12		CHEMBL2436193	=	Inhibition	%	81.0	CHEMBL267	Homo sapiens	INH	%	81.0
	13481617	CHEMBL2439450	Inhibition of c-Src (unknown origin) using [33P]-ATP as substrate at 10 uM after 30 mins by scintillation counting analysis relative to control	B	N=c1c2c([nH]c(=O)n1-c1ccccc1)N(c1ccccc1)C(=O)N1CCCC21		CHEMBL2436184	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	13481618	CHEMBL2439450	Inhibition of c-Src (unknown origin) using [33P]-ATP as substrate at 10 uM after 30 mins by scintillation counting analysis relative to control	B	N#CC1=C(N2C(=O)C(=O)N(c3ccccc3)C2=O)N(c2ccccc2)C(=O)N2CCCC12		CHEMBL2436202	=	Inhibition	%	45.0	CHEMBL267	Homo sapiens	INH	%	45.0
	13481619	CHEMBL2439450	Inhibition of c-Src (unknown origin) using [33P]-ATP as substrate at 10 uM after 30 mins by scintillation counting analysis relative to control	B	N#CCC(=O)NC1=C(C#N)C2CCCN2C(=O)N1c1ccccc1		CHEMBL2436197	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	13481910	CHEMBL2439371	Inhibition of human SRC	B	Cc1ccc(-c2csc(=N)n2CC(=O)N2CCN(c3ccccc3)CC2)cc1		CHEMBL2437291	=	Ki	nM	13480.0	CHEMBL267	Homo sapiens	Ki	uM	13.48
	13481911	CHEMBL2439371	Inhibition of human SRC	B	N=c1scc(-c2ccc(Cl)cc2)n1CC(=O)N1CCN(c2ccccc2)CC1		CHEMBL2437292	=	Ki	nM	1900.0	CHEMBL267	Homo sapiens	Ki	uM	1.9
	13481912	CHEMBL2439371	Inhibition of human SRC	B	N=c1scc(-c2ccccc2)n1CC(=O)N1CCN(c2ccccc2)CC1		CHEMBL2437293	=	Ki	nM	14130.0	CHEMBL267	Homo sapiens	Ki	uM	14.13
	13481913	CHEMBL2439371	Inhibition of human SRC	B	CC(=O)N1CCN(C(=O)Cn2c(-c3ccc(C)cc3)csc2=N)CC1		CHEMBL2437294	=	Ki	nM	15310.0	CHEMBL267	Homo sapiens	Ki	uM	15.31
	13481914	CHEMBL2439371	Inhibition of human SRC	B	CC(=O)N1CCN(C(=O)Cn2c(-c3ccc(Cl)cc3)csc2=N)CC1		CHEMBL2437295	=	Ki	nM	14760.0	CHEMBL267	Homo sapiens	Ki	uM	14.76
	13481915	CHEMBL2439371	Inhibition of human SRC	B	CC(=O)N1CCN(C(=O)Cn2c(-c3ccccc3)csc2=N)CC1		CHEMBL2437297	=	Ki	nM	34300.0	CHEMBL267	Homo sapiens	Ki	uM	34.3
	13481916	CHEMBL2439371	Inhibition of human SRC	B	Cc1ccc(-c2csc(=N)n2CC(=O)N2CCN(C)CC2)cc1		CHEMBL2437296	=	Ki	nM	4730.0	CHEMBL267	Homo sapiens	Ki	uM	4.73
	13481917	CHEMBL2439371	Inhibition of human SRC	B	CN1CCN(C(=O)Cn2c(-c3ccc(Cl)cc3)csc2=N)CC1		CHEMBL2437298	=	Ki	nM	3230.0	CHEMBL267	Homo sapiens	Ki	uM	3.23
	13481918	CHEMBL2439371	Inhibition of human SRC	B	CN1CCN(C(=O)Cn2c(-c3ccccc3)csc2=N)CC1		CHEMBL2437300	=	Ki	nM	7910.0	CHEMBL267	Homo sapiens	Ki	uM	7.91
	13481919	CHEMBL2439371	Inhibition of human SRC	B	Cc1ccc(-c2csc(=N)n2CC(=O)N2CCOCC2)cc1		CHEMBL2437299	=	Ki	nM	13270.0	CHEMBL267	Homo sapiens	Ki	uM	13.27
	13481920	CHEMBL2439371	Inhibition of human SRC	B	N=c1scc(-c2ccc(Cl)cc2)n1CC(=O)N1CCOCC1		CHEMBL2437302	=	Ki	nM	16690.0	CHEMBL267	Homo sapiens	Ki	uM	16.69
	13481921	CHEMBL2439371	Inhibition of human SRC	B	N=c1scc(-c2ccccc2)n1CC(=O)N1CCOCC1		CHEMBL2437301	=	Ki	nM	20170.0	CHEMBL267	Homo sapiens	Ki	uM	20.17
Active	13488427	CHEMBL2439430	Inhibition of human SRC at 1 uM	B	Clc1ccc2ncc(Br)n2n1		CHEMBL2436439		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Active	13488428	CHEMBL2439430	Inhibition of human SRC at 1 uM	B	CN1CCC(Nc2ccc3ncc(-c4cnn(-c5ccc(C#N)cc5)c4)n3n2)CC1		CHEMBL2436446		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Active	13488429	CHEMBL2439430	Inhibition of human SRC at 1 uM	B	c1ccc(-n2cc(-c3cnc4ccc(NC5CCNCC5)nn34)cn2)cc1		CHEMBL2436454		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	13490919	CHEMBL2446683	Inhibition of Src (unknown origin)	B	CCc1ccc2nc(Nc3cc(Cc4ccccc4)nc(N[C@H]4CC[C@H](O)CC4)n3)sc2c1		CHEMBL2441273	=	IC50	nM	39.81	CHEMBL267	Homo sapiens	pIC50		7.4
	13499582	CHEMBL2447148	Inhibition of c-Src (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA	B	C[C@@H](Sc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2442124	>	IC50	nM	1000.0	CHEMBL267	Homo sapiens	IC50	nM	1000.0
Active	13826418	CHEMBL3088486	Binding affinity to SRC (unknown origin)	B	C=CC(=O)N1CC[C@H](N2C(=O)N(c3ccccc3)Cc3cnc(Nc4ccc(N5CCN(C)CC5)c(C)c4)nc32)C1		CHEMBL3086102		Activity			CHEMBL267	Homo sapiens	Activity		
Not Active	13863478	CHEMBL3101877	Inhibition of SRC (unknown origin) at 1 uM after 1 hr	B	CC1(C)OC(=O)N([C@H]2CC[C@H](c3cnc(N)c(-c4ncccn4)c3)CC2)[C@H]1c1ccccc1		CHEMBL3099716		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	13863479	CHEMBL3101877	Inhibition of SRC (unknown origin) at 1 uM after 1 hr	B	CC1(C)OC(=O)N(c2ccc(-c3cnc(N)c(-c4ncccn4)c3)cc2)[C@H]1c1ccccc1		CHEMBL3099720		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	13866131	CHEMBL3100610	Inhibition of human SRC at 10 uM relative to control	B	COc1ccc(CNC(=O)c2cc(-c3cc(Cl)cc(Cl)c3)cnc2-c2cccnc2)cc1OC		CHEMBL3099899	=	Inhibition	%	-5.0	CHEMBL267	Homo sapiens	INH	%	-5.0
	13872172	CHEMBL3101925	Inhibition of human cSRC assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	63.0	CHEMBL267	Homo sapiens	Activity	%	63.0
	13872215	CHEMBL3102402	Inhibition of SRC (unknown origin) assessed as residual activity at 10 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	107.0	CHEMBL267	Homo sapiens	Activity	%	107.0
	13872245	CHEMBL3102551	Inhibition of SRC (unknown origin) assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	99.0	CHEMBL267	Homo sapiens	Activity	%	99.0
	13878351	CHEMBL3108316	Inhibition of SRC (unknown origin)	B	O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12		CHEMBL50	=	IC50	nM	120.0	CHEMBL267	Homo sapiens	IC50	uM	0.12
	13878352	CHEMBL3108316	Inhibition of SRC (unknown origin)	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	40.0	CHEMBL267	Homo sapiens	IC50	uM	0.04
	13878353	CHEMBL3108316	Inhibition of SRC (unknown origin)	B	Cc1c(O)c(O)c(O)c(C=O)c1-c1cc2c(C=O)c(C)c(O)c(O)c2o1		CHEMBL3104855	=	IC50	nM	490.0	CHEMBL267	Homo sapiens	IC50	uM	0.49
	13878354	CHEMBL3108316	Inhibition of SRC (unknown origin)	B	Cc1c(O)c(O)c(O)c2c1COC2=O		CHEMBL3104854	=	IC50	nM	3560.0	CHEMBL267	Homo sapiens	IC50	uM	3.56
	13878355	CHEMBL3108316	Inhibition of SRC (unknown origin)	B	COCc1c(C)c(O)c(O)c(O)c1C=O		CHEMBL3104853	=	IC50	nM	20000.0	CHEMBL267	Homo sapiens	IC50	uM	20.0
	13878356	CHEMBL3108316	Inhibition of SRC (unknown origin)	B	COC1OC(=O)c2c(O)c(O)c(O)c(C)c21		CHEMBL3104852	=	IC50	nM	12600.0	CHEMBL267	Homo sapiens	IC50	uM	12.6
	13878357	CHEMBL3108316	Inhibition of SRC (unknown origin)	B	Cc1c(O)c(O)c2c(c1C=O)[C@@H]1O[C@H](O2)c2c(C)c(O)c(O)c(O)c2C1=O		CHEMBL3104851	=	IC50	nM	370.0	CHEMBL267	Homo sapiens	IC50	uM	0.37
	13897436	CHEMBL3111635	Inhibition of recombinant SRC (unknown origin) using casein as substrate assessed as incorporation of [gamma-33P]-ATP into substrate by radiometric assay	B	COC(=O)c1cc(O)c(O)c(C[C@]2(C)[C@@H](C)CC[C@@]3(C)C(C)=CCC[C@H]32)c1		CHEMBL3109404	=	IC50	nM	8620.0	CHEMBL267	Homo sapiens	IC50	uM	8.62
	13897437	CHEMBL3111635	Inhibition of recombinant SRC (unknown origin) using casein as substrate assessed as incorporation of [gamma-33P]-ATP into substrate by radiometric assay	B	COc1cc2nc(C)oc2c(C[C@]2(C)[C@@H](C)CC[C@@]3(C)C(C)=CCC[C@H]32)c1O		CHEMBL3109402	=	IC50	nM	19700.0	CHEMBL267	Homo sapiens	IC50	uM	19.7
	13897438	CHEMBL3111635	Inhibition of recombinant SRC (unknown origin) using casein as substrate assessed as incorporation of [gamma-33P]-ATP into substrate by radiometric assay	B	CC1=CCC[C@@H]2[C@@]1(C)CC[C@H](C)[C@@]2(C)CC1=C(O)C(=O)C=C(NCCC(C)C)C1=O		CHEMBL3109401	=	IC50	nM	2200.0	CHEMBL267	Homo sapiens	IC50	uM	2.2
Active	13897485	CHEMBL3111651	Inhibition of recombinant SRC (unknown origin) using casein as substrate assessed as incorporation of [gamma-33P]-ATP into substrate at 10 uM by radiometric assay	B	CSCCCNC1=CC(=O)C(O)=C(C[C@]2(C)[C@@H](C)CC[C@@]3(C)C(C)=CCC[C@H]32)C1=O		CHEMBL3108787		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Active	13897486	CHEMBL3111651	Inhibition of recombinant SRC (unknown origin) using casein as substrate assessed as incorporation of [gamma-33P]-ATP into substrate at 10 uM by radiometric assay	B	CC1=CCC[C@@H]2[C@@]1(C)CC[C@H](C)[C@@]2(C)CC1=C(O)C(=O)C=C(NCCc2c[nH]c3ccccc23)C1=O		CHEMBL3109400		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Active	13897487	CHEMBL3111651	Inhibition of recombinant SRC (unknown origin) using casein as substrate assessed as incorporation of [gamma-33P]-ATP into substrate at 10 uM by radiometric assay	B	CC1=CCC[C@@H]2[C@@]1(C)CC[C@H](C)[C@@]2(C)CC1=C(O)C(=O)C=C(NCCc2ccccc2)C1=O		CHEMBL3109399		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Active	13897488	CHEMBL3111651	Inhibition of recombinant SRC (unknown origin) using casein as substrate assessed as incorporation of [gamma-33P]-ATP into substrate at 10 uM by radiometric assay	B	CC1=CCC[C@@H]2[C@@]1(C)CC[C@H](C)[C@@]2(C)CC1=C(O)C(=O)C=C(NCCc2ccc(O)cc2)C1=O		CHEMBL3109398		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	13898470	CHEMBL3110515	Inhibition of c-Src (unknown origin) at 5 uM after 120 mins relative to control	B	CN(CC(=O)N(Cc1ccc(C2CCCCC2)cc1)c1ccc(C(=O)NO)cc1)S(=O)(=O)c1c(F)c(F)c(F)c(F)c1F		CHEMBL3108910	=	Inhibition	%	50.0	CHEMBL267	Homo sapiens	INH	%	50.0
	13898471	CHEMBL3110515	Inhibition of c-Src (unknown origin) at 5 uM after 120 mins relative to control	B	CN(CC(=O)N(Cc1ccc(C2CCCCC2)cc1)c1ccc(C(=O)O)cc1)S(=O)(=O)c1c(F)c(F)c(F)c(F)c1F		CHEMBL3108909	=	Inhibition	%	50.0	CHEMBL267	Homo sapiens	INH	%	50.0
	13898472	CHEMBL3110515	Inhibition of c-Src (unknown origin) at 5 uM after 120 mins relative to control	B	CC(=O)Oc1cc(N(Cc2ccc(C3CCCCC3)cc2)C(=O)CN(C)S(=O)(=O)c2c(F)c(F)c(F)c(F)c2F)ccc1C(=O)O		CHEMBL3108782	=	Inhibition	%	50.0	CHEMBL267	Homo sapiens	INH	%	50.0
Not Active	13898500	CHEMBL3110525	Inhibition of Src in human 147EF cells after 6 hrs by by Western blotting analysis	B	CN(CC(=O)N(Cc1ccc(C2CCCCC2)cc1)c1ccc(C(=O)NO)cc1)S(=O)(=O)c1c(F)c(F)c(F)c(F)c1F		CHEMBL3108910		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	13898501	CHEMBL3110525	Inhibition of Src in human 147EF cells after 6 hrs by by Western blotting analysis	B	CN(CC(=O)N(Cc1ccc(C2CCCCC2)cc1)c1ccc(C(=O)O)cc1)S(=O)(=O)c1c(F)c(F)c(F)c(F)c1F		CHEMBL3108909		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	13898502	CHEMBL3110525	Inhibition of Src in human 147EF cells after 6 hrs by by Western blotting analysis	B	CC(=O)Oc1cc(N(Cc2ccc(C3CCCCC3)cc2)C(=O)CN(C)S(=O)(=O)c2c(F)c(F)c(F)c(F)c2F)ccc1C(=O)O		CHEMBL3108782		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	13898561	CHEMBL3110677	Inhibition of Src (unknown origin)	B	CCOc1ccc2cc(-c3nn(C(C)(C)C)c(N)c3C(N)=O)cnc2c1		CHEMBL3109011	>	IC50	nM	30000.0	CHEMBL267	Homo sapiens	IC50	uM	30.0
	13898564	CHEMBL3110677	Inhibition of Src (unknown origin)	B	CC(C)(C)n1nc(-c2cnc3ccccc3c2)c(C(N)=O)c1N		CHEMBL3109010	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	13898573	CHEMBL3110677	Inhibition of Src (unknown origin)	B	CCOc1ccc2cc(-c3nn(C(C)(C)C)c(N)c3C(N)=O)ccc2c1		CHEMBL3108913	=	IC50	nM	7300.0	CHEMBL267	Homo sapiens	IC50	uM	7.3
	13898574	CHEMBL3110677	Inhibition of Src (unknown origin)	B	COc1ccc2cc(-c3nn(C(C)(C)C)c(N)c3C(N)=O)ccc2c1		CHEMBL3108998	=	IC50	nM	6900.0	CHEMBL267	Homo sapiens	IC50	uM	6.9
	13898578	CHEMBL3110677	Inhibition of Src (unknown origin)	B	CC(C)(C)Cn1nc(-c2ccc3ccccc3c2)c(C(N)=O)c1N		CHEMBL3108992	=	IC50	nM	2700.0	CHEMBL267	Homo sapiens	IC50	uM	2.7
	13898580	CHEMBL3110677	Inhibition of Src (unknown origin)	B	CC(C)(C)n1nc(-c2ccc3ccccc3c2)c(C(N)=O)c1N		CHEMBL3108912	=	IC50	nM	1300.0	CHEMBL267	Homo sapiens	IC50	uM	1.3
	13898583	CHEMBL3110677	Inhibition of Src (unknown origin)	B	NC(=O)c1c(-c2ccc3ccccc3c2)nn(CC(F)(F)F)c1N		CHEMBL3108991	=	IC50	nM	980.0	CHEMBL267	Homo sapiens	IC50	uM	0.98
Not Active	13939894	CHEMBL3129411	Inhibition of Src kinase (unknown origin) assessed as total SRC level at 10 uM after 6 hrs by cell-based Western blotting analysis	B	CN(C)CCCN1C(=O)c2ccc3c4ccc5c6c(ccc(c7ccc(c2c37)C1=O)c64)C(=O)N(CCCN(C)C)C5=O		CHEMBL3126485		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	13939895	CHEMBL3129410	Inhibition of Src kinase (unknown origin) phosphorylation at 10 uM after 6 hrs by cell-based Western blotting analysis	B	CN(C)CCCN1C(=O)c2ccc3c4ccc5c6c(ccc(c7ccc(c2c37)C1=O)c64)C(=O)N(CCCN(C)C)C5=O		CHEMBL3126485		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	13939911	CHEMBL3128858	Inhibition of SCR phosphorylation in human MDA-MB-231 cells at 0.05 to 10 uM by Western blotting analysis	B	CN(C)CCCN1C(=O)c2ccc3c4ccc5c6c(ccc(c7ccc(c2c37)C1=O)c64)C(=O)N(CCCN(C)C)C5=O		CHEMBL3126485		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	13948205	CHEMBL3132612	Inhibition of Src receptor (unknown origin) using biotinylated poly-Glu-Tyr (4:1) as substrate preincubated for 5 mins measured after 12 hrs	B	N#Cc1c(Oc2ccc(F)c(NC(=O)Cc3cccc(C(F)(F)F)c3)c2)ccc2nc(NC(=O)C3CC3)sc12		CHEMBL3125890	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nmol/L	10000.0
	13954569	CHEMBL3130926	Inhibition of human cSRC assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125727	=	Activity	%	50.0	CHEMBL267	Homo sapiens	Activity	%	50.0
	13954571	CHEMBL3130926	Inhibition of human cSRC assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125728	=	Activity	%	47.0	CHEMBL267	Homo sapiens	Activity	%	47.0
	13954572	CHEMBL3132495	Inhibition of human SRC (1 to 530) assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125726	=	Activity	%	47.0	CHEMBL267	Homo sapiens	Activity	%	47.0
	13954715	CHEMBL3130926	Inhibition of human cSRC assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125726	=	Activity	%	85.0	CHEMBL267	Homo sapiens	Activity	%	85.0
	13954793	CHEMBL3132495	Inhibition of human SRC (1 to 530) assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125727	=	Activity	%	25.0	CHEMBL267	Homo sapiens	Activity	%	25.0
	13954796	CHEMBL3132495	Inhibition of human SRC (1 to 530) assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125728	=	Activity	%	23.0	CHEMBL267	Homo sapiens	Activity	%	23.0
	13965717	CHEMBL3135929	Inhibition of human full length SRC expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 70 uM after 90 mins by microfluidic peptide phosphorylation assay	B	CNCc1ccc(-c2ncnc3[nH]cnc23)cc1		CHEMBL376388	=	Inhibition	%	37.5	CHEMBL267	Homo sapiens	INH	%	37.5
	13966095	CHEMBL3137083	Inhibition of human full length SRC expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 1000 uM after 90 mins by microfluidic peptide phosphorylation assay	B	c1cnc2[nH]ccc2c1		CHEMBL389685	=	Inhibition	%	28.5	CHEMBL267	Homo sapiens	INH	%	28.5
	13973997	CHEMBL3135897	Inhibition of human full length SRC expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.1 uM after 90 mins by microfluidic peptide phosphorylation assay	B	C[C@H](CN(C)C)Oc1nc(Nc2cc3cccc(Cl)c3cn2)cnc1C#N		CHEMBL1928705	=	Inhibition	%	3.0	CHEMBL267	Homo sapiens	INH	%	3.0
	13974088	CHEMBL3134926	Inhibition of human full length SRC expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.35 uM after 90 mins by microfluidic peptide phosphorylation assay	B	COC(=O)c1cnc(Nc2cnc(C#N)cn2)cc1NCC1CCNCC1		CHEMBL1928692	=	Inhibition	%	7.5	CHEMBL267	Homo sapiens	INH	%	7.5
	13974179	CHEMBL3137119	Inhibition of human full length SRC expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 9 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CN(c2ncnc3[nH]c4cnccc4c23)CCO1		CHEMBL1928677	=	Inhibition	%	19.5	CHEMBL267	Homo sapiens	INH	%	19.5
	13974270	CHEMBL3136248	Inhibition of human full length SRC expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 90 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CN(c2ncnc3[nH]cnc23)CCO1		CHEMBL560373	=	Inhibition	%	22.0	CHEMBL267	Homo sapiens	INH	%	22.0
	13975008	CHEMBL3135304	Inhibition of human full length SRC expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 420 uM after 90 mins by microfluidic peptide phosphorylation assay	B	c1nc(N2CCOCC2)c2nc[nH]c2n1		CHEMBL271138	=	Inhibition	%	62.5	CHEMBL267	Homo sapiens	INH	%	62.5
	13975099	CHEMBL3135553	Inhibition of human full length SRC expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.02 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1(C(=O)NCc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL598194	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	13975190	CHEMBL3135644	Inhibition of human full length SRC expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.06 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1(Cc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL263664	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
tde	13975612	CHEMBL3135245	Inhibition of Src kinase activation in human HepG2 cells assessed as inhibition of phosphorylation at 10 uM by Western blot analysis	B	C=CCN1Cc2c(nn(-c3ccc(Cl)cc3Cl)c2NC(=O)Nc2ccccc2)C(F)(F)C1c1ccc(OC)cc1		CHEMBL3133915		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	13975833	CHEMBL3134756	Inhibition of human full length SRC expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 2 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL259141	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	13975924	CHEMBL3136398	Inhibition of human full length SRC expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 8 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL261249	=	Inhibition	%	1.5	CHEMBL267	Homo sapiens	INH	%	1.5
	13976017	CHEMBL3135217	Inhibition of human full length SRC expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.2 uM after 90 mins by microfluidic peptide phosphorylation assay	B	Clc1ccc(C2(c3ccc(-c4ncnc5[nH]cnc45)cc3)CCNCC2)cc1		CHEMBL228133	=	Inhibition	%	24.5	CHEMBL267	Homo sapiens	INH	%	24.5
	13976108	CHEMBL3136779	Inhibition of human full length SRC expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 95 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCCc1ccc(-c2ncnc3[nH]cnc23)cc1		CHEMBL227727	=	Inhibition	%	62.0	CHEMBL267	Homo sapiens	INH	%	62.0
	14533968	CHEMBL3223706	Inhibition of SH2 domain of Src (unknown origin) interaction to pTyr	B	CC(=O)N[C@@H](Cc1ccc(C(P(=O)(O)O)P(=O)(O)O)cc1)C(=O)N[C@@H](C)c1ccc(OCC2CCCCC2)c(C(N)=O)c1		CHEMBL348743	=	IC50	nM	350.0	CHEMBL267	Homo sapiens	IC50	nM	350.0
	14545492	CHEMBL3225222	Inhibition of c-SRC (unknown origin)	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	14553178	CHEMBL3223621	Inhibition of Src (unknown origin)	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	IC50	nM	14.0	CHEMBL267	Homo sapiens	IC50	uM	0.014
	14553179	CHEMBL3223621	Inhibition of Src (unknown origin)	B	CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1230790	=	IC50	nM	15.0	CHEMBL267	Homo sapiens	IC50	uM	0.015
	14553210	CHEMBL3223621	Inhibition of Src (unknown origin)	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	IC50	nM	170.0	CHEMBL267	Homo sapiens	IC50	uM	0.17
	14553214	CHEMBL3223621	Inhibition of Src (unknown origin)	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	IC50	nM	240.0	CHEMBL267	Homo sapiens	IC50	uM	0.24
	14553250	CHEMBL3223621	Inhibition of Src (unknown origin)	B	Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1234815	=	IC50	nM	1100.0	CHEMBL267	Homo sapiens	IC50	uM	1.1
	14553652	CHEMBL3223944	Inhibition of c-Src (unknown origin) at 10 uM assessed as residual enzyme activity	B	COc1ccc(-c2n[nH]c3ncc(-c4ccc(Cl)cc4N)cc23)cc1		CHEMBL3220823	=	Activity	%	78.7	CHEMBL267	Homo sapiens	Activity	%	78.7
	14585335	CHEMBL3240752	Inhibition of human Src assessed as enzyme activity at 1 uM relative to control	B	CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N		CHEMBL3236464	=	Activity	%	83.5	CHEMBL267	Homo sapiens	Activity	%	83.5
	14590409	CHEMBL3241996	Inhibition of SRC (unknown origin) at 5 uM	B	Clc1nc(Cl)c2sccc2n1		CHEMBL3236403	<	Inhibition	%	40.0	CHEMBL267	Homo sapiens	INH	%	40.0
	14590410	CHEMBL3241997	Inhibition of SRC N1 (unknown origin) at 5 uM	B	Clc1nc(Cl)c2sccc2n1		CHEMBL3236403	<	Inhibition	%	40.0	CHEMBL267	Homo sapiens	INH	%	40.0
	14593756	CHEMBL3242879	Inhibition of human Src	B	Oc1cccc(Nc2ccnc3[nH]c4ccccc4c23)c1		CHEMBL3133821	=	IC50	nM	3040.0	CHEMBL267	Homo sapiens	IC50	uM	3.04
	14645925	CHEMBL3270966	Inhibition of SRC (unknown origin)	B	Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1nc(Nc2ccc(C(=O)N3CCOCC3)cc2)c2nc[nH]c2n1		CHEMBL3263640	=	IC50	nM	2434.0	CHEMBL267	Homo sapiens	IC50	uM	2.434
	14648156	CHEMBL3267035	Inhibition of human Src at 1 uM relative to control	B	CC(C)CCNc1ccc(-c2cnc3ccc(NC4CCN(C)CC4)nn23)cn1		CHEMBL2380687	=	Inhibition	%	50.0	CHEMBL267	Homo sapiens	INH	%	50.0
	14648157	CHEMBL3267035	Inhibition of human Src at 1 uM relative to control	B	N[C@H]1CC[C@H](Nc2ccc3ncc(-c4cnc(Nc5ncccc5F)nc4)n3n2)CC1		CHEMBL3264059	>	Inhibition	%	80.0	CHEMBL267	Homo sapiens	INH	%	80.0
Active	14653674	CHEMBL3267814	Inhibition of purified recombinant c-SRC (unknown origin) at 1 uM after 60 mins by ELISA	B	CNC(=O)c1ccccc1Nc1nc(Nc2ccc3c(c2)C(c2ccccc2)CN(C)CC3)ncc1Cl		CHEMBL3263970		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Active	14653675	CHEMBL3267814	Inhibition of purified recombinant c-SRC (unknown origin) at 1 uM after 60 mins by ELISA	B	CNC(=O)c1ccccc1Nc1nc(Nc2ccc3c(c2)C(C)CN(C)CC3)ncc1Cl		CHEMBL3263971		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	14659385	CHEMBL3267958	Inhibition of SRC (unknown origin) at 1 uM	B	CCOP(=O)(CC)Cc1cccc(Nc2cc(-c3ccccc3OC)ncn2)c1		CHEMBL3264107	=	Inhibition	%	18.0	CHEMBL267	Homo sapiens	INH	%	18.0
	14659386	CHEMBL3267958	Inhibition of SRC (unknown origin) at 1 uM	B	CCCP(=O)(Cc1cccc(Nc2cc(-c3ccccc3OC)ncn2)c1)OCC		CHEMBL3264108	=	Inhibition	%	4.0	CHEMBL267	Homo sapiens	INH	%	4.0
	14664323	CHEMBL3271267	Inhibition of SRC (unknown origin) at 1 uM relative to control	B	CCOC(=O)c1sc(-c2ccncc2)nc1O		CHEMBL3261228	=	Inhibition	%	81.0	CHEMBL267	Homo sapiens	INH	%	81.0
	14664324	CHEMBL3271267	Inhibition of SRC (unknown origin) at 1 uM relative to control	B	NC(=O)c1sc(-c2ccnc(N)n2)nc1-c1ccc(Cl)cc1Cl		CHEMBL3261514	=	Inhibition	%	100.0	CHEMBL267	Homo sapiens	INH	%	100.0
	14664325	CHEMBL3271267	Inhibition of SRC (unknown origin) at 1 uM relative to control	B	COc1ccc(-c2nc(-c3ccnc(N)n3)sc2C(N)=O)c(Cl)c1		CHEMBL3261517	=	Inhibition	%	100.0	CHEMBL267	Homo sapiens	INH	%	100.0
	14668868	CHEMBL3269291	Inhibition of cSRC kinase (unknown origin) assessed as residual activity at 1 uM	B	CN(C)CCNc1cncc(-c2ccc3[nH]cc(-c4ccnc(N)n4)c3c2)n1		CHEMBL3264257	=	Activity	%	97.0	CHEMBL267	Homo sapiens	Activity	%	97.0
	14672871	CHEMBL3268325	Inhibition of SRC (unknown origin) at 1 uM by Z'-LYTE assay relative to control	B	CN(C)CCN(Cc1ccc(Cl)cc1)c1ccc2ccccc2n1		CHEMBL3265344	=	Inhibition	%	3.0	CHEMBL267	Homo sapiens	INH	%	3.0
	14746966	CHEMBL3295622	Inhibition of recombinant c-Src (unknown origin) using poly (4 Glu, Tyr) as substrate after 60 mins by ELISA	B	Nc1ncnc2scc(-c3ccc4c(C(=O)Nc5ccccc5)cccc4c3)c12		CHEMBL3288526	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	14753659	CHEMBL3300697	Inhibition of Src (unknown origin) assessed as incorporation of [32P] gamma-ATP in to myelin basic protein after 30 mins by autoradiographic analysis	B	c1ccc(-c2cccc(Nc3ncnc4cc5c(cc34)OCO5)c2)cc1		CHEMBL3040861	=	IC50	nM	32.0	CHEMBL267	Homo sapiens	IC50	uM	0.032
	14753660	CHEMBL3300697	Inhibition of Src (unknown origin) assessed as incorporation of [32P] gamma-ATP in to myelin basic protein after 30 mins by autoradiographic analysis	B	c1ccc(-c2cccc(Nc3ncnc4cc5c(cc34)OCCO5)c2)cc1		CHEMBL3040806	=	IC50	nM	642.0	CHEMBL267	Homo sapiens	IC50	uM	0.642
	14753661	CHEMBL3300697	Inhibition of Src (unknown origin) assessed as incorporation of [32P] gamma-ATP in to myelin basic protein after 30 mins by autoradiographic analysis	B	c1ccc(-c2cccc(Nc3ncnc4cc5c(cc34)OCCCO5)c2)cc1		CHEMBL3040910	=	IC50	nM	645.0	CHEMBL267	Homo sapiens	IC50	uM	0.645
	14753662	CHEMBL3300697	Inhibition of Src (unknown origin) assessed as incorporation of [32P] gamma-ATP in to myelin basic protein after 30 mins by autoradiographic analysis	B	Cl.c1cc(Nc2ncnc3cc4c(cc23)OCCO4)cc(-c2ccco2)c1		CHEMBL3297954	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	14753663	CHEMBL3300697	Inhibition of Src (unknown origin) assessed as incorporation of [32P] gamma-ATP in to myelin basic protein after 30 mins by autoradiographic analysis	B	Cl.c1cc(Nc2ncnc3cc4c(cc23)OCCO4)cc(-c2cccs2)c1		CHEMBL3297955	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	14753664	CHEMBL3300697	Inhibition of Src (unknown origin) assessed as incorporation of [32P] gamma-ATP in to myelin basic protein after 30 mins by autoradiographic analysis	B	Cl.c1ccc(-c2cccc(Nc3ncnc4cc5c(cc34)OCCO5)c2)nc1		CHEMBL3297956	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	14753665	CHEMBL3300697	Inhibition of Src (unknown origin) assessed as incorporation of [32P] gamma-ATP in to myelin basic protein after 30 mins by autoradiographic analysis	B	c1ccc(-c2ccnc(Nc3ncnc4cc5c(cc34)OCCO5)n2)cc1		CHEMBL3297957	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	14753666	CHEMBL3300697	Inhibition of Src (unknown origin) assessed as incorporation of [32P] gamma-ATP in to myelin basic protein after 30 mins by autoradiographic analysis	B	c1ccc(-c2csc(Nc3ncnc4cc5c(cc34)OCCO5)n2)cc1		CHEMBL3297958	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	14753667	CHEMBL3300697	Inhibition of Src (unknown origin) assessed as incorporation of [32P] gamma-ATP in to myelin basic protein after 30 mins by autoradiographic analysis	B	Cl.c1cc(Nc2ncnc3cc4c(cc23)OCCO4)cc(-c2ccc[nH]2)c1		CHEMBL3297959	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	14753668	CHEMBL3300697	Inhibition of Src (unknown origin) assessed as incorporation of [32P] gamma-ATP in to myelin basic protein after 30 mins by autoradiographic analysis	B	COc1cc2ncnc(Nc3cccc(-c4ccccc4)c3)c2cc1OC		CHEMBL2333991	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	14753669	CHEMBL3300697	Inhibition of Src (unknown origin) assessed as incorporation of [32P] gamma-ATP in to myelin basic protein after 30 mins by autoradiographic analysis	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	IC50	nM	44.0	CHEMBL267	Homo sapiens	IC50	uM	0.044
	14753670	CHEMBL3300697	Inhibition of Src (unknown origin) assessed as incorporation of [32P] gamma-ATP in to myelin basic protein after 30 mins by autoradiographic analysis	B	COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1O		CHEMBL67	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	14753671	CHEMBL3300697	Inhibition of Src (unknown origin) assessed as incorporation of [32P] gamma-ATP in to myelin basic protein after 30 mins by autoradiographic analysis	B	CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C		CHEMBL428647	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	14926969	CHEMBL3391352	Inhibition of Src (unknown origin) at 1 uM	B	Nc1ncnc2c1sc1cc(-c3cccc(C(=O)NCCc4cccnc4)c3)ccc12		CHEMBL3347513	=	Inhibition	%	23.0	CHEMBL267	Homo sapiens	INH	%	23.0
	14926970	CHEMBL3391352	Inhibition of Src (unknown origin) at 1 uM	B	Nc1ncnc2c1sc1cc(-c3cccc(C(=O)NCC(=O)N4CCOCC4)c3)ccc12		CHEMBL3347694	=	Inhibition	%	45.0	CHEMBL267	Homo sapiens	INH	%	45.0
	14926971	CHEMBL3391352	Inhibition of Src (unknown origin) at 1 uM	B	CN1CCN(C(=O)Nc2cccc(-c3ccc4c(c3)sc3c(N)ncnc34)c2)CC1		CHEMBL3347683	=	Inhibition	%	71.0	CHEMBL267	Homo sapiens	INH	%	71.0
	14926972	CHEMBL3391352	Inhibition of Src (unknown origin) at 1 uM	B	Nc1ncnc2c1sc1cc(-c3cccc(NC(=O)N4CCCC4)c3)ccc12		CHEMBL3347669	=	Inhibition	%	60.0	CHEMBL267	Homo sapiens	INH	%	60.0
	14927532	CHEMBL3391421	Inhibition of Src (unknown origin)	B	CC(C)=CCC[C@H](C)c1ccc(C)cc1O		CHEMBL451860	=	IC50	nM	35800.0	CHEMBL267	Homo sapiens	IC50	uM	35.8
Not Determined	14927745	CHEMBL3391138	Inhibition of Src kinase (unknown origin)	B	COC(=O)c1cc2cc(NC(=O)c3ccc4[nH]ccc4c3)cnc2[nH]1		CHEMBL3347277		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	14927746	CHEMBL3391138	Inhibition of Src kinase (unknown origin)	B	COC(=O)c1cc2cc(NCc3cnc4[nH]ccc4c3)cnc2[nH]1		CHEMBL3347426		IC50			CHEMBL267	Homo sapiens	IC50		
	14927747	CHEMBL3391138	Inhibition of Src kinase (unknown origin)	B	COC(=O)c1cc2cc(NCc3cc4nc[nH]c4cc3C)cnc2[nH]1		CHEMBL3347425	=	IC50	nM	3037.0	CHEMBL267	Homo sapiens	IC50	nM	3037.0
Not Determined	14927748	CHEMBL3391138	Inhibition of Src kinase (unknown origin)	B	COC(=O)c1cc2cc(NCc3ccc4[nH]cnc4c3)cnc2[nH]1		CHEMBL3347424		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	14927749	CHEMBL3391138	Inhibition of Src kinase (unknown origin)	B	COC(=O)c1cc2cc(NCc3ccc4cc[nH]c4c3)cnc2[nH]1		CHEMBL3347420		IC50			CHEMBL267	Homo sapiens	IC50		
	14927750	CHEMBL3391138	Inhibition of Src kinase (unknown origin)	B	COC(=O)c1cc2cc(NCc3ccc4[nH]ccc4c3)cnc2[nH]1		CHEMBL3347419	=	IC50	nM	759.0	CHEMBL267	Homo sapiens	IC50	nM	759.0
	14927751	CHEMBL3391138	Inhibition of Src kinase (unknown origin)	B	CCn1nccc1CNc1cnc2[nH]c(C(=O)OC)cc2c1		CHEMBL3347418	=	IC50	nM	1167.0	CHEMBL267	Homo sapiens	IC50	nM	1167.0
	14927752	CHEMBL3391138	Inhibition of Src kinase (unknown origin)	B	COC(=O)c1cc2cc(NCc3cc[nH]n3)cnc2[nH]1		CHEMBL3347390	=	IC50	nM	1473.0	CHEMBL267	Homo sapiens	IC50	nM	1473.0
	14927753	CHEMBL3391138	Inhibition of Src kinase (unknown origin)	B	COC(=O)c1cc2cc(NCc3cccs3)cnc2[nH]1		CHEMBL3347389	=	IC50	nM	209.0	CHEMBL267	Homo sapiens	IC50	nM	209.0
	14927754	CHEMBL3391138	Inhibition of Src kinase (unknown origin)	B	COC(=O)c1cc2cc(NCc3c(C)cccc3Cl)cnc2[nH]1		CHEMBL3347388	=	IC50	nM	3.4	CHEMBL267	Homo sapiens	IC50	nM	3.4
	14927755	CHEMBL3391138	Inhibition of Src kinase (unknown origin)	B	COC(=O)c1cc2cc(NCc3c(Cl)cccc3Cl)cnc2[nH]1		CHEMBL3347468	=	IC50	nM	9.5	CHEMBL267	Homo sapiens	IC50	nM	9.5
Not Determined	14927756	CHEMBL3391138	Inhibition of Src kinase (unknown origin)	B	COC(=O)c1cc2cc(NCc3ccccc3OC(F)(F)F)cnc2[nH]1		CHEMBL3347467		IC50			CHEMBL267	Homo sapiens	IC50		
	14927757	CHEMBL3391138	Inhibition of Src kinase (unknown origin)	B	COC(=O)c1cc2cc(NCc3ccccc3OC)cnc2[nH]1		CHEMBL3347466	=	IC50	nM	2224.0	CHEMBL267	Homo sapiens	IC50	nM	2224.0
	14927758	CHEMBL3391138	Inhibition of Src kinase (unknown origin)	B	COC(=O)c1cc2cc(NCc3ccccc3C(F)(F)F)cnc2[nH]1		CHEMBL3347453	=	IC50	nM	1423.0	CHEMBL267	Homo sapiens	IC50	nM	1423.0
	14927759	CHEMBL3391138	Inhibition of Src kinase (unknown origin)	B	COC(=O)c1cc2cc(NCc3ccccc3C)cnc2[nH]1		CHEMBL3347452	=	IC50	nM	12.0	CHEMBL267	Homo sapiens	IC50	nM	12.0
	14927760	CHEMBL3391138	Inhibition of Src kinase (unknown origin)	B	COC(=O)c1cc2cc(NCc3ccccc3Br)cnc2[nH]1		CHEMBL3347451	=	IC50	nM	168.0	CHEMBL267	Homo sapiens	IC50	nM	168.0
Not Determined	14927761	CHEMBL3391138	Inhibition of Src kinase (unknown origin)	B	COC(=O)c1cc2cc(NC(=O)c3cc(C)n[nH]3)cnc2[nH]1		CHEMBL3347440		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	14927762	CHEMBL3391138	Inhibition of Src kinase (unknown origin)	B	COC(=O)c1cc2cc(NC(=O)c3cccs3)cnc2[nH]1		CHEMBL3347439		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	14927763	CHEMBL3391138	Inhibition of Src kinase (unknown origin)	B	COC(=O)c1cc2cc(NC(=O)c3cccnc3)cnc2[nH]1		CHEMBL3347438		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	14927764	CHEMBL3391138	Inhibition of Src kinase (unknown origin)	B	COC(=O)c1cc2cc(NC(=O)C(C)C)cnc2[nH]1		CHEMBL3347437		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	14927765	CHEMBL3391138	Inhibition of Src kinase (unknown origin)	B	COC(=O)c1cc2cc(NC(=O)C3CC3)cnc2[nH]1		CHEMBL3347639		IC50			CHEMBL267	Homo sapiens	IC50		
	14927766	CHEMBL3391138	Inhibition of Src kinase (unknown origin)	B	COC(=O)c1cc2cc(NC(=O)c3c(C)cccc3Cl)cnc2[nH]1		CHEMBL3347638	=	IC50	nM	54.0	CHEMBL267	Homo sapiens	IC50	nM	54.0
	14927767	CHEMBL3391138	Inhibition of Src kinase (unknown origin)	B	COC(=O)c1cc2cc(NC(=O)c3c(Cl)cccc3Cl)cnc2[nH]1		CHEMBL3347637	=	IC50	nM	29.0	CHEMBL267	Homo sapiens	IC50	nM	29.0
	14927768	CHEMBL3391138	Inhibition of Src kinase (unknown origin)	B	COC(=O)c1cc2cc(NC(=O)c3c(F)cccc3OC)cnc2[nH]1		CHEMBL3347624	=	IC50	nM	324.0	CHEMBL267	Homo sapiens	IC50	nM	324.0
Not Determined	14927769	CHEMBL3391138	Inhibition of Src kinase (unknown origin)	B	COC(=O)c1cc2cc(NC(=O)c3ccccc3OC(F)(F)F)cnc2[nH]1		CHEMBL3347623		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	14927770	CHEMBL3391138	Inhibition of Src kinase (unknown origin)	B	COC(=O)c1cc2cc(NC(=O)c3ccccc3OC)cnc2[nH]1		CHEMBL3347622		IC50			CHEMBL267	Homo sapiens	IC50		
	14927771	CHEMBL3391138	Inhibition of Src kinase (unknown origin)	B	COC(=O)c1cc2cc(NC(=O)c3ccccc3C(F)(F)F)cnc2[nH]1		CHEMBL3347602	=	IC50	nM	1127.0	CHEMBL267	Homo sapiens	IC50	nM	1127.0
	14927772	CHEMBL3391138	Inhibition of Src kinase (unknown origin)	B	COC(=O)c1cc2cc(NC(=O)c3ccccc3C)cnc2[nH]1		CHEMBL3347601	=	IC50	nM	51.0	CHEMBL267	Homo sapiens	IC50	nM	51.0
Not Determined	14927773	CHEMBL3391138	Inhibition of Src kinase (unknown origin)	B	COC(=O)c1cc2cc(NC(=O)c3ccc(Br)cc3)cnc2[nH]1		CHEMBL3347600		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	14927774	CHEMBL3391138	Inhibition of Src kinase (unknown origin)	B	COC(=O)c1cc2cc(NC(=O)c3cccc(Br)c3)cnc2[nH]1		CHEMBL3347652		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	14927775	CHEMBL3391138	Inhibition of Src kinase (unknown origin)	B	O=C(Nc1cnc2[nH]c(CO)cc2c1)c1ccccc1Br		CHEMBL3347651		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	14927776	CHEMBL3391138	Inhibition of Src kinase (unknown origin)	B	COCc1cc2cc(NC(=O)c3ccccc3Br)cnc2[nH]1		CHEMBL3347650		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	14927777	CHEMBL3391138	Inhibition of Src kinase (unknown origin)	B	COC(=O)c1cc2cc(NC(=O)c3ccccc3Br)cnc2[nH]1		CHEMBL3347636		IC50			CHEMBL267	Homo sapiens	IC50		
	14927778	CHEMBL3391138	Inhibition of Src kinase (unknown origin)	B	O=C(Nc1cnc2[nH]c(Cc3ccc[nH]3)cc2c1)c1ccccc1Br		CHEMBL3347621	=	IC50	nM	513.0	CHEMBL267	Homo sapiens	IC50	nM	513.0
	14927779	CHEMBL3391138	Inhibition of Src kinase (unknown origin)	B	CN(C)CCCNC(=O)c1cc2cc(NC(=O)c3ccccc3Br)cnc2[nH]1		CHEMBL3347647	=	IC50	nM	2000.0	CHEMBL267	Homo sapiens	IC50	nM	2000.0
	14927780	CHEMBL3391137	Inhibition of Src kinase (unknown origin) at 10 uM	B	COC(=O)c1cc2cc(NC(=O)c3ccc4[nH]ccc4c3)cnc2[nH]1		CHEMBL3347277	=	Inhibition	%	6.0	CHEMBL267	Homo sapiens	INH	%	6.0
Not Determined	14927781	CHEMBL3391137	Inhibition of Src kinase (unknown origin) at 10 uM	B	COC(=O)c1cc2cc(NC(=O)Cc3ccc(OC)cc3)cnc2[nH]1		CHEMBL3347469		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Determined	14927782	CHEMBL3391137	Inhibition of Src kinase (unknown origin) at 10 uM	B	COC(=O)c1cc2cc(NC(=O)Cc3cccc(OC)c3)cnc2[nH]1		CHEMBL3347456		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Determined	14927783	CHEMBL3391137	Inhibition of Src kinase (unknown origin) at 10 uM	B	COC(=O)c1cc2cc(NC(=O)Cc3ccccc3Br)cnc2[nH]1		CHEMBL3347455		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	14927784	CHEMBL3391137	Inhibition of Src kinase (unknown origin) at 10 uM	B	COC(=O)c1cc2cc(Nc3ccc(OC)cc3)cnc2[nH]1		CHEMBL3347454	=	Inhibition	%	11.0	CHEMBL267	Homo sapiens	INH	%	11.0
	14927785	CHEMBL3391137	Inhibition of Src kinase (unknown origin) at 10 uM	B	COC(=O)c1cc2cc(Nc3cccc(OC)c3)cnc2[nH]1		CHEMBL3347443	=	Inhibition	%	10.0	CHEMBL267	Homo sapiens	INH	%	10.0
	14927786	CHEMBL3391137	Inhibition of Src kinase (unknown origin) at 10 uM	B	COC(=O)c1cc2cc(Nc3ccc(Br)cc3)cnc2[nH]1		CHEMBL3347442	=	Inhibition	%	22.0	CHEMBL267	Homo sapiens	INH	%	22.0
	14927787	CHEMBL3391137	Inhibition of Src kinase (unknown origin) at 10 uM	B	COC(=O)c1cc2cc(Nc3cccc(Br)c3)cnc2[nH]1		CHEMBL3347441	=	Inhibition	%	1.0	CHEMBL267	Homo sapiens	INH	%	1.0
	14927788	CHEMBL3391137	Inhibition of Src kinase (unknown origin) at 10 uM	B	COC(=O)c1cc2cc(NCc3cnc4[nH]ccc4c3)cnc2[nH]1		CHEMBL3347426	=	Inhibition	%	49.0	CHEMBL267	Homo sapiens	INH	%	49.0
	14927789	CHEMBL3391137	Inhibition of Src kinase (unknown origin) at 10 uM	B	COC(=O)c1cc2cc(NCc3cc4nc[nH]c4cc3C)cnc2[nH]1		CHEMBL3347425	=	Inhibition	%	79.0	CHEMBL267	Homo sapiens	INH	%	79.0
	14927790	CHEMBL3391137	Inhibition of Src kinase (unknown origin) at 10 uM	B	COC(=O)c1cc2cc(NCc3ccc4[nH]cnc4c3)cnc2[nH]1		CHEMBL3347424	=	Inhibition	%	61.0	CHEMBL267	Homo sapiens	INH	%	61.0
	14927791	CHEMBL3391137	Inhibition of Src kinase (unknown origin) at 10 uM	B	COC(=O)c1cc2cc(NCc3ccc4cc[nH]c4c3)cnc2[nH]1		CHEMBL3347420	=	Inhibition	%	28.0	CHEMBL267	Homo sapiens	INH	%	28.0
	14927792	CHEMBL3391137	Inhibition of Src kinase (unknown origin) at 10 uM	B	COC(=O)c1cc2cc(NCc3ccc4[nH]ccc4c3)cnc2[nH]1		CHEMBL3347419	=	Inhibition	%	88.0	CHEMBL267	Homo sapiens	INH	%	88.0
	14927793	CHEMBL3391137	Inhibition of Src kinase (unknown origin) at 10 uM	B	CCn1nccc1CNc1cnc2[nH]c(C(=O)OC)cc2c1		CHEMBL3347418	=	Inhibition	%	90.0	CHEMBL267	Homo sapiens	INH	%	90.0
	14927794	CHEMBL3391137	Inhibition of Src kinase (unknown origin) at 10 uM	B	COC(=O)c1cc2cc(NCc3cc[nH]n3)cnc2[nH]1		CHEMBL3347390	=	Inhibition	%	90.0	CHEMBL267	Homo sapiens	INH	%	90.0
	14927795	CHEMBL3391137	Inhibition of Src kinase (unknown origin) at 10 uM	B	COC(=O)c1cc2cc(NCc3cccs3)cnc2[nH]1		CHEMBL3347389	=	Inhibition	%	96.0	CHEMBL267	Homo sapiens	INH	%	96.0
	14927796	CHEMBL3391137	Inhibition of Src kinase (unknown origin) at 10 uM	B	COC(=O)c1cc2cc(NCc3c(C)cccc3Cl)cnc2[nH]1		CHEMBL3347388	=	Inhibition	%	100.0	CHEMBL267	Homo sapiens	INH	%	100.0
	14927797	CHEMBL3391137	Inhibition of Src kinase (unknown origin) at 10 uM	B	COC(=O)c1cc2cc(NCc3c(Cl)cccc3Cl)cnc2[nH]1		CHEMBL3347468	=	Inhibition	%	99.0	CHEMBL267	Homo sapiens	INH	%	99.0
	14927798	CHEMBL3391137	Inhibition of Src kinase (unknown origin) at 10 uM	B	COC(=O)c1cc2cc(NCc3ccccc3OC(F)(F)F)cnc2[nH]1		CHEMBL3347467	=	Inhibition	%	9.0	CHEMBL267	Homo sapiens	INH	%	9.0
	14927799	CHEMBL3391137	Inhibition of Src kinase (unknown origin) at 10 uM	B	COC(=O)c1cc2cc(NCc3ccccc3OC)cnc2[nH]1		CHEMBL3347466	=	Inhibition	%	87.0	CHEMBL267	Homo sapiens	INH	%	87.0
	14927800	CHEMBL3391137	Inhibition of Src kinase (unknown origin) at 10 uM	B	COC(=O)c1cc2cc(NCc3ccccc3C(F)(F)F)cnc2[nH]1		CHEMBL3347453	=	Inhibition	%	76.0	CHEMBL267	Homo sapiens	INH	%	76.0
	14927801	CHEMBL3391137	Inhibition of Src kinase (unknown origin) at 10 uM	B	COC(=O)c1cc2cc(NCc3ccccc3C)cnc2[nH]1		CHEMBL3347452	=	Inhibition	%	100.0	CHEMBL267	Homo sapiens	INH	%	100.0
	14927802	CHEMBL3391137	Inhibition of Src kinase (unknown origin) at 10 uM	B	COC(=O)c1cc2cc(NCc3ccccc3Br)cnc2[nH]1		CHEMBL3347451	=	Inhibition	%	81.0	CHEMBL267	Homo sapiens	INH	%	81.0
	14927803	CHEMBL3391137	Inhibition of Src kinase (unknown origin) at 10 uM	B	COC(=O)c1cc2cc(NC(=O)c3cc(C)n[nH]3)cnc2[nH]1		CHEMBL3347440	=	Inhibition	%	27.0	CHEMBL267	Homo sapiens	INH	%	27.0
	14927804	CHEMBL3391137	Inhibition of Src kinase (unknown origin) at 10 uM	B	COC(=O)c1cc2cc(NC(=O)c3cccs3)cnc2[nH]1		CHEMBL3347439	=	Inhibition	%	20.0	CHEMBL267	Homo sapiens	INH	%	20.0
Not Determined	14927805	CHEMBL3391137	Inhibition of Src kinase (unknown origin) at 10 uM	B	COC(=O)c1cc2cc(NC(=O)c3cccnc3)cnc2[nH]1		CHEMBL3347438		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Determined	14927806	CHEMBL3391137	Inhibition of Src kinase (unknown origin) at 10 uM	B	COC(=O)c1cc2cc(NC(=O)C(C)C)cnc2[nH]1		CHEMBL3347437		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Determined	14927807	CHEMBL3391137	Inhibition of Src kinase (unknown origin) at 10 uM	B	COC(=O)c1cc2cc(NC(=O)C3CC3)cnc2[nH]1		CHEMBL3347639		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	14927808	CHEMBL3391137	Inhibition of Src kinase (unknown origin) at 10 uM	B	COC(=O)c1cc2cc(NC(=O)c3c(C)cccc3Cl)cnc2[nH]1		CHEMBL3347638	=	Inhibition	%	94.0	CHEMBL267	Homo sapiens	INH	%	94.0
	14927809	CHEMBL3391137	Inhibition of Src kinase (unknown origin) at 10 uM	B	COC(=O)c1cc2cc(NC(=O)c3c(Cl)cccc3Cl)cnc2[nH]1		CHEMBL3347637	=	Inhibition	%	97.0	CHEMBL267	Homo sapiens	INH	%	97.0
	14927810	CHEMBL3391137	Inhibition of Src kinase (unknown origin) at 10 uM	B	COC(=O)c1cc2cc(NC(=O)c3c(F)cccc3OC)cnc2[nH]1		CHEMBL3347624	=	Inhibition	%	94.0	CHEMBL267	Homo sapiens	INH	%	94.0
	14927811	CHEMBL3391137	Inhibition of Src kinase (unknown origin) at 10 uM	B	COC(=O)c1cc2cc(NC(=O)c3ccccc3OC(F)(F)F)cnc2[nH]1		CHEMBL3347623	=	Inhibition	%	15.0	CHEMBL267	Homo sapiens	INH	%	15.0
	14927812	CHEMBL3391137	Inhibition of Src kinase (unknown origin) at 10 uM	B	COC(=O)c1cc2cc(NC(=O)c3ccccc3OC)cnc2[nH]1		CHEMBL3347622	=	Inhibition	%	28.0	CHEMBL267	Homo sapiens	INH	%	28.0
	14927813	CHEMBL3391137	Inhibition of Src kinase (unknown origin) at 10 uM	B	COC(=O)c1cc2cc(NC(=O)c3ccccc3C(F)(F)F)cnc2[nH]1		CHEMBL3347602	=	Inhibition	%	66.0	CHEMBL267	Homo sapiens	INH	%	66.0
	14927814	CHEMBL3391137	Inhibition of Src kinase (unknown origin) at 10 uM	B	COC(=O)c1cc2cc(NC(=O)c3ccccc3C)cnc2[nH]1		CHEMBL3347601	=	Inhibition	%	98.0	CHEMBL267	Homo sapiens	INH	%	98.0
Not Determined	14927815	CHEMBL3391137	Inhibition of Src kinase (unknown origin) at 10 uM	B	COC(=O)c1cc2cc(NC(=O)c3ccc(Br)cc3)cnc2[nH]1		CHEMBL3347600		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	14927816	CHEMBL3391137	Inhibition of Src kinase (unknown origin) at 10 uM	B	COC(=O)c1cc2cc(NC(=O)c3cccc(Br)c3)cnc2[nH]1		CHEMBL3347652	=	Inhibition	%	24.0	CHEMBL267	Homo sapiens	INH	%	24.0
Not Determined	14927817	CHEMBL3391137	Inhibition of Src kinase (unknown origin) at 10 uM	B	O=C(Nc1cnc2[nH]c(CO)cc2c1)c1ccccc1Br		CHEMBL3347651		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	14927818	CHEMBL3391137	Inhibition of Src kinase (unknown origin) at 10 uM	B	COCc1cc2cc(NC(=O)c3ccccc3Br)cnc2[nH]1		CHEMBL3347650	=	Inhibition	%	59.0	CHEMBL267	Homo sapiens	INH	%	59.0
	14927819	CHEMBL3391137	Inhibition of Src kinase (unknown origin) at 10 uM	B	COC(=O)c1cc2cc(NC(=O)c3ccccc3Br)cnc2[nH]1		CHEMBL3347636	=	Inhibition	%	50.0	CHEMBL267	Homo sapiens	INH	%	50.0
	14927820	CHEMBL3391137	Inhibition of Src kinase (unknown origin) at 10 uM	B	O=C(Nc1cnc2[nH]c(Cc3ccc[nH]3)cc2c1)c1ccccc1Br		CHEMBL3347621	=	Inhibition	%	72.0	CHEMBL267	Homo sapiens	INH	%	72.0
	14927821	CHEMBL3391137	Inhibition of Src kinase (unknown origin) at 10 uM	B	CN(C)CCCNC(=O)c1cc2cc(NC(=O)c3ccccc3Br)cnc2[nH]1		CHEMBL3347647	=	Inhibition	%	90.0	CHEMBL267	Homo sapiens	INH	%	90.0
	14979423	CHEMBL3372975	Inhibition of Src (unknown origin) in presence of 1 mM ATP	B	CN(Cc1ccccc1)C(=O)c1ccc(S(=O)(=O)Nc2ccccc2)cc1		CHEMBL3355482	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	14981085	CHEMBL3375434	Inhibition of c-Src (unknown origin) at 1 uM	B	CC(C)(O)[C@H]1CC[C@H](Nc2ccn3ncc(-c4cccc(Cl)c4)c3n2)CC1		CHEMBL3355987	>	Inhibition	%	50.0	CHEMBL267	Homo sapiens	INH	%	50.0
	14983165	CHEMBL3377043	Inhibition of SRC (unknown origin) at 1 uM	B	CN1CCN(c2ccc(-c3cnc4[nH]c5cnc(C#N)cc5c4c3)cc2)CC1		CHEMBL3359895	=	Inhibition	%	45.0	CHEMBL267	Homo sapiens	INH	%	45.0
	14984407	CHEMBL3384384	Inhibition of SRC (unknown origin) at 0.1 uM	B	CN1CCN(c2ccc(-c3cnc4[nH]c5cnc(C#N)cc5c4c3)cc2)CC1		CHEMBL3359895	=	Inhibition	%	11.0	CHEMBL267	Homo sapiens	INH	%	11.0
	14992112	CHEMBL3374161	Inhibition of c-SRC (unknown origin) at 1 uM by ELISA method	B	O=C(Nc1ccc(F)cc1)C1(C(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)[nH]c34)c(F)c2)CC1		CHEMBL3360678	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	14992113	CHEMBL3374161	Inhibition of c-SRC (unknown origin) at 1 uM by ELISA method	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Inhibition	%	63.2	CHEMBL267	Homo sapiens	INH	%	63.2
	14994875	CHEMBL3372478	Inhibition of c-Src (unknown origin) at 100 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Inhibition	%	94.0	CHEMBL267	Homo sapiens	INH	%	94.0
	14994876	CHEMBL3372478	Inhibition of c-Src (unknown origin) at 100 uM	B	CCCCCCCCCCCC(=O)NNC(=O)C1Sc2ccccc2N(Cc2ccccc2)C1=O		CHEMBL3358803	=	Inhibition	%	12.2	CHEMBL267	Homo sapiens	INH	%	12.2
	15002510	CHEMBL3366586	Inhibition of SRC (unknown origin) assessed as residual activity at 10 uM relative to control	B	Cc1cc(O)cc(-c2nn(C)cc2-c2cc(N3CCOCC3)nc(-c3cccnc3)n2)c1		CHEMBL3310332	=	Activity	%	25.0	CHEMBL267	Homo sapiens	Activity	%	25.0
	15005104	CHEMBL3366512	Inhibition of c-Src (unknown origin) after 60 mins by ELISA	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2cccc(NC(=O)CN)c2)ncc1Cl		CHEMBL3357439	>	IC50	nM	1000.0	CHEMBL267	Homo sapiens	IC50	uM	1.0
	15008000	CHEMBL3367995	Inhibition of human cSRC at 1 uM by radiometric Assay	B	NS(=O)(=O)c1cccc(-c2n[nH]c3ccc(NC(=O)Cc4ccccc4)cc23)c1		CHEMBL3330255	=	Inhibition	%	-10.0	CHEMBL267	Homo sapiens	INH	%	-10.0
	15008001	CHEMBL3367995	Inhibition of human cSRC at 1 uM by radiometric Assay	B	COC(C(=O)Nc1ccc2[nH]nc(-c3cccc(S(N)(=O)=O)c3)c2c1)c1ccccc1	Outside typical range	CHEMBL3330401	=	Inhibition	%	-48.0	CHEMBL267	Homo sapiens	INH	%	-48.0
	15008002	CHEMBL3367995	Inhibition of human cSRC at 1 uM by radiometric Assay	B	NS(=O)(=O)c1cccc(-c2n[nH]c3ccc(NC(=O)C(c4ccsc4)N4CCCC4)cc23)c1		CHEMBL3330410	=	Inhibition	%	-10.0	CHEMBL267	Homo sapiens	INH	%	-10.0
Active	15008693	CHEMBL3364211	Binding affinity to SRC (unknown origin)	B	Cc1ccc(O)cc1-n1c(N)c(C(N)=O)c2nc3ccccc3nc21		CHEMBL3321809		Activity			CHEMBL267	Homo sapiens	Activity		
Active	15008694	CHEMBL3364211	Binding affinity to SRC (unknown origin)	B	NC(=O)c1c(N)n(-c2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2nc3ccccc3nc12		CHEMBL3321811		Activity			CHEMBL267	Homo sapiens	Activity		
Active	15008695	CHEMBL3364211	Binding affinity to SRC (unknown origin)	B	NC(=O)c1c(N)n(-c2cccc(C(=O)Nc3cccc(C(F)(F)F)c3)c2)c2nc3ccccc3nc12		CHEMBL3321816		Activity			CHEMBL267	Homo sapiens	Activity		
	15009778	CHEMBL3363730	Inhibition of c-Src (unknown origin) at 10 uM	B	C[C@H](O)CNc1nccc(-n2ccnc2Cc2cccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c2)n1		CHEMBL3309549	=	Inhibition	%	2.1	CHEMBL267	Homo sapiens	INH	%	2.1
	15018697	CHEMBL3369197	Inhibition of Src (unknown origin) at 100 nM	B	O=C(N[C@H](CO)c1ccc(Cl)c(F)c1)N1CCc2cnc(NC3CCOCC3)nc2C1		CHEMBL3298678	=	Inhibition	%	8.8	CHEMBL267	Homo sapiens	INH	%	8.8
	15019206	CHEMBL3364399	Inhibition of SRC (unknown origin) at 1 uM in presence of 100 uM ATP	B	C=CC(=O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C		CHEMBL3298512	=	Inhibition	%	-4.0	CHEMBL267	Homo sapiens	INH	%	-4.0
	15022488	CHEMBL3380451	Inhibition of c-Src (unknown origin) at 1 uM	B	COc1ccc(C(=O)NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2[nH]c(C)c(C(=O)NCCN3CCCC3)c2C)c(F)c1		CHEMBL3329684	=	Inhibition	%	20.0	CHEMBL267	Homo sapiens	INH	%	20.0
	15025404	CHEMBL3362512	Inhibition of c-Src (unknown origin) at 1 uM by radioisotope-based P81 filter-binding assay	B	O=C1Nc2cc(NC(=O)c3c[nH]cc(-c4ccccc4F)c3=O)ccc2/C1=C/c1ccc[nH]1		CHEMBL3322590	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	15044439	CHEMBL3376777	Inhibition of c-Src (unknown origin)	B	O=C(Cc1cccc(Br)c1)Nc1ccc2ncnc(Nc3ccc(Br)cc3)c2c1		CHEMBL3310054	=	IC50	nM	27.3	CHEMBL267	Homo sapiens	IC50	nM	27.3
	15054174	CHEMBL3363275	Inhibition of Src kinase (unknown origin)	B	COc1ccc(/C=C/C(=O)c2c(O)ccc3c(C)cc(=O)oc23)cc1O		CHEMBL3309834	=	IC50	nM	14500.0	CHEMBL267	Homo sapiens	IC50	uM	14.5
	15055281	CHEMBL3380473	Inhibition of human recombinant SRC using poly(Glu,Tyr) substrate	B	COc1cc(-c2nc(-c3c[nH]c4ccccc34)c[nH]c2=O)cc(OC)c1OC		CHEMBL3358966	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	15058858	CHEMBL3373897	Inhibition of SRC (unknown origin) assessed as residual activity at 1 uM by radiometric protein kinase assay	B	COc1cc(-c2c[nH]c(=O)c(-c3cc(OC)c(OC)c(OC)c3)n2)ccc1O		CHEMBL3358999	=	Activity	%	49.0	CHEMBL267	Homo sapiens	Activity	%	49.0
Not Active	15071584	CHEMBL3381575	Inhibition of cSRC (unknown origin) at 10 uM	B	CCN(CC)CCO/N=C(\c1ccc(SC)cc1)c1cccc2ccccc12.O=C(O)C(=O)O		CHEMBL3356484		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	15072589	CHEMBL3388697	Inhibition of SRC (unknown origin) assessed as remaining enzyme activity at 10 uM by radioactive [33P]-ATP filter binding assay	B	Cc1ccc(-c2cc(C(=O)Nc3ccnc(Cl)c3)nn2-c2ccc3ccccc3n2)cc1		CHEMBL3338802	=	Activity	%	142.0	CHEMBL267	Homo sapiens	Activity	%	142.0
	15085841	CHEMBL3383513	Inhibition of purified c-Src (unknown origin) at 1 uM after 60 mins by ELISA kinase assay	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2nc3c(s2)CCN(C(=O)C2CCOCC2)CC3)ncc1Cl		CHEMBL3330859	=	Inhibition	%	51.3	CHEMBL267	Homo sapiens	INH	%	51.3
	15085900	CHEMBL3383513	Inhibition of purified c-Src (unknown origin) at 1 uM after 60 mins by ELISA kinase assay	B	CNC(=O)c1ccccc1Nc1nc(Nc2nc3c(s2)CCNCC3)ncc1Cl		CHEMBL3330850	=	Inhibition	%	20.7	CHEMBL267	Homo sapiens	INH	%	20.7
	15091066	CHEMBL3382236	Inhibition of human recombinant Src kinase expressed insect cells using Ulight-Poly GAT[EAY(1:1:1)]n substrate assessed as remaining enzyme activity at 1 uM after 10 mins relative to control	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Br)c(O)c(Br)c1		CHEMBL2206014	=	Activity	%	101.0	CHEMBL267	Homo sapiens	Activity	%	101.0
Not Active	15095921	CHEMBL3384725	Inhibition of SRC (unknown origin)	B	CCN1CCN(CC(=O)Nc2cc(Oc3ccc4c(c3)nc(Nc3cc(C(F)(F)F)ccc3F)n4C)ccn2)CC1		CHEMBL3335387		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	15105136	CHEMBL3382430	Inhibition of Src (unknown origin) expressed in HEK293 cells assessed as decrease in phosphorylation by chemiluminescence assay	B	COc1cc(Br)c(Br)c(/C=N/c2ccc3[nH]c(=O)[nH]c3c2)c1O		CHEMBL3335244	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	15105137	CHEMBL3382430	Inhibition of Src (unknown origin) expressed in HEK293 cells assessed as decrease in phosphorylation by chemiluminescence assay	B	CCOc1cc(Br)c(Br)c(/C=N/c2ccc3[nH]c(=O)[nH]c3c2)c1O		CHEMBL3335245	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	15105138	CHEMBL3382430	Inhibition of Src (unknown origin) expressed in HEK293 cells assessed as decrease in phosphorylation by chemiluminescence assay	B	O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12		CHEMBL44	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	15107861	CHEMBL3385828	Inhibition of wild type SRC (unknown origin) incubated for 5 mins by HTRF assay	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C(F)=C/CN(C)C		CHEMBL3357634	=	IC50	nM	1731.0	CHEMBL267	Homo sapiens	IC50	nM	1731.0
	15143831	CHEMBL3396217	Inhibition of purified c-Src (unknown origin) at 1 uM after 60 mins by ELISA	B	Nc1n[nH]c2cccc(-c3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)c12		CHEMBL3394469	=	Inhibition	%	11.8	CHEMBL267	Homo sapiens	INH	%	11.8
Not Determined	15143846	CHEMBL3396232	Inhibition of purified c-Src (unknown origin) at 0.1 uM after 60 mins by ELISA	B	Nc1n[nH]c2cccc(-c3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)c12		CHEMBL3394469		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Determined	15143861	CHEMBL3396247	Inhibition of purified c-Src (unknown origin) at 0.01 uM after 60 mins by ELISA	B	Nc1n[nH]c2cccc(-c3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)c12		CHEMBL3394469		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	15149015	CHEMBL3395759	Inhibition of human recombinant src kinase using KVEKIGEGTYGVVYK as substrate by filter binding assay in presence of [gamma-32P]ATP	B	ClC(Cn1ncc2c(Nc3cccc(Br)c3)nc(SCCN3CCOCC3)nc21)c1ccccc1		CHEMBL3394092	=	Ki	nM	130.0	CHEMBL267	Homo sapiens	Ki	uM	0.13
	15149016	CHEMBL3395759	Inhibition of human recombinant src kinase using KVEKIGEGTYGVVYK as substrate by filter binding assay in presence of [gamma-32P]ATP	B	Oc1cccc(Nc2nc(SC3CCCC3)nc3c2cnn3CC(Cl)c2ccccc2)c1		CHEMBL3394091	=	Ki	nM	7.0	CHEMBL267	Homo sapiens	Ki	uM	0.007
Not Active	15149017	CHEMBL3395759	Inhibition of human recombinant src kinase using KVEKIGEGTYGVVYK as substrate by filter binding assay in presence of [gamma-32P]ATP	B	Clc1cccc(Nc2nc(SC3CCCC3)nc3c2cnn3CC(Cl)c2ccccc2)c1		CHEMBL3394090		Ki			CHEMBL267	Homo sapiens	Ki		
	15149018	CHEMBL3395759	Inhibition of human recombinant src kinase using KVEKIGEGTYGVVYK as substrate by filter binding assay in presence of [gamma-32P]ATP	B	Fc1cccc(Nc2nc(SC3CCCC3)nc3c2cnn3CC(Cl)c2ccccc2)c1		CHEMBL3394089	=	Ki	nM	110.0	CHEMBL267	Homo sapiens	Ki	uM	0.11
	15149019	CHEMBL3395759	Inhibition of human recombinant src kinase using KVEKIGEGTYGVVYK as substrate by filter binding assay in presence of [gamma-32P]ATP	B	ClC(Cn1ncc2c(Nc3ccccc3)nc(SC3CCCC3)nc21)c1ccccc1		CHEMBL3394088	=	Ki	nM	120.0	CHEMBL267	Homo sapiens	Ki	uM	0.12
	15149020	CHEMBL3395759	Inhibition of human recombinant src kinase using KVEKIGEGTYGVVYK as substrate by filter binding assay in presence of [gamma-32P]ATP	B	CC(C)Sc1nc(Nc2cccc(O)c2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL3393071	=	Ki	nM	10.0	CHEMBL267	Homo sapiens	Ki	uM	0.01
	15149021	CHEMBL3395759	Inhibition of human recombinant src kinase using KVEKIGEGTYGVVYK as substrate by filter binding assay in presence of [gamma-32P]ATP	B	CC(C)Sc1nc(Nc2cccc(Br)c2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL3394087	=	Ki	nM	620.0	CHEMBL267	Homo sapiens	Ki	uM	0.62
	15149022	CHEMBL3395759	Inhibition of human recombinant src kinase using KVEKIGEGTYGVVYK as substrate by filter binding assay in presence of [gamma-32P]ATP	B	CC(C)Sc1nc(Nc2cccc(F)c2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL3394086	=	Ki	nM	260.0	CHEMBL267	Homo sapiens	Ki	uM	0.26
	15149023	CHEMBL3395759	Inhibition of human recombinant src kinase using KVEKIGEGTYGVVYK as substrate by filter binding assay in presence of [gamma-32P]ATP	B	CC(C)Sc1nc(Nc2ccccc2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL3394085	=	Ki	nM	300.0	CHEMBL267	Homo sapiens	Ki	uM	0.3
	15149024	CHEMBL3395759	Inhibition of human recombinant src kinase using KVEKIGEGTYGVVYK as substrate by filter binding assay in presence of [gamma-32P]ATP	B	CCCCSc1nc(Nc2cccc(O)c2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL3394084	=	Ki	nM	130.0	CHEMBL267	Homo sapiens	Ki	uM	0.13
	15149025	CHEMBL3395759	Inhibition of human recombinant src kinase using KVEKIGEGTYGVVYK as substrate by filter binding assay in presence of [gamma-32P]ATP	B	CSc1nc(Nc2cccc(O)c2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL3394083	=	Ki	nM	30.0	CHEMBL267	Homo sapiens	Ki	uM	0.03
	15149026	CHEMBL3395759	Inhibition of human recombinant src kinase using KVEKIGEGTYGVVYK as substrate by filter binding assay in presence of [gamma-32P]ATP	B	CC(Cn1ncc2c(Nc3cccc(O)c3)nc(SCCN3CCOCC3)nc21)c1ccccc1.Cl		CHEMBL3394082	=	Ki	nM	70.0	CHEMBL267	Homo sapiens	Ki	uM	0.07
	15149027	CHEMBL3395759	Inhibition of human recombinant src kinase using KVEKIGEGTYGVVYK as substrate by filter binding assay in presence of [gamma-32P]ATP	B	CC(Cn1ncc2c(Nc3cccc(Cl)c3)nc(SCCN3CCOCC3)nc21)c1ccccc1		CHEMBL3394081	=	Ki	nM	970.0	CHEMBL267	Homo sapiens	Ki	uM	0.97
	15149028	CHEMBL3395759	Inhibition of human recombinant src kinase using KVEKIGEGTYGVVYK as substrate by filter binding assay in presence of [gamma-32P]ATP	B	CC(Cn1ncc2c(Nc3cccc(F)c3)nc(SCCN3CCOCC3)nc21)c1ccccc1		CHEMBL3394080	=	Ki	nM	2340.0	CHEMBL267	Homo sapiens	Ki	uM	2.34
	15149029	CHEMBL3395759	Inhibition of human recombinant src kinase using KVEKIGEGTYGVVYK as substrate by filter binding assay in presence of [gamma-32P]ATP	B	CC(Cn1ncc2c(Nc3ccccc3)nc(SCCN3CCOCC3)nc21)c1ccccc1		CHEMBL3394079	=	Ki	nM	1440.0	CHEMBL267	Homo sapiens	Ki	uM	1.44
	15149030	CHEMBL3395759	Inhibition of human recombinant src kinase using KVEKIGEGTYGVVYK as substrate by filter binding assay in presence of [gamma-32P]ATP	B	CCSc1nc(Nc2cccc(O)c2)c2cnn(CC(C)c3ccccc3)c2n1		CHEMBL3394078	=	Ki	nM	110.0	CHEMBL267	Homo sapiens	Ki	uM	0.11
	15149031	CHEMBL3395759	Inhibition of human recombinant src kinase using KVEKIGEGTYGVVYK as substrate by filter binding assay in presence of [gamma-32P]ATP	B	CCSc1nc(Nc2cccc(Br)c2)c2cnn(CC(C)c3ccccc3)c2n1		CHEMBL3394077	=	Ki	nM	100.0	CHEMBL267	Homo sapiens	Ki	uM	0.1
	15149032	CHEMBL3395759	Inhibition of human recombinant src kinase using KVEKIGEGTYGVVYK as substrate by filter binding assay in presence of [gamma-32P]ATP	B	CCSc1nc(Nc2cccc(Cl)c2)c2cnn(CC(C)c3ccccc3)c2n1		CHEMBL3394076	=	Ki	nM	550.0	CHEMBL267	Homo sapiens	Ki	uM	0.55
	15149033	CHEMBL3395759	Inhibition of human recombinant src kinase using KVEKIGEGTYGVVYK as substrate by filter binding assay in presence of [gamma-32P]ATP	B	CCSc1nc(Nc2cccc(F)c2)c2cnn(CC(C)c3ccccc3)c2n1		CHEMBL3394075	=	Ki	nM	790.0	CHEMBL267	Homo sapiens	Ki	uM	0.79
	15149034	CHEMBL3395759	Inhibition of human recombinant src kinase using KVEKIGEGTYGVVYK as substrate by filter binding assay in presence of [gamma-32P]ATP	B	Cl.Oc1cccc(Nc2nc(SCCN3CCOCC3)nc3c2cnn3CCc2ccccc2)c1		CHEMBL3393986	=	Ki	nM	40.0	CHEMBL267	Homo sapiens	Ki	uM	0.04
	15149035	CHEMBL3395759	Inhibition of human recombinant src kinase using KVEKIGEGTYGVVYK as substrate by filter binding assay in presence of [gamma-32P]ATP	B	Clc1cccc(Nc2nc(SCCN3CCOCC3)nc3c2cnn3CCc2ccccc2)c1		CHEMBL3393985	=	Ki	nM	1200.0	CHEMBL267	Homo sapiens	Ki	uM	1.2
	15149036	CHEMBL3395759	Inhibition of human recombinant src kinase using KVEKIGEGTYGVVYK as substrate by filter binding assay in presence of [gamma-32P]ATP	B	CSc1nc(Nc2cccc(O)c2)c2cnn(CCc3ccccc3)c2n1		CHEMBL3393984	=	Ki	nM	620.0	CHEMBL267	Homo sapiens	Ki	uM	0.62
	15149037	CHEMBL3395759	Inhibition of human recombinant src kinase using KVEKIGEGTYGVVYK as substrate by filter binding assay in presence of [gamma-32P]ATP	B	CSc1nc(Nc2cccc(Br)c2)c2cnn(CCc3ccccc3)c2n1		CHEMBL3393983	=	Ki	nM	200.0	CHEMBL267	Homo sapiens	Ki	uM	0.2
	15149038	CHEMBL3395759	Inhibition of human recombinant src kinase using KVEKIGEGTYGVVYK as substrate by filter binding assay in presence of [gamma-32P]ATP	B	CSc1nc(Nc2cccc(F)c2)c2cnn(CCc3ccccc3)c2n1		CHEMBL3393982	=	Ki	nM	1060.0	CHEMBL267	Homo sapiens	Ki	uM	1.06
	15149039	CHEMBL3395759	Inhibition of human recombinant src kinase using KVEKIGEGTYGVVYK as substrate by filter binding assay in presence of [gamma-32P]ATP	B	CSc1nc(Nc2ccccc2)c2cnn(CCc3ccccc3)c2n1		CHEMBL3393981	=	Ki	nM	1460.0	CHEMBL267	Homo sapiens	Ki	uM	1.46
	15149040	CHEMBL3395759	Inhibition of human recombinant src kinase using KVEKIGEGTYGVVYK as substrate by filter binding assay in presence of [gamma-32P]ATP	B	Clc1cccc(Nc2nc(SCCN3CCOCC3)nc3c2cnn3CC(Cl)c2ccccc2)c1		CHEMBL1775036	=	Ki	nM	290.0	CHEMBL267	Homo sapiens	Ki	uM	0.29
	15149041	CHEMBL3395759	Inhibition of human recombinant src kinase using KVEKIGEGTYGVVYK as substrate by filter binding assay in presence of [gamma-32P]ATP	B	Cl[C@H](Cn1ncc2c(Nc3ccccc3)nc(SCCN3CCOCC3)nc21)c1ccccc1		CHEMBL3393980	=	Ki	nM	230.0	CHEMBL267	Homo sapiens	Ki	uM	0.23
	15149042	CHEMBL3395759	Inhibition of human recombinant src kinase using KVEKIGEGTYGVVYK as substrate by filter binding assay in presence of [gamma-32P]ATP	B	Cl[C@@H](Cn1ncc2c(Nc3ccccc3)nc(SCCN3CCOCC3)nc21)c1ccccc1		CHEMBL3393979	=	Ki	nM	200.0	CHEMBL267	Homo sapiens	Ki	uM	0.2
	15149043	CHEMBL3395759	Inhibition of human recombinant src kinase using KVEKIGEGTYGVVYK as substrate by filter binding assay in presence of [gamma-32P]ATP	B	ClC(Cn1ncc2c(Nc3ccccc3)nc(SCCN3CCOCC3)nc21)c1ccccc1		CHEMBL1775035	=	Ki	nM	240.0	CHEMBL267	Homo sapiens	Ki	uM	0.24
	15149183	CHEMBL3395776	Inhibition of c-src kinase (unknown origin)	B	ClC(Cn1ncc2c(Nc3ccccc3)nc(SCCN3CCOCC3)nc21)c1ccccc1		CHEMBL1775035	=	Ki	nM	210.0	CHEMBL267	Homo sapiens	Ki	uM	0.21
	15149953	CHEMBL3395922	Inhibition of cSRC (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2C2CC2)ccn1		CHEMBL3394102	<	Inhibition	%	50.0	CHEMBL267	Homo sapiens	INH	%	50.0
	15149954	CHEMBL3395922	Inhibition of cSRC (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2C2CCCCC2)ccn1		CHEMBL3394105	<	Inhibition	%	50.0	CHEMBL267	Homo sapiens	INH	%	50.0
	15149955	CHEMBL3395922	Inhibition of cSRC (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2CC2CCCO2)ccn1		CHEMBL3394108	<	Inhibition	%	50.0	CHEMBL267	Homo sapiens	INH	%	50.0
	15149956	CHEMBL3395922	Inhibition of cSRC (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	COC(Cn1c(SC2CCC(C(=O)O)CC2O)nc(-c2ccc(F)cc2)c1-c1ccnc(NC(C)=O)c1)OC		CHEMBL3394112	<	Inhibition	%	50.0	CHEMBL267	Homo sapiens	INH	%	50.0
	15149957	CHEMBL3395922	Inhibition of cSRC (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(Sc3cccc(I)n3)n2C2CCCCC2)ccn1		CHEMBL3394118	<	Inhibition	%	50.0	CHEMBL267	Homo sapiens	INH	%	50.0
	15151385	CHEMBL3395600	Inhibition of Src (unknown origin) at 0.1 uM	B	N#Cc1ccnc(Nc2cc(C3CCN(C4COC4)CC3)cc(N3CCC(F)(F)C3)n2)c1		CHEMBL3393333	>	Inhibition	%	80.0	CHEMBL267	Homo sapiens	INH	%	80.0
	15151389	CHEMBL3395604	Inhibition of Src_N1 (unknown origin) at 0.1 uM	B	N#Cc1ccnc(Nc2cc(C3CCN(C4COC4)CC3)cc(N3CCC(F)(F)C3)n2)c1		CHEMBL3393333	>	Inhibition	%	80.0	CHEMBL267	Homo sapiens	INH	%	80.0
	15173706	CHEMBL3405455	Inhibition of SRC (unknown origin)	B	Fc1cnc2[nH]cc(-c3ncc(F)c(N[C@H]4C5CCC(CC5)[C@@H]4c4nnn[nH]4)n3)c2c1		CHEMBL3401975	>	Ki	nM	4000.0	CHEMBL267	Homo sapiens	Ki	uM	4.0
	15173707	CHEMBL3405455	Inhibition of SRC (unknown origin)	B	O=P(O)(O)[C@H]1C2CCC(CC2)[C@@H]1Nc1nc(-c2c[nH]c3ncc(F)cc23)ncc1F		CHEMBL3401976	>	Ki	nM	4000.0	CHEMBL267	Homo sapiens	Ki	uM	4.0
	15173708	CHEMBL3405455	Inhibition of SRC (unknown origin)	B	O=P(O)(O)CC[C@H]1C2CCC(CC2)[C@@H]1Nc1nc(-c2c[nH]c3ncc(F)cc23)ncc1F		CHEMBL3401977	>	Ki	nM	4000.0	CHEMBL267	Homo sapiens	Ki	uM	4.0
	15173709	CHEMBL3405455	Inhibition of SRC (unknown origin)	B	O=c1[nH]c(=O)n(C[C@H]2C3CCC(CC3)[C@@H]2Nc2nc(-c3c[nH]c4ncc(F)cc34)ncc2F)o1		CHEMBL3401978	>	Ki	nM	4000.0	CHEMBL267	Homo sapiens	Ki	uM	4.0
	15173710	CHEMBL3405455	Inhibition of SRC (unknown origin)	B	Oc1cc([C@H]2C3CCC(CC3)[C@@H]2Nc2nc(-c3c[nH]c4ncc(F)cc34)ncc2F)no1		CHEMBL3401979	>	Ki	nM	4000.0	CHEMBL267	Homo sapiens	Ki	uM	4.0
	15173711	CHEMBL3405455	Inhibition of SRC (unknown origin)	B	CC(=O)NS(=O)(=O)[C@H]1C2CCC(CC2)[C@@H]1Nc1nc(-c2c[nH]c3ncc(F)cc23)ncc1F		CHEMBL3401980	>	Ki	nM	4000.0	CHEMBL267	Homo sapiens	Ki	uM	4.0
	15173712	CHEMBL3405455	Inhibition of SRC (unknown origin)	B	Oc1cc([C@H]2C3CCC(CC3)[C@@H]2Nc2nc(-c3c[nH]c4ncc(F)cc34)ncc2F)on1		CHEMBL3401981	>	Ki	nM	4000.0	CHEMBL267	Homo sapiens	Ki	uM	4.0
	15173713	CHEMBL3405455	Inhibition of SRC (unknown origin)	B	O=c1nc([C@H]2C3CCC(CC3)[C@@H]2Nc2nc(-c3c[nH]c4ncc(F)cc34)ncc2F)[nH]o1		CHEMBL3401982	>	Ki	nM	4000.0	CHEMBL267	Homo sapiens	Ki	uM	4.0
	15173714	CHEMBL3405455	Inhibition of SRC (unknown origin)	B	NS(=O)(=O)[C@H]1C2CCC(CC2)[C@@H]1Nc1nc(-c2c[nH]c3ncc(F)cc23)ncc1F		CHEMBL3401983	=	Ki	nM	3100.0	CHEMBL267	Homo sapiens	Ki	uM	3.1
	15173715	CHEMBL3405455	Inhibition of SRC (unknown origin)	B	OCC(O)[C@H]1C2CCC(CC2)[C@@H]1Nc1nc(-c2c[nH]c3ncc(F)cc23)ncc1F		CHEMBL3401984	=	Ki	nM	3500.0	CHEMBL267	Homo sapiens	Ki	uM	3.5
	15173716	CHEMBL3405455	Inhibition of SRC (unknown origin)	B	Oc1cc([C@H]2C3CCC(CC3)[C@@H]2Nc2nc(-c3c[nH]c4ncc(F)cc34)ncc2F)[nH]n1		CHEMBL3401985	>	Ki	nM	4000.0	CHEMBL267	Homo sapiens	Ki	uM	4.0
	15173717	CHEMBL3405455	Inhibition of SRC (unknown origin)	B	CNC(=O)[C@H]1C2CCC(CC2)[C@@H]1Nc1nc(-c2c[nH]c3ncc(F)cc23)ncc1F		CHEMBL3401986	=	Ki	nM	2500.0	CHEMBL267	Homo sapiens	Ki	uM	2.5
	15173718	CHEMBL3405455	Inhibition of SRC (unknown origin)	B	CC(O)[C@H]1C2CCC(CC2)[C@@H]1Nc1nc(-c2c[nH]c3ncc(F)cc23)ncc1F		CHEMBL3401987	=	Ki	nM	970.0	CHEMBL267	Homo sapiens	Ki	uM	0.97
	15173719	CHEMBL3405455	Inhibition of SRC (unknown origin)	B	Cc1noc([C@H]2C3CCC(CC3)[C@@H]2Nc2nc(-c3c[nH]c4ncc(F)cc34)ncc2F)n1		CHEMBL3401988	=	Ki	nM	2400.0	CHEMBL267	Homo sapiens	Ki	uM	2.4
	15173720	CHEMBL3405455	Inhibition of SRC (unknown origin)	B	Cc1nnc([C@H]2C3CCC(CC3)[C@@H]2Nc2nc(-c3c[nH]c4ncc(F)cc34)ncc2F)o1		CHEMBL3401989	>	Ki	nM	4000.0	CHEMBL267	Homo sapiens	Ki	uM	4.0
	15173721	CHEMBL3405455	Inhibition of SRC (unknown origin)	B	CS(=O)(=O)[C@H]1C2CCC(CC2)[C@@H]1Nc1nc(-c2c[nH]c3ncc(F)cc23)ncc1F		CHEMBL3401990	=	Ki	nM	3100.0	CHEMBL267	Homo sapiens	Ki	uM	3.1
	15192435	CHEMBL3413728	Inhibition of SRC (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1NC(=S)Nc1ccccc1		CHEMBL3408381	=	Inhibition	%	9.0	CHEMBL267	Homo sapiens	INH	%	9.0
	15192436	CHEMBL3413728	Inhibition of SRC (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=c1\sc(-c2ccccc2)nn1-c1ccccc1		CHEMBL3408382	=	Inhibition	%	5.0	CHEMBL267	Homo sapiens	INH	%	5.0
	15192437	CHEMBL3413728	Inhibition of SRC (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CC(=O)c1nn(-c2ccccc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1		CHEMBL3408383	=	Inhibition	%	27.0	CHEMBL267	Homo sapiens	INH	%	27.0
	15192438	CHEMBL3413728	Inhibition of SRC (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CC(=O)c1nn(-c2ccc(C)cc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1		CHEMBL3408384	=	Inhibition	%	14.0	CHEMBL267	Homo sapiens	INH	%	14.0
	15192439	CHEMBL3413728	Inhibition of SRC (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	COc1ccc(-n2nc(C(C)=O)s/c2=N\c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)cc1		CHEMBL3408385	=	Inhibition	%	25.0	CHEMBL267	Homo sapiens	INH	%	25.0
	15192440	CHEMBL3413728	Inhibition of SRC (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CC(=O)c1nn(-c2ccc(Cl)cc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1		CHEMBL3408386	=	Inhibition	%	37.0	CHEMBL267	Homo sapiens	INH	%	37.0
	15192441	CHEMBL3413728	Inhibition of SRC (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CCOC(=O)c1nn(-c2ccccc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1		CHEMBL3408387	=	Inhibition	%	57.0	CHEMBL267	Homo sapiens	INH	%	57.0
	15192442	CHEMBL3413728	Inhibition of SRC (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CCOC(=O)c1nn(-c2ccc(C)cc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1		CHEMBL3408388	=	Inhibition	%	80.0	CHEMBL267	Homo sapiens	INH	%	80.0
	15192443	CHEMBL3413728	Inhibition of SRC (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CCOC(=O)c1nn(-c2ccc(Cl)cc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1		CHEMBL3408389	=	Inhibition	%	98.0	CHEMBL267	Homo sapiens	INH	%	98.0
	15192444	CHEMBL3413728	Inhibition of SRC (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=c1\sc(C(=O)Nc2ccccc2)nn1-c1ccccc1		CHEMBL3408390	=	Inhibition	%	65.0	CHEMBL267	Homo sapiens	INH	%	65.0
	15192445	CHEMBL3413728	Inhibition of SRC (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=C1\SCC(=O)N1c1ccccc1		CHEMBL3408391	=	Inhibition	%	6.0	CHEMBL267	Homo sapiens	INH	%	6.0
	15192446	CHEMBL3413728	Inhibition of SRC (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=c1\scc(-c2ccccc2)n1-c1ccccc1		CHEMBL3408392	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	15192447	CHEMBL3413728	Inhibition of SRC (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=C1\S/C(=C2\SC(c3ccccc3)=NN2c2ccccc2)C(=O)N1c1ccccc1		CHEMBL3408393	=	Inhibition	%	5.0	CHEMBL267	Homo sapiens	INH	%	5.0
	15192448	CHEMBL3413728	Inhibition of SRC (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CC(=O)C1=NN(c2ccccc2)/C(=C2/S/C(=N\c3nc(-c4ccccc4)cc(-c4ccccc4)c3C#N)N(c3ccccc3)C2=O)S1		CHEMBL3408394	=	Inhibition	%	4.0	CHEMBL267	Homo sapiens	INH	%	4.0
	15192449	CHEMBL3413728	Inhibition of SRC (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CCOC(=O)C1=NN(c2ccccc2)/C(=C2/S/C(=N\c3nc(-c4ccccc4)cc(-c4ccccc4)c3C#N)N(c3ccccc3)C2=O)S1		CHEMBL3408395	=	Inhibition	%	4.0	CHEMBL267	Homo sapiens	INH	%	4.0
	15192450	CHEMBL3413728	Inhibition of SRC (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=C1\S/C(=C2\SC(C(=O)Nc3ccccc3)=NN2c2ccccc2)C(=O)N1c1ccccc1		CHEMBL3408396	=	Inhibition	%	4.0	CHEMBL267	Homo sapiens	INH	%	4.0
Not Active	15245017	CHEMBL3427997	Binding affinity to c-Src in human MCF7 cells by SDS-PAGE based pull-down assay	B	NC(=O)CC[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](CCCCNC(=O)CCCC[C@@H]2SC[C@@H]3NC(=O)N[C@H]23)NC(=O)CCCCCn2cc(nn2)C[C@H](C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]2CCCN2C(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2ccc(C(F)(F)P(=O)(O)O)cc2)NC1=O		CHEMBL3427584		Activity			CHEMBL267	Homo sapiens	Activity		
Not Active	15245018	CHEMBL3427997	Binding affinity to c-Src in human MCF7 cells by SDS-PAGE based pull-down assay	B	NC(=O)CC[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](CCCCNC(=O)CCCC[C@@H]2SC[C@@H]3NC(=O)N[C@H]23)n2cc(nn2)C[C@H](C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]2CCCN2C(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O		CHEMBL3427634		Activity			CHEMBL267	Homo sapiens	Activity		
Not Active	15245019	CHEMBL3427997	Binding affinity to c-Src in human MCF7 cells by SDS-PAGE based pull-down assay	B	CC(=O)N[C@@H](CCCCNC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@H]12)C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(N)=O		CHEMBL3427636		Activity			CHEMBL267	Homo sapiens	Activity		
	15250014	CHEMBL3428989	Inhibition of human c-Src using poly[Glu:Tyr] (4:1) peptide substrate at 1 uM by 33P Hotspot assay	B	CN1CCN(c2ccc(Nc3ncc(Cl)c(NC[C@H]4CCCO4)n3)cc2)CC1		CHEMBL3426891	=	Inhibition	%	71.3	CHEMBL267	Homo sapiens	INH	%	71.3
	15250054	CHEMBL3429152	Inhibition of human c-Src using poly[Glu:Tyr] (4:1) peptide substrate by 33P Hotspot assay	B	CN1CCN(c2ccc(Nc3ncc(Cl)c(NC[C@H]4CCCO4)n3)cc2)CC1		CHEMBL3426891	=	IC50	nM	438.0	CHEMBL267	Homo sapiens	IC50	nM	438.0
	15251805	CHEMBL3428742	Inhibition of Src (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL443738	=	Activity	%	99.0	CHEMBL267	Homo sapiens	Activity	%	99.0
	15251992	CHEMBL3428742	Inhibition of Src (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427170	=	Activity	%	182.0	CHEMBL267	Homo sapiens	Activity	%	182.0
	15252637	CHEMBL3428742	Inhibition of Src (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427171	=	Activity	%	83.0	CHEMBL267	Homo sapiens	Activity	%	83.0
	15252739	CHEMBL3428742	Inhibition of Src (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427172	=	Activity	%	102.0	CHEMBL267	Homo sapiens	Activity	%	102.0
	15252841	CHEMBL3428742	Inhibition of Src (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@@H](C(=O)O)CS3)sc2c1		CHEMBL3427173	=	Activity	%	88.0	CHEMBL267	Homo sapiens	Activity	%	88.0
	15253515	CHEMBL3428742	Inhibition of Src (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@H](C(=O)O)CS3)sc2c1		CHEMBL3427174	=	Activity	%	96.0	CHEMBL267	Homo sapiens	Activity	%	96.0
	15253617	CHEMBL3428742	Inhibition of Src (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@H]1CSC(c2nc3ccc(OC)cc3s2)=N1		CHEMBL3427175	=	Activity	%	89.0	CHEMBL267	Homo sapiens	Activity	%	89.0
	15253719	CHEMBL3428742	Inhibition of Src (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@@H]1CSC(c2nc3ccc(OC)cc3s2)=N1		CHEMBL3427176	=	Activity	%	87.0	CHEMBL267	Homo sapiens	Activity	%	87.0
	15253826	CHEMBL3429868	Inhibition of human Src T341M mutant	B	CCn1nc(C#Cc2cc(C(=O)Nc3ccc(CN4CCN(C)CC4)c(C(F)(F)F)c3)ccc2C)c2c(N)ncnc21		CHEMBL3426225	=	IC50	nM	30.0	CHEMBL267	Homo sapiens	IC50	uM	0.03
	15253884	CHEMBL3429862	Inhibition of human Src	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	IC50	nM	3.0	CHEMBL267	Homo sapiens	IC50	uM	0.003
	15253885	CHEMBL3429862	Inhibition of human Src	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	IC50	nM	0.3	CHEMBL267	Homo sapiens	IC50	uM	0.0003
	15253886	CHEMBL3429862	Inhibition of human Src	B	C=CC(=O)N1CCC(n2nc(C#Cc3cc(C(=O)Nc4ccc(CN5CCN(C)CC5)c(C(F)(F)F)c4)ccc3C)c3c(N)ncnc32)CC1		CHEMBL3426233	=	IC50	nM	15.0	CHEMBL267	Homo sapiens	IC50	uM	0.015
	15253887	CHEMBL3429862	Inhibition of human Src	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1nn(C2CCNCC2)c2ncnc(N)c12		CHEMBL3426232	=	IC50	nM	12.0	CHEMBL267	Homo sapiens	IC50	uM	0.012
Not Determined	15253888	CHEMBL3429862	Inhibition of human Src	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1nn(C2CCN(C(=O)OC(C)(C)C)CC2)c2ncnc(N)c12		CHEMBL3426231		IC50			CHEMBL267	Homo sapiens	IC50		
	15253889	CHEMBL3429862	Inhibition of human Src	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1nn([C@@H]2CCOC2)c2ncnc(N)c12		CHEMBL3426230	=	IC50	nM	7.0	CHEMBL267	Homo sapiens	IC50	uM	0.007
	15253890	CHEMBL3429862	Inhibition of human Src	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1nn([C@H]2CCOC2)c2ncnc(N)c12		CHEMBL3426229	=	IC50	nM	7.0	CHEMBL267	Homo sapiens	IC50	uM	0.007
	15253891	CHEMBL3429862	Inhibition of human Src	B	COCn1nc(C#Cc2cc(C(=O)Nc3ccc(CN4CCN(C)CC4)c(C(F)(F)F)c3)ccc2C)c2c(N)ncnc21		CHEMBL3426228	=	IC50	nM	8.0	CHEMBL267	Homo sapiens	IC50	uM	0.008
	15253892	CHEMBL3429862	Inhibition of human Src	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1nn(C2CCCC2)c2ncnc(N)c12		CHEMBL3426227	=	IC50	nM	19.0	CHEMBL267	Homo sapiens	IC50	uM	0.019
	15253893	CHEMBL3429862	Inhibition of human Src	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1nn(C2CCC2)c2ncnc(N)c12		CHEMBL3426226	=	IC50	nM	9.0	CHEMBL267	Homo sapiens	IC50	uM	0.009
	15253894	CHEMBL3429862	Inhibition of human Src	B	CCn1nc(C#Cc2cc(C(=O)Nc3ccc(CN4CCN(C)CC4)c(C(F)(F)F)c3)ccc2C)c2c(N)ncnc21		CHEMBL3426225	=	IC50	nM	0.9	CHEMBL267	Homo sapiens	IC50	uM	0.0009
	15253895	CHEMBL3429862	Inhibition of human Src	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1nn(C)c2ncnc(N)c12		CHEMBL3426224	=	IC50	nM	7.0	CHEMBL267	Homo sapiens	IC50	uM	0.007
	15253896	CHEMBL3429862	Inhibition of human Src	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(CCO)CC3)c(C(F)(F)F)c2)cc1C#Cc1nn(C(C)C)c2ncnc(N)c12		CHEMBL3426223	=	IC50	nM	4.0	CHEMBL267	Homo sapiens	IC50	uM	0.004
	15253897	CHEMBL3429862	Inhibition of human Src	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4nn(C(C)C)c5ncnc(N)c45)c3)cc2C(F)(F)F)CC1		CHEMBL3426222	=	IC50	nM	2.0	CHEMBL267	Homo sapiens	IC50	uM	0.002
	15253898	CHEMBL3429862	Inhibition of human Src	B	Cc1ccc(C(=O)Nc2ccc(CN3CCOCC3)c(C(F)(F)F)c2)cc1C#Cc1nn(C(C)C)c2ncnc(N)c12		CHEMBL3426221	=	IC50	nM	21.0	CHEMBL267	Homo sapiens	IC50	uM	0.021
	15253899	CHEMBL3429862	Inhibition of human Src	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1C#Cc1nn(C(C)C)c2ncnc(N)c12		CHEMBL3426220	=	IC50	nM	3.0	CHEMBL267	Homo sapiens	IC50	uM	0.003
	15253900	CHEMBL3429862	Inhibition of human Src	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(Br)c2)cc1C#Cc1nn(C(C)C)c2ncnc(N)c12		CHEMBL3425518	=	IC50	nM	1.0	CHEMBL267	Homo sapiens	IC50	uM	0.001
	15253901	CHEMBL3429862	Inhibition of human Src	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(Cl)c2)cc1C#Cc1nn(C(C)C)c2ncnc(N)c12		CHEMBL3426219	=	IC50	nM	2.0	CHEMBL267	Homo sapiens	IC50	uM	0.002
	15253902	CHEMBL3429862	Inhibition of human Src	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)cc2)cc1C#Cc1nn(C(C)C)c2ncnc(N)c12		CHEMBL3426218	=	IC50	nM	4.0	CHEMBL267	Homo sapiens	IC50	uM	0.004
	15253903	CHEMBL3429862	Inhibition of human Src	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1nn(C(C)C)c2ncnc(N)c12		CHEMBL3426217	=	IC50	nM	2.0	CHEMBL267	Homo sapiens	IC50	uM	0.002
	15253904	CHEMBL3429862	Inhibition of human Src	B	CCn1nc(C#Cc2cc(C(=O)Nc3ccc(CN4CCN(C)CC4)c(C(F)(F)F)c3)ccc2O)c2c(N)ncnc21		CHEMBL3426240	=	IC50	nM	3191.0	CHEMBL267	Homo sapiens	IC50	uM	3.191
	15253905	CHEMBL3429862	Inhibition of human Src	B	CCn1nc(C#Cc2cc(C(=O)Nc3ccc(CN4CCN(C)CC4)c(C(F)(F)F)c3)ccc2OC)c2c(N)ncnc21		CHEMBL3426239	=	IC50	nM	59.0	CHEMBL267	Homo sapiens	IC50	uM	0.059
Not Determined	15253906	CHEMBL3429862	Inhibition of human Src	B	CCn1nc(C#Cc2cc(C(=O)Nc3ccc(CN4CCN(C)CC4)c(C(F)(F)F)c3)ccc2F)c2c(N)ncnc21		CHEMBL3426238		IC50			CHEMBL267	Homo sapiens	IC50		
	15253907	CHEMBL3429862	Inhibition of human Src	B	CCn1nc(C#Cc2cc(C(=O)Nc3ccc(CN4CCN(C)CC4)c(C(F)(F)F)c3)ccc2C(C)C)c2c(N)ncnc21		CHEMBL3426237	=	IC50	nM	1409.0	CHEMBL267	Homo sapiens	IC50	uM	1.409
	15253908	CHEMBL3429862	Inhibition of human Src	B	CCc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1nn(CC)c2ncnc(N)c12		CHEMBL3426236	=	IC50	nM	83.0	CHEMBL267	Homo sapiens	IC50	uM	0.083
	15253909	CHEMBL3429862	Inhibition of human Src	B	CCn1nc(C#Cc2cc(C(=O)Nc3ccc(CN4CCN(C)CC4)c(C(F)(F)F)c3)ccc2Cl)c2c(N)ncnc21		CHEMBL3426235	=	IC50	nM	11.0	CHEMBL267	Homo sapiens	IC50	uM	0.011
	15253910	CHEMBL3429862	Inhibition of human Src	B	CCn1nc(C#Cc2cccc(C(=O)Nc3ccc(CN4CCN(C)CC4)c(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3426234	=	IC50	nM	5.0	CHEMBL267	Homo sapiens	IC50	uM	0.005
Dose-dependent effect	15253947	CHEMBL3428253	Inhibition of Src phosphorylation in human MDA-MB-231 cells after 20 hrs by Western blot analysis	B	CCn1nc(C#Cc2cc(C(=O)Nc3ccc(CN4CCN(C)CC4)c(C(F)(F)F)c3)ccc2C)c2c(N)ncnc21		CHEMBL3426225		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	15253948	CHEMBL3428253	Inhibition of Src phosphorylation in human MDA-MB-231 cells after 20 hrs by Western blot analysis	B	CCn1nc(C#Cc2cc(C(=O)Nc3ccc(CN4CCN(C)CC4)c(C(F)(F)F)c3)ccc2C)c2c(N)ncnc21		CHEMBL3426225	=	IC50	nM	30.0	CHEMBL267	Homo sapiens	IC50	uM	0.03
Active	15253949	CHEMBL3428254	Inhibition of Src in human MDA-MB-231 cells assessed as reduction of FAK phosphorylation at >0.03 uM after 20 hrs by Western blot analysis	B	CCn1nc(C#Cc2cc(C(=O)Nc3ccc(CN4CCN(C)CC4)c(C(F)(F)F)c3)ccc2C)c2c(N)ncnc21		CHEMBL3426225		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Active	15253950	CHEMBL3428254	Inhibition of Src in human MDA-MB-231 cells assessed as reduction of FAK phosphorylation at >0.03 uM after 20 hrs by Western blot analysis	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Active	15253956	CHEMBL3428258	Inhibition of Src phosphorylation in human MDA-MB-231 cells at 0.001 to 1 uM after 20 hrs by Western blot analysis	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	15254385	CHEMBL3428742	Inhibition of Src (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@@H](C(=O)O)C(C)(C)S3)sc2c1		CHEMBL3427177	=	Activity	%	109.0	CHEMBL267	Homo sapiens	Activity	%	109.0
	15254487	CHEMBL3428742	Inhibition of Src (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@H](C(=O)O)C(C)(C)S3)sc2c1		CHEMBL3427178	=	Activity	%	118.0	CHEMBL267	Homo sapiens	Activity	%	118.0
	15254589	CHEMBL3428742	Inhibition of Src (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@H]1C(=O)O		CHEMBL3427179	=	Activity	%	87.0	CHEMBL267	Homo sapiens	Activity	%	87.0
	15255279	CHEMBL3428742	Inhibition of Src (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@@H]1C(=O)O		CHEMBL3427180	=	Activity	%	90.0	CHEMBL267	Homo sapiens	Activity	%	90.0
	15255382	CHEMBL3428742	Inhibition of Src (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2ccc3cc(O)ccc3n2)=N1		CHEMBL3427181	=	Activity	%	115.0	CHEMBL267	Homo sapiens	Activity	%	115.0
	15255484	CHEMBL3428742	Inhibition of Src (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2ccc3cc(O)ccc3n2)=N1		CHEMBL3427182	=	Activity	%	95.0	CHEMBL267	Homo sapiens	Activity	%	95.0
	15256216	CHEMBL3428742	Inhibition of Src (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2ccc3cccc(O)c3n2)=N1		CHEMBL3427183	=	Activity	%	101.0	CHEMBL267	Homo sapiens	Activity	%	101.0
	15256318	CHEMBL3428742	Inhibition of Src (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2ccc3cccc(O)c3n2)=N1		CHEMBL3427184	=	Activity	%	73.0	CHEMBL267	Homo sapiens	Activity	%	73.0
Not Active	15257661	CHEMBL3430222	Induction of covalent modification of c-Src kinase domain (251 to 533 residues) T338M/S345C mutant (unknown origin) at 100 uM incubated for 1 hr by mass spectrometry method	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Oc2cccc(NC(=O)/C=C/C3CC3)c2)n1		CHEMBL3425672		Activity			CHEMBL267	Homo sapiens	Activity		
Not Active	15257662	CHEMBL3430222	Induction of covalent modification of c-Src kinase domain (251 to 533 residues) T338M/S345C mutant (unknown origin) at 100 uM incubated for 1 hr by mass spectrometry method	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Oc2cccc(NC(=O)CCC3CC3)c2)n1		CHEMBL3425673		Activity			CHEMBL267	Homo sapiens	Activity		
Active	15257663	CHEMBL3430223	Induction of covalent modification of wild type c-Src kinase domain (251 to 533 residues) (unknown origin) at 100 uM incubated for 1 hr by mass spectrometry method	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Oc2cccc(NC(=O)/C(C#N)=C/C3CC3)c2)n1		CHEMBL3425664		Activity			CHEMBL267	Homo sapiens	Activity		
Not Active	15257664	CHEMBL3430223	Induction of covalent modification of wild type c-Src kinase domain (251 to 533 residues) (unknown origin) at 100 uM incubated for 1 hr by mass spectrometry method	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Oc2cccc(NC(=O)CCC3CC3)c2)n1		CHEMBL3425673		Activity			CHEMBL267	Homo sapiens	Activity		
	15257665	CHEMBL3430224	Induction of covalent modification of c-Src kinase domain (251 to 533 residues) T338M/S345C mutant (unknown origin) assessed as protein mass increase at 100 uM incubated for 1 hr by mass spectrometry method	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Oc2cccc(NC(=O)/C(C#N)=C/C3CC3)c2)n1		CHEMBL3425664	=	Activity	Da	560.0	CHEMBL267	Homo sapiens	Activity	Da	560.0
	15257666	CHEMBL3430224	Induction of covalent modification of c-Src kinase domain (251 to 533 residues) T338M/S345C mutant (unknown origin) assessed as protein mass increase at 100 uM incubated for 1 hr by mass spectrometry method	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Oc2cccc(NC(=O)/C=C/C3CC3)c2)n1		CHEMBL3425672	=	Activity	Da	537.0	CHEMBL267	Homo sapiens	Activity	Da	537.0
	15600502	CHEMBL3580030	Inhibition of human cSRC assessed as residual activity at 10 uM relative to control	B	Nc1ncnc2c1c(-c1ccc(Cl)cc1)nn2CC(Cl)c1ccccc1		CHEMBL3578214	=	Activity	%	17.0	CHEMBL267	Homo sapiens	Activity	%	17.0
	15605131	CHEMBL3578905	Competitive binding affinity to SRC in human A375 cells after 15 mins in presence of ATP analogue	B	CNc1ncc2cc(-c3cc(NC(=O)NCCC(C)(C)C)c(F)cc3C)c(C)nc2n1		CHEMBL3577124	=	IC50	nM	310.0	CHEMBL267	Homo sapiens	IC50	nM	310.0
	15609947	CHEMBL3580047	Inhibition of human Src T341M mutant assessed as residual activity at 10 uM relative to control	B	Nc1ncnc2c1c(-c1ccc(Cl)cc1)nn2CC(Cl)c1ccccc1		CHEMBL3578214	=	Activity	%	98.0	CHEMBL267	Homo sapiens	Activity	%	98.0
	15609948	CHEMBL3580046	Inhibition of human Src (1-530) assessed as residual activity at 10 uM relative to control	B	Nc1ncnc2c1c(-c1ccc(Cl)cc1)nn2CC(Cl)c1ccccc1		CHEMBL3578214	=	Activity	%	2.0	CHEMBL267	Homo sapiens	Activity	%	2.0
	15616206	CHEMBL3583142	Inhibition of Tel-fused SRC (unknown origin) expressed in mouse BA/F3 cells after 48 hrs by luciferase reporter gene assay in absence of recombinant mouse IL3	B	OC1CCN(c2cc(-c3cnc4ccc(N5CCC[C@@H]5c5cccc(F)c5)nn34)ccn2)CC1		CHEMBL3582442	=	IC50	nM	4600.0	CHEMBL267	Homo sapiens	IC50	uM	4.6
	15616207	CHEMBL3583142	Inhibition of Tel-fused SRC (unknown origin) expressed in mouse BA/F3 cells after 48 hrs by luciferase reporter gene assay in absence of recombinant mouse IL3	B	O=C(O)CN1CCN(c2cc(-c3cnc4ccc(N5CCC[C@@H]5c5cccc(F)c5)nn34)ccn2)CC1		CHEMBL3582441	=	IC50	nM	2500.0	CHEMBL267	Homo sapiens	IC50	uM	2.5
	15616208	CHEMBL3583142	Inhibition of Tel-fused SRC (unknown origin) expressed in mouse BA/F3 cells after 48 hrs by luciferase reporter gene assay in absence of recombinant mouse IL3	B	N#Cc1ccc(-c2cnc3ccc(NCc4ccccc4)nn23)cc1		CHEMBL3582427	=	IC50	nM	4600.0	CHEMBL267	Homo sapiens	IC50	uM	4.6
	15620911	CHEMBL3585224	Inhibition of human his-tagged full length Src active enzyme using KVEKIGEGTYGVVYK substrate by scintillation counting analysis	B	Cc1cc(OCc2ccc(F)cc2F)cc(=O)n1Cc1ccc(C(F)(F)F)cc1	Non standard unit for type	CHEMBL3581151	=	ID50	uM	40.0	CHEMBL267	Homo sapiens	ID50	uM	40.0
	15620912	CHEMBL3585224	Inhibition of human his-tagged full length Src active enzyme using KVEKIGEGTYGVVYK substrate by scintillation counting analysis	B	COc1ccc2c(Nc3ccc(Cl)cc3Cl)c(C#N)cnc2c1	Non standard unit for type	CHEMBL167033	=	ID50	uM	0.2	CHEMBL267	Homo sapiens	ID50	uM	0.2
	15620913	CHEMBL3585224	Inhibition of human his-tagged full length Src active enzyme using KVEKIGEGTYGVVYK substrate by scintillation counting analysis	B	COc1cc2ncc(C#N)c(Nc3ccc(Cl)cc3Cl)c2cc1OC	Non standard unit for type	CHEMBL101917	=	ID50	uM	0.03	CHEMBL267	Homo sapiens	ID50	uM	0.03
	15620914	CHEMBL3585224	Inhibition of human his-tagged full length Src active enzyme using KVEKIGEGTYGVVYK substrate by scintillation counting analysis	B	NS(=O)(=O)c1ccc(Nc2nc(N3CCN(CCO)CC3)nc3[nH]cnc23)cc1	Non standard unit for type	CHEMBL1173298	=	ID50	uM	7.4	CHEMBL267	Homo sapiens	ID50	uM	7.4
	15620915	CHEMBL3585224	Inhibition of human his-tagged full length Src active enzyme using KVEKIGEGTYGVVYK substrate by scintillation counting analysis	B	OCCN1CCN(c2nc(Nc3ccccc3)c3nc[nH]c3n2)CC1	Non standard unit for type	CHEMBL1173660	=	ID50	uM	4.2	CHEMBL267	Homo sapiens	ID50	uM	4.2
	15620916	CHEMBL3585224	Inhibition of human his-tagged full length Src active enzyme using KVEKIGEGTYGVVYK substrate by scintillation counting analysis	B	NS(=O)(=O)c1ccc(Nc2nc(N3CCOCC3)nc3[nH]cnc23)cc1	Non standard unit for type	CHEMBL1172957	=	ID50	uM	0.9	CHEMBL267	Homo sapiens	ID50	uM	0.9
	15620917	CHEMBL3585224	Inhibition of human his-tagged full length Src active enzyme using KVEKIGEGTYGVVYK substrate by scintillation counting analysis	B	Oc1cccc(Nc2nc(NCc3ccccc3)nc3[nH]cnc23)c1	Non standard unit for type	CHEMBL3581162	=	ID50	uM	3.7	CHEMBL267	Homo sapiens	ID50	uM	3.7
	15620918	CHEMBL3585224	Inhibition of human his-tagged full length Src active enzyme using KVEKIGEGTYGVVYK substrate by scintillation counting analysis	B	CC(C)CCNc1nc(Nc2cccc(O)c2)c2nc[nH]c2n1	Non standard unit for type	CHEMBL3581163	=	ID50	uM	1.7	CHEMBL267	Homo sapiens	ID50	uM	1.7
	15620919	CHEMBL3585224	Inhibition of human his-tagged full length Src active enzyme using KVEKIGEGTYGVVYK substrate by scintillation counting analysis	B	Oc1cccc(Nc2nc(NCCc3c[nH]cn3)nc3[nH]cnc23)c1	Non standard unit for type	CHEMBL3581165	=	ID50	uM	1.1	CHEMBL267	Homo sapiens	ID50	uM	1.1
	15620920	CHEMBL3585224	Inhibition of human his-tagged full length Src active enzyme using KVEKIGEGTYGVVYK substrate by scintillation counting analysis	B	OCCNc1nc(Nc2cccc(O)c2)c2nc[nH]c2n1	Non standard unit for type	CHEMBL3581166	=	ID50	uM	2.6	CHEMBL267	Homo sapiens	ID50	uM	2.6
Not Active	15620921	CHEMBL3585225	Inhibition of human his-tagged full length Src active enzyme using KVEKIGEGTYGVVYK substrate at 100 uM by scintillation counting analysis	B	COc1ccc(Cn2c(C)cc(OCc3cccc(F)c3)cc2=O)cc1		CHEMBL3581152		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	15620922	CHEMBL3585225	Inhibition of human his-tagged full length Src active enzyme using KVEKIGEGTYGVVYK substrate at 100 uM by scintillation counting analysis	B	Cc1cc(OCc2ccc(F)cc2F)cc(=O)n1Cc1cn(Cc2cccc(C(F)(F)F)c2)nn1		CHEMBL3581157		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	15620957	CHEMBL3585225	Inhibition of human his-tagged full length Src active enzyme using KVEKIGEGTYGVVYK substrate at 100 uM by scintillation counting analysis	B	COc1ccc2c(Nc3ccc(N4CCN(C)CC4)cc3)c(C#N)cnc2c1		CHEMBL3581158		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	15620958	CHEMBL3585225	Inhibition of human his-tagged full length Src active enzyme using KVEKIGEGTYGVVYK substrate at 100 uM by scintillation counting analysis	B	CNc1nc(Nc2cccc(O)c2)c2nc[nH]c2n1	Non standard unit for type	CHEMBL3581164	=	ID50	uM	4.9	CHEMBL267	Homo sapiens	ID50	uM	4.9
	15622556	CHEMBL3588273	Inhibition of human recombinant Src at 1 uM	B	Cc1cc2cn[nH]c2cc1-c1cccc2c(N)c(C(N)=O)nnc12		CHEMBL3586447	=	Inhibition	%	87.0	CHEMBL267	Homo sapiens	INH	%	87.0
	15622570	CHEMBL3588353	Inhibition of human recombinant Src	B	Cc1cc2cn[nH]c2cc1-c1cccc2c(N)c(C(N)=O)nnc12		CHEMBL3586447	=	IC50	nM	67.0	CHEMBL267	Homo sapiens	IC50	nM	67.0
	15627189	CHEMBL3587040	Inhibition of SRC (unknown origin) using ATP and polyE4Y substrate by radiometric assay	B	COc1cc(N2CCc3nc(NC(=O)NCCc4cn(CC(F)F)cn4)sc3C2)cnc1Cl		CHEMBL3585362	>	Ki	nM	4000.0	CHEMBL267	Homo sapiens	Ki	uM	4.0
	15627190	CHEMBL3587040	Inhibition of SRC (unknown origin) using ATP and polyE4Y substrate by radiometric assay	B	COc1cncc(N2CCc3nc(NC(=O)NCCc4cn(CC(F)F)cn4)sc3C2)n1		CHEMBL3586678	>	Ki	nM	4000.0	CHEMBL267	Homo sapiens	Ki	uM	4.0
	15650021	CHEMBL3595201	Inhibition of human SRC at 0.1 uM relative to control	B	CCc1cc(NC(=O)Nc2ccc(-c3cnc(Nc4cc(N5CCN(CC)CC5)nc(C)n4)s3)cc2)no1		CHEMBL3593290	=	Inhibition	%	93.0	CHEMBL267	Homo sapiens	INH	%	93.0
	15651991	CHEMBL3595438	Inhibition of recombinant human Src at 1 uM relative to control	B	C[C@H]1CN(C)C(=O)[C@@H]1c1cc(Nc2ccnc(N(C)C[C@H]3CC[C@H](N)CC3)n2)n[nH]1		CHEMBL3594181	<	Inhibition	%	75.0	CHEMBL267	Homo sapiens	INH	%	75.0
	15656305	CHEMBL3598819	Inhibition of SRC (unknown origin) at 0.1 uM	B	CN1CCc2cc(-c3cnc4[nH]cc(C(=O)c5ccccc5Cl)c4c3)ccc2C1		CHEMBL3597011	>	Inhibition	%	95.0	CHEMBL267	Homo sapiens	INH	%	95.0
	15685214	CHEMBL3606408	Inhibition of wild type cSrc (251 to 533 residues) (unknown origin) pre-incubated for 30 mins before substrate and ATP addition by HTRF assay	B	C=CC(=O)Nc1ccc2c(Nc3cc[nH]n3)nc(-c3ccccc3)nc2c1		CHEMBL1232944	=	IC50	nM	211.0	CHEMBL267	Homo sapiens	IC50	uM	0.211
	15685215	CHEMBL3606408	Inhibition of wild type cSrc (251 to 533 residues) (unknown origin) pre-incubated for 30 mins before substrate and ATP addition by HTRF assay	B	CCC(=O)Nc1ccc2c(Nc3cc[nH]n3)nc(-c3ccccc3)nc2c1		CHEMBL3604910	=	IC50	nM	336.0	CHEMBL267	Homo sapiens	IC50	uM	0.336
	15685216	CHEMBL3606409	Inhibition of cSrc T338M mutant (unknown origin) pre-incubated for 30 mins before substrate and ATP addition by HTRF assay	B	C=CC(=O)Nc1ccc2c(Nc3cc[nH]n3)nc(-c3ccccc3)nc2c1		CHEMBL1232944	=	IC50	nM	65.0	CHEMBL267	Homo sapiens	IC50	uM	0.065
	15685217	CHEMBL3606409	Inhibition of cSrc T338M mutant (unknown origin) pre-incubated for 30 mins before substrate and ATP addition by HTRF assay	B	CCC(=O)Nc1ccc2c(Nc3cc[nH]n3)nc(-c3ccccc3)nc2c1		CHEMBL3604910	=	IC50	nM	60.0	CHEMBL267	Homo sapiens	IC50	uM	0.06
	15685218	CHEMBL3606409	Inhibition of cSrc T338M mutant (unknown origin) pre-incubated for 30 mins before substrate and ATP addition by HTRF assay	B	C=CC(=O)Nc1cccc(Oc2nc(Nc3cc(C)[nH]n3)cc(N3CCN(C)CC3)n2)c1		CHEMBL3604921	=	IC50	nM	170.0	CHEMBL267	Homo sapiens	IC50	uM	0.17
	15685219	CHEMBL3606409	Inhibition of cSrc T338M mutant (unknown origin) pre-incubated for 30 mins before substrate and ATP addition by HTRF assay	B	CCC(=O)Nc1cccc(Oc2nc(Nc3cc(C)[nH]n3)cc(N3CCN(C)CC3)n2)c1		CHEMBL3604924	=	IC50	nM	254.0	CHEMBL267	Homo sapiens	IC50	uM	0.254
	15685220	CHEMBL3606410	Inhibition of cSrc T338M/S345C mutant (unknown origin) pre-incubated for 30 mins before substrate and ATP addition by HTRF assay	B	C=CC(=O)Nc1ccc2c(Nc3cc[nH]n3)nc(-c3ccccc3)nc2c1		CHEMBL1232944	=	IC50	nM	43.0	CHEMBL267	Homo sapiens	IC50	uM	0.043
	15685221	CHEMBL3606410	Inhibition of cSrc T338M/S345C mutant (unknown origin) pre-incubated for 30 mins before substrate and ATP addition by HTRF assay	B	CCC(=O)Nc1ccc2c(Nc3cc[nH]n3)nc(-c3ccccc3)nc2c1		CHEMBL3604910	=	IC50	nM	48.0	CHEMBL267	Homo sapiens	IC50	uM	0.048
	15685222	CHEMBL3606410	Inhibition of cSrc T338M/S345C mutant (unknown origin) pre-incubated for 30 mins before substrate and ATP addition by HTRF assay	B	C=CC(=O)Nc1cccc(Oc2nc(Nc3cc(C)[nH]n3)cc(N3CCN(C)CC3)n2)c1		CHEMBL3604921	=	IC50	nM	28.0	CHEMBL267	Homo sapiens	IC50	uM	0.028
	15685223	CHEMBL3606410	Inhibition of cSrc T338M/S345C mutant (unknown origin) pre-incubated for 30 mins before substrate and ATP addition by HTRF assay	B	CCC(=O)Nc1cccc(Oc2nc(Nc3cc(C)[nH]n3)cc(N3CCN(C)CC3)n2)c1		CHEMBL3604924	=	IC50	nM	349.0	CHEMBL267	Homo sapiens	IC50	uM	0.349
	15685224	CHEMBL3606410	Inhibition of cSrc T338M/S345C mutant (unknown origin) pre-incubated for 30 mins before substrate and ATP addition by HTRF assay	B	C=CC(=O)Nc1cccc(Oc2nc(Nc3n[nH]c4ccccc34)cc(N3CCN(C)CC3)n2)c1		CHEMBL3604937	=	IC50	nM	17.0	CHEMBL267	Homo sapiens	IC50	uM	0.017
	15685225	CHEMBL3606410	Inhibition of cSrc T338M/S345C mutant (unknown origin) pre-incubated for 30 mins before substrate and ATP addition by HTRF assay	B	CCC(=O)Nc1cccc(Oc2nc(Nc3n[nH]c4ccccc34)cc(N3CCN(C)CC3)n2)c1		CHEMBL3604938	=	IC50	nM	260.0	CHEMBL267	Homo sapiens	IC50	uM	0.26
	15686139	CHEMBL3606977	Inhibition of SRC (unknown origin) at 250 nM by radioactive filter-binding assay	B	c1ccc2c(Nc3cc(C4CCC4)[nH]n3)nc(Nc3ccc4[nH]cnc4c3)nc2c1		CHEMBL3605055	>=	Inhibition	%	80.0	CHEMBL267	Homo sapiens	INH	%	80.0
Not Determined	15692337	CHEMBL3611261	Inhibition of c-Src (unknown origin) using biotinylated HER2 peptide as substrate by time resolved fluorescence method	B	O=C(NCc1cccnc1)Nc1ccccc1Cl		CHEMBL1299308		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	15692338	CHEMBL3611261	Inhibition of c-Src (unknown origin) using biotinylated HER2 peptide as substrate by time resolved fluorescence method	B	Cc1ccc([C@@H](C)NC(=O)Nc2ccccc2)cc1NC(=O)c1cnc2ccccn12		CHEMBL3608788		IC50			CHEMBL267	Homo sapiens	IC50		
	15692339	CHEMBL3611262	Inhibition of c-Src (unknown origin) using biotinylated HER2 peptide as substrate at 0.003 uM by time resolved fluorescence method	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Inhibition	%	99.0	CHEMBL267	Homo sapiens	INH	%	99.0
	15692340	CHEMBL3611263	Inhibition of c-Src (unknown origin) using biotinylated HER2 peptide as substrate at 100 uM by time resolved fluorescence method	B	O=C(NCc1cccc(NC(=O)c2cnc3ccccn23)c1)Nc1ccccc1		CHEMBL3608784	=	Inhibition	%	63.0	CHEMBL267	Homo sapiens	INH	%	63.0
	15692341	CHEMBL3611264	Inhibition of c-Src (unknown origin) using biotinylated HER2 peptide as substrate at 10 uM by time resolved fluorescence method	B	Cc1ccc(CNC(=O)Nc2ccccc2)cc1NC(=O)c1cnc2ccccn12		CHEMBL3608785	=	Inhibition	%	54.0	CHEMBL267	Homo sapiens	INH	%	54.0
	15692342	CHEMBL3611264	Inhibition of c-Src (unknown origin) using biotinylated HER2 peptide as substrate at 10 uM by time resolved fluorescence method	B	Cc1ccc([C@H](C)NC(=O)Nc2ccccc2)cc1NC(=O)c1cnc2ccccn12		CHEMBL3608787	=	Inhibition	%	4.0	CHEMBL267	Homo sapiens	INH	%	4.0
	15692343	CHEMBL3611264	Inhibition of c-Src (unknown origin) using biotinylated HER2 peptide as substrate at 10 uM by time resolved fluorescence method	B	Cc1ccc([C@H](C)NC(=O)Nc2cccc(F)c2)cc1NC(=O)c1cnc2ccccn12		CHEMBL3608789	=	Inhibition	%	22.0	CHEMBL267	Homo sapiens	INH	%	22.0
	15692344	CHEMBL3611264	Inhibition of c-Src (unknown origin) using biotinylated HER2 peptide as substrate at 10 uM by time resolved fluorescence method	B	Cc1ccc([C@H](C)NC(=O)c2cccc(C(F)(F)F)c2)cc1NC(=O)c1cnc2ccccn12		CHEMBL3608790	=	Inhibition	%	48.0	CHEMBL267	Homo sapiens	INH	%	48.0
	15692345	CHEMBL3611264	Inhibition of c-Src (unknown origin) using biotinylated HER2 peptide as substrate at 10 uM by time resolved fluorescence method	B	Cc1ccc([C@H](C)Nc2nc3cc(F)ccc3o2)cc1NC(=O)c1cnc2ccccn12		CHEMBL3608791	=	Inhibition	%	52.0	CHEMBL267	Homo sapiens	INH	%	52.0
	15692346	CHEMBL3611265	Inhibition of c-Src (unknown origin) using biotinylated HER2 peptide as substrate at 3 uM by time resolved fluorescence method	B	Cc1ccc(CNC(=O)Nc2cccc(F)c2)cc1NC(=O)c1cnc2ccccn12		CHEMBL3608786	=	Inhibition	%	40.0	CHEMBL267	Homo sapiens	INH	%	40.0
	15698416	CHEMBL3615120	Inhibition of His6-tagged Src kinase domain (unknown origin) using AEEEIYGEFEAKKKK as substrate preincubated for 10 mins followed by substrate/ATP addition measured after 30 mins by fluorescence assay	B	Nc1ccc2c(C(F)(F)F)cc(=O)oc2c1		CHEMBL1301731	=	IC50	nM	30900.0	CHEMBL267	Homo sapiens	IC50	uM	30.9
	15698417	CHEMBL3615120	Inhibition of His6-tagged Src kinase domain (unknown origin) using AEEEIYGEFEAKKKK as substrate preincubated for 10 mins followed by substrate/ATP addition measured after 30 mins by fluorescence assay	B	CCCCCCCCCCc1c(C)c2ccc(N)cc2oc1=O		CHEMBL3612751	=	IC50	nM	73500.0	CHEMBL267	Homo sapiens	IC50	uM	73.5
	15698418	CHEMBL3615120	Inhibition of His6-tagged Src kinase domain (unknown origin) using AEEEIYGEFEAKKKK as substrate preincubated for 10 mins followed by substrate/ATP addition measured after 30 mins by fluorescence assay	B	Br.CCCCCCCCCCc1c(C)c2ccc(N(CC)CCCC(=O)O)cc2oc1=O		CHEMBL3612750	=	IC50	nM	21600.0	CHEMBL267	Homo sapiens	IC50	uM	21.6
	15698419	CHEMBL3615120	Inhibition of His6-tagged Src kinase domain (unknown origin) using AEEEIYGEFEAKKKK as substrate preincubated for 10 mins followed by substrate/ATP addition measured after 30 mins by fluorescence assay	B	Br.CCCCCCc1c(C)c2ccc(N(CC)CCCC(=O)O)cc2oc1=O		CHEMBL3612749	=	IC50	nM	36500.0	CHEMBL267	Homo sapiens	IC50	uM	36.5
	15715102	CHEMBL3619917	Inhibition of c-Src C277S, C483S, S496S mutant (unknown origin)	B	CN1CCN(C(=O)CCSCCC(=O)Nc2cccc(Nc3nccc(Nc4cc(C5CC5)[nH]n4)n3)c2)C(c2ccccc2)C1		CHEMBL3617733	=	Ki	nM	120.0	CHEMBL267	Homo sapiens	Ki	uM	0.12
	15715103	CHEMBL3619917	Inhibition of c-Src C277S, C483S, S496S mutant (unknown origin)	B	O=C(CCS)Nc1cccc(Nc2nccc(Nc3cc(C4CC4)[nH]n3)n2)c1		CHEMBL3617731	=	Ki	nM	200.0	CHEMBL267	Homo sapiens	Ki	uM	0.2
	15715104	CHEMBL3619917	Inhibition of c-Src C277S, C483S, S496S mutant (unknown origin)	B	C=CC(=O)N1CCCC1c1ccco1		CHEMBL3617729	=	Ki	nM	160000.0	CHEMBL267	Homo sapiens	Ki	uM	160.0
	15715105	CHEMBL3619916	Inhibition of c-Src (unknown origin)	B	C[C@@H](NC(=O)CCCCCC(=O)Nc1cccc(Nc2nccc(Nc3cc(C4CC4)[nH]n3)n2)c1)c1ccco1		CHEMBL3617740	=	Ki	nM	130.0	CHEMBL267	Homo sapiens	Ki	uM	0.13
	15715106	CHEMBL3619916	Inhibition of c-Src (unknown origin)	B	C[C@H](NC(=O)CCCCCC(=O)Nc1cccc(Nc2nccc(Nc3cc(C4CC4)[nH]n3)n2)c1)c1ccco1		CHEMBL3617739	=	Ki	nM	370.0	CHEMBL267	Homo sapiens	Ki	uM	0.37
	15715107	CHEMBL3619916	Inhibition of c-Src (unknown origin)	B	O=C(CCCCCC(=O)N1CCC[C@@H]1c1ccco1)Nc1cccc(Nc2nccc(Nc3cc(C4CC4)[nH]n3)n2)c1		CHEMBL3617738	=	Ki	nM	70.0	CHEMBL267	Homo sapiens	Ki	uM	0.07
	15715108	CHEMBL3619916	Inhibition of c-Src (unknown origin)	B	O=C(CCCCCC(=O)N1CCC[C@H]1c1ccco1)Nc1cccc(Nc2nccc(Nc3cc(C4CC4)[nH]n3)n2)c1		CHEMBL3617737	=	Ki	nM	330.0	CHEMBL267	Homo sapiens	Ki	uM	0.33
	15715109	CHEMBL3619916	Inhibition of c-Src (unknown origin)	B	CC(NC(=O)CCCCCC(=O)Nc1cccc(Nc2nccc(Nc3cc(C4CC4)[nH]n3)n2)c1)c1ccco1		CHEMBL3617736	=	Ki	nM	230.0	CHEMBL267	Homo sapiens	Ki	uM	0.23
	15715110	CHEMBL3619916	Inhibition of c-Src (unknown origin)	B	O=C(CCCCCC(=O)N1CCCC1c1ccco1)Nc1cccc(Nc2nccc(Nc3cc(C4CC4)[nH]n3)n2)c1		CHEMBL3617735	=	Ki	nM	480.0	CHEMBL267	Homo sapiens	Ki	uM	0.48
	15715111	CHEMBL3619916	Inhibition of c-Src (unknown origin)	B	CN1CCN(C(=O)CCCCCC(=O)Nc2cccc(Nc3nccc(Nc4cc(C5CC5)[nH]n4)n3)c2)C(c2ccccc2)C1		CHEMBL3617734	=	Ki	nM	140.0	CHEMBL267	Homo sapiens	Ki	uM	0.14
	15715112	CHEMBL3619916	Inhibition of c-Src (unknown origin)	B	CN1CCN(C(=O)CCSCCC(=O)Nc2cccc(Nc3nccc(Nc4cc(C5CC5)[nH]n4)n3)c2)C(c2ccccc2)C1		CHEMBL3617733	=	Ki	nM	90.0	CHEMBL267	Homo sapiens	Ki	uM	0.09
	15715113	CHEMBL3619916	Inhibition of c-Src (unknown origin)	B	CCCC(=O)Nc1cccc(Nc2nccc(Nc3cc(C4CC4)[nH]n3)n2)c1		CHEMBL3617732	=	Ki	nM	400.0	CHEMBL267	Homo sapiens	Ki	uM	0.4
	15715114	CHEMBL3619916	Inhibition of c-Src (unknown origin)	B	CC(=O)Nc1cccc(Nc2nccc(Nc3cc(C4CC4)[nH]n3)n2)c1		CHEMBL3617730	=	Ki	nM	360.0	CHEMBL267	Homo sapiens	Ki	uM	0.36
	15715126	CHEMBL3619924	Inhibition of c-Src E280G mutant (unknown origin)	B	O=C(CCCCCC(=O)N1CCC[C@@H]1c1ccco1)Nc1cccc(Nc2nccc(Nc3cc(C4CC4)[nH]n3)n2)c1		CHEMBL3617738	=	Ki	nM	260.0	CHEMBL267	Homo sapiens	Ki	uM	0.26
Not Active	15723458	CHEMBL3620311	Inhibition of c-SRC (unknown origin) at 10 uM after 40 mins by scintillation counting analysis	B	Cc1ccccc1C(=O)Nc1cnoc1C		CHEMBL3616990		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	15736138	CHEMBL3627535	Inhibition of human Src (1 to 530 residues) at 0.1 uM	B	Cc1nn(-c2ccnc(Nc3ccc4c(c3)c(Cl)c(C)n4C)n2)cc1CN1CC(O)C1		CHEMBL3622956	<	Inhibition	%	25.0	CHEMBL267	Homo sapiens	INH	%	25.0
	15736139	CHEMBL3627536	Inhibition of human Src T341M mutant at 0.1 uM	B	Cc1nn(-c2ccnc(Nc3ccc4c(c3)c(Cl)c(C)n4C)n2)cc1CN1CC(O)C1		CHEMBL3622956	<	Inhibition	%	25.0	CHEMBL267	Homo sapiens	INH	%	25.0
	15745681	CHEMBL3625486	Inhibition of recombinant Src (unknown origin) using fluoresceinated peptide as substrate after 60 mins by HTRF assay	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3nc(C)c(C)s3)nc21		CHEMBL3622137	>	IC50	nM	2000.0	CHEMBL267	Homo sapiens	IC50	uM	2.0
	15745688	CHEMBL3625493	Inhibition of human Src expressed in bacterial expression system assessed as remaining activity at 1 uM relative to control	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3nc(C)c(C)s3)nc21		CHEMBL3622137	=	Activity	%	6.5	CHEMBL267	Homo sapiens	Activity	%	6.5
	15745908	CHEMBL3624482	Inhibition of recombinant Src (unknown origin) at 1 uM after 40 mins by scintillation counting analysis in presence of [gamma33P]-ATP	B	COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1OC(=O)N1CCN(C)C[C@H]1C		CHEMBL3623290	=	Inhibition	%	69.0	CHEMBL267	Homo sapiens	INH	%	69.0
	15745911	CHEMBL3624485	Inhibition of recombinant Src (unknown origin) after 40 mins by scintillation counting analysis in presence of [gamma33P]-ATP	B	COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1OC(=O)N1CCN(C)C[C@H]1C		CHEMBL3623290	=	IC50	nM	622.0	CHEMBL267	Homo sapiens	IC50	nM	622.0
	15747332	CHEMBL3624083	Inhibition of Src (1 to 530) (unknown origin) assessed as residual enzyme activity at 10 uM by kinaseprolier assay	B	NCCn1c(C2CCNCC2)nc2cc(C(N)=O)ccc21		CHEMBL3622826	>	Activity	%	65.0	CHEMBL267	Homo sapiens	Activity	%	65.0
	15753824	CHEMBL3630465	Inhibition of human Src kinase at 10 uM by kinase inhibition assay	B	Clc1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2SC3)cc1		CHEMBL3628818	=	Inhibition	%	8.8	CHEMBL267	Homo sapiens	INH	%	8.8
	15753883	CHEMBL3630475	Inhibition of human Src kinase by kinase inhibition assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	9.7	CHEMBL267	Homo sapiens	IC50	nM	9.7
	15753900	CHEMBL3630465	Inhibition of human Src kinase at 10 uM by kinase inhibition assay	B	COc1ccc(Nc2ncc3c(n2)-c2ccccc2SC3)cc1		CHEMBL3628537	=	Inhibition	%	12.0	CHEMBL267	Homo sapiens	INH	%	12.0
	15753982	CHEMBL3630465	Inhibition of human Src kinase at 10 uM by kinase inhibition assay	B	COc1ccc2c(c1)SCc1cnc(-c3ccccc3)nc1-2		CHEMBL481789	=	Inhibition	%	0.3	CHEMBL267	Homo sapiens	INH	%	0.3
	15754268	CHEMBL3631694	Inhibition of Src (unknown origin) at 1 uM by FRET method	B	N#Cc1ccnc(Nc2cc(C3CCN(C4COC4)CC3)n(C3CCCC3)n2)c1		CHEMBL3629013	=	Inhibition	%	55.4	CHEMBL267	Homo sapiens	INH	%	55.4
	15754951	CHEMBL3631843	Inhibition of Src (unknown origin) by FRET method	B	N#Cc1ccnc(Nc2cc(C3CCN(C4COC4)CC3)n(C3CCCC3)n2)c1	Outside typical range	CHEMBL3629013	=	IC50	nM	1010000.0	CHEMBL267	Homo sapiens	IC50	mM	1.01
	15755932	CHEMBL3631583	Inhibition of SRC (unknown origin) assessed as remaining activity at 10 uM by high-throughput assay relative to control	B	O=C1c2ccccc2-c2c1oc1ccccc1c2=O		CHEMBL3629616	=	Activity	%	83.0	CHEMBL267	Homo sapiens	Activity	%	83.0
	15756091	CHEMBL3632175	Inhibition of c-Src (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	99.1	CHEMBL267	Homo sapiens	INH	%	99.1
	15757071	CHEMBL3632175	Inhibition of c-Src (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	85.83	CHEMBL267	Homo sapiens	INH	%	85.83
	15758631	CHEMBL3632175	Inhibition of c-Src (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	81.09	CHEMBL267	Homo sapiens	INH	%	81.09
	15759958	CHEMBL3631059	Inhibition of Src (unknown origin) by radiometric protein kinase assay	B	O=C(Nc1ccc(Oc2ncnc3sccc23)cc1)Nc1cccc(Br)c1		CHEMBL3628808	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	15759959	CHEMBL3631059	Inhibition of Src (unknown origin) by radiometric protein kinase assay	B	O=C(Nc1ccc(Oc2ncnc3ccccc23)cc1)Nc1cccc(Br)c1		CHEMBL3628807	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	15759960	CHEMBL3631059	Inhibition of Src (unknown origin) by radiometric protein kinase assay	B	COc1cc2ncnc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)c2cc1OC		CHEMBL2018882	=	IC50	nM	5470.0	CHEMBL267	Homo sapiens	IC50	nM	5470.0
	15759961	CHEMBL3631059	Inhibition of Src (unknown origin) by radiometric protein kinase assay	B	O=C(Nc1ccc(Nc2ncnc3sc4c(c23)CCCC4)cc1)Nc1cccc(Br)c1		CHEMBL3628799	=	IC50	nM	7640.0	CHEMBL267	Homo sapiens	IC50	nM	7640.0
	15759962	CHEMBL3631059	Inhibition of Src (unknown origin) by radiometric protein kinase assay	B	O=C(Nc1ccc(Nc2ncnc3sccc23)cc1)Nc1cccc(Br)c1		CHEMBL3628798	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	15759963	CHEMBL3631059	Inhibition of Src (unknown origin) by radiometric protein kinase assay	B	O=C(Nc1ccc(Nc2ncnc3ccccc23)cc1)Nc1cccc(Br)c1		CHEMBL3628797	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
Not Determined	15759964	CHEMBL3631059	Inhibition of Src (unknown origin) by radiometric protein kinase assay	B	COc1cc2ncnc(Nc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)c2cc1OC		CHEMBL3628796		IC50			CHEMBL267	Homo sapiens	IC50		
	15760022	CHEMBL3631059	Inhibition of Src (unknown origin) by radiometric protein kinase assay	B	O=C(Nc1ccc(Oc2ncnc3sc4c(c23)CCCC4)cc1)Nc1cccc(Br)c1		CHEMBL3628811	=	IC50	nM	8460.0	CHEMBL267	Homo sapiens	IC50	nM	8460.0
	15770694	CHEMBL3636907	Inhibition of SRC (unknown origin)	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	15770695	CHEMBL3636907	Inhibition of SRC (unknown origin)	B	Cn1c(Nc2cccc(C(C)(C)C)c2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL3632719	>	IC50	nM	6000.0	CHEMBL267	Homo sapiens	IC50	uM	6.0
	15770696	CHEMBL3636907	Inhibition of SRC (unknown origin)	B	CC(=O)Nc1cc(Oc2ccc3c(c2)nc(Nc2cccc(C(C)(C)C)c2)n3C)ccn1		CHEMBL3335371	=	IC50	nM	2.0	CHEMBL267	Homo sapiens	IC50	uM	0.002
Not Active	15773142	CHEMBL3636569	Inhibition of Src phosphorylation in human MDA-MB-231 cells at 1 to 4 uM after 12 hrs by Western blot analysis	B	O=C(C1=Cc2cc(Br)ccc2S1(=O)=O)N1CCCCC1		CHEMBL3633707		Inhibition	%		CHEMBL267	Homo sapiens	INH		
213632	16258081	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	COc1cccc(F)c1-c1cc(C)c2nc(Nc3ccccc3)nnc2c1		CHEMBL3648006	>	IC50	nM	1000.0	CHEMBL267	Homo sapiens	IC50	nM	1000.0
213873	16258328	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1ccc(O)cc1-c1cc(C)c2nc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nnc2c1		CHEMBL3651288	=	IC50	nM	0.955	CHEMBL267	Homo sapiens	IC50	nM	0.955
213694	16258423	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3cccc(OCCCN4CCN(C)CC4)c3)nnc2c1		CHEMBL3648036	=	IC50	nM	38.9	CHEMBL267	Homo sapiens	IC50	nM	38.9
213782	16258675	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(S(N)(=O)=O)cc3)nc12		CHEMBL249820	=	IC50	nM	70.3	CHEMBL267	Homo sapiens	IC50	nM	70.3
278568	16259114	CHEMBL3707502	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	COCC(=O)Nc1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc(C)cc3)c3ccccc23)ccn1		CHEMBL3695569	=	IC50	nM	5.0	CHEMBL267	Homo sapiens	IC50	nM	5.0
278583	16259196	CHEMBL3707502	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ncnc4[nH]c(=O)[nH]c34)c3ccccc23)cc1		CHEMBL3695587	=	IC50	nM	35.0	CHEMBL267	Homo sapiens	IC50	nM	35.0
213879	16259573	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2c(Cl)ccc(O)c2F)cc2nnc(Nc3ccc(C(=O)N(C)CCN4CCCC4)cc3)nc12		CHEMBL3639501	=	IC50	nM	0.542	CHEMBL267	Homo sapiens	IC50	nM	0.542
213677	16259574	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2c(Cl)cccc2Cl)cc2nnc(Nc3cccnc3)nc12		CHEMBL3648031	=	IC50	nM	27.0	CHEMBL267	Homo sapiens	IC50	nM	27.0
213752	16259829	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	COc1ccc(Cl)c(-c2cc3nnc(Nc4ccc(C(=O)N5CCN(C)CC5)cc4)nc3cc2C)c1		CHEMBL3651202	=	IC50	nM	560.0	CHEMBL267	Homo sapiens	IC50	nM	560.0
213783	16260168	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1ccccc1-c1cc2nnc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nc2cc1NC(=O)NC(C)(C)C		CHEMBL3651226	=	IC50	nM	8000.0	CHEMBL267	Homo sapiens	IC50	nM	8000.0
213799	16260221	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc2nc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nnc2cc1-c1cc(O)ccc1F		CHEMBL3651241	=	IC50	nM	8.5	CHEMBL267	Homo sapiens	IC50	nM	8.5
286823	16260309	CHEMBL3707611	TR-FRET Assay: Compounds were screened in the TR-FRET assay for JAK2 and c-Src kinase inhibition. Ultra light poly GT (Perkin Elmer) was used as the substrate for JAK2 and c-Src with the ATP concentration of 10 μM and 50 μM, respectively. The Eu-labelled anti-phospho tyrosine antibody (Perkin Elmer) was added at 1 nM and the fluorescence emission at 615 nm and 665 nm was measured with an excitation wavelength of 340 nm.	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1N1CCc2nc(Nc3ccc(CC(=O)N4CCN(C)CC4)cc3)ncc2C1=O		CHEMBL3658093	=	IC50	nM	30.0	CHEMBL267	Homo sapiens	IC50	nM	30.0
213664	16260480	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	COc1cc(OC)cc(-c2cc(C)c3nc(Nc4ccc(C)cc4C)nnc3c2)c1		CHEMBL3648020	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	nM	100000.0
213825	16260566	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(S(=O)(=O)CCCN4CCCC4)cc3)nc12		CHEMBL399268	=	IC50	nM	5.0	CHEMBL267	Homo sapiens	IC50	nM	5.0
213717	16260839	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(C(=O)N4CCN(C)CC4)o3)nnc2c1		CHEMBL3648055	=	IC50	nM	94.0	CHEMBL267	Homo sapiens	IC50	nM	94.0
213634	16261049	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1cc2nnc(Nc3ccccc3)nc2c(C)c1C		CHEMBL221975	=	IC50	nM	130.0	CHEMBL267	Homo sapiens	IC50	nM	130.0
213639	16261623	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Clc1cccc(Cl)c1-c1ccc2nc(Nc3ccc(OCCN4CCCC4)cc3)nnc2c1		CHEMBL230271	=	IC50	nM	121.0	CHEMBL267	Homo sapiens	IC50	nM	121.0
278594	16261717	CHEMBL3707502	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	CNS(=O)(=O)Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)cnc34)c3ccccc23)cc1		CHEMBL3695574	=	IC50	nM	13.0	CHEMBL267	Homo sapiens	IC50	nM	13.0
213815	16261802	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc2nc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nnc2cc1N1CCCC(O)C1		CHEMBL3651254	=	IC50	nM	1772.0	CHEMBL267	Homo sapiens	IC50	nM	1772.0
286825	16261862	CHEMBL3707611	TR-FRET Assay: Compounds were screened in the TR-FRET assay for JAK2 and c-Src kinase inhibition. Ultra light poly GT (Perkin Elmer) was used as the substrate for JAK2 and c-Src with the ATP concentration of 10 μM and 50 μM, respectively. The Eu-labelled anti-phospho tyrosine antibody (Perkin Elmer) was added at 1 nM and the fluorescence emission at 615 nm and 665 nm was measured with an excitation wavelength of 340 nm.	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1N1CCc2nc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3)ncc2C1		CHEMBL3658096	=	IC50	nM	2.0	CHEMBL267	Homo sapiens	IC50	nM	2.0
213870	16261923	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2c(F)ccc(O)c2F)cc2nnc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nc12		CHEMBL440963	=	IC50	nM	3.1	CHEMBL267	Homo sapiens	IC50	nM	3.1
278584	16262076	CHEMBL3707502	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)cnc34)c3ccccc23)n(-c2ccc(O)cc2)n1		CHEMBL3695588	=	IC50	nM	10.0	CHEMBL267	Homo sapiens	IC50	nM	10.0
213645	16262339	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3cnc4ccccc4c3)nnc2c1		CHEMBL3648011	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
273886	16262552	CHEMBL3707805	Kinase Inhibition Assay: The compound of Example 39, 2-(1H-indol-5-ylamino)-6-(2,4-difluorophenylsulfonyl)-8-methylpyrido[2,3-d]pyrimidin-7(8H)-one, was subjected to a kinase inhibition assay for the kinases. Compounds were tested in 5 dose IC50 mode with 10-fold serial dilution starting at 10 μM. Staurosporine, a known protein kinase inhibitor, was tested in 5-dose IC50 mode with 3-fold serial dilution starting at 20 μM. Reactions were carried out in 10 μM ATP. The results are shown in Table 5. The results show that the compound of Example 39 is a kinase inhibitor highly selective for the kinase Plk2.	B	CN[C@H]1CC2OC([C@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(O)=NC4		CHEMBL3975634	=	IC50	nM	3.64	CHEMBL267	Homo sapiens	IC50	nM	3.64
213869	16263364	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2c(Cl)ccc(O)c2F)cc2nnc(Nc3ccc(S(=O)(=O)CCCN4CCCC4)cc3)nc12		CHEMBL3651286	=	IC50	nM	1.0	CHEMBL267	Homo sapiens	IC50	nM	1.0
213765	16263457	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc2nc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nnc2cc1-c1ccccc1CO		CHEMBL230509	=	IC50	nM	72.2	CHEMBL267	Homo sapiens	IC50	nM	72.2
213640	16263523	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(C4(CN)CC4)cc3)nnc2c1		CHEMBL3648010	=	IC50	nM	76.4	CHEMBL267	Homo sapiens	IC50	nM	76.4
286842	16263712	CHEMBL3707611	TR-FRET Assay: Compounds were screened in the TR-FRET assay for JAK2 and c-Src kinase inhibition. Ultra light poly GT (Perkin Elmer) was used as the substrate for JAK2 and c-Src with the ATP concentration of 10 μM and 50 μM, respectively. The Eu-labelled anti-phospho tyrosine antibody (Perkin Elmer) was added at 1 nM and the fluorescence emission at 615 nm and 665 nm was measured with an excitation wavelength of 340 nm.	B	Cc1ccc(NC(=O)c2cc(C(F)(F)F)ccn2)cc1N1CCc2nc(Nc3ccc(C(=O)N4CCN(C)CC4)cc3)ncc2C1		CHEMBL3658119	=	IC50	nM	27.0	CHEMBL267	Homo sapiens	IC50	nM	27.0
213699	16264185	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1noc(C)c1-c1cc(C)c2nc(Nc3ccc(OCCN4CCCC4)cc3)nnc2c1		CHEMBL230898	=	IC50	nM	207.0	CHEMBL267	Homo sapiens	IC50	nM	207.0
278599	16265147	CHEMBL3707502	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)cnc34)c3ccccc23)n(-c2ccc(S(C)(=O)=O)cc2)n1		CHEMBL3695579	=	IC50	nM	6.0	CHEMBL267	Homo sapiens	IC50	nM	6.0
286836	16265361	CHEMBL3707611	TR-FRET Assay: Compounds were screened in the TR-FRET assay for JAK2 and c-Src kinase inhibition. Ultra light poly GT (Perkin Elmer) was used as the substrate for JAK2 and c-Src with the ATP concentration of 10 μM and 50 μM, respectively. The Eu-labelled anti-phospho tyrosine antibody (Perkin Elmer) was added at 1 nM and the fluorescence emission at 615 nm and 665 nm was measured with an excitation wavelength of 340 nm.	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1N1CCc2nc(Nc3ccc(C(=O)NC4CCN(C)CC4)nc3)ncc2C1		CHEMBL3658111	=	IC50	nM	2.4	CHEMBL267	Homo sapiens	IC50	nM	2.4
213658	16265471	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	COc1ccc(Nc2nnc3cc(-c4c(C)cccc4C)cc(C)c3n2)cc1		CHEMBL220798	=	IC50	nM	140.0	CHEMBL267	Homo sapiens	IC50	nM	140.0
278579	16265778	CHEMBL3707502	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	CCn1c(=O)[nH]c2nccc(Oc3ccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4ccc(OC)cc4)c4ccccc34)c21		CHEMBL3695584	=	IC50	nM	9.0	CHEMBL267	Homo sapiens	IC50	nM	9.0
213713	16265950	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3cccc(C(=O)NCCN4CCCC4)c3)nnc2c1		CHEMBL3648051	=	IC50	nM	17.6	CHEMBL267	Homo sapiens	IC50	nM	17.6
286830	16266195	CHEMBL3707611	TR-FRET Assay: Compounds were screened in the TR-FRET assay for JAK2 and c-Src kinase inhibition. Ultra light poly GT (Perkin Elmer) was used as the substrate for JAK2 and c-Src with the ATP concentration of 10 μM and 50 μM, respectively. The Eu-labelled anti-phospho tyrosine antibody (Perkin Elmer) was added at 1 nM and the fluorescence emission at 615 nm and 665 nm was measured with an excitation wavelength of 340 nm.	B	Cc1ccc(NC(=O)N2CCCCC2)cc1N1CCc2nc(Nc3ccc(OCCN4CCCC4)cc3)ncc2C1		CHEMBL3658101	=	IC50	nM	1.0	CHEMBL267	Homo sapiens	IC50	nM	1.0
213695	16266492	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(OCCCN4CCN(C)CC4)cc3)nnc2c1		CHEMBL3648037	=	IC50	nM	35.8	CHEMBL267	Homo sapiens	IC50	nM	35.8
278567	16266951	CHEMBL3707502	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	COCC(=O)Nc1cc(COc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc(C)cc3)c3ccccc23)ccn1		CHEMBL3695568	=	IC50	nM	162.0	CHEMBL267	Homo sapiens	IC50	nM	162.0
278566	16267002	CHEMBL3707502	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	IC50	nM	1894.0	CHEMBL267	Homo sapiens	IC50	nM	1894.0
286840	16267032	CHEMBL3707611	TR-FRET Assay: Compounds were screened in the TR-FRET assay for JAK2 and c-Src kinase inhibition. Ultra light poly GT (Perkin Elmer) was used as the substrate for JAK2 and c-Src with the ATP concentration of 10 μM and 50 μM, respectively. The Eu-labelled anti-phospho tyrosine antibody (Perkin Elmer) was added at 1 nM and the fluorescence emission at 615 nm and 665 nm was measured with an excitation wavelength of 340 nm.	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1N1CCc2nc(Nc3ccc(S(=O)(=O)NC4CC4)cc3)ncc2C1		CHEMBL3658117	=	IC50	nM	16.0	CHEMBL267	Homo sapiens	IC50	nM	16.0
213797	16267245	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3cccc(S(=O)(=O)N4CCNCC4)c3)nc12		CHEMBL3651239	=	IC50	nM	52.8	CHEMBL267	Homo sapiens	IC50	nM	52.8
213820	16267423	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc2nc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nnc2cc1Nc1cc(O)ccc1Cl		CHEMBL3651256	=	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
213705	16267712	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2c(Cl)cccc2Cl)cc2nnc(Nc3ccc(OCCCN4CCN(C)CC4)cc3)nc12		CHEMBL3648045	=	IC50	nM	25.2	CHEMBL267	Homo sapiens	IC50	nM	25.2
213775	16267906	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	CC(=O)Nc1cc(-c2c(C)cccc2C)cc2nnc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nc12		CHEMBL3651220	=	IC50	nM	29.9	CHEMBL267	Homo sapiens	IC50	nM	29.9
278593	16268223	CHEMBL3707502	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	COc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)cnc34)c3ccccc23)cc1		CHEMBL3695573	=	IC50	nM	12.0	CHEMBL267	Homo sapiens	IC50	nM	12.0
213791	16269321	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(F)ccc1-c1cc2nnc(Nc3ccc(C(=O)NCCN4CCCC4)o3)nc2cc1C		CHEMBL3651234	=	IC50	nM	120.0	CHEMBL267	Homo sapiens	IC50	nM	120.0
278588	16269707	CHEMBL3707502	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)cnc34)c3ccccc23)n(-c2ccc(CO)nc2)n1		CHEMBL3695592	=	IC50	nM	8.0	CHEMBL267	Homo sapiens	IC50	nM	8.0
213750	16269871	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	CC(=O)Nc1cc(-c2c(C)cccc2C)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL231251	=	IC50	nM	6.8	CHEMBL267	Homo sapiens	IC50	nM	6.8
213657	16270059	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	COc1cccc(Nc2nnc3cc(-c4c(C)cccc4C)cc(C)c3n2)c1		CHEMBL3648016	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
213771	16270276	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc2nc(Nc3ccc(OCCN4CCCC4)cc3)nnc2cc1-c1cccc(O)c1		CHEMBL3651217	=	IC50	nM	17.7	CHEMBL267	Homo sapiens	IC50	nM	17.7
213821	16270725	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc2nc(Nc3ccc(OCCN4CCCC4)cc3)nnc2cc1-c1cc(O)ccc1Cl		CHEMBL3651257	=	IC50	nM	4.2	CHEMBL267	Homo sapiens	IC50	nM	4.2
213805	16270815	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(NCCCCN3CCCC3)nc12		CHEMBL3651245	=	IC50	nM	1450.0	CHEMBL267	Homo sapiens	IC50	nM	1450.0
304672	16270850	CHEMBL3706162	Enzyme Inhibition Assay: The kinase enzyme binding activities of compounds disclosed herein were determined using a proprietary assay which measures active site-directed competition binding to an immobilized ligand (Fabian, M. A. et al., Nature Biotechnol., 2005, 23:329-336). These assays were conducted by DiscoverX (formerly Ambit; San Diego, Calif.). The Kd value (Dissociation constant value) was calculated as the index of affinity of the compounds to each kinase. The enzyme inhibitory activities of compounds disclosed herein were determined by FRET using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen Ltd., Paisley, UK). The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), were evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) was incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccccc4)n3)c3ccccc23)cc1		CHEMBL3701217	=	IC50	nM	22.0	CHEMBL267	Homo sapiens	IC50	nM	22.0
213681	16270962	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2c(Cl)cccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL230686	=	IC50	nM	9.4	CHEMBL267	Homo sapiens	IC50	nM	9.4
213858	16271196	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(SCCN4CCCC4)cc3)nc12		CHEMBL3651278	=	IC50	nM	4.3	CHEMBL267	Homo sapiens	IC50	nM	4.3
213848	16271216	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(S(=O)(=O)N(CCN4CCCC4)C(C)C)cc3)nc12		CHEMBL250218	=	IC50	nM	4.8	CHEMBL267	Homo sapiens	IC50	nM	4.8
213801	16271639	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(F)ccc1-c1cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc2cc1C		CHEMBL3651243	=	IC50	nM	26.1	CHEMBL267	Homo sapiens	IC50	nM	26.1
213698	16271887	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1noc(C)c1-c1cc(C)c2nc(Nc3ccc(C(=O)N4CCN(C)CC4)cc3)nnc2c1		CHEMBL3648040	=	IC50	nM	552.0	CHEMBL267	Homo sapiens	IC50	nM	552.0
213692	16271957	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(O)cc(C)c1-c1cc(C)c2nc(Nc3ccc(OCCN4CCCC4)cc3)nnc2c1		CHEMBL3648035	=	IC50	nM	75.0	CHEMBL267	Homo sapiens	IC50	nM	75.0
213676	16271972	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2c(Cl)cccc2Cl)cc2nnc(Nc3ccncc3)nc12		CHEMBL3648030	=	IC50	nM	42.0	CHEMBL267	Homo sapiens	IC50	nM	42.0
213675	16272144	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	COc1ccc(Nc2nnc3cc(-c4c(Cl)cccc4Cl)cc(C)c3n2)cc1		CHEMBL3648029	=	IC50	nM	137.0	CHEMBL267	Homo sapiens	IC50	nM	137.0
213688	16272349	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2cncnc2)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL3648033	=	IC50	nM	1500.0	CHEMBL267	Homo sapiens	IC50	nM	1500.0
213689	16273392	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(N(C)C)cc3)nnc2c1		CHEMBL220912	=	IC50	nM	244.0	CHEMBL267	Homo sapiens	IC50	nM	244.0
213704	16273478	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2c(Cl)cccc2Cl)cc2nnc(Nc3ccc(OCCN4CCN(C)CC4)cc3)nc12		CHEMBL3648044	=	IC50	nM	23.2	CHEMBL267	Homo sapiens	IC50	nM	23.2
213790	16273526	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(F)nc3)nc12		CHEMBL3651233	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
213785	16273756	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3cccc(C(=O)NCCN(C)C)c3)nc12		CHEMBL3651228	=	IC50	nM	4.8	CHEMBL267	Homo sapiens	IC50	nM	4.8
213670	16273846	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	COc1cc(OC)cc(-c2cc(C)c3nc(Nc4cccc(C)c4C)nnc3c2)c1		CHEMBL3639468	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	nM	100000.0
213720	16274287	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(Cl)nc3)nnc2c1		CHEMBL3648057	=	IC50	nM	232.0	CHEMBL267	Homo sapiens	IC50	nM	232.0
213716	16274705	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3cccc(S(=O)(=O)NCCN4CCCC4)c3)nnc2c1		CHEMBL3648054	=	IC50	nM	26.4	CHEMBL267	Homo sapiens	IC50	nM	26.4
213840	16274749	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2c(Cl)cccc2Cl)cc2nnc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nc12		CHEMBL231219	=	IC50	nM	14.0	CHEMBL267	Homo sapiens	IC50	nM	14.0
213862	16275138	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2cccc(O)c2F)cc2nnc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nc12		CHEMBL3651280	=	IC50	nM	5.2	CHEMBL267	Homo sapiens	IC50	nM	5.2
273852	16275411	CHEMBL3707805	Kinase Inhibition Assay: The compound of Example 39, 2-(1H-indol-5-ylamino)-6-(2,4-difluorophenylsulfonyl)-8-methylpyrido[2,3-d]pyrimidin-7(8H)-one, was subjected to a kinase inhibition assay for the kinases. Compounds were tested in 5 dose IC50 mode with 10-fold serial dilution starting at 10 μM. Staurosporine, a known protein kinase inhibitor, was tested in 5-dose IC50 mode with 3-fold serial dilution starting at 20 μM. Reactions were carried out in 10 μM ATP. The results are shown in Table 5. The results show that the compound of Example 39 is a kinase inhibitor highly selective for the kinase Plk2.	B	Cn1c(=O)c(Sc2ccc(F)cc2)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3702566	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
213874	16275456	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nc12		CHEMBL3651289	=	IC50	nM	79.2	CHEMBL267	Homo sapiens	IC50	nM	79.2
213817	16276022	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	CNc1cc(-c2c(C)cccc2C)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL230830	=	IC50	nM	10.6	CHEMBL267	Homo sapiens	IC50	nM	10.6
213780	16276045	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(NCCN3CCCC3)nc12		CHEMBL3651224	=	IC50	nM	4510.0	CHEMBL267	Homo sapiens	IC50	nM	4510.0
213837	16276378	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2ccccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL268825	=	IC50	nM	34.8	CHEMBL267	Homo sapiens	IC50	nM	34.8
213671	16276934	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	COc1cc(OC)cc(-c2cc(C)c3nc(Nc4ccccc4OC)nnc3c2)c1		CHEMBL3648026	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	nM	100000.0
278586	16277161	CHEMBL3707502	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	COc1cc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)cnc34)c3ccccc23)ccc1CO		CHEMBL3695590	=	IC50	nM	6.0	CHEMBL267	Homo sapiens	IC50	nM	6.0
213687	16277427	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2ccccn2)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL230899	=	IC50	nM	1800.0	CHEMBL267	Homo sapiens	IC50	nM	1800.0
278569	16277781	CHEMBL3707502	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)[nH]c34)c3ccccc23)cc1		CHEMBL1090975	=	IC50	nM	7.0	CHEMBL267	Homo sapiens	IC50	nM	7.0
286847	16279914	CHEMBL3707611	TR-FRET Assay: Compounds were screened in the TR-FRET assay for JAK2 and c-Src kinase inhibition. Ultra light poly GT (Perkin Elmer) was used as the substrate for JAK2 and c-Src with the ATP concentration of 10 μM and 50 μM, respectively. The Eu-labelled anti-phospho tyrosine antibody (Perkin Elmer) was added at 1 nM and the fluorescence emission at 615 nm and 665 nm was measured with an excitation wavelength of 340 nm.	B	CNC(=O)c1ccc(Nc2ncc3c(n2)CCN(c2cc(NC(=O)c4cc(C(F)(F)F)ccn4)ccc2Cl)C3)cc1		CHEMBL3658126	=	IC50	nM	15.0	CHEMBL267	Homo sapiens	IC50	nM	15.0
213767	16279926	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1ccc2nc(Nc3ccc(=O)n(CCCN4CCCC4)c3)nnc2c1		CHEMBL3651213	=	IC50	nM	76.0	CHEMBL267	Homo sapiens	IC50	nM	76.0
213842	16280031	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2c(Cl)cccc2Cl)cc2nnc(Nc3ccc(S(=O)(=O)N(C)CCN4CCCC4)cc3)nc12		CHEMBL3651268	=	IC50	nM	44.2	CHEMBL267	Homo sapiens	IC50	nM	44.2
213729	16280539	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(S(=O)(=O)N4CCN(C)CC4)cc3)nnc2c1		CHEMBL446951	=	IC50	nM	137.0	CHEMBL267	Homo sapiens	IC50	nM	137.0
213737	16280543	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(S(=O)(=O)N(C)CCN4CCCC4)cc3)nnc2c1		CHEMBL3651194	=	IC50	nM	25.5	CHEMBL267	Homo sapiens	IC50	nM	25.5
213855	16280702	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2c(Cl)ccc(O)c2Cl)cc2nnc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nc12		CHEMBL400303	=	IC50	nM	1.5	CHEMBL267	Homo sapiens	IC50	nM	1.5
213718	16280709	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nnc2c1		CHEMBL231218	=	IC50	nM	9.1	CHEMBL267	Homo sapiens	IC50	nM	9.1
213749	16280911	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1cc(N)c2nc(Nc3ccc(OCCN4CCCC4)cc3)nnc2c1		CHEMBL230829	=	IC50	nM	9.7	CHEMBL267	Homo sapiens	IC50	nM	9.7
213851	16281111	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1nc(Nc2nnc3cc(-c4cc(O)ccc4Cl)cc(C)c3n2)cc(OCCN2CCCC2)n1		CHEMBL3651275	=	IC50	nM	77.7	CHEMBL267	Homo sapiens	IC50	nM	77.7
213864	16281364	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2ccc(O)c(F)c2)cc2nnc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nc12		CHEMBL3651281	=	IC50	nM	156.0	CHEMBL267	Homo sapiens	IC50	nM	156.0
213853	16281403	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(S(=O)(=O)N(C)CCN4CCOCC4)cc3)nc12		CHEMBL250423	=	IC50	nM	6.6	CHEMBL267	Homo sapiens	IC50	nM	6.6
213727	16281413	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2c(Cl)cccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)c(C#N)c3)nc12		CHEMBL3648063	=	IC50	nM	25.2	CHEMBL267	Homo sapiens	IC50	nM	25.2
213776	16281678	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	CC(=O)Nc1cc(-c2c(C)cccc2C)cc2nnc(Nc3ccc(S(=O)(=O)N(CCN4CCCC4)C(C)=O)cc3)nc12		CHEMBL3651221	=	IC50	nM	34.2	CHEMBL267	Homo sapiens	IC50	nM	34.2
286841	16281687	CHEMBL3707611	TR-FRET Assay: Compounds were screened in the TR-FRET assay for JAK2 and c-Src kinase inhibition. Ultra light poly GT (Perkin Elmer) was used as the substrate for JAK2 and c-Src with the ATP concentration of 10 μM and 50 μM, respectively. The Eu-labelled anti-phospho tyrosine antibody (Perkin Elmer) was added at 1 nM and the fluorescence emission at 615 nm and 665 nm was measured with an excitation wavelength of 340 nm.	B	Cc1ccc(NC(=O)c2cc(C(F)(F)F)ccn2)cc1N1CCc2nc(Nc3ccc(N4CCN(C)CC4)cc3)ncc2C1=O		CHEMBL3658118	=	IC50	nM	27.0	CHEMBL267	Homo sapiens	IC50	nM	27.0
278581	16282399	CHEMBL3707502	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	COc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)n(C)c34)c(Cl)c2Cl)cc1		CHEMBL3695586	=	IC50	nM	5.0	CHEMBL267	Homo sapiens	IC50	nM	5.0
281028	16282469	CHEMBL3707694	Millipore Kinase Panel Assay: Employing the Milipore panel of purified kinases EXAMPLE 87 (IC50=1 nM) inhibited 98% of purified Syk kinase activity at 50 nM. IC50 values were determined for those kinases that were inhibited by >80% at 300 nM in the Millipore kinase panel.	B	NC(=O)c1cnc(N[C@@H]2CCCC[C@@H]2N)nc1Nc1cccc(-n2nccn2)c1		CHEMBL2177736	=	IC50	nM	244.0	CHEMBL267	Homo sapiens	IC50	nM	244.0
213644	16283486	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccccn3)nnc2c1		CHEMBL218738	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
213696	16283535	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	COc1ccc(Nc2nnc3cc(-c4c(C)noc4C)cc(C)c3n2)cc1		CHEMBL3648038	=	IC50	nM	11700.0	CHEMBL267	Homo sapiens	IC50	nM	11700.0
213649	16284188	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1ccc(Nc2nnc3cc(-c4c(C)cccc4C)cc(C)c3n2)c(C)c1		CHEMBL441545	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
213852	16284322	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	CCN(CCN1CCCC1)S(=O)(=O)c1ccc(Nc2nnc3cc(-c4cc(O)ccc4Cl)cc(C)c3n2)cc1		CHEMBL250021	=	IC50	nM	3.2	CHEMBL267	Homo sapiens	IC50	nM	3.2
213764	16284611	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	COc1ccccc1-c1cc2nnc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nc2cc1C		CHEMBL3651211	=	IC50	nM	272.0	CHEMBL267	Homo sapiens	IC50	nM	272.0
286827	16284682	CHEMBL3707611	TR-FRET Assay: Compounds were screened in the TR-FRET assay for JAK2 and c-Src kinase inhibition. Ultra light poly GT (Perkin Elmer) was used as the substrate for JAK2 and c-Src with the ATP concentration of 10 μM and 50 μM, respectively. The Eu-labelled anti-phospho tyrosine antibody (Perkin Elmer) was added at 1 nM and the fluorescence emission at 615 nm and 665 nm was measured with an excitation wavelength of 340 nm.	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1N1CCc2nc(Nc3ccc(C(=O)NCCO)cc3)ncc2C1		CHEMBL3658098	=	IC50	nM	1.0	CHEMBL267	Homo sapiens	IC50	nM	1.0
286838	16284770	CHEMBL3707611	TR-FRET Assay: Compounds were screened in the TR-FRET assay for JAK2 and c-Src kinase inhibition. Ultra light poly GT (Perkin Elmer) was used as the substrate for JAK2 and c-Src with the ATP concentration of 10 μM and 50 μM, respectively. The Eu-labelled anti-phospho tyrosine antibody (Perkin Elmer) was added at 1 nM and the fluorescence emission at 615 nm and 665 nm was measured with an excitation wavelength of 340 nm.	B	CN1CCN(c2ccc(Nc3ncc4c(n3)CCN(c3cc(NC(=O)c5cccc(C(F)(F)F)c5)ccc3Cl)C4=O)cc2)CC1		CHEMBL3658115	=	IC50	nM	27.0	CHEMBL267	Homo sapiens	IC50	nM	27.0
213732	16284847	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(S(=O)(=O)NCCCN4CCCC4)cc3)nnc2c1		CHEMBL3648067	=	IC50	nM	29.2	CHEMBL267	Homo sapiens	IC50	nM	29.2
213662	16285041	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	COc1cc(OC)cc(-c2cc(C)c3nc(Nc4cccc(C)c4)nnc3c2)c1		CHEMBL3648018	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	nM	100000.0
213762	16285062	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc2nc(Nc3ccc(C(=O)N4CCN(C)CC4)cc3)nnc2cc1-c1cc(O)ccc1Cl		CHEMBL3651210	=	IC50	nM	3.4	CHEMBL267	Homo sapiens	IC50	nM	3.4
213641	16285160	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	CC(=O)Nc1nnc2cc(-c3c(C)cccc3C)cc(C)c2n1		CHEMBL221739	>	IC50	nM	1000.0	CHEMBL267	Homo sapiens	IC50	nM	1000.0
213772	16285348	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc2nc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nnc2cc1-c1cccc(CO)c1		CHEMBL3651218	=	IC50	nM	439.0	CHEMBL267	Homo sapiens	IC50	nM	439.0
213731	16287216	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3cccc(C(=O)NCCCN(C)C)c3)nnc2c1		CHEMBL3648066	=	IC50	nM	13.1	CHEMBL267	Homo sapiens	IC50	nM	13.1
213839	16287250	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2c(Cl)cccc2Cl)cc2nnc(Nc3ccc(C(=O)N4CCNCC4)cc3)nc12		CHEMBL3651266	=	IC50	nM	10.2	CHEMBL267	Homo sapiens	IC50	nM	10.2
213751	16287401	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	CC(=O)Nc1ccccc1-c1cc2nnc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nc2cc1C		CHEMBL3651201	=	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
213712	16287601	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(C(=O)NCCN(C)C)cc3)nnc2c1		CHEMBL3648050	=	IC50	nM	4.6	CHEMBL267	Homo sapiens	IC50	nM	4.6
213708	16287750	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(C(=O)NCCN4CCCC4)cc3)nnc2c1		CHEMBL3648048	=	IC50	nM	16.1	CHEMBL267	Homo sapiens	IC50	nM	16.1
213686	16289358	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2c(F)cccc2F)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL394518	=	IC50	nM	208.0	CHEMBL267	Homo sapiens	IC50	nM	208.0
278585	16289701	CHEMBL3707502	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)cnc34)c3ccccc23)n(-c2ccc(CO)cc2)n1		CHEMBL3695589	=	IC50	nM	11.0	CHEMBL267	Homo sapiens	IC50	nM	11.0
213668	16289703	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	CCOc1ccc(Nc2nnc3cc(-c4cc(OC)cc(OC)c4)cc(C)c3n2)cc1		CHEMBL3648024	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	nM	100000.0
213748	16290064	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1cc([N+](=O)[O-])c2nc(Nc3ccc(OCCN4CCCC4)cc3)n[n+]([O-])c2c1		CHEMBL3651200	=	IC50	nM	32.0	CHEMBL267	Homo sapiens	IC50	nM	32.0
213651	16290069	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1ccc(Nc2nnc3cc(-c4c(C)cccc4C)cc(C)c3n2)cc1C		CHEMBL220480	=	IC50	nM	957.0	CHEMBL267	Homo sapiens	IC50	nM	957.0
213672	16290225	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	COc1ccc(Nc2nnc3cc(-c4cc(OC)cc(OC)c4)cc(C)c3n2)cc1		CHEMBL3648027	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	nM	100000.0
213865	16290315	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2c(O)cccc2F)cc2nnc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nc12		CHEMBL3651282	=	IC50	nM	123.0	CHEMBL267	Homo sapiens	IC50	nM	123.0
286844	16291815	CHEMBL3707611	TR-FRET Assay: Compounds were screened in the TR-FRET assay for JAK2 and c-Src kinase inhibition. Ultra light poly GT (Perkin Elmer) was used as the substrate for JAK2 and c-Src with the ATP concentration of 10 μM and 50 μM, respectively. The Eu-labelled anti-phospho tyrosine antibody (Perkin Elmer) was added at 1 nM and the fluorescence emission at 615 nm and 665 nm was measured with an excitation wavelength of 340 nm.	B	CNC(=O)c1ccc(Nc2ncc3c(n2)CCN(c2cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc2Cl)C3)cc1		CHEMBL3639569	=	IC50	nM	13.0	CHEMBL267	Homo sapiens	IC50	nM	13.0
213678	16292097	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	CCN(CC)CCOc1ccc(Nc2nnc3cc(-c4c(C)cccc4C)cc(C)c3n2)cc1		CHEMBL218656	=	IC50	nM	9.67	CHEMBL267	Homo sapiens	IC50	nM	9.67
286829	16292289	CHEMBL3707611	TR-FRET Assay: Compounds were screened in the TR-FRET assay for JAK2 and c-Src kinase inhibition. Ultra light poly GT (Perkin Elmer) was used as the substrate for JAK2 and c-Src with the ATP concentration of 10 μM and 50 μM, respectively. The Eu-labelled anti-phospho tyrosine antibody (Perkin Elmer) was added at 1 nM and the fluorescence emission at 615 nm and 665 nm was measured with an excitation wavelength of 340 nm.	B	Cc1ccc(NC(=O)c2ccc(C(F)(F)F)s2)cc1N1CCc2nc(Nc3ccc(OCCN4CCCC4)cc3)ncc2C1		CHEMBL3658100	=	IC50	nM	2.0	CHEMBL267	Homo sapiens	IC50	nM	2.0
213753	16292319	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1cc(NS(C)(=O)=O)c2nc(Nc3ccc(OCCN4CCCC4)cc3)nnc2c1		CHEMBL390479	=	IC50	nM	20.4	CHEMBL267	Homo sapiens	IC50	nM	20.4
213878	16292321	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2c(Cl)ccc(O)c2F)cc2nnc(Nc3ccc(S(=O)(=O)N(C)CCN4CCCC4)cc3)nc12		CHEMBL3651292	=	IC50	nM	1.2	CHEMBL267	Homo sapiens	IC50	nM	1.2
213722	16292786	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3cccc(S(=O)(=O)N4CCN(C)CC4)c3)nnc2c1		CHEMBL436516	=	IC50	nM	322.0	CHEMBL267	Homo sapiens	IC50	nM	322.0
213872	16292912	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	CC(=O)Oc1ccc(Cl)c(-c2cc(C)c3nc(Nc4ccc(OCCN5CCCC5)cc4)nnc3c2)c1		CHEMBL271990	=	IC50	nM	53.2	CHEMBL267	Homo sapiens	IC50	nM	53.2
213819	16293057	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(S(=O)(=O)N(C)CCN4CCCC4)cc3)nc12		CHEMBL250019	=	IC50	nM	3.0	CHEMBL267	Homo sapiens	IC50	nM	3.0
213755	16293131	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1ccncc1-c1cc2nnc(Nc3ccc(C(=O)N4CCN(C)CC4)cc3)nc2cc1C		CHEMBL3651204	=	IC50	nM	47.2	CHEMBL267	Homo sapiens	IC50	nM	47.2
213636	16293157	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(OCCN4CCCC4)cc3)nnc2c1		CHEMBL436137	=	IC50	nM	6.8	CHEMBL267	Homo sapiens	IC50	nM	6.8
213653	16293171	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2ccccc2Cl)cc2nnc(Nc3ccccc3)nc12		CHEMBL3648014	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	nM	100000.0
213816	16293638	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(N4CCNCC4)nc3)nc12		CHEMBL3651255	=	IC50	nM	3.3	CHEMBL267	Homo sapiens	IC50	nM	3.3
278589	16294294	CHEMBL3707502	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)cnc34)c3ccccc23)s1		CHEMBL3695593	=	IC50	nM	17.0	CHEMBL267	Homo sapiens	IC50	nM	17.0
213638	16295635	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(C4(C#N)CC4)cc3)nnc2c1		CHEMBL3648009	=	IC50	nM	72.0	CHEMBL267	Homo sapiens	IC50	nM	72.0
213660	16295939	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3cccc(Cl)c3)nnc2c1		CHEMBL217961	=	IC50	nM	134.0	CHEMBL267	Homo sapiens	IC50	nM	134.0
213806	16295959	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(C(=O)N4CCNCC4)cc3)nc12		CHEMBL250214	=	IC50	nM	3.6	CHEMBL267	Homo sapiens	IC50	nM	3.6
213831	16296584	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	CC(=O)Nc1cccc(-c2cc(C)c3nc(Nc4ccc(OCCN5CCCC5)cc4)nnc3c2)c1		CHEMBL3651263	=	IC50	nM	3977.0	CHEMBL267	Homo sapiens	IC50	nM	3977.0
213795	16297112	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc2nc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nnc2cc1Br		CHEMBL397998	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
213646	16297251	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(Nc2nnc3cc(-c4c(C)cccc4C)cc(C)c3n2)c1		CHEMBL218742	=	IC50	nM	178.0	CHEMBL267	Homo sapiens	IC50	nM	178.0
286832	16297703	CHEMBL3707611	TR-FRET Assay: Compounds were screened in the TR-FRET assay for JAK2 and c-Src kinase inhibition. Ultra light poly GT (Perkin Elmer) was used as the substrate for JAK2 and c-Src with the ATP concentration of 10 μM and 50 μM, respectively. The Eu-labelled anti-phospho tyrosine antibody (Perkin Elmer) was added at 1 nM and the fluorescence emission at 615 nm and 665 nm was measured with an excitation wavelength of 340 nm.	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1N1CCc2nc(Nc3ccc(C(=O)N4CCN(C)CC4)cc3)ncc2C1=O		CHEMBL3658092	=	IC50	nM	19.0	CHEMBL267	Homo sapiens	IC50	nM	19.0
213725	16297922	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3nc(C(=O)NCCN4CCCC4)cs3)nnc2c1		CHEMBL3648061	=	IC50	nM	14.6	CHEMBL267	Homo sapiens	IC50	nM	14.6
213635	16298108	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1cc(C)c2nc(NCCCN3CCN(C)CC3)nnc2c1		CHEMBL3648008	=	IC50	nM	9000.0	CHEMBL267	Homo sapiens	IC50	nM	9000.0
213867	16298434	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(C(=O)N(C)CCN4CCCC4)cc3)nc12		CHEMBL3651284	=	IC50	nM	1.6	CHEMBL267	Homo sapiens	IC50	nM	1.6
213759	16298442	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc2nc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nnc2cc1-c1ccccc1N		CHEMBL3651208	=	IC50	nM	91.8	CHEMBL267	Homo sapiens	IC50	nM	91.8
286846	16298570	CHEMBL3707611	TR-FRET Assay: Compounds were screened in the TR-FRET assay for JAK2 and c-Src kinase inhibition. Ultra light poly GT (Perkin Elmer) was used as the substrate for JAK2 and c-Src with the ATP concentration of 10 μM and 50 μM, respectively. The Eu-labelled anti-phospho tyrosine antibody (Perkin Elmer) was added at 1 nM and the fluorescence emission at 615 nm and 665 nm was measured with an excitation wavelength of 340 nm.	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1N1CCc2nc(Nc3ccc(N4CCNCC4)cc3)ncc2C1=O		CHEMBL3658125	=	IC50	nM	17.0	CHEMBL267	Homo sapiens	IC50	nM	17.0
213885	16299278	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2c(Cl)ccc(O)c2Cl)cc2nnc(Nc3ccc(S(=O)(=O)N(C)CCN4CCCC4)cc3)nc12		CHEMBL3651295	=	IC50	nM	3.6	CHEMBL267	Homo sapiens	IC50	nM	3.6
213781	16300112	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(C(=O)NCCN4CCCC4)o3)nc12		CHEMBL3651225	=	IC50	nM	12.2	CHEMBL267	Homo sapiens	IC50	nM	12.2
213650	16300377	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1ccc(C)c(Nc2nnc3cc(-c4c(C)cccc4C)cc(C)c3n2)c1		CHEMBL374868	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
213882	16300380	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1ccc(C(=O)Oc2ccc(Cl)c(-c3cc(C)c4nc(Nc5ccc(OCCN6CCCC6)cc5)nnc4c3)c2)cc1		CHEMBL403990	=	IC50	nM	267.0	CHEMBL267	Homo sapiens	IC50	nM	267.0
213846	16300487	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1nc(Nc2nnc3cc(-c4c(Cl)cccc4Cl)cc(C)c3n2)cc(OCCN2CCCC2)n1		CHEMBL3651272	=	IC50	nM	365.0	CHEMBL267	Homo sapiens	IC50	nM	365.0
213844	16301097	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1nc(Nc2nnc3cc(-c4c(Cl)cccc4Cl)cc(C)c3n2)cc(N2CCN(CCO)CC2)n1		CHEMBL3651270	=	IC50	nM	383.0	CHEMBL267	Homo sapiens	IC50	nM	383.0
286849	16301469	CHEMBL3707611	TR-FRET Assay: Compounds were screened in the TR-FRET assay for JAK2 and c-Src kinase inhibition. Ultra light poly GT (Perkin Elmer) was used as the substrate for JAK2 and c-Src with the ATP concentration of 10 μM and 50 μM, respectively. The Eu-labelled anti-phospho tyrosine antibody (Perkin Elmer) was added at 1 nM and the fluorescence emission at 615 nm and 665 nm was measured with an excitation wavelength of 340 nm.	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1N1CCc2nc(Nc3ccc(C(=O)N4CCN(C)CC4)cc3)ncc2C1		CHEMBL3658087	=	IC50	nM	2.0	CHEMBL267	Homo sapiens	IC50	nM	2.0
213674	16301681	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	COc1cccc(Nc2nnc3cc(-c4c(Cl)cccc4Cl)cc(C)c3n2)c1		CHEMBL3648028	=	IC50	nM	189.0	CHEMBL267	Homo sapiens	IC50	nM	189.0
213697	16301997	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(C(=O)N4CCN(C)CC4)cc3)nnc2c1		CHEMBL3648039	=	IC50	nM	8.9	CHEMBL267	Homo sapiens	IC50	nM	8.9
278574	16302082	CHEMBL3707502	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)cnc34)c3ccccc23)cc1		CHEMBL1214134	=	IC50	nM	9.0	CHEMBL267	Homo sapiens	IC50	nM	9.0
213860	16302327	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(CN(CCO)C(C)C)cc3)nc12		CHEMBL3651279	=	IC50	nM	1.5	CHEMBL267	Homo sapiens	IC50	nM	1.5
213800	16302427	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	CCOc1cc2nc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nnc2cc1-c1ccccc1C		CHEMBL3651242	=	IC50	nM	27.2	CHEMBL267	Homo sapiens	IC50	nM	27.2
213724	16303060	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(S(=O)(=O)NCCN(C)C)cc3)nnc2c1		CHEMBL3648060	=	IC50	nM	14.6	CHEMBL267	Homo sapiens	IC50	nM	14.6
286833	16303088	CHEMBL3707611	TR-FRET Assay: Compounds were screened in the TR-FRET assay for JAK2 and c-Src kinase inhibition. Ultra light poly GT (Perkin Elmer) was used as the substrate for JAK2 and c-Src with the ATP concentration of 10 μM and 50 μM, respectively. The Eu-labelled anti-phospho tyrosine antibody (Perkin Elmer) was added at 1 nM and the fluorescence emission at 615 nm and 665 nm was measured with an excitation wavelength of 340 nm.	B	Cc1ccc(NC(=O)CC(C)C(F)(F)F)cc1N1CCc2nc(Nc3ccc(N4CCN(C)CC4)cc3)ncc2C1		CHEMBL3658106	=	IC50	nM	3.0	CHEMBL267	Homo sapiens	IC50	nM	3.0
286822	16303526	CHEMBL3707611	TR-FRET Assay: Compounds were screened in the TR-FRET assay for JAK2 and c-Src kinase inhibition. Ultra light poly GT (Perkin Elmer) was used as the substrate for JAK2 and c-Src with the ATP concentration of 10 μM and 50 μM, respectively. The Eu-labelled anti-phospho tyrosine antibody (Perkin Elmer) was added at 1 nM and the fluorescence emission at 615 nm and 665 nm was measured with an excitation wavelength of 340 nm.	B	CNC(=O)c1ccc(Nc2ncc3c(n2)CCN(c2cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc2C)C3)cn1		CHEMBL3658094	=	IC50	nM	4.0	CHEMBL267	Homo sapiens	IC50	nM	4.0
213856	16303673	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3cccc(SCCN4CCCC4)c3)nc12		CHEMBL3651276	=	IC50	nM	3.4	CHEMBL267	Homo sapiens	IC50	nM	3.4
213770	16303788	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc2nc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nnc2cc1-c1cccc(Cl)c1Cl		CHEMBL3651216	=	IC50	nM	142.0	CHEMBL267	Homo sapiens	IC50	nM	142.0
213659	16304272	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	CCOc1ccc(Nc2nnc3cc(-c4c(C)cccc4C)cc(C)c3n2)cc1		CHEMBL221431	=	IC50	nM	108.0	CHEMBL267	Homo sapiens	IC50	nM	108.0
278597	16304341	CHEMBL3707502	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	Cc1ccc(-n2nc(C3(C)CC3)cc2NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)cnc34)c3ccccc23)cc1		CHEMBL3695577	=	IC50	nM	10.0	CHEMBL267	Homo sapiens	IC50	nM	10.0
213866	16304535	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc2nc(Nc3ccc(S(=O)(=O)N(C)CCN4CCCC4)cc3)nnc2cc1-c1cc(O)ccc1Cl		CHEMBL3651283	=	IC50	nM	3.7	CHEMBL267	Homo sapiens	IC50	nM	3.7
213740	16304725	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(S(=O)(=O)N4CCNCC4)cc3)nnc2c1		CHEMBL218281	=	IC50	nM	128.0	CHEMBL267	Homo sapiens	IC50	nM	128.0
213812	16304749	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc2nc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nnc2cc1N(CCOCCO)C(C)C		CHEMBL3651251	=	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
213630	16305234	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccccc3)nnc2c1		CHEMBL374248	=	IC50	nM	294.0	CHEMBL267	Homo sapiens	IC50	nM	294.0
213838	16306856	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2ccccc2)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL230685	=	IC50	nM	341.0	CHEMBL267	Homo sapiens	IC50	nM	341.0
213814	16306917	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3cccc(S(=O)(=O)NCCN(C)C)c3)nc12		CHEMBL3651253	=	IC50	nM	4.2	CHEMBL267	Homo sapiens	IC50	nM	4.2
213700	16307047	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1noc(C)c1-c1cc(C)c2nc(Nc3ccc(OCCN4CCN(C)CC4)cc3)nnc2c1		CHEMBL3648041	=	IC50	nM	610.0	CHEMBL267	Homo sapiens	IC50	nM	610.0
213847	16307066	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(S(=O)(=O)N4CCN(C)CC4)cc3)nc12		CHEMBL3651273	=	IC50	nM	63.4	CHEMBL267	Homo sapiens	IC50	nM	63.4
213827	16307501	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3cccc(S(=O)(=O)N4CCN(C)CC4)c3)nc12		CHEMBL3651261	=	IC50	nM	433.0	CHEMBL267	Homo sapiens	IC50	nM	433.0
213629	16307878	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1ccc2nc(NCCN3CCN(C)CC3)nnc2c1		CHEMBL3648005	=	IC50	nM	5800.0	CHEMBL267	Homo sapiens	IC50	nM	5800.0
213757	16307913	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1ccc(Cl)cc1-c1cc2nnc(Nc3ccc(C(=O)N4CCN(C)CC4)cc3)nc2cc1C		CHEMBL3651206	=	IC50	nM	7.9	CHEMBL267	Homo sapiens	IC50	nM	7.9
213710	16308287	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	COc1ccc(Cl)c(-c2cc(C)c3nc(Nc4ccc(OCCN5CCCC5)cc4)nnc3c2)c1		CHEMBL394765	=	IC50	nM	788.0	CHEMBL267	Homo sapiens	IC50	nM	788.0
213715	16308513	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2c(Cl)cccc2Cl)cc2nnc(Nc3ccc(C#N)c(OCCN4CCCC4)c3)nc12		CHEMBL3648053	=	IC50	nM	21.0	CHEMBL267	Homo sapiens	IC50	nM	21.0
213661	16308533	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(Cl)c(Cl)c3)nnc2c1		CHEMBL3648017	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	nM	100000.0
213663	16308810	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	COc1cc(OC)cc(-c2cc(C)c3nc(Nc4ccc(C)cc4)nnc3c2)c1		CHEMBL3648019	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	nM	100000.0
286824	16309025	CHEMBL3707611	TR-FRET Assay: Compounds were screened in the TR-FRET assay for JAK2 and c-Src kinase inhibition. Ultra light poly GT (Perkin Elmer) was used as the substrate for JAK2 and c-Src with the ATP concentration of 10 μM and 50 μM, respectively. The Eu-labelled anti-phospho tyrosine antibody (Perkin Elmer) was added at 1 nM and the fluorescence emission at 615 nm and 665 nm was measured with an excitation wavelength of 340 nm.	B	Cc1ccc(NC(=O)c2cccc(C(C)(C)C)c2)cc1N1CCc2nc(Nc3ccc(N4CCN(C)CC4)cc3)ncc2C1=O		CHEMBL3658095	=	IC50	nM	28.0	CHEMBL267	Homo sapiens	IC50	nM	28.0
213684	16309103	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	CCN(CC)CCOc1cccc(Nc2nnc3cc(-c4c(C)cccc4C)cc(C)c3n2)c1		CHEMBL218102	=	IC50	nM	10.2	CHEMBL267	Homo sapiens	IC50	nM	10.2
213832	16309557	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	CNc1cccc(-c2cc(C)c3nc(Nc4ccc(S(=O)(=O)NCCN5CCCC5)cc4)nnc3c2)c1		CHEMBL231627	=	IC50	nM	631.0	CHEMBL267	Homo sapiens	IC50	nM	631.0
213810	16309565	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(N4CCOCC4)nc3)nc12		CHEMBL3651249	=	IC50	nM	6.8	CHEMBL267	Homo sapiens	IC50	nM	6.8
213706	16309591	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2c(Cl)cccc2Cl)cc2nnc(Nc3cccc(OCCCN4CCN(C)CC4)c3)nc12		CHEMBL3648046	=	IC50	nM	28.8	CHEMBL267	Homo sapiens	IC50	nM	28.8
213760	16309670	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc2nc(Nc3ccc(OCCN4CCCC4)cc3)nnc2cc1-c1sccc1C		CHEMBL3651209	=	IC50	nM	60.7	CHEMBL267	Homo sapiens	IC50	nM	60.7
213711	16309803	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3cccc(S(N)(=O)=O)c3)nnc2c1		CHEMBL218597	=	IC50	nM	143.0	CHEMBL267	Homo sapiens	IC50	nM	143.0
213773	16309827	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3cccnc3)nc12		CHEMBL3651219	=	IC50	nM	6.5	CHEMBL267	Homo sapiens	IC50	nM	6.5
213655	16310643	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	CCCCc1ccc(Nc2nnc3cc(-c4c(C)cccc4C)cc(C)c3n2)cc1		CHEMBL218842	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	nM	100000.0
213721	16311299	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(C(=O)NCCN4CCCC4)o3)nnc2c1		CHEMBL3648058	=	IC50	nM	17.5	CHEMBL267	Homo sapiens	IC50	nM	17.5
278590	16312113	CHEMBL3707502	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	COc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)cnc34)c3ccccc23)cc1		CHEMBL3695573	=	IC50	nM	406.0	CHEMBL267	Homo sapiens	IC50	nM	406.0
286848	16312198	CHEMBL3707611	TR-FRET Assay: Compounds were screened in the TR-FRET assay for JAK2 and c-Src kinase inhibition. Ultra light poly GT (Perkin Elmer) was used as the substrate for JAK2 and c-Src with the ATP concentration of 10 μM and 50 μM, respectively. The Eu-labelled anti-phospho tyrosine antibody (Perkin Elmer) was added at 1 nM and the fluorescence emission at 615 nm and 665 nm was measured with an excitation wavelength of 340 nm.	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1N1CCc2nc(Nc3ccc(OCCN4CCCC4)cc3)ncc2C1=O		CHEMBL3658086	=	IC50	nM	16.0	CHEMBL267	Homo sapiens	IC50	nM	16.0
213884	16312214	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2cc(OC(=O)C(C)C)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL272233	=	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
273853	16312294	CHEMBL3707805	Kinase Inhibition Assay: The compound of Example 39, 2-(1H-indol-5-ylamino)-6-(2,4-difluorophenylsulfonyl)-8-methylpyrido[2,3-d]pyrimidin-7(8H)-one, was subjected to a kinase inhibition assay for the kinases. Compounds were tested in 5 dose IC50 mode with 10-fold serial dilution starting at 10 μM. Staurosporine, a known protein kinase inhibitor, was tested in 5-dose IC50 mode with 3-fold serial dilution starting at 20 μM. Reactions were carried out in 10 μM ATP. The results are shown in Table 5. The results show that the compound of Example 39 is a kinase inhibitor highly selective for the kinase Plk2.	B	Cn1c(=O)c(Sc2ccc(F)cc2)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3702566	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
213709	16312747	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	COC(=O)c1ccc(Nc2nnc3cc(-c4c(C)cccc4C)cc(C)c3n2)o1		CHEMBL3648049	=	IC50	nM	1000.0	CHEMBL267	Homo sapiens	IC50	nM	1000.0
213707	16312753	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(C(=O)N4CCN(C)CC4)cc3)n[n+]([O-])c2c1		CHEMBL3648047	=	IC50	nM	96.1	CHEMBL267	Homo sapiens	IC50	nM	96.1
213811	16312942	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3cccc(OCCN4CCCC4)c3)nc12		CHEMBL3651250	=	IC50	nM	1.8	CHEMBL267	Homo sapiens	IC50	nM	1.8
213863	16313185	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2c(O)cccc2Cl)cc2nnc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nc12		CHEMBL231220	=	IC50	nM	12.6	CHEMBL267	Homo sapiens	IC50	nM	12.6
213841	16313706	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc2nc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nnc2cc1-c1cccc(C(N)=O)c1		CHEMBL3651267	=	IC50	nM	2216.0	CHEMBL267	Homo sapiens	IC50	nM	2216.0
278572	16313813	CHEMBL3707502	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)[nH]c34)c3ncccc23)n(-c2ccccc2)n1		CHEMBL3695570	=	IC50	nM	0.9	CHEMBL267	Homo sapiens	IC50	nM	0.9
213789	16315348	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	CC(=O)Nc1cc(-c2c(C)cccc2C)cc2nnc(Nc3ccc(C(=O)NCCN4CCCC4)o3)nc12		CHEMBL3651232	=	IC50	nM	137.0	CHEMBL267	Homo sapiens	IC50	nM	137.0
213850	16315454	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(S(=O)(=O)C4CCNCC4)cc3)nc12		CHEMBL250625	=	IC50	nM	5.2	CHEMBL267	Homo sapiens	IC50	nM	5.2
213877	16315692	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2c(F)ccc(O)c2F)cc2nnc(Nc3ccc(S(=O)(=O)CCCN4CCCC4)cc3)nc12		CHEMBL3651291	=	IC50	nM	3.8	CHEMBL267	Homo sapiens	IC50	nM	3.8
213690	16317083	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	COc1ccc(Nc2nnc3cc(-c4c(C)cccc4C)cc(C)c3n2)cn1		CHEMBL3648034	=	IC50	nM	341.0	CHEMBL267	Homo sapiens	IC50	nM	341.0
278578	16317194	CHEMBL3707502	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	COc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)n(C)c34)c3ccccc23)cc1		CHEMBL3695583	=	IC50	nM	7.0	CHEMBL267	Homo sapiens	IC50	nM	7.0
304678	16317439	CHEMBL3706162	Enzyme Inhibition Assay: The kinase enzyme binding activities of compounds disclosed herein were determined using a proprietary assay which measures active site-directed competition binding to an immobilized ligand (Fabian, M. A. et al., Nature Biotechnol., 2005, 23:329-336). These assays were conducted by DiscoverX (formerly Ambit; San Diego, Calif.). The Kd value (Dissociation constant value) was calculated as the index of affinity of the compounds to each kinase. The enzyme inhibitory activities of compounds disclosed herein were determined by FRET using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen Ltd., Paisley, UK). The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), were evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) was incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccccc4)n3)c3ccccc23)cc1		CHEMBL3701217	=	Kd	nM	10.0	CHEMBL267	Homo sapiens	Kd	nM	10.0
213808	16318195	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Oc1ccc(Cl)c(-c2cc(OCCN3CCCC3)c3nc(Nc4cccnc4)nnc3c2)c1		CHEMBL3651247	=	IC50	nM	46.5	CHEMBL267	Homo sapiens	IC50	nM	46.5
213652	16318610	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(F)c(Cl)c3)nnc2c1		CHEMBL3648013	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
213807	16319320	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc2nc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nnc2cc1-c1cc(O)ccc1Cl		CHEMBL3651246	=	IC50	nM	1.6	CHEMBL267	Homo sapiens	IC50	nM	1.6
213823	16319655	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(C(=O)N4CCN(CCO)CC4)nc3)nc12		CHEMBL3651259	=	IC50	nM	10.3	CHEMBL267	Homo sapiens	IC50	nM	10.3
213768	16319835	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2cccc3cc[nH]c23)cc2nnc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nc12		CHEMBL3651214	=	IC50	nM	339.0	CHEMBL267	Homo sapiens	IC50	nM	339.0
213809	16320023	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1ccccc1-c1cc2nnc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nc2cc1OCCO		CHEMBL3651248	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
213777	16320426	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nc12		CHEMBL249821	=	IC50	nM	3.6	CHEMBL267	Homo sapiens	IC50	nM	3.6
286834	16320608	CHEMBL3707611	TR-FRET Assay: Compounds were screened in the TR-FRET assay for JAK2 and c-Src kinase inhibition. Ultra light poly GT (Perkin Elmer) was used as the substrate for JAK2 and c-Src with the ATP concentration of 10 μM and 50 μM, respectively. The Eu-labelled anti-phospho tyrosine antibody (Perkin Elmer) was added at 1 nM and the fluorescence emission at 615 nm and 665 nm was measured with an excitation wavelength of 340 nm.	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1N1CCc2nc(Nc3ccc(C(=O)N4CCN(C)CC4)nc3)ncc2C1		CHEMBL3658108	=	IC50	nM	5.0	CHEMBL267	Homo sapiens	IC50	nM	5.0
213881	16321640	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	CC(=O)Oc1ccc(Cl)c(-c2cc(C)c3nc(Nc4cccc(OCCN5CCCC5)c4)nnc3c2)c1		CHEMBL3651294	=	IC50	nM	133.0	CHEMBL267	Homo sapiens	IC50	nM	133.0
213845	16321904	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1nc(Nc2nnc3cc(-c4cc(O)ccc4Cl)cc(C)c3n2)cc(N2CCN(CCO)CC2)n1		CHEMBL3651271	=	IC50	nM	68.8	CHEMBL267	Homo sapiens	IC50	nM	68.8
213796	16322000	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	COc1ccc(Nc2nnc3cc(-c4cc(O)ccc4Cl)cc(C)c3n2)cn1		CHEMBL3651238	=	IC50	nM	11.2	CHEMBL267	Homo sapiens	IC50	nM	11.2
213666	16322075	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	COc1cc(OC)cc(-c2cc(C)c3nc(Nc4ccc(C)c(C)c4)nnc3c2)c1		CHEMBL3648022	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	nM	100000.0
213818	16322655	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(C(=O)N4CCN(C)CC4)cc3)nc12		CHEMBL399246	=	IC50	nM	2.9	CHEMBL267	Homo sapiens	IC50	nM	2.9
278587	16322706	CHEMBL3707502	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)cnc34)c(Cl)c2Cl)n(-c2ccc(CO)cc2)n1		CHEMBL3695591	=	IC50	nM	7.0	CHEMBL267	Homo sapiens	IC50	nM	7.0
213643	16323209	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3cccc4cccnc34)nnc2c1		CHEMBL218160	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
213843	16323233	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2c(Cl)cccc2Cl)cc2nnc(Nc3ccc(O)cc3)nc12		CHEMBL3651269	=	IC50	nM	281.0	CHEMBL267	Homo sapiens	IC50	nM	281.0
273885	16323507	CHEMBL3707805	Kinase Inhibition Assay: The compound of Example 39, 2-(1H-indol-5-ylamino)-6-(2,4-difluorophenylsulfonyl)-8-methylpyrido[2,3-d]pyrimidin-7(8H)-one, was subjected to a kinase inhibition assay for the kinases. Compounds were tested in 5 dose IC50 mode with 10-fold serial dilution starting at 10 μM. Staurosporine, a known protein kinase inhibitor, was tested in 5-dose IC50 mode with 3-fold serial dilution starting at 20 μM. Reactions were carried out in 10 μM ATP. The results are shown in Table 5. The results show that the compound of Example 39 is a kinase inhibitor highly selective for the kinase Plk2.	B	CN[C@H]1CC2OC([C@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(O)=NC4		CHEMBL3975634	=	IC50	nM	4.01	CHEMBL267	Homo sapiens	IC50	nM	4.01
213702	16323788	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccnc(OCCN4CCCC4)c3)nnc2c1		CHEMBL437004	=	IC50	nM	5.6	CHEMBL267	Homo sapiens	IC50	nM	5.6
213758	16324162	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc2nc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nnc2cc1-c1ccccc1NS(C)(=O)=O		CHEMBL3651207	=	IC50	nM	5000.0	CHEMBL267	Homo sapiens	IC50	nM	5000.0
213756	16324988	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1ccncc1-c1cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc2cc1C		CHEMBL3651205	=	IC50	nM	44.3	CHEMBL267	Homo sapiens	IC50	nM	44.3
213739	16325019	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3cccc(S(=O)(=O)NCCN4CCNCC4)c3)nnc2c1		CHEMBL3651196	=	IC50	nM	28.8	CHEMBL267	Homo sapiens	IC50	nM	28.8
278591	16325061	CHEMBL3707502	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	COc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCc3ccnc4[nH]c(=O)cnc34)c3ccccc23)cc1		CHEMBL3695594	=	IC50	nM	35.0	CHEMBL267	Homo sapiens	IC50	nM	35.0
213829	16325912	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1ccc(C#N)cc1-c1cc(C)c2nc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nnc2c1		CHEMBL231316	=	IC50	nM	25.2	CHEMBL267	Homo sapiens	IC50	nM	25.2
213868	16326455	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2c(Cl)ccc(O)c2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL3651285	=	IC50	nM	1.1	CHEMBL267	Homo sapiens	IC50	nM	1.1
213746	16326841	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc2nc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nnc2cc1-c1ccccc1		CHEMBL230918	=	IC50	nM	315.0	CHEMBL267	Homo sapiens	IC50	nM	315.0
213745	16327364	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1ccccc1-c1cc2nnc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nc2cc1C		CHEMBL231237	=	IC50	nM	10.2	CHEMBL267	Homo sapiens	IC50	nM	10.2
278596	16327667	CHEMBL3707502	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	Cc1ccc(-n2nc(C3CC3)cc2NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)cnc34)c3ccccc23)cc1		CHEMBL3695576	=	IC50	nM	22.0	CHEMBL267	Homo sapiens	IC50	nM	22.0
213744	16327995	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2c(Cl)cccc2Cl)cc2nnc(Nc3ccnc(OCCN4CCCC4)c3)nc12		CHEMBL3651198	=	IC50	nM	12.2	CHEMBL267	Homo sapiens	IC50	nM	12.2
286831	16328182	CHEMBL3707611	TR-FRET Assay: Compounds were screened in the TR-FRET assay for JAK2 and c-Src kinase inhibition. Ultra light poly GT (Perkin Elmer) was used as the substrate for JAK2 and c-Src with the ATP concentration of 10 μM and 50 μM, respectively. The Eu-labelled anti-phospho tyrosine antibody (Perkin Elmer) was added at 1 nM and the fluorescence emission at 615 nm and 665 nm was measured with an excitation wavelength of 340 nm.	B	Cc1ccc(NC(=O)CC2CCCC2)cc1N1CCc2nc(Nc3ccc(OCCN4CCCC4)cc3)ncc2C1		CHEMBL3658102	=	IC50	nM	1.0	CHEMBL267	Homo sapiens	IC50	nM	1.0
213642	16328778	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1cc(C)c2nc(NC(=O)c3ccccc3)nnc2c1		CHEMBL218598	=	IC50	nM	1800.0	CHEMBL267	Homo sapiens	IC50	nM	1800.0
286852	16328881	CHEMBL3707611	TR-FRET Assay: Compounds were screened in the TR-FRET assay for JAK2 and c-Src kinase inhibition. Ultra light poly GT (Perkin Elmer) was used as the substrate for JAK2 and c-Src with the ATP concentration of 10 μM and 50 μM, respectively. The Eu-labelled anti-phospho tyrosine antibody (Perkin Elmer) was added at 1 nM and the fluorescence emission at 615 nm and 665 nm was measured with an excitation wavelength of 340 nm.	B	Cc1ccc(NC(=O)c2cccc(Br)c2)cc1N1CCc2nc(Nc3ccc(N4CCN(C)CC4)cc3)ncc2C1=O		CHEMBL3658090	=	IC50	nM	19.0	CHEMBL267	Homo sapiens	IC50	nM	19.0
286837	16328933	CHEMBL3707611	TR-FRET Assay: Compounds were screened in the TR-FRET assay for JAK2 and c-Src kinase inhibition. Ultra light poly GT (Perkin Elmer) was used as the substrate for JAK2 and c-Src with the ATP concentration of 10 μM and 50 μM, respectively. The Eu-labelled anti-phospho tyrosine antibody (Perkin Elmer) was added at 1 nM and the fluorescence emission at 615 nm and 665 nm was measured with an excitation wavelength of 340 nm.	B	Cc1ccc(NC(=O)CC(C)C(F)(F)F)cc1N1CCc2nc(Nc3ccc(OCCN4CCCC4)cc3)ncc2C1		CHEMBL3658113	=	IC50	nM	2.0	CHEMBL267	Homo sapiens	IC50	nM	2.0
213735	16329022	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3cccc(S(=O)(=O)N4CCN(C(=O)OC(C)(C)C)CC4)c3)nnc2c1		CHEMBL3648070	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
213822	16329560	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(C(=O)NCCN4CCCC4)nc3)nc12		CHEMBL3651258	=	IC50	nM	2.6	CHEMBL267	Homo sapiens	IC50	nM	2.6
213761	16329637	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc2nc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nnc2cc1-c1ccccc1C(F)(F)F		CHEMBL231338	=	IC50	nM	66.5	CHEMBL267	Homo sapiens	IC50	nM	66.5
213859	16329918	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(C(=O)N4CCS(=O)(=O)CC4)cc3)nc12		CHEMBL249819	=	IC50	nM	3.0	CHEMBL267	Homo sapiens	IC50	nM	3.0
213835	16330262	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2c(Cl)cccc2Cl)cc2nnc(Nc3ccc(S(=O)(=O)N4CCNCC4)cc3)nc12		CHEMBL3651264	=	IC50	nM	60.5	CHEMBL267	Homo sapiens	IC50	nM	60.5
213742	16330442	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc2nc(Nc3ccc(OCCN4CCCC4)cc3)nnc2cc1-c1c(C)cccc1C		CHEMBL230272	=	IC50	nM	12.3	CHEMBL267	Homo sapiens	IC50	nM	12.3
213883	16330547	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2cc(OC(=O)C(C)(C)C)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL270490	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
278601	16330599	CHEMBL3707502	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	CSc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)cnc34)c3ccccc23)cc1		CHEMBL3695581	=	IC50	nM	7.0	CHEMBL267	Homo sapiens	IC50	nM	7.0
213680	16330639	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(OCCCN4CCCC4)cc3)nnc2c1		CHEMBL397692	=	IC50	nM	12.6	CHEMBL267	Homo sapiens	IC50	nM	12.6
213778	16331321	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	CC(=O)Nc1cc2nc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nnc2cc1-c1ccccc1C		CHEMBL3651222	=	IC50	nM	111.0	CHEMBL267	Homo sapiens	IC50	nM	111.0
213763	16331665	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	=	IC50	nM	1.6	CHEMBL267	Homo sapiens	IC50	nM	1.6
213779	16331723	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc2nc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nnc2cc1-c1ccc(Cl)s1		CHEMBL3651223	=	IC50	nM	880.0	CHEMBL267	Homo sapiens	IC50	nM	880.0
286853	16331738	CHEMBL3707611	TR-FRET Assay: Compounds were screened in the TR-FRET assay for JAK2 and c-Src kinase inhibition. Ultra light poly GT (Perkin Elmer) was used as the substrate for JAK2 and c-Src with the ATP concentration of 10 μM and 50 μM, respectively. The Eu-labelled anti-phospho tyrosine antibody (Perkin Elmer) was added at 1 nM and the fluorescence emission at 615 nm and 665 nm was measured with an excitation wavelength of 340 nm.	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1N1CCc2nc(Nc3ccc(C(=O)NCCCN4CCCC4)cc3)ncc2C1=O		CHEMBL3658091	=	IC50	nM	17.0	CHEMBL267	Homo sapiens	IC50	nM	17.0
213830	16332120	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2cccc(NS(C)(=O)=O)c2)cc2nnc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nc12		CHEMBL230815	=	IC50	nM	2900.0	CHEMBL267	Homo sapiens	IC50	nM	2900.0
306881	16332300	CHEMBL3705393	Inhibition Assay: The inhibitory activity measurement against the kinases mentioned above was measured in the kinase inhibition reaction mixture containing 2 ul purified kinase protein (10-50 ng), 20 mM Tris-HCl, pH 8.0, 5 mM MgCl2, 0.5 mM dithiothreitol, 0.01 mM ATP, 4 ug of poly(D4Y)n peptide substrate (Promega), 0.2 uCi of 32P-ATP and the each compound shown in tablel. The mixture was incubated for 15 min at 30° C. and the reaction was then ended by adding a half volume of 30% phosphoric acid solution. Subsequently, the reaction mixture solution was spotted in avidin coated membrane (Promega). This membrane was washed using 50 mM phosphate, 0.1N NaCl buffer (pH 6.0) solution for 10 min 5 times and then the radioactivity of each spot was quantified by using a BAS image analyzer (Fuji).	B	Oc1cccc(Nc2ccnc3cc(-c4cccc(CN5CCOCC5)c4)sc23)c1		CHEMBL2336005	=	IC50	nM	1.3	CHEMBL267	Homo sapiens	IC50	nM	1.3
213648	16332466	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(Nc2nnc3cc(-c4c(C)cccc4C)cc(C)c3n2)c1C		CHEMBL218551	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
278577	16332827	CHEMBL3707502	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	COc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)[nH]c34)c3ccccc23)cc1		CHEMBL3695582	=	IC50	nM	7.0	CHEMBL267	Homo sapiens	IC50	nM	7.0
286854	16333130	CHEMBL3707611	TR-FRET Assay: Compounds were screened in the TR-FRET assay for JAK2 and c-Src kinase inhibition. Ultra light poly GT (Perkin Elmer) was used as the substrate for JAK2 and c-Src with the ATP concentration of 10 μM and 50 μM, respectively. The Eu-labelled anti-phospho tyrosine antibody (Perkin Elmer) was added at 1 nM and the fluorescence emission at 615 nm and 665 nm was measured with an excitation wavelength of 340 nm.	B	Cc1ccc(NC(=O)CC(C)C(F)(F)F)cc1N1CCc2nc(Nc3ccc(OCCN4CCN(C)CC4)cc3)ncc2C1		CHEMBL3658114	=	IC50	nM	66.0	CHEMBL267	Homo sapiens	IC50	nM	66.0
213792	16333280	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc2nc(Nc3cccnc3)nnc2cc1-c1cc(O)ccc1F		CHEMBL3651235	=	IC50	nM	26.8	CHEMBL267	Homo sapiens	IC50	nM	26.8
213728	16334391	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3cccc(C(=O)NC4CCNC4)c3)nnc2c1		CHEMBL3648064	=	IC50	nM	18.3	CHEMBL267	Homo sapiens	IC50	nM	18.3
213871	16334529	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2c(Cl)ccc(O)c2Cl)cc2nnc(Nc3ccc(S(=O)(=O)C4CCNCC4)cc3)nc12		CHEMBL3651287	=	IC50	nM	2.4	CHEMBL267	Homo sapiens	IC50	nM	2.4
213691	16334654	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	COc1ccc(Cl)cc1-c1cc(C)c2nc(Nc3ccc(OCCN4CCCC4)cc3)nnc2c1		CHEMBL230793	=	IC50	nM	1200.0	CHEMBL267	Homo sapiens	IC50	nM	1200.0
278571	16334774	CHEMBL3707502	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)n(C)c34)c3ccccc23)cc1		CHEMBL1090979	=	IC50	nM	4.0	CHEMBL267	Homo sapiens	IC50	nM	4.0
213738	16334826	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(C(=O)N4CCNCC4)cc3)nnc2c1		CHEMBL3651195	=	IC50	nM	11.9	CHEMBL267	Homo sapiens	IC50	nM	11.9
213654	16334938	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	COc1ccc(Nc2nnc3cc(-c4ccccc4OC)cc(C)c3n2)cc1		CHEMBL3648015	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
213736	16335536	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3cccc(S(=O)(=O)N4CCNCC4)c3)nnc2c1		CHEMBL218049	=	IC50	nM	48.2	CHEMBL267	Homo sapiens	IC50	nM	48.2
278595	16335574	CHEMBL3707502	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)cnc34)c3ccccc23)n(-c2ccc(Cl)cc2)n1		CHEMBL3695575	=	IC50	nM	16.0	CHEMBL267	Homo sapiens	IC50	nM	16.0
213734	16335772	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ncc(C(=O)NCCN4CCCC4)s3)nnc2c1		CHEMBL3648069	=	IC50	nM	286.0	CHEMBL267	Homo sapiens	IC50	nM	286.0
213834	16335871	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2cc(N)ccc2Cl)cc2nnc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nc12		CHEMBL231524	=	IC50	nM	51.0	CHEMBL267	Homo sapiens	IC50	nM	51.0
213769	16336477	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(N2CCCCC2)cc2nnc(Nc3cccnc3)nc12		CHEMBL3651215	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
213854	16336490	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2cc(O)ccc2Br)cc2nnc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nc12		CHEMBL398279	=	IC50	nM	4.1	CHEMBL267	Homo sapiens	IC50	nM	4.1
278582	16337103	CHEMBL3707502	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	COc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)[nH]c34)c3ncccc23)cc1		CHEMBL3695571	=	IC50	nM	0.8	CHEMBL267	Homo sapiens	IC50	nM	0.8
286826	16337242	CHEMBL3707611	TR-FRET Assay: Compounds were screened in the TR-FRET assay for JAK2 and c-Src kinase inhibition. Ultra light poly GT (Perkin Elmer) was used as the substrate for JAK2 and c-Src with the ATP concentration of 10 μM and 50 μM, respectively. The Eu-labelled anti-phospho tyrosine antibody (Perkin Elmer) was added at 1 nM and the fluorescence emission at 615 nm and 665 nm was measured with an excitation wavelength of 340 nm.	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1N1CCc2nc(Nc3cncnc3)ncc2C1		CHEMBL3658097	=	IC50	nM	2.0	CHEMBL267	Homo sapiens	IC50	nM	2.0
213826	16337352	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(S(=O)(=O)N4CCNCC4)cc3)nc12		CHEMBL250623	=	IC50	nM	6.6	CHEMBL267	Homo sapiens	IC50	nM	6.6
213669	16337424	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	COc1cc(OC)cc(-c2cc(C)c3nc(Nc4ccncc4)nnc3c2)c1		CHEMBL3648025	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	nM	100000.0
213683	16337506	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3cccc(OCCN4CCCC4)c3)nnc2c1		CHEMBL218549	=	IC50	nM	6.4	CHEMBL267	Homo sapiens	IC50	nM	6.4
286851	16337539	CHEMBL3707611	TR-FRET Assay: Compounds were screened in the TR-FRET assay for JAK2 and c-Src kinase inhibition. Ultra light poly GT (Perkin Elmer) was used as the substrate for JAK2 and c-Src with the ATP concentration of 10 μM and 50 μM, respectively. The Eu-labelled anti-phospho tyrosine antibody (Perkin Elmer) was added at 1 nM and the fluorescence emission at 615 nm and 665 nm was measured with an excitation wavelength of 340 nm.	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1N1CCc2nc(Nc3cccc(CN4CCN(C)CC4)c3)ncc2C1		CHEMBL3658089	=	IC50	nM	7.0	CHEMBL267	Homo sapiens	IC50	nM	7.0
213665	16337653	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	COc1cc(OC)cc(-c2cc(C)c3nc(Nc4cc(C)ccc4C)nnc3c2)c1		CHEMBL3648021	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	nM	100000.0
213836	16337664	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2c(Cl)cccc2Cl)cc2nnc(Nc3ccc(S(=O)(=O)N(CCN4CCCC4)C(C)C)cc3)nc12		CHEMBL3651265	=	IC50	nM	22.7	CHEMBL267	Homo sapiens	IC50	nM	22.7
213766	16337700	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1ccc(F)cc1-c1cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc2cc1C		CHEMBL3651212	=	IC50	nM	6.6	CHEMBL267	Homo sapiens	IC50	nM	6.6
213786	16337816	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc2nc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nnc2cc1-c1ccc(CO)s1		CHEMBL3651229	=	IC50	nM	1730.0	CHEMBL267	Homo sapiens	IC50	nM	1730.0
213701	16338035	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1noc(C)c1-c1cc(C)c2nc(Nc3ccc(OCC[N+]4(C)CCN(C)CC4)cc3)nnc2c1		CHEMBL3648042	=	IC50	nM	75000.0	CHEMBL267	Homo sapiens	IC50	nM	75000.0
213673	16338869	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccncc3)nnc2c1		CHEMBL221582	=	IC50	nM	36.0	CHEMBL267	Homo sapiens	IC50	nM	36.0
213703	16339161	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2c(Cl)cccc2Cl)cc2nnc(Nc3cccc(OCCN4CCN(C)CC4)c3)nc12		CHEMBL3648043	=	IC50	nM	27.4	CHEMBL267	Homo sapiens	IC50	nM	27.4
213747	16339163	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3cccc(S(=O)(=O)CCCN4CCCC4)c3)nnc2c1		CHEMBL3651199	=	IC50	nM	34.8	CHEMBL267	Homo sapiens	IC50	nM	34.8
213730	16339319	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3cccc(C(=O)NCCCN4CCN(C)CC4)c3)nnc2c1		CHEMBL3648065	=	IC50	nM	27.4	CHEMBL267	Homo sapiens	IC50	nM	27.4
213803	16339337	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc2nc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nnc2cc1-c1cn[nH]c1		CHEMBL3651244	=	IC50	nM	8000.0	CHEMBL267	Homo sapiens	IC50	nM	8000.0
213794	16339531	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	CC(=O)Nc1ccc(Nc2nnc3cc(-c4cc(O)ccc4Cl)cc(C)c3n2)cn1		CHEMBL3651237	=	IC50	nM	118.4	CHEMBL267	Homo sapiens	IC50	nM	118.4
286828	16339983	CHEMBL3707611	TR-FRET Assay: Compounds were screened in the TR-FRET assay for JAK2 and c-Src kinase inhibition. Ultra light poly GT (Perkin Elmer) was used as the substrate for JAK2 and c-Src with the ATP concentration of 10 μM and 50 μM, respectively. The Eu-labelled anti-phospho tyrosine antibody (Perkin Elmer) was added at 1 nM and the fluorescence emission at 615 nm and 665 nm was measured with an excitation wavelength of 340 nm.	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1N1CCc2nc(Nc3ccc(C(=O)N4CCCC4)cc3)ncc2C1		CHEMBL3658099	=	IC50	nM	6.0	CHEMBL267	Homo sapiens	IC50	nM	6.0
277733	16340521	CHEMBL3705608	Enzyme Inhibition Assay: The inhibitory activities of the compound of the invention against c-Src and Syk enzymes (Invitrogen) are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 μL) is incubated with the test compound (either 1 μg/mL, 0.1 μg/mL, 0.01 μg/mL, or 0.001 μg/mL, 2.5 μL each) for 2 hr at RT. The FRET peptides (8 μM, 2.5 μL) and appropriate ATP solutions (2.5 μL, 800 μM for c-Src, and 60 μM ATP for Syk) are then added to the enzymes/compound mixtures and the mixture incubated for 1 hr. Development reagent (protease, 5 μL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan® Flash, ThermoFisher Scientific).	B	C#Cc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(C(C)(C)C)cc(NS(C)(=O)=O)c4OC)c4ccccc34)n2)cc(C(=O)NCCOCCOCCOC)c1		CHEMBL3681949	=	IC50	nM	24.0	CHEMBL267	Homo sapiens	IC50	nM	24.0
213726	16340996	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2c(Cl)cccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)nc3)nc12		CHEMBL3648062	=	IC50	nM	15.3	CHEMBL267	Homo sapiens	IC50	nM	15.3
213741	16341508	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3cccc(C(=O)N4CCN(C)CC4)c3)nnc2c1		CHEMBL3651197	=	IC50	nM	88.6	CHEMBL267	Homo sapiens	IC50	nM	88.6
213876	16341767	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2c(Cl)ccc(O)c2Cl)cc2nnc(Nc3ccc(S(=O)(=O)CCCN4CCCC4)cc3)nc12		CHEMBL3651290	=	IC50	nM	2.1	CHEMBL267	Homo sapiens	IC50	nM	2.1
213787	16342138	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1ccccc1-c1cc2nnc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nc2cc1O		CHEMBL3651230	=	IC50	nM	117.0	CHEMBL267	Homo sapiens	IC50	nM	117.0
213813	16342406	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc2nc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nnc2cc1N(CCO)C(C)C		CHEMBL3651252	=	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
213824	16342995	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(N4CCN(CCO)CC4)nc3)nc12		CHEMBL3651260	=	IC50	nM	1.8	CHEMBL267	Homo sapiens	IC50	nM	1.8
213754	16343399	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc2nc(Nc3ccc(C(=O)N4CCN(C)CC4)cc3)nnc2cc1-c1cnccc1Cl		CHEMBL3651203	=	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
278575	16343656	CHEMBL3707502	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	Cc1nc2c(Oc3ccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4ccccc4)c4ccccc34)ccnc2[nH]c1=O		CHEMBL1214132	=	IC50	nM	7.0	CHEMBL267	Homo sapiens	IC50	nM	7.0
278600	16344054	CHEMBL3707502	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)cnc34)c3ccccc23)n(-c2ccc(Cl)c(Cl)c2)n1		CHEMBL3695580	=	IC50	nM	6.0	CHEMBL267	Homo sapiens	IC50	nM	6.0
213857	16344405	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	CCN(CC)CCN(C)Cc1ccc(Nc2nnc3cc(-c4cc(O)ccc4Cl)cc(C)c3n2)cc1		CHEMBL3651277	=	IC50	nM	4.3	CHEMBL267	Homo sapiens	IC50	nM	4.3
213798	16344929	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc2nc(Nc3ccc(OCCN4CCCC4)cc3)nnc2cc1-c1cc(O)ccc1F		CHEMBL3651240	=	IC50	nM	13.7	CHEMBL267	Homo sapiens	IC50	nM	13.7
213861	16345412	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2c(Cl)ccc(O)c2F)cc2nnc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nc12		CHEMBL250821	=	IC50	nM	0.7	CHEMBL267	Homo sapiens	IC50	nM	0.7
213637	16345689	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1ccc2nc(Nc3ccc(OCCN4CCCC4)cc3)nnc2c1		CHEMBL230999	=	IC50	nM	15.0	CHEMBL267	Homo sapiens	IC50	nM	15.0
278576	16346315	CHEMBL3707502	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)c(C)nc34)c3ccccc23)cc1		CHEMBL1214135	=	IC50	nM	7.0	CHEMBL267	Homo sapiens	IC50	nM	7.0
278580	16346538	CHEMBL3707502	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	COc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)n(C(C)C)c34)c3ccccc23)cc1		CHEMBL3695585	=	IC50	nM	12.0	CHEMBL267	Homo sapiens	IC50	nM	12.0
213719	16347809	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccnc(Cl)c3)nnc2c1		CHEMBL3648056	=	IC50	nM	118.0	CHEMBL267	Homo sapiens	IC50	nM	118.0
286835	16347900	CHEMBL3707611	TR-FRET Assay: Compounds were screened in the TR-FRET assay for JAK2 and c-Src kinase inhibition. Ultra light poly GT (Perkin Elmer) was used as the substrate for JAK2 and c-Src with the ATP concentration of 10 μM and 50 μM, respectively. The Eu-labelled anti-phospho tyrosine antibody (Perkin Elmer) was added at 1 nM and the fluorescence emission at 615 nm and 665 nm was measured with an excitation wavelength of 340 nm.	B	Cc1ccc(NC(=O)c2cc(C(F)(F)F)ccn2)cc1N1CCc2nc(Nc3ccc(N4CCN(C)CC4)cc3)ncc2C1		CHEMBL3658109	=	IC50	nM	6.0	CHEMBL267	Homo sapiens	IC50	nM	6.0
213875	16348369	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
213628	16348523	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1ccc2nc(Nc3ccccc3)nnc2c1		CHEMBL218042	=	IC50	nM	1520.0	CHEMBL267	Homo sapiens	IC50	nM	1520.0
213682	16348593	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(OCCN4CCN(C)CC4)cc3)nnc2c1		CHEMBL230614	=	IC50	nM	21.0	CHEMBL267	Homo sapiens	IC50	nM	21.0
278570	16348865	CHEMBL3707502	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)[nH]c34)c3ccccc23)n(-c2ccccc2)n1		CHEMBL1093756	=	IC50	nM	36.0	CHEMBL267	Homo sapiens	IC50	nM	36.0
213880	16349769	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2c(Cl)cccc2Cl)cc2c1nc(Nc1ccc(OCCN3CCCC3)cc1)n[n+]2[O-]		CHEMBL3651293	=	IC50	nM	90.3	CHEMBL267	Homo sapiens	IC50	nM	90.3
213685	16350012	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	COc1cccc(Cl)c1-c1cc(C)c2nc(Nc3ccc(OCCN4CCCC4)cc3)nnc2c1		CHEMBL230792	=	IC50	nM	505.0	CHEMBL267	Homo sapiens	IC50	nM	505.0
213647	16350455	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1ccc(Nc2nnc3cc(-c4c(C)cccc4C)cc(C)c3n2)cc1		CHEMBL3648012	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
213723	16350833	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3cccc(S(=O)(=O)NCCN(C)C)c3)nnc2c1		CHEMBL3648059	=	IC50	nM	41.4	CHEMBL267	Homo sapiens	IC50	nM	41.4
213793	16350838	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3cccc(N(C)C)c3)nc12		CHEMBL3651236	=	IC50	nM	21.6	CHEMBL267	Homo sapiens	IC50	nM	21.6
213679	16350995	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(OCCN4CCOCC4)cc3)nnc2c1		CHEMBL3648032	=	IC50	nM	32.9	CHEMBL267	Homo sapiens	IC50	nM	32.9
213849	16351450	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2c(Cl)cccc2Cl)cc2nnc(Nc3ccc(S(=O)(=O)CCCN4CCCC4)cc3)nc12		CHEMBL3651274	=	IC50	nM	21.6	CHEMBL267	Homo sapiens	IC50	nM	21.6
213774	16351655	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(F)ccc1-c1cc2nnc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nc2cc1C		CHEMBL397691	=	IC50	nM	20.4	CHEMBL267	Homo sapiens	IC50	nM	20.4
286839	16351753	CHEMBL3707611	TR-FRET Assay: Compounds were screened in the TR-FRET assay for JAK2 and c-Src kinase inhibition. Ultra light poly GT (Perkin Elmer) was used as the substrate for JAK2 and c-Src with the ATP concentration of 10 μM and 50 μM, respectively. The Eu-labelled anti-phospho tyrosine antibody (Perkin Elmer) was added at 1 nM and the fluorescence emission at 615 nm and 665 nm was measured with an excitation wavelength of 340 nm.	B	Cc1ccc(NC(=O)CCC(F)(F)F)cc1N1CCc2nc(Nc3ccc(C(=O)N4CCN(C)CC4)cc3)ncc2C1		CHEMBL3658116	=	IC50	nM	26.0	CHEMBL267	Homo sapiens	IC50	nM	26.0
213828	16352137	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Oc1ccc(Cl)c(-c2cc3nnc(Nc4ccc(OCCN5CCCC5)cc4)nc3cc2Cl)c1		CHEMBL3651262	=	IC50	nM	1.2	CHEMBL267	Homo sapiens	IC50	nM	1.2
213633	16352355	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	COc1cccc(OC)c1-c1cc(C)c2nc(Nc3ccccc3)nnc2c1		CHEMBL3648007	>	IC50	nM	1000.0	CHEMBL267	Homo sapiens	IC50	nM	1000.0
213788	16352595	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3nc(C(=O)NCCN4CCCC4)cs3)nc12		CHEMBL3651231	=	IC50	nM	5.7	CHEMBL267	Homo sapiens	IC50	nM	5.7
213714	16352623	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(C(=O)O)o3)nnc2c1		CHEMBL3648052	=	IC50	nM	1500.0	CHEMBL267	Homo sapiens	IC50	nM	1500.0
213833	16352984	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2cccc(N)c2)cc2nnc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nc12		CHEMBL231525	=	IC50	nM	282.0	CHEMBL267	Homo sapiens	IC50	nM	282.0
286845	16353208	CHEMBL3707611	TR-FRET Assay: Compounds were screened in the TR-FRET assay for JAK2 and c-Src kinase inhibition. Ultra light poly GT (Perkin Elmer) was used as the substrate for JAK2 and c-Src with the ATP concentration of 10 μM and 50 μM, respectively. The Eu-labelled anti-phospho tyrosine antibody (Perkin Elmer) was added at 1 nM and the fluorescence emission at 615 nm and 665 nm was measured with an excitation wavelength of 340 nm.	B	CNC(=O)c1ccc(Nc2ncc3c(n2)CCN(c2cc(NC(=O)c4cc(F)cc(C(F)(F)F)c4)ccc2Cl)C3)cc1		CHEMBL3658124	=	IC50	nM	20.0	CHEMBL267	Homo sapiens	IC50	nM	20.0
213733	16353842	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(C(=O)NCCCN4CCCC4)o3)nnc2c1		CHEMBL3648068	=	IC50	nM	18.3	CHEMBL267	Homo sapiens	IC50	nM	18.3
278598	16353874	CHEMBL3707502	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	Cc1ccc(-n2nc(C(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)cnc34)c3ccccc23)cc1		CHEMBL3695578	=	IC50	nM	8.0	CHEMBL267	Homo sapiens	IC50	nM	8.0
213631	16354139	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(C)c(-c2cc(C)c3nc(Nc4ccccc4)nnc3c2)c(C)c1		CHEMBL218109	>	IC50	nM	1000.0	CHEMBL267	Homo sapiens	IC50	nM	1000.0
213656	16354266	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	COc1ccccc1Nc1nnc2cc(-c3c(C)cccc3C)cc(C)c2n1		CHEMBL376860	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
278592	16354392	CHEMBL3707502	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	COc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)n(C)c34)c3ccccc23)cn1		CHEMBL3695572	=	IC50	nM	16.0	CHEMBL267	Homo sapiens	IC50	nM	16.0
286843	16354513	CHEMBL3707611	TR-FRET Assay: Compounds were screened in the TR-FRET assay for JAK2 and c-Src kinase inhibition. Ultra light poly GT (Perkin Elmer) was used as the substrate for JAK2 and c-Src with the ATP concentration of 10 μM and 50 μM, respectively. The Eu-labelled anti-phospho tyrosine antibody (Perkin Elmer) was added at 1 nM and the fluorescence emission at 615 nm and 665 nm was measured with an excitation wavelength of 340 nm.	B	Cc1cc(Nc2ncc3c(n2)CCN(c2cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc2Cl)C3=O)ccc1N1CCN(C)CC1		CHEMBL3658121	=	IC50	nM	20.0	CHEMBL267	Homo sapiens	IC50	nM	20.0
213802	16354800	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1ccc(C#N)cc1-c1cc2nnc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nc2cc1C		CHEMBL395984	=	IC50	nM	12.3	CHEMBL267	Homo sapiens	IC50	nM	12.3
213784	16355134	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	COc1cc2nc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nnc2cc1-c1ccccc1C		CHEMBL3651227	=	IC50	nM	10.0	CHEMBL267	Homo sapiens	IC50	nM	10.0
286850	16355947	CHEMBL3707611	TR-FRET Assay: Compounds were screened in the TR-FRET assay for JAK2 and c-Src kinase inhibition. Ultra light poly GT (Perkin Elmer) was used as the substrate for JAK2 and c-Src with the ATP concentration of 10 μM and 50 μM, respectively. The Eu-labelled anti-phospho tyrosine antibody (Perkin Elmer) was added at 1 nM and the fluorescence emission at 615 nm and 665 nm was measured with an excitation wavelength of 340 nm.	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1N1CCc2nc(Nc3ccc(N4CCN(C)CC4)cc3)ncc2C1=O		CHEMBL3658088	=	IC50	nM	10.0	CHEMBL267	Homo sapiens	IC50	nM	10.0
213693	16356105	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3cccc(OCCN4CCN(C)CC4)c3)nnc2c1		CHEMBL230615	=	IC50	nM	39.5	CHEMBL267	Homo sapiens	IC50	nM	39.5
213743	16356175	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc2nc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nnc2cc1-c1c(C)cccc1C		CHEMBL230816	=	IC50	nM	10.5	CHEMBL267	Homo sapiens	IC50	nM	10.5
213667	16356416	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	CCCCc1ccc(Nc2nnc3cc(-c4cc(OC)cc(OC)c4)cc(C)c3n2)cc1		CHEMBL3648023	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	nM	100000.0
278573	16356446	CHEMBL3707502	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)cnc34)c3ccccc23)n(-c2ccccc2)n1		CHEMBL1214131	=	IC50	nM	5.0	CHEMBL267	Homo sapiens	IC50	nM	5.0
	16358353	CHEMBL3721232	Inhibition of Src (unknown origin) expressed in Escherichia coli using biotin-(E4Y)3 substrate	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4cnn(C)c4)nc23)c1F		CHEMBL3716927	<=	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	16358354	CHEMBL3721232	Inhibition of Src (unknown origin) expressed in Escherichia coli using biotin-(E4Y)3 substrate	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(C#N)nc23)c1F		CHEMBL3718800	<=	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	16369028	CHEMBL3734116	Inhibition of Src (unknown origin) expressed in Escherichia coli using biotin-(E4Y)3 substrate	B	COc1ncnc2[nH]cc(C(=O)c3c(F)ccc(NS(=O)(=O)c4ccc(C(F)(F)F)cc4)c3F)c12		CHEMBL3731869	<=	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	16369029	CHEMBL3734116	Inhibition of Src (unknown origin) expressed in Escherichia coli using biotin-(E4Y)3 substrate	B	CCCS(=O)(=O)Nc1cccc(C(=O)c2c[nH]c3ncnc(OC)c23)c1F		CHEMBL3732618	<=	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	16369030	CHEMBL3734116	Inhibition of Src (unknown origin) expressed in Escherichia coli using biotin-(E4Y)3 substrate	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncnc(C)c23)c1F		CHEMBL3730594	<=	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	16369031	CHEMBL3734116	Inhibition of Src (unknown origin) expressed in Escherichia coli using biotin-(E4Y)3 substrate	B	O=C(c1cccc(NS(=O)(=O)c2ccccc2F)c1F)c1c[nH]c2ncncc12		CHEMBL3731654	<=	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	16369032	CHEMBL3734116	Inhibition of Src (unknown origin) expressed in Escherichia coli using biotin-(E4Y)3 substrate	B	O=C(c1cccc(NS(=O)(=O)c2c(F)cccc2F)c1F)c1c[nH]c2ncncc12		CHEMBL3733302	<=	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	16369033	CHEMBL3734116	Inhibition of Src (unknown origin) expressed in Escherichia coli using biotin-(E4Y)3 substrate	B	O=C(c1cccc(NS(=O)(=O)c2cc(F)ccc2F)c1F)c1c[nH]c2ncncc12		CHEMBL3727754	<=	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	16369034	CHEMBL3734116	Inhibition of Src (unknown origin) expressed in Escherichia coli using biotin-(E4Y)3 substrate	B	O=C(c1c(F)ccc(NS(=O)(=O)c2ccc(C(F)(F)F)cc2)c1F)c1c[nH]c2ncncc12		CHEMBL3728149	<=	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	16370652	CHEMBL3734204	Inhibition of Src (unknown origin)	B	CCCS(=O)(=O)Nc1ccc(Cl)c(C(=O)Nc2ccc(Nc3ncc(C)s3)nc2)c1F		CHEMBL3730067	<=	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	16370653	CHEMBL3734204	Inhibition of Src (unknown origin)	B	CCCS(=O)(=O)Nc1ccc(Cl)c(C(=O)Nc2ccc(NC(C)=O)nc2)c1F		CHEMBL3732214	<=	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	16376482	CHEMBL3734506	Inhibition of recombinant human SRC using fluorescein-labeled peptide as substrate by fluorescence-electrophoretic mobility shift assay	B	Cl.NCCN1C(=O)S/C(=C\CCC2CCCCC2)C1=O		CHEMBL3732044	=	Inhibition	%	2.0	CHEMBL267	Homo sapiens	INH	%	2.0
	16379629	CHEMBL3738543	Inhibition of SRC (unknown origin) at 200 nM by electrophoretic mobility shift assay	B	COc1ccc2c(c1CN1CCNCC1)O/C(=C\c1n[nH]c3ncccc13)C2=O		CHEMBL3735816	=	Inhibition	%	-0.9	CHEMBL267	Homo sapiens	INH	%	-0.9
	16379630	CHEMBL3738543	Inhibition of SRC (unknown origin) at 200 nM by electrophoretic mobility shift assay	B	COc1ccc2c(c1C(C)N1CCNCC1)O/C(=C\c1n[nH]c3ncccc13)C2=O		CHEMBL3735890	=	Inhibition	%	0.7	CHEMBL267	Homo sapiens	INH	%	0.7
	16388328	CHEMBL3737503	Inhibition of SRC (unknown origin) at 1 uM by selectscreen kinase profiling assay in presence of ATP	B	COc1cc2c(cc1OC)CN(CC(=O)Nc1ccc3c(c1)/C(=C/c1cnc[nH]1)C(=O)N3)CC2		CHEMBL3091673	=	Inhibition	%	27.0	CHEMBL267	Homo sapiens	INH	%	27.0
	16396098	CHEMBL3742496	Inhibition of c-Src (unknown origin) using Poly (Glu,Tyr) as substrate after 60 mins by ELISA	B	CS(=O)(=O)Cc1cccc(Nc2nccc(Oc3ccc4c(C(=O)Nc5ccccc5)cccc4c3)n2)c1		CHEMBL3740721	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	16396099	CHEMBL3742496	Inhibition of c-Src (unknown origin) using Poly (Glu,Tyr) as substrate after 60 mins by ELISA	B	CS(=O)(=O)Cc1cccc(Nc2nccc(Oc3ccc4c(C(=O)Nc5cccc(F)c5)cccc4c3)n2)c1		CHEMBL3740487	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	16396100	CHEMBL3742496	Inhibition of c-Src (unknown origin) using Poly (Glu,Tyr) as substrate after 60 mins by ELISA	B	CS(=O)(=O)Cc1cccc(Nc2nccc(Oc3ccc4c(C(=O)Nc5cccnc5)cccc4c3)n2)c1		CHEMBL3739732	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	16398563	CHEMBL3744319	Inhibition of SRC (unknown origin) at 30 uM by microfluidic assay relative to control	B	CC(=O)c1nn(-c2ccccc2)cc1C(=O)c1c(C)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3739750	=	Inhibition	%	21.0	CHEMBL267	Homo sapiens	INH	%	21.0
	16398564	CHEMBL3744319	Inhibition of SRC (unknown origin) at 30 uM by microfluidic assay relative to control	B	CC(=O)c1nn(-c2ccc(C)cc2)cc1C(=O)c1c(C)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3740247	=	Inhibition	%	23.0	CHEMBL267	Homo sapiens	INH	%	23.0
	16398565	CHEMBL3744319	Inhibition of SRC (unknown origin) at 30 uM by microfluidic assay relative to control	B	CC(=O)c1nn(-c2ccc(Cl)cc2)cc1C(=O)c1c(C)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3739587	=	Inhibition	%	22.0	CHEMBL267	Homo sapiens	INH	%	22.0
	16398566	CHEMBL3744319	Inhibition of SRC (unknown origin) at 30 uM by microfluidic assay relative to control	B	CCOC(=O)c1nn(-c2ccccc2)cc1C(=O)c1c(C)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3740131	=	Inhibition	%	23.0	CHEMBL267	Homo sapiens	INH	%	23.0
	16398567	CHEMBL3744319	Inhibition of SRC (unknown origin) at 30 uM by microfluidic assay relative to control	B	CCOC(=O)c1nn(-c2ccc(C)cc2)cc1C(=O)c1c(C)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3742349	=	Inhibition	%	21.0	CHEMBL267	Homo sapiens	INH	%	21.0
	16398568	CHEMBL3744319	Inhibition of SRC (unknown origin) at 30 uM by microfluidic assay relative to control	B	CCOC(=O)c1nn(-c2ccc(Cl)cc2)cc1C(=O)c1c(C)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3741526	=	Inhibition	%	12.0	CHEMBL267	Homo sapiens	INH	%	12.0
	16398569	CHEMBL3744319	Inhibition of SRC (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1C(=O)c1cn(-c2ccccc2)nc1C(=O)Nc1ccccc1		CHEMBL3740930	=	Inhibition	%	33.0	CHEMBL267	Homo sapiens	INH	%	33.0
	16398570	CHEMBL3744319	Inhibition of SRC (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1ccc(-n2cc(C(=O)c3c(C)[nH]c(-c4ccccc4)c3-c3ccccc3)c(C(=O)Nc3ccccc3)n2)cc1		CHEMBL3740713	=	Inhibition	%	12.0	CHEMBL267	Homo sapiens	INH	%	12.0
	16398571	CHEMBL3744319	Inhibition of SRC (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1C(=O)c1cn(-c2ccc(Cl)cc2)nc1C(=O)Nc1ccccc1		CHEMBL3740385	=	Inhibition	%	21.0	CHEMBL267	Homo sapiens	INH	%	21.0
	16398572	CHEMBL3744319	Inhibition of SRC (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1C(=O)c1cn(-c2ccccc2)nc1-c1ccccc1		CHEMBL3741069	=	Inhibition	%	12.0	CHEMBL267	Homo sapiens	INH	%	12.0
	16398573	CHEMBL3744319	Inhibition of SRC (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1-c1nnc(C)c2nn(-c3ccccc3)cc12		CHEMBL3740582	=	Inhibition	%	43.0	CHEMBL267	Homo sapiens	INH	%	43.0
	16398574	CHEMBL3744319	Inhibition of SRC (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1ccc(-n2cc3c(-c4c(C)[nH]c(-c5ccccc5)c4-c4ccccc4)nnc(C)c3n2)cc1		CHEMBL3742060	=	Inhibition	%	11.0	CHEMBL267	Homo sapiens	INH	%	11.0
	16398575	CHEMBL3744319	Inhibition of SRC (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1-c1nnc(C)c2nn(-c3ccc(Cl)cc3)cc12		CHEMBL3741655	=	Inhibition	%	22.0	CHEMBL267	Homo sapiens	INH	%	22.0
	16398576	CHEMBL3744319	Inhibition of SRC (unknown origin) at 30 uM by microfluidic assay relative to control	B	Oc1nnc(-c2c[nH]c(-c3ccccc3)c2-c2ccccc2)c2cn(-c3ccccc3)nc12		CHEMBL3740923	=	Inhibition	%	23.0	CHEMBL267	Homo sapiens	INH	%	23.0
	16398577	CHEMBL3744319	Inhibition of SRC (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1ccc(-n2cc3c(-c4c[nH]c(-c5ccccc5)c4-c4ccccc4)nnc(O)c3n2)cc1		CHEMBL3739586	=	Inhibition	%	21.0	CHEMBL267	Homo sapiens	INH	%	21.0
	16398578	CHEMBL3744319	Inhibition of SRC (unknown origin) at 30 uM by microfluidic assay relative to control	B	Oc1nnc(-c2c[nH]c(-c3ccccc3)c2-c2ccccc2)c2cn(-c3ccc(Cl)cc3)nc12		CHEMBL3742200	=	Inhibition	%	21.0	CHEMBL267	Homo sapiens	INH	%	21.0
	16398579	CHEMBL3744319	Inhibition of SRC (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1-c1ccc(NC(=O)c2ccccc2)c(=O)o1		CHEMBL3740003	=	Inhibition	%	12.0	CHEMBL267	Homo sapiens	INH	%	12.0
	16398580	CHEMBL3744319	Inhibition of SRC (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1c(C(=O)c2coc3ccc(O)cc23)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3741960	=	Inhibition	%	32.0	CHEMBL267	Homo sapiens	INH	%	32.0
	16398581	CHEMBL3744319	Inhibition of SRC (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1c(C(=O)c2coc3c2cc(O)c2ccccc23)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3740492	=	Inhibition	%	21.0	CHEMBL267	Homo sapiens	INH	%	21.0
	16413517	CHEMBL3743751	Inhibition of SRC (unknown origin)	B	O=C(O)C1CN(Cc2ccc(OCc3ccc(Cl)c(Cl)c3)cc2)C1		CHEMBL3741589	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	16417313	CHEMBL3750775	Inhibition of SRC (unknown origin) at 10 uM	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCN(S(C)(=O)=O)CC3)nc21		CHEMBL3747699	=	Inhibition	%	4.0	CHEMBL267	Homo sapiens	INH	%	4.0
	16417314	CHEMBL3750775	Inhibition of SRC (unknown origin) at 10 uM	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(Nc3ccc(N4CCC(O)CC4)cc3)nc21		CHEMBL3746959	=	Inhibition	%	100.0	CHEMBL267	Homo sapiens	INH	%	100.0
	16417315	CHEMBL3750775	Inhibition of SRC (unknown origin) at 10 uM	B	CN1CCN(CCCNc2ncc3cc(Oc4ccc(F)cc4F)c(=O)n(C)c3n2)CC1		CHEMBL3746022	=	Inhibition	%	18.0	CHEMBL267	Homo sapiens	INH	%	18.0
	16417316	CHEMBL3750775	Inhibition of SRC (unknown origin) at 10 uM	B	CN1CCN(c2ccc(Nc3ncc4cc(Oc5ccc(F)cc5F)c(=O)n(C)c4n3)cc2)CC1		CHEMBL3745734	=	Inhibition	%	99.0	CHEMBL267	Homo sapiens	INH	%	99.0
	16417317	CHEMBL3750775	Inhibition of SRC (unknown origin) at 10 uM	B	Cn1c(=O)c(Oc2c(Cl)cccc2Cl)cc2cnc(NC3CCOCC3)nc21		CHEMBL3747351	=	Inhibition	%	8.0	CHEMBL267	Homo sapiens	INH	%	8.0
	16417318	CHEMBL3750775	Inhibition of SRC (unknown origin) at 10 uM	B	CN1CCN(c2ccc(Nc3ncc4cc(Oc5c(Cl)cccc5Cl)c(=O)n(C)c4n3)cc2)CC1		CHEMBL3747023	=	Inhibition	%	72.0	CHEMBL267	Homo sapiens	INH	%	72.0
	16417319	CHEMBL3750775	Inhibition of SRC (unknown origin) at 10 uM	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NCCc3ccccn3)nc21		CHEMBL3746951	=	Inhibition	%	16.0	CHEMBL267	Homo sapiens	INH	%	16.0
	16417320	CHEMBL3750775	Inhibition of SRC (unknown origin) at 10 uM	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(Nc3ccc(N4CCCCC4)cc3)nc21		CHEMBL3746973	=	Inhibition	%	28.0	CHEMBL267	Homo sapiens	INH	%	28.0
	16417321	CHEMBL3750775	Inhibition of SRC (unknown origin) at 10 uM	B	CN(C)CCNc1ncc2cc(Oc3ccc(F)cc3F)c(=O)n(C)c2n1		CHEMBL3745857	=	Inhibition	%	6.0	CHEMBL267	Homo sapiens	INH	%	6.0
	16421946	CHEMBL3748463	Inhibition of c-Src (unknown origin)	B	C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C1		CHEMBL3651966	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	16425431	CHEMBL3749828	Inhibition of Src (unknown origin) at 1 uM	B	Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1		CHEMBL3746293	=	Inhibition	%	52.6	CHEMBL267	Homo sapiens	INH	%	52.6
	16426149	CHEMBL3750476	Inhibition of Src (unknown origin)	B	Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1		CHEMBL3746293	=	IC50	nM	924.0	CHEMBL267	Homo sapiens	IC50	nM	924.0
	16429072	CHEMBL3750810	Inhibition of SRC (unknown origin) at 1 uM	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCN(S(N)(=O)=O)CC3)nc21		CHEMBL3747489	=	Inhibition	%	7.0	CHEMBL267	Homo sapiens	INH	%	7.0
	16431748	CHEMBL3748640	Inhibition of human c-Src using poly[Glu:Tyr] (4:1) as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
Dose-dependent effect	16437755	CHEMBL3755362	Inhibition of Src in human K562 cells assessed as decrease of AKT expression after 48 hrs by Western blot analysis	B	COc1ccc2c(Nc3ccc(NC(=O)Nc4ccccc4)cc3)c3ccccc3nc2c1		CHEMBL3754039		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Dose-dependent effect	16437756	CHEMBL3755361	Inhibition of Src in human K562 cells assessed as decrease of ERK expression after 48 hrs by Western blot analysis	B	COc1ccc2c(Nc3ccc(NC(=O)Nc4ccccc4)cc3)c3ccccc3nc2c1		CHEMBL3754039		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	16437759	CHEMBL3755203	Inhibition of Src (unknown origin) at 10 uM after 15 mins by luminescence assay	B	COc1ccc2c(Nc3ccc(NC(=O)Nc4ccccc4)cc3)c3ccccc3nc2c1		CHEMBL3754039	=	Inhibition	%	59.67	CHEMBL267	Homo sapiens	INH	%	59.67
	16438252	CHEMBL3757180	Inhibition of GST-tagged human recombinant c-src using biotinylated peptide as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by microplate reader analysis	B	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	=	IC50	nM	5.0	CHEMBL267	Homo sapiens	IC50	nM	5.0
	16451618	CHEMBL3761199	Inhibition of SRC (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	47.3	CHEMBL267	Homo sapiens	INH	%	47.3
	16451752	CHEMBL3761199	Inhibition of SRC (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4c(Cl)cccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758602	=	Inhibition	%	66.5	CHEMBL267	Homo sapiens	INH	%	66.5
	16452417	CHEMBL3761295	Inhibition of SRC (unknown origin) at 1000 nM	B	CC1(C)OCc2c(Nc3n[nH]c4c(Cl)cccc34)nc(-c3cn[nH]c3C(F)F)nc21		CHEMBL3758739	=	Inhibition	%	47.6	CHEMBL267	Homo sapiens	INH	%	47.6
	16458647	CHEMBL3761603	Inhibition of SRC (unknown origin) at 500 nM	B	C[C@@H](Nc1ncnc2sc(-c3ccccc3C(N)=O)cc12)c1ccccc1		CHEMBL3759085	=	Inhibition	%	12.0	CHEMBL267	Homo sapiens	INH	%	12.0
	16458648	CHEMBL3761603	Inhibition of SRC (unknown origin) at 500 nM	B	C[C@@H](Nc1ncnc2sc(-c3ccc(C(=O)NCCN(C)C)cc3)cc12)c1ccccc1		CHEMBL3758800	=	Inhibition	%	18.0	CHEMBL267	Homo sapiens	INH	%	18.0
	16458649	CHEMBL3761603	Inhibition of SRC (unknown origin) at 500 nM	B	CN(C)CCNC(=O)c1ccc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3s2)cc1		CHEMBL3758376	=	Inhibition	%	17.0	CHEMBL267	Homo sapiens	INH	%	17.0
	16458650	CHEMBL3761603	Inhibition of SRC (unknown origin) at 500 nM	B	COc1cc(C(N)=O)ccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2s1		CHEMBL3759480	=	Inhibition	%	20.0	CHEMBL267	Homo sapiens	INH	%	20.0
	16458651	CHEMBL3761603	Inhibition of SRC (unknown origin) at 500 nM	B	COc1ccc(C(=O)NCCN(C)C)cc1-c1cc2c(N[C@H](C)c3ccccc3)ncnc2s1		CHEMBL3758582	=	Inhibition	%	9.0	CHEMBL267	Homo sapiens	INH	%	9.0
	16458652	CHEMBL3761603	Inhibition of SRC (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(N[C@H](C)c3ccccc3)ncnc2s1		CHEMBL3759559	=	Inhibition	%	10.0	CHEMBL267	Homo sapiens	INH	%	10.0
	16458653	CHEMBL3761603	Inhibition of SRC (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2s1		CHEMBL3758682	=	Inhibition	%	9.0	CHEMBL267	Homo sapiens	INH	%	9.0
	16458654	CHEMBL3761603	Inhibition of SRC (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(Nc3ccccc3)ncnc2s1		CHEMBL3758768	=	Inhibition	%	17.0	CHEMBL267	Homo sapiens	INH	%	17.0
	16458655	CHEMBL3761603	Inhibition of SRC (unknown origin) at 500 nM	B	C#Cc1cccc(Nc2ncnc3sc(-c4ccc(CO)cc4OC)cc23)c1		CHEMBL3758802	=	Inhibition	%	15.0	CHEMBL267	Homo sapiens	INH	%	15.0
	16458656	CHEMBL3761603	Inhibition of SRC (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1		CHEMBL3758351	=	Inhibition	%	14.0	CHEMBL267	Homo sapiens	INH	%	14.0
	16458657	CHEMBL3761603	Inhibition of SRC (unknown origin) at 500 nM	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Inhibition	%	42.0	CHEMBL267	Homo sapiens	INH	%	42.0
Active	16460526	CHEMBL3760243	Inhibition of Src phosphorylation in human HuH7 cells at 1 to 10 uM after 24 hrs by immunoblot analysis	B	CN(C)CCCNC(=O)c1cccc2nc3c(nc12)-c1ccccc1/C3=N\OCCCN(C)C.Cl		CHEMBL3759822		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	16461614	CHEMBL3762063	Inhibition of recombinant human c-Src using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA	B	Cn1cc(-c2cnc(Nc3cccc(Cn4nc(-c5cnn(C)c5)ccc4=O)c3)nc2)cn1		CHEMBL3759079	>	IC50	nM	1000.0	CHEMBL267	Homo sapiens	IC50	nM	1000.0
	16461615	CHEMBL3762063	Inhibition of recombinant human c-Src using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	IC50	nM	1000.0	CHEMBL267	Homo sapiens	IC50	nM	1000.0
	16465838	CHEMBL3768027	Inhibition of human cSRC at 10 uM	B	Cc1cncn1-c1cc(C(=O)Nc2cccc(CNc3ccc4c(C(=O)N[C@@H](C)C(N)=O)[nH]nc4c3)c2)cc(C(F)(F)F)c1		CHEMBL3764798	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	16474672	CHEMBL3767158	Inhibition of c-Src (unknown origin) at 10 uM	B	CN1CCN(CCCOc2ccc(N3C(=O)/C(=C/c4ccc(Oc5ccc(F)cc5)cc4)SC3=S)cc2)CC1		CHEMBL3765499	=	Inhibition	%	14.0	CHEMBL267	Homo sapiens	INH	%	14.0
Active	16481519	CHEMBL3767033	Binding affinity to Src kinase SH2 domain (unknown origin) by [15N]-HSQC-foot printing assay	B	O=C(Nc1ccc(C(=O)O)cc1)Nc1ccc(-c2nc(N3CCOCC3)nc(N3CCOCC3)n2)cc1		CHEMBL597824		Activity			CHEMBL267	Homo sapiens	Activity		
Active	16481520	CHEMBL3767033	Binding affinity to Src kinase SH2 domain (unknown origin) by [15N]-HSQC-foot printing assay	B	OC[C@@H]1O[C@H](n2cnc3c(NCc4ccco4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL3765340		Activity			CHEMBL267	Homo sapiens	Activity		
Active	16481521	CHEMBL3767034	Binding affinity to Src kinase SH2 domain (unknown origin) at 25 uM by STD-NMR spectroscopy	B	O=C(Nc1ccc(C(=O)O)cc1)Nc1ccc(-c2nc(N3CCOCC3)nc(N3CCOCC3)n2)cc1		CHEMBL597824		Activity			CHEMBL267	Homo sapiens	Activity		
Active	16481522	CHEMBL3767035	Binding affinity to Src kinase SH2 domain (unknown origin) at 100 uM by STD-NMR spectroscopy	B	OC[C@@H]1O[C@H](n2cnc3c(NCc4ccco4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL3765340		Activity			CHEMBL267	Homo sapiens	Activity		
	16483064	CHEMBL3773069	Inhibition of human SRC using Ac-EIYGEFKKK as substrate after 90 mins by luciferase reporter assay	B	CCOc1ccc2cc(-c3nn(C(C)C)c(N)c3C(N)=O)cnc2c1		CHEMBL3770409	>	IC50	nM	30000.0	CHEMBL267	Homo sapiens	IC50	uM	30.0
	16483065	CHEMBL3773069	Inhibition of human SRC using Ac-EIYGEFKKK as substrate after 90 mins by luciferase reporter assay	B	CCOc1ccc2cc(-c3nn(CC4CC4)c(N)c3C(N)=O)cnc2c1		CHEMBL3769940	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	16483066	CHEMBL3773069	Inhibition of human SRC using Ac-EIYGEFKKK as substrate after 90 mins by luciferase reporter assay	B	CCOc1ccc2cc(-c3nn(C4CCC4)c(N)c3C(N)=O)cnc2c1		CHEMBL3769685	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	16483067	CHEMBL3773069	Inhibition of human SRC using Ac-EIYGEFKKK as substrate after 90 mins by luciferase reporter assay	B	CCOc1ccc2cc(-c3nn(C4CCCC4)c(N)c3C(N)=O)cnc2c1		CHEMBL3769623	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	16483068	CHEMBL3773069	Inhibition of human SRC using Ac-EIYGEFKKK as substrate after 90 mins by luciferase reporter assay	B	CCOc1ccc2cc(-c3nn(C4CCCCC4)c(N)c3C(N)=O)cnc2c1		CHEMBL3770760	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	16483069	CHEMBL3773069	Inhibition of human SRC using Ac-EIYGEFKKK as substrate after 90 mins by luciferase reporter assay	B	CCOc1ccc2cc(-c3nn(C4CCCCCC4)c(N)c3C(N)=O)cnc2c1		CHEMBL3770649	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	16483070	CHEMBL3773069	Inhibition of human SRC using Ac-EIYGEFKKK as substrate after 90 mins by luciferase reporter assay	B	CCOc1ccc2cc(-c3nn(CC(C)(C)CO)c(N)c3C(N)=O)cnc2c1		CHEMBL3770743	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	16483071	CHEMBL3773069	Inhibition of human SRC using Ac-EIYGEFKKK as substrate after 90 mins by luciferase reporter assay	B	CCOc1ccc2cc(-c3nn(C(C)(C)C)c(N)c3C(N)=O)ccc2n1		CHEMBL3771306	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	16483072	CHEMBL3773069	Inhibition of human SRC using Ac-EIYGEFKKK as substrate after 90 mins by luciferase reporter assay	B	CCOc1ccc2cc(-c3nn(C(C)C)c(N)c3C(N)=O)ccc2n1		CHEMBL3770142	=	IC50	nM	3300.0	CHEMBL267	Homo sapiens	IC50	uM	3.3
	16483073	CHEMBL3773069	Inhibition of human SRC using Ac-EIYGEFKKK as substrate after 90 mins by luciferase reporter assay	B	CCOc1ccc2cc(-c3nn(CC4CC4)c(N)c3C(N)=O)ccc2n1		CHEMBL3771134	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	16483074	CHEMBL3773069	Inhibition of human SRC using Ac-EIYGEFKKK as substrate after 90 mins by luciferase reporter assay	B	CCOc1ccc2cc(-c3nn(C4CCCCC4)c(N)c3C(N)=O)ccc2n1		CHEMBL3770802	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
Not Determined	16483075	CHEMBL3773069	Inhibition of human SRC using Ac-EIYGEFKKK as substrate after 90 mins by luciferase reporter assay	B	CCOc1ccc2cc(-c3nn(C4CCCCCC4)c(N)c3C(N)=O)ccc2n1		CHEMBL3771104		IC50			CHEMBL267	Homo sapiens	IC50		
	16483076	CHEMBL3773069	Inhibition of human SRC using Ac-EIYGEFKKK as substrate after 90 mins by luciferase reporter assay	B	CCOc1ccc2cc(-c3nn(CC(C)(C)CO)c(N)c3C(N)=O)ccc2n1		CHEMBL3770980	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	16483077	CHEMBL3773069	Inhibition of human SRC using Ac-EIYGEFKKK as substrate after 90 mins by luciferase reporter assay	B	CC(C)(C)n1nc(-c2cnc3cc(F)ccc3c2)c(C(N)=O)c1N		CHEMBL3769459	>	IC50	nM	30000.0	CHEMBL267	Homo sapiens	IC50	uM	30.0
	16483078	CHEMBL3773069	Inhibition of human SRC using Ac-EIYGEFKKK as substrate after 90 mins by luciferase reporter assay	B	COc1ccc2cc(-c3nn(C(C)(C)C)c(N)c3C(N)=O)cnc2c1		CHEMBL3770425	>	IC50	nM	30000.0	CHEMBL267	Homo sapiens	IC50	uM	30.0
Not Determined	16483079	CHEMBL3773069	Inhibition of human SRC using Ac-EIYGEFKKK as substrate after 90 mins by luciferase reporter assay	B	CC(C)Oc1ccc2cc(-c3nn(C(C)(C)C)c(N)c3C(N)=O)cnc2c1		CHEMBL3770546		IC50			CHEMBL267	Homo sapiens	IC50		
	16483080	CHEMBL3773069	Inhibition of human SRC using Ac-EIYGEFKKK as substrate after 90 mins by luciferase reporter assay	B	CCCOc1ccc2cc(-c3nn(C(C)(C)C)c(N)c3C(N)=O)cnc2c1		CHEMBL3771242	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	16483081	CHEMBL3773069	Inhibition of human SRC using Ac-EIYGEFKKK as substrate after 90 mins by luciferase reporter assay	B	CC(C)(C)n1nc(-c2cnc3cc(OCC4CC4)ccc3c2)c(C(N)=O)c1N		CHEMBL3770076	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	16483082	CHEMBL3773069	Inhibition of human SRC using Ac-EIYGEFKKK as substrate after 90 mins by luciferase reporter assay	B	CC(C)(C)n1nc(-c2cnc3cc(OC4CC4)ccc3c2)c(C(N)=O)c1N		CHEMBL3770313	=	IC50	nM	4750.0	CHEMBL267	Homo sapiens	IC50	uM	4.75
	16483083	CHEMBL3773069	Inhibition of human SRC using Ac-EIYGEFKKK as substrate after 90 mins by luciferase reporter assay	B	CC(C)(C)n1nc(-c2ccc3nc(OC4CC4)ccc3c2)c(C(N)=O)c1N		CHEMBL3770299	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	16483084	CHEMBL3773069	Inhibition of human SRC using Ac-EIYGEFKKK as substrate after 90 mins by luciferase reporter assay	B	CC(C)(C)n1nc(-c2cnc3cc(OC4CCC4)ccc3c2)c(C(N)=O)c1N		CHEMBL3769798	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	16483085	CHEMBL3773069	Inhibition of human SRC using Ac-EIYGEFKKK as substrate after 90 mins by luciferase reporter assay	B	CC(C)(C)n1nc(-c2ccc3nc(OC4CCC4)ccc3c2)c(C(N)=O)c1N		CHEMBL3769990	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
Not Active	16484211	CHEMBL3773480	Inhibition of SRC (unknown origin)	B	COc1ncc(C)cc1CC[C@@](O)(CC(=O)O)C(=O)O		CHEMBL3771118		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	16486391	CHEMBL3772125	Inhibition of human recombinant SRC assessed as residual activity at 10 uM after 1 hr by qPCR analysis relative to control	B	Cc1c(Cl)cccc1NC(=O)c1sc2nc3c(cc2c1N)C(=O)CC3		CHEMBL3771285	=	Activity	%	95.0	CHEMBL267	Homo sapiens	Activity	%	95.0
	16495229	CHEMBL3778872	Inhibition of N-terminal His6-tagged recombinant human SRC expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	-6.0	CHEMBL267	Homo sapiens	Activity	%	-6.0
	16495230	CHEMBL3778873	Inhibition of N-terminal His6-tagged recombinant human SRC (1 to 530 residues) expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	-11.0	CHEMBL267	Homo sapiens	Activity	%	-11.0
	16495231	CHEMBL3778874	Inhibition of N-terminal His6-tagged recombinant human SRC T341M mutant expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	-5.0	CHEMBL267	Homo sapiens	Activity	%	-5.0
	16496148	CHEMBL3778872	Inhibition of N-terminal His6-tagged recombinant human SRC expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	-25.0	CHEMBL267	Homo sapiens	Activity	%	-25.0
	16496149	CHEMBL3778873	Inhibition of N-terminal His6-tagged recombinant human SRC (1 to 530 residues) expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	-11.0	CHEMBL267	Homo sapiens	Activity	%	-11.0
	16496150	CHEMBL3778874	Inhibition of N-terminal His6-tagged recombinant human SRC T341M mutant expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	-12.0	CHEMBL267	Homo sapiens	Activity	%	-12.0
Not Active	16497493	CHEMBL3777936	Inhibition of human SRC (1 to 536 residues) at 1 uM by radioactive [33P]-ATP filter binding assay	B	O=c1[nH]cnc2c(-n3cc(CCN4CCC(c5cccc(Cl)c5)CC4)cn3)nccc12		CHEMBL3774537		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	16507196	CHEMBL3778980	Inhibition of recombinant SRC (unknown origin) assessed as residual activity at 1 uM relative to control	B	CC(O)CNc1nc(NCc2ccc(-c3ccccn3)cc2)c2[nH]nc(C(C)C)c2n1		CHEMBL3774632	=	Activity	%	88.0	CHEMBL267	Homo sapiens	Activity	%	88.0
	16508938	CHEMBL3778872	Inhibition of N-terminal His6-tagged recombinant human SRC expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	7.0	CHEMBL267	Homo sapiens	Activity	%	7.0
	16508939	CHEMBL3778873	Inhibition of N-terminal His6-tagged recombinant human SRC (1 to 530 residues) expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	3.0	CHEMBL267	Homo sapiens	Activity	%	3.0
	16508940	CHEMBL3778874	Inhibition of N-terminal His6-tagged recombinant human SRC T341M mutant expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	-26.0	CHEMBL267	Homo sapiens	Activity	%	-26.0
	16510441	CHEMBL3784000	Inhibition of full length recombinant human C-terminal His-tagged SRC expressed in Baculovirus expression system	B	CNc1nc(Nc2ccc(C)c(N)c2)ncc1C(=O)Nc1cc(NC(=O)c2cccc(C(F)(F)F)c2)ccc1C		CHEMBL3780219	=	IC50	nM	90.0	CHEMBL267	Homo sapiens	IC50	nM	90.0
	16510486	CHEMBL3784002	Inhibition of TEL-SRC (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	CNc1nc(Nc2ccc(C)c(N)c2)ncc1C(=O)Nc1cc(NC(=O)c2cccc(C(F)(F)F)c2)ccc1C		CHEMBL3780219	=	GI50	nM	200.0	CHEMBL267	Homo sapiens	GI50	uM	0.2
	16510487	CHEMBL3784002	Inhibition of TEL-SRC (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	GI50	nM	2100.0	CHEMBL267	Homo sapiens	GI50	uM	2.1
	16510488	CHEMBL3784002	Inhibition of TEL-SRC (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	=	GI50	nM	470.0	CHEMBL267	Homo sapiens	GI50	uM	0.47
	16510489	CHEMBL3784002	Inhibition of TEL-SRC (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1	Outside typical range	CHEMBL1421	<	GI50	nM	0.3	CHEMBL267	Homo sapiens	GI50	uM	0.0003
	16510624	CHEMBL3784716	Binding affinity to SRC (unknown origin)	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	0.21	CHEMBL267	Homo sapiens	Kd	nM	0.21
	16510625	CHEMBL3784716	Binding affinity to SRC (unknown origin)	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	1.0	CHEMBL267	Homo sapiens	Kd	nM	1.0
	16510636	CHEMBL3784727	Inhibition of partial length human wild type SRC expressed in bacterial expression system assessed as residual activity at 1 uM relative to control	B	CNc1nc(Nc2ccc(C)c(N)c2)ncc1C(=O)Nc1cc(NC(=O)c2cccc(C(F)(F)F)c2)ccc1C		CHEMBL3780219	=	Activity	%	0.5	CHEMBL267	Homo sapiens	Activity	%	0.5
Not Active	16510637	CHEMBL3784576	Inhibition of SRC phosphorylation in human K562 cells at 0.01 to 3 uM after 1 hr by immunoblotting method	B	CNc1nc(Nc2ccc(C)c(N)c2)ncc1C(=O)Nc1cc(NC(=O)c2cccc(C(F)(F)F)c2)ccc1C		CHEMBL3780219		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	16510638	CHEMBL3784577	Inhibition of SRC phosphorylation in human KU812 cells at 0.01 to 3 uM after 1 hr by immunoblotting method	B	CNc1nc(Nc2ccc(C)c(N)c2)ncc1C(=O)Nc1cc(NC(=O)c2cccc(C(F)(F)F)c2)ccc1C		CHEMBL3780219		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	16510639	CHEMBL3784578	Inhibition of SRC phosphorylation in human MEG01 cells at 0.01 to 3 uM after 1 hr by immunoblotting method	B	CNc1nc(Nc2ccc(C)c(N)c2)ncc1C(=O)Nc1cc(NC(=O)c2cccc(C(F)(F)F)c2)ccc1C		CHEMBL3780219		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	16515656	CHEMBL3782397	Inhibition of partial length human SRC expressed in bacterial system at 1 uM	B	Cc1cnc(N)nc1OCC(C)(C)CO		CHEMBL3780032		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	16525680	CHEMBL3790308	Inhibition of SRC (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL1614712	=	IC50	nM	4000.0	CHEMBL267	Homo sapiens	IC50	uM	4.0
	16525681	CHEMBL3790308	Inhibition of SRC (unknown origin) in presence of [gamma33P]ATP	B	CC(=O)N1CCN([C@H]2C[C@@H](n3cc(-c4cc(OC[C@@H]5CCCO5)ccc4F)c4c(N)ncnc43)C2)CC1		CHEMBL3785951	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	16547748	CHEMBL3796157	Inhibition of human Src using myelin basic protein as substrate at 1 uM measured after 20 mins at 30 degC by liquid scintillation counting method in presence of [gamma-32P]-ATP	B	COc1cc2ncn(Cc3cccnc3Br)c(=O)c2cc1OC		CHEMBL3792855	=	Inhibition	%	3.0	CHEMBL267	Homo sapiens	INH	%	3.0
	16547749	CHEMBL3796157	Inhibition of human Src using myelin basic protein as substrate at 1 uM measured after 20 mins at 30 degC by liquid scintillation counting method in presence of [gamma-32P]-ATP	B	COc1cc2ncn(Cc3cccc(-c4ccccc4)c3)c(=O)c2cc1OC		CHEMBL3793594	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	16547750	CHEMBL3796157	Inhibition of human Src using myelin basic protein as substrate at 1 uM measured after 20 mins at 30 degC by liquid scintillation counting method in presence of [gamma-32P]-ATP	B	COc1cc2ncn(Cc3cccc(Br)c3)c(=O)c2cc1OC		CHEMBL3793760	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	16547751	CHEMBL3796157	Inhibition of human Src using myelin basic protein as substrate at 1 uM measured after 20 mins at 30 degC by liquid scintillation counting method in presence of [gamma-32P]-ATP	B	COc1cc2ncn(Cc3ccc(Br)cc3)c(=O)c2cc1OC		CHEMBL3793678	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	16547752	CHEMBL3796157	Inhibition of human Src using myelin basic protein as substrate at 1 uM measured after 20 mins at 30 degC by liquid scintillation counting method in presence of [gamma-32P]-ATP	B	COc1cc2ncn(CC(=O)c3ccc(Br)cc3)c(=O)c2cc1OC		CHEMBL3793297	=	Inhibition	%	4.0	CHEMBL267	Homo sapiens	INH	%	4.0
	16547753	CHEMBL3796157	Inhibition of human Src using myelin basic protein as substrate at 1 uM measured after 20 mins at 30 degC by liquid scintillation counting method in presence of [gamma-32P]-ATP	B	COc1cc2ncn(CC(O)c3ccc(Br)cc3)c(=O)c2cc1OC		CHEMBL3792891	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	16547754	CHEMBL3796157	Inhibition of human Src using myelin basic protein as substrate at 1 uM measured after 20 mins at 30 degC by liquid scintillation counting method in presence of [gamma-32P]-ATP	B	O=c1c2cc3c(cc2ncn1Cc1ccc(-c2ccccc2)cc1)OCCO3		CHEMBL3794032	=	Inhibition	%	5.0	CHEMBL267	Homo sapiens	INH	%	5.0
	16547755	CHEMBL3796157	Inhibition of human Src using myelin basic protein as substrate at 1 uM measured after 20 mins at 30 degC by liquid scintillation counting method in presence of [gamma-32P]-ATP	B	O=c1c2cc3c(cc2ncn1Cc1cccc(Br)c1)OCCO3		CHEMBL3793623	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	16547756	CHEMBL3796157	Inhibition of human Src using myelin basic protein as substrate at 1 uM measured after 20 mins at 30 degC by liquid scintillation counting method in presence of [gamma-32P]-ATP	B	O=c1c2cc3c(cc2ncn1Cc1ccc(Br)cc1)OCCO3		CHEMBL3792773	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	16547757	CHEMBL3796157	Inhibition of human Src using myelin basic protein as substrate at 1 uM measured after 20 mins at 30 degC by liquid scintillation counting method in presence of [gamma-32P]-ATP	B	O=C(Cn1cnc2cc3c(cc2c1=O)OCCO3)c1ccc(Br)cc1		CHEMBL3793356	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	16547758	CHEMBL3796157	Inhibition of human Src using myelin basic protein as substrate at 1 uM measured after 20 mins at 30 degC by liquid scintillation counting method in presence of [gamma-32P]-ATP	B	O=C(Cn1cnc2cc3c(cc2c1=O)OCCO3)c1cccc(Br)c1		CHEMBL3792910	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	16547759	CHEMBL3796157	Inhibition of human Src using myelin basic protein as substrate at 1 uM measured after 20 mins at 30 degC by liquid scintillation counting method in presence of [gamma-32P]-ATP	B	O=c1c2cc3c(cc2ncn1CC(O)c1cccc(Cl)c1)OCCO3		CHEMBL3793972	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	16547760	CHEMBL3796157	Inhibition of human Src using myelin basic protein as substrate at 1 uM measured after 20 mins at 30 degC by liquid scintillation counting method in presence of [gamma-32P]-ATP	B	O=c1c2cc3c(cc2ncn1Cc1ccc(Br)cc1)OCO3		CHEMBL3793896	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	16547761	CHEMBL3796157	Inhibition of human Src using myelin basic protein as substrate at 1 uM measured after 20 mins at 30 degC by liquid scintillation counting method in presence of [gamma-32P]-ATP	B	O=c1c2cc3c(cc2ncn1Cc1cccc(-c2ccccc2)c1)OCO3		CHEMBL3794041	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	16547762	CHEMBL3796157	Inhibition of human Src using myelin basic protein as substrate at 1 uM measured after 20 mins at 30 degC by liquid scintillation counting method in presence of [gamma-32P]-ATP	B	O=c1c2cc3c(cc2ncn1Cc1ccc(-c2ccccc2)cc1)OCO3		CHEMBL3794304	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	16547763	CHEMBL3796157	Inhibition of human Src using myelin basic protein as substrate at 1 uM measured after 20 mins at 30 degC by liquid scintillation counting method in presence of [gamma-32P]-ATP	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	=	Inhibition	%	16.0	CHEMBL267	Homo sapiens	INH	%	16.0
	16559661	CHEMBL3794819	Inhibition of full length human N-terminal GST-tagged SRC (1 to 536 residues) expressed in baculovirus expression system using fluorescence labelled srctide as substrate at 50 times IC50 by electrophoretic mobility shift assay relative to control	B	O=C(Nc1ccccc1)c1n[nH]c2ccccc12		CHEMBL508964	=	Inhibition	%	6.1	CHEMBL267	Homo sapiens	INH	%	6.1
	16559662	CHEMBL3794819	Inhibition of full length human N-terminal GST-tagged SRC (1 to 536 residues) expressed in baculovirus expression system using fluorescence labelled srctide as substrate at 50 times IC50 by electrophoretic mobility shift assay relative to control	B	O=C(Nc1ccc(C(=O)N2CCN(c3ccccc3)CC2)cc1)c1n[nH]c2ccccc12		CHEMBL3793843	=	Inhibition	%	2.5	CHEMBL267	Homo sapiens	INH	%	2.5
	16559663	CHEMBL3794819	Inhibition of full length human N-terminal GST-tagged SRC (1 to 536 residues) expressed in baculovirus expression system using fluorescence labelled srctide as substrate at 50 times IC50 by electrophoretic mobility shift assay relative to control	B	O=C(Nc1ccc(CN2CCN(c3ccccc3)CC2)cc1)c1n[nH]c2ccccc12		CHEMBL3792850	=	Inhibition	%	0.6	CHEMBL267	Homo sapiens	INH	%	0.6
	16563795	CHEMBL3802299	Inhibition of c-Src (unknown origin) by Z-LYTE assay	B	CC(NC(=O)c1ccc2[nH]nc(-c3ccncc3)c2c1)c1cccc(Cl)c1		CHEMBL3798631	>	IC50	nM	1000.0	CHEMBL267	Homo sapiens	IC50	nM	1000.0
	16563796	CHEMBL3802299	Inhibition of c-Src (unknown origin) by Z-LYTE assay	B	Cc1cc(-c2n[nH]c3ccc(C(=O)NC(C)c4c(Cl)cncc4Cl)cc23)ccn1		CHEMBL3798257	>	IC50	nM	1000.0	CHEMBL267	Homo sapiens	IC50	nM	1000.0
	16565459	CHEMBL3802854	Inhibition of full length N-terminal His-tagged recombinant human SRC preincubated for 5 mins measured after 10 mins in presence of ATP by AlphaScreen assay	B	C[C@H](c1ccccc1)N1c2cc(-n3c(=O)[nH]c4ncccc43)ccc2C(=O)NC1(C)C		CHEMBL3798011	>	IC50	nM	100.0	CHEMBL267	Homo sapiens	IC50	nM	100.0
	16565620	CHEMBL3803243	Inhibition of full length human recombinant N-terminal His6-tagged SRC expressed in baculovirus infected sf21 cells using KVEKIGEGTYGVVYK as substrate at 100 uM incubated for 10 mins by scintillation counting method relative to control	B	COc1ccc(/C=N/Nc2cc(C)c3ccccc3n2)cc1		CHEMBL3798597	=	Inhibition	%	31.0	CHEMBL267	Homo sapiens	INH	%	31.0
	16565621	CHEMBL3803243	Inhibition of full length human recombinant N-terminal His6-tagged SRC expressed in baculovirus infected sf21 cells using KVEKIGEGTYGVVYK as substrate at 100 uM incubated for 10 mins by scintillation counting method relative to control	B	C/C(=N\Nc1ccc2ccccc2n1)c1ccccc1O		CHEMBL1892026	=	Inhibition	%	5.0	CHEMBL267	Homo sapiens	INH	%	5.0
	16565622	CHEMBL3803243	Inhibition of full length human recombinant N-terminal His6-tagged SRC expressed in baculovirus infected sf21 cells using KVEKIGEGTYGVVYK as substrate at 100 uM incubated for 10 mins by scintillation counting method relative to control	B	Cc1cc(N/N=C/c2ccc(O)cc2)nc2ccccc12		CHEMBL3799359	=	Inhibition	%	21.0	CHEMBL267	Homo sapiens	INH	%	21.0
	16565623	CHEMBL3803243	Inhibition of full length human recombinant N-terminal His6-tagged SRC expressed in baculovirus infected sf21 cells using KVEKIGEGTYGVVYK as substrate at 100 uM incubated for 10 mins by scintillation counting method relative to control	B	COc1ccc(-c2nnc3c(NCCN4CCOCC4)cccn23)cc1OC		CHEMBL3798991	=	Inhibition	%	40.0	CHEMBL267	Homo sapiens	INH	%	40.0
	16565685	CHEMBL3801095	Inhibition of SRC (unknown origin)	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	1.0	CHEMBL267	Homo sapiens	Kd	nM	1.0
Not Active	16565686	CHEMBL3801095	Inhibition of SRC (unknown origin)	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336		Kd			CHEMBL267	Homo sapiens	Kd		
	16566748	CHEMBL3802997	Inhibition of human SRC using (poly [Glu, Tyr] 4:1) as substrate assessed as incorporation of 33P in substrate by [gamma33P] ATP-based kinase assay	B	CCOC(Cn1nc(-c2cnc3[nH]ccc3c2)c2c(N)ncnc21)OCC		CHEMBL3799221	=	IC50	nM	2450.0	CHEMBL267	Homo sapiens	IC50	nM	2450.0
	16566765	CHEMBL3802997	Inhibition of human SRC using (poly [Glu, Tyr] 4:1) as substrate assessed as incorporation of 33P in substrate by [gamma33P] ATP-based kinase assay	B	CCOC(Cn1nc(-c2ccc3oc(N)nc3c2)c2c(N)ncnc21)OCC		CHEMBL3800481	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	10'5nM	1.0
	16566815	CHEMBL3802997	Inhibition of human SRC using (poly [Glu, Tyr] 4:1) as substrate assessed as incorporation of 33P in substrate by [gamma33P] ATP-based kinase assay	B	Nc1nc2cc(-c3nn(CC4OCCO4)c4ncnc(N)c34)ccc2o1		CHEMBL3797590	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	10'5nM	1.0
	16566829	CHEMBL3802997	Inhibition of human SRC using (poly [Glu, Tyr] 4:1) as substrate assessed as incorporation of 33P in substrate by [gamma33P] ATP-based kinase assay	B	COC(Cn1nc(-c2ccc3oc(N)nc3c2)c2c(N)ncnc21)OC		CHEMBL3800138	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	10'5nM	1.0
	16574803	CHEMBL3802405	Inhibition of recombinant c-Src (unknown origin) using poly (Glu, Tyr) 4:1 as substrate at 1000 nM incubated for 60 mins by ELISA relative to control	B	Fc1ccc(-c2cnc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cc1		CHEMBL3797579	=	Inhibition	%	13.7	CHEMBL267	Homo sapiens	INH	%	13.7
	16575578	CHEMBL3802390	Inhibition of human C-Src at 10 uM measured after 40 mins by scintillation counting	B	CNC(=O)c1cc(Oc2ccc3nc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)sc3c2)ccn1		CHEMBL3797601	<	Inhibition	%	40.0	CHEMBL267	Homo sapiens	INH	%	40.0
	16578411	CHEMBL3802471	Inhibition of partial length wild type human SRC expressed in bacterial system assessed as enzyme activity at 1 uM relative to control	B	CN(C)S(=O)(=O)Nc1ccc(F)c(Nc2ncccc2-c2ncnc3[nH]cnc23)c1F		CHEMBL3798256	=	Activity	%	100.0	CHEMBL267	Homo sapiens	Activity	%	100.0
	16593617	CHEMBL3811756	Inhibition of full length His-tagged human recombinant cSRC expressed in baculovirus using Fluorescein-Poly GT as substrate	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cc(-n5cnc(C)c5)cc(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3808884	=	IC50	nM	40.0	CHEMBL267	Homo sapiens	IC50	nM	40.0
	16594838	CHEMBL3812899	Inhibition of human SRC (240 to 536 amino acid residues) expressed in bacterial system assessed as enzyme activity at 10 uM by KINOMEScan assay	B	O=C1C2=C(C(=O)c3c(O)ccc(O)c31)[C@@H](O)[C@@H](O)[C@@H](O)C2		CHEMBL1987813	=	Activity	%	91.0	CHEMBL267	Homo sapiens	Activity	%	91.0
	16595583	CHEMBL3811350	Inhibition of human SRC (1 to 530 residues) using GGEEEEYFELVKKKK as substrate after 40 mins by scintillation counting analysis in presence of [gamma-33P-ATP]	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	IC50	nM	1.0	CHEMBL267	Homo sapiens	IC50	nM	1.0
	16597056	CHEMBL3813083	Inhibition of SRC (unknown origin)	B	O=C1C2=C(C(=O)c3c(O)ccc(O)c31)[C@@H](O)[C@@H](O)[C@@H](O)C2		CHEMBL1987813	=	Inhibition	%	14.0	CHEMBL267	Homo sapiens	INH	%	14.0
	16608965	CHEMBL3812146	Inhibition of full length His-tagged human recombinant cSRC expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cccc(C)c4)ccc3C)cnc2[nH]1		CHEMBL3809587	=	Inhibition	%	84.0	CHEMBL267	Homo sapiens	INH	%	84.0
	16608966	CHEMBL3812146	Inhibition of full length His-tagged human recombinant cSRC expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cccc(Br)c4)ccc3C)cnc2[nH]1		CHEMBL3809563	=	Inhibition	%	85.0	CHEMBL267	Homo sapiens	INH	%	85.0
	16608967	CHEMBL3812146	Inhibition of full length His-tagged human recombinant cSRC expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cccc(C(C)C)c4)ccc3C)cnc2[nH]1		CHEMBL3808990	=	Inhibition	%	99.0	CHEMBL267	Homo sapiens	INH	%	99.0
	16608968	CHEMBL3812146	Inhibition of full length His-tagged human recombinant cSRC expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3810040	=	Inhibition	%	108.0	CHEMBL267	Homo sapiens	INH	%	108.0
	16608969	CHEMBL3812146	Inhibition of full length His-tagged human recombinant cSRC expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cccc(OC(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3809430	=	Inhibition	%	105.0	CHEMBL267	Homo sapiens	INH	%	105.0
	16608970	CHEMBL3812146	Inhibition of full length His-tagged human recombinant cSRC expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4ccc(C)c(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3808834	=	Inhibition	%	74.0	CHEMBL267	Homo sapiens	INH	%	74.0
	16608971	CHEMBL3812146	Inhibition of full length His-tagged human recombinant cSRC expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4ccc(Cl)c(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3808526	=	Inhibition	%	86.0	CHEMBL267	Homo sapiens	INH	%	86.0
	16608972	CHEMBL3812146	Inhibition of full length His-tagged human recombinant cSRC expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4ccc(O)c(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3809790	=	Inhibition	%	66.0	CHEMBL267	Homo sapiens	INH	%	66.0
	16608973	CHEMBL3812146	Inhibition of full length His-tagged human recombinant cSRC expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cc(N(C)C)cc(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3809345	=	Inhibition	%	108.0	CHEMBL267	Homo sapiens	INH	%	108.0
	16608974	CHEMBL3812146	Inhibition of full length His-tagged human recombinant cSRC expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4ccccc4OC)ccc3C)cnc2[nH]1		CHEMBL3808521	=	Inhibition	%	78.0	CHEMBL267	Homo sapiens	INH	%	78.0
	16608975	CHEMBL3812146	Inhibition of full length His-tagged human recombinant cSRC expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)Cc4ccccc4Br)ccc3C)cnc2[nH]1		CHEMBL3808744	=	Inhibition	%	65.0	CHEMBL267	Homo sapiens	INH	%	65.0
	16608976	CHEMBL3812146	Inhibition of full length His-tagged human recombinant cSRC expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)Cc4cccc(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3809756	=	Inhibition	%	58.0	CHEMBL267	Homo sapiens	INH	%	58.0
	16608977	CHEMBL3812146	Inhibition of full length His-tagged human recombinant cSRC expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cncc(C)c4)ccc3C)cnc2[nH]1		CHEMBL3808753	=	Inhibition	%	89.0	CHEMBL267	Homo sapiens	INH	%	89.0
	16608978	CHEMBL3812146	Inhibition of full length His-tagged human recombinant cSRC expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4ccnc(C)c4)ccc3C)cnc2[nH]1		CHEMBL3809705	=	Inhibition	%	51.0	CHEMBL267	Homo sapiens	INH	%	51.0
	16608979	CHEMBL3812146	Inhibition of full length His-tagged human recombinant cSRC expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cncc(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3809290	=	Inhibition	%	101.0	CHEMBL267	Homo sapiens	INH	%	101.0
	16608980	CHEMBL3812146	Inhibition of full length His-tagged human recombinant cSRC expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4ccnc(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3809745	=	Inhibition	%	42.0	CHEMBL267	Homo sapiens	INH	%	42.0
	16608981	CHEMBL3812146	Inhibition of full length His-tagged human recombinant cSRC expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4ccc(C(F)(F)F)nc4)ccc3C)cnc2[nH]1		CHEMBL3808503	=	Inhibition	%	39.0	CHEMBL267	Homo sapiens	INH	%	39.0
	16608982	CHEMBL3812146	Inhibition of full length His-tagged human recombinant cSRC expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4ccc5c(c4)OCC5)ccc3C)cnc2[nH]1		CHEMBL3808758	=	Inhibition	%	73.0	CHEMBL267	Homo sapiens	INH	%	73.0
	16608983	CHEMBL3812146	Inhibition of full length His-tagged human recombinant cSRC expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4ccc5c(c4)OCO5)ccc3C)cnc2[nH]1		CHEMBL3809960	=	Inhibition	%	68.0	CHEMBL267	Homo sapiens	INH	%	68.0
	16608984	CHEMBL3812146	Inhibition of full length His-tagged human recombinant cSRC expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4ccc5nn[nH]c5c4)ccc3C)cnc2[nH]1		CHEMBL3808725	=	Inhibition	%	34.0	CHEMBL267	Homo sapiens	INH	%	34.0
	16608985	CHEMBL3812146	Inhibition of full length His-tagged human recombinant cSRC expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4ccc5[nH]ccc5c4)ccc3C)cnc2[nH]1		CHEMBL3810116	=	Inhibition	%	59.0	CHEMBL267	Homo sapiens	INH	%	59.0
	16608986	CHEMBL3812146	Inhibition of full length His-tagged human recombinant cSRC expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4ccc(-c5csc(C)n5)cc4)ccc3C)cnc2[nH]1		CHEMBL3808982	=	Inhibition	%	72.0	CHEMBL267	Homo sapiens	INH	%	72.0
	16608987	CHEMBL3812146	Inhibition of full length His-tagged human recombinant cSRC expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cc[nH]c4)ccc3C)cnc2[nH]1		CHEMBL3809817	=	Inhibition	%	11.0	CHEMBL267	Homo sapiens	INH	%	11.0
	16608988	CHEMBL3812146	Inhibition of full length His-tagged human recombinant cSRC expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4ccc(CN5CCN(C)CC5)cc4)ccc3C)cnc2[nH]1		CHEMBL3808466	=	Inhibition	%	93.0	CHEMBL267	Homo sapiens	INH	%	93.0
	16608989	CHEMBL3812146	Inhibition of full length His-tagged human recombinant cSRC expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4ccc(CN5CCC(N(C)C)C5)c(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3810275	=	Inhibition	%	96.0	CHEMBL267	Homo sapiens	INH	%	96.0
	16608990	CHEMBL3812146	Inhibition of full length His-tagged human recombinant cSRC expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cc(-n5cnc(C)c5)cc(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3808884	=	Inhibition	%	49.0	CHEMBL267	Homo sapiens	INH	%	49.0
	16608991	CHEMBL3812146	Inhibition of full length His-tagged human recombinant cSRC expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	CC(=O)c1cc2cc(NCc3cc(NC(=O)c4ccc(CN5CCN(C)CC5)cc4)ccc3C)cnc2[nH]1		CHEMBL3808782	=	Inhibition	%	87.0	CHEMBL267	Homo sapiens	INH	%	87.0
	16608992	CHEMBL3812146	Inhibition of full length His-tagged human recombinant cSRC expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	CC(=O)c1cc2cc(NCc3cc(NC(=O)c4ccc(CN5CCC(N(C)C)C5)c(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3808527	=	Inhibition	%	91.0	CHEMBL267	Homo sapiens	INH	%	91.0
	16608993	CHEMBL3812146	Inhibition of full length His-tagged human recombinant cSRC expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	CC(=O)c1cc2cc(NCc3cc(NC(=O)c4cc(-n5cnc(C)c5)cc(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3809066	=	Inhibition	%	59.0	CHEMBL267	Homo sapiens	INH	%	59.0
	16608994	CHEMBL3812146	Inhibition of full length His-tagged human recombinant cSRC expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1CNc1cnc2[nH]c(C(=O)O)cc2c1		CHEMBL3808858	=	Inhibition	%	75.0	CHEMBL267	Homo sapiens	INH	%	75.0
	16608995	CHEMBL3812146	Inhibition of full length His-tagged human recombinant cSRC expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	Cc1ccc(NC(=O)c2ccc(CN3CCC(N(C)C)C3)c(C(F)(F)F)c2)cc1CNc1cnc2[nH]c(C(=O)O)cc2c1		CHEMBL3808943	=	Inhibition	%	86.0	CHEMBL267	Homo sapiens	INH	%	86.0
	16608996	CHEMBL3812146	Inhibition of full length His-tagged human recombinant cSRC expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	Cc1cn(-c2cc(C(=O)Nc3ccc(C)c(CNc4cnc5[nH]c(C(=O)O)cc5c4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL3809813	=	Inhibition	%	69.0	CHEMBL267	Homo sapiens	INH	%	69.0
	16608997	CHEMBL3812146	Inhibition of full length His-tagged human recombinant cSRC expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	CNC(=O)c1cc2cc(NCc3cc(NC(=O)c4ccc(CN5CCN(C)CC5)cc4)ccc3C)cnc2[nH]1		CHEMBL3808739	=	Inhibition	%	98.0	CHEMBL267	Homo sapiens	INH	%	98.0
	16608998	CHEMBL3812146	Inhibition of full length His-tagged human recombinant cSRC expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	CNC(=O)c1cc2cc(NCc3cc(NC(=O)c4ccc(CN5CCC(N(C)C)C5)c(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3809155	=	Inhibition	%	99.0	CHEMBL267	Homo sapiens	INH	%	99.0
	16608999	CHEMBL3812146	Inhibition of full length His-tagged human recombinant cSRC expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NC(=O)c3cc(NC(=O)c4ccc(CN5CCN(C)CC5)cc4)ccc3C)cnc2[nH]1		CHEMBL3809041	=	Inhibition	%	94.0	CHEMBL267	Homo sapiens	INH	%	94.0
	16609000	CHEMBL3812146	Inhibition of full length His-tagged human recombinant cSRC expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NC(=O)c3cc(NC(=O)c4ccc(CN5CCC(N(C)C)C5)c(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3810358	=	Inhibition	%	100.0	CHEMBL267	Homo sapiens	INH	%	100.0
	16609001	CHEMBL3812146	Inhibition of full length His-tagged human recombinant cSRC expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(CNc3cc(NC(=O)c4ccc(CN5CCN(C)CC5)cc4)ccc3C)cnc2[nH]1		CHEMBL3808803	=	Inhibition	%	47.0	CHEMBL267	Homo sapiens	INH	%	47.0
	16609002	CHEMBL3812146	Inhibition of full length His-tagged human recombinant cSRC expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(COc3cc(NC(=O)c4ccc(CN5CCN(C)CC5)cc4)ccc3C)cnc2[nH]1		CHEMBL3809924	=	Inhibition	%	58.0	CHEMBL267	Homo sapiens	INH	%	58.0
	16609003	CHEMBL3812146	Inhibition of full length His-tagged human recombinant cSRC expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(COc3cc(NC(=O)c4ccc(CN5CCC(N(C)C)C5)c(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3809233	=	Inhibition	%	87.0	CHEMBL267	Homo sapiens	INH	%	87.0
	16609004	CHEMBL3812146	Inhibition of full length His-tagged human recombinant cSRC expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(/C=C/c3cc(NC(=O)c4ccc(CN5CCN(C)CC5)cc4)ccc3C)cnc2[nH]1		CHEMBL3809631	=	Inhibition	%	40.0	CHEMBL267	Homo sapiens	INH	%	40.0
	16609005	CHEMBL3812146	Inhibition of full length His-tagged human recombinant cSRC expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(/C=C/c3cc(NC(=O)c4ccc(CN5CCC(N(C)C)C5)c(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3808402	=	Inhibition	%	55.0	CHEMBL267	Homo sapiens	INH	%	55.0
	16609006	CHEMBL3812146	Inhibition of full length His-tagged human recombinant cSRC expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(CCc3cc(NC(=O)c4ccc(CN5CCN(C)CC5)cc4)ccc3C)cnc2[nH]1		CHEMBL3808428	=	Inhibition	%	91.0	CHEMBL267	Homo sapiens	INH	%	91.0
	16609007	CHEMBL3812146	Inhibition of full length His-tagged human recombinant cSRC expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(CCc3cc(NC(=O)c4ccc(CN5CCC(N(C)C)C5)c(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3809462	=	Inhibition	%	101.0	CHEMBL267	Homo sapiens	INH	%	101.0
	16609008	CHEMBL3812146	Inhibition of full length His-tagged human recombinant cSRC expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	CC(=O)c1cc2cc(CCc3cc(NC(=O)c4ccc(CN5CCN(C)CC5)cc4)ccc3C)cnc2[nH]1		CHEMBL3808681	=	Inhibition	%	77.0	CHEMBL267	Homo sapiens	INH	%	77.0
	16609009	CHEMBL3812146	Inhibition of full length His-tagged human recombinant cSRC expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	CC(=O)c1cc2cc(CCc3cc(NC(=O)c4ccc(CN5CCC(N(C)C)C5)c(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3808421	=	Inhibition	%	97.0	CHEMBL267	Homo sapiens	INH	%	97.0
	16610411	CHEMBL3815867	Inhibition of recombinant human N-terminal poly His/GST-tagged SRC expressed in baculovirus infected insect cells using KVEKIGEGTYGVVYK peptide substrate assessed as residual activity at 100 uM by [gamma32P]ATP filter binding assay relative to control	B	CN1CCCCC1CCn1c2ccccc2c2ccccc21		CHEMBL3593723	=	Activity	%	100.0	CHEMBL267	Homo sapiens	Activity	%	100.0
	16610412	CHEMBL3815868	Inhibition of recombinant human N-terminal poly His/GST-tagged SRC expressed in baculovirus infected insect cells using KVEKIGEGTYGVVYK peptide substrate assessed as residual activity at 100 uM in presence of NP40 by [gamma32P]ATP filter binding assay relative to control	B	CN1CCCCC1CCn1c2ccccc2c2ccccc21		CHEMBL3593723	=	Activity	%	96.0	CHEMBL267	Homo sapiens	Activity	%	96.0
	16612729	CHEMBL3815736	Inhibition of human SRC (1 to 536 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL405665	=	Activity	%	-11.0	CHEMBL267	Homo sapiens	Activity	%	-11.0
	16612730	CHEMBL3815736	Inhibition of human SRC (1 to 536 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	CCCCc1cc(-c2c[nH]c3ncccc23)nc(N)n1		CHEMBL3814340	=	Activity	%	7.0	CHEMBL267	Homo sapiens	Activity	%	7.0
	16612731	CHEMBL3815736	Inhibition of human SRC (1 to 536 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	CCc1cc(-c2c[nH]c3ncc(-c4cnn(C5CCNCC5)c4)cc23)nc(N)n1		CHEMBL3814140	=	Activity	%	-34.0	CHEMBL267	Homo sapiens	Activity	%	-34.0
	16612732	CHEMBL3815736	Inhibition of human SRC (1 to 536 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	CCCCc1cc(-c2c[nH]c3ncc(-c4cnn(C5CCNCC5)c4)cc23)nc(N)n1		CHEMBL3815046	=	Activity	%	-68.0	CHEMBL267	Homo sapiens	Activity	%	-68.0
	16614443	CHEMBL3817309	Inhibition of human c-Src at 1 uM using poly[Glu:Tyr] (4:1) as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	4.0	CHEMBL267	Homo sapiens	INH	%	4.0
	16618660	CHEMBL3816414	Inhibition of full length recombinant human C-terminal His-tagged cytoplasmic SRC expressed in baculovirus expression system at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL267	Homo sapiens	INH	%	50.0
	16619698	CHEMBL3820365	Inhibition of recombinant human full length His-tagged SRC expressed in Baculovirus at 1 uM relative to control	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	>	Inhibition	%	75.0	CHEMBL267	Homo sapiens	INH	%	75.0
	16621534	CHEMBL3820673	Inhibition of SRC (unknown origin) incubated for 1 hr by spectrophotometric analysis	B	CN1C(=O)COc2c1cnc1ccc(Sc3nnc4c(F)cc(-c5cnn(C)c5)cn34)cc21		CHEMBL3818247	=	IC50	nM	15453.0	CHEMBL267	Homo sapiens	IC50	nM	15453.0
	16622241	CHEMBL3820673	Inhibition of SRC (unknown origin) incubated for 1 hr by spectrophotometric analysis	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	4.7	CHEMBL267	Homo sapiens	IC50	nM	4.7
	16627504	CHEMBL3820221	Inhibition of full length recombinant human N-terminal His6-tagged SRC expressed in Sf21 cells at 1 uM by radiometric assay relative to control	B	Cc1cc(-c2cnn3c(NCC4CCOCC4)nc(Oc4ccccc4)nc23)ccc1C(=O)NC1CC1		CHEMBL3819210	=	Inhibition	%	-3.0	CHEMBL267	Homo sapiens	INH	%	-3.0
	16627505	CHEMBL3820221	Inhibition of full length recombinant human N-terminal His6-tagged SRC expressed in Sf21 cells at 1 uM by radiometric assay relative to control	B	O=C(N[C@@H](c1ccccn1)C1CC1)c1ccc2[nH]nc(-c3ccc(N4C5CCC4CC(O)C5)cc3)c2c1	Outside typical range	CHEMBL3818239	=	Inhibition	%	-11.0	CHEMBL267	Homo sapiens	INH	%	-11.0
	16628458	CHEMBL3820161	Inhibition of Src (unknown origin) by HTRF assay	B	O=C(Nc1cc(Nc2c(Cl)cnc3c2OCO3)ccn1)C1CC1	Non standard unit for type	CHEMBL3818173	=	INH	uM	4.4	CHEMBL267	Homo sapiens	INH	uM	4.4
	16628475	CHEMBL3820178	Inhibition of human recombinant full-length Src expressed in insect Sf21 cells at 1 uM using KVEKIGEGTYGVVYK as substrate after 30 mins	B	O=C(Nc1cc(Nc2c(Cl)cnc3c2OCO3)ccn1)C1CC1		CHEMBL3818173	<	Inhibition	%	80.0	CHEMBL267	Homo sapiens	INH	%	80.0
	16635911	CHEMBL3825319	Inhibition of 6x-His-tagged human Src kinase domain (T250 to L536 residues) expressed in Sf9 cells incubated for 2 hrs in presence of biotinylated cdc2 peptide substrate by homogenous TR-FRET assay	B	CP(C)(=O)c1ccc(Nc2nc(C3CCCC3)nc3c2ncn3CCc2cccc(O)c2)cc1		CHEMBL1089405	=	IC50	nM	0.45	CHEMBL267	Homo sapiens	IC50	nM	0.45
	16640023	CHEMBL3824531	Inhibition of C-terminal His-tagged full length human SRC expressed in insect cells preincubated for 20 mins using poly[Glu,Tyr]4:1 as substrate measured after 5 to 120 mins in presence of [gamma-33P]ATP by Kinome assay	B	Cc1ccc(-c2nn(CCN3CCC(N(C)C)CC3)c3ncnc(N)c23)cc1		CHEMBL3823212	=	IC50	nM	126.0	CHEMBL267	Homo sapiens	IC50	nM	126.0
	16640024	CHEMBL3824531	Inhibition of C-terminal His-tagged full length human SRC expressed in insect cells preincubated for 20 mins using poly[Glu,Tyr]4:1 as substrate measured after 5 to 120 mins in presence of [gamma-33P]ATP by Kinome assay	B	Cc1ccc(-c2nn(CCN3CCC(CN(C)C)CC3)c3ncnc(N)c23)cc1		CHEMBL3823849	=	IC50	nM	303.0	CHEMBL267	Homo sapiens	IC50	nM	303.0
	16640025	CHEMBL3824531	Inhibition of C-terminal His-tagged full length human SRC expressed in insect cells preincubated for 20 mins using poly[Glu,Tyr]4:1 as substrate measured after 5 to 120 mins in presence of [gamma-33P]ATP by Kinome assay	B	Cc1ccc(-c2nn(CCN3CCC(CCN(C)C)CC3)c3ncnc(N)c23)cc1		CHEMBL3822591	=	IC50	nM	1040.0	CHEMBL267	Homo sapiens	IC50	nM	1040.0
	16640026	CHEMBL3824531	Inhibition of C-terminal His-tagged full length human SRC expressed in insect cells preincubated for 20 mins using poly[Glu,Tyr]4:1 as substrate measured after 5 to 120 mins in presence of [gamma-33P]ATP by Kinome assay	B	CCOC(Cn1nc(-c2cnc3[nH]ccc3c2)c2c(N)ncnc21)OCC		CHEMBL3799221	=	IC50	nM	2453.0	CHEMBL267	Homo sapiens	IC50	nM	2453.0
	16640027	CHEMBL3824531	Inhibition of C-terminal His-tagged full length human SRC expressed in insect cells preincubated for 20 mins using poly[Glu,Tyr]4:1 as substrate measured after 5 to 120 mins in presence of [gamma-33P]ATP by Kinome assay	B	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	=	IC50	nM	17.0	CHEMBL267	Homo sapiens	IC50	nM	17.0
	16640028	CHEMBL3824531	Inhibition of C-terminal His-tagged full length human SRC expressed in insect cells preincubated for 20 mins using poly[Glu,Tyr]4:1 as substrate measured after 5 to 120 mins in presence of [gamma-33P]ATP by Kinome assay	B	CN(C)CC1CCN(CCn2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)CC1		CHEMBL3823861	=	IC50	nM	27.0	CHEMBL267	Homo sapiens	IC50	nM	27.0
	16640029	CHEMBL3824531	Inhibition of C-terminal His-tagged full length human SRC expressed in insect cells preincubated for 20 mins using poly[Glu,Tyr]4:1 as substrate measured after 5 to 120 mins in presence of [gamma-33P]ATP by Kinome assay	B	COc1cc(-c2nn(CCN3CCC(N(C)C)CC3)c3ncnc(N)c23)ccc1NC(=O)OC(C)(C)C		CHEMBL3824089	<	IC50	nM	0.5	CHEMBL267	Homo sapiens	IC50	nM	0.5
	16640030	CHEMBL3824531	Inhibition of C-terminal His-tagged full length human SRC expressed in insect cells preincubated for 20 mins using poly[Glu,Tyr]4:1 as substrate measured after 5 to 120 mins in presence of [gamma-33P]ATP by Kinome assay	B	COc1cc(-c2nn(CCN3CCN(C)CC3)c3ncnc(N)c23)ccc1NC(=O)OC(C)(C)C		CHEMBL3823451	=	IC50	nM	21.0	CHEMBL267	Homo sapiens	IC50	nM	21.0
	16640031	CHEMBL3824531	Inhibition of C-terminal His-tagged full length human SRC expressed in insect cells preincubated for 20 mins using poly[Glu,Tyr]4:1 as substrate measured after 5 to 120 mins in presence of [gamma-33P]ATP by Kinome assay	B	COc1cc(-c2nn(CCN3CCC(N4CCCC4)CC3)c3ncnc(N)c23)ccc1NC(=O)OC(C)(C)C		CHEMBL3824233	<	IC50	nM	0.5	CHEMBL267	Homo sapiens	IC50	nM	0.5
	16640032	CHEMBL3824531	Inhibition of C-terminal His-tagged full length human SRC expressed in insect cells preincubated for 20 mins using poly[Glu,Tyr]4:1 as substrate measured after 5 to 120 mins in presence of [gamma-33P]ATP by Kinome assay	B	COc1cc(-c2nn(CCN3CCC(N4CCCCC4)CC3)c3ncnc(N)c23)ccc1NC(=O)OC(C)(C)C		CHEMBL3823104	=	IC50	nM	0.6	CHEMBL267	Homo sapiens	IC50	nM	0.6
	16640033	CHEMBL3824531	Inhibition of C-terminal His-tagged full length human SRC expressed in insect cells preincubated for 20 mins using poly[Glu,Tyr]4:1 as substrate measured after 5 to 120 mins in presence of [gamma-33P]ATP by Kinome assay	B	COc1cc(-c2nn(CCN3CCC(N(C)C)CC3)c3ncnc(N)c23)ccc1NC(=O)NC(C)(C)C		CHEMBL3823711	=	IC50	nM	194.0	CHEMBL267	Homo sapiens	IC50	nM	194.0
	16640034	CHEMBL3824531	Inhibition of C-terminal His-tagged full length human SRC expressed in insect cells preincubated for 20 mins using poly[Glu,Tyr]4:1 as substrate measured after 5 to 120 mins in presence of [gamma-33P]ATP by Kinome assay	B	COc1cc(-c2nn(CCN3CCC(N(C)C)CC3)c3ncnc(N)c23)ccc1NC(=O)CC(C)(C)C		CHEMBL3823255	=	IC50	nM	114.0	CHEMBL267	Homo sapiens	IC50	nM	114.0
	16640035	CHEMBL3824531	Inhibition of C-terminal His-tagged full length human SRC expressed in insect cells preincubated for 20 mins using poly[Glu,Tyr]4:1 as substrate measured after 5 to 120 mins in presence of [gamma-33P]ATP by Kinome assay	B	COc1cc(-c2nn(CCN3CCC(N(C)C)CC3)c3ncnc(N)c23)ccc1NCc1ccccc1		CHEMBL3823543	=	IC50	nM	3.5	CHEMBL267	Homo sapiens	IC50	nM	3.5
	16640036	CHEMBL3824531	Inhibition of C-terminal His-tagged full length human SRC expressed in insect cells preincubated for 20 mins using poly[Glu,Tyr]4:1 as substrate measured after 5 to 120 mins in presence of [gamma-33P]ATP by Kinome assay	B	CN(C)C1CCN(CCn2nc(-c3ccc(NC(=O)OC(C)(C)C)cc3)c3c(N)ncnc32)CC1		CHEMBL3824228	=	IC50	nM	71.0	CHEMBL267	Homo sapiens	IC50	nM	71.0
	16640037	CHEMBL3824531	Inhibition of C-terminal His-tagged full length human SRC expressed in insect cells preincubated for 20 mins using poly[Glu,Tyr]4:1 as substrate measured after 5 to 120 mins in presence of [gamma-33P]ATP by Kinome assay	B	CN(C)C1CCN(CCn2nc(-c3ccc(CC(=O)O)cc3)c3c(N)ncnc32)CC1		CHEMBL3824021	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	16640038	CHEMBL3824531	Inhibition of C-terminal His-tagged full length human SRC expressed in insect cells preincubated for 20 mins using poly[Glu,Tyr]4:1 as substrate measured after 5 to 120 mins in presence of [gamma-33P]ATP by Kinome assay	B	CN(C)C1CCN(CCn2nc(-c3ccc(CC(=O)OC(C)(C)C)cc3)c3c(N)ncnc32)CC1		CHEMBL3823620	=	IC50	nM	1.0	CHEMBL267	Homo sapiens	IC50	nM	1.0
	16640039	CHEMBL3824531	Inhibition of C-terminal His-tagged full length human SRC expressed in insect cells preincubated for 20 mins using poly[Glu,Tyr]4:1 as substrate measured after 5 to 120 mins in presence of [gamma-33P]ATP by Kinome assay	B	COc1cc(-c2nn(CCN3CCC(N(C)C)CC3)c3ncnc(N)c23)ccc1CC(=O)OC(C)(C)C		CHEMBL3824116	=	IC50	nM	1.0	CHEMBL267	Homo sapiens	IC50	nM	1.0
	16640040	CHEMBL3824531	Inhibition of C-terminal His-tagged full length human SRC expressed in insect cells preincubated for 20 mins using poly[Glu,Tyr]4:1 as substrate measured after 5 to 120 mins in presence of [gamma-33P]ATP by Kinome assay	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	<	IC50	nM	0.5	CHEMBL267	Homo sapiens	IC50	nM	0.5
Active	16640086	CHEMBL3824535	Inhibition of SRC phosphorylation at tyrosine 416 in human MDA-MB-231 cells at 3 to 100 nM preincubated for 1.5 hrs followed by serum stimulation for 1 hr by Western blot analysis	B	COc1cc(-c2nn(CCN3CCC(N(C)C)CC3)c3ncnc(N)c23)ccc1NC(=O)OC(C)(C)C		CHEMBL3824089		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Active	16640087	CHEMBL3824535	Inhibition of SRC phosphorylation at tyrosine 416 in human MDA-MB-231 cells at 3 to 100 nM preincubated for 1.5 hrs followed by serum stimulation for 1 hr by Western blot analysis	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	16640134	CHEMBL3824738	Competitive inhibition of C-terminal His-tagged full length human SRC expressed in insect cells preincubated for 20 mins using poly[Glu,Tyr]4:1 as substrate measured after 5 to 120 mins by Michaelis-Menten plot and by Lineweaver-Burk plot analysis analysis	B	COc1cc(-c2nn(CCN3CCC(N(C)C)CC3)c3ncnc(N)c23)ccc1NC(=O)OC(C)(C)C		CHEMBL3824089	=	Ki	nM	0.8	CHEMBL267	Homo sapiens	Ki	nM	0.8
Not Active	16640135	CHEMBL3824740	Time dependent inhibition of C-terminal His-tagged full length human SRC expressed in insect cells preincubated for 20 mins using poly[Glu,Tyr]4:1 as substrate measured every 10 mins for 120 mins in presence of [gamma-33P]ATP	B	COc1cc(-c2nn(CCN3CCC(N(C)C)CC3)c3ncnc(N)c23)ccc1NC(=O)OC(C)(C)C		CHEMBL3824089		TDI			CHEMBL267	Homo sapiens	TDI		
	16642021	CHEMBL3826432	Inhibition of His-tagged full-length recombinant human SRC expressed in baculovirus system at 100 nM by Z-lyte assay	B	O=C(CNC(=O)c1cccn(Cc2ccc(F)c(F)c2)c1=O)Nc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL3824119	=	Inhibition	%	7.0	CHEMBL267	Homo sapiens	INH	%	7.0
	16647319	CHEMBL3829051	Inhibition of human recombinant c-SRC assessed as residual activity at 1 uM relative to control	B	CN(Cc1nc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc2n1C)c1ncc(C(=O)NO)cn1		CHEMBL3827894	=	Activity	%	56.0	CHEMBL267	Homo sapiens	Activity	%	56.0
	16647320	CHEMBL3829052	Inhibition of human recombinant SRC T341M mutant assessed as residual activity at 1 uM relative to control	B	CN(Cc1nc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc2n1C)c1ncc(C(=O)NO)cn1		CHEMBL3827894	=	Activity	%	39.0	CHEMBL267	Homo sapiens	Activity	%	39.0
	16653347	CHEMBL3830183	Inhibition of recombinant human c-Src using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA	B	C[C@@H](Oc1ccc2[nH]nc(-c3nc4cc(N5CCN(C)CC5)ccc4[nH]3)c2c1)c1c(Cl)cncc1Cl		CHEMBL3827178	>	IC50	nM	100.0	CHEMBL267	Homo sapiens	IC50	nM	100.0
	16654237	CHEMBL3829771	Inhibition of human Src (1 to 536 residues) assessed as remaining enzyme activity at 50 uM after 30 mins by 33P-ATP filter-binding assay	B	Cc1cc(=O)c2c(O)cc(O)c([C@H]3CCN(C)C[C@H]3O)c2o1		CHEMBL1077604	=	Activity	%	61.0	CHEMBL267	Homo sapiens	Activity	%	61.0
	16655122	CHEMBL3830423	Inhibition of recombinant human c-Src expressed in insect Sf9 cells using poly(Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	CC1(C)c2cc(C3CCN(CC4CCOCC4)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3735648	=	IC50	nM	75.4	CHEMBL267	Homo sapiens	IC50	nM	75.4
	16668679	CHEMBL3854928	Inhibition of Src (unknown origin)	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	=	IC50	nM	110.0	CHEMBL267	Homo sapiens	IC50	uM	0.11
	16739537	CHEMBL3857078	Inhibition of recombinant full length human C-terminal His-tagged SRC expressed in baculovirus at 500 nM by Z'-LYTE assay	B	C[C@@H](Nc1ncnc2oc(-c3ccc(NCCN(C)C)cc3)cc12)c1ccccc1		CHEMBL3901622	=	Inhibition	%	12.0	CHEMBL267	Homo sapiens	INH	%	12.0
	16739538	CHEMBL3857078	Inhibition of recombinant full length human C-terminal His-tagged SRC expressed in baculovirus at 500 nM by Z'-LYTE assay	B	C[C@@H](Nc1ncnc2oc(-c3ccc(NCCN4CCCCC4)cc3)cc12)c1ccccc1		CHEMBL3891846	=	Inhibition	%	17.0	CHEMBL267	Homo sapiens	INH	%	17.0
	16739539	CHEMBL3857078	Inhibition of recombinant full length human C-terminal His-tagged SRC expressed in baculovirus at 500 nM by Z'-LYTE assay	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Inhibition	%	42.0	CHEMBL267	Homo sapiens	INH	%	42.0
	16742544	CHEMBL3857948	Binding affinity to Src SH2 domain (unknown origin) by isothermal titration calorimetry	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](CC(=O)NC)Cc1ccc(OP(=O)(O)O)cc1)C(=O)O		CHEMBL3981048	=	Ka		17000000.0	CHEMBL267	Homo sapiens	Ka		17000000.0
	16742545	CHEMBL3857948	Binding affinity to Src SH2 domain (unknown origin) by isothermal titration calorimetry	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1[C@@H](c2ccc(OP(=O)(O)O)cc2)[C@H]1C(=O)NC)C(=O)O		CHEMBL3960926	=	Ka		10000000.0	CHEMBL267	Homo sapiens	Ka		10000000.0
	16746297	CHEMBL3858965	Inhibition of SRC (unknown origin)	B	Cc1c(-c2c(F)cc(C(N)=O)c3[nH]c4c(c23)CC[C@H](C(C)(C)O)C4)cccc1-n1c(=O)c2cccc(F)c2n(C)c1=O		CHEMBL3900554	=	IC50	nM	1100.0	CHEMBL267	Homo sapiens	IC50	nM	1100.0
	16759955	CHEMBL3861875	Inhibition of human SRC by time-resolved fluorescence or time-resolved fluorescence assay	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(-c6ccccc6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681244	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	nM	50000.0
	16759956	CHEMBL3861875	Inhibition of human SRC by time-resolved fluorescence or time-resolved fluorescence assay	B	Cc1ccc2cc(C(=O)c3cnn(-c4ccc5nc(C)[nH]c5c4)c3N)[nH]c2c1		CHEMBL3895337	=	IC50	nM	3400.0	CHEMBL267	Homo sapiens	IC50	nM	3400.0
	16759957	CHEMBL3861875	Inhibition of human SRC by time-resolved fluorescence or time-resolved fluorescence assay	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(Br)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3676329	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	nM	50000.0
	16759958	CHEMBL3861875	Inhibition of human SRC by time-resolved fluorescence or time-resolved fluorescence assay	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(S(C)(=O)=O)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681317	=	IC50	nM	7000.0	CHEMBL267	Homo sapiens	IC50	nM	7000.0
	16759959	CHEMBL3861875	Inhibition of human SRC by time-resolved fluorescence or time-resolved fluorescence assay	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(CN6CCC(F)(F)CC6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681314	=	IC50	nM	390.0	CHEMBL267	Homo sapiens	IC50	nM	390.0
	16759960	CHEMBL3861875	Inhibition of human SRC by time-resolved fluorescence or time-resolved fluorescence assay	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(CN6CCOCC6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681278	=	IC50	nM	300.0	CHEMBL267	Homo sapiens	IC50	nM	300.0
	16759961	CHEMBL3861875	Inhibition of human SRC by time-resolved fluorescence or time-resolved fluorescence assay	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5cc(CN6CCOCC6)ccc5[nH]4)c3N)cc2[nH]1		CHEMBL3891894	=	IC50	nM	510.0	CHEMBL267	Homo sapiens	IC50	nM	510.0
	16759962	CHEMBL3861875	Inhibition of human SRC by time-resolved fluorescence or time-resolved fluorescence assay	B	Nc1c(C(=O)c2cc3ccccc3[nH]2)cnn1-c1ccc2[nH]c(=O)[nH]c2c1		CHEMBL3952373	=	IC50	nM	33000.0	CHEMBL267	Homo sapiens	IC50	nM	33000.0
	16759963	CHEMBL3861875	Inhibition of human SRC by time-resolved fluorescence or time-resolved fluorescence assay	B	Cc1cc2cc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3959997	=	IC50	nM	330.0	CHEMBL267	Homo sapiens	IC50	nM	330.0
	16759964	CHEMBL3861875	Inhibition of human SRC by time-resolved fluorescence or time-resolved fluorescence assay	B	Nc1c(C(=O)c2cc3ccccc3[nH]2)cnn1-c1ccc2[nH]ccc2c1		CHEMBL3941474	=	IC50	nM	230.0	CHEMBL267	Homo sapiens	IC50	nM	230.0
	16759965	CHEMBL3861875	Inhibition of human SRC by time-resolved fluorescence or time-resolved fluorescence assay	B	CCc1nc2cc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681287	=	IC50	nM	16000.0	CHEMBL267	Homo sapiens	IC50	nM	16000.0
	16759966	CHEMBL3861875	Inhibition of human SRC by time-resolved fluorescence or time-resolved fluorescence assay	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	=	IC50	nM	5900.0	CHEMBL267	Homo sapiens	IC50	nM	5900.0
	16759967	CHEMBL3861875	Inhibition of human SRC by time-resolved fluorescence or time-resolved fluorescence assay	B	Nc1c(C(=O)c2cc3ccccc3[nH]2)cnn1-c1ccc2nc[nH]c2c1		CHEMBL3934547	=	IC50	nM	2000.0	CHEMBL267	Homo sapiens	IC50	nM	2000.0
	16759968	CHEMBL3861875	Inhibition of human SRC by time-resolved fluorescence or time-resolved fluorescence assay	B	Nc1c(C(=O)c2cc3cc(CN4CCOCC4)ccc3[nH]2)cnn1-c1cc(O)ccc1Cl		CHEMBL3984621	=	IC50	nM	0.43	CHEMBL267	Homo sapiens	IC50	nM	0.43
	16759969	CHEMBL3861875	Inhibition of human SRC by time-resolved fluorescence or time-resolved fluorescence assay	B	Nc1c(C(=O)c2cc3ccccc3[nH]2)cnn1-c1ccccc1Cl		CHEMBL3956001	=	IC50	nM	11.0	CHEMBL267	Homo sapiens	IC50	nM	11.0
	16759970	CHEMBL3861875	Inhibition of human SRC by time-resolved fluorescence or time-resolved fluorescence assay	B	Nc1c(C(=O)c2cc3ccccc3[nH]2)cnn1-c1cc(O)ccc1Cl		CHEMBL3976548	=	IC50	nM	0.18	CHEMBL267	Homo sapiens	IC50	nM	0.18
	16759971	CHEMBL3861875	Inhibition of human SRC by time-resolved fluorescence or time-resolved fluorescence assay	B	Nc1c(C(=O)c2ccc3ncccc3c2)cnn1-c1cc(O)ccc1Cl		CHEMBL3947281	=	IC50	nM	31.0	CHEMBL267	Homo sapiens	IC50	nM	31.0
	16759972	CHEMBL3861875	Inhibition of human SRC by time-resolved fluorescence or time-resolved fluorescence assay	B	Nc1c(C(=O)c2cc3ccccc3o2)cnn1-c1cc(O)ccc1Cl		CHEMBL3981956	=	IC50	nM	4.3	CHEMBL267	Homo sapiens	IC50	nM	4.3
	16759973	CHEMBL3861875	Inhibition of human SRC by time-resolved fluorescence or time-resolved fluorescence assay	B	Cc1cccc(C(=O)c2cnn(-c3cc(O)ccc3Cl)c2N)c1		CHEMBL3905685	=	IC50	nM	250.0	CHEMBL267	Homo sapiens	IC50	nM	250.0
	16777255	CHEMBL3864912	Inhibition of recombinant c-Src (unknown origin) using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA	B	CCc1cc2c(cc1N1CCN(CC3(O)CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3958173	>	IC50	nM	1000.0	CHEMBL267	Homo sapiens	IC50	nM	1000.0
	16778159	CHEMBL3865049	Inhibition of human SRC using Ac-EIYGEFKKK as substrate after 90 mins by Kinase glo luciferase assay	B	CC(C)(C)n1nc(-c2ccc3ccccc3c2)c(C(N)=O)c1N		CHEMBL3108912	=	IC50	nM	1320.0	CHEMBL267	Homo sapiens	IC50	uM	1.32
Not Determined	16778160	CHEMBL3865049	Inhibition of human SRC using Ac-EIYGEFKKK as substrate after 90 mins by Kinase glo luciferase assay	B	CC(C)(C)n1nc(-c2ccc3cc(O)ccc3c2)c(C(N)=O)c1N		CHEMBL3108997		IC50			CHEMBL267	Homo sapiens	IC50		
	16778161	CHEMBL3865049	Inhibition of human SRC using Ac-EIYGEFKKK as substrate after 90 mins by Kinase glo luciferase assay	B	COc1ccc2cc(-c3nn(C(C)(C)C)c(N)c3C(N)=O)ccc2c1		CHEMBL3108998	=	IC50	nM	6930.0	CHEMBL267	Homo sapiens	IC50	uM	6.93
	16778162	CHEMBL3865049	Inhibition of human SRC using Ac-EIYGEFKKK as substrate after 90 mins by Kinase glo luciferase assay	B	COc1ccc2cc(-c3nn(C(C)(C)C)c(N)c3C(N)=O)cnc2c1		CHEMBL3770425	>	IC50	nM	30000.0	CHEMBL267	Homo sapiens	IC50	uM	30.0
	16778163	CHEMBL3865049	Inhibition of human SRC using Ac-EIYGEFKKK as substrate after 90 mins by Kinase glo luciferase assay	B	CCOc1ccc2cc(-c3nn(C(C)(C)C)c(N)c3C(N)=O)ccc2c1		CHEMBL3108913	=	IC50	nM	7270.0	CHEMBL267	Homo sapiens	IC50	uM	7.27
	16778164	CHEMBL3865049	Inhibition of human SRC using Ac-EIYGEFKKK as substrate after 90 mins by Kinase glo luciferase assay	B	CCOc1ccc2cc(-c3nn(C(C)(C)C)c(N)c3C(N)=O)cnc2c1		CHEMBL3109011	>	IC50	nM	30000.0	CHEMBL267	Homo sapiens	IC50	uM	30.0
	16778165	CHEMBL3865049	Inhibition of human SRC using Ac-EIYGEFKKK as substrate after 90 mins by Kinase glo luciferase assay	B	CCOc1ccc2cc(-c3nn(C(C)(C)C)c(N)c3C(N)=O)ccc2n1		CHEMBL3771306	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	16778166	CHEMBL3865049	Inhibition of human SRC using Ac-EIYGEFKKK as substrate after 90 mins by Kinase glo luciferase assay	B	CC(C)(C)n1nc(-c2cnc3cc(OC4CC4)ccc3c2)c(C(N)=O)c1N		CHEMBL3770313	=	IC50	nM	4750.0	CHEMBL267	Homo sapiens	IC50	uM	4.75
	16778167	CHEMBL3865049	Inhibition of human SRC using Ac-EIYGEFKKK as substrate after 90 mins by Kinase glo luciferase assay	B	CC(C)(C)n1nc(-c2ccc3nc(OC4CC4)ccc3c2)c(C(N)=O)c1N		CHEMBL3770299	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	16778168	CHEMBL3865049	Inhibition of human SRC using Ac-EIYGEFKKK as substrate after 90 mins by Kinase glo luciferase assay	B	CC(C)(C)n1nc(-c2cnc3cc(OC4CCC4)ccc3c2)c(C(N)=O)c1N		CHEMBL3769798	=	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
Not Determined	16778169	CHEMBL3865049	Inhibition of human SRC using Ac-EIYGEFKKK as substrate after 90 mins by Kinase glo luciferase assay	B	CC(C)n1nc(-c2ccc3ccccc3c2)c(C(N)=O)c1N		CHEMBL3108986		IC50			CHEMBL267	Homo sapiens	IC50		
	16778170	CHEMBL3865049	Inhibition of human SRC using Ac-EIYGEFKKK as substrate after 90 mins by Kinase glo luciferase assay	B	NC(=O)c1c(-c2ccc3ccccc3c2)nn(CC(F)(F)F)c1N		CHEMBL3108991	=	IC50	nM	980.0	CHEMBL267	Homo sapiens	IC50	uM	0.98
	16778171	CHEMBL3865049	Inhibition of human SRC using Ac-EIYGEFKKK as substrate after 90 mins by Kinase glo luciferase assay	B	CCOc1ccc2cc(-c3nn(CC(F)(F)F)c(N)c3C(N)=O)cnc2c1		CHEMBL3769900	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	16778172	CHEMBL3865049	Inhibition of human SRC using Ac-EIYGEFKKK as substrate after 90 mins by Kinase glo luciferase assay	B	CCOc1ccc2cc(-c3nn(C(C)C)c(N)c3C(N)=O)cnc2c1		CHEMBL3770409	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
Not Determined	16778173	CHEMBL3865049	Inhibition of human SRC using Ac-EIYGEFKKK as substrate after 90 mins by Kinase glo luciferase assay	B	CCOc1ccc2cc(-c3nn(C(C)C(C)C)c(N)c3C(N)=O)cnc2c1		CHEMBL3922004		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	16778174	CHEMBL3865049	Inhibition of human SRC using Ac-EIYGEFKKK as substrate after 90 mins by Kinase glo luciferase assay	B	CCOc1ccc2cc(-c3nn(C(C)C4CC4)c(N)c3C(N)=O)cnc2c1		CHEMBL3916476		IC50			CHEMBL267	Homo sapiens	IC50		
	16778175	CHEMBL3865049	Inhibition of human SRC using Ac-EIYGEFKKK as substrate after 90 mins by Kinase glo luciferase assay	B	CCOc1ccc2cc(-c3nn(CC(C)(C)CO)c(N)c3C(N)=O)cnc2c1		CHEMBL3770743	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
Not Determined	16778176	CHEMBL3865049	Inhibition of human SRC using Ac-EIYGEFKKK as substrate after 90 mins by Kinase glo luciferase assay	B	CCOc1ccc2cc(-c3nn(C(C)C(C)(C)CO)c(N)c3C(N)=O)cnc2c1		CHEMBL3956316		IC50			CHEMBL267	Homo sapiens	IC50		
	16778177	CHEMBL3865049	Inhibition of human SRC using Ac-EIYGEFKKK as substrate after 90 mins by Kinase glo luciferase assay	B	CCOc1ccc2cc(-c3nn(C4CCOC4)c(N)c3C(N)=O)cnc2c1		CHEMBL3922900	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	16778178	CHEMBL3865049	Inhibition of human SRC using Ac-EIYGEFKKK as substrate after 90 mins by Kinase glo luciferase assay	B	CCOc1ccc2cc(-c3nn(C4CCCC4)c(N)c3C(N)=O)cnc2c1		CHEMBL3769623	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	16778179	CHEMBL3865049	Inhibition of human SRC using Ac-EIYGEFKKK as substrate after 90 mins by Kinase glo luciferase assay	B	CCOc1ccc2cc(-c3nn(C4CCCCC4)c(N)c3C(N)=O)cnc2c1		CHEMBL3770760	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	16778180	CHEMBL3865049	Inhibition of human SRC using Ac-EIYGEFKKK as substrate after 90 mins by Kinase glo luciferase assay	B	CCOc1ccc2cc(-c3nn(C4CCCCCC4)c(N)c3C(N)=O)cnc2c1		CHEMBL3770649	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	16778181	CHEMBL3865049	Inhibition of human SRC using Ac-EIYGEFKKK as substrate after 90 mins by Kinase glo luciferase assay	B	CCOc1ccc2cc(-c3nn(C(C)C)c(N)c3C(N)=O)ccc2n1		CHEMBL3770142	=	IC50	nM	3330.0	CHEMBL267	Homo sapiens	IC50	uM	3.33
	16778182	CHEMBL3865049	Inhibition of human SRC using Ac-EIYGEFKKK as substrate after 90 mins by Kinase glo luciferase assay	B	CCOc1ccc2cc(-c3nn(CC(C)(C)CO)c(N)c3C(N)=O)ccc2n1		CHEMBL3770980	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	16778183	CHEMBL3865049	Inhibition of human SRC using Ac-EIYGEFKKK as substrate after 90 mins by Kinase glo luciferase assay	B	CCOc1ccc2cc(-c3nn(C4CCOC4)c(N)c3C(N)=O)ccc2n1		CHEMBL3973192	=	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	16778184	CHEMBL3865049	Inhibition of human SRC using Ac-EIYGEFKKK as substrate after 90 mins by Kinase glo luciferase assay	B	CCOc1ccc2cc(-c3nn(C4CCCCC4)c(N)c3C(N)=O)ccc2n1		CHEMBL3770802	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	16778185	CHEMBL3865049	Inhibition of human SRC using Ac-EIYGEFKKK as substrate after 90 mins by Kinase glo luciferase assay	B	CC(C)n1nc(-c2ccc3nc(OC4CCC4)ccc3c2)c(C(N)=O)c1N		CHEMBL3908956	=	IC50	nM	3330.0	CHEMBL267	Homo sapiens	IC50	uM	3.33
	16778186	CHEMBL3865049	Inhibition of human SRC using Ac-EIYGEFKKK as substrate after 90 mins by Kinase glo luciferase assay	B	CC(C)(CO)Cn1nc(-c2ccc3nc(OC4CCC4)ccc3c2)c(C(N)=O)c1N		CHEMBL3985876	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	16781500	CHEMBL3865552	Inhibition of N-terminal His6-tagged recombinant human Src (1 to 530 residues) expressed in baculovirus infected sf21 cells	B	CCS(=O)(=O)c1cc(Nc2ncc(F)c(N(Cc3ccccc3C#N)c3cc(CO)ccc3C)n2)ccc1N1CCN(C)CC1		CHEMBL3923175	=	IC50	nM	93.0	CHEMBL267	Homo sapiens	IC50	nM	93.0
	16781508	CHEMBL3865544	Inhibition of N-terminal His6-tagged recombinant human Src (1 to 530 residues) expressed in baculovirus infected sf21 cells at 100 nM	B	CCS(=O)(=O)c1cc(Nc2ncc(F)c(N(Cc3ccccc3C#N)c3cc(CO)ccc3C)n2)ccc1N1CCN(C)CC1		CHEMBL3923175	=	Inhibition	%	86.0	CHEMBL267	Homo sapiens	INH	%	86.0
Not Determined	16814225	CHEMBL3871311	Inhibition of recombinant human Src using KVEKIGEGTYGVVYK as substrate by [gamma-32P]ATP based assay	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	16814226	CHEMBL3871311	Inhibition of recombinant human Src using KVEKIGEGTYGVVYK as substrate by [gamma-32P]ATP based assay	B	O=c1c2cnn(-c3ccccc3)c2n2c(Nc3ccccc3)nnc2n1-c1ccccc1		CHEMBL3908573		IC50			CHEMBL267	Homo sapiens	IC50		
	16814227	CHEMBL3871311	Inhibition of recombinant human Src using KVEKIGEGTYGVVYK as substrate by [gamma-32P]ATP based assay	B	COc1ccc(-c2nnc3n(-c4ccccc4)c(=O)c4cnn(-c5ccccc5)c4n23)cc1		CHEMBL3954137	=	IC50	nM	67000.0	CHEMBL267	Homo sapiens	IC50	uM	67.0
Not Determined	16814228	CHEMBL3871311	Inhibition of recombinant human Src using KVEKIGEGTYGVVYK as substrate by [gamma-32P]ATP based assay	B	O=c1c2cnn(-c3ccccc3)c2n2c(-c3ccccc3)nnc2n1-c1ccccc1		CHEMBL3917521		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	16814229	CHEMBL3871311	Inhibition of recombinant human Src using KVEKIGEGTYGVVYK as substrate by [gamma-32P]ATP based assay	B	O=C(NNc1nc2c(cnn2-c2ccccc2)c(=O)n1-c1ccccc1)c1ccc(Cl)cc1		CHEMBL3967164		IC50			CHEMBL267	Homo sapiens	IC50		
	16814230	CHEMBL3871311	Inhibition of recombinant human Src using KVEKIGEGTYGVVYK as substrate by [gamma-32P]ATP based assay	B	COc1ccc(C(=O)NNc2nc3c(cnn3-c3ccccc3)c(=O)n2-c2ccccc2)cc1		CHEMBL3904850	=	IC50	nM	24000.0	CHEMBL267	Homo sapiens	IC50	uM	24.0
	16814231	CHEMBL3871311	Inhibition of recombinant human Src using KVEKIGEGTYGVVYK as substrate by [gamma-32P]ATP based assay	B	O=C(NNc1nc2c(cnn2-c2ccccc2)c(=O)n1-c1ccccc1)c1ccccc1		CHEMBL3911525	=	IC50	nM	4700.0	CHEMBL267	Homo sapiens	IC50	uM	4.7
Not Determined	16814232	CHEMBL3871311	Inhibition of recombinant human Src using KVEKIGEGTYGVVYK as substrate by [gamma-32P]ATP based assay	B	O=c1c2cnn(-c3ccccc3)c2nc(N/N=C/c2ccc(F)cc2)n1-c1ccccc1		CHEMBL3983676		IC50			CHEMBL267	Homo sapiens	IC50		
Not Determined	16814233	CHEMBL3871311	Inhibition of recombinant human Src using KVEKIGEGTYGVVYK as substrate by [gamma-32P]ATP based assay	B	NNc1nc2c(cnn2-c2ccccc2)c(=O)n1-c1ccccc1		CHEMBL3893030		IC50			CHEMBL267	Homo sapiens	IC50		
	16814238	CHEMBL3871309	Inhibition of recombinant human Src assessed as residual activity at 100 uM using KVEKIGEGTYGVVYK as substrate by [gamma-32P]ATP based assay relative to control	B	COc1ccc(-c2nnc3n(-c4ccccc4)c(=O)c4cnn(-c5ccccc5)c4n23)cc1		CHEMBL3954137	=	Activity	%	35.0	CHEMBL267	Homo sapiens	Activity	%	35.0
	16814239	CHEMBL3871309	Inhibition of recombinant human Src assessed as residual activity at 100 uM using KVEKIGEGTYGVVYK as substrate by [gamma-32P]ATP based assay relative to control	B	O=c1c2cnn(-c3ccccc3)c2n2c(-c3ccccc3)nnc2n1-c1ccccc1		CHEMBL3917521	=	Activity	%	50.0	CHEMBL267	Homo sapiens	Activity	%	50.0
	16814240	CHEMBL3871309	Inhibition of recombinant human Src assessed as residual activity at 100 uM using KVEKIGEGTYGVVYK as substrate by [gamma-32P]ATP based assay relative to control	B	COc1ccc(C(=O)NNc2nc3c(cnn3-c3ccccc3)c(=O)n2-c2ccccc2)cc1		CHEMBL3904850	=	Activity	%	20.0	CHEMBL267	Homo sapiens	Activity	%	20.0
	16814241	CHEMBL3871309	Inhibition of recombinant human Src assessed as residual activity at 100 uM using KVEKIGEGTYGVVYK as substrate by [gamma-32P]ATP based assay relative to control	B	O=C(NNc1nc2c(cnn2-c2ccccc2)c(=O)n1-c1ccccc1)c1ccccc1		CHEMBL3911525	=	Activity	%	7.0	CHEMBL267	Homo sapiens	Activity	%	7.0
	16817231	CHEMBL3871908	Activity at cSRC (unknown origin)	B	Cc1ccc(OCCNc2nc(Nc3cc(C)[nH]n3)cc(C)c2C#N)cn1		CHEMBL3893914	=	Km	nM	200000.0	CHEMBL267	Homo sapiens	Km	uM	200.0
	16817239	CHEMBL3871916	Inhibition of cSRC (unknown origin)	B	Cc1ccc(OCCNc2nc(Nc3cc(C)[nH]n3)cc(C)c2C#N)cn1		CHEMBL3893914	=	Ki	nM	480.0	CHEMBL267	Homo sapiens	Ki	uM	0.48
	16817247	CHEMBL3871924	Ratio of Km to Ki for cSRC (unknown origin)	B	Cc1ccc(OCCNc2nc(Nc3cc(C)[nH]n3)cc(C)c2C#N)cn1		CHEMBL3893914	=	Ratio	10'-4No_unit	24.0	CHEMBL267	Homo sapiens	Ratio	10'-4No_unit	24.0
	16836751	CHEMBL3875928	Inhibition of Src phosphorylation in human MDA-MB-231 cells at 1 to 5 uM after 48 hrs by Western blot method	B	COc1cc(/C=C/c2ccc(NC(=O)/C=C/c3cc(OC)c(OC)c(OC)c3)cc2)cc(OC)c1		CHEMBL3883561		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	16837393	CHEMBL3876051	Inhibition of human recombinant full length C-terminal His-tagged SRC cytoplasmic domain expressed in baculovirus expression system	B	CC1(C)C(=O)N([C@H]2CCc3c(O)cccc32)c2nc(Nc3ccccc3)ncc21		CHEMBL3884319	=	IC50	nM	668.0	CHEMBL267	Homo sapiens	IC50	nM	668.0
	16849484	CHEMBL3878107	Inhibition of SRC phosphorylation in human MDA-MB-231 cells at 1 to 5 uM after 24 hrs by Western blot method	B	O=S1(=O)C=Cc2cccc(Nc3cccc(C(F)(F)F)c3)c21		CHEMBL3947200		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	16880717	CHEMBL3880849	Inhibition of human c-Src after 40 mins in presence of [gamma33P-ATP] by scintillation counting	B	CNc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\[C@@H](C)[C@H](C)OC2=O		CHEMBL1097700	=	IC50	nM	91.0	CHEMBL267	Homo sapiens	IC50	nM	91.0
	16880729	CHEMBL3880864	Inhibition of human c-Src assessed as remaining activity at 0.1 uM after 40 mins in presence of [gamma33P-ATP] by scintillation counting	B	CNc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\[C@@H](C)[C@H](C)OC2=O		CHEMBL1097700	=	Activity	%	47.0	CHEMBL267	Homo sapiens	Activity	%	47.0
	16880730	CHEMBL3880864	Inhibition of human c-Src assessed as remaining activity at 0.1 uM after 40 mins in presence of [gamma33P-ATP] by scintillation counting	B	CCNc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\[C@@H](C)[C@H](C)OC2=O		CHEMBL1097999	=	Activity	%	31.0	CHEMBL267	Homo sapiens	Activity	%	31.0
	16880731	CHEMBL3880865	Inhibition of human c-Src assessed as remaining activity at 1 uM after 40 mins in presence of [gamma33P-ATP] by scintillation counting	B	CNc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\[C@@H](C)[C@H](C)OC2=O		CHEMBL1097700	=	Activity	%	5.0	CHEMBL267	Homo sapiens	Activity	%	5.0
	16880732	CHEMBL3880865	Inhibition of human c-Src assessed as remaining activity at 1 uM after 40 mins in presence of [gamma33P-ATP] by scintillation counting	B	CCNc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\[C@@H](C)[C@H](C)OC2=O		CHEMBL1097999	=	Activity	%	1.0	CHEMBL267	Homo sapiens	Activity	%	1.0
	16894853	CHEMBL3882091	Inhibition of human N-terminal GST-tagged full length human Src (Met1 to Leu536 residues) expressed in baculovirus expression system assessed as decrease in biotin signal transduction protein phosphorylation at Tyr160 preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA method	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CC(=O)NO)CC2)n1		CHEMBL3945209	<=	IC50	nM	100.0	CHEMBL267	Homo sapiens	IC50	uM	0.1
	16894854	CHEMBL3882091	Inhibition of human N-terminal GST-tagged full length human Src (Met1 to Leu536 residues) expressed in baculovirus expression system assessed as decrease in biotin signal transduction protein phosphorylation at Tyr160 preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA method	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCC(=O)NO)CC2)n1		CHEMBL3947855	<=	IC50	nM	100.0	CHEMBL267	Homo sapiens	IC50	uM	0.1
	16894855	CHEMBL3882091	Inhibition of human N-terminal GST-tagged full length human Src (Met1 to Leu536 residues) expressed in baculovirus expression system assessed as decrease in biotin signal transduction protein phosphorylation at Tyr160 preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA method	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCCC(=O)NO)CC2)n1		CHEMBL3964750	<=	IC50	nM	100.0	CHEMBL267	Homo sapiens	IC50	uM	0.1
	16894856	CHEMBL3882091	Inhibition of human N-terminal GST-tagged full length human Src (Met1 to Leu536 residues) expressed in baculovirus expression system assessed as decrease in biotin signal transduction protein phosphorylation at Tyr160 preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA method	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCCCC(=O)NO)CC2)n1		CHEMBL3907624	<=	IC50	nM	100.0	CHEMBL267	Homo sapiens	IC50	uM	0.1
	16894857	CHEMBL3882091	Inhibition of human N-terminal GST-tagged full length human Src (Met1 to Leu536 residues) expressed in baculovirus expression system assessed as decrease in biotin signal transduction protein phosphorylation at Tyr160 preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA method	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCCCCC(=O)NO)CC2)n1		CHEMBL3901629	<=	IC50	nM	100.0	CHEMBL267	Homo sapiens	IC50	uM	0.1
	16894858	CHEMBL3882091	Inhibition of human N-terminal GST-tagged full length human Src (Met1 to Leu536 residues) expressed in baculovirus expression system assessed as decrease in biotin signal transduction protein phosphorylation at Tyr160 preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA method	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCCCCCC(=O)NO)CC2)n1		CHEMBL3904339	<=	IC50	nM	100.0	CHEMBL267	Homo sapiens	IC50	uM	0.1
	16894859	CHEMBL3882091	Inhibition of human N-terminal GST-tagged full length human Src (Met1 to Leu536 residues) expressed in baculovirus expression system assessed as decrease in biotin signal transduction protein phosphorylation at Tyr160 preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA method	B	Cc1nc(NCCNCC(=O)NO)cc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)n1		CHEMBL3960592	<=	IC50	nM	100.0	CHEMBL267	Homo sapiens	IC50	uM	0.1
	16894860	CHEMBL3882091	Inhibition of human N-terminal GST-tagged full length human Src (Met1 to Leu536 residues) expressed in baculovirus expression system assessed as decrease in biotin signal transduction protein phosphorylation at Tyr160 preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA method	B	Cc1nc(NCCNCCCCCC(=O)NO)cc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)n1		CHEMBL3965755	<=	IC50	nM	100.0	CHEMBL267	Homo sapiens	IC50	uM	0.1
	16894861	CHEMBL3882091	Inhibition of human N-terminal GST-tagged full length human Src (Met1 to Leu536 residues) expressed in baculovirus expression system assessed as decrease in biotin signal transduction protein phosphorylation at Tyr160 preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA method	B	Cc1nc(NCCCCCC(=O)NO)cc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)n1		CHEMBL3984972	<=	IC50	nM	100.0	CHEMBL267	Homo sapiens	IC50	uM	0.1
	16894862	CHEMBL3882091	Inhibition of human N-terminal GST-tagged full length human Src (Met1 to Leu536 residues) expressed in baculovirus expression system assessed as decrease in biotin signal transduction protein phosphorylation at Tyr160 preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA method	B	Cc1nc(NCCCCCCC(=O)NO)cc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)n1		CHEMBL3889939	<=	IC50	nM	100.0	CHEMBL267	Homo sapiens	IC50	uM	0.1
	16894863	CHEMBL3882091	Inhibition of human N-terminal GST-tagged full length human Src (Met1 to Leu536 residues) expressed in baculovirus expression system assessed as decrease in biotin signal transduction protein phosphorylation at Tyr160 preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA method	B	Cc1nc(N)cc(N(CC(=O)NO)c2ncc(C(=O)Nc3c(C)cccc3Cl)s2)n1		CHEMBL3939723	=	IC50	nM	100.0	CHEMBL267	Homo sapiens	IC50	uM	0.1
	16907935	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(OCCN4CCCC4)cc3)nnc2c1		CHEMBL436137	=	IC50	nM	6.8	CHEMBL267	Homo sapiens	IC50	nM	6.8
	16907936	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1ccc2nc(Nc3ccc(OCCN4CCCC4)cc3)nnc2c1		CHEMBL230999	=	IC50	nM	15.0	CHEMBL267	Homo sapiens	IC50	nM	15.0
	16907937	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(C4(C#N)CC4)cc3)nnc2c1		CHEMBL3648009	=	IC50	nM	72.0	CHEMBL267	Homo sapiens	IC50	nM	72.0
	16907938	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Clc1cccc(Cl)c1-c1ccc2nc(Nc3ccc(OCCN4CCCC4)cc3)nnc2c1		CHEMBL230271	=	IC50	nM	121.0	CHEMBL267	Homo sapiens	IC50	nM	121.0
	16907939	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(C4(CN)CC4)cc3)nnc2c1		CHEMBL3648010	=	IC50	nM	76.4	CHEMBL267	Homo sapiens	IC50	nM	76.4
	16907940	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	COc1ccc(Nc2nnc3cc(-c4cc(OC)cc(OC)c4)cc(C)c3n2)cc1		CHEMBL3648027	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	16907941	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	COc1cc(OC)cc(-c2cc(C)c3nc(Nc4ccccc4OC)nnc3c2)c1		CHEMBL3648026	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	16907942	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	COc1cc(OC)cc(-c2cc(C)c3nc(Nc4cccc(C)c4C)nnc3c2)c1		CHEMBL3639468	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	16907943	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	COc1cc(OC)cc(-c2cc(C)c3nc(Nc4ccncc4)nnc3c2)c1		CHEMBL3648025	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	16907944	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	COc1cc(OC)cc(-c2cc(C)c3nc(Nc4cccc(C)c4)nnc3c2)c1		CHEMBL3648018	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	16907945	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	COc1cc(OC)cc(-c2cc(C)c3nc(Nc4ccc(C)cc4C)nnc3c2)c1		CHEMBL3648020	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	16907946	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	COc1cc(OC)cc(-c2cc(C)c3nc(Nc4cc(C)ccc4C)nnc3c2)c1		CHEMBL3648021	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	16907947	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	COc1cc(OC)cc(-c2cc(C)c3nc(Nc4ccc(C)c(C)c4)nnc3c2)c1		CHEMBL3648022	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	16907948	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(OCCCN4CCCC4)cc3)nnc2c1		CHEMBL397692	=	IC50	nM	12.6	CHEMBL267	Homo sapiens	IC50	nM	12.6
	16907949	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(OCCN4CCOCC4)cc3)nnc2c1		CHEMBL3648032	=	IC50	nM	32.9	CHEMBL267	Homo sapiens	IC50	nM	32.9
	16907950	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	CCN(CC)CCOc1ccc(Nc2nnc3cc(-c4c(C)cccc4C)cc(C)c3n2)cc1		CHEMBL218656	=	IC50	nM	9.67	CHEMBL267	Homo sapiens	IC50	nM	9.67
	16907951	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	COc1ccc(Nc2nnc3cc(-c4c(C)cccc4C)cc(C)c3n2)cc1		CHEMBL220798	=	IC50	nM	140.0	CHEMBL267	Homo sapiens	IC50	nM	140.0
	16907952	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	COc1cccc(Nc2nnc3cc(-c4c(C)cccc4C)cc(C)c3n2)c1		CHEMBL3648016	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	16907953	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	COc1ccccc1Nc1nnc2cc(-c3c(C)cccc3C)cc(C)c2n1		CHEMBL376860	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	16907954	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1ccc(Nc2nnc3cc(-c4c(C)cccc4C)cc(C)c3n2)cc1C		CHEMBL220480	=	IC50	nM	957.0	CHEMBL267	Homo sapiens	IC50	nM	957.0
	16907955	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(F)c(Cl)c3)nnc2c1		CHEMBL3648013	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	16907956	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	COc1cccc(Nc2nnc3cc(-c4c(Cl)cccc4Cl)cc(C)c3n2)c1		CHEMBL3648028	=	IC50	nM	189.0	CHEMBL267	Homo sapiens	IC50	nM	189.0
	16907957	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccncc3)nnc2c1		CHEMBL221582	=	IC50	nM	36.0	CHEMBL267	Homo sapiens	IC50	nM	36.0
	16907958	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	CC(=O)Nc1nnc2cc(-c3c(C)cccc3C)cc(C)c2n1		CHEMBL221739	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	16907959	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1cc(C)c2nc(NC(=O)c3ccccc3)nnc2c1		CHEMBL218598	=	IC50	nM	1800.0	CHEMBL267	Homo sapiens	IC50	nM	1800.0
	16907960	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3cccc4cccnc34)nnc2c1		CHEMBL218160	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	16907961	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccccn3)nnc2c1		CHEMBL218738	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	16907962	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3cnc4ccccc4c3)nnc2c1		CHEMBL3648011	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	16907963	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cccc(Nc2nnc3cc(-c4c(C)cccc4C)cc(C)c3n2)c1		CHEMBL218742	=	IC50	nM	178.0	CHEMBL267	Homo sapiens	IC50	nM	178.0
	16907964	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1ccc(Nc2nnc3cc(-c4c(C)cccc4C)cc(C)c3n2)cc1		CHEMBL3648012	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	16907965	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cccc(Nc2nnc3cc(-c4c(C)cccc4C)cc(C)c3n2)c1C		CHEMBL218551	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	16907966	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	CCOc1ccc(Nc2nnc3cc(-c4cc(OC)cc(OC)c4)cc(C)c3n2)cc1		CHEMBL3648024	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	16907967	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	CCCCc1ccc(Nc2nnc3cc(-c4cc(OC)cc(OC)c4)cc(C)c3n2)cc1		CHEMBL3648023	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	16907968	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1ccc2nc(Nc3ccccc3)nnc2c1		CHEMBL218042	=	IC50	nM	1520.0	CHEMBL267	Homo sapiens	IC50	nM	1520.0
	16907969	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1ccc2nc(NCCCN3CCN(C)CC3)nnc2c1		CHEMBL3941384	=	IC50	nM	5800.0	CHEMBL267	Homo sapiens	IC50	nM	5800.0
	16907970	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccccc3)nnc2c1		CHEMBL374248	=	IC50	nM	294.0	CHEMBL267	Homo sapiens	IC50	nM	294.0
	16907971	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(C)c(-c2cc(C)c3nc(Nc4ccccc4)nnc3c2)c(C)c1		CHEMBL218109	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	16907972	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(Cl)c(Cl)c3)nnc2c1		CHEMBL3648017	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	16907973	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3cccc(Cl)c3)nnc2c1		CHEMBL217961	=	IC50	nM	134.0	CHEMBL267	Homo sapiens	IC50	nM	134.0
	16907974	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	CCOc1ccc(Nc2nnc3cc(-c4c(C)cccc4C)cc(C)c3n2)cc1		CHEMBL221431	=	IC50	nM	108.0	CHEMBL267	Homo sapiens	IC50	nM	108.0
	16907975	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2c(Cl)cccc2Cl)cc2nnc(Nc3cccnc3)nc12		CHEMBL3648031	=	IC50	nM	27.0	CHEMBL267	Homo sapiens	IC50	nM	27.0
	16907976	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2c(Cl)cccc2Cl)cc2nnc(Nc3ccncc3)nc12		CHEMBL3648030	=	IC50	nM	42.0	CHEMBL267	Homo sapiens	IC50	nM	42.0
	16907977	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	COc1ccc(Nc2nnc3cc(-c4c(Cl)cccc4Cl)cc(C)c3n2)cc1		CHEMBL3648029	=	IC50	nM	137.0	CHEMBL267	Homo sapiens	IC50	nM	137.0
	16907978	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	CCCCc1ccc(Nc2nnc3cc(-c4c(C)cccc4C)cc(C)c3n2)cc1		CHEMBL218842	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	16907979	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	COc1ccc(Nc2nnc3cc(-c4ccccc4OC)cc(C)c3n2)cc1		CHEMBL3648015	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	16907980	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2ccccc2Cl)cc2nnc(Nc3ccccc3)nc12		CHEMBL3648014	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	16907981	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	COc1cccc(F)c1-c1cc(C)c2nc(Nc3ccccc3)nnc2c1		CHEMBL3648006	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	16907982	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	COc1cccc(OC)c1-c1cc(C)c2nc(Nc3ccccc3)nnc2c1		CHEMBL3648007	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	16907983	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1cc2nnc(Nc3ccccc3)nc2c(C)c1C		CHEMBL221975	=	IC50	nM	130.0	CHEMBL267	Homo sapiens	IC50	nM	130.0
	16907984	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1cc(C)c2nc(NCCCN3CCN(C)CC3)nnc2c1		CHEMBL3648008	=	IC50	nM	9000.0	CHEMBL267	Homo sapiens	IC50	nM	9000.0
	16907985	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1ccc(C)c(Nc2nnc3cc(-c4c(C)cccc4C)cc(C)c3n2)c1		CHEMBL374868	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	16907986	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1ccc(Nc2nnc3cc(-c4c(C)cccc4C)cc(C)c3n2)c(C)c1		CHEMBL441545	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	16907987	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2c(Cl)cccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL230686	=	IC50	nM	9.4	CHEMBL267	Homo sapiens	IC50	nM	9.4
	16907988	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(OCCN4CCN(C)CC4)cc3)nnc2c1		CHEMBL230614	=	IC50	nM	21.0	CHEMBL267	Homo sapiens	IC50	nM	21.0
	16907989	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3cccc(OCCN4CCCC4)c3)nnc2c1		CHEMBL218549	=	IC50	nM	6.4	CHEMBL267	Homo sapiens	IC50	nM	6.4
	16907990	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	CCN(CC)CCOc1cccc(Nc2nnc3cc(-c4c(C)cccc4C)cc(C)c3n2)c1		CHEMBL218102	=	IC50	nM	10.2	CHEMBL267	Homo sapiens	IC50	nM	10.2
	16907991	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	COc1cccc(Cl)c1-c1cc(C)c2nc(Nc3ccc(OCCN4CCCC4)cc3)nnc2c1		CHEMBL230792	=	IC50	nM	505.0	CHEMBL267	Homo sapiens	IC50	nM	505.0
	16907992	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2c(F)cccc2F)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL394518	=	IC50	nM	208.0	CHEMBL267	Homo sapiens	IC50	nM	208.0
	16907993	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2ccccn2)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL230899	=	IC50	nM	1800.0	CHEMBL267	Homo sapiens	IC50	nM	1800.0
	16907994	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2cncnc2)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL3648033	=	IC50	nM	1500.0	CHEMBL267	Homo sapiens	IC50	nM	1500.0
	16907995	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(N(C)C)cc3)nnc2c1		CHEMBL220912	=	IC50	nM	244.0	CHEMBL267	Homo sapiens	IC50	nM	244.0
	16907996	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	COc1ccc(Nc2nnc3cc(-c4c(C)cccc4C)cc(C)c3n2)cn1		CHEMBL3648034	=	IC50	nM	341.0	CHEMBL267	Homo sapiens	IC50	nM	341.0
	16907997	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	COc1ccc(Cl)cc1-c1cc(C)c2nc(Nc3ccc(OCCN4CCCC4)cc3)nnc2c1		CHEMBL230793	=	IC50	nM	1200.0	CHEMBL267	Homo sapiens	IC50	nM	1200.0
	16907998	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(O)cc(C)c1-c1cc(C)c2nc(Nc3ccc(OCCN4CCCC4)cc3)nnc2c1		CHEMBL3648035	=	IC50	nM	75.0	CHEMBL267	Homo sapiens	IC50	nM	75.0
	16907999	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3cccc(OCCN4CCN(C)CC4)c3)nnc2c1		CHEMBL230615	=	IC50	nM	39.5	CHEMBL267	Homo sapiens	IC50	nM	39.5
	16908000	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3cccc(OCCCN4CCN(C)CC4)c3)nnc2c1		CHEMBL3648036	=	IC50	nM	38.9	CHEMBL267	Homo sapiens	IC50	nM	38.9
	16908001	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(OCCCN4CCN(C)CC4)cc3)nnc2c1		CHEMBL3648037	=	IC50	nM	35.8	CHEMBL267	Homo sapiens	IC50	nM	35.8
	16908002	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	COc1ccc(Nc2nnc3cc(-c4c(C)noc4C)cc(C)c3n2)cc1		CHEMBL3648038	=	IC50	nM	11700.0	CHEMBL267	Homo sapiens	IC50	nM	11700.0
	16908003	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(C(=O)N4CCN(C)CC4)cc3)nnc2c1		CHEMBL3648039	=	IC50	nM	8.9	CHEMBL267	Homo sapiens	IC50	nM	8.9
	16908004	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1noc(C)c1-c1cc(C)c2nc(Nc3ccc(C(=O)N4CCN(C)CC4)cc3)nnc2c1		CHEMBL3648040	=	IC50	nM	552.0	CHEMBL267	Homo sapiens	IC50	nM	552.0
	16908005	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1noc(C)c1-c1cc(C)c2nc(Nc3ccc(OCCN4CCCC4)cc3)nnc2c1		CHEMBL230898	=	IC50	nM	207.0	CHEMBL267	Homo sapiens	IC50	nM	207.0
	16908006	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1noc(C)c1-c1cc(C)c2nc(Nc3ccc(OCCN4CCN(C)CC4)cc3)nnc2c1		CHEMBL3648041	=	IC50	nM	610.0	CHEMBL267	Homo sapiens	IC50	nM	610.0
	16908007	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1noc(C)c1-c1cc(C)c2nc(Nc3ccc(OCC[N+]4(C)CCN(C)CC4)cc3)nnc2c1.O=C([O-])C(F)(F)F		CHEMBL3956619	=	IC50	nM	75000.0	CHEMBL267	Homo sapiens	IC50	nM	75000.0
	16908008	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2c(Cl)cccc2Cl)cc2nnc(Nc3cccc(OCCN4CCN(C)CC4)c3)nc12		CHEMBL3648043	=	IC50	nM	27.4	CHEMBL267	Homo sapiens	IC50	nM	27.4
	16908009	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2c(Cl)cccc2Cl)cc2nnc(Nc3ccc(OCCCN4CCN(C)CC4)cc3)nc12		CHEMBL3648045	=	IC50	nM	25.2	CHEMBL267	Homo sapiens	IC50	nM	25.2
	16908010	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2c(Cl)cccc2Cl)cc2nnc(Nc3cccc(OCCCN4CCN(C)CC4)c3)nc12		CHEMBL3648046	=	IC50	nM	28.8	CHEMBL267	Homo sapiens	IC50	nM	28.8
	16908011	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(C(=O)N4CCN(C)CC4)cc3)n[n+]([O-])c2c1		CHEMBL3648047	=	IC50	nM	96.1	CHEMBL267	Homo sapiens	IC50	nM	96.1
	16908012	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(C(=O)NCCN4CCCC4)cc3)nnc2c1		CHEMBL3648048	=	IC50	nM	16.1	CHEMBL267	Homo sapiens	IC50	nM	16.1
	16908013	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	COC(=O)c1ccc(Nc2nnc3cc(-c4c(C)cccc4C)cc(C)c3n2)o1		CHEMBL3648049	=	IC50	nM	1000.0	CHEMBL267	Homo sapiens	IC50	nM	1000.0
	16908014	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	COc1ccc(Cl)c(-c2cc(C)c3nc(Nc4ccc(OCCN5CCCC5)cc4)nnc3c2)c1		CHEMBL394765	=	IC50	nM	788.0	CHEMBL267	Homo sapiens	IC50	nM	788.0
	16908015	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3cccc(S(N)(=O)=O)c3)nnc2c1		CHEMBL218597	=	IC50	nM	143.0	CHEMBL267	Homo sapiens	IC50	nM	143.0
	16908016	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3cccc(C(=O)NCCN4CCCC4)c3)nnc2c1		CHEMBL3648051	=	IC50	nM	17.6	CHEMBL267	Homo sapiens	IC50	nM	17.6
	16908017	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(C(=O)O)o3)nnc2c1		CHEMBL3648052	=	IC50	nM	1500.0	CHEMBL267	Homo sapiens	IC50	nM	1500.0
	16908018	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2c(Cl)cccc2Cl)cc2nnc(Nc3ccc(C#N)c(OCCN4CCCC4)c3)nc12		CHEMBL3648053	=	IC50	nM	21.0	CHEMBL267	Homo sapiens	IC50	nM	21.0
	16908019	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3cccc(S(=O)(=O)NCCN4CCCC4)c3)nnc2c1		CHEMBL3648054	=	IC50	nM	26.4	CHEMBL267	Homo sapiens	IC50	nM	26.4
	16908020	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(C(=O)N4CCN(C)CC4)o3)nnc2c1		CHEMBL3648055	=	IC50	nM	94.0	CHEMBL267	Homo sapiens	IC50	nM	94.0
	16908021	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nnc2c1		CHEMBL231218	=	IC50	nM	9.1	CHEMBL267	Homo sapiens	IC50	nM	9.1
	16908022	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccnc(Cl)c3)nnc2c1		CHEMBL3648056	=	IC50	nM	118.0	CHEMBL267	Homo sapiens	IC50	nM	118.0
	16908023	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(Cl)nc3)nnc2c1		CHEMBL3648057	=	IC50	nM	232.0	CHEMBL267	Homo sapiens	IC50	nM	232.0
	16908024	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(C(=O)NCCN4CCCC4)o3)nnc2c1		CHEMBL3648058	=	IC50	nM	17.5	CHEMBL267	Homo sapiens	IC50	nM	17.5
	16908025	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3cccc(S(=O)(=O)N4CCN(C)CC4)c3)nnc2c1		CHEMBL436516	=	IC50	nM	322.0	CHEMBL267	Homo sapiens	IC50	nM	322.0
	16908026	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3cccc(S(=O)(=O)NCCN(C)C)c3)nnc2c1		CHEMBL3648059	=	IC50	nM	41.4	CHEMBL267	Homo sapiens	IC50	nM	41.4
	16908027	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(S(=O)(=O)NCCN(C)C)cc3)nnc2c1		CHEMBL3648060	=	IC50	nM	14.6	CHEMBL267	Homo sapiens	IC50	nM	14.6
	16908028	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3nc(C(=O)NCCN4CCCC4)cs3)nnc2c1		CHEMBL3648061	=	IC50	nM	14.6	CHEMBL267	Homo sapiens	IC50	nM	14.6
	16908029	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2c(Cl)cccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)nc3)nc12		CHEMBL3648062	=	IC50	nM	15.3	CHEMBL267	Homo sapiens	IC50	nM	15.3
	16908030	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2c(Cl)cccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)c(C#N)c3)nc12		CHEMBL3648063	=	IC50	nM	25.2	CHEMBL267	Homo sapiens	IC50	nM	25.2
	16908031	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3cccc(C(=O)NC4CCNC4)c3)nnc2c1		CHEMBL3648064	=	IC50	nM	18.3	CHEMBL267	Homo sapiens	IC50	nM	18.3
	16908032	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(S(=O)(=O)N4CCN(C)CC4)cc3)nnc2c1		CHEMBL446951	=	IC50	nM	137.0	CHEMBL267	Homo sapiens	IC50	nM	137.0
	16908033	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3cccc(C(=O)NCCCN4CCN(C)CC4)c3)nnc2c1		CHEMBL3648065	=	IC50	nM	27.4	CHEMBL267	Homo sapiens	IC50	nM	27.4
	16908034	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3cccc(C(=O)NCCCN(C)C)c3)nnc2c1		CHEMBL3648066	=	IC50	nM	13.1	CHEMBL267	Homo sapiens	IC50	nM	13.1
	16908035	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(S(=O)(=O)NCCCN4CCCC4)cc3)nnc2c1		CHEMBL3648067	=	IC50	nM	29.2	CHEMBL267	Homo sapiens	IC50	nM	29.2
	16908036	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(C(=O)NCCCN4CCCC4)o3)nnc2c1		CHEMBL3648068	=	IC50	nM	18.3	CHEMBL267	Homo sapiens	IC50	nM	18.3
	16908037	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ncc(C(=O)NCCN4CCCC4)s3)nnc2c1		CHEMBL3648069	=	IC50	nM	286.0	CHEMBL267	Homo sapiens	IC50	nM	286.0
	16908038	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3cccc(S(=O)(=O)N4CCN(C(=O)OC(C)(C)C)CC4)c3)nnc2c1		CHEMBL3648070	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	16908039	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3cccc(S(=O)(=O)N4CCNCC4)c3)nnc2c1		CHEMBL218049	=	IC50	nM	48.2	CHEMBL267	Homo sapiens	IC50	nM	48.2
	16908040	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(S(=O)(=O)N(C)CCN4CCCC4)cc3)nnc2c1		CHEMBL3651194	=	IC50	nM	25.5	CHEMBL267	Homo sapiens	IC50	nM	25.5
	16908041	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(C(=O)N4CCNCC4)cc3)nnc2c1		CHEMBL3651195	=	IC50	nM	11.9	CHEMBL267	Homo sapiens	IC50	nM	11.9
	16908042	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3cccc(S(=O)(=O)NCCN4CCNCC4)c3)nnc2c1		CHEMBL3651196	=	IC50	nM	28.8	CHEMBL267	Homo sapiens	IC50	nM	28.8
	16908043	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(S(=O)(=O)N4CCNCC4)cc3)nnc2c1		CHEMBL218281	=	IC50	nM	128.0	CHEMBL267	Homo sapiens	IC50	nM	128.0
	16908044	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3cccc(C(=O)N4CCN(C)CC4)c3)nnc2c1		CHEMBL3651197	=	IC50	nM	88.6	CHEMBL267	Homo sapiens	IC50	nM	88.6
	16908045	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc2nc(Nc3ccc(OCCN4CCCC4)cc3)nnc2cc1-c1c(C)cccc1C		CHEMBL230272	=	IC50	nM	12.3	CHEMBL267	Homo sapiens	IC50	nM	12.3
	16908046	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc2nc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nnc2cc1-c1c(C)cccc1C		CHEMBL230816	=	IC50	nM	10.5	CHEMBL267	Homo sapiens	IC50	nM	10.5
	16908047	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2c(Cl)cccc2Cl)cc2nnc(Nc3ccnc(OCCN4CCCC4)c3)nc12.Cl		CHEMBL3905001	=	IC50	nM	12.2	CHEMBL267	Homo sapiens	IC50	nM	12.2
	16908048	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1ccccc1-c1cc2nnc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nc2cc1C		CHEMBL231237	=	IC50	nM	10.2	CHEMBL267	Homo sapiens	IC50	nM	10.2
	16908049	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc2nc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nnc2cc1-c1ccccc1		CHEMBL230918	=	IC50	nM	315.0	CHEMBL267	Homo sapiens	IC50	nM	315.0
	16908050	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3cccc(S(=O)(=O)CCCN4CCCC4)c3)nnc2c1		CHEMBL3651199	=	IC50	nM	34.8	CHEMBL267	Homo sapiens	IC50	nM	34.8
	16908051	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1cc([N+](=O)[O-])c2nc(Nc3ccc(OCCN4CCCC4)cc3)n[n+]([O-])c2c1		CHEMBL3651200	=	IC50	nM	32.0	CHEMBL267	Homo sapiens	IC50	nM	32.0
	16908052	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1cc(N)c2nc(Nc3ccc(OCCN4CCCC4)cc3)nnc2c1		CHEMBL230829	=	IC50	nM	9.7	CHEMBL267	Homo sapiens	IC50	nM	9.7
	16908053	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	CC(=O)Nc1cc(-c2c(C)cccc2C)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL231251	=	IC50	nM	6.8	CHEMBL267	Homo sapiens	IC50	nM	6.8
	16908054	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	CC(=O)Nc1ccccc1-c1cc2nnc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nc2cc1C		CHEMBL3651201	=	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	16908055	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	COc1ccc(Cl)c(-c2cc3nnc(Nc4ccc(C(=O)N5CCN(C)CC5)cc4)nc3cc2C)c1		CHEMBL3651202	=	IC50	nM	560.0	CHEMBL267	Homo sapiens	IC50	nM	560.0
	16908056	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1cc(NS(C)(=O)=O)c2nc(Nc3ccc(OCCN4CCCC4)cc3)nnc2c1		CHEMBL390479	=	IC50	nM	20.4	CHEMBL267	Homo sapiens	IC50	nM	20.4
	16908057	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc2nc(Nc3ccc(C(=O)N4CCN(C)CC4)cc3)nnc2cc1-c1cnccc1Cl		CHEMBL3651203	=	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	16908058	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1ccncc1-c1cc2nnc(Nc3ccc(C(=O)N4CCN(C)CC4)cc3)nc2cc1C		CHEMBL3651204	=	IC50	nM	47.2	CHEMBL267	Homo sapiens	IC50	nM	47.2
	16908059	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1ccncc1-c1cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc2cc1C		CHEMBL3651205	=	IC50	nM	44.3	CHEMBL267	Homo sapiens	IC50	nM	44.3
	16908060	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1ccc(Cl)cc1-c1cc2nnc(Nc3ccc(C(=O)N4CCN(C)CC4)cc3)nc2cc1C		CHEMBL3651206	=	IC50	nM	7.9	CHEMBL267	Homo sapiens	IC50	nM	7.9
	16908061	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc2nc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nnc2cc1-c1ccccc1NS(C)(=O)=O		CHEMBL3651207	=	IC50	nM	5000.0	CHEMBL267	Homo sapiens	IC50	nM	5000.0
	16908062	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc2nc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nnc2cc1-c1ccccc1N		CHEMBL3651208	=	IC50	nM	91.8	CHEMBL267	Homo sapiens	IC50	nM	91.8
	16908063	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc2nc(Nc3ccc(OCCN4CCCC4)cc3)nnc2cc1-c1sccc1C		CHEMBL3651209	=	IC50	nM	60.7	CHEMBL267	Homo sapiens	IC50	nM	60.7
	16908064	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc2nc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nnc2cc1-c1ccccc1C(F)(F)F		CHEMBL231338	=	IC50	nM	66.5	CHEMBL267	Homo sapiens	IC50	nM	66.5
	16908065	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc2nc(Nc3ccc(C(=O)N4CCN(C)CC4)cc3)nnc2cc1-c1cc(O)ccc1Cl		CHEMBL3651210	=	IC50	nM	3.4	CHEMBL267	Homo sapiens	IC50	nM	3.4
	16908066	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	=	IC50	nM	1.6	CHEMBL267	Homo sapiens	IC50	nM	1.6
	16908067	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	COc1ccccc1-c1cc2nnc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nc2cc1C		CHEMBL3651211	=	IC50	nM	272.0	CHEMBL267	Homo sapiens	IC50	nM	272.0
	16908068	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc2nc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nnc2cc1-c1ccccc1CO		CHEMBL230509	=	IC50	nM	72.2	CHEMBL267	Homo sapiens	IC50	nM	72.2
	16908069	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1ccc(F)cc1-c1cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc2cc1C		CHEMBL3651212	=	IC50	nM	6.6	CHEMBL267	Homo sapiens	IC50	nM	6.6
	16908070	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(=O)n(CCCN4CCCC4)c3)nnc2c1		CHEMBL3962103	=	IC50	nM	76.0	CHEMBL267	Homo sapiens	IC50	nM	76.0
	16908071	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2cccc3[nH]ccc23)cc2nnc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nc12		CHEMBL251015	=	IC50	nM	339.0	CHEMBL267	Homo sapiens	IC50	nM	339.0
	16908072	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(N2CCCCC2)cc2nnc(Nc3cccnc3)nc12		CHEMBL3651215	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	16908073	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc2nc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nnc2cc1-c1cccc(Cl)c1Cl		CHEMBL3651216	=	IC50	nM	142.0	CHEMBL267	Homo sapiens	IC50	nM	142.0
	16908074	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc2nc(Nc3ccc(OCCN4CCCC4)cc3)nnc2cc1-c1cccc(O)c1		CHEMBL3651217	=	IC50	nM	17.7	CHEMBL267	Homo sapiens	IC50	nM	17.7
	16908075	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc2nc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nnc2cc1-c1cccc(CO)c1		CHEMBL3651218	=	IC50	nM	439.0	CHEMBL267	Homo sapiens	IC50	nM	439.0
	16908076	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3cccnc3)nc12		CHEMBL3651219	=	IC50	nM	6.5	CHEMBL267	Homo sapiens	IC50	nM	6.5
	16908077	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(F)ccc1-c1cc2nnc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nc2cc1C		CHEMBL397691	=	IC50	nM	20.4	CHEMBL267	Homo sapiens	IC50	nM	20.4
	16908078	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	CC(=O)Nc1cc(-c2c(C)cccc2C)cc2nnc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nc12		CHEMBL3651220	=	IC50	nM	29.9	CHEMBL267	Homo sapiens	IC50	nM	29.9
	16908079	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	CC(=O)Nc1cc(-c2c(C)cccc2C)cc2nnc(Nc3ccc(S(=O)(=O)N(CCN4CCCC4)C(C)=O)cc3)nc12		CHEMBL3651221	=	IC50	nM	34.2	CHEMBL267	Homo sapiens	IC50	nM	34.2
	16908080	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nc12		CHEMBL249821	=	IC50	nM	3.6	CHEMBL267	Homo sapiens	IC50	nM	3.6
	16908081	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	CC(=O)Nc1cc2nc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nnc2cc1-c1ccccc1C		CHEMBL3651222	=	IC50	nM	111.0	CHEMBL267	Homo sapiens	IC50	nM	111.0
	16908082	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc2nc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nnc2cc1-c1ccc(Cl)s1		CHEMBL3651223	=	IC50	nM	880.0	CHEMBL267	Homo sapiens	IC50	nM	880.0
	16908083	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(NCCN3CCCC3)nc12		CHEMBL3651224	=	IC50	nM	4510.0	CHEMBL267	Homo sapiens	IC50	nM	4510.0
	16908084	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(C(=O)NCCN4CCCC4)o3)nc12		CHEMBL3651225	=	IC50	nM	12.2	CHEMBL267	Homo sapiens	IC50	nM	12.2
	16908085	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(S(N)(=O)=O)cc3)nc12		CHEMBL249820	=	IC50	nM	70.3	CHEMBL267	Homo sapiens	IC50	nM	70.3
	16908086	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1ccccc1-c1cc2nnc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nc2cc1NC(=O)NC(C)(C)C		CHEMBL3651226	=	IC50	nM	8000.0	CHEMBL267	Homo sapiens	IC50	nM	8000.0
	16908087	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	COc1cc2nc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nnc2cc1-c1ccccc1C		CHEMBL3651227	=	IC50	nM	10.0	CHEMBL267	Homo sapiens	IC50	nM	10.0
	16908088	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3cccc(C(=O)NCCN(C)C)c3)nc12		CHEMBL3651228	=	IC50	nM	4.8	CHEMBL267	Homo sapiens	IC50	nM	4.8
	16908089	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc2nc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nnc2cc1-c1ccc(CO)s1		CHEMBL3651229	=	IC50	nM	1730.0	CHEMBL267	Homo sapiens	IC50	nM	1730.0
	16908090	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1ccccc1-c1cc2nnc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nc2cc1O		CHEMBL3651230	=	IC50	nM	117.0	CHEMBL267	Homo sapiens	IC50	nM	117.0
	16908091	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3nc(C(=O)NCCN4CCCC4)cs3)nc12		CHEMBL3651231	=	IC50	nM	5.7	CHEMBL267	Homo sapiens	IC50	nM	5.7
	16908092	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	CC(=O)Nc1cc(-c2c(C)cccc2C)cc2nnc(Nc3ccc(C(=O)NCCN4CCCC4)o3)nc12		CHEMBL3651232	=	IC50	nM	137.0	CHEMBL267	Homo sapiens	IC50	nM	137.0
	16908093	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(F)nc3)nc12		CHEMBL3651233	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	16908094	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(F)ccc1-c1cc2nnc(Nc3ccc(C(=O)NCCN4CCCC4)o3)nc2cc1C		CHEMBL3651234	=	IC50	nM	120.0	CHEMBL267	Homo sapiens	IC50	nM	120.0
	16908095	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc2nc(Nc3cccnc3)nnc2cc1-c1cc(O)ccc1F		CHEMBL3651235	=	IC50	nM	26.8	CHEMBL267	Homo sapiens	IC50	nM	26.8
	16908096	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3cccc(N(C)C)c3)nc12		CHEMBL3651236	=	IC50	nM	21.6	CHEMBL267	Homo sapiens	IC50	nM	21.6
	16908097	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	CC(=O)Nc1ccc(Nc2nnc3cc(-c4cc(O)ccc4Cl)cc(C)c3n2)cn1		CHEMBL3651237	=	IC50	nM	118.4	CHEMBL267	Homo sapiens	IC50	nM	118.4
	16908098	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc2nc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nnc2cc1Br.O=S(=O)(O)C(F)(F)F		CHEMBL3906362	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	16908099	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	COc1ccc(Nc2nnc3cc(-c4cc(O)ccc4Cl)cc(C)c3n2)cn1		CHEMBL3651238	=	IC50	nM	11.2	CHEMBL267	Homo sapiens	IC50	nM	11.2
	16908100	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3cccc(S(=O)(=O)N4CCNCC4)c3)nc12		CHEMBL3651239	=	IC50	nM	52.8	CHEMBL267	Homo sapiens	IC50	nM	52.8
	16908101	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc2nc(Nc3ccc(OCCN4CCCC4)cc3)nnc2cc1-c1cc(O)ccc1F		CHEMBL3651240	=	IC50	nM	13.7	CHEMBL267	Homo sapiens	IC50	nM	13.7
	16908102	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc2nc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nnc2cc1-c1cc(O)ccc1F		CHEMBL3651241	=	IC50	nM	8.5	CHEMBL267	Homo sapiens	IC50	nM	8.5
	16908103	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	CCOc1cc2nc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nnc2cc1-c1ccccc1C		CHEMBL3651242	=	IC50	nM	27.2	CHEMBL267	Homo sapiens	IC50	nM	27.2
	16908104	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(F)ccc1-c1cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc2cc1C		CHEMBL3651243	=	IC50	nM	26.1	CHEMBL267	Homo sapiens	IC50	nM	26.1
	16908105	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1ccc(C#N)cc1-c1cc2nnc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nc2cc1C		CHEMBL395984	=	IC50	nM	12.3	CHEMBL267	Homo sapiens	IC50	nM	12.3
	16908106	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc2nc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nnc2cc1-c1cn[nH]c1		CHEMBL3651244	=	IC50	nM	8000.0	CHEMBL267	Homo sapiens	IC50	nM	8000.0
	16908107	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	COc1cc2nc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nnc2cc1-c1cccc(O)c1		CHEMBL3949485	=	IC50	nM	37.6	CHEMBL267	Homo sapiens	IC50	nM	37.6
	16908108	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(NCCCCN3CCCC3)nc12		CHEMBL3651245	=	IC50	nM	1450.0	CHEMBL267	Homo sapiens	IC50	nM	1450.0
	16908109	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(C(=O)N4CCNCC4)cc3)nc12		CHEMBL250214	=	IC50	nM	3.6	CHEMBL267	Homo sapiens	IC50	nM	3.6
	16908110	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc2nc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nnc2cc1-c1cc(O)ccc1Cl		CHEMBL3651246	=	IC50	nM	1.6	CHEMBL267	Homo sapiens	IC50	nM	1.6
	16908111	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Oc1ccc(Cl)c(-c2cc(OCCN3CCCC3)c3nc(Nc4cccnc4)nnc3c2)c1		CHEMBL3651247	=	IC50	nM	46.5	CHEMBL267	Homo sapiens	IC50	nM	46.5
	16908112	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1ccccc1-c1cc2nnc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nc2cc1OCCO		CHEMBL3651248	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	16908113	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(N4CCOCC4)nc3)nc12		CHEMBL3651249	=	IC50	nM	6.8	CHEMBL267	Homo sapiens	IC50	nM	6.8
	16908114	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3cccc(OCCN4CCCC4)c3)nc12		CHEMBL3651250	=	IC50	nM	1.8	CHEMBL267	Homo sapiens	IC50	nM	1.8
	16908115	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc2nc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nnc2cc1N(CCOCCO)C(C)C		CHEMBL3651251	=	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	16908116	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc2nc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nnc2cc1N(CCO)C(C)C		CHEMBL3651252	=	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	16908117	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3cccc(S(=O)(=O)NCCN(C)C)c3)nc12		CHEMBL3651253	=	IC50	nM	4.2	CHEMBL267	Homo sapiens	IC50	nM	4.2
	16908118	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc2nc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nnc2cc1N1CCCC(O)C1		CHEMBL3651254	=	IC50	nM	1772.0	CHEMBL267	Homo sapiens	IC50	nM	1772.0
	16908119	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(N4CCNCC4)nc3)nc12		CHEMBL3651255	=	IC50	nM	3.3	CHEMBL267	Homo sapiens	IC50	nM	3.3
	16908120	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	CNc1cc(-c2c(C)cccc2C)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL230830	=	IC50	nM	10.6	CHEMBL267	Homo sapiens	IC50	nM	10.6
	16908121	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(C(=O)N4CCN(C)CC4)cc3)nc12		CHEMBL399246	=	IC50	nM	2.9	CHEMBL267	Homo sapiens	IC50	nM	2.9
	16908122	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(S(=O)(=O)N(C)CCN4CCCC4)cc3)nc12		CHEMBL250019	=	IC50	nM	3.0	CHEMBL267	Homo sapiens	IC50	nM	3.0
	16908123	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc2nc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nnc2cc1Nc1cc(O)ccc1Cl		CHEMBL3651256	=	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	16908124	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc2nc(Nc3ccc(OCCN4CCCC4)cc3)nnc2cc1-c1cc(O)ccc1Cl		CHEMBL3651257	=	IC50	nM	4.2	CHEMBL267	Homo sapiens	IC50	nM	4.2
	16908125	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(C(=O)NCCN4CCCC4)nc3)nc12		CHEMBL3651258	=	IC50	nM	2.6	CHEMBL267	Homo sapiens	IC50	nM	2.6
	16908126	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(C(=O)N4CCN(CCO)CC4)nc3)nc12		CHEMBL3651259	=	IC50	nM	10.3	CHEMBL267	Homo sapiens	IC50	nM	10.3
	16908127	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(N4CCN(CCO)CC4)nc3)nc12		CHEMBL3651260	=	IC50	nM	1.8	CHEMBL267	Homo sapiens	IC50	nM	1.8
	16908128	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(S(=O)(=O)CCCN4CCCC4)cc3)nc12		CHEMBL399268	=	IC50	nM	5.0	CHEMBL267	Homo sapiens	IC50	nM	5.0
	16908129	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(S(=O)(=O)N4CCNCC4)cc3)nc12		CHEMBL250623	=	IC50	nM	6.6	CHEMBL267	Homo sapiens	IC50	nM	6.6
	16908130	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3cccc(S(=O)(=O)N4CCN(C)CC4)c3)nc12		CHEMBL3651261	=	IC50	nM	433.0	CHEMBL267	Homo sapiens	IC50	nM	433.0
	16908131	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Oc1ccc(Cl)c(-c2cc3nnc(Nc4ccc(OCCN5CCCC5)cc4)nc3cc2Cl)c1		CHEMBL3651262	=	IC50	nM	1.2	CHEMBL267	Homo sapiens	IC50	nM	1.2
	16908132	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1ccc(C#N)cc1-c1cc(C)c2nc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nnc2c1		CHEMBL231316	=	IC50	nM	25.2	CHEMBL267	Homo sapiens	IC50	nM	25.2
	16908133	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2cccc(NS(C)(=O)=O)c2)cc2nnc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nc12		CHEMBL230815	=	IC50	nM	2900.0	CHEMBL267	Homo sapiens	IC50	nM	2900.0
	16908134	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	CC(=O)Nc1cccc(-c2cc(C)c3nc(Nc4ccc(OCCN5CCCC5)cc4)nnc3c2)c1		CHEMBL3651263	=	IC50	nM	3977.0	CHEMBL267	Homo sapiens	IC50	nM	3977.0
	16908135	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	CNc1cccc(-c2cc(C)c3nc(Nc4ccc(S(=O)(=O)NCCN5CCCC5)cc4)nnc3c2)c1		CHEMBL231627	=	IC50	nM	631.0	CHEMBL267	Homo sapiens	IC50	nM	631.0
	16908136	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2cccc(N)c2)cc2nnc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nc12		CHEMBL231525	=	IC50	nM	282.0	CHEMBL267	Homo sapiens	IC50	nM	282.0
	16908137	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2cc(N)ccc2Cl)cc2nnc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nc12		CHEMBL231524	=	IC50	nM	51.0	CHEMBL267	Homo sapiens	IC50	nM	51.0
	16908138	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2c(Cl)cccc2Cl)cc2nnc(Nc3ccc(S(=O)(=O)N4CCNCC4)cc3)nc12		CHEMBL3651264	=	IC50	nM	60.5	CHEMBL267	Homo sapiens	IC50	nM	60.5
	16908139	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2c(Cl)cccc2Cl)cc2nnc(Nc3ccc(S(=O)(=O)N(CCN4CCCC4)C(C)C)cc3)nc12		CHEMBL3651265	=	IC50	nM	22.7	CHEMBL267	Homo sapiens	IC50	nM	22.7
	16908140	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2ccccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL268825	=	IC50	nM	34.8	CHEMBL267	Homo sapiens	IC50	nM	34.8
	16908141	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2ccccc2)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL230685	=	IC50	nM	341.0	CHEMBL267	Homo sapiens	IC50	nM	341.0
	16908142	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2c(Cl)cccc2Cl)cc2nnc(Nc3ccc(C(=O)N4CCNCC4)cc3)nc12		CHEMBL3651266	=	IC50	nM	10.2	CHEMBL267	Homo sapiens	IC50	nM	10.2
	16908143	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2c(Cl)cccc2Cl)cc2nnc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nc12		CHEMBL231219	=	IC50	nM	14.0	CHEMBL267	Homo sapiens	IC50	nM	14.0
	16908144	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc2nc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nnc2cc1-c1cccc(C(N)=O)c1		CHEMBL3651267	=	IC50	nM	2216.0	CHEMBL267	Homo sapiens	IC50	nM	2216.0
	16908145	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2c(Cl)cccc2Cl)cc2nnc(Nc3ccc(S(=O)(=O)N(C)CCN4CCCC4)cc3)nc12		CHEMBL3651268	=	IC50	nM	44.2	CHEMBL267	Homo sapiens	IC50	nM	44.2
	16908146	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2c(Cl)cccc2Cl)cc2nnc(Nc3ccc(O)cc3)nc12		CHEMBL3651269	=	IC50	nM	281.0	CHEMBL267	Homo sapiens	IC50	nM	281.0
	16908147	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1nc(Nc2nnc3cc(-c4c(Cl)cccc4Cl)cc(C)c3n2)cc(N2CCN(CCO)CC2)n1		CHEMBL3651270	=	IC50	nM	383.0	CHEMBL267	Homo sapiens	IC50	nM	383.0
	16908148	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1nc(Nc2nnc3cc(-c4cc(O)ccc4Cl)cc(C)c3n2)cc(N2CCN(CCO)CC2)n1		CHEMBL3651271	=	IC50	nM	68.8	CHEMBL267	Homo sapiens	IC50	nM	68.8
	16908149	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1nc(Nc2nnc3cc(-c4c(Cl)cccc4Cl)cc(C)c3n2)cc(OCCN2CCCC2)n1		CHEMBL3651272	=	IC50	nM	365.0	CHEMBL267	Homo sapiens	IC50	nM	365.0
	16908150	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(S(=O)(=O)N4CCN(C)CC4)cc3)nc12		CHEMBL3651273	=	IC50	nM	63.4	CHEMBL267	Homo sapiens	IC50	nM	63.4
	16908151	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(S(=O)(=O)N(CCN4CCCC4)C(C)C)cc3)nc12		CHEMBL250218	=	IC50	nM	4.8	CHEMBL267	Homo sapiens	IC50	nM	4.8
	16908152	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2c(Cl)cccc2Cl)cc2nnc(Nc3ccc(S(=O)(=O)CCCN4CCCC4)cc3)nc12		CHEMBL3651274	=	IC50	nM	21.6	CHEMBL267	Homo sapiens	IC50	nM	21.6
	16908153	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(S(=O)(=O)C4CCNCC4)cc3)nc12		CHEMBL250625	=	IC50	nM	5.2	CHEMBL267	Homo sapiens	IC50	nM	5.2
	16908154	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1nc(Nc2nnc3cc(-c4cc(O)ccc4Cl)cc(C)c3n2)cc(OCCN2CCCC2)n1		CHEMBL3651275	=	IC50	nM	77.7	CHEMBL267	Homo sapiens	IC50	nM	77.7
	16908155	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	CCN(CCN1CCCC1)S(=O)(=O)c1ccc(Nc2nnc3cc(-c4cc(O)ccc4Cl)cc(C)c3n2)cc1		CHEMBL250021	=	IC50	nM	3.2	CHEMBL267	Homo sapiens	IC50	nM	3.2
	16908156	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(S(=O)(=O)N(C)CCN4CCOCC4)cc3)nc12		CHEMBL250423	=	IC50	nM	6.6	CHEMBL267	Homo sapiens	IC50	nM	6.6
	16908157	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2cc(O)ccc2Br)cc2nnc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nc12		CHEMBL398279	=	IC50	nM	4.1	CHEMBL267	Homo sapiens	IC50	nM	4.1
	16908158	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2c(Cl)ccc(O)c2Cl)cc2nnc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nc12		CHEMBL400303	=	IC50	nM	1.5	CHEMBL267	Homo sapiens	IC50	nM	1.5
	16908159	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3cccc(SCCN4CCCC4)c3)nc12		CHEMBL3651276	=	IC50	nM	3.4	CHEMBL267	Homo sapiens	IC50	nM	3.4
	16908160	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	CCN(CC)CCN(C)Cc1ccc(Nc2nnc3cc(-c4cc(O)ccc4Cl)cc(C)c3n2)cc1		CHEMBL3651277	=	IC50	nM	4.3	CHEMBL267	Homo sapiens	IC50	nM	4.3
	16908161	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(SCCN4CCCC4)cc3)nc12		CHEMBL3651278	=	IC50	nM	4.3	CHEMBL267	Homo sapiens	IC50	nM	4.3
	16908162	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(C(=O)N4CCS(=O)(=O)CC4)cc3)nc12		CHEMBL249819	=	IC50	nM	3.0	CHEMBL267	Homo sapiens	IC50	nM	3.0
	16908163	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(CN(CCO)C(C)C)cc3)nc12		CHEMBL3651279	=	IC50	nM	1.5	CHEMBL267	Homo sapiens	IC50	nM	1.5
	16908164	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2c(Cl)ccc(O)c2F)cc2nnc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nc12		CHEMBL250821	=	IC50	nM	0.7	CHEMBL267	Homo sapiens	IC50	nM	0.7
	16908165	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2cccc(O)c2F)cc2nnc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nc12		CHEMBL3651280	=	IC50	nM	5.2	CHEMBL267	Homo sapiens	IC50	nM	5.2
	16908166	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2c(O)cccc2Cl)cc2nnc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nc12		CHEMBL231220	=	IC50	nM	12.6	CHEMBL267	Homo sapiens	IC50	nM	12.6
	16908167	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2ccc(O)c(F)c2)cc2nnc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nc12		CHEMBL3651281	=	IC50	nM	156.0	CHEMBL267	Homo sapiens	IC50	nM	156.0
	16908168	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2c(O)cccc2F)cc2nnc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nc12		CHEMBL3651282	=	IC50	nM	123.0	CHEMBL267	Homo sapiens	IC50	nM	123.0
	16908169	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc2nc(Nc3ccc(S(=O)(=O)N(C)CCN4CCCC4)cc3)nnc2cc1-c1cc(O)ccc1Cl		CHEMBL3651283	=	IC50	nM	3.7	CHEMBL267	Homo sapiens	IC50	nM	3.7
	16908170	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(C(=O)N(C)CCN4CCCC4)cc3)nc12		CHEMBL3651284	=	IC50	nM	1.6	CHEMBL267	Homo sapiens	IC50	nM	1.6
	16908171	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2c(Cl)ccc(O)c2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL3651285	=	IC50	nM	1.1	CHEMBL267	Homo sapiens	IC50	nM	1.1
	16908172	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2c(Cl)ccc(O)c2F)cc2nnc(Nc3ccc(S(=O)(=O)CCCN4CCCC4)cc3)nc12		CHEMBL3651286	=	IC50	nM	1.0	CHEMBL267	Homo sapiens	IC50	nM	1.0
	16908173	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2c(F)ccc(O)c2F)cc2nnc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nc12		CHEMBL440963	=	IC50	nM	3.1	CHEMBL267	Homo sapiens	IC50	nM	3.1
	16908174	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2c(Cl)ccc(O)c2Cl)cc2nnc(Nc3ccc(S(=O)(=O)C4CCNCC4)cc3)nc12		CHEMBL3651287	=	IC50	nM	2.4	CHEMBL267	Homo sapiens	IC50	nM	2.4
	16908175	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	CC(=O)Oc1ccc(Cl)c(-c2cc(C)c3nc(Nc4ccc(OCCN5CCCC5)cc4)nnc3c2)c1		CHEMBL271990	=	IC50	nM	53.2	CHEMBL267	Homo sapiens	IC50	nM	53.2
	16908176	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1ccc(O)cc1-c1cc(C)c2nc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nnc2c1		CHEMBL3651288	=	IC50	nM	0.955	CHEMBL267	Homo sapiens	IC50	nM	0.955
	16908177	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nc12		CHEMBL3651289	=	IC50	nM	79.2	CHEMBL267	Homo sapiens	IC50	nM	79.2
	16908178	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	16908179	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2c(Cl)ccc(O)c2Cl)cc2nnc(Nc3ccc(S(=O)(=O)CCCN4CCCC4)cc3)nc12		CHEMBL3651290	=	IC50	nM	2.1	CHEMBL267	Homo sapiens	IC50	nM	2.1
	16908180	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2c(F)ccc(O)c2F)cc2nnc(Nc3ccc(S(=O)(=O)CCCN4CCCC4)cc3)nc12		CHEMBL3651291	=	IC50	nM	3.8	CHEMBL267	Homo sapiens	IC50	nM	3.8
	16908181	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2c(Cl)ccc(O)c2F)cc2nnc(Nc3ccc(S(=O)(=O)N(C)CCN4CCCC4)cc3)nc12		CHEMBL3651292	=	IC50	nM	1.2	CHEMBL267	Homo sapiens	IC50	nM	1.2
	16908182	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2c(Cl)ccc(O)c2F)cc2nnc(Nc3ccc(C(=O)N(C)CCN4CCCC4)cc3)nc12		CHEMBL3639501	=	IC50	nM	0.542	CHEMBL267	Homo sapiens	IC50	nM	0.542
	16908183	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2c(Cl)cccc2Cl)cc2c1nc(Nc1ccc(OCCN3CCCC3)cc1)n[n+]2[O-]		CHEMBL3651293	=	IC50	nM	90.3	CHEMBL267	Homo sapiens	IC50	nM	90.3
	16908184	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	CC(=O)Oc1ccc(Cl)c(-c2cc(C)c3nc(Nc4cccc(OCCN5CCCC5)c4)nnc3c2)c1		CHEMBL3651294	=	IC50	nM	133.0	CHEMBL267	Homo sapiens	IC50	nM	133.0
	16908185	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1ccc(C(=O)Oc2ccc(Cl)c(-c3cc(C)c4nc(Nc5ccc(OCCN6CCCC6)cc5)nnc4c3)c2)cc1		CHEMBL403990	=	IC50	nM	267.0	CHEMBL267	Homo sapiens	IC50	nM	267.0
	16908186	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2cc(OC(=O)C(C)(C)C)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL270490	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	16908187	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2cc(OC(=O)C(C)C)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL272233	=	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	16908188	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2c(Cl)ccc(O)c2Cl)cc2nnc(Nc3ccc(S(=O)(=O)N(C)CCN4CCCC4)cc3)nc12		CHEMBL3651295	=	IC50	nM	3.6	CHEMBL267	Homo sapiens	IC50	nM	3.6
	16908189	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	COc1cc(OC)cc(-c2cc(C)c3nc(Nc4ccc(C)cc4)nnc3c2)c1		CHEMBL3648019	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	16908190	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cc(-c2c(Cl)cccc2Cl)cc2nnc(Nc3ccc(OCCN4CCN(C)CC4)cc3)nc12		CHEMBL3648044	=	IC50	nM	23.2	CHEMBL267	Homo sapiens	IC50	nM	23.2
	16908191	CHEMBL3883087	Inhibition of human recombinant c-Src using PTK2 substrate incubated for 90 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(C(=O)NCCN(C)C)cc3)nnc2c1		CHEMBL3648050	=	IC50	nM	4.6	CHEMBL267	Homo sapiens	IC50	nM	4.6
213804	17603182	CHEMBL3705261	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	COc1cc2nc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nnc2cc1-c1cccc(O)c1		CHEMBL3949485	=	IC50	nM	37.6	CHEMBL267	Homo sapiens	IC50	nM	37.6
342610	17720001	CHEMBL3887538	HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	=	IC50	nM	262.6	CHEMBL267	Homo sapiens	IC50	nM	262.6
342631	17720022	CHEMBL3887538	HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.	B	C=CC(=O)N[C@H]1CC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1		CHEMBL3647967	=	IC50	nM	14.3	CHEMBL267	Homo sapiens	IC50	nM	14.3
342805	17720196	CHEMBL3887561	Kinase Inhibition Assay: This example shows that the inhibitory activity of the compound, N1'-[3-fluoro-4-[[7-[4-(hydroxyamino)-4-oxobutoxy]-6-methoxy-4-quinolyl]oxy]phenyl]-N1-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide prepared in Example 9 in cells against kinases including ALK, AXL, FLT3, VEGFR2, c-KIT, c-MET, PDGFR-beta, RET and SRC (tested by Advanced Cellular Dynamics, 3550 General Atomics Court, Building 2, Room 639, San Diego, CA 92121. www.advancedcelldynamics.com and Carna Biosciences, Inc.(www.carnabio.com)) measured according to the method described in the literature (Reference: Daley, G. Q.; Baltimore, D. Proc. Natl. Acd. Sci. USA 1988, 85(23), 9312). Specific steps were as follows: The compound of the present invention was dissolved in dimethyl sulfoxide (DMSO) to make a stock solution of 2 mM, then the stock solution was diluted with DMSO following a 7 half-log series to concentrations ranging from 2 uM to 600 pM.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCC(=O)NO		CHEMBL3981567	>	IC50	nM	630.0	CHEMBL267	Homo sapiens	IC50	nM	630.0
363426	17738801	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	COCC(=O)Nc1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc(C)cc3)c3ccccc23)ccn1		CHEMBL3695569	=	IC50	nM	5.0	CHEMBL267	Homo sapiens	IC50	nM	5.0
363427	17738802	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]ccc5c4)n3)c3ccccc23)cc1		CHEMBL3897917	=	IC50	nM	21.0	CHEMBL267	Homo sapiens	IC50	nM	21.0
363428	17738803	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5c(c4)NC(=O)C5)n3)c3ccccc23)cc1		CHEMBL3972567	=	IC50	nM	4.0	CHEMBL267	Homo sapiens	IC50	nM	4.0
363429	17738804	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]nc(C(=O)NCCN6CCOCC6)c5c4)n3)c3ccccc23)cc1		CHEMBL3957923	=	IC50	nM	6.0	CHEMBL267	Homo sapiens	IC50	nM	6.0
363430	17738805	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5c(c4)ncn5C)n3)c3ccccc23)cc1		CHEMBL3940079	=	IC50	nM	4.0	CHEMBL267	Homo sapiens	IC50	nM	4.0
363431	17738806	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5onc(N)c5c4)n3)c3ccccc23)cc1		CHEMBL3922109	>	IC50	nM	1560.0	CHEMBL267	Homo sapiens	IC50	nM	1560.0
363432	17738807	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4cnc5[nH]ncc5c4)n3)c3ccccc23)cc1		CHEMBL3964537	=	IC50	nM	14.0	CHEMBL267	Homo sapiens	IC50	nM	14.0
363433	17738808	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]ncc5c4)n3)c3ccccc23)n(-c2ccc(O)cc2)n1		CHEMBL3894106	=	IC50	nM	10.0	CHEMBL267	Homo sapiens	IC50	nM	10.0
363434	17738809	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	COc1ccc(-n2nc(C3CCOC3)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]ncc5c4)n3)c3ccccc23)cc1		CHEMBL3921479	=	IC50	nM	2.0	CHEMBL267	Homo sapiens	IC50	nM	2.0
363435	17738810	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	COc1ccc(-n2nc(C(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(C)c5[nH]ncc5c4)n3)c3ccccc23)cc1		CHEMBL3943934	=	IC50	nM	4.0	CHEMBL267	Homo sapiens	IC50	nM	4.0
363436	17738811	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4cccc(CN5CCCC5=O)c4)c4ccccc34)n2)cc2cn[nH]c12		CHEMBL3915981	<	IC50	nM	1.0	CHEMBL267	Homo sapiens	IC50	nM	1.0
363437	17738812	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5c(c4)OCCO5)n3)c3ccccc23)n(-c2ccc(OCCN3CCOCC3)cc2)n1		CHEMBL3933807	=	IC50	nM	6.0	CHEMBL267	Homo sapiens	IC50	nM	6.0
363438	17738813	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]ncc5c4)n3)c3ccccc23)n(-c2ccc(OCCN3CCOCC3)cc2)n1		CHEMBL3931027	=	IC50	nM	13.0	CHEMBL267	Homo sapiens	IC50	nM	13.0
363439	17738814	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	COc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]ncc5c4)n3)c3ccccc23)cn1		CHEMBL3971588	=	IC50	nM	3.0	CHEMBL267	Homo sapiens	IC50	nM	3.0
363440	17738815	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3cc(Nc4ccc5[nH]ncc5c4)ncn3)c3ccccc23)n(-c2ccc(=O)n(CCO)c2)n1		CHEMBL3899497	=	IC50	nM	2.0	CHEMBL267	Homo sapiens	IC50	nM	2.0
363441	17738816	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]ncc5c4)n3)c3ccccc23)n(-c2ccc(OCCN3CCOCC3)nc2)n1		CHEMBL3933021	<	IC50	nM	1.0	CHEMBL267	Homo sapiens	IC50	nM	1.0
363442	17738817	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4cccc5[nH]ccc45)n3)c3ccccc23)cc1		CHEMBL3928618	=	IC50	nM	22.0	CHEMBL267	Homo sapiens	IC50	nM	22.0
363443	17738818	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4cccc5cc[nH]c45)n3)c3ccccc23)cc1		CHEMBL3964270	=	IC50	nM	138.0	CHEMBL267	Homo sapiens	IC50	nM	138.0
363444	17738819	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5c(ccn5C)c4)n3)c3ccccc23)cc1		CHEMBL3955192	=	IC50	nM	155.0	CHEMBL267	Homo sapiens	IC50	nM	155.0
363445	17738820	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5c(c4)CC(=O)N5)n3)c3ccccc23)cc1		CHEMBL3946614	=	IC50	nM	7.0	CHEMBL267	Homo sapiens	IC50	nM	7.0
363446	17738821	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5c(c4)CC(=O)N5C)n3)c3ccccc23)cc1		CHEMBL3975927	=	IC50	nM	113.0	CHEMBL267	Homo sapiens	IC50	nM	113.0
363447	17738822	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4cccc5[nH]ncc45)n3)c3ccccc23)cc1		CHEMBL3943340	=	IC50	nM	21.0	CHEMBL267	Homo sapiens	IC50	nM	21.0
363448	17738823	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]ncc5c4)n3)c3ccccc23)cc1		CHEMBL3935885	=	IC50	nM	19.0	CHEMBL267	Homo sapiens	IC50	nM	19.0
363449	17738824	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3cc(Nc4ccc5[nH]ncc5c4)ncn3)c3ccccc23)cc1		CHEMBL3958297	=	IC50	nM	16.0	CHEMBL267	Homo sapiens	IC50	nM	16.0
363450	17738825	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5cn[nH]c5c4)n3)c3ccccc23)cc1		CHEMBL3901815	=	IC50	nM	102.0	CHEMBL267	Homo sapiens	IC50	nM	102.0
363451	17738826	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4cccc5cn[nH]c45)n3)c3ccccc23)cc1		CHEMBL3978244	=	IC50	nM	46.0	CHEMBL267	Homo sapiens	IC50	nM	46.0
363452	17738827	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5c(cnn5C)c4)n3)c3ccccc23)cc1		CHEMBL3907109	=	IC50	nM	12.0	CHEMBL267	Homo sapiens	IC50	nM	12.0
363453	17738828	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(C)c5[nH]ncc5c4)n3)c3ccccc23)cc1		CHEMBL3956405	=	IC50	nM	11.0	CHEMBL267	Homo sapiens	IC50	nM	11.0
363454	17738829	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(Cl)c5[nH]ncc5c4)n3)c3ccccc23)cc1		CHEMBL3953685	=	IC50	nM	164.0	CHEMBL267	Homo sapiens	IC50	nM	164.0
363455	17738830	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5c(cnn5CCN5CCOCC5)c4)n3)c3ccccc23)cc1		CHEMBL3962324	=	IC50	nM	12.0	CHEMBL267	Homo sapiens	IC50	nM	12.0
363456	17738831	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]cnc5c4)n3)c3ccccc23)cc1		CHEMBL3919242	=	IC50	nM	17.0	CHEMBL267	Homo sapiens	IC50	nM	17.0
363457	17738832	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5ncn(C)c5c4)n3)c3ccccc23)cc1		CHEMBL3960029	=	IC50	nM	6.0	CHEMBL267	Homo sapiens	IC50	nM	6.0
363458	17738833	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4cnc5[nH]ccc5c4)n3)c3ccccc23)cc1		CHEMBL3932522	=	IC50	nM	14.0	CHEMBL267	Homo sapiens	IC50	nM	14.0
363459	17738834	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5c(c4)OCO5)n3)c3ccccc23)cc1		CHEMBL3921959	=	IC50	nM	23.0	CHEMBL267	Homo sapiens	IC50	nM	23.0
363460	17738835	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5scnc5c4)n3)c3ccccc23)cc1		CHEMBL3958914	=	IC50	nM	18.0	CHEMBL267	Homo sapiens	IC50	nM	18.0
363461	17738836	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5ncsc5c4)n3)c3ccccc23)cc1		CHEMBL3983442	=	IC50	nM	18.0	CHEMBL267	Homo sapiens	IC50	nM	18.0
363462	17738837	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]nnc5c4)n3)c3ccccc23)cc1		CHEMBL3958384	=	IC50	nM	14.0	CHEMBL267	Homo sapiens	IC50	nM	14.0
363463	17738838	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]ccc5c4)n3)c3ccccc23)n(-c2ccc(O)cc2)n1		CHEMBL3899975	=	IC50	nM	16.0	CHEMBL267	Homo sapiens	IC50	nM	16.0
363464	17738839	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	COc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]ccc5c4)n3)c3ccccc23)cc1		CHEMBL3984472	=	IC50	nM	10.0	CHEMBL267	Homo sapiens	IC50	nM	10.0
363465	17738840	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	COc1ccc(-n2nc(C(C)C)cc2NC(=O)Nc2ccc(Oc3cc(Nc4ccc5[nH]ncc5c4)ncn3)c3ccccc23)cc1		CHEMBL3912970	=	IC50	nM	11.0	CHEMBL267	Homo sapiens	IC50	nM	11.0
363466	17738841	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	COc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]ncc5c4)n3)c3ccccc23)cc1		CHEMBL3926692	=	IC50	nM	8.0	CHEMBL267	Homo sapiens	IC50	nM	8.0
363467	17738842	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	COc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5c(cnn5C)c4)n3)c3ccccc23)cc1		CHEMBL3935024	=	IC50	nM	16.0	CHEMBL267	Homo sapiens	IC50	nM	16.0
363468	17738843	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	COc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(C)c5[nH]ncc5c4)n3)c3ccccc23)cc1		CHEMBL3967247	=	IC50	nM	5.0	CHEMBL267	Homo sapiens	IC50	nM	5.0
363469	17738844	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	COc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5c(cnn5CCN5CCOCC5)c4)n3)c3ccccc23)cc1		CHEMBL3958953	=	IC50	nM	2.0	CHEMBL267	Homo sapiens	IC50	nM	2.0
363470	17738845	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	COc1ccc(-n2nc(C(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]nc(OCCN6CCOCC6)c5c4)n3)c3ccccc23)cc1		CHEMBL3927937	=	IC50	nM	2.0	CHEMBL267	Homo sapiens	IC50	nM	2.0
363471	17738846	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	COc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]nc(OCCN6CCOCC6)c5c4)n3)c3ccccc23)cc1		CHEMBL3950258	=	IC50	nM	5.0	CHEMBL267	Homo sapiens	IC50	nM	5.0
363472	17738847	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	COc1ccc(-n2nc(C(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]nc(C(=O)N(C)C)c5c4)n3)c3ccccc23)cc1		CHEMBL3922538	<	IC50	nM	1.0	CHEMBL267	Homo sapiens	IC50	nM	1.0
363473	17738848	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	COc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]nc(C(=O)N(C)C)c5c4)n3)c3ccccc23)cc1		CHEMBL3975188	<	IC50	nM	1.0	CHEMBL267	Homo sapiens	IC50	nM	1.0
363474	17738849	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]ccc5c4)n3)c3ccccc23)n(-c2cccc(CN3CCCC3=O)c2)n1		CHEMBL3949262	=	IC50	nM	4.0	CHEMBL267	Homo sapiens	IC50	nM	4.0
363475	17738850	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]ncc5c4)n3)c3ccccc23)n(-c2cccc(CN3CCCC3=O)c2)n1		CHEMBL3966684	=	IC50	nM	5.0	CHEMBL267	Homo sapiens	IC50	nM	5.0
363476	17738851	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5c(c4)NC(=O)C5)n3)c3ccccc23)n(-c2cccc(OCCN3CCOCC3)c2)n1		CHEMBL3936935	<	IC50	nM	1.0	CHEMBL267	Homo sapiens	IC50	nM	1.0
363477	17738852	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]ncc5c4)c3)c3ccccc23)n(-c2cccc(OCCN3CCOCC3)c2)n1		CHEMBL3925985	<	IC50	nM	1.0	CHEMBL267	Homo sapiens	IC50	nM	1.0
363478	17738853	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]ncc5c4)c3)c3ccccc23)n(-c2cccc(OCCN3CCOCC3)c2)n1		CHEMBL3965728	=	IC50	nM	3.0	CHEMBL267	Homo sapiens	IC50	nM	3.0
363479	17738854	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]ncc5c4)n3)c3ccccc23)n(-c2cccc(OCCN3CCOCC3)c2)n1		CHEMBL3893816	=	IC50	nM	4.0	CHEMBL267	Homo sapiens	IC50	nM	4.0
363480	17738855	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]ncc5c4)n3)c3ccccc23)n(-c2cccc(OCCN3CCOCC3)c2)n1		CHEMBL3920935	=	IC50	nM	7.0	CHEMBL267	Homo sapiens	IC50	nM	7.0
363481	17738856	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(C(C)C)nn4-c4cccc(OCCN5CCOCC5)c4)c4ccccc34)n2)cc2cn[nH]c12		CHEMBL3915395	<	IC50	nM	1.0	CHEMBL267	Homo sapiens	IC50	nM	1.0
363482	17738857	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4cccc(OCCN5CCOCC5)c4)c4ccccc34)n2)cc2cn[nH]c12		CHEMBL3898242	=	IC50	nM	2.0	CHEMBL267	Homo sapiens	IC50	nM	2.0
363483	17738858	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	COCCOc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(C)c5[nH]ncc5c4)c3)c3ccccc23)c1		CHEMBL3920172	=	IC50	nM	19.0	CHEMBL267	Homo sapiens	IC50	nM	19.0
363484	17738859	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1cc(Nc2cc(Oc3ccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4ccc(OCCN(C)C)cc4)c4ccccc34)ccn2)cc2cn[nH]c12		CHEMBL3892167	<	IC50	nM	1.0	CHEMBL267	Homo sapiens	IC50	nM	1.0
363485	17738860	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5c(c4)CCC5)n3)c3ccccc23)n(-c2ccc(OCCN3CCOCC3)cc2)n1		CHEMBL3958095	=	IC50	nM	23.0	CHEMBL267	Homo sapiens	IC50	nM	23.0
363486	17738861	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5c(c4)COC5)n3)c3ccccc23)n(-c2ccc(OCCN3CCOCC3)cc2)n1		CHEMBL3938312	=	IC50	nM	2.0	CHEMBL267	Homo sapiens	IC50	nM	2.0
363487	17738862	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5c(c4)NC(=O)C5)n3)c3ccccc23)n(-c2ccc(OCCN3CCOCC3)cc2)n1		CHEMBL3898648	<	IC50	nM	1.0	CHEMBL267	Homo sapiens	IC50	nM	1.0
363488	17738863	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5c(c4)NC(=O)C5(C)C)n3)c3ccccc23)n(-c2ccc(OCCN3CCOCC3)cc2)n1		CHEMBL3969828	=	IC50	nM	5.0	CHEMBL267	Homo sapiens	IC50	nM	5.0
363489	17738864	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5c(c4)C(=O)NC5)n3)c3ccccc23)n(-c2ccc(OCCN3CCOCC3)cc2)n1		CHEMBL3890213	<	IC50	nM	1.0	CHEMBL267	Homo sapiens	IC50	nM	1.0
363490	17738865	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5c(c4)CS(=O)(=O)C5)n3)c3ccccc23)n(-c2ccc(OCCN3CCOCC3)cc2)n1		CHEMBL3914683	=	IC50	nM	3.0	CHEMBL267	Homo sapiens	IC50	nM	3.0
363491	17738866	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5c(c4)OCO5)n3)c3ccccc23)n(-c2ccc(OCCN3CCOCC3)cc2)n1		CHEMBL3976445	=	IC50	nM	23.0	CHEMBL267	Homo sapiens	IC50	nM	23.0
363492	17738867	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1cc2cc(Nc3nccc(Oc4ccc(NC(=O)Nc5cc(C(C)(C)C)nn5-c5ccc(OCCN6CCOCC6)cc5)c5ccccc45)n3)ccc2[nH]1		CHEMBL3905700	=	IC50	nM	15.0	CHEMBL267	Homo sapiens	IC50	nM	15.0
363493	17738868	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]ncc5c4)c3)c3ccccc23)n(-c2ccc(OCCN3CCOCC3)cc2)n1		CHEMBL3936257	<	IC50	nM	1.0	CHEMBL267	Homo sapiens	IC50	nM	1.0
363494	17738869	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1cc(Nc2cc(Oc3ccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4ccc(OCCN5CCOCC5)cc4)c4ccccc34)ccn2)cc2cn[nH]c12		CHEMBL3900304	=	IC50	nM	3.0	CHEMBL267	Homo sapiens	IC50	nM	3.0
363495	17738870	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]ncc5c4)n3)c3ccccc23)n(-c2ccc(OCCN3CCOCC3)cc2)n1		CHEMBL3891402	=	IC50	nM	3.0	CHEMBL267	Homo sapiens	IC50	nM	3.0
363496	17738871	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3cc(Nc4ccc5[nH]ncc5c4)ncn3)c3ccccc23)n(-c2ccc(OCCN3CCOCC3)cc2)n1		CHEMBL3919491	=	IC50	nM	13.0	CHEMBL267	Homo sapiens	IC50	nM	13.0
363497	17738872	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1n[nH]c2cc(Nc3nccc(Oc4ccc(NC(=O)Nc5cc(C(C)(C)C)nn5-c5ccc(OCCN6CCOCC6)cc5)c5ccccc45)n3)ccc12		CHEMBL3980630	=	IC50	nM	12.0	CHEMBL267	Homo sapiens	IC50	nM	12.0
363498	17738873	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1n[nH]c2ccc(Nc3nccc(Oc4ccc(NC(=O)Nc5cc(C(C)(C)C)nn5-c5ccc(OCCN6CCOCC6)cc5)c5ccccc45)n3)cc12		CHEMBL3896872	=	IC50	nM	2.0	CHEMBL267	Homo sapiens	IC50	nM	2.0
363499	17738874	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4ccc(OCCN5CCOCC5)cc4)c4ccccc34)n2)cc2cn[nH]c12		CHEMBL3960541	=	IC50	nM	5.0	CHEMBL267	Homo sapiens	IC50	nM	5.0
363500	17738875	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5c(cnn5CCN5CCOCC5)c4)n3)c3ccccc23)n(-c2ccc(OCCN3CCOCC3)cc2)n1		CHEMBL3936603	<	IC50	nM	1.0	CHEMBL267	Homo sapiens	IC50	nM	1.0
363501	17738876	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1nc2cc(Nc3nccc(Oc4ccc(NC(=O)Nc5cc(C(C)(C)C)nn5-c5ccc(OCCN6CCOCC6)cc5)c5ccccc45)n3)ccc2[nH]1		CHEMBL3924003	<	IC50	nM	1.0	CHEMBL267	Homo sapiens	IC50	nM	1.0
363502	17738877	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5oc(=O)[nH]c5c4)n3)c3ccccc23)n(-c2ccc(OCCN3CCOCC3)cc2)n1		CHEMBL4110557	=	IC50	nM	15.0	CHEMBL267	Homo sapiens	IC50	nM	15.0
363503	17738878	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]c(=O)oc5c4)n3)c3ccccc23)n(-c2ccc(OCCN3CCOCC3)cc2)n1		CHEMBL3918561	=	IC50	nM	27.0	CHEMBL267	Homo sapiens	IC50	nM	27.0
363504	17738879	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5sncc5c4)n3)c3ccccc23)n(-c2ccc(OCCN3CCOCC3)cc2)n1		CHEMBL3984798	=	IC50	nM	8.0	CHEMBL267	Homo sapiens	IC50	nM	8.0
363505	17738880	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5scnc5c4)n3)c3ccccc23)n(-c2ccc(OCCN3CCOCC3)cc2)n1		CHEMBL3909641	=	IC50	nM	8.0	CHEMBL267	Homo sapiens	IC50	nM	8.0
363506	17738881	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5ncsc5c4)n3)c3ccccc23)n(-c2ccc(OCCN3CCOCC3)cc2)n1		CHEMBL3979828	=	IC50	nM	9.0	CHEMBL267	Homo sapiens	IC50	nM	9.0
363507	17738882	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]nnc5c4)n3)c3ccccc23)n(-c2ccc(OCCN3CCOCC3)cc2)n1		CHEMBL3899391	=	IC50	nM	5.0	CHEMBL267	Homo sapiens	IC50	nM	5.0
363508	17738883	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	COc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]ccc5c4)n3)c3ccccc23)cn1		CHEMBL3973916	=	IC50	nM	10.0	CHEMBL267	Homo sapiens	IC50	nM	10.0
363509	17738884	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	COc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]nc(C(=O)N6CCOCC6)c5c4)n3)c3ccccc23)cn1		CHEMBL3907174	=	IC50	nM	107.0	CHEMBL267	Homo sapiens	IC50	nM	107.0
363510	17738885	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)c1cc(NC(=O)Nc2ccc(Oc3cc(Nc4ccc5[nH]ncc5c4)ncn3)c3ccccc23)n(-c2ccc(=O)n(CCO)c2)n1		CHEMBL3935126	=	IC50	nM	3.0	CHEMBL267	Homo sapiens	IC50	nM	3.0
363511	17738886	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]ncc5c4)n3)c3ccccc23)n(-c2ccc(=O)n(CCO)c2)n1		CHEMBL3912657	<	IC50	nM	2.0	CHEMBL267	Homo sapiens	IC50	nM	2.0
363512	17738887	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]ncc5c4)n3)c3ccccc23)n(-c2ccc(=O)n(CCO)c2)n1		CHEMBL3944099	<	IC50	nM	1.0	CHEMBL267	Homo sapiens	IC50	nM	1.0
363513	17738888	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4ccc(=O)n(CCO)c4)c4ccccc34)n2)cc2cn[nH]c12		CHEMBL3921640	=	IC50	nM	2.0	CHEMBL267	Homo sapiens	IC50	nM	2.0
363514	17738889	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]ncc5c4)n3)c3ccccc23)n(-c2ccc(=O)n(CCN3CCOCC3)c2)n1		CHEMBL3949420	=	IC50	nM	3.0	CHEMBL267	Homo sapiens	IC50	nM	3.0
363515	17738890	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4ccc(=O)n(CCN5CCOCC5)c4)c4ccccc34)n2)cc2cn[nH]c12		CHEMBL3961674	<	IC50	nM	1.0	CHEMBL267	Homo sapiens	IC50	nM	1.0
363516	17738891	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5c(c4)NC(=O)C5)n3)c3ccccc23)n(-c2ccc(OCCN3CCOCC3)nc2)n1		CHEMBL3986904	<	IC50	nM	1.0	CHEMBL267	Homo sapiens	IC50	nM	1.0
363517	17738892	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4ccc(OCCN5CCOCC5)nc4)c4ccccc34)n2)cc2cn[nH]c12		CHEMBL3972709	=	IC50	nM	1.0	CHEMBL267	Homo sapiens	IC50	nM	1.0
363518	17738893	CHEMBL3887919	c-Src and Syk Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 uL) is incubated with the test compound (either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL, 2.5 uL each) for 2 hr at RT. The FRET peptides (8 uM, 2.5 uL), and appropriate ATP solutions (2.5 uL, 800 uM for c-Src, and 60 uM ATP for Syk) are then added to the enzymes/compound mixtures and incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5c(cnn5CCN5CCOCC5)c4)n3)c3ccccc23)n(-c2ccc(OCCN3CCOCC3)nc2)n1		CHEMBL3901628	<	IC50	nM	1.0	CHEMBL267	Homo sapiens	IC50	nM	1.0
365169	17740214	CHEMBL3887973	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activities of compounds disclosed herein were determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen Ltd., Paisley, UK). Recombinant, phosphorylated p38 MAPKγ (MAPK12: Invitrogen) was diluted in HEPES buffer, mixed with the test compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 μM) and ATP (100 μM) were added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan® Flash, ThermoFisher Scientific). The site-specific protease cleaves non-phosphorylated peptide only and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) for which high ratios indicate high phosphorylation and low rat	B	CC(=O)Nc1cc(COc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc(C)cc3)c3ccccc23)ccn1		CHEMBL3781102	=	IC50	nM	166.0	CHEMBL267	Homo sapiens	IC50	nM	166.0
365170	17740215	CHEMBL3887973	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activities of compounds disclosed herein were determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen Ltd., Paisley, UK). Recombinant, phosphorylated p38 MAPKγ (MAPK12: Invitrogen) was diluted in HEPES buffer, mixed with the test compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 μM) and ATP (100 μM) were added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan® Flash, ThermoFisher Scientific). The site-specific protease cleaves non-phosphorylated peptide only and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) for which high ratios indicate high phosphorylation and low rat	B	CC(=O)Nc1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc(C)cc3)c3ccccc23)ccn1		CHEMBL3972318	<	IC50	nM	18.0	CHEMBL267	Homo sapiens	IC50	nM	18.0
385002	17758424	CHEMBL3888244	In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	=	IC50	nM	262.6	CHEMBL267	Homo sapiens	IC50	nM	262.6
385023	17758445	CHEMBL3888244	In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.	B	C=CC(=O)N[C@H]1CC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1		CHEMBL3647967	=	IC50	nM	14.3	CHEMBL267	Homo sapiens	IC50	nM	14.3
409353	17774712	CHEMBL3888568	In vitro Kinase Assay: In vitro kinase assays for c-Src variants were performed in 50 mM Tris (pH 8.0), 10 mM MgCl2 and 1 mg/mL BSA. When obtaining kinetic parameters (kcat, Km) kinase and peptide substrate (IYGEFKKK) (SEQ ID NO:51) concentrations were 2 nM and 500 μM, respectively, while ATP concentrations ranged from 2000-0.655 μM. Addition of nonradioactive ATP supplemented with 32P ATP (3,000 Ci/mmol, NEN) was used to initiate kinase reactions. Time points were selected such that product formation never exceeded 10%. Reactions were quenched by spotting 3 μL quantities onto phosphocellulose sheets (P81, Whatman). Afterwards, the sheets were washed 3×5 minutes in 0.5% phosphoric acid and dried. Radioactivity was measured by phosphorimaging and recorded on a Typhoon fluorescence imager (Molecular Dynamics).	B	C=CC(=O)Nc1cccc(-c2nn(C(C)C)c3ncnc(N)c23)c1		CHEMBL3945901	=	IC50	nM	2319.0	CHEMBL267	Homo sapiens	IC50	nM	2319.0
409354	17774713	CHEMBL3888568	In vitro Kinase Assay: In vitro kinase assays for c-Src variants were performed in 50 mM Tris (pH 8.0), 10 mM MgCl2 and 1 mg/mL BSA. When obtaining kinetic parameters (kcat, Km) kinase and peptide substrate (IYGEFKKK) (SEQ ID NO:51) concentrations were 2 nM and 500 μM, respectively, while ATP concentrations ranged from 2000-0.655 μM. Addition of nonradioactive ATP supplemented with 32P ATP (3,000 Ci/mmol, NEN) was used to initiate kinase reactions. Time points were selected such that product formation never exceeded 10%. Reactions were quenched by spotting 3 μL quantities onto phosphocellulose sheets (P81, Whatman). Afterwards, the sheets were washed 3×5 minutes in 0.5% phosphoric acid and dried. Radioactivity was measured by phosphorimaging and recorded on a Typhoon fluorescence imager (Molecular Dynamics).	B	C=CC(=O)Nc1cccc(-c2nn(C(C)C)c3ncncc23)c1		CHEMBL3909085	>	IC50	nM	5000.0	CHEMBL267	Homo sapiens	IC50	nM	5000.0
409355	17774714	CHEMBL3888568	In vitro Kinase Assay: In vitro kinase assays for c-Src variants were performed in 50 mM Tris (pH 8.0), 10 mM MgCl2 and 1 mg/mL BSA. When obtaining kinetic parameters (kcat, Km) kinase and peptide substrate (IYGEFKKK) (SEQ ID NO:51) concentrations were 2 nM and 500 μM, respectively, while ATP concentrations ranged from 2000-0.655 μM. Addition of nonradioactive ATP supplemented with 32P ATP (3,000 Ci/mmol, NEN) was used to initiate kinase reactions. Time points were selected such that product formation never exceeded 10%. Reactions were quenched by spotting 3 μL quantities onto phosphocellulose sheets (P81, Whatman). Afterwards, the sheets were washed 3×5 minutes in 0.5% phosphoric acid and dried. Radioactivity was measured by phosphorimaging and recorded on a Typhoon fluorescence imager (Molecular Dynamics).	B	C=CS(=O)(=O)Nc1cccc(-c2nn(C(C)C)c3ncnc(N)c23)c1		CHEMBL3894472	=	IC50	nM	1004.0	CHEMBL267	Homo sapiens	IC50	nM	1004.0
409356	17774715	CHEMBL3888568	In vitro Kinase Assay: In vitro kinase assays for c-Src variants were performed in 50 mM Tris (pH 8.0), 10 mM MgCl2 and 1 mg/mL BSA. When obtaining kinetic parameters (kcat, Km) kinase and peptide substrate (IYGEFKKK) (SEQ ID NO:51) concentrations were 2 nM and 500 μM, respectively, while ATP concentrations ranged from 2000-0.655 μM. Addition of nonradioactive ATP supplemented with 32P ATP (3,000 Ci/mmol, NEN) was used to initiate kinase reactions. Time points were selected such that product formation never exceeded 10%. Reactions were quenched by spotting 3 μL quantities onto phosphocellulose sheets (P81, Whatman). Afterwards, the sheets were washed 3×5 minutes in 0.5% phosphoric acid and dried. Radioactivity was measured by phosphorimaging and recorded on a Typhoon fluorescence imager (Molecular Dynamics).	B	C=CS(=O)(=O)Nc1cccc(-c2nn(C(C)C)c3ncncc23)c1		CHEMBL3937010	>	IC50	nM	5000.0	CHEMBL267	Homo sapiens	IC50	nM	5000.0
409357	17774716	CHEMBL3888568	In vitro Kinase Assay: In vitro kinase assays for c-Src variants were performed in 50 mM Tris (pH 8.0), 10 mM MgCl2 and 1 mg/mL BSA. When obtaining kinetic parameters (kcat, Km) kinase and peptide substrate (IYGEFKKK) (SEQ ID NO:51) concentrations were 2 nM and 500 μM, respectively, while ATP concentrations ranged from 2000-0.655 μM. Addition of nonradioactive ATP supplemented with 32P ATP (3,000 Ci/mmol, NEN) was used to initiate kinase reactions. Time points were selected such that product formation never exceeded 10%. Reactions were quenched by spotting 3 μL quantities onto phosphocellulose sheets (P81, Whatman). Afterwards, the sheets were washed 3×5 minutes in 0.5% phosphoric acid and dried. Radioactivity was measured by phosphorimaging and recorded on a Typhoon fluorescence imager (Molecular Dynamics).	B	C=CS(=O)(=O)Nc1ccc(-c2nn(C(C)C)c3ncnc(N)c23)cc1		CHEMBL3933552	=	IC50	nM	899.0	CHEMBL267	Homo sapiens	IC50	nM	899.0
409358	17774717	CHEMBL3888568	In vitro Kinase Assay: In vitro kinase assays for c-Src variants were performed in 50 mM Tris (pH 8.0), 10 mM MgCl2 and 1 mg/mL BSA. When obtaining kinetic parameters (kcat, Km) kinase and peptide substrate (IYGEFKKK) (SEQ ID NO:51) concentrations were 2 nM and 500 μM, respectively, while ATP concentrations ranged from 2000-0.655 μM. Addition of nonradioactive ATP supplemented with 32P ATP (3,000 Ci/mmol, NEN) was used to initiate kinase reactions. Time points were selected such that product formation never exceeded 10%. Reactions were quenched by spotting 3 μL quantities onto phosphocellulose sheets (P81, Whatman). Afterwards, the sheets were washed 3×5 minutes in 0.5% phosphoric acid and dried. Radioactivity was measured by phosphorimaging and recorded on a Typhoon fluorescence imager (Molecular Dynamics).	B	CC(C)n1nc(-c2cccc(NC(=O)CCl)c2)c2c(N)ncnc21		CHEMBL3964551	>	IC50	nM	5000.0	CHEMBL267	Homo sapiens	IC50	nM	5000.0
409359	17774718	CHEMBL3888568	In vitro Kinase Assay: In vitro kinase assays for c-Src variants were performed in 50 mM Tris (pH 8.0), 10 mM MgCl2 and 1 mg/mL BSA. When obtaining kinetic parameters (kcat, Km) kinase and peptide substrate (IYGEFKKK) (SEQ ID NO:51) concentrations were 2 nM and 500 μM, respectively, while ATP concentrations ranged from 2000-0.655 μM. Addition of nonradioactive ATP supplemented with 32P ATP (3,000 Ci/mmol, NEN) was used to initiate kinase reactions. Time points were selected such that product formation never exceeded 10%. Reactions were quenched by spotting 3 μL quantities onto phosphocellulose sheets (P81, Whatman). Afterwards, the sheets were washed 3×5 minutes in 0.5% phosphoric acid and dried. Radioactivity was measured by phosphorimaging and recorded on a Typhoon fluorescence imager (Molecular Dynamics).	B	C=CC(=O)Nc1cccc(Cc2nn(C(C)C)c3ncnc(N)c23)c1		CHEMBL3930202	>	IC50	nM	5000.0	CHEMBL267	Homo sapiens	IC50	nM	5000.0
409360	17774719	CHEMBL3888568	In vitro Kinase Assay: In vitro kinase assays for c-Src variants were performed in 50 mM Tris (pH 8.0), 10 mM MgCl2 and 1 mg/mL BSA. When obtaining kinetic parameters (kcat, Km) kinase and peptide substrate (IYGEFKKK) (SEQ ID NO:51) concentrations were 2 nM and 500 μM, respectively, while ATP concentrations ranged from 2000-0.655 μM. Addition of nonradioactive ATP supplemented with 32P ATP (3,000 Ci/mmol, NEN) was used to initiate kinase reactions. Time points were selected such that product formation never exceeded 10%. Reactions were quenched by spotting 3 μL quantities onto phosphocellulose sheets (P81, Whatman). Afterwards, the sheets were washed 3×5 minutes in 0.5% phosphoric acid and dried. Radioactivity was measured by phosphorimaging and recorded on a Typhoon fluorescence imager (Molecular Dynamics).	B	C=CC(=O)Nc1ccc(Cc2nn(C(C)C)c3ncnc(N)c23)cc1		CHEMBL3902233	>	IC50	nM	5000.0	CHEMBL267	Homo sapiens	IC50	nM	5000.0
409361	17774720	CHEMBL3888568	In vitro Kinase Assay: In vitro kinase assays for c-Src variants were performed in 50 mM Tris (pH 8.0), 10 mM MgCl2 and 1 mg/mL BSA. When obtaining kinetic parameters (kcat, Km) kinase and peptide substrate (IYGEFKKK) (SEQ ID NO:51) concentrations were 2 nM and 500 μM, respectively, while ATP concentrations ranged from 2000-0.655 μM. Addition of nonradioactive ATP supplemented with 32P ATP (3,000 Ci/mmol, NEN) was used to initiate kinase reactions. Time points were selected such that product formation never exceeded 10%. Reactions were quenched by spotting 3 μL quantities onto phosphocellulose sheets (P81, Whatman). Afterwards, the sheets were washed 3×5 minutes in 0.5% phosphoric acid and dried. Radioactivity was measured by phosphorimaging and recorded on a Typhoon fluorescence imager (Molecular Dynamics).	B	C=CS(=O)(=O)Nc1cccc(Cc2nn(C(C)C)c3ncnc(N)c23)c1		CHEMBL2216823	>	IC50	nM	5000.0	CHEMBL267	Homo sapiens	IC50	nM	5000.0
409362	17774721	CHEMBL3888568	In vitro Kinase Assay: In vitro kinase assays for c-Src variants were performed in 50 mM Tris (pH 8.0), 10 mM MgCl2 and 1 mg/mL BSA. When obtaining kinetic parameters (kcat, Km) kinase and peptide substrate (IYGEFKKK) (SEQ ID NO:51) concentrations were 2 nM and 500 μM, respectively, while ATP concentrations ranged from 2000-0.655 μM. Addition of nonradioactive ATP supplemented with 32P ATP (3,000 Ci/mmol, NEN) was used to initiate kinase reactions. Time points were selected such that product formation never exceeded 10%. Reactions were quenched by spotting 3 μL quantities onto phosphocellulose sheets (P81, Whatman). Afterwards, the sheets were washed 3×5 minutes in 0.5% phosphoric acid and dried. Radioactivity was measured by phosphorimaging and recorded on a Typhoon fluorescence imager (Molecular Dynamics).	B	C=CS(=O)(=O)Nc1ccc(Cc2nn(C(C)C)c3ncnc(N)c23)cc1		CHEMBL3968877	=	IC50	nM	3083.0	CHEMBL267	Homo sapiens	IC50	nM	3083.0
409363	17774722	CHEMBL3888568	In vitro Kinase Assay: In vitro kinase assays for c-Src variants were performed in 50 mM Tris (pH 8.0), 10 mM MgCl2 and 1 mg/mL BSA. When obtaining kinetic parameters (kcat, Km) kinase and peptide substrate (IYGEFKKK) (SEQ ID NO:51) concentrations were 2 nM and 500 μM, respectively, while ATP concentrations ranged from 2000-0.655 μM. Addition of nonradioactive ATP supplemented with 32P ATP (3,000 Ci/mmol, NEN) was used to initiate kinase reactions. Time points were selected such that product formation never exceeded 10%. Reactions were quenched by spotting 3 μL quantities onto phosphocellulose sheets (P81, Whatman). Afterwards, the sheets were washed 3×5 minutes in 0.5% phosphoric acid and dried. Radioactivity was measured by phosphorimaging and recorded on a Typhoon fluorescence imager (Molecular Dynamics).	B	CCS(=O)(=O)Nc1cccc(Cc2nn(C(C)C)c3ncnc(N)c23)c1		CHEMBL3907668	>	IC50	nM	5000.0	CHEMBL267	Homo sapiens	IC50	nM	5000.0
409364	17774723	CHEMBL3888568	In vitro Kinase Assay: In vitro kinase assays for c-Src variants were performed in 50 mM Tris (pH 8.0), 10 mM MgCl2 and 1 mg/mL BSA. When obtaining kinetic parameters (kcat, Km) kinase and peptide substrate (IYGEFKKK) (SEQ ID NO:51) concentrations were 2 nM and 500 μM, respectively, while ATP concentrations ranged from 2000-0.655 μM. Addition of nonradioactive ATP supplemented with 32P ATP (3,000 Ci/mmol, NEN) was used to initiate kinase reactions. Time points were selected such that product formation never exceeded 10%. Reactions were quenched by spotting 3 μL quantities onto phosphocellulose sheets (P81, Whatman). Afterwards, the sheets were washed 3×5 minutes in 0.5% phosphoric acid and dried. Radioactivity was measured by phosphorimaging and recorded on a Typhoon fluorescence imager (Molecular Dynamics).	B	CC(C)n1nc(Cc2cccc(NC(=O)CCl)c2)c2c(N)ncnc21		CHEMBL3974148	>	IC50	nM	5000.0	CHEMBL267	Homo sapiens	IC50	nM	5000.0
409365	17774724	CHEMBL3888568	In vitro Kinase Assay: In vitro kinase assays for c-Src variants were performed in 50 mM Tris (pH 8.0), 10 mM MgCl2 and 1 mg/mL BSA. When obtaining kinetic parameters (kcat, Km) kinase and peptide substrate (IYGEFKKK) (SEQ ID NO:51) concentrations were 2 nM and 500 μM, respectively, while ATP concentrations ranged from 2000-0.655 μM. Addition of nonradioactive ATP supplemented with 32P ATP (3,000 Ci/mmol, NEN) was used to initiate kinase reactions. Time points were selected such that product formation never exceeded 10%. Reactions were quenched by spotting 3 μL quantities onto phosphocellulose sheets (P81, Whatman). Afterwards, the sheets were washed 3×5 minutes in 0.5% phosphoric acid and dried. Radioactivity was measured by phosphorimaging and recorded on a Typhoon fluorescence imager (Molecular Dynamics).	B	CC(C)n1nc(Cc2cccc(C(=O)CF)c2)c2c(N)ncnc21		CHEMBL3921542	>	IC50	nM	5000.0	CHEMBL267	Homo sapiens	IC50	nM	5000.0
409366	17774725	CHEMBL3888568	In vitro Kinase Assay: In vitro kinase assays for c-Src variants were performed in 50 mM Tris (pH 8.0), 10 mM MgCl2 and 1 mg/mL BSA. When obtaining kinetic parameters (kcat, Km) kinase and peptide substrate (IYGEFKKK) (SEQ ID NO:51) concentrations were 2 nM and 500 μM, respectively, while ATP concentrations ranged from 2000-0.655 μM. Addition of nonradioactive ATP supplemented with 32P ATP (3,000 Ci/mmol, NEN) was used to initiate kinase reactions. Time points were selected such that product formation never exceeded 10%. Reactions were quenched by spotting 3 μL quantities onto phosphocellulose sheets (P81, Whatman). Afterwards, the sheets were washed 3×5 minutes in 0.5% phosphoric acid and dried. Radioactivity was measured by phosphorimaging and recorded on a Typhoon fluorescence imager (Molecular Dynamics).	B	CC(=O)c1cccc(Cc2nn(C(C)C)c3ncnc(N)c23)c1		CHEMBL3944700	>	IC50	nM	5000.0	CHEMBL267	Homo sapiens	IC50	nM	5000.0
409367	17774726	CHEMBL3888568	In vitro Kinase Assay: In vitro kinase assays for c-Src variants were performed in 50 mM Tris (pH 8.0), 10 mM MgCl2 and 1 mg/mL BSA. When obtaining kinetic parameters (kcat, Km) kinase and peptide substrate (IYGEFKKK) (SEQ ID NO:51) concentrations were 2 nM and 500 μM, respectively, while ATP concentrations ranged from 2000-0.655 μM. Addition of nonradioactive ATP supplemented with 32P ATP (3,000 Ci/mmol, NEN) was used to initiate kinase reactions. Time points were selected such that product formation never exceeded 10%. Reactions were quenched by spotting 3 μL quantities onto phosphocellulose sheets (P81, Whatman). Afterwards, the sheets were washed 3×5 minutes in 0.5% phosphoric acid and dried. Radioactivity was measured by phosphorimaging and recorded on a Typhoon fluorescence imager (Molecular Dynamics).	B	C=CS(=O)(=O)Nc1cccc(Cc2nn(C)c3ncnc(N)c23)c1		CHEMBL3982153	>	IC50	nM	5000.0	CHEMBL267	Homo sapiens	IC50	nM	5000.0
409368	17774727	CHEMBL3888568	In vitro Kinase Assay: In vitro kinase assays for c-Src variants were performed in 50 mM Tris (pH 8.0), 10 mM MgCl2 and 1 mg/mL BSA. When obtaining kinetic parameters (kcat, Km) kinase and peptide substrate (IYGEFKKK) (SEQ ID NO:51) concentrations were 2 nM and 500 μM, respectively, while ATP concentrations ranged from 2000-0.655 μM. Addition of nonradioactive ATP supplemented with 32P ATP (3,000 Ci/mmol, NEN) was used to initiate kinase reactions. Time points were selected such that product formation never exceeded 10%. Reactions were quenched by spotting 3 μL quantities onto phosphocellulose sheets (P81, Whatman). Afterwards, the sheets were washed 3×5 minutes in 0.5% phosphoric acid and dried. Radioactivity was measured by phosphorimaging and recorded on a Typhoon fluorescence imager (Molecular Dynamics).	B	C=CS(=O)(=O)Nc1cccc(Cc2nn(C(C)(C)C)c3ncnc(N)c23)c1		CHEMBL3956774	>	IC50	nM	5000.0	CHEMBL267	Homo sapiens	IC50	nM	5000.0
409369	17774728	CHEMBL3888568	In vitro Kinase Assay: In vitro kinase assays for c-Src variants were performed in 50 mM Tris (pH 8.0), 10 mM MgCl2 and 1 mg/mL BSA. When obtaining kinetic parameters (kcat, Km) kinase and peptide substrate (IYGEFKKK) (SEQ ID NO:51) concentrations were 2 nM and 500 μM, respectively, while ATP concentrations ranged from 2000-0.655 μM. Addition of nonradioactive ATP supplemented with 32P ATP (3,000 Ci/mmol, NEN) was used to initiate kinase reactions. Time points were selected such that product formation never exceeded 10%. Reactions were quenched by spotting 3 μL quantities onto phosphocellulose sheets (P81, Whatman). Afterwards, the sheets were washed 3×5 minutes in 0.5% phosphoric acid and dried. Radioactivity was measured by phosphorimaging and recorded on a Typhoon fluorescence imager (Molecular Dynamics).	B	C=CS(=O)(=O)Nc1cccc(Cc2nn(C3CCCC3)c3ncnc(N)c23)c1		CHEMBL3894318	>	IC50	nM	5000.0	CHEMBL267	Homo sapiens	IC50	nM	5000.0
409370	17774729	CHEMBL3888568	In vitro Kinase Assay: In vitro kinase assays for c-Src variants were performed in 50 mM Tris (pH 8.0), 10 mM MgCl2 and 1 mg/mL BSA. When obtaining kinetic parameters (kcat, Km) kinase and peptide substrate (IYGEFKKK) (SEQ ID NO:51) concentrations were 2 nM and 500 μM, respectively, while ATP concentrations ranged from 2000-0.655 μM. Addition of nonradioactive ATP supplemented with 32P ATP (3,000 Ci/mmol, NEN) was used to initiate kinase reactions. Time points were selected such that product formation never exceeded 10%. Reactions were quenched by spotting 3 μL quantities onto phosphocellulose sheets (P81, Whatman). Afterwards, the sheets were washed 3×5 minutes in 0.5% phosphoric acid and dried. Radioactivity was measured by phosphorimaging and recorded on a Typhoon fluorescence imager (Molecular Dynamics).	B	C=CC(=O)Nc1cccc(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3965760	>	IC50	nM	5000.0	CHEMBL267	Homo sapiens	IC50	nM	5000.0
409371	17774730	CHEMBL3888568	In vitro Kinase Assay: In vitro kinase assays for c-Src variants were performed in 50 mM Tris (pH 8.0), 10 mM MgCl2 and 1 mg/mL BSA. When obtaining kinetic parameters (kcat, Km) kinase and peptide substrate (IYGEFKKK) (SEQ ID NO:51) concentrations were 2 nM and 500 μM, respectively, while ATP concentrations ranged from 2000-0.655 μM. Addition of nonradioactive ATP supplemented with 32P ATP (3,000 Ci/mmol, NEN) was used to initiate kinase reactions. Time points were selected such that product formation never exceeded 10%. Reactions were quenched by spotting 3 μL quantities onto phosphocellulose sheets (P81, Whatman). Afterwards, the sheets were washed 3×5 minutes in 0.5% phosphoric acid and dried. Radioactivity was measured by phosphorimaging and recorded on a Typhoon fluorescence imager (Molecular Dynamics).	B	C=CS(=O)(=O)Nc1cccc(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3951753	>	IC50	nM	5000.0	CHEMBL267	Homo sapiens	IC50	nM	5000.0
409372	17774731	CHEMBL3888568	In vitro Kinase Assay: In vitro kinase assays for c-Src variants were performed in 50 mM Tris (pH 8.0), 10 mM MgCl2 and 1 mg/mL BSA. When obtaining kinetic parameters (kcat, Km) kinase and peptide substrate (IYGEFKKK) (SEQ ID NO:51) concentrations were 2 nM and 500 μM, respectively, while ATP concentrations ranged from 2000-0.655 μM. Addition of nonradioactive ATP supplemented with 32P ATP (3,000 Ci/mmol, NEN) was used to initiate kinase reactions. Time points were selected such that product formation never exceeded 10%. Reactions were quenched by spotting 3 μL quantities onto phosphocellulose sheets (P81, Whatman). Afterwards, the sheets were washed 3×5 minutes in 0.5% phosphoric acid and dried. Radioactivity was measured by phosphorimaging and recorded on a Typhoon fluorescence imager (Molecular Dynamics).	B	C=CS(=O)(=O)Nc1ccc(Nc2ncnc3cc(OC)c(OC)cc23)cc1		CHEMBL3980620	=	IC50	nM	2170.0	CHEMBL267	Homo sapiens	IC50	nM	2170.0
409373	17774732	CHEMBL3888569	In vitro Kinase Assay: In vitro kinase assays for c-Src variants were performed in 50 mM Tris (pH 8.0), 10 mM MgCl2 and 1 mg/mL BSA. When obtaining kinetic parameters (kcat, Km) kinase and peptide substrate (IYGEFKKK) (SEQ ID NO:51) concentrations were 2 nM and 500 μM, respectively, while ATP concentrations ranged from 2000-0.655 μM. Addition of nonradioactive ATP supplemented with 32P ATP (3,000 Ci/mmol, NEN) was used to initiate kinase reactions. Time points were selected such that product formation never exceeded 10%. Reactions were quenched by spotting 3 μL quantities onto phosphocellulose sheets (P81, Whatman). Afterwards, the sheets were washed 3×5 minutes in 0.5% phosphoric acid and dried. Radioactivity was measured by phosphorimaging and recorded on a Typhoon fluorescence imager (Molecular Dynamics).	B	C=CC(=O)Nc1cccc(-c2nn(C(C)C)c3ncnc(N)c23)c1		CHEMBL3945901	=	IC50	nM	419.0	CHEMBL267	Homo sapiens	IC50	nM	419.0
409374	17774733	CHEMBL3888569	In vitro Kinase Assay: In vitro kinase assays for c-Src variants were performed in 50 mM Tris (pH 8.0), 10 mM MgCl2 and 1 mg/mL BSA. When obtaining kinetic parameters (kcat, Km) kinase and peptide substrate (IYGEFKKK) (SEQ ID NO:51) concentrations were 2 nM and 500 μM, respectively, while ATP concentrations ranged from 2000-0.655 μM. Addition of nonradioactive ATP supplemented with 32P ATP (3,000 Ci/mmol, NEN) was used to initiate kinase reactions. Time points were selected such that product formation never exceeded 10%. Reactions were quenched by spotting 3 μL quantities onto phosphocellulose sheets (P81, Whatman). Afterwards, the sheets were washed 3×5 minutes in 0.5% phosphoric acid and dried. Radioactivity was measured by phosphorimaging and recorded on a Typhoon fluorescence imager (Molecular Dynamics).	B	C=CC(=O)Nc1cccc(-c2nn(C(C)C)c3ncncc23)c1		CHEMBL3909085	>	IC50	nM	5000.0	CHEMBL267	Homo sapiens	IC50	nM	5000.0
409375	17774734	CHEMBL3888569	In vitro Kinase Assay: In vitro kinase assays for c-Src variants were performed in 50 mM Tris (pH 8.0), 10 mM MgCl2 and 1 mg/mL BSA. When obtaining kinetic parameters (kcat, Km) kinase and peptide substrate (IYGEFKKK) (SEQ ID NO:51) concentrations were 2 nM and 500 μM, respectively, while ATP concentrations ranged from 2000-0.655 μM. Addition of nonradioactive ATP supplemented with 32P ATP (3,000 Ci/mmol, NEN) was used to initiate kinase reactions. Time points were selected such that product formation never exceeded 10%. Reactions were quenched by spotting 3 μL quantities onto phosphocellulose sheets (P81, Whatman). Afterwards, the sheets were washed 3×5 minutes in 0.5% phosphoric acid and dried. Radioactivity was measured by phosphorimaging and recorded on a Typhoon fluorescence imager (Molecular Dynamics).	B	C=CS(=O)(=O)Nc1cccc(-c2nn(C(C)C)c3ncnc(N)c23)c1		CHEMBL3894472	=	IC50	nM	111.0	CHEMBL267	Homo sapiens	IC50	nM	111.0
409376	17774735	CHEMBL3888569	In vitro Kinase Assay: In vitro kinase assays for c-Src variants were performed in 50 mM Tris (pH 8.0), 10 mM MgCl2 and 1 mg/mL BSA. When obtaining kinetic parameters (kcat, Km) kinase and peptide substrate (IYGEFKKK) (SEQ ID NO:51) concentrations were 2 nM and 500 μM, respectively, while ATP concentrations ranged from 2000-0.655 μM. Addition of nonradioactive ATP supplemented with 32P ATP (3,000 Ci/mmol, NEN) was used to initiate kinase reactions. Time points were selected such that product formation never exceeded 10%. Reactions were quenched by spotting 3 μL quantities onto phosphocellulose sheets (P81, Whatman). Afterwards, the sheets were washed 3×5 minutes in 0.5% phosphoric acid and dried. Radioactivity was measured by phosphorimaging and recorded on a Typhoon fluorescence imager (Molecular Dynamics).	B	C=CS(=O)(=O)Nc1cccc(-c2nn(C(C)C)c3ncncc23)c1		CHEMBL3937010	>	IC50	nM	5000.0	CHEMBL267	Homo sapiens	IC50	nM	5000.0
409377	17774736	CHEMBL3888569	In vitro Kinase Assay: In vitro kinase assays for c-Src variants were performed in 50 mM Tris (pH 8.0), 10 mM MgCl2 and 1 mg/mL BSA. When obtaining kinetic parameters (kcat, Km) kinase and peptide substrate (IYGEFKKK) (SEQ ID NO:51) concentrations were 2 nM and 500 μM, respectively, while ATP concentrations ranged from 2000-0.655 μM. Addition of nonradioactive ATP supplemented with 32P ATP (3,000 Ci/mmol, NEN) was used to initiate kinase reactions. Time points were selected such that product formation never exceeded 10%. Reactions were quenched by spotting 3 μL quantities onto phosphocellulose sheets (P81, Whatman). Afterwards, the sheets were washed 3×5 minutes in 0.5% phosphoric acid and dried. Radioactivity was measured by phosphorimaging and recorded on a Typhoon fluorescence imager (Molecular Dynamics).	B	C=CS(=O)(=O)Nc1ccc(-c2nn(C(C)C)c3ncnc(N)c23)cc1		CHEMBL3933552	=	IC50	nM	145.0	CHEMBL267	Homo sapiens	IC50	nM	145.0
409378	17774737	CHEMBL3888569	In vitro Kinase Assay: In vitro kinase assays for c-Src variants were performed in 50 mM Tris (pH 8.0), 10 mM MgCl2 and 1 mg/mL BSA. When obtaining kinetic parameters (kcat, Km) kinase and peptide substrate (IYGEFKKK) (SEQ ID NO:51) concentrations were 2 nM and 500 μM, respectively, while ATP concentrations ranged from 2000-0.655 μM. Addition of nonradioactive ATP supplemented with 32P ATP (3,000 Ci/mmol, NEN) was used to initiate kinase reactions. Time points were selected such that product formation never exceeded 10%. Reactions were quenched by spotting 3 μL quantities onto phosphocellulose sheets (P81, Whatman). Afterwards, the sheets were washed 3×5 minutes in 0.5% phosphoric acid and dried. Radioactivity was measured by phosphorimaging and recorded on a Typhoon fluorescence imager (Molecular Dynamics).	B	CC(C)n1nc(-c2cccc(NC(=O)CCl)c2)c2c(N)ncnc21		CHEMBL3964551	=	IC50	nM	817.0	CHEMBL267	Homo sapiens	IC50	nM	817.0
409379	17774738	CHEMBL3888569	In vitro Kinase Assay: In vitro kinase assays for c-Src variants were performed in 50 mM Tris (pH 8.0), 10 mM MgCl2 and 1 mg/mL BSA. When obtaining kinetic parameters (kcat, Km) kinase and peptide substrate (IYGEFKKK) (SEQ ID NO:51) concentrations were 2 nM and 500 μM, respectively, while ATP concentrations ranged from 2000-0.655 μM. Addition of nonradioactive ATP supplemented with 32P ATP (3,000 Ci/mmol, NEN) was used to initiate kinase reactions. Time points were selected such that product formation never exceeded 10%. Reactions were quenched by spotting 3 μL quantities onto phosphocellulose sheets (P81, Whatman). Afterwards, the sheets were washed 3×5 minutes in 0.5% phosphoric acid and dried. Radioactivity was measured by phosphorimaging and recorded on a Typhoon fluorescence imager (Molecular Dynamics).	B	C=CC(=O)Nc1cccc(Cc2nn(C(C)C)c3ncnc(N)c23)c1		CHEMBL3930202	=	IC50	nM	2762.0	CHEMBL267	Homo sapiens	IC50	nM	2762.0
409380	17774739	CHEMBL3888569	In vitro Kinase Assay: In vitro kinase assays for c-Src variants were performed in 50 mM Tris (pH 8.0), 10 mM MgCl2 and 1 mg/mL BSA. When obtaining kinetic parameters (kcat, Km) kinase and peptide substrate (IYGEFKKK) (SEQ ID NO:51) concentrations were 2 nM and 500 μM, respectively, while ATP concentrations ranged from 2000-0.655 μM. Addition of nonradioactive ATP supplemented with 32P ATP (3,000 Ci/mmol, NEN) was used to initiate kinase reactions. Time points were selected such that product formation never exceeded 10%. Reactions were quenched by spotting 3 μL quantities onto phosphocellulose sheets (P81, Whatman). Afterwards, the sheets were washed 3×5 minutes in 0.5% phosphoric acid and dried. Radioactivity was measured by phosphorimaging and recorded on a Typhoon fluorescence imager (Molecular Dynamics).	B	C=CC(=O)Nc1ccc(Cc2nn(C(C)C)c3ncnc(N)c23)cc1		CHEMBL3902233	>	IC50	nM	5000.0	CHEMBL267	Homo sapiens	IC50	nM	5000.0
409381	17774740	CHEMBL3888569	In vitro Kinase Assay: In vitro kinase assays for c-Src variants were performed in 50 mM Tris (pH 8.0), 10 mM MgCl2 and 1 mg/mL BSA. When obtaining kinetic parameters (kcat, Km) kinase and peptide substrate (IYGEFKKK) (SEQ ID NO:51) concentrations were 2 nM and 500 μM, respectively, while ATP concentrations ranged from 2000-0.655 μM. Addition of nonradioactive ATP supplemented with 32P ATP (3,000 Ci/mmol, NEN) was used to initiate kinase reactions. Time points were selected such that product formation never exceeded 10%. Reactions were quenched by spotting 3 μL quantities onto phosphocellulose sheets (P81, Whatman). Afterwards, the sheets were washed 3×5 minutes in 0.5% phosphoric acid and dried. Radioactivity was measured by phosphorimaging and recorded on a Typhoon fluorescence imager (Molecular Dynamics).	B	C=CS(=O)(=O)Nc1cccc(Cc2nn(C(C)C)c3ncnc(N)c23)c1		CHEMBL2216823	=	IC50	nM	150.0	CHEMBL267	Homo sapiens	IC50	nM	150.0
409382	17774741	CHEMBL3888569	In vitro Kinase Assay: In vitro kinase assays for c-Src variants were performed in 50 mM Tris (pH 8.0), 10 mM MgCl2 and 1 mg/mL BSA. When obtaining kinetic parameters (kcat, Km) kinase and peptide substrate (IYGEFKKK) (SEQ ID NO:51) concentrations were 2 nM and 500 μM, respectively, while ATP concentrations ranged from 2000-0.655 μM. Addition of nonradioactive ATP supplemented with 32P ATP (3,000 Ci/mmol, NEN) was used to initiate kinase reactions. Time points were selected such that product formation never exceeded 10%. Reactions were quenched by spotting 3 μL quantities onto phosphocellulose sheets (P81, Whatman). Afterwards, the sheets were washed 3×5 minutes in 0.5% phosphoric acid and dried. Radioactivity was measured by phosphorimaging and recorded on a Typhoon fluorescence imager (Molecular Dynamics).	B	C=CS(=O)(=O)Nc1ccc(Cc2nn(C(C)C)c3ncnc(N)c23)cc1		CHEMBL3968877	=	IC50	nM	1759.0	CHEMBL267	Homo sapiens	IC50	nM	1759.0
409383	17774742	CHEMBL3888569	In vitro Kinase Assay: In vitro kinase assays for c-Src variants were performed in 50 mM Tris (pH 8.0), 10 mM MgCl2 and 1 mg/mL BSA. When obtaining kinetic parameters (kcat, Km) kinase and peptide substrate (IYGEFKKK) (SEQ ID NO:51) concentrations were 2 nM and 500 μM, respectively, while ATP concentrations ranged from 2000-0.655 μM. Addition of nonradioactive ATP supplemented with 32P ATP (3,000 Ci/mmol, NEN) was used to initiate kinase reactions. Time points were selected such that product formation never exceeded 10%. Reactions were quenched by spotting 3 μL quantities onto phosphocellulose sheets (P81, Whatman). Afterwards, the sheets were washed 3×5 minutes in 0.5% phosphoric acid and dried. Radioactivity was measured by phosphorimaging and recorded on a Typhoon fluorescence imager (Molecular Dynamics).	B	CCS(=O)(=O)Nc1cccc(Cc2nn(C(C)C)c3ncnc(N)c23)c1		CHEMBL3907668	=	IC50	nM	3497.0	CHEMBL267	Homo sapiens	IC50	nM	3497.0
409384	17774743	CHEMBL3888569	In vitro Kinase Assay: In vitro kinase assays for c-Src variants were performed in 50 mM Tris (pH 8.0), 10 mM MgCl2 and 1 mg/mL BSA. When obtaining kinetic parameters (kcat, Km) kinase and peptide substrate (IYGEFKKK) (SEQ ID NO:51) concentrations were 2 nM and 500 μM, respectively, while ATP concentrations ranged from 2000-0.655 μM. Addition of nonradioactive ATP supplemented with 32P ATP (3,000 Ci/mmol, NEN) was used to initiate kinase reactions. Time points were selected such that product formation never exceeded 10%. Reactions were quenched by spotting 3 μL quantities onto phosphocellulose sheets (P81, Whatman). Afterwards, the sheets were washed 3×5 minutes in 0.5% phosphoric acid and dried. Radioactivity was measured by phosphorimaging and recorded on a Typhoon fluorescence imager (Molecular Dynamics).	B	CC(C)n1nc(Cc2cccc(NC(=O)CCl)c2)c2c(N)ncnc21		CHEMBL3974148	>	IC50	nM	5000.0	CHEMBL267	Homo sapiens	IC50	nM	5000.0
409385	17774744	CHEMBL3888569	In vitro Kinase Assay: In vitro kinase assays for c-Src variants were performed in 50 mM Tris (pH 8.0), 10 mM MgCl2 and 1 mg/mL BSA. When obtaining kinetic parameters (kcat, Km) kinase and peptide substrate (IYGEFKKK) (SEQ ID NO:51) concentrations were 2 nM and 500 μM, respectively, while ATP concentrations ranged from 2000-0.655 μM. Addition of nonradioactive ATP supplemented with 32P ATP (3,000 Ci/mmol, NEN) was used to initiate kinase reactions. Time points were selected such that product formation never exceeded 10%. Reactions were quenched by spotting 3 μL quantities onto phosphocellulose sheets (P81, Whatman). Afterwards, the sheets were washed 3×5 minutes in 0.5% phosphoric acid and dried. Radioactivity was measured by phosphorimaging and recorded on a Typhoon fluorescence imager (Molecular Dynamics).	B	CC(C)n1nc(Cc2cccc(C(=O)CF)c2)c2c(N)ncnc21		CHEMBL3921542	=	IC50	nM	338.0	CHEMBL267	Homo sapiens	IC50	nM	338.0
409386	17774745	CHEMBL3888569	In vitro Kinase Assay: In vitro kinase assays for c-Src variants were performed in 50 mM Tris (pH 8.0), 10 mM MgCl2 and 1 mg/mL BSA. When obtaining kinetic parameters (kcat, Km) kinase and peptide substrate (IYGEFKKK) (SEQ ID NO:51) concentrations were 2 nM and 500 μM, respectively, while ATP concentrations ranged from 2000-0.655 μM. Addition of nonradioactive ATP supplemented with 32P ATP (3,000 Ci/mmol, NEN) was used to initiate kinase reactions. Time points were selected such that product formation never exceeded 10%. Reactions were quenched by spotting 3 μL quantities onto phosphocellulose sheets (P81, Whatman). Afterwards, the sheets were washed 3×5 minutes in 0.5% phosphoric acid and dried. Radioactivity was measured by phosphorimaging and recorded on a Typhoon fluorescence imager (Molecular Dynamics).	B	CC(=O)c1cccc(Cc2nn(C(C)C)c3ncnc(N)c23)c1		CHEMBL3944700	=	IC50	nM	4520.0	CHEMBL267	Homo sapiens	IC50	nM	4520.0
409387	17774746	CHEMBL3888569	In vitro Kinase Assay: In vitro kinase assays for c-Src variants were performed in 50 mM Tris (pH 8.0), 10 mM MgCl2 and 1 mg/mL BSA. When obtaining kinetic parameters (kcat, Km) kinase and peptide substrate (IYGEFKKK) (SEQ ID NO:51) concentrations were 2 nM and 500 μM, respectively, while ATP concentrations ranged from 2000-0.655 μM. Addition of nonradioactive ATP supplemented with 32P ATP (3,000 Ci/mmol, NEN) was used to initiate kinase reactions. Time points were selected such that product formation never exceeded 10%. Reactions were quenched by spotting 3 μL quantities onto phosphocellulose sheets (P81, Whatman). Afterwards, the sheets were washed 3×5 minutes in 0.5% phosphoric acid and dried. Radioactivity was measured by phosphorimaging and recorded on a Typhoon fluorescence imager (Molecular Dynamics).	B	C=CS(=O)(=O)Nc1cccc(Cc2nn(C)c3ncnc(N)c23)c1		CHEMBL3982153	=	IC50	nM	3161.0	CHEMBL267	Homo sapiens	IC50	nM	3161.0
409388	17774747	CHEMBL3888569	In vitro Kinase Assay: In vitro kinase assays for c-Src variants were performed in 50 mM Tris (pH 8.0), 10 mM MgCl2 and 1 mg/mL BSA. When obtaining kinetic parameters (kcat, Km) kinase and peptide substrate (IYGEFKKK) (SEQ ID NO:51) concentrations were 2 nM and 500 μM, respectively, while ATP concentrations ranged from 2000-0.655 μM. Addition of nonradioactive ATP supplemented with 32P ATP (3,000 Ci/mmol, NEN) was used to initiate kinase reactions. Time points were selected such that product formation never exceeded 10%. Reactions were quenched by spotting 3 μL quantities onto phosphocellulose sheets (P81, Whatman). Afterwards, the sheets were washed 3×5 minutes in 0.5% phosphoric acid and dried. Radioactivity was measured by phosphorimaging and recorded on a Typhoon fluorescence imager (Molecular Dynamics).	B	C=CS(=O)(=O)Nc1cccc(Cc2nn(C(C)(C)C)c3ncnc(N)c23)c1		CHEMBL3956774	=	IC50	nM	618.0	CHEMBL267	Homo sapiens	IC50	nM	618.0
409389	17774748	CHEMBL3888569	In vitro Kinase Assay: In vitro kinase assays for c-Src variants were performed in 50 mM Tris (pH 8.0), 10 mM MgCl2 and 1 mg/mL BSA. When obtaining kinetic parameters (kcat, Km) kinase and peptide substrate (IYGEFKKK) (SEQ ID NO:51) concentrations were 2 nM and 500 μM, respectively, while ATP concentrations ranged from 2000-0.655 μM. Addition of nonradioactive ATP supplemented with 32P ATP (3,000 Ci/mmol, NEN) was used to initiate kinase reactions. Time points were selected such that product formation never exceeded 10%. Reactions were quenched by spotting 3 μL quantities onto phosphocellulose sheets (P81, Whatman). Afterwards, the sheets were washed 3×5 minutes in 0.5% phosphoric acid and dried. Radioactivity was measured by phosphorimaging and recorded on a Typhoon fluorescence imager (Molecular Dynamics).	B	C=CS(=O)(=O)Nc1cccc(Cc2nn(C3CCCC3)c3ncnc(N)c23)c1		CHEMBL3894318	=	IC50	nM	196.0	CHEMBL267	Homo sapiens	IC50	nM	196.0
409390	17774749	CHEMBL3888569	In vitro Kinase Assay: In vitro kinase assays for c-Src variants were performed in 50 mM Tris (pH 8.0), 10 mM MgCl2 and 1 mg/mL BSA. When obtaining kinetic parameters (kcat, Km) kinase and peptide substrate (IYGEFKKK) (SEQ ID NO:51) concentrations were 2 nM and 500 μM, respectively, while ATP concentrations ranged from 2000-0.655 μM. Addition of nonradioactive ATP supplemented with 32P ATP (3,000 Ci/mmol, NEN) was used to initiate kinase reactions. Time points were selected such that product formation never exceeded 10%. Reactions were quenched by spotting 3 μL quantities onto phosphocellulose sheets (P81, Whatman). Afterwards, the sheets were washed 3×5 minutes in 0.5% phosphoric acid and dried. Radioactivity was measured by phosphorimaging and recorded on a Typhoon fluorescence imager (Molecular Dynamics).	B	C=CC(=O)Nc1cccc(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3965760	=	IC50	nM	1661.0	CHEMBL267	Homo sapiens	IC50	nM	1661.0
409391	17774750	CHEMBL3888569	In vitro Kinase Assay: In vitro kinase assays for c-Src variants were performed in 50 mM Tris (pH 8.0), 10 mM MgCl2 and 1 mg/mL BSA. When obtaining kinetic parameters (kcat, Km) kinase and peptide substrate (IYGEFKKK) (SEQ ID NO:51) concentrations were 2 nM and 500 μM, respectively, while ATP concentrations ranged from 2000-0.655 μM. Addition of nonradioactive ATP supplemented with 32P ATP (3,000 Ci/mmol, NEN) was used to initiate kinase reactions. Time points were selected such that product formation never exceeded 10%. Reactions were quenched by spotting 3 μL quantities onto phosphocellulose sheets (P81, Whatman). Afterwards, the sheets were washed 3×5 minutes in 0.5% phosphoric acid and dried. Radioactivity was measured by phosphorimaging and recorded on a Typhoon fluorescence imager (Molecular Dynamics).	B	C=CS(=O)(=O)Nc1cccc(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3951753	=	IC50	nM	1004.0	CHEMBL267	Homo sapiens	IC50	nM	1004.0
409392	17774751	CHEMBL3888569	In vitro Kinase Assay: In vitro kinase assays for c-Src variants were performed in 50 mM Tris (pH 8.0), 10 mM MgCl2 and 1 mg/mL BSA. When obtaining kinetic parameters (kcat, Km) kinase and peptide substrate (IYGEFKKK) (SEQ ID NO:51) concentrations were 2 nM and 500 μM, respectively, while ATP concentrations ranged from 2000-0.655 μM. Addition of nonradioactive ATP supplemented with 32P ATP (3,000 Ci/mmol, NEN) was used to initiate kinase reactions. Time points were selected such that product formation never exceeded 10%. Reactions were quenched by spotting 3 μL quantities onto phosphocellulose sheets (P81, Whatman). Afterwards, the sheets were washed 3×5 minutes in 0.5% phosphoric acid and dried. Radioactivity was measured by phosphorimaging and recorded on a Typhoon fluorescence imager (Molecular Dynamics).	B	C=CS(=O)(=O)Nc1ccc(Nc2ncnc3cc(OC)c(OC)cc23)cc1		CHEMBL3980620	=	IC50	nM	560.0	CHEMBL267	Homo sapiens	IC50	nM	560.0
409393	17774752	CHEMBL3888570	In vitro Kinase Assay: In vitro kinase assays for c-Src variants were performed in 50 mM Tris (pH 8.0), 10 mM MgCl2 and 1 mg/mL BSA. When obtaining kinetic parameters (kcat, Km) kinase and peptide substrate (IYGEFKKK) (SEQ ID NO:51) concentrations were 2 nM and 500 μM, respectively, while ATP concentrations ranged from 2000-0.655 μM. Addition of nonradioactive ATP supplemented with 32P ATP (3,000 Ci/mmol, NEN) was used to initiate kinase reactions. Time points were selected such that product formation never exceeded 10%. Reactions were quenched by spotting 3 μL quantities onto phosphocellulose sheets (P81, Whatman). Afterwards, the sheets were washed 3×5 minutes in 0.5% phosphoric acid and dried. Radioactivity was measured by phosphorimaging and recorded on a Typhoon fluorescence imager (Molecular Dynamics).	B	C=CS(=O)(=O)Nc1cccc(-c2nn(C(C)C)c3ncnc(N)c23)c1		CHEMBL3894472	=	IC50	nM	63.0	CHEMBL267	Homo sapiens	IC50	nM	63.0
409394	17774753	CHEMBL3888570	In vitro Kinase Assay: In vitro kinase assays for c-Src variants were performed in 50 mM Tris (pH 8.0), 10 mM MgCl2 and 1 mg/mL BSA. When obtaining kinetic parameters (kcat, Km) kinase and peptide substrate (IYGEFKKK) (SEQ ID NO:51) concentrations were 2 nM and 500 μM, respectively, while ATP concentrations ranged from 2000-0.655 μM. Addition of nonradioactive ATP supplemented with 32P ATP (3,000 Ci/mmol, NEN) was used to initiate kinase reactions. Time points were selected such that product formation never exceeded 10%. Reactions were quenched by spotting 3 μL quantities onto phosphocellulose sheets (P81, Whatman). Afterwards, the sheets were washed 3×5 minutes in 0.5% phosphoric acid and dried. Radioactivity was measured by phosphorimaging and recorded on a Typhoon fluorescence imager (Molecular Dynamics).	B	C=CS(=O)(=O)Nc1cccc(Cc2nn(C(C)C)c3ncnc(N)c23)c1		CHEMBL2216823	=	IC50	nM	207.0	CHEMBL267	Homo sapiens	IC50	nM	207.0
409395	17774754	CHEMBL3888570	In vitro Kinase Assay: In vitro kinase assays for c-Src variants were performed in 50 mM Tris (pH 8.0), 10 mM MgCl2 and 1 mg/mL BSA. When obtaining kinetic parameters (kcat, Km) kinase and peptide substrate (IYGEFKKK) (SEQ ID NO:51) concentrations were 2 nM and 500 μM, respectively, while ATP concentrations ranged from 2000-0.655 μM. Addition of nonradioactive ATP supplemented with 32P ATP (3,000 Ci/mmol, NEN) was used to initiate kinase reactions. Time points were selected such that product formation never exceeded 10%. Reactions were quenched by spotting 3 μL quantities onto phosphocellulose sheets (P81, Whatman). Afterwards, the sheets were washed 3×5 minutes in 0.5% phosphoric acid and dried. Radioactivity was measured by phosphorimaging and recorded on a Typhoon fluorescence imager (Molecular Dynamics).	B	CC(C)n1nc(Cc2cccc(C(=O)CF)c2)c2c(N)ncnc21		CHEMBL3921542	=	IC50	nM	67.0	CHEMBL267	Homo sapiens	IC50	nM	67.0
409396	17774755	CHEMBL3888571	In vitro Kinase Assay: In vitro kinase assays for c-Src variants were performed in 50 mM Tris (pH 8.0), 10 mM MgCl2 and 1 mg/mL BSA. When obtaining kinetic parameters (kcat, Km) kinase and peptide substrate (IYGEFKKK) (SEQ ID NO:51) concentrations were 2 nM and 500 μM, respectively, while ATP concentrations ranged from 2000-0.655 μM. Addition of nonradioactive ATP supplemented with 32P ATP (3,000 Ci/mmol, NEN) was used to initiate kinase reactions. Time points were selected such that product formation never exceeded 10%. Reactions were quenched by spotting 3 μL quantities onto phosphocellulose sheets (P81, Whatman). Afterwards, the sheets were washed 3×5 minutes in 0.5% phosphoric acid and dried. Radioactivity was measured by phosphorimaging and recorded on a Typhoon fluorescence imager (Molecular Dynamics).	B	C=CS(=O)(=O)Nc1cccc(-c2nn(C(C)C)c3ncnc(N)c23)c1		CHEMBL3894472	=	IC50	nM	131.0	CHEMBL267	Homo sapiens	IC50	nM	131.0
409397	17774756	CHEMBL3888571	In vitro Kinase Assay: In vitro kinase assays for c-Src variants were performed in 50 mM Tris (pH 8.0), 10 mM MgCl2 and 1 mg/mL BSA. When obtaining kinetic parameters (kcat, Km) kinase and peptide substrate (IYGEFKKK) (SEQ ID NO:51) concentrations were 2 nM and 500 μM, respectively, while ATP concentrations ranged from 2000-0.655 μM. Addition of nonradioactive ATP supplemented with 32P ATP (3,000 Ci/mmol, NEN) was used to initiate kinase reactions. Time points were selected such that product formation never exceeded 10%. Reactions were quenched by spotting 3 μL quantities onto phosphocellulose sheets (P81, Whatman). Afterwards, the sheets were washed 3×5 minutes in 0.5% phosphoric acid and dried. Radioactivity was measured by phosphorimaging and recorded on a Typhoon fluorescence imager (Molecular Dynamics).	B	C=CS(=O)(=O)Nc1cccc(Cc2nn(C(C)C)c3ncnc(N)c23)c1		CHEMBL2216823	=	IC50	nM	424.0	CHEMBL267	Homo sapiens	IC50	nM	424.0
409398	17774757	CHEMBL3888571	In vitro Kinase Assay: In vitro kinase assays for c-Src variants were performed in 50 mM Tris (pH 8.0), 10 mM MgCl2 and 1 mg/mL BSA. When obtaining kinetic parameters (kcat, Km) kinase and peptide substrate (IYGEFKKK) (SEQ ID NO:51) concentrations were 2 nM and 500 μM, respectively, while ATP concentrations ranged from 2000-0.655 μM. Addition of nonradioactive ATP supplemented with 32P ATP (3,000 Ci/mmol, NEN) was used to initiate kinase reactions. Time points were selected such that product formation never exceeded 10%. Reactions were quenched by spotting 3 μL quantities onto phosphocellulose sheets (P81, Whatman). Afterwards, the sheets were washed 3×5 minutes in 0.5% phosphoric acid and dried. Radioactivity was measured by phosphorimaging and recorded on a Typhoon fluorescence imager (Molecular Dynamics).	B	CC(C)n1nc(Cc2cccc(C(=O)CF)c2)c2c(N)ncnc21		CHEMBL3921542	=	IC50	nM	29.0	CHEMBL267	Homo sapiens	IC50	nM	29.0
412049	17776764	CHEMBL3888692	Mobility Shift Assay: Agents: 1-fold kinase buffer without MnCl2: 50 mM HEPES, pH 7.5, 0.0015% Brij-35, 10 mM MgCl2, 2 mM DTT. 1-fold kinase buffer with MnCl2: 50 mM HEPES, pH 7.5, 0.0015% Brij-35, 10 mM MgCl2, 10 mM MnCl2, 2 mM DTT. Termination solution: 100 mM HEPES, pH 7.5, 0.0015% Brij-35, 0.2% Coating Reagent#3, 50 mM EDTA. 2.5-fold kinase solution: The kinase was added to the 1-fold kinase buffer to form a 2.5-fold kinase solution. 2.5-fold substrate solution: FAM fluorescence-labelled polypeptide and ATP were added to the 1-fold kinase buffer to form a 2.5-fold substrate solution. Compounds: The final test concentration of the compound was 10 μM at maximum. Firstly, a 50-fold concentration (i.e. 500 μM) was prepared with 100% DMSO. The compound was diluted with 100% DMSO by 5 folds at 5 concentrations (successively 500 μM, 100 μM, 20 μM, 4 μM, and 0.8 μM). After diluting with 1-fold kinase buffer by 10 folds, 5 μl of the samples were transferred to a 384-well reaction plate. Two negative control wells and two positive control wells were set at each line respectively. Replication was made in a 96-well plate in five concentrations of 5-fold compound. 10% DMSO was added to the positive control well, and 5 μl of EDTA (250 mM) was added to the negative control well. Procedure: To the 384-well reaction plate was added 5-fold compound dissolved in 10% DMSO at 5 μl/well. To the 384-well reaction plate was added 2.5-fold kinase solution at 10 Î¼l/well. The plate was incubated at room temperature for 10 mins. To the 384-well reaction plate was added 2.5-fold substrate solution at 10 μl/well. The plate was incubated at 28° C. for a certain period. 25 μl termination solution was added to terminate the reaction.	B	Nc1ccc(-c2ccc3ncc4c(=O)[nH]c(=O)n(-c5cccc(C(F)(F)F)c5)c4c3n2)cn1		CHEMBL3903725	=	IC50	nM	842.0	CHEMBL267	Homo sapiens	IC50	nM	842.0
415931	17779512	CHEMBL3888795	Inhibition Assay: In a similar manner to Experimental Example 1, the % inhibitory activity (concentration of the compound 1.0 μM) and the IC50 values of the inventive compound of Example 1 against various kinases were obtained by using Kinase Profiling Service (Invitrogen) according to the manufacturer's instructions.	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1NC(=O)c1cccc2c(N)nccc12		CHEMBL3967980	>	IC50	nM	2500.0	CHEMBL267	Homo sapiens	IC50	nM	2500.0
421714	17784773	CHEMBL3888876	"Kinase Assay: FlashPlates from Perkin Elmer (Boston, Mass., USA) with a 50 μl reaction volume are used. The reaction cocktail was pipetted in 4 steps in the following order: 15 μl of ATP solution (in H2O), 20 μl of assay buffer (see below), 5 μl of test sample in 10% DMSO, 10 μl of enzyme/substrate mixture (in H2O). The assay for all enzymes contained 60 mM HEPES-NaOH, pH 7.5, 3 mM MgCl2, 3 mM MnCl2, 3 μM Na-orthovanadate, 1.2 mM DTT, 50 μg/ml PEG20000, 1 μM [γ-33P]-ATP (approx. 8×10^5 cpm per well), protein kinase (variable amounts; see Table 1), and substrate (variable amounts). Certain assays also contained 1 mM CaCl2, 4 mM EDTA, 5 μg/ml Phosphatidylserine and 1 μg/ml 1.2-Dioleyl-glycerol. The MYLK2, CAMK1D, CAMK2A, CAMK2B, CAMK2D, CAMK4, CAMKK2, DAPK2 and EEF2K assays additionally contained 1 μg/ml Calmodulin and 0.5 mM CaCl2. The PRKG1 and PRKG2 assays additionally contained 1 μM cGMP. Recombinant Protein Kinases: All protein kinases were expressed in Sf9 insect cells or in E. coli as recombinant GST-fusion proteins or His-tagged proteins. All kinases were produced from human cDNAs, except JAK2, for which the mouse cDNA was used. Kinases were purified by affinity chromatography using either GSH-agarose (Sigma) or Ni-NTH-agarose (Qiagen). The purity of the protein kinases was examined by SDS-PAGE/coomassie staining. The identity of the protein kinases was checked by mass spectroscopy. Assays were made under license from Chemicon International Inc. for JAK2. The reaction cocktails were incubated at 30° C. for 80 minutes. The reaction was stopped with 50 μl of 2% (v/v) H3PO4, plates were aspirated and washed two times with 200 μl 0.9% (w/v) NaCl. All assays were performed with a BeckmanCoulter Biomek 2000/SL robotic system. Incorporation of 33Pi (counting of ""cpm"") was determined with a microplate scintillation counter (Microbeta, Wallac)."	B	Nc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1c(Cl)cc(Cl)cc1Cl		CHEMBL2011291	=	IC50	nM	270.0	CHEMBL267	Homo sapiens	IC50	nM	270.0
421715	17784774	CHEMBL3888876	"Kinase Assay: FlashPlates from Perkin Elmer (Boston, Mass., USA) with a 50 μl reaction volume are used. The reaction cocktail was pipetted in 4 steps in the following order: 15 μl of ATP solution (in H2O), 20 μl of assay buffer (see below), 5 μl of test sample in 10% DMSO, 10 μl of enzyme/substrate mixture (in H2O). The assay for all enzymes contained 60 mM HEPES-NaOH, pH 7.5, 3 mM MgCl2, 3 mM MnCl2, 3 μM Na-orthovanadate, 1.2 mM DTT, 50 μg/ml PEG20000, 1 μM [γ-33P]-ATP (approx. 8×10^5 cpm per well), protein kinase (variable amounts; see Table 1), and substrate (variable amounts). Certain assays also contained 1 mM CaCl2, 4 mM EDTA, 5 μg/ml Phosphatidylserine and 1 μg/ml 1.2-Dioleyl-glycerol. The MYLK2, CAMK1D, CAMK2A, CAMK2B, CAMK2D, CAMK4, CAMKK2, DAPK2 and EEF2K assays additionally contained 1 μg/ml Calmodulin and 0.5 mM CaCl2. The PRKG1 and PRKG2 assays additionally contained 1 μM cGMP. Recombinant Protein Kinases: All protein kinases were expressed in Sf9 insect cells or in E. coli as recombinant GST-fusion proteins or His-tagged proteins. All kinases were produced from human cDNAs, except JAK2, for which the mouse cDNA was used. Kinases were purified by affinity chromatography using either GSH-agarose (Sigma) or Ni-NTH-agarose (Qiagen). The purity of the protein kinases was examined by SDS-PAGE/coomassie staining. The identity of the protein kinases was checked by mass spectroscopy. Assays were made under license from Chemicon International Inc. for JAK2. The reaction cocktails were incubated at 30° C. for 80 minutes. The reaction was stopped with 50 μl of 2% (v/v) H3PO4, plates were aspirated and washed two times with 200 μl 0.9% (w/v) NaCl. All assays were performed with a BeckmanCoulter Biomek 2000/SL robotic system. Incorporation of 33Pi (counting of ""cpm"") was determined with a microplate scintillation counter (Microbeta, Wallac)."	B	Nc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccccc1		CHEMBL2011292	=	IC50	nM	52000.0	CHEMBL267	Homo sapiens	IC50	nM	52000.0
421716	17784775	CHEMBL3888876	"Kinase Assay: FlashPlates from Perkin Elmer (Boston, Mass., USA) with a 50 μl reaction volume are used. The reaction cocktail was pipetted in 4 steps in the following order: 15 μl of ATP solution (in H2O), 20 μl of assay buffer (see below), 5 μl of test sample in 10% DMSO, 10 μl of enzyme/substrate mixture (in H2O). The assay for all enzymes contained 60 mM HEPES-NaOH, pH 7.5, 3 mM MgCl2, 3 mM MnCl2, 3 μM Na-orthovanadate, 1.2 mM DTT, 50 μg/ml PEG20000, 1 μM [γ-33P]-ATP (approx. 8×10^5 cpm per well), protein kinase (variable amounts; see Table 1), and substrate (variable amounts). Certain assays also contained 1 mM CaCl2, 4 mM EDTA, 5 μg/ml Phosphatidylserine and 1 μg/ml 1.2-Dioleyl-glycerol. The MYLK2, CAMK1D, CAMK2A, CAMK2B, CAMK2D, CAMK4, CAMKK2, DAPK2 and EEF2K assays additionally contained 1 μg/ml Calmodulin and 0.5 mM CaCl2. The PRKG1 and PRKG2 assays additionally contained 1 μM cGMP. Recombinant Protein Kinases: All protein kinases were expressed in Sf9 insect cells or in E. coli as recombinant GST-fusion proteins or His-tagged proteins. All kinases were produced from human cDNAs, except JAK2, for which the mouse cDNA was used. Kinases were purified by affinity chromatography using either GSH-agarose (Sigma) or Ni-NTH-agarose (Qiagen). The purity of the protein kinases was examined by SDS-PAGE/coomassie staining. The identity of the protein kinases was checked by mass spectroscopy. Assays were made under license from Chemicon International Inc. for JAK2. The reaction cocktails were incubated at 30° C. for 80 minutes. The reaction was stopped with 50 μl of 2% (v/v) H3PO4, plates were aspirated and washed two times with 200 μl 0.9% (w/v) NaCl. All assays were performed with a BeckmanCoulter Biomek 2000/SL robotic system. Incorporation of 33Pi (counting of ""cpm"") was determined with a microplate scintillation counter (Microbeta, Wallac)."	B	Nc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL2011293	=	IC50	nM	23000.0	CHEMBL267	Homo sapiens	IC50	nM	23000.0
421717	17784776	CHEMBL3888876	"Kinase Assay: FlashPlates from Perkin Elmer (Boston, Mass., USA) with a 50 μl reaction volume are used. The reaction cocktail was pipetted in 4 steps in the following order: 15 μl of ATP solution (in H2O), 20 μl of assay buffer (see below), 5 μl of test sample in 10% DMSO, 10 μl of enzyme/substrate mixture (in H2O). The assay for all enzymes contained 60 mM HEPES-NaOH, pH 7.5, 3 mM MgCl2, 3 mM MnCl2, 3 μM Na-orthovanadate, 1.2 mM DTT, 50 μg/ml PEG20000, 1 μM [γ-33P]-ATP (approx. 8×10^5 cpm per well), protein kinase (variable amounts; see Table 1), and substrate (variable amounts). Certain assays also contained 1 mM CaCl2, 4 mM EDTA, 5 μg/ml Phosphatidylserine and 1 μg/ml 1.2-Dioleyl-glycerol. The MYLK2, CAMK1D, CAMK2A, CAMK2B, CAMK2D, CAMK4, CAMKK2, DAPK2 and EEF2K assays additionally contained 1 μg/ml Calmodulin and 0.5 mM CaCl2. The PRKG1 and PRKG2 assays additionally contained 1 μM cGMP. Recombinant Protein Kinases: All protein kinases were expressed in Sf9 insect cells or in E. coli as recombinant GST-fusion proteins or His-tagged proteins. All kinases were produced from human cDNAs, except JAK2, for which the mouse cDNA was used. Kinases were purified by affinity chromatography using either GSH-agarose (Sigma) or Ni-NTH-agarose (Qiagen). The purity of the protein kinases was examined by SDS-PAGE/coomassie staining. The identity of the protein kinases was checked by mass spectroscopy. Assays were made under license from Chemicon International Inc. for JAK2. The reaction cocktails were incubated at 30° C. for 80 minutes. The reaction was stopped with 50 μl of 2% (v/v) H3PO4, plates were aspirated and washed two times with 200 μl 0.9% (w/v) NaCl. All assays were performed with a BeckmanCoulter Biomek 2000/SL robotic system. Incorporation of 33Pi (counting of ""cpm"") was determined with a microplate scintillation counter (Microbeta, Wallac)."	B	COc1ccc(-n2nc(-c3ccncc3)c(-c3ccc(F)cc3)c2N)cc1		CHEMBL2011294	=	IC50	nM	23000.0	CHEMBL267	Homo sapiens	IC50	nM	23000.0
421718	17784777	CHEMBL3888876	"Kinase Assay: FlashPlates from Perkin Elmer (Boston, Mass., USA) with a 50 μl reaction volume are used. The reaction cocktail was pipetted in 4 steps in the following order: 15 μl of ATP solution (in H2O), 20 μl of assay buffer (see below), 5 μl of test sample in 10% DMSO, 10 μl of enzyme/substrate mixture (in H2O). The assay for all enzymes contained 60 mM HEPES-NaOH, pH 7.5, 3 mM MgCl2, 3 mM MnCl2, 3 μM Na-orthovanadate, 1.2 mM DTT, 50 μg/ml PEG20000, 1 μM [γ-33P]-ATP (approx. 8×10^5 cpm per well), protein kinase (variable amounts; see Table 1), and substrate (variable amounts). Certain assays also contained 1 mM CaCl2, 4 mM EDTA, 5 μg/ml Phosphatidylserine and 1 μg/ml 1.2-Dioleyl-glycerol. The MYLK2, CAMK1D, CAMK2A, CAMK2B, CAMK2D, CAMK4, CAMKK2, DAPK2 and EEF2K assays additionally contained 1 μg/ml Calmodulin and 0.5 mM CaCl2. The PRKG1 and PRKG2 assays additionally contained 1 μM cGMP. Recombinant Protein Kinases: All protein kinases were expressed in Sf9 insect cells or in E. coli as recombinant GST-fusion proteins or His-tagged proteins. All kinases were produced from human cDNAs, except JAK2, for which the mouse cDNA was used. Kinases were purified by affinity chromatography using either GSH-agarose (Sigma) or Ni-NTH-agarose (Qiagen). The purity of the protein kinases was examined by SDS-PAGE/coomassie staining. The identity of the protein kinases was checked by mass spectroscopy. Assays were made under license from Chemicon International Inc. for JAK2. The reaction cocktails were incubated at 30° C. for 80 minutes. The reaction was stopped with 50 μl of 2% (v/v) H3PO4, plates were aspirated and washed two times with 200 μl 0.9% (w/v) NaCl. All assays were performed with a BeckmanCoulter Biomek 2000/SL robotic system. Incorporation of 33Pi (counting of ""cpm"") was determined with a microplate scintillation counter (Microbeta, Wallac)."	B	Nc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc([N+](=O)[O-])cc1		CHEMBL2011295	=	IC50	nM	82000.0	CHEMBL267	Homo sapiens	IC50	nM	82000.0
421719	17784778	CHEMBL3888876	"Kinase Assay: FlashPlates from Perkin Elmer (Boston, Mass., USA) with a 50 μl reaction volume are used. The reaction cocktail was pipetted in 4 steps in the following order: 15 μl of ATP solution (in H2O), 20 μl of assay buffer (see below), 5 μl of test sample in 10% DMSO, 10 μl of enzyme/substrate mixture (in H2O). The assay for all enzymes contained 60 mM HEPES-NaOH, pH 7.5, 3 mM MgCl2, 3 mM MnCl2, 3 μM Na-orthovanadate, 1.2 mM DTT, 50 μg/ml PEG20000, 1 μM [γ-33P]-ATP (approx. 8×10^5 cpm per well), protein kinase (variable amounts; see Table 1), and substrate (variable amounts). Certain assays also contained 1 mM CaCl2, 4 mM EDTA, 5 μg/ml Phosphatidylserine and 1 μg/ml 1.2-Dioleyl-glycerol. The MYLK2, CAMK1D, CAMK2A, CAMK2B, CAMK2D, CAMK4, CAMKK2, DAPK2 and EEF2K assays additionally contained 1 μg/ml Calmodulin and 0.5 mM CaCl2. The PRKG1 and PRKG2 assays additionally contained 1 μM cGMP. Recombinant Protein Kinases: All protein kinases were expressed in Sf9 insect cells or in E. coli as recombinant GST-fusion proteins or His-tagged proteins. All kinases were produced from human cDNAs, except JAK2, for which the mouse cDNA was used. Kinases were purified by affinity chromatography using either GSH-agarose (Sigma) or Ni-NTH-agarose (Qiagen). The purity of the protein kinases was examined by SDS-PAGE/coomassie staining. The identity of the protein kinases was checked by mass spectroscopy. Assays were made under license from Chemicon International Inc. for JAK2. The reaction cocktails were incubated at 30° C. for 80 minutes. The reaction was stopped with 50 μl of 2% (v/v) H3PO4, plates were aspirated and washed two times with 200 μl 0.9% (w/v) NaCl. All assays were performed with a BeckmanCoulter Biomek 2000/SL robotic system. Incorporation of 33Pi (counting of ""cpm"") was determined with a microplate scintillation counter (Microbeta, Wallac)."	B	Cc1ccc(-n2nc(-c3ccncc3)c(-c3ccc(F)cc3)c2N)cc1		CHEMBL2011296	=	IC50	nM	53000.0	CHEMBL267	Homo sapiens	IC50	nM	53000.0
421720	17784779	CHEMBL3888876	"Kinase Assay: FlashPlates from Perkin Elmer (Boston, Mass., USA) with a 50 μl reaction volume are used. The reaction cocktail was pipetted in 4 steps in the following order: 15 μl of ATP solution (in H2O), 20 μl of assay buffer (see below), 5 μl of test sample in 10% DMSO, 10 μl of enzyme/substrate mixture (in H2O). The assay for all enzymes contained 60 mM HEPES-NaOH, pH 7.5, 3 mM MgCl2, 3 mM MnCl2, 3 μM Na-orthovanadate, 1.2 mM DTT, 50 μg/ml PEG20000, 1 μM [γ-33P]-ATP (approx. 8×10^5 cpm per well), protein kinase (variable amounts; see Table 1), and substrate (variable amounts). Certain assays also contained 1 mM CaCl2, 4 mM EDTA, 5 μg/ml Phosphatidylserine and 1 μg/ml 1.2-Dioleyl-glycerol. The MYLK2, CAMK1D, CAMK2A, CAMK2B, CAMK2D, CAMK4, CAMKK2, DAPK2 and EEF2K assays additionally contained 1 μg/ml Calmodulin and 0.5 mM CaCl2. The PRKG1 and PRKG2 assays additionally contained 1 μM cGMP. Recombinant Protein Kinases: All protein kinases were expressed in Sf9 insect cells or in E. coli as recombinant GST-fusion proteins or His-tagged proteins. All kinases were produced from human cDNAs, except JAK2, for which the mouse cDNA was used. Kinases were purified by affinity chromatography using either GSH-agarose (Sigma) or Ni-NTH-agarose (Qiagen). The purity of the protein kinases was examined by SDS-PAGE/coomassie staining. The identity of the protein kinases was checked by mass spectroscopy. Assays were made under license from Chemicon International Inc. for JAK2. The reaction cocktails were incubated at 30° C. for 80 minutes. The reaction was stopped with 50 μl of 2% (v/v) H3PO4, plates were aspirated and washed two times with 200 μl 0.9% (w/v) NaCl. All assays were performed with a BeckmanCoulter Biomek 2000/SL robotic system. Incorporation of 33Pi (counting of ""cpm"") was determined with a microplate scintillation counter (Microbeta, Wallac)."	B	N#Cc1ccc(-n2nc(-c3ccncc3)c(-c3ccc(F)cc3)c2N)cc1		CHEMBL2011297	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	nM	100000.0
421721	17784780	CHEMBL3888876	"Kinase Assay: FlashPlates from Perkin Elmer (Boston, Mass., USA) with a 50 μl reaction volume are used. The reaction cocktail was pipetted in 4 steps in the following order: 15 μl of ATP solution (in H2O), 20 μl of assay buffer (see below), 5 μl of test sample in 10% DMSO, 10 μl of enzyme/substrate mixture (in H2O). The assay for all enzymes contained 60 mM HEPES-NaOH, pH 7.5, 3 mM MgCl2, 3 mM MnCl2, 3 μM Na-orthovanadate, 1.2 mM DTT, 50 μg/ml PEG20000, 1 μM [γ-33P]-ATP (approx. 8×10^5 cpm per well), protein kinase (variable amounts; see Table 1), and substrate (variable amounts). Certain assays also contained 1 mM CaCl2, 4 mM EDTA, 5 μg/ml Phosphatidylserine and 1 μg/ml 1.2-Dioleyl-glycerol. The MYLK2, CAMK1D, CAMK2A, CAMK2B, CAMK2D, CAMK4, CAMKK2, DAPK2 and EEF2K assays additionally contained 1 μg/ml Calmodulin and 0.5 mM CaCl2. The PRKG1 and PRKG2 assays additionally contained 1 μM cGMP. Recombinant Protein Kinases: All protein kinases were expressed in Sf9 insect cells or in E. coli as recombinant GST-fusion proteins or His-tagged proteins. All kinases were produced from human cDNAs, except JAK2, for which the mouse cDNA was used. Kinases were purified by affinity chromatography using either GSH-agarose (Sigma) or Ni-NTH-agarose (Qiagen). The purity of the protein kinases was examined by SDS-PAGE/coomassie staining. The identity of the protein kinases was checked by mass spectroscopy. Assays were made under license from Chemicon International Inc. for JAK2. The reaction cocktails were incubated at 30° C. for 80 minutes. The reaction was stopped with 50 μl of 2% (v/v) H3PO4, plates were aspirated and washed two times with 200 μl 0.9% (w/v) NaCl. All assays were performed with a BeckmanCoulter Biomek 2000/SL robotic system. Incorporation of 33Pi (counting of ""cpm"") was determined with a microplate scintillation counter (Microbeta, Wallac)."	B	Nc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(C(F)(F)F)cc1		CHEMBL2011298	=	IC50	nM	6700.0	CHEMBL267	Homo sapiens	IC50	nM	6700.0
421722	17784781	CHEMBL3888876	"Kinase Assay: FlashPlates from Perkin Elmer (Boston, Mass., USA) with a 50 μl reaction volume are used. The reaction cocktail was pipetted in 4 steps in the following order: 15 μl of ATP solution (in H2O), 20 μl of assay buffer (see below), 5 μl of test sample in 10% DMSO, 10 μl of enzyme/substrate mixture (in H2O). The assay for all enzymes contained 60 mM HEPES-NaOH, pH 7.5, 3 mM MgCl2, 3 mM MnCl2, 3 μM Na-orthovanadate, 1.2 mM DTT, 50 μg/ml PEG20000, 1 μM [γ-33P]-ATP (approx. 8×10^5 cpm per well), protein kinase (variable amounts; see Table 1), and substrate (variable amounts). Certain assays also contained 1 mM CaCl2, 4 mM EDTA, 5 μg/ml Phosphatidylserine and 1 μg/ml 1.2-Dioleyl-glycerol. The MYLK2, CAMK1D, CAMK2A, CAMK2B, CAMK2D, CAMK4, CAMKK2, DAPK2 and EEF2K assays additionally contained 1 μg/ml Calmodulin and 0.5 mM CaCl2. The PRKG1 and PRKG2 assays additionally contained 1 μM cGMP. Recombinant Protein Kinases: All protein kinases were expressed in Sf9 insect cells or in E. coli as recombinant GST-fusion proteins or His-tagged proteins. All kinases were produced from human cDNAs, except JAK2, for which the mouse cDNA was used. Kinases were purified by affinity chromatography using either GSH-agarose (Sigma) or Ni-NTH-agarose (Qiagen). The purity of the protein kinases was examined by SDS-PAGE/coomassie staining. The identity of the protein kinases was checked by mass spectroscopy. Assays were made under license from Chemicon International Inc. for JAK2. The reaction cocktails were incubated at 30° C. for 80 minutes. The reaction was stopped with 50 μl of 2% (v/v) H3PO4, plates were aspirated and washed two times with 200 μl 0.9% (w/v) NaCl. All assays were performed with a BeckmanCoulter Biomek 2000/SL robotic system. Incorporation of 33Pi (counting of ""cpm"") was determined with a microplate scintillation counter (Microbeta, Wallac)."	B	NC(=O)c1c(-c2ccncc2)nn(-c2c(Cl)cc(Cl)cc2Cl)c1N		CHEMBL2011299	=	IC50	nM	6400.0	CHEMBL267	Homo sapiens	IC50	nM	6400.0
421723	17784782	CHEMBL3888876	"Kinase Assay: FlashPlates from Perkin Elmer (Boston, Mass., USA) with a 50 μl reaction volume are used. The reaction cocktail was pipetted in 4 steps in the following order: 15 μl of ATP solution (in H2O), 20 μl of assay buffer (see below), 5 μl of test sample in 10% DMSO, 10 μl of enzyme/substrate mixture (in H2O). The assay for all enzymes contained 60 mM HEPES-NaOH, pH 7.5, 3 mM MgCl2, 3 mM MnCl2, 3 μM Na-orthovanadate, 1.2 mM DTT, 50 μg/ml PEG20000, 1 μM [γ-33P]-ATP (approx. 8×10^5 cpm per well), protein kinase (variable amounts; see Table 1), and substrate (variable amounts). Certain assays also contained 1 mM CaCl2, 4 mM EDTA, 5 μg/ml Phosphatidylserine and 1 μg/ml 1.2-Dioleyl-glycerol. The MYLK2, CAMK1D, CAMK2A, CAMK2B, CAMK2D, CAMK4, CAMKK2, DAPK2 and EEF2K assays additionally contained 1 μg/ml Calmodulin and 0.5 mM CaCl2. The PRKG1 and PRKG2 assays additionally contained 1 μM cGMP. Recombinant Protein Kinases: All protein kinases were expressed in Sf9 insect cells or in E. coli as recombinant GST-fusion proteins or His-tagged proteins. All kinases were produced from human cDNAs, except JAK2, for which the mouse cDNA was used. Kinases were purified by affinity chromatography using either GSH-agarose (Sigma) or Ni-NTH-agarose (Qiagen). The purity of the protein kinases was examined by SDS-PAGE/coomassie staining. The identity of the protein kinases was checked by mass spectroscopy. Assays were made under license from Chemicon International Inc. for JAK2. The reaction cocktails were incubated at 30° C. for 80 minutes. The reaction was stopped with 50 μl of 2% (v/v) H3PO4, plates were aspirated and washed two times with 200 μl 0.9% (w/v) NaCl. All assays were performed with a BeckmanCoulter Biomek 2000/SL robotic system. Incorporation of 33Pi (counting of ""cpm"") was determined with a microplate scintillation counter (Microbeta, Wallac)."	B	CCOC(=O)c1c(-c2ccncc2)nn(-c2c(Cl)cc(Cl)cc2Cl)c1N		CHEMBL2011300	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	nM	100000.0
421724	17784783	CHEMBL3888876	"Kinase Assay: FlashPlates from Perkin Elmer (Boston, Mass., USA) with a 50 μl reaction volume are used. The reaction cocktail was pipetted in 4 steps in the following order: 15 μl of ATP solution (in H2O), 20 μl of assay buffer (see below), 5 μl of test sample in 10% DMSO, 10 μl of enzyme/substrate mixture (in H2O). The assay for all enzymes contained 60 mM HEPES-NaOH, pH 7.5, 3 mM MgCl2, 3 mM MnCl2, 3 μM Na-orthovanadate, 1.2 mM DTT, 50 μg/ml PEG20000, 1 μM [γ-33P]-ATP (approx. 8×10^5 cpm per well), protein kinase (variable amounts; see Table 1), and substrate (variable amounts). Certain assays also contained 1 mM CaCl2, 4 mM EDTA, 5 μg/ml Phosphatidylserine and 1 μg/ml 1.2-Dioleyl-glycerol. The MYLK2, CAMK1D, CAMK2A, CAMK2B, CAMK2D, CAMK4, CAMKK2, DAPK2 and EEF2K assays additionally contained 1 μg/ml Calmodulin and 0.5 mM CaCl2. The PRKG1 and PRKG2 assays additionally contained 1 μM cGMP. Recombinant Protein Kinases: All protein kinases were expressed in Sf9 insect cells or in E. coli as recombinant GST-fusion proteins or His-tagged proteins. All kinases were produced from human cDNAs, except JAK2, for which the mouse cDNA was used. Kinases were purified by affinity chromatography using either GSH-agarose (Sigma) or Ni-NTH-agarose (Qiagen). The purity of the protein kinases was examined by SDS-PAGE/coomassie staining. The identity of the protein kinases was checked by mass spectroscopy. Assays were made under license from Chemicon International Inc. for JAK2. The reaction cocktails were incubated at 30° C. for 80 minutes. The reaction was stopped with 50 μl of 2% (v/v) H3PO4, plates were aspirated and washed two times with 200 μl 0.9% (w/v) NaCl. All assays were performed with a BeckmanCoulter Biomek 2000/SL robotic system. Incorporation of 33Pi (counting of ""cpm"") was determined with a microplate scintillation counter (Microbeta, Wallac)."	B	NC(=O)c1c(-c2ccncc2)nn(-c2ccccc2)c1N		CHEMBL2011301	=	IC50	nM	19000.0	CHEMBL267	Homo sapiens	IC50	nM	19000.0
421725	17784784	CHEMBL3888876	"Kinase Assay: FlashPlates from Perkin Elmer (Boston, Mass., USA) with a 50 μl reaction volume are used. The reaction cocktail was pipetted in 4 steps in the following order: 15 μl of ATP solution (in H2O), 20 μl of assay buffer (see below), 5 μl of test sample in 10% DMSO, 10 μl of enzyme/substrate mixture (in H2O). The assay for all enzymes contained 60 mM HEPES-NaOH, pH 7.5, 3 mM MgCl2, 3 mM MnCl2, 3 μM Na-orthovanadate, 1.2 mM DTT, 50 μg/ml PEG20000, 1 μM [γ-33P]-ATP (approx. 8×10^5 cpm per well), protein kinase (variable amounts; see Table 1), and substrate (variable amounts). Certain assays also contained 1 mM CaCl2, 4 mM EDTA, 5 μg/ml Phosphatidylserine and 1 μg/ml 1.2-Dioleyl-glycerol. The MYLK2, CAMK1D, CAMK2A, CAMK2B, CAMK2D, CAMK4, CAMKK2, DAPK2 and EEF2K assays additionally contained 1 μg/ml Calmodulin and 0.5 mM CaCl2. The PRKG1 and PRKG2 assays additionally contained 1 μM cGMP. Recombinant Protein Kinases: All protein kinases were expressed in Sf9 insect cells or in E. coli as recombinant GST-fusion proteins or His-tagged proteins. All kinases were produced from human cDNAs, except JAK2, for which the mouse cDNA was used. Kinases were purified by affinity chromatography using either GSH-agarose (Sigma) or Ni-NTH-agarose (Qiagen). The purity of the protein kinases was examined by SDS-PAGE/coomassie staining. The identity of the protein kinases was checked by mass spectroscopy. Assays were made under license from Chemicon International Inc. for JAK2. The reaction cocktails were incubated at 30° C. for 80 minutes. The reaction was stopped with 50 μl of 2% (v/v) H3PO4, plates were aspirated and washed two times with 200 μl 0.9% (w/v) NaCl. All assays were performed with a BeckmanCoulter Biomek 2000/SL robotic system. Incorporation of 33Pi (counting of ""cpm"") was determined with a microplate scintillation counter (Microbeta, Wallac)."	B	Nc1c(C(=O)O)c(-c2ccncc2)nn1-c1c(Cl)cc(Cl)cc1Cl		CHEMBL2011302	=	IC50	nM	55000.0	CHEMBL267	Homo sapiens	IC50	nM	55000.0
421726	17784785	CHEMBL3888876	"Kinase Assay: FlashPlates from Perkin Elmer (Boston, Mass., USA) with a 50 μl reaction volume are used. The reaction cocktail was pipetted in 4 steps in the following order: 15 μl of ATP solution (in H2O), 20 μl of assay buffer (see below), 5 μl of test sample in 10% DMSO, 10 μl of enzyme/substrate mixture (in H2O). The assay for all enzymes contained 60 mM HEPES-NaOH, pH 7.5, 3 mM MgCl2, 3 mM MnCl2, 3 μM Na-orthovanadate, 1.2 mM DTT, 50 μg/ml PEG20000, 1 μM [γ-33P]-ATP (approx. 8×10^5 cpm per well), protein kinase (variable amounts; see Table 1), and substrate (variable amounts). Certain assays also contained 1 mM CaCl2, 4 mM EDTA, 5 μg/ml Phosphatidylserine and 1 μg/ml 1.2-Dioleyl-glycerol. The MYLK2, CAMK1D, CAMK2A, CAMK2B, CAMK2D, CAMK4, CAMKK2, DAPK2 and EEF2K assays additionally contained 1 μg/ml Calmodulin and 0.5 mM CaCl2. The PRKG1 and PRKG2 assays additionally contained 1 μM cGMP. Recombinant Protein Kinases: All protein kinases were expressed in Sf9 insect cells or in E. coli as recombinant GST-fusion proteins or His-tagged proteins. All kinases were produced from human cDNAs, except JAK2, for which the mouse cDNA was used. Kinases were purified by affinity chromatography using either GSH-agarose (Sigma) or Ni-NTH-agarose (Qiagen). The purity of the protein kinases was examined by SDS-PAGE/coomassie staining. The identity of the protein kinases was checked by mass spectroscopy. Assays were made under license from Chemicon International Inc. for JAK2. The reaction cocktails were incubated at 30° C. for 80 minutes. The reaction was stopped with 50 μl of 2% (v/v) H3PO4, plates were aspirated and washed two times with 200 μl 0.9% (w/v) NaCl. All assays were performed with a BeckmanCoulter Biomek 2000/SL robotic system. Incorporation of 33Pi (counting of ""cpm"") was determined with a microplate scintillation counter (Microbeta, Wallac)."	B	Nc1cc(-c2ccncc2)nn1-c1c(Cl)cc(Cl)cc1Cl		CHEMBL2011303	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	nM	100000.0
421727	17784786	CHEMBL3888876	"Kinase Assay: FlashPlates from Perkin Elmer (Boston, Mass., USA) with a 50 μl reaction volume are used. The reaction cocktail was pipetted in 4 steps in the following order: 15 μl of ATP solution (in H2O), 20 μl of assay buffer (see below), 5 μl of test sample in 10% DMSO, 10 μl of enzyme/substrate mixture (in H2O). The assay for all enzymes contained 60 mM HEPES-NaOH, pH 7.5, 3 mM MgCl2, 3 mM MnCl2, 3 μM Na-orthovanadate, 1.2 mM DTT, 50 μg/ml PEG20000, 1 μM [γ-33P]-ATP (approx. 8×10^5 cpm per well), protein kinase (variable amounts; see Table 1), and substrate (variable amounts). Certain assays also contained 1 mM CaCl2, 4 mM EDTA, 5 μg/ml Phosphatidylserine and 1 μg/ml 1.2-Dioleyl-glycerol. The MYLK2, CAMK1D, CAMK2A, CAMK2B, CAMK2D, CAMK4, CAMKK2, DAPK2 and EEF2K assays additionally contained 1 μg/ml Calmodulin and 0.5 mM CaCl2. The PRKG1 and PRKG2 assays additionally contained 1 μM cGMP. Recombinant Protein Kinases: All protein kinases were expressed in Sf9 insect cells or in E. coli as recombinant GST-fusion proteins or His-tagged proteins. All kinases were produced from human cDNAs, except JAK2, for which the mouse cDNA was used. Kinases were purified by affinity chromatography using either GSH-agarose (Sigma) or Ni-NTH-agarose (Qiagen). The purity of the protein kinases was examined by SDS-PAGE/coomassie staining. The identity of the protein kinases was checked by mass spectroscopy. Assays were made under license from Chemicon International Inc. for JAK2. The reaction cocktails were incubated at 30° C. for 80 minutes. The reaction was stopped with 50 μl of 2% (v/v) H3PO4, plates were aspirated and washed two times with 200 μl 0.9% (w/v) NaCl. All assays were performed with a BeckmanCoulter Biomek 2000/SL robotic system. Incorporation of 33Pi (counting of ""cpm"") was determined with a microplate scintillation counter (Microbeta, Wallac)."	B	Clc1cc(Cl)c(N/N=C/c2ccncc2)c(Cl)c1		CHEMBL3958081	=	IC50	nM	2000.0	CHEMBL267	Homo sapiens	IC50	nM	2000.0
421728	17784787	CHEMBL3888876	"Kinase Assay: FlashPlates from Perkin Elmer (Boston, Mass., USA) with a 50 μl reaction volume are used. The reaction cocktail was pipetted in 4 steps in the following order: 15 μl of ATP solution (in H2O), 20 μl of assay buffer (see below), 5 μl of test sample in 10% DMSO, 10 μl of enzyme/substrate mixture (in H2O). The assay for all enzymes contained 60 mM HEPES-NaOH, pH 7.5, 3 mM MgCl2, 3 mM MnCl2, 3 μM Na-orthovanadate, 1.2 mM DTT, 50 μg/ml PEG20000, 1 μM [γ-33P]-ATP (approx. 8×10^5 cpm per well), protein kinase (variable amounts; see Table 1), and substrate (variable amounts). Certain assays also contained 1 mM CaCl2, 4 mM EDTA, 5 μg/ml Phosphatidylserine and 1 μg/ml 1.2-Dioleyl-glycerol. The MYLK2, CAMK1D, CAMK2A, CAMK2B, CAMK2D, CAMK4, CAMKK2, DAPK2 and EEF2K assays additionally contained 1 μg/ml Calmodulin and 0.5 mM CaCl2. The PRKG1 and PRKG2 assays additionally contained 1 μM cGMP. Recombinant Protein Kinases: All protein kinases were expressed in Sf9 insect cells or in E. coli as recombinant GST-fusion proteins or His-tagged proteins. All kinases were produced from human cDNAs, except JAK2, for which the mouse cDNA was used. Kinases were purified by affinity chromatography using either GSH-agarose (Sigma) or Ni-NTH-agarose (Qiagen). The purity of the protein kinases was examined by SDS-PAGE/coomassie staining. The identity of the protein kinases was checked by mass spectroscopy. Assays were made under license from Chemicon International Inc. for JAK2. The reaction cocktails were incubated at 30° C. for 80 minutes. The reaction was stopped with 50 μl of 2% (v/v) H3PO4, plates were aspirated and washed two times with 200 μl 0.9% (w/v) NaCl. All assays were performed with a BeckmanCoulter Biomek 2000/SL robotic system. Incorporation of 33Pi (counting of ""cpm"") was determined with a microplate scintillation counter (Microbeta, Wallac)."	B	Fc1ccc(-c2cn(-c3ccc(C(F)(F)F)cc3)nc2-c2ccncc2)cc1		CHEMBL2011305	=	IC50	nM	12000.0	CHEMBL267	Homo sapiens	IC50	nM	12000.0
421745	17784804	CHEMBL3888876	"Kinase Assay: FlashPlates from Perkin Elmer (Boston, Mass., USA) with a 50 μl reaction volume are used. The reaction cocktail was pipetted in 4 steps in the following order: 15 μl of ATP solution (in H2O), 20 μl of assay buffer (see below), 5 μl of test sample in 10% DMSO, 10 μl of enzyme/substrate mixture (in H2O). The assay for all enzymes contained 60 mM HEPES-NaOH, pH 7.5, 3 mM MgCl2, 3 mM MnCl2, 3 μM Na-orthovanadate, 1.2 mM DTT, 50 μg/ml PEG20000, 1 μM [γ-33P]-ATP (approx. 8×10^5 cpm per well), protein kinase (variable amounts; see Table 1), and substrate (variable amounts). Certain assays also contained 1 mM CaCl2, 4 mM EDTA, 5 μg/ml Phosphatidylserine and 1 μg/ml 1.2-Dioleyl-glycerol. The MYLK2, CAMK1D, CAMK2A, CAMK2B, CAMK2D, CAMK4, CAMKK2, DAPK2 and EEF2K assays additionally contained 1 μg/ml Calmodulin and 0.5 mM CaCl2. The PRKG1 and PRKG2 assays additionally contained 1 μM cGMP. Recombinant Protein Kinases: All protein kinases were expressed in Sf9 insect cells or in E. coli as recombinant GST-fusion proteins or His-tagged proteins. All kinases were produced from human cDNAs, except JAK2, for which the mouse cDNA was used. Kinases were purified by affinity chromatography using either GSH-agarose (Sigma) or Ni-NTH-agarose (Qiagen). The purity of the protein kinases was examined by SDS-PAGE/coomassie staining. The identity of the protein kinases was checked by mass spectroscopy. Assays were made under license from Chemicon International Inc. for JAK2. The reaction cocktails were incubated at 30° C. for 80 minutes. The reaction was stopped with 50 μl of 2% (v/v) H3PO4, plates were aspirated and washed two times with 200 μl 0.9% (w/v) NaCl. All assays were performed with a BeckmanCoulter Biomek 2000/SL robotic system. Incorporation of 33Pi (counting of ""cpm"") was determined with a microplate scintillation counter (Microbeta, Wallac)."	B	Nc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1c(Cl)cc(Cl)cc1Cl		CHEMBL2011291	=	IC50	nM	400.0	CHEMBL267	Homo sapiens	IC50	nM	400.0
445406	17805114	CHEMBL3889289	Enzyme Inhibition Assay: The inhibitory activities of the compound of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described hereinabove. The relevant enzyme (3000 ng/mL or 2000 ng/mL respectively, 2.5 μL) is incubated with the test compound (either 1 μg/mL, 0.1 μg/mL, 0.01 μg/mL, or 0.001 μg/mL, 2.5 μL each) for 2 hr at RT. The FRET peptides (8 μM, 2.5 μL), and appropriate ATP solutions (2.5 μL, 800 μM for c-Src, and 60 μM ATP for Syk) are then added to the enzymes/compound mixtures and the mixture incubated for 1 hr. Development reagent (protease, 5 μL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan® Flash, ThermoFisher Scientific).	B	COc1cc(Nc2cc(Oc3ccc(NC(=O)Nc4cc(C(C)(C)C)cc(NS(C)(=O)=O)c4OC)c4ccccc34)ccn2)ccc1C(=O)O		CHEMBL3915286	=	IC50	nM	14.0	CHEMBL267	Homo sapiens	IC50	nM	14.0
Inactive	17940063	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940064	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940065	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940066	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940067	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940068	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940069	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940070	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Active	17940071	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	168.0	CHEMBL267	Homo sapiens	Kd apparent	nM	168.0
Inactive	17940072	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940073	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940074	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940075	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940076	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940077	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940078	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940079	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940080	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940081	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940082	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940083	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940084	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940085	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940086	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940087	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940088	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940089	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940090	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940091	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Active	17940092	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	=	Kd	nM	1405.0	CHEMBL267	Homo sapiens	Kd apparent	nM	1405.0
Inactive	17940093	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940094	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940095	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940096	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940097	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940098	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Active	17940099	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	=	Kd	nM	459.0	CHEMBL267	Homo sapiens	Kd apparent	nM	459.0
Inactive	17940100	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940101	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940102	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940103	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940104	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940105	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940106	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Active	17940107	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	=	Kd	nM	5313.0	CHEMBL267	Homo sapiens	Kd apparent	nM	5313.0
Inactive	17940108	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940109	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940110	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940111	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940112	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940113	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12		CHEMBL3426621	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940114	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940115	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940116	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940117	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940118	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940119	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940120	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940121	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940122	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940123	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Active	17940124	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	=	Kd	nM	53.0	CHEMBL267	Homo sapiens	Kd apparent	nM	53.0
Inactive	17940125	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940126	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940127	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940128	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940129	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940130	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Active	17940131	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	=	Kd	nM	3555.0	CHEMBL267	Homo sapiens	Kd apparent	nM	3555.0
Inactive	17940132	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940133	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940134	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940135	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Active	17940136	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	=	Kd	nM	132.0	CHEMBL267	Homo sapiens	Kd apparent	nM	132.0
Inactive	17940137	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940138	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940139	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940140	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940141	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940142	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940143	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940144	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940145	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940146	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940147	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940148	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940149	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Active	17940150	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	28.0	CHEMBL267	Homo sapiens	Kd apparent	nM	28.0
Inactive	17940151	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940152	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940153	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940154	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940155	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940156	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940157	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940158	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940159	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940160	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940161	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940162	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940163	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940164	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940165	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Active	17940166	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	=	Kd	nM	491.0	CHEMBL267	Homo sapiens	Kd apparent	nM	491.0
Active	17940167	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	=	Kd	nM	92.0	CHEMBL267	Homo sapiens	Kd apparent	nM	92.0
Inactive	17940168	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940169	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940170	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940171	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940172	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940173	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940174	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940175	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940176	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940177	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940178	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940179	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940180	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940181	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940182	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940183	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940184	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940185	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940186	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940187	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940188	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940189	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940190	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940191	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940192	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940193	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940194	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940195	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940196	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Active	17940197	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	=	Kd	nM	1127.0	CHEMBL267	Homo sapiens	Kd apparent	nM	1127.0
Inactive	17940198	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940199	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Active	17940200	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	=	Kd	nM	109.0	CHEMBL267	Homo sapiens	Kd apparent	nM	109.0
Inactive	17940201	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940202	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940203	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940204	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940205	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940206	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940207	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17940208	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	=	Kd	nM	4.0	CHEMBL267	Homo sapiens	Kd apparent	nM	4.0
Inactive	17940209	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940210	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940211	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940212	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940213	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940214	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940215	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940216	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940217	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940218	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940219	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940220	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940221	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940222	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940223	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940224	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940225	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940226	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940227	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940228	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940229	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940230	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940231	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940232	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940233	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940234	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940235	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940236	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Active	17940237	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	=	Kd	nM	2085.0	CHEMBL267	Homo sapiens	Kd apparent	nM	2085.0
Inactive	17940238	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Active	17940239	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	Kd	nM	367.0	CHEMBL267	Homo sapiens	Kd apparent	nM	367.0
Inactive	17940240	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Active	17940241	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	=	Kd	nM	337.0	CHEMBL267	Homo sapiens	Kd apparent	nM	337.0
Inactive	17940242	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940243	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940244	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940245	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940246	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940247	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940248	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940249	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940250	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940251	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940252	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940253	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940254	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940255	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940256	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940257	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940258	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940259	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940260	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940261	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940262	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940263	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940264	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940265	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940266	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940267	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940268	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940269	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940270	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Active	17940271	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	Kd	nM	592.0	CHEMBL267	Homo sapiens	Kd apparent	nM	592.0
Inactive	17940272	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940273	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940274	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940275	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940276	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940277	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940278	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940279	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940280	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940281	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940282	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940283	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940284	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940285	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940286	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Active	17940287	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	=	Kd	nM	1858.0	CHEMBL267	Homo sapiens	Kd apparent	nM	1858.0
Inactive	17940288	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940289	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Active	17940290	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	=	Kd	nM	1153.0	CHEMBL267	Homo sapiens	Kd apparent	nM	1153.0
Inactive	17940291	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Active	17940292	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	3.0	CHEMBL267	Homo sapiens	Kd apparent	nM	3.0
Active	17940293	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	=	Kd	nM	5852.0	CHEMBL267	Homo sapiens	Kd apparent	nM	5852.0
Inactive	17940294	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940295	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940296	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Active	17940297	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	=	Kd	nM	1.0	CHEMBL267	Homo sapiens	Kd apparent	nM	1.0
Active	17940298	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	582.0	CHEMBL267	Homo sapiens	Kd apparent	nM	582.0
Inactive	17940299	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940300	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940301	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940302	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Active	17940303	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	=	Kd	nM	97.0	CHEMBL267	Homo sapiens	Kd apparent	nM	97.0
Inactive	17940304	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940305	CHEMBL3991888	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL267	Homo sapiens	Kd apparent	nM	30000.0
	17956316	CHEMBL3993688	Inhibition of human recombinant full length N-terminal His6-tagged Src expressed in Sf21 cells using KVEKIGEGTYGVVYK as substrate after 10 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CSc1nc(NCc2ccccc2)c2ccn(Cc3ccc(F)cc3)c2n1		CHEMBL4091022	=	Ki	nM	500.0	CHEMBL267	Homo sapiens	Ki	uM	0.5
	17956317	CHEMBL3993688	Inhibition of human recombinant full length N-terminal His6-tagged Src expressed in Sf21 cells using KVEKIGEGTYGVVYK as substrate after 10 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CSc1nc(NCCc2ccccc2)c2ccn(Cc3ccc(F)cc3)c2n1		CHEMBL4063136	=	Ki	nM	800.0	CHEMBL267	Homo sapiens	Ki	uM	0.8
	17956318	CHEMBL3993688	Inhibition of human recombinant full length N-terminal His6-tagged Src expressed in Sf21 cells using KVEKIGEGTYGVVYK as substrate after 10 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CSc1nc(NCCc2ccc(Cl)cc2)c2ccn(Cc3ccc(F)cc3)c2n1		CHEMBL4098763	=	Ki	nM	5000.0	CHEMBL267	Homo sapiens	Ki	uM	5.0
	17956327	CHEMBL3993688	Inhibition of human recombinant full length N-terminal His6-tagged Src expressed in Sf21 cells using KVEKIGEGTYGVVYK as substrate after 10 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CSc1nc(Nc2ccccc2)c2ccn(CC(Cl)c3ccccc3)c2n1		CHEMBL4103914	=	Ki	nM	1500.0	CHEMBL267	Homo sapiens	Ki	uM	1.5
	17956328	CHEMBL3993688	Inhibition of human recombinant full length N-terminal His6-tagged Src expressed in Sf21 cells using KVEKIGEGTYGVVYK as substrate after 10 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CSc1nc(Nc2cccc(Cl)c2)c2ccn(CC(Cl)c3ccccc3)c2n1		CHEMBL4068876	=	Ki	nM	700.0	CHEMBL267	Homo sapiens	Ki	uM	0.7
	17956329	CHEMBL3993688	Inhibition of human recombinant full length N-terminal His6-tagged Src expressed in Sf21 cells using KVEKIGEGTYGVVYK as substrate after 10 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CSc1nc(NCc2ccccc2)c2ccn(CC(Cl)c3ccccc3)c2n1		CHEMBL4096164	=	Ki	nM	6000.0	CHEMBL267	Homo sapiens	Ki	uM	6.0
	17956330	CHEMBL3993688	Inhibition of human recombinant full length N-terminal His6-tagged Src expressed in Sf21 cells using KVEKIGEGTYGVVYK as substrate after 10 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CCCCNc1nc(SC)nc2c1ccn2Cc1ccc(F)cc1		CHEMBL4060213	=	Ki	nM	3000.0	CHEMBL267	Homo sapiens	Ki	uM	3.0
	17956331	CHEMBL3993688	Inhibition of human recombinant full length N-terminal His6-tagged Src expressed in Sf21 cells using KVEKIGEGTYGVVYK as substrate after 10 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CSc1nc(N2CCCC2)c2ccn(Cc3ccc(F)cc3)c2n1		CHEMBL4088440	=	Ki	nM	2000.0	CHEMBL267	Homo sapiens	Ki	uM	2.0
	17956332	CHEMBL3993688	Inhibition of human recombinant full length N-terminal His6-tagged Src expressed in Sf21 cells using KVEKIGEGTYGVVYK as substrate after 10 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CSc1nc(N2CCCCC2)c2ccn(Cc3ccc(F)cc3)c2n1		CHEMBL4073713	=	Ki	nM	2500.0	CHEMBL267	Homo sapiens	Ki	uM	2.5
	17956333	CHEMBL3993688	Inhibition of human recombinant full length N-terminal His6-tagged Src expressed in Sf21 cells using KVEKIGEGTYGVVYK as substrate after 10 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CSc1nc(N2CCOCC2)c2ccn(Cc3ccc(F)cc3)c2n1		CHEMBL4100526	=	Ki	nM	4700.0	CHEMBL267	Homo sapiens	Ki	uM	4.7
	17964952	CHEMBL3995065	Inhibition of human SRC (L240 to L536 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by KINOMEscan assay relative to control	B	CNc1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)on3)c(C)c2)ncn1		CHEMBL4060295	=	Activity	%	80.0	CHEMBL267	Homo sapiens	Activity	%	80.0
	17979273	CHEMBL3998077	Inhibition of recombinant human C-terminal His-tagged SRC cytoplasmic domain expressed in baculovirus expression system at 10 uM by Z'-LYTE assay relative to control	B	CC1=Nc2c(Sc3ccccc3)ncnc2Sc2ccccc21		CHEMBL4061152	=	Inhibition	%	3.0	CHEMBL267	Homo sapiens	INH	%	3.0
	17985358	CHEMBL3999012	Inhibition of full-length recombinant human N-terminal GST-tagged SRC expressed in Escherichia coli assessed as residual activity at 100 uM using KVEKIGEGTYGVVYK-amide as substrate by ADP-Glo bioluminescence assay relative to control relative to control	B	CC(=O)c1cccc(Nc2nc(-c3sc(NC(=O)OC(C)(C)C)nc3C)cs2)c1		CHEMBL4085374	=	Activity	%	32.0	CHEMBL267	Homo sapiens	Activity	%	32.0
	17996272	CHEMBL4001421	Inhibition of human wild type partial length SRC (L240 to L536 residues) expressed in bacterial expression system at 10 uM by KinomeScan method relative to control	B	Cc1nc2nc(Sc3ccccc3)cnc2cc1NC(=O)Nc1ccccc1		CHEMBL4083528	=	Inhibition	%	3.0	CHEMBL267	Homo sapiens	INH	%	3.0
	18002363	CHEMBL4002774	Inhibition of recombinant c-Src (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	CN1CCN(Cc2ccc(NC(=O)c3ccc(Cl)c(C#Cc4cncc(N5CCOCC5)c4)c3)cc2C(F)(F)F)CC1		CHEMBL4091628	=	IC50	nM	10.8	CHEMBL267	Homo sapiens	IC50	nM	10.8
	18002381	CHEMBL4002774	Inhibition of recombinant c-Src (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	IC50	nM	2.5	CHEMBL267	Homo sapiens	IC50	nM	2.5
	18008716	CHEMBL4003793	Inhibition of human Src (1 to 530 residues) using GGEEEEYFELVKKKK as substrate in presence of [gamma-33P]ATP at 1 uM after 40 mins by scintillation counter method	B	CC(C)n1cnc2c(Nc3cccc(Cl)c3)nc(N[C@H]3CCCC[C@@H]3N)nc21		CHEMBL4088144	=	Inhibition	%	22.0	CHEMBL267	Homo sapiens	INH	%	22.0
	18008717	CHEMBL4003793	Inhibition of human Src (1 to 530 residues) using GGEEEEYFELVKKKK as substrate in presence of [gamma-33P]ATP at 1 uM after 40 mins by scintillation counter method	B	CC(C)n1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL4066861	=	Inhibition	%	69.0	CHEMBL267	Homo sapiens	INH	%	69.0
	18008718	CHEMBL4003793	Inhibition of human Src (1 to 530 residues) using GGEEEEYFELVKKKK as substrate in presence of [gamma-33P]ATP at 1 uM after 40 mins by scintillation counter method	B	CC(C)n1cnc2c(Nc3cc(N)cc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL4078898	=	Inhibition	%	78.0	CHEMBL267	Homo sapiens	INH	%	78.0
	18012398	CHEMBL4004218	Inhibition of recombinant full length human N-terminal GST-tagged SRC (1 to 536 residues) expressed in baculovirus expression system	B	COc1cc2ncccc2cc1NC(=O)c1csc2cncnc12		CHEMBL3822972	>	IC50	nM	50000.0	CHEMBL267	Homo sapiens	IC50	uM	50.0
	18031867	CHEMBL4007746	Inhibition of SRC (unknown origin) after 60 mins by TR-FRET assay	B	CC1(C)OCC(=O)Nc2cc(Nc3nc(NCC(F)(F)F)c4occc4n3)ccc21		CHEMBL4069365	=	IC50	nM	156.0	CHEMBL267	Homo sapiens	IC50	uM	0.156
	18053046	CHEMBL4011893	Inhibition of SRC (unknown origin) at 0.1 uM pretreated for 30 mins followed by substrate addition measured after 5 hrs in presence of 1 mM ATP relative to control	B	COC(=O)C1=C(Nc2ccccc2Cl)O/C(=C\c2c[nH]c3ncccc23)C1=O		CHEMBL4089159	=	Inhibition	%	1.7	CHEMBL267	Homo sapiens	INH	%	1.7
Not Determined	18062398	CHEMBL4013503	Inhibition of human wild type full length N-terminal GST/6His-tagged SRC (M1 to L536 residues) expressed in baculovirus infected Sf9 cells using src peptide as substrate after 5 mins in presence of [gamma-32P]ATP by scintillation counting method	B	CN1CCN(CCOC(=O)N(Cc2ccccc2)c2ncnc3c2cnn3CC(Cl)c2ccccc2)CC1		CHEMBL4068211		Ki			CHEMBL267	Homo sapiens	Ki		
	18062399	CHEMBL4013503	Inhibition of human wild type full length N-terminal GST/6His-tagged SRC (M1 to L536 residues) expressed in baculovirus infected Sf9 cells using src peptide as substrate after 5 mins in presence of [gamma-32P]ATP by scintillation counting method	B	CN1CCN(CCOC(=O)N(c2cccc(Br)c2)c2nc(SCCN3CCOCC3)nc3c2cnn3CC(Cl)c2ccccc2)CC1		CHEMBL4087882	>	Ki	nM	100000.0	CHEMBL267	Homo sapiens	Ki	uM	100.0
Not Determined	18062400	CHEMBL4013503	Inhibition of human wild type full length N-terminal GST/6His-tagged SRC (M1 to L536 residues) expressed in baculovirus infected Sf9 cells using src peptide as substrate after 5 mins in presence of [gamma-32P]ATP by scintillation counting method	B	CN1CCN(CCOC(=O)N(c2ccccc2)c2ncnc3c2cnn3CC(Cl)c2ccc(Br)cc2)CC1		CHEMBL4080000		Ki			CHEMBL267	Homo sapiens	Ki		
Not Determined	18062401	CHEMBL4013503	Inhibition of human wild type full length N-terminal GST/6His-tagged SRC (M1 to L536 residues) expressed in baculovirus infected Sf9 cells using src peptide as substrate after 5 mins in presence of [gamma-32P]ATP by scintillation counting method	B	CSc1nc(N(C(=O)OCCN2CCN(C)CC2)c2cccc(Cl)c2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL4090317		Ki			CHEMBL267	Homo sapiens	Ki		
	18062402	CHEMBL4013503	Inhibition of human wild type full length N-terminal GST/6His-tagged SRC (M1 to L536 residues) expressed in baculovirus infected Sf9 cells using src peptide as substrate after 5 mins in presence of [gamma-32P]ATP by scintillation counting method	B	CSc1nc(N(C(=O)OCCN2CCN(C)CC2)c2cccc(Br)c2)c2cnn(CC(C)c3ccccc3)c2n1		CHEMBL2407628	>	Ki	nM	100000.0	CHEMBL267	Homo sapiens	Ki	uM	100.0
	18062403	CHEMBL4013503	Inhibition of human wild type full length N-terminal GST/6His-tagged SRC (M1 to L536 residues) expressed in baculovirus infected Sf9 cells using src peptide as substrate after 5 mins in presence of [gamma-32P]ATP by scintillation counting method	B	CSc1nc(N(C(=O)OC(C)CN2CCN(C)CC2)c2cccc(Br)c2)c2cnn(CC(C)c3ccccc3)c2n1		CHEMBL4084427	>	Ki	nM	100000.0	CHEMBL267	Homo sapiens	Ki	uM	100.0
Not Determined	18062404	CHEMBL4013503	Inhibition of human wild type full length N-terminal GST/6His-tagged SRC (M1 to L536 residues) expressed in baculovirus infected Sf9 cells using src peptide as substrate after 5 mins in presence of [gamma-32P]ATP by scintillation counting method	B	CCC(CN1CCN(C)CC1)OC(=O)N(c1cccc(Br)c1)c1nc(SC)nc2c1cnn2CC(C)c1ccccc1		CHEMBL4069584		Ki			CHEMBL267	Homo sapiens	Ki		
	18062405	CHEMBL4013503	Inhibition of human wild type full length N-terminal GST/6His-tagged SRC (M1 to L536 residues) expressed in baculovirus infected Sf9 cells using src peptide as substrate after 5 mins in presence of [gamma-32P]ATP by scintillation counting method	B	CSc1nc(N(C(=O)OC(Cc2ccccc2)CN2CCN(C)CC2)c2cccc(Br)c2)c2cnn(CC(C)c3ccccc3)c2n1		CHEMBL4060917	>	Ki	nM	100000.0	CHEMBL267	Homo sapiens	Ki	uM	100.0
	18062406	CHEMBL4013503	Inhibition of human wild type full length N-terminal GST/6His-tagged SRC (M1 to L536 residues) expressed in baculovirus infected Sf9 cells using src peptide as substrate after 5 mins in presence of [gamma-32P]ATP by scintillation counting method	B	ClC(Cn1ncc2c(NCc3ccccc3)ncnc21)c1ccccc1		CHEMBL411043	=	Ki	nM	3000.0	CHEMBL267	Homo sapiens	Ki	uM	3.0
	18062407	CHEMBL4013503	Inhibition of human wild type full length N-terminal GST/6His-tagged SRC (M1 to L536 residues) expressed in baculovirus infected Sf9 cells using src peptide as substrate after 5 mins in presence of [gamma-32P]ATP by scintillation counting method	B	ClC(Cn1ncc2c(Nc3cccc(Br)c3)nc(SCCN3CCOCC3)nc21)c1ccccc1		CHEMBL3394092	=	Ki	nM	130.0	CHEMBL267	Homo sapiens	Ki	uM	0.13
	18062408	CHEMBL4013503	Inhibition of human wild type full length N-terminal GST/6His-tagged SRC (M1 to L536 residues) expressed in baculovirus infected Sf9 cells using src peptide as substrate after 5 mins in presence of [gamma-32P]ATP by scintillation counting method	B	ClC(Cn1ncc2c(Nc3ccccc3)ncnc21)c1ccc(Br)cc1		CHEMBL2397802	=	Ki	nM	60.0	CHEMBL267	Homo sapiens	Ki	uM	0.06
	18062409	CHEMBL4013503	Inhibition of human wild type full length N-terminal GST/6His-tagged SRC (M1 to L536 residues) expressed in baculovirus infected Sf9 cells using src peptide as substrate after 5 mins in presence of [gamma-32P]ATP by scintillation counting method	B	CSc1nc(Nc2cccc(Cl)c2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL400211	=	Ki	nM	720.0	CHEMBL267	Homo sapiens	Ki	uM	0.72
	18062410	CHEMBL4013503	Inhibition of human wild type full length N-terminal GST/6His-tagged SRC (M1 to L536 residues) expressed in baculovirus infected Sf9 cells using src peptide as substrate after 5 mins in presence of [gamma-32P]ATP by scintillation counting method	B	CSc1nc(Nc2cccc(Br)c2)c2cnn(CC(C)c3ccccc3)c2n1		CHEMBL1836680	=	Ki	nM	20.0	CHEMBL267	Homo sapiens	Ki	uM	0.02
	18064133	CHEMBL4013824	Inhibition of human c-SRC at 10 uM preincubated for 15 mins followed by peptide substrate addition measured after 3 hrs by caliper capillary electrophoresis method relative to control	B	C=CC(=O)Nc1ccc(CCn2c(=O)c(-c3ccccc3Cl)cc3cnc(NCCCCN(CC)CC)nc32)cc1		CHEMBL4103536	<	Inhibition	%	85.0	CHEMBL267	Homo sapiens	INH	%	85.0
	18083269	CHEMBL4018033	Inhibition of human SRC at 1 uM using poly(Glu,Tyr)4:1 as substrate by filter binding method relative to control	B	CS(=O)(=O)N1CCN(Cc2cn3cc(-c4cnc(N)nc4)nc(N4CCOCC4)c3n2)CC1		CHEMBL2087474	=	Inhibition	%	32.0	CHEMBL267	Homo sapiens	INH	%	32.0
Not Active	18083270	CHEMBL4018033	Inhibition of human SRC at 1 uM using poly(Glu,Tyr)4:1 as substrate by filter binding method relative to control	B	Nc1ncc(-c2cn3c4c(nc3c(N3CCOCC3)n2)CCN(S(=O)(=O)C2CC2)C4)cn1		CHEMBL4098032		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	18083271	CHEMBL4018033	Inhibition of human SRC at 1 uM using poly(Glu,Tyr)4:1 as substrate by filter binding method relative to control	B	CS(=O)(=O)N1CCc2c(nc3c(N4CCOCC4)nc(-c4cnc(N)nc4)cn23)C1		CHEMBL4068727		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	18083272	CHEMBL4018033	Inhibition of human SRC at 1 uM using poly(Glu,Tyr)4:1 as substrate by filter binding method relative to control	B	Nc1ncc(-c2cn3c4c(nc3c(N3CCOCC3)n2)CN(c2ccc(F)cc2)CC4)cn1		CHEMBL4088855	=	Inhibition	%	33.0	CHEMBL267	Homo sapiens	INH	%	33.0
	18085965	CHEMBL4018636	Inhibition of recombinant c-Src (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(Cl)ccc3O)cc12		CHEMBL4105329	=	IC50	nM	3.9	CHEMBL267	Homo sapiens	IC50	nM	3.9
	18085966	CHEMBL4018636	Inhibition of recombinant c-Src (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	OC[C@H](Nc1cnc(-c2cc(Cl)ccc2O)c(-c2ccc3cnccc3c2)c1)c1ccccc1		CHEMBL4067871	=	IC50	nM	6.4	CHEMBL267	Homo sapiens	IC50	nM	6.4
	18085967	CHEMBL4018636	Inhibition of recombinant c-Src (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(F)ccc3O)cc12		CHEMBL4062877	=	IC50	nM	5.7	CHEMBL267	Homo sapiens	IC50	nM	5.7
	18085968	CHEMBL4018636	Inhibition of recombinant c-Src (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3ccc(F)cc3O)cc12		CHEMBL4075917	=	IC50	nM	6.0	CHEMBL267	Homo sapiens	IC50	nM	6.0
	18096345	CHEMBL4021232	Inhibition of c-Src (unknown origin) using FAM-labeled peptide as substrate preincubated for 5 to 10 mins followed by substrate/ATP addition measured after 30 to 60 mins by mobility shift assay	B	CC(c1cc2cc(-c3cnn(C)c3)cnc2cc1F)n1nnc2ncc(-c3cnn(CCO)c3)nc21		CHEMBL4074262	=	IC50	nM	17056.0	CHEMBL267	Homo sapiens	IC50	nM	17056.0
	18114861	CHEMBL4025391	Inhibition of wild-type human partial length SRC (L240 to L536 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	99.0	CHEMBL267	Homo sapiens	Activity	%	99.0
Not Active	18134357	CHEMBL4029556	Inhibition of SRC (unknown origin) at <1 uM using biotinylated poly[Glu:Tyr] (4:1) as substrate pretreated for 5 mins followed by substrate addition measured after 10 mins by Alphascreen assay	B	CSc1sc(C(N)=O)c2c1-c1sncc1CC2		CHEMBL4082469		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	18134358	CHEMBL4029556	Inhibition of SRC (unknown origin) at <1 uM using biotinylated poly[Glu:Tyr] (4:1) as substrate pretreated for 5 mins followed by substrate addition measured after 10 mins by Alphascreen assay	B	COCCNC(=O)c1ccc(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)cn1		CHEMBL4066819		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	18135449	CHEMBL4029701	Inhibition of partial length wild type human cSRC (L240 to L536) expressed in bacterial expression system assessed as residual activity at 10 uM by KINOMEscan assay relative to control	B	O=C1NC(=S)S/C1=C\c1cscn1		CHEMBL4061891	=	Activity	%	74.0	CHEMBL267	Homo sapiens	Activity	%	74.0
	18135466	CHEMBL4029701	Inhibition of partial length wild type human cSRC (L240 to L536) expressed in bacterial expression system assessed as residual activity at 10 uM by KINOMEscan assay relative to control	B	O=C1NC(=S)S/C1=C\c1csc(-c2ccc(C(F)(F)F)cc2)n1		CHEMBL4075290	=	Activity	%	106.0	CHEMBL267	Homo sapiens	Activity	%	106.0
	18135483	CHEMBL4029701	Inhibition of partial length wild type human cSRC (L240 to L536) expressed in bacterial expression system assessed as residual activity at 10 uM by KINOMEscan assay relative to control	B	O=C1NC(=S)N2C(=O)C3Nc4cc(Cl)cc(Cl)c4C3C=C12		CHEMBL4096175	=	Activity	%	98.0	CHEMBL267	Homo sapiens	Activity	%	98.0
	18135500	CHEMBL4029701	Inhibition of partial length wild type human cSRC (L240 to L536) expressed in bacterial expression system assessed as residual activity at 10 uM by KINOMEscan assay relative to control	B	N=C1NC(=O)/C(=C/c2csc(-c3ccc(C(F)(F)F)cc3)n2)S1		CHEMBL4064860	=	Activity	%	113.0	CHEMBL267	Homo sapiens	Activity	%	113.0
	18140592	CHEMBL4031137	Inhibition of human Src kinase domain (254 to 536 residues) expressed in Escherichia coli BL21 (DE3) using abltide as substrate pre-incubated for 10 mins followed by ATP addition measured after 20 mins by ELISA	B	Nc1ncnc2c1c(Oc1cccc(Cl)c1)nn2Cc1ccncc1		CHEMBL4088414	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	18140593	CHEMBL4031137	Inhibition of human Src kinase domain (254 to 536 residues) expressed in Escherichia coli BL21 (DE3) using abltide as substrate pre-incubated for 10 mins followed by ATP addition measured after 20 mins by ELISA	B	Nc1ncnc2c1c(Oc1cccc(Cl)c1)nn2CC1CCCNC1		CHEMBL4060191	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	18140594	CHEMBL4031137	Inhibition of human Src kinase domain (254 to 536 residues) expressed in Escherichia coli BL21 (DE3) using abltide as substrate pre-incubated for 10 mins followed by ATP addition measured after 20 mins by ELISA	B	Nc1ncnc2c1c(Oc1cccc(Cl)c1)nn2CC1CCNCC1		CHEMBL4093769	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	18140613	CHEMBL4031137	Inhibition of human Src kinase domain (254 to 536 residues) expressed in Escherichia coli BL21 (DE3) using abltide as substrate pre-incubated for 10 mins followed by ATP addition measured after 20 mins by ELISA	B	CC(C)(C)n1nc(Cc2cccc(Cl)c2)c2c(N)ncnc21		CHEMBL2324597	=	IC50	nM	607.0	CHEMBL267	Homo sapiens	IC50	nM	607.0
	18140614	CHEMBL4031137	Inhibition of human Src kinase domain (254 to 536 residues) expressed in Escherichia coli BL21 (DE3) using abltide as substrate pre-incubated for 10 mins followed by ATP addition measured after 20 mins by ELISA	B	CC(C)(C)n1nc(Oc2cccc(Cl)c2)c2c(N)ncnc21		CHEMBL4087915	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	18140615	CHEMBL4031137	Inhibition of human Src kinase domain (254 to 536 residues) expressed in Escherichia coli BL21 (DE3) using abltide as substrate pre-incubated for 10 mins followed by ATP addition measured after 20 mins by ELISA	B	CC(C)(C)n1nc(Sc2cccc(Cl)c2)c2c(N)ncnc21		CHEMBL4065764	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	18140616	CHEMBL4031137	Inhibition of human Src kinase domain (254 to 536 residues) expressed in Escherichia coli BL21 (DE3) using abltide as substrate pre-incubated for 10 mins followed by ATP addition measured after 20 mins by ELISA	B	CC(C)(C)n1nc(Nc2cccc(Cl)c2)c2c(N)ncnc21		CHEMBL4086945	=	IC50	nM	828.0	CHEMBL267	Homo sapiens	IC50	nM	828.0
	18140617	CHEMBL4031137	Inhibition of human Src kinase domain (254 to 536 residues) expressed in Escherichia coli BL21 (DE3) using abltide as substrate pre-incubated for 10 mins followed by ATP addition measured after 20 mins by ELISA	B	CC(C)(C)n1nc(Cc2cc(F)cc(F)c2)c2c(N)ncnc21		CHEMBL2324593	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	18140618	CHEMBL4031137	Inhibition of human Src kinase domain (254 to 536 residues) expressed in Escherichia coli BL21 (DE3) using abltide as substrate pre-incubated for 10 mins followed by ATP addition measured after 20 mins by ELISA	B	CC(C)(C)n1nc(Oc2cc(F)cc(F)c2)c2c(N)ncnc21		CHEMBL4065140	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	18140619	CHEMBL4031137	Inhibition of human Src kinase domain (254 to 536 residues) expressed in Escherichia coli BL21 (DE3) using abltide as substrate pre-incubated for 10 mins followed by ATP addition measured after 20 mins by ELISA	B	CC(C)(C)n1nc(Oc2cccc(C(F)(F)F)c2)c2c(N)ncnc21		CHEMBL4097112	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	18140620	CHEMBL4031137	Inhibition of human Src kinase domain (254 to 536 residues) expressed in Escherichia coli BL21 (DE3) using abltide as substrate pre-incubated for 10 mins followed by ATP addition measured after 20 mins by ELISA	B	CC(C)(C)n1nc(Oc2cccc(Br)c2)c2c(N)ncnc21		CHEMBL4102392	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	18140621	CHEMBL4031137	Inhibition of human Src kinase domain (254 to 536 residues) expressed in Escherichia coli BL21 (DE3) using abltide as substrate pre-incubated for 10 mins followed by ATP addition measured after 20 mins by ELISA	B	COc1cccc(Oc2nn(C(C)(C)C)c3ncnc(N)c23)c1		CHEMBL4078124	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	18140622	CHEMBL4031137	Inhibition of human Src kinase domain (254 to 536 residues) expressed in Escherichia coli BL21 (DE3) using abltide as substrate pre-incubated for 10 mins followed by ATP addition measured after 20 mins by ELISA	B	Cc1cccc(Oc2nn(C(C)(C)C)c3ncnc(N)c23)c1		CHEMBL4094646	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	18140623	CHEMBL4031137	Inhibition of human Src kinase domain (254 to 536 residues) expressed in Escherichia coli BL21 (DE3) using abltide as substrate pre-incubated for 10 mins followed by ATP addition measured after 20 mins by ELISA	B	Nc1ncnc2c1c(Oc1cccc(Cl)c1)nn2CC1CNC1		CHEMBL4067196	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	18140624	CHEMBL4031137	Inhibition of human Src kinase domain (254 to 536 residues) expressed in Escherichia coli BL21 (DE3) using abltide as substrate pre-incubated for 10 mins followed by ATP addition measured after 20 mins by ELISA	B	Nc1ncnc2c1c(Oc1cccc(Cl)c1)nn2CC1CCNC1		CHEMBL4073069	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	18140682	CHEMBL4031137	Inhibition of human Src kinase domain (254 to 536 residues) expressed in Escherichia coli BL21 (DE3) using abltide as substrate pre-incubated for 10 mins followed by ATP addition measured after 20 mins by ELISA	B	Nc1ncnc2c1c(Sc1cccc(Cl)c1)nn2CC1CCNCC1(F)F		CHEMBL4088534	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	18140683	CHEMBL4031137	Inhibition of human Src kinase domain (254 to 536 residues) expressed in Escherichia coli BL21 (DE3) using abltide as substrate pre-incubated for 10 mins followed by ATP addition measured after 20 mins by ELISA	B	Nc1ncnc2c1c(Oc1cccc(Cl)c1)nn2CC1(C(F)(F)F)CC1		CHEMBL4098707	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	18140684	CHEMBL4031137	Inhibition of human Src kinase domain (254 to 536 residues) expressed in Escherichia coli BL21 (DE3) using abltide as substrate pre-incubated for 10 mins followed by ATP addition measured after 20 mins by ELISA	B	Nc1ncnc2c1c(Oc1cccc(Cl)c1)nn2CC1CCNC(=O)C1		CHEMBL4080665	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	18140685	CHEMBL4031137	Inhibition of human Src kinase domain (254 to 536 residues) expressed in Escherichia coli BL21 (DE3) using abltide as substrate pre-incubated for 10 mins followed by ATP addition measured after 20 mins by ELISA	B	CN1CCC(Cn2nc(Oc3cccc(Cl)c3)c3c(N)ncnc32)CC1		CHEMBL4090973	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	18140686	CHEMBL4031137	Inhibition of human Src kinase domain (254 to 536 residues) expressed in Escherichia coli BL21 (DE3) using abltide as substrate pre-incubated for 10 mins followed by ATP addition measured after 20 mins by ELISA	B	Nc1ncnc2c1c(Oc1cccc(Cl)c1)nn2CC1CCNCC1(F)F		CHEMBL4069991	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	18140687	CHEMBL4031137	Inhibition of human Src kinase domain (254 to 536 residues) expressed in Escherichia coli BL21 (DE3) using abltide as substrate pre-incubated for 10 mins followed by ATP addition measured after 20 mins by ELISA	B	Nc1ncnc2c1c(Sc1cccc(Cl)c1)cn2CC1CCNCC1		CHEMBL4074754	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	18140688	CHEMBL4031137	Inhibition of human Src kinase domain (254 to 536 residues) expressed in Escherichia coli BL21 (DE3) using abltide as substrate pre-incubated for 10 mins followed by ATP addition measured after 20 mins by ELISA	B	Nc1ncnc2c1c(Oc1ccc(F)c(Cl)c1)nn2CC1CCNCC1		CHEMBL4095218	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	18140689	CHEMBL4031137	Inhibition of human Src kinase domain (254 to 536 residues) expressed in Escherichia coli BL21 (DE3) using abltide as substrate pre-incubated for 10 mins followed by ATP addition measured after 20 mins by ELISA	B	Nc1ncnc2c1c(Cc1cc(F)cc(F)c1)nn2CC1CCNCC1		CHEMBL4080552	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	18140690	CHEMBL4031137	Inhibition of human Src kinase domain (254 to 536 residues) expressed in Escherichia coli BL21 (DE3) using abltide as substrate pre-incubated for 10 mins followed by ATP addition measured after 20 mins by ELISA	B	Nc1ncnc2c1c(Nc1cccc(Cl)c1)nn2CC1CCNCC1		CHEMBL4098582	=	IC50	nM	901.0	CHEMBL267	Homo sapiens	IC50	nM	901.0
	18140691	CHEMBL4031137	Inhibition of human Src kinase domain (254 to 536 residues) expressed in Escherichia coli BL21 (DE3) using abltide as substrate pre-incubated for 10 mins followed by ATP addition measured after 20 mins by ELISA	B	Cc1cccc(Sc2nn(CC3CCNCC3)c3ncnc(N)c23)c1		CHEMBL4069866	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	18140692	CHEMBL4031137	Inhibition of human Src kinase domain (254 to 536 residues) expressed in Escherichia coli BL21 (DE3) using abltide as substrate pre-incubated for 10 mins followed by ATP addition measured after 20 mins by ELISA	B	Nc1ncnc2c1c(Sc1cccc(Cl)c1)nn2CC1CCNCC1		CHEMBL4090858	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	18140693	CHEMBL4031137	Inhibition of human Src kinase domain (254 to 536 residues) expressed in Escherichia coli BL21 (DE3) using abltide as substrate pre-incubated for 10 mins followed by ATP addition measured after 20 mins by ELISA	B	Nc1ncnc2c1c(Cc1cccc(Cl)c1)nn2CC1CCNCC1		CHEMBL4096137	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	18140694	CHEMBL4031137	Inhibition of human Src kinase domain (254 to 536 residues) expressed in Escherichia coli BL21 (DE3) using abltide as substrate pre-incubated for 10 mins followed by ATP addition measured after 20 mins by ELISA	B	Nc1ncnc2c1c(Oc1cccc(Cl)c1)nn2CC1CCOCC1		CHEMBL4068845	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
Active	18149690	CHEMBL4033362	Inhibition of human Src at 0.5 uM relative to control	B	COc1cc2ncnc(Oc3ccc(NC(=O)Nc4ccc(CN5CCOCC5)c(C(F)(F)F)c4)c4ccccc34)c2cc1OC		CHEMBL4075561		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Active	18149691	CHEMBL4033362	Inhibition of human Src at 0.5 uM relative to control	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	18153102	CHEMBL4034326	Inhibition of SRC activation loop (unknown origin) at 10 uM	B	c1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4084955	=	Inhibition	%	-9.6	CHEMBL267	Homo sapiens	INH	%	-9.6
	18194703	CHEMBL4042011	Inhibition of recombinant c-Src (unknown origin) after 120 mins in presence of [33P]ATP	B	CN(CCO/N=C1C(=C2/C(=O)Nc3cc(Br)ccc32)/Nc2ccccc2/1)CC(O)CO		CHEMBL494867	<	IC50	nM	0.5	CHEMBL267	Homo sapiens	IC50	nM	0.5
	18194704	CHEMBL4042011	Inhibition of recombinant c-Src (unknown origin) after 120 mins in presence of [33P]ATP	B	CN(CCO/N=C1C(=C2/C(=O)Nc3cc(Br)ccc32)/Nc2ccccc2/1)CC(O)CO.Cl		CHEMBL495306	=	IC50	nM	0.61	CHEMBL267	Homo sapiens	IC50	nM	0.61
	18194705	CHEMBL4042011	Inhibition of recombinant c-Src (unknown origin) after 120 mins in presence of [33P]ATP	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\OCCN1CCCC1		CHEMBL494685	=	IC50	nM	4.9	CHEMBL267	Homo sapiens	IC50	nM	4.9
	18194706	CHEMBL4042011	Inhibition of recombinant c-Src (unknown origin) after 120 mins in presence of [33P]ATP	B	Cl.O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\OCCN1CCCC1		CHEMBL493883	=	IC50	nM	2.2	CHEMBL267	Homo sapiens	IC50	nM	2.2
	18194707	CHEMBL4042011	Inhibition of recombinant c-Src (unknown origin) after 120 mins in presence of [33P]ATP	B	Cl.Cl.O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\OCCN1CCNCC1		CHEMBL3216659	<	IC50	nM	0.5	CHEMBL267	Homo sapiens	IC50	nM	0.5
	18194708	CHEMBL4042011	Inhibition of recombinant c-Src (unknown origin) after 120 mins in presence of [33P]ATP	B	COCCN1CCN(CCO/N=C2C(=C3/C(=O)Nc4cc(Br)ccc43)/Nc3ccccc3/2)CC1		CHEMBL493656	=	IC50	nM	1.7	CHEMBL267	Homo sapiens	IC50	nM	1.7
	18194709	CHEMBL4042011	Inhibition of recombinant c-Src (unknown origin) after 120 mins in presence of [33P]ATP	B	COCCN1CCN(CCO/N=C2C(=C3/C(=O)Nc4cc(Br)ccc43)/Nc3ccccc3/2)CC1.Cl.Cl		CHEMBL3215571	=	IC50	nM	3.9	CHEMBL267	Homo sapiens	IC50	nM	3.9
	18194710	CHEMBL4042011	Inhibition of recombinant c-Src (unknown origin) after 120 mins in presence of [33P]ATP	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\OCCN1CCN(CCOCCO)CC1		CHEMBL493657	=	IC50	nM	0.83	CHEMBL267	Homo sapiens	IC50	nM	0.83
	18194719	CHEMBL4042013	Inhibition of recombinant GST-tagged c-Src (unknown origin) expressed in insect cells using pEY as substrate preincubated with enzyme followed by [33P]ATP addition measured after after 120 mins	B	Cl.Cl.O=C1Nc2c(Br)cccc2/C1=C1/Nc2ccccc2/C1=N\OCCN1CCNCC1		CHEMBL4080255	=	IC50	nM	200.0	CHEMBL267	Homo sapiens	IC50	uM	0.2
	18203915	CHEMBL4044202	Inhibition of wild-type human partial length SRC (L240 to L536 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	11.0	CHEMBL267	Homo sapiens	Activity	%	11.0
	18211666	CHEMBL4045682	Inhibition of SRC ATP binding site (QGAKFPIKWTAPEAALYGR) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	-2.3	CHEMBL267	Homo sapiens	INH	%	-2.3
	18211677	CHEMBL4045625	Inhibition of SRC ATP binding site (QGAKFPIKWTAPEAALYGR) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	-4.4	CHEMBL267	Homo sapiens	INH	%	-4.4
	18212122	CHEMBL4046140	Inhibition of SRC (unknown origin) at 1 uM relative to control	B	Cc1c(-c2ccncc2)c[nH]c1C(N)=O		CHEMBL4100387	<	Inhibition	%	20.0	CHEMBL267	Homo sapiens	INH	%	20.0
	18232183	CHEMBL4050323	Inhibition of human Src assessed as residual activity at 1 uM in presence of [33P]ATP by filter binding assay relative to control	B	NCCCC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CCCCCCCCOc1nc2cc(C(=O)O)ccc2c2cnccc12)C(=O)O		CHEMBL4077554	=	Activity	%	67.0	CHEMBL267	Homo sapiens	Activity	%	67.0
	18248625	CHEMBL4053908	Inhibition of SRC (unknown origin) at 1 uM relative to control	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn4c5c(cccc35)CCC4)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4104658	=	Inhibition	%	16.0	CHEMBL267	Homo sapiens	INH	%	16.0
	18250459	CHEMBL4054276	Inhibition of c-Src (unknown origin) using poly (Glu, Tyr) 4:1 as substrate at 100 uM after 1 hr by ELISA relative to control	B	CCCCCCCCCCCCCCC(=O)NC1CCN(C(=O)C2Sc3ccccc3N(CC)C2=O)CC1		CHEMBL4081419	=	Inhibition	%	3.2	CHEMBL267	Homo sapiens	INH	%	3.2
	18250460	CHEMBL4054277	Inhibition of c-Src (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA relative to control	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Inhibition	%	100.0	CHEMBL267	Homo sapiens	INH	%	100.0
	18253433	CHEMBL4055000	Inhibition of wild-type human partial length SRC (L240 to L536 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	75.0	CHEMBL267	Homo sapiens	Activity	%	75.0
	18253434	CHEMBL4055000	Inhibition of wild-type human partial length SRC (L240 to L536 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	97.0	CHEMBL267	Homo sapiens	Activity	%	97.0
	18265939	CHEMBL4057389	Inhibition of SRC (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	51.7	CHEMBL267	Homo sapiens	INH	%	51.7
	18266155	CHEMBL4057605	Inhibition of SRC (unknown origin) at 0.49 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1		CHEMBL4088455	=	Inhibition	%	5.0	CHEMBL267	Homo sapiens	INH	%	5.0
	18266212	CHEMBL4057662	Inhibition of SRC (unknown origin) at 0.078 uM relative to control	B	COC(=O)Nc1noc2cc(-c3c(-c4ccccn4)n[nH]c3C)ccc12		CHEMBL4066592	=	Inhibition	%	2.3	CHEMBL267	Homo sapiens	INH	%	2.3
	18268095	CHEMBL4057970	Inhibition of SRC (unknown origin)	B	CC(C)C(=O)N1CCC[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)C1		CHEMBL4069387	=	IC50	nM	265.0	CHEMBL267	Homo sapiens	IC50	nM	265.0
	18268096	CHEMBL4057970	Inhibition of SRC (unknown origin)	B	CC(C)C(=O)N1CCO[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)C1		CHEMBL4075954	=	IC50	nM	512.0	CHEMBL267	Homo sapiens	IC50	nM	512.0
	18268097	CHEMBL4057970	Inhibition of SRC (unknown origin)	B	COCC(=O)N1CCC[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)C1		CHEMBL4076024	=	IC50	nM	55.0	CHEMBL267	Homo sapiens	IC50	nM	55.0
	18268098	CHEMBL4057970	Inhibition of SRC (unknown origin)	B	COCC(=O)N1CCO[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)C1		CHEMBL4062498	=	IC50	nM	123.0	CHEMBL267	Homo sapiens	IC50	nM	123.0
	18268099	CHEMBL4057970	Inhibition of SRC (unknown origin)	B	Nc1nccn2c([C@@H]3CCCN(C4CCOCC4)C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c12		CHEMBL4077588	=	IC50	nM	77.0	CHEMBL267	Homo sapiens	IC50	nM	77.0
	18268100	CHEMBL4057970	Inhibition of SRC (unknown origin)	B	Nc1nccn2c([C@H]3CN(C4CCOCC4)CCO3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c12		CHEMBL4060757	=	IC50	nM	112.0	CHEMBL267	Homo sapiens	IC50	nM	112.0
	18269002	CHEMBL4058133	Inhibition of recombinant human full length N-terminal His6-tagged SRC expressed in Sf21 insect cells preincubated for 5 mins followed by substrate addition after 30 to 60 mins in presence of ATP by fluorescence assay	B	C=CS(=O)(=O)N1CCC[C@@H]1Cn1cc(-c2ccc3c(c2)OCO3)c2c(N)ncnc21		CHEMBL4095253	=	IC50	nM	197.0	CHEMBL267	Homo sapiens	IC50	nM	197.0
	18274914	CHEMBL4118350	Inhibition of SRC in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled QGAKFPIKWTAPEAALYGR probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3883384	=	Inhibition	%	50.5	CHEMBL267	Homo sapiens	INH	%	50.5
	18274915	CHEMBL4118350	Inhibition of SRC in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled QGAKFPIKWTAPEAALYGR probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl		CHEMBL3884839	=	Inhibition	%	-0.9	CHEMBL267	Homo sapiens	INH	%	-0.9
	18274916	CHEMBL4118350	Inhibition of SRC in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled QGAKFPIKWTAPEAALYGR probe by mass-spectrometric analysis relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	Inhibition	%	8.5	CHEMBL267	Homo sapiens	INH	%	8.5
Active	18275642	CHEMBL4118602	Binding affinity to SRC in human NCI-H23 cells at 1 uM by mass spectrometry based pull down assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(CCOCCOCCOCCNC(=O)CCCC[C@@H]4SC[C@@H]5NC(=O)N[C@H]45)CC3)cc2)ncc1Cl		CHEMBL4129274		Activity			CHEMBL267	Homo sapiens	Activity		
Active	18275871	CHEMBL4118831	Binding affinity to SRC in human NCI-H358 cells at 1 uM by mass spectrometry based pull down assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(CCOCCOCCOCCNC(=O)CCCC[C@@H]4SC[C@@H]5NC(=O)N[C@H]45)CC3)cc2)ncc1Cl		CHEMBL4129274		Activity			CHEMBL267	Homo sapiens	Activity		
	18282192	CHEMBL4120147	Inhibition of recombinant full length C-terminal His-tagged human Src cytoplasmic domain expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	CC(C)n1nc(-c2cnc(N)c(OC(F)(F)F)c2)cc1[C@@H]1[C@H]2CN(C3COC3)C[C@H]21		CHEMBL3719135	=	Inhibition	%	23.8	CHEMBL267	Homo sapiens	INH	%	23.8
	18282511	CHEMBL4120147	Inhibition of recombinant full length C-terminal His-tagged human Src cytoplasmic domain expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	Nc1ncc(-c2cc([C@@H]3[C@H]4CN(C5COC5)C[C@H]43)n(CC3CC3)n2)cc1C(F)(F)F		CHEMBL3715238	=	Inhibition	%	22.0	CHEMBL267	Homo sapiens	INH	%	22.0
	18282708	CHEMBL4120293	Inhibition of SRC (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	51.7	CHEMBL267	Homo sapiens	INH	%	51.7
	18282894	CHEMBL4120479	Inhibition of SRC (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1		CHEMBL4125807	=	Inhibition	%	15.7	CHEMBL267	Homo sapiens	INH	%	15.7
	18283108	CHEMBL4120693	Inhibition of SRC (unknown origin) at 0.164 uM relative to control	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12		CHEMBL4129737	=	Inhibition	%	5.7	CHEMBL267	Homo sapiens	INH	%	5.7
	18286352	CHEMBL4121602	Inhibition of recombinant full length C-terminal His-tagged human Src cytoplasmic domain expressed in baculovirus expression system at 10 uM in presence of ATP relative to control	B	CC(C)(C)NS(=O)(=O)c1ccc(-c2sc(C(=O)N[C@H]3C[C@H](C(=O)O)C3)nc2CC2CCCCC2)c2ccccc12		CHEMBL4128926	=	Inhibition	%	-4.0	CHEMBL267	Homo sapiens	INH	%	-4.0
	18330817	CHEMBL4136281	Inhibition of recombinant C-SRC (unknown origin) at 1 uM by off-chip mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Inhibition	%	95.0	CHEMBL267	Homo sapiens	INH	%	95.0
	18333229	CHEMBL4136609	Inhibition of recombinant SRC (unknown origin) using polyE4Y as substrate by pyruvate kinase-lactate dehydrogenase coupled assay	A	N#Cc1cccc(-c2nc(Nc3cc(C4CC4)[nH]n3)c3cc(Cl)ccc3n2)c1		CHEMBL4173877	=	Ki	nM	200.0	CHEMBL267	Homo sapiens	Ki	nM	200.0
	18333242	CHEMBL4136609	Inhibition of recombinant SRC (unknown origin) using polyE4Y as substrate by pyruvate kinase-lactate dehydrogenase coupled assay	A	N#Cc1ccc(-c2nc(Nc3cc(C4CC4)[nH]n3)c3cc(Cl)ccc3n2)cc1		CHEMBL4167265	=	Ki	nM	710.0	CHEMBL267	Homo sapiens	Ki	nM	710.0
	18333252	CHEMBL4136609	Inhibition of recombinant SRC (unknown origin) using polyE4Y as substrate by pyruvate kinase-lactate dehydrogenase coupled assay	A	N#Cc1cccc(-c2nc(Nc3cc(C4CC4)[nH]n3)c3ccccc3n2)c1		CHEMBL4174082	=	Ki	nM	22.0	CHEMBL267	Homo sapiens	Ki	nM	22.0
	18333256	CHEMBL4136609	Inhibition of recombinant SRC (unknown origin) using polyE4Y as substrate by pyruvate kinase-lactate dehydrogenase coupled assay	A	N#Cc1ccc(-c2nc(Nc3cc(C4CC4)[nH]n3)c3ccccc3n2)cc1		CHEMBL4166840	=	Ki	nM	18.0	CHEMBL267	Homo sapiens	Ki	nM	18.0
	18340579	CHEMBL4138668	Binding affinity to SRC (unknown origin) assessed as on rate constant	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1	Non standard unit for type	CHEMBL1421	=	K	/s/microM	5.0	CHEMBL267	Homo sapiens	K	/s/microM	5.0
	18340580	CHEMBL4138668	Binding affinity to SRC (unknown origin) assessed as on rate constant	B	C=CCc1ccccc1OCC(O)CNC(C)C	Non standard unit for type	CHEMBL266195	=	K	10'7/s/microM	1.0	CHEMBL267	Homo sapiens	K	10'7/s/microM	1.0
	18343069	CHEMBL4139115	Inhibition of Src kinase (unknown origin)	B	CN(CCN(C)Cc1ccc(C(=O)Nc2ccc3ncnc(Nc4cccc(Cl)c4)c3c2)cc1)CCn1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL4163321	=	IC50	nM	2900.0	CHEMBL267	Homo sapiens	IC50	uM	2.9
	18344195	CHEMBL4139436	Inhibition of SRC (unknown origin) at 10 uM after 15 mins by luminescence assay relative to control	B	COc1cccc(C(=O)Nc2ccc(Nc3ncnc4c3Cc3ccccc3N4)cc2)c1		CHEMBL4177109	=	Inhibition	%	88.77	CHEMBL267	Homo sapiens	INH	%	88.77
	18344196	CHEMBL4139436	Inhibition of SRC (unknown origin) at 10 uM after 15 mins by luminescence assay relative to control	B	Cc1cccc(C(=O)Nc2ccc(Nc3ncnc4c3Cc3ccccc3N4)cc2)c1		CHEMBL4169251	=	Inhibition	%	60.38	CHEMBL267	Homo sapiens	INH	%	60.38
	18344197	CHEMBL4139436	Inhibition of SRC (unknown origin) at 10 uM after 15 mins by luminescence assay relative to control	B	O=C(Nc1ccc(Nc2ncnc3c2Cc2ccccc2N3)cc1)c1cccc(Cl)c1		CHEMBL4166904	=	Inhibition	%	77.54	CHEMBL267	Homo sapiens	INH	%	77.54
	18344198	CHEMBL4139436	Inhibition of SRC (unknown origin) at 10 uM after 15 mins by luminescence assay relative to control	B	O=C(Nc1ccc(Nc2ncnc3c2Cc2ccccc2N3)cc1)c1cccc(F)c1		CHEMBL4177513	=	Inhibition	%	75.42	CHEMBL267	Homo sapiens	INH	%	75.42
	18344199	CHEMBL4139436	Inhibition of SRC (unknown origin) at 10 uM after 15 mins by luminescence assay relative to control	B	O=C(Nc1ccc(Nc2ncnc3c2Cc2ccccc2N3)cc1)c1ccccc1		CHEMBL4170300	=	Inhibition	%	66.31	CHEMBL267	Homo sapiens	INH	%	66.31
	18344200	CHEMBL4139436	Inhibition of SRC (unknown origin) at 10 uM after 15 mins by luminescence assay relative to control	B	O=C(Nc1cccc(Nc2ncnc3c2Cc2ccccc2N3)c1)c1cccc(C(F)(F)F)c1		CHEMBL4162375	=	Inhibition	%	72.88	CHEMBL267	Homo sapiens	INH	%	72.88
	18344201	CHEMBL4139436	Inhibition of SRC (unknown origin) at 10 uM after 15 mins by luminescence assay relative to control	B	COc1cccc(C(=O)Nc2cccc(Nc3ncnc4c3Cc3ccccc3N4)c2)c1		CHEMBL4160083	=	Inhibition	%	86.86	CHEMBL267	Homo sapiens	INH	%	86.86
	18344202	CHEMBL4139436	Inhibition of SRC (unknown origin) at 10 uM after 15 mins by luminescence assay relative to control	B	Cc1cccc(C(=O)Nc2cccc(Nc3ncnc4c3Cc3ccccc3N4)c2)c1		CHEMBL4170721	=	Inhibition	%	72.03	CHEMBL267	Homo sapiens	INH	%	72.03
	18344203	CHEMBL4139436	Inhibition of SRC (unknown origin) at 10 uM after 15 mins by luminescence assay relative to control	B	O=C(Nc1cccc(Nc2ncnc3c2Cc2ccccc2N3)c1)c1cccc(Cl)c1		CHEMBL4163447	=	Inhibition	%	79.23	CHEMBL267	Homo sapiens	INH	%	79.23
	18344204	CHEMBL4139436	Inhibition of SRC (unknown origin) at 10 uM after 15 mins by luminescence assay relative to control	B	O=C(Nc1cccc(Nc2ncnc3c2Cc2ccccc2N3)c1)c1cccc(F)c1		CHEMBL4174147	=	Inhibition	%	69.91	CHEMBL267	Homo sapiens	INH	%	69.91
	18344205	CHEMBL4139436	Inhibition of SRC (unknown origin) at 10 uM after 15 mins by luminescence assay relative to control	B	O=C(Nc1cccc(Nc2ncnc3c2Cc2ccccc2N3)c1)c1ccccc1		CHEMBL4164517	=	Inhibition	%	75.63	CHEMBL267	Homo sapiens	INH	%	75.63
	18344265	CHEMBL4139436	Inhibition of SRC (unknown origin) at 10 uM after 15 mins by luminescence assay relative to control	B	O=C(Nc1ccc(Nc2ncnc3c2Cc2ccccc2N3)cc1)c1cccc(C(F)(F)F)c1		CHEMBL4174673	=	Inhibition	%	76.69	CHEMBL267	Homo sapiens	INH	%	76.69
	18344266	CHEMBL4139436	Inhibition of SRC (unknown origin) at 10 uM after 15 mins by luminescence assay relative to control	B	O=C(Nc1ccccc1)Nc1ccc(Nc2ncnc3c2Cc2ccccc2N3)cc1		CHEMBL4166774	=	Inhibition	%	73.09	CHEMBL267	Homo sapiens	INH	%	73.09
	18344267	CHEMBL4139436	Inhibition of SRC (unknown origin) at 10 uM after 15 mins by luminescence assay relative to control	B	O=C(Nc1ccc(Nc2ncnc3c2Cc2ccccc2N3)cc1)Nc1cccc(F)c1		CHEMBL4171232	=	Inhibition	%	79.87	CHEMBL267	Homo sapiens	INH	%	79.87
	18344268	CHEMBL4139436	Inhibition of SRC (unknown origin) at 10 uM after 15 mins by luminescence assay relative to control	B	O=C(Nc1ccc(Nc2ncnc3c2Cc2ccccc2N3)cc1)Nc1cccc(Cl)c1		CHEMBL4163326	=	Inhibition	%	59.11	CHEMBL267	Homo sapiens	INH	%	59.11
	18344269	CHEMBL4139436	Inhibition of SRC (unknown origin) at 10 uM after 15 mins by luminescence assay relative to control	B	Cc1cccc(NC(=O)Nc2ccc(Nc3ncnc4c3Cc3ccccc3N4)cc2)c1		CHEMBL4167875	=	Inhibition	%	66.1	CHEMBL267	Homo sapiens	INH	%	66.1
	18344270	CHEMBL4139436	Inhibition of SRC (unknown origin) at 10 uM after 15 mins by luminescence assay relative to control	B	COc1cccc(NC(=O)Nc2ccc(Nc3ncnc4c3Cc3ccccc3N4)cc2)c1		CHEMBL4159953	=	Inhibition	%	86.01	CHEMBL267	Homo sapiens	INH	%	86.01
	18344271	CHEMBL4139436	Inhibition of SRC (unknown origin) at 10 uM after 15 mins by luminescence assay relative to control	B	O=C(Nc1ccc(Nc2ncnc3c2Cc2ccccc2N3)cc1)Nc1cccc(C(F)(F)F)c1		CHEMBL4164444	=	Inhibition	%	53.38	CHEMBL267	Homo sapiens	INH	%	53.38
	18344272	CHEMBL4139436	Inhibition of SRC (unknown origin) at 10 uM after 15 mins by luminescence assay relative to control	B	COc1ccc2c(Nc3ccc(NC(=O)Nc4ccccc4)cc3)c3ccccc3nc2c1		CHEMBL3754039	=	Inhibition	%	59.67	CHEMBL267	Homo sapiens	INH	%	59.67
	18344273	CHEMBL4139436	Inhibition of SRC (unknown origin) at 10 uM after 15 mins by luminescence assay relative to control	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Inhibition	%	97.12	CHEMBL267	Homo sapiens	INH	%	97.12
Dose-dependent effect	18344277	CHEMBL4139440	Inhibition of SRC phosphorylation in human A549 cells after 48 hrs by Western blot analysis	B	O=C(Nc1ccc(Nc2ncnc3c2Cc2ccccc2N3)cc1)c1cccc(F)c1		CHEMBL4177513		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	18344294	CHEMBL4139457	Inhibition of SRC (unknown origin) at 1 uM after 15 mins by luminescence assay relative to control	B	O=C(Nc1ccc(Nc2ncnc3c2Cc2ccccc2N3)cc1)c1cccc(F)c1		CHEMBL4177513	=	Inhibition	%	72.12	CHEMBL267	Homo sapiens	INH	%	72.12
	18379902	CHEMBL4145805	Inhibition of c-SRC (unknown origin) at 10 uM relative to control	B	COc1cc(NC(=O)Nc2cnc(Nc3ccc(N4CCOCC4)cc3)nc2Oc2ccc(C)cc2OC)cc(OC)c1		CHEMBL4159506	=	Inhibition	%	52.28	CHEMBL267	Homo sapiens	INH	%	52.28
	18380001	CHEMBL4145902	Inhibition of c-SRC (unknown origin)	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	2.2	CHEMBL267	Homo sapiens	IC50	nM	2.2
	18390499	CHEMBL4147644	Inhibition of Src (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 1 hr by ELISA	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	=	IC50	nM	178.0	CHEMBL267	Homo sapiens	IC50	umol/L	0.178
	18390500	CHEMBL4147644	Inhibition of Src (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 1 hr by ELISA	B	COc1cc2c(Oc3ccc(NC(=O)NN4C(=O)CSC4c4c(F)cccc4F)c(F)c3)ccnc2cc1OCCCN1CCCC1		CHEMBL4171115	=	IC50	nM	61.0	CHEMBL267	Homo sapiens	IC50	umol/L	0.061
	18390504	CHEMBL4147648	Potency index, ratio of cabozantinib IC50 to compound IC50 for inhibition of Src (unknown origin)	B	COc1cc2c(Oc3ccc(NC(=O)NN4C(=O)CSC4c4c(F)cccc4F)c(F)c3)ccnc2cc1OCCCN1CCCC1		CHEMBL4171115	=	Ratio IC50		2.9	CHEMBL267	Homo sapiens	Ratio IC50		2.9
Not Active	18418984	CHEMBL4153668	Inhibition of Src phosphorylation in human HCT116 cells at 4 to 12 uM after 20 hrs by Western blot analysis	B	CC(C)c1ccc(CN(Cc2c(F)c(F)c(F)c(F)c2F)c2cccc(S(N)(=O)=O)c2)cc1		CHEMBL4163020		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	18420797	CHEMBL4153886	Inhibition of SRC (unknown origin) at 10 uM by [33P]-ATP radiometric assay	B	Cc1ccc2nc3nc(NCc4ccc(CN5CCN(C)CC5)cc4)[nH]c(=O)c3cc2c1	Outside typical range	CHEMBL4163273	=	Inhibition	%	-19.0	CHEMBL267	Homo sapiens	INH	%	-19.0
	18420798	CHEMBL4153886	Inhibition of SRC (unknown origin) at 10 uM by [33P]-ATP radiometric assay	B	CN1CCN(Cc2ccc(CNc3nc4nc5ccc(Cl)cc5cc4c(=O)[nH]3)cc2)CC1	Outside typical range	CHEMBL4171176	=	Inhibition	%	-17.0	CHEMBL267	Homo sapiens	INH	%	-17.0
	18420799	CHEMBL4153886	Inhibition of SRC (unknown origin) at 10 uM by [33P]-ATP radiometric assay	B	O=c1[nH]c(NCc2ccc(CN3CCCCC3)cc2)nc2nc3ccccc3cc12	Outside typical range	CHEMBL4160278	=	Inhibition	%	-17.0	CHEMBL267	Homo sapiens	INH	%	-17.0
	18420800	CHEMBL4153886	Inhibition of SRC (unknown origin) at 10 uM by [33P]-ATP radiometric assay	B	COc1ccc2nc3nc(NCc4ccc(CN5CCN(C)CC5)cc4)[nH]c(=O)c3nc2c1	Outside typical range	CHEMBL4171939	=	Inhibition	%	-19.0	CHEMBL267	Homo sapiens	INH	%	-19.0
	18420801	CHEMBL4153886	Inhibition of SRC (unknown origin) at 10 uM by [33P]-ATP radiometric assay	B	COc1ccc(CCN2CCC(Nc3nc4nc5ccc(C)cc5nc4c(=O)[nH]3)CC2)cc1	Outside typical range	CHEMBL4167512	=	Inhibition	%	-21.0	CHEMBL267	Homo sapiens	INH	%	-21.0
	18420802	CHEMBL4153886	Inhibition of SRC (unknown origin) at 10 uM by [33P]-ATP radiometric assay	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1	Outside typical range	CHEMBL941	=	Inhibition	%	-30.0	CHEMBL267	Homo sapiens	INH	%	-30.0
	18431083	CHEMBL4155764	Inhibition of recombinant full length C-terminal His-tagged human Src cytoplasmic domain expressed in baculovirus expression system at 1 uM by Z'-Lyte assay relative to control	B	O=C1Nc2ccc(C(=O)N[C@H](CO)c3ccccc3)cc2/C1=C(\c1ccccc1)c1ncc[nH]1		CHEMBL4160587	=	Inhibition	%	96.0	CHEMBL267	Homo sapiens	INH	%	96.0
	18431335	CHEMBL4155787	Inhibition of SRC (unknown origin) at 1 uM relative to control	B	Cn1ncc2c(Oc3ccc4c(c3)nc(Nc3ccc(OC(F)(F)F)cc3)n4C)ncnc21		CHEMBL4170025	=	Inhibition	%	14.0	CHEMBL267	Homo sapiens	INH	%	14.0
	18434152	CHEMBL4156134	Inhibition of human full length Src expressed in baculovirus expression system at 500 nM by Z-LYTE assay relative to control	B	OC[C@@H](Nc1ncnc2sc(-c3ccc(O)cc3)cc12)c1ccccc1	Outside typical range	CHEMBL4177361	=	Inhibition	%	-12.0	CHEMBL267	Homo sapiens	INH	%	-12.0
	18434192	CHEMBL4156134	Inhibition of human full length Src expressed in baculovirus expression system at 500 nM by Z-LYTE assay relative to control	B	CCC(=O)Nc1ccc(-c2c[nH]c3ncnc(N[C@H](C)c4ccccc4)c23)cc1		CHEMBL4167749	=	Inhibition	%	16.0	CHEMBL267	Homo sapiens	INH	%	16.0
	18434252	CHEMBL4156134	Inhibition of human full length Src expressed in baculovirus expression system at 500 nM by Z-LYTE assay relative to control	B	CN(C)CCn1cc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL4159505	=	Inhibition	%	55.0	CHEMBL267	Homo sapiens	INH	%	55.0
	18434324	CHEMBL4156134	Inhibition of human full length Src expressed in baculovirus expression system at 500 nM by Z-LYTE assay relative to control	B	OCc1ccc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3[nH]2)cc1		CHEMBL4175024	=	Inhibition	%	74.0	CHEMBL267	Homo sapiens	INH	%	74.0
	18440457	CHEMBL4157281	Binding affinity to wild-type human partial length SRC (L240 to L536 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	81.0	CHEMBL267	Homo sapiens	Activity	%	81.0
	18443298	CHEMBL4157939	Inhibition of human SRC assessed as enzyme residual activity at 100 nM by radiometric filter binding assay relative to control	B	NCCCC[C@@H](NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)CCCCCNC(=O)CCC(=O)Nc1ncc(-c2ccc(C(=O)O)cc2)s1)C(=O)O		CHEMBL4177303	=	Activity	%	103.0	CHEMBL267	Homo sapiens	Activity	%	103.0
	18449487	CHEMBL4177948	Inhibition of SRC (unknown origin) at 1 uM	B	CCOC(=O)C1=C(CN2CCOCC2)NC(c2nccs2)=NC1c1ccc(F)cc1Br		CHEMBL3742114	=	Inhibition	%	-3.0	CHEMBL267	Homo sapiens	INH	%	-3.0
	18449878	CHEMBL4178112	Inhibition of human SRC (1 to 536 residues) assessed as residual activity at 500 nM in presence of 33P-ATP by filter binding assay relative to control	B	Cc1cccc(-c2nc(N)sc2-c2ccc3ncccc3n2)c1		CHEMBL4209540	=	Activity	%	105.0	CHEMBL267	Homo sapiens	Activity	%	105.0
	18450289	CHEMBL4178288	Inhibition of SRC (unknown origin) assessed as change in enzyme activity in presence of 1 uM ATP relative to control	B	CCN1CCN(Cc2ccc(-c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)cc(F)c7C6=O)c5CO)ccnc4[nH]3)nc2)CC1		CHEMBL3967108	=	Activity	%	-33.0	CHEMBL267	Homo sapiens	Activity	%	-33.0
	18450339	CHEMBL4178288	Inhibition of SRC (unknown origin) assessed as change in enzyme activity in presence of 1 uM ATP relative to control	B	O=C1c2c(F)cc(C3CC3)cc2OCCN1c1cccc(-c2ccnc3[nH]c(C4=CCN(C5COC5)CC4)cc23)c1CO		CHEMBL3966346	=	Activity	%	-26.0	CHEMBL267	Homo sapiens	Activity	%	-26.0
	18457618	CHEMBL4179660	Inhibition of human SRC at 1 uM using poly(Glu,Tyr)4:1 as substrate by filter binding method relative to control	B	CS(=O)(=O)N1CCN(Cc2cc3c(N4CCOCC4)nc(-c4cnc(N)nc4)cn3n2)CC1		CHEMBL4212439	<	Inhibition	%	25.0	CHEMBL267	Homo sapiens	INH	%	25.0
	18457619	CHEMBL4179660	Inhibition of human SRC at 1 uM using poly(Glu,Tyr)4:1 as substrate by filter binding method relative to control	B	CS(=O)(=O)N1CCN(Cc2nc3c(N4CCOCC4)nc(-c4cnc(N)nc4)cn3n2)CC1		CHEMBL4217392	<	Inhibition	%	25.0	CHEMBL267	Homo sapiens	INH	%	25.0
	18457620	CHEMBL4179660	Inhibition of human SRC at 1 uM using poly(Glu,Tyr)4:1 as substrate by filter binding method relative to control	B	CS(=O)(=O)N1CCN(Cc2cn3nc(-c4cnc(N)nc4)nc(N4CCOCC4)c3n2)CC1		CHEMBL4208064	<	Inhibition	%	25.0	CHEMBL267	Homo sapiens	INH	%	25.0
	18457621	CHEMBL4179660	Inhibition of human SRC at 1 uM using poly(Glu,Tyr)4:1 as substrate by filter binding method relative to control	B	CS(=O)(=O)N1CCN(Cc2nc3c(N4CCOCC4)nc(-c4cnc(N)nc4)c(Cl)n3n2)CC1		CHEMBL4205584	<	Inhibition	%	25.0	CHEMBL267	Homo sapiens	INH	%	25.0
	18458006	CHEMBL4179902	Inhibition of recombinant human SRC at 10 uM using Ulight-Poly GAT[EAY(1:1:1)]n as substrate after 10 mins by LANCE assay	B	N#Cc1cc(S(=O)(=O)Nc2ncns2)ccc1Oc1ccc(-c2cccc(C(F)(F)F)c2)cc1-c1ccnc(CNCCC2CCNCC2)c1		CHEMBL4217988	=	Inhibition	%	9.0	CHEMBL267	Homo sapiens	INH	%	9.0
	18463742	CHEMBL4181158	Inhibition of recombinant human N-Terminal His6-tagged cSRC expressed in Sf21 cells at 10 uM by filter binding radioactive ATP transferase assay relative to control	B	C=C(C)n1c(=O)n(C(C)=O)c2cc(Br)cnc21		CHEMBL4212680	=	Inhibition	%	-4.0	CHEMBL267	Homo sapiens	INH	%	-4.0
	18477358	CHEMBL4183793	Inhibition of full length human N-terminal GST-tagged SRC expressed in baculovirus expression system at 10 nM relative to control	B	N[C@H]1CC[C@H](Nc2nc(Nc3ccc(CN4CCOCC4)cc3)c3ncn(C4CCCC4)c3n2)CC1		CHEMBL4204373	>	Inhibition	%	90.0	CHEMBL267	Homo sapiens	INH	%	90.0
	18484413	CHEMBL4186060	Binding affinity to wild-type human partial length SRC (L240 to L536 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	96.0	CHEMBL267	Homo sapiens	Activity	%	96.0
	18484897	CHEMBL4186060	Binding affinity to wild-type human partial length SRC (L240 to L536 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	87.0	CHEMBL267	Homo sapiens	Activity	%	87.0
	18488641	CHEMBL4187181	Binding affinity to recombinant human Src at 10 uM after 10 mins by LANCE assay relative to control	B	CCOc1c(Cl)cc(C(=O)Nc2ccc(C(=O)O)c(C)c2)cc1OC(C)C		CHEMBL4202767	<=	Activity	%	25.0	CHEMBL267	Homo sapiens	Activity	%	25.0
	18489565	CHEMBL4187306	Inhibition of wild-type human partial length SRC (L240 to L536 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	Fc1cc(F)cc(-n2cnc3c(NCc4nc5c(F)c(F)ccc5[nH]4)nc(N4CCOCC4)nc32)c1		CHEMBL4207079	=	Activity	%	78.0	CHEMBL267	Homo sapiens	Activity	%	78.0
	18499450	CHEMBL4188976	Inhibition of wild-type human partial length SRC (L240 to L536 residues) expressed in bacterial expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP	B	CNc1ncc2c(-c3ccc(N4CCN(C(=O)C(C)(C)C)CC4)nc3)nn(CC3CCCC3)c2n1		CHEMBL4204515	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	18499451	CHEMBL4188976	Inhibition of wild-type human partial length SRC (L240 to L536 residues) expressed in bacterial expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP	B	CCN1CCN(c2ccc(-c3nn(CC4CCCC4)c4nc(NC)ncc34)cn2)CC1		CHEMBL4213775	=	IC50	nM	3600.0	CHEMBL267	Homo sapiens	IC50	uM	3.6
	18499452	CHEMBL4188976	Inhibition of wild-type human partial length SRC (L240 to L536 residues) expressed in bacterial expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP	B	CNc1ncc2c(-c3ccc(N4CCN(C)CC4)nc3)nn(CC3CCCC3)c2n1		CHEMBL4208852	=	IC50	nM	800.0	CHEMBL267	Homo sapiens	IC50	uM	0.8
	18499453	CHEMBL4188976	Inhibition of wild-type human partial length SRC (L240 to L536 residues) expressed in bacterial expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP	B	CNc1ncc2c(-c3ccc(N4CCN(C)CC4)cc3)nn(CC3CCCC3)c2n1		CHEMBL4218175	=	IC50	nM	93.0	CHEMBL267	Homo sapiens	IC50	uM	0.093
	18499454	CHEMBL4188976	Inhibition of wild-type human partial length SRC (L240 to L536 residues) expressed in bacterial expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP	B	Nc1nc(Nc2ccc3c(c2)CC[C@@H](N2CCCC2)CC3)nn1-c1cc2c(nn1)-c1ccccc1CCC2		CHEMBL3809489	=	IC50	nM	37.0	CHEMBL267	Homo sapiens	IC50	uM	0.037
	18499455	CHEMBL4188976	Inhibition of wild-type human partial length SRC (L240 to L536 residues) expressed in bacterial expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP	B	CNc1ncc2c(-c3ccc(N4CCN(C(=O)C(C)(C)C)CC4)nc3)nn(Cc3cn(Cc4ccccc4)nn3)c2n1		CHEMBL4207004	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	18499456	CHEMBL4188976	Inhibition of wild-type human partial length SRC (L240 to L536 residues) expressed in bacterial expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP	B	CCN1CCN(c2ccc(-c3nn(Cc4cn(Cc5ccccc5)nn4)c4nc(NC)ncc34)cn2)CC1		CHEMBL4217649	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	18499457	CHEMBL4188976	Inhibition of wild-type human partial length SRC (L240 to L536 residues) expressed in bacterial expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP	B	CNc1ncc2c(-c3ccc(N4CCN(C)CC4)nc3)nn(Cc3cn(Cc4ccccc4)nn3)c2n1		CHEMBL4218369	=	IC50	nM	8300.0	CHEMBL267	Homo sapiens	IC50	uM	8.3
	18499458	CHEMBL4188976	Inhibition of wild-type human partial length SRC (L240 to L536 residues) expressed in bacterial expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP	B	CNc1ncc2c(-c3ccc(N4CCNCC4)cc3)nn(Cc3cn(Cc4ccccc4)nn3)c2n1		CHEMBL4211308	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	18499459	CHEMBL4188976	Inhibition of wild-type human partial length SRC (L240 to L536 residues) expressed in bacterial expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP	B	CNc1ncc2c(-c3ccc(N4CCNCC4)nc3)nn(Cc3cn(-c4ccsc4C(=O)OC)nn3)c2n1		CHEMBL4205191	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	18499460	CHEMBL4188976	Inhibition of wild-type human partial length SRC (L240 to L536 residues) expressed in bacterial expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP	B	CNc1ncc2c(-c3ccc(N4CCNCC4)nc3)nn(Cc3cn(Cc4ccccc4)nn3)c2n1		CHEMBL4210084	=	IC50	nM	1000.0	CHEMBL267	Homo sapiens	IC50	uM	1.0
	18499461	CHEMBL4188976	Inhibition of wild-type human partial length SRC (L240 to L536 residues) expressed in bacterial expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP	B	CNc1ncc2c(-c3ccc(OC)cc3)nn(CC3OCCO3)c2n1		CHEMBL4209569	=	IC50	nM	7200.0	CHEMBL267	Homo sapiens	IC50	uM	7.2
	18499462	CHEMBL4188976	Inhibition of wild-type human partial length SRC (L240 to L536 residues) expressed in bacterial expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP	B	CNc1ncc2c(-c3ccc(N4CCNCC4)nc3)nn(CC3OCCO3)c2n1		CHEMBL4214476	=	IC50	nM	890.0	CHEMBL267	Homo sapiens	IC50	uM	0.89
	18499463	CHEMBL4188976	Inhibition of wild-type human partial length SRC (L240 to L536 residues) expressed in bacterial expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP	B	CNc1ncc2c(-c3ccc(N4CCNCC4)nc3)nn(CC3CCCC3)c2n1		CHEMBL4213003	=	IC50	nM	1100.0	CHEMBL267	Homo sapiens	IC50	uM	1.1
	18507597	CHEMBL4191202	Inhibition of recombinant full-length human Src T341M mutant at 1 uM using GGEEEEYFELVKKKK as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	7.0	CHEMBL267	Homo sapiens	INH	%	7.0
	18507598	CHEMBL4191201	Inhibition of recombinant human Src (1 to 530 residues) at 1 uM using GGEEEEYFELVKKKK as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	64.0	CHEMBL267	Homo sapiens	INH	%	64.0
	18507829	CHEMBL4190933	Inhibition of recombinant full-length human cSRC at 1 uM using KVEKIGEGTYGVVYK (Cdc2 peptide) as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	53.0	CHEMBL267	Homo sapiens	INH	%	53.0
	18531729	CHEMBL4195503	Inhibition of SRC (unknown origin) at 5 uM using KVEKIGEGTYGVVYK-amide as substrate by ADP-Glo kinase assay relative to control	B	O=C(NNC(=O)c1csc(-c2ccc(Cl)cc2Cl)n1)c1ccccn1		CHEMBL4213787	<	Inhibition	%	50.0	CHEMBL267	Homo sapiens	INH	%	50.0
	18531730	CHEMBL4195504	Inhibition of wild-type human partial length SRC (L240 to L536 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(NNC(=O)c1csc(-c2ccc(Cl)cc2Cl)n1)c1ccccn1		CHEMBL4213787	=	Activity	%	75.0	CHEMBL267	Homo sapiens	Activity	%	75.0
	18558647	CHEMBL4201071	Inhibition of human c-Src at 1 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1N1Cc2cnc(N)nc2N(C)C1=O		CHEMBL459850	=	Inhibition	%	100.0	CHEMBL267	Homo sapiens	INH	%	100.0
Not Active	18570952	CHEMBL4220987	Inhibition of SRC phosphorylation (unknown origin)	B	COC1=CC(=O)/C(=C(\C=C\c2ccccc2)OC)C1=O		CHEMBL4227292		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	18577619	CHEMBL4222206	Inhibition of human full length Src expressed in baculovirus expression system at 1 uM using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay relative to control	B	C=CC(=O)Nc1cccc(NC(=O)Nc2ccnc(Nc3ccc(N4CCC(N5CCOCC5)CC4)cc3OC)n2)c1		CHEMBL4225781	=	Inhibition	%	58.9	CHEMBL267	Homo sapiens	INH	%	58.9
	18577643	CHEMBL4222206	Inhibition of human full length Src expressed in baculovirus expression system at 1 uM using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay relative to control	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	=	Inhibition	%	12.1	CHEMBL267	Homo sapiens	INH	%	12.1
	18577667	CHEMBL4222206	Inhibition of human full length Src expressed in baculovirus expression system at 1 uM using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay relative to control	B	C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3699588	=	Inhibition	%	22.5	CHEMBL267	Homo sapiens	INH	%	22.5
	18653355	CHEMBL4230228	Inhibition of SRC (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	100.0	CHEMBL267	Homo sapiens	INH	%	100.0
	18653356	CHEMBL4230228	Inhibition of SRC (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	80.0	CHEMBL267	Homo sapiens	INH	%	80.0
	18655275	CHEMBL4230960	Binding affinity to wild-type human partial length SRC (L240 to L536 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	100.0	CHEMBL267	Homo sapiens	Activity	%	100.0
	18656114	CHEMBL4231156	Inhibition of recombinant human Src using Ulight-Poly GAT[EAY(1:1:1)]n as substrate measured after 10 mins by LANCE assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	8.8	CHEMBL267	Homo sapiens	IC50	10'-9M	8.8
	18656120	CHEMBL4231145	Inhibition of recombinant human Src at 10'-5 M using Ulight-Poly GAT[EAY(1:1:1)]n as substrate measured after 10 mins by LANCE assay relative to control	B	COc1ccc(Nc2ncc3c(n2)-c2ccccc2SC3)cc1OC		CHEMBL4240970	=	Inhibition	%	53.0	CHEMBL267	Homo sapiens	INH	%	53.0
	18656511	CHEMBL4231219	Inhibition of recombinant human Src expressed in insect cells using Ulight-Poly GAT[EAY(1:1:1)]n as substrate after 10 mins by LANCE method	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	5.0	CHEMBL267	Homo sapiens	IC50	10'-9M	5.0
	18663961	CHEMBL4232945	Inhibition of human SRC (L240 to L536 residues) expressed in bacterial expression system assessed as residual activity at 5 uM by KINOMEscan assay relative to control	B	CC(C)CN(C(=O)c1cccnc1)c1c2ccccc2c(=O)n2c1[nH]c1ccccc12		CHEMBL4247704	=	Activity	%	100.0	CHEMBL267	Homo sapiens	Activity	%	100.0
	18664058	CHEMBL4233042	Binding affinity to human SRC (L240 to L536 residues) expressed in bacterial expression system by KINOMEscan assay	B	CC(C)CN(C(=O)c1cccnc1)c1c2ccccc2c(=O)n2c1[nH]c1ccccc12		CHEMBL4247704	>=	Kd	nM	5000.0	CHEMBL267	Homo sapiens	Kd	uM	5.0
	18665453	CHEMBL4233412	Inhibition of SRC (unknown origin)	B	O=C(Cc1cccc(OCCCN2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL4245507	>	IC50	nM	5000.0	CHEMBL267	Homo sapiens	IC50	nM	5000.0
	18665466	CHEMBL4233412	Inhibition of SRC (unknown origin)	B	O=C(Cc1cccc(OCCCC2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL4251324	>	IC50	nM	3300.0	CHEMBL267	Homo sapiens	IC50	nM	3300.0
	18674910	CHEMBL4235439	Inhibition of SRC (unknown origin)	B	CS(=O)(=O)Nc1cccc(CC(=O)Nc2nc(-c3c[nH]c4ncccc34)cs2)c1		CHEMBL4249925	>	Ki	nM	4000.0	CHEMBL267	Homo sapiens	Ki	nM	4000.0
	18674911	CHEMBL4235439	Inhibition of SRC (unknown origin)	B	O=C(Cc1cccc(OCCCC2CCNCC2)c1)Nc1nc(-c2c[nH]c3ncccc23)cs1		CHEMBL4245242	>	Ki	nM	4000.0	CHEMBL267	Homo sapiens	Ki	nM	4000.0
	18674912	CHEMBL4235439	Inhibition of SRC (unknown origin)	B	CN1CCN(CCCOc2cccc(CC(=O)Nc3nc(-c4c[nH]c5ncccc45)cs3)c2)CC1		CHEMBL4248525	>	Ki	nM	4000.0	CHEMBL267	Homo sapiens	Ki	nM	4000.0
	18694028	CHEMBL4253481	Inhibition of recombinant human full length His-tagged SRC expressed in baculovirus expression system at 0.1 uM by Z'-Lyte assay relative to control	B	CC1=Nc2c(F)cc(-c3nc(Nc4ccc(C5CCN(C)CC5)cn4)ncc3F)cc2C12CCCC2		CHEMBL4277900	=	Inhibition	%	3.0	CHEMBL267	Homo sapiens	INH	%	3.0
	18694110	CHEMBL4253563	Inhibition of recombinant human full length His-tagged SRC expressed in baculovirus expression system at 1 uM by Z'-Lyte assay relative to control	B	CC1=Nc2c(F)cc(-c3nc(Nc4ccc(C5CCN(C)CC5)cn4)ncc3F)cc2C12CCCC2		CHEMBL4277900	=	Inhibition	%	7.0	CHEMBL267	Homo sapiens	INH	%	7.0
	18697687	CHEMBL4254360	Inhibition of wild-type human partial length SRC (L240 to L536 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCNc1cc(-c2ccc(NC(=O)Nc3cccc(Cl)c3)cc2C(F)(F)F)ccn1		CHEMBL4281348	=	Activity	%	93.0	CHEMBL267	Homo sapiens	Activity	%	93.0
	18702474	CHEMBL4255133	Inhibition of recombinant human full length His-tagged SRC expressed in baculovirus expression system at 1 uM relative to control	B	COc1ccc(S(N)(=O)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4278211	=	Inhibition	%	4.0	CHEMBL267	Homo sapiens	INH	%	4.0
	18702564	CHEMBL4255133	Inhibition of recombinant human full length His-tagged SRC expressed in baculovirus expression system at 1 uM relative to control	B	COc1ccc(C(N)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4282644	=	Inhibition	%	7.0	CHEMBL267	Homo sapiens	INH	%	7.0
	18702609	CHEMBL4255133	Inhibition of recombinant human full length His-tagged SRC expressed in baculovirus expression system at 1 uM relative to control	B	COc1ccc(S(C)(=O)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4287097	=	Inhibition	%	3.0	CHEMBL267	Homo sapiens	INH	%	3.0
	18702661	CHEMBL4255133	Inhibition of recombinant human full length His-tagged SRC expressed in baculovirus expression system at 1 uM relative to control	B	COc1cc(C)c(S(N)(=O)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4283739	=	Inhibition	%	1.0	CHEMBL267	Homo sapiens	INH	%	1.0
	18702704	CHEMBL4255133	Inhibition of recombinant human full length His-tagged SRC expressed in baculovirus expression system at 1 uM relative to control	B	COc1cc(C)c(C(N)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4294318	=	Inhibition	%	8.0	CHEMBL267	Homo sapiens	INH	%	8.0
	18702747	CHEMBL4255133	Inhibition of recombinant human full length His-tagged SRC expressed in baculovirus expression system at 1 uM relative to control	B	COc1cc(C)c(S(C)(=O)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4289040	=	Inhibition	%	-1.0	CHEMBL267	Homo sapiens	INH	%	-1.0
Not Active	18705628	CHEMBL4255924	Inhibition of SRC phosphorylation in human MDA-MB-231 cells at 5 uM after 24 hrs by immunoblot analysis	B	C[C@H](C(=O)N(Cc1ccc(C2CCCCC2)cc1)c1ccc(C(=O)O)cc1Cl)N(C)S(=O)(=O)c1c(F)c(F)c(F)c(F)c1F		CHEMBL4287027		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	18705629	CHEMBL4255924	Inhibition of SRC phosphorylation in human MDA-MB-231 cells at 5 uM after 24 hrs by immunoblot analysis	B	CC[C@H](C(=O)N(Cc1ccc(C2CCCCC2)cc1)c1ccc(C(=O)O)cc1C)N(C)S(=O)(=O)c1c(F)c(F)c(F)c(F)c1F		CHEMBL4283675		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	18706764	CHEMBL4256122	Inhibition of SRC (unknown origin) at 50 ug/ml by mobility shift assay relative to control	B	CC(C)c1ccc2c(c1)CC[C@@H]1[C@]2(C)CCC[C@@]1(C)C(=O)O		CHEMBL12850	=	Inhibition	%	61.2	CHEMBL267	Homo sapiens	INH	%	61.2
	18706778	CHEMBL4256135	Inhibition of SRC (unknown origin) by mobility shift assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	2.6	CHEMBL267	Homo sapiens	IC50	nM	2.6
	18708928	CHEMBL4256648	Inhibition of SRC (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	Nc1ccc[nH]c1=O		CHEMBL4286709	=	Inhibition	%	31.0	CHEMBL267	Homo sapiens	INH	%	31.0
	18708957	CHEMBL4256648	Inhibition of SRC (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	Cn1cc(-c2c[nH]c(=O)c(N)c2)cn1		CHEMBL4288628	=	Inhibition	%	86.0	CHEMBL267	Homo sapiens	INH	%	86.0
	18708985	CHEMBL4256648	Inhibition of SRC (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	Nc1cc(-c2ccncc2)c[nH]c1=O		CHEMBL12856	=	Inhibition	%	12.0	CHEMBL267	Homo sapiens	INH	%	12.0
	18709018	CHEMBL4256648	Inhibition of SRC (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	COc1ncc(-c2ccncc2)cc1N		CHEMBL4291350	=	Inhibition	%	8.0	CHEMBL267	Homo sapiens	INH	%	8.0
	18709047	CHEMBL4256648	Inhibition of SRC (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	Nc1cc(-c2ccnc3ccccc23)c[nH]c1=O		CHEMBL4280308	=	Inhibition	%	24.0	CHEMBL267	Homo sapiens	INH	%	24.0
	18709076	CHEMBL4256648	Inhibition of SRC (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	CNc1nccc(-c2c[nH]c(=O)c(N)c2)n1		CHEMBL4292538	=	Inhibition	%	89.0	CHEMBL267	Homo sapiens	INH	%	89.0
	18709105	CHEMBL4256648	Inhibition of SRC (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	Nc1cc(-c2ccnc(NC3CC3)n2)c[nH]c1=O		CHEMBL4282263	=	Inhibition	%	46.0	CHEMBL267	Homo sapiens	INH	%	46.0
	18709152	CHEMBL4256648	Inhibition of SRC (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	Cc1nc(O)c(N)cc1-c1ccncc1		CHEMBL302219	=	Inhibition	%	21.0	CHEMBL267	Homo sapiens	INH	%	21.0
	18709182	CHEMBL4256674	Inhibition of SRC (unknown origin) at 30 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	O=C(Nc1cc(-c2ccncc2)c[nH]c1=O)c1ccccc1		CHEMBL1738828	=	Inhibition	%	60.0	CHEMBL267	Homo sapiens	INH	%	60.0
	18709211	CHEMBL4256648	Inhibition of SRC (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	COc1cccc(C(=O)Nc2cc(-c3ccncc3)c[nH]c2=O)c1		CHEMBL4285109	=	Inhibition	%	59.0	CHEMBL267	Homo sapiens	INH	%	59.0
	18709253	CHEMBL4256674	Inhibition of SRC (unknown origin) at 30 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	CN1CCN(c2ccc(C(=O)Nc3cc(-c4ccncc4)c[nH]c3=O)cc2)CC1		CHEMBL4286130	=	Inhibition	%	98.0	CHEMBL267	Homo sapiens	INH	%	98.0
	18709286	CHEMBL4256674	Inhibition of SRC (unknown origin) at 30 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	O=C(Nc1cc(-c2ccnc(NC3CC3)n2)c[nH]c1=O)c1ccccc1		CHEMBL4291472	=	Inhibition	%	99.0	CHEMBL267	Homo sapiens	INH	%	99.0
	18725408	CHEMBL4259105	Inhibition of GST/His-tagged SRC (unknown origin)	B	CC(=O)n1nc(C)c(-c2ccc(Cl)c(Cl)c2)c1N		CHEMBL4276946	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	18737834	CHEMBL4261405	Inhibition of recombinant full length human cSRC using KVEKIGEGTYGVV as substrate after 40 mins in presence of [gamma-33P]-ATP by scintillation counting analysis	B	CCn1cc(-c2ccc3c(c2)CCN3C(=O)Cc2cccc(OC(F)(F)F)c2)c2c(N)ncnc21		CHEMBL4281823	=	IC50	nM	173.0	CHEMBL267	Homo sapiens	IC50	nM	173.0
	18737909	CHEMBL4261443	Inhibition of recombinant human Src (1 to 530 residues) using GGEEEEYFELVKK as substrate after 40 mins in presence of [gamma-33P]-ATP by scintillation counting analysis	B	CCn1cc(-c2ccc3c(c2)CCN3C(=O)Cc2cccc(OC(F)(F)F)c2)c2c(N)ncnc21		CHEMBL4281823	=	IC50	nM	207.0	CHEMBL267	Homo sapiens	IC50	nM	207.0
	18751242	CHEMBL4263951	Inhibition of SRC (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	18.0	CHEMBL267	Homo sapiens	INH	%	18.0
	18752212	CHEMBL4264549	Binding affinity to wild-type human partial length SRC (L240 to L536 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	89.0	CHEMBL267	Homo sapiens	Activity	%	89.0
	18761468	CHEMBL4266546	Inhibition of recombinant human N-terminal 6His-tagged full length c-SRC expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc([C@H]4CC[C@H](C(N)=O)CC4)c23)CC1		CHEMBL4279192	=	Inhibition	%	2.0	CHEMBL267	Homo sapiens	INH	%	2.0
	18761583	CHEMBL4266634	Inhibition of recombinant human N-terminal 6His-tagged SRC (1 to 530 residues) expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc([C@H]4CC[C@H](C(N)=O)CC4)c23)CC1		CHEMBL4279192	=	Inhibition	%	5.0	CHEMBL267	Homo sapiens	INH	%	5.0
	18761584	CHEMBL4266635	Inhibition of recombinant human N-terminal GST-tagged SRC (1 to 530 residues) expressed in Escherichia coli at 1 uM relative to control	B	CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc([C@H]4CC[C@H](C(N)=O)CC4)c23)CC1		CHEMBL4279192	=	Inhibition	%	5.0	CHEMBL267	Homo sapiens	INH	%	5.0
	18761764	CHEMBL4266546	Inhibition of recombinant human N-terminal 6His-tagged full length c-SRC expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C(C)C)c34)CC2)CC1		CHEMBL4278882	=	Inhibition	%	5.0	CHEMBL267	Homo sapiens	INH	%	5.0
	18761854	CHEMBL4266634	Inhibition of recombinant human N-terminal 6His-tagged SRC (1 to 530 residues) expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C(C)C)c34)CC2)CC1		CHEMBL4278882	=	Inhibition	%	17.0	CHEMBL267	Homo sapiens	INH	%	17.0
	18761855	CHEMBL4266635	Inhibition of recombinant human N-terminal GST-tagged SRC (1 to 530 residues) expressed in Escherichia coli at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C(C)C)c34)CC2)CC1		CHEMBL4278882	=	Inhibition	%	17.0	CHEMBL267	Homo sapiens	INH	%	17.0
	18761927	CHEMBL4266546	Inhibition of recombinant human N-terminal 6His-tagged full length c-SRC expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C5CCOCC5)c34)CC2)CC1	Outside typical range	CHEMBL4290222	=	Inhibition	%	-13.0	CHEMBL267	Homo sapiens	INH	%	-13.0
	18762017	CHEMBL4266634	Inhibition of recombinant human N-terminal 6His-tagged SRC (1 to 530 residues) expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C5CCOCC5)c34)CC2)CC1		CHEMBL4290222	=	Inhibition	%	1.0	CHEMBL267	Homo sapiens	INH	%	1.0
	18762018	CHEMBL4266635	Inhibition of recombinant human N-terminal GST-tagged SRC (1 to 530 residues) expressed in Escherichia coli at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C5CCOCC5)c34)CC2)CC1		CHEMBL4290222	=	Inhibition	%	-5.0	CHEMBL267	Homo sapiens	INH	%	-5.0
	18763061	CHEMBL4266858	Inhibition of c-Src (unknown origin) at 1 uM	B	CNC(=O)Nc1sc2c(C(C)C)cc(NS(=O)(=O)N(C)C)cc2c1C(N)=O		CHEMBL4290876	=	Inhibition	%	94.39	CHEMBL267	Homo sapiens	INH	%	94.39
	18763092	CHEMBL4266889	Inhibition of c-Src (unknown origin) at 10 uM	B	CNC(=O)Nc1sc2c(C(C)C)cc(NS(=O)(=O)c3cccs3)cc2c1C(N)=O		CHEMBL4288081	=	Inhibition	%	104.99	CHEMBL267	Homo sapiens	INH	%	104.99
	18764581	CHEMBL4267096	Inhibition of human Src at 100 nM	B	CN1CCC(c2nc(-c3ccc(F)cc3)c(-c3ccnc(Nc4ccc(N5CCNCC5)cc4)n3)s2)CC1		CHEMBL4288103	=	Inhibition	%	70.0	CHEMBL267	Homo sapiens	INH	%	70.0
	18764582	CHEMBL4267096	Inhibition of human Src at 100 nM	B	CN1CCC(c2nc(-c3cccc(S(C)(=O)=O)c3)c(-c3ccnc(Nc4ccc(N5CCNCC5)cc4)n3)s2)CC1		CHEMBL4286880	<	Inhibition	%	70.0	CHEMBL267	Homo sapiens	INH	%	70.0
	18764583	CHEMBL4267096	Inhibition of human Src at 100 nM	B	CN1CCC(c2nc(-c3ccc(F)c(NS(C)(=O)=O)c3)c(-c3ccnc(NCC4CC4)n3)s2)CC1		CHEMBL4286841	<	Inhibition	%	70.0	CHEMBL267	Homo sapiens	INH	%	70.0
	18765549	CHEMBL4267270	Inhibition of N-terminal GST-tagged full length human SRC cytoplasmic domain (1 to 536 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	COc1cccc(Nc2cc(Nc3cc(OC)ccc3OC)ncn2)c1		CHEMBL4288300	=	Inhibition	%	33.2	CHEMBL267	Homo sapiens	INH	%	33.2
	18765550	CHEMBL4267270	Inhibition of N-terminal GST-tagged full length human SRC cytoplasmic domain (1 to 536 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	COc1ccc(Nc2cc(NC(=O)c3ccccc3)ncn2)cc1		CHEMBL4283823	=	Inhibition	%	27.7	CHEMBL267	Homo sapiens	INH	%	27.7
	18765551	CHEMBL4267270	Inhibition of N-terminal GST-tagged full length human SRC cytoplasmic domain (1 to 536 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	O=C(O)CCCC(=O)Nc1cc(Nc2cccc(Cl)c2)ncn1		CHEMBL4282460	=	Inhibition	%	83.7	CHEMBL267	Homo sapiens	INH	%	83.7
	18765552	CHEMBL4267270	Inhibition of N-terminal GST-tagged full length human SRC cytoplasmic domain (1 to 536 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	CCOC(=O)c1ccc(Nc2cc(NC(=O)CCCC(=O)O)ncn2)cc1		CHEMBL4290750	=	Inhibition	%	11.4	CHEMBL267	Homo sapiens	INH	%	11.4
	18765553	CHEMBL4267270	Inhibition of N-terminal GST-tagged full length human SRC cytoplasmic domain (1 to 536 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	COc1cccc(Nc2cc(NC(=O)CCCC(=O)O)ncn2)c1		CHEMBL4294156	=	Inhibition	%	16.6	CHEMBL267	Homo sapiens	INH	%	16.6
	18765554	CHEMBL4267270	Inhibition of N-terminal GST-tagged full length human SRC cytoplasmic domain (1 to 536 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	O=C(O)CCCC(=O)Nc1cc(N2CCOCC2)ncn1		CHEMBL4283970	=	Inhibition	%	11.7	CHEMBL267	Homo sapiens	INH	%	11.7
	18769906	CHEMBL4268037	Inhibition of recombinant human c-SRC at 1000 nM after 60 mins by ELISA relative to control	B	Cc1ccc(C2=Nc3c(n[nH]c3C)Nc3nc(N4CCOCC4)ncc32)cc1		CHEMBL4282231	=	Inhibition	%	32.0	CHEMBL267	Homo sapiens	INH	%	32.0
Not Determined	18769907	CHEMBL4268037	Inhibition of recombinant human c-SRC at 1000 nM after 60 mins by ELISA relative to control	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	18769908	CHEMBL4268037	Inhibition of recombinant human c-SRC at 1000 nM after 60 mins by ELISA relative to control	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Inhibition	%	100.0	CHEMBL267	Homo sapiens	INH	%	100.0
Not Determined	18769909	CHEMBL4268037	Inhibition of recombinant human c-SRC at 1000 nM after 60 mins by ELISA relative to control	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL1614712		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	18769910	CHEMBL4268038	Inhibition of recombinant human c-SRC at 100 nM after 60 mins by ELISA relative to control	B	Cc1ccc(C2=Nc3c(n[nH]c3C)Nc3nc(N4CCOCC4)ncc32)cc1		CHEMBL4282231	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	18773309	CHEMBL4268756	Inhibition of human c-Src using KVEKIGEGTYGVVYK as substrate in presence of [gamma32P]ATP by scintillation counting method	B	CC(Cn1ncc2c(Nc3cc(O)ccc3Cl)ncnc21)c1ccccc1		CHEMBL4281871	=	Ki	nM	120.0	CHEMBL267	Homo sapiens	Ki	uM	0.12
	18773314	CHEMBL4268756	Inhibition of human c-Src using KVEKIGEGTYGVVYK as substrate in presence of [gamma32P]ATP by scintillation counting method	B	Oc1ccc(Cl)c(Nc2ncnc3c2cnn3CC(Cl)c2ccccc2)c1		CHEMBL4286320	=	Ki	nM	17.0	CHEMBL267	Homo sapiens	Ki	uM	0.017
	18773321	CHEMBL4268756	Inhibition of human c-Src using KVEKIGEGTYGVVYK as substrate in presence of [gamma32P]ATP by scintillation counting method	B	CSc1nc(Nc2cc(O)ccc2Cl)c2cnn(CC(C)c3ccccc3)c2n1		CHEMBL4278410	=	Ki	nM	50.0	CHEMBL267	Homo sapiens	Ki	uM	0.05
	18773328	CHEMBL4268756	Inhibition of human c-Src using KVEKIGEGTYGVVYK as substrate in presence of [gamma32P]ATP by scintillation counting method	B	CSc1nc(Nc2cc(O)ccc2Cl)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL4277981	=	Ki	nM	3.5	CHEMBL267	Homo sapiens	Ki	uM	0.0035
	18773336	CHEMBL4268767	Potency index ratio of 3-(6-(2-morpholinoethylthio)-1-(2-phenylpropyl)-1H-pyrazolo[3,4-d]pyrimidin-4-ylamino)phenol Ki to compound Ki for inhibition of human c-Src	B	CSc1nc(Nc2cc(O)ccc2Cl)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL4277981	=	Ratio Ki		20.0	CHEMBL267	Homo sapiens	Ratio Ki		20.0
	18773337	CHEMBL4268756	Inhibition of human c-Src using KVEKIGEGTYGVVYK as substrate in presence of [gamma32P]ATP by scintillation counting method	B	CC(Cn1ncc2c(Nc3cc(O)ccc3Cl)nc(SCCN3CCOCC3)nc21)c1ccccc1		CHEMBL4288646	=	Ki	nM	60.0	CHEMBL267	Homo sapiens	Ki	uM	0.06
	18773343	CHEMBL4268756	Inhibition of human c-Src using KVEKIGEGTYGVVYK as substrate in presence of [gamma32P]ATP by scintillation counting method	B	Oc1ccc(Cl)c(Nc2nc(SCCN3CCOCC3)nc3c2cnn3CC(Cl)c2ccccc2)c1		CHEMBL4286927	=	Ki	nM	3.5	CHEMBL267	Homo sapiens	Ki	uM	0.0035
	18773352	CHEMBL4268768	Potency index ratio of 3-(1-(2-chloro-2-phenylethyl)-6-(isopropylthio)-1H-pyrazolo[3,4-d]pyrimidin-4-ylamino)phenol Ki to compound Ki for inhibition of human c-Src	B	Oc1ccc(Cl)c(Nc2nc(SCCN3CCOCC3)nc3c2cnn3CC(Cl)c2ccccc2)c1		CHEMBL4286927	=	Ratio Ki		3.0	CHEMBL267	Homo sapiens	Ratio Ki		3.0
	18773353	CHEMBL4268756	Inhibition of human c-Src using KVEKIGEGTYGVVYK as substrate in presence of [gamma32P]ATP by scintillation counting method	B	CC(Cn1ncc2c(Nc3cc(O)ccc3Cl)nc(NCCO)nc21)c1ccccc1		CHEMBL4294817	=	Ki	nM	23.0	CHEMBL267	Homo sapiens	Ki	uM	0.023
	18773359	CHEMBL4268756	Inhibition of human c-Src using KVEKIGEGTYGVVYK as substrate in presence of [gamma32P]ATP by scintillation counting method	B	OCCNc1nc(Nc2cc(O)ccc2Cl)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL4283564	=	Ki	nM	74.0	CHEMBL267	Homo sapiens	Ki	uM	0.074
	18773368	CHEMBL4268756	Inhibition of human c-Src using KVEKIGEGTYGVVYK as substrate in presence of [gamma32P]ATP by scintillation counting method	B	CC(Cn1ncc2c(Nc3cc(O)ccc3Cl)nc(NCCN)nc21)c1ccccc1		CHEMBL4291408	=	Ki	nM	33.0	CHEMBL267	Homo sapiens	Ki	uM	0.033
	18773374	CHEMBL4268756	Inhibition of human c-Src using KVEKIGEGTYGVVYK as substrate in presence of [gamma32P]ATP by scintillation counting method	B	CSc1nc(Nc2cccc(O)c2)c2cnn(CC(C)c3ccccc3)c2n1		CHEMBL4293733	=	Ki	nM	840.0	CHEMBL267	Homo sapiens	Ki	uM	0.84
	18773379	CHEMBL4268756	Inhibition of human c-Src using KVEKIGEGTYGVVYK as substrate in presence of [gamma32P]ATP by scintillation counting method	B	Oc1cccc(Nc2nc(SCCN3CCOCC3)nc3c2cnn3CC(Cl)c2ccccc2)c1		CHEMBL4283149	=	Ki	nM	190.0	CHEMBL267	Homo sapiens	Ki	uM	0.19
	18773387	CHEMBL4268756	Inhibition of human c-Src using KVEKIGEGTYGVVYK as substrate in presence of [gamma32P]ATP by scintillation counting method	B	CC(Cn1ncc2c(Nc3cccc(O)c3)nc(NCCO)nc21)c1ccccc1		CHEMBL4290337	=	Ki	nM	300.0	CHEMBL267	Homo sapiens	Ki	uM	0.3
	18778954	CHEMBL4269644	Inhibition of human c-SRC using poly[Glu:Tyr] (4:1) as substrate at 1 uM by [gamma-33P]-ATP based assay relative to control	B	COc1cc2nccc(Nc3n[nH]c(C)c3C)c2cc1S(=O)(=O)C(C)(C)C		CHEMBL4293287	>	Inhibition	%	90.0	CHEMBL267	Homo sapiens	INH	%	90.0
	18782862	CHEMBL4270728	Inhibition of SRC (unknown origin) assessed as residual enzyme activity at 1 uM relative to untreated control	B	Cc1cccc(-c2nn3c(c2-c2ccc(O)cc2)C(C)C(C)(C)C3)n1		CHEMBL4277021	>	Activity	%	80.0	CHEMBL267	Homo sapiens	Activity	%	80.0
	18786392	CHEMBL4271723	Inhibition of recombinant c-Src (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA based spectrophotometric method	B	CNC(=O)c1cccc2cc(Oc3ccnc(NC(=O)c4ccc(N5CCN(C)CC5)cc4)c3)ccc12		CHEMBL4290371	>	IC50	nM	1000.0	CHEMBL267	Homo sapiens	IC50	nM	1000.0
	18803894	CHEMBL4274922	Inhibition of Src (unknown origin) using Src-family kinase bisamide rhodamine 110 peptide substrate after 1 hr by fluorescence assay	B	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	=	IC50	nM	0.5	CHEMBL267	Homo sapiens	IC50	nM	0.5
	18803901	CHEMBL4274919	Inhibition of Src (unknown origin) at 0.1 mM using Src-family kinase bisamide rhodamine 110 peptide substrate after 1 hr by fluorescence assay relative to control	B	Nc1nc2[nH]cc(CNC(=O)COc3ccc(Cl)cc3)c2c(=O)[nH]1		CHEMBL4292957	=	Inhibition	%	60.0	CHEMBL267	Homo sapiens	INH	%	60.0
	18803902	CHEMBL4274919	Inhibition of Src (unknown origin) at 0.1 mM using Src-family kinase bisamide rhodamine 110 peptide substrate after 1 hr by fluorescence assay relative to control	B	Cc1ccc(C(=O)NCc2c[nH]c3nc(N)[nH]c(=O)c23)s1		CHEMBL4285132	=	Inhibition	%	71.0	CHEMBL267	Homo sapiens	INH	%	71.0
	18803903	CHEMBL4274919	Inhibition of Src (unknown origin) at 0.1 mM using Src-family kinase bisamide rhodamine 110 peptide substrate after 1 hr by fluorescence assay relative to control	B	COc1ccc(CCCC(=O)NCc2c[nH]c3nc(N)[nH]c(=O)c23)cc1OC		CHEMBL4277831	=	Inhibition	%	54.0	CHEMBL267	Homo sapiens	INH	%	54.0
	18812049	CHEMBL4276189	Inhibition of human c-Src at 100 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Inhibition	%	94.0	CHEMBL267	Homo sapiens	INH	%	94.0
	18812050	CHEMBL4276189	Inhibition of human c-Src at 100 uM	B	O=C(NCc1ccccc1)c1ccc(C2CC(=O)N(Cc3ccccc3[N+](=O)[O-])c3ccccc3S2)cc1		CHEMBL4281295	=	Inhibition	%	7.2	CHEMBL267	Homo sapiens	INH	%	7.2
	18812051	CHEMBL4276189	Inhibition of human c-Src at 100 uM	B	O=C1CC(c2ccc(C(=O)NCc3cccc(Cl)c3)cc2)Sc2ccccc2N1		CHEMBL4277682	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
Not Active	18847266	CHEMBL4304954	Inhibition of wild-type human partial length SRC (L240 to L536 residues) expressed in bacterial expression system at 1 uM by Kinomescan method	B	O=C(Nc1ccc2[nH]nc(-c3ccc4[nH]ccc4c3)c2c1)c1c(Cl)cccc1Cl		CHEMBL4517719		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	18851328	CHEMBL4305820	Inhibition of SRC (unknown origin)	B	Cc1nc2c(F)cc(-c3nc(Nc4ccc5c(n4)CCN(CCN(C)C)C5)ncc3F)cc2n1C(C)C		CHEMBL4448494	=	IC50	nM	1053.0	CHEMBL267	Homo sapiens	IC50	nM	1053.0
	18858212	CHEMBL4308058	Binding affinity to wild-type human partial length SRC (L240 to L536 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	93.0	CHEMBL267	Homo sapiens	Activity	%	93.0
Active	18859185	CHEMBL4308404	Inhibition of c-Src phosphorylation at Y419 residue in human LNCAP cells at 50 uM incubated for 48 hrs by chemiluminescence reagent based autoradiography	B	COc1c2c(c(C)c3c1C(=O)OC3)O[C@@]1(C)C[C@]3(O)OC[C@]4(C)O[C@@]5(OC)CC[C@](C)([C@H]1C2)[C@]43O5		CHEMBL4520516		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	18860567	CHEMBL4308593	Inhibition of Src (unknown origin) assessed as residual activity at 10 uM relative to control	B	CN1CCC(N2CCN(c3ncc4cc(-c5c(Cl)cccc5Cl)c(=O)n(C)c4n3)CC2)CC1		CHEMBL4445155	=	Activity	%	10.5	CHEMBL267	Homo sapiens	Activity	%	10.5
	18860568	CHEMBL4308593	Inhibition of Src (unknown origin) assessed as residual activity at 10 uM relative to control	B	Cn1c(=O)c(-c2c(Cl)cc(NC(=O)OC(C)(C)C)cc2Cl)cc2cnc(N3CCN(c4ccncc4)CC3)nc21		CHEMBL4532540	=	Activity	%	8.0	CHEMBL267	Homo sapiens	Activity	%	8.0
	18860569	CHEMBL4308593	Inhibition of Src (unknown origin) assessed as residual activity at 10 uM relative to control	B	CN1CCC(N2CCN(c3ncc4cc(-c5c(Cl)cc(NC(=O)OC(C)(C)C)cc5Cl)c(=O)n(C)c4n3)CC2)CC1		CHEMBL4471123	=	Activity	%	10.4	CHEMBL267	Homo sapiens	Activity	%	10.4
	18860570	CHEMBL4308593	Inhibition of Src (unknown origin) assessed as residual activity at 10 uM relative to control	B	CN1CCC(N2CCN(c3ncc4cc(-c5c(Cl)cc(NC(=O)C(C)(C)C)cc5Cl)c(=O)n(C)c4n3)CC2)CC1		CHEMBL4561358	=	Activity	%	8.9	CHEMBL267	Homo sapiens	Activity	%	8.9
	18860572	CHEMBL4308595	Inhibition of Src (unknown origin) assessed as residual activity at 1 uM relative to control	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	=	Activity	%	99.5	CHEMBL267	Homo sapiens	Activity	%	99.5
	18881240	CHEMBL4312056	Binding affinity to wild-type human partial length SRC (L240 to L536 residues) expressed in bacterial expression system by TR-FRET assay	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Ki	nM	0.295	CHEMBL267	Homo sapiens	Ki	nM	0.295
	18881241	CHEMBL4312056	Binding affinity to wild-type human partial length SRC (L240 to L536 residues) expressed in bacterial expression system by TR-FRET assay	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCNCC2)n1		CHEMBL4538000	=	Ki	nM	0.449	CHEMBL267	Homo sapiens	Ki	nM	0.449
	18881242	CHEMBL4312056	Binding affinity to wild-type human partial length SRC (L240 to L536 residues) expressed in bacterial expression system by TR-FRET assay	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCOCCOCCNC(=O)OC(C)(C)C)CC2)n1		CHEMBL4469856	=	Ki	nM	0.785	CHEMBL267	Homo sapiens	Ki	nM	0.785
	18881243	CHEMBL4312056	Binding affinity to wild-type human partial length SRC (L240 to L536 residues) expressed in bacterial expression system by TR-FRET assay	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCOCCOCCN)CC2)n1		CHEMBL4474070	=	Ki	nM	0.261	CHEMBL267	Homo sapiens	Ki	nM	0.261
Not Determined	18881244	CHEMBL4312056	Binding affinity to wild-type human partial length SRC (L240 to L536 residues) expressed in bacterial expression system by TR-FRET assay	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCOCCOCCNC(=O)CCCCCC3(C)C(/C=C/C=C/C=C4/N(CCCS(=O)(=O)O)c5ccc(S(=O)(=O)O)cc5C4(C)C)=[N+](CCCS(=O)(=O)[O-])c4ccc(S(=O)(=O)O)cc43)CC2)n1		CHEMBL4460292		Ki			CHEMBL267	Homo sapiens	Ki		
	18881245	CHEMBL4312056	Binding affinity to wild-type human partial length SRC (L240 to L536 residues) expressed in bacterial expression system by TR-FRET assay	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCOCCOCCNC(=O)CS(=O)(=O)O)CC2)n1		CHEMBL4439020	=	Ki	nM	0.851	CHEMBL267	Homo sapiens	Ki	nM	0.851
	18881246	CHEMBL4312056	Binding affinity to wild-type human partial length SRC (L240 to L536 residues) expressed in bacterial expression system by TR-FRET assay	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCOCCOCCNC(=O)C3C(C(=O)O)C(C(=O)O)C3C(=O)O)CC2)n1		CHEMBL4451230	=	Ki	nM	0.925	CHEMBL267	Homo sapiens	Ki	nM	0.925
	18881343	CHEMBL4312079	Binding affinity to wild-type human partial length SRC (L240 to L536 residues) expressed in bacterial expression system by TR-FRET assay relative to parent compound	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCNCC2)n1		CHEMBL4538000	=	FC		1.52	CHEMBL267	Homo sapiens	FC		1.52
	18881344	CHEMBL4312079	Binding affinity to wild-type human partial length SRC (L240 to L536 residues) expressed in bacterial expression system by TR-FRET assay relative to parent compound	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCOCCOCCNC(=O)OC(C)(C)C)CC2)n1		CHEMBL4469856	=	FC		2.66	CHEMBL267	Homo sapiens	FC		2.66
	18881345	CHEMBL4312079	Binding affinity to wild-type human partial length SRC (L240 to L536 residues) expressed in bacterial expression system by TR-FRET assay relative to parent compound	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCOCCOCCN)CC2)n1		CHEMBL4474070	=	FC		0.88	CHEMBL267	Homo sapiens	FC		0.88
	18881346	CHEMBL4312079	Binding affinity to wild-type human partial length SRC (L240 to L536 residues) expressed in bacterial expression system by TR-FRET assay relative to parent compound	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCOCCOCCNC(=O)CCCCCC3(C)C(/C=C/C=C/C=C4/N(CCCS(=O)(=O)O)c5ccc(S(=O)(=O)O)cc5C4(C)C)=[N+](CCCS(=O)(=O)[O-])c4ccc(S(=O)(=O)O)cc43)CC2)n1		CHEMBL4460292	=	FC		1.25	CHEMBL267	Homo sapiens	FC		1.25
	18881347	CHEMBL4312079	Binding affinity to wild-type human partial length SRC (L240 to L536 residues) expressed in bacterial expression system by TR-FRET assay relative to parent compound	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCOCCOCCNC(=O)CS(=O)(=O)O)CC2)n1		CHEMBL4439020	=	FC		2.88	CHEMBL267	Homo sapiens	FC		2.88
	18881348	CHEMBL4312079	Binding affinity to wild-type human partial length SRC (L240 to L536 residues) expressed in bacterial expression system by TR-FRET assay relative to parent compound	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCOCCOCCNC(=O)C3C(C(=O)O)C(C(=O)O)C3C(=O)O)CC2)n1		CHEMBL4451230	=	FC		3.14	CHEMBL267	Homo sapiens	FC		3.14
	18885100	CHEMBL4313075	Inhibition of human c-Src using poly (Glu, Tyr)4:1 as substrate measured after 60 mins by ELISA relative to control	A	C=CC(=O)Nc1ccc(-n2nc3c(=O)[nH]nc(N)c3c2-c2oc3ccc(C)cc3c2C)cc1		CHEMBL4446835	>	IC50	nM	1000.0	CHEMBL267	Homo sapiens	IC50	nM	1000.0
	18885101	CHEMBL4313075	Inhibition of human c-Src using poly (Glu, Tyr)4:1 as substrate measured after 60 mins by ELISA relative to control	A	C=CC(=O)NCc1ccc(-n2nc3c(=O)[nH]nc(N)c3c2-c2oc3ccc(C)cc3c2C)cc1		CHEMBL4541330	>	IC50	nM	1000.0	CHEMBL267	Homo sapiens	IC50	nM	1000.0
	18886140	CHEMBL4313410	Inhibition of human c-SRC at 10 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	COc1ccc(-c2nn(-c3cccc(NC(=O)c4cccc(C(F)(F)F)c4)c3)cc2-c2ccncc2)cc1Cl		CHEMBL4553144	=	Inhibition	%	33.38	CHEMBL267	Homo sapiens	INH	%	33.38
	18892599	CHEMBL4314703	Inhibition of recombinant full-length human SRC assessed as residual activity at 10 uM using Cdc2 peptide as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	130.5	CHEMBL267	Homo sapiens	Activity	%	130.5
	18892969	CHEMBL4314935	Inhibition of human Src (1 to 530 residues) using GGEEEEYFELVKKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	123.5	CHEMBL267	Homo sapiens	Activity	%	123.5
	18892970	CHEMBL4314936	Inhibition of recombinant full-length human Src T341M mutant assessed as residual activity at 10 uM using GGEEEEYFELVKKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	122.0	CHEMBL267	Homo sapiens	Activity	%	122.0
	18893329	CHEMBL4315088	Inhibition of recombinant human full length His-tagged Src expressed in baculovirus expression system	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	=	IC50	nM	10.0	CHEMBL267	Homo sapiens	IC50	nM	10.0
	18910086	CHEMBL4320880	Binding affinity to cSRC (unknown origin)	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Kd	nM	39810.72	CHEMBL267	Homo sapiens	pKd		4.4
	18919448	CHEMBL4322805	Binding affinity to recombinant full-length N-terminal His-FLAG-GST-tagged SRC (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](NCCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4465866	=	Kd	nM	452.0	CHEMBL267	Homo sapiens	Kd	nM	452.0
	18919636	CHEMBL4322805	Binding affinity to recombinant full-length N-terminal His-FLAG-GST-tagged SRC (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](N(C)CCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4576489	=	Kd	nM	572.0	CHEMBL267	Homo sapiens	Kd	nM	572.0
	18930939	CHEMBL4325597	Inhibition of recombinant human full-length N-terminal His6-tagged Src expressed in Sf21 insect cells at 1000 nM using poly (Glu, Tyr)4:1 as substrate measured after 1 hr by ELISA relative to control	B	Cc1ccc(C(=O)Nc2ccc(Cl)cc2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4576115	=	Inhibition	%	72.8	CHEMBL267	Homo sapiens	INH	%	72.8
	18930963	CHEMBL4325621	Inhibition of recombinant human full-length N-terminal His6-tagged Src expressed in Sf21 insect cells at 100 nM using poly (Glu, Tyr)4:1 as substrate measured after 1 hr by ELISA relative to control	B	Cc1ccc(C(=O)Nc2ccc(Cl)cc2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4576115	=	Inhibition	%	61.7	CHEMBL267	Homo sapiens	INH	%	61.7
	18930985	CHEMBL4325643	Inhibition of recombinant human full-length N-terminal His6-tagged Src expressed in Sf21 insect cells at 10 nM using poly (Glu, Tyr)4:1 as substrate measured after 1 hr by ELISA relative to control	B	Cc1ccc(C(=O)Nc2ccc(Cl)cc2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4576115	=	Inhibition	%	1.5	CHEMBL267	Homo sapiens	INH	%	1.5
	18934074	CHEMBL4326606	Inhibition of human c-SRC at 10 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	CC(=O)N1CCN(c2ccc(Nc3ncc(C(F)(F)F)c(N4Cc5cccc(N(C)S(C)(=O)=O)c5C4)n3)cc2)CC1		CHEMBL4476226	=	Inhibition	%	88.2	CHEMBL267	Homo sapiens	INH	%	88.2
	18937747	CHEMBL4327603	Inhibition of human c-SRC assessed as residual activity at 1 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	99.54	CHEMBL267	Homo sapiens	Activity	%	99.54
	18937748	CHEMBL4327603	Inhibition of human c-SRC assessed as residual activity at 1 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	101.2	CHEMBL267	Homo sapiens	Activity	%	101.2
	18938444	CHEMBL4327964	Inhibition of human c-SRC assessed as residual activity at 100 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL267	Homo sapiens	Activity	%	65.0
	18938817	CHEMBL4328328	Inhibition of human c-SRC using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	2.91	CHEMBL267	Homo sapiens	IC50	10'-9M	2.91
	18948039	CHEMBL4330451	Inhibition of c-Src (unknown origin) using FAM-labelled peptide and ATP incubated for 10 mins by mobility shift assay	B	CCN1CCN(CCCOc2cc3nccc(Oc4c(F)cc(NC(=O)NN5C(=O)CSC5c5c(F)cccc5F)cc4F)c3cc2OC)CC1		CHEMBL4587222	=	IC50	nM	240.0	CHEMBL267	Homo sapiens	IC50	uM	0.24
	18950224	CHEMBL4331076	Inhibition of human c-SRC assessed as residual activity at 10 uM using poly[Glu:Tyr] (4:1) as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition and measured after 120 mins by Hotspot assay relative to control	B	CN1CCC(Nc2ccc(C(=O)Nc3cc(-c4cc(C#N)cs4)n[nH]3)cc2)CC1		CHEMBL4473820	=	Activity	%	17.9	CHEMBL267	Homo sapiens	Activity	%	17.9
	18950278	CHEMBL4331125	Inhibition of human c-SRC using poly[Glu:Tyr] (4:1) as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition and measured after 120 mins by Hotspot assay	B	CN1CCC(Nc2ccc(C(=O)Nc3cc(-c4cc(C#N)cs4)n[nH]3)cc2)CC1		CHEMBL4473820	=	IC50	nM	2396.0	CHEMBL267	Homo sapiens	IC50	nM	2396.0
	18950350	CHEMBL4331125	Inhibition of human c-SRC using poly[Glu:Tyr] (4:1) as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition and measured after 120 mins by Hotspot assay	B	CN1CCC(Nc2ccc(C(=O)Nc3cc(-c4cc(C#N)cs4)n[nH]3)cc2)CC1		CHEMBL4473820	=	IC50	nM	2511.89	CHEMBL267	Homo sapiens	pIC50		5.6
	18953724	CHEMBL4331959	Inhibition of Src (unknown origin) at 10 uM relative to control	B	Cc1n[nH]c2ccnc(Nc3ccccc3F)c12		CHEMBL4449552	=	Inhibition	%	23.0	CHEMBL267	Homo sapiens	INH	%	23.0
	18953794	CHEMBL4331959	Inhibition of Src (unknown origin) at 10 uM relative to control	B	Cc1n[nH]c2ccnc(NC3CCCCC3)c12		CHEMBL4440433	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	18953873	CHEMBL4331959	Inhibition of Src (unknown origin) at 10 uM relative to control	B	Cc1n[nH]c2ccnc(OC3CCCCC3)c12		CHEMBL4524629	=	Inhibition	%	47.0	CHEMBL267	Homo sapiens	INH	%	47.0
	18953965	CHEMBL4332018	Inhibition of Src (unknown origin) at 1 uM relative to control	B	CC(C)n1cc(-c2n[nH]c3ccnc(OC4CCOCC4)c23)cn1		CHEMBL4589022	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	18954029	CHEMBL4332018	Inhibition of Src (unknown origin) at 1 uM relative to control	B	c1cc(-c2n[nH]c3ccnc(OC4CCOCC4)c23)cc(N2CCOCC2)n1		CHEMBL4460272	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	18954096	CHEMBL4331959	Inhibition of Src (unknown origin) at 10 uM relative to control	B	Cc1n[nH]c2ccnc(Nc3ccc4ncsc4c3)c12		CHEMBL4588446	=	Inhibition	%	10.0	CHEMBL267	Homo sapiens	INH	%	10.0
	18958983	CHEMBL4333640	Binding affinity to wild-type human partial length SRC (L240 to L536 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	83.0	CHEMBL267	Homo sapiens	Activity	%	83.0
	18964216	CHEMBL4335045	Inhibition of recombinant human C-Src assessed as residual activity at 1 uM KVEKIGEGTYGVV as substrate incubated 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	82.0	CHEMBL267	Homo sapiens	Activity	%	82.0
	18964217	CHEMBL4335045	Inhibition of recombinant human C-Src assessed as residual activity at 1 uM KVEKIGEGTYGVV as substrate incubated 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	79.0	CHEMBL267	Homo sapiens	Activity	%	79.0
	18964704	CHEMBL4335293	Inhibition of human Src (1 to 530 residues) assessed as residual activity at 1 uM using GGEEEEYFELVKKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	74.0	CHEMBL267	Homo sapiens	Activity	%	74.0
	18964705	CHEMBL4335293	Inhibition of human Src (1 to 530 residues) assessed as residual activity at 1 uM using GGEEEEYFELVKKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	92.0	CHEMBL267	Homo sapiens	Activity	%	92.0
	18964706	CHEMBL4335294	Inhibition of recombinant full-length human Src T341M mutant at 1 uM assessed as residual activity at 1 uM using GGEEEEYFELVKKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	97.0	CHEMBL267	Homo sapiens	Activity	%	97.0
	18964707	CHEMBL4335294	Inhibition of recombinant full-length human Src T341M mutant at 1 uM assessed as residual activity at 1 uM using GGEEEEYFELVKKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	92.0	CHEMBL267	Homo sapiens	Activity	%	92.0
	18965853	CHEMBL4335776	Inhibition of recombinant full-length human SRC using KVEKIGEGTYGVVYK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting analysis	A	COc1cc2cn[nH]c2cc1-c1ccc(F)c2c(N)c(C(N)=O)cnc12		CHEMBL4475004	=	IC50	nM	902.5	CHEMBL267	Homo sapiens	IC50	nM	902.5
	18971863	CHEMBL4336873	Inhibition of recombinant human C-Src assessed as residual activity at 10 uM Cdc2 peptide as substrate incubated 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	27.0	CHEMBL267	Homo sapiens	Activity	%	27.0
	18972108	CHEMBL4337118	Inhibition of recombinant human SRC (1 to 530 residues) assessed as residual activity at 10 uM using GGEEEEYFELVKK as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	15.0	CHEMBL267	Homo sapiens	Activity	%	15.0
	18972109	CHEMBL4337119	Inhibition of recombinant full length human SRC T341M mutant assessed as residual activity at 10 uM using GGEEEEYFELVKK as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	74.0	CHEMBL267	Homo sapiens	Activity	%	74.0
	18985989	CHEMBL4340089	Inhibition of recombinant human SRC at 10 uM using Ulight-Poly GAT[EAY(1:1:1)]n substrate incubated for 30 mins by LANCE assay relative to untreated control	B	COc1ccc(Nc2ncc3c(n2)-c2cccnc2SC3)cc1		CHEMBL4582099	=	Inhibition	%	57.0	CHEMBL267	Homo sapiens	INH	%	57.0
	18985990	CHEMBL4340089	Inhibition of recombinant human SRC at 10 uM using Ulight-Poly GAT[EAY(1:1:1)]n substrate incubated for 30 mins by LANCE assay relative to untreated control	B	COc1ccc(Nc2ncc3c(n2)-c2cccnc2SC3)cc1OC		CHEMBL4463108	=	Inhibition	%	97.0	CHEMBL267	Homo sapiens	INH	%	97.0
	18985991	CHEMBL4340089	Inhibition of recombinant human SRC at 10 uM using Ulight-Poly GAT[EAY(1:1:1)]n substrate incubated for 30 mins by LANCE assay relative to untreated control	B	COc1cc(Nc2ncc3c(n2)-c2cccnc2SC3)cc(OC)c1OC		CHEMBL4584918	=	Inhibition	%	99.0	CHEMBL267	Homo sapiens	INH	%	99.0
	18989200	CHEMBL4340724	Inhibition of recombinant human full-length N-terminal GST-His6-fused SRC (M1 to L536 residues) expressed in Sf9 insect cells using Poly(Glu:Tyr)4:1 as substrate measured after 60 mins in presence of [gamma-33P]-ATP by scintillation counting method	B	CN(CCc1ccc(-c2ccccc2)cc1)Cc1cn(C)c2ccc(C(=O)Nc3ccc(F)cc3)cc12		CHEMBL4446681	=	IC50	nM	8800.0	CHEMBL267	Homo sapiens	IC50	uM	8.8
	18989967	CHEMBL4340956	Inhibition of N-terminal GST-His 6 tagged full length human SRC (M1-L536) expressed in Sf9 insect cells using Poly(Glu,Tyr)4:1 as substrate at 1 uM by Filter binding assay relative to control	B	COCCN1CCOc2c1cnn1c(-c3ccc4cccc(NCC5CCNCC5)c4n3)nnc21		CHEMBL4556293	<	Inhibition	%	25.0	CHEMBL267	Homo sapiens	INH	%	25.0
Active	18995249	CHEMBL4342192	Inhibition of SRC phosphorylation in human K562 cells up to 10 uM incubated for 48 hrs by human phospho-kinase array	B	O=C(Nc1ccc(C(F)(F)F)cc1)Nc1nnc(Sc2cc(NCCCN3CCOCC3)ncn2)s1		CHEMBL4537984		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	18997585	CHEMBL4342890	Inhibition of human recombinant Src expressed in baculovirus infected Sf9 insect cells assessed as reduction in phosphorylation of polyglutamic acid/tyrosine incubated for 15 mins by ELISA	B	COc1ccc(Cl)c(Nc2ncnc3cc(OCC4CCN(C)CC4)c(OC)cc23)c1		CHEMBL426161	=	IC50	nM	5.0	CHEMBL267	Homo sapiens	IC50	nM	5.0
	18997586	CHEMBL4342889	Inhibition of SRC (unknown origin)	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	=	IC50	nM	2.7	CHEMBL267	Homo sapiens	IC50	nM	2.7
	18997587	CHEMBL4342889	Inhibition of SRC (unknown origin)	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	=	IC50	nM	11.0	CHEMBL267	Homo sapiens	IC50	nM	11.0
	18997609	CHEMBL4342889	Inhibition of SRC (unknown origin)	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1	Outside typical range	CHEMBL2110732	=	IC50	nM	110000.0	CHEMBL267	Homo sapiens	IC50	mM	0.11
	19018947	CHEMBL4347062	Inhibition of human recombinant SRC using Ulight-Poly GAT[EAY(1:1:1) as substrate measured after 10 mins in the presence of ATP by LANCE method	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C[C@H]1CCCN1C[C@@H]1CO1		CHEMBL4525187	=	IC50	nM	123.0	CHEMBL267	Homo sapiens	IC50	nM	123.0
	19021568	CHEMBL4347791	Inhibition of recombinant human SRC at 20 nM using Ulight-Poly GAT[EAY(1:1:1)] as substrate measured after 10 mins by LANCE method relative to control	B	O=C(CCCCCn1cc(Nc2ncc(Cl)c(Nc3ccc(Cl)cc3)n2)cn1)NO		CHEMBL4526274	=	Inhibition	%	15.0	CHEMBL267	Homo sapiens	INH	%	15.0
	19021569	CHEMBL4347792	Inhibition of recombinant human SRC at 200 nM using Ulight-Poly GAT[EAY(1:1:1)] as substrate measured after 10 mins by LANCE method relative to control	B	O=C(CCCCCn1cc(Nc2ncc(Cl)c(Nc3ccc(Cl)cc3)n2)cn1)NO		CHEMBL4526274	=	Inhibition	%	24.0	CHEMBL267	Homo sapiens	INH	%	24.0
	19023406	CHEMBL4348019	Inhibition of SRC (unknown origin) by Z'-LYTE assay	B	Cc1nc(Nc2ncc(-c3ccccc3)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4440371	=	IC50	nM	97.0	CHEMBL267	Homo sapiens	IC50	uM	0.097
	19031498	CHEMBL4349487	Inhibition of cSRC (unknown origin)	B	Cc1cn(-c2cc(C(=O)Nc3cccc(Nc4ccc5c(c4)NC(=O)/C5=C\c4ccc[nH]4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL2037209	=	IC50	nM	53.0	CHEMBL267	Homo sapiens	IC50	nM	53.0
	19032217	CHEMBL4349810	Inhibition of recombinant human full length N-terminal GST and C-terminal His6-tagged SRC (M1 to L536) expressed in Sf9 insect cells at 20 nM using phosphatidylserine as substrate incubated for 60 mins in presence of [33P]-ATP by scintillation counting method	B	Cn1cc(-c2n[nH]c3ccc(NCc4cc(F)ccc4S(C)(=O)=O)cc23)cn1		CHEMBL4555442	=	Inhibition	%	2.0	CHEMBL267	Homo sapiens	INH	%	2.0
	19035291	CHEMBL4350387	Inhibition of human c-SRC assessed as residual activity at 10 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	O=C1NC2(CCCCC2)n2c1c(Cl)cc(Nc1ccncn1)c2=O		CHEMBL4439094	=	Activity	%	100.0	CHEMBL267	Homo sapiens	Activity	%	100.0
Not Active	19039818	CHEMBL4351824	Inhibition of recombinant full-length human SRC at 10 uM using Cdc2 peptide as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	19040166	CHEMBL4352067	Inhibition of human Src (1 to 530 residues) using GGEEEEYFELVKKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	19040167	CHEMBL4352068	Inhibition of recombinant full-length human Src T341M mutant at 10 uM using GGEEEEYFELVKKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Active	19041029	CHEMBL4352290	Inhibition of human c-SRC at 10 uM using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	19043744	CHEMBL4353210	Inhibition of human C-src using poly (Glu,Tyr)4:1 as substrate at 0.1 uM in presence of 33P-gamma ATP by hotspot kinase assay relative to control	B	CN1CCC(Nc2ccc(C(=O)Nc3cc(-c4ccc5c(c4)OCO5)n[nH]3)cc2)CC1		CHEMBL4456471	=	Inhibition	%	43.28	CHEMBL267	Homo sapiens	INH	%	43.28
	19059364	CHEMBL4357705	Inhibition of recombinant human His-tagged full length SRC expressed in baculovirus expression system using tyrosine-2 peptide as substrate incubated for 1 hr by Z'-LYTE assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3883384	=	IC50	nM	4.0	CHEMBL267	Homo sapiens	IC50	nM	4.0
	19059365	CHEMBL4357705	Inhibition of recombinant human His-tagged full length SRC expressed in baculovirus expression system using tyrosine-2 peptide as substrate incubated for 1 hr by Z'-LYTE assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1-c1cccs1		CHEMBL4574265	=	IC50	nM	3.0	CHEMBL267	Homo sapiens	IC50	nM	3.0
	19059366	CHEMBL4357705	Inhibition of recombinant human His-tagged full length SRC expressed in baculovirus expression system using tyrosine-2 peptide as substrate incubated for 1 hr by Z'-LYTE assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1-c1ccoc1		CHEMBL4538743	=	IC50	nM	2.0	CHEMBL267	Homo sapiens	IC50	nM	2.0
	19059367	CHEMBL4357705	Inhibition of recombinant human His-tagged full length SRC expressed in baculovirus expression system using tyrosine-2 peptide as substrate incubated for 1 hr by Z'-LYTE assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1-c1ccc(OC)nc1		CHEMBL4563120	=	IC50	nM	6.0	CHEMBL267	Homo sapiens	IC50	nM	6.0
	19059368	CHEMBL4357705	Inhibition of recombinant human His-tagged full length SRC expressed in baculovirus expression system using tyrosine-2 peptide as substrate incubated for 1 hr by Z'-LYTE assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1-c1ccc(C(C)=O)cc1		CHEMBL4562024	=	IC50	nM	6.0	CHEMBL267	Homo sapiens	IC50	nM	6.0
	19059369	CHEMBL4357705	Inhibition of recombinant human His-tagged full length SRC expressed in baculovirus expression system using tyrosine-2 peptide as substrate incubated for 1 hr by Z'-LYTE assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1-c1ccc(Oc2ccccc2)cc1		CHEMBL4442889	=	IC50	nM	5.0	CHEMBL267	Homo sapiens	IC50	nM	5.0
	19059370	CHEMBL4357705	Inhibition of recombinant human His-tagged full length SRC expressed in baculovirus expression system using tyrosine-2 peptide as substrate incubated for 1 hr by Z'-LYTE assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1OCc1ccc(C)cc1		CHEMBL4460150	=	IC50	nM	5.0	CHEMBL267	Homo sapiens	IC50	nM	5.0
	19059371	CHEMBL4357705	Inhibition of recombinant human His-tagged full length SRC expressed in baculovirus expression system using tyrosine-2 peptide as substrate incubated for 1 hr by Z'-LYTE assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1OCc1c(C)cccc1Cl		CHEMBL4462060	=	IC50	nM	3.0	CHEMBL267	Homo sapiens	IC50	nM	3.0
	19059372	CHEMBL4357705	Inhibition of recombinant human His-tagged full length SRC expressed in baculovirus expression system using tyrosine-2 peptide as substrate incubated for 1 hr by Z'-LYTE assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1OCc1ccc(Oc2ccccc2)cc1		CHEMBL4569421	=	IC50	nM	6.0	CHEMBL267	Homo sapiens	IC50	nM	6.0
	19059373	CHEMBL4357705	Inhibition of recombinant human His-tagged full length SRC expressed in baculovirus expression system using tyrosine-2 peptide as substrate incubated for 1 hr by Z'-LYTE assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	IC50	nM	3.0	CHEMBL267	Homo sapiens	IC50	nM	3.0
	19059374	CHEMBL4357705	Inhibition of recombinant human His-tagged full length SRC expressed in baculovirus expression system using tyrosine-2 peptide as substrate incubated for 1 hr by Z'-LYTE assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cc(Cl)cc1Cl		CHEMBL4436957	=	IC50	nM	9.0	CHEMBL267	Homo sapiens	IC50	nM	9.0
	19059375	CHEMBL4357705	Inhibition of recombinant human His-tagged full length SRC expressed in baculovirus expression system using tyrosine-2 peptide as substrate incubated for 1 hr by Z'-LYTE assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cc(C)cc1Cl		CHEMBL4453645	=	IC50	nM	8.0	CHEMBL267	Homo sapiens	IC50	nM	8.0
	19059376	CHEMBL4357705	Inhibition of recombinant human His-tagged full length SRC expressed in baculovirus expression system using tyrosine-2 peptide as substrate incubated for 1 hr by Z'-LYTE assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cc(C#N)cc1Cl		CHEMBL4442593	=	IC50	nM	14.0	CHEMBL267	Homo sapiens	IC50	nM	14.0
	19059377	CHEMBL4357705	Inhibition of recombinant human His-tagged full length SRC expressed in baculovirus expression system using tyrosine-2 peptide as substrate incubated for 1 hr by Z'-LYTE assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1cc(C)cc(Cl)c1		CHEMBL4561015	=	IC50	nM	4010.0	CHEMBL267	Homo sapiens	IC50	nM	4010.0
	19059378	CHEMBL4357705	Inhibition of recombinant human His-tagged full length SRC expressed in baculovirus expression system using tyrosine-2 peptide as substrate incubated for 1 hr by Z'-LYTE assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1cc(OC)c(OC)cc1C		CHEMBL4475369	=	IC50	nM	1010.0	CHEMBL267	Homo sapiens	IC50	nM	1010.0
	19059379	CHEMBL4357705	Inhibition of recombinant human His-tagged full length SRC expressed in baculovirus expression system using tyrosine-2 peptide as substrate incubated for 1 hr by Z'-LYTE assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(Cl)c(OC)cc(OC)c1Cl		CHEMBL4528820	=	IC50	nM	940.0	CHEMBL267	Homo sapiens	IC50	nM	940.0
	19059380	CHEMBL4357705	Inhibition of recombinant human His-tagged full length SRC expressed in baculovirus expression system using tyrosine-2 peptide as substrate incubated for 1 hr by Z'-LYTE assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1ccccc1CC		CHEMBL4592277	=	IC50	nM	79.0	CHEMBL267	Homo sapiens	IC50	nM	79.0
	19059381	CHEMBL4357705	Inhibition of recombinant human His-tagged full length SRC expressed in baculovirus expression system using tyrosine-2 peptide as substrate incubated for 1 hr by Z'-LYTE assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1ccc(Oc2ccccc2)cc1		CHEMBL4443649	>	IC50	nM	3330.0	CHEMBL267	Homo sapiens	IC50	nM	3330.0
	19059382	CHEMBL4357705	Inhibition of recombinant human His-tagged full length SRC expressed in baculovirus expression system using tyrosine-2 peptide as substrate incubated for 1 hr by Z'-LYTE assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2cccc(N3CCN(C)CC3)c2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4442601	=	IC50	nM	22.0	CHEMBL267	Homo sapiens	IC50	nM	22.0
	19059383	CHEMBL4357705	Inhibition of recombinant human His-tagged full length SRC expressed in baculovirus expression system using tyrosine-2 peptide as substrate incubated for 1 hr by Z'-LYTE assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccccc2N2CCN(C)CC2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4470506	=	IC50	nM	5.0	CHEMBL267	Homo sapiens	IC50	nM	5.0
	19059384	CHEMBL4357705	Inhibition of recombinant human His-tagged full length SRC expressed in baculovirus expression system using tyrosine-2 peptide as substrate incubated for 1 hr by Z'-LYTE assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4556686	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	nM	10000.0
	19059385	CHEMBL4357705	Inhibition of recombinant human His-tagged full length SRC expressed in baculovirus expression system using tyrosine-2 peptide as substrate incubated for 1 hr by Z'-LYTE assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2OC)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4447910	=	IC50	nM	1210.0	CHEMBL267	Homo sapiens	IC50	nM	1210.0
	19059386	CHEMBL4357705	Inhibition of recombinant human His-tagged full length SRC expressed in baculovirus expression system using tyrosine-2 peptide as substrate incubated for 1 hr by Z'-LYTE assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4460793	=	IC50	nM	3580.0	CHEMBL267	Homo sapiens	IC50	nM	3580.0
	19059387	CHEMBL4357705	Inhibition of recombinant human His-tagged full length SRC expressed in baculovirus expression system using tyrosine-2 peptide as substrate incubated for 1 hr by Z'-LYTE assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)c(C)c2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4452399	=	IC50	nM	4.0	CHEMBL267	Homo sapiens	IC50	nM	4.0
	19059388	CHEMBL4357705	Inhibition of recombinant human His-tagged full length SRC expressed in baculovirus expression system using tyrosine-2 peptide as substrate incubated for 1 hr by Z'-LYTE assay	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C)CC4)cc3)ncc2C(=O)Nc2c(C)cccc2Cl)c1		CHEMBL4517370	=	IC50	nM	226.0	CHEMBL267	Homo sapiens	IC50	nM	226.0
	19059389	CHEMBL4357705	Inhibition of recombinant human His-tagged full length SRC expressed in baculovirus expression system using tyrosine-2 peptide as substrate incubated for 1 hr by Z'-LYTE assay	B	C=CC(=O)Nc1ccc(Nc2nc(Nc3ccc(N4CCN(C)CC4)cc3)ncc2C(=O)Nc2c(C)cccc2Cl)cc1		CHEMBL4517070	=	IC50	nM	33.0	CHEMBL267	Homo sapiens	IC50	nM	33.0
	19059390	CHEMBL4357705	Inhibition of recombinant human His-tagged full length SRC expressed in baculovirus expression system using tyrosine-2 peptide as substrate incubated for 1 hr by Z'-LYTE assay	B	Cc1cccc(Cl)c1NC(=O)c1cnc(Nc2ccc(N3CCN(C)CC3)cc2)nc1Nc1ccccc1NC(=O)CCl		CHEMBL4578438	=	IC50	nM	8.0	CHEMBL267	Homo sapiens	IC50	nM	8.0
	19059391	CHEMBL4357705	Inhibition of recombinant human His-tagged full length SRC expressed in baculovirus expression system using tyrosine-2 peptide as substrate incubated for 1 hr by Z'-LYTE assay	B	C=CS(=O)(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4537568	=	IC50	nM	7.0	CHEMBL267	Homo sapiens	IC50	nM	7.0
	19059392	CHEMBL4357705	Inhibition of recombinant human His-tagged full length SRC expressed in baculovirus expression system using tyrosine-2 peptide as substrate incubated for 1 hr by Z'-LYTE assay	B	Cc1cccc(Cl)c1NC(=O)c1cnc(Nc2ccc(N3CCN(C)CC3)cc2)nc1Nc1ccccc1NC(=O)/C=C/CN(C)C		CHEMBL4463781	=	IC50	nM	121.0	CHEMBL267	Homo sapiens	IC50	nM	121.0
	19059393	CHEMBL4357705	Inhibition of recombinant human His-tagged full length SRC expressed in baculovirus expression system using tyrosine-2 peptide as substrate incubated for 1 hr by Z'-LYTE assay	B	CCC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4548584	=	IC50	nM	3.0	CHEMBL267	Homo sapiens	IC50	nM	3.0
Active	19059404	CHEMBL4357714	Inhibition of SRC in human NCI-H1975 cells assessed as blocking of SRC pulldown at 1 uM in presence of TL13-68 incubated for 2 hrs by Western blot analysis	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Active	19059405	CHEMBL4357714	Inhibition of SRC in human NCI-H1975 cells assessed as blocking of SRC pulldown at 1 uM in presence of TL13-68 incubated for 2 hrs by Western blot analysis	B	CCC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4548584		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Active	19059406	CHEMBL4357715	Inhibition of SRC in human HCC827 cells assessed as blocking of SRC pulldown at 1 uM in presence of TL13-68 incubated for 2 hrs by Western blot analysis	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Active	19059407	CHEMBL4357715	Inhibition of SRC in human HCC827 cells assessed as blocking of SRC pulldown at 1 uM in presence of TL13-68 incubated for 2 hrs by Western blot analysis	B	CCC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4548584		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Active	19059414	CHEMBL4357720	Inhibition of SRC in human NCI-H1975 cells assessed as reduction in phosphorylation of SRC Y416 at 1 uM in presence of TL13-68 incubated for 2 hrs by Western blot analysis	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Active	19059415	CHEMBL4357720	Inhibition of SRC in human NCI-H1975 cells assessed as reduction in phosphorylation of SRC Y416 at 1 uM in presence of TL13-68 incubated for 2 hrs by Western blot analysis	B	CCC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4548584		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Active	19059416	CHEMBL4357719	Inhibition of SRC in human HCC827 cells assessed as reduction in phosphorylation of SRC Y416 at 1 uM in presence of TL13-68 incubated for 2 hrs by Western blot analysis	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Active	19059417	CHEMBL4357719	Inhibition of SRC in human HCC827 cells assessed as reduction in phosphorylation of SRC Y416 at 1 uM in presence of TL13-68 incubated for 2 hrs by Western blot analysis	B	CCC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4548584		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Active	19059418	CHEMBL4357718	Inhibition of SRC in human NCI-H1975 cells assessed as blocking of SRC pulldown at 1 uM in presence of TL13-68 incubated for 2 hrs followed by compound washout and measured upto 4 hrs by Western blot analysis	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Active	19059419	CHEMBL4357718	Inhibition of SRC in human NCI-H1975 cells assessed as blocking of SRC pulldown at 1 uM in presence of TL13-68 incubated for 2 hrs followed by compound washout and measured upto 4 hrs by Western blot analysis	B	CCC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4548584		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Active	19059420	CHEMBL4357718	Inhibition of SRC in human NCI-H1975 cells assessed as blocking of SRC pulldown at 1 uM in presence of TL13-68 incubated for 2 hrs followed by compound washout and measured upto 4 hrs by Western blot analysis	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Active	19059421	CHEMBL4357717	Inhibition of SRC in human HCC827 cells assessed as reduction in phosphorylation of SRC Y416 at 1 uM in presence of TL13-68 incubated for 2 hrs followed by compound washout and measured upto 4 hrs by Western blot analysis	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Active	19059422	CHEMBL4357717	Inhibition of SRC in human HCC827 cells assessed as reduction in phosphorylation of SRC Y416 at 1 uM in presence of TL13-68 incubated for 2 hrs followed by compound washout and measured upto 4 hrs by Western blot analysis	B	CCC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4548584		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Active	19059423	CHEMBL4357717	Inhibition of SRC in human HCC827 cells assessed as reduction in phosphorylation of SRC Y416 at 1 uM in presence of TL13-68 incubated for 2 hrs followed by compound washout and measured upto 4 hrs by Western blot analysis	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	19059837	CHEMBL4358138	Binding affinity to wild-type human partial length SRC (L240 to L536 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	0.0	CHEMBL267	Homo sapiens	Activity	%	0.0
Active	19059898	CHEMBL4358199	Binding affinity to recombinant human His-tagged full length SRC expressed in baculovirus expression system assessed as covalent adduct formation via Cys277 residue measured after 2 hrs by LC-MS analysis	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441		Activity			CHEMBL267	Homo sapiens	Activity		
	19072929	CHEMBL4362104	Effect on SRC at Y419 phosphorylation level in human NCI-H1975 incubated for 12 hrs by human phosphokinase proteome profiler array relative to control	B	CCOc1ccc(-c2nc(C(=O)NO)c3[nH]c(=O)n(-c4ccccc4OC)c3n2)cc1		CHEMBL4443725	=	FC		0.61	CHEMBL267	Homo sapiens	FC		0.61
	19072968	CHEMBL4362143	Effect on SRC at Y419 phosphorylation level in human NCI-H1975 incubated for 12 hrs by human phosphokinase proteome profiler array relative to beta-catenin	B	CCOc1ccc(-c2nc(C(=O)NO)c3[nH]c(=O)n(-c4ccccc4OC)c3n2)cc1		CHEMBL4443725	=	FC		0.68	CHEMBL267	Homo sapiens	FC		0.68
	19073007	CHEMBL4362104	Effect on SRC at Y419 phosphorylation level in human NCI-H1975 incubated for 12 hrs by human phosphokinase proteome profiler array relative to control	B	CCOc1ccc(-c2nc(C(=O)NO)c3[nH]c(=O)n(-c4ccccc4OC)c3n2)cc1		CHEMBL4443725	=	log2FC		-0.72	CHEMBL267	Homo sapiens	log2FC		-0.72
	19073046	CHEMBL4362143	Effect on SRC at Y419 phosphorylation level in human NCI-H1975 incubated for 12 hrs by human phosphokinase proteome profiler array relative to beta-catenin	B	CCOc1ccc(-c2nc(C(=O)NO)c3[nH]c(=O)n(-c4ccccc4OC)c3n2)cc1		CHEMBL4443725	=	log2FC		-0.55	CHEMBL267	Homo sapiens	log2FC		-0.55
	19073108	CHEMBL4362104	Effect on SRC at Y419 phosphorylation level in human NCI-H1975 incubated for 12 hrs by human phosphokinase proteome profiler array relative to control	B	CCOc1ccc(-c2nc(/C(N)=N/O)c3[nH]c(=O)n(-c4ccccc4OC)c3n2)cc1		CHEMBL4515196	=	FC		0.64	CHEMBL267	Homo sapiens	FC		0.64
	19073147	CHEMBL4362143	Effect on SRC at Y419 phosphorylation level in human NCI-H1975 incubated for 12 hrs by human phosphokinase proteome profiler array relative to beta-catenin	B	CCOc1ccc(-c2nc(/C(N)=N/O)c3[nH]c(=O)n(-c4ccccc4OC)c3n2)cc1		CHEMBL4515196	=	FC		0.75	CHEMBL267	Homo sapiens	FC		0.75
	19073186	CHEMBL4362104	Effect on SRC at Y419 phosphorylation level in human NCI-H1975 incubated for 12 hrs by human phosphokinase proteome profiler array relative to control	B	CCOc1ccc(-c2nc(/C(N)=N/O)c3[nH]c(=O)n(-c4ccccc4OC)c3n2)cc1		CHEMBL4515196	=	log2FC		-0.64	CHEMBL267	Homo sapiens	log2FC		-0.64
	19073225	CHEMBL4362143	Effect on SRC at Y419 phosphorylation level in human NCI-H1975 incubated for 12 hrs by human phosphokinase proteome profiler array relative to beta-catenin	B	CCOc1ccc(-c2nc(/C(N)=N/O)c3[nH]c(=O)n(-c4ccccc4OC)c3n2)cc1		CHEMBL4515196	=	log2FC		-0.41	CHEMBL267	Homo sapiens	log2FC		-0.41
	19087836	CHEMBL4365088	Inhibition of human recombinant full length N-terminal GST tagged SRC expressed in Escherichia coli using KVEKIGEGTYGVVYK-amide as substrate measured after 60 mins in presence of ATP by ADP-Glo kinase assay	B	Nc1n[nH]c2cc(-c3ccc(C(=O)NCCNC(=O)c4ccc(Cl)c(C(F)(F)F)c4)cc3)ccc12		CHEMBL4467809	=	IC50	nM	15100.0	CHEMBL267	Homo sapiens	IC50	uM	15.1
	19090401	CHEMBL4365975	Inhibition of wild-type human partial length SRC (L240 to L536 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	68.0	CHEMBL267	Homo sapiens	Activity	%	68.0
	19091832	CHEMBL4366306	Inhibition of human c-SRC at 100 nM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	6.76	CHEMBL267	Homo sapiens	INH	%	6.76
	19092283	CHEMBL4366703	Inhibition of SRC (1 to 530 residues)(unknown origin) at 1 uM relative to control	B	Nc1nccc(Oc2ccc(Nc3nccc4ccn(-c5ccc(F)cc5)c(=O)c34)cc2F)c1Cl		CHEMBL4474232	=	Inhibition	%	35.0	CHEMBL267	Homo sapiens	INH	%	35.0
	19112050	CHEMBL4370682	Inhibition of pp60 src (unknown origin)	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	IC50	nM	34000.0	CHEMBL267	Homo sapiens	IC50	uM	34.0
	19114079	CHEMBL4371165	Inhibition of full length human recombinant pp60c-src using RR-SRC as substrate	B	O=C(Nc1cccc(O)c1)c1cc2ccc(O)cc2cc1O		CHEMBL141704	=	IC50	nM	16000.0	CHEMBL267	Homo sapiens	IC50	uM	16.0
	19114080	CHEMBL4371165	Inhibition of full length human recombinant pp60c-src using RR-SRC as substrate	B	O=C(NCc1cccc(O)c1)c1cc2cc(O)ccc2[nH]1		CHEMBL144785	=	IC50	nM	38000.0	CHEMBL267	Homo sapiens	IC50	uM	38.0
	19114089	CHEMBL4371170	Inhibition of human c-SRC expressed in mouse NIH/3T3 cells assessed as inhibition of cell growth in presence of 1.5% FCS by BrdU incorporation assay	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	=	IC50	nM	13.0	CHEMBL267	Homo sapiens	IC50	nM	13.0
	19114090	CHEMBL4371170	Inhibition of human c-SRC expressed in mouse NIH/3T3 cells assessed as inhibition of cell growth in presence of 1.5% FCS by BrdU incorporation assay	B	O=C(Cc1ccc(-c2ccccc2)cc1)NCc1cccc(F)c1		CHEMBL4436308	=	IC50	nM	349.0	CHEMBL267	Homo sapiens	IC50	nM	349.0
	19114091	CHEMBL4371170	Inhibition of human c-SRC expressed in mouse NIH/3T3 cells assessed as inhibition of cell growth in presence of 1.5% FCS by BrdU incorporation assay	B	O=C(Cc1ccc(-c2ccccc2)cn1)NCc1cccc(F)c1		CHEMBL4531095	=	IC50	nM	269.0	CHEMBL267	Homo sapiens	IC50	nM	269.0
	19114092	CHEMBL4371170	Inhibition of human c-SRC expressed in mouse NIH/3T3 cells assessed as inhibition of cell growth in presence of 1.5% FCS by BrdU incorporation assay	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1cccc(F)c1		CHEMBL4452185	=	IC50	nM	118.0	CHEMBL267	Homo sapiens	IC50	nM	118.0
	19114101	CHEMBL4371176	Inhibition of human c-SRC expressed in mouse NIH/3T3 cells assessed as inhibition of cell growth in presence of 0.5% FCS	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	=	IC50	nM	6.5	CHEMBL267	Homo sapiens	IC50	nM	6.5
	19114104	CHEMBL4371179	Inhibition of human recombinant pp60c-src expressed in baculovirus infected Sf9 insect cells using poly(Glu,Tyr) 4:1 as substrate after 15 mins	B	COc1cc2c(Nc3c(Cl)ccc4c3OCO4)ncnc2cc1OCCCN1CCCCC1		CHEMBL169186	<	IC50	nM	4.0	CHEMBL267	Homo sapiens	IC50	nM	4.0
	19114105	CHEMBL4371180	Inhibition of human c-SRC expressed in mouse NIH/3T3 cells assessed as reduction in BrdU incorporation after 24 hrs by ELISA	B	COc1cc2c(Nc3c(Cl)ccc4c3OCO4)ncnc2cc1OCCCN1CCCCC1		CHEMBL169186	=	IC50	nM	110.0	CHEMBL267	Homo sapiens	IC50	nM	110.0
	19114106	CHEMBL4371181	Inhibition of human c-SRC expressed in mouse NIH/3T3 cells assessed as reduction in cell growth	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	=	GI50	nM	20.0	CHEMBL267	Homo sapiens	GI50	nM	20.0
	19114107	CHEMBL4371181	Inhibition of human c-SRC expressed in mouse NIH/3T3 cells assessed as reduction in cell growth	B	COc1cc2c(Nc3c(Cl)ccc4c3OCO4)ncnc2cc1OCCCN1CCCCC1		CHEMBL169186	=	GI50	nM	87.0	CHEMBL267	Homo sapiens	GI50	nM	87.0
	19114165	CHEMBL4371211	Inhibition of Src (unknown origin)	B	O=C(Cc1ccc(-c2ccc(N3CCOCC3)cc2)cn1)NCc1cccc(F)c1		CHEMBL4297299	=	IC50	nM	67000.0	CHEMBL267	Homo sapiens	IC50	uM	67.0
	19114166	CHEMBL4371211	Inhibition of Src (unknown origin)	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	=	IC50	nM	67000.0	CHEMBL267	Homo sapiens	IC50	uM	67.0
	19114502	CHEMBL4371418	Binding affinity to SRC in SILAC-labeled human MDA-MB-231 cells lysate by mass spectrometry based kinAffinity assay	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4cc(F)ccc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4443828	=	Kd	nM	254.0	CHEMBL267	Homo sapiens	Kd(free)	uM	0.254
	19114529	CHEMBL4371355	Inhibition of SRC (unknown origin) using biotinylated peptide as substrate at 10 uM by TR-FRET assay relative to control	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4cc(F)ccc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4443828	=	Efficacy	%	83.0	CHEMBL267	Homo sapiens	Efficacy	%	83.0
	19114530	CHEMBL4371354	Inhibition of SRC (unknown origin) using fluorescence labeled peptide as substrate at 10 uM by IMAP assay relative to control	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4cc(F)ccc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4443828	=	Efficacy	%	83.0	CHEMBL267	Homo sapiens	Efficacy	%	83.0
	19114544	CHEMBL4371477	Inhibition of SRC (unknown origin)	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4ccccc4OC(F)(F)F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4470236	=	IC50	nM	1951.0	CHEMBL267	Homo sapiens	IC50	uM	1.951
	19114557	CHEMBL4371477	Inhibition of SRC (unknown origin)	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4ccccc4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4587811	=	IC50	nM	544.0	CHEMBL267	Homo sapiens	IC50	uM	0.544
	19114593	CHEMBL4371355	Inhibition of SRC (unknown origin) using biotinylated peptide as substrate at 10 uM by TR-FRET assay relative to control	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4ccccc4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4587811	=	Efficacy	%	83.0	CHEMBL267	Homo sapiens	Efficacy	%	83.0
	19114594	CHEMBL4371354	Inhibition of SRC (unknown origin) using fluorescence labeled peptide as substrate at 10 uM by IMAP assay relative to control	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4ccccc4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4587811	=	Efficacy	%	83.0	CHEMBL267	Homo sapiens	Efficacy	%	83.0
	19114629	CHEMBL4371477	Inhibition of SRC (unknown origin)	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4cc(F)ccc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4443828	=	IC50	nM	88.0	CHEMBL267	Homo sapiens	IC50	uM	0.088
	19114663	CHEMBL4371354	Inhibition of SRC (unknown origin) using fluorescence labeled peptide as substrate at 10 uM by IMAP assay relative to control	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4c(F)cccc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4462318	=	Efficacy	%	83.0	CHEMBL267	Homo sapiens	Efficacy	%	83.0
	19114664	CHEMBL4371355	Inhibition of SRC (unknown origin) using biotinylated peptide as substrate at 10 uM by TR-FRET assay relative to control	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4c(F)cccc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4462318	=	Efficacy	%	83.0	CHEMBL267	Homo sapiens	Efficacy	%	83.0
	19114690	CHEMBL4371418	Binding affinity to SRC in SILAC-labeled human MDA-MB-231 cells lysate by mass spectrometry based kinAffinity assay	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4c(F)cccc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4462318	=	Kd	nM	96.0	CHEMBL267	Homo sapiens	Kd(free)	uM	0.096
	19114740	CHEMBL4371477	Inhibition of SRC (unknown origin)	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4c(F)cccc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4462318	=	IC50	nM	44.0	CHEMBL267	Homo sapiens	IC50	uM	0.044
Active	19114757	CHEMBL4371392	Binding affinity to wild-type human partial length SRC (L240 to L536 residues) expressed in bacterial expression system assessed as residual binding level at 5 umol/L by Kinomescan method	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4ccccc4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL4536115		Activity			CHEMBL267	Homo sapiens	Activity		
	19114770	CHEMBL4371477	Inhibition of SRC (unknown origin)	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4ccccc4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL4536115	=	IC50	nM	995.0	CHEMBL267	Homo sapiens	IC50	uM	0.995
Active	19114782	CHEMBL4371392	Binding affinity to wild-type human partial length SRC (L240 to L536 residues) expressed in bacterial expression system assessed as residual binding level at 5 umol/L by Kinomescan method	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4ccccc4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCC(C)CC1		CHEMBL4447225		Activity			CHEMBL267	Homo sapiens	Activity		
	19114795	CHEMBL4371477	Inhibition of SRC (unknown origin)	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4ccccc4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCC(C)CC1		CHEMBL4447225	=	IC50	nM	1723.0	CHEMBL267	Homo sapiens	IC50	uM	1.723
	19114814	CHEMBL4371354	Inhibition of SRC (unknown origin) using fluorescence labeled peptide as substrate at 10 uM by IMAP assay relative to control	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4cc(F)ccc4F)cc3F)ccnc2cc1OCCCN1CCCC(C)C1		CHEMBL4457733	=	Efficacy	%	83.0	CHEMBL267	Homo sapiens	Efficacy	%	83.0
	19114815	CHEMBL4371355	Inhibition of SRC (unknown origin) using biotinylated peptide as substrate at 10 uM by TR-FRET assay relative to control	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4cc(F)ccc4F)cc3F)ccnc2cc1OCCCN1CCCC(C)C1		CHEMBL4457733	=	Efficacy	%	83.0	CHEMBL267	Homo sapiens	Efficacy	%	83.0
	19114829	CHEMBL4371477	Inhibition of SRC (unknown origin)	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4cc(F)ccc4F)cc3F)ccnc2cc1OCCCN1CCCC(C)C1		CHEMBL4457733	=	IC50	nM	113.0	CHEMBL267	Homo sapiens	IC50	uM	0.113
	19118534	CHEMBL4372378	Inhibition of recombinant human N-terminal His6-tagged Src (1 to 530 residues) expressed in baculovirus infected Sf21 insect cells at 1 uM in presence of [gamma-33P]-ATP or [gamma-32P]-ATP relative to control	B	Cc1cccc(Cn2nc(C)c3c(NC(=O)c4csc5c(N)ncnc45)cccc32)n1		CHEMBL4483816	=	Inhibition	%	4.0	CHEMBL267	Homo sapiens	INH	%	4.0
	19140838	CHEMBL4376602	Inhibition of recombinant full length human untagged SRC expressed in baculovirus expression system at 1 uM using biotin as substrate preincubated for 5 mins followed by substrate addition and measured after 30 to 60 mins in presence of ATP by HTRF assay relative to control	B	Cn1cc(-c2ccc(F)cc2)c(=O)c2c(Nc3ccc(Oc4ccnc(NC(=O)C5CC5)c4)c(F)c3)nccc21		CHEMBL4584949	<	Inhibition	%	50.0	CHEMBL267	Homo sapiens	INH	%	50.0
	19144766	CHEMBL4377782	Inhibition of recombinant full-length human cSRC at 1 uM using KVEKIGEGTYGVVYK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	35.0	CHEMBL267	Homo sapiens	INH	%	35.0
	19144893	CHEMBL4377909	Inhibition of human Src (1 to 530 residues) at 1 uM using GGEEEEYFELVKKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	36.0	CHEMBL267	Homo sapiens	INH	%	36.0
	19144894	CHEMBL4377910	Inhibition of recombinant full-length human Src T341M mutant at 1 uM using GGEEEEYFELVKKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	20.0	CHEMBL267	Homo sapiens	INH	%	20.0
	19145491	CHEMBL4378253	Inhibition of SRC (unknown origin)	B	C[C@H]1Oc2cc(cnc2N)Cc2c(nn(C)c2C#N)CN(C)C(=O)c2ccc(F)cc21		CHEMBL4436406	=	IC50	nM	5.3	CHEMBL267	Homo sapiens	IC50	nM	5.3
	19145492	CHEMBL4378253	Inhibition of SRC (unknown origin)	B	C[C@H]1CNC(=O)c2cnn3ccc(nc23)N[C@H](C)c2cc(F)ccc2O1		CHEMBL4298138	=	IC50	nM	5.3	CHEMBL267	Homo sapiens	IC50	nM	5.3
	19145496	CHEMBL4378256	Inhibition of SRC phosphorylation (unknown origin)	B	C[C@H]1CNC(=O)c2cnn3ccc(nc23)N[C@H](C)c2cc(F)ccc2O1		CHEMBL4298138	=	IC50	nM	107.0	CHEMBL267	Homo sapiens	IC50	nM	107.0
	19146901	CHEMBL4378891	Inhibition of recombinant full length human cSRC at 10 uM using KVEKIGEGTYGVVYK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CS(=O)(=O)Nc1ccc(Cc2ccc3ccccc3c2)cc1		CHEMBL4459587	=	Inhibition	%	-4.0	CHEMBL267	Homo sapiens	INH	%	-4.0
	19146974	CHEMBL4378818	Inhibition of recombinant human Src (1 to 530 residues) at 10 uM using GGEEEEYFELVKKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CS(=O)(=O)Nc1ccc(Cc2ccc3ccccc3c2)cc1		CHEMBL4459587	=	Inhibition	%	17.0	CHEMBL267	Homo sapiens	INH	%	17.0
	19147814	CHEMBL4379210	Inhibition of recombinant human C-Src using KVEKIGEGTYGVV as substrate incubated 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	19148046	CHEMBL4379442	Inhibition of recombinant human SRC (1 to 530 residues) using GGEEEEYFELVKK as substrate incubated for 40 mins in presence of [gamma33P]ATP by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	19148047	CHEMBL4379443	Inhibition of recombinant full length human SRC T341M mutant using GGEEEEYFELVKK as substrate incubated for 40 mins in presence of [gamma33P]ATP by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	19148350	CHEMBL4379606	Inhibition of human C-src at 100 nM using poly (Glu,Tyr) 4:1 as substrate in presence of 33P-gamma ATP by hotspot kinase assay relative to control	B	CCN1CCN(c2cc(Nc3ncc(-c4ccncc4)s3)nc(C)n2)CC1.Cl		CHEMBL4513768	=	Inhibition	%	94.0	CHEMBL267	Homo sapiens	INH	%	94.0
	19148351	CHEMBL4379607	Inhibition of human C-src using poly (Glu,Tyr) 4:1 as substrate in presence of 33P-gamma ATP by hotspot kinase assay	B	CCN1CCN(c2cc(Nc3ncc(-c4ccncc4)s3)nc(C)n2)CC1.Cl		CHEMBL4513768	=	IC50	nM	3.0	CHEMBL267	Homo sapiens	IC50	nM	3.0
	19159665	CHEMBL4382769	Binding affinity to wild-type human partial length SRC (L240 to L536 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	34.0	CHEMBL267	Homo sapiens	Activity	%	34.0
	19159841	CHEMBL4382853	Inhibition of recombinant c-SRC (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	C=CC(=O)N1CC[C@H](n2cc(-c3cc4cc(C)cc(OC)c4s3)c3c(N)ncnc32)C1		CHEMBL4475243	>	IC50	nM	1000.0	CHEMBL267	Homo sapiens	IC50	nM	1000.0
	19161582	CHEMBL4383428	Inhibition of wild type C-terminal FLAG-tagged human TEL fused SRC (unknown origin) transfected in mouse BAF3 cells assessed as growth inhibition after 72 hrs by CCK8 assay	B	CN1CCN(Cc2ccc(NC(=O)CCSc3ccc4c(/C=C/c5ccccn5)n[nH]c4c3)cc2C(F)(F)F)CC1		CHEMBL4439424	=	GI50	nM	1050.0	CHEMBL267	Homo sapiens	GI50	uM	1.05
Active	19163635	CHEMBL4383849	Inhibition of human c-SRC at 10 uM using poly[Glu:Tyr] (4:1) as substrate after 120 mins [gamma-33P]-ATP by filtration method	B	COc1ccc(Oc2nc(Nc3ccc(N4CCOCC4)nc3)ncc2NC(=O)c2cc(OC)cc(OC)c2)cc1		CHEMBL4461911		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	19173611	CHEMBL4385482	Inhibition of full-length recombinant human C-terminal His-tagged SRC cytoplasmic domain expressed in baculovirus expression system using FAM-Srctide peptide as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr by TR-FRET Lanthascreen assay	A	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccc(Cl)cc4)cc3)c(C(N)=O)c2N)C1		CHEMBL4520801	=	IC50	nM	72.0	CHEMBL267	Homo sapiens	IC50	nM	72.0
	19173612	CHEMBL4385482	Inhibition of full-length recombinant human C-terminal His-tagged SRC cytoplasmic domain expressed in baculovirus expression system using FAM-Srctide peptide as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr by TR-FRET Lanthascreen assay	A	N#CN1CCC[C@@H](n2nc(-c3ccc(Oc4ncc(Cl)cc4F)cc3)c(C(N)=O)c2N)C1		CHEMBL4462332	>	IC50	nM	20000.0	CHEMBL267	Homo sapiens	IC50	nM	20000.0
	19173613	CHEMBL4385482	Inhibition of full-length recombinant human C-terminal His-tagged SRC cytoplasmic domain expressed in baculovirus expression system using FAM-Srctide peptide as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr by TR-FRET Lanthascreen assay	A	N#CN1CCC[C@@H](n2nc(-c3ccc(Oc4cccc(C(F)(F)F)n4)cc3)c(C(N)=O)c2N)C1		CHEMBL4456974	=	IC50	nM	14400.0	CHEMBL267	Homo sapiens	IC50	nM	14400.0
	19173614	CHEMBL4385482	Inhibition of full-length recombinant human C-terminal His-tagged SRC cytoplasmic domain expressed in baculovirus expression system using FAM-Srctide peptide as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr by TR-FRET Lanthascreen assay	A	N#CN1CCC[C@@H](n2nc(-c3ccc(Oc4ccc(Cl)cn4)cc3)c(C(N)=O)c2N)C1		CHEMBL4469663	>	IC50	nM	20000.0	CHEMBL267	Homo sapiens	IC50	nM	20000.0
	19173615	CHEMBL4385482	Inhibition of full-length recombinant human C-terminal His-tagged SRC cytoplasmic domain expressed in baculovirus expression system using FAM-Srctide peptide as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr by TR-FRET Lanthascreen assay	A	N#CN1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c(C(N)=O)c2N)C1		CHEMBL4436118	=	IC50	nM	4.2	CHEMBL267	Homo sapiens	IC50	nM	4.2
	19173616	CHEMBL4385482	Inhibition of full-length recombinant human C-terminal His-tagged SRC cytoplasmic domain expressed in baculovirus expression system using FAM-Srctide peptide as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr by TR-FRET Lanthascreen assay	A	N#CN1CCC[C@@H](n2nc(-c3ccc(Oc4ccc(Cl)cc4)cc3)c(C(N)=O)c2N)C1		CHEMBL4456283	=	IC50	nM	1400.0	CHEMBL267	Homo sapiens	IC50	nM	1400.0
	19173617	CHEMBL4385482	Inhibition of full-length recombinant human C-terminal His-tagged SRC cytoplasmic domain expressed in baculovirus expression system using FAM-Srctide peptide as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr by TR-FRET Lanthascreen assay	A	CN(C)C/C=C/C(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccc(F)cc4F)cc3)c(C(N)=O)c2N)C1		CHEMBL4572913	=	IC50	nM	370.0	CHEMBL267	Homo sapiens	IC50	nM	370.0
	19173618	CHEMBL4385482	Inhibition of full-length recombinant human C-terminal His-tagged SRC cytoplasmic domain expressed in baculovirus expression system using FAM-Srctide peptide as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr by TR-FRET Lanthascreen assay	A	NC(=O)c1c(-c2ccc(Oc3ccc(F)cc3F)cc2)nn([C@@H]2CCCN(C(=O)/C=C/C(F)F)C2)c1N		CHEMBL4559065	=	IC50	nM	5840.0	CHEMBL267	Homo sapiens	IC50	nM	5840.0
	19173619	CHEMBL4385482	Inhibition of full-length recombinant human C-terminal His-tagged SRC cytoplasmic domain expressed in baculovirus expression system using FAM-Srctide peptide as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr by TR-FRET Lanthascreen assay	A	NC(=O)c1c(-c2ccc(Oc3ccc(F)cc3F)cc2)nn([C@@H]2CCCN(C(=O)/C=C/CF)C2)c1N		CHEMBL4556666	=	IC50	nM	3140.0	CHEMBL267	Homo sapiens	IC50	nM	3140.0
	19173620	CHEMBL4385482	Inhibition of full-length recombinant human C-terminal His-tagged SRC cytoplasmic domain expressed in baculovirus expression system using FAM-Srctide peptide as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr by TR-FRET Lanthascreen assay	A	NC(=O)c1c(-c2ccc(Oc3ccc(F)cc3F)cc2)nn([C@@H]2CCCN(C(=O)/C=C/CO)C2)c1N		CHEMBL4440096	=	IC50	nM	4610.0	CHEMBL267	Homo sapiens	IC50	nM	4610.0
	19173621	CHEMBL4385482	Inhibition of full-length recombinant human C-terminal His-tagged SRC cytoplasmic domain expressed in baculovirus expression system using FAM-Srctide peptide as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr by TR-FRET Lanthascreen assay	A	C=C(F)C(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccc(F)cc4F)cc3)c(C(N)=O)c2N)C1		CHEMBL4591391	=	IC50	nM	6480.0	CHEMBL267	Homo sapiens	IC50	nM	6480.0
	19173622	CHEMBL4385482	Inhibition of full-length recombinant human C-terminal His-tagged SRC cytoplasmic domain expressed in baculovirus expression system using FAM-Srctide peptide as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr by TR-FRET Lanthascreen assay	A	C/C=C/C(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccc(F)cc4F)cc3)c(C(N)=O)c2N)C1		CHEMBL4548556	=	IC50	nM	3410.0	CHEMBL267	Homo sapiens	IC50	nM	3410.0
	19173623	CHEMBL4385482	Inhibition of full-length recombinant human C-terminal His-tagged SRC cytoplasmic domain expressed in baculovirus expression system using FAM-Srctide peptide as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr by TR-FRET Lanthascreen assay	A	C=C(C)C(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccc(F)cc4F)cc3)c(C(N)=O)c2N)C1		CHEMBL4518667	=	IC50	nM	3350.0	CHEMBL267	Homo sapiens	IC50	nM	3350.0
	19173624	CHEMBL4385482	Inhibition of full-length recombinant human C-terminal His-tagged SRC cytoplasmic domain expressed in baculovirus expression system using FAM-Srctide peptide as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr by TR-FRET Lanthascreen assay	A	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccc(F)cc4F)cc3)c(C(N)=O)c2N)C1		CHEMBL4442732	=	IC50	nM	4030.0	CHEMBL267	Homo sapiens	IC50	nM	4030.0
	19173625	CHEMBL4385482	Inhibition of full-length recombinant human C-terminal His-tagged SRC cytoplasmic domain expressed in baculovirus expression system using FAM-Srctide peptide as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr by TR-FRET Lanthascreen assay	A	N#CN1CCC[C@@H](n2nc(-c3ccc(Oc4ccc(F)cc4F)cc3)c(C(N)=O)c2N)C1		CHEMBL4560385	=	IC50	nM	1630.0	CHEMBL267	Homo sapiens	IC50	nM	1630.0
	19173626	CHEMBL4385482	Inhibition of full-length recombinant human C-terminal His-tagged SRC cytoplasmic domain expressed in baculovirus expression system using FAM-Srctide peptide as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr by TR-FRET Lanthascreen assay	A	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	=	IC50	nM	38.0	CHEMBL267	Homo sapiens	IC50	nM	38.0
	19181150	CHEMBL4387361	Inhibition of recombinant full length human His-tagged SRC expressed in baculovirus expression system at 0.1 uM using tyrosine-2 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	=	Inhibition	%	7.5	CHEMBL267	Homo sapiens	INH	%	7.5
	19181375	CHEMBL4387361	Inhibition of recombinant full length human His-tagged SRC expressed in baculovirus expression system at 0.1 uM using tyrosine-2 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CC2(C1)CN(c1ccc(Nc3ncc(F)c(-c4cnn5c4[C@H](C)CCCC5)n3)nc1)C2		CHEMBL4545456	=	Inhibition	%	1.5	CHEMBL267	Homo sapiens	INH	%	1.5
	19191342	CHEMBL4389488	Inhibition of wild-type human partial length SRC (L240 to L536 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	80.0	CHEMBL267	Homo sapiens	INH	%	80.0
	19192151	CHEMBL4389965	Inhibition of wild-type human partial length SRC (L240 to L536 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	71.0	CHEMBL267	Homo sapiens	INH	%	71.0
	19200407	CHEMBL4391591	Binding affinity to wild-type human partial length SRC (L240 to L536 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	24.0	CHEMBL267	Homo sapiens	Activity	%	24.0
	19211858	CHEMBL4393295	Inhibition of c-SRC (unknown origin) using FAM-labelled peptide as substrate measured after 10 mins by mobility shift assay	B	COc1cc2c(Oc3ccc(C4SCC(=O)N4NC(=O)Nc4ccc(F)cc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4446992	=	IC50	nM	383.0	CHEMBL267	Homo sapiens	IC50	uM	0.383
Not Active	19221824	CHEMBL4395282	Inhibition of Src in human MDA-MB-231 cells assessed as reduction in Src phosphorylation at 1 to 4 uM incubated for 24 hrs by Western blot analysis	B	CCN(CC)c1ccc2cc(C(=O)N3CCN(C(=O)C4=Cc5c(Br)cccc5S4(=O)=O)CC3)c(=O)oc2c1		CHEMBL4471915		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	19221839	CHEMBL4395290	Inhibition of Src in human MDA-MB-231 cells assessed as reduction in Src phosphorylation at 4 uM incubated for 24 hrs by Western blot analysis	B	O=[N+]([O-])c1ccc2c(c1)S(=O)(=O)C=C2		CHEMBL1337170		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	19225491	CHEMBL4395911	Inhibition of human recombinant SRC at 1 uM using Ulight-Poly GAT[EAY(1:1:1)]n as substrate measured after 10 mins in presence of ATP by LANCE assay relative to control	B	CCc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4536012	=	Inhibition	%	51.61	CHEMBL267	Homo sapiens	INH	%	51.61
	19230938	CHEMBL4397170	Inhibition of recombinant human full-length N-terminal His6-tagged SRC expressed in Sf21 insect cells at 100 nM preincubated for 5 mins followed by ATP addition and measured after 10 mins by alphascreen assay relative to control	B	Cc1cc(-n2cc(C(=O)N3CCO[C@@H](C)C3)c3ccc(O[C@@H](C)c4ccc(F)cn4)nc32)n[nH]1		CHEMBL4440381	=	Inhibition	%	-2.0	CHEMBL267	Homo sapiens	INH	%	-2.0
	19236728	CHEMBL4398801	Inhibition of Src (unknown origin) at 100 nM relative to control	B	COc1cc2c(Nc3ccc(NC(=O)C(c4cc(F)ccc4F)N4Cc5ccccc5C4=O)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL4443483	=	Inhibition	%	50.0	CHEMBL267	Homo sapiens	INH	%	50.0
	19237275	CHEMBL4398961	Inhibition of SRC (unknown origin) at 10 uM using peptide as substrate incubated for 10 mins by caliper assay relative to control	B	O=C(Nc1nc(NCc2ccc(Cl)cc2)c2nc[nH]c2n1)c1ccccc1		CHEMBL4474543	=	Inhibition	%	15.4	CHEMBL267	Homo sapiens	INH	%	15.4
	19266329	CHEMBL4405279	Inhibition of wild-type human partial length SRC (L240 to L536 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL267	Homo sapiens	INH	%	50.0
	19272043	CHEMBL4406988	Inhibition of wild-type human partial length SRC (L240 to L536 residues) expressed in bacterial expression system assessed as enzyme remaining activity at 1000 nM by Kinomescan method relative to control	B	O=C(Nc1cccc(Br)c1)Nc1cc(Oc2ccc3nc(NC(=O)C4CC4)sc3c2)ccc1F		CHEMBL4465561	=	Activity	%	0.0	CHEMBL267	Homo sapiens	Activity	%	0.0
	19274865	CHEMBL4407570	Inhibition of full-length recombinant human C-terminal His-tagged SRC cytoplasmic domain expressed in baculovirus expression system at 25 uM using FRET-labeled tyr 02 peptide as substrate measured after 1 hr by Z'-lyte assay relative to control	A	Nc1ncc2cc(-c3c(Br)cccc3Br)c(N)nc2n1		CHEMBL57531	=	Inhibition	%	93.0	CHEMBL267	Homo sapiens	INH	%	93.0
	19274866	CHEMBL4407570	Inhibition of full-length recombinant human C-terminal His-tagged SRC cytoplasmic domain expressed in baculovirus expression system at 25 uM using FRET-labeled tyr 02 peptide as substrate measured after 1 hr by Z'-lyte assay relative to control	A	Nc1ncc2cc(-c3c(Cl)cccc3-c3cccnc3)c(N3C[C@H]4[C@H](N)[C@H]4C3)nc2n1		CHEMBL4453148	=	Inhibition	%	8.0	CHEMBL267	Homo sapiens	INH	%	8.0
	19274867	CHEMBL4407570	Inhibition of full-length recombinant human C-terminal His-tagged SRC cytoplasmic domain expressed in baculovirus expression system at 25 uM using FRET-labeled tyr 02 peptide as substrate measured after 1 hr by Z'-lyte assay relative to control	A	CC(C)COc1cccc(Cl)c1-c1cc2cnc(N)nc2nc1N1C[C@H]2[C@H](N)[C@H]2C1		CHEMBL4546703	=	Inhibition	%	8.0	CHEMBL267	Homo sapiens	INH	%	8.0
	19275969	CHEMBL4407972	Inhibition of full length recombinant human c-SRC at 1 uM using KVEKIGEGTYGVV as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	80.0	CHEMBL267	Homo sapiens	INH	%	80.0
	19294842	CHEMBL4412213	Inhibition of human wild type SRC (L240 to L536 residues) expressed in bacterial expression system at 5 uM relative to control	B	CCN(CC)CCCNc1nc(/C=C/c2ccc(OC)cc2)nc2ccc(Br)cc12		CHEMBL4458349	=	Inhibition	%	32.0	CHEMBL267	Homo sapiens	INH	%	32.0
	19295076	CHEMBL4412230	Inhibition of SRC (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	CC(=O)Oc1ccccc1/C=C/c1nc2ccccc2c(=O)[nH]1		CHEMBL4442304	=	Inhibition	%	40.0	CHEMBL267	Homo sapiens	INH	%	40.0
	19295077	CHEMBL4412230	Inhibition of SRC (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	CC(=O)Oc1cccc(/C=C/c2nc3ccccc3c(=O)[nH]2)c1		CHEMBL4453032	=	Inhibition	%	1.0	CHEMBL267	Homo sapiens	INH	%	1.0
	19295078	CHEMBL4412230	Inhibition of SRC (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	CC(=O)Oc1ccc(/C=C/c2nc3ccccc3c(=O)[nH]2)c(OC(C)=O)c1		CHEMBL4517514	=	Inhibition	%	51.0	CHEMBL267	Homo sapiens	INH	%	51.0
	19295079	CHEMBL4412230	Inhibition of SRC (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	COc1ccccc1/C=C/c1nc2ccccc2c(=O)[nH]1		CHEMBL1090672	=	Inhibition	%	40.0	CHEMBL267	Homo sapiens	INH	%	40.0
	19295080	CHEMBL4412230	Inhibition of SRC (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	COc1cccc(/C=C/c2nc3ccccc3c(=O)[nH]2)c1		CHEMBL1092204	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	19295081	CHEMBL4412230	Inhibition of SRC (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	COc1ccc(/C=C/c2nc3ccccc3c(=O)[nH]2)cc1		CHEMBL1092207	=	Inhibition	%	51.0	CHEMBL267	Homo sapiens	INH	%	51.0
	19295082	CHEMBL4412230	Inhibition of SRC (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	CCOc1ccccc1/C=C/c1nc2ccccc2c(=O)[nH]1		CHEMBL4459848	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	19295083	CHEMBL4412230	Inhibition of SRC (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	CCOc1ccc(/C=C/c2nc3ccccc3c(=O)[nH]2)cc1		CHEMBL4583163	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	19295084	CHEMBL4412230	Inhibition of SRC (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	CCCCOc1ccc(/C=C/c2nc3ccccc3c(=O)[nH]2)cc1		CHEMBL4559299	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	19295085	CHEMBL4412230	Inhibition of SRC (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	O=c1[nH]c(/C=C/c2cccc3c2OCO3)nc2ccccc12		CHEMBL4468697	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	19295086	CHEMBL4412230	Inhibition of SRC (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	O=c1[nH]c(/C=C/c2ccc3c(c2)OCO3)nc2ccccc12		CHEMBL4470620	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	19295087	CHEMBL4412230	Inhibition of SRC (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	O=c1[nH]c(/C=C/c2c(Br)ccc3c2OCO3)nc2ccccc12		CHEMBL4518551	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	19295088	CHEMBL4412230	Inhibition of SRC (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	O=c1[nH]c(/C=C/c2cc3c(cc2Br)OCO3)nc2ccccc12		CHEMBL4576121	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	19295089	CHEMBL4412230	Inhibition of SRC (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	O=c1[nH]c(/C=C/c2cccc([N+](=O)[O-])c2)nc2ccccc12		CHEMBL4445408	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	19295090	CHEMBL4412230	Inhibition of SRC (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	O=c1[nH]c(/C=C/c2ccc([N+](=O)[O-])cc2)nc2ccccc12		CHEMBL4539405	=	Inhibition	%	58.0	CHEMBL267	Homo sapiens	INH	%	58.0
	19295091	CHEMBL4412230	Inhibition of SRC (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	CC(=O)Oc1ccccc1/C=C/c1nc(Nc2ccccc2I)c2ccccc2n1		CHEMBL4455338	=	Inhibition	%	21.0	CHEMBL267	Homo sapiens	INH	%	21.0
	19295092	CHEMBL4412230	Inhibition of SRC (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	COc1ccc(OC)c(Nc2nc(/C=C/c3ccccc3OC(C)=O)nc3ccccc23)c1		CHEMBL4458986	=	Inhibition	%	57.0	CHEMBL267	Homo sapiens	INH	%	57.0
	19295093	CHEMBL4412230	Inhibition of SRC (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	COc1ccccc1/C=C/c1nc(Nc2ccccc2Cl)c2ccccc2n1		CHEMBL4550950	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	19295094	CHEMBL4412230	Inhibition of SRC (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	COc1ccccc1/C=C/c1nc(Nc2ccc(O)cc2)c2ccccc2n1		CHEMBL4472770	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	19295095	CHEMBL4412230	Inhibition of SRC (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	COc1ccccc1/C=C/c1nc(Nc2cccc(O)c2)c2ccccc2n1		CHEMBL4459984	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	19295096	CHEMBL4412230	Inhibition of SRC (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	COc1ccccc1/C=C/c1nc(Nc2ccc3c(c2)OCO3)c2ccccc2n1		CHEMBL4476482	=	Inhibition	%	84.0	CHEMBL267	Homo sapiens	INH	%	84.0
	19295097	CHEMBL4412230	Inhibition of SRC (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	COc1ccccc1/C=C/c1nc(NCc2ccc3c(c2)OCO3)c2ccccc2n1		CHEMBL4470772	=	Inhibition	%	14.0	CHEMBL267	Homo sapiens	INH	%	14.0
	19295098	CHEMBL4412230	Inhibition of SRC (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	COc1ccc(/C=C/c2nc(Nc3cccc(O)c3)c3ccccc3n2)cc1		CHEMBL4571210	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	19295099	CHEMBL4412230	Inhibition of SRC (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	Oc1cccc(Nc2nc(/C=C/c3cc4c(cc3Br)OCO4)nc3ccccc23)c1		CHEMBL4436086	=	Inhibition	%	41.0	CHEMBL267	Homo sapiens	INH	%	41.0
	19295100	CHEMBL4412230	Inhibition of SRC (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	O=[N+]([O-])c1cccc(/C=C/c2nc(Nc3cccc(O)c3)c3ccccc3n2)c1		CHEMBL4437669	=	Inhibition	%	55.0	CHEMBL267	Homo sapiens	INH	%	55.0
	19295101	CHEMBL4412230	Inhibition of SRC (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	Oc1ccc(Nc2nc(/C=C/c3cccc(Cl)c3)nc3ccccc23)cc1		CHEMBL4553117	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	19295102	CHEMBL4412230	Inhibition of SRC (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	Oc1cccc(Nc2nc(/C=C/c3cccc(Cl)c3)nc3ccccc23)c1		CHEMBL4535076	=	Inhibition	%	1.0	CHEMBL267	Homo sapiens	INH	%	1.0
	19295103	CHEMBL4412230	Inhibition of SRC (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	COc1ccc(/C=C/c2nc(NCCCN(C)C)c3ccccc3n2)cc1		CHEMBL186928	=	Inhibition	%	16.0	CHEMBL267	Homo sapiens	INH	%	16.0
	19295104	CHEMBL4412230	Inhibition of SRC (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	19295105	CHEMBL4412230	Inhibition of SRC (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Inhibition	%	98.0	CHEMBL267	Homo sapiens	INH	%	98.0
	19295106	CHEMBL4412230	Inhibition of SRC (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	=	Inhibition	%	11.0	CHEMBL267	Homo sapiens	INH	%	11.0
	19295107	CHEMBL4412230	Inhibition of SRC (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	COc1ccc(Cl)c(Nc2ncnc3cc(OCC4CCN(C)CC4)c(OC)cc23)c1		CHEMBL426161	=	Inhibition	%	100.0	CHEMBL267	Homo sapiens	INH	%	100.0
	19295143	CHEMBL4412238	Inhibition of SRC (unknown origin) preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay	B	COc1ccccc1/C=C/c1nc2ccccc2c(=O)[nH]1		CHEMBL1090672	=	IC50	nM	626.0	CHEMBL267	Homo sapiens	IC50	nM	626.0
	19295144	CHEMBL4412238	Inhibition of SRC (unknown origin) preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay	B	COc1ccccc1/C=C/c1nc(Nc2ccc3c(c2)OCO3)c2ccccc2n1		CHEMBL4476482	=	IC50	nM	209.0	CHEMBL267	Homo sapiens	IC50	nM	209.0
	19295145	CHEMBL4412238	Inhibition of SRC (unknown origin) preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay	B	Oc1cccc(Nc2nc(/C=C/c3cc4c(cc3Br)OCO4)nc3ccccc23)c1		CHEMBL4436086	=	IC50	nM	897.0	CHEMBL267	Homo sapiens	IC50	nM	897.0
	19295146	CHEMBL4412238	Inhibition of SRC (unknown origin) preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay	B	O=[N+]([O-])c1cccc(/C=C/c2nc(Nc3cccc(O)c3)c3ccccc3n2)c1		CHEMBL4437669	=	IC50	nM	804.0	CHEMBL267	Homo sapiens	IC50	nM	804.0
	19295147	CHEMBL4412238	Inhibition of SRC (unknown origin) preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	IC50	nM	0.9	CHEMBL267	Homo sapiens	IC50	nM	0.9
	19295860	CHEMBL4412337	Inhibition of c-Src (unknown origin) at 1000 nM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2c(-c3cnn(C4CC4)c3)n[nH]c2c1		CHEMBL4534119	=	Inhibition	%	96.8	CHEMBL267	Homo sapiens	INH	%	96.8
	19295890	CHEMBL4412367	Inhibition of c-Src (unknown origin) at 100 nM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2c(-c3cnn(C4CC4)c3)n[nH]c2c1		CHEMBL4534119	=	Inhibition	%	87.6	CHEMBL267	Homo sapiens	INH	%	87.6
	19295920	CHEMBL4412397	Inhibition of c-Src (unknown origin) at 10 nM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2c(-c3cnn(C4CC4)c3)n[nH]c2c1		CHEMBL4534119	=	Inhibition	%	64.5	CHEMBL267	Homo sapiens	INH	%	64.5
	19303781	CHEMBL4414233	Inhibition of cSRC (unknown origin) assessed as residual activity at 50 uM relative to control	B	O=C(O)c1ccc(Nc2nc(-c3cccc([N+](=O)[O-])c3)cs2)cc1		CHEMBL4462082	=	Activity	%	97.0	CHEMBL267	Homo sapiens	Activity	%	97.0
	19306164	CHEMBL4414988	Inhibition of human SRC at 1 uM using poly[Glu:Tyr] (4:1) as substrate preincubated for 15 to 20 mins followed by [gamma-33P]-ATP addition and measured after 120 mins by filter binding method relative to control	A	C=CC(=O)N1CCC([C@@H]2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1		CHEMBL3936761	=	Inhibition	%	29.0	CHEMBL267	Homo sapiens	INH	%	29.0
Active	19307924	CHEMBL4415526	Inhibition of Src (unknown origin) at 10 uM using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1ccc(-n2nc(C(=O)N3C[C@H](C)N[C@H](C)C3)nc2-c2ccc3c(c2)N(C2CCCC2)[C@H](C)C(=O)N3C)cc1		CHEMBL4451357		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	19312942	CHEMBL4416497	Inhibition of recombinant human N-terminal His6-tagged full length cSRC expressed in Sf21 insect cells at 10 uM using Src peptide s substrate relative to control	B	N#CC[C@H]1CC[C@H](n2c(=O)[nH]c3cnc(Nc4ccc[nH]c4=O)nc32)CC1		CHEMBL4463007	<	Inhibition	%	50.0	CHEMBL267	Homo sapiens	INH	%	50.0
Active	19317099	CHEMBL4417293	Inhibition of SRC (unknown origin) at 1000 nM relative to control	B	Cc1c(C(=O)Nc2ccc3ccccc3n2)cnn1-c1ccccc1Br		CHEMBL4555217		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	19320013	CHEMBL4417607	Inhibition of full length N-terminal GST-tagged human SRC (1 to 536 AA) expressed in baculovirus at 10 uM using FAM-labelled peptide as substrate pre-incubated for 10 mins followed by substrate addition by mobility shift assay relative to control	B	COc1ccc(OC)c(Nc2cc(NC(=O)Nc3c(Cl)cccc3Cl)ncn2)c1		CHEMBL4548481	=	Inhibition	%	45.78	CHEMBL267	Homo sapiens	INH	%	45.78
	19371123	CHEMBL4424844	Inhibition of human full-length N-terminal His-tagged SRC expressed in baculovirus infected Sf9 insect cells using Poly-(Glu4:Tyr) as substrate measured after 35 mins	A	COc1cc(C2CN(C(=O)c3cc(COC[C@@H](O)CO)ccn3)C2)ccc1OCc1ccc(C2CC2)cc1		CHEMBL4474690	>	IC50	nM	1000.0	CHEMBL267	Homo sapiens	IC50	nM	1000.0
	19411432	CHEMBL4427733	Inhibition of SRC (unknown origin)	B	Cc1cnc(-c2cc(Cl)ccc2F)cc1-n1c(=O)n(CC(N)=O)c2cnccc21		CHEMBL4564126	>=	IC50	nM	5000.0	CHEMBL267	Homo sapiens	IC50	uM	5.0
	19411488	CHEMBL4427677	Inhibition of SRC (unknown origin) at 1 uM relative to control	B	Cc1cnc(-c2cc(Cl)ccc2F)cc1-n1c(=O)n(CC(N)=O)c2cnccc21		CHEMBL4564126	<=	Inhibition	%	16.0	CHEMBL267	Homo sapiens	INH	%	16.0
	19432590	CHEMBL4429389	Inhibition of partial length human SRC expressed in bacterial system	B	Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1cnc2ccccc2c1=O		CHEMBL3918580	=	IC50	nM	3190.0	CHEMBL267	Homo sapiens	IC50	uM	3.19
	19440260	CHEMBL4431286	Inhibition of SRC (unknown origin) at 20 nM relative to control	B	c1ccc(Nc2nc(Nc3cn[nH]c3)nc3[nH]ccc23)cc1		CHEMBL4448847	=	Inhibition	%	12.6	CHEMBL267	Homo sapiens	INH	%	12.6
	19440261	CHEMBL4431286	Inhibition of SRC (unknown origin) at 20 nM relative to control	B	Clc1cccc(Nc2nc(Nc3cn[nH]c3)ncc2Cl)c1		CHEMBL4453646	=	Inhibition	%	27.0	CHEMBL267	Homo sapiens	INH	%	27.0
Active	19442570	CHEMBL4432054	Inhibition of c-Src phosphorylation in human A549 cells at 3 to 9 uM after 24 hrs by Western blot analysis	B	C[C@H]1CC[C@@]2(OC1)O[C@H]1C[C@H]3[C@@H]4CC[C@@H]5C[C@@H](O[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)CC[C@]5(C)[C@H]4CC[C@]3(C)[C@H]1[C@@H]2C		CHEMBL508990		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	19445431	CHEMBL4432492	Inhibition of recombinant c-SRC (unknown origin) at 1 uM using poly (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	Nc1nccc(Oc2ccc(NC(=O)c3cc4ccccc4n(-c4ccccc4)c3=O)cc2F)c1Cl		CHEMBL4582423	=	Inhibition	%	81.7	CHEMBL267	Homo sapiens	INH	%	81.7
	19445477	CHEMBL4432492	Inhibition of recombinant c-SRC (unknown origin) at 1 uM using poly (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	=	Inhibition	%	85.4	CHEMBL267	Homo sapiens	INH	%	85.4
	19475359	CHEMBL4479454	Inhibition of human c- SRC	B	C[C@@H](c1cc2cccnc2cc1F)n1cnc2ncc(-c3cnn(C)c3)nc21		CHEMBL4068255	>	IC50	nM	30000.0	CHEMBL267	Homo sapiens	IC50	nM	30000.0
	19476632	CHEMBL4479780	Inhibition of full-length recombinant human His-tagged SRC expressed in baculovirus expression system by Adapta assay	B	O=C(NCC(F)(F)F)c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)cs1		CHEMBL4569508	=	IC50	nM	37.0	CHEMBL267	Homo sapiens	IC50	nM	37.0
	19476732	CHEMBL4479780	Inhibition of full-length recombinant human His-tagged SRC expressed in baculovirus expression system by Adapta assay	B	Cn1cc(-c2cnc3c(-c4csc(C(=O)NCC(F)(F)F)c4)cnn3c2)cn1		CHEMBL4550702	=	IC50	nM	42.0	CHEMBL267	Homo sapiens	IC50	nM	42.0
	19476832	CHEMBL4479780	Inhibition of full-length recombinant human His-tagged SRC expressed in baculovirus expression system by Adapta assay	B	Cn1cc(-c2cnc3c(-c4csc(C(=O)N[C@@H]5CCCC[C@@H]5N)c4)cnn3c2)cn1		CHEMBL4568087	=	IC50	nM	3.0	CHEMBL267	Homo sapiens	IC50	nM	3.0
	19476932	CHEMBL4479780	Inhibition of full-length recombinant human His-tagged SRC expressed in baculovirus expression system by Adapta assay	B	Cc1sc(C(=O)N[C@@H]2[C@H](N)CCCC2(F)F)cc1-c1cnn2cc(Cl)cnc12		CHEMBL4552628	=	IC50	nM	8100.0	CHEMBL267	Homo sapiens	IC50	nM	8100.0
	20598181	CHEMBL4602910	Inhibition of human SRC	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	<	IC50	nM	1000.0	CHEMBL267	Homo sapiens	IC50	uM	1.0
	20600673	CHEMBL4603625	Inhibition of recombinant full length human His-tagged SRC expressed in baculovirus expression system using tyrosine-2 peptide as substrate incubated for 60 mins in presence of ATP by Z'-LYTE assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	>	IC50	nM	100000.0	CHEMBL267	Homo sapiens	IC50	uM	100.0
	20608955	CHEMBL4605664	Inhibition of SRC (unknown origin) assessed as residual activity incubated for 5 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay	B	Cc1ccc(C(=O)Nc2ccc(CN3CCC4C=NNC4C3)c(Cl)c2)cc1C#Cc1cnc2cccnn12		CHEMBL4640297	=	IC50	nM	709.7	CHEMBL267	Homo sapiens	IC50	uM	0.7097
	20608966	CHEMBL4605653	Inhibition of SRC (unknown origin) assessed as residual activity at 10 uM incubated for 5 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	Cc1ccc(C(=O)Nc2ccc(CN3CCC4C=NNC4C3)c(Cl)c2)cc1C#Cc1cnc2cccnn12		CHEMBL4640297	=	Activity	%	23.0	CHEMBL267	Homo sapiens	Activity	%	23.0
	20609001	CHEMBL4605653	Inhibition of SRC (unknown origin) assessed as residual activity at 10 uM incubated for 5 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	Cc1ccc(C(=O)Nc2ccc(CN3Cc4cn[nH]c4C3)c(Cl)c2)cc1C#Cc1cnc2cccnn12		CHEMBL4638981	=	Activity	%	15.0	CHEMBL267	Homo sapiens	Activity	%	15.0
	20609012	CHEMBL4605664	Inhibition of SRC (unknown origin) assessed as residual activity incubated for 5 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay	B	Cc1ccc(C(=O)Nc2ccc(CN3Cc4cn[nH]c4C3)c(Cl)c2)cc1C#Cc1cnc2cccnn12		CHEMBL4638981	=	IC50	nM	431.3	CHEMBL267	Homo sapiens	IC50	uM	0.4313
	20609033	CHEMBL4605653	Inhibition of SRC (unknown origin) assessed as residual activity at 10 uM incubated for 5 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	=	Activity	%	74.0	CHEMBL267	Homo sapiens	Activity	%	74.0
	20609049	CHEMBL4605653	Inhibition of SRC (unknown origin) assessed as residual activity at 10 uM incubated for 5 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	Activity	%	11.0	CHEMBL267	Homo sapiens	Activity	%	11.0
	20609594	CHEMBL4605817	Inhibition of SRC (unknown origin) transfected in mouse Ba/F3 cells assessed as reduction in cell viability incubated for 48 hrs by brightglo-luciferase reporter gene assay	B	COc1ccc(-c2cnn3c(N)c(-c4ccccc4)c(OC4CCN(C)CC4)nc23)cc1OC		CHEMBL4640601	=	IC50	nM	120.0	CHEMBL267	Homo sapiens	IC50	uM	0.12
	20609595	CHEMBL4605817	Inhibition of SRC (unknown origin) transfected in mouse Ba/F3 cells assessed as reduction in cell viability incubated for 48 hrs by brightglo-luciferase reporter gene assay	B	COC(=O)Nc1ccc(-c2c(OC3CCN(C)CC3)nc3c(-c4ccc(OC)c(OC)c4)cnn3c2N)cc1		CHEMBL4634073	=	IC50	nM	5000.0	CHEMBL267	Homo sapiens	IC50	uM	5.0
	20609596	CHEMBL4605817	Inhibition of SRC (unknown origin) transfected in mouse Ba/F3 cells assessed as reduction in cell viability incubated for 48 hrs by brightglo-luciferase reporter gene assay	B	COc1ccc(-c2cnn3c(N)c(-c4nccs4)c(OC4CCN(C)CC4)nc23)cc1OC		CHEMBL4636995	=	IC50	nM	2400.0	CHEMBL267	Homo sapiens	IC50	uM	2.4
	20612847	CHEMBL4606482	Inhibition of human Src expressed in Escherichia coli BL21 using Abltide peptide as substrate incubated for 20 to 40 mins by ELISA	A	Nc1ncnc2c1c(Oc1cc(C(F)(F)F)ccn1)nn2C1CC1		CHEMBL4634455	>	IC50	nM	20000.0	CHEMBL267	Homo sapiens	IC50	nM	20000.0
	20612848	CHEMBL4606482	Inhibition of human Src expressed in Escherichia coli BL21 using Abltide peptide as substrate incubated for 20 to 40 mins by ELISA	A	Nc1ncnc2c1c(Oc1cc(C(F)(F)F)ccn1)nn2[C@@H]1CCCC[C@H]1O		CHEMBL4646408	>	IC50	nM	20000.0	CHEMBL267	Homo sapiens	IC50	nM	20000.0
	20612849	CHEMBL4606482	Inhibition of human Src expressed in Escherichia coli BL21 using Abltide peptide as substrate incubated for 20 to 40 mins by ELISA	A	N#Cc1ccnc(Oc2nn([C@H]3C[C@H](F)C3)c3ncnc(N)c23)c1		CHEMBL4642579	>	IC50	nM	20000.0	CHEMBL267	Homo sapiens	IC50	nM	20000.0
	20654883	CHEMBL4616959	Inhibition of SRC (unknown origin)	B	CCCCNc1nc(SCCC)nc2c1cnn2CC(Cl)c1ccccc1		CHEMBL454922	=	Ki	nM	2570.4	CHEMBL267	Homo sapiens	pKi		5.59
	20654885	CHEMBL4616959	Inhibition of SRC (unknown origin)	B	ClC(Cn1ncc2c(NCc3ccccc3)ncnc21)c1ccccc1		CHEMBL411043	=	Ki	nM	3019.95	CHEMBL267	Homo sapiens	pKi		5.52
	20654893	CHEMBL4616959	Inhibition of SRC (unknown origin)	B	CCCSc1nc(NCc2ccccc2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL454923	=	Ki	nM	512.86	CHEMBL267	Homo sapiens	pKi		6.29
	20667007	CHEMBL4619608	Inhibition of human c-SRC using poly(Glu,Tyr)4:1 substrate and [gamma-33P]-ATP incubated for 40 mins by scintillation counting method	A	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C(=O)CCCc4cn(CCOCCOCCOCCNc5cccc6c5C(=O)N(C5CCC(=O)NC5=O)C6=O)nn4)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL4640401	=	IC50	nM	2575.0	CHEMBL267	Homo sapiens	IC50	nM	2575.0
	20667008	CHEMBL4619608	Inhibition of human c-SRC using poly(Glu,Tyr)4:1 substrate and [gamma-33P]-ATP incubated for 40 mins by scintillation counting method	A	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	IC50	nM	10.0	CHEMBL267	Homo sapiens	IC50	nM	10.0
	20667019	CHEMBL4619618	Safety index, ratio of compound IC50 to ponatinib IC50 for inhibition of human c-SRC using poly(Glu,Tyr)4:1 substrate and [gamma-33P]-ATP incubated for 40 mins by scintillation counting method	A	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C(=O)CCCc4cn(CCOCCOCCOCCNc5cccc6c5C(=O)N(C5CCC(=O)NC5=O)C6=O)nn4)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL4640401	=	Ratio IC50		257.0	CHEMBL267	Homo sapiens	Ratio IC50		257.0
	20680023	CHEMBL4622590	Inhibition of recombinant human C-terminal His-tagged SRC expressed in baculovirus expression system using polyGT as substrate incubated for 1 hr by Lanthascreen assay	B	Cn1cc(-c2ccnc(-n3ncc4cc(C(C)(C)C)cc(F)c4c3=O)c2CO)cc(NC(=O)[C@@H]2C[C@@H]2F)c1=O		CHEMBL4634904	>	Inhibition	%	50.0	CHEMBL267	Homo sapiens	INH	%	50.0
	20681259	CHEMBL4623165	Inhibition of SRC (unknown origin) using FAM-labeled peptide and ATP as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(-n2c(C)ccc2CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL4644718	=	IC50	nM	178.0	CHEMBL267	Homo sapiens	IC50	nM	178.0
	20681260	CHEMBL4623165	Inhibition of SRC (unknown origin) using FAM-labeled peptide and ATP as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	IC50	nM	16.0	CHEMBL267	Homo sapiens	IC50	nM	16.0
	20683637	CHEMBL4623616	Inhibition of c-SRC (unknown origin) at 10 nM relative to control	B	C[C@@H](Oc1cncc(-c2cnn(C3CCNCC3)c2)c1)c1c(Cl)ccc(F)c1Cl.Cl		CHEMBL4644985	=	Inhibition	%	-10.0	CHEMBL267	Homo sapiens	INH	%	-10.0
	20683638	CHEMBL4623617	Inhibition of c-SRC (unknown origin) at 100 nM relative to control	B	C[C@@H](Oc1cncc(-c2cnn(C3CCNCC3)c2)c1)c1c(Cl)ccc(F)c1Cl.Cl		CHEMBL4644985	=	Inhibition	%	-7.0	CHEMBL267	Homo sapiens	INH	%	-7.0
	20704520	CHEMBL4628025	Inhibition of recombinant human full-length N-terminal GST-tagged SRC (1 to 536 residues) expressed in baculovirus expression system using FAM-labelled P4 peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr in presence of ATP by fluorescence assay	A	Cc1ccc(C(=O)Nc2cccc(N3CCN(C)CC3)c2)cc1Nc1nccc(-c2ccc(F)cc2)n1		CHEMBL4632839	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	20704521	CHEMBL4628025	Inhibition of recombinant human full-length N-terminal GST-tagged SRC (1 to 536 residues) expressed in baculovirus expression system using FAM-labelled P4 peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr in presence of ATP by fluorescence assay	A	Cc1cc(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5ccc(F)cc5)n4)c3)cc(N3CCN(C)CC3)c2)on1		CHEMBL4648729	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	20704522	CHEMBL4628025	Inhibition of recombinant human full-length N-terminal GST-tagged SRC (1 to 536 residues) expressed in baculovirus expression system using FAM-labelled P4 peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr in presence of ATP by fluorescence assay	A	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5ccc(F)cc5)n4)c3)cc(N3CCOCC3)c2)cn1		CHEMBL4638611	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	20704523	CHEMBL4628025	Inhibition of recombinant human full-length N-terminal GST-tagged SRC (1 to 536 residues) expressed in baculovirus expression system using FAM-labelled P4 peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr in presence of ATP by fluorescence assay	A	Cc1cn(-c2cc(CN3CCCC[C@H]3C(N)=O)cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5ccc(F)cc5)n4)c3)c2)cn1		CHEMBL4646469	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	20704524	CHEMBL4628025	Inhibition of recombinant human full-length N-terminal GST-tagged SRC (1 to 536 residues) expressed in baculovirus expression system using FAM-labelled P4 peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr in presence of ATP by fluorescence assay	A	Cc1cn(-c2cc(CN3CCCC[C@H]3C(=O)O)cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5ccc(F)cc5)n4)c3)c2)cn1		CHEMBL4639891	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	20704525	CHEMBL4628025	Inhibition of recombinant human full-length N-terminal GST-tagged SRC (1 to 536 residues) expressed in baculovirus expression system using FAM-labelled P4 peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr in presence of ATP by fluorescence assay	A	Cc1cn(-c2cc(CN3CCC[C@H](N)C3)cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5ccc(F)cc5)n4)c3)c2)cn1		CHEMBL4637487	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	20704550	CHEMBL4628025	Inhibition of recombinant human full-length N-terminal GST-tagged SRC (1 to 536 residues) expressed in baculovirus expression system using FAM-labelled P4 peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr in presence of ATP by fluorescence assay	A	CCCCc1cc(NC(=O)c2ccc(C)c(Nc3nccc(-c4ccccc4)n3)c2)cc(-n2cnc(C)c2)c1		CHEMBL4633069	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	20704551	CHEMBL4628025	Inhibition of recombinant human full-length N-terminal GST-tagged SRC (1 to 536 residues) expressed in baculovirus expression system using FAM-labelled P4 peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr in presence of ATP by fluorescence assay	A	Cc1cn(-c2cc(CCS(N)(=O)=O)cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5ccccc5)n4)c3)c2)cn1		CHEMBL4642587	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	20704552	CHEMBL4628025	Inhibition of recombinant human full-length N-terminal GST-tagged SRC (1 to 536 residues) expressed in baculovirus expression system using FAM-labelled P4 peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr in presence of ATP by fluorescence assay	A	Cc1cn(-c2cc(CCC(=O)O)cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5ccccc5)n4)c3)c2)cn1		CHEMBL4637172	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	20704553	CHEMBL4628025	Inhibition of recombinant human full-length N-terminal GST-tagged SRC (1 to 536 residues) expressed in baculovirus expression system using FAM-labelled P4 peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr in presence of ATP by fluorescence assay	A	Cc1cn(-c2cc(/C=C/C(=O)O)cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5ccccc5)n4)c3)c2)cn1		CHEMBL4642089	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	20704554	CHEMBL4628025	Inhibition of recombinant human full-length N-terminal GST-tagged SRC (1 to 536 residues) expressed in baculovirus expression system using FAM-labelled P4 peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr in presence of ATP by fluorescence assay	A	Cc1cn(-c2cc(CN3CCN(C)CC3)cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5ccccc5)n4)c3)c2)cn1		CHEMBL4635318	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	20704555	CHEMBL4628025	Inhibition of recombinant human full-length N-terminal GST-tagged SRC (1 to 536 residues) expressed in baculovirus expression system using FAM-labelled P4 peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr in presence of ATP by fluorescence assay	A	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5ccccc5)n4)c3)cc(N3CCN(C)CC3)c2)cn1		CHEMBL4642128	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	20704556	CHEMBL4628025	Inhibition of recombinant human full-length N-terminal GST-tagged SRC (1 to 536 residues) expressed in baculovirus expression system using FAM-labelled P4 peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr in presence of ATP by fluorescence assay	A	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5ccccc5)n4)c3)cc(N3CCNCC3)c2)cn1		CHEMBL4638783	=	IC50	nM	4360.0	CHEMBL267	Homo sapiens	IC50	uM	4.36
	20704557	CHEMBL4628025	Inhibition of recombinant human full-length N-terminal GST-tagged SRC (1 to 536 residues) expressed in baculovirus expression system using FAM-labelled P4 peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr in presence of ATP by fluorescence assay	A	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5ccccc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL4642181	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	20704558	CHEMBL4628025	Inhibition of recombinant human full-length N-terminal GST-tagged SRC (1 to 536 residues) expressed in baculovirus expression system using FAM-labelled P4 peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr in presence of ATP by fluorescence assay	A	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	=	IC50	nM	1900.0	CHEMBL267	Homo sapiens	IC50	uM	1.9
	20704614	CHEMBL4628025	Inhibition of recombinant human full-length N-terminal GST-tagged SRC (1 to 536 residues) expressed in baculovirus expression system using FAM-labelled P4 peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr in presence of ATP by fluorescence assay	A	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Oc4ccccc4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL4638092	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	20704615	CHEMBL4628025	Inhibition of recombinant human full-length N-terminal GST-tagged SRC (1 to 536 residues) expressed in baculovirus expression system using FAM-labelled P4 peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr in presence of ATP by fluorescence assay	A	Cc1ccc(C(=O)Nc2cc(N3CCN(C)CC3)cc(-n3cnc(C)c3)c2)cc1		CHEMBL4637818	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	20704616	CHEMBL4628025	Inhibition of recombinant human full-length N-terminal GST-tagged SRC (1 to 536 residues) expressed in baculovirus expression system using FAM-labelled P4 peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr in presence of ATP by fluorescence assay	A	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Oc4ccccc4)c3)cc(N3CCN(C)CC3)c2)cn1		CHEMBL4649103	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	20704617	CHEMBL4628025	Inhibition of recombinant human full-length N-terminal GST-tagged SRC (1 to 536 residues) expressed in baculovirus expression system using FAM-labelled P4 peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr in presence of ATP by fluorescence assay	A	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Oc4cccc5ccncc45)c3)cc(N3CCN(C)CC3)c2)cn1		CHEMBL4638350	=	IC50	nM	2610.0	CHEMBL267	Homo sapiens	IC50	uM	2.61
	20704618	CHEMBL4628025	Inhibition of recombinant human full-length N-terminal GST-tagged SRC (1 to 536 residues) expressed in baculovirus expression system using FAM-labelled P4 peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr in presence of ATP by fluorescence assay	A	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(C(=O)c4cccc(C#N)c4)c3)cc(N3CCN(C)CC3)c2)cn1		CHEMBL4649346	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	20704619	CHEMBL4628025	Inhibition of recombinant human full-length N-terminal GST-tagged SRC (1 to 536 residues) expressed in baculovirus expression system using FAM-labelled P4 peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr in presence of ATP by fluorescence assay	A	Cc1cn(-c2cc(CN3CCC[C@H](N)C3)cc(NC(=O)c3ccc(C)c(Oc4ccccc4)c3)c2)cn1		CHEMBL4643586	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	22391632	CHEMBL4666950	Inhibition of recombinant human C-terminal His-tagged full length SRC expressed in baculovirus expression system using Tyr 02 as substrate at 0.1 uM incubated for 60 mins by Z'-Lyte assay relative to control	B	O=C(Nc1c[nH]nc1-c1cc(Cl)ccc1OC(F)F)c1cnn2cccnc12		CHEMBL4744172	=	Inhibition	%	38.0	CHEMBL267	Homo sapiens	INH	%	38.0
	22391633	CHEMBL4666950	Inhibition of recombinant human C-terminal His-tagged full length SRC expressed in baculovirus expression system using Tyr 02 as substrate at 0.1 uM incubated for 60 mins by Z'-Lyte assay relative to control	B	Cn1cc(NC(=O)c2cnn3cccnc23)c(-c2cc(Cl)ccc2OC(F)F)n1		CHEMBL4777342	=	Inhibition	%	28.0	CHEMBL267	Homo sapiens	INH	%	28.0
	22391634	CHEMBL4666950	Inhibition of recombinant human C-terminal His-tagged full length SRC expressed in baculovirus expression system using Tyr 02 as substrate at 0.1 uM incubated for 60 mins by Z'-Lyte assay relative to control	B	O=C(Nc1c[nH]nc1-c1cc2ccccc2cc1OC(F)F)c1cnn2cccnc12		CHEMBL4745474	=	Inhibition	%	35.0	CHEMBL267	Homo sapiens	INH	%	35.0
	22392171	CHEMBL4667266	Inhibition of recombinant human C-terminal His-tagged full length SRC expressed in baculovirus expression system using Tyr 02 as substrate at 10 uM incubated for 60 mins by Z'-Lyte assay relative to control	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c3ncc(C(F)(F)C(F)(F)F)cc23)COc2ccccc21		CHEMBL4785812	=	Inhibition	%	2.0	CHEMBL267	Homo sapiens	INH	%	2.0
	22393881	CHEMBL4667722	Binding affinity to T7-tagged Src (unknown origin) expressed in Escherichia coli BL21 incubated for 1 hr	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	1.0	CHEMBL267	Homo sapiens	Kd	nM	1.0
	22396519	CHEMBL4668625	Inhibition of c-Src (unknown origin) using biotin-KVEKIGEGTYGVVYK as substrate by ELISA	B	CCn1c2ccccc2c2cc(/C=N/OC)ccc21		CHEMBL4780637	=	IC50	nM	40000.0	CHEMBL267	Homo sapiens	IC50	uM	40.0
	22396520	CHEMBL4668625	Inhibition of c-Src (unknown origin) using biotin-KVEKIGEGTYGVVYK as substrate by ELISA	B	CO/N=C/c1ccc(O)c(O)c1		CHEMBL117488	=	IC50	nM	41000.0	CHEMBL267	Homo sapiens	IC50	uM	41.0
	22396521	CHEMBL4668625	Inhibition of c-Src (unknown origin) using biotin-KVEKIGEGTYGVVYK as substrate by ELISA	B	CCn1c2ccccc2c2cc(/C=N/OCCO/N=C/c3ccc(O)c(O)c3)ccc21		CHEMBL4793660	=	IC50	nM	64.0	CHEMBL267	Homo sapiens	IC50	nM	64.0
	22423113	CHEMBL4674128	Inhibition of human c-SRC using poly[Glu:Tyr] (4:1) as substrate at 0.5 uM by [gamma-33P]-ATP assay relative to control	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Inhibition	%	80.0	CHEMBL267	Homo sapiens	INH	%	80.0
	22423793	CHEMBL4674472	Inhibition of human c-SRC using poly[Glu:Tyr] (4:1) as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	62.14	CHEMBL267	Homo sapiens	Activity	%	62.14
	22423794	CHEMBL4674472	Inhibition of human c-SRC using poly[Glu:Tyr] (4:1) as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	60.43	CHEMBL267	Homo sapiens	Activity	%	60.43
	22428001	CHEMBL4675517	Inhibition of SRC (unknown origin)	A	CCOc1ccc2cc(-c3nn(CC4CC4)c(N)c3C(N)=O)ccc2c1		CHEMBL4740515	=	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	22428002	CHEMBL4675517	Inhibition of SRC (unknown origin)	A	C#CCOc1ccc2cc(-c3nn(C(C)(C)C)c(N)c3C(N)=O)ccc2c1		CHEMBL4800671	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	22428003	CHEMBL4675517	Inhibition of SRC (unknown origin)	A	CC(C)(C)n1nc(-c2ccc3cc(OC4CC4)ccc3c2)c(C(N)=O)c1N		CHEMBL4791496	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	22428004	CHEMBL4675517	Inhibition of SRC (unknown origin)	A	CC(C)(CO)n1nc(-c2ccc3cc(OC4CC4)ccc3c2)c(C(N)=O)c1N		CHEMBL4750862	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	22428005	CHEMBL4675517	Inhibition of SRC (unknown origin)	A	CC(C)(CO)n1nc(-c2ccc3nc(OC4CC4)ccc3c2)c(C(N)=O)c1N		CHEMBL4753185	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	22428006	CHEMBL4675517	Inhibition of SRC (unknown origin)	A	CC(C)(CO)n1nc(-c2cnc3cc(OC4CC4)ccc3c2)c(C(N)=O)c1N		CHEMBL4777462	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	22428007	CHEMBL4675517	Inhibition of SRC (unknown origin)	A	CCOc1ccc2cc(-c3nn(C(C)(C)CO)c(N)c3C(N)=O)ccc2c1		CHEMBL4750746	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	22428008	CHEMBL4675517	Inhibition of SRC (unknown origin)	A	CCOc1ccc2cc(-c3nn(C(C)(C)CO)c(N)c3C(N)=O)ccc2n1		CHEMBL4787093	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	22428009	CHEMBL4675517	Inhibition of SRC (unknown origin)	A	CCOc1ccc2cc(-c3nn(C(C)(C)CO)c(N)c3C(N)=O)cnc2c1		CHEMBL4762379	=	IC50	nM	4700.0	CHEMBL267	Homo sapiens	IC50	uM	4.7
	22428010	CHEMBL4675517	Inhibition of SRC (unknown origin)	A	CC(C)(CCO)n1nc(-c2ccc3cc(OC4CC4)ccc3c2)c(C(N)=O)c1N		CHEMBL4756756	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	22428011	CHEMBL4675517	Inhibition of SRC (unknown origin)	A	CC(C)(CCO)n1nc(-c2ccc3nc(OC4CC4)ccc3c2)c(C(N)=O)c1N		CHEMBL4742781	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	22428012	CHEMBL4675517	Inhibition of SRC (unknown origin)	A	CC(C)(CCO)n1nc(-c2cnc3cc(OC4CC4)ccc3c2)c(C(N)=O)c1N		CHEMBL4759936	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	22428013	CHEMBL4675517	Inhibition of SRC (unknown origin)	A	CCOc1ccc2cc(-c3nn(C(C)(C)CCO)c(N)c3C(N)=O)ccc2c1		CHEMBL4743192	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	22428014	CHEMBL4675517	Inhibition of SRC (unknown origin)	A	CCOc1ccc2cc(-c3nn(C(C)(C)CCO)c(N)c3C(N)=O)ccc2n1		CHEMBL4744995	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	22428015	CHEMBL4675517	Inhibition of SRC (unknown origin)	A	CCOc1ccc2cc(-c3nn(C(C)(C)CCO)c(N)c3C(N)=O)cnc2c1		CHEMBL4750009	=	IC50	nM	2500.0	CHEMBL267	Homo sapiens	IC50	uM	2.5
	22428016	CHEMBL4675517	Inhibition of SRC (unknown origin)	A	CC(CCO)n1nc(-c2ccc3cc(OC4CC4)ccc3c2)c(C(N)=O)c1N		CHEMBL4751897	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	22428017	CHEMBL4675517	Inhibition of SRC (unknown origin)	A	CC(CCO)n1nc(-c2ccc3nc(OC4CC4)ccc3c2)c(C(N)=O)c1N		CHEMBL4756763	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	22428018	CHEMBL4675517	Inhibition of SRC (unknown origin)	A	CC(CCO)n1nc(-c2cnc3cc(OC4CC4)ccc3c2)c(C(N)=O)c1N		CHEMBL4796309	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	22428019	CHEMBL4675517	Inhibition of SRC (unknown origin)	A	CCOc1ccc2cc(-c3nn(C(C)CCO)c(N)c3C(N)=O)ccc2c1		CHEMBL4787718	=	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	22428020	CHEMBL4675517	Inhibition of SRC (unknown origin)	A	CCOc1ccc2cc(-c3nn(C(C)CCO)c(N)c3C(N)=O)ccc2n1		CHEMBL4764836	=	IC50	nM	5400.0	CHEMBL267	Homo sapiens	IC50	uM	5.4
	22428021	CHEMBL4675517	Inhibition of SRC (unknown origin)	A	CCOc1ccc2cc(-c3nn(C(C)CCO)c(N)c3C(N)=O)cnc2c1		CHEMBL3769570	=	IC50	nM	3500.0	CHEMBL267	Homo sapiens	IC50	uM	3.5
	22428022	CHEMBL4675517	Inhibition of SRC (unknown origin)	A	CC(C)(CO)Cn1nc(-c2ccc3cc(OC4CC4)ccc3c2)c(C(N)=O)c1N		CHEMBL4751724	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	22428023	CHEMBL4675517	Inhibition of SRC (unknown origin)	A	CC(C)(CO)Cn1nc(-c2ccc3nc(OC4CC4)ccc3c2)c(C(N)=O)c1N		CHEMBL4749451	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	22428024	CHEMBL4675517	Inhibition of SRC (unknown origin)	A	CC(C)(CO)Cn1nc(-c2cnc3cc(OC4CC4)ccc3c2)c(C(N)=O)c1N		CHEMBL4756120	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	22428025	CHEMBL4675517	Inhibition of SRC (unknown origin)	A	CCOc1ccc2cc(-c3nn(CC(C)(C)CO)c(N)c3C(N)=O)ccc2c1		CHEMBL4753941	=	IC50	nM	6300.0	CHEMBL267	Homo sapiens	IC50	uM	6.3
	22428026	CHEMBL4675517	Inhibition of SRC (unknown origin)	A	CCOc1ccc2cc(-c3nn(CC(C)(C)CO)c(N)c3C(N)=O)ccc2n1		CHEMBL3770980	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	22428027	CHEMBL4675517	Inhibition of SRC (unknown origin)	A	CCOc1ccc2cc(-c3nn(CC(C)(C)CO)c(N)c3C(N)=O)cnc2c1		CHEMBL3770743	>	IC50	nM	10000.0	CHEMBL267	Homo sapiens	IC50	uM	10.0
	22447013	CHEMBL4679719	Inhibition of SRC (unknown origin)	B	Cc1nc(NC(=O)NCCc2cn(CC(F)F)cn2)sc1C#Cc1cccnc1		CHEMBL4795990	>	Ki	nM	4000.0	CHEMBL267	Homo sapiens	Ki	uM	4.0
	22447014	CHEMBL4679719	Inhibition of SRC (unknown origin)	B	COc1cc(C#Cc2sc(NC(=O)NCCOCC3CC3)nc2C)cnc1OC		CHEMBL4759283	>	Ki	nM	4000.0	CHEMBL267	Homo sapiens	Ki	uM	4.0
	22447015	CHEMBL4679719	Inhibition of SRC (unknown origin)	B	Cc1nc(NC(=O)NCCOCC2CC2)sc1C#Cc1ccc2cncn2c1		CHEMBL4764646	>	Ki	nM	4000.0	CHEMBL267	Homo sapiens	Ki	uM	4.0
	22447016	CHEMBL4679719	Inhibition of SRC (unknown origin)	B	Cc1cncc(C#Cc2sc(NC(=O)NC[C@H](C)OCC3CC3)nc2C)c1		CHEMBL4784202	>	Ki	nM	4000.0	CHEMBL267	Homo sapiens	Ki	uM	4.0
	22447017	CHEMBL4679719	Inhibition of SRC (unknown origin)	B	Cc1cc(C#Cc2sc(NC(=O)NC[C@H](C)OCC3CC3)nc2C)cnc1C		CHEMBL4756664	>	Ki	nM	4000.0	CHEMBL267	Homo sapiens	Ki	uM	4.0
	22482648	CHEMBL4687854	Inhibition of human c-SRC assessed as residual activity at 10 uM relative to control	A	CN1CCC(CNC2=NC(=O)/C(=C/c3csc(-c4ccc(OC(F)(F)F)cc4)n3)S2)CC1		CHEMBL4757567	=	Activity	%	101.0	CHEMBL267	Homo sapiens	Activity	%	101.0
Not Determined	22752729	CHEMBL4700187	Inhibition of human SRC by kinase-profiling analysis	B	C#Cc1nc(Nc2ccc(S(N)(=O)=O)cc2)nc2[nH]cnc12		CHEMBL4074015		IC50			CHEMBL267	Homo sapiens	IC50		
	22752730	CHEMBL4700187	Inhibition of human SRC by kinase-profiling analysis	B	C#Cc1nc(Nc2ccccc2)nc2[nH]cnc12		CHEMBL4094562	=	IC50	nM	11200.0	CHEMBL267	Homo sapiens	IC50	uM	11.2
	22771714	CHEMBL4704554	Inhibition of human recombinant Src at 100 nM in presence of [gamma33P]ATP by radiometric assay relative to control	B	C=CC(=O)NCCNc1c(NCc2ccc(Nc3ncc(Cl)c(Nc4ccccc4C(=O)NC)n3)cc2)c(=O)c1=O		CHEMBL4752642	=	Inhibition	%	52.1	CHEMBL267	Homo sapiens	INH	%	52.1
	22771715	CHEMBL4704554	Inhibition of human recombinant Src at 100 nM in presence of [gamma33P]ATP by radiometric assay relative to control	B	C=CC(=O)NCCNc1c(NCc2ccc(Nc3ncc(Cl)c(NCc4cccnc4N(C)S(C)(=O)=O)n3)cc2)c(=O)c1=O		CHEMBL4751164	=	Inhibition	%	17.9	CHEMBL267	Homo sapiens	INH	%	17.9
	22771716	CHEMBL4704554	Inhibition of human recombinant Src at 100 nM in presence of [gamma33P]ATP by radiometric assay relative to control	B	C=CC(=O)NCCNc1c(NCc2ccc(Nc3ncc(C(F)(F)F)c(Nc4ccccc4C(=O)NC)n3)cc2)c(=O)c1=O		CHEMBL4777260	=	Inhibition	%	55.6	CHEMBL267	Homo sapiens	INH	%	55.6
	22771717	CHEMBL4704554	Inhibition of human recombinant Src at 100 nM in presence of [gamma33P]ATP by radiometric assay relative to control	B	CNC(=O)c1ccccc1Nc1nc(Nc2ccc(CNc3c(NCCNC(=O)/C(C#N)=C/C(C)C)c(=O)c3=O)cc2)ncc1Cl		CHEMBL4783568	=	Inhibition	%	31.1	CHEMBL267	Homo sapiens	INH	%	31.1
	22788907	CHEMBL4709113	Inhibition of c-Src (unknown origin) using FAM-labelled peptide and ATP incubated for 10 mins by mobility shift assay	B	COc1cc2c(Oc3ccc(NC(=O)NN4C(=O)CSC4c4c(F)cccc4F)cc3)ccnc2cc1OC1CCN(C(=O)NC(C)C)CC1		CHEMBL4781937	=	IC50	nM	421.0	CHEMBL267	Homo sapiens	IC50	uM	0.42100000000000004
	22804193	CHEMBL4712061	Inhibition of c-SRC (unknown origin) at 100 uM pre-incubated for 20 mins followed by 33P-gamma-ATP addition and measured after 120 mins by filter-binding method relative to control	B	COc1ccc(-n2cc(-c3ccc4nonc4c3)c3cc(-c4ccc(C(=O)O)cc4)cnc32)cc1		CHEMBL4747136	=	Inhibition	%	35.0	CHEMBL267	Homo sapiens	INH	%	35.0
	22804194	CHEMBL4712061	Inhibition of c-SRC (unknown origin) at 100 uM pre-incubated for 20 mins followed by 33P-gamma-ATP addition and measured after 120 mins by filter-binding method relative to control	B	O=C(O)c1ccc(-c2cnc3[nH]cc(-c4ccc5nonc5c4)c3c2)cc1		CHEMBL4752578	=	Inhibition	%	47.0	CHEMBL267	Homo sapiens	INH	%	47.0
	22809755	CHEMBL4713290	Inhibition of recombinant human Src (1 to 530 residues) assessed as residual activity at 1 uM using GGEEEEYFELVKK as substrate incubated for 40 mins in presence of Km ATP by radiometric scintillation counting analysis relative to control	B	CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2ccc(Cl)cc2)[C@H](C)C1		CHEMBL4761365	=	Activity	%	82.0	CHEMBL267	Homo sapiens	Activity	%	82.0
Not Active	22816510	CHEMBL4714912	Inhibition of Src phosphorylation at Tyr416 in human Hela cells upto 80 uM after 24 hrs by Western blot analysis	B	CC(=O)Oc1ccccc1C(=O)Nc1ncc([N+](=O)[O-])s1		CHEMBL1401		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	22818087	CHEMBL4715310	Inhibition of SRC (unknown origin)	B	C[C@@H](c1ccc2ncccc2c1)c1nnc2sc(-c3cnn(C)c3)nn12		CHEMBL4791034	>	Ki	nM	4000.0	CHEMBL267	Homo sapiens	Ki	uM	4.0
	22820460	CHEMBL4716232	Inhibition of human C-Src assessed as residual activity at 1 uM relative to control	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	Activity	%	113.0	CHEMBL267	Homo sapiens	Activity	%	113.0
	22820461	CHEMBL4716232	Inhibition of human C-Src assessed as residual activity at 1 uM relative to control	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCNC2		CHEMBL4782674	=	Activity	%	10.0	CHEMBL267	Homo sapiens	Activity	%	10.0
	22823752	CHEMBL4717048	Inhibition of human SRC	B	C[C@H]1CC[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)CN1C(=O)C1CC1		CHEMBL4103954	=	IC50	nM	89.0	CHEMBL267	Homo sapiens	IC50	nM	89.0
	22823753	CHEMBL4717048	Inhibition of human SRC	B	CC1(C(=O)N2CCC[C@@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4F)c4c(N)nccn34)C2)COC1		CHEMBL4799627	=	IC50	nM	116.0	CHEMBL267	Homo sapiens	IC50	nM	116.0
	22836402	CHEMBL4718889	Inhibition of recombinant human His-tagged full length SRC expressed in baculovirus expression system at 500 nM using Tyr 02 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Inhibition	%	42.0	CHEMBL267	Homo sapiens	INH	%	42.0
	22836403	CHEMBL4718889	Inhibition of recombinant human His-tagged full length SRC expressed in baculovirus expression system at 500 nM using Tyr 02 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	OCC[C@@H](Nc1ncnc2[nH]c(-c3ccccc3)cc12)c1ccccc1		CHEMBL4786776	=	Inhibition	%	25.0	CHEMBL267	Homo sapiens	INH	%	25.0
	22836404	CHEMBL4718889	Inhibition of recombinant human His-tagged full length SRC expressed in baculovirus expression system at 500 nM using Tyr 02 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	CN(C)CCNCc1ccc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3[nH]2)cc1F		CHEMBL4748367	=	Inhibition	%	76.0	CHEMBL267	Homo sapiens	INH	%	76.0
	22836405	CHEMBL4718889	Inhibition of recombinant human His-tagged full length SRC expressed in baculovirus expression system at 500 nM using Tyr 02 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	CCOc1ccccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2[nH]1		CHEMBL4776396	=	Inhibition	%	40.0	CHEMBL267	Homo sapiens	INH	%	40.0
	22836406	CHEMBL4718889	Inhibition of recombinant human His-tagged full length SRC expressed in baculovirus expression system at 500 nM using Tyr 02 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	COc1ccccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2[nH]1		CHEMBL4783569	=	Inhibition	%	59.0	CHEMBL267	Homo sapiens	INH	%	59.0
	22836407	CHEMBL4718889	Inhibition of recombinant human His-tagged full length SRC expressed in baculovirus expression system at 500 nM using Tyr 02 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	OC[C@@H](Nc1ncnc2[nH]c(-c3ccccc3)cc12)c1ccccc1		CHEMBL4780286	=	Inhibition	%	59.0	CHEMBL267	Homo sapiens	INH	%	59.0
	22843242	CHEMBL4720257	Inhibition of recombinant human SRC using Ulight-Poly GAT[EAY(1:1:1)]n as substrate incubate for 10 mins by LANCE assay	B	C=CC(=O)N1CCC(Cn2cc(-c3ccc4c(c3)OCO4)c3c(N)ncnc32)CC1		CHEMBL4755698	=	IC50	nM	1000.9	CHEMBL267	Homo sapiens	IC50	nM	1000.9
	22843243	CHEMBL4720257	Inhibition of recombinant human SRC using Ulight-Poly GAT[EAY(1:1:1)]n as substrate incubate for 10 mins by LANCE assay	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	=	IC50	nM	171.0	CHEMBL267	Homo sapiens	IC50	nM	171.0
	22843481	CHEMBL4720478	Inhibition of human c-SRC assessed as residual activity using poly[Glu:Tyr] (4:1) as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	72.08	CHEMBL267	Homo sapiens	Activity	%	72.08
	22843832	CHEMBL4720818	Inhibition of human c-SRC using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	2.59	CHEMBL267	Homo sapiens	IC50	10^-9M	2.59
	22844636	CHEMBL4721311	Inhibition of wild-type human partial length c-Src (M1 to L450 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	98.95	CHEMBL267	Homo sapiens	Activity	%	98.95
	22845476	CHEMBL4721757	Binding affinity to Nluc-tagged SRC (unknown origin) expressed in HeLa cells assessed as change in melting temperature incubated for 30 to 60 mins by NaLTSA assay	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	Delta Tm	degrees C	4.1	CHEMBL267	Homo sapiens	deltaTm	degrees C	4.1
	22845496	CHEMBL4721777	Binding affinity to human SRC using poly[Glu:Tyr] (4:1) as substrate by radiometric hotspot kinase assay	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	IC50	nM	5.4	CHEMBL267	Homo sapiens	IC50	nM	5.4
Not Active	22848437	CHEMBL4722710	Inhibition of SRC phosphorylation in human U-87 MG cells at 25 uM after 12 hrs by Western blotting analysis	B	C=CCn1c(SCC(=O)Nc2ccc(/C(C)=N\O)cc2)nnc1-c1cc(-c2ccccc2)nc2ccccc12		CHEMBL4747318		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	22848438	CHEMBL4722710	Inhibition of SRC phosphorylation in human U-87 MG cells at 25 uM after 12 hrs by Western blotting analysis	B	C=CCn1c(SCC(=O)Nc2ccc(/C(C)=N\O)cc2)nnc1-c1cc(-c2ccc(Cl)cc2)nc2ccccc12		CHEMBL4740393		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	22848439	CHEMBL4722711	Inhibition of SRC phosphorylation in human MDA-MB-468 cells at 25 uM after 12 hrs by Western blotting analysis	B	C=CCn1c(SCC(=O)Nc2ccc(/C(C)=N\O)cc2)nnc1-c1cc(-c2ccccc2)nc2ccccc12		CHEMBL4747318		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	22848440	CHEMBL4722711	Inhibition of SRC phosphorylation in human MDA-MB-468 cells at 25 uM after 12 hrs by Western blotting analysis	B	C=CCn1c(SCC(=O)Nc2ccc(/C(C)=N\O)cc2)nnc1-c1cc(-c2ccc(Cl)cc2)nc2ccccc12		CHEMBL4740393		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	22848441	CHEMBL4722712	Inhibition of SRC phosphorylation in human MIA PaCa-2 cells at 25 uM after 12 hrs by Western blotting analysis	B	C=CCn1c(SCC(=O)Nc2ccc(/C(C)=N\O)cc2)nnc1-c1cc(-c2ccccc2)nc2ccccc12		CHEMBL4747318		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	22848442	CHEMBL4722712	Inhibition of SRC phosphorylation in human MIA PaCa-2 cells at 25 uM after 12 hrs by Western blotting analysis	B	C=CCn1c(SCC(=O)Nc2ccc(/C(C)=N\O)cc2)nnc1-c1cc(-c2ccc(Cl)cc2)nc2ccccc12		CHEMBL4740393		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	22848443	CHEMBL4722713	Inhibition of SRC phosphorylation in human NCI-H157 cells at 25 uM after 12 hrs by Western blotting analysis	B	C=CCn1c(SCC(=O)Nc2ccc(/C(C)=N\O)cc2)nnc1-c1cc(-c2ccccc2)nc2ccccc12		CHEMBL4747318		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	22848444	CHEMBL4722713	Inhibition of SRC phosphorylation in human NCI-H157 cells at 25 uM after 12 hrs by Western blotting analysis	B	C=CCn1c(SCC(=O)Nc2ccc(/C(C)=N\O)cc2)nnc1-c1cc(-c2ccc(Cl)cc2)nc2ccccc12		CHEMBL4740393		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	22848445	CHEMBL4722714	Inhibition of SRC phosphorylation in human A549 cells at 25 uM after 12 hrs by Western blotting analysis	B	C=CCn1c(SCC(=O)Nc2ccc(/C(C)=N\O)cc2)nnc1-c1cc(-c2ccccc2)nc2ccccc12		CHEMBL4747318		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	22848446	CHEMBL4722714	Inhibition of SRC phosphorylation in human A549 cells at 25 uM after 12 hrs by Western blotting analysis	B	C=CCn1c(SCC(=O)Nc2ccc(/C(C)=N\O)cc2)nnc1-c1cc(-c2ccc(Cl)cc2)nc2ccccc12		CHEMBL4740393		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	22848447	CHEMBL4722715	Inhibition of SRC phosphorylation in human A-375 cells at 5 to 50 uM after 12 hrs by Western blotting analysis	B	C=CCn1c(SCC(=O)Nc2ccc(/C(C)=N\O)cc2)nnc1-c1cc(-c2ccccc2)nc2ccccc12		CHEMBL4747318		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	22848448	CHEMBL4722715	Inhibition of SRC phosphorylation in human A-375 cells at 5 to 50 uM after 12 hrs by Western blotting analysis	B	C=CCn1c(SCC(=O)Nc2ccc(/C(C)=N\O)cc2)nnc1-c1cc(-c2ccc(Cl)cc2)nc2ccccc12		CHEMBL4740393		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	22853417	CHEMBL4724260	Effect on recombinant full-length human N-terminal GST-tagged SRC expressed in expressed in Escherichia coli in presence of substrate and [gamma-32ATP] at 10 uM incubated for 30 mins by scintillation counting based radiometry assay relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Activity	%	22.0	CHEMBL267	Homo sapiens	Activity	%	22.0
	22853418	CHEMBL4724260	Effect on recombinant full-length human N-terminal GST-tagged SRC expressed in expressed in Escherichia coli in presence of substrate and [gamma-32ATP] at 10 uM incubated for 30 mins by scintillation counting based radiometry assay relative to control	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	=	Activity	%	26.0	CHEMBL267	Homo sapiens	Activity	%	26.0
	22853419	CHEMBL4724260	Effect on recombinant full-length human N-terminal GST-tagged SRC expressed in expressed in Escherichia coli in presence of substrate and [gamma-32ATP] at 10 uM incubated for 30 mins by scintillation counting based radiometry assay relative to control	B	CN1CCN(CCCOc2ccc3ncnc(Nc4ccc(Oc5cccc(C(F)(F)F)c5)c(Cl)c4)c3c2)CC1		CHEMBL4749477	=	Activity	%	30.0	CHEMBL267	Homo sapiens	Activity	%	30.0
	22853420	CHEMBL4724260	Effect on recombinant full-length human N-terminal GST-tagged SRC expressed in expressed in Escherichia coli in presence of substrate and [gamma-32ATP] at 10 uM incubated for 30 mins by scintillation counting based radiometry assay relative to control	B	O=C(Nc1ccc2ncnc(Nc3ccc(Oc4cccc(F)c4)c(Cl)c3)c2c1)c1ccc(CNCCO)cc1		CHEMBL4782561	=	Activity	%	-10.0	CHEMBL267	Homo sapiens	Activity	%	-10.0
	22853421	CHEMBL4724260	Effect on recombinant full-length human N-terminal GST-tagged SRC expressed in expressed in Escherichia coli in presence of substrate and [gamma-32ATP] at 10 uM incubated for 30 mins by scintillation counting based radiometry assay relative to control	B	Cc1cccc(Oc2ccc(Nc3ncnc4ccc(NC(=O)CNCCO)cc34)cc2Cl)c1		CHEMBL4753194	=	Activity	%	-15.0	CHEMBL267	Homo sapiens	Activity	%	-15.0
	22853422	CHEMBL4724260	Effect on recombinant full-length human N-terminal GST-tagged SRC expressed in expressed in Escherichia coli in presence of substrate and [gamma-32ATP] at 10 uM incubated for 30 mins by scintillation counting based radiometry assay relative to control	B	O=C(CN1CCOCC1)Nc1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c2c1		CHEMBL4777529	=	Activity	%	38.0	CHEMBL267	Homo sapiens	Activity	%	38.0
	22853423	CHEMBL4724260	Effect on recombinant full-length human N-terminal GST-tagged SRC expressed in expressed in Escherichia coli in presence of substrate and [gamma-32ATP] at 10 uM incubated for 30 mins by scintillation counting based radiometry assay relative to control	B	O=C(CN1CCOCC1)Nc1ccc2ncnc(Nc3ccc(Oc4cccc(F)c4)c(Cl)c3)c2c1		CHEMBL4757576	=	Activity	%	-9.0	CHEMBL267	Homo sapiens	Activity	%	-9.0
	22853424	CHEMBL4724260	Effect on recombinant full-length human N-terminal GST-tagged SRC expressed in expressed in Escherichia coli in presence of substrate and [gamma-32ATP] at 10 uM incubated for 30 mins by scintillation counting based radiometry assay relative to control	B	O=C(CN1CCOCC1)Nc1ccc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2c1		CHEMBL3637894	=	Activity	%	-2.0	CHEMBL267	Homo sapiens	Activity	%	-2.0
	22853425	CHEMBL4724260	Effect on recombinant full-length human N-terminal GST-tagged SRC expressed in expressed in Escherichia coli in presence of substrate and [gamma-32ATP] at 10 uM incubated for 30 mins by scintillation counting based radiometry assay relative to control	B	O=C(CNCCO)Nc1ccc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2c1		CHEMBL4783947	=	Activity	%	26.0	CHEMBL267	Homo sapiens	Activity	%	26.0
	22853925	CHEMBL4724368	Inhibition of SRC (unknown origin)	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	=	IC50	nM	119.2	CHEMBL267	Homo sapiens	IC50	nM	119.2
	22853927	CHEMBL4724370	Inhibition of SRC S345C mutant (unknown origin)	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	=	IC50	nM	15.88	CHEMBL267	Homo sapiens	IC50	nM	15.88
	22882868	CHEMBL4727428	Inhibition of SRC (unknown origin)	B	Nc1nccn2c([C@@H]3CC[C@H]4COC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12		CHEMBL4749037	=	IC50	nM	92.0	CHEMBL267	Homo sapiens	IC50	nM	92.0
	22882869	CHEMBL4727428	Inhibition of SRC (unknown origin)	B	Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12		CHEMBL4106978	=	IC50	nM	33.0	CHEMBL267	Homo sapiens	IC50	nM	33.0
	22882870	CHEMBL4727428	Inhibition of SRC (unknown origin)	B	CC1(C)OC(=O)N2C[C@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4)c4c(N)nccn34)CC[C@H]21		CHEMBL4108687	=	IC50	nM	69.0	CHEMBL267	Homo sapiens	IC50	nM	69.0
	22882871	CHEMBL4727428	Inhibition of SRC (unknown origin)	B	COc1cc(C(=O)Nc2cc(C(F)(F)F)ccn2)ccc1-c1nc([C@@H]2CC[C@H]3CCC(=O)N3C2)n2ccnc(N)c12		CHEMBL4114929	=	IC50	nM	71.0	CHEMBL267	Homo sapiens	IC50	nM	71.0
	22882872	CHEMBL4727428	Inhibition of SRC (unknown origin)	B	Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3OC3CC3)c12		CHEMBL4107779	=	IC50	nM	946.0	CHEMBL267	Homo sapiens	IC50	nM	946.0
Not Active	22889562	CHEMBL4729081	Inhibition of wild-type human partial length SRC (L240 to L536 residues) expressed in bacterial expression system at 1 uM by Kinomescan method	B	COc1cc(OCc2ccnc(Nc3cnn(C)c3)n2)cc2sc(N[C@H]3CCCC[C@@H]3O)nc12		CHEMBL4748740		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	22892180	CHEMBL4729720	Inhibition of Src (unknown origin)	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	IC50	nM	1.0	CHEMBL267	Homo sapiens	IC50	nM	1.0
	22905072	CHEMBL4732803	Inhibition of human recombinant c-SRC (1-530 aa) at 10 uM by radiometric assay	B	COc1ccc2c(Nc3cc(OC)c(OC)c(OC)c3)n[nH]c2c1		CHEMBL4759658	=	Inhibition	%	35.0	CHEMBL267	Homo sapiens	INH	%	35.0
	22949462	CHEMBL4765804	Inhibition of human GST-HIS-tagged SRC assessed as residual activity at 0.1 uM relative to control	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1cn(C)c3ccc(OC)cc13)C(=O)N2		CHEMBL104519	=	Activity	%	92.0	CHEMBL267	Homo sapiens	Activity	%	92.0
	22949463	CHEMBL4765804	Inhibition of human GST-HIS-tagged SRC assessed as residual activity at 0.1 uM relative to control	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cn(C)c3ccc(O)cc13)C(=O)N2		CHEMBL4798255	=	Activity	%	79.0	CHEMBL267	Homo sapiens	Activity	%	79.0
	22949464	CHEMBL4765804	Inhibition of human GST-HIS-tagged SRC assessed as residual activity at 0.1 uM relative to control	B	COc1ccc2c(c1)c(/C=C1\C(=O)Nc3ccc(S(=O)(=O)N(C)C)cc31)cn2C		CHEMBL322153	=	Activity	%	93.0	CHEMBL267	Homo sapiens	Activity	%	93.0
	22949465	CHEMBL4765804	Inhibition of human GST-HIS-tagged SRC assessed as residual activity at 0.1 uM relative to control	B	COc1ccc2[nH]cc(/C=C3\C(=O)Nc4ccc(S(N)(=O)=O)cc43)c2c1		CHEMBL106226	=	Activity	%	107.0	CHEMBL267	Homo sapiens	Activity	%	107.0
	22949466	CHEMBL4765804	Inhibition of human GST-HIS-tagged SRC assessed as residual activity at 0.1 uM relative to control	B	COc1ccc2c(c1)c(/C=C1\C(=O)Nc3ccc(S(N)(=O)=O)cc31)cn2C		CHEMBL104333	=	Activity	%	113.0	CHEMBL267	Homo sapiens	Activity	%	113.0
	22949467	CHEMBL4765804	Inhibition of human GST-HIS-tagged SRC assessed as residual activity at 0.1 uM relative to control	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Activity	%	124.0	CHEMBL267	Homo sapiens	Activity	%	124.0
	22949468	CHEMBL4765805	Inhibition of human GST-HIS-tagged SRC assessed as residual activity at 1 uM relative to control	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1cn(C)c3ccc(OC)cc13)C(=O)N2		CHEMBL104519	=	Activity	%	73.0	CHEMBL267	Homo sapiens	Activity	%	73.0
	22949469	CHEMBL4765805	Inhibition of human GST-HIS-tagged SRC assessed as residual activity at 1 uM relative to control	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cn(C)c3ccc(O)cc13)C(=O)N2		CHEMBL4798255	=	Activity	%	68.0	CHEMBL267	Homo sapiens	Activity	%	68.0
	22949470	CHEMBL4765805	Inhibition of human GST-HIS-tagged SRC assessed as residual activity at 1 uM relative to control	B	COc1ccc2c(c1)c(/C=C1\C(=O)Nc3ccc(S(=O)(=O)N(C)C)cc31)cn2C		CHEMBL322153	=	Activity	%	70.0	CHEMBL267	Homo sapiens	Activity	%	70.0
	22949471	CHEMBL4765805	Inhibition of human GST-HIS-tagged SRC assessed as residual activity at 1 uM relative to control	B	COc1ccc2[nH]cc(/C=C3\C(=O)Nc4ccc(S(N)(=O)=O)cc43)c2c1		CHEMBL106226	=	Activity	%	74.0	CHEMBL267	Homo sapiens	Activity	%	74.0
	22949472	CHEMBL4765805	Inhibition of human GST-HIS-tagged SRC assessed as residual activity at 1 uM relative to control	B	COc1ccc2c(c1)c(/C=C1\C(=O)Nc3ccc(S(N)(=O)=O)cc31)cn2C		CHEMBL104333	=	Activity	%	91.0	CHEMBL267	Homo sapiens	Activity	%	91.0
	22949473	CHEMBL4765805	Inhibition of human GST-HIS-tagged SRC assessed as residual activity at 1 uM relative to control	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Activity	%	108.0	CHEMBL267	Homo sapiens	Activity	%	108.0
	22950540	CHEMBL4766129	Inhibition of human full length recombinant Src using Cdc2 peptide as substrate incubated for 40 mins in presence of [gamma33P-ATP] by radiometric scintillation counting analysis	B	Cc1ccc(NC(=O)c2ccc(C)c(C(F)(F)F)c2)cc1C#Cc1nn([C@H]2CC[C@H](O)CC2)c2ncnc(N)c12		CHEMBL4798527	=	IC50	nM	3.0	CHEMBL267	Homo sapiens	IC50	uM	0.003
Dose-dependent effect	22950666	CHEMBL4766228	Inhibition of Src in human MDA-MB-231 cells assessed as reduction in phosphorylation of Src incubated for 20 hrs by Western blot analysis	B	Cc1ccc(NC(=O)c2ccc(C)c(C(F)(F)F)c2)cc1C#Cc1nn([C@H]2CC[C@H](O)CC2)c2ncnc(N)c12		CHEMBL4798527		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	22950667	CHEMBL4766228	Inhibition of Src in human MDA-MB-231 cells assessed as reduction in phosphorylation of Src incubated for 20 hrs by Western blot analysis	B	Cc1ccc(NC(=O)c2ccc(C)c(C(F)(F)F)c2)cc1C#Cc1nn([C@H]2CC[C@H](O)CC2)c2ncnc(N)c12		CHEMBL4798527	=	IC50	nM	30.0	CHEMBL267	Homo sapiens	IC50	uM	0.03
Active	22950668	CHEMBL4766229	Inhibition of Src in human MDA-MB-231 cells assessed as inhibition of FAK phosphorylation at 0.1 to 0.3 uM incubated for 20 hrs by Western blot analysis	B	Cc1ccc(NC(=O)c2ccc(C)c(C(F)(F)F)c2)cc1C#Cc1nn([C@H]2CC[C@H](O)CC2)c2ncnc(N)c12		CHEMBL4798527		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Active	22950669	CHEMBL4766230	Inhibition of Src in human MDA-MB-231 cells assessed as inhibition of STAT3 phosphorylation at 0.1 to 0.3 uM incubated for 20 hrs by Western blot analysis	B	Cc1ccc(NC(=O)c2ccc(C)c(C(F)(F)F)c2)cc1C#Cc1nn([C@H]2CC[C@H](O)CC2)c2ncnc(N)c12		CHEMBL4798527		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Active	22950673	CHEMBL4766234	Inhibition of Src in human MDA-MB-231 cells assessed as reduction in phosphorylation of SRC at 0.03 to 0.3 uM incubated for 20 hrs by Western blot analysis	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Active	22950674	CHEMBL4766235	Inhibition of Src in human MDA-MB-231 cells assessed as inhibition of FAK phosphorylation at 0.03 to 0.3 uM incubated for 20 hrs by Western blot analysis	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	22952807	CHEMBL4766744	Inhibition of recombinant human C-Src assessed as residual activity at 10 uM KVEKIGEGTYGVVYK as substrate incubated 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	26.0	CHEMBL267	Homo sapiens	Activity	%	26.0
	22953005	CHEMBL4766942	Inhibition of recombinant human SRC (1 to 530 residues) assessed as residual activity at 10 uM using GGEEEEYFELVKKKK as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	30.0	CHEMBL267	Homo sapiens	Activity	%	30.0
	22956522	CHEMBL4767790	Inhibition of SRC (unknown origin) at 0.1 uM incubated for 1 hr by ELISA relative to control	B	Cn1cc(NC(=O)c2cnn3ccc(N[C@@H]4CCCNC4)nc23)c(C(F)F)n1		CHEMBL3634506	>	Inhibition	%	50.0	CHEMBL267	Homo sapiens	INH	%	50.0
	22960872	CHEMBL4768787	Inhibition of human c-SRC at 100 nM in presence of ATP relative to control	B	Cl.O=C1Nc2ccc(F)cc2/C1=C1/Nc2ccccc2/C1=N\OCCN1CCNCC1		CHEMBL4791998	=	Inhibition	%	87.0	CHEMBL267	Homo sapiens	INH	%	87.0
	22960873	CHEMBL4768788	Inhibition of human c-SRC in presence of ATP	B	Cl.O=C1Nc2ccc(F)cc2/C1=C1/Nc2ccccc2/C1=N\OCCN1CCNCC1		CHEMBL4791998	=	IC50	nM	9.52	CHEMBL267	Homo sapiens	IC50	nM	9.52
	22967724	CHEMBL4769971	Inhibition of SRC (unknown origin) by ADP-Glo assay	B	C=CC(=O)Nc1cccc(Nc2ncnc(Nc3ccc(C(=O)N4CCCCC4)cc3)n2)c1		CHEMBL4791249	=	IC50	nM	524.0	CHEMBL267	Homo sapiens	IC50	nM	524.0
	22967725	CHEMBL4769971	Inhibition of SRC (unknown origin) by ADP-Glo assay	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	=	IC50	nM	40.0	CHEMBL267	Homo sapiens	IC50	nM	40.0
	22989350	CHEMBL4774930	Inhibition of c-Src (unknown origin) at 1 uM relative to control	B	Nc1n[nH]c2cccc(C#Cc3cccc(NC(=O)c4ccc(N5CCOCC5)c(C(F)(F)F)c4)c3)c12		CHEMBL4793906	=	Inhibition	%	87.75	CHEMBL267	Homo sapiens	INH	%	87.75
	22989371	CHEMBL4774950	Inhibition of c-Src (unknown origin) in presence of ATP	B	Nc1n[nH]c2cccc(C#Cc3cccc(NC(=O)c4ccc(N5CCOCC5)c(C(F)(F)F)c4)c3)c12		CHEMBL4793906	=	IC50	nM	66.0	CHEMBL267	Homo sapiens	IC50	uM	0.066
	22989372	CHEMBL4774950	Inhibition of c-Src (unknown origin) in presence of ATP	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	3.12	CHEMBL267	Homo sapiens	IC50	uM	0.00312
	22990699	CHEMBL4775140	Inhibition of c-SRC (unknown origin)	B	CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1		CHEMBL49120	<	IC50	nM	100.0	CHEMBL267	Homo sapiens	IC50	nM	100.0
	23120398	CHEMBL4804382	Inhibition of SRC in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	IC50	nM	300.0	CHEMBL267	Homo sapiens	IC50	uM	0.3
	23120399	CHEMBL4804382	Inhibition of SRC in human NCI-H929 cells by mass spectroscopic analysis	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	IC50	nM	2200.0	CHEMBL267	Homo sapiens	IC50	uM	2.2
	23120400	CHEMBL4804382	Inhibition of SRC in human NCI-H929 cells by mass spectroscopic analysis	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1	Outside typical range	CHEMBL4867931	=	IC50	nM	-2000.0	CHEMBL267	Homo sapiens	IC50	uM	-2.0
	23120401	CHEMBL4804382	Inhibition of SRC in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O	Outside typical range	CHEMBL4855730	=	IC50	nM	-36400.0	CHEMBL267	Homo sapiens	IC50	uM	-36.4
	23120402	CHEMBL4804382	Inhibition of SRC in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O	Outside typical range	CHEMBL4868141	=	IC50	nM	-8400.0	CHEMBL267	Homo sapiens	IC50	uM	-8.4
	23120403	CHEMBL4804382	Inhibition of SRC in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	=	IC50	nM	28300.0	CHEMBL267	Homo sapiens	IC50	uM	28.3
	23121438	CHEMBL4804564	Inhibition of SRC in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	23121439	CHEMBL4804564	Inhibition of SRC in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	23121440	CHEMBL4804564	Inhibition of SRC in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	23121441	CHEMBL4804564	Inhibition of SRC in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	23121442	CHEMBL4804564	Inhibition of SRC in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	23121443	CHEMBL4804564	Inhibition of SRC in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	=	Inhibition	%	0.0	CHEMBL267	Homo sapiens	INH	%	0.0
	23122822	CHEMBL4805173	Inhibition of human SRC assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	92.0	CHEMBL267	Homo sapiens	Activity	%	92.0
	23123517	CHEMBL4805761	Inhibition of human SRC assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	97.0	CHEMBL267	Homo sapiens	Activity	%	97.0
	23123969	CHEMBL4806213	Inhibition of DNA-tagged human SRC assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	100.0	CHEMBL267	Homo sapiens	Activity	%	100.0
	23125124	CHEMBL4806778	Inhibition of human SRC assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	100.0	CHEMBL267	Homo sapiens	Activity	%	100.0
	23125125	CHEMBL4806778	Inhibition of human SRC assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	96.0	CHEMBL267	Homo sapiens	Activity	%	96.0
	23127331	CHEMBL4807586	Inhibition of His-tagged SRC (unknown origin) using poly(Glu, Tyr) as substrate in presence of [32P]gammaATP by microplate scintillation counter analysis	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)ccnc3C)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4878274	<	IC50	nM	1.5	CHEMBL267	Homo sapiens	IC50	nM	1.5
	23127332	CHEMBL4807586	Inhibition of His-tagged SRC (unknown origin) using poly(Glu, Tyr) as substrate in presence of [32P]gammaATP by microplate scintillation counter analysis	B	Cc1nc(Nc2ncc(C(=O)Nc3ncccc3C)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4865214	<	IC50	nM	1.5	CHEMBL267	Homo sapiens	IC50	nM	1.5
	23127333	CHEMBL4807586	Inhibition of His-tagged SRC (unknown origin) using poly(Glu, Tyr) as substrate in presence of [32P]gammaATP by microplate scintillation counter analysis	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Br)ccnc3C)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4865345	<	IC50	nM	1.5	CHEMBL267	Homo sapiens	IC50	nM	1.5
	23127334	CHEMBL4807586	Inhibition of His-tagged SRC (unknown origin) using poly(Glu, Tyr) as substrate in presence of [32P]gammaATP by microplate scintillation counter analysis	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cncc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4869199	<	IC50	nM	1.5	CHEMBL267	Homo sapiens	IC50	nM	1.5
	23127335	CHEMBL4807586	Inhibition of His-tagged SRC (unknown origin) using poly(Glu, Tyr) as substrate in presence of [32P]gammaATP by microplate scintillation counter analysis	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cncc3C)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4857583	<	IC50	nM	1.5	CHEMBL267	Homo sapiens	IC50	nM	1.5
	23127336	CHEMBL4807586	Inhibition of His-tagged SRC (unknown origin) using poly(Glu, Tyr) as substrate in presence of [32P]gammaATP by microplate scintillation counter analysis	B	Cc1nc(Nc2ncc(C(=O)Nc3cccnc3C)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4872654	<	IC50	nM	1.5	CHEMBL267	Homo sapiens	IC50	nM	1.5
	23127337	CHEMBL4807586	Inhibition of His-tagged SRC (unknown origin) using poly(Glu, Tyr) as substrate in presence of [32P]gammaATP by microplate scintillation counter analysis	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	<	IC50	nM	1.5	CHEMBL267	Homo sapiens	IC50	nM	1.5
	23127338	CHEMBL4807586	Inhibition of His-tagged SRC (unknown origin) using poly(Glu, Tyr) as substrate in presence of [32P]gammaATP by microplate scintillation counter analysis	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)nn(C)c3C)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4859689	=	IC50	nM	22.8	CHEMBL267	Homo sapiens	IC50	nM	22.8
	23127339	CHEMBL4807586	Inhibition of His-tagged SRC (unknown origin) using poly(Glu, Tyr) as substrate in presence of [32P]gammaATP by microplate scintillation counter analysis	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)noc3C)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4850733	=	IC50	nM	6.44	CHEMBL267	Homo sapiens	IC50	nM	6.44
	23127340	CHEMBL4807586	Inhibition of His-tagged SRC (unknown origin) using poly(Glu, Tyr) as substrate in presence of [32P]gammaATP by microplate scintillation counter analysis	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(N2CCN(C)CC2)n1		CHEMBL4851745	<	IC50	nM	1.5	CHEMBL267	Homo sapiens	IC50	nM	1.5
	23127341	CHEMBL4807586	Inhibition of His-tagged SRC (unknown origin) using poly(Glu, Tyr) as substrate in presence of [32P]gammaATP by microplate scintillation counter analysis	B	Cc1nc(NCCO)cc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)n1		CHEMBL4857318	<	IC50	nM	1.5	CHEMBL267	Homo sapiens	IC50	nM	1.5
	23127342	CHEMBL4807586	Inhibition of His-tagged SRC (unknown origin) using poly(Glu, Tyr) as substrate in presence of [32P]gammaATP by microplate scintillation counter analysis	B	Cc1nc(Nc2ncc(C(=O)NC3CN4CCC3CC4)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4856384	=	IC50	nM	73.7	CHEMBL267	Homo sapiens	IC50	nM	73.7
	23127343	CHEMBL4807586	Inhibition of His-tagged SRC (unknown origin) using poly(Glu, Tyr) as substrate in presence of [32P]gammaATP by microplate scintillation counter analysis	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	=	IC50	nM	1.0	CHEMBL267	Homo sapiens	IC50	nM	1.0
	23127344	CHEMBL4807586	Inhibition of His-tagged SRC (unknown origin) using poly(Glu, Tyr) as substrate in presence of [32P]gammaATP by microplate scintillation counter analysis	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	IC50	nM	1.0	CHEMBL267	Homo sapiens	IC50	nM	1.0
	23128596	CHEMBL4808007	Inhibition of GST/HIS-tagged SRC (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	<	Activity	%	25.0	CHEMBL267	Homo sapiens	Activity	%	25.0
	23128597	CHEMBL4808007	Inhibition of GST/HIS-tagged SRC (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	<	Activity	%	25.0	CHEMBL267	Homo sapiens	Activity	%	25.0
	23128598	CHEMBL4808007	Inhibition of GST/HIS-tagged SRC (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	<	Activity	%	25.0	CHEMBL267	Homo sapiens	Activity	%	25.0
	23128924	CHEMBL4808100	Inhibition of SRC (unknown origin) at 0.5 uM relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)c3nc(SC)oc3-c3ccc(F)cc3)cc2F)ccn1		CHEMBL4855209	=	Inhibition	%	40.0	CHEMBL267	Homo sapiens	INH	%	40.0
	23158835	CHEMBL4812087	Inhibition of full length SRC (1 to 536 residues) (unknown origin) expressed in Sf21 cells at 10 uM preincubated for 10 mins followed by peptide substrate addition relative to control	B	CC(C)(C)OC(=O)c1ccc(NC(=O)c2ccc(Cl)c(S(N)(=O)=O)c2)cc1		CHEMBL4860361	=	Inhibition	%	1.42	CHEMBL267	Homo sapiens	INH	%	1.42
	23192958	CHEMBL4818919	Inhibition of recombinant human SRC (1 to 530 residues) using GGEEEEYFELVKKKK as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	C=CC(=O)N1CC[C@@H](NC(=O)c2sc3nccc4c3c2NC(=O)N4c2ccc(Oc3ccccc3)cc2C)C1		CHEMBL4851021	=	IC50	nM	3490.0	CHEMBL267	Homo sapiens	IC50	uM	3.49
Active	23197048	CHEMBL4819987	Inhibition of recombinant SRC (unknown origin) assessed as residual activity at 1 uM	B	CC(C)(C)c1ccc(C(=O)Nc2cccc(-c3cc4[nH]cnc4c(Nc4ccc(C(=O)N5CCOCC5)cc4)n3)c2)cc1		CHEMBL4865664		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	23205686	CHEMBL4821573	Inhibition of SRC (unknown origin)	B	COc1cc(Nc2nc(NCc3cccc(NC(=O)CCl)c3)n3ccnc3c2C(N)=O)cc(OC)c1		CHEMBL4870513	>	IC50	nM	1000.0	CHEMBL267	Homo sapiens	IC50	uM	1.0
	23208891	CHEMBL4822247	Inhibition of wild-type human partial length SRC (L240 to L536 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	CCc1cc(NC(=O)[C@H](O)c2cc(F)cc(F)c2)ccc1-c1cnc(N)c(C(=O)NC(C)C)c1		CHEMBL4857782	=	Activity	%	97.0	CHEMBL267	Homo sapiens	Activity	%	97.0
	23208892	CHEMBL4822247	Inhibition of wild-type human partial length SRC (L240 to L536 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	Cc1cccc(CC(=O)N2CCc3c2ccc(-c2cn(C)c4ncnc(N)c24)c3F)n1		CHEMBL2441340	=	Activity	%	7.0	CHEMBL267	Homo sapiens	Activity	%	7.0
	23209859	CHEMBL4822468	Inhibition of human SRC at 1 uM	B	Cc1nn(C(C)C)c(C)c1-c1nc2c(-c3ccc4c(c3)CCCC[C@H]4NC(=O)c3nc(C(C)(C)C)no3)ccnc2[nH]1		CHEMBL4877846	>	Inhibition	%	80.0	CHEMBL267	Homo sapiens	INH	%	80.0
	23209894	CHEMBL4822491	Inhibition of human SRC	B	Cc1nn(C(C)C)c(C)c1-c1nc2c(-c3ccc4c(c3)CCCC[C@H]4NC(=O)c3nc(C(C)(C)C)no3)ccnc2[nH]1		CHEMBL4877846	=	IC50	nM	27.12	CHEMBL267	Homo sapiens	IC50	nM	27.12
	23216093	CHEMBL4823608	Inhibition of recombinant human C-Src using KVEKIGEGTYGVVYK as substrate incubated 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay	B	CC(C)n1cc(C(=O)Nc2ccc(Oc3ccnc(NC(=O)C4CC4)c3)c(F)c2)c(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL4873571	>	IC50	nM	1000.0	CHEMBL267	Homo sapiens	IC50	nM	1000.0
	23248257	CHEMBL4830434	Inhibition of human c-SRC using poly[Glu:Tyr] (4:1) as substrate assessed as enzyme activity incubated for 2 hrs by [gamma-33P]-ATP assay relative to control	B	CC(C)c1c2cc(-c3ccnc(Nc4ccc5c(N6CCN(C)CC6)ccnc5c4)n3)ccc2nn1C		CHEMBL4856177	<	Activity	%	20.0	CHEMBL267	Homo sapiens	Activity	%	20.0
	23250062	CHEMBL4830979	Inhibition of C-terminal His-tagged human recombinant SRC expressed in baculovirus expression system at 1 uM by Z'-LYTE assay	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccc(NCc3ccc(S(=O)(=O)F)cc3)cc2)n1		CHEMBL4866162	=	Inhibition	%	100.0	CHEMBL267	Homo sapiens	INH	%	100.0
Not Active	23250063	CHEMBL4830979	Inhibition of C-terminal His-tagged human recombinant SRC expressed in baculovirus expression system at 1 uM by Z'-LYTE assay	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(Cl)c(Nc2cccc(NC(C)=O)c2)n1		CHEMBL4856343		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Active	23250116	CHEMBL4831006	Inhibition of C-terminal His-tagged human recombinant SRC expressed in baculovirus expression system at 100 nM by Z'-LYTE assay	B	C#CCNC(=O)c1cc(Nc2cc(C3CC3)[nH]n2)nc(N2CCN(Cc3ccc(S(=O)(=O)F)cc3)CC2)n1		CHEMBL4855850		Inhibition	%		CHEMBL267	Homo sapiens	INH		
Not Active	23250117	CHEMBL4831006	Inhibition of C-terminal His-tagged human recombinant SRC expressed in baculovirus expression system at 100 nM by Z'-LYTE assay	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccc(NCc3ccc(S(=O)(=O)F)cc3)cc2)n1		CHEMBL4866162		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	23256907	CHEMBL4832280	Inhibition of C-SRC (unknown origin) at 10 uM incubated for 40 mins in presence of Mg/ATP mix by [gamma p33]-ATP based scintillation counting method relative to control	B	CS(=O)(=O)c1nccc(-c2c(-c3cccc(OCc4ccccc4)c3)nc3sccn23)n1	Outside typical range	CHEMBL4860202	=	Inhibition	%	-22.15	CHEMBL267	Homo sapiens	INH	%	-22.15
	23256908	CHEMBL4832280	Inhibition of C-SRC (unknown origin) at 10 uM incubated for 40 mins in presence of Mg/ATP mix by [gamma p33]-ATP based scintillation counting method relative to control	B	CS(=O)(=O)c1nccc(-c2c(-c3cccc(OCc4ccc(F)cc4)c3)nc3sccn23)n1		CHEMBL4873517	=	Inhibition	%	2.46	CHEMBL267	Homo sapiens	INH	%	2.46
	23265665	CHEMBL4834286	Inhibition of SRC (unknown origin) expressed in mouse BaF3 cells assessed as reduction in cell proliferation incubated for 48 hrs by cell proliferation assay	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2[C@H]1C[C@@H](CO)C1		CHEMBL4858720	=	IC50	nM	63.0	CHEMBL267	Homo sapiens	IC50	uM	0.063
	23265666	CHEMBL4834286	Inhibition of SRC (unknown origin) expressed in mouse BaF3 cells assessed as reduction in cell proliferation incubated for 48 hrs by cell proliferation assay	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCCC1		CHEMBL169390	=	IC50	nM	120.0	CHEMBL267	Homo sapiens	IC50	uM	0.12
	23265667	CHEMBL4834286	Inhibition of SRC (unknown origin) expressed in mouse BaF3 cells assessed as reduction in cell proliferation incubated for 48 hrs by cell proliferation assay	B	CC(=O)N1CCN([C@H]2C[C@@H](n3cc(-c4cc(O)ccc4F)c4c(N)ncnc43)C2)CC1		CHEMBL4854822	=	IC50	nM	2400.0	CHEMBL267	Homo sapiens	IC50	uM	2.4
	23285158	CHEMBL4838203	Inhibition of SRC (unknown origin) by ELISA	B	CC(C)n1cc(C(=O)Nc2cc(F)c(-c3c[nH]c4ncnc(N)c34)cc2F)c(=O)c(-c2ccc(F)cc2)c1		CHEMBL4871361	>	IC50	nM	1000.0	CHEMBL267	Homo sapiens	IC50	nM	1000.0
	23289195	CHEMBL4839033	Inhibition of Src (unknown origin)	B	CCN1CCN(c2ccc(Nc3ncc4scc(-c5cccc(NS(C)(=O)=O)c5)c4n3)cc2)CC1		CHEMBL4846921	=	IC50	nM	3.4	CHEMBL267	Homo sapiens	IC50	nM	3.4
	23289210	CHEMBL4839048	Inhibition of Src (unknown origin) at 0.1 uM	B	CCN1CCN(c2ccc(Nc3ncc4scc(-c5cccc(NS(C)(=O)=O)c5)c4n3)cc2)CC1		CHEMBL4846921	=	Inhibition	%	93.1	CHEMBL267	Homo sapiens	INH	%	93.1
	23291279	CHEMBL4839542	Inhibition of human recombinant Src (1-530) at 5 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2ccc(Cl)cc2Cl)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4467948	=	Inhibition	%	4.0	CHEMBL267	Homo sapiens	INH	%	4.0
	23291280	CHEMBL4839542	Inhibition of human recombinant Src (1-530) at 5 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2ccc(OC(F)(F)F)cc2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4850154	=	Inhibition	%	71.0	CHEMBL267	Homo sapiens	INH	%	71.0
	23291281	CHEMBL4839542	Inhibition of human recombinant Src (1-530) at 5 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4862806	=	Inhibition	%	-10.0	CHEMBL267	Homo sapiens	INH	%	-10.0
	23291351	CHEMBL4839566	Inhibition of human recombinant Src (1-530) at 50 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2ccc(Cl)cc2Cl)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4467948	=	Inhibition	%	49.0	CHEMBL267	Homo sapiens	INH	%	49.0
	23291352	CHEMBL4839566	Inhibition of human recombinant Src (1-530) at 50 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2ccc(OC(F)(F)F)cc2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4850154	=	Inhibition	%	95.0	CHEMBL267	Homo sapiens	INH	%	95.0
	23291353	CHEMBL4839566	Inhibition of human recombinant Src (1-530) at 50 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4862806	=	Inhibition	%	98.0	CHEMBL267	Homo sapiens	INH	%	98.0
	23291423	CHEMBL4839590	Inhibition of human recombinant Src (1-530) at 500 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2ccc(Cl)cc2Cl)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4467948	=	Inhibition	%	79.0	CHEMBL267	Homo sapiens	INH	%	79.0
	23291424	CHEMBL4839590	Inhibition of human recombinant Src (1-530) at 500 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2ccc(OC(F)(F)F)cc2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4850154	=	Inhibition	%	96.0	CHEMBL267	Homo sapiens	INH	%	96.0
	23291425	CHEMBL4839590	Inhibition of human recombinant Src (1-530) at 500 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4862806	=	Inhibition	%	92.0	CHEMBL267	Homo sapiens	INH	%	92.0
	23291450	CHEMBL4839600	Inhibition of human recombinant Src (1-530) by radiometric scintillation counting analysis	B	Cc1ccc(C(=O)Nc2ccc(Cl)cc2Cl)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4467948	=	IC50	nM	163.0	CHEMBL267	Homo sapiens	IC50	nM	163.0
	23291451	CHEMBL4839600	Inhibition of human recombinant Src (1-530) by radiometric scintillation counting analysis	B	Cc1ccc(C(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4862806	=	IC50	nM	12.0	CHEMBL267	Homo sapiens	IC50	nM	12.0
	23297798	CHEMBL4841278	Inhibition of SRC (unknown origin)	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3Cl)cc12		CHEMBL4876497	>	IC50	nM	1000.0	CHEMBL267	Homo sapiens	IC50	nM	1000.0
Not Active	23299137	CHEMBL4841681	Inhibition of SRC (unknown origin)	A	C=CC(=O)N1CCCC[C@H]1c1nc(-c2ccc(C(=O)Nc3cc(C(F)(F)F)ccn3)cc2)c(C(N)=O)n1N		CHEMBL4864983		Inhibition	%		CHEMBL267	Homo sapiens	INH		
	23299252	CHEMBL4841726	Inhibition of SRC (unknown origin) at 1000 nM relative to control	B	Nc1c(-c2nc3cc(N4CCN(C(=O)CCCCCNc5cccc6c5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)ccc3[nH]2)c(=O)[nH]c2cccc(F)c12		CHEMBL4860038	=	Inhibition	%	37.0	CHEMBL267	Homo sapiens	INH	%	37.0
	23299253	CHEMBL4841726	Inhibition of SRC (unknown origin) at 1000 nM relative to control	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Inhibition	%	79.0	CHEMBL267	Homo sapiens	INH	%	79.0
	23306298	CHEMBL4843181	Inhibition of human recombinant N terminal His6 tagged full length Src assessed as residual activity at 5 uM using KVEKIGEGTYGVVYK as a substrate in the presence of NP-40 incubated for 10 mins by scintillation counting analysis relative to control	A	Fc1cccc(Nc2nc(NCCOc3ccccc3)nc3[nH]cnc23)c1		CHEMBL4845724	=	Activity	%	45.0	CHEMBL267	Homo sapiens	Activity	%	45.0
	23306299	CHEMBL4843181	Inhibition of human recombinant N terminal His6 tagged full length Src assessed as residual activity at 5 uM using KVEKIGEGTYGVVYK as a substrate in the presence of NP-40 incubated for 10 mins by scintillation counting analysis relative to control	A	FC(F)(F)c1cccc(Nc2nc(NCCOc3ccccc3)nc3[nH]cnc23)c1		CHEMBL4848338	=	Activity	%	47.0	CHEMBL267	Homo sapiens	Activity	%	47.0
	23306300	CHEMBL4843181	Inhibition of human recombinant N terminal His6 tagged full length Src assessed as residual activity at 5 uM using KVEKIGEGTYGVVYK as a substrate in the presence of NP-40 incubated for 10 mins by scintillation counting analysis relative to control	A	Fc1cccc(NNc2nc(NCCOc3ccccc3)nc3[nH]cnc23)c1		CHEMBL4847429	=	Activity	%	84.0	CHEMBL267	Homo sapiens	Activity	%	84.0
	23306301	CHEMBL4843181	Inhibition of human recombinant N terminal His6 tagged full length Src assessed as residual activity at 5 uM using KVEKIGEGTYGVVYK as a substrate in the presence of NP-40 incubated for 10 mins by scintillation counting analysis relative to control	A	Fc1cccc(/N=N/c2nc(NCCOc3ccccc3)nc3[nH]cnc23)c1		CHEMBL4873306	>	Activity	%	98.0	CHEMBL267	Homo sapiens	Activity	%	98.0
	23306302	CHEMBL4843181	Inhibition of human recombinant N terminal His6 tagged full length Src assessed as residual activity at 5 uM using KVEKIGEGTYGVVYK as a substrate in the presence of NP-40 incubated for 10 mins by scintillation counting analysis relative to control	A	Oc1cccc(Nc2nc(NCCOc3ccccc3)nc3[nH]cnc23)c1		CHEMBL4450646	=	Activity	%	59.0	CHEMBL267	Homo sapiens	Activity	%	59.0
Not Active	23317658	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	91.0	CHEMBL267	Homo sapiens	% Control	%	91.0
Not Active	23318126	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	98.0	CHEMBL267	Homo sapiens	% Control	%	98.0
Not Active	23318792	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	81.0	CHEMBL267	Homo sapiens	% Control	%	81.0
Not Active	23319276	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	100.0	CHEMBL267	Homo sapiens	% Control	%	100.0
Not Active	23319912	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL267	Homo sapiens	% Control	%	100.0
Not Active	23320388	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	75.2	CHEMBL267	Homo sapiens	% Control	%	75.2
Not Active	23321066	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	93.0	CHEMBL267	Homo sapiens	% Control	%	93.0
Not Active	23321534	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	100.0	CHEMBL267	Homo sapiens	% Control	%	100.0
Not Active	23322164	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	99.0	CHEMBL267	Homo sapiens	% Control	%	99.0
Not Active	23322632	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	100.0	CHEMBL267	Homo sapiens	% Control	%	100.0
Not Active	23323321	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	100.0	CHEMBL267	Homo sapiens	% Control	%	100.0
Not Active	23323789	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	100.0	CHEMBL267	Homo sapiens	% Control	%	100.0
Not Active	23323984	CHEMBL4880603	cSRC (h) Millipore kinase activity assay	B	CC1=C(C#N)C(c2ccc3[nH]nc(C)c3c2)C(C#N)=C(C)N1		CHEMBL4593677		Inhibition	%	8.0	CHEMBL267	Homo sapiens	% inhibition	%	8.0
Not Active	23324643	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	100.0	CHEMBL267	Homo sapiens	% Control	%	100.0
Not Active	23325278	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	89.0	CHEMBL267	Homo sapiens	% Control	%	89.0
Not Active	23325746	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	89.0	CHEMBL267	Homo sapiens	% Control	%	89.0
Not Active	23326393	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	90.0	CHEMBL267	Homo sapiens	% Control	%	90.0
Not Active	23326861	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	88.0	CHEMBL267	Homo sapiens	% Control	%	88.0
Not Active	23327561	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	98.0	CHEMBL267	Homo sapiens	% Control	%	98.0
Not Active	23328029	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	98.0	CHEMBL267	Homo sapiens	% Control	%	98.0
Not Active	23328616	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	81.0	CHEMBL267	Homo sapiens	% Control	%	81.0
Not Active	23329084	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	100.0	CHEMBL267	Homo sapiens	% Control	%	100.0
Not Active	23329311	CHEMBL4881018	cSRC(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	113.0	CHEMBL267	Homo sapiens	% residual kinase activity	%	113.0
Not Active	23330030	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL267	Homo sapiens	% Control	%	100.0
Not Active	23330498	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	99.0	CHEMBL267	Homo sapiens	% Control	%	99.0
Not Active	23331254	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	97.0	CHEMBL267	Homo sapiens	% Control	%	97.0
Not Active	23331722	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	96.0	CHEMBL267	Homo sapiens	% Control	%	96.0
Not Active	23332309	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	92.6	CHEMBL267	Homo sapiens	% Control	%	92.6
Not Active	23332775	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	100.0	CHEMBL267	Homo sapiens	% Control	%	100.0
Not Active	23333493	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	95.9	CHEMBL267	Homo sapiens	% Control	%	95.9
Not Active	23334132	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	100.0	CHEMBL267	Homo sapiens	% Control	%	100.0
Not Active	23334600	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	100.0	CHEMBL267	Homo sapiens	% Control	%	100.0
Not Active	23334887	CHEMBL4881511	cSRC (h) Upstate kinase activity assay	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		Inhibition	%	-4.0	CHEMBL267	Homo sapiens	% inhibition	%	-4.0
Not Active	23335579	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	100.0	CHEMBL267	Homo sapiens	% Control	%	100.0
Not Active	23336047	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	92.0	CHEMBL267	Homo sapiens	% Control	%	92.0
Not Active	23336674	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	100.0	CHEMBL267	Homo sapiens	% Control	%	100.0
Not Active	23337142	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	100.0	CHEMBL267	Homo sapiens	% Control	%	100.0
Not Active	23337776	CHEMBL4882147	SRC Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	90.5	CHEMBL267	Homo sapiens	% Ctrl	%	90.5
Not Active	23337777	CHEMBL4882148	SRC N1 Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	85.0	CHEMBL267	Homo sapiens	% Ctrl	%	85.0
Not Active	23338223	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	90.0	CHEMBL267	Homo sapiens	% Control	%	90.0
Not Active	23338691	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	84.0	CHEMBL267	Homo sapiens	% Control	%	84.0
Not Active	23339303	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	100.0	CHEMBL267	Homo sapiens	% Control	%	100.0
Not Active	23339771	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	100.0	CHEMBL267	Homo sapiens	% Control	%	100.0
Not Active	23340408	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	100.0	CHEMBL267	Homo sapiens	% Control	%	100.0
Not Active	23340876	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	96.0	CHEMBL267	Homo sapiens	% Control	%	96.0
Not Active	23341533	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL267	Homo sapiens	% Control	%	100.0
Not Active	23342001	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	99.0	CHEMBL267	Homo sapiens	% Control	%	99.0
Not Active	23342617	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	93.0	CHEMBL267	Homo sapiens	% Control	%	93.0
Not Active	23343085	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	100.0	CHEMBL267	Homo sapiens	% Control	%	100.0
Slightly Active	23343289	CHEMBL4882474	SRC Invitrogen selectivity data (BI)	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Ctrl	%	25.0	CHEMBL267	Homo sapiens	% Ctrl	%	25.0
Not Active	23343715	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	93.0	CHEMBL267	Homo sapiens	% Control	%	93.0
Not Active	23344183	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	100.0	CHEMBL267	Homo sapiens	% Control	%	100.0
Not Active	23344821	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	90.0	CHEMBL267	Homo sapiens	% Control	%	90.0
Not Active	23345394	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	100.0	CHEMBL267	Homo sapiens	% Control	%	100.0
Not Active	23345862	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	100.0	CHEMBL267	Homo sapiens	% Control	%	100.0
Not Active	23346020	CHEMBL4882587	Invitrogen kinase assay (SRC)	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		IC50	nM	100.0	CHEMBL267	Homo sapiens	IC50	nM	100.0
Not Active	23346439	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	53.7	CHEMBL267	Homo sapiens	% Control	%	53.7
Not Active	23346907	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	100.0	CHEMBL267	Homo sapiens	% Control	%	100.0
Not Active	23347507	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	94.6	CHEMBL267	Homo sapiens	% Control	%	94.6
Not Active	23347999	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	100.0	CHEMBL267	Homo sapiens	% Control	%	100.0
Not Active	23348578	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL267	Homo sapiens	% Control	%	100.0
Not Active	23349046	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	100.0	CHEMBL267	Homo sapiens	% Control	%	100.0
Not Active	23349633	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	100.0	CHEMBL267	Homo sapiens	% Control	%	100.0
Not Active	23350251	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	93.0	CHEMBL267	Homo sapiens	% Control	%	93.0
Not Active	23350719	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	100.0	CHEMBL267	Homo sapiens	% Control	%	100.0
Not Active	23351324	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	100.0	CHEMBL267	Homo sapiens	% Control	%	100.0
Not Active	23351792	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	96.0	CHEMBL267	Homo sapiens	% Control	%	96.0
Not Active	23352228	CHEMBL4882917	SRC Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	4.972	CHEMBL267	Homo sapiens	% Inhibition	%	4.9718
Not Active	23352229	CHEMBL4882918	SRC N1 Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	5.784	CHEMBL267	Homo sapiens	% Inhibition	%	5.7836
Not Active	23352816	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	81.0	CHEMBL267	Homo sapiens	% Control	%	81.0
Not Active	23353284	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	100.0	CHEMBL267	Homo sapiens	% Control	%	100.0
Slightly Active	23353517	CHEMBL4883009	Protein Tyrosine Kinase, SRC Eurofins-Panlabs enzyme assay	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		Inhibition	%	67.0	CHEMBL267	Homo sapiens	% inhibition	%	67.0
	23353518	CHEMBL4883009	Protein Tyrosine Kinase, SRC Eurofins-Panlabs enzyme assay	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1	Non standard unit for type	CHEMBL1800685		IC50	µM	9.02	CHEMBL267	Homo sapiens	IC50	µM	9.02
Not Active	23353519	CHEMBL4883009	Protein Tyrosine Kinase, SRC Eurofins-Panlabs enzyme assay	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		Inhibition	%	-8.0	CHEMBL267	Homo sapiens	% inhibition	%	-8.0
Not Active	23353520	CHEMBL4883009	Protein Tyrosine Kinase, SRC Eurofins-Panlabs enzyme assay	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		Inhibition	%	-3.0	CHEMBL267	Homo sapiens	% inhibition	%	-3.0
Not Active	23353521	CHEMBL4883009	Protein Tyrosine Kinase, SRC Eurofins-Panlabs enzyme assay	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		Inhibition	%	-3.0	CHEMBL267	Homo sapiens	% inhibition	%	-3.0
Not Active	23354166	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL267	Homo sapiens	% Control	%	100.0
Not Active	23354634	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL267	Homo sapiens	% Control	%	100.0
Not Active	23355366	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	95.0	CHEMBL267	Homo sapiens	% Control	%	95.0
Not Active	23355834	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL267	Homo sapiens	% Control	%	100.0
Not Active	23356470	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL267	Homo sapiens	% Control	%	100.0
Not Active	23356938	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL267	Homo sapiens	% Control	%	100.0
Not Active	23357547	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	100.0	CHEMBL267	Homo sapiens	% Control	%	100.0
Not Active	23358194	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	88.0	CHEMBL267	Homo sapiens	% Control	%	88.0
Not Active	23358662	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	100.0	CHEMBL267	Homo sapiens	% Control	%	100.0
Not Active	23359248	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	100.0	CHEMBL267	Homo sapiens	% Control	%	100.0
Not Active	23359846	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	88.0	CHEMBL267	Homo sapiens	% Control	%	88.0
Not Active	23360314	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	99.0	CHEMBL267	Homo sapiens	% Control	%	99.0
Not Active	23360899	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	100.0	CHEMBL267	Homo sapiens	% Control	%	100.0
Not Active	23361367	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	99.0	CHEMBL267	Homo sapiens	% Control	%	99.0
Not Active	23361940	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	95.0	CHEMBL267	Homo sapiens	% Control	%	95.0
Not Active	23362476	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	95.0	CHEMBL267	Homo sapiens	% Control	%	95.0
Not Active	23362944	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	80.0	CHEMBL267	Homo sapiens	% Control	%	80.0
Not Active	23363316	CHEMBL4883274	SRC Kinase activity screen	B	CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5ccncc5)ccc4n3)cc2)CC1		CHEMBL4531334		Inhibition	%	46.66	CHEMBL267	Homo sapiens	% inhibition	%	46.6643
Not Active	23363317	CHEMBL4883274	SRC Kinase activity screen	B	CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5ccncc5)ccc4n3)cc2)CC1		CHEMBL4531334		Inhibition	%	13.15	CHEMBL267	Homo sapiens	% inhibition	%	13.1502
Not Active	23364586	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	78.0	CHEMBL267	Homo sapiens	% Control	%	78.0
Not Active	23365054	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	76.0	CHEMBL267	Homo sapiens	% Control	%	76.0
Not Active	23365793	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	100.0	CHEMBL267	Homo sapiens	% Control	%	100.0
Not Active	23366336	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	93.0	CHEMBL267	Homo sapiens	% Control	%	93.0
Not Active	23366926	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	100.0	CHEMBL267	Homo sapiens	% Control	%	100.0
Not Active	23367394	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL267	Homo sapiens	% Control	%	100.0
Not Active	23367749	CHEMBL4884102	SRC ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	119.0	CHEMBL267	Homo sapiens	% Residual activity with Skepinone-L	%	119.0
Not Active	23368272	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	93.0	CHEMBL267	Homo sapiens	% Control	%	93.0
Not Active	23368740	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	91.0	CHEMBL267	Homo sapiens	% Control	%	91.0
Not Active	23369339	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	100.0	CHEMBL267	Homo sapiens	% Control	%	100.0
Not Active	23369807	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	100.0	CHEMBL267	Homo sapiens	% Control	%	100.0
Not Active	23370033	CHEMBL4884277	cSRC(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	85.0	CHEMBL267	Homo sapiens	% residual kinase activity	%	85.0
Not Active	23370775	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	94.0	CHEMBL267	Homo sapiens	% Control	%	94.0
Not Active	23371243	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	89.0	CHEMBL267	Homo sapiens	% Control	%	89.0
Not Active	23372052	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	100.0	CHEMBL267	Homo sapiens	% Control	%	100.0
Not Active	23372520	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	94.0	CHEMBL267	Homo sapiens	% Control	%	94.0
	23373743	CHEMBL4885520	Src(SRC1LGF5) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL267	Homo sapiens	pIC50		6.0
Not Active	23375107	CHEMBL4886095	Src Kinase panel	B	CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O		CHEMBL4475494		Inhibition	%	23.8	CHEMBL267	Homo sapiens	% Inhibition	%	23.8
Not Active	23375411	CHEMBL4886393	v-src sarcoma  viral oncogene homolog Millipore kinase panel	B	COCCc1ccc(-c2c(C)nc3c(N4CCOCC4)ccnn23)cn1		CHEMBL2180408		Inhibition	%	-5.0	CHEMBL267	Homo sapiens	% inhibition	%	-5.0
Not Active	23375947	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	100.0	CHEMBL267	Homo sapiens	% Control	%	100.0
Not Active	23376415	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	92.0	CHEMBL267	Homo sapiens	% Control	%	92.0
Not Active	23376992	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	92.0	CHEMBL267	Homo sapiens	% Control	%	92.0
Not Active	23377460	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	85.0	CHEMBL267	Homo sapiens	% Control	%	85.0
Not Active	23378320	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	91.0	CHEMBL267	Homo sapiens	% Control	%	91.0
Not Active	23378788	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	90.0	CHEMBL267	Homo sapiens	% Control	%	90.0
Not Active	23379392	CHEMBL4883009	Protein Tyrosine Kinase, SRC Eurofins-Panlabs enzyme assay	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		Inhibition	%	0.0	CHEMBL267	Homo sapiens	% inhibition	%	0.0
Not Active	23379955	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	100.0	CHEMBL267	Homo sapiens	% Control	%	100.0
Not Active	23380423	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	56.0	CHEMBL267	Homo sapiens	% Control	%	56.0
Not Active	23381117	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	100.0	CHEMBL267	Homo sapiens	% Control	%	100.0
Not Active	23381765	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL267	Homo sapiens	% Control	%	100.0
Not Active	23382233	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	98.0	CHEMBL267	Homo sapiens	% Control	%	98.0
Not Active	23382433	CHEMBL4887148	SRC Invitrogen kinase activity assay	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		Inhibition	%	58.0	CHEMBL267	Homo sapiens	% inhibition	%	58.0
	23382434	CHEMBL4887148	SRC Invitrogen kinase activity assay	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	>	IC50	nM	1000.0	CHEMBL267	Homo sapiens	IC50	nM	1000.0
Not Active	23382857	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	79.0	CHEMBL267	Homo sapiens	% Control	%	79.0
Not Active	23383325	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	60.0	CHEMBL267	Homo sapiens	% Control	%	60.0
Not Active	23383990	CHEMBL4887592	SRC Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	79.0	CHEMBL267	Homo sapiens	% Ctrl	%	79.0
Not Active	23383991	CHEMBL4887592	SRC Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	92.0	CHEMBL267	Homo sapiens	% Ctrl	%	92.0
Not Active	23383992	CHEMBL4887593	SRC N1 Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	88.0	CHEMBL267	Homo sapiens	% Ctrl	%	88.0
Not Active	23384072	CHEMBL4887670	SRC DUNDEE kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	73.8	CHEMBL267	Homo sapiens	% Ctrl	%	73.8
Not Active	23384240	CHEMBL4887835	cSRC(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	7.51	CHEMBL267	Homo sapiens	% inhibition	%	7.51
Not Active	23384718	CHEMBL4888244	SRC SelectScreen Kinase panel (LifeTechnologies)	B	C=CC(=O)Nc1ccc2[nH]c(=O)n(C3CCN(Cc4ccc(-c5nc6cc[nH]c(=O)c6cc5-c5ccccc5)cc4)CC3)c2c1		CHEMBL4795065		Inhibition	%	10.0	CHEMBL267	Homo sapiens	% Inhibition	%	10.0
Not Active	23385240	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	99.0	CHEMBL267	Homo sapiens	% Control	%	99.0
Not Active	23385707	CHEMBL4879964	KinomeScan assay: inhibition of SRC	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	98.0	CHEMBL267	Homo sapiens	% Control	%	98.0
Not Active	23385908	CHEMBL4888381	SRC Invitrogen kinase panel	B	COc1nc2ccc([C@@](O)(c3ccccc3)C3CCN(C(C)=O)CC3)cc2c(Cl)c1Cc1ccc(-n2cccn2)cc1		CHEMBL4802042		Inhibition	%	4.0	CHEMBL267	Homo sapiens	% inhibition	%	4.0
